Citrus Sinensis ID: 047591
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1624 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGT6 | 1031 | LRR receptor-like serine/ | yes | no | 0.527 | 0.831 | 0.357 | 1e-145 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.533 | 0.858 | 0.359 | 1e-141 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.531 | 0.841 | 0.344 | 1e-129 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.581 | 0.804 | 0.308 | 1e-124 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.512 | 0.664 | 0.323 | 1e-118 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.539 | 0.701 | 0.315 | 1e-116 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.586 | 0.838 | 0.310 | 1e-112 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.546 | 0.885 | 0.328 | 1e-111 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.553 | 0.787 | 0.322 | 1e-109 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.562 | 0.824 | 0.302 | 1e-109 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 517 bits (1332), Expect = e-145, Method: Compositional matrix adjust.
Identities = 354/989 (35%), Positives = 512/989 (51%), Gaps = 132/989 (13%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIP 97
TD ALL+ K+ ++ + + +WN S+ CNW+GVTCG R RV L++
Sbjct: 30 TDMQALLEFKSQVSENNKREVLASWN--------HSSPFCNWIGVTCGRRRERVISLNLG 81
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM 157
L G I P + NLSFL LN++ N F T+P ++ G LF
Sbjct: 82 GFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKV-----------------GRLF--- 121
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
L+ ++S N + G++PSSL +CS+L + +S N L +P +G+L++L L L
Sbjct: 122 -----RLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDL 176
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK 277
+ NNL G FP ++ N++SL+ + A N + G IP
Sbjct: 177 SKNNLTGNFPASLGNLTSLQKLDFAYNQM-------------------------RGEIPD 211
Query: 278 DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI 337
++ T + + N+ +G P ++N S++E + L N SGNL + G
Sbjct: 212 EVARLTQMVFF--------QIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGY 263
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
LPNL RL L N +G IP ++ N S L ++S N SG + +FG R L L +
Sbjct: 264 LLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRN 323
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+ L S S + F ++ NC L YL + N G LP S+ NLS +L + G +
Sbjct: 324 NSLGNNSSSGLE-FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
G IP + GNL ++ LSL N L+ +P + GKL NLQ +DL N I G IPS +
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L L L N+ +IP L L L + +NRLN TIP + + +D S N L+
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLIS 637
G P+++G L++L GL S N+LS +P +IGG + +L + N F G+IP+ I L+S
Sbjct: 503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVS 561
Query: 638 LE---------------------------------KGEIPSGGPFVNFTEGSFMQNYALC 664
L+ +G +P+ G F N T S N +C
Sbjct: 562 LKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNIC 621
Query: 665 GSLR-LQVQAC-ETSSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRCC----TRNKNL 718
G +R +Q++ C +S ++ K + + V+ + + L LIII C + KN
Sbjct: 622 GGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNN 681
Query: 719 PILEN--DSLSLATWR-RISYQELQRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIK 774
N DS +L + ++SY+EL T FS +NLIG+G+FG+V+K L P VA+K
Sbjct: 682 ASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVK 741
Query: 775 VFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN-----HGFKALILEYMPQGSLEK 829
V NL GA KSF AECE + +RHRNLVK+I+ CS+ + F+AL+ E+MP+GSL+
Sbjct: 742 VLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDM 801
Query: 830 WLY--------SHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDD 880
WL H +L ++L+I IDVASALEYLH H H PV HCD+KPSN+LLDDD
Sbjct: 802 WLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCH-DPVAHCDIKPSNILLDDD 860
Query: 881 TVAHLSDFGISKLL---DGEDSVTQTMTL---ATFGYMAPEYGSEGIVSTCGDVYSFGIL 934
AH+SDFG+++LL D E + Q + T GY APEYG G S GDVYSFGIL
Sbjct: 861 LTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGIL 920
Query: 935 MIETFTRKMPTDEMFTGETSLKKWVEESL 963
++E F+ K PTDE F G+ +L + + L
Sbjct: 921 LLEMFSGKKPTDESFAGDYNLHSYTKSIL 949
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 360/1001 (35%), Positives = 520/1001 (51%), Gaps = 134/1001 (13%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIP 97
TD ALLQ K+ ++ D + +WN S +CNW GVTCG ++ R +
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLS-SWN--------HSFPLCNWKGVTCGRKNKR-----VT 69
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM 157
+L LG RL++ G +
Sbjct: 70 HLELG-----------------------------------RLQL---------GGVISPS 85
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
+L+ L S D+ N G +P +G S+L+ L + N L G IP + N + L+ L L
Sbjct: 86 IGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRL 145
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK 277
+ N L G P + ++++L + L N++ G LP L L L++L L G IP
Sbjct: 146 DSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGN-LTLLEQLALSHNNLEGEIPS 204
Query: 278 DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI 337
D+ T + L L ANN +G+ P ++N S+++++ + NH SG L GI
Sbjct: 205 DVAQLTQIWSLQLV--------ANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGI 256
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
LPNLL + GN +G IP+++ N S L L ++ N +G + TFGN L++L L
Sbjct: 257 LLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHT 315
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+ L + S S+ F +SLTNC L L I N G LP S+ NLS L G +
Sbjct: 316 NSLGSDS-SRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLIS 374
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
G IP + GNL N+ L L QN L+ +PT++GKL NL+ L L N + G IP+ + +
Sbjct: 375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L TL L N + +PT L N + L L + N+LN TIP ++ +L +D S N L
Sbjct: 435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIG-----------------------GLKDL 614
G LPQDIG L+ L L L N+LS +P ++G GL +
Sbjct: 495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGV 554
Query: 615 TYLALARNGFQGSIPEAIGSLISLE---------KGEIPSGGPFVNFTEGSFMQNYALCG 665
+ L+ N GSIPE S LE +G++P G F N T S + N LCG
Sbjct: 555 KEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCG 614
Query: 666 SLR-LQVQAC--ETSSTQQSKSSKLLRYVLPAVATAVVMLALI------IIFIRCCTRNK 716
+ Q++ C + S + SS+L + V+ V+ + +L L+ +I++R +NK
Sbjct: 615 GIMGFQLKPCLSQAPSVVKKHSSRLKKVVI-GVSVGITLLLLLFMASVTLIWLRKRKKNK 673
Query: 717 NLPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMN-VAIKV 775
+L + +ISY +L+ T+GFS SN++G+GSFG+VYKA L VA+KV
Sbjct: 674 ETNNPTPSTLEVL-HEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKV 732
Query: 776 FNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN-----HGFKALILEYMPQGSLEKW 830
N+Q GA+KSF AECE L+ +RHRNLVK++++CS+ + F+ALI E+MP GSL+ W
Sbjct: 733 LNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMW 792
Query: 831 LYSHKY--------TLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDT 881
L+ + TL + +RL+I IDVAS L+YLH H H P+ HCDLKPSNVLLDDD
Sbjct: 793 LHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCH-EPIAHCDLKPSNVLLDDDL 851
Query: 882 VAHLSDFGISKLL---DGEDSVTQTMTL---ATFGYMAPEYGSEGIVSTCGDVYSFGILM 935
AH+SDFG+++LL D E Q + T GY APEYG G S GDVYSFGIL+
Sbjct: 852 TAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILL 911
Query: 936 IETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELL 976
+E FT K PT+E+F G +L + + +L + ++VD +L
Sbjct: 912 LEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL 952
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1197), Expect = e-129, Method: Compositional matrix adjust.
Identities = 346/1004 (34%), Positives = 509/1004 (50%), Gaps = 141/1004 (14%)
Query: 26 AKLMSITEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCG 85
A+ + +TE TD+ ALL+ K+ ++ + +WN S +C+W GV CG
Sbjct: 30 AQTIRLTEE---TDKQALLEFKSQVS-ETSRVVLGSWN--------DSLPLCSWTGVKCG 77
Query: 86 SRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLS 145
+H RVT + + L L G + P V NLSFL SLN++ N FHG +P+E+
Sbjct: 78 LKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEV------------ 125
Query: 146 SNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQN 205
GNLF L+ ++S+N G +P L +CS L L +S N L +P
Sbjct: 126 -----GNLF--------RLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLE 172
Query: 206 IGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELN 265
G+L++L+ L L NNL G+FP ++ N++SL+++ N + G +P D+ R
Sbjct: 173 FGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIAR--------- 223
Query: 266 LRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGN 325
L+ N G+ P I+N S++ + + GN
Sbjct: 224 ------------------------LKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGN 259
Query: 326 HLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFG 385
SG L G LPNL LY+ N+ +G IP ++ N S L L++ N +G + +FG
Sbjct: 260 SFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFG 319
Query: 386 NCRQLQILNLAYSQLATGSLSQGQ-SFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSK 444
R +L L + + G+ S G F +LTNC L+YL + N G LP + NLS
Sbjct: 320 --RLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLST 377
Query: 445 SLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNI 504
L G + G IP GNL ++ L L +N L +P ++G+L L+ + L N +
Sbjct: 378 QLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGL 437
Query: 505 QGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLE 564
G IPS L + L L L N+ + IP+ L + + L LNL +N+LN +IP L
Sbjct: 438 SGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELP 497
Query: 565 YILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSS----------------- 607
++V++ S NLL G L QDIG LK L L +S N+LS IP +
Sbjct: 498 SLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSF 557
Query: 608 ------IGGLKDLTYLALARNGFQGSIPEAIGSLISLE---------KGEIPSGGPFVNF 652
I GL L +L L++N G+IPE + + L+ G +P+ G F N
Sbjct: 558 VGPIPDIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNT 617
Query: 653 TEGSFMQNYALCGSL-RLQVQACETSSTQQSKSSKLLRYVLPAVATAVVMLALII----- 706
+ S N LCG + LQ+Q C ++ S + + + + A ++L +
Sbjct: 618 SAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLC 677
Query: 707 ---IFIRCCTRNKNLPILEND---SLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSV 760
+ ++ N N END S + + +ISY EL + T GFS SNLIG+G+FG+V
Sbjct: 678 WYKLRVKSVRANNN----ENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAV 733
Query: 761 YKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN-----HGF 814
+K L VAIKV NL GA KSF AECE L +RHRNLVK+++ CS+ + F
Sbjct: 734 FKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDF 793
Query: 815 KALILEYMPQGSLEKWLYSHKY--------TLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+AL+ E+MP G+L+ WL+ + TL + RL+I IDVASAL YLH P+
Sbjct: 794 RALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIA 853
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA------TFGYMAPEYGSEG 920
HCD+KPSN+LLD D AH+SDFG+++LL D T + + T GY APEYG G
Sbjct: 854 HCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGG 913
Query: 921 IVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLR 964
S GDVYSFGI+++E FT K PT+++F +L + + +L+
Sbjct: 914 HPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQ 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-124, Method: Compositional matrix adjust.
Identities = 352/1140 (30%), Positives = 554/1140 (48%), Gaps = 196/1140 (17%)
Query: 19 LLAILFMAKLMSITEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCN 78
+L + F +++ + + + AL K I+ DP +W + + CN
Sbjct: 10 ILTLTFFFFGIALAKQSFEPEIEALKSFKNGISNDPLGVLS-DWTIIGSLRH------CN 62
Query: 79 WVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNEL----- 133
W G+TC S G V +S+ L G + P +ANL++L L+++ N F G +P E+
Sbjct: 63 WTGITCDST-GHVVSVSLLEKQLEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTE 121
Query: 134 -------------------WLMPRLRIIDLSSNRISGNLFDDMCNS-------------- 160
W + + +DL +N +SG++ +++C +
Sbjct: 122 LNQLILYLNYFSGSIPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLT 181
Query: 161 ---------LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTE 211
L L+ F + N +TG +P S+G + L L +S N+LTG+IP++ GNL
Sbjct: 182 GKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLN 241
Query: 212 LMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMT 271
L L L N L+G+ P I N SSL + L +N L G +P +L L LQ L +
Sbjct: 242 LQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGN-LVQLQALRIYKNKL 300
Query: 272 TGRIPKDIGNCTLLNYLGLRDNQLT----------------DFGANNLTGLIPSIIFNNS 315
T IP + T L +LGL +N L +NN TG P I N
Sbjct: 301 TSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLR 360
Query: 316 NIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNL 375
N+ V+ + N++SG LP+ G+ L NL L N L+G IPSSI N + L +L+LS N
Sbjct: 361 NLTVLTVGFNNISGELPADLGL-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQ 419
Query: 376 FSGLVANTFG-----------------------NCRQLQILNLAYSQLATGSLSQGQSFF 412
+G + FG NC L+ L++A + L TG+L
Sbjct: 420 MTGEIPRGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNL-TGTLK------ 472
Query: 413 SSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIA 472
+ + LR L + N G +P +GNL K L Y S G IP E NL+ +
Sbjct: 473 PLIGKLQKLRILQVSYNSLTGPIPREIGNL-KDLNILYLHSNGFTGRIPREMSNLTLLQG 531
Query: 473 LSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQI 532
L +Y N L IP + ++ L LDLS N G IP+ +LESL L LQGN I
Sbjct: 532 LRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSI 591
Query: 533 PTCLANLTSLRALNLSSNRLNSTIPSTFW-SLEYI-LVVDFSLNLLSGCLPQDIGNLKVL 590
P L +L+ L ++S N L TIP SL+ + L ++FS NLL+G +P+++G L+++
Sbjct: 592 PASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMV 651
Query: 591 TGLYLSGNQLSCSIPSSIGGLKD-------------------------LTYLALARNGFQ 625
+ LS N S SIP S+ K+ + L L+RN F
Sbjct: 652 QEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFS 711
Query: 626 GSIPEAIGS---LISLE------------------------------KGEIPSGGPFVNF 652
G IP++ G+ L+SL+ KG +P G F N
Sbjct: 712 GEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNI 771
Query: 653 TEGSFMQNYALCGSLR-LQVQACETSSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRC 711
M N LCGS + L+ + S+ SK ++++ +L + A +++L L++I + C
Sbjct: 772 NASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLI-LTC 830
Query: 712 C---------TRNKNLPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYK 762
C + +LP L+ S +R +EL++ TD F+ +N+IG+ S +VYK
Sbjct: 831 CKKKEKKIENSSESSLPDLD----SALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYK 886
Query: 763 ATLPYGMNVAIKVFNLQLDGA--IKSFDAECEVLRRVRHRNLVKIISSCSNHG-FKALIL 819
L G +A+KV NL+ A K F E + L +++HRNLVKI+ G KAL+L
Sbjct: 887 GQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVL 946
Query: 820 EYMPQGSLEKWLYSHKYTL-NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD 878
+M G+LE ++ + ++ +++D+ + +AS ++YLH G+ P++HCDLKP+N+LLD
Sbjct: 947 PFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLD 1006
Query: 879 DDTVAHLSDFGISKLL----DGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGIL 934
D VAH+SDFG +++L DG + + + T GY+APE+ V+T DV+SFGI+
Sbjct: 1007 SDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGII 1066
Query: 935 MIETFTRKMPT--DEMFTGETSLKKWVEESL---RLAVTEVVDAEL----LSSEEEEGAD 985
M+E T++ PT ++ + + +L++ VE+S+ R + V+D EL +S ++EE +
Sbjct: 1067 MMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIE 1126
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 429 bits (1102), Expect = e-118, Method: Compositional matrix adjust.
Identities = 317/981 (32%), Positives = 481/981 (49%), Gaps = 149/981 (15%)
Query: 101 LGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNS 160
L G IP + L+ L +L++S N G + E W M +L + L+ NR+SG+L +C++
Sbjct: 276 LQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSN 335
Query: 161 LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGN 220
T L+ +S Q++G++P+ + +C LK L +S N LTG+IP ++ L EL LYLN N
Sbjct: 336 NTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNN 395
Query: 221 NLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIG 280
+L+G +I N+++L+ L +N+L G +P ++ L L+ + L + +G +P +IG
Sbjct: 396 SLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGF-LGKLEIMYLYENRFSGEMPVEIG 454
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLP 340
NCT L + I YGN LSG +PSS G L
Sbjct: 455 NCTRL--------------------------------QEIDWYGNRLSGEIPSSIG-RLK 481
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
+L RL+L N L G IP+S+ N ++TV++L+ N SG + ++FG L++ + Y+
Sbjct: 482 DLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELF-MIYNNS 540
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG--G 458
G+L SL N + L + +N + G S+ L S Y E G G
Sbjct: 541 LQGNLPD------SLINLKNLTRINFSSNKFNG----SISPLCGSSSYLSFDVTENGFEG 590
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESL 518
IP E G +N+ L L +NQ IP T GK+ L LD+S N++ G IP EL + L
Sbjct: 591 DIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKL 650
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
+ L N L IPT L L L L LSSN+ ++P+ +SL IL + N L+G
Sbjct: 651 THIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNG 710
Query: 579 CLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISL 638
+PQ+IGNL+ L L L NQLS +PS+IG L L L L+RN G IP IG L L
Sbjct: 711 SIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDL 770
Query: 639 EK----------GEIPS------------------------------------------- 645
+ G IPS
Sbjct: 771 QSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLE 830
Query: 646 ---GGPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSKS-SKLLRYVLPAVATAVVM 701
F + +F+ N LCGS + C + ++ +S S ++ A+++ +
Sbjct: 831 GKLKKQFSRWQADAFVGNAGLCGS---PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAI 887
Query: 702 LALIIIFIRCCTRNKNL--------------------PILENDSLSLATWRRISYQELQR 741
++++ I +N +L P+ N I + ++
Sbjct: 888 ALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNG----GAKSDIKWDDIME 943
Query: 742 LTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHR 800
T +E +IG+G G VYKA L G +A+K + D + KSF+ E + L +RHR
Sbjct: 944 ATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHR 1003
Query: 801 NLVKIISSCSNH--GFKALILEYMPQGSLEKWLYSHKYT-----LNIQQRLDIMIDVASA 853
+LVK++ CS+ G LI EYM GS+ WL++++ T L + RL I + +A
Sbjct: 1004 HLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQG 1063
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE---DSVTQTMTLATFG 910
+EYLH+ P++H D+K SNVLLD + AHL DFG++K+L G ++ + TM ++G
Sbjct: 1064 VEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYG 1123
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRL----- 965
Y+APEY + DVYS GI+++E T KMPT+ MF ET + +WVE L
Sbjct: 1124 YIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSE 1183
Query: 966 AVTEVVDAELLS--SEEEEGA 984
A +++D+EL S EEE A
Sbjct: 1184 AREKLIDSELKSLLPCEEEAA 1204
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-116, Method: Compositional matrix adjust.
Identities = 332/1051 (31%), Positives = 498/1051 (47%), Gaps = 175/1051 (16%)
Query: 94 LSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNL 153
L++ + L G IP + L + SL + N G +P EL L + + N ++G +
Sbjct: 172 LALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTI 231
Query: 154 FDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELM 213
++ L LE ++++N +TG++PS LG+ S+L+ LS+ N+L G IP+++ +L L
Sbjct: 232 PAEL-GRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQ 290
Query: 214 ELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273
L L+ NNL GE P +N+S L +VLANN L GSLP +C +L++L L +G
Sbjct: 291 TLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSG 350
Query: 274 RIPKDIGNCTLLNYLGLRDN--------------QLTDFG-------------------- 299
IP ++ C L L L +N +LTD
Sbjct: 351 EIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNL 410
Query: 300 ------ANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLS 353
NNL G +P I +EV+ LY N SG +P G N +L + ++GN+
Sbjct: 411 QWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIG-NCTSLKMIDMFGNHFE 469
Query: 354 GVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFS 413
G IP SI +L +L L +N G + + GNC QL IL+LA +QL+ GS+ F
Sbjct: 470 GEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLS-GSIPSSFGFL- 527
Query: 414 SLTNCRYLRYLAIQTNPWKGILPNSVGNL----------------------SKSLEYFYA 451
+ L L + N +G LP+S+ +L S S F
Sbjct: 528 -----KGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDV 582
Query: 452 GSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE 511
+ IP E GN N+ L L +NQL IP T+GK++ L LD+S N + G+IP +
Sbjct: 583 TNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQ 642
Query: 512 LCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDF 571
L + L + L N L IP L L+ L L LSSN+ ++P+ ++ +LV+
Sbjct: 643 LVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSL 702
Query: 572 SLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNG-------- 623
N L+G +PQ+IGNL L L L NQ S S+P ++G L L L L+RN
Sbjct: 703 DGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVE 762
Query: 624 -----------------FQGSIPEAIGSLISLEK---------GEIPS------------ 645
F G IP IG+L LE GE+P
Sbjct: 763 IGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLN 822
Query: 646 ------GGP----FVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSKSSKLLRYVLPAV 695
GG F + SF+ N LCGS + +++ QQ S++ V+ +
Sbjct: 823 VSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSAR--SVVIISA 880
Query: 696 ATAVVMLALIIIFIRCCTRNKN------------------------LPILENDSLSLATW 731
+A+ + L+I+ I + ++ P+ N A+
Sbjct: 881 ISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNG----ASK 936
Query: 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD-GAIKSFDAE 790
I ++++ T SE +IG+G G VYKA L G VA+K + D + KSF E
Sbjct: 937 SDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSRE 996
Query: 791 CEVLRRVRHRNLVKIISSCSN--HGFKALILEYMPQGSLEKWLYS-------HKYTLNIQ 841
+ L R+RHR+LVK++ CS+ G LI EYM GS+ WL+ K L+ +
Sbjct: 997 VKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWE 1056
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL-DGEDSV 900
RL I + +A +EYLHH P++H D+K SNVLLD + AHL DFG++K+L + D+
Sbjct: 1057 ARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTN 1116
Query: 901 TQTMTL--ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKW 958
T + T ++GY+APEY + DVYS GI+++E T KMPTD +F E + +W
Sbjct: 1117 TDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRW 1176
Query: 959 VEESLRLAVT---EVVDAEL--LSSEEEEGA 984
VE L +A + +++D +L L EE+ A
Sbjct: 1177 VETHLEVAGSARDKLIDPKLKPLLPFEEDAA 1207
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1043), Expect = e-112, Method: Compositional matrix adjust.
Identities = 328/1057 (31%), Positives = 508/1057 (48%), Gaps = 105/1057 (9%)
Query: 10 KMNIPCGRALLAI-------LFMAKLMSITEANITTDEAALLQVKAHIALDPQNFFERNW 62
+M IP +AL LF+A +S T A +T+E + L H + P W
Sbjct: 4 QMPIPRKKALTVSHFSITLSLFLAFFISSTSA--STNEVSALISWLHSSNSPPPSVFSGW 61
Query: 63 NLSATTNTSSSNSVCNWVGVTCGSRHGR-VTDLSIPNLGLGGTIPPHVANLSFLVSLNIS 121
N S + C W +TC S + VT++++ ++ L PP++++ + L L IS
Sbjct: 62 N-------PSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVIS 114
Query: 122 GNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSS 181
G + +E+ L +IDLSSN + G + + L L+ ++SN +TG++P
Sbjct: 115 NTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSL-GKLKNLQELCLNSNGLTGKIPPE 173
Query: 182 LGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNN-LQGEFPPTIFNVSSLRVIV 240
LGDC LK L + N L+ +P +G ++ L + GN+ L G+ P I N +L+V+
Sbjct: 174 LGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLG 233
Query: 241 LANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT---- 296
LA + GSLPV L +L LQ L++ M +G IPK++GNC+ L L L DN L+
Sbjct: 234 LAATKISGSLPVSL-GQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLP 292
Query: 297 -DFGA-----------NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLR 344
+ G NNL G IP I ++ I L N+ SG +P S G NL NL
Sbjct: 293 KELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFG-NLSNLQE 351
Query: 345 LYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGS 404
L L NN++G IPS + N +KL ++ N SGL+ G ++L I L + G+
Sbjct: 352 LMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIF-LGWQNKLEGN 410
Query: 405 LSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEF 464
+ L C+ L+ L + N G LP + L ++L S + G IP E
Sbjct: 411 IPD------ELAGCQNLQALDLSQNYLTGSLPAGLFQL-RNLTKLLLISNAISGVIPLEI 463
Query: 465 GNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQ 524
GN ++++ L L N++ IP +G LQNL LDLS NN+ G +P E+ L L L
Sbjct: 464 GNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLS 523
Query: 525 GNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI 584
N LQ +P L++LT L+ L++SSN L IP + L + + S N +G +P +
Sbjct: 524 NNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSL 583
Query: 585 GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTY-LALARNGFQGSIPEAIGSL-------- 635
G+ L L LS N +S +IP + ++DL L L+ N G IPE I +L
Sbjct: 584 GHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDI 643
Query: 636 ------------------ISLE------KGEIPSGGPFVNFTEGSFMQNYALC--GSLRL 669
+SL G +P F N LC G
Sbjct: 644 SHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSC 703
Query: 670 QVQACETSSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILENDSLS-- 727
V +TQ+ S LR + + + +LA ++ + R K + +NDS +
Sbjct: 704 FVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLA--VLGVLAVIRAKQMIRDDNDSETGE 761
Query: 728 -LATWRRISYQEL----QRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIK------VF 776
L TW+ +Q+L + + E N+IG G G VYKA +P +A+K V
Sbjct: 762 NLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVP 821
Query: 777 NL----QLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY 832
NL + G SF AE + L +RH+N+V+ + C N + L+ +YM GSL L+
Sbjct: 822 NLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLH 881
Query: 833 --SHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGI 890
S +L + R I++ A L YLHH P++H D+K +N+L+ D ++ DFG+
Sbjct: 882 ERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGL 941
Query: 891 SKLLDGEDSVTQTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949
+KL+D D + T+A ++GY+APEYG ++ DVYS+G++++E T K P D
Sbjct: 942 AKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 1001
Query: 950 TGETSLKKWVEESLRLAVTEVVDAELLSSEEEEGADL 986
+ WV+ ++ +V+D L + E E ++
Sbjct: 1002 PDGLHIVDWVK---KIRDIQVIDQGLQARPESEVEEM 1035
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 405 bits (1041), Expect = e-111, Method: Compositional matrix adjust.
Identities = 322/981 (32%), Positives = 480/981 (48%), Gaps = 94/981 (9%)
Query: 30 SITEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHG 89
S T A T+ ALL +K+ +D + +WNLS T C+W GVTC
Sbjct: 18 SFTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTT--------FCSWTGVTCDVSLR 69
Query: 90 RVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI 149
VT L + L L GT+ VA+L L +L+++ N+ G +P ++ + LR ++LS+N
Sbjct: 70 HVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVF 129
Query: 150 SGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNL 209
+G+ D++ + L L D+ +N +TG LP SL + ++L+ L + N +G+IP G
Sbjct: 130 NGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTW 189
Query: 210 TELMELYLNGNNLQGEFPPTIFNVSSLRVIVLAN-NSLFGSLPVDLCRRLPSLQELNLRD 268
L L ++GN L G+ PP I N+++LR + + N+ LP ++ L L + +
Sbjct: 190 PVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGN-LSELVRFDAAN 248
Query: 269 CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLS 328
C TG IP +IG L+ L L+ N T L GLI S+++ + L N +
Sbjct: 249 CGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQEL-GLI-------SSLKSMDLSNNMFT 300
Query: 329 GNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCR 388
G +P+S L NL L L+ N L G IP I +L VL+L N F+G + G
Sbjct: 301 GEIPTSFS-QLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENG 359
Query: 389 QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQT--NPWKGILPNSVGNLSKSL 446
+L IL+L+ ++L TG+L C R + + T N G +P+S+G +SL
Sbjct: 360 RLVILDLSSNKL-TGTLPPNM--------CSGNRLMTLITLGNFLFGSIPDSLGK-CESL 409
Query: 447 EYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQ-NLQGLDLSYNNIQ 505
G L G IP E L + + L N L +P + G + +L + LS N +
Sbjct: 410 TRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLS 469
Query: 506 GSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEY 565
GS+P+ + L + LLL GN IP + L L L
Sbjct: 470 GSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKL-------------------- 509
Query: 566 ILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ 625
DFS NL SG + +I K+LT + LS N+LS IP+ + G+K L YL L+RN
Sbjct: 510 ----DFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLV 565
Query: 626 GSIPEAIGSLISLE---------KGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQACET 676
GSIP I S+ SL G +PS G F F SF+ N LCG + C
Sbjct: 566 GSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPY---LGPCGK 622
Query: 677 SSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILENDSLSLAT----WR 732
+ Q +V P AT ++L L ++F C + I++ SL A+ WR
Sbjct: 623 GTHQS--------HVKPLSATTKLLLVLGLLF--CSMVFAIVAIIKARSLRNASEAKAWR 672
Query: 733 RISYQEL----QRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKS-- 786
++Q L + D E N+IG G G VYK T+P G VA+K G+
Sbjct: 673 LTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHG 732
Query: 787 FDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLD 845
F+AE + L R+RHR++V+++ CSNH L+ EYMP GSL + L+ K L+ R
Sbjct: 733 FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYK 792
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL-DGEDSVTQTM 904
I ++ A L YLHH ++H D+K +N+LLD + AH++DFG++K L D S +
Sbjct: 793 IALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSA 852
Query: 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE---E 961
++GY+APEY V DVYSFG++++E T K P E G + +WV +
Sbjct: 853 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDG-VDIVQWVRSMTD 911
Query: 962 SLRLAVTEVVDAELLSSEEEE 982
S + V +V+D L S E
Sbjct: 912 SNKDCVLKVIDLRLSSVPVHE 932
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1024), Expect = e-109, Method: Compositional matrix adjust.
Identities = 323/1003 (32%), Positives = 498/1003 (49%), Gaps = 104/1003 (10%)
Query: 61 NWNLSATTNTSSSNSVCN-WVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLN 119
NWN S N+ CN W +TC S+ G +TD+ I ++ L ++P ++ L L
Sbjct: 60 NWN-------SIDNTPCNNWTFITCSSQ-GFITDIDIESVPLQLSLPKNLPAFRSLQKLT 111
Query: 120 ISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLP 179
ISG GTLP L L+++DLSSN + G++ + + L LE+ ++SNQ+TG++P
Sbjct: 112 ISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSL-SKLRNLETLILNSNQLTGKIP 170
Query: 180 SSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNN-LQGEFPPTIFNVSSLRV 238
+ CSKLK L + N LTG IP +G L+ L + + GN + G+ P I + S+L V
Sbjct: 171 PDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTV 230
Query: 239 IVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTD- 297
+ LA S+ G+LP L +L L+ L++ M +G IP D+GNC+ L L L +N L+
Sbjct: 231 LGLAETSVSGNLPSSL-GKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGS 289
Query: 298 ---------------FGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNL 342
N+L G IP I N SN+++I L N LSG++PSS G L L
Sbjct: 290 IPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG-RLSFL 348
Query: 343 LRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFG----------------- 385
+ N SG IP++I N S L L+L +N SGL+ + G
Sbjct: 349 EEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEG 408
Query: 386 -------NCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNS 438
+C LQ L+L+ + L TG++ G L R L L + +N G +P
Sbjct: 409 SIPPGLADCTDLQALDLSRNSL-TGTIPSG------LFMLRNLTKLLLISNSLSGFIPQE 461
Query: 439 VGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLD 498
+GN S SL G + G IP+ G+L I L N+L +P +G LQ +D
Sbjct: 462 IGNCS-SLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMID 520
Query: 499 LSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPS 558
LS N+++GS+P+ + L L L + N +IP L L SL L LS N + +IP+
Sbjct: 521 LSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPT 580
Query: 559 TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLT-GLYLSGNQLSCSIPSSIGGLKDLTYL 617
+ + ++D N LSG +P ++G+++ L L LS N+L+ IPS I L L+ L
Sbjct: 581 SLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSIL 640
Query: 618 ALARNGFQGSI-PEA-IGSLISLE------KGEIPSGGPFVNFTEGSFMQNYALCGSLRL 669
L+ N +G + P A I +L+SL G +P F + N LC S +
Sbjct: 641 DLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQ- 699
Query: 670 QVQACETSSTQ---------QSKSSKLLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPI 720
+C + + S++ KL + + VV++ L + + RN +
Sbjct: 700 --DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNID--- 754
Query: 721 LENDSLSLAT--WRRISYQELQRLTDG----FSESNLIGAGSFGSVYKATLPYGMNVAIK 774
E DS T W+ +Q+L D E N+IG G G VY+A + G +A+K
Sbjct: 755 NERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVK 814
Query: 775 -----VFNLQLDGAIK----SFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQG 825
+ N D K SF AE + L +RH+N+V+ + C N + L+ +YMP G
Sbjct: 815 KLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNG 874
Query: 826 SLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH 884
SL L+ + +L+ R I++ A L YLHH P++H D+K +N+L+ D +
Sbjct: 875 SLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPY 934
Query: 885 LSDFGISKLLDGEDSVTQTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKM 943
++DFG++KL+D D + T+A ++GY+APEYG ++ DVYS+G++++E T K
Sbjct: 935 IADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQ 994
Query: 944 PTDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEEEEGADL 986
P D L WV ++ EV+D+ L S E E ++
Sbjct: 995 PIDPTVPEGIHLVDWVRQN--RGSLEVLDSTLRSRTEAEADEM 1035
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 399 bits (1024), Expect = e-109, Method: Compositional matrix adjust.
Identities = 328/1085 (30%), Positives = 516/1085 (47%), Gaps = 171/1085 (15%)
Query: 22 ILFMAKLMSITEA-NITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWV 80
+LF+ SI A + +D AALL + H P + ++WN S +T C+W+
Sbjct: 9 LLFLCSTSSIYAAFALNSDGAALLSLTRHWTSIPSDI-TQSWNASDST-------PCSWL 60
Query: 81 GVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLR 140
GV C R V L++ + G+ G P +++L L + +SGN F G++P++L L
Sbjct: 61 GVECDRRQ-FVDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLE 119
Query: 141 IIDLSSNRISGNL-----------------------FDDMCNSLTELESFDVSSNQITGQ 177
IDLSSN +GN+ F + S+ LE+ + N + G
Sbjct: 120 HIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGS 179
Query: 178 LPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLR 237
+PS++G+ S+L L + N+ +G +P ++GN+T L ELYLN NNL G P T+ N+ +L
Sbjct: 180 IPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLV 239
Query: 238 VIVLANNSLFGSLPVDL--CRR--------------LP-------SLQELNLRDCMTTG- 273
+ + NNSL G++P+D C++ LP SL+E C +G
Sbjct: 240 YLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGP 299
Query: 274 -----------------------RIPKDIGNCTLLNYLGLRDNQLT-----DFG------ 299
RIP ++G C + L L+ NQL + G
Sbjct: 300 IPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQ 359
Query: 300 -----ANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSG 354
NNL+G +P I+ +++ +QLY N+LSG LP L L+ L L+ N+ +G
Sbjct: 360 YLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDM-TELKQLVSLALYENHFTG 418
Query: 355 VIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSS 414
VIP + S L VL+L+RN+F+G + + ++L+ L L Y+ L GS+ S
Sbjct: 419 VIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLE-GSVP------SD 471
Query: 415 LTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALS 474
L C L L ++ N +G LP+ V ++L +F G IP GNL N+ A+
Sbjct: 472 LGGCSTLERLILEENNLRGGLPDFVE--KQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIY 529
Query: 475 LYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPT 534
L NQL+ +IP +G L L+ L+LS+N ++G +PSEL L+ L N L IP+
Sbjct: 530 LSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPS 589
Query: 535 CLANLTSLRALNLSSNRLNSTIPSTFW-----------------------SLEYILVVDF 571
L +LT L L+L N + IP++ + +L+ + ++
Sbjct: 590 TLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNL 649
Query: 572 SLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEA 631
S N L+G LP D+G LK+L L +S N LS ++ + ++ LT++ ++ N F G +P
Sbjct: 650 SSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVP-- 706
Query: 632 IGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQ--SKSSKLLR 689
PS F+N + SF N LC + AC SS + + S +
Sbjct: 707 ------------PSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRPCNMQSNTGK 754
Query: 690 YVLPAVATAVVMLALIIIFIRC-----------CTRNKNLPILENDSLSLATWRRISYQE 738
L + A+++L ++FI C C ++ ++ ++S +
Sbjct: 755 GGLSTLGIAMIVLG-ALLFIICLFLFSAFLFLHCKKS-----VQEIAISAQEGDGSLLNK 808
Query: 739 LQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIK--VFNLQLDGAIKSFDAECEVLRR 796
+ T+ ++ +IG G+ G++YKATL A+K VF +G++ S E E + +
Sbjct: 809 VLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSV-SMVREIETIGK 867
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK--YTLNIQQRLDIMIDVASAL 854
VRHRNL+K+ + ++ YM GSL L+ L+ R +I + A L
Sbjct: 868 VRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGL 927
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD-GEDSVTQTMTLATFGYMA 913
YLH ++H D+KP N+LLD D H+SDFGI+KLLD S+ T GYMA
Sbjct: 928 AYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMA 987
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLA--VTEVV 971
PE + S DVYS+G++++E TRK D F GET + WV + ++V
Sbjct: 988 PENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIV 1047
Query: 972 DAELL 976
D LL
Sbjct: 1048 DPSLL 1052
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1624 | ||||||
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.764 | 0.627 | 0.428 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.587 | 0.876 | 0.480 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.575 | 0.860 | 0.491 | 0.0 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.575 | 0.892 | 0.470 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.577 | 0.899 | 0.494 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.533 | 0.816 | 0.508 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.556 | 0.887 | 0.460 | 0.0 | |
| 359482811 | 1118 | PREDICTED: probable LRR receptor-like se | 0.576 | 0.837 | 0.446 | 0.0 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.575 | 0.856 | 0.456 | 0.0 | |
| 147769371 | 1241 | hypothetical protein VITISV_010511 [Viti | 0.541 | 0.708 | 0.464 | 0.0 |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2574), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 634/1481 (42%), Positives = 828/1481 (55%), Gaps = 239/1481 (16%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIP 97
TD+++LL +KAHI LDP + NW S+ S C W+GV+C ++ RV L +
Sbjct: 506 TDQSSLLALKAHITLDPHHVLAGNW--------STKTSFCEWIGVSCNAQQQRVIALDLS 557
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM 157
NLGL GTIPP + NLSFLVSL++S N FHG +P + RL+ + L +N +G + +
Sbjct: 558 NLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPIPPSFGNLNRLQSLFLGNNSFTGTIPPSI 617
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
N ++ LE+ D+ SNQ+ G +PS++ + S L+ +++++N L+G IP+ I L L LYL
Sbjct: 618 GN-MSMLETLDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGTIPEEISFLPSLEYLYL 676
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVD-LCRRLPSLQELNLRDCMTTGRIP 276
N+ P IF +S+L+ I L N GS+P+D +C PSLQ + L TG I
Sbjct: 677 RSNSFTSPIPSAIFKISTLKAIDLGKNGFSGSMPLDIMCAHRPSLQLIGLDSNRFTGTIH 736
Query: 277 KDIGNCTLLNYLGLRDNQLT------DFGA-----------NNLTGLIPSIIFNNSNIEV 319
IGNCT L L L N LT + G+ N+LTG IP IFN S++
Sbjct: 737 GGIGNCTSLRELYLSSNDLTAGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVS 796
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
L N+LSGNLP + G LPNL L L N LSG+IPSSI NASKL L+ N+ +G
Sbjct: 797 GSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGS 856
Query: 380 VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSV 439
+ + G+ R L+ LNL + L S Q SF +SLTNC+ LR L + NP GILP S+
Sbjct: 857 IPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILPISI 916
Query: 440 GNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDL 499
GNLS SL+ F A +C+L G IP E GNLSN+ LSL N L TIP ++G+LQ LQGL L
Sbjct: 917 GNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYL 976
Query: 500 SYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPST 559
N +QGSIP+++CQL +L L L N L IP CL LT LR L L SN+LNSTIPST
Sbjct: 977 PSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPST 1036
Query: 560 FWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLAL 619
WSL +IL +D S N L G LP D+GNLKVL + LS NQLS IPS+IGGL+DLT L+L
Sbjct: 1037 LWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSL 1096
Query: 620 ARNGFQGSIPEAIGSLISLE---------------------------------KGEIPSG 646
A N F+G I + +L SLE GEIP
Sbjct: 1097 AHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPE 1156
Query: 647 GPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSKSSKLLRYVLPAVATAVVMLALII 706
GPF NF+ SFM N AL
Sbjct: 1157 GPFANFSAESFMMNKAL------------------------------------------- 1173
Query: 707 IFIRCCTRNKNLPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLP 766
C RN LP +++SL ATWRRISYQE+ + T+GFS NL+G GS GSVY+ TL
Sbjct: 1174 ----CRKRNAVLPT-QSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLS 1228
Query: 767 YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNH--GFKALILEYMPQ 824
G N AIKVFNLQ + A KSFDAECEV+ +RHRNL+KI+SSCSN FKAL+LEY+P
Sbjct: 1229 DGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPN 1288
Query: 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH 884
GSLE+WLYSH Y L+I QRL+IMIDVA A+EYLHHG TPV+HCDLKPSN+LLD+D H
Sbjct: 1289 GSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGH 1348
Query: 885 LSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+ DFGI+KLL E+S+ +T TLAT GYMAP+Y S GIV+T GDVYS+GI+++ETFTR+ P
Sbjct: 1349 VGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRP 1408
Query: 945 TDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEEEE-------GAD------------ 985
TDE+F+ E S+K WV + L ++TEVVDA LL E+E+ GA+
Sbjct: 1409 TDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFLERLHLGANNLKGESSIQELS 1468
Query: 986 ----LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQ 1041
L + +L+ L +S N + G +P ++GNL+ L L G + K G IP
Sbjct: 1469 FLTSLTNCKRLRILYLSFNPLIGILPISIGNLST--SLQLFGAS------TCKLKGNIPT 1520
Query: 1042 NLGNCTLLNFLILRQNQLT--------------GVRLASNKLIGRIPSMIFNNSNIEAIQ 1087
+GN + L L L N LT G+ L +NKL G IP+ I N+ +
Sbjct: 1521 EIGNLSNLYQLSLNNNDLTGTIPPSIGQLQKLQGLYLPANKLQGSIPNDICQLRNLVELY 1580
Query: 1088 LYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP 1147
L N SG +P+ +G L L+ L L N L+ IP ++ + + ++ L +S N G +P
Sbjct: 1581 LANNQLSGSIPACLGE-LAFLRHLYLGSNKLNSTIPLTLWSLNDILSLDMSSNFLVGYLP 1639
Query: 1148 NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGN 1207
+ GN + L +DLS N L+ +++ L L L +N L+G + +S N
Sbjct: 1640 SDMGNLKVLVKIDLSRNQLSG-------EIPSNIGGLLDLTSLSLAHNRLEGPILHSFSN 1692
Query: 1208 LSTSLEYFFASSTELRGAIPVEFE----------------GEIPSGGPFVNFTAESLMQN 1251
L SLE+ S L G IP E GEIP+ GPF NF+AES M N
Sbjct: 1693 LK-SLEFMDLSDNALSGEIPKSLEGLVYLKYLNMSFNRLYGEIPTEGPFANFSAESFMMN 1751
Query: 1252 LVLGGSSRLQVPPCKTGSSQQSKATRLALRYILPAIATTMAVLALIIILLRRRKRDKSRP 1311
L GS RL++PPC+T + + + L L+YILP IA+T+ +LALI + R RKR+
Sbjct: 1752 KALCGSPRLKLPPCRTVTRWSTTISWLLLKYILPTIASTLLLLALIFVWTRCRKRN---- 1807
Query: 1312 TENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE 1371
+F+ +A F
Sbjct: 1808 ----------------------------------AVFNMQEEAAF--------------- 1818
Query: 1372 DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKALIL 1410
KSFDAECEVMR IRHRNL KI+SSCSN FKAL L
Sbjct: 1819 ----KSFDAECEVMRHIRHRNLIKIISSCSNSYIDFKALTL 1855
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/1051 (48%), Positives = 652/1051 (62%), Gaps = 97/1051 (9%)
Query: 20 LAILFMAKLM----SITEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNS 75
LA L + + + +I ++N+T D +ALL +K H DP F +NW SS+ S
Sbjct: 9 LAFLLLTRWLQFSLAIPKSNLT-DLSALLVLKEHSNFDP--FMSKNW--------SSATS 57
Query: 76 VCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWL 135
C+W GVTC RH RV L++ N+G+ G +PPH+ NLSFLV +++S N + G LPNEL
Sbjct: 58 FCHWYGVTCSERHNRVVALTLSNMGIKGIVPPHIGNLSFLVHIDMSNNSYSGHLPNELGN 117
Query: 136 MPRLRIIDLSSNRISGNLFDDMC------------NSLTE----------LESFDVSSNQ 173
+ RL+ ++ S+N G + + NSLT L + D++ N
Sbjct: 118 LHRLKFMNFSNNSFVGEIPSSLAMLPKLQHLLLANNSLTAGRSSIFNITTLNTLDLNDNL 177
Query: 174 ITGQLPSSLG-DCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFN 232
+ G + ++G + S L+ L++ N+L+G P I +L L +YL NNL G + N
Sbjct: 178 LGGNILDNIGGNLSNLQVLNMGLNQLSGSFPPKILDLPSLKFIYLQVNNLSGNLKEILCN 237
Query: 233 VSS-LRVIVLANNSLFGSLPVDL--CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLG 289
+S L+++ LA N L+G +P DL C+ L SL L TG IP+ IGN T L +L
Sbjct: 238 QNSKLQLLNLAGNQLYGQIPSDLYKCKELRSLA---LHANKFTGSIPRTIGNLTKLKWLS 294
Query: 290 LRDNQLT----------------DFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPS 333
L N LT NNL G IP +FN S ++ I + N+L GNLP+
Sbjct: 295 LGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPT 354
Query: 334 STGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQIL 393
S G++LPNL+ LYL N LSG IPS I NASKLT+LEL N F+G + ++ G+ R LQ L
Sbjct: 355 SLGLHLPNLIWLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTL 414
Query: 394 NLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGS 453
L + L++ SQ + FSSL NC+ L+YL + NP G LP+SVGNLS SLE F A
Sbjct: 415 KLGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASD 474
Query: 454 CELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC 513
+ G + GNLS++ L+L N L IPTT+G L++LQGL L N++ GSIPSELC
Sbjct: 475 GLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELC 534
Query: 514 QLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSL 573
L +L L L GN L IPTC +NLTSLR L L+SNR STI ST W+L+ IL V+ +
Sbjct: 535 DLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLAS 594
Query: 574 NLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIG 633
N L+G LP +I NL+ + + +S NQLS IP SIGGL+DL L L+ N QG IP+++G
Sbjct: 595 NYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVG 654
Query: 634 SLISLE---------------------------------KGEIPSGGPFVNFTEGSFMQN 660
+ SLE +GEIP GG F NF+ SF+ N
Sbjct: 655 DIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGN 714
Query: 661 YALCGSLRLQVQACE---TSSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRCCTRNKN 717
ALCGS RLQV C+ + +T+ S +LRYVLPA+ AV +LA +I+ R C R
Sbjct: 715 EALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAK 774
Query: 718 LPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFN 777
I E+D L+L T RRISY ELQ T+GF ESN +G GSFGSVYK TL G +A KVFN
Sbjct: 775 FSI-EDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFN 833
Query: 778 LQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT 837
LQL+ A KSFD ECEVLR +RHRNLVKII+SCS FKAL+LE+MP SLEKWLYS Y
Sbjct: 834 LQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYF 893
Query: 838 LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897
LN QRL+IM+DVAS LEYLHHG+ P+ HCD+KPSNVLL++D VA L+DFGISKLL E
Sbjct: 894 LNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGEE 953
Query: 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957
SV QTMTLAT GYMAPEYGSEGIVS GDVYS+G+L++ETFT+K PTD+MFT + SLK
Sbjct: 954 GSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKS 1013
Query: 958 WVEESLRLAVTEVVDAELLSSEEEEGADLGD 988
WVE+SL VT+V+DA LL EE+ A D
Sbjct: 1014 WVEQSLSCEVTQVIDANLLGIEEDHLAAKKD 1044
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 862 bits (2226), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/1022 (49%), Positives = 640/1022 (62%), Gaps = 87/1022 (8%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIP 97
TD+++LL +KAHI LDP + NW S+ S C W+GV+C ++ RV L +
Sbjct: 31 TDQSSLLALKAHITLDPHHVLAGNW--------STKTSFCEWIGVSCNAQQQRVIALDLS 82
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM 157
NLGL GTIPP + NLSFLVSL++S N FHG +P E+ + L ++L N +SG +
Sbjct: 83 NLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPPSF 142
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
N L L+S + +N TG +P S+G+ S L+ L + N L G IP+ IG L+ + L +
Sbjct: 143 GN-LNRLQSLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDI 201
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRR------------------LP 259
N L G P IFN+SSL+ I L NSL G LP +C +P
Sbjct: 202 QSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIP 261
Query: 260 S-------LQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT-----DFGA------- 300
S LQ L L TG IP+ I + T L L L N L+ + G+
Sbjct: 262 SNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVL 321
Query: 301 ----NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVI 356
N+LTG IP IFN S++ L N+LSGNLP + G LPNL L L N LSG+I
Sbjct: 322 NIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGII 381
Query: 357 PSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLT 416
PSSI NASKL L+ N+ +G + + G+ R L+ LNL + L S Q SF +SLT
Sbjct: 382 PSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLT 441
Query: 417 NCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLY 476
NC+ LR L + NP GILP S+GNLS SL+ F A +C+L G IP E GNLSN+ LSL
Sbjct: 442 NCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLN 501
Query: 477 QNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCL 536
N L TIP ++G+LQ LQGL L N +QGSIP+++CQL +L L L N L IP CL
Sbjct: 502 NNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACL 561
Query: 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLS 596
LT LR L L SN+LNSTIPST WSL +IL +D S N L G LP D+GNLKVL + LS
Sbjct: 562 GELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLS 621
Query: 597 GNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE----------------- 639
NQLS IPS+IGGL+DLT L+LA N F+G I + +L SLE
Sbjct: 622 RNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSL 681
Query: 640 ----------------KGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSK 683
GEIP GPF NF+ SFM N ALCGS RL++ C T + +
Sbjct: 682 EGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTT 741
Query: 684 SSK-LLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILENDSLSLATWRRISYQELQRL 742
S LL+Y+LPA+ + ++ LALI ++ RC RN LP +++SL ATWRRISYQE+ +
Sbjct: 742 ISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPT-QSESLLTATWRRISYQEIFQA 800
Query: 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNL 802
T+GFS NL+G GS GSVY+ TL G N AIKVFNLQ + A KSFDAECEV+ +RHRNL
Sbjct: 801 TNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNL 860
Query: 803 VKIISSCSNH--GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
+KI+SSCSN FKAL+LEY+P GSLE+WLYSH Y L+I QRL+IMIDVA A+EYLHHG
Sbjct: 861 IKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHG 920
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEG 920
TPV+HCDLKPSN+LLD+D H+ DFGI+KLL E+S+ +T TLAT GYMAP+Y S G
Sbjct: 921 CSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNG 980
Query: 921 IVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEE 980
IV+T GDVYS+GI+++ETFTR+ PTDE+F+ E S+K WV + L ++TEVVDA LL E+
Sbjct: 981 IVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGED 1040
Query: 981 EE 982
E+
Sbjct: 1041 EQ 1042
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 846 bits (2185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/1009 (47%), Positives = 634/1009 (62%), Gaps = 75/1009 (7%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIP 97
DE AL+ +KAHI D Q NW S+ +S CNW G++C + RV+ +++
Sbjct: 8 VDEFALIALKAHITYDSQGILATNW--------STKSSYCNWYGISCNAPQQRVSAINLS 59
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM 157
N+GL GTI P V NLSFLVSL+++ N F G++PN + + L+ + L +N ++G + ++
Sbjct: 60 NMGLEGTIAPQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNL 119
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
+ EL +S NQ TG +P ++G S L+ L +++N+LTG IP+ IGNL+ L L L
Sbjct: 120 SHC-RELRGLSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQL 178
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK 277
N + G P IF VSSL+ I+ ANNSL GSLP+D+C+ LP+LQ L L +G++P
Sbjct: 179 GSNGISGPIPAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPT 238
Query: 278 DIGNCTLLNYLGLRDNQLT----------------DFGANNLTGLIPS----------II 311
+ C L L L N+ T D N+L G IP+ +
Sbjct: 239 TLSLCRELLSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLS 298
Query: 312 FNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLEL 371
FN S ++ + L NHLSG+LPSS G LP+L LY+ N SG IP SI N SKLTVL L
Sbjct: 299 FNISKLQTLGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSL 358
Query: 372 SRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
S N F+G V N +LQ L+LAY+QL L+ G F +SLTNC++LR L I NP
Sbjct: 359 SDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPL 418
Query: 432 KGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKL 491
G LPNS+GNL +LE F A +C+ G IP GNL+N+I L L N L +IPTT+G+L
Sbjct: 419 TGTLPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQL 478
Query: 492 QNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNR 551
Q LQ L + N I+GSIP++LC L++L L L N L IP+C +L +LR L+L SN
Sbjct: 479 QKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNV 538
Query: 552 LNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGL 611
L IP +FWSL +LV++ S N L+G LP ++GN+K +T L LS N +S IPS +G L
Sbjct: 539 LAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKL 598
Query: 612 KDLTYLALARNGFQGSIPEAIGSLISLE-------------------------------- 639
++L L+L++N QG IP G L+SLE
Sbjct: 599 QNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNK 658
Query: 640 -KGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSKSSK--LLRYVLPAVA 696
+GEIP+GGPFV FT SFM N ALCG+ QV AC+ ++ QS +K +L+Y+L V
Sbjct: 659 LQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVG 718
Query: 697 TAVVMLALIIIFIRCCTRNKNLPI-LENDSLSLATWRRISYQELQRLTDGFSESNLIGAG 755
+ V ++ I+++IR R N+ I DS T +IS+Q+L T+ F E NLIG G
Sbjct: 719 STVTLVVFIVLWIR---RRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKG 775
Query: 756 SFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK 815
S G VYK L G+ VAIKVFNL+ GA++SF++ECEV++ +RHRNLV+II+ CSN FK
Sbjct: 776 SQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFK 835
Query: 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNV 875
AL+L+YMP GSLEK LYSH Y L++ QRL+IMIDVASALEYLHH + V+HCDLKPSNV
Sbjct: 836 ALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNV 895
Query: 876 LLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILM 935
LLDDD VAH++DFGI+KLL +S+ QT TL+T GYMAPE+GS GIVST DVYS+GIL+
Sbjct: 896 LLDDDMVAHVADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYGILL 955
Query: 936 IETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEEEEGA 984
+E F RK P DEMFTG+ +LK WV ESL +V +VVD LL E+E+ A
Sbjct: 956 MEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLA 1003
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/1004 (49%), Positives = 639/1004 (63%), Gaps = 66/1004 (6%)
Query: 22 ILFMAKLMSITEA--NITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNW 79
IL + +SI + NI +D+ ALL +K I DP N NW+++ SVC W
Sbjct: 15 ILLYSFFVSIADGVTNIASDQDALLALKVRIIRDPNNLLAANWSITT--------SVCTW 66
Query: 80 VGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRL 139
VGVTCG+RHGRVT L + ++GL GTIPPH+ NLSFL ++ NRFHG+LP+EL + R+
Sbjct: 67 VGVTCGARHGRVTALDLSDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRI 126
Query: 140 RIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGD--CSKLKRLSVSFNE 197
+ +S+N SG + S T+L+ +SSN+ TG LP+ L + S L L N
Sbjct: 127 KAFGMSTNYFSGEI-PSWIGSFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNN 185
Query: 198 LTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCR 256
LTGR+P NI +L L LYLN N G P T+ L+++ L+ N GS+ D+
Sbjct: 186 LTGRLPPNIFTHLANLRALYLNSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGN 245
Query: 257 RLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSN 316
L LQEL L +G IP +IG+ L + L N L+GL+PS I+N S
Sbjct: 246 -LTMLQELYLGGNNFSGTIPDEIGDLAHLEEIILN--------VNGLSGLVPSGIYNASK 296
Query: 317 IEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLF 376
+ I L N LSG LPSS+ NLPNL + NN +G IP S+ NASKL ++L N F
Sbjct: 297 MTAIGLALNQLSGYLPSSS--NLPNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSF 354
Query: 377 SGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILP 436
G + + GN + L++ + + L S S G S FSSLT C++LR + NP G LP
Sbjct: 355 YGPIPDELGNLKSLEVFSFWVNHLTVKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLP 414
Query: 437 NSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQG 496
SVGNLS SLE C + G IP E GNLS++ L L N L TIPTT+ KL LQ
Sbjct: 415 ISVGNLSSSLEVVEIFDCGITGTIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQE 474
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTI 556
L L YN ++GS P ELC L+SL L L+ NAL QIP+CL N+ SLR L++ N+ +STI
Sbjct: 475 LKLHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTI 534
Query: 557 PSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTY 616
PST W L IL ++ S N LSG L DIGNLK +T + LSGNQLS IPSSIGGLK L
Sbjct: 535 PSTLWRLADILELNLSSNSLSGSLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLN 594
Query: 617 LALARNGFQGSIPEAIGSLISLE---------------------------------KGEI 643
L+LA N +GSIP+ G ISL+ +GEI
Sbjct: 595 LSLAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEI 654
Query: 644 PSGGPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSK-SSKL-LRYVLPAVATAVVM 701
P+G F+N + SFM N LCG+ +LQVQ CETS+ Q SK +SKL LRY L A ++
Sbjct: 655 PNGRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTILA 714
Query: 702 LALI-IIFIRCCTRNKNLPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSV 760
+A + IIFIR +R +N+ I E L LAT +RISY+EL++ TD F+E NL+G GSFGSV
Sbjct: 715 VAAVAIIFIR--SRKRNMRITEG-LLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSV 771
Query: 761 YKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS--NHGFKALI 818
YK T G +VA+KVFNLQ++GA KSFD ECEVLR +RHRNLVKII+SCS N FKAL+
Sbjct: 772 YKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALV 831
Query: 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD 878
LE+MP SLEKWL S K+ L + +RL+IM+DVASA+EYLHHG+ P++HCDLKPSN+LLD
Sbjct: 832 LEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLD 891
Query: 879 DDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIET 938
++ VAH++DFGI+KLL E S QT+TLAT GYMAPEYGSEG+VST GD+YSFGIL++ET
Sbjct: 892 ENMVAHVTDFGIAKLLGDEHSFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMET 951
Query: 939 FTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEEEE 982
FTRK PTD+MF E S+K+WV+ES+ VT++ D +LL EE+
Sbjct: 952 FTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQH 995
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2135), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/918 (50%), Positives = 604/918 (65%), Gaps = 52/918 (5%)
Query: 103 GTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG--NLFDDMCNS 160
G I + NLS L L++ N F G + L+ MP LR+I+L +N +SG + M N
Sbjct: 102 GNISEEIRNLSNLKILDLGHNHFSGVISPILFNMPSLRLINLRANSLSGILQVVMIMSNI 161
Query: 161 LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGN 220
+ LE ++ NQ+ G++PS+L C++L+ L + N TG IP+ I LT+L ELYL N
Sbjct: 162 PSTLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKN 221
Query: 221 NLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIG 280
NL G+ P I + SL + L N L G++P ++ L E+++ + TG IP ++G
Sbjct: 222 NLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGN-CTYLMEIHVENNNLTGVIPNEMG 280
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLP 340
N L Q D G NN+TG IPS FN S + + + N+LSG+LPS+TG+ LP
Sbjct: 281 NLHTL--------QELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLP 332
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
NL LYL N LSG IP SI NASKL VL+LS N FSG + + GN R LQ LNLA + L
Sbjct: 333 NLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENIL 392
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI 460
+ SL SF SSL+NCR L YL NP +G LP S+GNLS SLE YA C + G I
Sbjct: 393 TSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNI 452
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNT 520
P GNLSN+I L L QN+L IP+ +G+L++LQ L+ N +QG IP+E+C LE L+
Sbjct: 453 PRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSY 512
Query: 521 LLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCL 580
L L N +P CL+N+TSLR L L SNR S IP+TFWSL+ +L ++ S N L+G L
Sbjct: 513 LYLLENGFSGSLPACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTL 571
Query: 581 PQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE- 639
P +IGNLKV+T + S NQLS IP+SI L++L + +L+ N QG IP + G L+SLE
Sbjct: 572 PLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEF 631
Query: 640 --------------------------------KGEIPSGGPFVNFTEGSFMQNYALCGSL 667
+GEI GGPF NF+ SFM N ALCG +
Sbjct: 632 LDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPI 691
Query: 668 RLQVQACETSST-QQSKSSK--LLRYVLPAVATAVVMLAL-IIIFIRCCTRNKNLPILEN 723
R+QV C++ ST +QSK + ++RY++PA+A +++LAL +IIF R R + +
Sbjct: 692 RMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLST---QE 748
Query: 724 DSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGA 783
D L ATWR+ISY EL R T+GF+E+NL+G GS GSVYK TL G+ +A+KVF+LQL+G
Sbjct: 749 DPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGE 808
Query: 784 IKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQR 843
+ FD+ECEVLR +RHRNLVKIISSC N FKALILE++P GSLEKWLYSH Y L+I QR
Sbjct: 809 LMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQR 868
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
L+IMIDVASALEYLHHG PV+HCDLKPSNVL+++D VAH+SDFGIS+LL D+VTQT
Sbjct: 869 LNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEGDAVTQT 928
Query: 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESL 963
+TLAT GYMAPEYG EGIVS GDVYS+GI ++ETFTRK PTD+MF GE SLK WV++SL
Sbjct: 929 LTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSL 988
Query: 964 RLAVTEVVDAELLSSEEE 981
A+TEV+DA LL EE
Sbjct: 989 PKAITEVIDANLLIEEEH 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2132), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/1019 (46%), Positives = 616/1019 (60%), Gaps = 115/1019 (11%)
Query: 16 GRALLAILFMAKLMSITEANIT------TDEAALLQVKAHIALDPQNFFERNWNLSATTN 69
GR + IL LMS+ + I+ TD++ALL K HI DPQN +W
Sbjct: 2 GRVWITILVSMLLMSLPKKCISIPTSNFTDQSALLAFKDHITFDPQNMLTHSW------- 54
Query: 70 TSSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTL 129
SS S CNW+GV+C R RVT L + ++GL GT+
Sbjct: 55 -SSKTSFCNWMGVSCSLRRQRVTALDLSSMGL------------------------LGTI 89
Query: 130 PNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLK 189
P +L GNL + L+ + +N G LPS +G+ +L+
Sbjct: 90 PPQL-----------------GNL--------SFLQYLILYNNSFHGDLPSEIGNLRRLQ 124
Query: 190 RLSVSFNELTGRI-PQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFG 248
+ + N+L+ I P++ GNL L EL +GNNL G P TIFN+SSL+V+ L N LFG
Sbjct: 125 VMDIGSNKLSLVIVPESFGNLHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFG 184
Query: 249 SLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT------------ 296
SLP ++C LP L+ L L +G+IP D+ C L L L N T
Sbjct: 185 SLPKNMCDHLPRLEMLLLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPM 244
Query: 297 ----DFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352
+ G N L+G +P IFN +++ +Q+ N+LSG++P I+LPNL L L N +
Sbjct: 245 LEVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGI 304
Query: 353 SGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFF 412
+G +P + N S+L +L+LS N +G V FGN R LQ+L+L + SQ +F
Sbjct: 305 TGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFI 364
Query: 413 SSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIA 472
+SLTN R L+ L I NP G+LPNSVGNLS L FY + +L G IP E GNLSN+I
Sbjct: 365 TSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIV 424
Query: 473 LSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQI 532
LSL +N L IPTTVG L+ +Q L L NN+ GSIPS++C L + L N L +I
Sbjct: 425 LSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEI 484
Query: 533 PTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTG 592
P+C+ NLTSLR L L N L+STIP WSL+ +L+++ N L G LP +G ++ G
Sbjct: 485 PSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIG 544
Query: 593 LYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE------------- 639
+ LS NQLS +IPS+IG L++L +L++N FQGSIPEA G L+SLE
Sbjct: 545 IRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEI 604
Query: 640 --------------------KGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQACETSST 679
+GEIP GGPF NFT SF+ N LCG RLQV C S
Sbjct: 605 PKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESR 664
Query: 680 QQSKS-SKLLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILENDSLSLATWRRISYQE 738
+ SK+ S+LLR+ LP VA+ ++++A I + + C R + PI E ++ A RRISY E
Sbjct: 665 KDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVT-AIQRRISYLE 723
Query: 739 LQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR 798
L T+ F ESNL+G GSFGSVY+ L G+NVA+K+FNLQL A +SFD ECE++R +R
Sbjct: 724 LLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIR 783
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
HRNLVKII SCSN FKAL+LEYMP+GSLEKWLYSH Y L+I QR++IMIDVASALEYLH
Sbjct: 784 HRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLH 843
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS 918
HG+P+PV+HCDLKPSNVLLD+D VAH+ DFGI+KLL +S QT TLAT GYMAPEYG
Sbjct: 844 HGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENESFAQTRTLATIGYMAPEYGL 903
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
+G+VST DVYSFGI+++E TRK PTDEMF GE SLK+ V+ESL +V ++VD+ +L+
Sbjct: 904 DGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLN 962
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482811|ref|XP_002270207.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2073), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/1051 (44%), Positives = 616/1051 (58%), Gaps = 115/1051 (10%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIP 97
TD++ALL K+ I + NW + S CNWVGV+C R RVT L +
Sbjct: 32 TDQSALLAFKSDIIDPTHSILGGNW--------TQETSFCNWVGVSCSRRRQRVTALRLQ 83
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM 157
GL GT+ P++ NLSF+V L++S N F G LP EL + RLRI+ L +N++ G + +
Sbjct: 84 KRGLKGTLSPYLGNLSFIVLLDLSNNSFGGHLPYELGHLYRLRILILQNNQLEGKIPPSI 143
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
+ LE ++SN ++G +P LG KL L + N L G IP ++GN++ L L L
Sbjct: 144 SHC-RRLEFISLASNWLSGGIPEELGILPKLDSLLLGGNNLRGTIPSSLGNISTLELLGL 202
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD--------- 268
L G P IFN+SSL I+L NS+ GSL VD+C+ P+++EL D
Sbjct: 203 RETGLTGSIPSLIFNISSLLSIILTGNSISGSLSVDICQHSPNIEELLFTDNQLSGQLPS 262
Query: 269 ----CMT-----------------------------------TGRIPKDIGNCTLLNYLG 289
C TG IP IGN + L L
Sbjct: 263 GIHRCRELLFASLSYNRFDGQIPEEIGSLRNLEELYLGGNHLTGPIPSSIGNISSLQILF 322
Query: 290 LRDNQLTD----------------FGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPS 333
L DN++ N LTG IP IFN S+++++ + N+LSGNLPS
Sbjct: 323 LEDNKIQGSIPSTLGNLLNLSYLVLELNELTGAIPQEIFNISSLQILSVVKNNLSGNLPS 382
Query: 334 STGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQIL 393
+TG+ LPNL+ L+L GN LSG IP S+ N S+LT +++ NLF+G + + GN + LQ L
Sbjct: 383 TTGLGLPNLMVLFLAGNGLSGKIPPSLSNYSQLTKIDIGNNLFTGPIPPSLGNLKFLQTL 442
Query: 394 NLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGS 453
+L +QL SF ++LTNCR L + + NP GI+PNS+GNLS + A
Sbjct: 443 SLGENQLKVEPGRPELSFITALTNCRLLEEITMPNNPLGGIIPNSIGNLSNHVRNIVAFG 502
Query: 454 CELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC 513
C+L G IP+ G+L N+ L L N L IP+T+G+L+NLQ +++ N ++G IP ELC
Sbjct: 503 CQLKGHIPSGIGSLKNLGTLELGDNNLNGNIPSTIGRLENLQRMNIFNNELEGPIPEELC 562
Query: 514 QLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSL 573
L L L L N L IP C+ NL+ L+ L LSSN L S+IP+ WSL +L ++ S
Sbjct: 563 GLRDLGELSLYNNKLSGSIPHCIGNLSRLQKLFLSSNSLTSSIPTGLWSLGNLLFLNLSF 622
Query: 574 NLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIG 633
N L G LP D+G L V+ + LS N+L +IP +G + L L L+RN FQ +IPE +G
Sbjct: 623 NSLGGSLPSDMGTLTVIEDIDLSWNKLIGNIPGILGTFESLYSLNLSRNSFQEAIPETLG 682
Query: 634 SLISLE---------------------------------KGEIPSGGPFVNFTEGSFMQN 660
L +LE GEIP+GGPFVNFT SF++N
Sbjct: 683 KLRALEFMDLSQNNLSGTIPKSFEALSHLKYLNLSFNNLSGEIPNGGPFVNFTAQSFLEN 742
Query: 661 YALCGSLRLQVQACETSSTQQSKSSK-LLRYVLPAVATAVVMLALIII---FIRCCTRNK 716
ALCG L V C T+ TQ+SK+ + LL+YVLP +A VV AL + + + R +
Sbjct: 743 KALCGRSILLVSPCPTNRTQESKTKQVLLKYVLPGIAAVVVFGALYYMLKNYRKGKLRIQ 802
Query: 717 NLPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVF 776
NL D L R ISY ELQR T+ F E+NL+G GSFGSVYK L G VA+KV
Sbjct: 803 NLV----DLLPSIQHRMISYLELQRATNSFCETNLLGVGSFGSVYKGILSDGTTVAVKVL 858
Query: 777 NLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY 836
NL+L+GA KSFDAEC+VL R+RHRNL+K+ISSCSN +AL+L+YM GSLEKWLYSH Y
Sbjct: 859 NLRLEGAFKSFDAECKVLARIRHRNLIKVISSCSNLDVRALVLQYMSNGSLEKWLYSHNY 918
Query: 837 TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896
LN+ QR+ IM+DVA ALEYLHH PV+HCDLKPSNVLLDDD VAH+ DFG++K+L
Sbjct: 919 CLNLFQRVSIMLDVALALEYLHHSQSEPVVHCDLKPSNVLLDDDMVAHVGDFGLAKILVE 978
Query: 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
VTQT TL T GY+APEYGSEG VST GDVYS+GI+++E FTRK PTDEMF+ E SL+
Sbjct: 979 NKVVTQTKTLGTLGYIAPEYGSEGRVSTKGDVYSYGIMLLEIFTRKKPTDEMFSEELSLR 1038
Query: 957 KWVEESLRLAVTEVVDAELLSSEE-EEGADL 986
+WV SL V EVVD LLS E+ E G D+
Sbjct: 1039 QWVNASLPENVMEVVDGGLLSIEDGEAGGDV 1069
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/1048 (45%), Positives = 635/1048 (60%), Gaps = 113/1048 (10%)
Query: 35 NITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDL 94
NITTD+AALL ++AHI DP NW SATT SVCNWVG+ CG +H RVT L
Sbjct: 6 NITTDQAALLALRAHITSDPFGITTNNW--SATT------SVCNWVGIICGVKHKRVTSL 57
Query: 95 SIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLF 154
+ +GL GT PP V LSFL + I N FH LP EL +PRL+++ L +N SG +
Sbjct: 58 NFSFMGLTGTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSGEI- 116
Query: 155 DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELME 214
L +E + NQ +G +P+SL + + L L++ N+L+G IP+ IGNLT L +
Sbjct: 117 PTWIGRLPRMEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREIGNLTLLQD 176
Query: 215 LYLNGNNL-----------------------QGEFPPTIFNVSSLRVIVLANNSLFGSLP 251
LYLN N L G P IFN+SSL ++ L+ N+ G LP
Sbjct: 177 LYLNSNQLTEIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLP 236
Query: 252 VDLCRRLPSLQEL-------------------NLRDC-----MTTGRIPKDIGNCTLL-- 285
D+C LPSL L NL D TG IP+++GN T +
Sbjct: 237 DDICEDLPSLGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQ 296
Query: 286 -----NYLG---------LRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNL 331
NYL L++ + N G IP IFN S + I L N LSG L
Sbjct: 297 IFLGVNYLSGEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTL 356
Query: 332 PSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQ 391
P+ G+ LPNL++L L N L+G IP SI N+S LT+ ++ N FSGL+ N FG L+
Sbjct: 357 PADLGVGLPNLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLR 416
Query: 392 ILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYA 451
+NL + T S + FS LTN L L + NP LP+S N S S +Y
Sbjct: 417 WINLELNNFTTESPPSERGIFSFLTNLTSLVRLELSHNPLNIFLPSSFVNFSSSFQYLSM 476
Query: 452 GSCELGGGIPAEFGN-LSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPS 510
+ + G IP + GN L ++I L + NQ+ TIPT++GKL+ LQGL LS N+++G+IP+
Sbjct: 477 VNTGIKGMIPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPA 536
Query: 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVD 570
E+CQLE+L+ L L N L IP C NL++LR L+L SN LNST+PS+ WSL YIL ++
Sbjct: 537 EICQLENLDELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLN 596
Query: 571 FSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPE 630
S N L G LP +IGNL+V+ + +S NQLS IPSSIGGL +L L+L N +GSIP+
Sbjct: 597 LSSNSLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPD 656
Query: 631 AIGSLISLE---------------------------------KGEIPSGGPFVNFTEGSF 657
+ G+L++LE +GEIP+GGPF NF+ SF
Sbjct: 657 SFGNLVNLEILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSF 716
Query: 658 MQNYALC-GSLRLQVQACETSSTQQS--KSSKLLRYVLPAVATAVVMLALIIIFIRCCTR 714
+ N LC S R QV C T ++Q S K++KL+ Y+LP++ A++ L L+++F+ R
Sbjct: 717 ISNIGLCSASSRFQVAPCTTKTSQGSGRKTNKLV-YILPSILLAMLSLILLLLFMTYRHR 775
Query: 715 NKNLPILENDSLSL-ATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAI 773
K + E+ L WRR +YQEL + TDGFSESNLIG GSFGSVYKATL G A+
Sbjct: 776 KKE-QVREDTPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAV 834
Query: 774 KVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYS 833
K+F+L A KSF+ ECE+L +RHRNLVKII+SCS+ FKALILEYMP G+L+ WLY+
Sbjct: 835 KIFDLLTQDANKSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDMWLYN 894
Query: 834 HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893
H LN+ +RLDI+IDVA AL+YLH+G+ P++HCDLKP+N+LLD D VAHL+DFGISKL
Sbjct: 895 HDCGLNMLERLDIVIDVALALDYLHNGYGKPIVHCDLKPNNILLDGDMVAHLTDFGISKL 954
Query: 894 LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFT-GE 952
L G DS+TQT+TLAT GYMAPE G +GIVS DVYS+GIL++ETFTRK PTDEMF+ GE
Sbjct: 955 LGGGDSITQTITLATVGYMAPELGLDGIVSRKCDVYSYGILLMETFTRKKPTDEMFSAGE 1014
Query: 953 TSLKKWVEESLRLAVTEVVDAELLSSEE 980
SL++WV ++ ++ VVD +LL+ ++
Sbjct: 1015 MSLREWVAKAYPHSINNVVDPDLLNDDK 1042
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2058), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/960 (46%), Positives = 600/960 (62%), Gaps = 81/960 (8%)
Query: 101 LGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNS 160
L G IP + NLS L L +S N G +P E++ + L+ ID S+N ++G + ++ +
Sbjct: 244 LTGGIPREIGNLSKLNILQLSSNGISGPIPTEIFNISSLQEIDFSNNSLTGEIPSNLSHC 303
Query: 161 LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGN 220
EL +S NQ TG +P ++G S L+ L +S+N+LTG IP+ IGNL+ L L L N
Sbjct: 304 -RELRVLSLSFNQFTGGIPQAIGSLSNLEGLYLSYNKLTGGIPREIGNLSNLNILQLGSN 362
Query: 221 NLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGR------ 274
+ G P IFN+SSL++I +NNSL GSLP+D+C+ LP+LQ L L +G+
Sbjct: 363 GISGPIPAEIFNISSLQIIDFSNNSLSGSLPMDICKHLPNLQGLYLLQNHLSGQLPTTLS 422
Query: 275 ------------------IPKDIGNCTLLNYLGLRDNQLT----------------DFGA 300
IP++IGN + L + LR N L D G
Sbjct: 423 LCGELLYLSLAVNKFRGSIPREIGNLSKLEDISLRSNSLVGSIPTSFGNLMALKYLDLGM 482
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
N LTG +P IFN S ++++ L NHLSG+LP S G LP+L LY+ N SG IP SI
Sbjct: 483 NFLTGTVPEAIFNISELQILVLVQNHLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSI 542
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
N SKL L++ N F+G V GN +L++LNLA +QL L+ G F +SLTNC++
Sbjct: 543 SNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKF 602
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480
LR+L I NP+KG LPNS+GNL +LE F A +C+ G IP GNL+N+I L L N L
Sbjct: 603 LRHLWIDDNPFKGTLPNSLGNLPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDL 662
Query: 481 ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLT 540
+IPTT+G+LQ LQ L ++ N I+GSIP++LC L++L L L N L IP+C +L
Sbjct: 663 TRSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLP 722
Query: 541 SLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQL 600
+L+ L L SN L IP++ WSL +LV++ S N L+G LP ++GN+K +T L LS N +
Sbjct: 723 ALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLV 782
Query: 601 SCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE--------------------- 639
S IP +G ++L L+L++N QG IP G L+SLE
Sbjct: 783 SGYIPRRMGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALI 842
Query: 640 ------------KGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSKSSK- 686
+GEIP+GGPF NFT SFM N ALCG+ QV AC+ ++ QS +K
Sbjct: 843 YLKYLNVSSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKS 902
Query: 687 -LLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILEN-DSLSLATWRRISYQELQRLTD 744
+L+Y+L V + + ++ I+++IR R N+ I DS T +IS+Q+L T+
Sbjct: 903 FILKYILLPVGSTITLVVFIVLWIR---RRDNMEIXTPIDSWLPGTHEKISHQQLLYATN 959
Query: 745 GFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
F E NLIG GS G VYK L G+ VAIKVFNL+ GA++SFD+ECEV++ +RHRNLV+
Sbjct: 960 DFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVR 1019
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
II+ CSN FKAL+L+YMP GSLEKWLYSH Y L++ QRL+IMIDVASALEYLHH +
Sbjct: 1020 IITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSL 1079
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
V+HCDLKPSNVLLDDB VAH++DFGI+KLL +S+ QT TL T GYMAPE+GS+GIVST
Sbjct: 1080 VVHCDLKPSNVLLDDBMVAHVTDFGIAKLLTKTESMQQTKTLGTIGYMAPEHGSDGIVST 1139
Query: 925 CGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEEEEGA 984
DVYS+GIL++E F RK P DEMFTG+ +LK WV ESL +V +VVD LL E+E+ A
Sbjct: 1140 KSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLA 1198
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1624 | ||||||
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.336 | 0.436 | 0.303 | 9.8e-127 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.511 | 0.810 | 0.354 | 1.3e-124 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.413 | 0.664 | 0.311 | 4.4e-119 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.370 | 0.481 | 0.304 | 2e-101 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.430 | 0.677 | 0.311 | 2.6e-78 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.527 | 0.847 | 0.335 | 1.5e-113 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.344 | 0.468 | 0.327 | 1.7e-113 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.370 | 0.596 | 0.326 | 6.9e-85 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.501 | 0.726 | 0.3 | 5.2e-91 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.526 | 0.728 | 0.327 | 1.1e-110 |
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 9.8e-127, Sum P(3) = 9.8e-127
Identities = 175/577 (30%), Positives = 273/577 (47%)
Query: 79 WVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELW-LMP 137
W GVTCG R + L++ LGL G+I P + + L+ +++S NR G +P L L
Sbjct: 63 WTGVTCGGRE--IIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSS 120
Query: 138 RLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNE 197
L + L SN +SG++ + SL L+S + N++ G +P + G+ L+ L+++
Sbjct: 121 SLESLHLFSNLLSGDIPSQL-GSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCR 179
Query: 198 LTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRR 257
LTG IP G L +L L L N L+G P I N +SL + A N L GSLP +L R
Sbjct: 180 LTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAEL-NR 238
Query: 258 LPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT----------------DFGAN 301
L +LQ LNL D +G IP +G+ + YL L NQL D +N
Sbjct: 239 LKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSN 298
Query: 302 NLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSIC 361
NLTG+I + + +E + L N LSG+LP + N +L +L+L LSG IP+ I
Sbjct: 299 NLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEIS 358
Query: 362 NASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLAXXXXXXXXXXXXXXXNCRYL 421
N L +L+LS N +G + ++ Q++ L + L N L
Sbjct: 359 NCQSLKLLDLSNNTLTGQIPDSL-----FQLVEL--TNLYLNNNSLEGTLSSSISNLTNL 411
Query: 422 RYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLA 481
+ + N +G +P +G L K LE Y G +P E GN + + + Y N+L+
Sbjct: 412 QEFTLYHNNLEGKVPKEIGFLGK-LEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLS 470
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCXXXXXX 541
IP+++G+L++L L L N + G+IP+ L + + L N L IP+
Sbjct: 471 GEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTA 530
Query: 542 XXXXXXXXXXXXXXIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
+P + +L+ + ++FS N +G + G+ L+ ++ N
Sbjct: 531 LELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLS-FDVTENGFE 589
Query: 602 CSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISL 638
IP +G +L L L +N F G IP G + L
Sbjct: 590 GDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISEL 626
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1206 (429.6 bits), Expect = 1.3e-124, Sum P(2) = 1.3e-124
Identities = 315/889 (35%), Positives = 458/889 (51%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQI 174
+V L + + G + L + LR +DL N +SG + ++ + L+ L+ ++S N I
Sbjct: 81 VVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPEL-SRLSRLQLLELSDNSI 139
Query: 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIG-NLTELMELYLNGNNLQGEFPPTIFNV 233
G +P+++G C+KL L +S N+L G IP+ IG +L L LYL N L GE P + N+
Sbjct: 140 QGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNL 199
Query: 234 SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDN 293
+SL+ L+ N L G++P L +L SL +NL +G IP I N + L +R+N
Sbjct: 200 TSLQEFDLSFNRLSGAIPSSL-GQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVREN 258
Query: 294 QLTDFGANNLTGLIPSIIFNNSNI-EVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352
+L G G+IP+ F ++ EVI + N G +P+S N +L + ++GN
Sbjct: 259 KL---G-----GMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVA-NASHLTVIQIYGNLF 309
Query: 353 SGVIPSSICNASKLTVLELSRNLFSGLVANTFG------NCRQLQILNLAYSQLAXXXXX 406
SG+I S LT L L RNLF + +G NC +LQ LNL + L
Sbjct: 310 SGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPN 369
Query: 407 XXXXXXXXXXNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGN 466
L +LA++ N G +P +GNL L++ Y + G +P+ G
Sbjct: 370 SFSNLSTS------LSFLALELNKITGSIPKDIGNLI-GLQHLYLCNNNFRGSLPSSLGR 422
Query: 467 LSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGN 526
L N+ L Y+N L+ +IP +G L L L L N G IP L L +L +L L N
Sbjct: 423 LKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTN 482
Query: 527 ALQNQIPT-CXXXXXXXXXXXXXXXXXXXXIPSTFWSLEYILVVDFSLNLLSGCLPQDIG 585
L IP+ IP L+ ++ N LSG +P +G
Sbjct: 483 NLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLG 542
Query: 586 NLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK----- 640
+ ++L LYL N LS SIPS++G LK L L L+ N G IP ++ + L
Sbjct: 543 DCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSF 602
Query: 641 ----GEIPSGGPFVNFTEGSFMQNYALCGSLR-LQVQACEXXXXXXXXXXXXXRYVLPAV 695
GE+P+ G F + S N LCG + L + C VLP
Sbjct: 603 NSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFP-----VLPIS 657
Query: 696 ATAVVMLALIIIFIRCCTRNKNLPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAG 755
+ LA++ T +K S+ +SY +L + TDGF+ +NL+G+G
Sbjct: 658 VSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSG 717
Query: 756 SFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS---NH 812
SFGSVYK L +VA+KV L+ A+KSF AECE LR +RHRNLVKI++ CS N
Sbjct: 718 SFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNR 777
Query: 813 G--FKALILEYMPQGSLEKWLY------SHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
G FKA++ ++MP GSLE W++ + + LN+ +R+ I++DVA AL+YLH P P
Sbjct: 778 GNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEP 837
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLL-DGEDSVTQTMT----LATFGYMAPEYGSE 919
V+HCD+K SNVLLD D VAH+ DFG++++L DG + Q+ + + T GY APEYG
Sbjct: 838 VVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVG 897
Query: 920 GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVT 968
I ST GD+YS+GIL++E T K PTD F + L+++VE L VT
Sbjct: 898 LIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVT 946
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 786 (281.7 bits), Expect = 4.4e-119, Sum P(2) = 4.4e-119
Identities = 224/720 (31%), Positives = 352/720 (48%)
Query: 142 IDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGR 201
+DL N G + ++ L+ LE D+ N + G +P L +CS+L L + N L G
Sbjct: 95 LDLYENFFGGTIPQEV-GQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGS 153
Query: 202 IPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL 261
+P +G+LT L++L L GNN++G+ P ++ N++ L + L++N+L G +P D+ + L +
Sbjct: 154 VPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQ-LTQI 212
Query: 262 QELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQ 321
L L +G P + N + L LG+ N + +L L+P+++ N
Sbjct: 213 WSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMG----- 267
Query: 322 LYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVA 381
GN+ +G++P++ N+ L RL + NNL+G IP+ N L +L L N +
Sbjct: 268 --GNYFTGSIPTTLS-NISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSS 323
Query: 382 N------TFGNCRQLQILNLAYSQLAXXXXXXXXXXXXXXXNCRYLRYLAIQTNPWKGIL 435
+ NC QL+ L + ++L L L + G +
Sbjct: 324 RDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAK------LVTLDLGGTLISGSI 377
Query: 436 PNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQ 495
P +GNL +L+ L G +P G L N+ LSL+ N+L+ IP +G + L+
Sbjct: 378 PYDIGNLI-NLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLE 436
Query: 496 GLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCXXXXXXXXXXXXXXXXXXXX 555
LDLS N +G +P+ L L L + N L IP
Sbjct: 437 TLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGS 496
Query: 556 IPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLT 615
+P +L+ + + N LSG LPQ +GN + L+L GN IP + GL +
Sbjct: 497 LPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVK 555
Query: 616 YLALARNGFQGSIPEAIGSLISLE---------KGEIPSGGPFVNFTEGSFMQNYALCGS 666
+ L+ N GSIPE S LE +G++P G F N T S + N LCG
Sbjct: 556 EVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGG 615
Query: 667 LR-LQVQAC-EXXXXXXXXXXXXXRYVLPAVATAVVMLALI------IIFIRCCTRNKNL 718
+ Q++ C + V+ V+ + +L L+ +I++R +NK
Sbjct: 616 IMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKET 675
Query: 719 PILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNV-AIKVFN 777
+L + +ISY +L+ T+GFS SN++G+GSFG+VYKA L V A+KV N
Sbjct: 676 NNPTPSTLEVLH-EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLN 734
Query: 778 LQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN---HG--FKALILEYMPQGSLEKWLY 832
+Q GA+KSF AECE L+ +RHRNLVK++++CS+ G F+ALI E+MP GSL+ WL+
Sbjct: 735 MQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 2.0e-101, Sum P(2) = 2.0e-101
Identities = 195/641 (30%), Positives = 302/641 (47%)
Query: 94 LSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNL 153
LS+ L G IP +A+L L +L++S N G +P E W M +L + L++N +SG+L
Sbjct: 268 LSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSL 327
Query: 154 FDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELM 213
+C++ T LE +S Q++G++P L C LK+L +S N L G IP+ + L EL
Sbjct: 328 PKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELT 387
Query: 214 ELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273
+LYL+ N L+G P+I N+++L+ +VL +N+L G LP ++ L L+ L L + +G
Sbjct: 388 DLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISA-LRKLEVLFLYENRFSG 446
Query: 274 RIPKDIGNCTLL-------NY--------LG-LRDNQLTDFGANNLTGLIPSIIFNNSNI 317
IP++IGNCT L N+ +G L++ L N L G +P+ + N +
Sbjct: 447 EIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQL 506
Query: 318 EVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377
++ L N LSG++PSS G L L +L L+ N+L G +P S+ + LT + LS N +
Sbjct: 507 NILDLADNQLSGSIPSSFGF-LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLN 565
Query: 378 GLVANTFGNCRQLQILNLAYSQLAXXXXXXXXXXXXXXXNCRYLRYLAIQTNPWKGILPN 437
G + G+ +Y N + L L + N G +P
Sbjct: 566 GTIHPLCGSS--------SYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPW 617
Query: 438 SVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGL 497
++G + + L S L G IP + + + L N L+ IP +GKL L L
Sbjct: 618 TLGKI-RELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGEL 676
Query: 498 DLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCXXXXXXXXXXXXXXXXXXXXIP 557
LS N S+P+EL L L L GN+L IP +P
Sbjct: 677 KLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLP 736
Query: 558 STFWSLEYILVVDFSLNLLSGCLPQDIGNLKVL-TGLYLSGNQLSCSIPSSIGGLKDLTY 616
L + + S N L+G +P +IG L+ L + L LS N + IPS+IG L L
Sbjct: 737 QAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLET 796
Query: 617 LALARNGFQGSIPEAIGSLISLEKGEIPS---GGP----FVNFTEGSFMQNYALCGSLRL 669
L L+ N G +P ++G + SL + GG F + SF+ N LCGS
Sbjct: 797 LDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGS--- 853
Query: 670 QVQACEXXXXXXXXXXXXXR-YVLPAVATAVVMLALIIIFI 709
+ C R V+ + +A+ + L+I+ I
Sbjct: 854 PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVI 894
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.6e-78, P = 2.6e-78
Identities = 233/747 (31%), Positives = 352/747 (47%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQI 174
++SLN+ G + G + + + LR+++L+ N G+ L L+ ++S N +
Sbjct: 75 VISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSF-GSTIPQKVGRLFRLQYLNMSYNLL 133
Query: 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVS 234
G++PSSL +CS+L + +S N L +P +G+L++L L L+ NNL G FP ++ N++
Sbjct: 134 EGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLT 193
Query: 235 SLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQ 294
SL+ + A N + G +P D RL + + +G P + N + L L L DN
Sbjct: 194 SLQKLDFAYNQMRGEIP-DEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNS 252
Query: 295 LTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSG 354
+ + L+P N+ + L N +G +P + N+ +L R + N LSG
Sbjct: 253 FSGNLRADFGYLLP-------NLRRLLLGTNQFTGAIPKTLA-NISSLERFDISSNYLSG 304
Query: 355 VIPSSICNASKLTVL-----ELSRNLFSGL-VANTFGNCRQLQILNLAYSQLAXXXXXXX 408
IP S L L L N SGL NC QL+ L++ Y++L
Sbjct: 305 SIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASI 364
Query: 409 XXXXXXXXNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLS 468
L L + N G +P+ +GNL SL+ + L G +P FG L
Sbjct: 365 ANLSTT------LTSLFLGQNLISGTIPHDIGNLV-SLQELSLETNMLSGELPVSFGKLL 417
Query: 469 NIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNAL 528
N+ + LY N ++ IP+ G + LQ L L+ N+ G IP L + L L + N L
Sbjct: 418 NLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRL 477
Query: 529 QNQIPTCXXXXXXXXXXXXXXXXXXXXIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLK 588
IP P LE ++ + S N LSG +PQ IG
Sbjct: 478 NGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCL 537
Query: 589 VLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE--------- 639
+ L++ GN +IP I L L + + N G IP + SL SL
Sbjct: 538 SMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKF 596
Query: 640 KGEIPSGGPFVNFTEGSFMQNYALCGSLR-LQVQACEXXXXXXXXXXXXXRY-VLPAVAT 697
+G +P+ G F N T S N +CG +R +Q++ C R V+ +
Sbjct: 597 EGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICI 656
Query: 698 AVVMLALIIIFIRCC----TRNKNLPILEN--DSLSLATWR-RISYQELQRLTDGFSESN 750
+ L LIII C + KN N DS +L + ++SY+EL T FS +N
Sbjct: 657 GIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTN 716
Query: 751 LIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
LIG+G+FG+V+K L P VA+KV NL GA KSF AECE + +RHRNLVK+I+ C
Sbjct: 717 LIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVC 776
Query: 810 SN-----HGFKALILEYMPQGSLEKWL 831
S+ + F+AL+ E+MP+GSL+ WL
Sbjct: 777 SSLDSEGNDFRALVYEFMPKGSLDMWL 803
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 1.5e-113, P = 1.5e-113
Identities = 306/913 (33%), Positives = 468/913 (51%)
Query: 79 WVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPR 138
W VTCG +H RVT L++ L LGG + P + N+SFL+SL++S N F G +P E+ + R
Sbjct: 56 WKWVTCGRKHKRVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFR 115
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNEL 198
L + ++ N + G + + N + L + D+ SN + +PS LG +KL L + N L
Sbjct: 116 LEHLYMAFNSLEGGIPATLSNC-SRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNL 174
Query: 199 TGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRL 258
G++P+++GNLT L L NN++GE P + +S + + L+ N FG P + L
Sbjct: 175 KGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYN-L 233
Query: 259 PSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIE 318
+L++L L +G + D GN L N +R+ L G N+L G IP+ + N S ++
Sbjct: 234 SALEDLFLFGSGFSGSLKPDFGNL-LPN---IRELNL---GENDLVGAIPTTLSNISTLQ 286
Query: 319 VIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLS----GVIP--SSICNASKLTVLELS 372
+ N ++G + + G +P+L L L N L G + S+ N + L +L +
Sbjct: 287 KFGINKNMMTGGIYPNFG-KVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVG 345
Query: 373 RNLFSGLVANTFGNCR-QLQILNLAYSQLAXXXXXXXXXXXXXXXNCRYLRYLAIQTNPW 431
G + + N +L LNL + N L+ L + N
Sbjct: 346 YTRLGGALPTSIANMSTELISLNLIGNHF-------FGSIPQDIGNLIGLQRLQLGKNML 398
Query: 432 KGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKL 491
G LP S+G L + L S + G IP+ GNL+ + L L N +P ++GK
Sbjct: 399 TGPLPTSLGKLLR-LGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKC 457
Query: 492 QNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCXXXXXXXXXXXXXXXX 551
++ L + YN + G+IP E+ Q+ +L L ++GN+L +P
Sbjct: 458 SHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNK 517
Query: 552 XXXXIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGL 611
+P T + + + N G +P +I L + + LS N LS SIP
Sbjct: 518 FSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANF 576
Query: 612 KDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLRLQV 671
L YL L+ N F G +P G+ + I N G +++ L L Q
Sbjct: 577 SKLEYLNLSINNFTGKVPSK-GNF---QNSTIVFVFGNKNLCGG--IKDLKLKPCLA-QE 629
Query: 672 QACEXXXXXXXXXXXXXRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILENDSLSLATW 731
E + A+ +V+ ++++ + R +N+ L L +
Sbjct: 630 PPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFH- 688
Query: 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMN-VAIKVFNLQLDGAIKSFDAE 790
+ISY +L+ T+GFS SN++G+GSFG+V+KA LP VA+KV N+Q GA+KSF AE
Sbjct: 689 EKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAE 748
Query: 791 CEVLRRVRHRNLVKIISSCSN---HG--FKALILEYMPQGSLEKWLYSHKY--------T 837
CE L+ RHRNLVK++++C++ G F+ALI EY+P GS++ WL+ + T
Sbjct: 749 CESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRT 808
Query: 838 LNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL-- 894
L + +RL+I+IDVAS L+YLH H H P+ HCDLKPSNVLL+DD AH+SDFG+++LL
Sbjct: 809 LTLLERLNIVIDVASVLDYLHVHCHE-PIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLK 867
Query: 895 -DGEDSVTQTMTLA---TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFT 950
D E + Q + T GY APEYG G S GDVYSFG+L++E FT K PTDE+F
Sbjct: 868 FDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFG 927
Query: 951 GETSLKKWVEESL 963
G +L + + +L
Sbjct: 928 GNLTLHSYTKLAL 940
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 1.7e-113, Sum P(3) = 1.7e-113
Identities = 197/602 (32%), Positives = 277/602 (46%)
Query: 93 DLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGN 152
+L + G IPP + NL L +L++SGN G LP L +P+L +DLS N SG+
Sbjct: 93 ELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNHFSGS 152
Query: 153 LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTEL 212
L SL L S DVS+N ++G++P +G S L L + N +G+IP IGN++ L
Sbjct: 153 LPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIGNISLL 212
Query: 213 MELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTT 272
G P I + L + L+ N L S+P L +L LNL
Sbjct: 213 KNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSF-GELHNLSILNLVSAELI 271
Query: 273 GRIPKDIGNCTLLNYLGLRDNQLTD-------------FGA--NNLTGLIPSIIFNNSNI 317
G IP ++GNC L L L N L+ F A N L+G +PS + +
Sbjct: 272 GLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQLSGSLPSWMGKWKVL 331
Query: 318 EVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377
+ + L N SG +P + P L L L N LSG IP +C + L ++LS NL S
Sbjct: 332 DSLLLANNRFSGEIPHEIE-DCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLS 390
Query: 378 GLVANTFGNCRQLQILNLAYSQLAXXXXXXXXXXXXXXXNCRYLRYLAIQTNPWKGILPN 437
G + F C L L L +Q+ L L + +N + G +P
Sbjct: 391 GTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP--------LMALDLDSNNFTGEIPK 442
Query: 438 SVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGL 497
S+ + +E F A L G +PAE GN +++ L L NQL IP +GKL +L L
Sbjct: 443 SLWKSTNLME-FTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVL 501
Query: 498 DLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCXXXXXXXXXXXXXXXXXXXXIP 557
+L+ N QG IP EL SL TL L N LQ QIP IP
Sbjct: 502 NLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIP 561
Query: 558 ST----FWSLEY----IL----VVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIP 605
S F +E L + D S N LSG +P+++G VL + LS N LS IP
Sbjct: 562 SKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIP 621
Query: 606 SSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCG 665
+S+ L +LT L L+ N GSIP+ +G+ + L+ + + N G +++ L G
Sbjct: 622 ASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLAN-----NQLNGHIPESFGLLG 676
Query: 666 SL 667
SL
Sbjct: 677 SL 678
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 6.9e-85, Sum P(2) = 6.9e-85
Identities = 218/667 (32%), Positives = 335/667 (50%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGN-----------NL----EAYLYNNKF 1035
+L L++ N I G+IP +GNL L+ L L N NL E L++N+F
Sbjct: 363 ELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRF 422
Query: 1036 TGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSG 1095
+G IP +GN T QL + L++N G +P + + S++ +Q+ N +G
Sbjct: 423 SGEIPSFIGNLT----------QLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNG 472
Query: 1096 HLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ 1155
+P I +P L L + N+LSG +P+ I ++ L L N SG +P T G C
Sbjct: 473 TIPKEI-MQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLS 531
Query: 1156 LQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYF 1215
++++ L NH G+ + ++ + L NN L G++ N S LEY
Sbjct: 532 MEVIYLQENHFD-GT-------IPDIKGLMGVKNVDLSNNNLSGSISEYFENFS-KLEYL 582
Query: 1216 FASSTELRGAIPVE--FEGEIPSGGPFVNFTAESLMQNLVLGGSSRLQVPPCKTGSSQQS 1273
S G +P E F+ F N ++ L L Q PP +T
Sbjct: 583 NLSDNNFEGRVPTEGIFQNATLVS-VFGNKNLCGSIKELKLKPCIA-QAPPVETRHPSLL 640
Query: 1274 KATRLALRY-ILPXXXXXXXXXXXXXXXXXXXXXDKSRPTENNLLNTAALRRISYQELRL 1332
K + + I + S P + + ++SY +LR
Sbjct: 641 KKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFH----EKLSYGDLRN 696
Query: 1333 ATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHR 1391
AT+GFS SN++G+G F +V+KA + A+K+ ++Q A+KSF AECE ++ IRHR
Sbjct: 697 ATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHR 756
Query: 1392 NLAKIVSSCSN---PG--FKALILQYMPQGSLEKWLYS------H--NYLLNIEQRLDIM 1438
NL K++++C++ G F+ALI ++MP GSL+KWL+ H + L + +RL+I
Sbjct: 757 NLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIA 816
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD--SMKQTMT 1496
IDVA L+YLH I HCDLKPSN+LLDDD+ AH+ DFG+A+LL D S ++
Sbjct: 817 IDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLS 876
Query: 1497 LA----TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE 1552
A TIGY APEYG G S GDVYSFG+L++E T ++PT+++F G L + +
Sbjct: 877 SAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKA 936
Query: 1553 SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612
+LP+ V D+ D ++L + C+ ++ + L+C EE P R+ +A L
Sbjct: 937 ALPERVLDIADKSILHSGLRVGFPVLE-CLKGILDVGLRCCEESPLNRLATSEAAKELIS 995
Query: 1613 IKTKFLK 1619
I+ +F K
Sbjct: 996 IRERFFK 1002
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 5.2e-91, P = 5.2e-91
Identities = 264/880 (30%), Positives = 423/880 (48%)
Query: 101 LGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNS 160
L G IPP + N+ + L +S N+ G++P+ L + L ++ L N ++G + ++ N
Sbjct: 210 LTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGN- 268
Query: 161 LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGN 220
+ + + +S N++TG +PSSLG+ L LS+ N LTG IP +GN+ +++L L+ N
Sbjct: 269 MESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNN 328
Query: 221 NLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIG 280
L G P ++ N+ +L ++ L N L G +P +L + S+ +L L + TG IP G
Sbjct: 329 KLTGSIPSSLGNLKNLTILYLYENYLTGVIPPEL-GNMESMIDLQLNNNKLTGSIPSSFG 387
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLP 340
N L YL L N LTG+IP + N ++ + L N L+G++P S G N
Sbjct: 388 NLKNLTYLYLY--------LNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFG-NFT 438
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
L LYL N+LSG IP + N+S LT L L N F+G T R+LQ ++L Y+ L
Sbjct: 439 KLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHL 498
Query: 401 AXXXXXXXXXXXXXXXNCRYL--RYLAIQTNPWKGILP--NSV--------GNLSKSLEY 448
R+L ++ + GI P N + G +S + E
Sbjct: 499 EGPIPKSLRDCKSLI-RARFLGNKFTGDIFEAF-GIYPDLNFIDFSHNKFHGEISSNWEK 556
Query: 449 ------FYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYN 502
+ + G IP E N++ ++ L L N L +P +G L NL L L+ N
Sbjct: 557 SPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGN 616
Query: 503 NIQGSIPSELCQLESLNTLLLQGNALQNQIPTCXXXXXXXXXXXXXXXXXXXXIPSTFWS 562
+ G +P+ L L +L +L L N ++IP IP
Sbjct: 617 QLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPRLS-K 675
Query: 563 LEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
L + +D S N L G +P + +L+ L L LS N LS IP++ G+ LT + ++ N
Sbjct: 676 LTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNN 735
Query: 623 GFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLRLQ-VQACEXXXXXX 681
+G +P+ P+ F T + +N LC ++ Q ++ C
Sbjct: 736 KLEGPLPDT------------PT---FRKATADALEENIGLCSNIPKQRLKPCRELKKPK 780
Query: 682 XXXXXXXRYVLPAVATAVVMLALIIIFIRCCTRNK-----NLPILENDSLSL-ATWRRIS 735
++P + V++ F C + K N +++S+ + +
Sbjct: 781 KNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFK 840
Query: 736 YQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI------KSFDA 789
YQ++ T+ F ++LIG G + VY+A L + +A+K + +D I + F
Sbjct: 841 YQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPVVKQEFLN 899
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT--LNIQQRLDIM 847
E + L +RHRN+VK+ CS+ LI EYM +GSL K L + + L +R++++
Sbjct: 900 EVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVV 959
Query: 848 IDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA 907
VA AL Y+HH TP++H D+ N+LLD+D A +SDFG +KLL DS +
Sbjct: 960 KGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLK-TDSSNWSAVAG 1018
Query: 908 TFGYMAPEYG-SEGIVSTCGDVYSFGILMIETFTRKMPTD 946
T+GY+APE+ + + C DVYSFG+L++E K P D
Sbjct: 1019 TYGYVAPEFAYTMKVTEKC-DVYSFGVLILELIIGKHPGD 1057
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 301/919 (32%), Positives = 461/919 (50%)
Query: 80 VGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRL 139
+ V+ G+ +TDL + L G IP NL L SL ++ N G +P E+ L
Sbjct: 208 IPVSIGTL-ANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSL 266
Query: 140 RIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELT 199
++L N+++G + ++ N L +L++ + N++T +PSSL ++L L +S N L
Sbjct: 267 VQLELYDNQLTGKIPAELGN-LVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLV 325
Query: 200 GRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLP 259
G I + IG L L L L+ NN GEFP +I N+ +L V+ + N++ G LP DL L
Sbjct: 326 GPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADL-GLLT 384
Query: 260 SLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT---------------DFGANNLT 304
+L+ L+ D + TG IP I NCT L L L NQ+T G N+ T
Sbjct: 385 NLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNHFT 444
Query: 305 GLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNAS 364
G IP IFN SN+E + + N+L+G L G L L L + N+L+G IP I N
Sbjct: 445 GEIPDDIFNCSNLETLSVADNNLTGTLKPLIG-KLQKLRILQVSYNSLTGPIPREIGNLK 503
Query: 365 KLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLAXXXXXXXXXXXXXXXNCRYLRYL 424
L +L L N F+G + N LQ L + YS + + L L
Sbjct: 504 DLNILYLHSNGFTGRIPREMSNLTLLQGLRM-YSN------DLEGPIPEEMFDMKLLSVL 556
Query: 425 AIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTI 484
+ N + G +P L +SL Y + G IPA +LS + + N L TI
Sbjct: 557 DLSNNKFSGQIPALFSKL-ESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTI 615
Query: 485 P-TTVGKLQNLQ-GLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCXXXXXXX 542
P + L+N+Q L+ S N + G+IP EL +LE + + L N IP
Sbjct: 616 PGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNV 675
Query: 543 XXXXXXXXXXXXXIPS-TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
IP F ++ I+ ++ S N SG +PQ GN+ L L LS N L+
Sbjct: 676 FTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLT 735
Query: 602 CSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNY 661
IP S+ L L +L LA N +G +PE+ G F N M N
Sbjct: 736 GEIPESLANLSTLKHLKLASNNLKGHVPES---------------GVFKNINASDLMGNT 780
Query: 662 ALCGSLRLQVQACEXXXXXXXXXXXXXRYVLPAV--ATAVVMLALIIIFIRCCTRN-KNL 718
LCGS + ++ C R +L + A A++++ L+++ + CC + K +
Sbjct: 781 DLCGSKK-PLKPC-TIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKI 838
Query: 719 PILENDSL----SLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIK 774
SL S +R +EL++ TD F+ +N+IG+ S +VYK L G +A+K
Sbjct: 839 ENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVK 898
Query: 775 VFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSCSNHG-FKALILEYMPQGSLEKWL 831
V NL+ A K F E + L +++HRNLVKI+ G KAL+L +M G+LE +
Sbjct: 899 VLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTI 958
Query: 832 YSHKYTL-NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGI 890
+ + ++ +++D+ + +AS ++YLH G+ P++HCDLKP+N+LLD D VAH+SDFG
Sbjct: 959 HGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGT 1018
Query: 891 SKLLD-GEDSVTQTMTLA---TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPT- 945
+++L ED T T A T GY+APE+ V+T DV+SFGI+M+E T++ PT
Sbjct: 1019 ARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTS 1078
Query: 946 -DEMFTGETSLKKWVEESL 963
++ + + +L++ VE+S+
Sbjct: 1079 LNDEDSQDMTLRQLVEKSI 1097
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1624 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-94 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 4e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 8e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.001 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 328 bits (842), Expect = 3e-94
Identities = 281/967 (29%), Positives = 451/967 (46%), Gaps = 105/967 (10%)
Query: 14 PCGRALLAILFMAKLMSITEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSS 73
C + + F+ S+ A + LL K+ I DP + NWN SS
Sbjct: 8 HCPYLIFMLFFLFLNFSMLHAE---ELELLLSFKSSIN-DPLKYLS-NWN--------SS 54
Query: 74 NSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNEL 133
VC W G+TC + RV + + + G I + L ++ ++N+S N+ G +P+++
Sbjct: 55 ADVCLWQGITC-NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDI 113
Query: 134 W-LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLS 192
+ LR ++LS+N +G++ S+ LE+ D+S+N ++G++P+ +G S LK L
Sbjct: 114 FTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170
Query: 193 VSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPV 252
+ N L G+IP ++ NLT L L L N L G+ P + + SL+ I L N+L G +P
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230
Query: 253 DLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIF 312
++ L SL L+L TG IP +GN L YL L N+L+ G IP IF
Sbjct: 231 EI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS--------GPIPPSIF 281
Query: 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELS 372
+ + + L N LSG +P I L NL L+L+ NN +G IP ++ + +L VL+L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340
Query: 373 RNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWK 432
N FSG + G L +L+L+ + L TG + +G L + L L + +N +
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNL-TGEIPEG------LCSSGNLFKLILFSNSLE 393
Query: 433 GILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQ 492
G +P S+G +SL G +P+EF L + L + N L I + +
Sbjct: 394 GEIPKSLGA-CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
+LQ L L+ N G +P + + L L L N +P L +L+ L L LS N+L
Sbjct: 453 SLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511
Query: 553 NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLK 612
+ IP S + ++ +D S N LSG +P + VL+ L LS NQLS IP ++G ++
Sbjct: 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 613 DLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQ 672
L + ++ N GS +PS G F+ + N LCG
Sbjct: 572 SLVQVNISHNHLHGS---------------LPSTGAFLAINASAVAGNIDLCGG------ 610
Query: 673 ACETSS----TQQSKSSKLLRYVLPAVATAVVMLALI---IIFIRCCTRNKNLPILENDS 725
+T+S ++ + + + + A ++LAL+ +FIR N L +EN+
Sbjct: 611 --DTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIR-GRNNLELKRVENED 667
Query: 726 LSLATWRRISYQELQRLTDGFSES-------------NLIGAGSFGSVYKA-TLPYGMNV 771
TW ELQ S+S N+I G G+ YK ++ GM
Sbjct: 668 ---GTW------ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQF 718
Query: 772 AIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWL 831
+K N ++ S A+ + +++H N+VK+I C + LI EY+ +L + L
Sbjct: 719 VVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 832 YSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891
+ L+ ++R I I +A AL +LH V+ +L P +++D HL +
Sbjct: 775 RN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829
Query: 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTG 951
LL T T + Y+APE ++ D+Y FG+++IE T K P D F
Sbjct: 830 GLL-----CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 952 ETSLKKW 958
S+ +W
Sbjct: 885 HGSIVEW 891
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-48
Identities = 168/655 (25%), Positives = 295/655 (45%), Gaps = 82/655 (12%)
Query: 984 ADLGDSNKLKRLSISVNKITGTIPRTV---GNLTELRELHLHGNNLEAYLYNNKFTGRIP 1040
+LG N L L +S N +TG IP + GNL +L L++N G IP
Sbjct: 350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL------------ILFSNSLEGEIP 397
Query: 1041 QNLGNCTLLNFLILRQNQLTG--------------VRLASNKLIGRIPSMIFNNSNIEAI 1086
++LG C L + L+ N +G + +++N L GRI S ++ +++ +
Sbjct: 398 KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457
Query: 1087 QLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLI 1146
L N F G LP S G L+ L L N SG +P + + S+++ L LSEN SG I
Sbjct: 458 SLARNKFFGGLPDSFGS--KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515
Query: 1147 PNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIG 1206
P+ +C++L LDLS N L+ G S + L +L L N L G +P ++G
Sbjct: 516 PDELSSCKKLVSLDLSHNQLS------GQ-IPASFSEMPVLSQLDLSQNQLSGEIPKNLG 568
Query: 1207 NLSTSLEYFFASSTELRGAIPVEFEGEIPSGGPFVNFTAESLMQNLVL-GGSSRLQVPPC 1265
N+ + ++ + + G +PS G F+ A ++ N+ L GG + +PPC
Sbjct: 569 NVESLVQVNISHN---------HLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC 619
Query: 1266 KTGSSQQSKATRLALRYILPAIATTMAVLALIIILLRRRKRDKSRPTENN-------LLN 1318
K +++ + + L A +A++A + +R R + + EN +
Sbjct: 620 KR--VRKTPSWWFYITCTLGAF-LVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676
Query: 1319 TAALRRISYQELRLATNGFSESNLLGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKS 1377
+ + I+ ++ + E N++ G + YK + +G +K + + S
Sbjct: 677 SKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSS 732
Query: 1378 FDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI 1437
A+ M +++H N+ K++ C + LI +Y+ +L + L + L+ E+R I
Sbjct: 733 EIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKI 785
Query: 1438 MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL 1497
I +A AL +LH S +++ +L P +++D HL L G+ +
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLPGLLCTDTKCFI 840
Query: 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557
++ Y+APE ++ D+Y FG++++E LT + P D F + W D
Sbjct: 841 SS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899
Query: 1558 VTDV-IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611
D+ ID ++ D++ + + VM+LAL C+ P R D L L+
Sbjct: 900 HLDMWIDPSI-----RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 67/190 (35%), Positives = 105/190 (55%), Gaps = 8/190 (4%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIK-SFDAECEVLRRVRHRNLVKIISSC 809
+G G FG+VY A G VAIK+ + ++ E E+L+++ H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ L++EY GSL+ L ++ L+ + L I++ + LEYLH +IH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 870 LKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-YGSEGIVSTCGD 927
LKP N+LLD D L+DFG+SKLL + S+ +T+ + T YMAPE +G S D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176
Query: 928 VYSFGILMIE 937
++S G+++ E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQ--LDGAIKSFDAECEVLRRVRHRNLVKIISS 808
+G+GSFG+VYKA G VA+K+ + ++ E +LRR+ H N+V++I +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIH 867
+ L++EY G L +L L+ + I + + LEYLH +G +IH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG----IIH 121
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-------YGSEG 920
DLKP N+LLD++ V ++DFG++K L S T T YMAPE YG +
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK- 179
Query: 921 IVSTCGDVYSFGILMIETFTRKMP 944
DV+S G+++ E T K P
Sbjct: 180 -----VDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQ-LDGAIKSFDAECEVLRRVRHRNLVKIIS 807
+G GSFG VY A G VAIKV + + + E ++L++++H N+V++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVI 866
+ L++EY G L L L+ + + + SALEYLH G ++
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHSKG----IV 119
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------YGSEG 920
H DLKP N+LLD+D L+DFG+++ LD T + T YMAPE YG
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTF-VGTPEYMAPEVLLGKGYGKA- 176
Query: 921 IVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957
D++S G+++ E T K P F G+ L +
Sbjct: 177 -----VDIWSLGVILYELLTGKPP----FPGDDQLLE 204
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-44
Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 8/190 (4%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G F +VY A G AIKI + L+ E E+++++ H N+ K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
+ L+++Y GSL+ L + L+ ++ L I++ + LEYLH S IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 1461 LKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-YGSEGIVSTSGD 1518
LKP N+LLD D+ L DFG++KLL S+ +T+ + T YMAPE +G S D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176
Query: 1519 VYSFGILMME 1528
++S G+++ E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 12/221 (5%)
Query: 752 IGAGSFGSVYKATL-----PYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G+FG VYK L + VA+K + I+ F E ++R++ H N+VK+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ C+ +++EYM G L +L ++ L++ L + +A +EYL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN---F 123
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC 925
IH DL N L+ ++ V +SDFG+S+ L +D + +MAPE EG ++
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 926 GDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFG+L+ E FT + P M + E + ++++ RL
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGM-SNEE-VLEYLKNGYRL 222
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 752 IGAGSFGSVYKATL-----PYGMNVAIKVFNLQLDG-AIKSFDAECEVLRRVRHRNLVKI 805
+G G+FG VYK TL VA+K + F E +++++ H N+V++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ C+ ++ EYMP G L +L H L ++ L + + +A +EYL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN---F 123
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVST 924
+H DL N L+ ++ V +SDFG+S+ + +D + +MAPE +G ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRLA 966
DV+SFG+L+ E FT + P M + E + + +E+ RL
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPGM-SNE-EVLELLEDGYRLP 224
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 8/218 (3%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRA-LKSFDAECEVMRRIRHRNLAKIVS 1398
LG G F VY A G AIK+ ++ + + E +++++++H N+ ++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
+ L+++Y G L L L + ++ + + ALEYLH S I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
DLKP N+LLD+D L DFG+A+ LD K T + T YMAPE + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556
++S G+++ E LT + P K + P
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 216
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQEDR--ALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG+G F +VYKA G A+KI + ++ ++ E ++RR+ H N+ +++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ L+++Y G L +L L + ++ I + + LEYLH S IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTSG 1517
DLKP N+LLD++ V + DFG+AK L S T T YMAPE G G
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGY-GPKV 180
Query: 1518 DVYSFGILMMETLTRRKP 1535
DV+S G+++ E LT + P
Sbjct: 181 DVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 13/222 (5%)
Query: 752 IGAGSFGSVYKATL-----PYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G+FG VYK TL + VA+K + I+ F E ++R++ H N+VK+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHHGHPTP 864
+ C+ +++EYMP G L +L ++ L++ L + +A +EYL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
IH DL N L+ ++ V +SDFG+S+ L +D +MAPE EG ++
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFG+L+ E FT + P M + + +++++ RL
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGM-SNAE-VLEYLKKGYRL 223
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 35/267 (13%)
Query: 1343 LGTGIFSSVYKAT-----FADGTNAAIKIFSLQEDR---ALKSFDAECEVMRRIRHRNLA 1394
LG G F VYK A+K +L+ED ++ F E +MR++ H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVK--TLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
K++ C+ ++++YM G L +L + L++ L + +A +EYL S
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SK 121
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
+ IH DL N L+ +++V + DFG+++ L D ++ I +MAPE EG +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 1515 TSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573
+ DV+SFG+L+ E T +P M S + + + + L
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGM-------------SNEEVLEYLKNGYRLPQPPN- 227
Query: 1574 DIAAKKKCMSSVMSLALKCSEEIPEER 1600
C + L L+C E PE+R
Sbjct: 228 -------CPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 68/232 (29%), Positives = 111/232 (47%), Gaps = 20/232 (8%)
Query: 750 NLIGAGSFGSVYKATLPYGMN----VAIKVFNLQ-LDGAIKSFDAECEVLRRVRHRNLVK 804
+G G+FG VYK L VA+K + K F E V++++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHK--------YTLNIQQRLDIMIDVASALEY 856
++ C+ L+LEYM G L +L + TL+++ L I +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPE 915
L +H DL N L+ +D V +SDFG+S+ + +D +T +MAPE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRLA 966
+GI ++ DV+SFG+L+ E FT P + E + +++ + RL
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRKGYRLP 227
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 36/268 (13%)
Query: 1343 LGTGIFSSVYKAT-----FADGTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLA 1394
LG G F VYK T A+K +L+ED + ++ F E +MR++ H N+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVK--TLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWL-YSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
K++ C+ ++++YMP G L +L + L++ L + +A +EYL S
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV 1513
+ IH DL N L+ +++V + DFG+++ L D K I +MAPE EG
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 1514 STSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572
++ DV+SFG+L+ E T +P M S + + + L
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGM-------------SNAEVLEYLKKGYRLPKPPN 228
Query: 1573 ADIAAKKKCMSSVMSLALKCSEEIPEER 1600
C + L L+C E PE+R
Sbjct: 229 --------CPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGA--IKSFDAECEVLRRVRHRNLVKII 806
L+G GSFGSVY A G +A+K L D +++ + E +L ++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 807 SSCSNHGFKAL--ILEYMPQGSLEKWLYS---------HKYTLNIQQRLDIMIDVASALE 855
S + L LEY+ GSL L KYT + L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT----------RQILEGLA 115
Query: 856 YLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMA 913
YLH +G ++H D+K +N+L+D D V L+DFG +K L ++ T ++ T +MA
Sbjct: 116 YLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
PE D++S G +IE T K P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 34/267 (12%)
Query: 1343 LGTGIFSSVYKAT-----FADGTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLA 1394
LG G F VYK T T A+K +L+E + F E +M+++ H N+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVK--TLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
+++ C+ ++ +YMP G L +L H L ++ L + + +A +EYL S
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIV 1513
+ +H DL N L+ +++V + DFG+++ + D K+ I +MAPE +G
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 1514 STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573
++ DV+SFG+L+ E +FT + + S + + + D L
Sbjct: 182 TSKSDVWSFGVLLWE----------IFTL--GEQPYPGMSNEEVLELLEDGYRL------ 223
Query: 1574 DIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ C + L L+C PE+R
Sbjct: 224 --PRPENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQLDG-AIKSFDAECEVLRRVRHRNLVKIISSC 809
IG G FG V G VA+K L+ D A ++F AE V+ +RH NLV+++
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 810 SNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
++ EYM +GSL +L S + + + Q+L +DV +EYL + +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDV 928
DL NVL+ +D VA +SDFG++K E S Q + APE E ST DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 929 YSFGILMIETFT------RKMPTDE 947
+SFGIL+ E ++ ++P +
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKD 207
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 22/221 (9%)
Query: 1341 NLLGTGIFSSVYKATFADGTN----AAIKIFSLQED---RALKSFDAECEVMRRIRHRNL 1393
LG G F VYK A+K +L+ED K F E VM+++ H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK--TLKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL--------LNIEQRLDIMIDVACAL 1445
+++ C+ L+L+YM G L +L + L+++ L I +A +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMA 1504
EYL S +H DL N L+ +D+V + DFG+++ + D K+T I +MA
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 1505 PEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
PE +GI ++ DV+SFG+L+ E T P + EV
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG G FG VYKA G VAIKV L+ + E ++L++ +H N+VK S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++E+ GSL+ L S TL Q + ++ LEYLH +IH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDI 124
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------YGSEGIVST 924
K +N+LL D L DFG+S D+ + + T +MAPE Y +
Sbjct: 125 KAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYDYK----- 177
Query: 925 CGDVYSFGILMIETFTRKMP 944
D++S GI IE K P
Sbjct: 178 -ADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 1341 NLLGTGIFSSVYKATFAD-GTNAAIK--IFSLQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LLG G F SVY A D G A+K S + L++ + E ++ ++H N+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 1398 SSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALEYLH 1449
S + L L+Y+ GSL LL +L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYG 1508
S I+H D+K +N+L+D D V L DFG AK L +++ + T ++ T +MAPE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ D++S G ++E T + P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 752 IGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAI-KSFDAECEVLRRVRHRNLVKIISSC 809
+G GS G VYK P G A+K ++ D K E + LR +VK C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 810 SNHGFK----ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+K +++LEYM GSL L + I + L+YLH +
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT-LATFGYMAPE------YGS 918
IH D+KPSN+L++ ++DFGISK+L E+++ Q T + T YM+PE Y
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGESY-- 177
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMP 944
S D++S G+ ++E K P
Sbjct: 178 ----SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 70/205 (34%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 746 FSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQ--LDGAIKSFDAECEVLRRVRHRNL 802
+ +LIG G+FG VYK L G VAIK +L+ + A+KS E ++L+ ++H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI--MIDVASALEYLH-H 859
VK I S +ILEY GSL + + K+ + L + V L YLH
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQII--KKFG-PFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
G VIH D+K +N+L D V L+DFG++ L+ ++ + T +MAPE
Sbjct: 119 G----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEM 173
Query: 920 GIVSTCGDVYSFGILMIETFTRKMP 944
ST D++S G +IE T P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 7e-28
Identities = 74/209 (35%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRH-RNLVKII 806
+G GSFG VY A VA+KV +L ++ F E ++L + H N+VK+
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNI--QQRLDIMIDVASALEYLHHGHPTP 864
+ G L++EY+ GSLE L + + L I+ + SALEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 865 VIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQTMTLA-----TFGYMAPEY-- 916
+IH D+KP N+LLD D V L DFG++KLL S + L T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 917 -GSEGIVSTCGDVYSFGILMIETFTRKMP 944
S S+ D++S GI + E T P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-28
Identities = 89/258 (34%), Positives = 123/258 (47%), Gaps = 34/258 (13%)
Query: 984 ADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNL 1043
+LG LK + + N ++G IP +G LT L L L NNL TG IP +L
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL---------TGPIPSSL 256
Query: 1044 GNCTLLNFLILRQNQLTG--------------VRLASNKLIGRIPSMIFNNSNIEAIQLY 1089
GN L +L L QN+L+G + L+ N L G IP ++ N+E + L+
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLF 316
Query: 1090 GNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNT 1149
N+F+G +P ++ LP LQ L LW N SG IP ++ + + +L LS N +G IP
Sbjct: 317 SNNFTGKIPVALTS-LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
Query: 1150 FGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
+ L L L N L SL CR LRR+ LQ+N G LP+ L
Sbjct: 376 LCSSGNLFKLILFSNSLEG-------EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL- 427
Query: 1210 TSLEYFF-ASSTELRGAI 1226
L YF S+ L+G I
Sbjct: 428 -PLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQED-RALKSFDAECE 1383
I+ +EL+L +G G F V + G A+K L++D A ++F AE
Sbjct: 3 INSKELKL-------GATIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEAS 52
Query: 1384 VMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVA 1442
VM +RH NL +++ ++ +YM +GSL +L S ++ + Q+L +DV
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGY 1502
+EYL + +H DL NVL+ +D+VA + DFG+AK S Q + +
Sbjct: 113 EGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKW 165
Query: 1503 MAPEYGSEGIVSTSGDVYSFGILMME 1528
APE E ST DV+SFGIL+ E
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 83/286 (29%), Positives = 125/286 (43%), Gaps = 35/286 (12%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRH-RNLAKIV 1397
LG G F VY A D A+K+ + + + + ++ F E +++ + H N+ K+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNI--EQRLDIMIDVACALEYLHQGYSTS 1455
+ G L+++Y+ GSLE L + + L I+ + ALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 1456 IIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLA-----TIGYMAPEY-- 1507
IIH D+KP N+LLD D V L DFG+AKLL S L T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 1508 -GSEGIVSTSGDVYSFGILMMETLTRRKP---TDDMFTGEVCLKHWVEESLPDAVTDVID 1563
S S+S D++S GI + E LT P + LK +E P + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609
+N + A L K + P+ R++ L++
Sbjct: 242 SNPELISKAA------------SDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 65/192 (33%), Positives = 103/192 (53%), Gaps = 5/192 (2%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIK-SFDAECEVLRRVRHRNLVKIISSC 809
IG G+FG VYK L VA+K L +K F E E+L++ H N+VK+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+++E +P GSL +L K L +++ L + +D A+ +EYL + IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 870 LKPSNVLLDDDTVAHLSDFGISKL-LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDV 928
L N L+ ++ V +SDFG+S+ G +V+ + + APE + G ++ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 929 YSFGILMIETFT 940
+S+GIL+ ETF+
Sbjct: 179 WSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 71/215 (33%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 752 IGAGSFGSVY----KAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G GSFG V K T Y M V +K + ++ E +L R+ H +VK+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLH-H 859
+ L+LEY P G L +SH L+ + R ++ ALEYLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL----FSH---LSKEGRFSEERARFYAAEIVLALEYLHSL 112
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
G +I+ DLKP N+LLD D L+DFG++K L E S T T T Y+APE
Sbjct: 113 G----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLG 167
Query: 920 GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETS 954
D +S G+L+ E T K P F E
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP----FYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 749 SNLIGAGSFGSVYKATLPY-----GMNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRNL 802
+G G FG V G VA+K N + +S F+ E E+LR + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 803 VKIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
VK C G ++ LI+EY+P GSL +L H+ +N+++ L + ++YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED---SVTQTMTLATFGYMAPEYG 917
IH DL N+L++ + + +SDFG++K+L + V + F Y APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMPT 945
S+ DV+SFG+ + E FT P+
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAI-KSFDAECEVLRRVRHRNLVKIISSC 809
+GAG+ G V K P G +A+K L+++ AI K E ++L + +V +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
N+G ++ +EYM GSL+K L + + + I + V L YLH H +IH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRD 126
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
+KPSN+L++ L DFG+S L +S+ +T T YMAPE S D++
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDIW 183
Query: 930 SFGILMIETFTRKMP 944
S G+ +IE T + P
Sbjct: 184 SLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKI---FSLQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
LG G F V D G A+K+ + + + ++ E ++ RI H + K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVACALEYLHQGY 1452
+ L+L+Y P G L +SH L+ E R ++ ALEYLH
Sbjct: 61 AFQTEEKLYLVLEYAPGGEL----FSH---LSKEGRFSEERARFYAAEIVLALEYLH--- 110
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYGSEG 1511
S II+ DLKP N+LLD D L DFG+AK + +T T T Y+APE
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
+ D +S G+L+ E LT + P F E
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP----FYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 6/210 (2%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
F+ +G+G FG V++ + VAIK+ + F E + L+R+RH++L+ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTP 864
+ CS +I E M +GSL +L S + L + +D+ VA + YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--- 124
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
IH DL N+L+ +D V ++DFG+++L+ ED + + + APE S G ST
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGET 953
DV+SFGIL+ E FT ++P M E
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 78/273 (28%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
F+ LG+G F V++ + + AIKI + + F E + ++R+RH++L +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ CS +I + M +GSL +L S +L + +D+ VA + YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLL-DGVDSMKQTMTLATIGY--MAPEYGSEGI 1512
IH DL N+L+ +D+V + DFG+A+L+ + V I Y APE S G
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK----KIPYKWTAPEAASHGT 180
Query: 1513 VSTSGDVYSFGILMMETLTRRK-PTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571
ST DV+SFGIL+ E T + P M E V D I A
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------------VYDQITAGY----- 221
Query: 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVK 1604
+ KC + + L+C PE+R + K
Sbjct: 222 --RMPCPAKCPQEIYKIMLECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
+G+G FG V+ ++VAIK+ +GA+ F E +V+ ++ H NLV++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ ++ EYM G L +L K L + LD+ DV A+EYL IH D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L+ +D V +SDFG+++ + + + T + PE S+ DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 930 SFGILMIETFTR-KMPTDEMFTGET 953
SFG+LM E F+ KMP + E
Sbjct: 186 SFGVLMWEVFSEGKMPYERFSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 5/217 (2%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIK-SFDAECEVLRRVRHRNLVKIISSC 809
L+G G+FG V+K TL VA+K L +K F +E +L++ H N+VK+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ +++E +P G +L K L +Q + +D A+ + YL + IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L+ ++ V +SDFG+S+ D + + + APE + G S+ DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 930 SFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLA 966
S+GIL+ ETF+ + T + + ++ VE+ R++
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQA-REQVEKGYRMS 214
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-24
Identities = 87/250 (34%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
L+ L +S N ++G IP +G+ + L+ L L GN L G+IP +L N T L F
Sbjct: 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL---------VGKIPNSLTNLTSLEF 192
Query: 1052 LILRQNQLTG--------------VRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHL 1097
L L NQL G + L N L G IP I +++ + L N+ +G +
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 1098 PSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQ 1157
PSS+G L NLQ L L+ N LSG IP SI + ++I L LS+N SG IP + L+
Sbjct: 253 PSSLGN-LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311
Query: 1158 ILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFA 1217
IL L N+ TG LT+ L+ L L +N G +P ++G +L
Sbjct: 312 ILHLFSNNF-TGKIPVA------LTSLPRLQVLQLWSNKFSGEIPKNLGK-HNNLTVLDL 363
Query: 1218 SSTELRGAIP 1227
S+ L G IP
Sbjct: 364 STNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIK--SFDAECEVLRRVRHRNLVKIISSC 809
+GAG FG V+ T VA+K G + +F E ++++++RH LV++ + C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
S ++ EYM +GSL +L S + L + Q +D+ +A + YL + IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127
Query: 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPE---YGSEGIVS 923
DL N+L+ ++ V ++DFG+++L+ ED A F + APE YG I S
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 924 TCGDVYSFGILMIETFTR-KMPTDEMFTGET 953
DV+SFGIL+ E T ++P M E
Sbjct: 186 ---DVWSFGILLTEIVTYGRVPYPGMTNREV 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 6/194 (3%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G F VYKA G AIK+ L+ + E +++++ +H N+ K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
+++++ GSL+ L S N L Q + ++ LEYLH S IIH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYS 1521
K +N+LL D L DFG++ D+ + + T +MAPE + D++S
Sbjct: 125 KAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWS 182
Query: 1522 FGILMMETLTRRKP 1535
GI +E + P
Sbjct: 183 LGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 1341 NLLGTGIFSSVYKAT-FADGTNAAIKIFSL----QEDR--ALKSFDAECEVMRRIRHRNL 1393
+G G F VY +DG +K L +++R AL E ++++++ H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNY---LLNIEQRLDIMIDVACALEYLHQ 1450
K S G ++++Y G L + + EQ LD + + AL+YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE---- 1506
S I+H D+KP N+ L + + LGDFGI+K+L + +T+ + T Y++PE
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQN 177
Query: 1507 --YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y + D++S G ++ E T + P F GE
Sbjct: 178 KPY------NYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVKII 806
IG GSFG VY G +K +L + DA E ++L+++ H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYT---LNIQQRLDIMIDVASALEYLHHGHPT 863
S G +++EY G L + + K +Q LD + + AL+YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------YG 917
++H D+KP N+ L + + L DFGISK+L + +T+ + T Y++PE Y
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNKPYN 181
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ D++S G ++ E T K P F GE
Sbjct: 182 YK------SDIWSLGCVLYELCTLKHP----FEGEN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 35/279 (12%)
Query: 1340 SNLLGTGIFSSVYKATF---ADGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNL 1393
LG G F V + D T + + SL E++ F+ E E++R + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 1394 AKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLH-Q 1450
K C PG ++ LI++Y+P GSL +L H +N+++ L + ++YL Q
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG------VDSMKQTMTLATIGYMA 1504
Y IH DL N+L++ + + + DFG+AK+L V ++ I + A
Sbjct: 129 RY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES----PIFWYA 180
Query: 1505 PEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDD---MFTGEVCLKHWVEESLPDAVTDV 1561
PE S++ DV+SFG+ + E T P+ F + + VT +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM-----IVTRL 235
Query: 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ LL +E + C V L C E P++R
Sbjct: 236 L--ELL--KEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 69/230 (30%), Positives = 125/230 (54%), Gaps = 19/230 (8%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV 797
LQ+LT G +IG G FG+V + G VA+K N++ D ++F E V+ ++
Sbjct: 4 NLQKLTLG----EIIGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKL 56
Query: 798 RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEY 856
H+NLV+++ ++G +++E M +G+L +L + + +++ Q L +DVA +EY
Sbjct: 57 HHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
L ++H DL N+L+ +D VA +SDFG++++ S+ + + APE
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEA 168
Query: 917 GSEGIVSTCGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
S+ DV+S+G+L+ E F+ + P +M E +K+ VE+ R+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGYRM 216
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 1337 FSESNLLGTGIFSSVYKA-TFADGTNAAIKIFSLQEDR--ALKSFDAECEVMRRIRHRNL 1393
+ +L+G G F VYK G AIK SL++ + ALKS E ++++ ++H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
K + S +IL+Y GSL + + + V L YLH+
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYLHE--- 117
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYGSEGI 1512
+IH D+K +N+L D V L DFG+A L+ V K ++ T +MAPE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAPEVIEMSG 175
Query: 1513 VSTSGDVYSFGILMMETLTRRKP 1535
ST+ D++S G ++E LT P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
IG+G FG V+ VAIK +GA+ + F E +V+ ++ H LV++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ L+ E+M G L +L + + + + L + +DV + YL + VIH D
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L+ ++ V +SDFG+++ + + + T T + +PE S S+ DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 930 SFGILMIETFTR-KMPTDEMFTGE 952
SFG+LM E F+ K P + E
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-23
Identities = 69/191 (36%), Positives = 99/191 (51%), Gaps = 12/191 (6%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISS-CS 810
IG G FG V G VA+K ++ D ++F AE V+ ++RH NLV+++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 811 NHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
G ++ EYM +GSL +L S + L L +DV A+EYL + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L NVL+ +D VA +SDFG++K E S TQ + APE E ST DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 930 SFGILMIETFT 940
SFGIL+ E ++
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 65/198 (32%), Positives = 96/198 (48%), Gaps = 28/198 (14%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQ---LDGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG G+ G VYKAT G VAIK L+ + I E +++ +H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82
Query: 808 S--CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S + + +++EYM GSL + + +N Q + +V LEYLH + V
Sbjct: 83 SYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---V 137
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------YGSE 919
IH D+K N+LL D L+DFG + L E S ++ + T +MAPE YG +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYGPK 196
Query: 920 GIVSTCGDVYSFGILMIE 937
V D++S GI+ IE
Sbjct: 197 --V----DIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 752 IGAGSFGSVYKATLPYG------MNVAIKVF-NLQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G G+FG V+ + VA+K + A K F+ E E+L +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSH-------------KYTLNIQQRLDIMIDVA 851
C+ ++ EYM G L K+L SH L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFG 910
S + YL H +H DL N L+ D V + DFG+S+ + D T+
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M PE +T DV+SFG+++ E FT
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 1e-22
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQL--DG----AIKSFDAECEVLRRVRHRNLVK 804
IG G++G VYKA G VA+K ++ +G AI+ E ++L+++RH N+V+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 805 IISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHP 862
+ ++ G + ++ EYM L L S + Q M + L+YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG- 120
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------- 915
++H D+K SN+L+++D V L+DFG+++ +S T + T Y PE
Sbjct: 121 --ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSL 955
YG E V D++S G ++ E F K F G T L
Sbjct: 179 YGPE--V----DMWSVGCILAELFLGKPI----FQGSTEL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-22
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-----ECEVLRRVRHRNLV 803
IG+G++G V A G VAIK + D I DA E ++LR +RH N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI---DAKRILREIKLLRHLRHENII 62
Query: 804 K---IISSCSNHGFKALIL--EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
I+ S F + + E M + L K + S + L + + L+YLH
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH 120
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE- 915
+ VIH DLKPSN+L++ + + DFG+++ +D ++ +T + T Y APE
Sbjct: 121 SAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177
Query: 916 ------YGSEGIVSTCGDVYSFGILMIETFTRK 942
Y ++ I D++S G + E TRK
Sbjct: 178 LLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 1343 LGTGIFSSVYKATFADGTNA--AIKIFSLQEDRAL-KSFDAECEVMRRIRHRNLAKIVSS 1399
LG G VYK T A+K + D K E + +R + K +
Sbjct: 9 LGQGSSGVVYKVRH-KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL-DIMIDVACALEYLHQGYSTSIIH 1458
G +++L+YM GSL L + E L I + L+YLH IIH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKI--PEPVLAYIARQILKGLDYLHT--KRHIIH 123
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT-LATIGYMAPE------YGSEG 1511
D+KPSN+L++ + DFGI+K+L+ +++ Q T + T+ YM+PE Y
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLE--NTLDQCNTFVGTVTYMSPERIQGESY---- 177
Query: 1512 IVSTSGDVYSFGILMMETLTRRKP 1535
S + D++S G+ ++E + P
Sbjct: 178 --SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 77/291 (26%), Positives = 121/291 (41%), Gaps = 44/291 (15%)
Query: 1343 LGTGIFSSVYKATFA------DGTNAAIKIFS-LQEDRALKSFDAECEVMRRIRHRNLAK 1395
LG G F V+ D A+K + A K F+ E E++ +H N+ K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSH----NYL---------LNIEQRLDIMIDVA 1442
C+ ++ +YM G L K+L SH +L L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIG 1501
+ YL S +H DL N L+ D+V +GDFG+++ + D + T+ I
Sbjct: 133 SGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561
+M PE +T DV+SFG+++ E T K + W S + V +
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYGLS-NEEVIEC 236
Query: 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612
I L C S V + L C + P++R+N+KD L+K
Sbjct: 237 ITQGRLLQRPRT-------CPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 71/261 (27%), Positives = 122/261 (46%), Gaps = 30/261 (11%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402
LG G F V+ T+ T AIK + ++F E +VM+++RH L ++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 1403 -PGFKALILQYMPQGSLEKWLY-SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
P + ++ +YM +GSL +L L + Q +D+ +A + Y+ + + +H D
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L+ +N+L+ +++V + DFG+A+L++ + + I + APE G + DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579
SFGIL+ E T+ R P M EV D V E +
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVL----------DQV-----------ERGYRMPCPP 226
Query: 1580 KCMSSVMSLALKCSEEIPEER 1600
+C S+ L +C + PEER
Sbjct: 227 ECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 746 FSESN---LIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRN 801
+ E+ ++G G++G VY A L + +AIK + ++ E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLE-----KW--LYSHKYTLNIQQRLDIMIDVASAL 854
+V+ + S S +GF + +E +P GSL KW L ++ T+ + + L
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGL 121
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
+YLH ++H D+K NVL++ + V +SDFG SK L G + T+T T T YMA
Sbjct: 122 KYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMA 177
Query: 914 PEYGSEGI--VSTCGDVYSFGILMIETFTRKMPTDEM 948
PE +G D++S G ++E T K P E+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 8/205 (3%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F V+ T+ T A+K +L+ + ++F E ++M+++RH L ++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVK--TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 1402 NPGFKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
++ +YM +GSL +L S L + Q +D+ +A + YL S + IH D
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L N+L+ +++V + DFG+A+L++ + + I + APE + G + DV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEV 1544
SFGIL+ E +T R P M EV
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREV 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 752 IGAGSFGSVYKAT--LPYG--MNVAIKVF-NLQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G G+FGSV K + G + VA+K + K F E V+ ++ H +V++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
C L++E P G L K+L + + + ++ VA + YL H +
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FV 117
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSEGIVST 924
H DL NVLL + A +SDFG+S+ L + T + + APE + G S+
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+S+G+ + E F+ P EM G + +E RL
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAM-LESGERL 217
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKS--FDAECEVLRRVRHRNLVKIISSC 809
+G G FG V +VAIK+ +G++ F E +V+ ++ H LV++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ ++ EYM G L +L H Q L++ DV + YL IH D
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L+DD +SDFG+S+ + ++ + + + PE S+ DV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 930 SFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
+FG+LM E ++ KMP + ET K V + LRL
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEK--VSQGLRL 220
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-21
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402
+G G F +V + + G A+K ++ D ++F E VM ++ H+NL +++ +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 1403 PGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
G ++++ M +G+L +L + L+++ Q L +DVA +EYL S ++H DL
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYS 1521
N+L+ +D VA + DFG+A+ V SM + + + APE S+ DV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLAR----VGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 1522 FGILMMETLTR-RKPTDDMFTGEV 1544
+G+L+ E + R P M EV
Sbjct: 183 YGVLLWEVFSYGRAPYPKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
IG G+ VY A LP VAIK +L + ++ E + + + H N+VK +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI---MIDVASALEYLH-HGHPTPV 865
L++ Y+ GSL + Y I + +V LEYLH +G
Sbjct: 69 VVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---- 123
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMTLATF-G---YMAPEYGSEG 920
IH D+K N+LL +D ++DFG+S L DG D TF G +MAPE +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR--TRKVRKTFVGTPCWMAPEVMEQV 181
Query: 921 IVSTCG-DVYSFGILMIETFTRKMP 944
D++SFGI IE T P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 10/209 (4%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDG-AIKSFDAECEVLR 795
E++R TD + + +G G +G VY+ Y + VA+K L+ D ++ F E V++
Sbjct: 2 EMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMK 57
Query: 796 RVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYS-HKYTLNIQQRLDIMIDVASAL 854
++H NLV+++ C+ +I E+M G+L +L ++ +N L + ++SA+
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
EYL + IH DL N L+ ++ + ++DFG+S+L+ G+ + AP
Sbjct: 118 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
Query: 915 EYGSEGIVSTCGDVYSFGILMIETFTRKM 943
E + S DV++FG+L+ E T M
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGM 203
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-21
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 27/209 (12%)
Query: 750 NLIGAGSFGSVYKATLP---YGMNVAIKVFN-LQLDGAIKSFDAECEVLRRV-RHRNLVK 804
++IG G+FG V +A + MN AIK+ + + F E EVL ++ H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKY---------------TLNIQQRLDIMID 849
++ +C N G+ + +EY P G+L +L + TL QQ L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLAT 908
VA+ ++YL IH DL NVL+ ++ + ++DFG+S+ GE+ V +TM
Sbjct: 128 VATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIE 937
+MA E + + +T DV+SFG+L+ E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 7/188 (3%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G GS+GSVYKA G VAIKV + + ++ E +L++ +VK S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ +++EY GS+ + TL ++ I+ LEYLH IH D
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRD 124
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
+K N+LL+++ A L+DFG+S L + T+ + T +MAPE E + D++
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV-IGTPFWMAPEVIQEIGYNNKADIW 183
Query: 930 SFGILMIE 937
S GI IE
Sbjct: 184 SLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 33/224 (14%)
Query: 733 RISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIK-SFDAE 790
S EL+R+ N IG+G+ G+VYK P G A+KV + ++ E
Sbjct: 70 AKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 791 CEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDV 850
E+LR V H N+VK ++G ++LE+M GSLE + + Q D+ +
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE-----QFLADVARQI 177
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM-----T 905
S + YLH H ++H D+KPSN+L++ ++DFG+S++L QTM +
Sbjct: 178 LSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL------AQTMDPCNSS 228
Query: 906 LATFGYMAPEY----GSEGIVSTC-GDVYSFGILMIETFTRKMP 944
+ T YM+PE + G GD++S G+ ++E + + P
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 69/215 (32%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 749 SNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDA---ECEVLRRVRHRNLVK 804
N IG G+FG VY A L G +A+K +Q D K+ E +VL ++H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ-DNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 805 IISSCSNHGFKALI-LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS---ALEYLH-H 859
H K I +EY G+LE+ L ++ + + + I + L YLH H
Sbjct: 64 YYG-VEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHV-IRVYTLQLLEGLAYLHSH 118
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG---YMAPEY 916
G ++H D+KP+N+ LD + V L DFG + L + + G YMAPE
Sbjct: 119 G----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 917 GSEGIVSTCG---DVYSFGILMIETFTRKMPTDEM 948
+ G G D++S G +++E T K P E+
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 752 IGAGSFGSVYKAT-LPYGMN----VAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKI 805
+G+G+FG+VYK +P G VAIKV + A K E V+ V H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 806 ISSC--SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ C S LI + MP G L ++ +HK + Q L+ + +A + YL
Sbjct: 75 LGICLSSQV---QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR-- 129
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD-GEDSVTQTMTLATFGYMAPEYGSEGIV 922
++H DL NVL+ ++DFG++KLLD E +MA E I
Sbjct: 130 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 923 STCGDVYSFGILMIETFT 940
+ DV+S+G+ + E T
Sbjct: 189 THKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 30/261 (11%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402
LG G F V+ T+ T A+K + +SF E ++M+++RH L ++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 1403 -PGFKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
P + ++ +YM +GSL +L L + +D+ VA + Y+ + + IH D
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L+ +N+L+ D +V + DFG+A+L++ + + I + APE G + DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579
SFGIL+ E +T+ R P M EV L E + +
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREV---------------------LEQVERGYRMPCPQ 226
Query: 1580 KCMSSVMSLALKCSEEIPEER 1600
C S+ L L+C ++ PEER
Sbjct: 227 DCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 8e-21
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAI-KSFDAECEVLRRVRHRNLVKIISS 808
IG G+ G V+KA G VA+K L +L+G I E + L+ +H +VK++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 809 CSNHGFK-ALILEYMPQGSLEKWL--YSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
HG L++EYMP L + L + M+ L+ + + H +
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-----LKGVAYMHANGI 120
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGS----E 919
+H DLKP+N+L+ D V ++DFG+++L E+ + +AT Y APE YG+
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 920 GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
G+ D+++ G + E P +F GE
Sbjct: 181 GV-----DLWAVGCIFAELL-NGSP---LFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQED------RALKSFDAECEVMRRIRHRNLAK 1395
+G G + VYKA G AIK L+ + AL+ E ++++ + H N+ K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
++ + G L+ ++M L K + L + + L + H S
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIV 1513
I+H DLKP N+L++ + V L DFG+A+ G T + T Y APE G +G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGDKG-Y 176
Query: 1514 STSGDVYSFGILMMETLTRR 1533
ST D++S G + E L+RR
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-20
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 751 LIGAGSFGSVYKATL-----PYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRV-RHRN 801
+IG GSF +V A Y AIK+ + L + +K E EVL R+ H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEY----AIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLH-H 859
++K+ + + +LEY P G L Y KY +L+ + ++ ALEYLH
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGEL--LQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG--------- 910
G +IH DLKP N+LLD D ++DFG +K+LD S AT
Sbjct: 122 G----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 911 ----------YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
Y++PE +E D+++ G ++ + T K P
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 9/222 (4%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRNLVKIISSC 809
IG G+FG V+ L VA+K L +K+ F E +L++ H N+V++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ +++E + G +L + L +++ + ++ + A+ +EYL H IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 870 LKPSNVLLDDDTVAHLSDFGISKL-LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDV 928
L N L+ + V +SDFG+S+ DG + T M + APE + G S+ DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 929 YSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRLAVTE 969
+SFGIL+ E F+ +P + +T ++ +E+ +RL E
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQT--REAIEQGVRLPCPE 219
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 5e-20
Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 1341 NLLGTGIFSSVYKAT----FADGTN---AAIKIFSLQE---DRALKSFDAECEVMRRIRH 1390
N LG+G F VY+ T G+ A+K +L++ D+ K F E +M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYS------HNYLLNIEQRLDIMIDVACA 1444
N+ K++ C + +I++ M G L +L LL +++ LDI +DVA
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLL-----DDDMVAHLGDFGIAKLLDGVDSM-KQTMTLA 1498
YL Q IH DL N L+ D D V +GDFG+A+ + D K+ L
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE +G +T DV+SFG+LM E LT
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 1342 LLGTGIFSSVYKATFA--DGTNAAIKIFSLQED----RALKSFDAECEVMRRIRHRNLAK 1395
+LG G F SV + + DG+ + + +++ D ++ F +E M+ H N+ K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 1396 IV------SSCSNPGFKALILQYMPQGSLEKWLYSHN-----YLLNIEQRLDIMIDVACA 1444
++ SS +IL +M G L +L L ++ L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT-MTLATIGYM 1503
+EYL + + IH DL N +L +DM + DFG++K + D +Q + + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTR 1532
A E ++ + ++ DV++FG+ M E TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG+G F V+ + + AIK+ ++ ED F E +VM ++ H NL ++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED----DFIEEAKVMMKLSHPNLVQLYGV 67
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
C+ ++ +YM G L +L L E LD+ DV A+EYL S IH
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHR 124
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL N L+ +D V + DFG+A+ + T + + PE S+ DV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 1520 YSFGILMMETLTRRK-PTDDMFTGEV 1544
+SFG+LM E + K P + EV
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 751 LIGAGSFGSVYKATL--PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRNLVK 804
++G G FGSV + L G + + V ++LD I+ F +E ++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 805 IISSC----SNHGFKA--LILEYMPQGSLEKWLYSHK-----YTLNIQQRLDIMIDVASA 853
+I C S +IL +M G L +L + L +Q L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYM 912
+EYL + + IH DL N +L +D ++DFG+SK + D Q + ++
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 913 APEYGSEGIVSTCGDVYSFGILMIETFTRKM 943
A E ++ + ++ DV++FG+ M E TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 75/304 (24%), Positives = 128/304 (42%), Gaps = 59/304 (19%)
Query: 1342 LLGTGIFSSVYKATFAD------GTNAAIKIFSLQEDRA---LKSFDAECEVMRRI-RHR 1391
LG G F V KA + A+K+ L++D L +E E+M+ I +H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWL---------YSHNYLLNIEQRL---DIM- 1438
N+ ++ C+ G ++++Y G+L +L S + E+ L D++
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 1439 --IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496
VA +E+L S IH DL NVL+ +D V + DFG+A+ + +D ++T
Sbjct: 137 FAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-- 191
Query: 1497 LATIG-----YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE 1551
T G +MAPE + + + DV+SFG+L+ E T G
Sbjct: 192 --TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGG--------- 232
Query: 1552 ESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611
P + + L G + + C + L C E+P +R K + +L
Sbjct: 233 SPYPGIPVEELFKLLKEGYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
Query: 1612 KIKT 1615
++ T
Sbjct: 290 RMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 6e-20
Identities = 70/201 (34%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 752 IGAGSFGSV--YK---ATLPYGMNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRNLVKI 805
+G G FG V Y A G VA+K + S + E +L+ + H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 806 ISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
CS G K LI+EY+P GSL +L HK LN+ Q L + + YLH H
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH-- 127
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLL-DGED--SVTQTMTLATFGYMAPEYGSEG 920
IH DL NVLLD+D + + DFG++K + +G + V + F Y A E E
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKEN 185
Query: 921 IVSTCGDVYSFGILMIETFTR 941
S DV+SFG+ + E T
Sbjct: 186 KFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 751 LIGAGSFGSVYKATL-PYGMN----VAIKVFNLQLDGA--IKSFDAECEVLRRVRHRNLV 803
+G G+FGSV P N VA+K LQ A ++ F+ E E+L+ ++H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 804 KIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
K C + G + L++EY+P GSL +L H+ L+ ++ L + +EYL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL--DGED-SVTQTMTLATFGYMAPEYGS 918
+H DL N+L++ + + DFG++K+L D E V + F Y APE +
Sbjct: 129 ---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLT 184
Query: 919 EGIVSTCGDVYSFGILMIETFT 940
E S DV+SFG+++ E FT
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 11/209 (5%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKAT--LPYG--MNVAIKVFNLQLDGAIKS-FDAECE 792
E+QR + + IG G FG VY+ P + VA+K +++ F E
Sbjct: 2 EIQR--EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 793 VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS 852
++R+ H ++VK+I + + +++E P G L +L +KY+L++ + +++
Sbjct: 60 IMRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
AL YL +H D+ NVL+ L DFG+S+ L+ E + +M
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175
Query: 913 APEYGSEGIVSTCGDVYSFGILMIETFTR 941
APE + ++ DV+ FG+ M E
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 8e-20
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
+G G FG V+ T VAIK G + ++F E +V++++RH LV++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
S ++ EYM +GSL +L L + Q +D+ +AS + Y+ + +H
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDV 928
DL+ +N+L+ ++ V ++DFG+++L++ + + + APE G + DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 929 YSFGILMIETFTR-KMPTDEMFTGE 952
+SFGIL+ E T+ ++P M E
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 10/204 (4%)
Query: 1336 GFSESNLLGTGIFSSVYKATFADGTNA-AIKIFSLQ---EDRALKSFDAECEVMRRIRHR 1391
F ++G G F V D A+K + Q E ++++ E +++ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
L + S + L++ + G L ++ S + EQ + ++ ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH-- 117
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG 1511
S IIH D+KP N+LLD+ H+ DF IA + T T T GYMAPE
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 1512 IVSTSGDVYSFGILMMETLTRRKP 1535
S + D +S G+ E L ++P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSL---QEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G G F VYK T A+K + + F E E++++ H N+ K++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIG 59
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
C ++++ +P GSL +L L +++ L + +D A +EYL S + IH
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIH 116
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGV-----DSMKQTMTLATIGYMAPEYGSEGIV 1513
DL N L+ ++ V + DFG+++ +G D +KQ I + APE + G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI----PIKWTAPEALNYGRY 172
Query: 1514 STSGDVYSFGILMMETLT 1531
++ DV+S+GIL+ ET +
Sbjct: 173 TSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKI----FSLQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G+G F V+ + + AIK +ED F E +VM ++ H L ++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED-----FIEEAQVMMKLSHPKLVQLYG 66
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
C+ L+ ++M G L +L + + E L + +DV + YL +++IH
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIH 123
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
DL N L+ ++ V + DFG+ + + T T + + +PE S S+ D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 1519 VYSFGILMMETLTR-RKPTDDMFTGEV 1544
V+SFG+LM E + + P ++ EV
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 63/188 (33%), Positives = 96/188 (51%), Gaps = 12/188 (6%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSS-CS 1401
+G G F V + G A+K ++ D ++F AE VM ++RH NL +++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
G ++ +YM +GSL +L S +L + L +DV A+EYL + + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L NVL+ +D VA + DFG+ K S + T L + + APE E ST DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP-VKWTAPEALREKKFSTKSDVW 183
Query: 1521 SFGILMME 1528
SFGIL+ E
Sbjct: 184 SFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-19
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS---LQEDRALKSFDAECEVMRRI-RHRNLAKI 1396
++G G FS+V A AIKI L +++ +K E EV+ R+ H + K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+ + +L+Y P G L +++ L+ + ++ ALEYLH S I
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH---SKGI 123
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG--------------- 1501
IH DLKP N+LLD DM + DFG AK+LD S + AT
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 1502 ----YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
Y++PE +E S D+++ G ++ + LT + P
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 62/230 (26%), Positives = 111/230 (48%), Gaps = 26/230 (11%)
Query: 750 NLIGAGSFGSVYKATL-----PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLV 803
+IG G FG V + L ++VAIK D F E ++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKE-IDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYL-HHGHP 862
++ + +I EYM GSL+K+L + + Q + ++ +AS ++YL +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG-----YMAPEYG 917
+H DL N+L++ + V +SDFG+S+ L+ ++ T G + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG----GKIPIRWTAPEAI 180
Query: 918 SEGIVSTCGDVYSFGILMIE--TFTRKMPTDEMFTGETSLKKWVEESLRL 965
+ ++ DV+SFGI+M E ++ + P +M + + +K VE+ RL
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGER-PYWDM-SNQDVIKA-VEDGYRL 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 8/205 (3%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRA-LKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F V++ + + T A+K +L+ K F AE ++M+++RH L ++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 1402 NPGFKALILQYMPQGSLEKWLY-SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
++ + M GSL ++L L + Q +D+ VA + YL + + IH D
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L NVL+ ++ + + DFG+A+++ + I + APE S DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEV 1544
SFGIL+ E +T R P M EV
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTNAEV 213
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 28/262 (10%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQED--RALK-SFDAECEVMRRIRHRNLAKIVS 1398
LLG G F V+K T D T A+K + +ED + LK F +E ++++ H N+ K++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
C+ ++++ +P G +L L +Q + +D A + YL S + IH
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIH 116
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
DL N L+ ++ V + DFG+++ D + I + APE + G S+ D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578
V+S+GIL+ ET F+ VC P + G ++
Sbjct: 177 VWSYGILLWET----------FSLGVC-------PYPGMTNQQAREQVEKGYR---MSCP 216
Query: 1579 KKCMSSVMSLALKCSEEIPEER 1600
+KC V + +C + PE R
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENR 238
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 1343 LGTGIFSSVYKATF-ADGTNA----AIKIFSLQEDRALKSFDA---ECEVMRRIRHRNLA 1394
LG+G F +VYK + +G AIK+ L+E+ + K+ E VM + H ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
+++ C + LI Q MP G L ++ +H + + L+ + +A + YL +
Sbjct: 73 RLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---K 128
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD-GVDSMKQTMTLATIGYMAPEYGSEGIV 1513
++H DL NVL+ + DFG+AKLLD I +MA E I
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 1514 STSGDVYSFGILMMETLT-RRKPTDDMFTGEV 1544
+ DV+S+G+ + E +T KP + + E+
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 1343 LGTGIFSSV----YKATFADGTNAAIKIFSLQEDRALK---SFDAECEVMRRIRHRNLAK 1395
LG G F V Y DGT + + +L+ + + + E +++ + H N+ K
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 1396 IVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
CS G K LI++Y+P GSL +L H LN+ Q L + + YLH S
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---S 125
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG-----YMAPEYG 1508
IH DL NVLLD+D + +GDFG+AK V + + G + A E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAK---AVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRRKP 1535
E S + DV+SFG+ + E LT
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 10/217 (4%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGA-IKSFDAECEVLRRVRHRNLVKIISSCS 810
+GAG FG V++ VA+K L+ K F AE ++++++RH L+++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
++ E M GSL ++L L + Q +D+ VAS + YL + IH D
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L NVL+ ++ + ++DFG+++++ + + + APE S DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 930 SFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
SFGIL+ E T +MP M T L++ V++ R+
Sbjct: 189 SFGILLTEIVTYGRMPYPGM-TNAEVLQQ-VDQGYRM 223
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-19
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 41/216 (18%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIK------------SFDAECEVLRRV 797
++IG G+FG V KA IK L++D AIK F E EVL ++
Sbjct: 13 DVIGEGNFGQVLKAR--------IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 798 -RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWL---------------YSHKYTLNIQ 841
H N++ ++ +C + G+ L +EY P G+L +L S TL+ Q
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
Q L DVA ++YL IH DL N+L+ ++ VA ++DFG+S+ E V
Sbjct: 125 QLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 179
Query: 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIE 937
+TM +MA E + + +T DV+S+G+L+ E
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 3e-19
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 1341 NLLGTGIFSSVYKATFAD-GTNAAIK----IFSLQED--RALKSFDAECEVMRRIRHRNL 1393
+G+G + V A G AIK +F D R L+ E +++R +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 1394 AKIVS---SCSNPGFKALIL--QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL 1448
++ S F + + + M + L K + S L + + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 1449 HQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGYMAPE 1506
H S ++IH DLKPSN+L++ + + DFG+A+ +D + K +T + T Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 1507 -------YGSEGIVSTSGDVYSFGILMMETLTRR 1533
Y ++ I D++S G + E LTR+
Sbjct: 177 LLLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 67/248 (27%), Positives = 115/248 (46%), Gaps = 47/248 (18%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGAIKSFD--- 788
EL R D + +G G+FG V KA VA+K+ L+ D K
Sbjct: 8 ELPR--DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLV 63
Query: 789 AECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWL---------YSHKYTL 838
+E E+++ + +H+N++ ++ C+ G +++EY G+L +L S
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 839 NIQQRL---DIM---IDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892
++ L D++ VA +E+L IH DL NVL+ +D V ++DFG+++
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
Query: 893 LLDGEDSVTQTMTLATFG-----YMAPEYGSEGIVSTCGDVYSFGILMIETFT------R 941
+ D +T T G +MAPE + + + DV+SFG+L+ E FT
Sbjct: 181 DIHHIDYYRKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
Query: 942 KMPTDEMF 949
+P +E+F
Sbjct: 237 GIPVEELF 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 35/212 (16%)
Query: 751 LIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDG-----AIKSFDAECEVLRRVRHRNLVK 804
L+G+GSFGSVY+ L G A+K +L DG A+K + E +L +++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLY---SHKYTLNIQQRLDIMIDVASALEYLHHGH 861
+ + + LE +P GSL K L S + I+ LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG---YMAPEYGS 918
+H D+K +N+L+D + V L+DFG++K V + + G +MAPE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPE--- 171
Query: 919 EGIVSTCG------DVYSFGILMIETFTRKMP 944
+++ G D++S G ++E T K P
Sbjct: 172 --VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 736 YQELQRLTDGFSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVL 794
Y+ +QR IG+G++G VYKA + G VAIKV L+ + E +L
Sbjct: 5 YELIQR----------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISML 54
Query: 795 RRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
+ RH N+V S +++EY GSL+ + L+ Q + + L
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGL 114
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT-----LATF 909
YLH IH D+K +N+LL +D L+DFG+S L T T+ + T
Sbjct: 115 AYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTP 165
Query: 910 GYMAPEYGSE----GIVSTCGDVYSFGILMIE 937
+MAPE + G C D+++ GI IE
Sbjct: 166 YWMAPEVAAVERKGGYDGKC-DIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 68/280 (24%), Positives = 119/280 (42%), Gaps = 33/280 (11%)
Query: 1342 LLGTGIFSSVYKATF----ADGTNAAIKIFSLQEDRALKS-FDAECEVMRRIRHRNLAKI 1396
+G G F VY+ + + A+K +++ F E +MR+ H ++ K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 1397 VSSCS-NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ + NP + ++++ P G L +L + Y L++ + ++ AL YL S
Sbjct: 73 IGVITENPVW--IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKR 127
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVST 1515
+H D+ NVL+ LGDFG+++ L+ K + I +MAPE + ++
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 1516 SGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574
+ DV+ FG+ M E L KP V+ + DVI + +GE
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPF-----------QGVKNN------DVI-GRIENGER--- 226
Query: 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614
+ C ++ SL KC P +R + A L I
Sbjct: 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 10/204 (4%)
Query: 745 GFSESNLIGAGSFGSVYKATLPYGMNV-AIKVFNLQL---DGAIKSFDAECEVLRRVRHR 800
F +IG G+FG V + A+K N Q G++++ E +L+ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
LV + S + L+++ + G L ++ S K + +Q + ++ ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEG 920
+IH D+KP N+LLD+ H++DF I+ + T T T GYMAPE
Sbjct: 120 G---IIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 921 IVSTCGDVYSFGILMIETFTRKMP 944
S D +S G+ E K P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 4e-19
Identities = 67/204 (32%), Positives = 93/204 (45%), Gaps = 36/204 (17%)
Query: 1343 LGTGIFSSVYKATFADGTNA-AIKIFSLQEDRALKSFD---AECEVMRRIRHRNLAKIVS 1398
LGTG F V A+KI S + LK + E +++ IRH L +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI------DVACALEYLHQGY 1452
S + L+++Y+P G L +SH L R + V ALEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSH---LRKSGRFPEPVARFYAAQVVLALEYLH--- 118
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEG 1511
S I++ DLKP N+LLD D + DFG AK + G +T TL T Y+APE
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPE----- 168
Query: 1512 IVSTSG-----DVYSFGILMMETL 1530
I+ + G D ++ GIL+ E L
Sbjct: 169 IILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 36/267 (13%)
Query: 1343 LGTGIFSSVYKATF--ADGT--NAAIKIFSLQEDRALKS-FDAECEVMRRIRHRNLAKIV 1397
LG G F SV K + G A+K + A K F E VM ++ H + +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
C L+++ P G L K+L + + + + VA + YL S +
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQVAMGMAYLE---SKHFV 117
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA---TIGYMAPEYGSEGIVS 1514
H DL NVLL + A + DFG+++ L G S T A + + APE + G S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 1515 TSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573
+ DV+S+G+ + E + KP +M G + + A L SGE
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEM-KG------------AEVI-----AMLESGER-- 216
Query: 1574 DIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ ++C + S+ L C + PE+R
Sbjct: 217 -LPRPEECPQEIYSIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402
LG G F V+ T+ T AIK ++F E ++M+++RH L + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 1403 -PGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
P + ++ ++M +GSL +L + L + Q +D+ +A + Y+ + + IH D
Sbjct: 73 EPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L+ +N+L+ D++V + DFG+A+L++ + + I + APE G + DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEV 1544
SFGIL+ E +T+ R P M EV
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRAL-KSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G V K G A+K L+ + A+ K E +++ + + +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
N G ++ ++YM GSL+K L + I + V L YLH+ + IIH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
+KPSN+L++ L DFG++ L V+S+ +T T YMAPE S D++
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDIW 183
Query: 1521 SFGILMMETLTRRKP 1535
S G+ ++E T R P
Sbjct: 184 SLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 13/227 (5%)
Query: 747 SESNLIGAGSFGSVYKATL--PYGMNVAIKVFNLQLDGAIKS---FDAECEVLRRVRHRN 801
++ +IGAG FG V++ L P VA+ + L+ K F +E ++ + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
++++ + +I EYM G+L+K+L H + Q + ++ +A+ ++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD-- 125
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL--DGEDSVTQTMTLATFGYMAPEYGSE 919
+H DL N+L++ + +SDFG+S++L D E + T + + APE +
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 920 GIVSTCGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
++ DV+SFGI+M E + + P +M E + K + + RL
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDGFRL 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSS 1399
+ LG G + VY+ + + + + +L+ED ++ F E VM+ I+H NL +++
Sbjct: 12 HKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 1400 CS-NPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
C+ P F +I ++M G+L +L N +N L + ++ A+EYL + I
Sbjct: 71 CTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSG 1517
H DL N L+ ++ + + DFG+++L+ G I + APE + S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 1518 DVYSFGILMMETLT 1531
DV++FG+L+ E T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-18
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 42/205 (20%)
Query: 752 IGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAIKSFD---AECEVLRRVRHRNLVK 804
+G GSFG V +K + Y A+K+ + +K + E +L+ +RH LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKY---YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMI------DVASALEYLH 858
+ S + L++EY+P G L +SH L R + V ALEYLH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGEL----FSH---LRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL-ATFGYMAPEYG 917
+++ DLKP N+LLD D ++DFG +K + G +T TL T Y+APE
Sbjct: 119 SLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPE-- 168
Query: 918 SEGIVSTCG-----DVYSFGILMIE 937
I+ + G D ++ GIL+ E
Sbjct: 169 ---IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 752 IGAGSFGSVYKATL--PYGM----NVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRNLVK 804
+G G+FG VYK L P +VAIK + ++ F E E++ ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSH---------------KYTLNIQQRLDIMID 849
++ C+ ++ EY+ G L ++L + K +L+ L I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLAT 908
+A+ +EYL H +H DL N L+ + +SDFG+S+ + D Q+ +L
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M PE G +T D++SFG+++ E F+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-18
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 750 NLIGAGSFGSVYKATLP---YGMNVAIKVFN-LQLDGAIKSFDAECEVLRRV-RHRNLVK 804
++IG G+FG V KA + M+ AIK + F E EVL ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKY---------------TLNIQQRLDIMID 849
++ +C + G+ L +EY P G+L +L + TL+ QQ L D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLAT 908
VA ++YL IH DL N+L+ ++ VA ++DFG+S+ G++ V +TM
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIE 937
+MA E + + +T DV+S+G+L+ E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
+G G+FG VYKA G+ A K+ ++ + ++ F E ++L +H N+V + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++E+ G+L+ + + L Q + + AL +LH VIH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDL 129
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC----- 925
K N+LL D L+DFG+S T + T +MAPE V C
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPE------VVACETFKD 182
Query: 926 ------GDVYSFGILMIETFTRKMPTDEM 948
D++S GI +IE + P E+
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 750 NLIGAGSFGSVYKAT----LPYG---MNVAIKVFNLQLDGAI----KSFDAECEVLRRVR 798
N +G+G+FG VY+ T L G + VA+K GA K F E ++
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT------LNIQQRLDIMIDVAS 852
H N+VK++ C + + +I+E M G L +L + L +++ LDI +DVA
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLL-----DDDTVAHLSDFGISKLLDGEDSV-TQTMTL 906
YL H IH DL N L+ D D V + DFG+++ + D + L
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 907 ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+MAPE +G +T DV+SFG+LM E T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 69/291 (23%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 1343 LGTGIFSSVYKATFA------DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
LG G F V+ A D A+K + A + F E E++ ++H+++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNY--------------LLNIEQRLDIMIDVA 1442
C+ ++ +YM G L ++L SH L + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIG 1501
+ YL S +H DL N L+ +V +GDFG+++ + D + T+ I
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561
+M PE +T D++SFG+++ E T K + W + S T+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQLS----NTEA 233
Query: 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612
I+ + G E + + C V ++ C + P++RM +KD + L+
Sbjct: 234 IEC-ITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 3e-18
Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 61/274 (22%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAEC--EV--LRRVRHRNLVKII 806
+G G++G VYKA G VA+K ++LD + + E+ L+ ++H N+VK++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
L+ EY L+K+L L+ IM + L Y H ++
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---IL 120
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-------YGSE 919
H DLKP N+L++ D V L+DFG+++ G T T + T Y APE Y +
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVVTLWYRAPEILLGSKHYST- 178
Query: 920 GIVSTCGDVYSFGILMIETFTRK--------------------MPTDEMFTGETSLK--- 956
+ D++S G + E T K PT+E + G T L
Sbjct: 179 AV-----DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 957 ----KWVEESLRLAVTEVVDAELLSSEEEEGADL 986
K+ + L ++L + EG DL
Sbjct: 234 PTFPKFPPKDLE---------KVLPRLDPEGIDL 258
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 65/238 (27%), Positives = 115/238 (48%), Gaps = 27/238 (11%)
Query: 752 IGAGSFGSVYKATLPYGM-----NVAIKVFNLQLDGAIK-SFDAECEVLRRVRHRNLVKI 805
+G+G+FG V K Y M +VAIKV + + +++ E E++ ++ + +V++
Sbjct: 3 LGSGNFGCVKKGV--YKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
I C L++E G L K+L K + + +++M V+ ++YL +
Sbjct: 61 IGVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSEGIVS 923
+H DL NVLL + A +SDFG+SK L +DS + + + + APE + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 924 TCGDVYSFGILMIETFT------RKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
+ DV+S+GI M E F+ +KM E+ + ++E+ RL E+
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-------FIEQGKRLDCPAECPPEM 227
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 12/198 (6%)
Query: 751 LIGAGSFGSVYKATL--PYG--MNVAIKVF-NLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G GSFG V + G + VA+K + +L + F E ++ + H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 806 ISSCSNHGFKALILEYMPQGSL-EKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
H ++ E P GSL ++ I D + +A+ + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMTLAT-FGYMAPEYGSEGIV 922
IH DL N+LL D + DFG+ + L ED L F + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 923 STCGDVYSFGILMIETFT 940
S DV+ FG+ + E FT
Sbjct: 178 SHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-18
Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 51/283 (18%)
Query: 1341 NLLGTGIFSSVYKATFA-DGT--NAAIKI---FSLQEDRALKSFDAECEVMRRI-RHRNL 1393
+++G G F V +A DG NAAIK+ F+ + D + F E EV+ ++ H N+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHHPNI 65
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL---------------LNIEQRLDIM 1438
++ +C N G+ + ++Y P G+L +L L L +Q L
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTL 1497
DVA ++YL + IH DL NVL+ +++ + + DFG+++ G + +K+TM
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557
+ +MA E + + +T DV+SFG+L+ E ++ + G C + + E LP
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP---YCGMTCAELY--EKLPQG 234
Query: 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ + C V L +C + P ER
Sbjct: 235 YR---------------MEKPRNCDDEVYELMRQCWRDRPYER 262
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKS-FDAECEVLRRVRHRNLVKIISS 808
IG GSFG+V K G + K + + K +E +LR ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 809 CSNHGFKAL--ILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLHHG 860
+ + L ++EY G L + L + ++ I+ + AL H+
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKER--KYIEEEFIWRILTQLLLALYECHNR 124
Query: 861 -HPTP-VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS 918
P V+H DLKP+N+ LD + L DFG++K+L + S +T + T YM+PE +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQLN 183
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMP 944
D++S G L+ E P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 4e-18
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALK---SFDA--ECEVMRRIRHRNLA 1394
LG G ++ VYKA G AIK L E + K +F A E ++++ ++H N+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLL---NIEQRLDIMIDVACALEYLHQG 1451
++ + L+ ++M LEK + + +L +I+ M+ LEYLH
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLEYLHSN 121
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGS 1509
+ I+H DLKP+N+L+ D V L DFG+A+ G + K T + T Y APE +G+
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELLFGA 177
Query: 1510 EGIVSTSGDVYSFGILMMETLTRR 1533
D++S G + E L R
Sbjct: 178 R-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-18
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRN--- 1392
+G G + VYKA G A+K ++ ++ A++ E ++++++RH N
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
L +IV+S ++ +YM L L S Q M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--- 117
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE------ 1506
S I+H D+K SN+L+++D V L DFG+A+ +S T + T+ Y PE
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 1507 -YGSEGIVSTSGDVYSFGILMMETLTRR 1533
YG E V D++S G ++ E +
Sbjct: 178 RYGPE--V----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 20/212 (9%)
Query: 733 RISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAE 790
R S Q +++L G G FG V+ T VA+K G + +SF E
Sbjct: 5 RESLQLIKKL----------GNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEE 51
Query: 791 CEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMID 849
++++++RH LV++ + S ++ EYM +GSL +L + L + +D+
Sbjct: 52 AQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF 909
VA+ + Y+ + IH DL+ +N+L+ D V ++DFG+++L++ + +
Sbjct: 111 VAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFTR 941
+ APE G + DV+SFGIL+ E T+
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVKIISS 808
IG G++G VYKA G VAIK L+ + A E ++L+ + H N++K++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIH 867
+ G L+ E+M L K + + L + + L + H HG ++H
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG----ILH 121
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGSEGIVSTC 925
DLKP N+L++ + V L+DFG+++ T + T Y APE G +G ST
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLGDKG-YSTP 179
Query: 926 GDVYSFGILMIETFTRK 942
D++S G + E +R+
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 70/262 (26%), Positives = 123/262 (46%), Gaps = 32/262 (12%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F V+ + T AIK SL++ + ++F AE +M++++H L ++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 1402 N-PGFKALILQYMPQGSLEKWLYSHNYL-LNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
P + +I +YM GSL +L + + L I + +D+ +A + ++ + + IH
Sbjct: 72 QEPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHR 126
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL+ +N+L+ + + + DFG+A+L++ + + I + APE + G + DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 1520 YSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578
+SFGIL+ E +T R P M EV NL E +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVI------------------QNL---ERGYRMPRP 225
Query: 1579 KKCMSSVMSLALKCSEEIPEER 1600
C + L C +E PEER
Sbjct: 226 DNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 1342 LLGTGIFSSVYKATF---ADGTNAAIKIFSLQEDRA--LKSFDAECEVMRRIRHRNLAKI 1396
LG G F SV + D T + + LQ A L+ F+ E E+++ ++H N+ K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 1397 VSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
C + G + L+++Y+P GSL +L H L+ + L + +EYL S
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL--DGVDSMKQTMTLATIGYMAPEYGSEGI 1512
+H DL N+L++ + +GDFG+ K+L D + + I + APE +E
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 1513 VSTSGDVYSFGILMMETLT 1531
S + DV+SFG+++ E T
Sbjct: 188 FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-18
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 1337 FSESN---LLGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRN 1392
+ E+ +LG G + VY A + AIK ++ R ++ E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLE-----KW--LYSHNYLLNI--EQRLDIMIDVAC 1443
+ + + S S GF + ++ +P GSL KW L + + +Q L+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE------- 119
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGY 1502
L+YLH I+H D+K NVL++ V + DFG +K L G++ +T T T+ Y
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQY 175
Query: 1503 MAPEYGSEGI--VSTSGDVYSFGILMMETLTRRKP 1535
MAPE +G D++S G ++E T + P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-17
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 1343 LGTGIFSSVYKATFADG---------TNAAIKIF-SLQEDRALKSFDAECEVMRRI-RHR 1391
LG G F V A A G T A+K+ S ++ L +E E+M+ I +H+
Sbjct: 26 LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWL---------YSHNYLLNIEQRLDIMIDVA 1442
N+ ++ +C+ G +I++Y +G+L ++L Y +N E++L V+
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 1443 CA------LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496
CA +EYL S IH DL NVL+ +D V + DFG+A+ + +D K+T
Sbjct: 145 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 1497 -LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + I + DV+SFG+L+ E T
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 751 LIGAGSFGSVYKATLPYGMN------VAIKVFNLQLDGA---------IKSFDAECEVLR 795
LIG+GSFGSVY GMN +A+K L A + + E +L+
Sbjct: 7 LIGSGSFGSVY-----LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 796 RVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL--DIMIDVASA 853
++H N+V+ + S + + LEY+P GS+ L ++ ++ L + + +
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKG 118
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT-----LAT 908
L YLH+ +IH D+K +N+L+D+ +SDFGISK L+ T+T +
Sbjct: 119 LNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+MAPE + + D++S G L++E T K P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LGTG F V + + AIK+ S+ ED F E +VM ++ H L ++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED----EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
C+ ++ +YM G L +L H Q L++ DV + YL S IH
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAK-LLDGVDSMKQTM-TLATIGYMAPEYGSEGIVSTSG 1517
DL N L+DD + DFG+++ +LD D ++ + + + PE S+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 1518 DVYSFGILMMETLTRRKPTDDMFTGEVCLKH 1548
DV++FG+LM E + K + F ++
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 8/215 (3%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRNL 1393
F N +G G F V+K AD A+K L + + +A E V+ ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ S + G ++++Y G L K L L +Q I + L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--- 118
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI 1512
S I+H D+K N+ LD +GD G+AKLL + T+ + T Y++PE +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCEDKP 177
Query: 1513 VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547
+ DV++ G+++ E T + P D G + LK
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
+G+G FG V+ + VAIK N +GA+ + F E +V+ ++ H LV++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ ++ E+M G L +L + L+ L + DV +EYL IH D
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L+ V +SDFG+++ + ++ + + + PE + S+ DV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 930 SFGILMIETFTR-KMP 944
SFG+LM E FT KMP
Sbjct: 186 SFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 35/250 (14%)
Query: 746 FSESNL-----IGAGSFGSVYKATLPYGMN------VAIKVF------NLQLDGAIKSFD 788
F SNL +G G FG V+ A V +K NLQ + F
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-----FR 56
Query: 789 AECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT--------LNI 840
E ++ R++ H+N+V+++ C +ILEY G L+++L + K L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 841 QQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900
+Q++ + +A +++L + +H DL N L+ +S +SK + +
Sbjct: 117 KQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWV 959
L ++APE E ST DV+SFG+LM E FT+ ++P + + E L +
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQ 232
Query: 960 EESLRLAVTE 969
L L V E
Sbjct: 233 AGKLELPVPE 242
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 13/191 (6%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G + SVYKA + G AIK+ ++ED L+ E ++++ + K S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
++++Y GS+ + N L E+ I+ LEYLH S IH D
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRD 124
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEGIVSTSG 1517
+K N+LL+++ A L DFG++ L D+M + T+ IG +MAPE E +
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTV--IGTPFWMAPEVIQEIGYNNKA 180
Query: 1518 DVYSFGILMME 1528
D++S GI +E
Sbjct: 181 DIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 1340 SNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDR--ALKSFDAECEVMRRIRHRNLAKI 1396
N +G G F VY A D G A+K +Q++ +K E +V+ ++H NL K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 1397 VSSCSNPGF-----KALILQ-YMPQGSLEKWL-YSHNYLLNIEQRLDIMIDVACALEYLH 1449
G K I Y G+LE+ L + ++ + + + L YLH
Sbjct: 65 Y------GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEG--LAYLH 116
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL----DGVDSMKQTMTLATIGYMAP 1505
S I+H D+KP+N+ LD + V LGDFG A L + Q++ T YMAP
Sbjct: 117 ---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAP 172
Query: 1506 EYGSEGIVSTSG---DVYSFGILMMETLTRRKP 1535
E + G G D++S G +++E T ++P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-17
Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 45/285 (15%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
LG G F V+ A D A+K A K F E E++ ++H ++ K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRLDIMIDV 1441
C + ++ +YM G L K+L +H L + Q L I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 1442 ACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATI 1500
A + YL S +H DL N L+ +++ +GDFG+++ + D + T+ I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 1501 GYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560
+M PE +T DV+SFG+++ E T K + W + S + +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLSNTEVIEC 237
Query: 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKD 1605
+ +L + C V + L C + P++R+N+K+
Sbjct: 238 ITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
+G G FG V+ T VAIK G + ++F E ++++++RH LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 810 SNHGFKALILEYMPQGSLEKWLYSH--KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
S ++ E+M +GSL +L KY L + Q +D+ +A + Y+ + IH
Sbjct: 71 SEEPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMN---YIH 125
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
DL+ +N+L+ D+ V ++DFG+++L++ + + + APE G + D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 928 VYSFGILMIETFTR-KMPTDEMFTGE 952
V+SFGIL+ E T+ ++P M E
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-17
Identities = 88/315 (27%), Positives = 133/315 (42%), Gaps = 58/315 (18%)
Query: 988 DSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------------YLY 1031
+S+++ + +S I+G I + L ++ ++L N L L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 1032 NNKFTGRIPQNLGNCTLLNFLILRQNQLTG--------------VRLASNKLIGRIPSMI 1077
NN FTG IP+ G+ L L L N L+G + L N L+G+IP+ +
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 1078 FNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGL 1137
N +++E + L N G +P +G + +L+ + L NNLSG IP I + + L L
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 1138 SENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
N +G IP++ GN + LQ L L N L+ S+ + + L L L +N L
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSG-------PIPPSIFSLQKLISLDLSDNSL 296
Query: 1198 KGALPNSIGNLSTSLEYFFASSTELRGAIPV----------------EFEGEIPSG-GPF 1240
G +P + L LE S G IPV +F GEIP G
Sbjct: 297 SGEIPELVIQLQN-LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 1241 VNFTAESLMQNLVLG 1255
N T L N + G
Sbjct: 356 NNLTVLDLSTNNLTG 370
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-17
Identities = 77/296 (26%), Positives = 135/296 (45%), Gaps = 51/296 (17%)
Query: 1341 NLLGTGIFSSVYKATF-ADG--TNAAIKI---FSLQEDRALKSFDAECEVMRRI-RHRNL 1393
+++G G F V KA DG +AAIK ++ ++D + F E EV+ ++ H N+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNI 70
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL---------------LNIEQRLDIM 1438
++ +C + G+ L ++Y P G+L +L L L+ +Q L
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTL 1497
DVA ++YL Q IH DL N+L+ ++ VA + DFG+++ G + +K+TM
Sbjct: 131 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184
Query: 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557
+ +MA E + + +T+ DV+S+G+L+ E ++ + G C + + E LP
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELY--EKLPQG 239
Query: 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
+ C V L +C E P ER + L +L ++
Sbjct: 240 YR---------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 752 IGAGSFGSVYKAT----LPYG--MNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G+FG V+ A LP M VA+K + A + F E E+L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKY--------------TLNIQQRLDIMIDVA 851
C+ ++ EYM G L ++L SH L + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFG 910
S + YL H +H DL N L+ V + DFG+S+ + D T+
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M PE +T D++SFG+++ E FT
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 7e-17
Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G VYKAT A G AIK L++ + E +M+ +H N+ S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
++++YM GSL + + +N Q + +V LEYLH S ++IH D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE------YGSEGIVST 1515
K N+LL D L DFG A L S + ++ + T +MAPE YG
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYG------P 195
Query: 1516 SGDVYSFGILMME 1528
D++S GI+ +E
Sbjct: 196 KVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 751 LIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIIS 807
++G G++G V K G VAIK F D K+ E +VLR++RH N+V +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVI 866
+ G L+ EY+ + LE L + L + + A+ Y H H +I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCHSHN----II 122
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-------YGSE 919
H D+KP N+L+ + V L DFG ++ L + T +AT Y APE YG
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 920 GIVSTCGDVYSFGILMIETFT 940
DV++ G +M E
Sbjct: 183 ------VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 8/205 (3%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNV-AIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNL 802
F N IG GSFG V+K V A+K +L + +A E VL ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGH 861
++ S + G +++EY G L K L L Q I + L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-- 119
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGI 921
++H D+K N+ LD + D G++KLL + T+ + T Y++PE +
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCEDKP 177
Query: 922 VSTCGDVYSFGILMIETFTRKMPTD 946
+ DV++ G+++ E T K P D
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 25/284 (8%)
Query: 1343 LGTGIFSSVYKATF---ADGTNAAIKIFSLQ-EDRALKSFD--AECEVMRRIRHRNLAKI 1396
LG G F V + D T + + SL+ E D E E++R + H N+ K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 1397 VSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
C+ G LI++++P GSL+++L + +N++Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-----ATIGYMAPEYGS 1509
+H DL NVL++ + +GDFG+ K +++ K+ T+ + + + APE
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTK---AIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569
+ + DV+SFG+ + E LT T + LK VT ++ +L
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVTRLV--RVL-- 239
Query: 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
EE + C V L KC E P +R ++ + + I
Sbjct: 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 752 IGAGSFGSVYKATL-PYGMN----VAIKVFNLQLDGA-IKSFDAECEVLRRVRHRNLVKI 805
+G G FG V P G N VA+K + G I E E+LR + H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 806 ISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
C+ G LI+E++P GSL+++L +K +N++Q+L + + ++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 129
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED---SVTQTMTLATFGYMAPEYGSEG 920
+H DL NVL++ + + DFG++K ++ + +V + F Y APE +
Sbjct: 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQS 187
Query: 921 IVSTCGDVYSFGILMIETFT 940
DV+SFG+ + E T
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 746 FSESNL-----IGAGSFGSVYKATL-PYGMNVAIKVFNLQLDG-AIKSFDAECEVLRRVR 798
F+ +L IG G+FG+V K P G +A+K +D K + +V+ R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 799 H-RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVA 851
+VK + G + +E M SL+K Y + Y ++ + I +
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVY-EVLKSVIPEEILGKIAVATV 117
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
AL YL +IH D+KPSN+LLD + L DFGIS L DS+ +T Y
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPY 173
Query: 912 MAPE----YGSEG--IVSTCGDVYSFGILMIETFTRKMPTDE 947
MAPE +G + S DV+S GI + E T K P +
Sbjct: 174 MAPERIDPSARDGYDVRS---DVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F VYKA + G AA KI ++ + L+ F E +++ +H N+ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
+++++ G+L+ + L Q + + AL +LH S +IH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTS----- 1516
K N+LL D L DFG++ + T + T +MAPE +V+
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPE-----VVACETFKDN 183
Query: 1517 -----GDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547
D++S GI ++E P ++ V LK
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 63/229 (27%), Positives = 116/229 (50%), Gaps = 15/229 (6%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS- 1401
LG G F V+ AT+ T A+K ++++F AE VM+ ++H L K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 1402 NPGFKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
P + +I ++M +GSL +L S + + +D +A + ++ Q + IH D
Sbjct: 73 EPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 127
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L+ +N+L+ +V + DFG+A++++ + + I + APE + G + DV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEV--CLKHWVE----ESLPDAVTDVI 1562
SFGIL+ME +T R P M EV L+ E+ P+ + +++
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 65/223 (29%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 1343 LGTGIFSSVYKATFA-DGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
LG G F V A+K + E + +E E++ H + K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC---ALEYLHQGYSTS 1455
+ + + ++++Y G L L R I AC A EYLH +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYI----ACVVLAFEYLH---NRG 113
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEGIV- 1513
II+ DLKP N+LLD + L DFG AK L ++T T T Y+APE I+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPEYVAPE-----IIL 165
Query: 1514 ----STSGDVYSFGILMMETLTRRKP-----TDDMFTGEVCLK 1547
S D +S GIL+ E LT R P D M LK
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFD---AECEVMRRIRHRN 1392
+GTG F V+ A+K+ ++ E LK E V++ + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ ++ + + F ++++Y+P G L +L + N ++ CALEYLH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH--- 118
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPE-YGSE 1510
S I++ DLKP N+LLD + L DFG AK L D +T TL T Y+APE S+
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RD---RTWTLCGTPEYLAPEVIQSK 173
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKP 1535
G + + D ++ GIL+ E L P
Sbjct: 174 G-HNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 52/222 (23%)
Query: 751 LIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGA-----IKSFDAECEVLRRVRHRNLVK 804
L+G G+FG VY + G +A+K D + + + E ++L+ ++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSH---------KYTLNIQQRLDIMIDVASALE 855
+ ++ +EYMP GS++ L ++ KYT I + +E
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GVE 118
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD-------GEDSVTQTMTLAT 908
YLH ++H D+K +N+L D L DFG SK L G SVT T
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY--- 172
Query: 909 FGYMAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+M+PE YG + DV+S G ++E T K P
Sbjct: 173 --WMSPEVISGEGYGRK------ADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 73/298 (24%), Positives = 118/298 (39%), Gaps = 45/298 (15%)
Query: 1343 LGTGIFSSVYKATF------ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
LG G F V+ A D A+K D A K F E E++ ++H ++ K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHN------------YLLNIEQRLDIMIDVACA 1444
C ++ +YM G L K+L +H L Q L I +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYM 1503
+ YL S +H DL N L+ ++++ +GDFG+++ + D + T+ I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563
PE +T DV+S G+++ E T K + W + S + + +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLSNNEVIECITQ 237
Query: 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVK---DALANLKKIKTKFL 1618
+L + C V L L C + P R+N+K L NL K +L
Sbjct: 238 GRVLQ--------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-16
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 752 IGAGSFGSVYKATL----PYG--MNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G+FG V+ A P M VA+K A K F E E+L ++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSH---------------KYTLNIQQRLDIMIDV 850
C + ++ EYM G L K+L +H K L + Q L I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATF 909
AS + YL H +H DL N L+ + + + DFG+S+ + D T+
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M PE +T DV+SFG+++ E FT
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRH---R 800
+ LIG G++G+VY+ +P G VA+K+ NL D + E +L ++R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASAL 854
N+ K S +I+EY GS+ TL + I+ +V AL
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVR--------TLMKAGPIAEKYISVIIREVLVAL 114
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
+Y+H VIH D+K +N+L+ + L DFG++ LL+ S T T +MAP
Sbjct: 115 KYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAP 170
Query: 915 EYGSEGIV-STCGDVYSFGILMIETFTRKMP 944
E +EG T D++S GI + E T P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 56/145 (38%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 826 SLEKWLYSHKYTLNIQQRLDIM----IDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT 881
SL+K Y Y + DI+ + + ALEYLH VIH D+KPSNVL++ +
Sbjct: 85 SLDK-FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNG 141
Query: 882 VAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY----GSEGIVSTCGDVYSFGILMIE 937
L DFGIS L DSV +T+ YMAPE ++ DV+S GI MIE
Sbjct: 142 QVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199
Query: 938 TFTRKMPTDEMFTGETSLKKWVEES 962
T + P D T LK+ VEE
Sbjct: 200 LATGRFPYDSWKTPFQQLKQVVEEP 224
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 67/231 (29%), Positives = 94/231 (40%), Gaps = 39/231 (16%)
Query: 743 TDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHR 800
T F +IG G++G VYKA G VAIK+ ++ D + E +LR+ H
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHP 63
Query: 801 NLVK-----IISSCSNHGFKA-LILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMI 848
N+ I + + + L++E GS+ + K +RL I+
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILR 120
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLAT 908
+ L YLH VIH D+K N+LL + L DFG+S LD T T
Sbjct: 121 ETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176
Query: 909 FGYMAPEYGSEGIVSTC-----------GDVYSFGILMIETFTRKMPTDEM 948
+MAPE V C DV+S GI IE K P +M
Sbjct: 177 PYWMAPE------VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 61/187 (32%), Positives = 90/187 (48%), Gaps = 7/187 (3%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG G+ G+VY A + G VAIK NLQ + E V+R +H N+V + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++EY+ GSL + + ++ Q + + ALE+LH VIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
K N+LL D L+DFG + E S TM + T +MAPE + D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 931 FGILMIE 937
GI+ IE
Sbjct: 201 LGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAK 1395
LLG G F VY D G A+K D + + + + E ++++ ++H + +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ ++ ++YMP GS++ L ++ L R + +EYLH S
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEGI 1512
I+H D+K +N+L D LGDFG +K L + T + G +M+PE S
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-CSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 1513 VSTSGDVYSFGILMMETLTRRKP 1535
DV+S G ++E LT + P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 7e-16
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 746 FSESNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQLDGA--IKSFDAECEVLRRVRH 799
F+ ++G G FGSV +A L VA+K+ + + I+ F E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 800 RNLVKIISSCSNHGFKA------LILEYMPQGSLEKWLYSHK-----YTLNIQQRLDIMI 848
N++K+I K +IL +M G L +L + +TL +Q + MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ-TMTLA 907
D+AS +EYL + IH DL N +L+++ ++DFG+SK + D Q +
Sbjct: 121 DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 908 TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTR 941
++A E ++ + +T DV++FG+ M E TR
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-16
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 1343 LGTGIFSSVYKATF--------ADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRN 1392
LG G F V A A+K+ D+ L +E E+M+ I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWL---------YSHNYLLNIEQRLDIMIDVAC 1443
+ ++ +C+ G ++++Y +G+L ++L YS + E++L V+C
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 1444 A------LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT- 1496
A +EYL S IH DL NVL+ +D V + DFG+A+ + +D K+T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + + DV+SFG+L+ E T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 74/237 (31%), Positives = 105/237 (44%), Gaps = 48/237 (20%)
Query: 751 LIGAGSFGSVYKATLPYGMN----VAIKVFNL------QLDGAIKSFDAECEVLRRVRHR 800
++G G +G V++ G + A+KV Q D A AE +L V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA--HTKAERNILEAVKHP 60
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS-------- 852
+V +I + G LILEY+ G L + H +++ M D A
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGEL----FMH-----LEREGIFMEDTACFYLSEISL 111
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
ALE+LH +I+ DLKP N+LLD L+DFG+ K E +VT T T YM
Sbjct: 112 ALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYM 167
Query: 913 APEYGSEGIVSTCG-----DVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLR 964
APE I+ G D +S G LM + T P FT E KK +++ L+
Sbjct: 168 APE-----ILMRSGHGKAVDWWSLGALMYDMLTGAPP----FTAENR-KKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 7e-16
Identities = 69/207 (33%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLV 803
F+ IG GSFG VYKA VAIKV +L + + I+ E + L + R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 804 KIISSCSNHGFK-ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHP 862
K S G K +I+EY GS L L+ I+ +V LEYLH
Sbjct: 63 KYYGSFL-KGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEG- 118
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT-LATF-G---YMAPEYG 917
IH D+K +N+LL ++ L+DFG+S G+ +T TM+ TF G +MAPE
Sbjct: 119 --KIHRDIKAANILLSEEGDVKLADFGVS----GQ--LTSTMSKRNTFVGTPFWMAPEVI 170
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMP 944
+ D++S GI IE + P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 53/204 (25%), Positives = 103/204 (50%), Gaps = 6/204 (2%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402
LG G F V+ + + T A+K ++++F E +M+ ++H L ++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 1403 PGFKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
+I +YM +GSL +L S + + + +D +A + Y+ + + IH DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYS 1521
+ +NVL+ + ++ + DFG+A++++ + + I + APE + G + DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 1522 FGILMMETLTRRK-PTDDMFTGEV 1544
FGIL+ E +T K P M +V
Sbjct: 190 FGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQE------DRALKS-FDAECEVMRRIRHRNLA 1394
+G G F +V K +DG KI +E K +E ++R ++H N+
Sbjct: 8 IGKGSFGTVRKVRRKSDG-----KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 1395 KIVSSCSNPGFKAL--ILQYMPQGSLEKWL---YSHNYLLNIEQRLDIMIDVACALEYLH 1449
+ + + L +++Y G L + + + E I+ + AL H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 1450 QGY--STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY 1507
+++H DLKP+N+ LD + LGDFG+AK+L S +T + T YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQ 181
Query: 1508 GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ D++S G L+ E P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-16
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 1337 FSESNLLGTGIFSSVYKATFA--DGTNAAIKIFSLQED----RALKSFDAECEVMRRIRH 1390
F+ +LG G F SV +A DG+ + + L+ D ++ F E M+ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 1391 RNLAKI--VSSCSNPGFK----ALILQYMPQGSLEKWLYSHN-----YLLNIEQRLDIMI 1439
N+ K+ VS S + +IL +M G L +L + L ++ + MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ-TMTLA 1498
D+A +EYL S + IH DL N +L+++M + DFG++K + D +Q +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTR 1532
+ ++A E ++ + +T DV++FG+ M E +TR
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-16
Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 751 LIGAGSFGSVY--KATLPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKI 805
+IGAG FG V + LP + + + L+ + + F +E ++ + H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ ++ EYM GSL+ +L H + Q + ++ +AS ++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGY 127
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLL--DGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
+H DL N+L++ + V +SDFG+S++L D E + T + APE + +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 924 TCGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
+ DV+S+GI+M E + + P EM + K +EE RL
Sbjct: 188 SASDVWSYGIVMWEVMSYGERPYWEM--SNQDVIKAIEEGYRL 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 8e-16
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 1343 LGTGIFSSVYKATFADGTN---------AAIKIFSLQ-EDRALKSFDAECEVMRRI-RHR 1391
LG G F V +A A G + A+K+ D+ L +E E+M+ I +H+
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-----NYLLNI----EQRLDIMIDVA 1442
N+ ++ C+ G +I++Y +G+L ++L + +Y +I E++L V+
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 1443 CA------LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496
CA +EYL S IH DL NVL+ +D V + DFG+A+ + +D K+T
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 1497 -LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + + DV+SFGILM E T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 752 IGAGSFGSVYKATLPYG-------MNVAIKVFNLQLDGAIK-SFDAECEVLRRV-RHRNL 802
+GAG+FG V +AT YG M VA+K+ + + + +E +++ + H N+
Sbjct: 43 LGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHHGH 861
V ++ +C+ G +I EY G L +L + + L ++ L VA + +L +
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMTLATFGYMAPEYGSEG 920
IH DL NVLL + + DFG+++ +++ + V + +MAPE
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218
Query: 921 IVSTCGDVYSFGILMIETFT------RKMPTDEMF 949
+ + DV+S+GIL+ E F+ MP D F
Sbjct: 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 72/282 (25%), Positives = 107/282 (37%), Gaps = 59/282 (20%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRA-LKSFDAECEVMRRIRHRNLAKIVSSC 1400
+G G + VY A AIK L++ + + E + M + H N+ K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIM--------IDVAC--------- 1443
L++ Y+ GSL LDIM +D A
Sbjct: 69 VVGDELWLVMPYLSGGSL----------------LDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 1444 -ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGI-AKLLDGVDSMKQTMT--LAT 1499
LEYLH S IH D+K N+LL +D + DFG+ A L DG D ++ + T
Sbjct: 113 KGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 1500 IGYMAPEYGSEGIVSTSG-DVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558
+MAPE + D++SFGI +E T P +V +
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML----------- 218
Query: 1559 TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ + S E AD KK S + C ++ P +R
Sbjct: 219 --TLQNDPPSLETGAD---YKKYSKSFRKMISLCLQKDPSKR 255
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 52/190 (27%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN 811
+GAG FG V+ VAIK Q + ++F AE ++++++H LV++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 812 HGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+I EYM GSL +L + + L I + +D+ +A + ++ + IH DL
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDL 128
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
+ +N+L+ + ++DFG+++L++ + + + APE + G + DV+S
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 931 FGILMIETFT 940
FGIL+ E T
Sbjct: 189 FGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 63/229 (27%), Positives = 115/229 (50%), Gaps = 15/229 (6%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN 811
+GAG FG V+ AT VA+K ++++F AE V++ ++H LVK+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 812 HGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+I E+M +GSL +L S + + + +D +A + ++ + IH DL
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE---YGSEGIVSTCGD 927
+ +N+L+ V ++DFG++++++ + + + APE +GS I S D
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS---D 185
Query: 928 VYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
V+SFGIL++E T ++P M E + + +E R+ E EL
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPEEL 232
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-15
Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 33/217 (15%)
Query: 1343 LGTGIFSSVYKATF--------ADGTNAAIKIFSLQED---RALKSFDAECEVMRRI-RH 1390
LG G F V A + A+K+ L++D + L +E E+M+ I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWL---------YSHNYLLNIEQRLDIMIDV 1441
+N+ ++ +C+ G +I++Y +G+L ++L YS++ ++++ V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 1442 AC------ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495
+C +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D K+T
Sbjct: 141 SCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 1496 T-LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + + DV+SFG+LM E T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 53/220 (24%), Positives = 111/220 (50%), Gaps = 15/220 (6%)
Query: 1335 NGFSESNLLGTGIFSSVYKATF--ADGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIR 1389
+ ++ ++G G F V++ A+ I +L+ ++ + F +E +M +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 1390 HRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLH 1449
H N+ ++ + +I +YM G+L+K+L H+ + Q + ++ +A ++YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA----TIGYMAP 1505
+ +H DL N+L++ ++ + DFG++++L+ D + T T + I + AP
Sbjct: 125 D---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSGGKIPIRWTAP 179
Query: 1506 EYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
E + +++ DV+SFGI+M E ++ +P DM EV
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-15
Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 31/214 (14%)
Query: 1341 NLLGTGIFSSVYKATFA-DG--TNAAIKI---FSLQEDRALKSFDAECEVMRRI-RHRNL 1393
+++G G F V KA DG +AAIK ++ ++D + F E EV+ ++ H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNI 58
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL---------------LNIEQRLDIM 1438
++ +C + G+ L ++Y P G+L +L L L+ +Q L
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTL 1497
DVA ++YL Q IH DL N+L+ ++ VA + DFG+++ G + +K+TM
Sbjct: 119 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 172
Query: 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MA E + + +T+ DV+S+G+L+ E ++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 69/226 (30%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSL-----------QEDRALKSFDAECEVMRRIRH 1390
+LG G + V++ G + KIF++ Q+D A AE ++ ++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKH 59
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC------- 1443
+ ++ + G LIL+Y+ G L +++E+ M D AC
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGEL---------FMHLEREGIFMEDTACFYLSEIS 110
Query: 1444 -ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGY 1502
ALE+LHQ II+ DLKP N+LLD L DFG+ K ++ T TI Y
Sbjct: 111 LALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEY 166
Query: 1503 MAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKPTDDMFTGE 1543
MAPE I+ SG D +S G LM + LT P FT E
Sbjct: 167 MAPE-----ILMRSGHGKAVDWWSLGALMYDMLTGAPP----FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 56/226 (24%), Positives = 109/226 (48%), Gaps = 8/226 (3%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN 811
+GAG FG V+ VA+K ++++F E +++ ++H LV++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 812 HGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+I EYM +GSL +L S + + + + +D +A + Y+ + IH DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 129
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
+ +NVL+ + + ++DFG++++++ + + + APE + G + DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 931 FGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
FGIL+ E T K+P M + ++ R+ E EL
Sbjct: 190 FGILLYEIVTYGKIPYPGMSNSDVMSA--LQRGYRMPRMENCPDEL 233
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-15
Identities = 63/233 (27%), Positives = 111/233 (47%), Gaps = 41/233 (17%)
Query: 752 IGAGSFGSVYKATLPYGMN---------VAIKVFNLQLDGAIKSFD---AECEVLRRV-R 798
+G G FG V +A YG++ VA+K+ L+ + K +E E+++ + +
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGK 76
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY---------------SHKYTLNIQQR 843
H+N++ ++ C+ G +I+EY +G+L ++L + L+ +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
+ VA +EYL IH DL NVL+ +D V ++DFG+++ + D +T
Sbjct: 137 VSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 904 MT-LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRK------MPTDEMF 949
+MAPE + + + DV+SFGILM E FT +P +E+F
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 45/190 (23%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVK 804
I G++G V+ K+T G AIKV + + E ++L + + +VK
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 805 IISS--CSNHGFKALILEYMPQGSLEKWLYS---------HKYTLNIQQRLDIMIDVASA 853
+ S + + L++EY+P G L L + Y I A
Sbjct: 58 LYYSFQGKKNLY--LVMEYLPGGDLASLLENVGSLDEDVARIYIAEI----------VLA 105
Query: 854 LEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-------LLDGEDSVTQTMT 905
LEYLH +G +IH DLKP N+L+D + L+DFG+SK + +D
Sbjct: 106 LEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 906 LATFGYMAPE 915
+ T Y+APE
Sbjct: 162 VGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 1343 LGTGIFSSVYKATFAD------GTNAAIKIFSLQEDRALK---SFDAECEVMRRIRHRNL 1393
LG G F VY+ T AIK ++ E+ +++ F E VM+ ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIK--TVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 1394 AKI--VSSCSNPGFKALILQYMPQGSLEKWLYSH------NYLLNIEQRLDIM---IDVA 1442
++ V S P ++++ M +G L+ +L S N L + ++A
Sbjct: 72 VRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIG 1501
+ YL + +H DL N ++ +D+ +GDFG+ + + D K L +
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+MAPE +G+ +T DV+SFG+++ E T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 56/214 (26%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 1341 NLLGTGIFSSVYKA----TFADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAK 1395
++G G F V + + AIK D+ F E +M + H N+ +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 1396 I--VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ-GY 1452
+ V + S P +I +YM GSL+K+L ++ + Q + ++ +A ++YL + Y
Sbjct: 70 LEGVVTKSRPVM--IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT-LATIGYMAPEYGSEG 1511
+H DL N+L++ ++V + DFG+++ L+ ++ T I + APE +
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 1512 IVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+++ DV+SFGI+M E ++ +P DM +V
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 56/147 (38%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 1417 SLEKWLYSHNYLLNIEQRLDIM----IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM 1472
SL+K Y Y + DI+ + + ALEYLH S+IH D+KPSNVL++ +
Sbjct: 85 SLDK-FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNG 141
Query: 1473 VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY----GSEGIVSTSGDVYSFGILMME 1528
L DFGI+ L VDS+ +T+ YMAPE ++ DV+S GI M+E
Sbjct: 142 QVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199
Query: 1529 TLTRRKPTDDMFTGEVCLKHWVEESLP 1555
T R P D T LK VEE P
Sbjct: 200 LATGRFPYDSWKTPFQQLKQVVEEPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 1329 ELRLATNGFSESNLLGTGIFSSVYKA---TFADGTNA-AIKIFSLQEDRALK---SFDAE 1381
E+ L+ F E LG G F VYK + +A ++ I +L+E+ K F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 1382 CEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHN--------------- 1426
E+M ++H N+ ++ C+ ++ +Y+ G L ++L ++
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 1427 YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486
L+ L I I +A +EYL S +H DL N L+ + + + DFG+++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 1487 GVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMME 1528
D + Q+ +L + +M PE G +T D++SFG+++ E
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 4e-15
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKS------FDA--ECEVLRRVRHR 800
+G G++ VYKA G VAIK L G K F A E ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKL---GERKEAKDGINFTALREIKLLQELKHP 62
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTL---NIQQRLDIMIDVASALEYL 857
N++ ++ + L+ E+M LEK + L +I+ M+ LEYL
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLEYL 118
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-- 915
H ++H DLKP+N+L+ D V L+DFG+++ G + T + T Y APE
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELL 174
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRK 942
+G+ D++S G + E R
Sbjct: 175 FGARHYGVGV-DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 1342 LLGTGIFSSVY---KATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRR-----IRHRN 1392
+LG G F V+ K T D G A+K+ + LK D M R + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ K+ + G LIL ++ G L L S + E + ++A AL++LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEG 1511
S II+ DLKP N+LLD++ L DFG++K + +D K+ + T+ YMAPE +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 1512 IVSTSGDVYSFGILMMETLTRRKP 1535
+ S D +SFG+LM E LT P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (191), Expect = 5e-15
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRNLAK 1395
LG G + VYKA G A+K L + AL+ E +++ ++H N+ K
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKHPNIVK 62
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
++ L+ +Y L+K+L L+ IM + L Y H S
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHR 118
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-------YG 1508
I+H DLKP N+L++ D V L DFG+A+ G+ T + T+ Y APE Y
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVVTLWYRAPEILLGSKHY- 176
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRR 1533
ST+ D++S G + E +T +
Sbjct: 177 -----STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 19/223 (8%)
Query: 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIK---IFSLQEDRALKSFDAECEVMRRIRHRN 1392
F +G G FS VY+AT DG A+K IF L + +A E ++++++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLY---SHNYLLNIEQRLDIMIDVACALEYLH 1449
+ K +S ++L+ G L + + L+ + + + ALE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPE 1506
S ++H D+KP+NV + V LGD G+ + S K T + +G YM+PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPE 176
Query: 1507 YGSEGIVSTSGDVYSFGILMMETLTRRKP--TDDMFTGEVCLK 1547
E + D++S G L+ E + P D M +C K
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 62/263 (23%), Positives = 115/263 (43%), Gaps = 26/263 (9%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKS-FDAECEVMRRIRHRNLAKIVSSC 1400
+G G F V+ AD T A+K LK+ F E ++++ H N+ +++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
+ ++++ + G +L + L +++ + ++ + A +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKL-LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
L N L+ + V + DFG+++ DGV + M + + APE + G S+ DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 1520 YSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579
+SFGIL+ E + G V + + +A+ E+ + +
Sbjct: 180 WSFGILLWEAFS---------LGAVPYANLSNQQTREAI-----------EQGVRLPCPE 219
Query: 1580 KCMSSVMSLALKCSEEIPEERMN 1602
C +V L +C E P +R +
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-15
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 42/226 (18%)
Query: 751 LIGAGSFGSVYKATLPYGMNV------AIKVFNL----------QLDGAIKSFDAECEVL 794
LIG G++G VY A +NV A+K L + +K+ +E E L
Sbjct: 8 LIGKGTYGRVYLA-----LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 795 RRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASA 853
+ + H N+V+ + + + ++ LEY+P GS+ L ++ ++ + + V
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--TEQVLEG 120
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL-ATFGYM 912
L YLH ++H DLK N+L+D D + +SDFGISK D Q M++ + +M
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 913 APEYGSEGIVSTCG-------DVYSFGILMIETFTRKMP--TDEMF 949
APE ++ + D++S G +++E F + P +E
Sbjct: 178 APE-----VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAI-KSFDAECEVLRRVRHRN 801
+ E + +G G+ GSV K L GM A+K + + K E E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 802 LVKIISSCSNH--GFKALILEYMPQGSLEKWLYSH--KYTLNIQQR--LDIMIDVASALE 855
+VK + + + +EY GSL+ +Y K I ++ I V L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE--DSVTQTMTLATFGYMA 913
YLH +IH D+KPSN+LL L DFG+S GE +S+ T T +F YMA
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF-YMA 171
Query: 914 PEYGSEGIVSTCGDVYSFGILMIE 937
PE S DV+S G+ ++E
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 1342 LLGTGIFSSVYKA-TFADGTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAK 1395
LLG+G F SVY+ DG A+K SL +D A+K + E ++ +++H N+ +
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL------LNIEQRLDIMIDVACALEYLH 1449
+ + + L+ +P GSL K L + L Q L LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH 119
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPE 1506
+ +H D+K +N+L+D + V L DFG+AK ++ + + G +MAPE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPE 171
Query: 1507 Y-GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+G + D++S G ++E T + P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-15
Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 41/233 (17%)
Query: 752 IGAGSFGSVYKATLPYGMN---------VAIKVFNLQLDGAIKSFD---AECEVLRRV-R 798
+G G FG V A G++ VA+K+ L+ D K +E E+++ + +
Sbjct: 26 LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGK 82
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWL---------YSHKYTLNIQQRLDI--- 846
H+N++ ++ +C+ G +I+EY +G+L ++L Y + T +++L
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 847 ---MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
VA +EYL IH DL NVL+ +D V ++DFG+++ + D +T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 904 MT-LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT------RKMPTDEMF 949
+MAPE + I + DV+SFG+L+ E FT +P +E+F
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 54/277 (19%)
Query: 746 FSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNL 802
F + IG G++G VYKA G VA+K L + G + E +L+ + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG-- 860
VK++ L+ E++ Q L+K++ + + I L + S L L G
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLS-GIPLPL-----IKSYLFQLLQGLA 114
Query: 861 --HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--Y 916
H V+H DLKP N+L++ + L+DFG+++ G T T + T Y APE
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 173
Query: 917 GSEGIVSTCGDVYSFGILMIETFTRK--------------------MPTDEMFTGETSLK 956
G + ST D++S G + E TR+ P + ++ G TSL
Sbjct: 174 GCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232
Query: 957 -------KWVEESLRLAVTEVVDAELLSSEEEEGADL 986
KW + +++ +E+G DL
Sbjct: 233 DYKPSFPKWARQDFS---------KVVPPLDEDGRDL 260
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 1341 NLLGTGIFSSVYKATF----ADGTNAAIKIFSLQEDRALKS---FDAECEVMRRIRHRNL 1393
LG G F VY+ + D + + +L E + + F E +M + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 1394 AKIVSSC--SNPGFKALILQYMPQGSLEKWLY------SHNYLLNIEQRLDIMIDVACAL 1445
+++ P F ++L+ M G L+ +L L ++ L DVA
Sbjct: 72 VRLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKLLDGVDSM-KQTMTLATIG 1501
+YL IH D+ N LL VA + DFG+A+ + K + I
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMME 1528
+M PE +GI ++ DV+SFG+L+ E
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWE 213
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-15
Identities = 66/245 (26%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 1309 SRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIK-I 1366
S + ++ +A S EL N +G+G +VYK G A+K I
Sbjct: 55 SSSSSSSASGSAPSAAKSLSEL-------ERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 1367 FSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHN 1426
+ ED + E E++R + H N+ K + G ++L++M GSLE
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE------G 161
Query: 1427 YLLNIEQRL-DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485
+ EQ L D+ + + YLH I+H D+KPSN+L++ + DFG++++L
Sbjct: 162 THIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
Query: 1486 DGVDSMKQTM-----TLATIGYMAPEYGSEGIVST----------SGDVYSFGILMMETL 1530
QTM ++ TI YM+PE ++T +GD++S G+ ++E
Sbjct: 219 A------QTMDPCNSSVGTIAYMSPER-----INTDLNHGAYDGYAGDIWSLGVSILEFY 267
Query: 1531 TRRKP 1535
R P
Sbjct: 268 LGRFP 272
|
Length = 353 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-15
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 752 IGAGSFGSVYKAT------LPYGMNVAIKVFNLQLDGA-IKSFDAECEVLRRVRHRNLVK 804
+G G FG V KAT VA+K+ + ++ +E +L++V H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWL-YSHKY----------------------TLNIQ 841
+ +CS G LI+EY GSL +L S K L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-V 900
+ ++ ++YL ++H DL NVL+ + +SDFG+S+ + EDS V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
++ +MA E + I +T DV+SFG+L+ E T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 1336 GFSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRN 1392
F LG G + SVYK +D A+K L + DA E ++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 1393 LAKIVSSCSNPGF-----KALILQYMPQGSLEKWLYSHNYLLNI--EQRL-DIMIDVACA 1444
+ F ++++Y P G L K + + EQ + I I +
Sbjct: 61 I-----ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG--- 1501
L+ LH I+H DLK +N+LL + + +GD GI+K+ +K+ M IG
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKV------LKKNMAKTQIGTPH 166
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
YMAPE S D++S G L+ E T P
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 752 IGAGSFGSVYKATLPYGMN-------VAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G G+FG V+ A Y + VA+K D A K F E E+L ++H ++VK
Sbjct: 13 LGEGAFGKVFLAEC-YNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSH------------KYTLNIQQRLDIMIDVAS 852
C ++ EYM G L K+L +H L Q L I +A+
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGY 911
+ YL H +H DL N L+ ++ + + DFG+S+ + D T+ +
Sbjct: 132 GMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 912 MAPEYGSEGIVSTCGDVYSFGILMIETFT 940
M PE +T DV+S G+++ E FT
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSL------QEDRALKS----FDAECEVMRRIRH 1390
L+G G + VY A G A+K L + D K +E E ++ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL--DIMIDVACALEYL 1448
N+ + + + + ++ L+Y+P GS+ L ++ E++L V L YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYL 124
Query: 1449 HQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEY 1507
H S I+H DLK N+L+D D + + DFGI+K D + Q M++ ++ +MAPE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 1508 GSEGIVSTSG--DVYSFGILMMETLTRRKPTDDM 1539
S D++S G +++E R+P D
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 1e-14
Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 36/227 (15%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVR---H 799
+ E IG G++G+VYKA L G VA+K + L +G S E +L+++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 800 RNLVKIISSC----SNHGFK-ALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASA 853
N+V+++ C ++ K L+ E++ Q L +L K L + D+M +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 854 LEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
+++LH H ++H DLKP N+L+ D ++DFG++++ E ++T + T Y
Sbjct: 120 VDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS--VVVTLWYR 173
Query: 913 APE------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
APE Y + D++S G + E F R+ +F G +
Sbjct: 174 APEVLLQSSYA-----TPV-DMWSVGCIFAELFRRR----PLFRGTS 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 1342 LLGTGIFSSVYKATFA-DGTNAAIKIFSL------QEDRALKSFDA---ECEVMRRIRHR 1391
L+G+G F SVY A G A+K L +DR DA E +++ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL--DIMIDVACALEYLH 1449
N+ + + S + + L+Y+P GS+ L ++ E+ L + + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAF---EETLVRNFVRQILKGLNYLH 123
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-----LLDGVDSMKQTMTLATIGYMA 1504
+ IIH D+K +N+L+D+ + DFGI+K L + + ++ +MA
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 1505 PEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
PE + + D++S G L++E LT + P D
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 37/231 (16%)
Query: 752 IGAGSFGSVYKATLPYGMN-------VAIKVFNLQLDGAIKSFD---AECEVLRRV-RHR 800
+G G FG V A G++ V + V L+ D K +E E+++ + +H+
Sbjct: 23 LGEGCFGQVVMAE-ALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK-----YTLNIQQRLDIMI------- 848
N++ ++ +C+ G +I+EY +G+L ++L + + Y+ +I + D +
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 849 ---DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905
VA +EYL IH DL NVL+ ++ V ++DFG+++ ++ D +T
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 906 -LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT------RKMPTDEMF 949
+MAPE + + + DV+SFG+LM E FT +P +E+F
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 751 LIGAGSFGSVY---KATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNL 802
++G GSFG V+ K T P Y M V +K L++ +++ E ++L V H +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKV-LKKATLKVRDRVRT-KMERDILAEVNHPFI 60
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHP 862
VK+ + G LIL+++ G L L K + ++ D+ +A L H H
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEE--DVKFYLAELALALDHLHS 116
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL-ATFGYMAPEYGSEGI 921
+I+ DLKP N+LLD++ L+DFG+SK + D + + T YMAPE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 922 VSTCGDVYSFGILMIETFTRKMP 944
+ D +SFG+LM E T +P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 13/208 (6%)
Query: 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRAL-KSFDAECEVMRRIRHRN 1392
E + LG G SV K G A+K + + L K E E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 1393 LAKIVSSCSNP--GFKALILQYMPQGSLE---KWLYSHNYLLNIEQRLDIMIDVACALEY 1447
+ K + + + ++Y GSL+ K + + + I V L Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY 1507
LH S IIH D+KPSN+LL L DFG++ L V+S+ T T T YMAPE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFT-GTSFYMAPER 174
Query: 1508 GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
S + DV+S G+ ++E R P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFD---AECEVLRRVRHRN 801
F++ IG GSFG+VY A + VAIK + + + + E L+++RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 802 LVKIISSCSNHGFKA-LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
++ C A L++EY GS L HK L Q ++I AL+ L +
Sbjct: 77 TIEY-KGCYLREHTAWLVMEYC-LGSASDILEVHKKPL---QEVEIAAICHGALQGLAYL 131
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY---G 917
H IH D+K N+LL + L+DFG + L+ +S + T +MAPE
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPEVILAM 186
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
EG DV+S GI IE RK P M
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
+G G+FG VYKA G A KV + + ++ + E E+L H +VK++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
G +++E+ P G+++ + L Q I + LE L + H +IH DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVICRQMLEALQYLHSMKIIHRDL 136
Query: 871 KPSNVLLDDDTVAHLSDFGIS----KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC- 925
K NVLL D L+DFG+S K L DS + T +MAPE V C
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-----IGTPYWMAPE------VVMCE 185
Query: 926 ----------GDVYSFGILMIETFTRKMPTDEM 948
D++S GI +IE + P E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-14
Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 1062 VRLASNKLIGRIPSMIFN-NSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSG 1120
+ L++N+L G IP IF +S++ + L N+F+G +P +PNL+ L L N LSG
Sbjct: 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETLDLSNNMLSG 154
Query: 1121 IIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTS 1180
IP+ I + S + +L L N+ G IPN+ N L+ L L+ N L +
Sbjct: 155 EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE------- 207
Query: 1181 LTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEFEGEIPSGGPF 1240
L + L+ + L N L G +P IG L TSL + L G IP S G
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGL-TSLNHLDLVYNNLTGPIP-------SSLGNL 259
Query: 1241 VNFTAESLMQNLVLGGSSRLQVPP 1264
N L QN + G +PP
Sbjct: 260 KNLQYLFLYQNKLSG-----PIPP 278
|
Length = 968 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFD---AECEVLRRVRH 799
D +G G+FG V+ A+KV + +K E VL+ V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
++++ + + F +++EY+P G L +L + + L ++ ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH- 118
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL-ATFGYMAPE-YG 917
+++ DLKP N+LLD + L+DFG +K L +T TL T Y+APE
Sbjct: 119 --SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPEVIQ 171
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMP 944
S+G + D ++ GIL+ E P
Sbjct: 172 SKG-HNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 34/225 (15%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDA----ECEVL 794
+R D F IG G++G VYKA G VA+K ++LD + F E ++L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK--KVRLDNEKEGFPITAIREIKIL 60
Query: 795 RRVRHRNLVK----IISSCSNHGFKA------LILEYMPQ---GSLEKWL--YSHKYTLN 839
R++ HRN+V + FK L+ EYM G LE L +S + +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 840 IQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899
++L LE L++ H +H D+K SN+LL++ L+DFG+++L + E+S
Sbjct: 121 FMKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 900 VTQTMTLATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRK 942
T + T Y PE G E DV+S G ++ E FT+K
Sbjct: 172 RPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 752 IGAGSFGSVYKATL---PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKII 806
+G G FGSV + L + VA+K + + ++ F +E ++ H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 807 SSC----SNHGFKA--LILEYMPQGSLEKWL-YSH----KYTLNIQQRLDIMIDVASALE 855
C + G+ + +IL +M G L +L YS L Q + M D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ-TMTLATFGYMAP 914
YL IH DL N +L+++ ++DFG+SK + D Q + ++A
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 915 EYGSEGIVSTCGDVYSFGILMIETFTR 941
E ++ + +T DV+SFG+ M E TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 1342 LLGTGIFSSVYKATF---ADGTNAAIKIFSLQEDRALKSFDAECEVMRRI---RHRNLAK 1395
LLG+G+F +V+K + D + I ++Q+ ++F + M + H + +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
++ C + L+ Q P GSL + H L+ ++ L+ + +A + YL +
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HR 129
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT-IGYMAPEYGSEGIVS 1514
++H +L N+LL D + + DFG+A LL D T I +MA E G +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 1515 TSGDVYSFGILMMETLT 1531
DV+S+G+ + E ++
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 1343 LGTGIFSSVYKATF---ADGTNAAIKIFSLQEDRALK-SFDAECEVMRRIRHRNLAKIVS 1398
LG+G F V K + + AIK+ + +++++ E E+M ++ + + +++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
C L+++ G L K+L + + +++M V+ ++YL + +H
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVH 118
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT--IGYMAPEYGSEGIVSTS 1516
DL NVLL + A + DFG++K L DS + + + + APE + S+
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 1517 GDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
DV+S+GI M E + +KP M EV
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEV 207
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 745 GFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRN 801
F +G GS+GSVYK L A+K +L + DA E +L V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNI---QQRLDIMIDVASALEYLH 858
++ + + +++EY P G L K + K + Q+ I I + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS 918
++H DLK +N+LL + + + D GISK+L + TQ T YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWK 174
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
S D++S G L+ E T P F +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP----FEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 751 LIGAGSFGSVYKATLPYG----MNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKI 805
+IGAG FG V + L + VAIK + + F +E ++ + H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ +I E+M G+L+ +L + + Q + ++ +A+ ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNY 127
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG-----YMAPEYGSEG 920
+H DL N+L++ + V +SDFG+S+ L+ +D+ T T + G + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 921 IVSTCGDVYSFGILMIETFT 940
++ DV+S+GI+M E +
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 36/216 (16%)
Query: 752 IGAGSFGSVYKATLPYGMNV-AIK------VFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G G FG V + A+K + I S E E+L H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI--MIDVASALEYLHHGHP 862
+ + + + +++EY G L L R I ++ A EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL-ATFGYMAPEYGSEGI 921
+I+ DLKP N+LLD + L DFG +K L S +T T T Y+APE I
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPE-----I 163
Query: 922 VSTCG-----DVYSFGILMIETFTRKMPTDEMFTGE 952
+ G D +S GIL+ E T + P F +
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-14
Identities = 59/232 (25%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 752 IGAGSFGSVYKATL--------PYGMNVAIKVFNLQLDGAIKSFD---AECEVLRRV-RH 799
+G G FG V A + VA+K+ L+ D K +E E+++ + +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK---------------YTLNIQQRL 844
+N++ ++ +C+ G +++EY +G+L ++L + + L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 845 DIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904
VA +EYL IH DL NVL+ +D V ++DFG+++ + D +T
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 905 T-LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT------RKMPTDEMF 949
+MAPE + + + DV+SFG+L+ E FT +P +E+F
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
+G G V+KA G A+K +L+ E E + ++ +H + K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ L+++YMP L + L L Q M + + Y+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGS----EGIV 1513
DLKP+N+L+ D V + DFG+A+L + + +AT Y APE YG+ G+
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV- 182
Query: 1514 STSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
D+++ G + E L P +F GE
Sbjct: 183 ----DLWAVGCIFAELL-NGSP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-14
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 47/221 (21%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQ------EDRALKSFDAECEVMRRIRHRNLA 1394
LGTG FSS Y+A GT A+K + ++ +++ E +M R+ H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSH---------NYLLNIEQRLDIMIDVACAL 1445
+++ + L +++M GS+ L + NY + + L
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKLLD----GVDSMKQTMTLATI 1500
YLH+ IIH D+K +N+L+D + DFG A L G + + L TI
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL-LGTI 172
Query: 1501 GYMAPE------YGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+MAPE YG S DV+S G +++E T + P
Sbjct: 173 AFMAPEVLRGEQYGR------SCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 750 NLIGAGSFGSVYKATL----PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVK 804
+IG G FG VY TL ++ A+K N D ++ F E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 805 IISSC-SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
++ C + G ++L YM G L ++ S + ++ + + VA +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---K 117
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMTLATF--GYMAPEYGSEG 920
+H DL N +LD+ ++DFG+++ + D E T A +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 921 IVSTCGDVYSFGILMIETFTRKMP 944
+T DV+SFG+L+ E TR P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 750 NLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRNL 802
+G G+FG VY+ + VA+K +S F E ++ + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLY------SHKYTLNIQQRLDIMIDVASALEY 856
V++I + ++LE M G L+ +L +L ++ L DVA +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 857 LHHGHPTPVIHCDLKPSNVLLDD---DTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYM 912
L H IH D+ N LL VA ++DFG+++ + + + +M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 913 APEYGSEGIVSTCGDVYSFGILMIETFT 940
PE +GI ++ DV+SFG+L+ E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 9e-14
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYG----MNVAIKVFNLQLDG--AI 784
R + EL+R+ ++G+G+FG+VYK +P G + VAIK+ N + G A
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKAN 53
Query: 785 KSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL 844
F E ++ + H +LV+++ C + + L+ + MP G L +++ HK + Q L
Sbjct: 54 VEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLL 112
Query: 845 DIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG-EDSVTQT 903
+ + +A + YL ++H DL NVL+ ++DFG+++LL+G E
Sbjct: 113 NWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+MA E + DV+S+G+ + E T
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 14/193 (7%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G+G + VYKA A G AIK+ L+ + E +++ RH N+ S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
++++Y GSL+ L+ Q + + L YLH+ T IH D+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDI 127
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSE---GIVST 1515
K +N+LL +D L DFG++ L + +++ IG +MAPE + G
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSF----IGTPYWMAPEVAAVERKGGYDG 183
Query: 1516 SGDVYSFGILMME 1528
D+++ GI +E
Sbjct: 184 KCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYG----MNVAIKVFNLQLDGAIKS 786
R + EL++L L+G+G FG+V+K +P G + VAIK +Q ++
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQT 52
Query: 787 FDAECE---VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQR 843
F + + + H +V+++ C + L+ + P GSL + H+ +L+ Q+
Sbjct: 53 FQEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 844 LDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902
L+ + +A + YL H ++H +L N+LL D++ ++DFG++ LL +D
Sbjct: 112 LNWCVQIAKGMYYLEEHR----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
Query: 903 TMTLAT-FGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
T +MA E G + DV+S+G+ + E +
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAI-KSFDAECEVLRRVRHRNLVKIISSC 809
+GAG+ GSV K +P G +A KV ++ ++ K E +++ R +V +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
N + +E+M GSL++ +Y + ++ I + V L YL++ H ++H D
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRD 129
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGE--DSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
+KPSN+L++ L DFG+S GE +S+ T + T YM+PE G + D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVS----GELINSIADTF-VGTSTYMSPERIQGGKYTVKSD 184
Query: 928 VYSFGILMIETFTRKMPTDE 947
V+S GI +IE K P
Sbjct: 185 VWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 41/129 (31%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDI-MIDVACALEYLHQGYSTSIIHCDLKPSNV 1466
L++ M G L+ +Y+ E R + C LE+LHQ I++ DLKP NV
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENV 126
Query: 1467 LLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILM 1526
LLDD + D G+A ++ K T GYMAPE + S D ++ G +
Sbjct: 127 LLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTL 184
Query: 1527 METLTRRKP 1535
E + R P
Sbjct: 185 YEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAK 1395
LLG G F VY AD G A+K + + + + + E ++++ + H + +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 1396 IVSSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLL-NIEQRLDIMIDVACALEYLHQGY 1452
+P + L +++MP GS++ L S+ L N+ ++ I LE + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMA----PEYG 1508
S I+H D+K +N+L D LGDFG +K L QT+ L+ G + P +
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-------QTICLSGTGMKSVTGTPYWM 176
Query: 1509 SEGIVSTSG-----DVYSFGILMMETLTRRKP 1535
S ++S G D++S G ++E LT + P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 751 LIGAGSFGSVYKATLPYGMN----VAIKVFNLQ--LDGAIKSFDAECEVLRRVRHRNLVK 804
++G G+FG V+ L V IK ++ + EC+VL+ + H N+++
Sbjct: 7 VVGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY-------L 857
+ +++EY P G+L ++ IQ+R + ++D + L + L
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLAL 114
Query: 858 HHGHPTPVIHCDLKPSNVLLDD-DTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
HH H ++H DLK N+LLD V + DFGISK+L S T+ + T Y++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTV-VGTPCYISPEL 172
Query: 917 GSEGIVSTCGDVYSFGILMIE 937
+ D+++ G ++ E
Sbjct: 173 CEGKPYNQKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 752 IGAGSFGSVYKATLP------YGMNVAIK-VFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G GSFG VY+ VAIK V F E V++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 805 IISSCSNHGFKAL-ILEYMPQGSLEKWLYSHK---------YTLNIQQRLDIMIDVASAL 854
++ S G L ++E M +G L+ +L S + +Q+ + + ++A +
Sbjct: 74 LLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYMA 913
YL +H DL N ++ +D + DFG+++ + D + L +MA
Sbjct: 133 AYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFT 940
PE +G+ +T DV+SFG+++ E T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQL--DGAIKSFDAECEVLRRVR---HRNLVKI 805
IG G++G+VYKA P+ G VA+K +Q DG S E +L+R+ H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 806 ISSC----SNHGFK-ALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHH 859
+ C ++ K L+ E++ Q L +L L + D+M L++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
++H DLKP N+L+ L+DFG++++ + ++T + T Y APE +
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLLQ 181
Query: 920 GIVSTCGDVYSFGILMIETFTRK 942
+T D++S G + E F RK
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 14/218 (6%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAI-----KSFDAECEVLRRVRH 799
F + ++G+G+FG+VYK +P G V I V +L A K E V+ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
++ +++ C + LI + MP G L ++ HK + Q L+ + +A + YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM-TLATFGYMAPEYGS 918
++H DL NVL+ ++DFG++KLL ++ +MA E
Sbjct: 128 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 919 EGIVSTCGDVYSFGILMIE--TFTRKMPTDEMFTGETS 954
I + DV+S+G+ + E TF K P D + E S
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSK-PYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 58/277 (20%)
Query: 730 TWRRISYQELQRLTDGFSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGA----- 783
WRR L+G G+FG VY + G +A K +
Sbjct: 3 NWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE 47
Query: 784 IKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL--ILEYMPQGSLEKWLYSH-KYTLNI 840
+ + + E ++L+ ++H +V+ + K L +EYMP GS++ L ++ T ++
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 841 QQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD----- 895
++ I LE + + H ++H D+K +N+L D L DFG SK L
Sbjct: 108 TRKYTRQI-----LEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162
Query: 896 --GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
G SVT T +M+PE S DV+S G ++E T K P
Sbjct: 163 GTGIRSVTGTPY-----WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP--------- 208
Query: 954 SLKKWVEESLRLAV----TEVVDAELLSSEEEEGADL 986
W E A+ T+ + +L S E D
Sbjct: 209 ----WAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 19/226 (8%)
Query: 1334 TNGFSESNLLGTGIFSSVYKAT-FADGTNAA---IKIFSLQEDRALKSFDAECEVMRRIR 1389
F +G G FS VYKA DG A ++IF + + +A + E ++++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 1390 HRNLAKIVSSCSNPGFKALILQYMPQGSLE---KWLYSHNYLLNIEQRLDIMIDVACALE 1446
H N+ K ++S ++L+ G L K L+ + + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YM 1503
++H S I+H D+KP+NV + V LGD G+ + S K T + +G YM
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYM 173
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTRRKP--TDDMFTGEVCLK 1547
+PE E + D++S G L+ E + P D M +C K
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 1337 FSESNL-----LGTGIFSSVYKATFAD-GTNAAIK-IFSLQEDRALKSFDAECEVMRRIR 1389
F+ +L +G G F +V K GT A+K I S +++ K + +V+ +R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58
Query: 1390 HRNLAKIVS---SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL--DIMIDVAC- 1443
+ IV + G I + SL+K Y + Y ++ + +I+ +A
Sbjct: 59 SSDCPYIVKFYGALFREG-DCWICMELMDISLDK-FYKYVYE-VLKSVIPEEILGKIAVA 115
Query: 1444 ---ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI 1500
AL YL + IIH D+KPSN+LLD + L DFGI+ L VDS+ +T
Sbjct: 116 TVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCR 171
Query: 1501 GYMAPE----YGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
YMAPE +G S DV+S GI + E T + P
Sbjct: 172 PYMAPERIDPSARDGYDVRS-DVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIK---VFNLQLDGAIKSFDAECEVLRRVRHRN 801
F IG G F VY+AT L G+ VA+K +F+L A E ++L+++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL-------DIMIDVASAL 854
++K +S ++LE G L + + K Q+RL + + SAL
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK----QKRLIPEKTVWKYFVQLCSAL 119
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
E H H V+H D+KP+NV + V L D G+ + + + ++ + T YM+P
Sbjct: 120 E---HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSP 175
Query: 915 EYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
E E + D++S G L+ E + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIF----SLQEDRALKSFDAECEVMRRIRHRN 1392
LG G F V KAT A T A+K+ S E R L S E +++++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS---EFNLLKQVNHPH 64
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWL----------------YSHNYLLNIEQRLD 1436
+ K+ +CS G LI++Y GSL +L + +YL N ++R
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 1437 IMIDVACALEYLHQGYS----TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-M 1491
M D+ + +G ++H DL NVL+ + + DFG+++ + DS +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
K++ + +MA E + I +T DV+SFG+L+ E +T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 15/170 (8%)
Query: 1375 LKSFDAECEVMRRIRHRNLAKIVSSC----SNPGFKA--LILQYMPQGSLEKWL-YSH-- 1425
++ F +E M+ H N+ +++ C + G+ + +IL +M G L +L YS
Sbjct: 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG 103
Query: 1426 --NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483
L + + M D+A +EYL S S IH DL N +L+++M + DFG++K
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
Query: 1484 LLDGVDSMKQ-TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTR 1532
+ D +Q + + ++A E ++ + +T DV+SFG+ M E TR
Sbjct: 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 3e-13
Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG G+ G+V+ A + G VAIK NLQ + E V++ +++ N+V + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++EY+ GSL + + ++ Q + + ALE+LH VIH D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDI 141
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
K NVLL D L+DFG + E S TM + T +MAPE + D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 931 FGILMIETFTRKMP 944
GI+ IE + P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 752 IGAGSFGSVYKA---TLPYGMNVAIKVF-NLQLDGAIK-SFDAECEVLRRVRHRNLVKII 806
+G+G+FG+V K VA+K+ N D A+K E V++++ + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
C + L++E G L K+L +K+ + + +++ V+ ++YL T +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKH-VTEKNITELVHQVSMGMKYLEE---TNFV 117
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSEGIVST 924
H DL NVLL A +SDFG+SK L +++ + T + + APE + S+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 925 CGDVYSFGILMIETFT 940
DV+SFG+LM E F+
Sbjct: 178 KSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 26/218 (11%)
Query: 1342 LLGTGIFSSVYKATFA-DGTNA----AIKIFSLQEDRALKS---FDAECEVMRRIRHRNL 1393
+LG+G F +VYK + +G AIKI L E K+ F E +M + H +L
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKI--LNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+++ C +P + L+ Q MP G L +++ H + + L+ + +A + YL +
Sbjct: 72 VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE--- 127
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG------VDSMKQTMTLATIGYMAPEY 1507
++H DL NVL+ + DFG+A+LL+G D K I +MA E
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM-----PIKWMALEC 182
Query: 1508 GSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEV 1544
+ DV+S+G+ + E +T KP D + T E+
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK---IFSLQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G G FS VY+AT D A+K IF + + +A + E ++++++ H N+ K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 1399 SCSNPGFKALILQYMPQGSLE---KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
S ++L+ G L K+ L+ + + A+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEGI 1512
++H D+KP+NV + V LGD G+ + S K T + +G YM+PE E
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 1513 VSTSGDVYSFGILMMETLTRRKP--TDDMFTGEVCLK 1547
+ D++S G L+ E + P D M +C K
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 10/210 (4%)
Query: 1343 LGTGIFSS--VYKATFADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRNLAKIVS 1398
LG G F +Y+ T D + K +L + DA E ++ ++H N+ +
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 1399 SCSNPGFKALILQYMPQGSL-EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
+ + ++Y G+L +K + L E L + + A+ Y+H+ I+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGIL 123
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSG 1517
H D+K N+ L + LGDFGI+K+L SM +T+ + T YM+PE +
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFKS 182
Query: 1518 DVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547
D+++ G ++ E LT ++ D + +K
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVK 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 743 TDGFSESNLIGAGSFGSVYKAT-LPYGMNVA---IKVFNLQLDGAIKSFDAECEVLRRVR 798
F IG G F VYKA L G VA +++F + A + E ++L+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLE---KWLYSHKYTLNIQQRLDIMIDVASALE 855
H N++K ++S + ++LE G L K K + + + + SALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
++H ++H D+KP+NV + V L D G+ + + + ++ + T YM+PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPE 176
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRKMP--TDEM 948
E + D++S G L+ E + P D+M
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 81/271 (29%), Positives = 121/271 (44%), Gaps = 53/271 (19%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISS 808
IG G++G VYK G VA+K L+ +G + E +L+ ++H N+V +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG----HPTP 864
LI E++ L+K+L S L Q +D + V S L + G H
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDS----LPKGQYMDAEL-VKSYLYQILQGILFCHSRR 121
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGSEGIV 922
V+H DLKP N+L+D+ V L+DFG+++ G T + T Y APE GS
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSP-RY 179
Query: 923 STCGDVYSFGILMIETFTRK--------------------MPTDEMFTGETSLK------ 956
ST D++S G + E T+K PT++++ G TSL
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239
Query: 957 -KWVEESLRLAVTEVVDAELLSSEEEEGADL 986
KW + SLR AV + +E+G DL
Sbjct: 240 PKWKKGSLRSAVKNL---------DEDGLDL 261
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 64/271 (23%), Positives = 101/271 (37%), Gaps = 37/271 (13%)
Query: 1342 LLGTGIFSSVYKATFADGT----NAAIKIFSLQEDR---ALKSFDAECEVMRRIRHRNLA 1394
LG G F V + ++ A+K L+ D+ + F E +M + H NL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 1395 KIVSSCSNPGFKALILQYMPQGSL-EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
++ ++ + P GSL ++ I D + +A + YL
Sbjct: 60 RLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--- 115
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDGVDSMKQTMTLAT-IGYMAPEYGSEG 1511
IH DL N+LL D +GDFG+ + L D L + APE
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFT-GEVCLKHWVEESLPDAVTDVIDANLLSGE 1570
S + DV+ FG+ + E MFT GE + W S + ID GE
Sbjct: 176 TFSHASDVWMFGVTLWE----------MFTYGE---EPWAGLSGSQ-ILKKIDKE---GE 218
Query: 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM 1601
+ + C + ++ L+C P +R
Sbjct: 219 R---LERPEACPQDIYNVMLQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSL-----QEDRALKSFDAECEVMRRIRHRNLAKI 1396
+G G F +Y A +D + IK L +E A K E ++ +++H N+
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWL-YSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+S G ++++Y G L K + L + +Q L + ++ L+++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121
Query: 1456 IIHCDLKPSNVLLDDD-MVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYGSEGIV 1513
I+H D+K N+ L + MVA LGDFGIA+ L+ DSM+ T T Y++PE
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 1514 STSGDVYSFGILMMETLTRRKP 1535
+ D++S G ++ E T + P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 68/271 (25%), Positives = 109/271 (40%), Gaps = 36/271 (13%)
Query: 1341 NLLGTGIFSSVYKATFADG----TNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAK 1395
++G G F VY T D + A+K + D ++ F E +M+ H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 1396 IVSSC-SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
++ C + G ++L YM G L ++ S + ++ + + VA +EYL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-----MKQTMTLATIGYMAPEYGS 1509
+H DL N +LD+ + DFG+A+ D D T + +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569
+T DV+SFG+L+ E +TR P PD + I LL G
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP-----------------PYPDVDSFDITVYLLQG 218
Query: 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ + C + + L C PE R
Sbjct: 219 RR---LLQPEYCPDPLYEVMLSCWHPKPEMR 246
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 42/159 (26%), Positives = 81/159 (50%), Gaps = 7/159 (4%)
Query: 1381 ECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMI 1439
EC+V++ + H N+ + + ++++Y P G+L +++ N LL+ + L +
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
+ AL ++H I+H DLK N+LLD MV +GDFGI+K+L K +
Sbjct: 109 QILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVG 163
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTD 1537
T Y++PE + D+++ G ++ E + ++ +
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-13
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F VYKA + G AA K+ + + L+ + E E++ H + K++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL-DIMIDVAC-----ALEYLHQGYSTS 1455
G +++++ P G+++ +L +++ L + I V C AL+YLH S
Sbjct: 80 WDGKLWIMIEFCPGGAVDA------IMLELDRGLTEPQIQVICRQMLEALQYLH---SMK 130
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIA----KLLDGVDSMKQTMTLATIGYMAPE-YGSE 1510
IIH DLK NVLL D L DFG++ K L DS + T +MAPE E
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-----IGTPYWMAPEVVMCE 185
Query: 1511 GIVST----SGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547
+ T D++S GI ++E P ++ V LK
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-13
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 1359 GTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRNLAKIVSS-CSNPGFKALILQYMP 1414
G AIK+ + +E+ F E + R+ H N+ ++ S + PG + +Y+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 1415 QGSLEKWLYSHNYLLNIEQ-RLDIMIDVACALEYLH-QGYSTSIIHCDLKPSNVLL---D 1469
+L + L + L E RL M+ V AL H QG I+H DLKP N+++
Sbjct: 63 GRTLREVLAADGALPAGETGRL--MLQVLDALACAHNQG----IVHRDLKPQNIMVSQTG 116
Query: 1470 DDMVAHLGDFGIAKLLDGV-DSMKQTMTLAT--IG---YMAPEYGSEGIVSTSGDVYSFG 1523
A + DFGI LL GV D+ T+T T +G Y APE V+ + D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 1524 ILMMETLTRRKPTDDMFTGEVCLKHW--VEESLPDAV 1558
++ +E LT ++ E+ + V+ SLP +
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI 213
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-13
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 746 FSESNLIGAGSFGSVYKA-TLPYGMNVAIKV--FNLQLDGAIKSFDAECEVLRRVRHRNL 802
F + N IG G++G VY+A G VA+K + + DG S E +L +RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 803 VK----IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
V+ ++ + F L++EY Q L L + + Q +M+ + L+YLH
Sbjct: 69 VELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--Y 916
+IH DLK SN+LL D ++DFG+++ G + T + T Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTLWYRAPELLL 181
Query: 917 GSEGIVSTCGDVYSFGILMIETFTRK 942
G +T D+++ G ++ E K
Sbjct: 182 GCT-TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 10/195 (5%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG+G F V+ + AIK ++ E+ F E +VM ++ H L ++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE----DFIEEAKVMMKLSHPKLVQLYGV 67
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
C+ ++ ++M G L +L L+ + L + DV +EYL + S IH
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHR 124
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL N L+ V + DFG+ + + + + + + PE + S+ DV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 1520 YSFGILMMETLTRRK 1534
+SFG+LM E T K
Sbjct: 185 WSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 21/234 (8%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAK 1395
LLG G F VY AD G A+K D + + + + E ++++ +RH + +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 1396 IVSSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLL-NIEQRLDIMIDVACALEYLHQGY 1452
+P K L ++YMP GS++ L ++ L N+ +R I + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLH--- 123
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGS 1509
S I+H D+K +N+L D LGDFG +K + + M T + G +M+PE S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-CMSGTGIKSVTGTPYWMSPEVIS 182
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES---LPDAVTD 1560
DV+S ++E LT + P + K + + LPD V+D
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 1337 FSESNL-----LGTGIFSSVY----KATFADGTNAAIKIFSLQ---EDRALKSFDAECEV 1384
F SNL LG G F V+ K +G + + +LQ ++ F E ++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWL--------YSHNYLLNIEQRLD 1436
R++ H+N+ +++ C +IL+Y G L+++L L+ +Q++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496
+ +A +++L + +H DL N L+ + ++K + + K
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
L + ++APE E ST DV+SFG+LM E T
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 60/248 (24%), Positives = 117/248 (47%), Gaps = 33/248 (13%)
Query: 1372 DRALKSFDAECEVMRRIRHRNLAKI--VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLL 1429
++ + F +E +M + H N+ + V + S P ++ +YM GSL+ +L H+
Sbjct: 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM--IVTEYMENGSLDAFLRKHDGQF 103
Query: 1430 NIEQRLDIMIDVACALEYLHQ-GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488
+ Q + ++ +A ++YL GY +H DL N+L++ ++V + DFG++++L+
Sbjct: 104 TVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159
Query: 1489 DSMKQTMTLATIG--YMAPEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEVC 1545
T I + APE + +++ DV+S+GI+M E ++ +P +M
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM------ 213
Query: 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKD 1605
+ DVI A EE + A C +++ L L C ++ ER +
Sbjct: 214 -----------SNQDVIKAI----EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQ 258
Query: 1606 ALANLKKI 1613
++ L K+
Sbjct: 259 IVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 1343 LGTGIFSSVYKATFADG---TNAAIKIF--------SLQEDRALKSFDAECEVMRRI-RH 1390
LG G F V +AT A G ++A +K+ E AL S E ++M + H
Sbjct: 43 LGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELKIMSHLGNH 98
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNY-LLNIEQRLDIMIDVACALEYLH 1449
N+ ++ +C+ G +I +Y G L +L L +E L VA + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDGVDSMKQTMTLATIGYMAPEYG 1508
S + IH DL NVLL + + DFG+A+ +++ + + + + +MAPE
Sbjct: 159 ---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 1509 SEGIVSTSGDVYSFGILMMETLT 1531
+ + DV+S+GIL+ E +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIK--IFSLQEDRALKSFDAECEVMRRIR---H 1390
+ E +G G + +VYKA G A+K L E+ S E +++++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 1391 RNLAKIVSSCSNPGFK-----ALILQYMPQGSLEKWLYSHNYL-------LNIEQRLDIM 1438
N+ +++ C P L+ +++ Q L YL L E D+M
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DL------ATYLSKCPKPGLPPETIKDLM 113
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
+ +++LH S I+H DLKP N+L+ D + DFG+A++ M T +
Sbjct: 114 RQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVV 168
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
T+ Y APE + +T D++S G + E L RR+P +F G
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRP---LFRGT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG G+ G+VY A + G VAIK NLQ + E V+R ++ N+V + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++EY+ GSL + + ++ Q + + AL++LH VIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDI 141
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
K N+LL D L+DFG + E S TM + T +MAPE + D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 931 FGILMIETFTRKMP 944
GI+ IE + P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-12
Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRN 801
D F + + +GAG+ G V+K + P G+ +A K+ +L++ AI++ E +VL
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL--DIMIDVASALEYLHH 859
+V + + G ++ +E+M GSL++ L K I +++ + I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
H ++H D+KPSN+L++ L DFG+S L DS+ + + T YM+PE
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSPERLQG 176
Query: 920 GIVSTCGDVYSFGILMIETFTRKMP 944
S D++S G+ ++E + P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 23/195 (11%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG GS G V AT G VA+K +L+ + E ++R +H N+V++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCD 869
+++E++ G+L + +H +N +Q + + V AL +LH G VIH D
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLAVLKALSFLHAQG----VIHRD 140
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY-MAPE------YGSEGIV 922
+K ++LL D LSDFG + E V + +L Y MAPE YG+E
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTE--- 195
Query: 923 STCGDVYSFGILMIE 937
D++S GI++IE
Sbjct: 196 ---VDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK---VFNLQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG G F VY+AT L VA+K +F + A + E ++L+++ H N++K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 808 SCSNHGFKALILEYMPQGSLEKWL-YSHKYTLNIQQRL--DIMIDVASALEYLHHGHPTP 864
S ++LE G L + + Y K I +R + + SA+E H H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE---HMHSRR 126
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
V+H D+KP+NV + V L D G+ + + + ++ + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYNF 185
Query: 925 CGDVYSFGILMIETFTRKMP--TDEM 948
D++S G L+ E + P D+M
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 1343 LGTGIFSSVYKATFADGTNA----AIKIFS----LQEDRALKSFDAECEVMRRIRHRNLA 1394
LGTG + V+ G +A A+K+ +Q+ + + E +V+ +R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR----- 62
Query: 1395 KIVSSCSNP-------GFKA-----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA 1442
P F+ LIL Y+ G L LY + E R+ I ++
Sbjct: 63 ------RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIV 115
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGY 1502
AL++LHQ II+ D+K N+LLD + L DFG++K + + TI Y
Sbjct: 116 LALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
Query: 1503 MAPEY--GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
MAPE G G + D +S G+L E LT P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 752 IGAGSFGSVYKATLPY-GMN----VAIKVF-NLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G +FG +YK L GM+ VAIK ++ F E ++ + H N+V +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSH----------------KYTLNIQQRLDIMID 849
+ + ++ EY+ QG L ++L K +L+ L I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLAT 908
+A+ +EYL +H DL N+L+ + +SD G+S+ + D Q +L
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M PE G S+ D++SFG+++ E F+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 42/234 (17%)
Query: 750 NLIGAGSFGSVYKA--TLPYGMNVAIK-VFNLQLDGAIKSFDA-------------ECEV 793
+G G++G V KA TL + VAIK V +++ + E ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 794 LRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASA 853
+ ++H N++ ++ F L+++ M L+K + K L Q I++ + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-----------LLDGEDSVTQ 902
L LH + +H DL P+N+ ++ + ++DFG+++ D +
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 903 TMT--LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
MT + T Y APE G+E D++S G + E T K +F GE
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAV-DMWSVGCIFAELLTGK----PLFPGE 237
|
Length = 335 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 40/233 (17%)
Query: 1341 NLLGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDA--------------ECEVM 1385
LG G + V KA G AIK + E + D E ++M
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 1386 RRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACAL 1445
I+H N+ +V F L++ M L+K + L Q I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-----------LLDGVDSMKQT 1494
LH+ Y +H DL P+N+ ++ + + DFG+A+ D ++
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 1495 MT--LATIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
MT + T+ Y APE G+E + D++S G + E LT KP +F GE
Sbjct: 190 MTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLT-GKP---LFPGE 237
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 8/180 (4%)
Query: 1358 DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-GFKALILQYMP 1414
DG IK +L+ R K+ + E +++ +++H N+ S G +++ +
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 1415 QGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473
G L L LL Q ++ + +A AL+YLH+ + I+H DLK NV L +
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNI 140
Query: 1474 AHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRR 1533
+GD GIA++L+ M T+ + T YM+PE S + DV++ G + E T +
Sbjct: 141 IKVGDLGIARVLENQCDMASTL-IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 751 LIGAGSFGSVYKATLPY----GMNVAIKVFNLQLDGA-----IKSFDAECEVLRRVRHRN 801
L+G G+FG VY L Y G +A+K + + + + E ++L+ + H
Sbjct: 9 LLGQGAFGRVY---LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 802 LVKIISSCSNHGFKAL--ILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLH 858
+V+ + + L +E+MP GS++ L S+ T N+ ++ I LE +
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVS 120
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA----P 914
+ H ++H D+K +N+L D L DFG SK L QT+ L+ G + P
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-------QTICLSGTGMKSVTGTP 173
Query: 915 EYGSEGIVSTCG-----DVYSFGILMIETFTRKMPTDE 947
+ S ++S G D++S G ++E T K P E
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 38/99 (38%), Positives = 51/99 (51%), Gaps = 14/99 (14%)
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
AL YL + + +IH D+KPSN+LLD L DFGI+ L VDS +T + YM
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYM 181
Query: 1504 APE-------YGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
APE I + DV+S GI ++E T + P
Sbjct: 182 APERIDPPDPNPKYDIRA---DVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-12
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 66/216 (30%)
Query: 752 IGAGSFGSVYKA----TLPYGMNVAIKVFNLQLDGAIKSFDA------------ECEVLR 795
+G G++G V+KA T VA+K K FDA E L+
Sbjct: 15 LGKGAYGIVWKAIDRRT---KEVVALK----------KIFDAFRNATDAQRTFREIMFLQ 61
Query: 796 RVR-HRNLVKIISSCSNHGFKA-------LILEYMPQGSLEKWLYS--HKYTLNIQQRLD 845
+ H N+VK+++ KA L+ EYM E L++ L +
Sbjct: 62 ELGDHPNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY 111
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD--GEDSVTQT 903
IM + AL+Y+H G+ VIH DLKPSN+LL+ D L+DFG+++ L E+
Sbjct: 112 IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 904 MT--LATFGYMAPEYGSEGIV--STCGDVYSFGILM 935
+T +AT Y APE I+ ST Y+ G+ M
Sbjct: 169 LTDYVATRWYRAPE-----ILLGSTR---YTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAK 1395
LLG G F VY D G A K + + + + + E ++++ ++H + +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 1396 IVSSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+ K L ++YMP GS++ L ++ L R + + YLH S
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSE 1510
I+H D+K +N+L D LGDFG +K L + M T + G +M+PE S
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-CMSGTGIRSVTGTPYWMSPEVISG 183
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKP 1535
DV+S G ++E LT + P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 44/123 (35%), Positives = 58/123 (47%), Gaps = 14/123 (11%)
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905
+ + + AL YL H VIH D+KPSN+LLD L DFGIS L DS +T +
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRS 174
Query: 906 LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKW 958
YMAPE I + DV+S GI ++E T + P T L K
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRA---DVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
Query: 959 VEE 961
++E
Sbjct: 232 LQE 234
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-12
Identities = 37/89 (41%), Positives = 51/89 (57%)
Query: 470 IIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQ 529
I L L L IP + KL++LQ ++LS N+I+G+IP L + SL L L N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 530 NQIPTCLANLTSLRALNLSSNRLNSTIPS 558
IP L LTSLR LNL+ N L+ +P+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 4e-12
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG G+ G+VY A + G VAI+ NLQ + E V+R ++ N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++EY+ GSL + + ++ Q + + ALE+LH VIH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
K N+LL D L+DFG + E S TM + T +MAPE + D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 931 FGILMIETFTRKMP 944
GI+ IE + P
Sbjct: 202 LGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 4e-12
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 53/226 (23%)
Query: 736 YQELQRLTDGFSESNLIGAGSFGSVYKAT--LPYGMNVAIKVFNLQLDGAIKSFDAECEV 793
Y+ +++L G G+FGSVY A + VAIK + S++ EC
Sbjct: 1 YKVIKQL----------GDGTFGSVYLARNKETGEL-VAIKKMKKKF----YSWE-ECMN 44
Query: 794 LRRVR-------HRNLVKI--ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTL--NIQQ 842
LR V+ H N+VK+ + ++ + + EYM +G+L + + K
Sbjct: 45 LREVKSLRKLNEHPNIVKLKEVFRENDELY--FVFEYM-EGNLYQLMKDRKGKPFSESVI 101
Query: 843 RLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
R I+ + L ++H HG H DLKP N+L+ V ++DFG+++ +
Sbjct: 102 R-SIIYQILQGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPP 154
Query: 902 QTMTLATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFT 940
T ++T Y APE Y S+ D+++ G +M E +T
Sbjct: 155 YTDYVSTRWYRAPEILLRSTSY------SSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-12
Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 465 GNLSNIIALSLYQNQLAS--TIPTTVGKLQNLQ---GLDLSYN-NIQGSIPSEL------ 512
G + I A+ +++ A T+ V LQ L+ GL L + N +P +
Sbjct: 349 GTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGAD 408
Query: 513 CQLES------LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYI 566
CQ +S ++ L L L+ IP ++ L L+++NLS N + IP + S+ +
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 567 LVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGL 611
V+D S N +G +P+ +G L L L L+GN LS +P+++GG
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-12
Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 29/133 (21%)
Query: 79 WVGVTCG----SRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELW 134
W G C + L + N GL G IP ++ L L S+N+SGN G +P L
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 135 LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS 194
+ L ++DLS N +G+ +P SLG + L+ L+++
Sbjct: 464 SITSLEVLDLSYNSFNGS-------------------------IPESLGQLTSLRILNLN 498
Query: 195 FNELTGRIPQNIG 207
N L+GR+P +G
Sbjct: 499 GNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-12
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG GS G V AT + G VA+K +L+ + E ++R H N+V + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++E++ G+L + +H +N +Q + + V AL YLH+ VIH D+
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLSVLRALSYLHN---QGVIHRDI 144
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
K ++LL D LSDFG + E +++ + T +MAPE S T D++S
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL-VGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 931 FGILMIETFTRKMP 944
GI++IE + P
Sbjct: 204 LGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-12
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRN 801
D F + +GAG+ G V K P G+ +A K+ +L++ AI++ E +VL
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL--DIMIDVASALEYLHH 859
+V + + G ++ +E+M GSL++ L K I + + + I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
H ++H D+KPSN+L++ L DFG+S L DS+ + + T YM+PE
Sbjct: 122 KHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSPERLQG 176
Query: 920 GIVSTCGDVYSFGILMIETFTRKMP 944
S D++S G+ ++E + P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 752 IGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKI 805
+G GS+G V ++ G IK NL+ K+ + E ++L +++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTD---GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 806 ISSCSNH-GFKALILEYMPQGSLEKWLYSHKYTLNIQ-QRLDIMIDVASALEYLHHGHPT 863
S G +++ + G L L K L + Q ++ + +A AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
++H DLK NV L + + D GI+++L+ + + T+ + T YM+PE S +
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPELFSNKPYN 180
Query: 924 TCGDVYSFGILMIETFTRK 942
DV++ G + E T K
Sbjct: 181 YKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVF-NLQLDGAIKSFDA-ECEVLRRVRHRNLVKIIS 807
L+G GS+G V K G VAIK F + D +K E +L+++RH NLV +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
L+ E++ L+ L + L+ + + + +E+ H + +IH
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-------YGSEG 920
D+KP N+L+ V L DFG ++ L V T +AT Y APE YG
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVATRWYRAPELLVGDTKYGRA- 181
Query: 921 IVSTCGDVYSFGILMIETFT 940
D+++ G L+ E T
Sbjct: 182 -----VDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 9e-12
Identities = 63/226 (27%), Positives = 92/226 (40%), Gaps = 21/226 (9%)
Query: 1330 LRLATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRI 1388
L T F ++G G + VYKA G AIKI + ED + E ++R+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 1389 -RHRNLAK-----IVSSCSNPGFKA-LILQYMPQGS---LEKWLYSHNYLLNIEQRLDIM 1438
H N+A I + + L+++ GS L K L L E I+
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
+ L YLH+ +IH D+K N+LL + L DFG++ LD + T
Sbjct: 120 RETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-G 175
Query: 1499 TIGYMAPE-----YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
T +MAPE + DV+S GI +E + P DM
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-12
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 752 IGAGSFGSVYKATLPYG-------MNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRNLV 803
+G FG VYK L +G VAIK + +G ++ F E + R++H N+V
Sbjct: 13 LGEDRFGKVYKGHL-FGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSH---------------KYTLNIQQRLDIMI 848
++ + ++I Y L ++L K TL + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT-QTMTLA 907
+A+ +E+L H V+H DL NVL+ D +SD G+ + + D +L
Sbjct: 132 QIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 908 TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M+PE G S D++S+G+++ E F+
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 36/262 (13%)
Query: 1342 LLGTGIFSSVYKATFADG------------TNAAIKIFSLQEDRALKSFDAECEVMR-RI 1388
LG+G F VYK + N A + D+++ +E +++ ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 1389 RHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYS------HNYLLNIEQRL-DIMIDV 1441
RH N+ + + + I+ + +G+ ++ + E+R+ +I + +
Sbjct: 67 RHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRF---TEERIWNIFVQM 122
Query: 1442 ACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG 1501
AL YLH+ I+H DL P+N++L +D + DFG+AK K T + TI
Sbjct: 123 VLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTIL 178
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP--TDDMFTGEVCLKHWVEESLPDA-- 1557
Y PE DV++FG ++ + T + P + +M + + V E LP+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 1558 ---VTDVIDANLL-SGEEEADI 1575
VTDVI + L E DI
Sbjct: 239 SEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 12/216 (5%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAI--KIFSLQE---DRALKSFDAECEVMRRIRH 1390
F + +LG+G F +VYK + +G I I L+E +A K E VM + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
++ +++ C + LI Q MP G L ++ H + + L+ + +A + YL +
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM-TLATIGYMAPEYGS 1509
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 128 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 1510 EGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEV 1544
I + DV+S+G+ + E +T KP D + E+
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 752 IGAGSFGSVYKATLPY-----GMNVAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVK 804
+G G+FG ATL Y V K NL + DA E +L ++H N++
Sbjct: 8 LGKGAFGE---ATL-YRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 805 IISSCSNHGFKALILEYMPQGSL-EKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ + + +EY G+L +K + + L + + SA+ Y+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
++H D+K N+ L + L DFGISK+L E S+ +T+ + T YM+PE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYN 179
Query: 924 TCGDVYSFGILMIETFTRK 942
D+++ G ++ E T K
Sbjct: 180 FKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-11
Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 768 GMNVAIKVFNLQLDGA-----IKSFDAECEVLRRVRHRNLVKIISS-CSNHGFKALILEY 821
G VAIK+ L+ D F E + R+ H N+V ++ S + G + EY
Sbjct: 3 GHEVAIKL--LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---D 878
+P +L + L + L + +M+ V L+ L H ++H DLKP N+++
Sbjct: 61 VPGRTLREVLAADG-ALPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 879 DDTVAHLSDFGISKLLDG-EDSVTQTMTLAT--FG---YMAPEYGSEGIVSTCGDVYSFG 932
A + DFGI LL G D+ T+T T G Y APE V+ D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 933 ILMIETFT 940
++ +E T
Sbjct: 177 LIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-11
Identities = 33/86 (38%), Positives = 52/86 (60%), Gaps = 1/86 (1%)
Query: 142 IDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGR 201
+ L + + G + +D+ + L L+S ++S N I G +P SLG + L+ L +S+N G
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 202 IPQNIGNLTELMELYLNGNNLQGEFP 227
IP+++G LT L L LNGN+L G P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 752 IGAGSFGSVYKAT----LPYGMNVAIKVFNLQLDGAI---KSFDAECEVLRRVRHRNLVK 804
IG G+FG V++A LPY + V L+ + + F E ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSH---------------------KYTLNIQQR 843
++ C+ L+ EYM G L ++L L+ ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
L I VA+ + YL +H DL N L+ ++ V ++DFG+S+ + D +
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 904 MT-LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKM 943
+M PE +T DV+++G+++ E F+ M
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNV-AIKVFNLQ-LDGAIKSFDAECEVLRRVRHRNLV 803
F++ IG GSFG V+K V AIK+ +L+ + I+ E VL + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
K S +I+EY+ GS L L+ Q I+ ++ L+YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK- 122
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
IH D+K +NVLL + L+DFG++ L + + + + T +MAPE +
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 924 TCGDVYSFGILMIETFTRKMPTDEM 948
+ D++S GI IE + P E+
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 13/222 (5%)
Query: 751 LIGAGSFGSVYKA--TLPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKI 805
++G G FG + + LP + + + L+ D + F AE L + H N+V++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ ++ EYM G+L+ +L H+ L Q + ++ +AS ++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGY 128
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG-YMAPEYGSEGIVST 924
+H L VL++ D V +S F + D +++ TM+ + + APE S+
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQ-EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFGI+M E + + P +M + K VE+ RL
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDM--SGQDVIKAVEDGFRL 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQ---LDGAIKSFDA---ECEVLRRVRH 799
+++ ++G G++G+VY G +A+K L + A K ++ E ++L+ ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSH---------KYTLNIQQRLDIMIDV 850
N+V+ + +C + ++ +E++P GS+ L KYT I
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------- 113
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL-----DGEDSVTQTMT 905
+ YLH+ V+H D+K +NV+L + + L DFG ++ L G S
Sbjct: 114 --GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
T +MAPE +E D++S G + E T K P M
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 8/205 (3%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNV-AIKVFNLQ-LDGAIKSFDAECEVLRRVRHRNLV 803
F++ IG GSFG V+K V AIK+ +L+ + I+ E VL + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
K S +I+EY+ GS L + + + Q ++ ++ L+YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLHSEKK- 122
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
IH D+K +NVLL + L+DFG++ L T F +MAPE +
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAYD 179
Query: 924 TCGDVYSFGILMIETFTRKMPTDEM 948
+ D++S GI IE + P +M
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 54/240 (22%), Positives = 109/240 (45%), Gaps = 23/240 (9%)
Query: 1343 LGTGIFSSVY----KATFADGTNAAIKIFSLQEDRALKS---FDAECEVMRRIRHRNLAK 1395
LG G F VY K D + I ++ E +++ F E VM+ ++ +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYS---------HNYLLNIEQRLDIMIDVACALE 1446
++ S +I++ M +G L+ +L S ++++ + + ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT-MTLATIGYMAP 1505
YL+ + +H DL N ++ +D +GDFG+ + + D ++ L + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 1506 EYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL---PDAVTDVI 1562
E +G+ +T DV+SFG+++ E T + + E L+ +E L PD D++
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDML 250
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 17/199 (8%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G +VY A A G AIK +LQ+ + E VMR +H N+ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC-----ALEYLHQGYSTSI 1456
++++Y+ GSL ++ + I C ALE+LH S +
Sbjct: 87 VGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLH---SNQV 136
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTS 1516
IH D+K N+LL D L DFG + S + TM + T +MAPE +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 195
Query: 1517 GDVYSFGILMMETLTRRKP 1535
D++S GI+ +E + P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 751 LIGAGSFGSVYKATLPY----GMNVAIKVFNLQLDGA-----IKSFDAECEVLRRVRHRN 801
L+G G+FG VY L Y G +A+K D + + + E ++L+ +RH
Sbjct: 9 LLGRGAFGEVY---LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 802 LVKIISSCSNHGFKAL--ILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLH 858
+V+ + K L +EYMP GS++ L ++ T N+ +R I L+ +
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI-----LQGVS 120
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD-------GEDSVTQTMTLATFGY 911
+ H ++H D+K +N+L D L DFG SK + G SVT T +
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY-----W 175
Query: 912 MAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947
M+PE S DV+S ++E T K P E
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 70/306 (22%), Positives = 126/306 (41%), Gaps = 48/306 (15%)
Query: 1329 ELRLATNGFSESNLLGTGIFSSVYKA-TFADGTNAA--IKIFSLQEDRALK---SFDAEC 1382
EL L+ F E LG F +YK + G + A + I +L++ + F E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 1383 EVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLY----------SHNYLLNIE 1432
+M + H N+ ++ + ++ +Y+ QG L ++L S + ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 1433 QRLD------IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486
LD I I +A +EYL + +H DL N+L+ + + + D G+++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 1487 GVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC 1545
D + Q +L I +M PE G S+ D++SFG+++ E +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FG 223
Query: 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKD 1605
L+ + S + + V LL E+ C + SL +C +E P R KD
Sbjct: 224 LQPYYGFSNQEVIEMVRKRQLLPCSED--------CPPRMYSLMTECWQEGPSRRPRFKD 275
Query: 1606 ALANLK 1611
L+
Sbjct: 276 IHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-11
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 20/154 (12%)
Query: 576 LSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSL 635
L G +P DI L+ L + LSGN + +IP S+G + L L L+ N F GSIPE++G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 636 ISLEK---------GEIPS--GGPFVNFTEGSFMQNYALCGSLRLQVQACETSSTQQSKS 684
SL G +P+ GG ++ +F N LCG + S
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-----IPGLRACGPHLSVG 544
Query: 685 SKLLRYVLPAVATAVVMLALIIIFIRCCTRNKNL 718
+K+ A +V L L+I + R +N+
Sbjct: 545 AKIGI----AFGVSVAFLFLVICAMCWWKRRQNI 574
|
Length = 623 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIV---- 1397
LG G V+ A +D A+K L + +++K E +++RR+ H N+ K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 1398 -------SSCSNP-GFKAL-ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL 1448
+ ++ I+Q + L + L RL M + L+Y+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLAN-VLEQGPLSEEHARL-FMYQLLRGLKYI 130
Query: 1449 HQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQ--TMTLATIGYMAP 1505
H S +++H DLKP+NV ++ +D+V +GDFG+A+++D S K + L T Y +P
Sbjct: 131 H---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 1506 EYG-SEGIVSTSGDVYSFGILMMETLTRR 1533
S + + D+++ G + E LT +
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-11
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 44/221 (19%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA---------ECEVLR 795
+ + IG G++G V AT P G+ VAIK I F+ E ++LR
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK--------KISPFEHQTFCQRTLREIKILR 58
Query: 796 RVRHRNLVKI---ISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLN-----IQQRLD 845
R +H N++ I I S F ++ E M L K + + + + + Q L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQIL- 116
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905
L+Y+H + V+H DLKPSN+LL+ + + DFG++++ D E T +T
Sbjct: 117 ------RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 906 --LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRK 942
+AT Y APE S+G + D++S G ++ E + +
Sbjct: 168 EYVATRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECE-VMRRI-----RHRNLAK 1395
+LG G F V A GTN I +L++D L+ D EC V RR+ H L
Sbjct: 2 VLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQ--RLDIM------IDVACALEY 1447
+ + +++Y+ G L + +I+ R D ++ C L++
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL---------MFHIQSSGRFDEARARFYAAEIICGLQF 111
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY 1507
LH II+ DLK NVLLD D + DFG+ K + T T Y+APE
Sbjct: 112 LH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEI 167
Query: 1508 GSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
+ S D +SFG+L+ E L + P F GE
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDA----ECEVLRRVRHRNLVKII 806
IG G+FG V+KA VA+K + ++ + F E ++L+ ++H N+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 807 SSCSN-----HGFKA---LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
C + +K L+ E+ L L + + + +M + + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK---LLDGEDSVTQTMTLATFGYMAPE 915
++H D+K +N+L+ D + L+DFG+++ L T + T Y PE
Sbjct: 137 RNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 916 -------YGSEGIVSTCGDVYSFGILMIETFTR 941
YG D++ G +M E +TR
Sbjct: 194 LLLGERDYG------PPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
+G G+FG VYKA G+ A KV + + + ++ + E ++L H N+VK++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++E+ G+++ + + L Q I + LE L++ H +IH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQ---IRVVCKQTLEALNYLHENKIIHRDL 129
Query: 871 KPSNVLLDDDTVAHLSDFGIS----KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC- 925
K N+L D L+DFG+S + + DS + T +MAPE V C
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-----IGTPYWMAPE------VVMCE 178
Query: 926 ----------GDVYSFGILMIETFTRKMPTDEM 948
DV+S GI +IE + P E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 7/187 (3%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG GS G V A + G VA+K+ +L+ + E ++R +H+N+V++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++E++ G+L + + LN +Q + V AL YLH VIH D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
K ++LL D LSDFG + +D + + T +MAPE S T D++S
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 931 FGILMIE 937
GI++IE
Sbjct: 203 LGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 69/291 (23%), Positives = 126/291 (43%), Gaps = 42/291 (14%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRH---R 1391
+ L+G G + +VY+ G A+KI +L D + E ++ ++R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLD--IMIDVACALEYLH 1449
N+ K S +I++Y GS+ + + I ++ I+ +V AL+Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVALKYIH 118
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS 1509
+IH D+K +N+L+ + L DFG+A LL+ S + T T +MAPE +
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 1510 EGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568
EG T D++S GI + E T P D A+ + +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSD-------------VDAFRAMMLIPKSKPPR 221
Query: 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619
E+ ++ +++ C +E P+ER++ ++ L K+K++K
Sbjct: 222 LEDNGYSKLLREFVAA-------CLDEEPKERLSAEELL------KSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 32/194 (16%)
Query: 745 GFSESNLIGAGSFGSVYKA---TLPYGMNVAIKVF---NLQLDGAIKSFDAECEVLRRVR 798
+ IG G++G VYKA G AIK F Q G +S E +LR ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 799 HRNLVKIISSCSNHGFKA--LILEYMPQGSLE--KWLYSHKYTLNIQQRL--DIMIDVAS 852
H N+V ++ H K+ L+ +Y + K+ + ++I + ++ + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILN 119
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGIS-------KLLDGEDSVT 901
+ YLH V+H DLKP+N+L+ + V + D G++ K L D V
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV- 175
Query: 902 QTMTLATFGYMAPE 915
+ T Y APE
Sbjct: 176 ----VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVM-RRI-----RHRNLAK 1395
+LG G F V A GT+ I L++D L+ D +C + +RI +H L
Sbjct: 2 VLGKGSFGKVMLAE-LKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQ--RLD------IMIDVACALEY 1447
+ +++Y+ G L + I++ + D +V AL +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL---------MFQIQRSRKFDEPRSRFYAAEVTLALMF 111
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPE 1506
LH+ +I+ DLK N+LLD + L DFG+ K +G+ + T T T Y+APE
Sbjct: 112 LHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPE 166
Query: 1507 YGSEGIVSTSGDVYSFGILMMETLTRRKP-----TDDMF 1540
E S D ++ G+LM E + + P DD+F
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA-IKSFDAECEVLRRVRHRNLVKIISSC 809
+G G++GSVYK P G+ +A+K L+LD + E ++L + +V +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNI---QQRLDIMIDVASALEYLHHGHPTPVI 866
G + +EYM GSL+K LY+ I V L++L H +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H D+KP+NVL++ + L DFG+S L S+ +T + YMAPE G +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKT-NIGCQSYMAPERIKSGGPNQNP 182
Query: 927 ------DVYSFGILMIE 937
DV+S G+ ++E
Sbjct: 183 TYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-11
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 18/225 (8%)
Query: 751 LIGAGSFGSVY---KATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRN- 801
++G G++G V+ K T Y M V K +Q ++ E VL VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
LV + + LIL+Y+ G + ++H Y + ++ + L H H
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEM----FTHLYQRDNFSEDEVRFYSGEIILALEHLH 122
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-YGSEG 920
+++ D+K N+LLD + L+DFG+SK E+ T YMAPE +G
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 921 IVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRL 965
D +S GIL+ E T P FT E E S R+
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASP----FTLEGERNTQSEVSRRI 223
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 58/237 (24%)
Query: 737 QELQRLT----DGFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAI--KSFDA 789
QEL + D + + +G+G++G V A G VAIK + AI K
Sbjct: 4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEK----WLYSH-----KYTLNI 840
E +L+ + H N +I L+ + P SLE +L +H +
Sbjct: 64 ELRLLKHMDHEN---VIG---------LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK 111
Query: 841 QQRLD------IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894
Q+L ++ + L+Y+H +IH DLKPSN+ +++D + DFG+++
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168
Query: 895 DGEDSVTQTMT--LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRK 942
D E MT +AT Y APE Y + D++S G +M E T K
Sbjct: 169 DDE------MTGYVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECE-VMRRI-----RHRNLAK 1395
+LG G F V+ A GTN I +L++D L D EC V +R+ H L
Sbjct: 2 MLGKGSFGKVFLAEL-KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
+ + +++Y+ G L + S H + ++ + ++ C L++LH S
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF--DLPRATFYAAEIICGLQFLH---SK 115
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
I++ DLK N+LLD D + DFG+ K + + K T Y+APE +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK-ENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 1515 TSGDVYSFGILMMETLTRRKP 1535
TS D +SFG+L+ E L + P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 4e-11
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 1346 GIFSSVY----KATFADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
G + V+ K+T G AIK+ + + E +++ + + + K+
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
S L+++Y+P G L L + L R+ + ++ ALEYLH IIH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI-YIAEIVLALEYLHS---NGIIH 116
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAK-------LLDGVDSMKQTMTLATIGYMAPEYGSEG 1511
DLKP N+L+D + L DFG++K + D + + T Y+APE
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE----- 171
Query: 1512 IVSTSG-----DVYSFGILMMETLT 1531
++ G D +S G ++ E L
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-11
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 1/96 (1%)
Query: 456 LGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQL 515
L G IP + L ++ +++L N + IP ++G + +L+ LDLSYN+ GSIP L QL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 516 ESLNTLLLQGNALQNQIPTCLANLTSLRA-LNLSSN 550
SL L L GN+L ++P L RA N + N
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 746 FSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNL---QLDGAIKSFDAECEVLRRVRHRN 801
FS+ IG GSFG+VY A + VAIK + Q + + E L+++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
++ L++EY GS L HK L Q ++I AL+ L + H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLH 132
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY---GS 918
+IH D+K N+LL + + L DFG + ++ + + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMD 187
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
EG DV+S GI IE RK P M
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 50/214 (23%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 1342 LLGTGIFSSVYKATFA----DGTNAAIKIF-SLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
++G G F V + AIK S ++ + F +E +M + H N+ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+ +I ++M G+L+ +L ++ + Q + ++ +A ++YL + +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNY 127
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-----TIGYMAPEYGSEG 1511
+H DL N+L++ ++V + DFG+++ L+ D+ T T + I + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLED-DTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 1512 IVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+++ DV+S+GI+M E ++ +P DM +V
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 752 IGAGSFGSVY--------KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRN-- 801
+G G++G V+ A Y M V K +Q + E +VL VR R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-RCPF 66
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
LV + + LIL+Y+ G L LY ++ + R+ I ++ AL++LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ-- 123
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY--GSE 919
+I+ D+K N+LLD + L+DFG+SK E+ T YMAPE G
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 920 GIVSTCGDVYSFGILMIETFTRKMP 944
G D +S G+L E T P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 45/244 (18%)
Query: 744 DGFSESNLIGAGSFGSVYKATL--PYGMN---VAIKVFNLQLDGA----IKSFDAECEVL 794
D + S+L+ G+FG ++ L V +K D A + E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLL 62
Query: 795 RRVRHRNLVKIISSCS-NHGFKALILEYMPQGSLEKWLYSHKY-------TLNIQQRLDI 846
+ H+N++ I+ C + ++ YM G+L+ +L + L+ QQ + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 847 MIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK---------LLDG 896
I +A + YLH G VIH D+ N ++D++ ++D +S+ L D
Sbjct: 123 AIQIACGMSYLHKRG----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM--FTGET 953
E+ + +MA E S+ DV+SFG+L+ E T + P E+ F
Sbjct: 179 ENRPVK--------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230
Query: 954 SLKK 957
LK
Sbjct: 231 YLKD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-11
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 746 FSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNL---QLDGAIKSFDAECEVLRRVRHRN 801
F++ IG GSFG+VY A + VAIK + Q + + E + L+R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
++ L++EY GS L HK L Q ++I AL+ L + H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAITHGALQGLAYLH 142
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY---GS 918
+IH D+K N+LL + L+DFG + + +S + T +MAPE
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVILAMD 197
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
EG DV+S GI IE RK P M
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 64/234 (27%)
Query: 751 LIGAGSFGSVY-----KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
L+G G G V+ + + V K + +K E E+L + H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDK-KEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS--------ALEYL 857
+S + L+++Y P G L + L Q + +VA ALEYL
Sbjct: 67 YASFQTETYLCLVMDYCPGGEL----FR---LLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 858 H-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT--------------- 901
H G +++ DLKP N+LL + LSDF +SK D E
Sbjct: 120 HLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 902 -QTMTLA------------TFGYMAPEYGSEGIVSTCG-----DVYSFGILMIE 937
+ T + T Y+APE ++S G D ++ GIL+ E
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-11
Identities = 87/396 (21%), Positives = 141/396 (35%), Gaps = 61/396 (15%)
Query: 12 NIPCGRALLAILFMAKLMSITE-ANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNT 70
+ P L + L L + T ++ L+ NLS+ T
Sbjct: 1 STPAENLLKSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLL 60
Query: 71 SSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPP--------------HVANLSFLV 116
+S+ + + ++ L L P + L+ L
Sbjct: 61 LLPSSLSRLLSLD-LLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLT 119
Query: 117 SLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176
SL++ N P L L+ +DLS N+I
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-------------------------- 153
Query: 177 QLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSL 236
LPS L + LK L +SFN+L+ +P+ + NL+ L L L+GN + + PP I +S+L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 237 RVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT 296
+ L+NNS+ L L L +L L L +P+ IGN + L L L +NQ++
Sbjct: 212 EELDLSNNSII-ELLSSL-SNLKNLSGLEL-SNNKLEDLPESIGNLSNLETLDLSNNQIS 268
Query: 297 DFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVI 356
S + + +N+ + L GN LS LP + L L L N L +
Sbjct: 269 SI----------SSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL----NLLLTLK 314
Query: 357 PSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392
+ S L + N + +
Sbjct: 315 ALELKLNSILLNNNILSNGETSSPEALSILESLNNL 350
|
Length = 394 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 752 IGAGSFGSVYKATLPYGMN-VAIKVFNL---QLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG GSFG+VY AT + VA+K + Q + + E + L++++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
L++EY GS L HK L Q ++I AL+ L + H +IH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY---GSEGIVST 924
D+K N+LL + L+DFG + +S + T +MAPE EG
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMDEGQYDG 199
Query: 925 CGDVYSFGILMIETFTRKMPTDEM 948
DV+S GI IE RK P M
Sbjct: 200 KVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 64/248 (25%), Positives = 100/248 (40%), Gaps = 47/248 (18%)
Query: 1337 FSESNLLGTGIFSSV----YKATFADGTNAAIKIFSLQEDRALKSFD---AECEVMRRIR 1389
F LGTG F V +K T G AIK +E +K E ++ +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 1390 HRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIM----IDVACAL 1445
H + ++ S + +L+++ G L L N D+ ++ A
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-----DVAKFYHAELVLAF 131
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMA 1504
EYLH S II+ DLKP N+LLD+ + DFG AK + +T TL T Y+A
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFTLCGTPEYLA 183
Query: 1505 PEYGSEGIVSTSG-----DVYSFGILMMETLTRRKPTDD---------MFTGEVCLKHWV 1550
PE ++ + G D ++ G+L+ E + P D + G + +W
Sbjct: 184 PE-----VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238
Query: 1551 EESLPDAV 1558
+ D V
Sbjct: 239 DGRARDLV 246
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-11
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 751 LIGAGSFGSVY----KATLPY-GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
L+G G+FG V KA+ Y M + K + D + E VL+ RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSL 60
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S ++EY+ G L L + + R ++ SAL+YLH G +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK---I 116
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPEYGSEGI 921
++ DLK N++LD D ++DFG+ K + +T T+ TF Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 922 VSTCGDVYSFGILMIETFTRKMP 944
D + G++M E ++P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-11
Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 62/275 (22%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDG------AIKSFDAECEVLRRVRHRNLVK 804
IG G++G VYKA G VA+K L+ + AI+ E +L+ + H N+V+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 805 ---IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL-DIMIDVASALEYLHHG 860
++ S + L+ E++ L+K++ S T + + + + Y H
Sbjct: 63 LLDVVHSENK---LYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH-S 117
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGS 918
H V+H DLKP N+L+D + L+DFG+++ G T T + T Y APE GS
Sbjct: 118 HR--VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGS 174
Query: 919 EGIVSTCGDVYSFGILMIETFTRK--------------------MPTDEMFTGETSLK-- 956
ST D++S G + E R+ P ++++ G TSL
Sbjct: 175 R-QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233
Query: 957 -----KWVEESLRLAVTEVVDAELLSSEEEEGADL 986
KW + L V + +E+G DL
Sbjct: 234 KPTFPKWARQDLSKVVPNL---------DEDGLDL 259
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 8e-11
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRAL--KSFDAECEVMRRIRHRNLAKIVS 1398
++G G + V K G AIK F ED K+ E +V+R++RH N+ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
+ G L+ +Y+ + LE L + L + + + A+ Y H S +IIH
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-------YGSEG 1511
D+KP N+L+ + V L DFG A+ L + T +AT Y APE YG
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK-- 181
Query: 1512 IVSTSGDVYSFGILMMETLTRR 1533
DV++ G +M E L
Sbjct: 182 ----PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-11
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 1342 LLGTGIFSSVYKATFADGTNA----AIKIFS----LQEDRALKSFDAECEVMRRIRHRNL 1393
+LGTG + V+ G + A+K+ +Q+ + ++ E V+ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 1394 AKIVSSCSNPGFKA-LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ K LIL Y+ G + LY + E R ++ ALE+LH+
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLHK-- 123
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI 1512
I++ D+K N+LLD + L DFG++K + + TI YMAPE I
Sbjct: 124 -LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI----I 178
Query: 1513 VSTSG-----DVYSFGILMMETLTRRKP 1535
G D +S GIL+ E LT P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-11
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKI------FSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
+G G + V+ A D G A+K F L E R + + E +++ + L K
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT---ERDILTTTKSEWLVK 65
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ-GYST 1454
++ + + + L ++Y+P G L + L R M ++ A++ LH+ GY
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY-- 122
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGI 1512
IH DLKP N L+D L DFG++K G+ + ++ + + YMAPE G
Sbjct: 123 --IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSV-VGSPDYMAPEVLRGKG-- 174
Query: 1513 VSTSGDVYSFGILMMETLTRRKP-----TDDMFTGEVCLKHWVE 1551
+ D +S G ++ E L P ++ + LK+W E
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN---LKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-11
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAI-KSFDAECEVLRRVRHRNLVKIISSC 809
+G G+ G+VYKA L +A+KV L + + K +E E+L + ++ +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
++ E+M GSL+ + ++ L I + V L YL ++H D
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLW---SLKILHRD 120
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
+KPSN+L++ L DFG+S L +S+ +T + T YMAPE S DV+
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTY-VGTNAYMAPERISGEQYGIHSDVW 177
Query: 930 SFGILMIETFTRKMPTDEMFTGETSL 955
S GI +E + P ++ + SL
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-11
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQ--EDRALKSFDAECEVMRRIR---HRNLAKI 1396
+G G + +VYKA G A+K +Q ED S E +++R+ H N+ ++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 1397 VSSCSNPGFK-----ALILQYMPQGSLEKWLYSHNYL-LNIEQRLDIMIDVACALEYLHQ 1450
+ C+ L+ +++ Q L +L L E D+M L++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE 1510
+ I+H DLKP N+L+ L DFG+A++ M T + T+ Y APE +
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVLLQ 181
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
+T D++S G + E + RRKP +F G
Sbjct: 182 STYATPVDMWSVGCIFAE-MFRRKP---LFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRN- 1392
F +G G + VYKA D G A+K L ++ A E +++R++ HRN
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 1393 --LAKIVSSCSNP-GFKA------LILQYMPQ---GSLEKWLYSHNYLLNIEQRLDIMID 1440
L +IV+ + FK L+ +YM G LE L + + M
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE----DHIKSFMKQ 124
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI 1500
+ L Y H+ + +H D+K SN+LL++ L DFG+A+L + +S T + T+
Sbjct: 125 LLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 1501 GYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRR 1533
Y PE G E + DV+S G ++ E T++
Sbjct: 182 WYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 47/221 (21%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQ------LDGAIKSFDAECEVLRRVRHRNLV 803
+G G+F S Y+A + G +A+K + +++ E ++ R+ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSH---------KYTLNIQQRLDIMIDVASAL 854
+++ + L +E+M GS+ L + YT + + L
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHL--SDFGISKLLDGEDSVT---QTMTLATF 909
YLH +IH D+K +N+L+ D T L +DFG + L + + Q L T
Sbjct: 117 SYLHENQ---IIHRDVKGANLLI-DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 910 GYMAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+MAPE YG +C DV+S G ++IE T K P
Sbjct: 173 AFMAPEVLRGEQYG-----RSC-DVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G G FG V KAT G A K + L+ + E ++L +V R +V
Sbjct: 1 LGKGGFGEVCACQVKAT---GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ + L++ M G L+ +Y+ + + + + LE+LH
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR-- 115
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
+++ DLKP NVLLDD +SD G++ L G + T GYMAPE +
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYD 172
Query: 924 TCGDVYSFGILMIETFTRKMP 944
D ++ G + E + P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDA---ECEVLRRVRHRNLVKIIS 807
IG GSFG +Y A + IK +L +K +A E +L +++H N+V +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLT-KMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 808 SCSNHGFKALILEYMPQGSLEKWL-YSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
S +G +++EY G L K + + Q L + ++ L+ H H ++
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK---HIHDRKIL 123
Query: 867 HCDLKPSNVLLDDD-TVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC 925
H D+K N+ L + VA L DFGI++ L+ + T + T Y++PE +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNRPYNNK 182
Query: 926 GDVYSFGILMIETFTRKMP 944
D++S G ++ E T K P
Sbjct: 183 TDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 29/232 (12%)
Query: 1372 DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNI 1431
D+ + F AE + + H N+ ++ + ++ +YM G+L+ +L H L
Sbjct: 47 DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA 106
Query: 1432 EQRLDIMIDVACALEYLHQ-GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490
Q + ++ +A ++YL + GY +H L VL++ D+V + F + D ++
Sbjct: 107 GQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFRRLQ-EDKSEA 161
Query: 1491 MKQTMTLATIG-YMAPEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKH 1548
+ TM+ + + APE S++ DV+SFGI+M E ++ +P DM
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--------- 212
Query: 1549 WVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ DVI A E+ + A + C + + L L C ++ ER
Sbjct: 213 --------SGQDVIKAV----EDGFRLPAPRNCPNLLHQLMLDCWQKERGER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-10
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGA---IKSFDAECEVLRRVRHRNLV 803
L+G G+FG V KAT G A+K+ ++ A + E VL+ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ + H ++EY G L L + + R ++ SALEYLH
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLHSRD-- 115
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPEYGSE 919
V++ D+K N++LD D ++DFG+ K + ++ T+ TF Y+APE +
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 920 GIVSTCGDVYSFGILMIETFTRKMP 944
D + G++M E ++P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 8/205 (3%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNV-AIKVFNLQ-LDGAIKSFDAECEVLRRVRHRNLV 803
F++ IG GSFG VYK V AIK+ +L+ + I+ E VL + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ S +I+EY+ GS L L I+ ++ L+YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSERK- 122
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
IH D+K +NVLL + L+DFG++ L + + + + T +MAPE +
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 924 TCGDVYSFGILMIETFTRKMPTDEM 948
D++S GI IE + P ++
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA-----ECEVMRRIRH 1390
F + +LG G F V A G A K L++ R K E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLH 1449
+ + + + L+L M G L+ +Y+ N E+ L ++ C LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS 1509
+ + ++ DLKP N+LLDD + D G+A + +S++ + T+GYMAPE +
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG--RVGTVGYMAPEVLN 174
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKP 1535
+ S D + G L+ E + + P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 16/207 (7%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKS-FDAECEVLRRVRHRN 801
D F + +GAG+ G V K P G+ +A K+ +L++ AI++ E +VL
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL--DIMIDVASALEYLHH 859
+V + + G ++ +E+M GSL++ L K I + + I I V L YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YG 917
H ++H D+KPSN+L++ L DFG+S L DS+ + + T YM+PE G
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQG 172
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMP 944
+ V + D++S G+ ++E + P
Sbjct: 173 THYTVQS--DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 5/152 (3%)
Query: 1381 ECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIE-QRLDIMI 1439
E V+ ++H N+ + S G +++ Y G L K + + +L E Q LD +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499
+ AL+++H I+H D+K N+ L D LGDFGIA++L+ + +T + T
Sbjct: 109 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGT 164
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
Y++PE + D+++ G ++ E T
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 752 IGAGSFGSVYKAT--LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVR---HRNLVK 804
IG G++G V+KA G VA+K +Q +G S E VLR + H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 805 IISSCS-----NHGFKALILEYMPQG---SLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+ C+ L+ E++ Q L+K T I+ D+M + L++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 125
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
LH V+H DLKP N+L+ L+DFG++++ + + T + T Y APE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEV 180
Query: 917 GSEGIVSTCGDVYSFGILMIETFTRK 942
+ +T D++S G + E F RK
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 58/290 (20%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIFSLQEDRAL---KSFDAECEVMRRIRHRNL 1393
+G G F V++A + T A+K+ L+E+ + F E +M H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWL--------------------YSHNYL-LNIE 1432
K++ C+ L+ +YM G L ++L N L L+
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 1433 QRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492
++L I VA + YL + +H DL N L+ ++MV + DFG+++ + D K
Sbjct: 131 EQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 1493 QTMT-LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWV 1550
+ I +M PE +T DV+++G+++ E + +P M EV + +
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-IYY-- 244
Query: 1551 EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
V D N+LS + C + +L C ++P +R
Sbjct: 245 ----------VRDGNVLSCPD--------NCPLELYNLMRLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 1359 GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418
G A+K+ L++ + + E +MR +H+N+ ++ S ++++++ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 1419 EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGD 1478
+ LN EQ + V AL YLH S +IH D+K ++LL D L D
Sbjct: 106 TDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSD 160
Query: 1479 FGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
FG + D K+ + T +MAPE S T D++S GI+++E + P
Sbjct: 161 FGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNA----AIKIFS----LQEDRALKSFDAECEVMRRI 1388
F +LGTG + V+ G ++ A+K+ +Q+ + + E +V+ I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 1389 RHRNLAKIVSSCSNPGFKA-LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI-DVACALE 1446
R + K LIL Y+ G L L EQ + I ++ ALE
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF--KEQEVQIYSGEIVLALE 119
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
+LH+ II+ D+K N+LLD + L DFG++K + + TI YMAP+
Sbjct: 120 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 1507 Y--GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
G +G + D +S G+LM E LT P
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 70/267 (26%), Positives = 109/267 (40%), Gaps = 41/267 (15%)
Query: 1346 GIFSSVYKA-TFADGTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHR-NLAKIVSSC 1400
G F SVY A + G AIK+ + + + AE +M +AK+ S
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI-DVACALEYLHQGYSTSIIHC 1459
+ + L+++Y+ G + + L E I +V +E LHQ IIH
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGL--PEDWAKQYIAEVVLGVEDLHQ---RGIIHR 121
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTS-GD 1518
D+KP N+L+D L DFG+++ G+++ K + T Y+APE G+ D
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRN--GLENKK---FVGTPDYLAPET-ILGVGDDKMSD 175
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA----- 1573
+S G ++ E L P F E PDAV D I + ++ EE
Sbjct: 176 WWSLGCVIFEFLFGYPP----FHAET----------PDAVFDNILSRRINWPEEVKEFCS 221
Query: 1574 ----DIAAKKKCMSSVMSLALKCSEEI 1596
D+ + CM L +EI
Sbjct: 222 PEAVDLINRLLCMDPAKRLGANGYQEI 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 751 LIGAGSFGSVY----KATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
L+G G+FG V KAT Y M + K + D + E VL+ RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTAL 60
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S H ++EY G L + S + + + ++ SAL YLH V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---V 116
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPEYGSEGI 921
++ DLK N++LD D ++DFG+ K + ++ T+ TF Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 922 VSTCGDVYSFGILMIETFTRKMP 944
D + G++M E ++P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 752 IGAGSFGSVYKATLPYGMNVA-IKVFNLQLDGAIK---SFDAECEVLRRVRHRNLVKIIS 807
IG G FG V GM+ A + V L+ F E + R + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTL------NIQQRLDIMIDVASALEYLHHGH 861
C L+LE+ P G L+ +L S++ + ++ QR+ +VAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPE----Y 916
IH DL N L D + D+G++ ED +T+ ++APE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 917 GSEGIV---STCGDVYSFGILMIETFT 940
G + + + +++S G+ M E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 9/190 (4%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG+G++G VYKA + G AIKV L+ E +++ +H N+V S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+ +E+ GSL+ +Y L+ Q + + L YLH +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDI 132
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS---EGIVSTCGD 927
K +N+LL D+ L+DFG+S + + ++ + T +MAPE + +G + D
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSF-IGTPYWMAPEVAAVERKGGYNQLCD 191
Query: 928 VYSFGILMIE 937
+++ GI IE
Sbjct: 192 IWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 40/232 (17%)
Query: 735 SYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMN------VAIKVFNLQLD-GAIKSF 787
++++L++L G G++ +VYK G N VA+K +L + G +
Sbjct: 1 NFKQLEKL----------GEGTYATVYK-----GRNRTTGEIVALKEIHLDAEEGTPSTA 45
Query: 788 DAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIM 847
E +++ ++H N+V++ L+ EYM + L+K++ +H ++ LD
Sbjct: 46 IREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTH----GVRGALDPN 100
Query: 848 IDVASALEYLHHG----HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
V S L G H V+H DLKP N+L++ L+DFG+++ G T +
Sbjct: 101 T-VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFS 158
Query: 904 MTLATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ T Y AP+ GS ST D++S G +M E T + +F G
Sbjct: 159 NEVVTLWYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITGR----PLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 39/283 (13%)
Query: 1342 LLGTGIFSSVYKATFA-DGTN----AAIKIFSLQED---RALKSFDAECEVMRRIRHRNL 1393
+LG+G F +VYK + DG N AIK+ L+E+ +A K E VM + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKV--LRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+++ C + L+ Q MP G L ++ + + + L+ + +A + YL +
Sbjct: 72 CRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGYMAPEYGSEG 1511
++H DL NVL+ + DFG+A+LLD +D + I +MA E
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMALESILHR 186
Query: 1512 IVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570
+ DV+S+G+ + E +T KP D + E+ PD L GE
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI----------PDL--------LEKGE 228
Query: 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
+ C V + +KC E R ++ + ++
Sbjct: 229 R---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-10
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNA--AIKIFSLQEDRALKSFDAECEVMRRIRHRNLA 1394
F+ +G G F VYKA TN AIK+ L+E + E ++ + I
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKRTNQVVAIKVIDLEEA----EDEIE-DIQQEI------ 50
Query: 1395 KIVSSCSNP-----------GFK-ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA 1442
+ +S C +P G K +I++Y GS L L+ I+ +V
Sbjct: 51 QFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVL 108
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGY 1502
LEYLH+ IH D+K +N+LL ++ L DFG++ L S + T T +
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFW 164
Query: 1503 MAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
MAPE + D++S GI +E P D+
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 8/205 (3%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNA-AIKIFSLQE-DRALKSFDAECEVMRRIRHRNLA 1394
F++ +G G F V+K AIKI L+E + ++ E V+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
K S +I++Y+ GS L + + + Q ++ ++ L+YLH S
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 120
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
IH D+K +NVLL + L DFG+A L + T + T +MAPE +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSAYD 179
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDM 1539
+ D++S GI +E P DM
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F VYKA + G AA K+ + + L+ + E +++ H N+ K++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL-DIMIDVAC-----ALEYLHQGYSTS 1455
+++++ G+++ +L +E+ L + I V C AL YLH+
Sbjct: 73 YENNLWILIEFCAGGAVDA------VMLELERPLTEPQIRVVCKQTLEALNYLHE---NK 123
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-------ATIGYMAPEY- 1507
IIH DLK N+L D L DFG+ S K T T+ T +MAPE
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 1508 ----GSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547
+ DV+S GI ++E P ++ V LK
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 752 IGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG GS G V AT+ G VA+K +L+ + E ++R +H N+V++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+++E++ G+L + +H +N +Q + + V AL LH VIH D+
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYS 930
K ++LL D LSDFG + E +++ + T +MAPE S D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISRLPYGPEVDIWS 201
Query: 931 FGILMIETFTRKMP 944
GI++IE + P
Sbjct: 202 LGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-10
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 47/225 (20%)
Query: 751 LIGAGSFGSVYKATLPYGMNV-AIKVFNLQLDGAIKSFDAEC-EVLRRV-----RHRNLV 803
++G GSFG V A L + A+KV L+ D ++ D EC +RV +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 804 KIISSC---SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQ--RLD------IMIDVAS 852
++ SC + F ++EY+ G L +IQ+ R D ++
Sbjct: 60 QL-HSCFQTKDRLF--FVMEYVNGGDL---------MFHIQRSGRFDEPRARFYAAEIVL 107
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK--LLDGEDSVTQTMTLATF 909
L++LH G +I+ DLK NVLLD + ++DFG+ K +L G VT + T
Sbjct: 108 GLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTP 160
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
Y+APE S D ++ G+L+ E + P DE+F
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-10
Identities = 68/281 (24%), Positives = 101/281 (35%), Gaps = 71/281 (25%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPYGMNV-AIKVFN---LQLDGAIKSFDAECEVLRRVRH 799
D F +IG G+FG V+ V A+KV + I AE ++L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASA 853
+VK+ S + L++EYMP G L L + + ++ A
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-------IRKDVFPEETARFYIAELVLA 113
Query: 854 LEYLHH-GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-------------------- 892
L+ +H G IH D+KP N+L+D D L+DFG+ K
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 893 ---LLDGEDSVTQTMTLA-----TFGYMAPE------YGSEGIVSTCGDVYSFGILMIET 938
+L Q A T Y+APE YG D +S G+++ E
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG------LECDWWSLGVILYEM 223
Query: 939 FTRKMPTDEMFTGETSLKKW-----VEESLRLAVTEVVDAE 974
P F +T + + +ESLR V E
Sbjct: 224 LYGFPP----FYSDTLQETYNKIINWKESLRFPPDPPVSPE 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 57/169 (33%), Positives = 76/169 (44%), Gaps = 10/169 (5%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFN---LQLDGAIKSFDAECEVL-RRVRHRNLVKII 806
IG GSFG V A G A+KV + K AE VL + V+H LV +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
S +L+Y+ G L L + + R ++ASAL YLH +I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNII 118
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
+ DLKP N+LLD L+DFG+ K E S T + T Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 57/172 (33%), Positives = 79/172 (45%), Gaps = 16/172 (9%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFD-----AECEVM-RRIRHRNLAK 1395
+G G F V A ADG A+K+ LQ+ LK + AE V+ + ++H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ S +L Y+ G L L R ++A AL YLH S +
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPE 1506
II+ DLKP N+LLD L DFG+ K +G++ K T T T Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 752 IGAGSFGSVYKATLPYGMNVA-IKVFNLQLDGAIKS---FDAECEVLRRVRHRNLVKIIS 807
IG G FG V + G A + V L++ +++ F E + R ++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIM----IDVASALEYLHHGHPT 863
C+ L++E+ P G L+ +L S + + + ++A L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPE-----YG 917
IH DL N LL D + D+G+S ED VT ++APE +G
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 918 SEGIV--STCGDVYSFGILMIETF 939
+ +V + +V+S G+ + E F
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 1343 LGTGIFSSVYKATFADGTNA---AIKIFSLQ-EDRALK-SFDAECEVMRRIRHRNLAKIV 1397
LG+G F +V K + + A+KI D ALK E VM+++ + + +++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
C + L+++ G L K+L N + + +++ V+ ++YL + T+ +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEE---TNFV 117
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT--IGYMAPEYGSEGIVST 1515
H DL NVLL A + DFG++K L ++ + T + + APE + S+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 1516 SGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
DV+SFG+LM E + +KP M EV
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 751 LIGAGSFGSVYKATLPYGMNV-AIKVFNLQLDGAIKSFDAECEVL-RRV-----RHRNLV 803
++G GSFG V A L V AIKV L+ D ++ D +C + +R+ +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQ--RLD------IMIDVASALE 855
+ ++EY+ G L IQ+ + D +V AL
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDL---------MFQIQRSRKFDEPRSRFYAAEVTLALM 110
Query: 856 YLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
+LH HG VI+ DLK N+LLD + L+DFG+ K T T T Y+AP
Sbjct: 111 FLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAP 165
Query: 915 EYGSEGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
E E D ++ G+LM E + P D++F
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 751 LIGAGSFGSVYKAT-LPYGMN----VAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVK 804
++G+G+FG+VYK +P G N VAIKV A K E V+ V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
++ C + L+ + MP G L ++ +K + Q L+ + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VR 129
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG-----YMAPEYGSE 919
++H DL NVL+ ++DFG+++LLD + +T A G +MA E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLD----IDETEYHADGGKVPIKWMALESILH 185
Query: 920 GIVSTCGDVYSFGILMIETFT 940
+ DV+S+G+ + E T
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 52/168 (30%), Positives = 75/168 (44%), Gaps = 10/168 (5%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVF-NLQLDGAIKSFDA-ECEVLRRVRHRNLVKIISS 808
IG GS+G V+K G VAIK F + D IK E +L++++H NLV +I
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIH 867
L+ EY L + L + + I+ A+ + H H IH
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN----CIH 123
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
D+KP N+L+ L DFG +++L G T +AT Y APE
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-10
Identities = 53/170 (31%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 1381 ECEVMRRIRHRNLAKIVSSCSNPG--FKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLD 1436
E +++R +H N+ I PG FK +++ M + L ++S L R
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY- 111
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT-M 1495
+ + L+Y+H S ++IH DLKPSN+L+++D +GDFG+A+ L + + M
Sbjct: 112 FLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 1496 T--LATIGYMAPEYG-SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTG 1542
T +AT Y APE S +T+ D++S G + E L RR+ +F G
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ----LFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 43/170 (25%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 783 AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY------ 836
A F E +++ R+++ N+++++ C + +I EYM G L ++L +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 837 -----TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891
+++I L + + +AS ++YL + +H DL N L+ + ++DFG+S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 892 K-LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+ L G+ Q + +MA E G +T DV++FG+ + E FT
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 7/152 (4%)
Query: 1408 LILQYMPQGSLEKWLYSHNYL-LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466
L++ M G L+ +Y+ L +E+ + + C + +LH S I++ D+KP NV
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126
Query: 1467 LLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILM 1526
LLDD L D G+A L ++ Q T GYMAPE E S D ++ G +
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYSYPVDWFAMGCSI 184
Query: 1527 METLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558
E + R P D +V + +L D V
Sbjct: 185 YEMVAGRTPFKD-HKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 752 IGAGSFGSVYKATL----PYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVKI 805
IG GSFG KA L G IK N+ + ++ E VL ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTL-NIQQRLDIMIDVASALEYLHHGHPTP 864
S +G ++++Y G L K + + + L Q LD + + AL+ H H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK---HVHDRK 121
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
++H D+K N+ L D L DFGI+++L+ + +T + T Y++PE +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPYNN 180
Query: 925 CGDVYSFGILMIETFTRK 942
D+++ G ++ E T K
Sbjct: 181 KSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467
IL M G L L H E R ++ LE++H + +++ DLKP+N+L
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANIL 129
Query: 1468 LDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILM 1526
LD+ + D G+A K ++ T GYMAPE +G +S D +S G ++
Sbjct: 130 LDEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCML 186
Query: 1527 METLTRRKPTDDMFTGEVCLKHWVEE-------SLPDAVTDVIDANLLSGEEEADIAAKK 1579
+ L P T + KH ++ LPD+ + + + LL G + D++ +
Sbjct: 187 FKLLRGHSPFRQHKTKD---KHEIDRMTLTVNVELPDSFSPELKS-LLEGLLQRDVSKRL 242
Query: 1580 KCM 1582
C+
Sbjct: 243 GCL 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 51/220 (23%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQ------EDRALKSFDAECEVMRRIRH 1390
+++ +LG G + +VY G A+K L ++ + E ++++ ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNI------EQRLDIMIDVACA 1444
N+ + + +C + ++ ++++P GS+ L L +Q LD
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------G 114
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD--GVDSMKQTMTLATIG- 1501
+ YLH ++H D+K +NV+L + + L DFG A+ L G+ M + G
Sbjct: 115 VAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 1502 --YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
+MAPE +E D++S G + E T + P M
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-10
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVKII- 806
+G+G++GSV A G VAIK + I + A E +L+ ++H N++ ++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 807 ---SSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
S+ S F+ L++ YM Q L+K + H + + Q L V L L + H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYM-QTDLQK-IMGHPLSEDKVQYL-----VYQMLCGLKYIH 134
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGI 921
+IH DLKP N+ +++D + DFG+++ D E T + T Y APE I
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV----I 186
Query: 922 VS-----TCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
++ D++S G +M EM TG+T K
Sbjct: 187 LNWMHYNQTVDIWSVGCIM----------AEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 36/96 (37%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA-KLLDGVDSMKQTMTLAT 1499
+ LE+LHQ II+ DLKP NVLLD+D + D G+A +L DG K T
Sbjct: 106 IISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GT 160
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
G+MAPE S D ++ G+ + E + R P
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-10
Identities = 60/219 (27%), Positives = 87/219 (39%), Gaps = 34/219 (15%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSL---QEDRALKSFDAECEVMRRIRHRN 1392
F++ +G G F +VY A AIK S Q + + E ++++RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 1393 LAKIVSSCSNPGFKA---------LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC 1443
+ +K L+++Y GS L H L + I
Sbjct: 77 TIE---------YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQ 126
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
L YLH S IH D+K N+LL + L DFG A L+ +S + T +M
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWM 178
Query: 1504 APEY---GSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
APE EG DV+S GI +E R+ P +M
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 69/306 (22%), Positives = 123/306 (40%), Gaps = 48/306 (15%)
Query: 1329 ELRLATNGFSESNLLGTGIFSSVYKA-----TFADGTNA-AIKIFSLQEDRALKS-FDAE 1381
E+ L+T F E LG F VYK + T A AIK + + L+ F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 1382 CEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHN--------------- 1426
+ R++H N+ ++ + ++I Y L ++L +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 1427 YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486
L + I+ +A +E+L S ++H DL NVL+ D + + D G+ + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 1487 GVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC 1545
D K +L I +M+PE G S D++S+G+++ E +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YG 223
Query: 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKD 1605
L+ + S D + + + +L ++ C + V +L L+C E P R KD
Sbjct: 224 LQPYCGYSNQDVIEMIRNRQVLPCPDD--------CPAWVYTLMLECWNEFPSRRPRFKD 275
Query: 1606 ALANLK 1611
+ L+
Sbjct: 276 IHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA-----ECEVMRRIRH 1390
F + +LG G F V A G A K L++ R K E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIM--IDVACALEYL 1448
R + + + L+L M G L+ +Y H E+ + ++ C LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 1449 HQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYG 1508
HQ I++ DLKP N+LLDD + D G+A + ++K + T+GYMAPE
Sbjct: 119 HQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVV 173
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ S D ++ G L+ E + + P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-10
Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 43/246 (17%)
Query: 1304 RKRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAA 1363
+K+D E N ++ Y++ F+ LGTG F V AT+ +
Sbjct: 11 KKKDSDSTKEPKRKN-----KMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPP 58
Query: 1364 IKIFSLQEDRALKSFD-----AECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418
+ I ++ + +K +E +++ I H + S + + L+L+++ G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 1419 EKWLYSHNYLLNIEQRLDIMIDVAC--------ALEYLHQGYSTSIIHCDLKPSNVLLDD 1470
+L + N DV C EYL S +I++ DLKP N+LLD
Sbjct: 119 FTFLRRNKRFPN---------DVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDK 166
Query: 1471 DMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEGIVSTSGDVYSFGILMMET 1529
D + DFG AK++D +T TL T Y+APE + D ++ GI + E
Sbjct: 167 DGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 1530 LTRRKP 1535
L P
Sbjct: 222 LVGCPP 227
|
Length = 340 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRAL-KSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G SV K GT A K+ + ++ K E ++M R + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
N + +++M GSL++ +Y + +E I + V L YL+ I+H D
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLY--NVHRIMHRD 129
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
+KPSN+L++ L DFG++ L ++S+ T + T YM+PE G + DV+
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGEL--INSIADTF-VGTSTYMSPERIQGGKYTVKSDVW 186
Query: 1521 SFGILMMETLTRRKPTDD 1538
S GI ++E + P
Sbjct: 187 SLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 7/194 (3%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G +V+ A A G AIK +LQ+ + E VM+ +++ N+ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
++++Y+ GSL + ++ Q + + ALE+LH + +IH D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYS 1521
K NVLL D L DFG + S + TM + T +MAPE + D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 1522 FGILMMETLTRRKP 1535
GI+ +E + P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G +VY A A G AIK +LQ+ + E VMR ++ N+ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
++++Y+ GSL + ++ Q + + AL++LH S +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYS 1521
K N+LL D L DFG + S + TM + T +MAPE + D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 1522 FGILMMETLTRRKP 1535
GI+ +E + P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 1359 GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418
G A+K L++ + + E +MR H N+ + +S ++++++ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 1419 EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGD 1478
+ +H + N EQ + + V AL YLH + +IH D+K ++LL D L D
Sbjct: 107 TD-IVTHTRM-NEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161
Query: 1479 FGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
FG + + K+ + T +MAPE S T D++S GI+++E + P
Sbjct: 162 FGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 82/331 (24%), Positives = 125/331 (37%), Gaps = 85/331 (25%)
Query: 741 RLTDGFSESNLIGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAIKSFD---AECEV 793
+L+D F +G GSFG V +K T Y AIK + +K E +
Sbjct: 16 KLSD-FEMGETLGTGSFGRVRIAKHKGTGEY---YAIKCLKKREILKMKQVQHVAQEKSI 71
Query: 794 LRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS- 852
L + H +V ++ S + +LE++ G L L N DVA
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN---------DVAKF 122
Query: 853 -------ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT-QTM 904
A EYLH +I+ DLKP N+LLD+ ++DFG +K V +T
Sbjct: 123 YHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTF 173
Query: 905 TL-ATFGYMAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP---------TDEMF 949
TL T Y+APE ++ + G D ++ G+L+ E P +++
Sbjct: 174 TLCGTPEYLAPE-----VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
Query: 950 TGETSLKKWVEESLRLAVTEVVDAELLSSEEEEGADLGDSNKLKRLSISVNKITGTIPRT 1009
G W + R V LL ++ KRL GT+
Sbjct: 229 AGRLKFPNWFDGRARDLVK-----GLLQTDHT-----------KRL--------GTLKGG 264
Query: 1010 VGNLTELRELHLHGNNLEAYLYNNKFTGRIP 1040
V ++ + HG N + LY + IP
Sbjct: 265 VADVK--NHPYFHGANWDK-LYARYYPAPIP 292
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-09
Identities = 65/239 (27%), Positives = 107/239 (44%), Gaps = 33/239 (13%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G G +G V+ K T G VA+K L ++ E ++L + LVK
Sbjct: 9 VGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH-GHPT 863
++ + + + L +EY+P G L ++ L+ M ++ A++ LH G+
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGY-- 122
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGSEGI 921
IH DLKP N L+D L+DFG+SK G + ++ + YMAPE G +G
Sbjct: 123 --IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPD-YMAPEVLRG-KGY 175
Query: 922 VSTCGDVYSFGILMIETFTRKMP-----TDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
T D +S G ++ E P +E + +LK W +E+L+ V + L
Sbjct: 176 DFTV-DYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYW-KETLQRPVYDDPRFNL 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDA-ECEVMRRIRHRNLAKIVSSC 1400
LG G +++VYK G A+K L + S E +M+ ++H N+ ++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYL--LNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
L+ +YM + L+K++ +H L+ + + + H+ ++H
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLH 123
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTS 1516
DLKP N+L++ L DFG+A+ G+ + + T+ Y AP+ GS STS
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVVTLWYRAPDVLLGSR-TYSTS 181
Query: 1517 GDVYSFGILMMETLTRRKPTDDMFTG 1542
D++S G +M E +T R +F G
Sbjct: 182 IDIWSVGCIMAEMITGRP----LFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-09
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAEC-EVMRRI-----RHRNLAK 1395
+LG G F V A GT+ + L++D L+ D EC +R+ +H L +
Sbjct: 2 VLGKGSFGKVLLAEL-KGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQ--RLD------IMIDVACALEY 1447
+ S +++Y+ G L + +I++ R D ++ L++
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDL---------MFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK--LLDGVDSMKQTMTL-ATIGYMA 1504
LH+ II+ DLK NVLLD + + DFG+ K +L GV T T T Y+A
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIA 164
Query: 1505 PEYGSEGIVSTSGDVYSFGILMMETLTRRKP-----TDDMF 1540
PE S + D ++ G+L+ E L + P D++F
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA---------ECEVLRRVRHRN 801
IG+G++G V A G VAIK +FD E ++LR +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIP-------HAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 802 LV---KIISSCSNHGFKA-LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYL 857
++ I+ ++++ M + L ++S L + + + L+Y+
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYI 123
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MT--LATFGYMAP 914
H + VIH DLKPSN+L+++D + DFG+++ L + + MT +AT Y AP
Sbjct: 124 HSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 915 EYG-SEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSL 955
E S +T D++S G + E R+ ++F G+ +
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPGKNYV 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 735 SYQELQRLTDGFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFNLQLD-GAIKSFDAECE 792
SY++L++L G GS+ +VYK G VA+KV LQ + G + E
Sbjct: 6 SYEKLEKL----------GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55
Query: 793 VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS 852
+L+ ++H N+V + L+ EY+ L +++ H L+ + + +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
L Y+H + ++H DLKP N+L+ D L+DFG+++ S T + + T Y
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYR 170
Query: 913 APE--YGSEGIVSTCGDVYSFGILMIE 937
P+ GS STC D++ G + +E
Sbjct: 171 PPDVLLGSTE-YSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 1e-09
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIK----IF-SLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
+G G FS V KA + G AIK F SL++ L E + +RR+ I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSPH--PNI 60
Query: 1397 VSSC-----SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
+ G AL+ + M +L + + L ++ M + +L+++H+
Sbjct: 61 LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR- 118
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGYMAPE-YG 1508
I H D+KP N+L+ DD++ L DFG + G+ S K T ++T Y APE
Sbjct: 119 --NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYS-KPPYTEYISTRWYRAPECLL 171
Query: 1509 SEGIVSTSGDVYSFGILMMETLT 1531
++G D+++ G + E L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 71/251 (28%), Positives = 106/251 (42%), Gaps = 42/251 (16%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNL-QLDGAIKSFDA-ECEVLRRVRHRNLVKIISS 808
IG G++G VYKA +A+K L Q D + S E +L+ ++H N+V++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL--DIMIDVASALEYLHHGHPTPVI 866
+ L+ EY+ L+K + S RL + + + Y H V+
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VL 124
Query: 867 HCDLKPSNVLLDDDTVA-HLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGSEGIVS 923
H DLKP N+L+D T A L+DFG+++ G T T + T Y APE GS S
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAPEILLGSRH-YS 182
Query: 924 TCGDVYSFGILMIETFTRK--------------------MPTDEMFTGETSL-------K 956
T D++S G + E +K P +E + G TSL
Sbjct: 183 TPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP 242
Query: 957 KWVEESLRLAV 967
KW + L V
Sbjct: 243 KWPPKDLATVV 253
|
Length = 294 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+LG G F V A G + +L++D L D EC ++ + R LA +
Sbjct: 2 VLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEK---RVLA---LAWE 54
Query: 1402 NPGFKALILQYMPQGSL---EKWLYSHNYLLNIEQ--RLDIM------IDVACALEYLHQ 1450
NP L + + L ++L + + +I+ R D+ ++ C L++LH
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH- 113
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE 1510
S II+ DLK NV+LD D + DFG+ K + + + T Y+APE
Sbjct: 114 --SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKP-----TDDMF 1540
+ S D +SFG+L+ E L + P D++F
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 41/236 (17%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVM-RRI-----RHRNLA 1394
+LG G F V A G A+K+ L++D L+ D EC + +RI H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQ--RLD------IMIDVACALE 1446
++ P +++++ G L + +I++ R D ++ AL
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL---------MFHIQKSRRFDEARARFYAAEITSALM 110
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAP 1505
+LH II+ DLK NVLLD + L DFG+ K +G+ + K T T T Y+AP
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAP 165
Query: 1506 EYGSEGIVSTSGDVYSFGILMMETLTRRKP-----TDDMFTG----EVCLKHWVEE 1552
E E + S D ++ G+L+ E L P DD+F EV W+ +
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 781 DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSH------ 834
D A + F E ++L R+ N+ +++ C+ +I+EYM G L ++L H
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 835 ----KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGI 890
+L+ L + +AS + YL + +H DL N L+ + ++DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 891 SKLLDGED-SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT--RKMPTDE 947
S+ L D Q +MA E G +T DV++FG+ + E T R+ P +
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 948 M 948
+
Sbjct: 237 L 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 1337 FSESNLLGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRNL 1393
F + +G G + VYKA G A+K L + A E +++ + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ--- 1450
K++ L+ +++ Q L+K++ + + I + YL Q
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA----SPLSG-----IPLPLIKSYLFQLLQ 111
Query: 1451 ----GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
+S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPE 170
Query: 1507 --YGSEGIVSTSGDVYSFGILMMETLTRR 1533
G + ST+ D++S G + E +TRR
Sbjct: 171 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNA-AIKIFSLQE-DRALKSFDAECEVMRRIRHRNLA 1394
F++ +G G F V+K AIKI L+E + ++ E V+ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
K S +I++Y+ GS L L+ Q I+ ++ L+YLH S
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
IH D+K +NVLL + L DFG+A L +K+ + T +MAPE +
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 1515 TSGDVYSFGILMMETLTRRKP 1535
+ D++S GI +E L + +P
Sbjct: 180 SKADIWSLGITAIE-LAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-09
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 31/205 (15%)
Query: 435 LPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNL 494
+P +G L +L+ ++ +P+ NL N+ L L N L+ +P + L NL
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNL 188
Query: 495 QGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS 554
LDLS N I +P E+ L +L L L N ++ + L+NL +L L LS+N+L
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNN-SIIELLSSLSNLKNLSGLELSNNKLE- 245
Query: 555 TIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDL 614
LP+ IGNL L L LS NQ+ S SS+G L +L
Sbjct: 246 ------------------------DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNL 279
Query: 615 TYLALARNGFQGSIPEAIGSLISLE 639
L L+ N ++P L+ LE
Sbjct: 280 RELDLSGNSLSNALPLIALLLLLLE 304
|
Length = 394 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 21/213 (9%)
Query: 746 FSESNLIGAGSFGSVY--------KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV 797
F ++G G++G V+ + Y M V K +Q + E +VL +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 798 RHRN-LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL---DIMIDVASA 853
R LV + + LIL+Y+ G L ++H L+ ++R ++ I
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTH---LSQRERFKEQEVQIYSGEI 114
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
+ L H H +I+ D+K N+LLD + L+DFG+SK ++ T YMA
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 914 PEY--GSEGIVSTCGDVYSFGILMIETFTRKMP 944
P+ G +G D +S G+LM E T P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 29/255 (11%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVF---NLQLDGAIKSFDAECEVLRRVRHR-NLV 803
I G+FGSVY ++T Y AIKV ++ + + AE ++ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDY---FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
K+ S + + L++EY+ G + + L + +V +E LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG-- 117
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
+IH D+KP N+L+D L+DFG+S+ G ++ + T Y+APE G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLEN---KKFVGTPDYLAPET-ILGVGD 170
Query: 924 T-CGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE-ESLRLAVTEVVDAELLSSEEE 981
D +S G ++ E P F ET + S R+ E V E S E
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP----FHAETPDAVFDNILSRRINWPEEVK-EFCSPEAV 225
Query: 982 EGAD-LGDSNKLKRL 995
+ + L + KRL
Sbjct: 226 DLINRLLCMDPAKRL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-09
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 751 LIGAGSFGSVY----KAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
L+G G+FG V KAT Y M + K + D + E VL+ RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFLTAL 60
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S H ++EY G L L + + R ++ SAL+YLH V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS--EKNV 117
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDG-EDSVTQTMTLATFGYMAPEYGSEGIVST 924
++ DLK N++LD D ++DFG+ K +G +D T T Y+APE +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 925 CGDVYSFGILMIETFTRKMP 944
D + G++M E ++P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVKIISS 808
+G GS+ +VYK + G VA+KV +++ + + F A E +L+ ++H N+V +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
+ EYM L +++ H L+ M + L Y+H H ++H
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHR 127
Query: 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGSEGIVSTCG 926
DLKP N+L+ L+DFG+++ S T + + T Y P+ G+ S+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATD-YSSAL 185
Query: 927 DVYSFGILMIETF 939
D++ G + IE
Sbjct: 186 DIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNA-AIKIFSLQE-DRALKSFDAECEVMRRIRHRNLA 1394
F++ +G G F VYK AIKI L+E + ++ E V+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 1395 KIVSSCSNPGFKALILQYMPQGS----LEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
+ S +I++Y+ GS L+ Y+ I + ++ L+YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATI------LREILKGLDYLH- 118
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE 1510
S IH D+K +NVLL + L DFG+A L +K+ + T +MAPE +
Sbjct: 119 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIKQ 175
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
D++S GI +E P D+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 9/201 (4%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G+G + VYKA G AAIK+ L+ E +M+ +H N+ S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
+ +++ GSL+ +Y L+ Q + + L YLH S +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS---EGIVSTSGD 1518
K +N+LL D+ L DFG++ + + +++ + T +MAPE + +G + D
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSF-IGTPYWMAPEVAAVERKGGYNQLCD 191
Query: 1519 VYSFGILMMETLTRRKPTDDM 1539
+++ GI +E + P D+
Sbjct: 192 IWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 16/186 (8%)
Query: 1372 DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH------ 1425
D A + F E +++ R+ N+A+++ C+ +I++YM G L ++L H
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 1426 --NYLLNIEQR--LDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGI 1481
++ L + +A + YL S + +H DL N L+ + + DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 1482 AKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT--RRKPTDD 1538
++ L D + Q I +MA E G +T DV++FG+ + E LT R +P +
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 1539 MFTGEV 1544
+ +V
Sbjct: 237 LTDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-09
Identities = 75/323 (23%), Positives = 132/323 (40%), Gaps = 44/323 (13%)
Query: 1340 SNLLGTGIFSSV-YKATFADGTNAAIKIFSLQ------EDRALKSFDA--ECEVMRRIR- 1389
S +LG+G +V +DG A+K+ ++ ++RA C+ ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 1390 HRNLAKIVSSCSNP---GFKALILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVAC 1443
H + AK NP AL+L Y G L + + S N + + I V
Sbjct: 97 HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV--DSMKQTMTLATIG 1501
A+ ++H S +IH D+K +N+LL + + LGDFG +K+ D + +T T
Sbjct: 155 AVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPY 210
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESLPDAVT 1559
Y+APE S D++S G+L+ E LT ++P D EV K + LP +++
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270
Query: 1560 ---DVIDANLLSGEEEADIAAKK-------KCMSSVM--------SLALKCSEEIPEERM 1601
I LLS + + ++ K K S + + + I +
Sbjct: 271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQ 330
Query: 1602 NVKDALANLKKIKTKFLKDVQQA 1624
K L ++ + +++
Sbjct: 331 QTKQLLQVERRRIVRQMEESLST 353
|
Length = 496 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G +VY A A G AI+ +LQ+ + E VMR ++ N+ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
++++Y+ GSL + ++ Q + + ALE+LH S +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYS 1521
K N+LL D L DFG + S + TM + T +MAPE + D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 1522 FGILMMETLTRRKP 1535
GI+ +E + P
Sbjct: 202 LGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 15/221 (6%)
Query: 744 DGFSESNLIGAGSFGSVY----KATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR 798
F +L+G G FG V KAT Y M V +K L + F+ E ++L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
+ ++ + + L++EY P G L L ++Y + + +A + +H
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDM-AQFYLAELVLAIH 116
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY-- 916
H +H D+KP NVL+D L+DFG + L V + + T Y+APE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 917 ----GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+G D +S G++ E + P E + +T
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 12/193 (6%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRNLAKIVSS 1399
LG G +++VYK + +G A+K+ LQE+ F A E +++ ++H N+ +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
L+ +Y+ L +++ H L+ E + + L Y+HQ Y I+H
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHR 127
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTSG 1517
DLKP N+L+ D L DFG+A+ V S + + T+ Y P+ GS ST
Sbjct: 128 DLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTE-YSTCL 185
Query: 1518 DVYSFGILMMETL 1530
D++ G + +E +
Sbjct: 186 DMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-09
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 1343 LGTGIFSSVYKATFA---DGTNAAIK----IFS--LQEDRALKSFDAECEVMRRIR-HRN 1392
LG G + V A A + AIK +FS + RAL+ E +++R R H+N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 1393 LAKIVS-SCSNPG-FKALILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVACA 1444
+ + PG F L L Y E + ++ Q L + + C
Sbjct: 64 ITCLYDMDIVFPGNFNELYL-YE-----ELMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD---GVDSMKQTMTLATIG 1501
L+Y+H S +++H DLKP N+L++ D + DFG+A+ G ++ T +AT
Sbjct: 118 LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 1502 YMAPEYG-SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y APE S + + DV+S G ++ E L RKP +F G+
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLG-RKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 1343 LGTGIFSSVYKATFAD------GTNAAIKIFSLQEDRALKS---FDAECEVMRRIRHRNL 1393
LG G F VY+ D T A+K ++ E +L+ F E VM+ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVK--TVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYS---------HNYLLNIEQRLDIMIDVACA 1444
+++ S ++++ M G L+ +L S +++ + + ++A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYM 1503
+ YL+ + +H DL N ++ D +GDFG+ + + D K L + +M
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLT 1531
APE +G+ +TS D++SFG+++ E +
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFD-----AECEVM-RRIRHRNLA 1394
++G G F V A +DG+ A+K+ LQ+ LK + AE V+ + ++H L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
+ S +L Y+ G L L L R +VA A+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEGIV 1513
+II+ DLKP N+LLD L DFG+ K +GV+ + T T T Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 1514 STSGDVYSFGILMMETL 1530
+ D + G ++ E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 12/186 (6%)
Query: 1345 TGIFSSVYKATFADGTNAAIKIFSL--QEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402
TGI + G A+K L Q+ R L F+ E +MR +H N+ ++ SS
Sbjct: 32 TGIVCIATDKST--GRQVAVKKMDLRKQQRREL-LFN-EVVIMRDYQHPNIVEMYSSYLV 87
Query: 1403 PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLK 1462
++++++ G+L + +H + N EQ + + V AL +LH + +IH D+K
Sbjct: 88 GDELWVVMEFLEGGALTD-IVTHTRM-NEEQIATVCLAVLKALSFLH---AQGVIHRDIK 142
Query: 1463 PSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSF 1522
++LL D L DFG + + ++ + T +MAPE S T D++S
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201
Query: 1523 GILMME 1528
GI+++E
Sbjct: 202 GIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-09
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 11/231 (4%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTE 163
++P + NL L +L++S N LP L + L +DLS N+IS L+
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS--DLPPEIELLSA 210
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223
LE D+S+N I +L SSL + L L +S N+L +P++IGNL+ L L L+ N Q
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN--Q 266
Query: 224 GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCT 283
++ ++++LR + L+ NSL +LP+ L LNL + ++ +
Sbjct: 267 ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL----KALELKLNS 322
Query: 284 LLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334
+L + N T + ++ N ++ N +
Sbjct: 323 ILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAI 373
|
Length = 394 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-09
Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 771 VAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEK 829
VA+K+ + A F E +++ R++ N++++++ C +I EYM G L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 830 WLYSHKY----------TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD 879
+L H+ T++ + + +AS ++YL + +H DL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165
Query: 880 DTVAHLSDFGISK-LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIET 938
+ ++DFG+S+ L G+ Q + +M+ E G +T DV++FG+ + E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 939 FT--RKMP----TDEMF---TGE 952
T ++ P +DE TGE
Sbjct: 226 LTLCKEQPYSQLSDEQVIENTGE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 7e-09
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDA-------ECEVMRRIR 1389
F + N +G G + VY+A D T+ +I +L++ R D E ++ +R
Sbjct: 9 FEKLNRIGEGTYGIVYRAR--DTTSG--EIVALKKVRMDNERDGIPISSLREITLLLNLR 64
Query: 1390 HRNLAK----IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACAL 1445
H N+ + +V + F L+++Y Q L L + + Q +M+ + L
Sbjct: 65 HPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAP 1505
+YLH+ + IIH DLK SN+LL D + DFG+A+ G+ + T + T+ Y AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTLWYRAP 177
Query: 1506 E--YGSEGIVSTSGDVYSFGILMMETLT 1531
E G +T+ D+++ G ++ E L
Sbjct: 178 ELLLGCT-TYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-09
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRAL--KSFDAECEVMRRIRHRNLAKIVS 1398
L+G G + V K + G AIK F ED + K E +++++RH NL ++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 1399 SCSNPGFKALILQYMPQ---GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
L+ +++ LEK Y + + ++ + + +E+ H S +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEK--YPNGLDESRVRK--YLFQILRGIEFCH---SHN 120
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-------YG 1508
IIH D+KP N+L+ V L DFG A+ L + T +AT Y APE YG
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRAPELLVGDTKYG 179
Query: 1509 SEGIVSTSGDVYSFGILMMETLT 1531
+ D+++ G L+ E LT
Sbjct: 180 R------AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 751 LIGAGSFGSVYKA--TLPYGMNVAIKVFNL----------QLDGAIKSFDAECEVLR-RV 797
+G+G+FG VYK +A+K N+ + D +I +E +++ ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 798 RHRNLVKIISS-CSNHGFKAL--ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
RH N+V+ + N + ++E P G L K ++ +I + + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
YLH ++H DL P+N++L +D ++DFG++K E +T + T Y P
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILYSCP 182
Query: 915 E------YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
E YG + DV++FG ++ + T + P
Sbjct: 183 EIVKNEPYGEK------ADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 57/230 (24%)
Query: 751 LIGAGSFGSVYKATLPYGMNV-AIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
++G GSFG V A L + A+KV L+ D ++ D EC + + +I+S
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEK-------RILSLA 52
Query: 810 SNHGFKA-------------LILEYMPQGSLEKWLYSHKYTLNIQQ--RLD------IMI 848
NH F ++E++ G L +IQ+ R D
Sbjct: 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL---------MFHIQKSRRFDEARARFYAA 103
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLAT 908
++ SAL +LH +I+ DLK NVLLD + L+DFG+ K + + T +T
Sbjct: 104 EITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTST 155
Query: 909 F----GYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
F Y+APE E + D ++ G+L+ E P D++F
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 19/195 (9%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
+G+G++G VYKA L G A+K+ L+ E +++ +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
+ + +EY GSL+ +Y L+ Q + + L YLH +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT-----LATFGYMAPEYGS---EGIV 922
K +N+LL D+ L+DFG++ +T T+ + T +MAPE + G
Sbjct: 133 KGANILLTDNGDVKLADFGVAA------KITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 923 STCGDVYSFGILMIE 937
+ D+++ GI IE
Sbjct: 187 NQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-09
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 752 IGAGSFGSV----YKATLPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G G FG V K T G A K + L+ K E E+L +V +V
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY-------L 857
+ + + L++ M G L+ +Y N+ +R +++ + Y +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIY------NVGER---GLEMERVIHYSAQITCGI 108
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYG 917
H H +++ D+KP NVLLDD LSD G++ L ++TQ T GYMAPE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEIL 166
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMP 944
E S D ++ G + E + P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 54/230 (23%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 752 IGAGSFGSVYKATLPYGM-------NVAIKVFNLQLDGAIK-SFDAECEVLRRVRHRNLV 803
+G GSFG VY+ + G+ VAIK N + F E V++ ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLN---------IQQRLDIMIDVASAL 854
+++ S +I+E M +G L+ +L S + + +++ + + ++A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYMA 913
YL+ +H DL N ++ +D + DFG+++ + D + L +M+
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESL 963
PE +G+ +T DV+SFG+++ E T + + E L+ +E L
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 9e-09
Identities = 43/158 (27%), Positives = 66/158 (41%), Gaps = 46/158 (29%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ-GYSTSIIHCDLKPSNV 1466
L+++YMP G L L + R I ++ AL+ +H+ G+ IH D+KP N+
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF----IHRDIKPDNI 132
Query: 1467 LLDDDMVAHLGDFGIAK-----------LLDGVDSMKQTMTLA--------------TIG 1501
L+D D L DFG+ K L D + + + L T+G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192
Query: 1502 ---YMAPE------YGSEGIVSTSGDVYSFGILMMETL 1530
Y+APE YG D +S G+++ E L
Sbjct: 193 TPDYIAPEVLRGTPYG------LECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDA---ECEVLRRVRHRNLVK 804
+G G FG V +AT G A K N + K ++ E +L +V R +V
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQ----QRLDIMIDVASALEYLHHG 860
+ + L++ M G L H Y ++ + A + L H
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLR----YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS-KLLDGEDSVTQTMTLA-TFGYMAPEY-- 916
H +I+ DLKP NVLLD+D +SD G++ +L DG+ ++T A T G+MAPE
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAPELLQ 170
Query: 917 GSEGIVSTCGDVYSFGILMIETFTRKMP 944
G E S D ++ G+ + E + P
Sbjct: 171 GEEYDFSV--DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-09
Identities = 71/245 (28%), Positives = 104/245 (42%), Gaps = 34/245 (13%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDAECE 792
+ + L TD + IG G++G VYK T G A+K+ + D + +AE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYN 70
Query: 793 VLRRV-RHRNLVKII------SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD 845
+L+ + H N+VK G L+LE GS+ + + K L QRLD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVG-GQLWLVLELCNGGSVTELV---KGLLICGQRLD 126
Query: 846 ---IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902
I + AL L H H +IH D+K +N+LL + L DFG+S L + +
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRR 185
Query: 903 TMTLATFGYMAPEYGSEGIVSTCG-----------DVYSFGILMIETFTRKMPTDEMFTG 951
++ T +MAPE V C DV+S GI IE P +M
Sbjct: 186 NTSVGTPFWMAPE------VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239
Query: 952 ETSLK 956
+T K
Sbjct: 240 KTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-09
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIK----VF-NLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
IG G+FG V+ T P G VA+K VF NL + K E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV---SCKRVFRELKMLCFFKHDNVLSA 64
Query: 806 IS-------SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVAS 852
+ + ++ E M Q L K + S Q L + +
Sbjct: 65 LDILQPPHIDPFEEIY--VVTELM-QSDLHKIIVS-------PQPLSSDHVKVFLYQILR 114
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
L+YLH ++H D+KP N+L++ + V + DFG++++ + ++S T + T Y
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 913 APE--YGSEGIVSTCGDVYSFGILMIETFTRKM 943
APE GS S D++S G + E R++
Sbjct: 172 APEILMGSRHYTSAV-DIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 1e-08
Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 25/129 (19%)
Query: 1425 HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484
N L ++ +R IM + AL+Y+H G ++IH DLKPSN+LL+ D L DFG+A+
Sbjct: 101 ANILEDVHKRY-IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156
Query: 1485 LD--GVDSMKQTMT--LATIGYMAPE-------YGSEGIVSTSGDVYSFGILMMETLTRR 1533
L + +T +AT Y APE Y ++G+ D++S G ++ E +
Sbjct: 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRY-TKGV-----DMWSVGCILGE-MLLG 209
Query: 1534 KPTDDMFTG 1542
KP +F G
Sbjct: 210 KP---LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 1337 FSESNLLGTGIFSSVYKA-TFADGTNAAIKIFSL---QEDRALKSFDAECEVMRRIRHRN 1392
FS+ +G G F +VY A + AIK S Q + + E ++++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ L+++Y GS L H L Q ++I AL+ L +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLH 132
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY---GS 1509
S ++IH D+K N+LL + + LGDFG A ++ + + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMD 187
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
EG DV+S GI +E R+ P +M
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 1342 LLGTGIFSSVYKA-TFADGTNAAIKIFS----LQEDRALKSFDAECEVMRRIRHRNLAKI 1396
LLG G F V A G A+KI + +D + E V++ RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSL 60
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
S +++Y+ G L L S + + ++ ++ AL+YLH G I
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV-DSMKQTMTLATIGYMAPEYGSEGIVST 1515
++ DLK N++LD D + DFG+ K +G+ D+ T Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 1516 SGDVYSFGILMMETLTRRKP 1535
+ D + G++M E + R P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-08
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 37/209 (17%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAEC----EV--MRRI-RHRNLA 1394
LG G F SVY A G AIK + + S++ EC EV +R++ H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNY-LLNIEQRLDIMIDVACALEYLH-QGY 1452
K+ + +YM +G+L + + + I+ + L ++H G+
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ-TMTLATIGYMAPE----- 1506
H DLKP N+L+ V + DFG+A+ + S T ++T Y APE
Sbjct: 121 ----FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 1507 --YGSEGIVSTSGDVYSFGILMMETLTRR 1533
Y S+ D+++ G +M E T R
Sbjct: 174 TSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 16/210 (7%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNA-AIKIFSL---QEDRALKSFDAECEVMRRIRHRN 1392
F++ +G G F +VY A AIK S Q + + E + ++RI+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ L+++Y GS L H L Q ++I AL+ L +
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAITHGALQGLAYLH 142
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY---GS 1509
S ++IH D+K N+LL + L DFG A + +S + T +MAPE
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVILAMD 197
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
EG DV+S GI +E R+ P +M
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 35/206 (16%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G +VYKA A+K+ L D E+ ++I +I+ C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL---------DITVELQKQIMSE--LEILYKCD 57
Query: 1402 NP---GFK---------ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLH 1449
+P GF ++ ++M GSL+ + ++L I + V L YL
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL- 111
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS 1509
+S I+H D+KPSN+L++ L DFG++ L V+S+ +T + T YMAPE S
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTY-VGTNAYMAPERIS 166
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKP 1535
DV+S GI ME R P
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-08
Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 1395 KIVSSCSNP---GFK---------ALILQYMPQGSLEKWLYSHNYLLNIEQRL-DIMIDV 1441
K++ C++P GF ++ +++M GSL++ L + E L I I V
Sbjct: 51 KVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PENILGKISIAV 108
Query: 1442 ACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG 1501
L YL + + I+H D+KPSN+L++ L DFG++ L +DSM + + T
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRS 163
Query: 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
YM+PE + D++S G+ ++E R P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 1374 ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWL----------Y 1423
A F E ++M R+++ N+ +++ C + +I +YM G L ++L +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 1424 SHNY-LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482
++N ++I L + + +A ++YL S + +H DL N L+ + + DFG++
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 1483 KLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMME--TLTRRKP 1535
+ L D + Q + I +MA E G +T+ DV++FG+ + E TL + +P
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 752 IGAGSFGSVYKATLPYG--MNVAIKVFNLQLDGAIKSFD---AECEVLRRVRHRNLVKII 806
+G GSFG V AT VAIK F K D +E ++L + H V +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL----EYLHHGHP 862
S + + L+LE++ G +L +K N D+ A+ + EYL +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-----DVGCFYAAQIVLIFEYLQSLN- 151
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL-ATFGYMAPEYGSEGI 921
+++ DLKP N+LLD D ++DFG +K++D T+T TL T Y+APE
Sbjct: 152 --IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAPEILLNVG 204
Query: 922 VSTCGDVYSFGILMIE 937
D ++ GI + E
Sbjct: 205 HGKAADWWTLGIFIYE 220
|
Length = 340 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-08
Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 3/133 (2%)
Query: 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNV 875
AL+L+Y G L + + S T + + + L +HH H +IH D+K +N+
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANI 174
Query: 876 LLDDDTVAHLSDFGISKLLDG--EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGI 933
LL + + L DFG SK+ D V +T T Y+APE S D++S G+
Sbjct: 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYYVAPEIWRRKPYSKKADMFSLGV 233
Query: 934 LMIETFTRKMPTD 946
L+ E T K P D
Sbjct: 234 LLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 19/224 (8%)
Query: 1330 LRLATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRI 1388
LR F L+G G + VYK G AAIK+ + D + E ++++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59
Query: 1389 -RHRNLAKIVSSC---SNPGFKA---LILQYMPQGSLEKWLY-SHNYLLNIEQRLDIMID 1440
HRN+A + + PG L++++ GS+ + + L E I +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI 1500
+ L +LHQ +IH D+K NVLL ++ L DFG++ LD + T + T
Sbjct: 120 ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTP 175
Query: 1501 GYMAPEY-----GSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
+MAPE + D++S GI +E P DM
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-08
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKA----TLPYGMNVAIKVFNLQLDGAIKSFDA----ECE 792
R D + + N I G++G VY+A T G VA+K L+++ + F E
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKT---GEIVALK--KLKMEKEKEGFPITSLREIN 56
Query: 793 VLRRVRHRNLVKI--ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDV 850
+L +++H N+V + + SN +++EY+ + L+ + + K + +M+ +
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EHDLKSLMETMKQPFLQSEVKCLMLQL 115
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL--AT 908
S + +LH ++H DLK SN+LL++ + + DFG+++ S + T T
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVVT 169
Query: 909 FGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRK 942
Y APE G ST D++S G + E T+K
Sbjct: 170 LWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQ-EDRALKSFDA-ECEVMRRIRHRNLAKIVSS 1399
+G G + VYK G A+K L+ E+ + S E +++ ++H N+ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ-------GY 1452
LI +++ L+K+L S L Q +D + YL+Q +
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDS----LPKGQYMDAEL----VKSYLYQILQGILFCH 118
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSE 1510
S ++H DLKP N+L+D+ V L DFG+A+ G+ T + T+ Y APE GS
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 1511 GIVSTSGDVYSFGILMMETLTRR 1533
ST D++S G + E T++
Sbjct: 178 -RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-08
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 1083 IEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLF 1142
I+ + L G +P+ I L +LQ + L GN++ G IP S+ + + + +L LS N F
Sbjct: 420 IDGLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 1143 SGLIPNTFGNCRQLQILDLSLNHLT 1167
+G IP + G L+IL+L+ N L+
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECE-VLRRV-----RHRNLVK 804
++G GSFG V+ A L G N + L+ D + D EC V +RV H L
Sbjct: 2 MLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYS-HKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ + ++EY+ G L + S HK+ L + ++ L++LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDL--PRATFYAAEIICGLQFLH---SK 115
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
+++ DLK N+LLD D ++DFG+ K D+ T T T Y+APE +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYN 174
Query: 924 TCGDVYSFGILMIETFTRKMP 944
T D +SFG+L+ E + P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 37/164 (22%), Positives = 74/164 (45%), Gaps = 28/164 (17%)
Query: 1385 MRRIRHRNLAKIVSSCS-NPGFKALILQYMPQGSLEKWLYSHNYL-------LNIEQRLD 1436
+ + H+N+ I+ C + ++ YM G+L+ +L L+ +Q +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK---------LLDG 1487
+ I +AC + YLH +IH D+ N ++D+++ + D +++ L D
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ + +MA E S++ DV+SFG+L+ E +T
Sbjct: 179 ENR--------PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSL-QEDRALKSFDA-ECEVMRRIRHRN---LAKI 1396
+G G + VYKA G A+K L ED + S E +++ + H N L +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL-DIMIDVACALEYLHQGYSTS 1455
V S + L+ +++ L+K++ S + + + + Y H S
Sbjct: 67 VHSENK---LYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHR 119
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIV 1513
++H DLKP N+L+D + L DFG+A+ GV T + T+ Y APE GS
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGSR-QY 177
Query: 1514 STSGDVYSFGILMMETLTRR 1533
ST D++S G + E + RR
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 29/204 (14%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS--LQEDRALKSFDAECEVMRRIRHRN----LA 1394
+G+G + SV A G AIK S Q + K E +++ ++H N L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 1395 KIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
S+ S F+ L++ YM Q L+K + L+ ++ ++ + C L+Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHP---LSEDKVQYLVYQMLCGLKYIH--- 134
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI 1512
S IIH DLKP N+ +++D + DFG+A+ D + T + T Y APE I
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEV----I 186
Query: 1513 VS-----TSGDVYSFGILMMETLT 1531
++ + D++S G +M E LT
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-08
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 33/205 (16%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFD-----AECEVLRRVR-HRNLVK 804
IG G+F V KA + G AIK + KS + E + LRR+ H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 805 IISSC--SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGH 861
+I G AL+ E M +L + + K L ++ M + +L+++H +G
Sbjct: 63 LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGI 921
+ H D+KP N+L+ DD + L+DFG + + + T+ ++T Y APE
Sbjct: 121 ---IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTE--YISTRWYRAPE-----C 169
Query: 922 VSTCG------DVYSFGILMIETFT 940
+ T G D+++ G + E +
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 9/201 (4%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G+G + VYKA G AA+KI L+ E +++ +H N+ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
+ + ++Y GSL+ +Y L+ Q + + L YLH S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS---EGIVSTSGD 1518
K +N+LL D+ L DFG+A + + +++ + T +MAPE + G + D
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSF-IGTPYWMAPEVAAVEKNGGYNQLCD 191
Query: 1519 VYSFGILMMETLTRRKPTDDM 1539
+++ GI +E + P D+
Sbjct: 192 IWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-08
Identities = 64/239 (26%), Positives = 99/239 (41%), Gaps = 46/239 (19%)
Query: 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFS--LQEDRALKSFDAECEV 1384
YQ L+ +G GI + Y A N AIK S Q K E +
Sbjct: 19 YQNLKPIGSG-------AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKW--------LYSHNYLLNIEQRLD 1436
M+ + H+N+ +++ + PQ SLE++ L N I+ LD
Sbjct: 70 MKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELD 117
Query: 1437 ------IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490
++ + C +++LH S IIH DLKPSN+++ D + DFG+A+ S
Sbjct: 118 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TS 172
Query: 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW 1549
T + T Y APE + D++S G +M E + R K +F G + W
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MVRHKI---LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-08
Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 25/111 (22%)
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGY 1502
L+Y+H S +++H DLKPSN+LL+ + + DFG+A+ MT + T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYVVTRWY 174
Query: 1503 MAPE-------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL 1546
APE Y T+ DV+S G + E L RKP +F G+ +
Sbjct: 175 RAPELLLNCSEYT------TAIDVWSVGCIFAELLG-RKP---LFPGKDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLV 803
F ++G G++G VYK + G AIKV ++ D + E +L++ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 804 K-----IISSCSNHGFKA-LILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEY 856
I S H + L++E+ GS+ + + K L I ++ L +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
LH VIH D+K NVLL ++ L DFG+S LD T + T +MAPE
Sbjct: 137 LHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEV 192
Query: 917 -----GSEGIVSTCGDVYSFGILMIE 937
+ D++S GI IE
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 752 IGAGSFGSVY-----KATLPYGMNV--AIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G GSFG+VY KA + V I V L + +++ + E ++L ++ H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNI---QQRLDIMIDVASALEYLHHGH 861
+S +I EY L+ L K+T Q + I + + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGI 921
++H DLK N+ L ++ + + DFG+S+LL G + T T T YM+PE
Sbjct: 127 ---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQG 181
Query: 922 VSTCGDVYSFGILMIE 937
+ D++S G ++ E
Sbjct: 182 YDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 35/227 (15%)
Query: 737 QELQRLTDGFSESNLIGAGSFGSV----YKATLP-YGMNVAIKVFNLQLDGAIKSFDAEC 791
++LQ + + +IG G+FG V +K++ Y M + K F + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSK-FEMIKRSDSAFFWEER 94
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL----------EKWLYSHKYTLNIQ 841
+++ +V++ + + + +++EYMP G L EKW + YT +
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW--AKFYTAEVV 152
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
LD + H +IH D+KP N+LLD L+DFG +D V
Sbjct: 153 LALDAI-------------HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199
Query: 902 QTMTLATFGYMAPEY----GSEGIVSTCGDVYSFGILMIETFTRKMP 944
+ T Y++PE G +G D +S G+ + E P
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 65/220 (29%), Positives = 93/220 (42%), Gaps = 37/220 (16%)
Query: 751 LIGAGSFGSVYKATLPYGMN--VAIKVFNLQLDGAIKSFDAECE-VLRRV-----RHRNL 802
++G GSFG V A L G N AIK L+ D ++ D EC V RRV H L
Sbjct: 2 VLGKGSFGKVMLAELK-GTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQ--RLDIM------IDVASAL 854
+ + ++EY+ G L +IQ R D ++ L
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDL---------MFHIQSSGRFDEARARFYAAEIICGL 109
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
++LH +I+ DLK NVLLD D ++DFG+ K + T T Y+AP
Sbjct: 110 QFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165
Query: 915 EYGSEGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
E + D +SFG+L+ E + P DE+F
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 4e-08
Identities = 58/241 (24%), Positives = 89/241 (36%), Gaps = 64/241 (26%)
Query: 1342 LLGTGIFSSVYKATFADGTNA--AIKI---FSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
LLG G V+ GT A+K+ + + +K E E++ + H L +
Sbjct: 8 LLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA--------CALEYL 1448
+S + L++ Y P G L LL + + +VA ALEYL
Sbjct: 67 YASFQTETYLCLVMDYCPGGEL-------FRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 1449 H-QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK--------------- 1492
H G I++ DLKP N+LL + L DF ++K D
Sbjct: 120 HLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 1493 -QTMTLATIG------------YMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRK 1534
+ T + Y+APE ++S G D ++ GIL+ E L
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 1535 P 1535
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-08
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMID 849
E ++L +V + +V + + L+L M G L+ +Y+ ++R +
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER--ALFY 107
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF 909
A L L H ++ DLKP N+LLDD +SD G++ + +S+ + T
Sbjct: 108 AAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG--RVGTV 165
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTE 969
GYMAPE + + D + G L+ EM G++ + E+ R E
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIY----------EMIEGQSPFRGRKEKVKR----E 211
Query: 970 VVDAELLSSEEEEGADLGDSNK 991
VD +L +EE A + K
Sbjct: 212 EVDRRVLETEEVYSAKFSEEAK 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 1343 LGTGIFSSVYKATFADGTNAA-IKIFSLQEDRALK---SFDAECEVMRRIRHRNLAKIVS 1398
+G G F V G + A + + L+ F E + R + H N+ + +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI----DVACALEYLHQGYST 1454
C L+L++ P G L+ +L S+ ++ + D++ +VA L +LHQ
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---A 119
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT-IGYMAPE----YGS 1509
IH DL N L D+ +GD+G+A D A + ++APE G
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 1510 EGIV---STSGDVYSFGILMMETLT 1531
+ + + +++S G+ M E T
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMA 1504
L+YLH S I+H D+KP N+L++ + V + DFG+A++ + +S T + T Y A
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 1505 PE--YGSEGIVSTSGDVYSFGILMMETLTRR 1533
PE GS +++ D++S G + E L RR
Sbjct: 173 PEILMGSRH-YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-08
Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467
++++YMP G L + NY + + +V AL+ +H S +IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNML 174
Query: 1468 LDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY----GSEGIVSTSGDVYSFG 1523
LD L DFG +D ++ + T Y++PE G +G D +S G
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 1524 ILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID-ANLLSGEEEADIAAKKK 1580
+ + E L P + +SL + ++D N L+ E+ +I+ K
Sbjct: 235 VFLFEMLVGDTP-------------FYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 40/237 (16%)
Query: 744 DGFSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHR 800
D + + IG G++G VYKA G VA+K L++D G + E +L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 801 N----LVKIISSCSNHGFKA---LILEYMPQGSLEKWLYSH------KYTLNIQQRLDIM 847
L+ + +G K L+ EY+ L+K++ S+ + M
Sbjct: 61 IYIVRLLDVEHVEEKNG-KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF--M 116
Query: 848 IDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSV---TQ 902
+ + + H HG V+H DLKP N+L+D + ++D G+ + S+ +
Sbjct: 117 YQLLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF----SIPVKSY 168
Query: 903 TMTLATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957
T + T Y APE GS ST D++S G + E +RK P +F G++ L++
Sbjct: 169 THEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQQ 220
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-08
Identities = 36/137 (26%), Positives = 56/137 (40%), Gaps = 7/137 (5%)
Query: 755 GSFGSVYKATLPYGMNVAIKVFNL--QLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNH 812
+ K P VA+K NL +K E R+++H N++ ++S
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 813 GFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLK 871
++ M GS E L +H L I+ DV +AL+Y+H IH +K
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVK 128
Query: 872 PSNVLLDDDTVAHLSDF 888
S++LL D LS
Sbjct: 129 ASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-08
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIK--VFNLQLDGA-IKSFDAECEVLRRVRHRNLVKII- 806
+G G+FG VYKA + G VA+K + + + DG I + E ++L++++H N+V +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74
Query: 807 ---SSCSNHGFKA----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
K ++ YM L L + L Q M+ + + YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE 133
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ----------TMTLATF 909
H ++H D+K +N+L+D+ + ++DFG+++ DG + T + T
Sbjct: 134 NH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 910 GYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRK 942
Y PE Y T D++ G + E FTR+
Sbjct: 191 WYRPPELLLGERRYT------TAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 19/233 (8%)
Query: 1321 ALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFD 1379
+L I LR F ++G G + VYK G AAIK+ + ED +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIK 60
Query: 1380 AECEVMRRI-RHRNLAKIVSSC---SNPGFKA---LILQYMPQGSLEKWLY-SHNYLLNI 1431
E ++++ HRN+A + S PG L++++ GS+ + + L
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 1432 EQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491
+ I ++ L +LH + +IH D+K NVLL ++ L DFG++ LD
Sbjct: 121 DWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 1492 KQTMTLATIGYMAPEY-----GSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
+ T + T +MAPE + D++S GI +E P DM
Sbjct: 178 RNTF-IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-08
Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 45/252 (17%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISS 808
+G+G++GSV A G+ VA+K + I K E +L+ ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 79
Query: 809 CSNHGFKALILEYMPQGSLEK----WLYSHKYTLNIQ-----QRLD------IMIDVASA 853
L+ + P SLE+ +L +H ++ Q+L ++ +
Sbjct: 80 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
L+Y+H +IH DLKPSN+ +++D + DFG+++ D E T +AT Y A
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRA 185
Query: 914 PEYGSEGI-VSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVD 972
PE + + D++S G +M E T + +F G + + ++ LRL T
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT----LFPGTDHIDQ-LKLILRLVGTP--G 238
Query: 973 AELLSSEEEEGA 984
AELL E A
Sbjct: 239 AELLKKISSESA 250
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466
+ IL M G L L H E R ++ LE++H + +++ DLKP+N+
Sbjct: 73 SFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF---VVYRDLKPANI 128
Query: 1467 LLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGIL 1525
LLD+ + D G+A K ++ T GYMAPE +G+ +S D +S G +
Sbjct: 129 LLDEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 185
Query: 1526 MMETLTRRKP 1535
+ + L P
Sbjct: 186 LFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G V AT + G A+K L++ + + E +MR +H N+ ++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
++++++ G+L + +H + N EQ + + V AL LH + +IH D+
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRM-NEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYS 1521
K ++LL D L DFG + ++++ + T +MAPE S D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISRLPYGPEVDIWS 201
Query: 1522 FGILMMETLTRRKP 1535
GI+++E + P
Sbjct: 202 LGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-08
Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 19/183 (10%)
Query: 1363 AIKIFSLQED---RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419
A+K+ L+ED A F E ++M R++ N+ ++++ C +I +YM G L
Sbjct: 50 AVKM--LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 1420 KWLYSHNYLLNIEQR----------LDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469
++L H E+ + + +A ++YL S + +H DL N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVG 164
Query: 1470 DDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMME 1528
+ + DFG+++ L D + Q + I +M+ E G +T+ DV++FG+ + E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 1529 TLT 1531
LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMN-VAIKVF-NLQLDGAIKSFD-AECEVLRRVRHRNL 802
F ++G G++G V K VAIK F + + + +K E ++LR ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 803 VKIISSCSNHGFKALILEY-----------MPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
V++ + G L+ EY MP G + + S+ Y L
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------------- 109
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
++ +H H ++H D+KP N+L+ + V L DFG ++ L + T +AT Y
Sbjct: 110 --IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 912 MAPEYGSEGIVSTCGDVYSFGILMIE------TFTRKMPTDEMFTGETSLKKWVEESLRL 965
+PE D++S G ++ E F + D++FT + L E ++L
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 7e-08
Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 20/97 (20%)
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
L+Y+H S IIH DLKPSN+ +++D + DFG+A+ D D M T +AT Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD--DEM--TGYVATRWYR 182
Query: 1504 APE-------YGSEGIVSTSGDVYSFGILMMETLTRR 1533
APE Y + + D++S G +M E LT +
Sbjct: 183 APEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-08
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 172 NQ-ITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTI 230
NQ + G +P+ + L+ +++S N + G IP ++G++T L L L+ N+ G P ++
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 231 FNVSSLRVIVLANNSLFGSLPVDLCRRL 258
++SLR++ L NSL G +P L RL
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 8e-08
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 42/220 (19%)
Query: 1337 FSESNLLGTG----IFSSVYKATFADGTNAAIKIFSLQED-----RALKSFDAECEVMRR 1387
+ + +G G + S+ +K T G AIK S E R L+ E +++RR
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPT---GVKVAIKKISPFEHQTFCQRTLR----EIKILRR 59
Query: 1388 IRHRNLAKIVSSCSNPGFKAL----ILQYMPQGSLEKWLYSHNYLLN------IEQRLDI 1437
+H N+ I+ P F++ I+Q + + L K + + + L N + Q L
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILR- 117
Query: 1438 MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT- 1496
L+Y+H S +++H DLKPSN+LL+ + + DFG+A++ D +T
Sbjct: 118 ------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 1497 -LATIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRR 1533
+AT Y APE S+G + + D++S G ++ E L+ R
Sbjct: 169 YVATRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-08
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 1436 DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495
D+M + L++LH S ++H DLKP N+L+ L DFG+A++ M T
Sbjct: 114 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTS 168
Query: 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ T+ Y APE + +T D++S G + E + RRKP
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-08
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 21/215 (9%)
Query: 1335 NGFSESNLLGTGIFSSVY----KATFADGTNAAIKIFS---LQEDRALKSFDAECEVMRR 1387
F +L+G G F V KAT G A+K+ L + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 1388 IRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEY 1447
+ ++ + + L+++Y P G L L + + + + ++ A+
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 1448 LHQ-GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
+HQ GY +H D+KP NVL+D L DFG A L + + + T Y+APE
Sbjct: 118 VHQMGY----VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 1507 Y------GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+G D +S G++ E + R P
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499
++ C LE LH I++ DLKP N+LLDD + D G+A + ++++ + T
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG--RVGT 164
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+GYMAPE + S D + G L+ E + + P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-08
Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG GSFG V + T I+ ++ + AE VL +V +V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIM---IDVASALEYLHHGHPTP 864
S + L+L ++ G L + L + R D+ A L L + H
Sbjct: 61 SFQSPEKLYLVLAFINGGEL-------FHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
VI+ DLKP N+LLD L DFG+ KL +D T T T Y+APE +
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTK 172
Query: 925 CGDVYSFGILMIETFTRKMP-----TDEMFTGETSLKKWVEESLRL 965
D ++ G+L+ E T P +EM+ +K ++E LR
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMY------RKILQEPLRF 212
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 17/216 (7%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLV 803
F L+G G++G VYK + G AIKV ++ D + E +L++ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 804 KIISSCSNHGFKA------LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYL 857
+ L++E+ GS+ + + K N + I L L
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGL 124
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY- 916
H H VIH D+K NVLL ++ L DFG+S LD T + T +MAPE
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVI 183
Query: 917 ----GSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
+ D++S GI IE P +M
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 9e-08
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 752 IGAGSFGSV---YKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISS 808
IG+G+ G V Y A L NVAIK + + F + R R L+K
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHAKRAYRELVLMK---- 71
Query: 809 CSNH-GFKALILEYMPQGSLEK----WLYSHKYTLNIQQRLDIMID--VASALEY----- 856
C NH +L+ + PQ SLE+ +L N+ Q + + +D S L Y
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
+ H H +IH DLKPSN+++ D + DFG+++ S T + T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE- 188
Query: 917 GSEGIVSTCG-----DVYSFGILMIETFTRKMPTDEMFTGETSLKKW 958
++ G D++S G +M E K+ +F G + +W
Sbjct: 189 ----VILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-08
Identities = 67/231 (29%), Positives = 98/231 (42%), Gaps = 60/231 (25%)
Query: 1322 LRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFS--LQEDRALKSFD 1379
L+R YQ L+ +G GI + Y G N AIK S Q K
Sbjct: 15 LKR--YQNLKPIGSG-------AQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY 63
Query: 1380 AECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKW--------LYSHNYLLNI 1431
E +M+ + H+N I+ L+ + PQ SLE++ L N I
Sbjct: 64 RELVLMKLVNHKN---IIG---------LLNVFTPQKSLEEFQDVYLVMELMDANLCQVI 111
Query: 1432 EQRLD------IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485
+ LD ++ + C +++LH S IIH DLKPSN+++ D + DFG+A+
Sbjct: 112 QMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-T 167
Query: 1486 DGVDSMKQTMT--LATIGYMAPE------YGSEGIVSTSGDVYSFGILMME 1528
G M MT + T Y APE Y E + D++S G +M E
Sbjct: 168 AGTSFM---MTPYVVTRYYRAPEVILGMGY-KENV-----DIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-07
Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI----- 805
+G GS G V+ A VA+K L ++K E +++RR+ H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 806 ---------ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+ S + ++ EYM + L + RL M + L+Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLAN-VLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 857 LHHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQ--TMTLATFGYMA 913
+H + V+H DLKP+NV ++ +D V + DFG+++++D S + L T Y +
Sbjct: 130 IHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 914 PEYG-SEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957
P S + D+++ G + E T K +F G L++
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQ 227
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-07
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 39/208 (18%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRNLAK 1395
+G G + V+K + G AIK F ED AL+ E ++++++H NL
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 1396 IVSSCSNPGFKA-----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
++ F+ L+ +Y L + L + + I+ A+ + H+
Sbjct: 65 LIEV-----FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE---- 1506
+ IH D+KP N+L+ L DFG A++L G T +AT Y APE
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVG 174
Query: 1507 ---YGSEGIVSTSGDVYSFGILMMETLT 1531
YG DV++ G + E LT
Sbjct: 175 DTQYG------PPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 1343 LGTGIFSSVYKAT--FADGTNAAIKIFSLQEDRALKSFDA-ECEVMRRIRHRNLAKIVSS 1399
+G G + VYKA + T A KI QED + S E +++ ++H N+ ++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 1400 CSNPGFKALILQYMPQGSLEKWL-YSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
+ L+ +Y+ L+K + S ++ N + + + Y H S ++H
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125
Query: 1459 CDLKPSNVLLDDDMVA-HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVST 1515
DLKP N+L+D A L DFG+A+ G+ T + T+ Y APE GS ST
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAPEILLGSRH-YST 183
Query: 1516 SGDVYSFGILMMETLTRR 1533
D++S G + E + ++
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-07
Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 7/144 (4%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISS 808
IG G++G+V+KA VA+K L D G S E +L+ ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
+ L+ EY Q L+K+ S ++ + M + L + H + V+H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHR 123
Query: 869 DLKPSNVLLDDDTVAHLSDFGISK 892
DLKP N+L++ + L+DFG+++
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 11/174 (6%)
Query: 784 IKSFDAECEVLRRVRHRNLVKI----ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLN 839
I + E + LRR+ N++KI I + +LILEY +G L + L K L+
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLS 120
Query: 840 IQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899
+ +LD+ ID L L+ P + +L + L+ ++ + G+ K+L
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178
Query: 900 VTQTMTLATFGY-MAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
+ F Y M + SE + D+YS G+++ E FT K+P + + T E
Sbjct: 179 KNVNF-MVYFSYKMLNDIFSEYTIKD--DIYSLGVVLWEIFTGKIPFENLTTKE 229
|
Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-07
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 36/228 (15%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISS 808
N+IG GSFG VY+A + VAIK LQ D K + E +++ + H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQ-DPQYK--NRELLIMKNLNHINIIFLKDY 127
Query: 809 CSNHGFKA--------LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS-----ALE 855
FK +++E++PQ ++ K Y Y N ++ + S AL
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHK--YMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISK-LLDGEDSVTQTMTLATFGYMA 913
Y+H + H DLKP N+L+D +T L DFG +K LL G+ SV+ + + Y A
Sbjct: 185 YIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRA 238
Query: 914 PE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWV 959
PE G+ +T D++S G ++ E +F+G++S+ + V
Sbjct: 239 PELMLGATN-YTTHIDLWSLGCIIAEMILGY----PIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 35/227 (15%)
Query: 737 QELQRLTDGFSESNLIGAGSFGSV----YKATLP-YGMNVAIKVFNLQLDGAIKSFDAEC 791
++L+ + + +IG G+FG V +K+T Y M + K F + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEER 94
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL----------EKWLYSHKYTLNIQ 841
+++ +V++ + + + +++EYMP G L EKW + YT +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW--ARFYTAEVV 152
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
LD + H IH D+KP N+LLD L+DFG ++ E V
Sbjct: 153 LALDAI-------------HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199
Query: 902 QTMTLATFGYMAPEY----GSEGIVSTCGDVYSFGILMIETFTRKMP 944
+ T Y++PE G +G D +S G+ + E P
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-07
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 38/197 (19%)
Query: 1336 GFSESNLLGTGIFSSVYKA---TFADGTNAAIKIF-SLQEDRALKSFDAECEVM--RRIR 1389
+ +G G + VYKA DG AIK F +E S A E+ R ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 1390 HRNLAKIVSSCSNPGFKA--LILQYMPQGSLE--KWLYSHNYLLNIEQRL--DIMIDVAC 1443
H N+ +V K+ L+ Y + K+ + ++I + ++ +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILN 119
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIAKL----------LDGVD 1489
+ YLH + ++H DLKP+N+L+ + V +GD G+A+L LD V
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV- 175
Query: 1490 SMKQTMTLATIGYMAPE 1506
+ TI Y APE
Sbjct: 176 -------VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-07
Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 54/280 (19%)
Query: 274 RIPKDIGNC---TLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGN 330
R+ +I T L L L +N +TD + P I SN++ + L N + +
Sbjct: 104 RLRSNISELLELTNLTSLDLDNNNITD--------IPPLIGLLKSNLKELDLSDNKIE-S 154
Query: 331 LPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQL 390
LPS NLPNL L L N+LS +P + N S L L+LS N S + L
Sbjct: 155 LPSPLR-NLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 391 QILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFY 450
+ L+L+ + + SSL+N + L L + N
Sbjct: 212 EELDLSNNSI--------IELLSSLSNLKNLSGLELSNNK-------------------- 243
Query: 451 AGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPS 510
+P GNLSN+ L L NQ+ + +++G L NL+ LDLS N++ ++P
Sbjct: 244 ------LEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPL 295
Query: 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSN 550
L L L N L L + L N+ SN
Sbjct: 296 ---IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332
|
Length = 394 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 1343 LGTGIFSSVYKATFADGTN--AAIKIFSL---QEDRALKSFDAECEVMRRIRHRNLAKIV 1397
+G G F +VY AT + TN A+K S Q + + E + +++++H N +
Sbjct: 29 IGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
L+++Y GS L H L Q ++I AL+ L +S ++I
Sbjct: 88 GCYLKEHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAITHGALQGLAYLHSHNMI 143
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY---GSEGIVS 1514
H D+K N+LL + L DFG A +S + T +MAPE EG
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMDEGQYD 198
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDM 1539
DV+S GI +E R+ P +M
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 1342 LLGTGIFSSVY----KATFADGTNAAIKIFS----LQEDRALKSFDAECEVMRRIRHRNL 1393
LLG G F V KAT G A+KI + +D + E V++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+ S +++Y G L + S + + ++ ++ AL YLH S
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALGYLH---S 113
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEGI 1512
+++ DLK N++LD D + DFG+ K +G+ T T Y+APE +
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 1513 VSTSGDVYSFGILMMETLTRRKP 1535
+ D + G++M E + R P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 46/202 (22%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKS---FDAECEVMRRIRHRNLAKIVS 1398
+G G F V + T A + + L+ +++ F E + R ++H NL + +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIM----IDVACALEYLHQGYST 1454
C+ L++++ P G L+ +L S + + ++A L +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---N 119
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPE-----YG 1508
+ IH DL N LL D+ +GD+G++ D L + ++APE +G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 1509 SEGIV--STSGDVYSFGILMME 1528
+ +V + +V+S G+ + E
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 58/172 (33%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 751 LIGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFD-----AECEVL-RRVRHRNLV 803
+IG GSFG V A G A+KV LQ +K + AE VL + ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ S +L+Y+ G L L + L + R +VASA+ YLH +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN-- 116
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
+I+ DLKP N+LLD L+DFG+ K + T T T Y+APE
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 751 LIGAGSFGSVY---KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
+IG G FG VY KA G A+K + + IK E L R ++ ++S
Sbjct: 1 IIGRGGFGEVYGCRKADT--GKMYAMKCLDKK---RIKMKQGETLALNE---RIMLSLVS 52
Query: 808 S-------CSNHGFK-----ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALE 855
+ C ++ F + IL+ M G L L H + ++ A +
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIIL 108
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
L H H V++ DLKP+N+LLD+ +SD G++ + ++ T GYMAPE
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPE 165
Query: 916 YGSEGIV-STCGDVYSFGILM 935
+G+ + D +S G ++
Sbjct: 166 VLQKGVAYDSSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-07
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 42/218 (19%)
Query: 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFS--LQEDRALKSFDAECEV 1384
YQ+L+ +G GI + + G N A+K S Q K E +
Sbjct: 23 YQQLKPIGSG-------AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVL 73
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKW--------LYSHNYLLNIEQRLD 1436
++ + H+N+ +++ + PQ SLE++ L N I LD
Sbjct: 74 LKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELD 121
Query: 1437 ------IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490
++ + C +++LH S IIH DLKPSN+++ D + DFG+A+ +
Sbjct: 122 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTN 176
Query: 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMME 1528
T + T Y APE + D++S G +M E
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-07
Identities = 63/239 (26%), Positives = 96/239 (40%), Gaps = 46/239 (19%)
Query: 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFS--LQEDRALKSFDAECEV 1384
YQ L+ +G GI + Y A N AIK S Q K E +
Sbjct: 26 YQNLKPIGSG-------AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKW--------LYSHNYLLNIEQRLD 1436
M+ + H+N+ L+ + PQ SLE++ L N I+ LD
Sbjct: 77 MKCVNHKNII------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124
Query: 1437 ------IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490
++ + C +++LH S IIH DLKPSN+++ D + DFG+A+ S
Sbjct: 125 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TS 179
Query: 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW 1549
T + T Y APE + D++S G +M E + +F G + W
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 44/225 (19%)
Query: 752 IGAGSFGSVYKA---------TLPYGMN--------VAIKVFNLQLDG---AIKSFDAEC 791
+G G FG V+ TL + N VA+K+ L+ D A F E
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKI--LRPDANKNARNDFLKEV 70
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY--------------- 836
++L R++ N+++++ C + +I EYM G L ++L SH
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 837 ---TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK- 892
++ L + + +AS ++YL +H DL N L+ ++ ++DFG+S+
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIE 937
L G+ Q + +MA E G +T DV++FG+ + E
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 1376 KSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLY-------SHNYL 1428
K+ E ++++ I HR + ++ + K+ + MP+ + + Y
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA-KLLDG 1487
+ I++RL AL YLH IIH D+K N+ LD+ A LGDFG A KL
Sbjct: 188 ITIQRRL------LEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
D+ + T+ +PE + D++S G+++ E +
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFN--LQLDGAIKSFDAECEVLRRVRHRNLV 803
+G GSFG VY+ VA+K N L I+ F E V++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 72
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTL---------NIQQRLDIMIDVASAL 854
+++ S +++E M G L+ +L S + +Q+ + + ++A +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYMA 913
YL+ +H DL N ++ D + DFG+++ + D + L +MA
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFT 940
PE +G+ +T D++SFG+++ E +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-07
Identities = 72/262 (27%), Positives = 109/262 (41%), Gaps = 50/262 (19%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-----ECEVLRRVRHRNLVK- 804
IG G++G V A VAIK D I DA E ++LR + H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI---DAKRTLREIKLLRHLDHENVIAI 69
Query: 805 --IISSCSNHGFKALILEY-MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
I+ F + + Y + L + + S + TL+ + + L+Y+H +
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSAN 128
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE---- 915
V+H DLKPSN+LL+ + + DFG+++ MT + T Y APE
Sbjct: 129 ---VLHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 916 ---YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVD 972
Y T DV+S G + E RK +F G K +V + L+L
Sbjct: 183 CSEYT------TAIDVWSVGCIFAELLGRK----PLFPG----KDYVHQ-LKLIT----- 222
Query: 973 AELLSSEEEEGADLGDSNKLKR 994
ELL S EE + K +R
Sbjct: 223 -ELLGSPSEEDLGFIRNEKARR 243
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 6/129 (4%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466
L+L M G L+ +Y+ EQR + ++ C LE L + I++ DLKP N+
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENI 133
Query: 1467 LLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILM 1526
LLDD + D G+A + ++++ + T+GYMAPE + + S D + G L+
Sbjct: 134 LLDDRGHIRISDLGLAVQIPEGETVRG--RVGTVGYMAPEVINNEKYTFSPDWWGLGCLI 191
Query: 1527 METLTRRKP 1535
E + + P
Sbjct: 192 YEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 35/205 (17%)
Query: 752 IGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKII 806
IG G+FG VY+ Y M V K K A+ EV + RN++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK----------KEIVAKKEVAHTIGERNIL-VR 49
Query: 807 SSCSNHGFKA-------------LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASA 853
+ F L+ +YM G L W + + + + ++ A
Sbjct: 50 TLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFSEDRAKFYIAELVLA 108
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
LE+LH +++ DLKP N+LLD L DFG+SK ++ T T T Y+A
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLA 164
Query: 914 PE-YGSEGIVSTCGDVYSFGILMIE 937
PE E + D +S G+L+ E
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
F+ +LG G F V A AIKI L++D ++ D EC ++ + +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEK-------R 52
Query: 1396 IVSSCSNPGFKA-------------LILQYMPQGSLEKWLYSHNYLLNIE--QRLDIMID 1440
+++ P F +++Y+ G L +Y + + Q + +
Sbjct: 53 VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAE 109
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK--LLDGVDSMKQTMTL- 1497
++ L +LH+ II+ DLK NV+LD + + DFG+ K ++DGV T T
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV----TTRTFC 162
Query: 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTD 1537
T Y+APE + S D +++G+L+ E L + P D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 1332 LATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRH 1390
L + F + + LG G V+K + G A K+ L+ A+++ +++R +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN-----QIIREL-- 54
Query: 1391 RNLAKIVSSCSNP---GFK---------ALILQYMPQGSLEKWLYSHNYLLNIEQRL-DI 1437
+++ C++P GF ++ +++M GSL++ L + EQ L +
Sbjct: 55 ----QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKV 108
Query: 1438 MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL 1497
I V L YL + + I+H D+KPSN+L++ L DFG++ L +DSM + +
Sbjct: 109 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-V 163
Query: 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
T YM+PE S D++S G+ ++E R P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKI---- 1396
+G G + VYK T DG+ AA+KI D + +AE +++ + H N+ K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 1397 --VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVACALEYL 1448
G L+L+ GS+ + + LL QRLD I+ L++L
Sbjct: 89 YKADKLVG-GQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHL 144
Query: 1449 HQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-- 1506
H + IIH D+K +N+LL + L DFG++ L +++ ++ T +MAPE
Sbjct: 145 H---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVI 200
Query: 1507 -----YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
Y DV+S GI +E P DM
Sbjct: 201 ACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 40/220 (18%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+LG G F V A GT+ I L++D ++ D EC ++ + ++++
Sbjct: 7 VLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEK-------RVLALSG 58
Query: 1402 NPGFKA-------------LILQYMPQGSLEKWLYSHNYLLNIEQRLDIM--IDVACALE 1446
P F +++Y+ G L +Y + ++ + ++A L
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK--LLDGVDSMKQTMTL-ATIGYM 1503
+LH S II+ DLK NV+LD + + DFG+ K + DGV T T T Y+
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV----TTKTFCGTPDYI 168
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
APE + S D ++FG+L+ E L + P F GE
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-A 1498
+++ AL +LH+ II+ DLK NVLLD + L D+G+ K +G+ T T
Sbjct: 104 EISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCG 158
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTD 1537
T Y+APE S D ++ G+LM E + R P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-07
Identities = 33/97 (34%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTG 1169
GL L L G IP+ I + + LS N G IP + G+ L++LDLS N
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG- 480
Query: 1170 SSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIG 1206
S SL LR L L N L G +P ++G
Sbjct: 481 ------SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-07
Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466
++ +++M GSL++ L + E + I V L YL + + I+H D+KPSN+
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNI 135
Query: 1467 LLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILM 1526
L++ L DFG++ L +DSM + + T YM+PE S D++S G+ +
Sbjct: 136 LVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 1527 METLTRRKP 1535
+E R P
Sbjct: 193 VELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 31/210 (14%)
Query: 751 LIGAGSFGSVY---KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
+IG G FG VY KA G A+K + + IK E L R ++ ++S
Sbjct: 1 IIGRGGFGEVYGCRKADT--GKMYAMKCLDKK---RIKMKQGETLALNE---RIMLSLVS 52
Query: 808 S-------CSNHGFKA-----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALE 855
+ C + F IL+ M G L L H + ++ +
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIIL 108
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
L H H V++ DLKP+N+LLD+ +SD G++ + ++ T GYMAPE
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPE 165
Query: 916 YGSEGIV-STCGDVYSFGILMIETFTRKMP 944
+G + D +S G ++ + P
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 45/188 (23%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 1363 AIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKW 1421
A+KI ++ A F E +++ R++ N+ +++ C + +I +YM G L ++
Sbjct: 50 AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109
Query: 1422 LYSHNYL------------------LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKP 1463
L SH+ ++ L + + +A ++YL S + +H DL
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLAT 166
Query: 1464 SNVLLDDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSF 1522
N L+ +++ + DFG+++ L D + Q + I +MA E G +T+ DV++F
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226
Query: 1523 GILMMETL 1530
G+ + E L
Sbjct: 227 GVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-07
Identities = 60/201 (29%), Positives = 84/201 (41%), Gaps = 27/201 (13%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G F VY+ D A+K+ S +E A K EV I RN+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 1402 NP---GFK---------ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI-DVACALEYL 1448
+P G K L+ YM G L W + E R I ++ ALE+L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFS-EDRAKFYIAELVLALEHL 112
Query: 1449 HQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-Y 1507
H+ I++ DLKP N+LLD L DFG++K + T T Y+APE
Sbjct: 113 HK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVL 168
Query: 1508 GSEGIVSTSGDVYSFGILMME 1528
E + D +S G+L+ E
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 752 IGAGSFGSVYKATLPYGMN-VAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G G++ +V+K N VA+K L+ + GA + E +L+ ++H N+V +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
L+ EY+ L+++L + +++ M + L Y H ++H D
Sbjct: 73 HTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRD 128
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE--YGSEGIVSTC 925
LKP N+L+++ L+DFG+++ + T+T + + T Y P+ GS ST
Sbjct: 129 LKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTE-YSTP 184
Query: 926 GDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRL 965
D++ G ++ E T + MF G T V+E L L
Sbjct: 185 IDMWGVGCILYEMATGR----PMFPGST-----VKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 29/241 (12%)
Query: 752 IGAGSFGSVYKATLPYGMN-VAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G G++ +VYK N VA+K L+ + GA + E +L+ ++H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
L+ EY+ + L+++L ++N+ ++ + + L L++ H V+H D
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE--YGSEGIVSTC 925
LKP N+L+++ L+DFG+++ + T+T + + T Y P+ GS ST
Sbjct: 130 LKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTD-YSTQ 185
Query: 926 GDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAV------TEVVDAELLSSE 979
D++ G + E T + +F G T VEE L TE +LS+E
Sbjct: 186 IDMWGVGCIFYEMSTGR----PLFPGST-----VEEQLHFIFRILGTPTEETWPGILSNE 236
Query: 980 E 980
E
Sbjct: 237 E 237
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIM-- 847
E ++L +V R +V + + L+L M G L+ +Y H ++ +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYA 108
Query: 848 IDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS-KLLDGEDSVTQTMTL 906
++ LE LH +++ DLKP N+LLDD +SD G++ + +G+ T +
Sbjct: 109 AEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRV 162
Query: 907 ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
T GYMAPE + D ++ G L+ E + P
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-07
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFS--LQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
+G+G + SV A G A+K S Q K E +++ ++H N+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 79
Query: 1400 CSNPGFKALILQYMPQGSLEK----WLYSH------NYLLNIEQRLD-----IMIDVACA 1444
L+ + P SLE+ +L +H N ++ ++ D ++ +
Sbjct: 80 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMA 1504
L+Y+H S IIH DLKPSN+ +++D + DFG+A+ D D M T +AT Y A
Sbjct: 133 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEM--TGYVATRWYRA 185
Query: 1505 PEYGSEGI-VSTSGDVYSFGILMMETLTRR 1533
PE + + + D++S G +M E LT R
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-07
Identities = 74/278 (26%), Positives = 113/278 (40%), Gaps = 58/278 (20%)
Query: 714 RNKNLPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSV---YKATLPYGMN 770
R+ N +E + +R YQ L+ IG+G+ G V Y A L N
Sbjct: 6 RDNNFYSVEIGDSTFTVLKR--YQNLKP----------IGSGAQGIVCAAYDAILE--RN 51
Query: 771 VAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNH-GFKALILEYMPQGSLEK 829
VAIK + + F + R R L+K C NH L+ + PQ SLE+
Sbjct: 52 VAIKKLS-------RPFQNQTHAKRAYRELVLMK----CVNHKNIIGLLNVFTPQKSLEE 100
Query: 830 ----WLYSHKYTLNIQQRLDIMID--VASALEY-----LHHGHPTPVIHCDLKPSNVLLD 878
++ N+ Q + + +D S L Y + H H +IH DLKPSN+++
Sbjct: 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160
Query: 879 DDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG-----DVYSFGI 933
D + DFG+++ S T + T Y APE ++ G D++S G
Sbjct: 161 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE-----VILGMGYKENVDIWSVGC 213
Query: 934 LMIETFTRKMPTDEMFTGETSLKKW--VEESLRLAVTE 969
+M E + +F G + +W V E L E
Sbjct: 214 IMGEMIKGGV----LFPGTDHIDQWNKVIEQLGTPCPE 247
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-07
Identities = 33/118 (27%), Positives = 50/118 (42%), Gaps = 20/118 (16%)
Query: 1435 LDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG------- 1487
L I + +EY+H S ++H DLKP N+LL + D+G A
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 1488 -----VDSMKQTMT-----LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ +MT + T YMAPE S S D+Y+ G+++ + LT P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 7e-07
Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 7/133 (5%)
Query: 1350 SVYKATFADGTNAAIKIFSL--QEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407
+ K T A+K +L LK E R+++H N+ V+S
Sbjct: 17 HLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELY 75
Query: 1408 LILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466
++ M GS E L +H L I+ DV AL+Y+H S IH +K S++
Sbjct: 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHI 132
Query: 1467 LLDDDMVAHLGDF 1479
LL D L
Sbjct: 133 LLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 42/131 (32%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467
L+++Y+ G L + L R ++ AL +LH+ II+ DLK NVL
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE---RGIIYRDLKLDNVL 128
Query: 1468 LDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEGIVSTSGDVYSFGILM 1526
LD D L D+G+ K +G+ T T T Y+APE S D ++ G+LM
Sbjct: 129 LDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLM 186
Query: 1527 METLTRRKPTD 1537
E + R P D
Sbjct: 187 FEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-07
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDG 1487
L +E + VA +E+L S IH DL N+LL ++ V + DFG+A+ +
Sbjct: 170 LTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226
Query: 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
D +++ + +MAPE + + +T DV+SFG+L+ E +
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDG 1487
L +E + VA +E+L S IH DL N+LL ++ V + DFG+A+ +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
D +++ + +MAPE + + + DV+SFG+L+ E +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-07
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIK-IFSLQEDR-----ALKSFDAECEVMRRIRHRNLAK 1395
+G G F V+KA A+K + E AL+ E ++++ ++H N+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 1396 IVSSCSNP-----GFKA---LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEY 1447
++ C +K L+ ++ L L + N + + +M + L Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK---LLDGVDSMKQTMTLATIGYMA 1504
+H I+H D+K +N+L+ D + L DFG+A+ L + T + T+ Y
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191
Query: 1505 PE-------YGSEGIVSTSGDVYSFGILMMETLTR 1532
PE YG D++ G +M E TR
Sbjct: 192 PELLLGERDYG------PPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-07
Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 1380 AECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI-- 1437
AE V+ ++ + + S +P L+L ++ G L + H L E R D+
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL----FHH---LQREGRFDLSR 94
Query: 1438 ----MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493
++ CALE LH ++I+ DLKP N+LLD L DFG+ K L+ D K
Sbjct: 95 ARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKT 150
Query: 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES 1553
T Y+APE + + D ++ G+L+ E LT P D E+ + ++E
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEP 209
Query: 1554 L--PDAVTDVIDANLLSG 1569
L PD D +LL G
Sbjct: 210 LRFPDGF-DRDAKDLLIG 226
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-07
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 13/216 (6%)
Query: 1328 QELRLATNGFSESNLLGTGIFSSV----YKATFADGTNAAIKIFSLQEDRALKSFDAECE 1383
++LR+ + ++G G F V +K+T + F + + F E +
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 1384 VMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC 1443
+M + ++ + + + ++++YMP G L + NY + + +V
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVL 153
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
AL+ +H S IH D+KP N+LLD L DFG ++ ++ + T Y+
Sbjct: 154 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 1504 APEY----GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+PE G +G D +S G+ + E L P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-07
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 838 LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDG 896
L L VA +E+L + +H DL NVLL + + DFG+++ ++
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+ V++ T +MAPE + + +T DV+S+GIL+ E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-07
Identities = 32/107 (29%), Positives = 58/107 (54%), Gaps = 10/107 (9%)
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMTLAT 908
VA+ +E+L + +H DL NVL+ + + + DFG+++ ++ + +++ T
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFT------RKMPTDEMF 949
+MAPE + +T DV+SFGIL+ E FT ++P +E F
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-07
Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 18/174 (10%)
Query: 751 LIGAGSFGSVYKATLPY-GMNVAIKVFNLQL---DGAIKSFDAECEVL-RRVRHRNLVKI 805
+IG GSFG V A G A+KV ++ K AE VL + V+H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S +L+++ G L L + + R ++ASAL YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPE 915
++ DLKP N+LLD L+DFG+ K + + Q+ T TF Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 9e-07
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 8/164 (4%)
Query: 1373 RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLN-- 1430
RA + E + R+ H N+ KI + +I Q L ++Y +
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDR 263
Query: 1431 --IEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488
++Q IM + CA+EY+H +IH D+K N+ L+ D LGDFG A +
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTR 1532
+ T+ +PE + D++S G+++++ L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-06
Identities = 26/69 (37%), Positives = 40/69 (57%), Gaps = 1/69 (1%)
Query: 327 LSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGN 386
L G +P+ L +L + L GN++ G IP S+ + + L VL+LS N F+G + + G
Sbjct: 430 LRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 387 CRQLQILNL 395
L+ILNL
Sbjct: 489 LTSLRILNL 497
|
Length = 623 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-06
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFN--LQLDGAIKSFDAECEVLRRVRHRNLVKIISS 808
IG+G+ G V A G+NVA+K + Q K E +L+ V H+N++ +++
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 809 CSNHGFKALILEYMPQGSLEK----WLYSHKYTLNIQQRLDIMID--VASALEY-----L 857
+ PQ SLE+ +L N+ Q + + +D S L Y +
Sbjct: 89 ------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYG 917
H H +IH DLKPSN+++ D + DFG+++ + T + T Y APE
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVI 194
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKW 958
D++S G +M E + +F G + +W
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-06
Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 834 HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK- 892
+K L ++ + VA +E+L IH DL N+LL ++ V + DFG+++
Sbjct: 172 YKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARD 228
Query: 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+ D V + +MAPE + + + DV+SFG+L+ E F+
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 10/170 (5%)
Query: 751 LIGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+IG GSFG V A Y + V K L+ +L+ V+H LV +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S +L+Y+ G L L + L + R ++ASAL YLH + +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---I 117
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
++ DLKP N+LLD L+DFG+ K + T T T Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 48/245 (19%)
Query: 735 SYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMN-VAIKVFNLQLD-GAIKSFDA--E 790
+Y++L +L G GS+ +VYK VA+K L+ + GA F A E
Sbjct: 6 TYKKLDKL----------GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIRE 53
Query: 791 CEVLRRVRHRNLV---KIISSCSNHGFKALIL--EYMPQGSLEKWLYSHKYTLNIQQRLD 845
+L+ ++H N+V II H K L L EY+ L++++ L++
Sbjct: 54 ASLLKDLKHANIVTLHDII-----HTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRL 107
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTM 904
+ + L Y H V+H DLKP N+L+ + L+DFG+++ SV ++T
Sbjct: 108 FLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR----AKSVPSKTY 160
Query: 905 T--LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE 960
+ + T Y P+ GS ST D++ G + E T P +F G T VE
Sbjct: 161 SNEVVTLWYRPPDVLLGSTE-YSTSLDMWGVGCIFYEMAT-GRP---LFPGSTD----VE 211
Query: 961 ESLRL 965
+ L
Sbjct: 212 DQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 742 LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVR 798
+T+ + + +G G+FG V A G NVAIK + K E ++L+ +R
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 799 HRNLVKI----ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
H N++ + IS + F + E + L + L S Q + + L
Sbjct: 68 HENIISLSDIFISPLEDIYF---VTELLGT-DLHRLLTSRPLEKQFIQYF--LYQILRGL 121
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
+Y+H V+H DLKPSN+L++++ + DFG++++ D + T ++T Y AP
Sbjct: 122 KYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAP 174
Query: 915 E-------YGSEGIVSTCGDVYSFGILMIETFTRK 942
E Y E D++S G + E K
Sbjct: 175 EIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-06
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 1342 LLGTGIFSSVY----KATFADGTNAAIKIFS----LQEDRALKSFDAECEVMRRIRHRNL 1393
LLG G F V KAT G A+KI + +D + E V++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFL 57
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+ + +++Y G L L S + E+ ++ ALEYLH S
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH---S 113
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV-DSMKQTMTLATIGYMAPEYGSEGI 1512
+++ D+K N++LD D + DFG+ K +G+ D T Y+APE +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 1513 VSTSGDVYSFGILMMETLTRRKP 1535
+ D + G++M E + R P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 1343 LGTGIFSSVY----KATFADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRNLAKI 1396
LG G F +VY K A+ +K + E ++ A E +++ ++ H + K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWL--YSHN-YLLNIEQRLDIMIDVACALEYLHQGYS 1453
+S +I +Y L+ L H L+ Q + I + + Y+HQ
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--- 124
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV 1513
I+H DLK N+ L ++++ +GDFG+++LL G + T T T YM+PE
Sbjct: 125 RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQGY 182
Query: 1514 STSGDVYSFGILMME 1528
+ D++S G ++ E
Sbjct: 183 DSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 18/217 (8%)
Query: 1350 SVYKATFADGTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRNLAKI----VSSCSN 1402
S+YK F + I+ F + + E + +RRI N+ KI + +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 1403 PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLK 1462
+LIL+Y +G L + L L+ + +LD+ ID L L++ + + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 1463 PSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGY-MAPEYGSEGIVSTSGDVYS 1521
+ L+ ++ + G+ K+L K + Y M + SE + D+YS
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLNDIFSEYTIKD--DIYS 207
Query: 1522 FGILMMETLTRRKPTDDMFTGEV---CLKHWVEESLP 1555
G+++ E T + P +++ T E+ + LP
Sbjct: 208 LGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244
|
Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 22/194 (11%)
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMI 848
E +L +V R +V + + L+L M G L+ +Y+ + Q+ +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS-KLLDGEDSVTQTMTLA 907
++ LE L +++ DLKP N+LLDD +SD G++ ++ +GE T +
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVG 163
Query: 908 TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAV 967
T GYMAPE + + D + G L+ EM G++ +K E R
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIY----------EMIQGQSPFRKRKERVKR--- 210
Query: 968 TEVVDAELLSSEEE 981
E VD + +EE
Sbjct: 211 -EEVDRRVKEDQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 41/178 (23%), Positives = 80/178 (44%), Gaps = 11/178 (6%)
Query: 1365 KIFSLQEDRALKSFDA------ECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418
+ ++++E R KS A E ++ +++H N+ S G ++++Y G L
Sbjct: 26 QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85
Query: 1419 EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477
+ + L E L + + ++++H+ ++H D+K N+ L + LG
Sbjct: 86 MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLG 142
Query: 1478 DFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
DFG A+LL + T + T Y+ PE + D++S G ++ E T + P
Sbjct: 143 DFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-06
Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 16/122 (13%)
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-A 1498
++A L +LH S II+ DLK NV+LD + + DFG+ K + + K T T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCG 163
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558
T Y+APE + S D ++FG+L+ E L + P F GE E+ L ++
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP----FDGE------DEDELFQSI 213
Query: 1559 TD 1560
+
Sbjct: 214 ME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-06
Identities = 61/246 (24%), Positives = 97/246 (39%), Gaps = 67/246 (27%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSV----YKATLP-YGMNVAIKVFNLQLDGAIKSFDA--- 789
+L+ + F +IG G+FG V +K++ Y M + L IK D+
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL------LSKFEMIKRSDSAFF 90
Query: 790 --ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL----------EKWLYSHKYT 837
E +++ +V++ + + + +++EYMP G L EKW + YT
Sbjct: 91 WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW--ARFYT 148
Query: 838 LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897
+ LD + H IH D+KP N+LLD L+DFG +D
Sbjct: 149 AEVVLALDAI-------------HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195
Query: 898 DSVTQTMTLATFGYMAPE----------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947
V + T Y++PE YG E C D +S G+ + E
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-----C-DWWSVGVFLY----------E 239
Query: 948 MFTGET 953
M G+T
Sbjct: 240 MLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-06
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDG 1487
L +E + VA +E+L S IH DL N+LL ++ V + DFG+A+ +
Sbjct: 171 LTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
D +++ + +MAPE + + +T DV+SFG+L+ E +
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-06
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 752 IGAGSFGSV-YKATLPYGMNVAIKVFN--LQLDGAIKSFDAECEVLRRVRHRN---LVKI 805
+G+G++G+V G VAIK Q + K E +L+ ++H N L+ +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 806 ISSCSN----HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
+ + H F L++ +M L K + K + + R+ + V L+ L + H
Sbjct: 83 FTPDLSLDRFHDF-YLVMPFMGT-DLGKLMKHEKLS---EDRIQFL--VYQMLKGLKYIH 135
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGI 921
+IH DLKP N+ +++D + DFG+++ D E T + T Y APE +
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWM 191
Query: 922 VST-CGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE 960
T D++S G +M E T K +F G L + +E
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGK----PLFKGHDHLDQLME 227
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 35/147 (23%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLA--KIVSS 1399
LL G+ + VY D +KI +E A + E +++ + + L K+++S
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ G+ L+++++ +L++ ++ E++ DI +A L LHQ + H
Sbjct: 62 GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLD 1486
DL P N+L+DD + + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-06
Identities = 26/61 (42%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 493 NLQGLDLSYNNIQGSIPSELCQ-LESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNR 551
NL+ LDLS N + IP + L +L L L GN L + P + L SLR+L+LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 552 L 552
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 1381 ECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMID 1440
E +++ + H ++ ++ + + ++L + L +L + L I+Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI 1500
+ L YLH IIH D+K N+ ++D +GD G A+ V + T+
Sbjct: 166 ILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTV 220
Query: 1501 GYMAPEYGSEGIVSTSGDVYSFGILMMETL 1530
APE + ++ D++S GI++ E L
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 241 LANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGA 300
L N L G +P D+ +L LQ +NL G IP +G+ T L L D
Sbjct: 425 LDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL--------DLSY 475
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTG 336
N+ G IP + +++ ++ L GN LSG +P++ G
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 1342 LLGTGIFSSVY----KATFADGTNAAIKIFS----LQEDRALKSFDAECEVMRRIRHRNL 1393
LLG G F V KAT G A+KI + +D + E V++ RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 57
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+ S +++Y G L L S + + ++ ++ AL+YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLHS--E 114
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV-DSMKQTMTLATIGYMAPEYGSEGI 1512
++++ DLK N++LD D + DFG+ K +G+ D T Y+APE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 1513 VSTSGDVYSFGILMMETLTRRKP 1535
+ D + G++M E + R P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-06
Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 58/229 (25%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIK------------IFSLQEDRALKSFDAECEVMRRIR 1389
LG G F VYKA G A+K I +L+E + LK +++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK----------KLK 65
Query: 1390 HRNLAKIVS--------SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDV 1441
H N+ ++ S G ++ YM L L + + L Q M+ +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQL 124
Query: 1442 ACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG----------VDSM 1491
+ YLH+ I+H D+K +N+L+D+ + + DFG+A+ DG +
Sbjct: 125 LEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 1492 KQTMTLATIGYMAPE-------YGSEGIVSTSGDVYSFGILMMETLTRR 1533
K T + T Y PE Y T+ D++ G + E TRR
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYT------TAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 20/228 (8%)
Query: 751 LIGAGSFGSVYKATLPYGMNV-AIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKII 806
+IG GS+ V L + A+KV +L D I E V + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 807 SSCSNHGFKA-LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
SC + L++EY+ G L + + R ++ AL +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE---RGI 117
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY--GSEGIVS 923
I+ DLK NVLLD D L+D+G+ K G T T T Y+APE G E S
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYGFS 176
Query: 924 TCGDVYSFGILMIETFTRKMPTD------EMFTGETSLKKWVEESLRL 965
D ++ G+LM E + P D +M T + + +E+ +R+
Sbjct: 177 V--DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMTLAT 908
VA +E+L IH DL N+LL ++ V + DFG+++ + D V +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+MAPE + + +T DV+SFG+L+ E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-06
Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 51/221 (23%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-----ECEVLRRVRHRNLVK 804
+IG GS+G V A G VAIK N + DA E ++LR +RH ++V+
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS---DATRILREIKLLRLLRHPDIVE 63
Query: 805 ---IISSCSNHGFKAL--ILEYMPQGSLEKW------LYSHKYTLNIQQRLDIMIDVASA 853
I+ S FK + + E M + L + L + + Q L A
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLL-------RA 115
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK--LLDGEDSVTQTMTLATFGY 911
L+Y+H + V H DLKP N+L + D + DFG+++ D ++ T +AT Y
Sbjct: 116 LKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 912 MAPEYGSEGIVSTCG----------DVYSFGILMIETFTRK 942
APE CG D++S G + E T K
Sbjct: 173 RAPEL--------CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-06
Identities = 41/141 (29%), Positives = 62/141 (43%), Gaps = 25/141 (17%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLD------------IMIDVACALEYLHQGYSTS 1455
LI++Y G L K I+QRL + + AL+ +H S
Sbjct: 142 LIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRK 189
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
++H DLK +N+ L + LGDFG +K D V + T Y+APE S
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 1515 TSGDVYSFGILMMETLTRRKP 1535
D++S G+++ E LT +P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-06
Identities = 17/47 (36%), Positives = 22/47 (46%), Gaps = 8/47 (17%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTC 84
D ALL K+ + DP +WN SS+ C+W GVTC
Sbjct: 3 DDRDALLAFKSSLNGDPSGALS-SWN-------PSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 43/224 (19%)
Query: 737 QELQRLTDGFSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDA--ECEV 793
+ Q LT +G+G++GSV A VA+K + I + E +
Sbjct: 15 ERYQNLTP-------VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67
Query: 794 LRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTL---------NIQ--Q 842
L+ ++H N++ L+ + P S+E ++ Y + NI Q
Sbjct: 68 LKHMKHENVI------------GLLDVFTPATSIEN--FNEVYLVTNLMGADLNNIVKCQ 113
Query: 843 RLD---IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899
+L + + L L + H +IH DLKPSNV +++D + DFG+++ D E
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-- 171
Query: 900 VTQTMTLATFGYMAPEYGSEGI-VSTCGDVYSFGILMIETFTRK 942
T +AT Y APE + + D++S G +M E K
Sbjct: 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 68/250 (27%), Positives = 99/250 (39%), Gaps = 66/250 (26%)
Query: 744 DGFSESNLIGAGSFGSVY----KATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR 798
+ F +IG G+FG V K T Y M +K + D + AE +VL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD-QLAHVKAERDVLAESD 59
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI----MIDVASAL 854
+V + S + + LI+E++P G L L KY + D+ M + A+
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSE---DVTRFYMAECVLAI 114
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS-------------KLLDGE---- 897
E +H IH D+KP N+L+D LSDFG+S KLL G+
Sbjct: 115 EAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 898 ----------DSVTQTM-------------------TLATFGYMAPE-YGSEGIVSTCGD 927
DS+ TM T+ T Y+APE + +G C D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC-D 230
Query: 928 VYSFGILMIE 937
+S G +M E
Sbjct: 231 WWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-06
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECE-VLRRV-----RHRNLVK 804
++G GSFG V A L G V L+ D + D EC V +RV + L
Sbjct: 2 VLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIM------IDVASALEYLH 858
+ + ++E++ G L + + + R D+ ++ L++LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL-------MFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS 918
+I+ DLK NV+LD D ++DFG+ K D+ T T Y+APE
Sbjct: 114 ---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQ 169
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
+ D +SFG+L+ E + P DE+F
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-06
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMTLAT 908
VA +E+L IH DL N+LL ++ V + DFG+++ + D V +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+MAPE + + +T DV+SFG+L+ E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-06
Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 10/97 (10%)
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMA 1504
L+Y+H S IIH DLKPSNV +++D + DFG+A+ D D M T +AT Y A
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEM--TGYVATRWYRA 183
Query: 1505 PEYGSEGI-VSTSGDVYSFGILMMETLTRRK--PTDD 1538
PE + + + D++S G +M E L + P +D
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 66/242 (27%), Positives = 105/242 (43%), Gaps = 30/242 (12%)
Query: 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRA-LKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G + SVYK G A+K L+ D + E +++ + + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNI--EQRL-DIMIDVACALEYLHQGYSTSII 1457
G + ++YM GSL+K LY+ E L I V L++L + ++ II
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEG--- 1511
H D+KP+NVL++ + L DFG++ L V S+ +T IG YMAPE G
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKT----NIGCQSYMAPERIKSGGPN 179
Query: 1512 ---IVSTSGDVYSFGILMMETLTRRKP-----TDDMFTGEVCLKHWVEESLPDAVTDVID 1563
+ DV+S G+ ++E R P ++F + +LP +D D
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD--D 237
Query: 1564 AN 1565
A
Sbjct: 238 AQ 239
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 1335 NGFSESNLLGTGIFSSVYKATFADGTN-AAIKIF--SLQEDRALKSFDAECEVMRRIRHR 1391
N F ++G G + V K + AIK F S + + ++ E +++R ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 1392 NLAKIVSSCSNPGFKALILQY-----------MPQGSLEKWLYSHNYLLNIEQRLDIMID 1440
N+ ++ + G L+ +Y MP G + + S+ Y L
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI 1500
++ +H + I+H D+KP N+L+ + V L DFG A+ L + T +AT
Sbjct: 110 ----IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165
Query: 1501 GYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y +PE + D++S G ++ E L+ +P +F GE
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGE-LSDGQP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-06
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDG 1487
L L VA +E+L S + +H DL NVLL + + DFG+A+ ++
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ + + T + +MAPE + + +T DV+S+GIL+ E +
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-06
Identities = 33/119 (27%), Positives = 60/119 (50%), Gaps = 4/119 (3%)
Query: 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473
P+ + L + + L+ + VA +E+L S + +H DL NVL+ + +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 1474 AHLGDFGIAK-LLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ DFG+A+ ++ + + + T + +MAPE + +T DV+SFGIL+ E T
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-A 1498
+++ AL YLH+ II+ DLK NVLLD + L D+G+ K +G+ T T
Sbjct: 104 EISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCG 158
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTD 1537
T Y+APE S D ++ G+LM E + R P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 6e-06
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496
+M+ + + +LH + I+H DLK SN+LL++ + + DFG+A+ G T
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQL 166
Query: 1497 LATIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRR 1533
+ T+ Y APE G ST+ D++S G + E LT++
Sbjct: 167 VVTLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 8/124 (6%)
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS-KLLDGEDSVTQTMTLATFGYMAPE 915
L H +++ DLKP N+LLDD +SD G++ ++ +GE T + T GYMAPE
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPE 171
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
+ D + G L+ E K P F K E R+ + +E
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKEKVKREEVERRVKEDQEEYSEK 227
Query: 976 LSSE 979
S
Sbjct: 228 FSEA 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-06
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 751 LIGAGSFGSVYKATLPYGMN--VAIKVFNLQLDGAIKSFDAECEVL-RRV-----RHRNL 802
++G GSFG V A G + AIK+ L+ D I+ D EC ++ +RV + L
Sbjct: 7 VLGKGSFGKVMLAERK-GTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIM--IDVASALEYLHHG 860
++ S ++EY+ G L +Y + ++ + ++A L +LH
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK--LLDGEDSVTQTMTLATFGYMAPEYGS 918
+I+ DLK NV+LD + ++DFG+ K + DG VT T Y+APE +
Sbjct: 119 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIA 174
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
D ++FG+L+ E + P DE+F
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-06
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 49/233 (21%)
Query: 1329 ELRLATNGFSESNLLGTGIFSSV----YKATFADGTNAAIKIFSLQEDRALKSFDA---- 1380
+LR+ F ++G G F V +K++ A+K+ S + +K D+
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLS--KFEMIKRSDSAFFW 91
Query: 1381 -ECEVMRRIRHRNLAKIVSSC---SNPGFKALILQYMPQGSL----------EKWLYSHN 1426
E ++M H N IV + + ++++YMP G L EKW
Sbjct: 92 EERDIMA---HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW----- 143
Query: 1427 YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486
R +V AL+ +H S IH D+KP N+LLD L DFG +D
Sbjct: 144 ------ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193
Query: 1487 GVDSMKQTMTLATIGYMAPEY----GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
++ + T Y++PE G +G D +S G+ + E L P
Sbjct: 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-06
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 39/220 (17%)
Query: 752 IGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLR----------RV 797
+G G FG V YK T AIK G I + D E E L
Sbjct: 7 LGRGHFGKVLLAEYKKTGEL---YAIKALK---KGDIIARD-EVESLMCEKRIFETANSE 59
Query: 798 RHRNLVKIISSC---SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
RH LV + + C +H ++EY G L ++ H + + + V L
Sbjct: 60 RHPFLVNLFA-CFQTEDHVC--FVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGL 114
Query: 855 EYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
+YLH + +++ DLK N+LLD + ++DFG+ K G T T T ++A
Sbjct: 115 QYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLA 169
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
PE +E + D + G+L+ E + P F G+
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 8e-06
Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 52/231 (22%)
Query: 752 IGAGSFGSV---YKATLPYGMNVAIKVFN--LQLDGAIKSFDAECEVLRRVRHRNLVKII 806
IG+G+ G V Y G NVAIK + Q K E +++ V H+N II
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN---II 78
Query: 807 SSCSNHGFKALILEYMPQGSLEKW--------LYSHKYTLNIQQRLDIMIDVASALEY-- 856
L+ + PQ SLE++ L IQ LD + S L Y
Sbjct: 79 G---------LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH--ERMSYLLYQM 127
Query: 857 ---LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
+ H H +IH DLKPSN+++ D + DFG+++ S T + T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 185
Query: 914 PE------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKW 958
PE Y E + D++S G +M E + +F G + +W
Sbjct: 186 PEVILGMGY-KENV-----DIWSVGCIMGEMIRGTV----LFPGTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-06
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 1343 LGTGIFSSVYK--ATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G +++VYK + D A +I E+ A + E +++ ++H N+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
L+ +Y+ + L+++L +N+ + + L Y H+ ++H D
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRD 129
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTSGD 1518
LKP N+L+++ L DFG+A+ + + + + T+ Y P+ GS ST D
Sbjct: 130 LKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTD-YSTQID 187
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL 1554
++ G + E T R +F G VEE L
Sbjct: 188 MWGVGCIFYEMSTGRP----LFPGST-----VEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 33/148 (22%), Positives = 67/148 (45%), Gaps = 15/148 (10%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV--KIISS 808
L+ G VY + +K+ + GA + E +L+ + + L K+++S
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGA--DREREVAILQLLARKGLPVPKVLAS 61
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV-IH 867
+ G+ L++E++ +L++ ++ +++ DI +A L LH P V H
Sbjct: 62 GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQ-LPLLVLCH 112
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLD 895
DL P N+L+DD + + D+ +
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-06
Identities = 29/78 (37%), Positives = 50/78 (64%), Gaps = 6/78 (7%)
Query: 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNV 875
L++EY+ G ++ L+ + Y + + + + +VA AL+YLH HG +IH DLKP N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHG----IIHRDLKPDNM 135
Query: 876 LLDDDTVAHLSDFGISKL 893
L+ ++ L+DFG+SK+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-05
Identities = 78/271 (28%), Positives = 114/271 (42%), Gaps = 27/271 (9%)
Query: 988 DSNKLKRLSISVNKITGTI-PRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNC 1046
+S + RL+++++ T + P ++ L L L G + N +P N
Sbjct: 43 ESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNL 102
Query: 1047 TLLNFLILRQNQLTGVR--LASNKLIGRIPSMIFN-NSNIEAIQLYGNHFSGHLPSSIGP 1103
L I +LT + N I IP +I SN++ + L N LPS +
Sbjct: 103 NRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR- 160
Query: 1104 YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSL 1163
LPNL+ L L N+LS +P + N S + L LS N S +P L+ LDLS
Sbjct: 161 NLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218
Query: 1164 NHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELR 1223
N + +SL+N + L L L NN L+ LP SIGNLS +LE S+ ++
Sbjct: 219 NSII--------ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS-NLETLDLSNNQIS 268
Query: 1224 GAIPVEFEGEIPSGGPFVNFTAESLMQNLVL 1254
I S G N L N +
Sbjct: 269 ---------SISSLGSLTNLRELDLSGNSLS 290
|
Length = 394 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-05
Identities = 47/193 (24%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRNLAKIVSS 1399
LG G +++VYK + +G A+K+ S++ + + F A E +++ ++H N+ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ +YM L +++ H L+ M + L Y+H + I+H
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHR 127
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTSG 1517
DLKP N+L+ L DFG+A+ + S + + T+ Y P+ G+ S++
Sbjct: 128 DLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATD-YSSAL 185
Query: 1518 DVYSFGILMMETL 1530
D++ G + +E L
Sbjct: 186 DIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 50/195 (25%), Positives = 96/195 (49%), Gaps = 19/195 (9%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQED------RALKSFDAECEVMRRIRHRNLAK 1395
+G G + +V+KA + A+K L +D AL+ E +++ ++H+N+ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ + L+ +Y Q L+K+ S N ++ E M + L + H S +
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIV 1513
++H DLKP N+L++ + L DFG+A+ G+ + + T+ Y P+ +G++
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKL-Y 177
Query: 1514 STSGDVYSFGILMME 1528
STS D++S G + E
Sbjct: 178 STSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 10/192 (5%)
Query: 755 GSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGF 814
GS G V+ T +G KV + G K+ E ++L+ + HR ++ +I +
Sbjct: 103 GSEGEVFVCT-KHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRW--- 157
Query: 815 KALILEYMPQGSLEKWLY-SHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPS 873
K+ + MP+ + + Y L ++Q + I + AL YLH +IH D+K
Sbjct: 158 KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTE 214
Query: 874 NVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFG 932
N+ LD+ A L DFG + LD Q + T +PE + D++S G
Sbjct: 215 NIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAG 274
Query: 933 ILMIETFTRKMP 944
+++ E + +
Sbjct: 275 LVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-05
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNV-AIKVFNLQLDGAIKSFDAEC-----EVLRRVRH 799
F+ ++G GSFG V A + AIK+ L+ D I+ D EC VL
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 800 RNLVKIISSCSNHGFKAL-----ILEYMPQGSLEKWLYSHKYTLNIQ--QRLDIMIDVAS 852
+ + SC F+ + ++EY+ G L +Y + + Q + +++
Sbjct: 60 PPFLTQLHSC----FQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISV 112
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK--LLDGEDSVTQTMTLATFG 910
L +LH +I+ DLK NV+LD + ++DFG+ K ++DG VT T
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPD 166
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
Y+APE + D +++G+L+ E + P DE+F
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 1343 LGTGIFSSVYKATFADGTN-AAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G +++V+K N A+K L+ E+ A + E +++ ++H N+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
L+ +Y+ L+++L + L+++ M + L Y H+ I+H D
Sbjct: 73 HTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRD 128
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTSGD 1518
LKP N+L+++ L DFG+A+ V + + + T+ Y P+ GS ST D
Sbjct: 129 LKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTE-YSTPID 186
Query: 1519 VYSFGILMMETLTRRKPTDDMFTG 1542
++ G ++ E T R MF G
Sbjct: 187 MWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-05
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 44/230 (19%)
Query: 751 LIGAGSFGSVYKATLPY-GMNVAIKVFNLQL-DGAI--KSFDAECEVLRRVRHRNLVKII 806
LIG G G VY A P VA+K L + + K F E ++ + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 807 SSCSN-----------HGF--KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASA 853
S CS+ G+ K+L+ + SL K L + T ++ L I + +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL--AEKT-SVGAFLSIFHKICAT 125
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED------------SVT 901
+EY+H V+H DLKP N+LL + D+G + E+
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 902 QTMT-----LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+MT + T YMAPE G ST D+Y+ G+++ + T P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASEST--DIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 745 GFSESNLIGAGSFGSVYKATLPYGMN-VAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV 803
G++ + GS G V+ AT P + V +K+ G + E +L+ V H +++
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVI 120
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
++ + + ++L + L +L L I Q L I + L YLH
Sbjct: 121 RMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH-AQR- 177
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM---APEYGSEG 920
+IH D+K N+ ++D + D G ++ V L G + APE +
Sbjct: 178 -IIHRDVKTENIFINDVDQVCIGDLGAAQF-----PVVAPAFLGLAGTVETNAPEVLARD 231
Query: 921 IVSTCGDVYSFGILMIET--FTRKMPTDEMFTGETSLK 956
++ D++S GI++ E + + D T E +K
Sbjct: 232 KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
|
Length = 357 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 10/104 (9%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-AT 1499
V L+YLH+ I++ DLK N+LLD + + DFG+ K +G+ +T T T
Sbjct: 110 VVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGT 164
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
++APE +E + + D + G+L+ E L P F G+
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 752 IGAGSFGSVYKATLPYGMNVA-IKVFNLQLDGAIK---SFDAECEVLRRVRHRNLVKIIS 807
IG G FG V + + VA + V L+ + + K F + + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 808 SCSNHGFKALILEYMPQGSL------EKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
C L+ EY G L E+W + L +Q+ + ++A+ + ++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKHN 119
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSE- 919
+H DL N L D + D+GI ED + T+ ++APE E
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 920 --GIVST----CGDVYSFGILMIETF 939
G+++ +V++ G+ + E F
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-05
Identities = 43/156 (27%), Positives = 63/156 (40%), Gaps = 22/156 (14%)
Query: 1390 HRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLH 1449
+ N K+ S + LI+ Y+ G L L L E + I+ + AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK-IIRQLVEALNDLH 126
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMV-AHLGDFGIAK------LLDGVDSMKQTMTLATIGY 1502
+IIH D+K NVL D +L D+G+ K DG T+ Y
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-----------TLDY 172
Query: 1503 MAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
+PE S D ++ G+L E LT + P +
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK--LLD 1486
L+++ L VA +++L S + IH D+ NVLL D VA + DFG+A+ + D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 1487 GVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMME 1528
+K L + +MAPE + + + DV+S+GIL+ E
Sbjct: 266 SNYVVKGNARLP-VKWMAPESIFDCVYTVQSDVWSYGILLWE 306
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-05
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPYGMNV-AIKVFN---LQLDGAIKSFDAECEVLRRVRH 799
D F +IG G+FG V + + + A+K+ N + F E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
+ + + + + + L+++Y G L L + L + ++ A+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE---- 915
H +H D+KP NVLLD + L+DFG ++ + +V ++ + T Y++PE
Sbjct: 121 LH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 916 -------YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
YG E C D +S G+ M E + P
Sbjct: 178 MEDGMGKYGPE-----C-DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-05
Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 7/152 (4%)
Query: 1381 ECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLY-SHNYLLNIEQRLDIMI 1439
E ++R I H ++ ++ + + F LIL P+ + + Y + + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499
V A++YLH+ IIH D+K N+ ++ LGDFG A +++ K T
Sbjct: 190 SVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
I APE + + D++S GI++ E T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-05
Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 1061 GVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSG 1120
G+ L + L G IP+ I ++++I L GN G++P S+G + +L+ L L N+ +G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNG 480
Query: 1121 IIPSSICNASQVILLGLSENLFSGLIPNTFG 1151
IP S+ + + +L L+ N SG +P G
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-05
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 1331 RLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRH 1390
R + N++G G F VY+A D T+ + I + +D K + E +M+ + H
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDPQYK--NRELLIMKNLNH 118
Query: 1391 RNLAKIVSSCSNPGFKA--------LILQYMPQGSLEKWL--YSHNYLLNIEQRLDIMI- 1439
N+ + FK ++++++PQ ++ K++ Y+ N L + +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLV 172
Query: 1440 -----DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAK-LLDGVDSMK 1492
+ AL Y+H S I H DLKP N+L+D + L DFG AK LL G S+
Sbjct: 173 KLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 1493 QTMTLATIGYMAPE--YGSEGIVSTSGDVYSFGILMMETL 1530
+ + Y APE G+ +T D++S G ++ E +
Sbjct: 230 Y---ICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 751 LIGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVK 804
+IG GS+ V L Y M V IK + D I E V H LV
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKV-IKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLH 858
+ S ++E++ G L + + Q++L +++ AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL-------MFHMQRQRKLPEEHARFYSAEISLALNFLH 113
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK--LLDGEDSVTQTMTLATFGYMAPEY 916
+I+ DLK NVLLD + L+D+G+ K + G+ T + T Y+APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEI 167
Query: 917 --GSEGIVSTCGDVYSFGILMIETFTRKMPTD 946
G + S D ++ G+LM E + P D
Sbjct: 168 LRGEDYGFSV--DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-A 1498
++A AL YLH S +I++ DLKP N+LLD L DFG+ K +G+ T T
Sbjct: 104 EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCG 158
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETL 1530
T Y+APE + + D + G ++ E L
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 39/214 (18%)
Query: 1334 TNGFSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDA---------ECE 1383
TN + + +G G F V A G N AIK + +K F E +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61
Query: 1384 VMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC 1443
+++ +RH N+ + +P + + L + L S Q + +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYF--LYQILR 119
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
L+Y+H S ++H DLKPSN+L++++ + DFG+A++ D + T ++T Y
Sbjct: 120 GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYR 172
Query: 1504 APE-------YGSEGIVSTSGDVYSFGILMMETL 1530
APE Y E D++S G + E L
Sbjct: 173 APEIMLTWQKYDVE------VDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 751 LIGAGSFGSVYKATLPYGMN----VAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKI 805
++G GSFG +A L +N A+K L A++ E +L +++H N+V
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQR-LDIMIDVASALEYLHHGHPTP 864
S G +++EY G L + + + L + L + + ++++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--- 120
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
V+H D+K N+ L + L DFG ++LL + T + T Y+ PE +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYNN 179
Query: 925 CGDVYSFGILMIETFTRKMP 944
D++S G ++ E T K P
Sbjct: 180 KSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-05
Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 52/245 (21%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNV-AIKVFNLQLDGAIKSFDAECEVL-RRV-----R 798
F+ ++G GSFG V A + AIK+ L+ D I+ D EC ++ +RV +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQ--------RLDIMIDV 850
L ++ S ++EY+ G L +IQQ + ++
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---------MYHIQQVGKFKEPHAVFYAAEI 110
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG 910
A L +LH +I+ DLK NV+LD + ++DFG+ K T+T T
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPD 166
Query: 911 YMAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLR 964
Y+APE YG D ++FG+L+ E + P F GE E+ L
Sbjct: 167 YIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQPP----FDGED------EDELF 210
Query: 965 LAVTE 969
++ E
Sbjct: 211 QSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-05
Identities = 17/60 (28%), Positives = 27/60 (45%)
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
NL L L N L+ + + L VL+LS N + + F L+ L+L+ + L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 27/77 (35%), Positives = 48/77 (62%), Gaps = 4/77 (5%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467
L+++Y+ G ++ L+ + Y + E + + +VA AL+YLH+ IIH DLKP N+L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYF-DEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNML 136
Query: 1468 LDDDMVAHLGDFGIAKL 1484
+ ++ L DFG++K+
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-05
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 752 IGAGSFGSVYKATLPYGMN-VAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G G++ +V+K N VA+K L+ + GA + E +L+ ++H N+V +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
L+ EY+ + L++++ NI ++ I + L L + H V+H D
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGSEGIVSTCGD 927
LKP N+L+++ L+DFG+++ + T + + T Y P+ GS ST D
Sbjct: 130 LKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSE-YSTQID 187
Query: 928 VYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRL 965
++ G + E + + +F G T VE+ L L
Sbjct: 188 MWGVGCIFFEMASGR----PLFPGST-----VEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 752 IGAGSFGSVYKATLPYGMN---VAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVKII 806
+G G++G VYKA G + A+K Q++G S A E +LR ++H N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 807 SSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY-----LHH 859
+H + L+ +Y + L + H+ + ++ + + + +L Y +H+
Sbjct: 65 KVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 860 GHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGEDSVTQTM--TLATFGYMA 913
H V+H DLKP+N+L+ + ++D G ++L + + + TF Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 914 PE--YGSEGIVSTCGDVYSFGILMIETFTRK 942
PE G+ D+++ G + E T +
Sbjct: 184 PELLLGARHYTKAI-DIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 752 IGAGSFGSVYKATLPYGMN---VAIKVFNLQLDGAIKSFDA--ECEVLRRVRHRNLVKII 806
+G G++G VYKA G + A+K Q++G S A E +LR ++H N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 807 SSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY-----LHH 859
+H + L+ +Y + L + H+ + ++ + + + +L Y +H+
Sbjct: 65 KVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 860 GHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGEDSVTQTM--TLATFGYMA 913
H V+H DLKP+N+L+ + ++D G ++L + + + TF Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 914 PE--YGSEGIVSTCGDVYSFGILMIETFTRK 942
PE G+ D+++ G + E T +
Sbjct: 184 PELLLGARHYTKAI-DIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-05
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 288 LGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL 347
LGL DNQ L G IP+ I +++ I L GN + GN+P S G ++ +L L L
Sbjct: 423 LGL-DNQ-------GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDL 473
Query: 348 WGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFG 385
N+ +G IP S+ + L +L L+ N SG V G
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-05
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQTMT--LATF 909
L+Y+H + V+H DLKP N+L++ D + DFG+++ + MT +AT
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 910 GYMAPEYG-SEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
Y APE S + DV+S G ++ E RK +F G+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-05
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVM-------RRIRHRNL 1393
++G G F V A A+ A+K+ LQ+ LK E +M + ++H L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKK-KEEKHIMSERNVLLKNVKHPFL 58
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+ S +L Y+ G L L L R ++A AL YLH S
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEGI 1512
+I++ DLKP N+LLD L DFG+ K + ++ T T T Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 1513 VSTSGDVYSFGILMMETLTRRKPTDDMFTGEV 1544
+ D + G ++ E L P T E+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 1343 LGTGIFSSV-YKATFADGTNAAIKIF--SLQEDRALKSFDAECEVMRRIRHRNLAKIV-- 1397
+G+G + +V G AIK Q + K E +++ ++H N+ ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 1398 --SSCSNPGFKALILQYMP-QGSLEKWLYSHNYLLNIEQRLDIMI-DVACALEYLHQGYS 1453
S F L MP G+ L H L E R+ ++ + L+Y+H +
Sbjct: 83 FTPDLSLDRFHDFYL-VMPFMGTDLGKLMKHEKL--SEDRIQFLVYQMLKGLKYIH---A 136
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV 1513
IIH DLKP N+ +++D + DFG+A+ D + T + T Y APE +
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS----EMTGYVVTRWYRAPEVILNWMH 192
Query: 1514 STSG-DVYSFGILMMETLTRR 1533
T D++S G +M E LT +
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-05
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPYGMNV-AIKVFN---LQLDGAIKSFDAECEVLRRVRH 799
+ F +IG G+FG V L V A+K+ N + F E +VL +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
+ + + + + L+++Y G L L + L + ++ A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE---- 915
H +H D+KP N+L+D + L+DFG L + +V ++ + T Y++PE
Sbjct: 121 LH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 916 -------YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
YG E C D +S G+ M E + P
Sbjct: 178 MEDGKGKYGPE-----C-DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-05
Identities = 64/250 (25%), Positives = 95/250 (38%), Gaps = 50/250 (20%)
Query: 744 DGFSESNLIGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR 798
D F +IG G+FG V Y M + K L+ + + AE ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
+VK+ S + LI+E++P G + L K TL+ + + + A++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIH 118
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG---------------EDSVTQT 903
IH D+KP N+LLD LSDFG+ L D Q
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 904 M-------------------TLATFGYMAPE-YGSEGIVSTCGDVYSFGILMIETFTRKM 943
M T+ T Y+APE + G C D +S G++M E
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC-DWWSLGVIMYEMLIGYP 234
Query: 944 PTDEMFTGET 953
P F ET
Sbjct: 235 P----FCSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-05
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 16/146 (10%)
Query: 837 TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896
L+ + L VA + +L + IH DL N+LL + + DFG+++ +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 897 EDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT------RKMPTDEMF 949
+ + V + +MAPE + + DV+S+GIL+ E F+ MP D F
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 950 TGETSLKKWVEESLRLAVTEVVDAEL 975
K ++E R+ E +E+
Sbjct: 327 Y------KMIKEGYRMLSPECAPSEM 346
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 743 TDGFSESNLIGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HR 800
+D + IG G++G V+K G A+K+ + D + +AE +L+ + H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHP 75
Query: 801 NLVKIISSCSNHGFKA-----LILEYMPQGSLEKWLYSHKYTLNIQQRLD---IMIDVAS 852
N+VK K L+LE GS+ + K L +R++ I +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERMEEPIIAYILHE 132
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
AL L H H IH D+K +N+LL + L DFG+S L + + ++ T +M
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSVGTPFWM 191
Query: 913 APEYGS--EGIVST----CGDVYSFGILMIE 937
APE + + + ST C DV+S GI IE
Sbjct: 192 APEVIACEQQLDSTYDARC-DVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 786 SFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD 845
+F ++ ++ H++LVK+ C ++ EY+ G L+ +L+ K +++ +LD
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLD 105
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDT----VAHLSDFGISK-LLDGE 897
+ +ASAL YL ++H ++ N+L+ + LSD GI +L E
Sbjct: 106 VAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162
Query: 898 DSVTQTMTLATFGYMAPEYGSEGIVST--CGDVYSFGILMIETFTR 941
+ V + ++APE G S D +SFG ++E +
Sbjct: 163 ERVERI------PWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 46/227 (20%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC- 1400
+G G + VYKA G A+K + D E +R +L +++S
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 1401 ------------SNPGFKA---LILQYMPQGSLEKWLYSH-----NYL-LNIEQRLDIMI 1439
G K L+ +Y+ L+K++ S+ L + M
Sbjct: 62 YIVRLLDVEHVEEKNG-KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF--MY 117
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
+ + + H ++H DLKP N+L+D + + D G+ + + T +
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYTHEIV 173
Query: 1499 TIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
T+ Y APE GS ST D++S G + E ++R++P +F G+
Sbjct: 174 TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAE-MSRKQP---LFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-05
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK--LLDGVDSMKQTMTLATIG 1501
AL+Y+H + ++ H DLKP N+L + D + DFG+A+ D ++ T +AT
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 1502 YMAPEY-GS-EGIVSTSGDVYSFGILMMETLTRR 1533
Y APE GS + + D++S G + E LT +
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-05
Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 1042 NLGNCTLLNFL---ILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLP 1098
L N L F+ I + L + L+ N + G IP + + +++E + L N F+G +P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 1099 SSIGPYLPNLQGLILWGNNLSGIIPSSI 1126
S+G L +L+ L L GN+LSG +P+++
Sbjct: 484 ESLGQ-LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-05
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 14/203 (6%)
Query: 751 LIGAGSFGSVYKATLPYGMNV-AIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKI 805
+IG GS+ V L + A+KV +L D I E V + H LV +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S ++EY+ G L + + R +++ AL YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHE---RGI 117
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISK--LLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
I+ DLK NVLLD + L+D+G+ K L G+ T + T Y+APE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYG 174
Query: 924 TCGDVYSFGILMIETFTRKMPTD 946
D ++ G+LM E + P D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 752 IGAGSFGSVYKATLP--------YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV 803
+G G+F ++K + V +KV + +SF ++ ++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
C ++ EY+ GSL+ +L +K +NI +L++ +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---K 119
Query: 864 PVIHCDLKPSNVLL----DDDT----VAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
+ H ++ NVLL D T LSD GIS + ++ + L ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLERIPWVPPE 174
Query: 916 YGSEG-IVSTCGDVYSFGILMIETFT 940
+S D +SFG + E F+
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 35/161 (21%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 1377 SFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLD 1436
+F +M ++ H++L K+ C ++ +Y+ G L+ +L+ +++ +LD
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLD 105
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDM----VAHLGDFGIAKLLDGVD 1489
+ +A AL YL ++H ++ N+L+ + L D GI + +
Sbjct: 106 VAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162
Query: 1490 SMKQTMTLATIGYMAPEYGSEGIVSTS--GDVYSFGILMME 1528
+ I ++APE G S + D +SFG ++E
Sbjct: 163 ER-----VERIPWIAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-05
Identities = 63/250 (25%), Positives = 95/250 (38%), Gaps = 50/250 (20%)
Query: 744 DGFSESNLIGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR 798
+ F +IG G+FG V Y M + K L+ + + AE ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEAD 59
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
+VK+ S + LI+E++P G + L K TL ++ + + A++ +H
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIH 118
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG---------------EDSVTQT 903
IH D+KP N+LLD LSDFG+ L D Q
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 904 M-------------------TLATFGYMAPE-YGSEGIVSTCGDVYSFGILMIETFTRKM 943
M T+ T Y+APE + G C D +S G++M E
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC-DWWSLGVIMYEMLIGYP 234
Query: 944 PTDEMFTGET 953
P F ET
Sbjct: 235 P----FCSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-05
Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 30/112 (26%)
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
A++ +H +H D+KP NVLLD + L+DFG L + +V + + T Y+
Sbjct: 114 AIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170
Query: 913 APE-----------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+PE YG E C D +S G+ M EM GET
Sbjct: 171 SPEILQAMEDGKGRYGPE-----C-DWWSLGVCMY----------EMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-05
Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 9/79 (11%)
Query: 983 GADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN 1042
D+ L+ +++S N I G IP ++G++T L L L +Y N F G IP++
Sbjct: 435 PNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL------SY---NSFNGSIPES 485
Query: 1043 LGNCTLLNFLILRQNQLTG 1061
LG T L L L N L+G
Sbjct: 486 LGQLTSLRILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-05
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 215 LYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGR 274
L L+ L+G P I + L+ I L+ NS+ G++P L + SL+ L+L G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL-GSITSLEVLDLSYNSFNGS 481
Query: 275 IPKDIGNCTLLNYLGLRDNQLT 296
IP+ +G T L L L N L+
Sbjct: 482 IPESLGQLTSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 7e-05
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 1/61 (1%)
Query: 138 RLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNE 197
L+ +DLS+NR++ + D L L+ D+S N +T P + L+ L +S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 198 L 198
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-05
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 838 LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDG 896
L++ L VA +++L + IH D+ NVLL D VA + DFG+++ +++
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+ V + +MAPE + + + DV+S+GIL+ E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-05
Identities = 30/106 (28%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 1436 DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK--LLDG--VDSM 1491
+IM D+ LEY+H I H D+KP N+++D + ++ D+GIA ++ G ++
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 1492 KQTMTL--ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
K+ L T+ Y + + V+ GD+ S G M++ + P
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-05
Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 68/210 (32%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ-GYSTSIIHCDLKPSNV 1466
LI++Y+P G + L + E R I + A++ +H+ GY IH D+KP N+
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLGY----IHRDIKPDNL 132
Query: 1467 LLDDDMVAHLGDFGI------------------AKLLDGVDSMKQTMT------------ 1496
LLD L DFG+ A + +D + + M+
Sbjct: 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNR 192
Query: 1497 --LA--TIG---YMAPE------YGSEGIVSTSGDVYSFGILMMETLTRRKP--TDDMFT 1541
LA T+G Y+APE Y E D +S G++M E L P +D+
Sbjct: 193 RALAYSTVGTPDYIAPEVFLQTGYNKE------CDWWSLGVIMYEMLVGYPPFCSDN--P 244
Query: 1542 GEVCLK--HW-------VEESLPDAVTDVI 1562
E K +W E L D+I
Sbjct: 245 QETYRKIINWKETLQFPDEVPLSPEAKDLI 274
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-05
Identities = 48/188 (25%), Positives = 79/188 (42%), Gaps = 45/188 (23%)
Query: 789 AECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMI 848
AE ++L + +VK+ S + + LI+EY+P G + L K T ++ +
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIA 108
Query: 849 DVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL------------- 894
+ A++ +H G+ IH D+KP N+LLD LSDFG+ L
Sbjct: 109 ETILAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 895 -----DGEDSVTQTM-------------------TLATFGYMAPE-YGSEGIVSTCGDVY 929
+ D +++ M T+ T Y+APE + G C D +
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC-DWW 223
Query: 930 SFGILMIE 937
S G++M E
Sbjct: 224 SLGVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 29/171 (16%)
Query: 789 AECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD--- 845
+E L H +VK + LI+EY G L K I+QRL
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHL 164
Query: 846 ---------IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896
+ + AL+ +H ++H DLK +N+ L + L DFG SK
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-- 219
Query: 897 EDSVTQTMTLATFG---YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
DSV+ + + G Y+APE S D++S G+++ E T P
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488
L+ E L VA + +L S + IH DL N+LL + + DFG+A+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN- 266
Query: 1489 DS---MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMME 1528
DS +K L + +MAPE + + DV+S+GIL+ E
Sbjct: 267 DSNYVVKGNARLP-VKWMAPESIFNCVYTFESDVWSYGILLWE 308
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 15/198 (7%)
Query: 1343 LGTGIFSSVYKAT---FADG-----TNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLA 1394
LG G F+ ++K D T +K+ +SF +M ++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
C ++ +Y+ GSL+ +L + L+NI +L++ +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---K 119
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD---GVDSMKQTMTLATIGYMAPEYGSEG 1511
+ H ++ NVLL + G+ KL D + + + + L I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 1512 -IVSTSGDVYSFGILMME 1528
+S + D +SFG + E
Sbjct: 180 QNLSLAADKWSFGTTLWE 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 42/202 (20%), Positives = 72/202 (35%), Gaps = 28/202 (13%)
Query: 977 SSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFT 1036
+ E + L + LK L +S N ++ +P+ + NL+ L L L GN +
Sbjct: 150 NKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS--------- 199
Query: 1037 GRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH 1096
+P + + L L L N + + + + L + NN + + GN
Sbjct: 200 -DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGN----- 253
Query: 1097 LPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFG--NCR 1154
L NL+ L L N +S SS+ + + + L LS N S +P
Sbjct: 254 --------LSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL 303
Query: 1155 QLQILDLSLNHLTTGSSTQGHS 1176
+L + L
Sbjct: 304 ELLLNLLLTLKALELKLNSILL 325
|
Length = 394 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 42/195 (21%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 1343 LGTGIFSSVYK--ATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G +++V+K + + A +I E+ A + E +++ ++H N+ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
L+ +Y+ + L++++ ++++ + + L Y H+ ++H D
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRD 129
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTSGD 1518
LKP N+L+++ L DFG+A+ V + + + T+ Y P+ GS ST D
Sbjct: 130 LKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSE-YSTQID 187
Query: 1519 VYSFGILMMETLTRR 1533
++ G + E + R
Sbjct: 188 MWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 39/131 (29%), Positives = 56/131 (42%), Gaps = 21/131 (16%)
Query: 1444 ALEYLHQ-GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGY 1502
A++ +HQ GY +H D+KP NVLLD + L DFG L +++ + + T Y
Sbjct: 114 AIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169
Query: 1503 MAPEY-----GSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC-------LKHWV 1550
++PE +G D +S G+ M E L P F E + H
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP----FYAESLVETYGKIMNHKE 225
Query: 1551 EESLPDAVTDV 1561
P VTDV
Sbjct: 226 HFQFPPDVTDV 236
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-04
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 196 NELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDL 254
NEL +P+N+ GN+ L Y N N L P T+ + +++ + L+ N + +L
Sbjct: 209 NELKS-LPENLQGNIKTL---YANSNQLT-SIPATLPD--TIQEMELSINRI-----TEL 256
Query: 255 CRRLPS-LQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFN 313
RLPS LQ L+L +P+++ L YL + DN + A+ +G+ + +
Sbjct: 257 PERLPSALQSLDL-FHNKISCLPENLPEE--LRYLSVYDNSIRTLPAHLPSGITHLNVQS 313
Query: 314 NS----------NIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNA 363
NS ++ ++ N L+ +LP+S LP L++ N V+P ++
Sbjct: 314 NSLTALPETLPPGLKTLEAGENALT-SLPAS----LPPELQVLDVSKNQITVLPETL--P 366
Query: 364 SKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLA 401
+T L++SRN + L N LQI+ + + L
Sbjct: 367 PTITTLDVSRNALTNLPENLPA---ALQIMQASRNNLV 401
|
Length = 754 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 14/197 (7%)
Query: 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV 803
GF+ + GS G V++++ P Y V +K G S E +LRR+ H ++
Sbjct: 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPAVL 223
Query: 804 KIISSCSNHGFKALIL-EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHP 862
++ G L+L +Y + L +L + L + Q + + SA++Y+H
Sbjct: 224 ALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG--- 278
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPEYGSEGI 921
+IH D+K NVL++ L DFG + G S +A T APE +
Sbjct: 279 EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP 338
Query: 922 VSTCGDVYSFGILMIET 938
+ D++S G+++ E
Sbjct: 339 YTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 3e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 1107 NLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHL 1166
NL+ L L N L+ I + + +L LS N + + P F L+ LDLS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-04
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG G FG V+ K T + AI L+ + E V+R ++H+N+V+ I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 808 SCSNHGFKAL--ILEYMPQGSLEKWLYS-HKYTLNIQQR--LDIMIDVASALEYLHHGHP 862
N + L ++E+ G L + + +K I++ +DI + AL Y H+
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 863 TP----VIHCDLKPSNVL-----------------LDDDTVAHLSDFGISKLLDGEDSVT 901
P V+H DLKP N+ L+ +A + DFG+SK + G +S+
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-GIESMA 198
Query: 902 QTMTLATFGYMAPEYGSEGIVS--TCGDVYSFGILMIETFTRKMP 944
+ + T Y +PE S D+++ G ++ E + K P
Sbjct: 199 HS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-04
Identities = 56/237 (23%), Positives = 88/237 (37%), Gaps = 42/237 (17%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRN 1392
F ++G G F V D G A+KI + E + AE +++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ K+ S + LI++++P G + L + L E + I + A++ +HQ
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQ-- 119
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV---------------DSMKQTM-- 1495
IH D+KP N+LLD L DFG+ L D Q M
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 1496 -----------------TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
T+ T Y+APE + + D +S G++M E L P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-04
Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 845 DIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK--LLDGED--- 898
+IM D+ + LEY+H HG + H D+KP N+++D + ++ D+GI+ ++ G+
Sbjct: 130 NIMKDMLTTLEYIHEHG----ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185
Query: 899 -SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+ + T Y + + V+ GD+ S G M++ K+P
Sbjct: 186 SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-04
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 1381 ECEVMRRIRHRNLAKIVSSCSNPGFKALIL-QYMPQGSLEKWLYSHNYLLNIEQRLDIMI 1439
E ++RR+ H + ++ G L+L +Y + L +L + L + Q +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 1440 DVACALEYLH-QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
+ A++Y+H +G IIH D+K NVL++ LGDFG A G S +A
Sbjct: 268 QLLSAIDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 1499 -TIGYMAPEYGSEGIVSTSGDVYSFGILMMET 1529
T+ APE + + S D++S G+++ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-04
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 1363 AIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL--ILQYMPQGSLEK 1420
AI L+E R E VMR ++H+N+ + + N + L ++++ G L +
Sbjct: 45 AISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 1421 WLYS-HNYLLNIEQR--LDIMIDVACALEYLHQ----GYSTSIIHCDLKPSNVLLDDDM- 1472
+ + IE+ +DI + AL Y H ++H DLKP N+ L +
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 1473 ----------------VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS-- 1514
+A +GDFG++K + G++SM + + T Y +PE S
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNI-GIESMAHS-CVGTPYYWSPELLLHETKSYD 221
Query: 1515 TSGDVYSFGILMMETLTRRKP 1535
D+++ G ++ E + + P
Sbjct: 222 DKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 3/46 (6%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV 797
I A S V++A L G VA+KV Q G K ++ ++L+ +
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKV---QRPGVKKRIRSDLKLLKFL 61
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-04
Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 19/99 (19%)
Query: 1004 GTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVR 1063
G IP + L L+ ++L GN++ G IP +LG+ T L L L N G
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIR---------GNIPPSLGSITSLEVLDLSYNSFNGS- 481
Query: 1064 LASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIG 1102
IP + +++ + L GN SG +P+++G
Sbjct: 482 ---------IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-04
Identities = 38/162 (23%), Positives = 63/162 (38%), Gaps = 16/162 (9%)
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQ-------- 841
E L R+ H N++KI + YM + LYS Y
Sbjct: 213 EILALGRLNHENILKIEEILRSEANT-----YMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
Q IM + A+EY+H +IH D+K N+ L+ D L DFG + + E
Sbjct: 268 QTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKM 943
+ T +PE + D++S G+++++ +
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-04
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 352 LSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSF 411
L G IP+ I L + LS N G + + G+ L++L+L+Y+ GS+ +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF-NGSIPE---- 484
Query: 412 FSSLTNCRYLRYLAIQTNPWKGILPNSVG 440
SL LR L + N G +P ++G
Sbjct: 485 --SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 8e-04
Identities = 23/61 (37%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 187 KLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNS 245
LK L +S N LT L L L L+GNNL P F + SLR + L+ N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 246 L 246
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-04
Identities = 50/207 (24%), Positives = 76/207 (36%), Gaps = 66/207 (31%)
Query: 746 FSESNL--IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV------ 797
FSE I + S V++A L G VA+KV Q G + +A+ ++LRR+
Sbjct: 125 FSEFEPEPIASASIAQVHRAVLKSGEEVAVKV---QRPGIRERIEADLKLLRRLARLIKR 181
Query: 798 -----RHRNLVKIISSCSNHGFKALILE--YMPQG-SLEK-----------------WLY 832
R +LV+++ K L E Y + + E+ W Y
Sbjct: 182 LPPGGRRLDLVEVVDEFE----KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEY 237
Query: 833 SHKYTLNIQQRLD-IMIDVASALE--------------------YLHHGHPTPVIHCDLK 871
+ + L + +D I I +AL+ L G H D
Sbjct: 238 TTRRVL-TMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGF----FHADPH 292
Query: 872 PSNVLLDDDTVAHLSDFGISKLLDGED 898
P N+L+ D L DFGI LD +
Sbjct: 293 PGNILVRSDGRIVLLDFGIVGRLDPKF 319
|
Length = 517 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 0.001
Identities = 24/59 (40%), Positives = 34/59 (57%), Gaps = 9/59 (15%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLG 1044
LG L+ L +S N G+IP ++G LT LR L+L+GN+L +GR+P LG
Sbjct: 462 LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL---------SGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRIRHRN---LAKI 1396
LG G +++VYK + G A+K L+ + F A E +++ ++H N L I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHDI 71
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+ + L+ +Y+ L++++ L++ + + L Y HQ +
Sbjct: 72 IHTKKT---LTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---V 124
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVS 1514
+H DLKP N+L+ + L DFG+A+ V S + + T+ Y P+ GS S
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTE-YS 182
Query: 1515 TSGDVYSFGILMMETLTRR 1533
TS D++ G + E T R
Sbjct: 183 TSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 48/176 (27%), Positives = 69/176 (39%), Gaps = 64/176 (36%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ-GYSTSIIHCDLKPSNV 1466
LI++++P G L L ++ R M + A+E +H+ G+ IH D+KP N+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVHKLGF----IHRDIKPDNI 132
Query: 1467 LLDDDMVAHLGDFGIA-------------KLLDG--------------VDSMKQTM---- 1495
L+D L DFG++ KLL G VDS+ TM
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKD 192
Query: 1496 ---------------TLATIGYMAPE------YGSEGIVSTSGDVYSFGILMMETL 1530
T+ T Y+APE YG E D +S G +M E L
Sbjct: 193 QIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE------CDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 0.001
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 20/107 (18%)
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499
++ A+ +HQ +H D+KP NVLLD + L DFG ++ +++ ++ + T
Sbjct: 110 EMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGT 166
Query: 1500 IGYMAPE-----------YGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
Y++PE YG E D +S G+ M E L P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 0.001
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 23/170 (13%)
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY-SHKYTLNIQQRLDIMI 848
E +LR + H +++++ + + + F LIL P+ + + Y + K + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL---LDGEDSVTQTMT 905
V A++YLH +IH D+K N+ ++ L DFG + ++ T
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSL 955
+AT APE + D++S GI++ EM T SL
Sbjct: 247 IAT---NAPELLARDPYGPAVDIWSAGIVLF----------EMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 0.001
Identities = 55/237 (23%), Positives = 87/237 (36%), Gaps = 42/237 (17%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRN 1392
F ++G G F V D G A+KI + E + AE +++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ K+ S + LI++++P G + L + L + I + A++ +HQ
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQ-- 119
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV---------------DSMKQTM-- 1495
IH D+KP N+LLD L DFG+ L D Q M
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 1496 -----------------TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
T+ T Y+APE + + D +S G++M E L P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 0.001
Identities = 81/295 (27%), Positives = 108/295 (36%), Gaps = 71/295 (24%)
Query: 139 LRIIDLSSNRISGNLFDDMCNSL-TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNE 197
LR IDL R S NL + S+ T LE+ +S +LPSS+ +KL+ L +S E
Sbjct: 636 LRNIDL---RGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCE 692
Query: 198 LTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVD---- 253
+P I NL L L L+G + FP N+S L + A +L ++
Sbjct: 693 NLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLENLDE 751
Query: 254 --LCRRL-------------------PSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRD 292
LC PSL L L D + +P I N L +L
Sbjct: 752 LILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLE--- 808
Query: 293 NQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352
I N N+E LP TGINL +L L L G +
Sbjct: 809 ------------------IENCINLE-----------TLP--TGINLESLESLDLSGCSR 837
Query: 353 SGVIPSSICNASKL----TVLE---LSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
P N S L T +E FS L C LQ ++L S+L
Sbjct: 838 LRTFPDISTNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKL 892
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 6/95 (6%)
Query: 799 HRNLVKIISSCSN-HGFKALILEYMPQGSLE--KWLYSHKYTLNIQQRLDIMIDVASALE 855
+R S + G + + P+ + +++ + + + +A L+
Sbjct: 38 NRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTEDFSDPENLEKIAKLLK 97
Query: 856 YLHHGHPTPVI--HCDLKPSNVLLDDDTVAHLSDF 888
LH ++ H DL P N LLDD + L D+
Sbjct: 98 KLHSSPLPDLVPCHNDLLPGNFLLDDGRL-WLIDW 131
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 32/155 (20%)
Query: 752 IGAGSFGSVYKA-----TLPYGMNVAIK--VFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
IG G+FG V Y M K V +K AE ++L + +VK
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEADNEWVVK 65
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI---------MIDVASALE 855
+ S + +++Y+P G + +L I RL I + ++ A+E
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDM--------MSLLI--RLGIFEEDLARFYIAELTCAIE 115
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGI 890
+H IH D+KP N+L+D D L+DFG+
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 38/153 (24%), Positives = 54/153 (35%), Gaps = 51/153 (33%)
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG------------ 1487
++ CA+E +H+ IH D+KP N+L+D D L DFG L G
Sbjct: 109 ELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG---LCTGFRWTHDSKYYQK 162
Query: 1488 -----VDSM-----------------------KQTMTLA-----TIGYMAPEYGSEGIVS 1514
DSM + LA T Y+APE +
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547
D +S G+++ E L + P E LK
Sbjct: 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLK 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 46/238 (19%)
Query: 744 DGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFNLQ---LDGAIKSFDAECEVLRR 796
+ F LI G++G+VY K T A+K N Q L I+ E ++L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVFVERDILTF 57
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+ +V + S +++EY+ G L + L + + ALEY
Sbjct: 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFAETVLALEY 116
Query: 857 LH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK---------LLDG--EDSVTQTM 904
LH +G ++H DLKP N+L+ L+DFG+SK L +G E + +
Sbjct: 117 LHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 905 TLATFG---YMAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
G Y+APE YG D ++ GI++ E +P F G+T
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVGCVP----FFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 54/246 (21%), Positives = 83/246 (33%), Gaps = 60/246 (24%)
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRI-PQNIGNLTE----L 212
L EL+ D + + SL S L+ L ++ N L R L + L
Sbjct: 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139
Query: 213 MELYLNGNNLQGEFPPTIFNV----SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
+L L N L+G + L+ + LANN + + L L + L +
Sbjct: 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV-- 197
Query: 269 CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLS 328
L L +N LTD GA+ L + S ++EV+ +L
Sbjct: 198 -------------------LDLNNNGLTDEGASALAETLAS----LKSLEVL-----NLG 229
Query: 329 GNLPSSTGI---------NLPNLLRLYLWGNN--------LSGVIPSSICNASKLTVLEL 371
N + G +LL L L N+ L+ V+ L L+L
Sbjct: 230 DNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKES----LLELDL 285
Query: 372 SRNLFS 377
N F
Sbjct: 286 RGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.002
Identities = 20/63 (31%), Positives = 28/63 (44%), Gaps = 7/63 (11%)
Query: 1135 LGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQN 1194
L LS N + + F L++LDLS N+LT+ S + + LR L L
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISP-------EAFSGLPSLRSLDLSG 57
Query: 1195 NPL 1197
N L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.002
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 19/166 (11%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467
L++ Y G L L L + + ++ A++ +HQ + +H D+KP N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNIL 134
Query: 1468 LDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY-----GSEGIVSTSGDVYSF 1522
+D + L DFG L +++ ++ + T Y++PE +G D +S
Sbjct: 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL 194
Query: 1523 GILMMETLTRRKPTDDMFTGEV-------CLKHWVEESLPDAVTDV 1561
G+ M E L P F E + H P VTDV
Sbjct: 195 GVCMYEMLYGETP----FYAESLVETYGKIMNHKERFQFPAQVTDV 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.003
Identities = 22/59 (37%), Positives = 31/59 (52%)
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNL 222
L+S D+S+N++T + LK L +S N LT P+ L L L L+GNNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.003
Identities = 20/60 (33%), Positives = 27/60 (45%)
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
+L +L L N L L +L+ L+LS N L S P F L + +D S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.003
Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 10/150 (6%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRAL-----KSFDAECEVMRRIRHR 1391
F + LG G F V A D T A + +L++ L AE +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE 61
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
+ ++ S + ++ Y+P G + L R I ++ CA+E +H+
Sbjct: 62 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHK- 119
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGI 1481
IH D+KP N+L+D D L DFG+
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 39/167 (23%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKS-----FDAECEVMRRIRHRNLAKI 1396
L+ G + +Y F G A IK R KS D E +RR R RN A++
Sbjct: 1 LIAKGAEAIIYLGDF-LGLKAVIKE------RVPKSYRHPELD---ERIRRERTRNEARL 50
Query: 1397 VSSCS------------NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACA 1444
+S +P K ++++Y+ L ++ E +++ ++
Sbjct: 51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPL-------KDVIE-EGNDELLREIGRL 102
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491
+ LH I+H DL SN+++ DD + +L DFG+ K D ++
Sbjct: 103 VGKLH---KAGIVHGDLTTSNIIVRDDKL-YLIDFGLGKYSDEIEDK 145
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.003
Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 40/217 (18%)
Query: 132 ELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVS--SNQITG----QLPSS---- 181
EL +M L +DLS N I +++CN + + + V S+ TG +L S+
Sbjct: 25 ELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVML 84
Query: 182 ---LGDCSKLKRLSVSFNELTGRIPQNIGNL----TELMELYLNGNNLQGEFP------- 227
L C +L+++ +S N P+ +G+L T+L+ L LN N L G
Sbjct: 85 LKALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGL-GPIAGGRIGKA 143
Query: 228 -------PTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIG 280
+ L V++ N L L S + L G P+ +
Sbjct: 144 LFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVT 203
Query: 281 N--------CTLLNYLGLRDNQLTDFGANNLTGLIPS 309
L L L+DN T G+ L +
Sbjct: 204 MLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCE 240
|
Length = 388 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.004
Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 235 SLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQ 294
+L+ + L+NN L +P + LP+L+ L+L T P+ L L L N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 295 L 295
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 25/111 (22%), Positives = 45/111 (40%), Gaps = 24/111 (21%)
Query: 794 LRRVRHRNLVKIISSCSNHGFKA------------LILEYMPQGSLEKWLYSHKYTLNIQ 841
LRR R R +I++ G +++EY+ L+ L
Sbjct: 41 LRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA------- 93
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892
R D++ +V + LH ++H DL SN++L + + DFG+ +
Sbjct: 94 -RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGRI-YFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 40/132 (30%), Positives = 59/132 (44%), Gaps = 24/132 (18%)
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNI--EQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSN 1465
L+LQ+ G L W + +L NI E ++ AL+ LH+ I+ DL P+N
Sbjct: 62 LVLQHAEGGKL--WSHISKFL-NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNN 115
Query: 1466 VLLDDDMVAHLGDFG----IAKLLDG--VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
+LLDD L F + DG V++M Y APE G + + D
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----------YCAPEVGGISEETEACDW 165
Query: 1520 YSFGILMMETLT 1531
+S G ++ E LT
Sbjct: 166 WSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1624 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.98 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.98 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-111 Score=1157.75 Aligned_cols=873 Identities=30% Similarity=0.507 Sum_probs=749.6
Q ss_pred ChhhHHHHHHHHHHhccCCccccccCCCCCCCCCCCCCCCCccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcc
Q 047591 36 ITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFL 115 (1624)
Q Consensus 36 ~~~d~~aLl~~k~~~~~~p~~~~~~~W~~~~~~~~~~~~~~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L 115 (1624)
.+.|++||++||+++. ||.+.+ .+|+ .+.+||.|.||+|++ .++|+.|+|++++++|.+|+.+..+++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~-~~w~--------~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L 95 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYL-SNWN--------SSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYI 95 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccC-CCCC--------CCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCC
Confidence 4689999999999995 777654 5785 245899999999986 5799999999999999999999999999
Q ss_pred cEEEecCCCccccCCcccC-CCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccc
Q 047591 116 VSLNISGNRFHGTLPNELW-LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS 194 (1624)
Q Consensus 116 ~~L~Ls~N~l~g~iP~~~~-~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls 194 (1624)
+.|+|++|+++|.+|..+. .+++|++|||++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|+
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~ 172 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCChHHhcCCCCCEEECc
Confidence 9999999999999999876 999999999999999998886 358999999999999999999999999999999999
Q ss_pred cccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCc
Q 047591 195 FNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGR 274 (1624)
Q Consensus 195 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ 274 (1624)
+|.+++.+|..|+++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..+ +++++|++|+|++|.+++.
T Consensus 173 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~ 251 (968)
T PLN00113 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI-GGLTSLNHLDLVYNNLTGP 251 (968)
T ss_pred cCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhH-hcCCCCCEEECcCceeccc
Confidence 999999999999999999999999999999999999999999999999999999999775 6899999999999999999
Q ss_pred CCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCC
Q 047591 275 IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSG 354 (1624)
Q Consensus 275 ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g 354 (1624)
+|..++++++|+.|+|++|+ ++|.+|..+.++.+|+.|+|++|+++|.+|..+. ++++|++|++++|.+++
T Consensus 252 ~p~~l~~l~~L~~L~L~~n~--------l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~ 322 (968)
T PLN00113 252 IPSSLGNLKNLQYLFLYQNK--------LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI-QLQNLEILHLFSNNFTG 322 (968)
T ss_pred cChhHhCCCCCCEEECcCCe--------eeccCchhHhhccCcCEEECcCCeeccCCChhHc-CCCCCcEEECCCCccCC
Confidence 99999999999999998765 5677899999999999999999999999998876 79999999999999999
Q ss_pred cCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCcc
Q 047591 355 VIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGI 434 (1624)
Q Consensus 355 ~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~ 434 (1624)
.+|..++++++|+.|+|++|.+++.+|..++.+++|+.|+|++|++.. ..+..+..+..|+.|++++|++.+.
T Consensus 323 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~-------~~p~~~~~~~~L~~L~l~~n~l~~~ 395 (968)
T PLN00113 323 KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG-------EIPEGLCSSGNLFKLILFSNSLEGE 395 (968)
T ss_pred cCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe-------eCChhHhCcCCCCEEECcCCEeccc
Confidence 999999999999999999999999999999999999999999999864 2345667788899999999999999
Q ss_pred CCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccC
Q 047591 435 LPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ 514 (1624)
Q Consensus 435 ~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~ 514 (1624)
+|..+.++. +|+.|++++|+++|.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|++.|.+|..+ .
T Consensus 396 ~p~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~ 473 (968)
T PLN00113 396 IPKSLGACR-SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-G 473 (968)
T ss_pred CCHHHhCCC-CCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-c
Confidence 999999886 89999999999999999999999999999999999999999999999999999999999999999876 4
Q ss_pred CCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceee
Q 047591 515 LESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLY 594 (1624)
Q Consensus 515 l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~ 594 (1624)
.++|+.|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|..+.++.+|+.|||++|.++|.+|..++.+++|+.|+
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcCCCCccccccCCccccccccccCCCCCCCchhhhccccccCCCCCCCCCccccCCcccccccccccccc-ccccc
Q 047591 595 LSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLR-LQVQA 673 (1624)
Q Consensus 595 Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~~~~i~~~~~~~~~~~~~~~~n~~lcg~~~-~~l~~ 673 (1624)
|++|+++|.+|..+..+++|+.|++++|+++|.+|. .++|.++.+.+|.||+.+||+.+ ....+
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~---------------~~~~~~~~~~~~~~n~~lc~~~~~~~~~~ 618 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS---------------TGAFLAINASAVAGNIDLCGGDTTSGLPP 618 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCC---------------cchhcccChhhhcCCccccCCccccCCCC
Confidence 999999999999999999999999999999998885 56788899999999999999754 33446
Q ss_pred ccccCccccccccccceehhhhHHHHHHHHHhheeeeecccC-CCCCcccCCc--ccc-----hhccccCHHHHHhhcCC
Q 047591 674 CETSSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRCCTRN-KNLPILENDS--LSL-----ATWRRISYQELQRLTDG 745 (1624)
Q Consensus 674 c~~~s~~~~~~~~~l~~v~~~v~~~~v~l~l~~i~~~~~~r~-~~~~~~~~~~--~~~-----~~~~~~~~~el~~~t~~ 745 (1624)
|.... +......+++.++++++++++++++++++++|+ .+....+... ... .....++++++ ...
T Consensus 619 c~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 691 (968)
T PLN00113 619 CKRVR----KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSS 691 (968)
T ss_pred Ccccc----ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---Hhh
Confidence 64321 111112222222222222222222222222221 1111111110 000 01122344444 356
Q ss_pred CCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 746 FSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
|...++||+|+||+||+|+. .+|+.||||++..... ...+|++++++++|||||+++|+|.+++..|+|||||++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 77889999999999999986 5789999999864322 123568899999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||++|.++.+++. ||.+...... ..
T Consensus 768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~ 837 (968)
T PLN00113 768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TK 837 (968)
T ss_pred CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CC
Confidence 99999996 37899999999999999999998777889999999999999999988876 7766543221 12
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHHHHHHHhhh-hhhhccchhccC
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRL-AVTEVVDAELLS 977 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~~~~~~~~~-~~~~~~d~~Ll~ 977 (1624)
..||++|||||++....++.|+|||||||++|||+||+.||+........+.+|++..... ...+.+|+.+..
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 3689999999999989999999999999999999999999976655556677887655433 245566665543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-100 Score=1044.55 Aligned_cols=873 Identities=32% Similarity=0.533 Sum_probs=583.3
Q ss_pred CcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccc
Q 047591 113 SFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLS 192 (1624)
Q Consensus 113 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 192 (1624)
.+++.|||++|+++|.+|..+..+++|++|||++|+++|.+|.+++..+++|++|+|++|+++|.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 46899999999999999999999999999999999999999999888899999999999999998886 5688999999
Q ss_pred cccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeeccccccc
Q 047591 193 VSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTT 272 (1624)
Q Consensus 193 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~ 272 (1624)
|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..+ +++++|++|+|++|+++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPREL-GQMKSLKWIYLGYNNLS 225 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHH-cCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999988888888888888888887777554 46677777777777777
Q ss_pred CcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCcc
Q 047591 273 GRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352 (1624)
Q Consensus 273 g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l 352 (1624)
+.+|..|+++++|++|+|++| +++|.+|..++ ++++|++|+|++|++
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n--------------------------------~l~~~~p~~l~-~l~~L~~L~L~~n~l 272 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYN--------------------------------NLTGPIPSSLG-NLKNLQYLFLYQNKL 272 (968)
T ss_pred CcCChhHhcCCCCCEEECcCc--------------------------------eeccccChhHh-CCCCCCEEECcCCee
Confidence 666666666666666665544 44444554443 566677777777777
Q ss_pred CCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCC
Q 047591 353 SGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWK 432 (1624)
Q Consensus 353 ~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~ 432 (1624)
++.+|.++.++++|++|+|++|.+++.+|..|.++++|++|++++|++
T Consensus 273 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~-------------------------------- 320 (968)
T PLN00113 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF-------------------------------- 320 (968)
T ss_pred eccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCcc--------------------------------
Confidence 777777777777777777777777766666655555555554443332
Q ss_pred ccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccc
Q 047591 433 GILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL 512 (1624)
Q Consensus 433 g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l 512 (1624)
.+.+|..++++++|+.|+|++|++++.+|..++.+.+|+.|+|++|+++|.+|.++
T Consensus 321 ------------------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~ 376 (968)
T PLN00113 321 ------------------------TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376 (968)
T ss_pred ------------------------CCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH
Confidence 12234444555556666666666666666666666666666666666666666666
Q ss_pred cCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccce
Q 047591 513 CQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTG 592 (1624)
Q Consensus 513 ~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~ 592 (1624)
+.+++|+.|++++|++.+.+|..++.+++|+.|+|++|+++| .+|..+.+++.|+.
T Consensus 377 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~------------------------~~p~~~~~l~~L~~ 432 (968)
T PLN00113 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG------------------------ELPSEFTKLPLVYF 432 (968)
T ss_pred hCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee------------------------ECChhHhcCCCCCE
Confidence 666666666666666655555555555555555555555554 45556666666666
Q ss_pred eeccCCcCCCCccccccCCccccccccccCCCCCCCchhhhccccccCCCCCCCCCccccCCcccccccccccccccccc
Q 047591 593 LYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQ 672 (1624)
Q Consensus 593 L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~~~~i~~~~~~~~~~~~~~~~n~~lcg~~~~~l~ 672 (1624)
|+|++|+++|.+|..+..+++|+.|+|++|++.|.+|..+
T Consensus 433 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~---------------------------------------- 472 (968)
T PLN00113 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF---------------------------------------- 472 (968)
T ss_pred EECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc----------------------------------------
Confidence 6666666666666666677777777777776654222100
Q ss_pred cccccCccccccccccceehhhhHHHHHHHHHhheeeeecccCCCCCcccCCcccchhccccCHHHHHhhcCCCCCccee
Q 047591 673 ACETSSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILENDSLSLATWRRISYQELQRLTDGFSESNLI 752 (1624)
Q Consensus 673 ~c~~~s~~~~~~~~~l~~v~~~v~~~~v~l~l~~i~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~el~~~t~~f~~~~~i 752 (1624)
T Consensus 473 -------------------------------------------------------------------------------- 472 (968)
T PLN00113 473 -------------------------------------------------------------------------------- 472 (968)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCCHHHHHH
Q 047591 753 GAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY 832 (1624)
Q Consensus 753 G~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 832 (1624)
+ . +
T Consensus 473 ~-----------~----------------------------------~-------------------------------- 475 (968)
T PLN00113 473 G-----------S----------------------------------K-------------------------------- 475 (968)
T ss_pred c-----------c----------------------------------c--------------------------------
Confidence 0 0 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccccccccccc
Q 047591 833 SHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912 (1624)
Q Consensus 833 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 912 (1624)
T Consensus 476 -------------------------------------------------------------------------------- 475 (968)
T PLN00113 476 -------------------------------------------------------------------------------- 475 (968)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHHHHHHHhhhhhhhccchhccCchhhhccccCCcccc
Q 047591 913 APEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEEEEGADLGDSNKL 992 (1624)
Q Consensus 913 aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~Ll~~~~~e~~~l~~~~~L 992 (1624)
.+
T Consensus 476 ------------------------------------------------------------------------------~L 477 (968)
T PLN00113 476 ------------------------------------------------------------------------------RL 477 (968)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred eeeecccccccCCchhhhhchhhhHHhhccCCCccccccccccccccCCcccCccccceeeeccceeecccccCCccccc
Q 047591 993 KRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGR 1072 (1624)
Q Consensus 993 ~~Lal~~n~~~g~i~~~i~~l~~L~~l~l~~n~~~~~l~~n~~~~~~p~~~~~~~~l~~~~~~~n~~~~~~~~~~~~~g~ 1072 (1624)
+.+.++. |.++|.+|..++++++|+.|++++
T Consensus 478 ~~L~ls~---------------------------------n~l~~~~~~~~~~l~~L~~L~Ls~---------------- 508 (968)
T PLN00113 478 ENLDLSR---------------------------------NQFSGAVPRKLGSLSELMQLKLSE---------------- 508 (968)
T ss_pred eEEECcC---------------------------------CccCCccChhhhhhhccCEEECcC----------------
Confidence 0000000 011111121111121122222222
Q ss_pred cccccccccccceeeccccccccCCCccccCCCccccccccccccccccCCccccccccceEEeccccccccccCCcccC
Q 047591 1073 IPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152 (1624)
Q Consensus 1073 ~~~~~~~~~~l~~l~l~~n~l~G~ip~~~~~~l~~l~~L~L~~N~l~G~iP~~i~~l~~L~~L~ls~N~lsG~iP~~l~~ 1152 (1624)
|.++|.+|.+++. +++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.||..+++
T Consensus 509 ------------------N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 569 (968)
T PLN00113 509 ------------------NKLSGEIPDELSS-CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569 (968)
T ss_pred ------------------CcceeeCChHHcC-ccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhc
Confidence 2222234444443 455555555555555555555555555555555555555555555555
Q ss_pred cCccceeeccCCcccCCCCCCCCcccccccccccceeeeccCCCCcccCCCcccccccccccccccCCccccCCCccccc
Q 047591 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEFEG 1232 (1624)
Q Consensus 1153 l~~L~~L~Ls~N~Ls~~~~~~~~~~p~~l~~~~~L~~l~ls~N~l~G~iP~~l~~l~~~l~~~~~s~n~l~g~ip~~~~g 1232 (1624)
++.|+.|++++|++ +|.||.
T Consensus 570 l~~L~~l~ls~N~l-------------------------------~~~~p~----------------------------- 589 (968)
T PLN00113 570 VESLVQVNISHNHL-------------------------------HGSLPS----------------------------- 589 (968)
T ss_pred CcccCEEeccCCcc-------------------------------eeeCCC-----------------------------
Confidence 55555555555555 445553
Q ss_pred CCCCCCCCcccCccccccccCCCCCC-CCCCCCCCCCCCCCccccceeehhhHHHHHHH--HHHHHHHHHHhhhccccCC
Q 047591 1233 EIPSGGPFVNFTAESLMQNLVLGGSS-RLQVPPCKTGSSQQSKATRLALRYILPAIATT--MAVLALIIILLRRRKRDKS 1309 (1624)
Q Consensus 1233 ~ip~~~~~~~~~~~s~~~n~~lcg~~-~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~k~~~~ 1309 (1624)
.+.|..+++.++.+|+.+||.. ....|||.... +...+.. +++.+++++ +++++++++++++|++.+.
T Consensus 590 ----~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (968)
T PLN00113 590 ----TGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR----KTPSWWF-YITCTLGAFLVLALVAFGFVFIRGRNNLEL 660 (968)
T ss_pred ----cchhcccChhhhcCCccccCCccccCCCCCcccc----ccceeee-ehhHHHHHHHHHHHHHHHHHHHHhhhcccc
Confidence 2234456667788999999854 33457785321 1111122 222222222 1222222222233222111
Q ss_pred CCccc--cccc-----chhccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHH
Q 047591 1310 RPTEN--NLLN-----TAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAE 1381 (1624)
Q Consensus 1310 ~~~~~--~~~~-----~~~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E 1381 (1624)
+..+. ..+. ......++++++. ..|...++||+|+||+||+|++ .++..||||.++.... ...+|
T Consensus 661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~ 733 (968)
T PLN00113 661 KRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSE 733 (968)
T ss_pred cccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHH
Confidence 11111 0010 0112234455544 3577788999999999999987 4788999998863322 12356
Q ss_pred HHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCC
Q 047591 1382 CEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461 (1624)
Q Consensus 1382 ~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 1461 (1624)
++++++++|||||+++|+|.+++..++|||||++|+|.++++. ++|.++.+|+.|||+||+|||+.++++|+||||
T Consensus 734 ~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 809 (968)
T PLN00113 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809 (968)
T ss_pred HHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence 8899999999999999999999999999999999999999963 799999999999999999999877789999999
Q ss_pred CCCcEEecCCCcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 047591 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFT 1541 (1624)
Q Consensus 1462 K~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~ 1541 (1624)
||+||++|.++.+++. ||.+..... .....||++|||||+..+..++.|+|||||||++|||+||+.|++....
T Consensus 810 kp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 810 SPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred CHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 9999999999998886 776654321 1223689999999999999999999999999999999999999976544
Q ss_pred cchhhhhhhhhcCChh-HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1542 GEVCLKHWVEESLPDA-VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1542 ~~~~l~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
....+..|++....+. ..+.+|+.+..... ...+++.++.+++.+||+.+|++||||+||+++|+++.+
T Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGDVS-----VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCcHHHHHHHhcCccchhheeCccccCCCC-----ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4455666765443322 33344444322111 112345678899999999999999999999999998865
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-54 Score=513.49 Aligned_cols=289 Identities=41% Similarity=0.689 Sum_probs=248.2
Q ss_pred hccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeee
Q 047591 1321 ALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400 (1624)
Q Consensus 1321 ~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~ 1400 (1624)
..+.|+|+|++.||++|+..++||+|+||.||||.+.+|+.||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46789999999999999999999999999999999999999999987644332146699999999999999999999999
Q ss_pred ccCC-eeEEEEEecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEee
Q 047591 1401 SNPG-FKALILQYMPQGSLEKWLYSHNY-LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGD 1478 (1624)
Q Consensus 1401 ~~~~-~~~lV~ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~D 1478 (1624)
.+.+ +.+||||||++|+|.++|+.... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999997765 889999999999999999999999989999999999999999999999999
Q ss_pred ecceeecCC-CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCC-ccchhhhhhhhhcCCh
Q 047591 1479 FGIAKLLDG-VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMF-TGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1479 FGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~-~~~~~l~~~~~~~~~~ 1556 (1624)
||+|+.... ........ .||.+|+||||...+..++|+|||||||+|+|++||+.|.+... .++..+..|....+.+
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999977654 22211111 79999999999999999999999999999999999999887543 3445578887665554
Q ss_pred -hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1557 -AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1557 -~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.+.+++|+.+..+.... .+++.++.++|.+|++.+|++||+|.||+++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~-----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPD-----EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCCh-----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 57889998876322111 1456779999999999999999999999999966543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=478.45 Aligned_cols=279 Identities=42% Similarity=0.695 Sum_probs=236.2
Q ss_pred hccccCHHHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeee
Q 047591 730 TWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809 (1624)
Q Consensus 730 ~~~~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 809 (1624)
..+.|+++|+.+||++|+..++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999999999999988755433146699999999999999999999999
Q ss_pred ccCC-eEEEEEEecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEe
Q 047591 810 SNHG-FKALILEYMPQGSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSD 887 (1624)
Q Consensus 810 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~D 887 (1624)
.+++ .++||||||++|+|.++|+.... .++|.+|++||.++|+||+|||+.++++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 59999999999999999998766 899999999999999999999999988999999999999999999999999
Q ss_pred eeeeeccCC-CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccC-cCcchHHHHHHHHhhh
Q 047591 888 FGISKLLDG-EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF-TGETSLKKWVEESLRL 965 (1624)
Q Consensus 888 FGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~-~~~~~l~~~~~~~~~~ 965 (1624)
||+|+.... ........ .||.+|+||||...+..+.|+|||||||+++|++||+.|.+... .++..+..|+...+..
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999977654 32222211 79999999999999999999999999999999999999987543 3455688998777766
Q ss_pred -hhhhccchhcc-CchhhhccccCCcccceeeeccccccc----CCchhhhhch
Q 047591 966 -AVTEVVDAELL-SSEEEEGADLGDSNKLKRLSISVNKIT----GTIPRTVGNL 1013 (1624)
Q Consensus 966 -~~~~~~d~~Ll-~~~~~e~~~l~~~~~L~~Lal~~n~~~----g~i~~~i~~l 1013 (1624)
.+.+++|+++. ..++.+ .++.++..+++.|.+.+ +.|.+++..+
T Consensus 300 ~~~~eiiD~~l~~~~~~~~----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDE----KEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred cchhheeCCCccCCCCChH----HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 58999999987 443321 33455777777776544 4555554433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=459.42 Aligned_cols=550 Identities=23% Similarity=0.293 Sum_probs=352.6
Q ss_pred eeecCCccceEEEEe----cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeEEEEEEecC
Q 047591 751 LIGAGSFGSVYKATL----PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 751 ~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
.+|+|+||.|+.++. +.|..+|+|+...... +.......|..++..++ ||.+|++.-+++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998642 3467788888764432 11224566888888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|+|...+.... ..+......+...+|-|++++|. .+|+|||+|++||++|.+|++|+.|||+++..-..+..
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 999999886544 45555566677888999999998 45999999999999999999999999999976543322
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHHHHHHHhhhhhhhccchhccCchhhhc
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLSSEEEEG 983 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~Ll~~~~~e~ 983 (1624)
+||.-|||||... .....+|.||||++++||+||..||.. ...+...... ..++.-+.+....-+
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~---- 218 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLF---- 218 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHH----
Confidence 7999999999987 456778999999999999999999864 1111111100 001111111111100
Q ss_pred cccCCcccceeeecc--cccccCCchhhhhchhhhHHhhccCCCccccccccccccccCCcccCccccceeeeccceeec
Q 047591 984 ADLGDSNKLKRLSIS--VNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTG 1061 (1624)
Q Consensus 984 ~~l~~~~~L~~Lal~--~n~~~g~i~~~i~~l~~L~~l~l~~n~~~~~l~~n~~~~~~p~~~~~~~~l~~~~~~~n~~~~ 1061 (1624)
..+-.+ .|++. .=|+.+...+ + + --+. .+..
T Consensus 219 ---------~~l~~r~p~nrLg-~~~~~~~eik--~-----h----------------------------~f~~--~i~~ 251 (612)
T KOG0603|consen 219 ---------RQLFKRNPENRLG-AGPDGVDEIK--Q-----H----------------------------EFFQ--SIDW 251 (612)
T ss_pred ---------HHHHhhCHHHHhc-cCcchhHHHh--c-----c----------------------------chhe--eeeH
Confidence 000000 11111 1111110000 0 0 0000 0000
Q ss_pred ccccCCccccccccccccccccceeeccccccccCCCccccCCCccccccccccccccccCCccccccccceEEeccccc
Q 047591 1062 VRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENL 1141 (1624)
Q Consensus 1062 ~~~~~~~~~g~~~~~~~~~~~l~~l~l~~n~l~G~ip~~~~~~l~~l~~L~L~~N~l~G~iP~~i~~l~~L~~L~ls~N~ 1141 (1624)
.++.. =.+|+.+..
T Consensus 252 ~~l~~----------------------------r~~~~~fkp-------------------------------------- 265 (612)
T KOG0603|consen 252 NELEA----------------------------RSRPPPFKP-------------------------------------- 265 (612)
T ss_pred hhHhh----------------------------cCCCCCCCC--------------------------------------
Confidence 00000 001110000
Q ss_pred cccccCCcccCcCccceeeccCCcccCCCCCCCCcccccccccccceeeeccCCCCcccCCCcccccccccccccccCCc
Q 047591 1142 FSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTE 1221 (1624)
Q Consensus 1142 lsG~iP~~l~~l~~L~~L~Ls~N~Ls~~~~~~~~~~p~~l~~~~~L~~l~ls~N~l~G~iP~~l~~l~~~l~~~~~s~n~ 1221 (1624)
|..+. . ....++..
T Consensus 266 --~~~~e-------------------------------------------------------~------~~~~fd~e--- 279 (612)
T KOG0603|consen 266 --GSITE-------------------------------------------------------R------DVAQFDPE--- 279 (612)
T ss_pred --cccch-------------------------------------------------------h------hhhhcCch---
Confidence 00000 0 00000000
Q ss_pred cccCCCcccccCCCCCCCCcccCccccccc-cCCCCCCCCCCCCCCCCCCCCccccceeehhhHHHHHHHHHHHHHHHHH
Q 047591 1222 LRGAIPVEFEGEIPSGGPFVNFTAESLMQN-LVLGGSSRLQVPPCKTGSSQQSKATRLALRYILPAIATTMAVLALIIIL 1300 (1624)
Q Consensus 1222 l~g~ip~~~~g~ip~~~~~~~~~~~s~~~n-~~lcg~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1300 (1624)
|+-.+|..-.+.-|.+ +. ...-|. ..+.|.++.
T Consensus 280 ft~~~P~dsp~~~~~~------------s~~~if~g~-----------------------sfva~~il~----------- 313 (612)
T KOG0603|consen 280 FTSQVPADSPLLSASG------------SDHTIFSGP-----------------------SFVAPGVLE----------- 313 (612)
T ss_pred hccCCcccCCCCCCCc------------cccchhcCC-----------------------CccChHHhh-----------
Confidence 0000111000000000 00 000000 000000000
Q ss_pred hhhccccCCCCcccccccchhccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHH
Q 047591 1301 LRRRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFD 1379 (1624)
Q Consensus 1301 ~~~~k~~~~~~~~~~~~~~~~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~ 1379 (1624)
. ..... .++.|.....+|.|+|++|-++... +++..|||++.... .+-.
T Consensus 314 ------------------~--~~~~~------~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~ 363 (612)
T KOG0603|consen 314 ------------------D--AVTAP------FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQ 363 (612)
T ss_pred ------------------c--cccCC------cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccc
Confidence 0 00000 2334444556999999999999764 57889999986542 2234
Q ss_pred HHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEE
Q 047591 1380 AECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458 (1624)
Q Consensus 1380 ~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH 1458 (1624)
+|+.++... +||||+++.+.|.+..+.|+|||++.+|-+.+.+....... .++..|+.+|+.|+.|||. .+|||
T Consensus 364 ~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~--~e~~~w~~~lv~Av~~LH~---~gvvh 438 (612)
T KOG0603|consen 364 DEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC--SEASQWAAELVSAVDYLHE---QGVVH 438 (612)
T ss_pred cccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH--HHHHHHHHHHHHHHHHHHh---cCeee
Confidence 577666655 79999999999999999999999999998888776554322 6677899999999999996 89999
Q ss_pred cCCCCCcEEe-cCCCcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 047591 1459 CDLKPSNVLL-DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTD 1537 (1624)
Q Consensus 1459 rDlK~~NILl-d~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~ 1537 (1624)
||+||+|||+ ++.++++|+|||.++..... ..+.+-|..|.|||+.....|++++|+||||++||||+||+.||.
T Consensus 439 RDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 439 RDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred cCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 9999999999 58999999999999977543 223356889999999999999999999999999999999999987
Q ss_pred CCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1538 DMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1538 ~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+.. + ...+..+... ...+....+|+..|++.||.+||+|+|+...
T Consensus 515 ~~P~~~e-i----------------~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 515 AHPAGIE-I----------------HTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cCCchHH-H----------------HHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 5433311 1 1111111111 2345567889999999999999999998753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=441.94 Aligned_cols=265 Identities=31% Similarity=0.490 Sum_probs=217.9
Q ss_pred ccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchh--hHHHHHHHHHHHHHhcCCCceeEEEeeec
Q 047591 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRNLAKIVSSCS 1401 (1624)
Q Consensus 1324 ~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~HpNIv~l~g~~~ 1401 (1624)
.+.++++... +.||+|+||+||+|.|.....||||++...+. ...++|.+|+.+|.+++|||||+++|+|.
T Consensus 37 ~i~~~~l~~~-------~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 37 EIDPDELPIE-------EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred ecChHHhhhh-------hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4455555543 45999999999999996555599999975432 22679999999999999999999999999
Q ss_pred cCC-eeEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc-eEEcCCCCCcEEecCCC-cEEEe
Q 047591 1402 NPG-FKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTS-IIHCDLKPSNVLLDDDM-VAHLG 1477 (1624)
Q Consensus 1402 ~~~-~~~lV~ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~-iiHrDlK~~NILld~~~-~~kl~ 1477 (1624)
++. ...+|||||++|+|.+++++ .+..+++..+++||.|||+||+|||+ .+ ||||||||+|||++.++ ++||+
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEEC
Confidence 887 79999999999999999998 47789999999999999999999996 44 99999999999999997 99999
Q ss_pred eecceeecCCCCCccccccccccccccccccC--CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC
Q 047591 1478 DFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS--EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP 1555 (1624)
Q Consensus 1478 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~ 1555 (1624)
|||+++...... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.+.......
T Consensus 187 DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~---------- 255 (362)
T KOG0192|consen 187 DFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA---------- 255 (362)
T ss_pred CCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH----------
Confidence 999998765422 2334468999999999998 669999999999999999999999999876431111
Q ss_pred hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1556 DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1556 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
..++....... .+..|+..+..++.+||+.||++||+|.|++..|+.+...+..
T Consensus 256 ---~~v~~~~~Rp~-------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 256 ---SAVVVGGLRPP-------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---HHHHhcCCCCC-------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11111111111 1123778899999999999999999999999999999876553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=427.18 Aligned_cols=262 Identities=30% Similarity=0.498 Sum_probs=222.3
Q ss_pred cccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc
Q 047591 1323 RRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402 (1624)
Q Consensus 1323 ~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~ 1402 (1624)
..+..+++... +.||+|-||+||.|.|.....||||.++.. ....+.|.+|+++|++++|+|||+++|+|..
T Consensus 201 wei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 201 WEIPREELKLI-------RELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred eeecHHHHHHH-------HHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 34555666654 569999999999999988889999998643 3345789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecc
Q 047591 1403 PGFKALILQYMPQGSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGI 1481 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGl 1481 (1624)
++..+||||||+.|+|.+||+. .+..+...+.+.++.|||+||+||++ +++|||||.++|||++++..|||+|||+
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccccc
Confidence 8899999999999999999996 56788999999999999999999995 8999999999999999999999999999
Q ss_pred eeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHH
Q 047591 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560 (1624)
Q Consensus 1482 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~ 1560 (1624)
||...+..........-.+.|.|||.+..+.++.|||||||||+||||+| |+.||..+...+. .+
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------------~~ 415 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------------LE 415 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------------HH
Confidence 99665555544444455678999999999999999999999999999999 8888877643221 11
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.++. +.+++.+..|+..++++|..||+.+|++||||+.....|+++.+.
T Consensus 416 ~le~-------GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 416 LLER-------GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHhc-------cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2221 123445568999999999999999999999999999988887653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=396.21 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=210.9
Q ss_pred ccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeec
Q 047591 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401 (1624)
Q Consensus 1324 ~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~ 1401 (1624)
.++.+|++. .+.||+|..|+|||++++ +++.+|.|++... +....++..+|++++++.+||+||++||.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 466777765 478999999999999986 5788999998544 3455689999999999999999999999999
Q ss_pred cCC-eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1402 NPG-FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1402 ~~~-~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
.++ ...++||||.+|||++++... ..+++...-+|+.+|++||.|||+ .++||||||||+|||++..|++||||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 888 599999999999999998765 357888888999999999999996 4899999999999999999999999999
Q ss_pred ceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHH
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~ 1560 (1624)
.++.+... ...+.+||..|||||.+.+..|+.++||||||++++|+++|+.|+....... ..|. +.+..
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~---~~~~-----~Ll~~ 293 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY---LDIF-----ELLCA 293 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC---CCHH-----HHHHH
Confidence 99987543 3456789999999999999999999999999999999999999986531100 0111 11122
Q ss_pred HHhhhccCCchHHHHHHHH-HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1561 VIDANLLSGEEEADIAAKK-KCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~-~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+++. ... ..+. .+++++..++..|+++||.+||+.+|++++
T Consensus 294 Iv~~----ppP----~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 IVDE----PPP----RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HhcC----CCC----CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2221 110 0112 477889999999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=411.06 Aligned_cols=488 Identities=28% Similarity=0.407 Sum_probs=397.6
Q ss_pred ccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcc
Q 047591 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKL 188 (1624)
Q Consensus 109 i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 188 (1624)
...-..|+.|++++|.++ .+-+.+.++..|.+|++++|+++ ++|+.+ +.+..++.|+.++|+++ .+|+.++.+.+|
T Consensus 41 wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~ai-g~l~~l~~l~vs~n~ls-~lp~~i~s~~~l 116 (565)
T KOG0472|consen 41 WWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAI-GELEALKSLNVSHNKLS-ELPEQIGSLISL 116 (565)
T ss_pred hhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHH-HHHHHHHHhhcccchHh-hccHHHhhhhhh
Confidence 334455778888899887 56667788888999999999987 567665 57888999999999998 799999999999
Q ss_pred cccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeeccc
Q 047591 189 KRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268 (1624)
Q Consensus 189 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~ 268 (1624)
+.|+.++|.+. ++|++|+.+..|+.|+..+|+++ ..|+.++++++|..|++.+|++. .+|++... |+.|++||.-+
T Consensus 117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~ 192 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNS 192 (565)
T ss_pred hhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcccch
Confidence 99999999999 89999999999999999999998 78999999999999999999998 67777765 99999999999
Q ss_pred ccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEec
Q 047591 269 CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLW 348 (1624)
Q Consensus 269 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls 348 (1624)
|.+. .+|+.++.+.+|..|||..|++.. +| +|..++.|.+|+++.|+++ .+|...+.+|++|..|||.
T Consensus 193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~~---------lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLR 260 (565)
T KOG0472|consen 193 NLLE-TLPPELGGLESLELLYLRRNKIRF---------LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLR 260 (565)
T ss_pred hhhh-cCChhhcchhhhHHHHhhhccccc---------CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecc
Confidence 8775 899999999999999999999875 45 6778899999999999998 8999999999999999999
Q ss_pred CCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCccccc--cccccccccee--
Q 047591 349 GNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFS--SLTNCRYLRYL-- 424 (1624)
Q Consensus 349 ~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~--~l~~l~~L~~L-- 424 (1624)
.|++. +.|++++-+.+|+.||||+|.+++.++ ++|++ .|+.|-+.+|.+.+.... ... .-.-+++|+.-
T Consensus 261 dNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~-sLgnl-hL~~L~leGNPlrTiRr~----ii~~gT~~vLKyLrs~~~ 333 (565)
T KOG0472|consen 261 DNKLK-EVPDEICLLRSLERLDLSNNDISSLPY-SLGNL-HLKFLALEGNPLRTIRRE----IISKGTQEVLKYLRSKIK 333 (565)
T ss_pred ccccc-cCchHHHHhhhhhhhcccCCccccCCc-ccccc-eeeehhhcCCchHHHHHH----HHcccHHHHHHHHHHhhc
Confidence 99999 689999999999999999999998754 78999 899999999998753211 000 00112333320
Q ss_pred --eeccCC----CCccCCC-ccc--CccccchhhccCCcccCCCCCCCcCCCCc---ccEEeccCCccCCCccchhcccc
Q 047591 425 --AIQTNP----WKGILPN-SVG--NLSKSLEYFYAGSCELGGGIPAEFGNLSN---IIALSLYQNQLASTIPTTVGKLQ 492 (1624)
Q Consensus 425 --~l~~N~----~~g~~p~-~~~--~l~~~L~~L~l~~n~l~g~ip~~~~~l~~---L~~L~L~~N~l~g~iP~~~~~l~ 492 (1624)
.++... -.+..|. .+. ....+.+.|+++.-+++. +|.+...-.. .+..+++.|++. ++|..+..+.
T Consensus 334 ~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lk 411 (565)
T KOG0472|consen 334 DDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELK 411 (565)
T ss_pred cCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHH
Confidence 011110 0111111 111 112356778888878774 4544333333 788999999997 7999888888
Q ss_pred cccee-cccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeec
Q 047591 493 NLQGL-DLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDF 571 (1624)
Q Consensus 493 ~L~~L-~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldL 571 (1624)
.+.+. ++++|.+ +.+|..++.+++|+.|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..++.+-.
T Consensus 412 elvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtlla 488 (565)
T KOG0472|consen 412 ELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLA 488 (565)
T ss_pred HHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHh
Confidence 77654 5555555 499999999999999999999997 79999999999999999999996 68999999999999989
Q ss_pred ccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchh
Q 047591 572 SLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEA 631 (1624)
Q Consensus 572 s~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~ 631 (1624)
++|++...-|+.+.++.+|.+|||.+|.+. .||+.+|++++|.+|++++|+|. .|..
T Consensus 489 s~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~ 545 (565)
T KOG0472|consen 489 SNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRH 545 (565)
T ss_pred ccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHH
Confidence 999997544444999999999999999999 89999999999999999999998 4543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=390.32 Aligned_cols=200 Identities=30% Similarity=0.490 Sum_probs=179.5
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQ--LDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
..+|...+.||+|+||+||+|+++ ++.+||||.+..+ .....+....|+++|+.++|||||+++++++.++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888888999999999999864 6899999999766 3445667899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC------CceEEEeeeeeec
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD------TVAHLSDFGISKL 893 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~------~~~kl~DFGla~~ 893 (1624)
|||.+|||.+||+.++ .+++.....++.|+|.||++||+.+ ||||||||+||||+.. -.+||+|||+||.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998775 7999999999999999999999954 9999999999999865 4579999999999
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
+.... ...+.+|++.|||||++..++|+.|+|+||.|+|+|||+||+.||+..
T Consensus 165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 87432 334568999999999999999999999999999999999999999753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=390.50 Aligned_cols=199 Identities=28% Similarity=0.495 Sum_probs=177.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.+|.....||+|+||+||||+++ ++..||||.+... .....+-...|+.+|+.++|||||++++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 45666677999999999999886 5789999998655 34556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC------CcEEEeeecceeec
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD------MVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~------~~~kl~DFGla~~~ 1485 (1624)
||.+|+|.+|++.++ .++......++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+||.+
T Consensus 90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999875 57888888899999999999996 899999999999999865 46899999999998
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCC
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~ 1539 (1624)
.+.. -..+.+|++-|||||++...+|+.|+|+||.|+|+|||++|+.||+..
T Consensus 166 ~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7432 234568999999999999999999999999999999999999999854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=422.12 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=215.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
+....+.||+|+||+||+|+.. +.+.||||.++...+. ..++|++|+++++.++|||||+|+|.|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3344567999999999999763 3456999999766544 78899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc---------CCC----CCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1409 ILQYMPQGSLEKWLYSH---------NYL----LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~---------~~~----l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
|+|||..|||.+||+.+ +.. ++..+.+.||.|||.||+||-+ ..+|||||..+|+|+.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence 99999999999999843 122 7788999999999999999985 7899999999999999999999
Q ss_pred EeeecceeecCCCCCcccc-ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhc
Q 047591 1476 LGDFGIAKLLDGVDSMKQT-MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
|+|||++|.+...++.+.. ...-.++|||||.+..++||++||||||||+|||+.| |+.||.+..+.++
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--------- 714 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--------- 714 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH---------
Confidence 9999999987766655443 3345789999999999999999999999999999998 8999987544322
Q ss_pred CChhHHHHH-hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1554 LPDAVTDVI-DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1554 ~~~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+.+ +..+ ...++.|+.++++||..||+.+|++||+|+|+-..|++.-..
T Consensus 715 -----Ie~i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 -----IECIRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -----HHHHHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1222 1222 223468999999999999999999999999999999986543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=378.75 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=200.0
Q ss_pred CCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhh-------HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDR-------ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~-------~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
|-..+.+|+|+||.|-+|.- .+|+.||||+++..... ......+|+++|++++|||||++++++..++..|+
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 44567899999999999965 47999999999754211 12234699999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC---CcEEEeeecceeec
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD---MVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~kl~DFGla~~~ 1485 (1624)
|||||++|+|.+.+-.++. +..+.-.-++.|++.|+.|||+ .||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 254 VlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 9999999999999977654 4445556699999999999996 899999999999999755 78999999999987
Q ss_pred CCCCCccccccccccccccccccCCCC---cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGI---VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
.. .....+.+|||.|.|||++.+.. +..|+|+||+||+||-++||..||.+.........+...
T Consensus 330 g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~----------- 396 (475)
T KOG0615|consen 330 GE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK----------- 396 (475)
T ss_pred cc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-----------
Confidence 53 23445678999999999986543 345889999999999999999999765433222222211
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+........+.+..++..+++.+++..||++|||++|+++.
T Consensus 397 ------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 ------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11111223455677888999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=393.89 Aligned_cols=264 Identities=27% Similarity=0.452 Sum_probs=212.3
Q ss_pred cccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeee
Q 047591 1323 RRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSC 1400 (1624)
Q Consensus 1323 ~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~ 1400 (1624)
..+.++|+.+ ...||+|+||+||||+|. ..||||+++... +...+.|..|+.++++-+|.||+=+.|||
T Consensus 387 WeIp~~ev~l-------~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 387 WEIPPEEVLL-------GERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccCHHHhhc-------cceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 3455555554 468999999999999995 479999997653 45678999999999999999999999999
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
..+.. ++|+.+|++-+|+.+||.....++..+.++||.|||+||.|||. ++|||||||+.||+++++++|||+|||
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccc
Confidence 98888 99999999999999999887889999999999999999999996 899999999999999999999999999
Q ss_pred ceeecCC-CCCccccccccccccccccccCC---CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1481 IAKLLDG-VDSMKQTMTLATIGYMAPEYGSE---GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1481 la~~~~~-~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
+|..-.. ..........|..-|||||+++. ..|++.+|||||||++|||+||..||... ..+. .-|+-.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq--IifmVG---- 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ--IIFMVG---- 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh--eEEEec----
Confidence 9864321 11122223458889999998754 46899999999999999999999999732 2111 112110
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..... .........|++++.+|+..||..++++||.+.+++..|+.+..+
T Consensus 607 -------rG~l~---pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 -------RGYLM---PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -------ccccC---ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00000 001122357888999999999999999999999999998887664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=390.30 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=206.8
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
..|...++||+|||+.||+++. ..|..||+|++... +....+...+||+|.++++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3577889999999999999987 78999999998642 4456678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|+|++|+|.++++ ....+++.+...+..||+.||.|||+ .+|||||||-.|++|++++++||+|||+|..+...+.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999988 44567778888899999999999996 7899999999999999999999999999998875433
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
...+.+|||-|+|||++.....+..+||||+||+||-|++|++||+...-.+. +..... .+
T Consensus 174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-y~~Ik~------------~~----- 234 (592)
T KOG0575|consen 174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-YNKIKL------------NE----- 234 (592)
T ss_pred -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-HHHHHh------------cC-----
Confidence 34456899999999999999999999999999999999999999975311111 111000 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+........+|+.+.++.+|.+|||+++|+..
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00111234456789999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.09 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=198.0
Q ss_pred CCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEe-eeccCCe-eEEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVS-SCSNPGF-KALILQ 1411 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g-~~~~~~~-~~lV~e 1411 (1624)
|...++||+|+||+|||+.. .+|..+|.|.++.. +....+....|+.+|++++|||||++++ .+.++.+ .+||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 33456899999999999965 58999999987633 3445667889999999999999999999 4555544 899999
Q ss_pred ecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-ceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1412 YMPQGSLEKWLY---SHNYLLNIEQRLDIMIDVACALEYLHQGYST-SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1412 y~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
||..|+|.+.++ +.+..++...++++..|+++||.++|....+ -|+||||||.||+||.+|.+|++|||+++++..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 999999999886 4567789999999999999999999963333 288999999999999999999999999999865
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.. ......+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+..- ..+.. -+ .
T Consensus 181 ~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L~~------------KI----~ 241 (375)
T KOG0591|consen 181 KT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSLCK------------KI----E 241 (375)
T ss_pred hh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--HHHHH------------HH----H
Confidence 43 344557899999999999999999999999999999999999999975311 01110 01 1
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+.... . .....+..+.+++..|++.||+.||+.-..+.
T Consensus 242 qgd~~~-~-p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 242 QGDYPP-L-PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred cCCCCC-C-cHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 110000 0 00234567888999999999999998544433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=406.05 Aligned_cols=269 Identities=22% Similarity=0.415 Sum_probs=224.0
Q ss_pred cccCHHHHHHHhCCC---------CcCCeEeecCceEEEEEEEcC----CceEEEEEeccc-hhhHHHHHHHHHHHHHhc
Q 047591 1323 RRISYQELRLATNGF---------SESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRI 1388 (1624)
Q Consensus 1323 ~~~~~~~l~~at~~f---------~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l 1388 (1624)
..++|+|--.|-..| ...++||.|.||+||+|+++- ...||||.++.. .++...+|+.|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 345666544443333 456799999999999998852 356999999754 356678999999999999
Q ss_pred CCCceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1389 RHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1389 ~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
.||||++|.|+.......++|.|||+||+|+.||+++...+++.+.+.+.++||.||+||-+ .+.|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 99999999999999999999999999999999999887779999999999999999999995 899999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCCcccccccc--ccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA--TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVC 1545 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~ 1545 (1624)
+.+..+||+|||++|.+++......++.-| .++|.|||.+..+++|.++|||||||+|||.++ |.+||.+|.+.++
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV- 843 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV- 843 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-
Confidence 999999999999999886543222232223 468999999999999999999999999999887 9999987754322
Q ss_pred hhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1546 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
...|.. +.+.+.+.+|+..+.+||+.||++|-.+||+|.|++..|.++.+
T Consensus 844 -------------IkaIe~-------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 844 -------------IKAIEQ-------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -------------HHHHHh-------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 111211 22344567899999999999999999999999999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.13 Aligned_cols=266 Identities=21% Similarity=0.266 Sum_probs=203.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.|.....+|+|+||+|||++.+ +|+.||||+|...+ ....+-.++|+++|++++|||+|.++.+|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 3455567999999999999986 58999999996433 23456679999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
|+.. +.+-|......++.+...+|+.|+++|+.|+|. .+||||||||+||||..++.+|+||||+|+.+... ...
T Consensus 83 ~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~ 157 (396)
T KOG0593|consen 83 CDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDN 157 (396)
T ss_pred cchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cch
Confidence 9884 444455555567888889999999999999995 78999999999999999999999999999998742 334
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHHHhhhc-c
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDVIDANL-L 1567 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~~d~~l-~ 1567 (1624)
.+.++.|.+|+|||.+.+ ..|++.+||||.||++.||+||.+-|.+.. +++.-.-+. ..+......++..+- .
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 567889999999998766 789999999999999999999998765432 122111111 122222333332211 1
Q ss_pred -----CCchHH--HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 -----SGEEEA--DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 -----~~~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...+.. -...-.+....+.+++.+|++.||++|++.+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 01111234557889999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=390.09 Aligned_cols=199 Identities=35% Similarity=0.564 Sum_probs=174.5
Q ss_pred cceeecCCccceEEEEecCCCEEEEEEeecccch--hHHHHHHHHHHHHhcCCCceeeeeeeeccCC-eEEEEEEecCCC
Q 047591 749 SNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDG--AIKSFDAECEVLRRVRHRNLVKIISSCSNHG-FKALILEYMPQG 825 (1624)
Q Consensus 749 ~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~g 825 (1624)
.+.||+|+||+||+|.+.....||||++...... ..+.|.+|+.+|++++|||||+++|+|.+.. ...+|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3459999999999999974444999999765422 2568999999999999999999999999988 789999999999
Q ss_pred CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC-ceEEEeeeeeeccCCCCCcccc
Q 047591 826 SLEKWLYS-HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 826 sL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|.++++. .+..+++..+++||.|||+||+|||+..+ ||||||||+|||++.++ ++||+|||+++...... ...+
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~ 202 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMT 202 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-cccc
Confidence 99999988 46789999999999999999999999654 99999999999999997 99999999998765432 2233
Q ss_pred cccccccccCccccC--CCCCCcchhHHHHHHHHHHHHcCCCCCCccCc
Q 047591 904 MTLATFGYMAPEYGS--EGIVSTCGDVYSFGILMIETFTRKMPTDEMFT 950 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~--~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~ 950 (1624)
...||+.|||||++. ...|+.|+|||||||++|||+||+.||..+..
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 357999999999998 66899999999999999999999999987654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=417.80 Aligned_cols=257 Identities=27% Similarity=0.490 Sum_probs=214.9
Q ss_pred CCcCCeEeecCceEEEEEEEcC--Cc----eEEEEEecc-chhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFAD--GT----NAAIKIFSL-QEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~--~~----~vAvK~~~~-~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
....+.||+|+||.||+|...+ |. .||||.++. .+.....+|.+|+.+|++++|||||+++|.|.+.+..+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 3445789999999999998753 43 388888754 3456778999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1410 LQYMPQGSLEKWLYSH------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
+|||++|+|..||++. ...+...+.+.++.|||+|+.||++ ++.|||||.++|+||++...+||+|||+||
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999987 5678999999999999999999996 899999999999999999999999999999
Q ss_pred ecCCCCCcccccc-ccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1484 LLDGVDSMKQTMT-LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
.+...+....... .-...|||||.+..+.++.|+|||||||+|||++| |..||.+..+.++ +..|.+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~~---------- 919 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVLE---------- 919 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHHh----------
Confidence 6655444433332 33468999999999999999999999999999999 7788876533221 111111
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
. .+...+..|+.+++++|..||+.+|++||+|..+++++..+....
T Consensus 920 ------g----gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 920 ------G----GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ------C----CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1 133445789999999999999999999999999999998886643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=365.41 Aligned_cols=243 Identities=25% Similarity=0.337 Sum_probs=195.9
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
-++|...++||+|+||+||.++.. +++.+|+|+++... ....+...+|..||.+++||.||+++..|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356888899999999999999765 57889999997543 34567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
+||+.||.|..+|.+++. ++.+...-++.+|+.||.|||+ .+||||||||+|||||++|+++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred EeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 999999999999987654 5666666699999999999996 89999999999999999999999999999864332
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....+.+||+.|||||++.+..|+..+|+||+||++|||+||.+||..... ..+.+. +....+..
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~--------I~~~k~~~- 244 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDK--------ILKGKLPL- 244 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHH--------HhcCcCCC-
Confidence 2334457999999999999999999999999999999999999999975321 111111 11101000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCC
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMN 1602 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt 1602 (1624)
. +.-......++..+.+..+|++|..
T Consensus 245 ~-------p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 245 P-------PGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred C-------CccCCHHHHHHHHHHhccCHHHhcC
Confidence 0 0112344667888899999999963
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=373.61 Aligned_cols=251 Identities=30% Similarity=0.457 Sum_probs=200.4
Q ss_pred CCcCCeEeecCceEEEEEEEcC-CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC--eeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG--FKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~--~~~lV~ey~ 1413 (1624)
+...+.||+|+||+||++...+ |...|||..........+...+|+.+|++++|||||+.+|.....+ ..++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4556889999999999998764 8999999886553333677899999999999999999999855544 689999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeecceeecCC--CCC
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDG--VDS 1490 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFGla~~~~~--~~~ 1490 (1624)
++|||.+++.+.+..++.+...+++.||++||+|||+ ++||||||||+|||++. ++.+||+|||+|+.... ...
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999999876578999999999999999999995 89999999999999999 79999999999987763 112
Q ss_pred ccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCC-CccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDM-FTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~-~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.......||+.|||||++..+ ....++||||+||++.||+||+.||.+. ......+........|
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P------------- 242 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP------------- 242 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-------------
Confidence 223356899999999998854 3446999999999999999999998753 1111111111111111
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
..+...+....+++.+|+..+|++|||++|+++.-
T Consensus 243 -------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 -------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11123455678899999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=376.69 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=207.6
Q ss_pred hccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeee
Q 047591 1321 ALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400 (1624)
Q Consensus 1321 ~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~ 1400 (1624)
....+.|+++.. .+.||+|+-|.||.|++. ++.||||+++..+ ..+|+-|++++||||+.+.|+|
T Consensus 117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeee
Confidence 355677777654 468999999999999985 5789999765222 3568889999999999999999
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
....-++||||||+.|-|+..|+... .+.....+.+..+||.||.|||. ..|||||||+-||||..+..+||+|||
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEecccc
Confidence 99999999999999999999998653 45667788899999999999996 789999999999999999999999999
Q ss_pred ceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHH
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~ 1560 (1624)
.++..... ...-.++||..|||||++.....++|+||||||||||||+||..||.+.....+. |--
T Consensus 258 TS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---wGV--------- 323 (904)
T KOG4721|consen 258 TSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---WGV--------- 323 (904)
T ss_pred chHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---Eec---------
Confidence 99877543 2333578999999999999999999999999999999999999999765332221 100
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
-.+. .....+..|++-+.-|+..||+..|..||+|.+++..|+-.
T Consensus 324 --GsNs------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 324 --GSNS------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred --cCCc------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 0000 11223457888889999999999999999999999998754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=390.60 Aligned_cols=269 Identities=26% Similarity=0.383 Sum_probs=217.7
Q ss_pred ccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcC--C--ce-EEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeE
Q 047591 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFAD--G--TN-AAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAK 1395 (1624)
Q Consensus 1324 ~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~--~--~~-vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~ 1395 (1624)
.+..+.++...++....+.||+|+||+||+|++.. + .. ||||..+.. .....++|++|+++|++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34445555666666667899999999999998753 2 23 899988752 2456789999999999999999999
Q ss_pred EEeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1396 l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
+||++..+...++|||+|+||+|.++|++.+..++..++++++.++|+||+|||. .++|||||.++|+|++.++.+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999999887789999999999999999999996 8999999999999999999999
Q ss_pred EeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhh-hhc
Q 047591 1476 LGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWV-EES 1553 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~-~~~ 1553 (1624)
|+|||+++.-.... .......-...|+|||.+..+.|+.++|||||||++||+.+ |..||.++... ..+.++ ...
T Consensus 303 ISDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~ 379 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNG 379 (474)
T ss_pred eCccccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcC
Confidence 99999987643111 11111235678999999999999999999999999999999 88899875432 222222 111
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.+ ...+...+..+..++.+||..+|++||||.++.+.++.+....
T Consensus 380 ~r-------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 380 YR-------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred cc-------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 10 0111234566778889999999999999999999999987653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=371.35 Aligned_cols=258 Identities=23% Similarity=0.410 Sum_probs=210.6
Q ss_pred cCCeEeecCceEEEEEEEcCCceEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCC
Q 047591 1339 ESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417 (1624)
Q Consensus 1339 ~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gs 1417 (1624)
..+.||+|-||+|..+....+..||||.++..... ..++|.+|+++|.+++|||||+++|+|..++...+|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 45679999999999999988899999999866544 45899999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc-ccc
Q 047591 1418 LEKWLYSHNYL-LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK-QTM 1495 (1624)
Q Consensus 1418 L~~~l~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~ 1495 (1624)
|.+|+.++... .+-+.-++|+.|||.||+||.. ..+||||+.++|+|+|+++++||+|||++|-+...++.. +..
T Consensus 622 LnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 622 LNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred HHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 99999876432 3556678899999999999995 899999999999999999999999999999766555433 334
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHc--CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT--RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt--g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
.+-.++|||||.+..+++++++|||+|||++||+++ ...||.++..+.+ + +...++++. .....
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-----v-----en~~~~~~~----~~~~~ 764 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-----V-----ENAGEFFRD----QGRQV 764 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-----H-----HhhhhhcCC----CCcce
Confidence 456789999999999999999999999999999876 6788876533211 0 111111111 11111
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
....+.-|+.++++++++||..+.++||+|+++...|++.
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1223456899999999999999999999999999888753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=366.35 Aligned_cols=264 Identities=25% Similarity=0.323 Sum_probs=209.0
Q ss_pred CCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKALILQ 1411 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~lV~e 1411 (1624)
|...+.||+|.||.||||+. .+|+.||+|+++.+. +.......+||.||++++|||||+|.+...++ ...|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 44456799999999999975 579999999887554 55667789999999999999999999987665 68999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
||++ ||.-++...+..++..++..|+.|++.||+|+|. ++|+|||||.+|||||.+|.+||+|||+|+++......
T Consensus 199 YMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred cccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9987 8999998888889999999999999999999995 89999999999999999999999999999999877766
Q ss_pred cccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccch-----------hhhhhhhhcCChhHH
Q 047591 1492 KQTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV-----------CLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~-----------~l~~~~~~~~~~~~~ 1559 (1624)
..+..+-|.+|.|||.+. ...|+.++|+||.||||.||++|++.+.+...-+. ....|....+|..
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~-- 352 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA-- 352 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc--
Confidence 677788999999999765 46799999999999999999999998765322111 1111221122210
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..+.+ .......-.......+...++|+...+..||++|.|+.++++
T Consensus 353 ~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00000 000011111112345677889999999999999999999885
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.67 Aligned_cols=204 Identities=30% Similarity=0.427 Sum_probs=180.5
Q ss_pred cccCHHHHHhhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeee
Q 047591 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSC 809 (1624)
Q Consensus 732 ~~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~ 809 (1624)
..++..|+++ .+.||+|..|+|||++++ +++.+|+|++....+ ...++..+|+++++..+||+||+++|+|
T Consensus 74 ~~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF 146 (364)
T KOG0581|consen 74 NGISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF 146 (364)
T ss_pred cccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence 3466777764 468999999999999975 688999999965544 3457889999999999999999999999
Q ss_pred ccCC-eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEee
Q 047591 810 SNHG-FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDF 888 (1624)
Q Consensus 810 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DF 888 (1624)
...+ ..+++||||.+|||++++... ..+++...-+|+.+|++||.|||+. +.||||||||+|||+...|.+|||||
T Consensus 147 ~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 147 YSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred EeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 9888 599999999999999999765 3689999999999999999999974 35999999999999999999999999
Q ss_pred eeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 889 GISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 889 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
|.++.+... .....+||..|||||.+.+..|+.++||||||+.++|+++|+.||...
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 999987654 334567999999999999999999999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=356.16 Aligned_cols=269 Identities=24% Similarity=0.332 Sum_probs=199.8
Q ss_pred CCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHH--hcCCCceeEEEeeeccCC----eeEEEEEec
Q 047591 1340 SNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMR--RIRHRNLAKIVSSCSNPG----FKALILQYM 1413 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~--~l~HpNIv~l~g~~~~~~----~~~lV~ey~ 1413 (1624)
..+||+|.||.||||.+. ++.||||+|..+ ..+.|.+|-+|.+ .++|+||++++++-.... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 467999999999999985 599999999744 3467888888877 468999999999876554 789999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh------cCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ------GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~------~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
++|||.+||..+ .++|....+|+.-+|+||+|||+ ++.++|+|||||++|||+.+|+++.|+|||+|..+..
T Consensus 291 ~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 291 PKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred cCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 999999999865 68999999999999999999997 3467899999999999999999999999999998864
Q ss_pred CCCc-cccccccccccccccccCCCC------cCcccchHHHHHHHHHHHcCCCCCCC--CCccchhhhhhhhhcC-Chh
Q 047591 1488 VDSM-KQTMTLATIGYMAPEYGSEGI------VSTSGDVYSFGILMMETLTRRKPTDD--MFTGEVCLKHWVEESL-PDA 1557 (1624)
Q Consensus 1488 ~~~~-~~~~~~gt~~y~APE~~~~~~------~~~k~DV~SfGvil~Elltg~~P~~~--~~~~~~~l~~~~~~~~-~~~ 1557 (1624)
.... .....+||.+|||||++.+.. .-.+.||||+|.|||||+++..-++. ..........-+..+- -+.
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 3322 222468999999999876643 23468999999999999998765421 1111111111111110 011
Q ss_pred HHH-HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1558 VTD-VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1558 ~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..+ ++....+...... -....-+..+.+.+..||+.||+.|.|+.=|.+++.++...
T Consensus 449 mq~~VV~kK~RP~~p~~--W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDA--WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHhhccCCCChhh--hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 122 2222211111110 01123467788999999999999999999999998887543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.00 Aligned_cols=199 Identities=31% Similarity=0.420 Sum_probs=178.0
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..++||+|+||+||.++. ++++.+|+|+++.+. ....+...+|..+|.+++||+||+++-.|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5788999999999999999985 468999999987542 235677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+.||+|..+|.+++ .+++..+.-++.+|+.||.|||+ ++|||||+||+|||||++|+++++|||+++.......
T Consensus 105 d~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred eccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 9999999999998655 78888888899999999999999 4599999999999999999999999999997554433
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .+.+||+.|||||++.+..|+..+|+||+||++|||+||..||..
T Consensus 181 ~t-~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 181 AT-RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred cc-ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 33 336899999999999999999999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=376.15 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=208.4
Q ss_pred CCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
|..-..||+|+.|.||.|+- .+++.||||++........+-..+|+.+|+..+|+|||+++..|...++.|.|||||++
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 44456799999999999964 56889999999887777778889999999999999999999999888999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+.+... .+++.+...|+.++++||+|||. .+|||||||++|||++.++.+||+|||++..+..... ...+
T Consensus 355 gsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T 428 (550)
T KOG0578|consen 355 GSLTDVVTKT--RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST 428 (550)
T ss_pred Cchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence 9999988643 58889999999999999999996 8999999999999999999999999999988865443 5566
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
.+|||+|||||+.....|++|+||||+|++.+||+.|++||-.. .-...-|. +.+ ....+.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~PlrAlyL----------Ia~------ng~P~l 489 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYL----------IAT------NGTPKL 489 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---ChHHHHHH----------Hhh------cCCCCc
Confidence 78999999999999999999999999999999999999998421 11001110 000 011122
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++.....+.++..+|++.||++|++++|+++.
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3345667789999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=354.86 Aligned_cols=260 Identities=26% Similarity=0.322 Sum_probs=207.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.|....+||.|..++||+|+.. .+..||||++..+.. ...+..++|+..|+.++||||++.+.+|..+.+.|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 45667789999999999999864 578999999987653 3468899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|.+||+.+.++.. ...++......|..++++||.|||+ .|-||||||+.|||||++|.+||+|||.+..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999753 3347888888999999999999996 89999999999999999999999999997766543211
Q ss_pred --cc-cccccccccccccccC--CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1492 --KQ-TMTLATIGYMAPEYGS--EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1492 --~~-~~~~gt~~y~APE~~~--~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.. ...+||++|||||++. ...|+.|+|||||||+..||++|..||..+......+.. .....|.......
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-Lqn~pp~~~t~~~---- 257 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-LQNDPPTLLTSGL---- 257 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCCCCcccccC----
Confidence 11 3458999999999843 346999999999999999999999999876544332221 1111111111111
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+....+...+.+.+++..|++.||.+|||+.++++.
T Consensus 258 -------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 258 -------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111223455678899999999999999999998864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=382.78 Aligned_cols=260 Identities=23% Similarity=0.395 Sum_probs=203.6
Q ss_pred HhCCCCcCCeEeecCceEEEEEEE------cCCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCC
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATF------ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~------~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~ 1404 (1624)
..++|...+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++++++ +|||||+++++|..++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 345677788999999999999975 235679999986432 33456799999999999 8999999999887644
Q ss_pred -eeEEEEEecCCCCHHHHHHhcC---------------------------------------------------------
Q 047591 1405 -FKALILQYMPQGSLEKWLYSHN--------------------------------------------------------- 1426 (1624)
Q Consensus 1405 -~~~lV~ey~~~gsL~~~l~~~~--------------------------------------------------------- 1426 (1624)
..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5789999999999999997531
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-ccccccccccc
Q 047591 1427 ----YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIG 1501 (1624)
Q Consensus 1427 ----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~ 1501 (1624)
..+++.++.+++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+|+....... .......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 237788899999999999999996 7999999999999999999999999999986543221 12223456788
Q ss_pred cccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHH
Q 047591 1502 YMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKK 1580 (1624)
Q Consensus 1502 y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 1580 (1624)
|||||++.+..++.++|||||||++|||+| |+.||.+....+... .. +.+..... .+..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-~~-----------~~~~~~~~--------~~~~ 301 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-QR-----------LKDGTRMR--------APEN 301 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HH-----------HhcCCCCC--------CCCC
Confidence 999999988899999999999999999997 999987532211110 00 00000000 0123
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1581 CMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1581 ~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 45568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=382.93 Aligned_cols=481 Identities=28% Similarity=0.430 Sum_probs=402.6
Q ss_pred cccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccc
Q 047591 131 NELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLT 210 (1624)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~ 210 (1624)
+.+|.-..|+.|++++|.+.- +-++ ..+|..|..|++++|+++ ++|++++.+.+++.|+.|+|+++ .+|+.++.+.
T Consensus 39 e~wW~qv~l~~lils~N~l~~-l~~d-l~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~ 114 (565)
T KOG0472|consen 39 ENWWEQVDLQKLILSHNDLEV-LRED-LKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLI 114 (565)
T ss_pred hhhhhhcchhhhhhccCchhh-ccHh-hhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhh
Confidence 345666789999999999974 3333 368999999999999999 79999999999999999999999 9999999999
Q ss_pred cccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeec
Q 047591 211 ELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGL 290 (1624)
Q Consensus 211 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~L 290 (1624)
+|..|+.++|.+. ++|++++.+..|+.|+..+|+++ ++|.+++ .+.+|..|++.+|++....|..+. ++.|+.||.
T Consensus 115 ~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~ 190 (565)
T KOG0472|consen 115 SLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDC 190 (565)
T ss_pred hhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHH-HHHHHHHhhccccchhhCCHHHHH-HHHHHhccc
Confidence 9999999999998 89999999999999999999998 7888875 688999999999999977666666 999999999
Q ss_pred cCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCccccc-CCCCCcEE
Q 047591 291 RDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSIC-NASKLTVL 369 (1624)
Q Consensus 291 s~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~-~l~~L~~L 369 (1624)
..|-+ +.+|+.++.+.+|+-|+|.+|++. .+|+.- ....|.+|+++.|++. .+|.+.+ ++.+|.+|
T Consensus 191 ~~N~L---------~tlP~~lg~l~~L~~LyL~~Nki~-~lPef~--gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vL 257 (565)
T KOG0472|consen 191 NSNLL---------ETLPPELGGLESLELLYLRRNKIR-FLPEFP--GCSLLKELHVGENQIE-MLPAEHLKHLNSLLVL 257 (565)
T ss_pred chhhh---------hcCChhhcchhhhHHHHhhhcccc-cCCCCC--ccHHHHHHHhcccHHH-hhHHHHhcccccceee
Confidence 88865 458999999999999999999998 788443 4678999999999998 7888887 89999999
Q ss_pred ecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCc--cccch
Q 047591 370 ELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNL--SKSLE 447 (1624)
Q Consensus 370 ~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l--~~~L~ 447 (1624)
||.+|+++. .|+.+.-+++|.+||+++|.++. ++.+++++ .|+.|.+.+|++.- +-..+-+. ..-|+
T Consensus 258 DLRdNklke-~Pde~clLrsL~rLDlSNN~is~--------Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLK 326 (565)
T KOG0472|consen 258 DLRDNKLKE-VPDEICLLRSLERLDLSNNDISS--------LPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLK 326 (565)
T ss_pred ecccccccc-CchHHHHhhhhhhhcccCCcccc--------CCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHH
Confidence 999999985 57788999999999999999975 55678888 89999999999842 22222111 11244
Q ss_pred hhcc-----CCccc------CCCCCC----CcCCCCcccEEeccCCccCCCccchhccccc---cceecccccccccCCC
Q 047591 448 YFYA-----GSCEL------GGGIPA----EFGNLSNIIALSLYQNQLASTIPTTVGKLQN---LQGLDLSYNNIQGSIP 509 (1624)
Q Consensus 448 ~L~l-----~~n~l------~g~ip~----~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~---L~~L~Ls~N~l~g~iP 509 (1624)
||.- +-++- .+..|. ....+.+.+.|+++.=+++ .+|++.+.-.. .+..+++.|++. ++|
T Consensus 327 yLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elP 404 (565)
T KOG0472|consen 327 YLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELP 404 (565)
T ss_pred HHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhh
Confidence 4432 11111 112121 2334667889999999998 68887766655 889999999999 899
Q ss_pred ccccCCCCCcee-ecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCccccccc
Q 047591 510 SELCQLESLNTL-LLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLK 588 (1624)
Q Consensus 510 ~~l~~l~~L~~L-~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~ 588 (1624)
..+..+..+.+. .+++|.+ +-+|..++.+++|..|+|++|-+. .+|.+++++..|+.||+|.|+|. .+|..+..+.
T Consensus 405 k~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq 481 (565)
T KOG0472|consen 405 KRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQ 481 (565)
T ss_pred hhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHH
Confidence 999888877654 5555555 589999999999999999999997 58999999999999999999997 7999999999
Q ss_pred ccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhhhccccccCCCCCCCCCcc
Q 047591 589 VLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFV 650 (1624)
Q Consensus 589 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~~~~i~~~~~~~ 650 (1624)
.|+.+-.++|++.-.-|+.+.++.+|..|||.+|.++ +||+.++++++|+...+ +|+||.
T Consensus 482 ~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL-~gNpfr 541 (565)
T KOG0472|consen 482 TLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLEL-DGNPFR 541 (565)
T ss_pred HHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEe-cCCccC
Confidence 9999888889998544455999999999999999998 79999999999998776 577776
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=368.89 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=209.4
Q ss_pred hhccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchh---hHHHHHHHHHHHHHhcCCCceeEE
Q 047591 1320 AALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLAKI 1396 (1624)
Q Consensus 1320 ~~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~---~~~~~f~~E~~~l~~l~HpNIv~l 1396 (1624)
..++.++.+++.. .....||+|++|.||+|.+ +|+.||||.++.... ...+.|.+|+++|++++|||||++
T Consensus 10 ~~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 3456677777743 2246899999999999998 688999999864322 235788999999999999999999
Q ss_pred Eeeecc----CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC
Q 047591 1397 VSSCSN----PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM 1472 (1624)
Q Consensus 1397 ~g~~~~----~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~ 1472 (1624)
+|++.+ ....++||||+++|+|.+++++.+ .++|..+++++.|++.|++|||+ ..+++||||||+|||+++++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENY 160 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCC
Confidence 999866 346789999999999999998653 57899999999999999999996 24788999999999999999
Q ss_pred cEEEeeecceeecCCCCCccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh
Q 047591 1473 VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV 1550 (1624)
Q Consensus 1473 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~ 1550 (1624)
.+||+|||+++.+.... ....||+.|+|||+..+ ..++.++|||||||++|||+||+.||......+. ....
T Consensus 161 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i- 234 (283)
T PHA02988 161 KLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLI- 234 (283)
T ss_pred cEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHH-
Confidence 99999999998654321 23468999999999865 6899999999999999999999999975421111 1111
Q ss_pred hhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1551 EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
+..... ...+..++..+.+++.+||+.||++||||+|+++.|+.++.
T Consensus 235 -----------~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 -----------INKNNS-------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -----------HhcCCC-------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 100000 00112356678899999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=366.51 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=203.2
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~ 1407 (1624)
.-++|.-.+.||+|+|++||+|+.. .++++|||++... .+...+-..+|-.+|.++ .||.||+|+..|+++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4467777899999999999999764 6899999998643 234455677889999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+|+||+++|+|.++|++-+. ++......+|.+|+.||+|||. .|||||||||+|||||+||++||+|||-|+.+.+
T Consensus 151 FvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999998764 4555555699999999999995 8999999999999999999999999999998864
Q ss_pred CCCc------------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC
Q 047591 1488 VDSM------------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP 1555 (1624)
Q Consensus 1488 ~~~~------------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~ 1555 (1624)
.... .....+||..|.+||++.....+..+|+||||||||.|++|++||.+.... ...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liF--------- 296 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIF--------- 296 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHH---------
Confidence 3211 124579999999999999999999999999999999999999999754211 011
Q ss_pred hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+++... .-++..++.+.+|+.+.+..||.+|+|.+|+-++
T Consensus 297 ---qkI~~l~y---------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 ---QKIQALDY---------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---HHHHHhcc---------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11221111 1112334567789999999999999999777553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=357.87 Aligned_cols=202 Identities=29% Similarity=0.436 Sum_probs=170.9
Q ss_pred CCCCCcceeecCCccceEEEE-ecCCCEEEEEEeecccc-h------hHHHHHHHHHHHHhcCCCceeeeeeeeccCCeE
Q 047591 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLD-G------AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~~~~~~~-~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 815 (1624)
+-|-..+.+|+|+||.|-+|. .++|+.||||++..+.. . ......+|+++|++++|||||+++++++..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 445667899999999999997 45799999999975431 1 112346999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC---CceEEEeeeeee
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD---TVAHLSDFGISK 892 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~~kl~DFGla~ 892 (1624)
|||||||+||+|.+++-.++ .+.++....++.|++.|+.|||+ .+|+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999998765 57778888899999999999999 469999999999999765 789999999999
Q ss_pred ccCCCCCcccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHcCCCCCCccCcC
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGI---VSTCGDVYSFGILMIETFTRKMPTDEMFTG 951 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~k~DvwS~Gvil~elltg~~P~~~~~~~ 951 (1624)
.... .+ ...+.+|||.|.|||++..+. +..|+|+||+|||||-+++|..||++....
T Consensus 328 ~~g~-~s-fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 328 VSGE-GS-FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred cccc-ce-ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 8763 23 334468999999999986543 344889999999999999999999875543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.79 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=204.1
Q ss_pred CCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHH-HHHHHHHHHHhcC-CCceeEEEeeeccCC-eeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALK-SFDAECEVMRRIR-HRNLAKIVSSCSNPG-FKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~-~f~~E~~~l~~l~-HpNIv~l~g~~~~~~-~~~lV~e 1411 (1624)
.|...+.||.|.||.||+|+- .+|..||||.++.+-....+ .=.||++.|++++ |||||++...+.+.+ ..++|||
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 455557799999999999975 46889999988654322222 2368999999999 999999999998887 9999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
||+. +|++.+++++..++.++...|+.||.+||+|+|+ .|+.|||+||+|||+.....+||+|||+||.+... .
T Consensus 91 ~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--p 164 (538)
T KOG0661|consen 91 FMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--P 164 (538)
T ss_pred hhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC--C
Confidence 9975 9999999888999999999999999999999996 89999999999999999999999999999987543 3
Q ss_pred ccccccccccccccccc-CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh--hhhhh----hhcCChh--HHHHH
Q 047591 1492 KQTMTLATIGYMAPEYG-SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC--LKHWV----EESLPDA--VTDVI 1562 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~-~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~--l~~~~----~~~~~~~--~~~~~ 1562 (1624)
..+.++.|.+|+|||++ +.+.|+.++||||+|||++|+.+-++-|.+....+.. +.... ++.+++. +...+
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 45678899999999974 6788999999999999999999988766553221110 11111 1111111 11111
Q ss_pred hhhccCCchHHHHH-HHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIA-AKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~-~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.-.+-. .....+. .-..+..+..+++.+|++-||++|||++|++++
T Consensus 245 nf~~P~-~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 245 NFRFPQ-VKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccCCCc-CCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 101000 0000000 112367788999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=343.15 Aligned_cols=202 Identities=27% Similarity=0.410 Sum_probs=174.8
Q ss_pred CCCCcceeecCCccceEEEE-ecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeee-eeccCCe-EEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIIS-SCSNHGF-KALIL 819 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV~ 819 (1624)
+|.+.+.||+|+||+|||++ ..+|..||.|.++... ....+....|+.+|++++|||||++++ .+.++.. +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 36667899999999999997 5689999999887432 345567889999999999999999998 4444444 89999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 820 EYMPQGSLEKWLYS---HKYTLNIQQRLDIMIDVASALEYLHHGHPT-PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
|||..|||.+.++. .+..+++..+++++.|+++||..+|...+. .|+||||||.||+||.+|.+|++|||++|.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998753 445789999999999999999999985432 28999999999999999999999999999987
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.+.+.. ...+|||.||+||.+.+..|+.|+||||+||++|||..-+.||..
T Consensus 180 s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g 230 (375)
T KOG0591|consen 180 SKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG 230 (375)
T ss_pred chhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence 654433 345799999999999999999999999999999999999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=364.77 Aligned_cols=262 Identities=22% Similarity=0.397 Sum_probs=217.4
Q ss_pred HHHHHHhCCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1328 QELRLATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1328 ~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
++++...-+....+.||-|.||.||.|.|+. .-.||||.++ ++....++|..|+.+|+.++|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3333333344556889999999999999974 5679999886 3445678999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1407 ALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
|||+|||.+|+|.+||++.. ..++.-..+.+|.||+.||+||.. +.+|||||.++|+|+.++..+||+|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999764 456666678899999999999995 88999999999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.+..........-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||.+... . .+.+.+..
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----S---------qVY~LLEk 481 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----S---------QVYGLLEK 481 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----H---------HHHHHHhc
Confidence 8766655554455678999999988899999999999999999998 7778865321 1 12222222
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
. .++..++.|++++++||++||+-+|.+||+|.|+-+.++.+-
T Consensus 482 g-------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 482 G-------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred c-------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1 223445789999999999999999999999999999988763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=365.81 Aligned_cols=199 Identities=25% Similarity=0.371 Sum_probs=179.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQ---LDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
..|...++||+|||+.||.++. .+|..||+|++... .....+...+||++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588889999999999999987 88999999999753 3445677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|+|++|+|.++++ +...+++.++..+..||+.||.|||+. +|||||||-.|++++++.++||+|||||..+..+..
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999988 445899999999999999999999994 599999999999999999999999999998875433
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .+.+|||.|+|||++.....+..+||||+|||+|-|++|++||+.
T Consensus 174 rk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 174 RK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred cc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 33 345899999999999988899999999999999999999999974
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=356.69 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=204.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++++++||||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45677789999999999999764 35679999887542 33456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++......+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999998766678999999999999999999996 799999999999999999999999999876543221
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
........++..|+|||+..+..++.++|||||||++||+++ |+.||.+.... .....+. +....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~-----------~~~~~- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVE-----------DGFRL- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHH-----------CCCCC-
Confidence 111122345678999999988999999999999999999875 99998654211 1111111 10000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
..+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01134566788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.57 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=204.0
Q ss_pred CCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.|...+.+|+|.||+||+|+. .+|+.||||+++... +.......+|++.|+.++||||+.++++|-+.+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 355567899999999999975 478999999987543 23345778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
|+. +|+..+++....+...+...++.++.+|++|||. ..|+||||||.|+|++++|.+||+|||+|+........
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~- 157 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI- 157 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence 985 9999999888889999999999999999999996 89999999999999999999999999999988654432
Q ss_pred ccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh-------hhcCChh--HHHHH
Q 047591 1493 QTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV-------EESLPDA--VTDVI 1562 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~-------~~~~~~~--~~~~~ 1562 (1624)
.+..+-|.+|.|||.+. ...|+..+||||.|||+.||+-|.+=+.+.. +-..+...+ .+.+|+. ..|.+
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 33347899999999765 4679999999999999999998875443321 111111111 1122221 11111
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.-..... ......-..+.....+++.+.+..+|.+|+|++|++++
T Consensus 237 ~~~~~P~--~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPK--PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCC--CccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111100 00000113456678999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=364.48 Aligned_cols=211 Identities=31% Similarity=0.521 Sum_probs=181.0
Q ss_pred cceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCCHH
Q 047591 749 SNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLE 828 (1624)
Q Consensus 749 ~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 828 (1624)
.+.||+|.||+||.|.+....+||||.++.. .-..+.|.+|+++|++++|+|||+++|+|..++.+|||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 4679999999999999987789999999764 223478999999999999999999999999988999999999999999
Q ss_pred HHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccccc
Q 047591 829 KWLYS-HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA 907 (1624)
Q Consensus 829 ~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 907 (1624)
+||+. .+..+...+.+.++.|||+|++||++. .+|||||.++|||++++..+||+|||+||...++.........-
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf 366 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF 366 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC
Confidence 99987 456788999999999999999999984 49999999999999999999999999999665554444444445
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccCcCcchHHHHHHHHhhh
Q 047591 908 TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEMFTGETSLKKWVEESLRL 965 (1624)
Q Consensus 908 t~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~~~~~~~l~~~~~~~~~~ 965 (1624)
...|.|||.+..+.++.|||||||||+||||+| |+.||..+... .+.+.++...|.
T Consensus 367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~~~le~GyRl 423 (468)
T KOG0197|consen 367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVLELLERGYRL 423 (468)
T ss_pred CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHHHHHhccCcC
Confidence 678999999999999999999999999999999 78998776432 233444444443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=363.78 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=200.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-----------------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-----------------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKI 1396 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-----------------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l 1396 (1624)
+.|...+.||+|+||+||+|.+.+ +..||+|++.... ....++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 356667899999999999997642 2369999886543 3345689999999999999999999
Q ss_pred EeeeccCCeeEEEEEecCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEE
Q 047591 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHN------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458 (1624)
Q Consensus 1397 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH 1458 (1624)
++++.+.+..++||||+++|+|.+++.... ..++|.++.+++.||+.||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999986431 246888999999999999999996 78999
Q ss_pred cCCCCCcEEecCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc--CCCC
Q 047591 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT--RRKP 1535 (1624)
Q Consensus 1459 rDlK~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt--g~~P 1535 (1624)
|||||+|||+++++.+||+|||+++.+...... ......++..|||||+...+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876433221 1222346789999999888889999999999999999997 4566
Q ss_pred CCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1536 TDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1536 ~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
|....... .+ ..+ .+........ .....+..|+..+.+++.+||+.+|++||||+|+.+.|+
T Consensus 242 ~~~~~~~~-~~-~~~--------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ-VI-ENA--------GEFFRDQGRQ----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH-HH-HHH--------HHHhhhcccc----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 65432111 11 110 0000000000 000011245677899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=356.41 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=202.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|..-+.||+|+||.||||+.+ +.+.||+|.+.+. .++..+...+|++|+++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45666678999999999999775 5788999988543 45667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+.+ +|..+|..++ .++.++...|+.+++.||.|||. .+|+|||+||.|||++..+++|+||||+||.+.... .
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S 155 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence 9987 9999997665 57788888999999999999995 899999999999999999999999999999886533 3
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
..+...|||-|||||...++.|+..+|.||+|||+|||++|++||.... +-+.++ .+. .++.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~--------~I~-----~d~v 217 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVK--------SIL-----KDPV 217 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHH--------HHh-----cCCC
Confidence 4455689999999999999999999999999999999999999985311 111111 111 1000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. +......+..+....+.+||.+|.|..+++..
T Consensus 218 ~~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KP----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CC----cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 00 11234556778888899999999999988754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=373.09 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=201.6
Q ss_pred CCCCcCCeEeecCceEEEEEEE------cCCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF------ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~------~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||+||+|++ .++..||||+++... ....+.+.+|+++++.+ +|||||+++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3466678999999999999974 235679999986432 33456789999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC------------------------------------------------------------
Q 047591 1407 ALILQYMPQGSLEKWLYSHN------------------------------------------------------------ 1426 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~------------------------------------------------------------ 1426 (1624)
++|||||++|+|.+++++..
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999996432
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1427 --------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1427 --------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
..++|+.+.+++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 247888999999999999999996 799999999999999999999999999998764332211
Q ss_pred -ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1493 -QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1493 -~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.....++..|||||+..+..++.++|||||||++|||+| |..||........ ...+ +.......
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~------------~~~~~~~~- 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKM------------IKEGYRML- 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHH------------HHhCccCC-
Confidence 112345678999999998999999999999999999998 8888865422211 1111 11110000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
.+...+.++.+++.+||+.+|++||+|+|+++.|++
T Consensus 338 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 ------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 011234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=365.73 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=200.9
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc----hh-hHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCe
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ----ED-RALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~----~~-~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~ 1405 (1624)
....|...+.||+|+||+||.|... ++..||||++..+ .. ...+...+|+.++++++ ||||++++.++..+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3456778899999999999999764 6899999977543 11 23456678999999999 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC-CcEEEeeecceee
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKL 1484 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~kl~DFGla~~ 1484 (1624)
.++||||+.+|+|.+++.+ ...+..+...+++.|+++|++|||+ ++|+||||||+|||+|.+ +.+||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999998 4456667888899999999999996 899999999999999999 9999999999998
Q ss_pred cCCCCCccccccccccccccccccCCCC-cC-cccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGI-VS-TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||++..... ... . +
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-l~~------------k-i 235 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-LYR------------K-I 235 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-HHH------------H-H
Confidence 74 1222344568999999999998866 75 88999999999999999999998722110 000 0 1
Q ss_pred hhhccCCchHHHHHHHHHh-HHHHHHHHHHccccCCCCCCCHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKC-MSSVMSLALKCSEEIPEERMNVKDAL 1607 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~-~~~~~~l~~~C~~~~P~~RPt~~evl 1607 (1624)
...- ...+..+ ..++..++.+|+..+|.+|+|+.|++
T Consensus 236 ~~~~--------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 RKGE--------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred hcCC--------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1000 0011122 45678899999999999999999998
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=354.27 Aligned_cols=247 Identities=32% Similarity=0.554 Sum_probs=194.1
Q ss_pred CCeEeecCceEEEEEEEc-----CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1340 SNLLGTGIFSSVYKATFA-----DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-----~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.+.||+|+||.||+|++. .+..||||+++... ....+.|.+|++.+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999987 24679999996533 345789999999999999999999999999888899999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-c
Q 047591 1414 PQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-M 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-~ 1491 (1624)
++|+|.++|+.. ...+++.++.+|+.|||+||+|||+ .+|+||||+++||++++++.+||+|||+++....... .
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999986 6778999999999999999999996 7899999999999999999999999999987732221 1
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+...|+|||.+....++.++||||||+++|||+| |+.|+.+....+ ... .+.+.....
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-~~~------------~~~~~~~~~-- 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-IIE------------KLKQGQRLP-- 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-HHH------------HHHTTEETT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccc------------cccccccce--
Confidence 2223457789999999988889999999999999999999 678886542211 111 111111100
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
.+..++..+.+++.+||+.+|++||||+|+++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1123566788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=350.27 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=202.0
Q ss_pred CCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+|...+.||+|+||.||+|++.++..+|+|.+... ....+.|.+|++++++++||||++++++|.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45666889999999999999988888999987532 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.++++.....++++.+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 99999998655568999999999999999999996 789999999999999999999999999998664333222233
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
..++..|+|||+.....++.++|||||||++|||+| |+.||......+ ....+... .....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~i~~~-----------~~~~~----- 222 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMISRG-----------FRLYR----- 222 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC-----------CCCCC-----
Confidence 346678999999988889999999999999999999 888986532111 11111100 00000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus 223 ---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 ---PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=351.99 Aligned_cols=199 Identities=31% Similarity=0.441 Sum_probs=177.4
Q ss_pred CCCCcceeecCCccceEEEE-ecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccC--CeEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNH--GFKALIL 819 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 819 (1624)
.|...+.||+|.||.||||+ ..+|+.||+|++..+. ++......|||.||++++|||||+|.+...+. +.+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 45556789999999999998 5689999999987665 45566778999999999999999999988766 6899999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|||+. ||.-.+......++..++..|++|++.||+|+|.. +|+|||||.+|||||.+|.+||+|||||+++.....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99987 99999987777899999999999999999999994 599999999999999999999999999999988776
Q ss_pred cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...+..+.|.+|.|||.+.+ ..|++++|+||.|||+.||++|+..+..
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 66777789999999998654 5799999999999999999999987643
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=370.29 Aligned_cols=256 Identities=21% Similarity=0.375 Sum_probs=202.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||+||+|++. ++..||||+++... ....+.+.+|+++++++ +|||||+++++|.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 45777789999999999999752 23579999986432 33456789999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC------------------------------------------------------------
Q 047591 1407 ALILQYMPQGSLEKWLYSHN------------------------------------------------------------ 1426 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~------------------------------------------------------------ 1426 (1624)
++||||+++|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999986421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc-ccccc
Q 047591 1427 ---------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMT 1496 (1624)
Q Consensus 1427 ---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~ 1496 (1624)
..+++++.++|+.||+.||+|||+ .+|+||||||+|||+++++++||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 236788899999999999999996 79999999999999999999999999999866432211 11123
Q ss_pred ccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
.+++.|||||+.....++.++|||||||++|||++ |+.||........ ....+.......
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-------------~~~~~~~~~~~~------ 335 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-------------FYKMVKRGYQMS------ 335 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-------------HHHHHHcccCcc------
Confidence 45678999999988899999999999999999997 9999865322111 011111100000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 336 -~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 -RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011245688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=353.85 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=199.7
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|...+.||+|+||+||+|... +|+.||||.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 566789999999999999874 68999999886432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
+++|+|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999999888654 3458899999999999999999996 899999999999999999999999999998764322
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......||+.|||||++.+..++.++|||||||++|||++|+.||........ .+.++..+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~ 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--------------REEVDRRVKEDQE 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--------------HHHHHHHhhcccc
Confidence 12345799999999999999999999999999999999999999975322110 0001111100000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~~ 1609 (1624)
..+...+..+.+++.+||+.+|++||+ ++|+++.
T Consensus 223 ----~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 ----EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001223456788999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.54 Aligned_cols=197 Identities=28% Similarity=0.397 Sum_probs=175.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh---hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~---~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|.....||.|+||.|..++.+ +|.-+|+|+++.+.- +..+...+|..+|+.+.||.++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34556688999999999999876 577899999976543 34456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|.|..++++.+. ++......+|.||+.|++|||. ..|++||+||+|||+|.+|++||+|||+|+.+.+.
T Consensus 124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999999987654 5666666799999999999995 89999999999999999999999999999988542
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~ 1539 (1624)
.-+.+|||.|+|||.+....|+.++|.|||||++|||+.|..||.+.
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 34568999999999999999999999999999999999999999754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.57 Aligned_cols=197 Identities=28% Similarity=0.401 Sum_probs=177.4
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD---GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||.|+||+|.+++.+ +|..+|+|+++.+.- ...+...+|..+|+.+.||++|++++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45777889999999999999865 588999999976532 34566788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||++||.|..+++..+ ++++..+.-+|.||+.|++|||+.. ||+||+||+|||+|++|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 9999999999998765 7899999999999999999999954 999999999999999999999999999987543
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
..+.+|||.|+|||.+....+..++|.|||||++|||+.|..||...
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 34568999999999999999999999999999999999999998653
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=359.52 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=204.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCc----eEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGT----NAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~----~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.+|...+.||+|+||+||+|++. ++. .||||+++.. .....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45788899999999999999874 333 3899988643 234567899999999999999999999999764 5679
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|+||+++|+|.+++++....+++..+++++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 999999999999998877678999999999999999999996 79999999999999999999999999999876533
Q ss_pred CCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.... .....++..|||||+..+..++.++|||||||++|||+| |+.||++....+ +..+. ....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~------------~~~~ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL------------EKGE 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH------------hCCC
Confidence 2211 122335678999999999999999999999999999998 999986532111 11111 1100
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.. ..+..|+..+.+++.+||+.+|++||++.|++..+.++..
T Consensus 229 ~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RL-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CC-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00 0012345567889999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=354.52 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=216.3
Q ss_pred CCCcCCeEeecCceEEEEEEEcC---Cc--eEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFAD---GT--NAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~---~~--~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.....++||+|-||.||+|.+.+ |. .||||.-+.. .....+.|+.|+.+|++++|||||+++|.|.+ ...++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 33445789999999999998742 33 4788877653 33457889999999999999999999999964 467999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
||+++-|.|..||..++..++......++.||+.||+|||. ...|||||.++|||+...--+|++|||++|.++..+
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999999988889999999999999999999995 899999999999999999999999999999998777
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
....+...-.+.|||||.+.-.+++.++|||=|||.+||+++ |..||.+..+.++..+ +
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~------------------i-- 605 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH------------------I-- 605 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE------------------e--
Confidence 666665556788999999999999999999999999999987 9999976544332111 1
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
+.+.+.+.++.|+..++.++.+||+.+|.+||++.|+...|.++..
T Consensus 606 -EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 -ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1112344567899999999999999999999999999999988765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.35 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=200.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHh--cCCCceeEEEeeeccC----CeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRR--IRHRNLAKIVSSCSNP----GFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~--l~HpNIv~l~g~~~~~----~~~~l 1408 (1624)
......+.||+|.||+||+|+| .|..||||+|...++ +.+.+|.+|.+. ++|+||+.+++.=..+ .+.+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 3455567899999999999999 478999999975443 678889999986 5999999999875432 36899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ-----GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
|.+|.++|||++||.. ..++.+..++++..+|.||+|||. +..+.|.|||||+.|||+..++.+.|+|+|+|-
T Consensus 287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999976 468899999999999999999994 346889999999999999999999999999998
Q ss_pred ecCCCC---CccccccccccccccccccCCCC------cCcccchHHHHHHHHHHHcCC----------CCCCCCCccch
Q 047591 1484 LLDGVD---SMKQTMTLATIGYMAPEYGSEGI------VSTSGDVYSFGILMMETLTRR----------KPTDDMFTGEV 1544 (1624)
Q Consensus 1484 ~~~~~~---~~~~~~~~gt~~y~APE~~~~~~------~~~k~DV~SfGvil~Elltg~----------~P~~~~~~~~~ 1544 (1624)
...... .......+||.+|||||++.... .-..+||||||.|+||++.+. .||.+....+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 765432 12334578999999999876532 234689999999999998753 45554332221
Q ss_pred hhhhhhhhcCChhHHHHH-hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1545 CLKHWVEESLPDAVTDVI-DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1545 ~l~~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
... ...+++ ...+....+.. -..-+++..+.++|..||..+|..|-|+--+-+.|.++..
T Consensus 445 s~e---------eMrkVVCv~~~RP~ipnr--W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFE---------EMRKVVCVQKLRPNIPNR--WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHH---------HHhcceeecccCCCCCcc--cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 111 111221 11111111110 0112467788999999999999999999888888887763
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=350.69 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=198.7
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
+...++|....+||+||||+||.|+-+ +|..+|+|+++..+ ....+..+.|-.+|...++|+||+|+..|.+.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999765 58999999997543 24467788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
||||||+|||++..+|...+ .++.+....++.+++.|++-+|+ .|+|||||||+|+|||..|++|++|||+++-+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999998655 45666666799999999999996 899999999999999999999999999985332
Q ss_pred C----------------------CCCc-----cc-------------------cccccccccccccccCCCCcCcccchH
Q 047591 1487 G----------------------VDSM-----KQ-------------------TMTLATIGYMAPEYGSEGIVSTSGDVY 1520 (1624)
Q Consensus 1487 ~----------------------~~~~-----~~-------------------~~~~gt~~y~APE~~~~~~~~~k~DV~ 1520 (1624)
. .+.. .. -..+|||-|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 00 124799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCccch--hhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCC
Q 047591 1521 SFGILMMETLTRRKPTDDMFTGEV--CLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPE 1598 (1624)
Q Consensus 1521 SfGvil~Elltg~~P~~~~~~~~~--~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~ 1598 (1624)
|+|||+|||+.|.+||......+. .+..|...- . .+. ...+..+..+|+.+|+. ||+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-------------~-fP~------~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-------------K-FPE------EVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-------------c-CCC------cCcccHHHHHHHHHHhc-CHH
Confidence 999999999999999976544333 233443211 0 000 11234567889999998 999
Q ss_pred CCCC
Q 047591 1599 ERMN 1602 (1624)
Q Consensus 1599 ~RPt 1602 (1624)
+|-.
T Consensus 432 ~RLG 435 (550)
T KOG0605|consen 432 NRLG 435 (550)
T ss_pred HhcC
Confidence 9986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=352.00 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=205.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.|...++||+|+||.||||... .++.||+|++..+.. ...+..++|+.++...+|+||.+.||.|......+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4566688999999999999764 578899999986543 34678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
.+|++.+.+.... .++.....-|+.++..|+.|||. .+.||||||+.|||+..+|.+|++|||+|..+..... ..
T Consensus 94 ~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-rr 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-RR 168 (467)
T ss_pred cCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh-cc
Confidence 9999999997543 33666666788999999999996 7899999999999999999999999999988765443 33
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
.+.+||+.|||||++....|+.|+||||+|++.+||++|.+|+.+.....+.. .+....|...
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--lIpk~~PP~L--------------- 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--LIPKSAPPRL--------------- 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--eccCCCCCcc---------------
Confidence 66899999999999998899999999999999999999999997754422210 0111111110
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+...+.+++..|++.+|+.||++.++++.
T Consensus 232 ----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 ----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 01345668899999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=352.07 Aligned_cols=197 Identities=30% Similarity=0.452 Sum_probs=178.1
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.... +...+...+|+++++.++|||||+++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888899999999999999865 57899999997543 3456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+.+ +|..+|...+ .++++.+..|+.++..||.|||+. +|+|||+||+|||++..+++|+||||+||.+... ..
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TS 155 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ce
Confidence 9987 9999997654 799999999999999999999994 5999999999999999999999999999987654 33
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
..+...|||.|||||...++.|+..+|+||+|||+||+++|++||.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 4455679999999999999999999999999999999999999985
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=366.32 Aligned_cols=258 Identities=23% Similarity=0.390 Sum_probs=204.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccch-hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~ 1405 (1624)
.++|...++||+|+||+||+|++.. +..||||+++... ....+.|.+|+++++++. |||||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4567777899999999999998631 3469999986432 334568999999999996 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcC-----------------------------------------------------------
Q 047591 1406 KALILQYMPQGSLEKWLYSHN----------------------------------------------------------- 1426 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 1426 (1624)
.++|||||++|+|.+++++..
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999987531
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC
Q 047591 1427 ------------------------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD 1470 (1624)
Q Consensus 1427 ------------------------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 1470 (1624)
..+++.++++++.|+++||+|||+ .+|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 236788889999999999999996 79999999999999999
Q ss_pred CCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhh
Q 047591 1471 DMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKH 1548 (1624)
Q Consensus 1471 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~ 1548 (1624)
++.+||+|||+++....... .......+++.|||||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 99999999999987643221 12223457788999999988889999999999999999997 899987543221110
Q ss_pred hhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1549 WVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1549 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
..+..... ...+..++..+.+++.+||+.+|++|||+.++.+.|+++.
T Consensus 351 -----------~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 -----------NKIKSGYR-------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -----------HHHhcCCC-------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 01110000 0011235567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=347.29 Aligned_cols=254 Identities=23% Similarity=0.408 Sum_probs=206.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||+||+|...++..||+|.+.... ...+.|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4567778999999999999998888889999876432 235789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+|+|.+++++. +..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999754 4568899999999999999999996 7999999999999999999999999999987654322222
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....++..|+|||+...+.++.++|||||||++|||+| |+.||...... ....++..... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-----------~~---- 224 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR-----------MP---- 224 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC-----------CC----
Confidence 33346778999999988889999999999999999999 99998643211 11111111000 00
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
....++..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 ----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0012345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.11 Aligned_cols=248 Identities=24% Similarity=0.315 Sum_probs=205.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
-++|...+.||+|.||.||.|+.+ ++-.||+|++.... ....+++.+|++|.+.++||||+++|+++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356788899999999999999875 56789999985432 34467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1410 LQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
+||.++|++.+.|++. ...++......++.|+|.|+.|+|. +.||||||||+|+|++.++..||+|||-+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999854 3457777788899999999999995 899999999999999999999999999986543
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.....+.+||.-|.+||...+..++.++|+|++||+.||++.|.+||.....++ ..+..... .+
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~k~------------~~-- 239 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIRKV------------DL-- 239 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHHHc------------cc--
Confidence 334556789999999999999999999999999999999999999997654221 11111110 00
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+...+..+.+++.+|+..+|.+|.+..||++.
T Consensus 240 -------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 -------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0112234557789999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=352.13 Aligned_cols=270 Identities=20% Similarity=0.245 Sum_probs=203.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 35777889999999999999886 57889999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++++.+..+. .....++++.+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+|+........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99988776544 334568889999999999999999996 79999999999999999999999999999876543332
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh-hhhhhhhcCChhHHHHH--hhhc--
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC-LKHWVEESLPDAVTDVI--DANL-- 1566 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~-l~~~~~~~~~~~~~~~~--d~~l-- 1566 (1624)
......||+.|+|||+..+..++.++|||||||++|||++|+.||......+.. .........+....... ++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 333457999999999998888999999999999999999999999753221110 00011111111110000 0000
Q ss_pred -----cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1567 -----LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1567 -----~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..............++..+.+++.+|++.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000111111235677999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=345.60 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=206.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|++.. ...||||+++... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 467788999999999999998853 3579999886443 34457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++......+++.++++++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999999998766678999999999999999999996 899999999999999999999999999998775222
Q ss_pred C-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1490 S-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1490 ~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
. .......+++.|+|||+.....++.++|||||||++|||++ |..||.+....+ ....+.. ....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~-----------~~~~ 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVED-----------GYRL 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHc-----------CCCC
Confidence 1 11122345678999999988899999999999999999998 999986532111 1111110 0000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
. .+..++..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 228 ~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 P--------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0123456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=344.69 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=205.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.++|...+.||+|+||.||+|.+.+++.||+|.++... ...+.|.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45677789999999999999998778889999986433 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++++|.+++.... ..+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997643 568999999999999999999996 799999999999999999999999999998775322222
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....++..|+|||+.....++.++|||||||++|||+| |+.||...... .... .++......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~-------------~~~~~~~~~-- 224 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQ-------------QVDQGYRMP-- 224 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH-------------HHHcCCCCC--
Confidence 222233468999999988899999999999999999999 99898653211 1111 111100000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
....++..+.+++.+|++.+|++||+++++++.|++
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 -----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011245668899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=344.45 Aligned_cols=253 Identities=23% Similarity=0.395 Sum_probs=205.0
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
+|...+.||+|+||.||+|.+. .++.||+|++... ....+.|.+|++++++++||||++++++|..++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4666788999999999999875 4788999988643 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999754 3468999999999999999999996 7999999999999999999999999999987654332222
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....+++.|+|||+..+..++.++|||||||++|||+| |..|+......+ . .+.+.......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~------------~~~~~~~~~~~--- 225 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V------------YELLEKGYRME--- 225 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H------------HHHHHCCCCCC---
Confidence 22335678999999988899999999999999999998 888886432111 0 01111110000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.+..++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 226 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0123456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=359.09 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=210.4
Q ss_pred CCeEeecCceEEEEEEEc-CC----ceEEEEEecc-chhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1340 SNLLGTGIFSSVYKATFA-DG----TNAAIKIFSL-QEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-~~----~~vAvK~~~~-~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
..+||+|+||+||||.|- .| .+||+|++.. ...++.++|.+|+-+|.+++|||++||+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 578999999999999883 33 4589998853 34556789999999999999999999999998766 78999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc-c
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-K 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~-~ 1492 (1624)
|.|+|.+|++.++..+-....+.|..|||+||.|||+ ++++||||.++|||+.+-..+||.|||+|+.+...+.. .
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999999988888889999999999999999996 89999999999999999999999999999988654422 2
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....-.+.|||=|.+....|+.++|||||||++||++| |..||+.+...++ .+.+..
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~dlle~------- 915 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------PDLLEK------- 915 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------hHHHhc-------
Confidence 222344678999999999999999999999999999999 9999987643322 222211
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
..+...++-|..+++.++.+||..|++.||+|++..+.+.++-+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 11233456788999999999999999999999999998877643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=355.72 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=204.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+.. ++..+|+|++.... ....++|.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467888899999999999999876 57889999887542 3445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999999997643 47888899999999999999996 246999999999999999999999999999865432
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC-------C---------
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL-------P--------- 1555 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~-------~--------- 1555 (1624)
......||+.|+|||+..+..++.++|||||||++|||+||+.||......+ +........ +
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccccc
Confidence 1233569999999999998899999999999999999999999996432211 111110000 0
Q ss_pred ---------------hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 ---------------DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 ---------------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+..+......... .........+.+++.+||+.+|++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK---LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcC---CCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000000 0001235678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=348.96 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=208.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
++|...+.||+|+||+||++... ++..+|+|.+........+.|.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46777889999999999999752 345689998876555667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEE
Q 047591 1409 ILQYMPQGSLEKWLYSHN------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHL 1476 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl 1476 (1624)
||||+++|+|.+++...+ ..+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999997543 248999999999999999999996 79999999999999999999999
Q ss_pred eeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcC
Q 047591 1477 GDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESL 1554 (1624)
Q Consensus 1477 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~ 1554 (1624)
+|||+++....... .......+++.|+|||+.....++.++|||||||++|||+| |+.||......+ ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~------ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIEC------ 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH------
Confidence 99999986643221 11223346788999999988889999999999999999999 888886432211 0111
Q ss_pred ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
+....... ....++..+.+++.+||+.+|.+|||++||.+.|+++.+..
T Consensus 235 -------i~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 235 -------ITQGRVLQ-------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred -------HHcCCcCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 11000000 00123456889999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=343.98 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=201.8
Q ss_pred CCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+|...+.||+|+||+||+|++.++..+|+|.++.. ....+.|.+|++++++++||||++++++|.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 35556789999999999999887778999987633 23346799999999999999999999999988889999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++......+++.++++++.||+.|++|||+ .+|+||||||+||++++++.+||+|||.++............
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 99999998765578999999999999999999996 799999999999999999999999999998764332222222
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
..++..|+|||+.....++.++|||||||++|||+| |+.||....... ... .+.. ......
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~-----------~~~~-~~~~~~---- 222 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE-----------KVSQ-GLRLYR---- 222 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH-----------HHhc-CCCCCC----
Confidence 346678999999988889999999999999999999 999986432111 000 0110 000000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 223 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 ---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112456789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=345.51 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=201.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCc----eEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGT----NAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~----~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+|...+.||+|+||+||+|++. ++. .+|+|.+.... ....+++..|+.++++++||||+++++++.. ...++|
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4556689999999999999874 344 36777765332 2345678889999999999999999998854 456899
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
+||+++|+|.+++......+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 99999999999998776778999999999999999999996 789999999999999999999999999998764322
Q ss_pred C-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1490 S-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1490 ~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
. .......++..|+|||+...+.++.++|||||||++|||+| |+.||.+.... ... +.+.....
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~------------~~~~~~~~ 229 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVP------------DLLEKGER 229 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH------------HHHHCCCc
Confidence 1 12223457789999999988899999999999999999998 99998654211 111 11111100
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.. .+..|...+.+++.+||..+|++|||+.|+++.|+.+...
T Consensus 230 ~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LA-------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00 0112445678899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=342.62 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=200.6
Q ss_pred CCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
|...+.||+|+||.||+|.+.++..+|+|++... ......|.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 5556789999999999999887778999988532 223457889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
+|.++++.....+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.............
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 9999998766678999999999999999999996 7899999999999999999999999999986643222222222
Q ss_pred ccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
.++..|+|||+..+..++.++|||||||++|||+| |+.||+.....+. . . .+......
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~-~------------~~~~~~~~------- 220 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-V-E------------SVSAGYRL------- 220 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-H-H------------HHHcCCcC-------
Confidence 34568999999988899999999999999999999 7888864321110 0 0 01100000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
..+..++..+.+++.+||..+|++||||.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00112456788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=347.15 Aligned_cols=253 Identities=26% Similarity=0.496 Sum_probs=204.4
Q ss_pred CCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
+|...+.||+|+||.||+|.... ...||+|.+.... ......|.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45567889999999999998643 2568999886433 3345679999999999999999999999999899999
Q ss_pred EEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc
Q 047591 1409 ILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 1473 (1624)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 999999999999997532 357888999999999999999996 78999999999999999999
Q ss_pred EEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhh
Q 047591 1474 AHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1474 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~ 1551 (1624)
+||+|||+++....... .......+++.|||||+.....++.++|||||||++|||+| |..||.+....+ +
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~----- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--V----- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H-----
Confidence 99999999986543321 12233457889999999888899999999999999999998 999986532211 1
Q ss_pred hcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1552 ESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
.+.+...... ..+..++.++.+++.+||+.+|++||+++|+++.|++
T Consensus 236 -------~~~i~~~~~~-------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -------IEMIRSRQLL-------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------HHHHHcCCcC-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111100 0123567789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=355.50 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=194.9
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
++||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 68899999986432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
+|.+++...+ .+++.+...++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 9999987643 57888999999999999999996 799999999999999999999999999998543221 122345
Q ss_pred ccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHH
Q 047591 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 1576 (1624)
.||+.|||||++.+..++.++|||||||++|||+||+.||...... .....+ ..... .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~-----------~~~~~-~-------- 213 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI-----------LMEEI-R-------- 213 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHH-----------HcCCC-C--------
Confidence 7999999999999889999999999999999999999998643111 110000 00000 0
Q ss_pred HHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1577 AKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1577 ~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
.+......+.+++.+|++.||++|| +++|+++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0112345678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=348.12 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=208.1
Q ss_pred CCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+|...+.||+|+||.||+|++. ++..+|+|.+........+.|.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4566689999999999999753 3456899988766556667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1410 LQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
|||+++|+|.+++...+ ..+++.+++.++.|++.|++|||+ .+|+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999997542 347899999999999999999996 799999999999999999999
Q ss_pred EEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhh
Q 047591 1475 HLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEE 1552 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~ 1552 (1624)
||+|||+++....... .......++..|+|||+.....++.++|||||||++|||+| |+.||......+ ....
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~---- 237 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIEC---- 237 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH----
Confidence 9999999986543221 11233457889999999988899999999999999999999 999986532211 1111
Q ss_pred cCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1553 SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1553 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
+........ ...++..+.+++.+||+.+|++|||+++|++.|+++....
T Consensus 238 ---------~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 238 ---------ITQGRVLER-------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred ---------HhCCCCCCC-------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 100000000 1124567889999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=344.94 Aligned_cols=255 Identities=30% Similarity=0.486 Sum_probs=209.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
..+|...+.||+|+||.||+|++.++..+|+|++..........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34566778999999999999999888999999987665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.+++++. +..+++.++.+++.|++.|++|||+ .+|+||||||+||++++++.+||+|||.+........ .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence 999999999863 4568999999999999999999996 7899999999999999999999999999987643221 1
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....++..|+|||+.....++.++|||||||++|||++ |+.||......+ .. +.+......
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~-------------~~~~~~~~~--- 223 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VY-------------DQITAGYRM--- 223 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HH-------------HHHHhCCcC---
Confidence 223346778999999888889999999999999999999 889986532111 11 111111000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
..+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 ----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01123456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.08 Aligned_cols=197 Identities=26% Similarity=0.336 Sum_probs=169.5
Q ss_pred CCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-h-hHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-G-AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.|+....+|+|+||+|||++.+ +|+.||||+|....+ . ..+-.+||+++|++++|||+|.|+.+|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 3555678999999999999965 699999999965433 2 345679999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
|+. ++-+-|......++.+...+|+.|+++|+.|+|++. ||||||||+|||++.++.+|+||||+||.+... ...
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~ 157 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDN 157 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-cch
Confidence 987 444556666667888999999999999999999954 999999999999999999999999999988742 234
Q ss_pred cccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 902 QTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
.+..+.|.+|.|||.+-+ ..|...+||||.||++.||+||..-|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 455689999999998765 679999999999999999999986554
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=345.80 Aligned_cols=268 Identities=19% Similarity=0.278 Sum_probs=202.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45777899999999999999875 67899999986443 23345778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++ |+|.+++...+..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 98 49999998776678899999999999999999996 7999999999999999999999999999986543221 2
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh---hhcCChhHHHHHhh----
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV---EESLPDAVTDVIDA---- 1564 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~---~~~~~~~~~~~~d~---- 1564 (1624)
.....||+.|||||++.+ ..++.++||||+||++|||+||+.||......+. +.... ....++.+.++.+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhhh
Confidence 233468999999998754 5689999999999999999999999865322211 11110 01111111111100
Q ss_pred -hccCCc-hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 -NLLSGE-EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 -~l~~~~-~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...... .............+..+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00000111223456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.07 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=201.1
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++.|+..++||+|+|++||++.. .+|+..|+|+++.. .....+...+|+.|.+.++|||||++...+.++...|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35566678999999999999965 46888999987643 2345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~~~~~ 1487 (1624)
|+|.+|+|...+-++ ...+....-.++.||+.||+|+|. .+|||||+||+|+|+.. ..-+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999998766543 345666777899999999999996 89999999999999954 3468999999999886
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
+.......+|||+|||||++....|+..+||||.|||||-|+.|+.||.+..... ...+. .
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I-----------------~ 225 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQI-----------------K 225 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHH-----------------h
Confidence 3445566789999999999999999999999999999999999999997522111 01111 1
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+......+.+....++..+|+.+++..||.+|.|+.|+++
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111111223344566788999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=349.21 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=199.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 35777889999999999999875 68899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999997654 57888889999999999999996 79999999999999999999999999999866432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......+. . ..+......
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-~------------~~i~~~~~~--- 216 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-Y------------EKILAGKLE--- 216 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H------------HHHHhCCcC---
Confidence 2234699999999999888899999999999999999999999865321110 0 011110000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~~ 1609 (1624)
.+......+.+++.+|++.||.+||+ ++|+++.
T Consensus 217 ------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00122345778999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=351.94 Aligned_cols=245 Identities=28% Similarity=0.432 Sum_probs=201.0
Q ss_pred CeEeecCceEEEEEEEcCC-ceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1341 NLLGTGIFSSVYKATFADG-TNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~~-~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
-++|+|.||+||.|+..+. ..+|||-+..+..+..+...+||..-++++|+|||+.+|+|.+.++.-+.||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999987654 558999887777777788999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec-CCCcEEEeeecceeecCCCCCcccccc
Q 047591 1420 KWLYSHNYLL--NIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1420 ~~l~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
..|+..-..+ +..+.-.+..||.+||.|||+ ..|||||||-+|||++ -.|.+||+|||.++.+...... ..+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc-cccc
Confidence 9998653344 556667789999999999996 7899999999999997 5789999999999988755443 3346
Q ss_pred ccccccccccccCCC--CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1497 LATIGYMAPEYGSEG--IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~--~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
.||..|||||++..+ .|+.++|||||||++.||.||++||.++-.... .++...+....
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkVGmyKvH---- 797 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKVGMYKVH---- 797 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhhcceecC----
Confidence 799999999998765 489999999999999999999999976432211 12222222211
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+.+++...+...++++|++++|.+||+++++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1223444566778999999999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=356.05 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=202.0
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
+|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5777889999999999999886 57899999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++|+|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999997643 57888888999999999999996 7999999999999999999999999999986543
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccch--hhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV--CLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~--~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+..|... +......
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------~~~~~~~- 223 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET---------LQRPVYD- 223 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc---------ccCCCCC-
Confidence 22345799999999999888999999999999999999999999975322111 11111000 0000000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....++..+.+++.+|+..+|++||+++|+++.
T Consensus 224 ------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 ------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0001235667889999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=353.21 Aligned_cols=239 Identities=24% Similarity=0.281 Sum_probs=191.9
Q ss_pred EeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
||+|+||+||+|+.. +++.||+|+++.. .....+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 5788999998643 233456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccccc
Q 047591 1419 EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498 (1624)
Q Consensus 1419 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 1498 (1624)
.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 99997643 57889999999999999999996 799999999999999999999999999998643222 22334579
Q ss_pred ccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHH
Q 047591 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578 (1624)
Q Consensus 1499 t~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 1578 (1624)
|+.|||||++.+..++.++|||||||++|||+||+.||.+....+ .. ......... .+
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-----~~--------~~~~~~~~~---------~~ 213 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-----MY--------RKILQEPLR---------FP 213 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-----HH--------HHHHcCCCC---------CC
Confidence 999999999998899999999999999999999999986432110 00 011100000 00
Q ss_pred HHhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 047591 1579 KKCMSSVMSLALKCSEEIPEERMN---VKDALA 1608 (1624)
Q Consensus 1579 ~~~~~~~~~l~~~C~~~~P~~RPt---~~evl~ 1608 (1624)
......+.+++.+|++.+|++||+ +.|++.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 123456778999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=367.80 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=200.3
Q ss_pred CCcCCeEeecCceEEEEEEEc-C-CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-D-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~-~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
|...+.||+|+||.||+|... + +..||+|............+.+|++++++++|||||+++++|...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667789999999999999764 3 56788887765555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-
Q 047591 1415 QGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS- 1490 (1624)
Q Consensus 1415 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~- 1490 (1624)
+|+|.+++++. ...+++.+...++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 3457888899999999999999996 7999999999999999999999999999987653322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+||++|||||++.+..++.++|||||||++|||+||+.||......+. + ..+.......
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-~------------~~~~~~~~~~-- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-M------------QQVLYGKYDP-- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-H------------HHHHhCCCCC--
Confidence 123345699999999999889999999999999999999999999864321100 0 0011000000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..++..+.+++.+||+.+|++||++.|++.
T Consensus 291 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01123456888999999999999999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=347.54 Aligned_cols=270 Identities=22% Similarity=0.311 Sum_probs=201.1
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467888899999999999999876 688999999864432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++ ++|.+++......++++.+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 996 68888887766668888999999999999999996 799999999999999999999999999998653222 2
Q ss_pred cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--hcC-ChhHHHH-----H
Q 047591 1492 KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESL-PDAVTDV-----I 1562 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--~~~-~~~~~~~-----~ 1562 (1624)
......||+.|||||++.+ ..++.++||||+||++|||+||+.||.+.......+..... ... .+.+... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2234568999999998754 56899999999999999999999999764322111111100 000 0000000 0
Q ss_pred hhhccC--CchH-HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1563 DANLLS--GEEE-ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1563 d~~l~~--~~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
++.... .... ............+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0000 000001112356788999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=355.19 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=201.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC-Ce
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP-GF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~-~~ 1405 (1624)
+.|...++||+|+||.||+|... .++.||+|+++... ....+.+.+|+++++++ +||||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 35667789999999999999642 24689999986432 33456788999999999 899999999988654 56
Q ss_pred eEEEEEecCCCCHHHHHHhcC-----------------------------------------------------------
Q 047591 1406 KALILQYMPQGSLEKWLYSHN----------------------------------------------------------- 1426 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 1426 (1624)
.++||||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999999986421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-cccccccccccccc
Q 047591 1427 -YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMA 1504 (1624)
Q Consensus 1427 -~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~A 1504 (1624)
..++|+.+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.+..... .......++..|||
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257899999999999999999996 7999999999999999999999999999987643222 22223456788999
Q ss_pred ccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHH
Q 047591 1505 PEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMS 1583 (1624)
Q Consensus 1505 PE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~ 1583 (1624)
||++.+..++.++|||||||++|||+| |+.||......+ .+. ..+....... .+..+..
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~------------~~~~~~~~~~-------~~~~~~~ 303 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC------------RRLKEGTRMR-------APEYATP 303 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH------------HHHhccCCCC-------CCccCCH
Confidence 999999999999999999999999998 999986532111 111 1111000000 0112345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1584 SVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1584 ~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68899999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=352.01 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=194.8
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
++||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999874 68899999986432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 9999887543 57889999999999999999996 799999999999999999999999999987542221 122335
Q ss_pred ccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHH
Q 047591 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 1576 (1624)
.||+.|||||++.+..++.++|||||||++|||+||+.||....... ..... ..... .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~------------~~~~~-~-------- 213 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELI------------LMEEI-R-------- 213 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHH------------hcCCC-C--------
Confidence 69999999999988899999999999999999999999986432111 11110 00000 0
Q ss_pred HHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1577 AKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1577 ~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
.+..+...+.+++.+|++.+|++|| ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0112345678899999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=356.73 Aligned_cols=245 Identities=23% Similarity=0.277 Sum_probs=198.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45777789999999999999886 57889999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+ .++++....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999998654 46778888899999999999996 799999999999999999999999999998764321
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
....||+.|||||++.+..++.++|||||||++|||+||+.||.+..... ... .+......
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~------------~i~~~~~~--- 233 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYE------------KILAGRLK--- 233 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHH------------HHhcCCcC---
Confidence 23579999999999998889999999999999999999999986432110 000 01110000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~~ 1609 (1624)
.+..+...+.+++.+||+.||++||+ ++|+++.
T Consensus 234 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00112345778999999999999997 6777643
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=339.24 Aligned_cols=258 Identities=21% Similarity=0.330 Sum_probs=206.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|+.. +++.||||.++.. .....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46777899999999999999875 6889999987532 2344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
||+++|+|.+++.. ....++..++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998853 23457888999999999999999996 7999999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
... ......|++.|+|||+..+..++.++|||||||++|||+||+.||............ .+.....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~------------~~~~~~~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ------------KIEQCDY 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH------------HHhcCCC
Confidence 221 122346889999999988888999999999999999999999998543211111111 1111000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
... ....++..+.+++.+||+.+|++||++.||++.+++++
T Consensus 226 ~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPL------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 01234466889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=338.23 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=196.8
Q ss_pred EeecCceEEEEEEEc---CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1343 LGTGIFSSVYKATFA---DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
||+|+||+||+|++. ++..||+|++.... ....+.|.+|++++++++||||++++++|. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999874 34569999886543 334567999999999999999999999885 4577999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc--cccc
Q 047591 1419 EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK--QTMT 1496 (1624)
Q Consensus 1419 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~--~~~~ 1496 (1624)
.+++......+++.++++++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......... ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 99998766678999999999999999999996 799999999999999999999999999998654332211 1222
Q ss_pred ccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
.++..|+|||+.....++.++|||||||++|||++ |+.||.+....+ .... +......
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~------------~~~~~~~------- 217 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSF------------IEQGKRL------- 217 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH------------HHCCCCC-------
Confidence 34678999999888889999999999999999996 999987543211 1111 1110000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
..+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 01123456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=336.31 Aligned_cols=247 Identities=25% Similarity=0.427 Sum_probs=200.0
Q ss_pred CeEeecCceEEEEEEEcCCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
++||+|+||.||+|...+++.+|+|+++... ......|.+|++++++++||||++++++|...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999886443 334457899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccccc
Q 047591 1420 KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499 (1624)
Q Consensus 1420 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 1499 (1624)
+++......+++.+++.++.|++.||.|+|+ .+++||||||+||++++++.+|++|||+++..............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9998766668999999999999999999996 7999999999999999999999999999976543222222223456
Q ss_pred cccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHH
Q 047591 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578 (1624)
Q Consensus 1500 ~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 1578 (1624)
+.|+|||+...+.++.++|||||||++|||++ |..||........ ... +...... ..+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~~------------~~~~~~~-------~~~ 216 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--REQ------------VEKGYRM-------SCP 216 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHH------------HHcCCCC-------CCC
Confidence 78999999988889999999999999999999 8999865321110 000 1000000 001
Q ss_pred HHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1579 KKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1579 ~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
..++..+.+++.+|++.+|++||++.|+++.|+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 124567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=353.32 Aligned_cols=388 Identities=23% Similarity=0.259 Sum_probs=261.6
Q ss_pred cEEEccCCCCCCccchhhhcc-CCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceecc
Q 047591 140 RIIDLSSNRISGNLFDDMCNS-LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLN 218 (1624)
Q Consensus 140 ~~L~Ls~N~l~g~~~~~~~~~-l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 218 (1624)
+.||++++.|...--..+-+- ...-+.||+|+|+|+..=+..|-++++|+.+++.+|.|+ .||...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 568888888753100000000 123455677777776655666666667777777666666 666655555566666666
Q ss_pred CCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCccccc
Q 047591 219 GNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDF 298 (1624)
Q Consensus 219 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l 298 (1624)
+|.|+..-.+++.-+..|+.||||.|.++ .||.. +|..-.++++|+|++|+|+++
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~------------------------sfp~~~ni~~L~La~N~It~l 188 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLIS-EIPKP------------------------SFPAKVNIKKLNLASNRITTL 188 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhh-cccCC------------------------CCCCCCCceEEeecccccccc
Confidence 66666544555555666666666666655 44433 344445566666666766666
Q ss_pred CccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccc
Q 047591 299 GANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378 (1624)
Q Consensus 299 ~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 378 (1624)
+...|. ++++|..|.|++|+++ ++|...|.+|++|+.|+|..|++.-.--..|.+|.+|+.|.|..|.++.
T Consensus 189 ~~~~F~--------~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k 259 (873)
T KOG4194|consen 189 ETGHFD--------SLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK 259 (873)
T ss_pred cccccc--------ccchheeeecccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc
Confidence 554444 3467778888888887 7888888789999999999999874445678889999999999999999
Q ss_pred cCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCC
Q 047591 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGG 458 (1624)
Q Consensus 379 ~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g 458 (1624)
+-...|..|.++++|+|++|+++...
T Consensus 260 L~DG~Fy~l~kme~l~L~~N~l~~vn------------------------------------------------------ 285 (873)
T KOG4194|consen 260 LDDGAFYGLEKMEHLNLETNRLQAVN------------------------------------------------------ 285 (873)
T ss_pred ccCcceeeecccceeecccchhhhhh------------------------------------------------------
Confidence 88889999999999999888875310
Q ss_pred CCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCcccccc
Q 047591 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLAN 538 (1624)
Q Consensus 459 ~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~ 538 (1624)
-.|+-+|+.|+.|+||.|.+...-++.+...++|++|||++|+|+..-|..|..|..|+.|+|++|.++..--..|..
T Consensus 286 --~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ 363 (873)
T KOG4194|consen 286 --EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG 363 (873)
T ss_pred --cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence 124556677777777777777766777777777888888888777655667777777777777777777555556777
Q ss_pred ccCCccccccCccccccCch---hhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCcccc
Q 047591 539 LTSLRALNLSSNRLNSTIPS---TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLT 615 (1624)
Q Consensus 539 l~~L~~L~Ls~N~l~g~iP~---~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~ 615 (1624)
+++|+.|||++|.|++.|.+ .|..|++|+.|+|.+|++...--..|..+..|+.|||.+|.+-..-|.+|..+ .|+
T Consensus 364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk 442 (873)
T KOG4194|consen 364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK 442 (873)
T ss_pred hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh
Confidence 77777777777777776654 35556666666666666654333456666666666666666665556666555 555
Q ss_pred cccc
Q 047591 616 YLAL 619 (1624)
Q Consensus 616 ~L~l 619 (1624)
.|.+
T Consensus 443 ~Lv~ 446 (873)
T KOG4194|consen 443 ELVM 446 (873)
T ss_pred hhhh
Confidence 5554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.13 Aligned_cols=267 Identities=21% Similarity=0.257 Sum_probs=198.1
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--hHHHHHHHHHHHHHhcCCCceeEEEeeec--cCCeeEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRNLAKIVSSCS--NPGFKALIL 1410 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~HpNIv~l~g~~~--~~~~~~lV~ 1410 (1624)
.|...+.|++|.||.||+|+.. +++.||.|+++.+.+ ...-.-.+||.+|.+++|||||.+-.... +-+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 3455688999999999999875 578899999976543 33345689999999999999999987664 456799999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|||++ +|...+..-++.+...+..-++.|+++|++|||. ..|+|||||++|+|+...|.+||+|||+||.+... .
T Consensus 157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~ 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-L 231 (419)
T ss_pred HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC-c
Confidence 99987 8999998777778888888999999999999996 78999999999999999999999999999988654 2
Q ss_pred ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh-------hcCChhH-HHH
Q 047591 1491 MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE-------ESLPDAV-TDV 1561 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~-------~~~~~~~-~~~ 1561 (1624)
...+..+-|.+|.|||.+.+ ..|++.+||||+|||+.||+++++-|.+...-+. +...+. ..+|... ...
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCCccccch
Confidence 33455678999999997654 5799999999999999999999986654321111 111110 0111100 000
Q ss_pred Hh-hhccCCchHHHHHHHHH---hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1562 ID-ANLLSGEEEADIAAKKK---CMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1562 ~d-~~l~~~~~~~~~~~~~~---~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+. ........ ......-. ....-++++...+..||.+|-|+.|+++.
T Consensus 311 ~k~~~f~~~py-n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPY-NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCc-hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 00000000 00111111 23567889999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=344.37 Aligned_cols=267 Identities=23% Similarity=0.387 Sum_probs=205.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-----CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-----DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-----~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~ 1407 (1624)
+.|...+.||+|+||+||+|.+. ++..||+|.+........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 35666789999999999999753 477899999876666667889999999999999999999998754 34688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++.+....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 9999999999999998766678999999999999999999996 7999999999999999999999999999987653
Q ss_pred CCCcc--ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC-----hhHHH
Q 047591 1488 VDSMK--QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP-----DAVTD 1560 (1624)
Q Consensus 1488 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~-----~~~~~ 1560 (1624)
..... .....++..|+|||+..+..++.++|||||||++|||++|+.|+..... .....+..... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHHH
Confidence 32211 1112244569999999888899999999999999999999877543211 00000000000 01111
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
.+..... ......++..+.+++.+||+.+|++|||++|+++.|++++
T Consensus 238 ~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKNNGR-------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhcCCc-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1111100 0011234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=339.08 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=202.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
+.|...+.||+|+||+||+|++.++..||+|+++... ...+.|.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3466778899999999999998777789999986432 23467899999999999999999999875 456799999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+|+|.+++.+. +..++++.+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999864 3457999999999999999999996 7999999999999999999999999999987654332222
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....++..|+|||+..+..++.++|||||||++|||+| |+.||......+. .+.+......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--------------~~~~~~~~~~---- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGYRM---- 222 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--------------HHHHhcCCCC----
Confidence 23456778999999988889999999999999999999 7878765322111 0111100000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.....++..+.+++.+|++.+|++||+++++++.|++.
T Consensus 223 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00123456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=344.02 Aligned_cols=202 Identities=26% Similarity=0.449 Sum_probs=177.9
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 816 (1624)
-.++|...+.||+|+|++||+|+. ++++++|||++..+. +...+-..+|-++|.++ .||.||+|+-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788889999999999999984 579999999986432 33445567899999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+|+||+++|+|.++|+..+ .+++.....++.+|+.||+|||.+ +||||||||+|||+|+||++||+|||-|+.+.+
T Consensus 151 FvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999999998765 789988999999999999999994 599999999999999999999999999998864
Q ss_pred CCCc----------c--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSV----------T--QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~----------~--~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... . ....+||..|.+||++..+..+..+|+|+||||+|+|+.|+.||..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 3221 1 1336899999999999999999999999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=344.14 Aligned_cols=253 Identities=28% Similarity=0.474 Sum_probs=203.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
+.|...+.||+|+||.||+|+..+ +..||||.++..... ..+.|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346667889999999999998643 467999998654333 5678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1408 LILQYMPQGSLEKWLYSHN-------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
+||||+++|+|.++++..+ ..+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999997542 347888999999999999999996 799999999999999999999
Q ss_pred EEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhh
Q 047591 1475 HLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEE 1552 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~ 1552 (1624)
||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |+.||......+ ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~----- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VI----- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH-----
Confidence 9999999986543221 11223456789999999999999999999999999999999 999986432211 11
Q ss_pred cCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1553 SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1553 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
+.+........ +..++..+.+++.+||+.+|++|||++|+++.|+
T Consensus 235 -------~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 -------ECITQGRLLQR-------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -------HHHHcCCcCCC-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11110000000 1134567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=340.78 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=202.6
Q ss_pred CcCCeEeecCceEEEEEEE-----cCCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEEE
Q 047591 1338 SESNLLGTGIFSSVYKATF-----ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKALI 1409 (1624)
Q Consensus 1338 ~~~~~lG~G~~G~Vyk~~~-----~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~lV 1409 (1624)
...+.||+|+||+||++.+ .++..||+|.++... ....+.|.+|++++++++||||++++++|... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5668899999999988754 357789999986543 23457889999999999999999999988653 457899
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++... .+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999999764 48999999999999999999996 799999999999999999999999999998765322
Q ss_pred Cc--cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC-ChhHHHHHhhhc
Q 047591 1490 SM--KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL-PDAVTDVIDANL 1566 (1624)
Q Consensus 1490 ~~--~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~-~~~~~~~~d~~l 1566 (1624)
.. ......++..|+|||+.....++.++|||||||++|||+||+.|+............+..... .....+.++...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 11 112234567799999998888999999999999999999999998643211111111111000 011112222111
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
.. ..+..++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 242 ~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RL-------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CC-------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 10 011235678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=342.70 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=202.2
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
++++|...+.||+|+||+||+|.+. .+..||||++.... .....+|.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888899999999999999763 24679999885432 2345678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEE
Q 047591 1406 KALILQYMPQGSLEKWLYSHN---------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHL 1476 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl 1476 (1624)
.++||||+++|+|.+++.+.. ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999997532 235788899999999999999996 79999999999999999999999
Q ss_pred eeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcC
Q 047591 1477 GDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESL 1554 (1624)
Q Consensus 1477 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~ 1554 (1624)
+|||+++........ ......+++.|||||+..++.++.++|||||||++|||+| |+.||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-~~~~~------ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-QVLRF------ 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH------
Confidence 999999865432221 1122346788999999988889999999999999999999 68887643211 11111
Q ss_pred ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
+........ +..++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ------~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 ------VMEGGLLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ------HHcCCcCCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111000 11345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=338.90 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=205.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CC---ceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DG---TNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~---~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|..+.. .....+.|.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346777899999999999999875 23 36899988644 23445789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.+++.+....+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+|++|||+++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 999999999999998766678999999999999999999996 78999999999999999999999999999876432
Q ss_pred CCcccc--ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1489 DSMKQT--MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1489 ~~~~~~--~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
...... ....++.|+|||+.....++.++|||||||++|||+| |+.||......+ . ...+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~------------~~~i~~~ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--V------------MKAINDG 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--H------------HHHHhcC
Confidence 211111 1223567999999988889999999999999999998 999986432111 1 1111110
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
... +....++..+.+++.+||+.+|++||++++|++.|+++
T Consensus 227 ~~~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 FRL-------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.49 Aligned_cols=205 Identities=28% Similarity=0.472 Sum_probs=177.0
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|...+.+|+|.||.||+|+. ++|+.||||+++... ++......||+..|+.++|||||.|+++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3466678899999999999984 679999999998653 3334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
||+. ||+..+++....++..+...++.++.+|++|||... |+|||+||.|+|++++|.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9985 999999988888999999999999999999999965 999999999999999999999999999998755432
Q ss_pred ccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHH
Q 047591 901 TQTMTLATFGYMAPEYGS-EGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~-~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~ 957 (1624)
.+..+.|.+|.|||.+. ...|+..+||||.|||+.||+-|..= +.|+.++.+
T Consensus 158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~----fpG~sDidQ 210 (318)
T KOG0659|consen 158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF----FPGDSDIDQ 210 (318)
T ss_pred -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC----CCCCchHHH
Confidence 33447899999999765 45689999999999999999988743 456655544
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=336.20 Aligned_cols=247 Identities=22% Similarity=0.389 Sum_probs=198.1
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
+.||+|+||+||+|+.. +++.+|+|.+.... ......|.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999875 68899999875332 33456799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc-ccccc
Q 047591 1419 EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK-QTMTL 1497 (1624)
Q Consensus 1419 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 1497 (1624)
.+++...+..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||+++......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99998766678999999999999999999996 789999999999999999999999999988654221111 11112
Q ss_pred cccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHH
Q 047591 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576 (1624)
Q Consensus 1498 gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 1576 (1624)
++..|+|||++..+.++.++|||||||++|||++ |..|+....... ....++......
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------------~~~~~~~~~~~~------- 216 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAIEQGVRLP------- 216 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------------HHHHHHcCCCCC-------
Confidence 3467999999988889999999999999999998 888876432111 111111110000
Q ss_pred HHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1577 AKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1577 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.+..++..+.+++.+|++.+|++|||+.|+.++|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 01234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=353.51 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=198.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC--CceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD--GTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~--~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+++++.++|||||++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 457777899999999999998653 3679999886432 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+|+.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999999999997654 57888999999999999999996 79999999999999999999999999999876432
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...... .... .+.+.... -
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~------------~i~~~~~~-~ 247 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQ------------KILEGIIY-F 247 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHH------------HHhcCCCC-C
Confidence 23457999999999998888999999999999999999999999653211 0001 11110000 0
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
+......+.+++.+|++.+|++|+ +++|+++.
T Consensus 248 --------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 --------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011234567899999999999995 78888764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=350.88 Aligned_cols=242 Identities=23% Similarity=0.293 Sum_probs=194.9
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 68899999986432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 999988754 357889999999999999999996 799999999999999999999999999988643211 122345
Q ss_pred ccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHH
Q 047591 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 1576 (1624)
.||+.|||||++.+..++.++|||||||++|||+||+.||......+. .. .+.. .. ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-~~-------------~~~~---~~-----~~ 213 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FE-------------LILM---ED-----IK 213 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-HH-------------Hhcc---CC-----cc
Confidence 799999999999888999999999999999999999999864321110 00 0000 00 00
Q ss_pred HHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1577 AKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1577 ~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
.+......+.+++.+|++.+|++|| ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0112345677899999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=336.85 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=201.5
Q ss_pred CCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+|...+.||+|+||.||+|...++..+|+|.++.... ..+.|.+|+.++++++|||++++++++. .+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 4566788999999999999988888899999864332 3467999999999999999999999885 4567999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1416 GSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1416 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
|+|.+++++. ...++++++.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.+.........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 9999999864 3458999999999999999999996 78999999999999999999999999999876543322222
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...++..|+|||+.....++.++|||||||++|||++ |+.||.+....+ .. .+ +......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~-~~------------~~~~~~~----- 222 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-VL-EQ------------VERGYRM----- 222 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-HH-HH------------HHcCCCC-----
Confidence 3346678999999888889999999999999999999 888886532111 11 11 1110000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
..+...+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=343.99 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=204.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-Cc--eEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-GT--NAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-~~--~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...++||+|+||+||+|...+ +. .+|+|.++.. .....+.|.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467778899999999999998754 33 4788887632 334457899999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1410 LQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
|||+++|+|.+++++.. ..+++.++..|+.|++.|++|||+ .+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999997532 247889999999999999999996 799999999999999999999
Q ss_pred EEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhc
Q 047591 1475 HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
||+|||+++..... ........+..|+|||+.....++.++|||||||++|||+| |+.||........
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~--------- 227 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL--------- 227 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---------
Confidence 99999998643211 11112233567999999988889999999999999999998 9999865321110
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
.+.+....... .+..++..+.+++.+||+.+|.+|||++++++.|+.+..+...
T Consensus 228 -----~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 -----YEKLPQGYRME-------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred -----HHHHhcCCCCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 01111111000 0123456788999999999999999999999999988775543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=342.81 Aligned_cols=266 Identities=22% Similarity=0.300 Sum_probs=195.3
Q ss_pred CCCcCCeEeecCceEEEEEEEc--CCceEEEEEeccch--hhHHHHHHHHHHHHHhc---CCCceeEEEeeec-----cC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA--DGTNAAIKIFSLQE--DRALKSFDAECEVMRRI---RHRNLAKIVSSCS-----NP 1403 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~--~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l---~HpNIv~l~g~~~-----~~ 1403 (1624)
+|...+.||+|+||+||+|+.. +++.||||+++... +.....+.+|+++++++ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5777889999999999999863 46789999886432 22334567788877766 6999999999884 24
Q ss_pred CeeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1404 GFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
...++||||++ |+|.+++... ...+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999997 6999998754 3457899999999999999999996 79999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh---cCChhHH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE---SLPDAVT 1559 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~---~~~~~~~ 1559 (1624)
+..... .......||+.|+|||+.....++.++|||||||++|||++|+.||.+....+ .+...+.. ..++...
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWP 234 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhch
Confidence 876432 22334568999999999988889999999999999999999999997542211 11111110 0011111
Q ss_pred HHHh--hhccC-CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1560 DVID--ANLLS-GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1560 ~~~d--~~l~~-~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.... ..... ............+...+.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000 0000000111234566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=349.66 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=174.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+.. ++..+|+|++... .....+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467888899999999999999886 5788999988654 23445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++|+|.+++...+ .+++.....++.|++.||+|||+ ..+|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999997654 47888888999999999999996 247999999999999999999999999998765322
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
......||..|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234689999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=337.65 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=204.6
Q ss_pred HHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1329 ELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1329 ~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
|++.+++++.....||+|+||+||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 35667888888899999999999999865 57789999887665566778999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeecceee
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLL--NIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFGla~~ 1484 (1624)
+||||+++++|.++++.....+ ++..+..++.||+.|++|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999998654444 788888999999999999996 79999999999999986 67999999999986
Q ss_pred cCCCCCccccccccccccccccccCCC--CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEG--IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
...... ......|++.|+|||+.... .++.++|||||||++|||++|+.|+........ ..|..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~----------- 224 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKV----------- 224 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhh-----------
Confidence 643221 22234589999999987654 378999999999999999999999864321111 11100
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...... ...+..+...+.+++.+||+.+|++|||+.|+++.
T Consensus 225 --~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 --GMFKIH----PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --hhhccC----CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000 00011234567889999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=340.45 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=204.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCc----eEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGT----NAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~----~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
++|...+.||+|+||+||+|++. ++. .||+|+++.. .....+.+.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 46777789999999999999864 444 3799988643 334457889999999999999999999998754 5689
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
+|||+++|+|.+++++....+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 999999999999998766678999999999999999999996 79999999999999999999999999999877532
Q ss_pred CCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
... ......+++.|||||...+..++.++|||||||++|||+| |+.||+..... .+..++.. ..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~------------~~ 228 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEK------------GE 228 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC------------CC
Confidence 221 1122345678999999988889999999999999999999 88888643211 11111111 00
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
... .+..++..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 229 ~~~-------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 RLP-------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred cCC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 000 01234567889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=356.86 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=202.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36778899999999999999875 68899999987432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999998765678999999999999999999996 7999999999999999999999999999987754333
Q ss_pred ccccccccccccccccccC------CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1491 MKQTMTLATIGYMAPEYGS------EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~------~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.......||+.|+|||++. ...++.++|||||||++|||+||+.||....... ... .+...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~------------~i~~~ 224 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYN------------NIMNF 224 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHH------------HHHcC
Confidence 3333457999999999875 4568899999999999999999999996532111 011 11110
Q ss_pred h-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1565 N-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1565 ~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ..... .....+..+.+++.+|+. +|++|||++++++.
T Consensus 225 ~~~~~~~------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QRFLKFP------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCccCCC------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 00000 001234567788899997 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=342.32 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=200.7
Q ss_pred CCCcCCeEeecCceEEEEEEE-----cCCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-----ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-----~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+|...+.||+|+||+||+|.+ .++..||+|.+.... ....+.|.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 456668899999999999975 245789999886432 34457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc
Q 047591 1410 LQYMPQGSLEKWLYSHN----------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 1473 (1624)
|||+++|+|.+++.... ..+++.+.+.++.|++.||+|||+ .+|+||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 99999999999986321 247888999999999999999996 78999999999999999999
Q ss_pred EEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhh
Q 047591 1474 AHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1474 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~ 1551 (1624)
+||+|||+++....... .......++..|+|||+..+..++.++|||||||++|||+| |..||......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------- 233 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------- 233 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 99999999986543221 12223446778999999988889999999999999999999 88888543111
Q ss_pred hcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1552 ESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
.+.+.++..... ..+..++..+.+++.+||+.+|++||++.++.+.|++
T Consensus 234 -----~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -----EVIEMVRKRQLL-------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----HHHHHHHcCCcC-------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111000 0112345668889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=345.81 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=200.0
Q ss_pred CCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|..+..||+|+-|.|..|++ .+|+.+|||++.... +.......+|+.+|+-+.|||++++|+++++..+.|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 44457899999999999987 479999999997552 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++|.|.+++..++.. ...+..++..||..|+.|+|. .+|+|||+||+|+|||..+.+||+|||+|.+-.+.. .
T Consensus 94 v~gGELFdylv~kG~l-~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-l- 167 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPL-PEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-L- 167 (786)
T ss_pred cCCchhHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-c-
Confidence 9999999999887754 446666899999999999996 799999999999999999999999999998754322 2
Q ss_pred ccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
-.+.+|+|.|.|||++.+..| +.++||||.|||||-|+||+.||++.. ++.... -|. .+..
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLl---------KV~----~G~f 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLL---------KVQ----RGVF 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHH---------HHH----cCcc
Confidence 234589999999999998877 578999999999999999999998632 111110 010 1111
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+...+.++.+|+.++++.||++|.|++||+++
T Consensus 230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1112345667889999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=350.80 Aligned_cols=242 Identities=23% Similarity=0.340 Sum_probs=197.8
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~l 1408 (1624)
-++|....+||+|+||+|+.|..+ +++.+|||++++.. +.+.+..+.|..|+.-. +||.+++++.++.+++..+.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 456777899999999999999886 56789999997543 45567888898888877 59999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+.||++..+. +...++.....-||..|+.||.|||+ .+||+||||-+|||||.+|++||+|||++|..-..
T Consensus 447 vmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999944433 33467888888899999999999996 89999999999999999999999999999965422
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
+ ..+++.+|||.|||||++.+..|+..+|.|||||+||||++|+.||.+...++ ++|.-+ .
T Consensus 522 g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-----------------~FdsI~-~ 582 (694)
T KOG0694|consen 522 G-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-----------------VFDSIV-N 582 (694)
T ss_pred C-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-----------------HHHHHh-c
Confidence 2 24567899999999999999999999999999999999999999997532111 111111 1
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
++ ...+..++.+..+++.+.+..+|++|..+
T Consensus 583 d~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DE----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 00 11123456678889999999999999977
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=358.40 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=202.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||.||+|++. .+..||||+++... ....+.+.+|++++.++. |||||+++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 34555689999999999999864 23579999996432 333457899999999997 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC------------------------------------------------------------
Q 047591 1407 ALILQYMPQGSLEKWLYSHN------------------------------------------------------------ 1426 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~------------------------------------------------------------ 1426 (1624)
++||||+++|+|.+++++.+
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999997532
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1427 -------------------------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1427 -------------------------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
..+++...++|+.|++.||+|||+ .+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 136778889999999999999995 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~ 1547 (1624)
+++.+||+|||+++....... .......+++.|||||+.....++.++|||||||++|||++ |+.||......+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--- 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--- 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence 999999999999986543221 11223457889999999988889999999999999999998 8888864322111
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
..+.+...... ..+..++..+.+++.+||+.+|++||+|+|+++.|+++.
T Consensus 351 ----------~~~~~~~~~~~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 ----------FYNAIKRGYRM-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----------HHHHHHcCCCC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111100 001124567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=344.62 Aligned_cols=259 Identities=25% Similarity=0.468 Sum_probs=205.7
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~ 1403 (1624)
...++|...+.||+|+||.||+|.+.. ...+|+|.+... .......+.+|+++++++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344567778899999999999998742 357899988643 234456789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1404 GFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
+..++||||+++|+|.++++.. ...+++..+++++.|++.|++|||+ .+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 9999999999999999999642 3458899999999999999999996 799999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l 1546 (1624)
++++.+|++|||+++.+....... .....++..|+|||+..+..++.++|||||||++|||++ |..||......+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 999999999999998765432211 122345678999999888899999999999999999998 888876432111
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
..+.+...... ..+..++..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 243 -----------~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -----------LFKLLKEGYRM-------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----------HHHHHHcCCcC-------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 01111111000 001234567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=337.63 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=205.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||.||+|.+.+ ...||||...... ....+.|.+|+.++++++||||++++++|.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346667899999999999998743 2468999886544 4456789999999999999999999998865 557899
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+|++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999999998766678999999999999999999996 799999999999999999999999999998765433
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
....+...++..|+|||+.....++.++|||||||++|||++ |+.||......+. . .+.... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~-~~~~~~-----------~~~- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-I-GRIENG-----------ERL- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-H-HHHHcC-----------CcC-
Confidence 222333345678999999888889999999999999999996 9999865432211 1 111000 000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..+..++..+.+++.+|+..+|++|||+.|+++.|+++...
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01123456788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=337.81 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=196.2
Q ss_pred CcCCeEeecCceEEEEEEEcCC-c--eEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------Cee
Q 047591 1338 SESNLLGTGIFSSVYKATFADG-T--NAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------GFK 1406 (1624)
Q Consensus 1338 ~~~~~lG~G~~G~Vyk~~~~~~-~--~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~~~ 1406 (1624)
...+.||+|+||.||+|++.+. . .||+|.++.. .....+.|.+|++++++++||||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4467899999999999987643 3 5899987643 344567899999999999999999999987432 246
Q ss_pred EEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecc
Q 047591 1407 ALILQYMPQGSLEKWLYSH-----NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGI 1481 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGl 1481 (1624)
++||||+++|+|.+++... ...+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999988532 2457899999999999999999996 7999999999999999999999999999
Q ss_pred eeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHH
Q 047591 1482 AKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1482 a~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~ 1559 (1624)
++.+....... .....+++.|+|||+.....++.++|||||||++|||++ |+.||......+ +...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~-------- 228 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDYLR-------- 228 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--------
Confidence 98764332211 122346778999999988899999999999999999999 788886432111 100000
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
...... ....++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 229 ---~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 ---QGNRLK--------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---cCCCCC--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 0113455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=336.76 Aligned_cols=253 Identities=25% Similarity=0.458 Sum_probs=199.8
Q ss_pred CCcCCeEeecCceEEEEEEEcC----CceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe-----
Q 047591 1337 FSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF----- 1405 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~----- 1405 (1624)
|...+.||+|+||+||+|.+.. +..||||+++.. .....+.|.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 3456789999999999998743 367999998643 23445789999999999999999999998866544
Q ss_pred -eEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeee
Q 047591 1406 -KALILQYMPQGSLEKWLYSH-----NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1406 -~~lV~ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
.++||||+++|+|..++... ...+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999998642 2358899999999999999999996 79999999999999999999999999
Q ss_pred cceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1480 GIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1480 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
|+++......... .....++..|+|||+.....++.++|||||||++|||++ |..||.+....+ ...+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~-------- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDY-------- 227 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------
Confidence 9998765432221 112345678999999988889999999999999999999 888886532111 1111
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
+.+..... .+..++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 228 ---~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 ---LRHGNRLK--------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---HHcCCCCC--------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11100000 1124566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=339.60 Aligned_cols=238 Identities=19% Similarity=0.317 Sum_probs=188.8
Q ss_pred eEeecCceEEEEEEEcC-------------------------CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEE
Q 047591 1342 LLGTGIFSSVYKATFAD-------------------------GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~~-------------------------~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l 1396 (1624)
.||+|+||.||+|.+.. ...||+|++........+.|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13488898865555556789999999999999999999
Q ss_pred EeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC----
Q 047591 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM---- 1472 (1624)
Q Consensus 1397 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---- 1472 (1624)
+++|.+....++||||+++|+|..++.+....+++..+++++.||++||+|||+ .+|+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999999998766678999999999999999999996 7999999999999997643
Q ss_pred ---cEEEeeecceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHH-cCCCCCCCCCccchhhh
Q 047591 1473 ---VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETL-TRRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1473 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Ell-tg~~P~~~~~~~~~~l~ 1547 (1624)
.+|++|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.|+......+ ..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~ 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KE 231 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HH
Confidence 4899999998644221 22357889999998765 56899999999999999995 7898886532211 11
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
.+ ++..... . ......+.+++.+||+.+|++||||+|+++.|
T Consensus 232 ~~------------~~~~~~~-~--------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RF------------YEKKHRL-P--------EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH------------HHhccCC-C--------CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 1110000 0 01123578899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=358.64 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=200.1
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
...++|...+.||+|+||+||+|+.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567888899999999999999875 57889999986432 233456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++... .++...+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998754 36777788899999999999996 7999999999999999999999999999987654
Q ss_pred CCCccccccccccccccccccCC----CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSE----GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~----~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
..........||+.|||||++.. ..++.++|||||||++|||+||+.||...... ... ..+.+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~------------~~i~~ 261 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTY------------SKIMD 261 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHH------------HHHHc
Confidence 33223344679999999998754 34889999999999999999999998653211 001 11111
Q ss_pred hh-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 047591 1564 AN-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEE--RMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPt~~evl~~ 1609 (1624)
.. ..... .....+..+.+++.+|++.+|++ |||++|+++.
T Consensus 262 ~~~~~~~~------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKNSLTFP------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCcCCCC------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 00000 00123456788999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=336.21 Aligned_cols=238 Identities=18% Similarity=0.328 Sum_probs=189.9
Q ss_pred eEeecCceEEEEEEEcC-------------CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1342 LLGTGIFSSVYKATFAD-------------GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~~-------------~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.||+|+||+||+|++.+ ...||+|.+........+.|.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998642 12488898766555566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc-------EEEeeecc
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV-------AHLGDFGI 1481 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-------~kl~DFGl 1481 (1624)
||||+++|+|..+++.....+++..+++++.||++||+|||+ .+|+||||||+|||++.++. +|++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 999999999999998766678999999999999999999996 89999999999999987664 89999999
Q ss_pred eeecCCCCCccccccccccccccccccC-CCCcCcccchHHHHHHHHHHH-cCCCCCCCCCccchhhhhhhhhcCChhHH
Q 047591 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETL-TRRKPTDDMFTGEVCLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1482 a~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Ell-tg~~P~~~~~~~~~~l~~~~~~~~~~~~~ 1559 (1624)
+..... .....|+..|||||++. ...++.++|||||||++|||+ +|+.|+......+. ..
T Consensus 159 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----------- 220 (262)
T cd05077 159 PITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ER----------- 220 (262)
T ss_pred CccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HH-----------
Confidence 875532 12346888999999876 567899999999999999998 57877754211110 00
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
......... ......+.+++.+||+.+|++||++.|+++.+
T Consensus 221 -~~~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 -FYEGQCMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HHhcCccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000000 01134578899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=335.17 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=201.0
Q ss_pred CCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+|.....||+|+||.||+|.+.++..+|+|...... ...+.|.+|++++++++|||++++++++. .+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 466678899999999999998777789999875332 23467899999999999999999999875 4568999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1416 GSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1416 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
|+|.+++++. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 9999999764 3457999999999999999999996 78999999999999999999999999999876433322222
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...++..|+|||+.....++.++|||||||++|||+| |+.||.+....+ ...+..... ...
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~------------~~~---- 223 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGY------------RMP---- 223 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------CCC----
Confidence 3356788999999988889999999999999999999 888986542211 111111100 000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
.+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 ---CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011234568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=344.38 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=201.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCc--eEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGT--NAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~--~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|+..+.||+|+||+||+|++. ++. .+|+|.++.. .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 45667789999999999999875 454 3577766532 234457889999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1410 LQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
|||+++|+|.+++++.+ ..+++.+++.++.|++.|++|||+ .+|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999997542 257889999999999999999996 899999999999999999999
Q ss_pred EEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhc
Q 047591 1475 HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
||+|||+++..... .......++..|+|||+.....++.++|||||||++|||+| |..||......+ ..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~------ 233 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY------ 233 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HH------
Confidence 99999998643211 11122234678999999888889999999999999999998 999986432111 00
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
+.+....... .+..++..+.+++.+||+.+|++||+++++++.|+++......
T Consensus 234 ------~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 234 ------EKLPQGYRLE-------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred ------HHHhcCCcCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 0010000000 0012345678899999999999999999999999987654443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=350.03 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=195.1
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----CeeEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-----GFKAL 1408 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-----~~~~l 1408 (1624)
|...+.||+|+||.||+|+.. ++..||||++... ......++.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 566789999999999999865 6889999988632 223456789999999999999999999987543 24799
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|||||+ ++|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 82 VFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999996 68999887543 57899999999999999999996 79999999999999999999999999999865322
Q ss_pred C--CccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc---CC-hhHHH
Q 047591 1489 D--SMKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES---LP-DAVTD 1560 (1624)
Q Consensus 1489 ~--~~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~---~~-~~~~~ 1560 (1624)
. ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ...++... .+ +....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPETISR 234 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHH
Confidence 1 111234579999999998765 678999999999999999999999986532111 00111000 00 00111
Q ss_pred HHhh-------hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1561 VIDA-------NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1561 ~~d~-------~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+... .+..............+...+.+++.+|++.+|++|||++|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 000000000000111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=335.71 Aligned_cols=250 Identities=24% Similarity=0.438 Sum_probs=195.1
Q ss_pred CeEeecCceEEEEEEEcC----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeec-cCCeeEEEEEecC
Q 047591 1341 NLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCS-NPGFKALILQYMP 1414 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~-~~~~~~lV~ey~~ 1414 (1624)
++||+|+||+||+|.+.+ +..||+|.+... .....+.|.+|+.+++.++||||++++++|. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 356999987532 3345678899999999999999999999875 4556899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC---c
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS---M 1491 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~---~ 1491 (1624)
+|+|.+++.+.....++..++.++.|++.|++|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999998766667888889999999999999996 7999999999999999999999999999986543211 1
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCC-CCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRK-PTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~-P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......++..|+|||+.....++.++|||||||++|||+||+. |+..... ..+..++ .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~-----------~~~~~~~-- 222 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL-----------LQGRRLL-- 222 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH-----------hcCCCCC--
Confidence 1123346778999999888889999999999999999999654 5543211 1111111 0000000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
.+..++..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 223 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 ------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01123556889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=343.21 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=205.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc--------CCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA--------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~--------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~ 1403 (1624)
.++|...+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 345667789999999999999752 24579999886432 34457899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
+..++||||+++|+|.+++.+.. ..+++.+++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999997532 347888999999999999999996 799999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l 1546 (1624)
++++.+||+|||+++......... .....+++.|+|||+..+..++.++|||||||++|||+| |..|+......+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 999999999999998765432221 222346788999999988889999999999999999999 777775432111
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+ .+.+....... .+..++..+.+++.+||+.+|++||||.|+++.|+++.+-
T Consensus 248 --~---------~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 --L---------FKLLKEGHRMD-------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred --H---------HHHHHcCCcCC-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 0 01111000000 0123566788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=357.39 Aligned_cols=364 Identities=29% Similarity=0.404 Sum_probs=251.6
Q ss_pred CEEEccCCccc-ccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheecc
Q 047591 165 ESFDVSSNQIT-GQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLAN 243 (1624)
Q Consensus 165 ~~L~Ls~N~l~-g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~ 243 (1624)
+-.|+++|.++ +..|.....+++++.|.|...+|. .+|++++.|.+|++|.+++|++. .+-..+..|+.|+.+++..
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhc
Confidence 34455555555 345556666666666666666665 66666666666666666666665 4445555566666666666
Q ss_pred ccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEee
Q 047591 244 NSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLY 323 (1624)
Q Consensus 244 N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls 323 (1624)
|++.. .-||..|..+..|+.||||+|++.. +|..+.+-+++-+|+||
T Consensus 88 N~LKn------------------------sGiP~diF~l~dLt~lDLShNqL~E---------vP~~LE~AKn~iVLNLS 134 (1255)
T KOG0444|consen 88 NNLKN------------------------SGIPTDIFRLKDLTILDLSHNQLRE---------VPTNLEYAKNSIVLNLS 134 (1255)
T ss_pred ccccc------------------------CCCCchhcccccceeeecchhhhhh---------cchhhhhhcCcEEEEcc
Confidence 66532 1345555556666666666666554 45566666777777777
Q ss_pred cccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccC
Q 047591 324 GNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403 (1624)
Q Consensus 324 ~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~ 403 (1624)
+|++. +||..++.+|+.|-+||||+|+|. .+|+.+..+..|+.|+||+|.+....-..+-.+++|+.|.+++.+=+
T Consensus 135 ~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT-- 210 (1255)
T KOG0444|consen 135 YNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT-- 210 (1255)
T ss_pred cCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch--
Confidence 77776 789999999999999999999998 67888999999999999999876543333333444444444332211
Q ss_pred CCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCC
Q 047591 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLAST 483 (1624)
Q Consensus 404 ~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~ 483 (1624)
...+|.++..|.+|..+|||.|.+. .
T Consensus 211 -----------------------------------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~ 236 (1255)
T KOG0444|consen 211 -----------------------------------------------------LDNIPTSLDDLHNLRDVDLSENNLP-I 236 (1255)
T ss_pred -----------------------------------------------------hhcCCCchhhhhhhhhccccccCCC-c
Confidence 1235667777777777777777775 5
Q ss_pred ccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCcccc-ccCchhhcc
Q 047591 484 IPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLN-STIPSTFWS 562 (1624)
Q Consensus 484 iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~-g~iP~~~~~ 562 (1624)
+|+.+-++.+|+.|+||+|+|+ .+.-..+...+|++|+||.|+++ .+|+++..|+.|+.|.+.+|+|+ .-||+.++.
T Consensus 237 vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGK 314 (1255)
T KOG0444|consen 237 VPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGK 314 (1255)
T ss_pred chHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhh
Confidence 7777777777777777777777 45555666677777777777777 67777777777777777777764 226777777
Q ss_pred ccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCC
Q 047591 563 LEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ 625 (1624)
Q Consensus 563 l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 625 (1624)
|.+|+++..++|.|. -+|+.+..|..|+.|.|++|+|. ++|..+--|+.|+.|||..|.=-
T Consensus 315 L~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 315 LIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 777777777777776 47888888888888888888887 68888888888888888877543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=340.34 Aligned_cols=259 Identities=21% Similarity=0.365 Sum_probs=207.9
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcC-----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-CCee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFAD-----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-PGFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~-----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-~~~~ 1406 (1624)
.++|...++||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567788999999999999998865 678999988643 33456778999999999999999999998866 5678
Q ss_pred EEEEEecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeee
Q 047591 1407 ALILQYMPQGSLEKWLYSHN-------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
++++||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999997532 458899999999999999999996 79999999999999999999999999
Q ss_pred cceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1480 GIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1480 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
|+++.+...... ......++..|+|||+.....++.++|||||||++||+++ |+.||..... ..+..++.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~-- 237 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR-- 237 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC--
Confidence 999866433221 1122346778999999988889999999999999999999 9999865321 111222111100
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
. . ....++..+.+++.+||..+|++|||+.|+++.|+.+.++
T Consensus 238 --------~-~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 --------L-A--------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --------C-C--------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0 0 0123456788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=356.35 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=194.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.|...+.||+|+||+||+|+.. +++.+|||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4667789999999999999875 57889999986432 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS- 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~- 1490 (1624)
|+++|+|.+++.+.+ .+++.....++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999997654 46778888899999999999996 7999999999999999999999999999864311000
Q ss_pred ---------------------------------------------ccccccccccccccccccCCCCcCcccchHHHHHH
Q 047591 1491 ---------------------------------------------MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGIL 1525 (1624)
Q Consensus 1491 ---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvi 1525 (1624)
......+||+.|||||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999988889999999999999
Q ss_pred HHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh-ccCCchHHHHHHHHHhHHHHHHHHHH--ccccCCCCCCC
Q 047591 1526 MMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN-LLSGEEEADIAAKKKCMSSVMSLALK--CSEEIPEERMN 1602 (1624)
Q Consensus 1526 l~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~l~~~--C~~~~P~~RPt 1602 (1624)
+|||+||+.||......+... . +++.. ... ......+..++.+++.+ |+..+|..||+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~-~------------i~~~~~~~~------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQL-K------------VINWENTLH------IPPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHH-H------------HHccccccC------CCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 999999999996532211110 0 01000 000 00001123445566655 77778888999
Q ss_pred HHHHHHH
Q 047591 1603 VKDALAN 1609 (1624)
Q Consensus 1603 ~~evl~~ 1609 (1624)
++|+++.
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=353.87 Aligned_cols=201 Identities=25% Similarity=0.350 Sum_probs=174.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46788899999999999999875 57899999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+ .+++.+...++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+|+.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999997653 57888999999999999999996 8999999999999999999999999999976532110
Q ss_pred ----------------------------------ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCC
Q 047591 1491 ----------------------------------MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPT 1536 (1624)
Q Consensus 1491 ----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~ 1536 (1624)
......+||+.|||||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012347999999999998889999999999999999999999999
Q ss_pred CCC
Q 047591 1537 DDM 1539 (1624)
Q Consensus 1537 ~~~ 1539 (1624)
.+.
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=339.92 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=201.7
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
++++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34667888999999999999998753 4668899876433 3345679999999999999999999999999899
Q ss_pred eEEEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC---cEEE
Q 047591 1406 KALILQYMPQGSLEKWLYSHN------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM---VAHL 1476 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~kl 1476 (1624)
.++||||+++|+|.+++...+ ..++|.++++++.||+.|++|||+ .+++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997643 258999999999999999999996 7899999999999998754 6999
Q ss_pred eeecceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcC
Q 047591 1477 GDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESL 1554 (1624)
Q Consensus 1477 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~ 1554 (1624)
+|||+++.+....... ......+..|||||+..+..++.++|||||||++|||+| |+.||+.....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----------- 229 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------- 229 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------
Confidence 9999998764322111 112234568999999988899999999999999999997 999986532211
Q ss_pred ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
..+.+....... .+..++..+.+++.+|++.+|++||++.||++.|+
T Consensus 230 ---~~~~~~~~~~~~-------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 ---VMEFVTGGGRLD-------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHHHHHcCCcCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111110000 01234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=344.72 Aligned_cols=196 Identities=29% Similarity=0.395 Sum_probs=178.0
Q ss_pred CCCCcceeecCCccceEEEE-ecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 745 GFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
.|..-..||+|+.|.||.|. ..+++.||||++........+-..+|+.+|+..+|+|||++++.|...+++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 45556789999999999997 45789999999988777666778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|+|.+.+... .+++.+...|+.++++||+|||.. +|||||||.+|||++.++.+||+|||++..+..+...+.
T Consensus 354 ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~- 427 (550)
T KOG0578|consen 354 GGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS- 427 (550)
T ss_pred CCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc-
Confidence 99999988543 589999999999999999999984 599999999999999999999999999999887766444
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
..+|||+|||||+.....|++|+|||||||+++||+.|+.||-
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 4579999999999999999999999999999999999999985
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=336.34 Aligned_cols=255 Identities=22% Similarity=0.413 Sum_probs=203.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-C---CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-D---GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~---~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.+|...+.||+|+||.||+|++. + +..+|+|.++... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 35667789999999999999864 2 3368999886432 34457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++......+++.++++|+.|++.|++|||+ .+|+||||||+||+++.++.+|++|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999998766678999999999999999999996 799999999999999999999999999998764322
Q ss_pred Cccc--cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1490 SMKQ--TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1490 ~~~~--~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.... ....++..|+|||+..+..++.++|||||||++||+++ |+.||.+....+ ...+.....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~------------ 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEEGY------------ 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhCCC------------
Confidence 2111 11234568999999988889999999999999999887 999986532111 111111000
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
. ......++..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 227 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 R-------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred c-------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 000122456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=355.58 Aligned_cols=257 Identities=19% Similarity=0.266 Sum_probs=198.6
Q ss_pred HHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1330 LRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1330 l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
+....++|...+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344567888899999999999999886 57889999986422 2344668899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+++|+|.+++... .++......++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999999754 46788888999999999999996 79999999999999999999999999999877
Q ss_pred CCCCCccccccccccccccccccCCC----CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEG----IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
............||+.|||||++.+. .++.++||||+||++|||+||+.||...... ... ..+
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~------------~~i 259 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTY------------SKI 259 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHH------------HHH
Confidence 54333233456799999999987543 3789999999999999999999999643211 011 111
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEE--RMNVKDALAN 1609 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPt~~evl~~ 1609 (1624)
++....-. .......+..+.+++.+|+..++.+ |||+.|+++.
T Consensus 260 ~~~~~~~~-----~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKNSLN-----FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCcccC-----CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11100000 0000122445667788888755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=360.87 Aligned_cols=203 Identities=30% Similarity=0.495 Sum_probs=175.5
Q ss_pred CCCCcceeecCCccceEEEEec------CCCEEEEEEeecccch-hHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLDG-AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
+-...+.||+|+||+||+|+.. +.+.||||.++...+. ..++|++|++++..++|||||+|+|.|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3345578999999999999753 3467999999876655 77899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC---------CC----CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceE
Q 047591 818 ILEYMPQGSLEKWLYSHK---------YT----LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH 884 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~---------~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~k 884 (1624)
|+|||..|||.+||+.+. .. ++..+.+.||.|||.||+||-+++ +|||||.++|+|+.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 999999999999998542 12 788899999999999999999865 99999999999999999999
Q ss_pred EEeeeeeeccCCCCCcccc-cccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccCc
Q 047591 885 LSDFGISKLLDGEDSVTQT-MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEMFT 950 (1624)
Q Consensus 885 l~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~~~ 950 (1624)
|+|||++|..-..+.+... ...-..+|||||.+..+.||++||||||||||||+.| |+.||.....
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 9999999976444433322 2335679999999999999999999999999999998 8999987543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=346.67 Aligned_cols=245 Identities=23% Similarity=0.379 Sum_probs=201.8
Q ss_pred CeEeecCceEEEEEEEc--CCc--eEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA--DGT--NAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~--~~~--~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+|++|.|. .|+ .||||+++..... ...+|.+|+.+|.+++|||+|+|||...+ ....+|||+++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 67999999999999995 344 4899999765443 67899999999999999999999999887 667899999999
Q ss_pred CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc-
Q 047591 1416 GSLEKWLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ- 1493 (1624)
Q Consensus 1416 gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~- 1493 (1624)
|||.+.|++ ....+-....-+|+.|||.||.||.. ++.|||||.++|+|+.....+||+|||+.+.+...+....
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999997 45567777888999999999999995 8999999999999999999999999999998875543221
Q ss_pred -cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1494 -TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1494 -~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
....-.+.|-|||.+....++.++|||+|||++|||+| |+.||.+.... .+-+.+|.
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------qIL~~iD~------- 330 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------QILKNIDA------- 330 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------HHHHhccc-------
Confidence 11234567999999999999999999999999999999 67787653211 11222331
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
.++...++.|+..++++|+.||...|++||||..+.+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 222334568999999999999999999999999997554
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=336.62 Aligned_cols=253 Identities=22% Similarity=0.415 Sum_probs=202.7
Q ss_pred CCcCCeEeecCceEEEEEEEcC-C---ceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFAD-G---TNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~-~---~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
|...+.||+|+||.||+|++.. + ..||||+++.. .....++|..|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 5567899999999999998753 3 35999998644 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++|+|.+++......+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.+|++|||+++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 999999999998766678999999999999999999996 79999999999999999999999999998866432211
Q ss_pred c-cc-cc--ccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1492 K-QT-MT--LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1492 ~-~~-~~--~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
. .. .. ..+..|+|||+.....++.++|||||||++|||++ |+.||...... ....++.... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~----------~- 229 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY----------R- 229 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC----------c-
Confidence 1 11 11 12457999999988899999999999999999997 99998653211 1111111100 0
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
...+..++..+.+++.+||+.+|++||++++++..|+++
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001123556788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=353.50 Aligned_cols=264 Identities=20% Similarity=0.209 Sum_probs=198.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
..+|...+.||+|+||.||+|... +++.||+|... .+.+.+|++++++++|||||++++++...+..++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357888999999999999999764 57889999643 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+. ++|.+++... ..+++.+++.|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+.........
T Consensus 165 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 95 7898888654 357899999999999999999996 799999999999999999999999999997643322222
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCc------cchhhhhhhhh------cCCh----
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFT------GEVCLKHWVEE------SLPD---- 1556 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~------~~~~l~~~~~~------~~~~---- 1556 (1624)
.....||+.|+|||++.+..++.++|||||||++|||+||+.|+..... ....+...+.. ..+.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 3345799999999999888999999999999999999999988643210 01111111110 0010
Q ss_pred hHHHHH-h--hhcc-CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1557 AVTDVI-D--ANLL-SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1557 ~~~~~~-d--~~l~-~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...+.. . .... ..............+..+.+++.+|++.||++|||++|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 011111 0 0000 00000001111234567889999999999999999999985
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=345.30 Aligned_cols=240 Identities=25% Similarity=0.301 Sum_probs=189.2
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHh-cCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRR-IRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~-l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.||||+++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 57789999986432 2334556677777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++...+ .++..+...++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 99999987654 57888888999999999999996 799999999999999999999999999998653322 22334
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||++|+.||......+ .... +......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~-------------i~~~~~~------- 214 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDS-------------ILNDRPH------- 214 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHH-------------HHcCCCC-------
Confidence 579999999999988889999999999999999999999996532111 0000 0000000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDAL 1607 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl 1607 (1624)
.+..+...+.+++.+||+.+|++||++.+.+
T Consensus 215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 0012344567899999999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=339.02 Aligned_cols=244 Identities=24% Similarity=0.290 Sum_probs=193.4
Q ss_pred EeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
||+|+||+||+|... +++.+|||.+.... ....+.+..|++++++++||||+++.+++..++..++|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 68899999886432 22346778999999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1419 EKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1419 ~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
..+++. ....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988864 23468899999999999999999996 7999999999999999999999999999987643322 2233
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||+..+..++.++|||||||++|||+||+.||....... ....... .......
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~--------~~~~~~~--------- 218 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ--------RILNDSV--------- 218 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHH--------hhcccCC---------
Confidence 579999999999999999999999999999999999999986432110 0000000 0000000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
..+..++..+.+++.+|++.+|++|| |++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01123456678899999999999999 6667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=326.54 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=207.5
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
|+....||+|+||.||||.++ .|.++|+|.+.. +.+.++...|+.+|++.+.|.+|++||.|......++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 455578999999999999775 699999998754 44578899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
||..+.++.++..+..++...|..+.++||+|||. ..-||||||+.|||++.+|.+|++|||.|..+.+ .-....+
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhhCc
Confidence 99999999888889999999999999999999996 6779999999999999999999999999987643 2334556
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
+.|||-|||||++..-.|+.++||||+|++-.||..|++||.+....... ++-...| ....
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---FMIPT~P----------------PPTF 249 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---FMIPTKP----------------PPTF 249 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---EeccCCC----------------CCCC
Confidence 78999999999999999999999999999999999999999875332211 1100001 0011
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++.-..++-+++.+|+-..|++|-|+.++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1233446678899999999999999999988764
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=335.80 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=205.5
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
+|...+.||+|+||.||+|+.. ++..+|||.+... .....++|.+|+++++.++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 5666788999999999999864 7889999987542 23345688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|+++++|.+++.. ....+++.++..++.|++.|++|||+ .+|+|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999864 23468999999999999999999996 79999999999999999999999999998876432
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.. ......|+..|+|||+..+..++.++|||||||++|||++|+.||.............+.. ...+..
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~-- 228 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--------CDYPPL-- 228 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc--------CCCCCC--
Confidence 21 1223468999999999988889999999999999999999999985432111111110000 000000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
....++..+.+++.+||+.+|++||||.+|++.++++.
T Consensus 229 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 --------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00124456888999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=330.90 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=203.5
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3666789999999999999875 5888999988643 344567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
+++++|.++++.. +..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999864 5678999999999999999999996 7999999999999999999999999999987654322
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......|++.|+|||+..+..++.++|||||||++|||+||+.||...... ...... .. ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~-----------~~-~~~~~~- 221 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKI-----------IR-GVFPPV- 221 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-----------Hc-CCCCCC-
Confidence 223346889999999999888999999999999999999999998643211 111110 00 000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...++..+.+++.+||+.+|++||++.|+++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=338.71 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=202.3
Q ss_pred CCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
|...+.||+|+||+||+|+.. ....+|+|.+.... ....+++.+|++++++++||||++++++|...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 566788999999999999763 23568888876433 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcE
Q 047591 1410 LQYMPQGSLEKWLYSHN-----------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 1466 (1624)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 99999999999986421 247889999999999999999996 7999999999999
Q ss_pred EecCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccch
Q 047591 1467 LLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEV 1544 (1624)
Q Consensus 1467 Lld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~ 1544 (1624)
++++++.+||+|||+++....... .......++..|+|||+..+..++.++|||||||++|||+| |+.||......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-- 236 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-- 236 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999999986543222 11223346778999999888889999999999999999999 99998653211
Q ss_pred hhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1545 CLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1545 ~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.+.. .+....... .+..++..+.+++.+||+.+|++||+++|+++.|+++-.
T Consensus 237 ~~~~------------~~~~~~~~~-------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RLFN------------LLKTGYRME-------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHH------------HHhCCCCCC-------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111 111111000 012344568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=331.08 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=193.6
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhh--------------HHHHHHHHHHHHHhcCCCceeEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDR--------------ALKSFDAECEVMRRIRHRNLAKIV 1397 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~--------------~~~~f~~E~~~l~~l~HpNIv~l~ 1397 (1624)
.-+.|.....||+|.||.|-+|+.. +++.||||++...... ..+...+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467777888999999999999764 6899999999643211 135789999999999999999999
Q ss_pred eeeccC--CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1398 SSCSNP--GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1398 g~~~~~--~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
.+..++ +..|||+|||..|.+.. ....+..+...+..+|..++..||+|||. .+||||||||+|+||+++|++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEE
Confidence 998764 57899999999998643 22223337888889999999999999995 8999999999999999999999
Q ss_pred EeeecceeecCCCC----CccccccccccccccccccCCC----CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhh
Q 047591 1476 LGDFGIAKLLDGVD----SMKQTMTLATIGYMAPEYGSEG----IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1476 l~DFGla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~----~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~ 1547 (1624)
|+|||.+....... ...-...+|||.|||||...++ ..+.+.||||+||+||.|+.|+.||.+.+.-+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---- 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---- 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH----
Confidence 99999987653221 1112236899999999987653 24678899999999999999999996532111
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....++...+..... ++.-..+.+|+++.+++||++|.+..||..+
T Consensus 327 ---------l~~KIvn~pL~fP~~-------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 327 ---------LFDKIVNDPLEFPEN-------PEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred ---------HHHHHhcCcccCCCc-------ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 111222222211110 1233457789999999999999999998654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=355.96 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=197.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46788899999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999997654 57888889999999999999996 7999999999999999999999999999976532110
Q ss_pred c-------------------------------------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCC
Q 047591 1491 M-------------------------------------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRR 1533 (1624)
Q Consensus 1491 ~-------------------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~ 1533 (1624)
. .....+||+.|||||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 001246999999999998889999999999999999999999
Q ss_pred CCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 047591 1534 KPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN---VKDALAN 1609 (1624)
Q Consensus 1534 ~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt---~~evl~~ 1609 (1624)
.||......+. ........ ..+.. .. .......+.+++.+|+. +|++|++ ++|+++.
T Consensus 237 ~Pf~~~~~~~~-~~~i~~~~----------~~~~~-~~------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQET-YRKIINWK----------ETLQF-PD------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHH-HHHHHcCC----------CccCC-CC------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99975322111 00000000 00000 00 00123456778888886 8999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.93 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=202.4
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--------hHHHHHHHHHHHHHhc-CCCceeEEEeeecc
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--------RALKSFDAECEVMRRI-RHRNLAKIVSSCSN 1402 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--------~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~ 1402 (1624)
.-+.|.+.+++|+|..++|.++..+ +|...|+|++..... ...+.-.+|+.||+++ -||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456778899999999999998664 688899998854321 2234557899999998 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1403 PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
+.+.++|+|.|+.|.|.++|.+. ..++.....+|+.|+..|++|||. +.||||||||+|||+|++..+||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999764 346667777899999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccccccC------CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGS------EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
..+.+.+ .....+|||+|.|||.+. ...|+..+|+||.|||||.++.|.+||..... ...+
T Consensus 171 ~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-mlML---------- 237 (411)
T KOG0599|consen 171 CQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-MLML---------- 237 (411)
T ss_pred eccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-HHHH----------
Confidence 9887654 344568999999999654 34588999999999999999999999843110 0001
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+..+...-..+.+.+....+.+|+.+|++.||.+|.|.+|+++.
T Consensus 238 -------R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 -------RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -------HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111222222223445667778899999999999999999999874
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=339.24 Aligned_cols=252 Identities=25% Similarity=0.440 Sum_probs=202.4
Q ss_pred CCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++.....||+|+||.||+|... ++..+|+|.+........+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4555688999999999999642 3567899988766666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1410 LQYMPQGSLEKWLYSHN--------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
|||+++|+|.++++..+ ..+++.+++.++.|++.|++|||+ .+|+||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEE
Confidence 99999999999997643 247899999999999999999996 7999999999999999999999
Q ss_pred EeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhc
Q 047591 1476 LGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
|+|||+++....... .......+++.|+|||+..+..++.++|||||||++|||+| |+.||......+.
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------- 233 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--------- 233 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---------
Confidence 999999986543221 11222345788999999988889999999999999999999 8888864321111
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.+.+...... ..+..++..+.+++.+||+.+|++||+++|+.+.|+
T Consensus 234 -----~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 -----IECITQGREL-------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----HHHHHcCccC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0001100000 001234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=347.66 Aligned_cols=396 Identities=24% Similarity=0.324 Sum_probs=269.4
Q ss_pred CCCCccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCc
Q 047591 73 SNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGN 152 (1624)
Q Consensus 73 ~~~~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~ 152 (1624)
.++.|.=.-..|+.. ++..+ .-..|.|-+|+. -+.||+|+|+++..-+..|.++++|+.++|.+|.++ .
T Consensus 48 a~c~c~~~lldcs~~--~lea~--~~~~l~g~lp~~------t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~ 116 (873)
T KOG4194|consen 48 ATCPCNTRLLDCSDR--ELEAI--DKSRLKGFLPSQ------TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-R 116 (873)
T ss_pred CcCCCCceeeecCcc--ccccc--cccccCCcCccc------eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-h
Confidence 345566555666542 22222 123456767664 367999999999888888999999999999999997 4
Q ss_pred cchhhhccCCCcCEEEccCCcccccCCccccCCCccccccccccccccccc-CcccccccccceeccCCcCCCCCCCccc
Q 047591 153 LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIP-QNIGNLTELMELYLNGNNLQGEFPPTIF 231 (1624)
Q Consensus 153 ~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 231 (1624)
||. +.....+|+.|+|.+|.|+..-.+++..++.|+.||||.|.++ +|| ++|..-.++++|+|++|.|+..--..|.
T Consensus 117 IP~-f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~ 194 (873)
T KOG4194|consen 117 IPR-FGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFD 194 (873)
T ss_pred ccc-ccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeecccccccccccccc
Confidence 554 4455566999999999998766778888999999999999998 555 4677778899999999999876677888
Q ss_pred ccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCcccccccccccc
Q 047591 232 NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSII 311 (1624)
Q Consensus 232 ~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~ 311 (1624)
++.+|..|.|++|+++ .+|...|++|++|+.|+|..|++.-.---.|..|.+|+.|.|..|.+..+... .|
T Consensus 195 ~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG--------~F 265 (873)
T KOG4194|consen 195 SLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDG--------AF 265 (873)
T ss_pred ccchheeeecccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCc--------ce
Confidence 8888888889999887 78888888888888888888887644345677788888888777776655433 33
Q ss_pred ccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCccccccccccc
Q 047591 312 FNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQ 391 (1624)
Q Consensus 312 ~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~ 391 (1624)
+.+.+++.|+|+.|+++. +-++...+|+.|+.|+||+|.+...-++++....+|++||||+|+|+.+.+..|..|++|+
T Consensus 266 y~l~kme~l~L~~N~l~~-vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le 344 (873)
T KOG4194|consen 266 YGLEKMEHLNLETNRLQA-VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLE 344 (873)
T ss_pred eeecccceeecccchhhh-hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhh
Confidence 445667777777777663 3322222566666666666666666666666666666666666666666666666666666
Q ss_pred EEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCccc
Q 047591 392 ILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNII 471 (1624)
Q Consensus 392 ~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~ 471 (1624)
+|+|++|.+... -...|..+++|+
T Consensus 345 ~LnLs~Nsi~~l--------------------------------------------------------~e~af~~lssL~ 368 (873)
T KOG4194|consen 345 ELNLSHNSIDHL--------------------------------------------------------AEGAFVGLSSLH 368 (873)
T ss_pred hhcccccchHHH--------------------------------------------------------HhhHHHHhhhhh
Confidence 666666655321 011244455555
Q ss_pred EEeccCCccCCCccc---hhccccccceecccccccccCCC-ccccCCCCCceeecccccccCCCccccccccCCccccc
Q 047591 472 ALSLYQNQLASTIPT---TVGKLQNLQGLDLSYNNIQGSIP-SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNL 547 (1624)
Q Consensus 472 ~L~L~~N~l~g~iP~---~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~L 547 (1624)
.|||++|.+++.|-+ .|..|++|+.|+|.+|+|. .|| ..|.++..|+.|||.+|.+...-|.+|..+ .|+.|-+
T Consensus 369 ~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 369 KLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred hhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 555555555544432 3445566666666666666 343 356666666666666666665556666665 5555554
Q ss_pred cC
Q 047591 548 SS 549 (1624)
Q Consensus 548 s~ 549 (1624)
+.
T Consensus 447 nS 448 (873)
T KOG4194|consen 447 NS 448 (873)
T ss_pred cc
Confidence 43
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=342.20 Aligned_cols=268 Identities=22% Similarity=0.377 Sum_probs=204.0
Q ss_pred CCCcCCeEeecCceEEEEEEEc-----CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-----DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKA 1407 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-----~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~ 1407 (1624)
-|...+.||+|+||+||+|++. ++..||+|.++... ....+.|.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 3566788999999999999752 46789999986443 34457899999999999999999999998765 5689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++++|.+++.+....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999997765568999999999999999999996 8999999999999999999999999999987643
Q ss_pred CCCc--cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhh-hhhhhcCChhHHHHHhh
Q 047591 1488 VDSM--KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK-HWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1488 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~-~~~~~~~~~~~~~~~d~ 1564 (1624)
.... ......|+..|+|||+..+..++.++|||||||++|||+|++.|............ .+..+.......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 2211 11234567789999998888899999999999999999998877533211000000 00000000011111111
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.... ..+..++..+.+++.+|++.+|++|||++|+++.++++
T Consensus 242 ~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 GKRL-------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CccC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1000 01123567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.12 Aligned_cols=268 Identities=24% Similarity=0.285 Sum_probs=199.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEec--cchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-----CCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFS--LQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-----PGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~--~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-----~~~~ 1406 (1624)
..|...+.||+|+||.|++|... +|+.||||++. .+.....++-.+|+++++.++|+||+.+++.+.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 34444578999999999999774 68999999886 4555667888999999999999999999998754 3468
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
|+|+|+| ..+|.+.++... .++.+...-++.|+.+||+|+|+ .+|+|||+||+|++++.+...||+|||+|+..+
T Consensus 102 YiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred EEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence 9999999 458999887653 36667777799999999999995 899999999999999999999999999999885
Q ss_pred CC-CCcccccccccccccccccc-CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC---ChhHHHH
Q 047591 1487 GV-DSMKQTMTLATIGYMAPEYG-SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL---PDAVTDV 1561 (1624)
Q Consensus 1487 ~~-~~~~~~~~~gt~~y~APE~~-~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~---~~~~~~~ 1561 (1624)
.. .....+..+.|.+|.|||.+ ....||+++||||.|||+.||++|+.-|.+... ......+.+.+ ++.....
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCCHHHHHH
Confidence 42 12234667899999999975 557899999999999999999999987754311 11111111111 1111111
Q ss_pred Hh-----h---hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1562 ID-----A---NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1562 ~d-----~---~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+. . .+.......-...-+...+...+|..+++..||.+|+|++|+++.
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 0 000000000011112445678899999999999999999999874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=349.00 Aligned_cols=243 Identities=22% Similarity=0.283 Sum_probs=194.4
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
++||+|+||+||+|+.. +++.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 68899999986432 234567789999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
+|.+++... ..+++.++..++.||+.||+|||+ ..+|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTF 156 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccc
Confidence 999988754 357899999999999999999995 2689999999999999999999999999987643221 122335
Q ss_pred ccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHH
Q 047591 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 1576 (1624)
.||+.|||||++.+..++.++|||||||++|||+||+.||....... . .+.+......
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~------------~~~i~~~~~~-------- 214 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--L------------FELILMEEIR-------- 214 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--H------------HHHHhcCCCC--------
Confidence 69999999999988899999999999999999999999986432111 0 0111000000
Q ss_pred HHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1577 AKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1577 ~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
.+......+.+++.+|++.||++|+ +++|+++.
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0012345577899999999999997 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=349.02 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=196.0
Q ss_pred CCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccc----hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQ----EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~----~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
+|...+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++++++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 3666789999999999999763 5788999998642 223456788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++|+|.+++.+.. .+++++...++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997643 57888999999999999999996 799999999999999999999999999998654
Q ss_pred CCCCccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
...........||+.|||||++.+. .++.++|||||||++|||+||+.||........ .... . ..+....
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~-~-------~~~~~~~ 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEV-S-------RRILKCD 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHH-H-------HHHhcCC
Confidence 3333333345799999999988764 478999999999999999999999864211100 0000 0 0000000
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
. ..+......+.+++.+|++.||++|| +++|+++.
T Consensus 228 ----~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ----P-----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----C-----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 00012345577899999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=345.60 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=192.6
Q ss_pred CeEeecCceEEEEEEEc----CCceEEEEEeccch----hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1341 NLLGTGIFSSVYKATFA----DGTNAAIKIFSLQE----DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~~----~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.||+|+||.||+++.. +++.||||+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 57889999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++|+|.+++...+ .+.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 99999999997654 46777888899999999999996 7999999999999999999999999999975432221 2
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
.....||+.|||||++.+..++.++|||||||++|||++|+.||....... . ...+..... .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~------------~~~~~~~~~-~---- 218 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-T------------IDKILKGKL-N---- 218 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-H------------HHHHHcCCC-C----
Confidence 233569999999999988889999999999999999999999986532110 0 011111100 0
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
.+..+...+.+++.+|++.+|++|| ++.++++
T Consensus 219 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 ----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0112345678899999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=342.82 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=198.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC---------------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD---------------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVS 1398 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~---------------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g 1398 (1624)
++|...+.||+|+||.||+|+... ...||+|.++... ......|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 456777899999999999987642 1248999886442 334567999999999999999999999
Q ss_pred eeccCCeeEEEEEecCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEE
Q 047591 1399 SCSNPGFKALILQYMPQGSLEKWLYSHN-----------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467 (1624)
Q Consensus 1399 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NIL 1467 (1624)
++...+..++||||+++++|.+++.... ..+++.++++++.|++.||+|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999996532 236889999999999999999996 79999999999999
Q ss_pred ecCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc--CCCCCCCCCccch
Q 047591 1468 LDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT--RRKPTDDMFTGEV 1544 (1624)
Q Consensus 1468 ld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt--g~~P~~~~~~~~~ 1544 (1624)
+++++.+||+|||+++........ ......+++.|+|||+...+.++.++|||||||++|||+| |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 999999999999999865432211 1122345778999999888889999999999999999998 556665432111
Q ss_pred hhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1545 CLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1545 ~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
...... ...+....... ...+..++..+.+++.+||+.+|++||+|++|++.|+
T Consensus 241 ~~~~~~---------~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTG---------EFFRNQGRQIY----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHH---------Hhhhhcccccc----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111100 00000000000 0001124567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=341.21 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=203.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||.||+|+.. ++..||||+++... ....+.|.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 45777899999999999999752 24579999886442 33456899999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1407 ALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
++||||+++|+|.++++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997643 348999999999999999999996 78999999999999999999999999999865
Q ss_pred CCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1486 DGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1486 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
..... .......++..|+|||+..+..++.++|||||||++|||+| |+.||......+. . ...++
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~------------~~~~~ 258 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-F------------YKLIK 258 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-H------------HHHHH
Confidence 43221 11122346788999999988889999999999999999998 9999865422111 1 11111
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
....... +...+..+.+++.+|++.+|++|||++|+++.|++.
T Consensus 259 ~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EGYRMAQ-------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCcCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1110000 011235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=368.24 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=202.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...++||+|+||+||+|+.. +++.||||++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46777899999999999999875 5889999998643 2334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1411 QYMPQGSLEKWLYSH----------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
||+++|+|.+++... ....++.++++++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998641 1235677889999999999999996 799999999999999999999999999
Q ss_pred ceeecCCCCC-----------------ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccc
Q 047591 1481 IAKLLDGVDS-----------------MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543 (1624)
Q Consensus 1481 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~ 1543 (1624)
+|+....... ......+||+.|||||+..+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 01112469999999999999999999999999999999999999986421111
Q ss_pred hhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHHH
Q 047591 1544 VCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-VKDALANLKKIKT 1615 (1624)
Q Consensus 1544 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-~~evl~~L~~i~~ 1615 (1624)
.... .... ++ . .......++..+.+++.+|++.+|++||+ ++++.+.|+....
T Consensus 239 i~~~----~~i~-------~P------~--~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR----DVIL-------SP------I--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh----hhcc-------Ch------h--hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1000 0000 00 0 00011234566788999999999999975 6777777776543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=335.75 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=203.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||.||+|...+++.||+|.+.... ...++|.+|++++++++||||+++++++ ..+..++||||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 4567778999999999999998889999999886433 2346789999999999999999999986 4567899999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+|+|.+++... +..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 99999998753 4568999999999999999999995 7999999999999999999999999999987653332222
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....++..|+|||+.....++.++|||||||++|||++ |+.||.+....+ .... +......
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~------------~~~~~~~---- 222 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQN------------LERGYRM---- 222 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHH------------HHcCCCC----
Confidence 33456788999999988889999999999999999999 999987542211 1111 1100000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
..+..++..+.+++.+|++.+|++|||++++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=336.46 Aligned_cols=202 Identities=33% Similarity=0.508 Sum_probs=172.7
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCC--eEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG--FKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E 820 (1624)
.++...+.||+|+||.||++... +|...|||..........+.+.+|+.+|++++|||||+++|.....+ ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34566789999999999999865 48999999987664333677899999999999999999999855554 6899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC-CCceEEEeeeeeeccCC--C
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD-DTVAHLSDFGISKLLDG--E 897 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~~kl~DFGla~~~~~--~ 897 (1624)
|+++|+|.+++.+.+..+++..+.++..||++||+|||+ ++||||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998876579999999999999999999997 46999999999999999 79999999999997763 2
Q ss_pred CCcccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGI-VSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~-~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.........||+.|||||++..+. ...++||||+||+++||+||+.||.+.
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 222233467999999999988543 345899999999999999999999763
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=351.36 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=189.8
Q ss_pred cCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1339 ESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1339 ~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
..+.||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 3468999999999999875 6889999998543 2344578999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
+|.+.. ..++.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+..... .....
T Consensus 158 ~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 158 SLEGTH-----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred cccccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 986532 34567778899999999999996 7999999999999999999999999999987643221 22345
Q ss_pred ccccccccccccCC-----CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1497 LATIGYMAPEYGSE-----GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1497 ~gt~~y~APE~~~~-----~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.||..|+|||++.. ...+.++|||||||++|||++|+.||......+ |... ...+.. ....
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~-----~~~~~~----~~~~ 294 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASL-----MCAICM----SQPP 294 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHH-----HHHHhc----cCCC
Confidence 79999999998642 334578999999999999999999986321111 1000 000000 0000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....+..++.+++.+||+.+|++|||+.|+++.
T Consensus 295 ----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012345568899999999999999999999875
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=331.03 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=208.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999886 7899999987532 2334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
||+++|+|.+++.. .+..+++.++..++.+++.|++|||+ .+|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 23457899999999999999999996 7999999999999999999999999999986643
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
... ......|++.|+|||+..+..++.++|||||||++|||++|+.|+...... ...+. +.+.....
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---------~~~~~~~~ 225 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLC---------KKIEKCDY 225 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHH---------hhhhcCCC
Confidence 221 223346889999999988888999999999999999999999998542211 11110 00110000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
... ....++..+.+++.+||..+|++|||+.+++++|++++
T Consensus 226 ~~~------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPL------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCC------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 01134556889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=355.07 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=202.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 35777889999999999999875 68899999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD- 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~- 1489 (1624)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999865 467888999999999999999996 899999999999999999999999999998664332
Q ss_pred ---------------------------CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCcc
Q 047591 1490 ---------------------------SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTG 1542 (1624)
Q Consensus 1490 ---------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~ 1542 (1624)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223457999999999999889999999999999999999999999753211
Q ss_pred chhhhhhhhhcCChhHHHHHh--hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 047591 1543 EVCLKHWVEESLPDAVTDVID--ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-VKDALAN 1609 (1624)
Q Consensus 1543 ~~~l~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-~~evl~~ 1609 (1624)
+. .. .+.. ..... .....++..+.+++.+|+. +|++||+ ++|+++.
T Consensus 237 ~~-~~------------~i~~~~~~~~~-------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ET-YN------------KIINWKESLRF-------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-HH------------HHhccCCcccC-------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 00 0110 00000 0001134567889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=345.62 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=192.9
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.+|+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5788999998643 233456788899998877 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|..++... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 9999988654 357889999999999999999996 799999999999999999999999999997543221 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccch---hhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV---CLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~---~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
..||+.|+|||++.+..++.++|||||||++|||+||+.||+....... ....+ ..+.+......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~i~~~~~~---- 223 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--------LFQVILEKQIR---- 223 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH--------HHHHHhcCCCC----
Confidence 5799999999999999999999999999999999999999963211110 00011 11111100000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMN------VKDALA 1608 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt------~~evl~ 1608 (1624)
.+..++..+.+++.+|++.||++||+ +.|+++
T Consensus 224 ----~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 224 ----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 01223456788999999999999998 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=334.37 Aligned_cols=248 Identities=29% Similarity=0.486 Sum_probs=195.2
Q ss_pred CeEeecCceEEEEEEEcC-Cc--eEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFAD-GT--NAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~-~~--~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||.||+|++.+ +. .+|+|.++.. .....+.|.+|+++++++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998854 43 4688877643 234456889999999999 899999999999999999999999999
Q ss_pred CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1416 GSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1416 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
|+|.+++++.. ..++++++..++.|++.|++|||+ .+|+||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 247899999999999999999996 799999999999999999999999999
Q ss_pred ceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHH
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~ 1559 (1624)
+++.... .........+..|+|||+.....++.++|||||||++|||+| |+.||......+. .
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--------------~ 221 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------------Y 221 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--------------H
Confidence 9864321 111122234667999999988889999999999999999997 9999865321110 0
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
+.+....... .+..++..+.+++.+||+.+|.+|||+.|+++.|+++-
T Consensus 222 ~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 222 EKLPQGYRLE-------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHhCCCCCC-------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0111100000 01123456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=346.42 Aligned_cols=202 Identities=28% Similarity=0.436 Sum_probs=176.4
Q ss_pred hhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecc----cc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeccCC
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQ----LD-GAIKSFDAECEVLRRVR-HRNLVKIISSCSNHG 813 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 813 (1624)
...++|...+.||+|+||+||+|.. .+|..||||++..+ .. ...+...+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457888999999999999999975 57899999977653 11 23456678999999999 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC-CceEEEeeeeee
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD-TVAHLSDFGISK 892 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~~kl~DFGla~ 892 (1624)
..|+||||+.+|+|.+++.+ ...+.+.++.+++.|++.|++|+|.. +|+||||||+|||+|.+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999988 55788899999999999999999994 59999999999999999 999999999999
Q ss_pred ccCCCCCcccccccccccccCccccCCCC-C-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGI-V-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... ........+||+.|+|||++.... | ..++||||+||+||.|++|+.||++
T Consensus 170 ~~~~-~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 170 ISPG-EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred ccCC-CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 8741 222334468999999999998766 6 4789999999999999999999986
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=340.31 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=203.3
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
.+++|...+.||+|+||.||+|...+ +..||+|.++... ......|.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678888999999999999997542 4579999876432 2334578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEE
Q 047591 1406 KALILQYMPQGSLEKWLYSHN---------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHL 1476 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl 1476 (1624)
.++||||+++|+|.+++...+ ...++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 234677888999999999999996 79999999999999999999999
Q ss_pred eeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcC
Q 047591 1477 GDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESL 1554 (1624)
Q Consensus 1477 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~ 1554 (1624)
+|||+++........ ......++..|+|||+..++.++.++|||||||++|||++ |+.||......+ ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~------ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLK------ 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------
Confidence 999999865432221 1122345778999999988899999999999999999999 777875432111 111
Q ss_pred ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+.+..... .+..++..+.+++.+|++.+|++|||+.|+++.|++....
T Consensus 233 -----~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 233 -----FVMDGGYLD--------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred -----HHHcCCCCC--------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 111111100 0123456788999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=340.26 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=202.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-----------------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-----------------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKI 1396 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-----------------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l 1396 (1624)
.+|...+.||+|+||.||+|+..+ +..||+|.+.... ....+.|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 457778899999999999997642 2458999886543 3456789999999999999999999
Q ss_pred EeeeccCCeeEEEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcE
Q 047591 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHN----------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466 (1624)
Q Consensus 1397 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 1466 (1624)
+++|..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999997643 257899999999999999999996 7999999999999
Q ss_pred EecCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc--CCCCCCCCCccc
Q 047591 1467 LLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT--RRKPTDDMFTGE 1543 (1624)
Q Consensus 1467 Lld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt--g~~P~~~~~~~~ 1543 (1624)
+++.++.+||+|||+++........ ......+++.|||||+...+.++.++|||||||++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9999999999999999866433221 1223456789999999888889999999999999999998 667775432111
Q ss_pred hhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1544 VCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1544 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
. +. ...... ...........+..++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 242 ~-~~-~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 V-IE-NAGHFF------------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H-HH-HHHhcc------------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 10 000000 000000000011234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=341.34 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=204.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc--------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA--------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~--------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~ 1404 (1624)
++|...+.||+|+||.||+|+.. ++..+|+|.++.. .....+.+.+|+++++++ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45777889999999999999753 2346999998743 234456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1405 FKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
..++||||+++|+|.+++.... ..+++.++++++.|++.||+|||+ .+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999997542 247899999999999999999996 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~ 1547 (1624)
+++++||+|||.++......... .....+++.|||||+..+..++.++|||||||++|||++ |+.||......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----- 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----
Confidence 99999999999998654322111 122234578999999988889999999999999999998 88887542110
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+.+.+....... .+..++..+.+++.+||+.+|++||||.||++.|+++...
T Consensus 250 ---------~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ---------ELFKLLKEGHRMD-------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ---------HHHHHHHcCCCCC-------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 0111111111000 0123456788899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=332.08 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=196.1
Q ss_pred eEeecCceEEEEEEEc---CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1342 LLGTGIFSSVYKATFA---DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
.||+|+||+||+|.+. ++..+|+|+++... ....++|.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4899999999999763 46789999886432 334678999999999999999999999885 45668999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc--cc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK--QT 1494 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~--~~ 1494 (1624)
+|.+++...+ .++++.+.+++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997543 57899999999999999999996 789999999999999999999999999998764332211 12
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...+++.|||||......++.++|||||||++|||+| |+.||.+.... ... +.+......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~------------~~i~~~~~~----- 217 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVT------------QMIESGERM----- 217 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH------------HHHHCCCCC-----
Confidence 2334678999999888889999999999999999998 99998753221 111 111111000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
..+..++.++.+++.+||+.+|++||+|++|++.|+..
T Consensus 218 --~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 --ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01123556788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=335.58 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=199.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 45777789999999999999874 67889999987554445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.++++..+ .+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++...... ...
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06646 89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKR 163 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-ccc
Confidence 9999999987543 57889999999999999999996 799999999999999999999999999998764221 122
Q ss_pred cccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1494 TMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
....|++.|+|||.+. ...++.++|||||||++|||++|+.|+......+. ...+....... +..
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~-------~~~---- 231 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQP-------PKL---- 231 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCCC-------CCC----
Confidence 3356889999999863 45578899999999999999999999854321111 00110000000 000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......+..+.+++.+||+.+|++|||++++++.
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0001234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=347.90 Aligned_cols=258 Identities=22% Similarity=0.383 Sum_probs=199.9
Q ss_pred CCCCcCCeEeecCceEEEEEEE------cCCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC-Ce
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF------ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP-GF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~------~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~-~~ 1405 (1624)
++|...+.||+|+||+||+|.+ .+++.||||+++... ....+.+.+|++++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4577788999999999999974 246789999986432 33456788999999999 689999999988654 46
Q ss_pred eEEEEEecCCCCHHHHHHhcC-----------------------------------------------------------
Q 047591 1406 KALILQYMPQGSLEKWLYSHN----------------------------------------------------------- 1426 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 1426 (1624)
.++||||+++|+|.++++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999987431
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-cccccccc
Q 047591 1427 -------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLA 1498 (1624)
Q Consensus 1427 -------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~g 1498 (1624)
..+++.++.+++.||++||+|||+ .+|+||||||+||++++++++||+|||+++....... .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 236788889999999999999996 7999999999999999999999999999986532211 11222345
Q ss_pred ccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHH
Q 047591 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAA 1577 (1624)
Q Consensus 1499 t~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 1577 (1624)
++.|+|||+..+..++.++|||||||++|||++ |..||........ ....+...... ..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------------~~~~~~~~~~~-------~~ 303 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------------FCRRLKEGTRM-------RA 303 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-------------HHHHHhccCCC-------CC
Confidence 678999999888889999999999999999997 8888865322111 01111100000 00
Q ss_pred HHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1578 KKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1578 ~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
+......+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01133467899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=362.45 Aligned_cols=256 Identities=22% Similarity=0.291 Sum_probs=202.4
Q ss_pred HHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC--
Q 047591 1330 LRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG-- 1404 (1624)
Q Consensus 1330 l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~-- 1404 (1624)
.+...++|...+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.++..++|+||++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3344578888999999999999999764 6899999998643 2344567899999999999999999988764322
Q ss_pred ------eeEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1405 ------FKALILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1405 ------~~~lV~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
..++||||+++|+|.++++.. ...+++.....|+.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence 367999999999999999753 3467888899999999999999996 7999999999999999999999
Q ss_pred EeeecceeecCCCC-CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC
Q 047591 1476 LGDFGIAKLLDGVD-SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL 1554 (1624)
Q Consensus 1476 l~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~ 1554 (1624)
|+|||+++.+.... ........||+.|||||++.+..++.++|||||||++|||+||+.||...... .++.
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~--- 255 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMH--- 255 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH---
Confidence 99999998764322 11223457999999999999989999999999999999999999998643211 1110
Q ss_pred ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....... . ..+..++..+.+++.+||+.+|++||++.++++.
T Consensus 256 -----~~~~~~~-~-------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 -----KTLAGRY-D-------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HHhcCCC-C-------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0000000 0 0012345668899999999999999999999764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=344.84 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=192.9
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 47889999986432 23456678899999876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|..++.+.+ .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 99999887653 57888899999999999999996 799999999999999999999999999998643222 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||+||+.||......+ .... +......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~------------i~~~~~~-------- 214 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFES------------ILHDDVL-------- 214 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHH------------HHcCCCC--------
Confidence 569999999999988899999999999999999999999997532111 1111 1100000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERM-------NVKDALAN 1609 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RP-------t~~evl~~ 1609 (1624)
.+..+...+.+++.+|++.+|++|| +++++++.
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0011345677899999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=344.29 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=194.1
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..+++++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 5788999998643 223456788999999998 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 9999988754 357899999999999999999996 799999999999999999999999999987532211 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccc---hhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE---VCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~---~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
..||+.|||||++.+..++.++|||||||++|||+||+.||+.....+ .....+ ..+.+.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~~----- 222 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY--------LFQVILEKQI----- 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH--------HHHHHHcCCC-----
Confidence 579999999999998899999999999999999999999996421111 000011 1111111000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMN------VKDALA 1608 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt------~~evl~ 1608 (1624)
..+..++..+.+++.+|++.+|++||+ ++|+++
T Consensus 223 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 ---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 011223456788999999999999997 567654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=335.93 Aligned_cols=202 Identities=30% Similarity=0.376 Sum_probs=175.7
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|....+||+|+||+||+|+. .+|..+|+|+++... .+..+...+|-.+|...++|+||+|+-.|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 57899999999999999999985 479999999997543 34567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC--
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG-- 896 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~-- 896 (1624)
|||+||||+...|...+ .++++.+..++.+++.|++-||+. ++|||||||+|+|||..|++|++||||+.-+..
T Consensus 220 MEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999997655 788888899999999999999994 599999999999999999999999999864321
Q ss_pred --------------------CCCc-----cc-------------------ccccccccccCccccCCCCCCcchhHHHHH
Q 047591 897 --------------------EDSV-----TQ-------------------TMTLATFGYMAPEYGSEGIVSTCGDVYSFG 932 (1624)
Q Consensus 897 --------------------~~~~-----~~-------------------~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~G 932 (1624)
.+.. .. ...+|||.|||||++.+..|+..+|+||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 00 013799999999999998899999999999
Q ss_pred HHHHHHHcCCCCCCcc
Q 047591 933 ILMIETFTRKMPTDEM 948 (1624)
Q Consensus 933 vil~elltg~~P~~~~ 948 (1624)
||+|||+.|.+||...
T Consensus 376 ~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSE 391 (550)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999998754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=344.24 Aligned_cols=236 Identities=21% Similarity=0.290 Sum_probs=189.6
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.||||++.... ....+.+.+|.++++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 57899999986432 23456778899998876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 99999987653 57888999999999999999996 799999999999999999999999999987643221 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||+||+.||......+ ..... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i------------~~~~~~-------- 214 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAI------------LNDEVV-------- 214 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHH------------hcCCCC--------
Confidence 579999999999988899999999999999999999999996532111 01110 000000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
.+......+.+++.+|++.||++||++
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 001234567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=338.20 Aligned_cols=195 Identities=29% Similarity=0.503 Sum_probs=171.2
Q ss_pred ccCHHHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccC
Q 047591 733 RISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNH 812 (1624)
Q Consensus 733 ~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 812 (1624)
.+.|++|.+ .+-+|.|+-|.||+|+++ ++.||||+++... ..++.-|++++|||||++.|+|...
T Consensus 120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 467777653 468999999999999986 7899999875322 2578889999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
...++|||||+.|-|+..|+... .++....+++.++||.|+.|||.+. |||||||+-||||..+..+||+|||-++
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred ceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 99999999999999999998654 6777788899999999999999854 9999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
..... + .....+||..|||||+++....++|+||||||||||||+||..||.+.
T Consensus 261 e~~~~-S-TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 261 ELSDK-S-TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhhhh-h-hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 87554 2 223357999999999999999999999999999999999999999753
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=333.88 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=189.1
Q ss_pred eEeecCceEEEEEEEcC---CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCC
Q 047591 1342 LLGTGIFSSVYKATFAD---GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~~---~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gs 1417 (1624)
.||+|+||.||+|.+.+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998754 3468999876443 2344678999999999999999999999999999999999999999
Q ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-cc
Q 047591 1418 LEKWLYSHN----YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MK 1492 (1624)
Q Consensus 1418 L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-~~ 1492 (1624)
|.++++... ...++..+.+++.|++.|++|||+ .+|+||||||+||++++++++|++|||+++....... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999997532 346777888999999999999996 7999999999999999999999999999975433221 11
Q ss_pred ccccccccccccccccCCC-------CcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1493 QTMTLATIGYMAPEYGSEG-------IVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~-------~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.....|+..|+|||+.... .++.++|||||||++|||++ |+.||......+.....+..... ...++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~ 233 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----KLPKP 233 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----CCCCC
Confidence 2234578899999987532 35889999999999999996 99998653222111000000000 00000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.+ ...+...+.+++.+|| .+|++|||++||++.|+
T Consensus 234 ~~-----------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RL-----------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cc-----------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 0112345677889999 58999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=329.82 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=197.7
Q ss_pred CeEeecCceEEEEEEEcC----CceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFAD----GTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+++++++.|||||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999997642 26799999864432 35678999999999999999999999876 4467999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc-
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT- 1494 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~- 1494 (1624)
|+|.+++.... .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998654 67899999999999999999996 78999999999999999999999999999876433222111
Q ss_pred -ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1495 -MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1495 -~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
...++..|+|||......++.++|||||||++|||+| |+.||..... .....++....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER----------------- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-----------------
Confidence 1234568999999988899999999999999999998 9999865422 111111111100
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
...+..++..+.+++.+||..+|++||++.|+++.|+++.
T Consensus 217 --~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 --LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0011234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=338.27 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=199.0
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|...++||+|+||+||++... +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 666789999999999999875 68899999886432 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 99999999887543 458999999999999999999996 799999999999999999999999999998764322
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... .... .+...+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~---------~~~~~~~~~~~---- 222 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKRE---------EVERRVKEDQE---- 222 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHH---------HHHHHhhhccc----
Confidence 122346899999999998888999999999999999999999999753211 0000 01111110000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
..+...+..+.+++.+||+.||++|| +++++++.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 ----EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00122345678899999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=340.58 Aligned_cols=261 Identities=22% Similarity=0.382 Sum_probs=200.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-----------------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-----------------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKI 1396 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-----------------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l 1396 (1624)
++|...+.||+|+||+||++.+. ++..||+|++... .....++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45777889999999999998643 2346899998644 33445789999999999999999999
Q ss_pred EeeeccCCeeEEEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcE
Q 047591 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHN----------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNV 1466 (1624)
Q Consensus 1397 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 1466 (1624)
++++...+..++||||+++|+|.+++.... ..+++.+..+++.|++.|++|||+ .+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999997532 246788899999999999999996 7899999999999
Q ss_pred EecCCCcEEEeeecceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc--CCCCCCCCCccc
Q 047591 1467 LLDDDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT--RRKPTDDMFTGE 1543 (1624)
Q Consensus 1467 Lld~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt--g~~P~~~~~~~~ 1543 (1624)
++++++.+||+|||+++.+....... .....+++.|+|||+...+.++.++|||||||++|||+| |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998654322111 122345678999998888889999999999999999998 667775432111
Q ss_pred hhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1544 VCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1544 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
. ... ............. ...+..++..+.+++.+||+.+|++||+|.|+++.|++
T Consensus 242 ~-~~~---------~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V-IEN---------TGEFFRDQGRQVY----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-HHH---------HHHHHhhcccccc----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 000 0000000000000 00112355678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=350.49 Aligned_cols=268 Identities=22% Similarity=0.264 Sum_probs=199.3
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC-----eeE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG-----FKA 1407 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~-----~~~ 1407 (1624)
+|+..+.||+|+||+||+|+.. +++.||||++... .....+++.+|+++++.++||||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4777899999999999999864 6899999988542 2334578899999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 5888887654 457899999999999999999996 7999999999999999999999999999987654
Q ss_pred CCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh---hhcCChhH-----
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV---EESLPDAV----- 1558 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~---~~~~~~~~----- 1558 (1624)
..........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.... .....+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhH
Confidence 33333344568999999998766 457999999999999999999999997532211 111110 00000000
Q ss_pred --HHHHhhhccCCch-HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1559 --TDVIDANLLSGEE-EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1559 --~~~~d~~l~~~~~-~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+......... .............+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0001000000000 00000011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=332.13 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=205.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.++|...+.||+|+||+||+|...++..+|||.+.... ...+++.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 45677889999999999999998888889999986433 33467999999999999999999999999888999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++++|.+++.+.. ..++++++..++.|++.|++|||+ .+|+||||||+||++++++.+|++|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999998643 568999999999999999999996 789999999999999999999999999998765322212
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....++..|+|||...+..++.++|||||||++|||+| |+.||....... .+.. +.......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~-------------~~~~~~~~-- 224 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQ-------------VERGYRMP-- 224 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH-------------HHcCCCCC--
Confidence 222335678999999988889999999999999999999 999986432111 1111 10000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
.+..++..+.+++.+|+..+|++||+++|+.+.|+.
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 -----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=351.78 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=201.5
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeecc
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~ 1402 (1624)
..++....++|...+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4556667789999999999999999999876 57889999986422 2344668899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1403 PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
.+..++||||+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999998754 36777888899999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccccccCCC----CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEG----IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~ 1558 (1624)
+.+............||+.|||||++... .++.++|||||||++|||++|+.||...... .....+....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~----- 263 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHK----- 263 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC-----
Confidence 87754333333456799999999987543 3789999999999999999999999643211 1111111000
Q ss_pred HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 047591 1559 TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEE--RMNVKDALAN 1609 (1624)
Q Consensus 1559 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPt~~evl~~ 1609 (1624)
.... .......+..+.+++.+|+...+.+ ||++.|+++.
T Consensus 264 ------~~~~------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 ------NSLT------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ------Cccc------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0000 0011123456778888999744433 7789888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=341.56 Aligned_cols=240 Identities=25% Similarity=0.305 Sum_probs=190.4
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHh-cCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRR-IRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~-l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||+||+|+.. +++.||||+++... +...+.+..|..+++. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999876 47889999986542 2334567778888876 4999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++.+. ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 9999999764 357889999999999999999996 799999999999999999999999999987542211 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||+||+.||...... .+... +...-..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~------------i~~~~~~------- 214 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQS------------IRMDNPC------- 214 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHH------------HHhCCCC-------
Confidence 57999999999998889999999999999999999999998653211 11110 1000000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVK-DAL 1607 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~-evl 1607 (1624)
.+..+...+.+++.+|++.+|++||++. ++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0012334577899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=329.46 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=203.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45667789999999999999874 78899999875544 56789999999999999999999999998999999999999
Q ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+++|.+++.... ..+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||.++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999997654 368999999999999999999996 799999999999999999999999999998763221
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....++..|+|||+...+.++.++|||||||++|||++ |+.||...... .+.. .+.......
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~------------~~~~~~~~~--- 219 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP------------HVEKGYRME--- 219 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH------------HHhcCCCCC---
Confidence 12345678999999988889999999999999999997 99998643111 1111 111000000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.+..++..+.+++.+|++.+|++|||+.|++++|+.+
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 ----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0123456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=331.16 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=201.4
Q ss_pred CCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+|...+.||+|+||.||+|.+.+++.+|+|.+.... .....|.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 455668899999999999998778899999876332 2345789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++......++++.+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 99999998766668899999999999999999996 789999999999999999999999999998664322222223
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
..++.+|+|||+..++.++.++|||||||++|||++ |+.||......+ ... .+.......
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~------------~~~~~~~~~----- 221 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE------------TINAGFRLY----- 221 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH------------HHhCCCCCC-----
Confidence 345678999999988889999999999999999998 899986432111 000 000000000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.+...+..+.+++.+||+.+|++|||++|+++.|+
T Consensus 222 --~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 222 --KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 00112456889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=355.56 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=205.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCC-ceEEEEEeccchhhHHHHHHHHHHHHHhcC-CCceeEEEee-ecc------CCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADG-TNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSS-CSN------PGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~-~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~-~~~------~~~ 1405 (1624)
......++|.+|||+.||.|+...+ ..+|+|++-..++.+.+...+|+++|+.+. |||||.+++. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455678999999999999988765 999999987778888999999999999997 9999999993 221 135
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1406 KALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
.+|.||||++|+|-+++..+ ...++..++++|+.|+++|+++||. +.++|||||||-+||||+.++..||||||-|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 78999999999999999854 2348999999999999999999996 688999999999999999999999999998863
Q ss_pred cCC-CCCccc-------ccccccccccccccc---CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc
Q 047591 1485 LDG-VDSMKQ-------TMTLATIGYMAPEYG---SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1485 ~~~-~~~~~~-------~~~~gt~~y~APE~~---~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
.-. .+.... ....-|+-|+|||++ .+..+++|+||||+||+||-|+..+.||++.-.-.+.-..+ .
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y---~ 272 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY---S 272 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc---c
Confidence 321 111111 113468999999964 56789999999999999999999999997631111110110 1
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+|+ .......+..|+..|++++|++||++-||+..+.++..+
T Consensus 273 ~P~---------------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 273 FPP---------------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred CCC---------------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 111 123466788999999999999999999999999888654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=329.95 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=201.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-----hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-----DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-----~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
++|...+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999864 58899999875332 1234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++++|.+++...+ .+++..+.+++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999987653 47788889999999999999996 79999999999999999999999999999876432
Q ss_pred CCccc--cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DSMKQ--TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~~~~--~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
..... ....|+..|+|||+..+..++.++|||||||++|||++|+.||.+...... ... ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~------------~~~~~~ 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFK------------IATQPT 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHH------------HhccCC
Confidence 22111 234688899999999888899999999999999999999999865321111 000 000000
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. ..+..+...+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NP-------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CC-------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 0012234567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=344.34 Aligned_cols=201 Identities=24% Similarity=0.346 Sum_probs=174.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36777889999999999999875 58899999986422 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999998766678888999999999999999996 8999999999999999999999999999987654333
Q ss_pred ccccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1491 MKQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
.......||+.|||||++. ...++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 2333456999999999875 24678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=335.93 Aligned_cols=240 Identities=22% Similarity=0.348 Sum_probs=190.0
Q ss_pred CeEeecCceEEEEEEEcC--------CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1341 NLLGTGIFSSVYKATFAD--------GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~--------~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.||+|+||+||+|.... ...+|+|.+........+.|.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997642 234888887655555567899999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc--------EEEeeecceee
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV--------AHLGDFGIAKL 1484 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--------~kl~DFGla~~ 1484 (1624)
+++|+|.++++..+..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. +|++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999998776678999999999999999999996 89999999999999987765 69999998865
Q ss_pred cCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCC-CCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRR-KPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~-~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
... .....+++.|||||++.+ ..++.++|||||||++|||++|. .|+...... .... ..
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~------------~~ 218 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQ------------FY 218 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHH------------HH
Confidence 432 123468889999998876 45799999999999999999995 444322110 0000 00
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
..... .+.....++.+++.+||+.+|++|||++|+++.|+
T Consensus 219 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDRHQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hcccc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00012245788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=338.25 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=198.4
Q ss_pred CcCCeEeecCceEEEEEEEcC------CceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1338 SESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1338 ~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
...+.||+|+||+||+|++.+ +..||+|+++.... ...+.|.+|+.++++++||||+++++++.+.+..++++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 334679999999999998632 46799999874432 33467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1411 QYMPQGSLEKWLYSH---------------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
||+++++|.+++... ...+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+|
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceE
Confidence 999999999998632 2347888899999999999999996 7999999999999999999999
Q ss_pred EeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhc
Q 047591 1476 LGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
|+|||+++........ ......+++.|||||+...+.++.++|||||||++|||+| |..||.+.... ....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~----- 237 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIE----- 237 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-----
Confidence 9999998866432221 1123346789999999988889999999999999999998 77787543211 0111
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
.+.+..... .+..++..+.+++.+||+.+|++||+++|+++.|+.
T Consensus 238 ------~i~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ------MIRNRQVLP--------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------HHHcCCcCC--------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111000 012356678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=333.99 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=193.2
Q ss_pred EeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
||+|+||+||+++.. +|+.+|+|.+.... ....+.+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 58999999886422 12334567799999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccc
Q 047591 1419 EKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL 1497 (1624)
Q Consensus 1419 ~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 1497 (1624)
.++++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 99886543 458899999999999999999996 899999999999999999999999999998764322 223346
Q ss_pred cccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHH
Q 047591 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAA 1577 (1624)
Q Consensus 1498 gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 1577 (1624)
||+.|+|||+..+..++.++|||||||++|||++|+.||...... ........ ..+...... .
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~--------~~~~~~~~~--------~ 218 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKR--------RTLEDEVKF--------E 218 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHH--------Hhhcccccc--------c
Confidence 899999999998888999999999999999999999998642111 00000000 001000000 0
Q ss_pred HHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1578 KKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1578 ~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
....+.++.+++.+|++.+|++||+++|+++..
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 012345678999999999999999997776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=343.36 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=191.5
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHH---HhcCCCceeEEEeeeccCCeeEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVM---RRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l---~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 345678999999999999875 58899999986432 22345666776655 567899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|..++++ ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999988864 358999999999999999999996 799999999999999999999999999987543222
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ... .+......
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~------------~i~~~~~~-- 219 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFD------------SIVNDEVR-- 219 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHH------------HHHhCCCC--
Confidence 12234579999999999988899999999999999999999999986432111 000 11110000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
.+..++..+.+++.+|++.+|++||+ +.++++
T Consensus 220 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 -------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01123456788999999999999995 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=329.52 Aligned_cols=252 Identities=26% Similarity=0.442 Sum_probs=203.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||.||+|.+.++..+|+|.+... ....+.|.+|++++++++|+||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 467778899999999999999877888999987643 2345688999999999999999999999877 77899999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+|+|.+++.+. +...++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 99999999764 4567899999999999999999996 7899999999999999999999999999987643332223
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....++..|+|||+...+.++.++|||||||++||++| |+.||...... ....+...... ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-----------~~---- 223 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR-----------MP---- 223 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCC-----------CC----
Confidence 33456778999999988889999999999999999999 89898653211 11111111100 00
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
.....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001234568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=340.62 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=206.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe-eEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF-KALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~-~~lV~ 1410 (1624)
++|...+++|+|+||.++.++.+ +++.+|+|.+.... +...+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 45667789999999999988764 57789999886543 3444578899999999999999999999998888 99999
Q ss_pred EecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1411 QYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
+||+||++.+.+.+.+ ..++.++..++..|++.|+.|||+ ..|+|||||+.||++..+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998654 778999999999999999999995 799999999999999999999999999999987654
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
. ...+.+||+.||.||.+.+..|+.|+||||+||++|||++-+++|........ +..+.. ....
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------------i~ki~~-~~~~- 224 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------------ILKINR-GLYS- 224 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-------------HHHHhh-ccCC-
Confidence 2 34457899999999999999999999999999999999999999875321111 111111 1111
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.+.....++..++..|++.+|+.||++.+++.+
T Consensus 225 ------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 ------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 0112335567889999999999999999999987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.49 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=199.2
Q ss_pred CCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.|...+.||+|.||.|-+|+- ..|+.||||.++.. ++.+.-.+++||+||+.++||||++++.+|+..+...+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 344456799999999999964 67999999988643 45667788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|..+|.|++|+.+++. ++..+..++..||.+|+.|+|. .+++|||||-+|||+|+++.+||+|||++-.+... .
T Consensus 134 YaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 134 YASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred ecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 9999999999987664 5666666899999999999996 79999999999999999999999999999877533 2
Q ss_pred cccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
-.++++|++-|.+||.+.+..| ++.+|-||+||+||-|+.|..|||+... +..+++ +... ..
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQ---------Is~G---aY 270 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQ---------ISRG---AY 270 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHH---------hhcc---cc
Confidence 3456789999999999988877 6889999999999999999999986321 111111 0000 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+ +..+....-|+..++..+|++|-|+.||...
T Consensus 271 rE------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 271 RE------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cC------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 00 1123445678889999999999999998764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=325.30 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=187.5
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC-----eeEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG-----FKALIL 1410 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~-----~~~lV~ 1410 (1624)
|...+++|.|+||.||+|... ++..||||+.-.+.. --.+|+++|++++|||||+++-+|.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 445689999999999999875 468899997642221 1246899999999999999998875422 235899
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC-CcEEEeeecceeecC
Q 047591 1411 QYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~kl~DFGla~~~~ 1486 (1624)
||||. +|.++++. .+..++.-...-++.|+.+||+|||+ .+|+||||||.|+|+|.+ |.+||||||-|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99997 89998874 23444544555599999999999996 899999999999999976 999999999999986
Q ss_pred CCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc-CC--hhHHHHH
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES-LP--DAVTDVI 1562 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~-~~--~~~~~~~ 1562 (1624)
..+. ...+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.... ..++..++-- .| +.+. .+
T Consensus 178 ~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~-~m 253 (364)
T KOG0658|consen 178 KGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIK-SM 253 (364)
T ss_pred cCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHh-hc
Confidence 5443 345678999999997654 67999999999999999999999877542211 1111111100 00 0111 00
Q ss_pred hhh--------ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DAN--------LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~--------l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+. +.... ..+ ......+.+..+++.+++..+|.+|.+..|++..
T Consensus 254 n~~y~~~~~p~ik~~~-~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHP-WHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCccccccc-cee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 011 00000 000 0113456788999999999999999999998864
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=329.39 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=198.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeec-cCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS-NPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~-~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||.||+|... |..||+|..+.. ...+.|.+|+.++++++|+|++++++++. +.+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35667789999999999999764 788999988533 23467999999999999999999999764 556789999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.+++++.. ..++++.+++++.|++.||+|||+ .+|+||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998654 358899999999999999999996 799999999999999999999999999998654321
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
....++..|||||+..+..++.++|||||||++|||++ |+.||..... .....++.... ..
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~------------~~--- 218 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY------------KM--- 218 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC------------CC---
Confidence 22345678999999988889999999999999999998 8888754211 11111111100 00
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.....++..+.+++.+||+.+|++|||++++++.|+++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00123456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=339.61 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=202.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCc----eEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGT----NAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~----~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
++|...+.||+|+||.||+|++. ++. .||+|.+.... ......|.+|+.++++++||||++++|+|..+ ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45666789999999999999874 343 46888876432 23345789999999999999999999998754 4679
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|+||+++|+|.+++......++++.+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCc
Confidence 999999999999998776678999999999999999999996 79999999999999999999999999999876532
Q ss_pred CCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
... ......++..|||||+..+..++.++|||||||++|||+| |+.||.+.... ....++ ....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~------------~~~~ 228 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLL------------EKGE 228 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH------------HCCC
Confidence 221 1222346778999999988889999999999999999998 88998653211 111111 1100
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.. ..+..++..+.+++.+||..+|++||+++|+++.|+++...
T Consensus 229 ~~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 RL-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 00112445678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=334.72 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=202.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
.++|...+.||+|+||+||+|...+ +..||+|...... ......|.+|+++++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3467777899999999999998743 3679999986432 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEe
Q 047591 1407 ALILQYMPQGSLEKWLYSHN---------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~ 1477 (1624)
++||||+++|+|.+++.... ..++|..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 99999999999999997532 246889999999999999999996 799999999999999999999999
Q ss_pred eecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCC
Q 047591 1478 DFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLP 1555 (1624)
Q Consensus 1478 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~ 1555 (1624)
|||+++.+..... .......+|..|+|||....+.++.++|||||||++|||+| |+.||.+....+ ...+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~---- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVI---- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHh----
Confidence 9999986643322 12233457889999999888889999999999999999999 888886432111 111111
Q ss_pred hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1556 DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1556 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
+..... .+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 236 -------~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -------DGGHLD--------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------cCCCCC--------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000000 01123567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=342.28 Aligned_cols=241 Identities=22% Similarity=0.263 Sum_probs=192.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
+|...+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4667789999999999999876 46789999986432 23345677888888877 5899999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999999999987653 47889999999999999999996 799999999999999999999999999998643221
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.......||+.|||||++.+..++.++|||||||++|||+||+.||....... ..... ......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i------------~~~~~~--- 219 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSI------------MEHNVA--- 219 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-HHHHH------------HhCCCC---
Confidence 22234579999999999999999999999999999999999999997532111 11111 110000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
.+...+.++.+++.+|++.+|++|++.
T Consensus 220 ------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 001234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=339.75 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=204.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc--------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA--------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~--------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~ 1404 (1624)
++|...+.||+|+||.||+|+.. ....+|+|+++.. .......+.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45666789999999999999752 2456899988643 234456789999999999 6999999999999989
Q ss_pred eeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1405 FKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
..++||||+++|+|.+++.... ..+++.++++++.|++.||+|||+ .+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 9999999999999999997532 347899999999999999999996 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~ 1547 (1624)
+++.+||+|||+++......... .....++..|||||+...+.++.++|||||||++|||++ |+.||......+ .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~- 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--L- 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--H-
Confidence 99999999999998764322211 122234568999999888889999999999999999999 888886432111 0
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.+.+...... ..+..++.++.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 246 -----------~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 -----------FKLLREGHRM-------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -----------HHHHHcCCCC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 0111100000 001234557889999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=342.15 Aligned_cols=241 Identities=24% Similarity=0.277 Sum_probs=191.8
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCC-ceeEEEeeeccCCeeEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHR-NLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~Hp-NIv~l~g~~~~~~~~~lV~ 1410 (1624)
+|...+.||+|+||+||+|+.. +++.||||++... .....+.+..|+++++.++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3667789999999999999876 4678999998643 234456788999999999765 5888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999987643 47889999999999999999996 799999999999999999999999999987532211
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ... +..... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~------------i~~~~~-~-- 219 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQS------------IMEHNV-S-- 219 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHH------------HHcCCC-C--
Confidence 122345699999999999988999999999999999999999999975321110 100 100000 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
.+......+.+++.+|++.+|++|++.
T Consensus 220 ------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 ------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 001234567789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=343.90 Aligned_cols=255 Identities=19% Similarity=0.230 Sum_probs=196.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+++.. +++.+|+|++.... ....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36777899999999999999886 46789999985322 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++++.+..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999998766678899999999999999999996 8999999999999999999999999999986543333
Q ss_pred ccccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1491 MKQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
.......||+.|||||++. ...++.++|||||||++|||++|+.||......+. ... +....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-~~~------------i~~~~ 224 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGK------------IMNHK 224 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-HHH------------HhCCC
Confidence 2333457999999999875 35689999999999999999999999964321111 110 00000
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIP--EERMNVKDALAN 1609 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P--~~RPt~~evl~~ 1609 (1624)
..... ......++..+.+++.+|+..++ ..|++++|+++.
T Consensus 225 ~~~~~----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERFQF----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccccC----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000 00011234556777777765444 447899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=331.20 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=199.2
Q ss_pred CeEeecCceEEEEEEEcC--C--ceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFAD--G--TNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~--~--~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||+||+|.+.+ + ..||||.+..... ...+.|.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998753 3 3589999876544 567889999999999999999999999988 889999999999
Q ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc--c
Q 047591 1416 GSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM--K 1492 (1624)
Q Consensus 1416 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~--~ 1492 (1624)
|+|.+++.+.. ..++|.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998754 568999999999999999999996 79999999999999999999999999999876542211 1
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....++..|+|||+..+..++.++|||||||++|||+| |+.||......+ ....+.. ......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~-----------~~~~~~--- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDK-----------EGERLE--- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh-----------cCCcCC---
Confidence 123457889999999988899999999999999999999 999986432211 1111100 000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
....++..+.+++.+|++.+|++||+++|+++.|.
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01124567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=339.03 Aligned_cols=268 Identities=17% Similarity=0.280 Sum_probs=201.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45777889999999999999875 57889999886443 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++ +|.+++...+..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 985 8999888776678899999999999999999996 7999999999999999999999999999986543221 2
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHHH------
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDVI------ 1562 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~~------ 1562 (1624)
.....+|+.|+|||+..+ ..++.++|||||||++|||+||+.||......+. +..... ...++.+....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 223468999999998754 5689999999999999999999999965422111 111000 00001111100
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+.................+..++.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000001111234567789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=340.93 Aligned_cols=240 Identities=23% Similarity=0.279 Sum_probs=190.1
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||.||+|+.. +|+.||+|+++... +...+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999876 57889999986432 23445677788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++... ..+++.+...++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 9999998764 357888899999999999999996 799999999999999999999999999987532211 22334
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. +.+......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~------------~~~~~~~~~------- 214 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELF------------ESIRVDTPH------- 214 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH------------HHHHhCCCC-------
Confidence 57999999999999889999999999999999999999999643211 000 001000000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVK-DAL 1607 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~-evl 1607 (1624)
.+..+..++.+++.+|++.||++||++. ++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 -YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0012345677899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=330.28 Aligned_cols=238 Identities=21% Similarity=0.387 Sum_probs=189.9
Q ss_pred CeEeecCceEEEEEEEcCCc-----------eEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1341 NLLGTGIFSSVYKATFADGT-----------NAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~~~-----------~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+.||+|+||.||+|++.+.. .||+|++...... .+.|.+|++++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999886432 4777876544333 6889999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-------cEEEeeecce
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-------VAHLGDFGIA 1482 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-------~~kl~DFGla 1482 (1624)
|||+++|+|.+++......+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998766578999999999999999999995 7999999999999999888 7999999999
Q ss_pred eecCCCCCccccccccccccccccccCCC--CcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEG--IVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~ 1559 (1624)
+.... .....++..|+|||++... .++.++|||||||++|||++ |..|+...... .. ..+..
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~-~~~~~-------- 220 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EK-ERFYQ-------- 220 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hH-HHHHh--------
Confidence 86543 2234577889999998766 78999999999999999999 46676543211 11 11110
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
+....... ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 221 ---~~~~~~~~----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ---DQHRLPMP----------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---cCCCCCCC----------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 0145788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=338.45 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=203.5
Q ss_pred CeEeecCceEEEEEEEcC-CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1341 NLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
-.||.|+||.||||..++ +-..|.|++..++....+.|+-||+||...+||+||+|++.|+.++..++..|||+||-++
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 358999999999998764 4457889998888888999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccccc
Q 047591 1420 KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499 (1624)
Q Consensus 1420 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 1499 (1624)
..+-+-+..+..++..-+++|++.||.|||. ..|||||||+.|||++-+|.++++|||.+.... ........++||
T Consensus 118 aimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRDsFIGT 193 (1187)
T KOG0579|consen 118 AIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRDSFIGT 193 (1187)
T ss_pred HHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch-hHHhhhccccCC
Confidence 9988888889999999999999999999995 899999999999999999999999999975432 122344567899
Q ss_pred ccccccccc-----CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1500 IGYMAPEYG-----SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1500 ~~y~APE~~-----~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
|+|||||+. ....|+.++|||||||+|.||..+.+|..+.....+.++- . .+-|. .++
T Consensus 194 PYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-a-KSePP--------TLl------- 256 (1187)
T KOG0579|consen 194 PYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-A-KSEPP--------TLL------- 256 (1187)
T ss_pred cccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-h-hcCCC--------ccc-------
Confidence 999999975 3568999999999999999999999998765443332221 1 11111 111
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+..-...+.++..+|+..+|+.||+..++++.
T Consensus 257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 112234567889999999999999999998863
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=340.84 Aligned_cols=241 Identities=22% Similarity=0.285 Sum_probs=193.5
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.||||+++... ....+.+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 47889999986432 23456778899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++.+.+ .+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 99999887653 57899999999999999999996 799999999999999999999999999987532221 12233
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||+||+.||....... ... .+......
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~-----------~i~~~~~~-------- 214 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQ-----------SILEDEVR-------- 214 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHH-----------HHHcCCCC--------
Confidence 569999999999999999999999999999999999999996432110 000 00000000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNV-----KDALA 1608 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~-----~evl~ 1608 (1624)
.+..++..+.+++.+||+.||++||++ .++++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 011234567889999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=328.03 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=204.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||.||+|++.+ +..+|+|.+..... .++|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 567778899999999999999875 78899999865433 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|.+++...+..+++..+..++.|++.|++|||+ .+|+||||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 9999999998777788999999999999999999996 7899999999999999999999999999987653321 22
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|+..|+|||+..+..++.++|||||||++|||+||+.|+.......... .. .. .....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~-~~------------~~~~~---- 218 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MI-PN------------KPPPT---- 218 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hh-cc------------CCCCC----
Confidence 33458899999999988899999999999999999999999986532211100 00 00 00000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..........+.+++.+||+.+|++|||+.|+++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0011223456788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=369.13 Aligned_cols=467 Identities=29% Similarity=0.353 Sum_probs=305.8
Q ss_pred ccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcc
Q 047591 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKL 188 (1624)
Q Consensus 109 i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 188 (1624)
+...-+|+.||+|+|+++ ..|..+..+.+|+.|.++.|.|.. +| ..+.++.+|++|.|.+|++. .+|.++..+.+|
T Consensus 41 ~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~-vp-~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl 116 (1081)
T KOG0618|consen 41 VEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRS-VP-SSCSNMRNLQYLNLKNNRLQ-SLPASISELKNL 116 (1081)
T ss_pred hhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhh-Cc-hhhhhhhcchhheeccchhh-cCchhHHhhhcc
Confidence 333444666666666664 566666666666666666666652 33 33345666666666666665 466666666666
Q ss_pred cccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCc-Eeecc
Q 047591 189 KRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQ-ELNLR 267 (1624)
Q Consensus 189 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~-~L~Ls 267 (1624)
++||+|+|++. .+|..+..++.+..+..++|...-.+ +..+ .+.++|..|.+.+.++.++. .|+ .|+|+
T Consensus 117 ~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l----g~~~-ik~~~l~~n~l~~~~~~~i~----~l~~~ldLr 186 (1081)
T KOG0618|consen 117 QYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL----GQTS-IKKLDLRLNVLGGSFLIDIY----NLTHQLDLR 186 (1081)
T ss_pred cccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh----cccc-chhhhhhhhhcccchhcchh----hhheeeecc
Confidence 66666666665 66666666666666666666221112 2221 55666666666665554442 233 36666
Q ss_pred cccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEe
Q 047591 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL 347 (1624)
Q Consensus 268 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 347 (1624)
+|.+. --.+.++.+|+.|....|++..+. ....+|+.|+.++|.++...+... -.+|+++++
T Consensus 187 ~N~~~---~~dls~~~~l~~l~c~rn~ls~l~------------~~g~~l~~L~a~~n~l~~~~~~p~---p~nl~~~di 248 (1081)
T KOG0618|consen 187 YNEME---VLDLSNLANLEVLHCERNQLSELE------------ISGPSLTALYADHNPLTTLDVHPV---PLNLQYLDI 248 (1081)
T ss_pred cchhh---hhhhhhccchhhhhhhhcccceEE------------ecCcchheeeeccCcceeeccccc---cccceeeec
Confidence 66654 224455666666666666654432 123567788888888874333322 347888999
Q ss_pred cCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeec
Q 047591 348 WGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQ 427 (1624)
Q Consensus 348 s~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~ 427 (1624)
+.|++++ +|++++.+.+|+.|+..+|+|+ .+|..+..+++|+.|...+|.++..+ ..+..++.|+.|+|+
T Consensus 249 s~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip--------~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 249 SHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIP--------PFLEGLKSLRTLDLQ 318 (1081)
T ss_pred chhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCC--------Ccccccceeeeeeeh
Confidence 9999985 5788999999999999999995 45666777888999999999887532 334557888999999
Q ss_pred cCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccC
Q 047591 428 TNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGS 507 (1624)
Q Consensus 428 ~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~ 507 (1624)
.|++....+..+.-+..+++.|..+.|.+.-..--.=..+..|+.|+|.+|+|+...=+.+....+|++|+|++|+|. .
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~ 397 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-S 397 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-c
Confidence 999865444333333334777888888776433222234667888889999888777667778888899999999888 5
Q ss_pred CCc-cccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCC-CCcccc
Q 047591 508 IPS-ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC-LPQDIG 585 (1624)
Q Consensus 508 iP~-~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~-iP~~l~ 585 (1624)
+|+ .+.++..|+.|+||+|+|+ .+|+++.++..|++|...+|++. ..| ++..+..|+.+|+|.|+|+-. +|...-
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 554 5678888888899999988 68888888888888888888886 456 777888888888888887643 333332
Q ss_pred cccccceeeccCCcCCCCccccccCCccccccccccC
Q 047591 586 NLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622 (1624)
Q Consensus 586 ~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 622 (1624)
.++|++|||++|...-.--..|-.++.+..+++.-|
T Consensus 475 -~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 475 -SPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred -CcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 267777777777743222333444444444444433
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=335.11 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=202.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
.++|...+.||+|+||.||+|... ++..||+|++.... ....+.|.+|++++++++||||++++++|...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456788889999999999999863 46789999886443 34457799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCc
Q 047591 1407 ALILQYMPQGSLEKWLYSHN---------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSN 1465 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~N 1465 (1624)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999997431 236788899999999999999996 799999999999
Q ss_pred EEecCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccc
Q 047591 1466 VLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGE 1543 (1624)
Q Consensus 1466 ILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~ 1543 (1624)
|++++++.+||+|||+++.+...... ......+++.|+|||+.....++.++|||||||++|||++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998865432211 1122345678999999888889999999999999999998 888875432111
Q ss_pred hhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1544 VCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1544 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
+ ...+.+..... .+..++..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 241 -----~--------~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -----V--------IYYVRDGNVLS--------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----H--------HHHHhcCCCCC--------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 01111111110 012345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=350.73 Aligned_cols=368 Identities=28% Similarity=0.410 Sum_probs=273.4
Q ss_pred cCCCcccEEEecCCCcc-ccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcc
Q 047591 110 ANLSFLVSLNISGNRFH-GTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKL 188 (1624)
Q Consensus 110 ~~L~~L~~L~Ls~N~l~-g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 188 (1624)
+-|+..+-.|+++|.|+ +.+|..+.+|+++++|.|...++. .+|+++ +.|.+|++|.+++|++. .+-.++..|+.|
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL-~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L 80 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEEL-SRLQKLEHLSMAHNQLI-SVHGELSDLPRL 80 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHH-HHHhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence 44677788899999998 568999999999999999999886 577665 67999999999999998 677889999999
Q ss_pred ccccccccccc-ccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecc
Q 047591 189 KRLSVSFNELT-GRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267 (1624)
Q Consensus 189 ~~L~Ls~N~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls 267 (1624)
+.+++.+|+|. .-||+.|..|..|+.||||+|++. +.|..+.+-.++-.|+||+|++. +||..+|-+|+.|-+||||
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccc
Confidence 99999999995 358889999999999999999998 89999999999999999999997 8999999999999999999
Q ss_pred cccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEe
Q 047591 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL 347 (1624)
Q Consensus 268 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 347 (1624)
+|++. .+|+.+..|..|+.|+|++|.+..+. +. .+| .+++|+.|.+
T Consensus 159 ~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ---Lr-------------------------QLP-----smtsL~vLhm 204 (1255)
T KOG0444|consen 159 NNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ---LR-------------------------QLP-----SMTSLSVLHM 204 (1255)
T ss_pred cchhh-hcCHHHHHHhhhhhhhcCCChhhHHH---Hh-------------------------cCc-----cchhhhhhhc
Confidence 99998 68888999999999999999865321 11 122 2455566666
Q ss_pred cCCccC-CcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeee
Q 047591 348 WGNNLS-GVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAI 426 (1624)
Q Consensus 348 s~N~l~-g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l 426 (1624)
++.+=+ ..+|.++..+.+|..+|||.|++. .+|+++-++.+|+.|+||.|+|+...
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~---------------------- 261 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELN---------------------- 261 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeee----------------------
Confidence 555322 247888888888888888888887 45667777777777777777765310
Q ss_pred ccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccc-
Q 047591 427 QTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQ- 505 (1624)
Q Consensus 427 ~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~- 505 (1624)
...+...+|+.|+||+|+++ .+|..+.+|++|+.|.+.+|+++
T Consensus 262 -----------------------------------~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 262 -----------------------------------MTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred -----------------------------------ccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence 01223445666666666665 46666666666666666666654
Q ss_pred cCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccc
Q 047591 506 GSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIG 585 (1624)
Q Consensus 506 g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~ 585 (1624)
.-||+.++.|.+|+.+..++|++. .+|+.++.|..|+.|.|++|+|- ++|+.|.
T Consensus 306 eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-------------------------TLPeaIH 359 (1255)
T KOG0444|consen 306 EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-------------------------TLPEAIH 359 (1255)
T ss_pred cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-------------------------echhhhh
Confidence 125666666666666666666665 45666666666666666666653 3566666
Q ss_pred cccccceeeccCCcCC
Q 047591 586 NLKVLTGLYLSGNQLS 601 (1624)
Q Consensus 586 ~l~~L~~L~Ls~N~l~ 601 (1624)
-|+.|..|||..|.=-
T Consensus 360 lL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 360 LLPDLKVLDLRENPNL 375 (1255)
T ss_pred hcCCcceeeccCCcCc
Confidence 6666666666666543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=343.07 Aligned_cols=201 Identities=23% Similarity=0.330 Sum_probs=174.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46777889999999999999875 57889999986422 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999998755678888899999999999999996 8999999999999999999999999999987654333
Q ss_pred ccccccccccccccccccCC-----CCcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSE-----GIVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~-----~~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
.......||+.|||||++.+ +.++.++|||||||++|||+||+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 33334579999999998765 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=352.44 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=194.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36777899999999999999775 68899999885432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999999764 356788888899999999999996 7999999999999999999999999999964321000
Q ss_pred ------------c----------------------------------cccccccccccccccccCCCCcCcccchHHHHH
Q 047591 1491 ------------M----------------------------------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGI 1524 (1624)
Q Consensus 1491 ------------~----------------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGv 1524 (1624)
. .....+||+.|||||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999998889999999999999
Q ss_pred HHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCC---C
Q 047591 1525 LMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER---M 1601 (1624)
Q Consensus 1525 il~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R---P 1601 (1624)
++|||+||+.||......+. ....... . ..+.- . ........+.+++.+|+. +|.+| +
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~~--~--------~~~~~-p------~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-YRKIINW--R--------ETLYF-P------DDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-HHHHHcc--C--------CccCC-C------CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999965322111 1110000 0 00000 0 001123456788888987 66665 5
Q ss_pred CHHHHHHH
Q 047591 1602 NVKDALAN 1609 (1624)
Q Consensus 1602 t~~evl~~ 1609 (1624)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=334.23 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=197.4
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC------C
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP------G 1404 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~------~ 1404 (1624)
++..|...+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++++ +||||+++++++... +
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566777889999999999999875 57889999986433 3345788999999998 799999999998642 4
Q ss_pred eeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1405 FKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
..++||||+++|+|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 678999999999999999864 3568899999999999999999996 799999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhH
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~ 1558 (1624)
...... .......|++.|+|||++. ...++.++|||||||++|||++|+.|+++..........+ ..
T Consensus 160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~---~~---- 231 (272)
T cd06637 160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RN---- 231 (272)
T ss_pred eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---cC----
Confidence 764322 1233457899999999875 3468889999999999999999999986532111100000 00
Q ss_pred HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1559 TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1559 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..... ....++..+.+++.+||..+|++|||++|+++
T Consensus 232 ---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 ---PAPRL----------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---CCCCC----------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 01124456789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=335.71 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=201.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
..|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 35667788999999999999864 68899999887655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++.+. .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 999999998653 47889999999999999999996 7999999999999999999999999999886543221 12
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|++.|+|||+..+..++.++|||||||++|||++|+.||........ ...+.....+ .+ .
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~---------~~-~----- 237 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP---------EL-Q----- 237 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCC---------CC-C-----
Confidence 334689999999999888899999999999999999999999864321111 0000000000 00 0
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+......+.+++.+||..+|++|||+.|+++.
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011233457789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=322.18 Aligned_cols=271 Identities=24% Similarity=0.303 Sum_probs=201.0
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--hHHHHHHHHHHHHHhcCCCc-eeEEEeeeccCC------ee
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRN-LAKIVSSCSNPG------FK 1406 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~HpN-Iv~l~g~~~~~~------~~ 1406 (1624)
|...+.||+|+||+||+|+.. +|+.||+|+++...+ .......+|+.++++++|+| ||++++++.+.+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 344456999999999999764 689999999876543 45567789999999999999 999999998877 78
Q ss_pred EEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1407 ALILQYMPQGSLEKWLYSHN---YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
++|+||+.. +|.+++.... ..++......++.|+.+||+|||+ .+|+||||||.|||++++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999975 9999998655 356777888999999999999996 899999999999999999999999999999
Q ss_pred ecCCCCCccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-cCC--hhHH
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-SLP--DAVT 1559 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-~~~--~~~~ 1559 (1624)
...-. ....+..++|..|.|||++.+. .|++.+||||+|||+.||++++.-|.+....+. +....+. ..| +.+.
T Consensus 169 a~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-l~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-LFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-HHHHHHHcCCCCccCCC
Confidence 65422 2234556899999999987665 799999999999999999998877765432111 1111110 001 1111
Q ss_pred HHH---hhhc-cCCc--hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 047591 1560 DVI---DANL-LSGE--EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKI 1613 (1624)
Q Consensus 1560 ~~~---d~~l-~~~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~--L~~i 1613 (1624)
.+. +-.. .... ................+++.+|++.+|.+|.+++.++++ +..+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111 1110 0000 000011111222467899999999999999999999986 5544
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=332.33 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=198.9
Q ss_pred CcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1338 SESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1338 ~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
...+.||+|+||.||+|... ++..+|+|.+........+.|.+|++++++++||||+++++++..++..++||||+++|
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 33467999999999999876 47788999887655566788999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccc
Q 047591 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496 (1624)
Q Consensus 1417 sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 1496 (1624)
+|..++.+....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 88 ~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 163 (282)
T cd06643 88 AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF 163 (282)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccccc
Confidence 9999887656678999999999999999999996 799999999999999999999999999987653221 122335
Q ss_pred ccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1497 LATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1497 ~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ..........+ .+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------~~----- 228 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP---------TL----- 228 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCC---------CC-----
Confidence 6899999999863 4567889999999999999999999986532111 11111100000 00
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+..++..+.+++.+||+.+|++||++.++++.
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011234567899999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=352.53 Aligned_cols=266 Identities=22% Similarity=0.292 Sum_probs=192.7
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--------
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-------- 1403 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-------- 1403 (1624)
...+|...++||+|+||+||+|... +++.||||++.... ....+|+.++++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457888899999999999999875 57899999875322 2345799999999999999998876321
Q ss_pred CeeEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeee
Q 047591 1404 GFKALILQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDF 1479 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DF 1479 (1624)
...++||||+++ ++.+++.. .+..+++.....++.||+.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 77777653 34568899999999999999999996 7999999999999999664 7999999
Q ss_pred cceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh--cCCh
Q 047591 1480 GIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE--SLPD 1556 (1624)
Q Consensus 1480 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~--~~~~ 1556 (1624)
|+|+.+.... ......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+....+. +...... ....
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCH
Confidence 9998764322 2234578999999998755 4689999999999999999999999975422111 1111110 0000
Q ss_pred hHHHHHhhhcc----C--CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1557 AVTDVIDANLL----S--GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1557 ~~~~~~d~~l~----~--~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.......+... . .........+...+.++.+++.+|++.+|++|||+.|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000000 0 00001111122345678999999999999999999999854
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=332.82 Aligned_cols=265 Identities=23% Similarity=0.408 Sum_probs=206.1
Q ss_pred CCCcCCeEeecCceEEEEEEEc-----CCceEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-----DGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKA 1407 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-----~~~~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~ 1407 (1624)
.|...+.||+|+||.||+|++. ++..+|||++...... ..+.|.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3455578999999999999864 3678999998754433 56789999999999999999999999877 55789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999998776678999999999999999999996 7999999999999999999999999999987653
Q ss_pred CCCc--cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc----CChhHHHH
Q 047591 1488 VDSM--KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES----LPDAVTDV 1561 (1624)
Q Consensus 1488 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~----~~~~~~~~ 1561 (1624)
.... ......++..|+|||+.....++.++|||||||++|||+||+.|+......... +.... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLEL 238 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHHH
Confidence 2211 111234566799999988888999999999999999999999997543221110 00000 00011111
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
+..... ...+..++.++.+++.+||+.+|++||||.|++++|+++
T Consensus 239 ~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER-------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc-------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111110 011124567789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=325.37 Aligned_cols=247 Identities=26% Similarity=0.447 Sum_probs=199.3
Q ss_pred CeEeecCceEEEEEEEcCCceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
+.||+|+||.||+|...+++.||+|+...... ...+.|.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999987799999998865433 35578999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc-ccccc
Q 047591 1420 KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ-TMTLA 1498 (1624)
Q Consensus 1420 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~-~~~~g 1498 (1624)
+++.+....+++..++.++.+++.|++|||+ .+|+||||||+||+++.++.+||+|||+++.......... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9998766678899999999999999999996 7899999999999999999999999999986542211111 12234
Q ss_pred ccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHH
Q 047591 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAA 1577 (1624)
Q Consensus 1499 t~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 1577 (1624)
+..|+|||+..++.++.++|||||||++|||+| |..||...... ... +.+...... ..
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~------------~~~~~~~~~-------~~ 216 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTR------------ERIESGYRM-------PA 216 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHH------------HHHhcCCCC-------CC
Confidence 667999999888889999999999999999999 78887543211 111 111110000 00
Q ss_pred HHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1578 KKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1578 ~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
+..++..+.+++.+|+..+|++|||+.|+++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1234557889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=333.28 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=197.2
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|...+.||+|+||+||+|.+. +++.+|+|.+.... ....+.+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 455678999999999999875 68899999886432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
+++|+|.+++...+ ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999987543 468999999999999999999996 799999999999999999999999999997654322
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......|+..|+|||+..+..++.++|||||||++|||+||+.||........ ... ++........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~-------------~~~~~~~~~~ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REE-------------VDRRVLETEE 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-------------HHHhhhcccc
Confidence 12234689999999999888999999999999999999999999965321110 000 1111100000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
......+..+.+++.+|++.+|++||| ++|+++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 001223456788999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=339.28 Aligned_cols=194 Identities=29% Similarity=0.516 Sum_probs=167.7
Q ss_pred CCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 747 SESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 747 ~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
.....||+|+||+||+|+|. ..||||++.... ....+.|++|+.++++-+|.||+=+.|||..++. .+|+-+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 35578999999999999985 479999998654 3466889999999999999999999999999887 999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC-CCcccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE-DSVTQT 903 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~-~~~~~~ 903 (1624)
-+|+.+||..+..++..+..+||.|||+|+.|||. +.|||||||+.||++++++++||+|||++..-..- ......
T Consensus 472 sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 472 SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 99999999877788889999999999999999998 56999999999999999999999999998642211 011112
Q ss_pred cccccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 904 MTLATFGYMAPEYGSE---GIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~---~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
...|..-|||||+++. ..|+..+||||||||+|||+||..||.
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 2357889999998754 468999999999999999999999997
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=335.34 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=202.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||.||+|... ++..+|+|.+... .....+++.+|++++++++||||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36788899999999999999875 5788999988643 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++|+|.++++.. ..+++..+..++.|+++||+|||+ ..+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999999999765 457888899999999999999996 258999999999999999999999999998765322 1
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC---C--------------
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL---P-------------- 1555 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~---~-------------- 1555 (1624)
.....|++.|+|||+..+..++.++|||||||++|||+||+.||...... ....+..... +
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCC
Confidence 23356899999999988888999999999999999999999998643211 1111111000 0
Q ss_pred ----hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 ----DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 ----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+..+........ .. ........+.+++.+|++.+|++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPP--KL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCc--cC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111110000000 00 001134568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=350.66 Aligned_cols=200 Identities=22% Similarity=0.337 Sum_probs=170.6
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.|...+.||+|+||+||+|+.. +++.+|+|++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4677789999999999999875 57889999986432 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC--
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-- 1489 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-- 1489 (1624)
||++|+|.+++.+.+ .++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997654 46777788899999999999996 799999999999999999999999999975321000
Q ss_pred --------------------------------------------CccccccccccccccccccCCCCcCcccchHHHHHH
Q 047591 1490 --------------------------------------------SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGIL 1525 (1624)
Q Consensus 1490 --------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvi 1525 (1624)
.......+||+.|||||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112469999999999988899999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 047591 1526 MMETLTRRKPTDDM 1539 (1624)
Q Consensus 1526 l~Elltg~~P~~~~ 1539 (1624)
+|||+||+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=342.98 Aligned_cols=238 Identities=27% Similarity=0.348 Sum_probs=191.0
Q ss_pred CeEeecCceEEEEEEE----cCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1341 NLLGTGIFSSVYKATF----ADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~----~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
+.||+|+||.||+++. .+|+.+|+|++.... ......+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 357889999986433 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++.+. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++...... ....
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999999754 357899999999999999999996 799999999999999999999999999998654321 1223
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
...||+.|||||+..+..++.++|||||||++|||+||+.||......+. .. .+.... ..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~------------~i~~~~-~~------ 216 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-MT------------MILKAK-LG------ 216 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-HH------------HHHcCC-CC------
Confidence 45799999999999888899999999999999999999999865321110 00 000000 00
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKD 1605 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~e 1605 (1624)
.+...+..+.+++.+|++.+|++||++.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00123455778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=330.28 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=203.5
Q ss_pred CCCcCCeEeecCceEEEEEEEcC-Cc----eEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFAD-GT----NAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~-~~----~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.|...+.||+|+||+||+|.+.+ |. .+|+|...... ......+.+|++++++++||||++++++|.. +..++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 45566899999999999998753 33 58899876443 3445789999999999999999999999987 788999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++......+++..+.+++.||+.|++|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999998876678999999999999999999996 899999999999999999999999999998765322
Q ss_pred Ccc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1490 SMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1490 ~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
... .....++..|+|||......++.++|||||||++||++| |+.||+..... .+... +.....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~------------~~~~~~ 229 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDL------------LEKGER 229 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHH------------HhCCCC
Confidence 211 112234678999999888889999999999999999999 99998653211 11111 111000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
. ..+..+...+.+++.+||..+|++|||+.++++.|+++...
T Consensus 230 ~-------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 L-------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 00112345678899999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=332.28 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=198.4
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|...++||+|+||+||+|... +++.+|||.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 556688999999999999875 68899999885432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
+++|+|.+++...+ ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999986543 458889999999999999999996 899999999999999999999999999997654322
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......||..|||||+..+..++.++|||||||++|||++|+.||........ .. .....++. ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~---------~~~~~~~~-~~---- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-RE---------EVERLVKE-VQ---- 221 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HH---------HHHhhhhh-hh----
Confidence 12234699999999999888999999999999999999999999975321110 00 00001100 00
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
......+...+.+++.+||+.+|++||| ++|+++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0001224456788999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=346.49 Aligned_cols=209 Identities=31% Similarity=0.462 Sum_probs=176.3
Q ss_pred CCCCcceeecCCccceEEEEecC--C--CE-EEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLPY--G--MN-VAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~--g--~~-vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
+-...+.||+|+||+||+|++.. + .. ||||..+... ....++|++|+++|++++|||||+++|++.....+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33344789999999999998753 2 23 8999987522 446789999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+|||+|+||+|.+||+..+..++..++.+++.++|+||+|||. +.+|||||.++|+|++.++.+||+|||+++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999999999887789999999999999999999998 4599999999999999999999999999986541
Q ss_pred CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccCcCcchHHHHH
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEMFTGETSLKKWV 959 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~~~~~~~l~~~~ 959 (1624)
. ........-...|+|||.+..+.++.++|||||||++||+.+ |..||.++.. ..+++++
T Consensus 315 ~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI 375 (474)
T KOG0194|consen 315 Y-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKI 375 (474)
T ss_pred e-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHH
Confidence 1 111112235679999999999999999999999999999999 8889977542 2445555
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=330.15 Aligned_cols=248 Identities=31% Similarity=0.482 Sum_probs=196.3
Q ss_pred CeEeecCceEEEEEEEcC-------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1341 NLLGTGIFSSVYKATFAD-------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~-------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.||+|+||.||+|++.+ +..+|+|.+.... ......|.+|++++++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998743 2468999875432 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-----cEEEeeecc
Q 047591 1413 MPQGSLEKWLYSH------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-----VAHLGDFGI 1481 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-----~~kl~DFGl 1481 (1624)
+++|+|.+++++. ...+++.+++.++.|++.|++|||+ .+++||||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999752 2347899999999999999999996 7899999999999999877 899999999
Q ss_pred eeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHH
Q 047591 1482 AKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1482 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~ 1559 (1624)
++........ ......++..|+|||+..++.++.++|||||||++|||+| |+.||......+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~---------- 225 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQH---------- 225 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHH----------
Confidence 9865432211 1122346788999999998999999999999999999998 999986432111 1111
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
++.... ......++..+.+++.+||+.+|++||+++++++.|++
T Consensus 226 --~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 --VTAGGR-------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --HhcCCc-------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 110000 00112345678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=351.28 Aligned_cols=193 Identities=24% Similarity=0.300 Sum_probs=168.2
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
..+|...+.||+|+||.||+|+.. .++.||||... ...+.+|++++++++|||||++++++...+..++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888899999999999999876 47889999542 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc-
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM- 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~- 1491 (1624)
+. |+|.+++......++|.++++|+.|+++||+|||+ .+||||||||+|||++.++.+||+|||+|+........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 79999987766678999999999999999999996 79999999999999999999999999999876433221
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCC
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPT 1536 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~ 1536 (1624)
......||+.|||||++.+..++.++|||||||++|||++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 122356999999999999889999999999999999999988765
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=351.62 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=193.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
+|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5777889999999999999865 58899999986432 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC--
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-- 1489 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-- 1489 (1624)
|+++|+|.+++.+.+ .++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999997654 46777778899999999999996 799999999999999999999999999985321000
Q ss_pred ----------------------------------------CccccccccccccccccccCCCCcCcccchHHHHHHHHHH
Q 047591 1490 ----------------------------------------SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMET 1529 (1624)
Q Consensus 1490 ----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~El 1529 (1624)
........||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134699999999999988999999999999999999
Q ss_pred HcCCCCCCCCCccchh--hhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCC---CHH
Q 047591 1530 LTRRKPTDDMFTGEVC--LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERM---NVK 1604 (1624)
Q Consensus 1530 ltg~~P~~~~~~~~~~--l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP---t~~ 1604 (1624)
+||+.||......+.. +..|... .. ......+...+.+++.+|+ .+|++|+ |+.
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~-------------~~-------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETT-------------LH-------IPSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCcc-------------cc-------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 9999999754221110 0011000 00 0000122344566677765 4999999 888
Q ss_pred HHHHH
Q 047591 1605 DALAN 1609 (1624)
Q Consensus 1605 evl~~ 1609 (1624)
|+++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=341.31 Aligned_cols=237 Identities=25% Similarity=0.293 Sum_probs=187.0
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHH-HHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECE-VMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~-~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +|+.||+|++.... ....+++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999875 68899999986432 223345555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 99999987643 57888888999999999999996 799999999999999999999999999987542221 12334
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||++|+.||......+ .. ..+......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~------------~~i~~~~~~-------- 214 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-MY------------DNILNKPLR-------- 214 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-HH------------HHHHcCCCC--------
Confidence 579999999999998899999999999999999999999986532111 00 011110000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVK 1604 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 1604 (1624)
.+...+..+.+++.+|++.+|++||++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 -LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0012245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=333.51 Aligned_cols=197 Identities=25% Similarity=0.387 Sum_probs=172.6
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHH-HHHHHHHHHhcC-CCceeeeeeeeccCC-eEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKS-FDAECEVLRRVR-HRNLVKIISSCSNHG-FKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~-~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lV 818 (1624)
.++|...+.||.|.||.||+|+. .+|..||||+++.+.....+. =.||+..|+++. |||||+|.+.+.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 35677778999999999999984 579999999998665433222 368999999998 999999999999888 89999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
||||+. +|++.++++...+++.++..|+.||.+||+|+|++ ++.|||+||+|||+.....+||+|||+||.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 999985 99999999988999999999999999999999995 59999999999999999999999999999876543
Q ss_pred CcccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 899 SVTQTMTLATFGYMAPEYG-SEGIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~-~~~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
..+..+.|.+|.|||++ +.+.|+.+.||||+|||++|+++-+.=|
T Consensus 165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 34556899999999975 6778999999999999999999988544
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=326.01 Aligned_cols=247 Identities=28% Similarity=0.482 Sum_probs=202.0
Q ss_pred CeEeecCceEEEEEEEcC----CceEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFAD----GTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||.||+|.... +..+|+|+++..... ..+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999998764 778999998754433 367899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1416 GSLEKWLYSH--------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1416 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
|+|.+++... ...+++.++.+++.|+++|++|||+ .+|+||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 4678999999999999999999996 8999999999999999999999999999987754
Q ss_pred CCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1488 VDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1488 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
... .......+++.|+|||......++.++||||+||++|||++ |+.||...... .+.. .+.+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~-----------~~~~~~ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLE-----------YLRKGY 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHH-----------HHHcCC
Confidence 321 12233467889999999888889999999999999999999 58898754211 1111 111100
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.. ..+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 225 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RL--------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC--------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 011234567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=340.36 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=197.5
Q ss_pred CCeEeecCceEEEEEEEc-CCceEEEEEecc----chhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe--eEEEEEe
Q 047591 1340 SNLLGTGIFSSVYKATFA-DGTNAAIKIFSL----QEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF--KALILQY 1412 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~----~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~--~~lV~ey 1412 (1624)
..+||+|+|-+||||... +|..||.-.++. +.....++|..|+.+|+.++|||||++|.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999764 577787543322 234566899999999999999999999999987665 6789999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|..|+|..|.++.+ ..+......+++||.+||.|||. ..++|||||||.+||+|+. .|.+||+|.|+|..+....
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 99999999998765 46788889999999999999997 4689999999999999986 4899999999999875432
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
....+|||.|||||+.. ..|++.+||||||+.|+||+|+..||.+........+......-|+.+..+-|
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d-------- 270 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD-------- 270 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC--------
Confidence 23378999999999876 78999999999999999999999999876544443443333333333322222
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+++.+++.+|+.. .++|||+.|+++.
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3467899999999 9999999999863
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=342.78 Aligned_cols=242 Identities=23% Similarity=0.279 Sum_probs=189.1
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHH-HHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECE-VMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~-~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +|+.+|+|++.... ....+.+.+|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999875 68899999986432 233455666655 46789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|..++... ..+++.+...++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 9999988754 357888899999999999999996 799999999999999999999999999987542211 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||++|+.||......+ .. ..+....+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~------------~~~~~~~~~~------- 215 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-MY------------DNILHKPLVL------- 215 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-HH------------HHHHcCCccC-------
Confidence 579999999999999999999999999999999999999986432111 00 1111111000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.......+.+++.+|++.+|.+||++++.++.
T Consensus 216 --~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 216 --RPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred --CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 01233456789999999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=347.20 Aligned_cols=216 Identities=26% Similarity=0.459 Sum_probs=183.6
Q ss_pred cccCHHHHHhhcCCC---------CCcceeecCCccceEEEEecC----CCEEEEEEeeccc-chhHHHHHHHHHHHHhc
Q 047591 732 RRISYQELQRLTDGF---------SESNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQL-DGAIKSFDAECEVLRRV 797 (1624)
Q Consensus 732 ~~~~~~el~~~t~~f---------~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l 797 (1624)
..++|++=.+|...| .+.++||.|.||+||+|+++. ...||||.++... ++...+|..|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 345666544444444 345899999999999999753 3579999998654 44567899999999999
Q ss_pred CCCceeeeeeeeccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 798 RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 798 ~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
+||||++|.|+.......++|.|||+||+|+.||+.+...+++.+.+.+..+||.|+.||-+ ++.|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 99999999999999999999999999999999999988889999999999999999999998 569999999999999
Q ss_pred CCCCceEEEeeeeeeccCCCCCccccccc--ccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccCc
Q 047591 878 DDDTVAHLSDFGISKLLDGEDSVTQTMTL--ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEMFT 950 (1624)
Q Consensus 878 d~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~~~ 950 (1624)
+.+.++||+|||++|.+.++.....+..- -..+|.|||.+..+.+|.++||||||||+||.++ |.+||=+|..
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 99999999999999987554422222222 2468999999999999999999999999999776 9999876643
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=338.41 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=190.4
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.+|||+++... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57889999987432 33456788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 99999887543 57899999999999999999996 799999999999999999999999999997532221 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccc-hhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE-VCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~-~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
..||+.|||||+..+..++.++|||||||++|||+||+.||+...... .....+ ....+......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~------ 221 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY--------LFQVILEKPIR------ 221 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH--------HHHHHHhCCCC------
Confidence 579999999999999999999999999999999999999996422111 000001 11111000000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVK 1604 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 1604 (1624)
.+...+..+.+++.+|++.||++||+++
T Consensus 222 --~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 --IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0112345577899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=328.52 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=196.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+|...++||+|+||.||+|+.. +++.||+|++... .....++|.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5666789999999999999864 6788999988644 2334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|..+. .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999997653 35778888999999999999996 89999999999999999999999999999865432 22
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....||..|+|||+..+..++.++|||||||++|||+||+.||.......... .+......+.........
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-- 221 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLP-- 221 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------chHHHHHHHhccCCCCCC--
Confidence 33578999999999988889999999999999999999999986532211100 000111111100000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01123457889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=339.62 Aligned_cols=258 Identities=25% Similarity=0.449 Sum_probs=203.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC--------CceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD--------GTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~--------~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~ 1404 (1624)
..|...+.||+|+||.||+|+... +..||+|.++.. .....+++.+|+++++++ +||||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 356777899999999999997521 236899988643 234567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1405 FKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
..++||||+++|+|.+++.+.. ..++|.+++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999997532 347889999999999999999996 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~ 1547 (1624)
+++.+||+|||+++........ ......++..|||||+.....++.++|||||||++|||++ |+.||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 9999999999999876432211 1122334678999999988899999999999999999999 788876432111
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+ .+.+....... .+..++..+.+++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 245 -~---------~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 245 -L---------FKLLKEGHRMD-------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -H---------HHHHHcCCCCC-------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 0 01111000000 0123455788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=335.50 Aligned_cols=241 Identities=27% Similarity=0.366 Sum_probs=196.4
Q ss_pred CCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1340 SNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
.+.||.|+||.||-|+.. +..+||||.++.. ......++..|+..|++++|||+|.+-|||..+...|||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 456999999999999864 5788999998643 23345678999999999999999999999999999999999996
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
||-.+.+.-++..+...++..|+.+++.||+|||. .+.||||||+.|||+.+.|.+|++|||-|.+..+. ..
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----ns 181 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NS 181 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----hc
Confidence 58888887666677788888999999999999995 78999999999999999999999999999887643 35
Q ss_pred ccccccccccccc---CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1496 TLATIGYMAPEYG---SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1496 ~~gt~~y~APE~~---~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
++|||+|||||++ ..+.|+-|+||||+||++.||..+++|...|... ..+.+.....-| .+.+
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQNesP---------tLqs---- 247 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP---------TLQS---- 247 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhcCCC---------CCCC----
Confidence 7899999999975 5688999999999999999999999997655322 223332221111 1111
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+-...+..++..|++.-|.+|||..++++.
T Consensus 248 ------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 248 ------NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ------chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1224557788899999999999999987764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=329.42 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=197.6
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
+|...+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4555678999999999999875 588899999876554555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++...+ .+++.+...++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++...... .....
T Consensus 90 ~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~ 164 (267)
T cd06645 90 GGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRK 164 (267)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccccc
Confidence 999999987654 57889999999999999999996 79999999999999999999999999999766422 12223
Q ss_pred ccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC-ChhHHHHHhhhccCCc
Q 047591 1495 MTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL-PDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~-~~~~~~~~d~~l~~~~ 1570 (1624)
...|++.|+|||++. ...++.++|||||||++|||++|+.|+......... ........ +...
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~------------ 231 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKSNFQPPKL------------ 231 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-HhhhccCCCCCcc------------
Confidence 457899999999864 456889999999999999999999998543221110 00000000 0000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....++..+.+++.+|++.+|++|||++++++
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 -----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000122345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=332.49 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=203.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||+||+|.+. ++..+|+|+.+.......+.|.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45666778999999999999875 57889999987666666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++.+.+..+++.+...++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~ 160 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKR 160 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-ccc
Confidence 9999999998766678999999999999999999996 799999999999999999999999999987653221 222
Q ss_pred cccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1494 TMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
....||+.|+|||+.. ...++.++|||||||++|||++|+.||....... ....+.....+ .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------~--- 227 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEPP---------T--- 227 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCCC---------C---
Confidence 3456899999999864 3457889999999999999999999986532111 11111100000 0
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+..++..+.+++.+||+.+|++||++.++++.
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 ------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00112344567889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=337.64 Aligned_cols=241 Identities=23% Similarity=0.284 Sum_probs=191.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
+|...++||+|+||+||+|+.. +++.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3666789999999999999875 58899999986432 234567888999998886 567888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+ .+++.++..|+.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999987643 57899999999999999999996 799999999999999999999999999987543221
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.......||+.|||||++.+..++.++|||||||++|||+||+.||........ . ..+..... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~------------~~i~~~~~-~-- 219 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-F------------QSIMEHNV-S-- 219 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-H------------HHHHhCCC-C--
Confidence 122345699999999999888899999999999999999999999975321110 0 01111000 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
.+..++..+.+++.+|++.+|++|++.
T Consensus 220 ------~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ------YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011234567789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=331.25 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=201.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||.||+|+.. ++..+|+|++........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 44666778999999999999875 47899999987666666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|..++.+....+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++...... ....
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence 9999999887666678999999999999999999996 79999999999999999999999999998764322 1222
Q ss_pred cccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1494 TMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
....+++.|+|||++. ...++.++|||||||++|||+||+.|+...... .....+.....+ .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~---------~--- 234 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPP---------T--- 234 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCCc---------c---
Confidence 3456889999999874 345788999999999999999999998643211 111111100000 0
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+..++..+.+++.+||+.+|++||++.|+++.
T Consensus 235 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 ------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00011234567889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=324.88 Aligned_cols=249 Identities=19% Similarity=0.307 Sum_probs=200.6
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+|...+.||+|+||.||+++.. ++..+|+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3566789999999999999875 5788999988643 3445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.+++... +..++.+..+.++.|++.||+|||+ .+|+|+||||+||++++++.++++|||.++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999998753 4457889999999999999999996 7999999999999999999999999999987643222 2
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
.....|++.|+|||+..+..++.++|||||||++|||++|+.||+....... ... +....... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~------------~~~~~~~~-~-- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-ILK------------VCQGSYKP-L-- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-HHH------------HhcCCCCC-C--
Confidence 2335689999999999888899999999999999999999999864311110 000 00000000 0
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+..++..+.+++.+||+.+|++|||+.|++..
T Consensus 221 -----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01233457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=325.45 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=204.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56777889999999999999875 57789999987655556688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|.+++......++..++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++....... ...
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-hcc
Confidence 9999999998765678899999999999999999996 799999999999999999999999999987654321 122
Q ss_pred cccccccccccccccCCC---CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1494 TMTLATIGYMAPEYGSEG---IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~---~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
....++..|+|||..... .++.++|||||||++|||+||+.|+.+........ ...... ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~------------~~~~- 224 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSN------------FPPP- 224 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcc------------CCCc-
Confidence 335688899999998766 88999999999999999999999986532211100 000000 0000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
........+..+.+++.+||..+|++|||+.|++.
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 ---KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ---cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00011233456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=327.90 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=187.5
Q ss_pred eEeecCceEEEEEEEcC---CceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCC
Q 047591 1342 LLGTGIFSSVYKATFAD---GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~~---~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gs 1417 (1624)
.||+|+||+||+|+..+ ...+|+|.+.... ....+.|.+|+++++.++||||++++++|.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997643 3467888765432 3345678999999999999999999999999999999999999999
Q ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-cc
Q 047591 1418 LEKWLYSHN----YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MK 1492 (1624)
Q Consensus 1418 L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-~~ 1492 (1624)
|.+++.+.. ...++.....++.||+.|++|||+ .+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997643 234677888999999999999996 7999999999999999999999999999875432221 11
Q ss_pred ccccccccccccccccC-------CCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1493 QTMTLATIGYMAPEYGS-------EGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~-------~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.....+++.|+|||+.. ...++.++|||||||++|||++ |+.||......+ .+...+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~--------- 228 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQDI--------- 228 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccCc---------
Confidence 22335677899999753 3456889999999999999999 777876432211 11111111000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.+.. ......++..+.+++..|| .+|++|||++||++.|.
T Consensus 229 ~~~~------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPK------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCC------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000 0001223455677888899 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=339.92 Aligned_cols=241 Identities=23% Similarity=0.284 Sum_probs=187.2
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHH-HHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAEC-EVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~-~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||+||+|+.. +++.+|+|++.... ....+.+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 56789999986432 22233444444 456789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++...+ .+...+...++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 99999997654 45667777899999999999996 799999999999999999999999999997543221 12334
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|||||++.+..++.++|||||||++|||++|+.||......+. . ..+......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~------------~~i~~~~~~-------- 214 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-Y------------DNILNKPLQ-------- 214 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-H------------HHHHhCCcC--------
Confidence 5799999999999999999999999999999999999999965321110 0 011110000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....+..+.+++.+|++.+|.+||++.+.+.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 -LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 00123456788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=325.85 Aligned_cols=190 Identities=32% Similarity=0.470 Sum_probs=160.7
Q ss_pred CcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHh--cCCCceeeeeeeeccCC----eEEEEEEe
Q 047591 748 ESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRR--VRHRNLVKIISSCSNHG----FKALILEY 821 (1624)
Q Consensus 748 ~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~Ey 821 (1624)
..++||+|.||.||||.+. ++.||||++..+ ..+.|.+|-+|.+. |+|+||++++++-+... +.+||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4468999999999999985 599999999854 34668888887764 68999999999876555 78999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG------HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
.+.|+|.+||..+ .++|....+|+..+|+||+|||+. +.++|+|||||++|||+.+|+++-|+|||+|..+.
T Consensus 290 h~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred ccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999999865 689999999999999999999964 45789999999999999999999999999999887
Q ss_pred CCCCccc-ccccccccccCccccCCCC------CCcchhHHHHHHHHHHHHcCCC
Q 047591 896 GEDSVTQ-TMTLATFGYMAPEYGSEGI------VSTCGDVYSFGILMIETFTRKM 943 (1624)
Q Consensus 896 ~~~~~~~-~~~~gt~~Y~aPE~~~~~~------~~~k~DvwS~Gvil~elltg~~ 943 (1624)
.+..... ...+||.+|||||++.+.. .-.+.||||+|.|||||+++-.
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 5543322 2368999999999875432 2245799999999999999753
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=330.35 Aligned_cols=254 Identities=23% Similarity=0.390 Sum_probs=202.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|.....||+|+||+||+|+.. +...||+|.+...... ..+.|.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45777789999999999999864 2456899988654433 5678999999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeee
Q 047591 1408 LILQYMPQGSLEKWLYSHN--------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543 158999999999999999999996 78999999999999999999999999
Q ss_pred cceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhH
Q 047591 1480 GIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAV 1558 (1624)
Q Consensus 1480 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~ 1558 (1624)
|+++..............+++.|+|||...+..++.++|||||||++|||++ |..||....... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~------- 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQ------- 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHH-------
Confidence 9987554333223334467888999999888889999999999999999999 777875432111 111100
Q ss_pred HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1559 TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1559 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
....... ....++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 233 ----~~~~~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 ----AGKLELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----cCCcCCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000000 01134567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=330.37 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=202.4
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+|...+.||+|+||+||+|... +++.+|+|+..... ....+.|.+|+++++.++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 4555678999999999999875 58889999876432 345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++.+.+ .+++..+..++.+++.|++|||+ ..+|+||||||+||++++++.++|+|||+++...... .
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~ 159 (284)
T cd06620 86 DCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A 159 (284)
T ss_pred CCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence 9999999987643 57899999999999999999996 3579999999999999999999999999987553211 1
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|+..|+|||++.+..++.++|||||||++|||+||+.||+.....+.. ...+..+.+.+..........
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~- 232 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQIVQEPPPR- 232 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhHHHHHHHHHhhccCCC-
Confidence 2346899999999988888999999999999999999999999754321110 000111111111111000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
. ....++..+.+++.+|++.+|++|||++|++++.
T Consensus 233 -~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 -L-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -C-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 0012456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=324.29 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=198.4
Q ss_pred CCcCCeEeecCceEEEEEEEcCCceEEEEEeccch------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
|...+.||+|+||+||+|...+++.+|||.+.... ....+.+.+|++++++++|+||++++++|.+.+..++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 56678999999999999988889999999875321 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD- 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~- 1489 (1624)
||+++|+|.+++.+.+ .++++.+..++.|++.|++|||+ .+|+|+||||+||++++++.+||+|||+++......
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 82 EFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999997654 46788889999999999999996 789999999999999999999999999987653211
Q ss_pred ----CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1490 ----SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1490 ----~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
........|+..|+|||+..+..++.++|||||||++|||+||+.||........ ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~-----------~ 225 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGAHR-----------G 225 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhhcc-----------C
Confidence 1111234689999999999888899999999999999999999999965321111 00000000 0
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.... .+..+...+.+++.+||+.+|++||++.|+++
T Consensus 226 ~~~~-------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPR-------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC-------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 01123456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=330.45 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=202.5
Q ss_pred cCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeec-
Q 047591 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCS- 1401 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~- 1401 (1624)
+.++.+..++++|...+.||+|+||+||+|+.. +++.+|+|+++... .....+.+|+.+++++ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666778889999999999999999999875 57889999875432 2245688899999999 6999999999873
Q ss_pred ----cCCeeEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1402 ----NPGFKALILQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1402 ----~~~~~~lV~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
..+..++||||+++|+|.++++. .+..+++..+..++.|+++|++|||+ .+|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 34568999999999999998863 23467888899999999999999996 799999999999999999999
Q ss_pred EEeeecceeecCCCCCccccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhh
Q 047591 1475 HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW 1549 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~ 1549 (1624)
||+|||+++.+.... .......|++.|+|||++. ...++.++|||||||++|||+||+.|+....... .+..+
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKI 241 (286)
T ss_pred EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhc
Confidence 999999998764322 2223346999999999864 3457899999999999999999999986532111 00000
Q ss_pred hhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1550 VEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
... .+ ... ..+..+...+.+++.+||+.+|++|||+.|+++.
T Consensus 242 ~~~-~~--------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 PRN-PP--------PTL---------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccc-CC--------Ccc---------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 00 000 0001123457889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=324.08 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=200.7
Q ss_pred CCCcCCeEeecCceEEEEEEEcC--CceEEEEEeccc----------hhhHHHHHHHHHHHHHh-cCCCceeEEEeeecc
Q 047591 1336 GFSESNLLGTGIFSSVYKATFAD--GTNAAIKIFSLQ----------EDRALKSFDAECEVMRR-IRHRNLAKIVSSCSN 1402 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~--~~~vAvK~~~~~----------~~~~~~~f~~E~~~l~~-l~HpNIv~l~g~~~~ 1402 (1624)
+|...+.||+|+||.||+|.+.. ++.+|+|.+... .....+++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36667889999999999999865 678999987532 22345667889998875 799999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeee
Q 047591 1403 PGFKALILQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
.+..++||||+++++|.+++.. ....+++..+++++.|++.||+|||+ ..+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998753 45568899999999999999999995 368999999999999999999999999
Q ss_pred cceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHH
Q 047591 1480 GIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1480 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~ 1559 (1624)
|+++...... ......|+..|+|||+..++.++.++|||||||++|||++|+.||....... .. .
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-~~------------~ 223 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-LA------------T 223 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-HH------------H
Confidence 9998765432 2334568999999999988889999999999999999999999985421110 00 0
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.+.+....... ...++..+.+++.+||+.+|++||++.||.++++
T Consensus 224 ~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 KIVEAVYEPLP-------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHhhccCCcCC-------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111000000 0123456888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=320.77 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=202.2
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|+..++||+|+||.||.++.. ++..+|+|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 667789999999999998764 5788999987643 3445678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.+++.+. +..+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||+++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999865 4568999999999999999999996 7899999999999999999999999999987654332 2
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
.....|++.|+|||+..+..++.++|||||||++|||++|+.||+.....+ ....+........
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------------~~~~~~~~~~~~~--- 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------------LVVKIVQGNYTPV--- 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------------HHHHHHcCCCCCC---
Confidence 234568999999999888888999999999999999999999986422111 0011111000000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...++..+.+++.+||+.+|++||+++|+++.
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 02334567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=342.17 Aligned_cols=265 Identities=21% Similarity=0.225 Sum_probs=196.1
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
...+|...+.||+|+||+||+|+.. ++..||+|+.... ....|+.++++++||||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4567889999999999999999875 4678999975322 23568999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+. |+|.+++......+++.++.+|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++..... .
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 995 69999998776778999999999999999999996 79999999999999999999999999999754321 1
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCC-CCCCcc-ch-------hhhhhhh------hcCC-
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPT-DDMFTG-EV-------CLKHWVE------ESLP- 1555 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~-~~~~~~-~~-------~l~~~~~------~~~~- 1555 (1624)
......||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... .. .+...+. ..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 223456999999999999889999999999999999999976654 321111 00 0000000 0000
Q ss_pred ----hhHHHHHhhh-ccCC-chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 ----DAVTDVIDAN-LLSG-EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 ----~~~~~~~d~~-l~~~-~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+.++.. .... ...........++..+.+++.+|++.||++|||+.||++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0001111100 0000 0000001112334556779999999999999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=344.93 Aligned_cols=201 Identities=25% Similarity=0.354 Sum_probs=173.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36777899999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999997653 47888888999999999999996 8999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCC
Q 047591 1491 ----------------------------------MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPT 1536 (1624)
Q Consensus 1491 ----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~ 1536 (1624)
......+||+.|||||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011347999999999999899999999999999999999999999
Q ss_pred CCC
Q 047591 1537 DDM 1539 (1624)
Q Consensus 1537 ~~~ 1539 (1624)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=330.89 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=201.7
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4677788999999999999986 468999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|.+++.+. .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 999999998653 47889999999999999999996 7999999999999999999999999999987643322 22
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|++.|+|||+..+..++.++|||||||++|||+||+.||............+... .+. .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~---------~------- 235 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPE---------L------- 235 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCC---------C-------
Confidence 33468899999999988889999999999999999999999986422111100000000 000 0
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..+...+..+.+++.+||+.+|++||+++|+++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001123345678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=310.96 Aligned_cols=198 Identities=26% Similarity=0.365 Sum_probs=169.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeecc--CCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSN--HGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 818 (1624)
+.|...+.|++|+||.||+|+. ++++.||.|+++...+ +..-.-.||+.+|.+++|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3466678999999999999986 4689999999976543 333356799999999999999999887653 4569999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
||||+. ||...++..+..+...++.-++.|+++|++|||..+ |+||||||+|+|+.+.|.+||+|||+||.+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999986 999999888778999999999999999999999976 9999999999999999999999999999986542
Q ss_pred CcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 899 SVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
...+..+.|.+|.|||.+.+ ..|++..||||+|||+.||++++.=|.
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 23455678999999997654 568999999999999999999986543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=335.71 Aligned_cols=272 Identities=18% Similarity=0.266 Sum_probs=197.5
Q ss_pred CCeEeec--CceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1340 SNLLGTG--IFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1340 ~~~lG~G--~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
.++||+| +||+||+++.. +|+.||||++.... ....+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3679999 68899999774 68899999986542 3345677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc--
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-- 1491 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~-- 1491 (1624)
+|+|.+++..+ ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++|||.+.........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999754 3458899999999999999999996 78999999999999999999999999875433211100
Q ss_pred ----cccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhH------H
Q 047591 1492 ----KQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV------T 1559 (1624)
Q Consensus 1492 ----~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~------~ 1559 (1624)
......++..|||||++.+ ..++.++|||||||++|||+||+.||.+......... ......+... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH-HhcCCccccccccchhh
Confidence 0112356788999999865 4589999999999999999999999975432211111 1111111000 0
Q ss_pred HHH---------hhhccC----------CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHH
Q 047591 1560 DVI---------DANLLS----------GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKIKT 1615 (1624)
Q Consensus 1560 ~~~---------d~~l~~----------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~--L~~i~~ 1615 (1624)
+.. +..... ................+.+++.+|++.||++|||++|+++. +++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 000 000000 00000000112335678899999999999999999999873 555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=340.80 Aligned_cols=266 Identities=23% Similarity=0.267 Sum_probs=195.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC------
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG------ 1404 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~------ 1404 (1624)
.++|...+.||+|+||+||+|+.. +|..||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 367888899999999999999874 5889999998643 2344567889999999999999999999886443
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++||||+++ ++.+.++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 46999999975 56666643 36788888999999999999996 7999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc-CC-h------
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES-LP-D------ 1556 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~-~~-~------ 1556 (1624)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ +....+.. .+ .
T Consensus 173 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 173 ACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHHHHH
Confidence 5322 222345789999999999988999999999999999999999999975321110 10000000 00 0
Q ss_pred --hHHHHHhhhc-cCCch-HH---------HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1557 --AVTDVIDANL-LSGEE-EA---------DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1557 --~~~~~~d~~l-~~~~~-~~---------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....+.... ..... .. ...........+.+++.+|++.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000110000 00000 00 000011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=330.37 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=202.5
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.+|...+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3577778999999999999976 468899999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++.+. .+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 999999988654 47899999999999999999996 7999999999999999999999999999886543322 12
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|+..|+|||...+..++.++|||||||++|||+||+.||........ .. .... ....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~-~~~~------------~~~~----- 233 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY-LIAT------------NGTP----- 233 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHh------------cCCc-----
Confidence 234688999999999888899999999999999999999999865322111 00 0000 0000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+..++..+.+++.+||+.+|++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000112344567889999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=337.39 Aligned_cols=237 Identities=23% Similarity=0.267 Sum_probs=185.0
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHH-HHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECE-VMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~-~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 57889999986432 223345555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|..++... ..+...++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9999888754 346777788899999999999996 799999999999999999999999999987532222 12234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~------------~~i~~~~~~-------- 214 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMY------------DNILHKPLQ-------- 214 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHH------------HHHhcCCCC--------
Confidence 57999999999998888999999999999999999999998653111 000 011110000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVK 1604 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 1604 (1624)
.+......+.+++.+|++.+|++||+..
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 -LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0011234577899999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=332.62 Aligned_cols=269 Identities=18% Similarity=0.258 Sum_probs=201.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45777789999999999999875 57889999886443 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++ ++|.+++...+..+++.....++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++....... .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 97 69999998766678899999999999999999996 7999999999999999999999999999976532221 1
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh--hhhhhhhcCChhHHHHHhhhcc--
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC--LKHWVEESLPDAVTDVIDANLL-- 1567 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~--l~~~~~~~~~~~~~~~~d~~l~-- 1567 (1624)
.....+++.|+|||+..+ ..++.++|||||||++|||+||+.||......+.. ..........+.+...++....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 223467899999998654 45789999999999999999999998653221110 0001001111111111111000
Q ss_pred ----CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 ----SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ----~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.............++..+.+++.+|++.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000001111234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=345.02 Aligned_cols=249 Identities=28% Similarity=0.415 Sum_probs=183.1
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----------
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP----------- 1403 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~----------- 1403 (1624)
|.+..+||+||||.|||++.+ ||+.+|||++... .+.......+|+.++++++|||||+++..+.+.
T Consensus 481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred hHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 444457999999999999876 8999999998654 344456788999999999999999997321000
Q ss_pred --------------------------------------------------------------------------------
Q 047591 1404 -------------------------------------------------------------------------------- 1403 (1624)
Q Consensus 1404 -------------------------------------------------------------------------------- 1403 (1624)
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence
Q ss_pred ----------------------------CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 047591 1404 ----------------------------GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455 (1624)
Q Consensus 1404 ----------------------------~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 1455 (1624)
...||=||||+.-.+.++++++...-.....+++..+|+.||+|+|+ .+
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~g 717 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QG 717 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cc
Confidence 12367799999988887777654332456678899999999999996 78
Q ss_pred eEEcCCCCCcEEecCCCcEEEeeecceeecC-----------------CCCCccccccccccccccccccCCC---CcCc
Q 047591 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD-----------------GVDSMKQTMTLATIGYMAPEYGSEG---IVST 1515 (1624)
Q Consensus 1456 iiHrDlK~~NILld~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~APE~~~~~---~~~~ 1515 (1624)
||||||||.||++|++..+||+|||+|.... .......+..+||.-|+|||...+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0112245667899999999987654 4999
Q ss_pred ccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHcccc
Q 047591 1516 SGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEE 1595 (1624)
Q Consensus 1516 k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~ 1595 (1624)
|+|+||+|||++||+. ||.-.......+.......+|.. .+..+ ..+..-.+++...++.
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~----------------~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFD----------------PEHPEEASLIRWLLSH 857 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccc----------------ccchHHHHHHHHHhcC
Confidence 9999999999999985 55432111112222212222222 11111 1122345788899999
Q ss_pred CCCCCCCHHHHHH
Q 047591 1596 IPEERMNVKDALA 1608 (1624)
Q Consensus 1596 ~P~~RPt~~evl~ 1608 (1624)
||.+|||+.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=360.51 Aligned_cols=255 Identities=19% Similarity=0.270 Sum_probs=196.7
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCe
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGF 1405 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~ 1405 (1624)
....++|...+.||+|+||+||+|+.. .+..+|+|++... .......|..|+.++++++|||||++++++.. .+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344567888899999999999999875 4678999988643 23445789999999999999999999998754 456
Q ss_pred eEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcC----CCceEEcCCCCCcEEecC--------
Q 047591 1406 KALILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGY----STSIIHCDLKPSNVLLDD-------- 1470 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~----~~~iiHrDlK~~NILld~-------- 1470 (1624)
.++||||+++|+|.++|... ...+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999753 346899999999999999999999632 146999999999999964
Q ss_pred ---------CCcEEEeeecceeecCCCCCccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCC
Q 047591 1471 ---------DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDM 1539 (1624)
Q Consensus 1471 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~ 1539 (1624)
...+||+|||+++.+.... ......||+.|||||++.. ..++.++||||||||+|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3458999999998764322 2234579999999998743 45899999999999999999999999643
Q ss_pred CccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1540 FTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1540 ~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..... ++ ..+.... .. .....+..+.+++..||+.+|++||++.|++.
T Consensus 247 ~~~~q----li---------~~lk~~p--~l------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQ----LI---------SELKRGP--DL------PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHH----HH---------HHHhcCC--CC------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21111 10 0010000 00 00112456788999999999999999999984
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=324.82 Aligned_cols=250 Identities=18% Similarity=0.315 Sum_probs=184.8
Q ss_pred eEeecCceEEEEEEEcCCc---eEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCC
Q 047591 1342 LLGTGIFSSVYKATFADGT---NAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~~~~---~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gs 1417 (1624)
.||+|+||+||+|...++. .+++|.+.... ....+.|.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999765433 35666655332 3456789999999999999999999999999999999999999999
Q ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-ccc
Q 047591 1418 LEKWLYSHN---YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQ 1493 (1624)
Q Consensus 1418 L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-~~~ 1493 (1624)
|.+++++.. ...++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998642 335666778899999999999996 7899999999999999999999999999864322111 112
Q ss_pred cccccccccccccccCC-------CCcCcccchHHHHHHHHHHHcC-CCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1494 TMTLATIGYMAPEYGSE-------GIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~-------~~~~~k~DV~SfGvil~Elltg-~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
....|+..|+|||+... ..++.++|||||||++|||+++ ..||...... ..+........ ....++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~----~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQ----VKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhcc----cccCCCc
Confidence 23468899999998643 2457899999999999999975 6677543211 11111111100 0111111
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
+.. .....+.+++..|| .+|++||+++|+++.|.
T Consensus 234 ~~~-----------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LEL-----------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCC-----------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 12345677888999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.26 Aligned_cols=201 Identities=29% Similarity=0.379 Sum_probs=178.4
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQ---LDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|-||.||.|+. +++..||+|++... ..+...++.+|++|-+.++||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46788999999999999999985 46789999998532 233456889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 819 LEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
+||.+.|+++..|++.. ..+++.....++.|+|.|+.|+|. +.||||||||+|+|++.++..||+|||.+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998543 358888888999999999999998 459999999999999999999999999987654
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
.....+.+||..|.|||.......+.++|+|++||+.||++.|..||....
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 233445689999999999999999999999999999999999999998755
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=322.24 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=192.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-----hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-----EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-----~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~ 1406 (1624)
.+|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999874 5889999987532 12345678999999999999999999998865 3567
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++++|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999997654 47888899999999999999995 789999999999999999999999999998654
Q ss_pred CCCC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1487 GVDS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1487 ~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.... .......++.+|+|||+..+..++.++|||||||++|||+||+.||.+...... .. +...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~------------~~~~- 223 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IF------------KIAT- 223 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HH------------HHhc-
Confidence 3211 111234588999999999888899999999999999999999999865321111 00 0000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..... ..+..+...+.+++ +||..+|++||+|+|+++
T Consensus 224 --~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 --QPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00000 00111223344454 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=335.00 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=205.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccchh---hHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQED---RALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~---~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+.|...+.||+|.||+||+++... |+.+|+|++..... ...+...+|+++|+++. |||||.+++.|++++..++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 345666889999999999998764 99999999865433 24568899999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC----CcEEEeeecceeec
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD----MVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~----~~~kl~DFGla~~~ 1485 (1624)
||++.+|.|.+.+.+. . ++......++.||+.|++|||. .+|+|||+||+|+|+... +.+|++|||+|...
T Consensus 115 mEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999999776 3 7888889999999999999996 899999999999999643 47999999999988
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
.. .......+||+.|+|||++....|+..+||||.||++|.|++|..||.+....+... .+....
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------~i~~~~ 254 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------AILRGD 254 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------HHHcCC
Confidence 65 334456789999999999999999999999999999999999999997643222211 111111
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ......+......+.+++.+++..||.+|+|+.+++++
T Consensus 255 ~-----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 F-----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C-----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 00111223445667889999999999999999999984
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=317.75 Aligned_cols=204 Identities=28% Similarity=0.368 Sum_probs=175.9
Q ss_pred CCCCCcceeecCCccceEEEE-ecCCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
+.|...+.||.|..++||+|+ .+.++.||||++..+.. ...+.+.+|+..|+.++|||||+++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 457777899999999999998 46789999999987654 3458899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 822 MPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|.+||+.+.++..- ..+++..+..|.+++++||.|||+. +-||||||+.|||||++|.+||+|||.+..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 99999999997642 3588888999999999999999995 5899999999999999999999999987655432211
Q ss_pred --cc-ccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHcCCCCCCccCc
Q 047591 901 --TQ-TMTLATFGYMAPEYGS--EGIVSTCGDVYSFGILMIETFTRKMPTDEMFT 950 (1624)
Q Consensus 901 --~~-~~~~gt~~Y~aPE~~~--~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~ 950 (1624)
.. .+.+||+.|||||++. -..|+.|+|||||||+..|+++|..||..+.+
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 11 3458999999999853 34589999999999999999999999987543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=300.21 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=205.0
Q ss_pred hCCCCcCCeEeecCceEEEEEE-EcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----CeeE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-----GFKA 1407 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~-~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-----~~~~ 1407 (1624)
.+.|...+.+|+|||+-||.++ ..++..+|+|++.....+..+..++|++..++++|||++++++++..+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3567777899999999999997 457888999988766677788899999999999999999999987543 3589
Q ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1408 LILQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
|+++|...|||.+.+.. .+..++..+.+.|+.+|++||++||+ ..++.+||||||.|||+.+++.+++.|||-+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999998864 35678999999999999999999996 345799999999999999999999999998875
Q ss_pred cCCCC--C------ccccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc
Q 047591 1485 LDGVD--S------MKQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1485 ~~~~~--~------~~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
..-.- . ........|..|+|||.+. +...++++|||||||+||+|+.|..||+..+..+..+...+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~-- 256 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ-- 256 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee--
Confidence 43110 0 0112235789999999753 456799999999999999999999999754432222111110
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
...+. .+.....+..+.+++.+|++.||.+||++.|++..++.+
T Consensus 257 ---------n~q~s-------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 257 ---------NAQIS-------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------ccccc-------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 00000 000012456788999999999999999999999988765
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=326.87 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=198.5
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+|...+.||+|+||+||+|.+. ++..+|+|.++.. .+...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4566788999999999999886 6889999988643 3344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1414 PQGSLEKWLYSH--NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++++|.+++... ...+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++.+...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999999998764 2368999999999999999999995 358999999999999999999999999999765322
Q ss_pred cccccccccccccccccCCC------CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1492 KQTMTLATIGYMAPEYGSEG------IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~------~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
......|+++|+|||+..+. .++.++|||||||++|||+||+.||........ .. ......+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~---------~~~~~~~~~ 226 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FA---------QLSAIVDGD 226 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HH---------HHHHHhhcC
Confidence 12234688899999987543 358899999999999999999999864211110 00 011111100
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
... .+..+...+.+++.+||+.+|++||+++|++..
T Consensus 227 ~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPT--------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCC--------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 000 011245667889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=325.60 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=197.4
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|...+.||+|+||+||+|+.. ++..||||+++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3566788999999999999875 68899999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1413 MPQGSLEKWLYSH--NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
++ |+|.+++... +..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 6899888643 2568899999999999999999996 799999999999999999999999999998654321
Q ss_pred ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhH---HHHHh
Q 047591 1491 MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAV---TDVID 1563 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~---~~~~d 1563 (1624)
.......+++.|+|||+..+ ..++.++|||||||++|||+||+.||......... ..... ......+ ...-+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL-FRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhcchhhHH
Confidence 12223467899999998754 45789999999999999999999998643211110 00000 0000000 00000
Q ss_pred --hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 --ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 --~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.................+..++.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000011224567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=324.68 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=200.5
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
|+..+.||+|+||.||+|+.. ++..||+|++.... ....+.|.+|++++++++||||+++++++.+....++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 455678999999999999875 57889999886443 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++... .+++.+...++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||+++...... ....
T Consensus 86 ~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06640 86 GGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence 99999998653 47888899999999999999996 799999999999999999999999999998764332 2223
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
...++..|+|||+..+..++.++|||||||++|||+||+.|+.+....... ..+......
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------------~~~~~~~~~------ 219 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--------------FLIPKNNPP------ 219 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--------------hhhhcCCCC------
Confidence 346888999999998888999999999999999999999998754321110 000000000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....++..+.+++.+||+.+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 -TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0112345668899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=362.85 Aligned_cols=455 Identities=30% Similarity=0.368 Sum_probs=344.5
Q ss_pred cCCccccCCCcccEEEecCCCccccCCc-ccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccc
Q 047591 104 TIPPHVANLSFLVSLNISGNRFHGTLPN-ELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSL 182 (1624)
Q Consensus 104 ~ip~~i~~L~~L~~L~Ls~N~l~g~iP~-~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l 182 (1624)
-||..|..-..|+.|+++.|.+- ..|- .+...-+|+.|||++|+++. .|..+ ..+..|+.|+++.|.|. .+|.+.
T Consensus 12 ~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~~-fp~~i-t~l~~L~~ln~s~n~i~-~vp~s~ 87 (1081)
T KOG0618|consen 12 LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQISS-FPIQI-TLLSHLRQLNLSRNYIR-SVPSSC 87 (1081)
T ss_pred ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeecccccccc-CCchh-hhHHHHhhcccchhhHh-hCchhh
Confidence 37777877778999999999886 3443 33445569999999999974 45444 56889999999999998 789999
Q ss_pred cCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCc
Q 047591 183 GDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQ 262 (1624)
Q Consensus 183 ~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ 262 (1624)
+++.+|++|.|..|.+. ..|.++..+++|++|++|.|+|. .+|..+..++.++.++.++|...-.++ . ...+
T Consensus 88 ~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg-----~-~~ik 159 (1081)
T KOG0618|consen 88 SNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG-----Q-TSIK 159 (1081)
T ss_pred hhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc-----c-ccch
Confidence 99999999999999999 89999999999999999999997 899999999999999999993322222 2 2388
Q ss_pred EeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCc
Q 047591 263 ELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNL 342 (1624)
Q Consensus 263 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L 342 (1624)
.++|..|.+.+.++..+++++. .|||++|.+..+ .+.++.+|+.|....|+++- +-...++|
T Consensus 160 ~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~-----------dls~~~~l~~l~c~rn~ls~-----l~~~g~~l 221 (1081)
T KOG0618|consen 160 KLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL-----------DLSNLANLEVLHCERNQLSE-----LEISGPSL 221 (1081)
T ss_pred hhhhhhhhcccchhcchhhhhe--eeecccchhhhh-----------hhhhccchhhhhhhhcccce-----EEecCcch
Confidence 8999999999999999999988 899999987532 34567889999999999872 22356789
Q ss_pred cEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccc
Q 047591 343 LRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLR 422 (1624)
Q Consensus 343 ~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~ 422 (1624)
+.|+.++|.++...+.. --.+|+++|+|+|++++.+ ++++.|.+|+.|+..+|+|... +..+...+
T Consensus 222 ~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~l--------p~ri~~~~--- 287 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDVHP--VPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVAL--------PLRISRIT--- 287 (1081)
T ss_pred heeeeccCcceeecccc--ccccceeeecchhhhhcch-HHHHhcccceEecccchhHHhh--------HHHHhhhh---
Confidence 99999999998433322 2358999999999999887 9999999999999999998542 22222233
Q ss_pred eeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccc-hhccccc-cceeccc
Q 047591 423 YLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPT-TVGKLQN-LQGLDLS 500 (1624)
Q Consensus 423 ~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~-~~~~l~~-L~~L~Ls 500 (1624)
+|+.|....|++. -+|+....+++|+.|+|..|+|. .+|+ .+..+.. |..|+.+
T Consensus 288 ----------------------~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s 343 (1081)
T KOG0618|consen 288 ----------------------SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVS 343 (1081)
T ss_pred ----------------------hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhh
Confidence 4555555555554 35666677778888888888875 3444 3333333 6777777
Q ss_pred ccccccCCCcc-ccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCC
Q 047591 501 YNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579 (1624)
Q Consensus 501 ~N~l~g~iP~~-l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~ 579 (1624)
.|.++ ..|.. =..+..|+.|+|.+|+|+...=+.+-+...|+.|+|++|+|.......+.+++.|+.|+||+|+|+ .
T Consensus 344 ~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~ 421 (1081)
T KOG0618|consen 344 SNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-T 421 (1081)
T ss_pred hcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-h
Confidence 77777 44421 123456777788888887666666777777888888888775433335667777788888888887 5
Q ss_pred CCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCC-CCCch
Q 047591 580 LPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ-GSIPE 630 (1624)
Q Consensus 580 iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~-g~iP~ 630 (1624)
+|+++.++..|++|...+|++. ..| ++.++++|+.+|+|.|+|+ +.+|.
T Consensus 422 Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~ 471 (1081)
T KOG0618|consen 422 LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPE 471 (1081)
T ss_pred hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhh
Confidence 7777888888888888888877 466 7777888888888888775 34444
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=320.28 Aligned_cols=249 Identities=28% Similarity=0.506 Sum_probs=200.1
Q ss_pred CcCCeEeecCceEEEEEEEcC-----CceEEEEEeccchhh-HHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1338 SESNLLGTGIFSSVYKATFAD-----GTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1338 ~~~~~lG~G~~G~Vyk~~~~~-----~~~vAvK~~~~~~~~-~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
...+.||+|+||.||+|++.+ +..||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 345789999999999998864 377999998654332 56789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1412 YMPQGSLEKWLYSHNYL-LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|+++++|.+++...... +++.++..++.|++.|++|||+ .+++||||||+||++++++.+|++|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999865443 8999999999999999999996 7999999999999999999999999999987654432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.......+++.|+|||......++.++||||+||+++||++ |+.|+...... .....+. ......
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~-----------~~~~~~- 224 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLK-----------KGYRLP- 224 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh-----------cCCCCC-
Confidence 22222347889999999988889999999999999999999 77787642111 1111110 000000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
....++..+.+++.+|+..+|++|||+.|+++.|
T Consensus 225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0112456788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=351.38 Aligned_cols=273 Identities=21% Similarity=0.256 Sum_probs=196.8
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCC------ceeEEEee
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHR------NLAKIVSS 1399 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~Hp------NIv~l~g~ 1399 (1624)
.+++...+++|...+.||+|+||+||+|... .++.||||+++... ...+.+..|++++++++|. ++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3455566788999999999999999999875 57889999986322 2334566788888877654 58899998
Q ss_pred eccC-CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC------
Q 047591 1400 CSNP-GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM------ 1472 (1624)
Q Consensus 1400 ~~~~-~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~------ 1472 (1624)
+..+ +..++||||+ +++|.+++.+. ..+++..+..|+.||+.||+|||+ ..+||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence 8654 5688999988 67899988765 357889999999999999999995 25899999999999998765
Q ss_pred ----------cEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCcc
Q 047591 1473 ----------VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTG 1542 (1624)
Q Consensus 1473 ----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~ 1542 (1624)
.+||+|||.+.... ......+||+.|||||++.+..++.++|||||||++|||+||+.||+.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999876432 1234467999999999999999999999999999999999999999753221
Q ss_pred chhhhhh--hhhcCChhH---------HHHHhhh--ccCCchHHHH--------HHHHHhHHHHHHHHHHccccCCCCCC
Q 047591 1543 EVCLKHW--VEESLPDAV---------TDVIDAN--LLSGEEEADI--------AAKKKCMSSVMSLALKCSEEIPEERM 1601 (1624)
Q Consensus 1543 ~~~l~~~--~~~~~~~~~---------~~~~d~~--l~~~~~~~~~--------~~~~~~~~~~~~l~~~C~~~~P~~RP 1601 (1624)
+. +... .....+..+ .+.++.. +......... .........+.+|+.+|++.||++||
T Consensus 352 ~~-~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 EH-LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HH-HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 11 1100 001111111 1111110 0000000000 00001134577999999999999999
Q ss_pred CHHHHHHH
Q 047591 1602 NVKDALAN 1609 (1624)
Q Consensus 1602 t~~evl~~ 1609 (1624)
|++|++++
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999863
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=332.69 Aligned_cols=193 Identities=22% Similarity=0.294 Sum_probs=158.2
Q ss_pred CCeEeecCceEEEEEEEc---CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeEEEEEecC
Q 047591 1340 SNLLGTGIFSSVYKATFA---DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKALILQYMP 1414 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~lV~ey~~ 1414 (1624)
...||+|+||+||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999865 45779999886432 23457889999999999999999998854 456789999986
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe----cCCCcEEEeeecce
Q 047591 1415 QGSLEKWLYSH--------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1415 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~kl~DFGla 1482 (1624)
++|.+++... ...+++.....++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4888887532 1247888889999999999999996 799999999999999 45679999999999
Q ss_pred eecCCCCC--ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1483 KLLDGVDS--MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1483 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
+....... .......||+.|||||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87643221 12234578999999998766 4689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=330.92 Aligned_cols=196 Identities=26% Similarity=0.403 Sum_probs=173.5
Q ss_pred CCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 746 FSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
|...+.||+|+-|.|-.|++ .+|+.+|||++.... +.......+|+.+|+-+.|||++++++.++++.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 45567899999999999985 689999999997542 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
+++|.|.+++..++ .+++.++.+++.||..|++|+|..+ |+|||+||+|+|||..+.+||+|||+|....++.-
T Consensus 94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl-- 167 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL-- 167 (786)
T ss_pred cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc--
Confidence 99999999998765 7888899999999999999999965 99999999999999999999999999987654432
Q ss_pred cccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 902 QTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
-.+.||+|.|.|||++.+..| ..++||||+|||||.++||+.||++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 223589999999999988877 6789999999999999999999984
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=324.20 Aligned_cols=248 Identities=27% Similarity=0.361 Sum_probs=201.4
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+|...+.||.|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4666788999999999999875 57889999986543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|.+++... .+++.++..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||+++.+.... ...
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 999999999764 67899999999999999999996 789999999999999999999999999998875432 223
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|++.|+|||+..+..++.++|||||||++|||+||+.||........ . . .+..........
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-~-~------------~~~~~~~~~~~~- 220 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-L-F------------LIPKNNPPSLEG- 220 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-H-H------------HhhhcCCCCCcc-
Confidence 345688999999999888899999999999999999999999864321110 0 0 000000000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++..+.+++.+||..+|++|||++++++.
T Consensus 221 -----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 -----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0134567889999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=328.22 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=198.0
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 334467999999999999875 57889999886433 3445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+++|.+++.. ..+++..+..++.|+++|++|||+ .+|+|+||||+||++++++.+|++|||+++.+.... ....
T Consensus 86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 86 GGSALDLLKP--GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 9999998864 357889999999999999999996 799999999999999999999999999998764322 1222
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
...|+..|+|||+..+..++.++|||||||++|||+||+.|+.+...... ..+.....+ +.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~--------~~~-------- 221 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPKNSP--------PTL-------- 221 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--HhhhhcCCC--------CCC--------
Confidence 34688999999999888899999999999999999999999865322111 111100000 000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...++..+.+++.+||+.+|++||+|.|+++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01234567889999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=340.14 Aligned_cols=266 Identities=23% Similarity=0.253 Sum_probs=196.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------C
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------G 1404 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~ 1404 (1624)
.++|...+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 467888899999999999999764 5788999988643 234456788999999999999999999987543 3
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++||||+++ ++.+++.. .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 56999999975 67776653 37888889999999999999996 7999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh----------cC
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE----------SL 1554 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~----------~~ 1554 (1624)
.... .......||+.|+|||+..+..++.++|||||||++|||++|+.||......+. ....+.. ..
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhh
Confidence 5432 222345789999999999888899999999999999999999999965321111 0000000 00
Q ss_pred ChhHHHHHhhhcc-C----------CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 PDAVTDVIDANLL-S----------GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~-~----------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.......++.... . .....+..........+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0111111110000 0 00000000111224567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=326.33 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=192.8
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhc---CCCceeEEEeeecc-----CCe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRI---RHRNLAKIVSSCSN-----PGF 1405 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l---~HpNIv~l~g~~~~-----~~~ 1405 (1624)
|...+.||+|+||+||+|+.. +++.||+|.++... ......+.+|+++++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 666788999999999999875 58899999886432 22234566787777765 79999999998754 345
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1406 KALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
.++||||++ ++|.+++... ...++++++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 789999998 4898888754 3458899999999999999999996 7899999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHH
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDV 1561 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~ 1561 (1624)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+ .+..... ......+...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCccc
Confidence 64322 2233568999999999988889999999999999999999999986432211 1111110 0000000000
Q ss_pred Hh---hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1562 ID---ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1562 ~d---~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. .................+...+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000000000111234566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=327.74 Aligned_cols=268 Identities=23% Similarity=0.278 Sum_probs=201.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777789999999999999986 47899999875432 2245678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++++++.++.... ..+++.++..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 99999998877643 347999999999999999999996 789999999999999999999999999998764432 2
Q ss_pred cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccch--hhhhhhhhcCChhHHHHHhh----
Q 047591 1492 KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV--CLKHWVEESLPDAVTDVIDA---- 1564 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~--~l~~~~~~~~~~~~~~~~d~---- 1564 (1624)
......++..|+|||+..+ ..++.++|||||||++|||+||+.||......+. .+..+. ..+........+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-GNLIPRHQEIFQKNPLF 234 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh-CCCchhhHHHhccchHh
Confidence 2233568899999998764 4578899999999999999999988854321110 011111 1111111111110
Q ss_pred --hccCCch--HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 --NLLSGEE--EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 --~l~~~~~--~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
....... .........++..+.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 0001111245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=322.43 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=196.7
Q ss_pred CcCCeEeecCceEEEEEEEcC-CceEEEEEeccchhhH--HHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1338 SESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRA--LKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1338 ~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~~~--~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
...+.||+|+||+||+|+... ++.+|+|++....... .....+|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 345789999999999998864 5689999997654322 2344669999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++.++|+|||.+.... .......
T Consensus 82 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 82 GGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred cccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999983 3457899999999999999999997 799999999999999999999999999998642 1222334
Q ss_pred ccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...+|..|+|||+.. +..++.++||||+|+++|||++|+.||....... ........ ..........
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~----~~~~~~~~~~------ 224 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKI----LKRPLPSSSQ------ 224 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHH----HHTHHHHHTT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhc----cccccccccc------
Confidence 457899999999988 8889999999999999999999999987641100 00000000 0000000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
........+.+++.+|++.+|++||++.|+++
T Consensus 225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011367889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=339.68 Aligned_cols=266 Identities=23% Similarity=0.252 Sum_probs=196.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------C
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------G 1404 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~ 1404 (1624)
.++|...+.||+|+||+||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888899999999999999864 5788999998643 234456788999999999999999999987543 3
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++||||+++ ++.+++.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 57999999975 77777753 36888899999999999999996 7999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh----------cC
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE----------SL 1554 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~----------~~ 1554 (1624)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ....+.. .+
T Consensus 176 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 176 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhh
Confidence 5432 122345789999999999988999999999999999999999999965322111 1111110 00
Q ss_pred ChhHHHHHhhhc-cCCch----------HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 PDAVTDVIDANL-LSGEE----------EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 ~~~~~~~~d~~l-~~~~~----------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+...+...- ..... .............+.+++.+|++.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000011110000 00000 00000001123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=327.93 Aligned_cols=261 Identities=26% Similarity=0.322 Sum_probs=203.0
Q ss_pred cCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeecc
Q 047591 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSN 1402 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~ 1402 (1624)
+..+++..++++|...+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445666677899999999999999999999874 67889999886432 2345678899999999 89999999999865
Q ss_pred C-----CeeEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1403 P-----GFKALILQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1403 ~-----~~~~lV~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
. +..++||||+++|+|.++++. .+..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 358999999999999998863 34568899999999999999999996 799999999999999999999
Q ss_pred EEeeecceeecCCCCCccccccccccccccccccCCC-----CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhh
Q 047591 1475 HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG-----IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW 1549 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~ 1549 (1624)
||+|||+++....... ......|+..|+|||+.... .++.++|||||||++|||++|+.||....... .+..+
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~ 245 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKI 245 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHH
Confidence 9999999886543221 22234688999999986543 36899999999999999999999986532111 11111
Q ss_pred hhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1550 VEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....+ .+. .+.+....+.+++.+||+.+|++||++.|+++.
T Consensus 246 ~~~~~~---------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPPP---------TLL---------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCCC---------CCC---------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 100000 000 011233467889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=317.85 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=198.7
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeecc-CCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSN-PGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-~~~~~lV~e 1411 (1624)
+|...+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4667789999999999999875 57889999886432 3445678999999999999999999998764 446789999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1412 YMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|+++++|.+++... ...+++.++..++.+++.|++|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999864 4458999999999999999999996 7999999999999999999999999999987643222
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......|++.|+|||+..+..++.++|||||||+++||++|+.||+....... ....... ....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~-------------~~~~- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEG-------------KLPP- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhc-------------CCCC-
Confidence 22334689999999999988999999999999999999999999864321110 0000000 0000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+......+.+++.+|++.+|++|||+.|++++
T Consensus 222 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=323.22 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=196.9
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
|.....||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 455678999999999999874 57889999885322 12346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999765 357888889999999999999996 789999999999999999999999999998765
Q ss_pred CCCC-----ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1487 GVDS-----MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1487 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
.... .......|+..|+|||+..+..++.++|||||||++|||+||+.||....... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~------------~~~ 224 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AI------------FKI 224 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HH------------HHH
Confidence 2211 11122458899999999988889999999999999999999999997532111 00 000
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. ..... .+..++..+.+++.+||+.+|++||++.|+++
T Consensus 225 ~~-~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GE-NASPE-------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hc-cCCCc-------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 00000 01123456788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=318.60 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=198.6
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-----hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-----DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-----~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
|...+.||+|+||+||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 556788999999999999886 78999999886433 235578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++.+.. .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999997653 47889999999999999999996 799999999999999999999999999988764322
Q ss_pred ccccccccccccccccccCCCC-cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGI-VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~-~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......|+..|+|||...... ++.++|||||||++|||++|+.||....... ....+... ... .
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~-----------~~~-~- 221 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS-----------KEL-P- 221 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc-----------ccC-C-
Confidence 223456889999999887666 8999999999999999999999986532111 01000000 000 0
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..+..+...+.+++.+||+.+|++||++.|++.
T Consensus 222 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 001123456778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=334.91 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=174.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 817 (1624)
.++|...++||+|+||+|+++..+ +++.+|||+++... ....+..+.|..|+.... ||.+++|+.+|++.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 357888999999999999999875 67899999998653 345678889999998875 9999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+.|||+..+.+ ...+++..+.-||..|+.||+|||++ +|||||||-+|||+|.+|++||+|||++|.....
T Consensus 447 vmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999999555443 34688988899999999999999995 5999999999999999999999999999975433
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. ...+.+|||.|||||++.+..|+..+|.|||||++|||+.|..||..
T Consensus 522 g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 522 GD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred CC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 33 34456899999999999999999999999999999999999999863
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=323.19 Aligned_cols=253 Identities=25% Similarity=0.453 Sum_probs=196.5
Q ss_pred CCcCCeEeecCceEEEEEEEc----CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC------
Q 047591 1337 FSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG------ 1404 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~------ 1404 (1624)
|...++||+|+||+||+|.+. .+..||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345678999999999999864 3578999988643 3345678999999999999999999999885432
Q ss_pred eeEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeee
Q 047591 1405 FKALILQYMPQGSLEKWLYSH-----NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
..++++||+++|+|.+++... ...+++....+++.|++.|++|||+ .+|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999987532 2347888999999999999999996 78999999999999999999999999
Q ss_pred cceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1480 GIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1480 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
|+++........ ......+++.|++||......++.++|||||||++|||++ |+.|+...... .+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~----- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIK----- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHc-----
Confidence 999866432211 1222345678999999988889999999999999999999 78887643221 11111110
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
...... ...++..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 231 ------~~~~~~--------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 ------GNRLKQ--------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------CCcCCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 012345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=320.59 Aligned_cols=245 Identities=26% Similarity=0.453 Sum_probs=196.1
Q ss_pred CCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+|...+.||+|+||.||+|.. .++.||+|..+... ..+.|.+|+.++++++||||+++++++... ..++||||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 466678999999999999975 67789999886432 346789999999999999999999998654 47999999999
Q ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1416 GSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1416 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
|+|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++..... ..
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~ 155 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VD 155 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc----CC
Confidence 99999998653 457899999999999999999996 79999999999999999999999999999865321 11
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....+..|+|||+..++.++.++|||||||++|||++ |+.||......+ .. +.+.......
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~------------~~~~~~~~~~---- 217 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VK------------ECVEKGYRME---- 217 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HH------------HHHhCCCCCC----
Confidence 2234568999999988899999999999999999998 898886532111 11 1111111000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
....++..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 012345667899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=323.80 Aligned_cols=267 Identities=21% Similarity=0.250 Sum_probs=202.0
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|...+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 566788999999999999875 68899999986543 344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+++|.+++......+++.++..++.||++||+|||+ .+|+||||||+||+++.++.++|+|||+++..........
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 999999998766778999999999999999999996 7999999999999999999999999999987654332223
Q ss_pred cccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC----ChhHHHHHh---hh
Q 047591 1494 TMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL----PDAVTDVID---AN 1565 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~----~~~~~~~~d---~~ 1565 (1624)
....|+..|+|||+..+ ..++.++||||+||++|||+||+.||......+ .+ .++.... +....+..+ ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QL-AIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HH-HHHHHHcCCCChHHHhhccCcchhh
Confidence 34568999999998754 446899999999999999999987775432111 11 1111110 000110000 00
Q ss_pred ---ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1566 ---LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1566 ---l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...................+.+++.+|++.+|++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000001112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=324.12 Aligned_cols=250 Identities=28% Similarity=0.344 Sum_probs=193.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHH-HHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEV-MRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~-l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||.||+|+.. +|+.||+|+++... .....++..|+.+ ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36777889999999999999875 58999999886442 2233455566665 667799999999999999999999999
Q ss_pred ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|++ |+|.+++.. .+..+++..+.+++.||+.||+|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 688888764 33568999999999999999999996 238999999999999999999999999999865422
Q ss_pred CCccccccccccccccccccCC----CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSE----GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~----~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
...+...|+..|+|||+... ..++.++|||||||++|||++|+.||.........+........ .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~ 226 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---------P 226 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC---------C
Confidence 12233468899999998754 45689999999999999999999998643221111111111000 0
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+ . ...++..+.+++.+||+.+|++|||++|+++
T Consensus 227 ~~---~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QL---P-------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC---C-------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 0123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=318.81 Aligned_cols=248 Identities=21% Similarity=0.346 Sum_probs=200.8
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|+..+.||+|+||.||+++.. +|+.+|+|.+... .....+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 666789999999999999764 6789999988643 2344568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++++|.+++... ...+++.++++++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 999999999764 3457899999999999999999996 7999999999999999999999999999987643221 1
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
.....|++.|+|||+..+..++.++|||||||+++||+||+.|+...... +.++..+......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----------------~~~~~~~~~~~~~ 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----------------NLVLKIIRGSYPP 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----------------HHHHHHhcCCCCC
Confidence 22346889999999998888999999999999999999999998642111 0111101000000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+..+...+.+++.+||+.+|++||+|+||++.
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 012345568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=357.36 Aligned_cols=257 Identities=25% Similarity=0.441 Sum_probs=208.1
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc----C----CceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA----D----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~----~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~ 1403 (1624)
.+++...+.+|+|+||.|++|... . ...||||.++.. .....+.+..|+++|+.+ +||||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 334444568999999999999753 1 346999998643 335678999999999998 699999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
+..++|+||++.|+|.+++++.+ ..+...+.+.++.|||.||+||++ .++|||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999999766 347888999999999999999995 889999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCCcccccccc--ccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA--TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVC 1545 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~ 1545 (1624)
.++..+||+|||+|+.....+........| ...|||||.+....|+.|+|||||||+|||++| |..||.+..... .
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-E 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-H
Confidence 999999999999999765544433232233 345999999999999999999999999999999 778886532111 1
Q ss_pred hhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1546 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
+..+++ .+ .+...+..|..+++++|+.||+.+|++||++.|+++.++..
T Consensus 531 l~~~l~----------------~G---~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 531 LLEFLK----------------EG---NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHh----------------cC---CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111111 11 12233467888999999999999999999999999999884
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=322.57 Aligned_cols=268 Identities=22% Similarity=0.295 Sum_probs=200.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|.....||+|+||.||+|+.. +++.||+|++.... ....+.|.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35777789999999999999886 58899999886432 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++++++..+.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++++||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 99999888876543 357999999999999999999996 8999999999999999999999999999987654321
Q ss_pred cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh--hhhhhhhcCChhHHHHHhhh---
Q 047591 1492 KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC--LKHWVEESLPDAVTDVIDAN--- 1565 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~--l~~~~~~~~~~~~~~~~d~~--- 1565 (1624)
......++..|+|||+..+ ..++.++|||||||++|||+||+.||.+....+.. .........+ ...+..+..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQFF 234 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhccccccc
Confidence 2223457889999998765 56789999999999999999999999754322111 0111001000 001111100
Q ss_pred --cc-CCch--HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1566 --LL-SGEE--EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1566 --l~-~~~~--~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+. .... ..........+..+.+++.+||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000 0000011223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=327.62 Aligned_cols=192 Identities=22% Similarity=0.298 Sum_probs=157.6
Q ss_pred CeEeecCceEEEEEEEcC---CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeec--cCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFAD---GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS--NPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~---~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~--~~~~~~lV~ey~~~ 1415 (1624)
..||+|+||+||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999998753 4679999886432 2346788999999999999999999884 35677999999875
Q ss_pred CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe----cCCCcEEEeeeccee
Q 047591 1416 GSLEKWLYSH--------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1416 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~kl~DFGla~ 1483 (1624)
+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++++||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 787777521 2247888899999999999999996 799999999999999 566799999999998
Q ss_pred ecCCCCC--ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1484 LLDGVDS--MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1484 ~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 7643221 12234578999999998765 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=342.23 Aligned_cols=265 Identities=21% Similarity=0.207 Sum_probs=196.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc---CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA---DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
..|...+.||+|+||.||+|... .+..||||.+... +.+.+|++++++++|||||++++++...+..++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46788889999999999999754 3567899987532 345689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS- 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~- 1490 (1624)
|+. ++|.+++.. ...+++.+++.|+.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|+.......
T Consensus 167 ~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 167 KYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 996 689888843 4568999999999999999999996 7999999999999999999999999999986653322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccc--hhhhhhhhh------cCCh----hH
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE--VCLKHWVEE------SLPD----AV 1558 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~--~~l~~~~~~------~~~~----~~ 1558 (1624)
.......||+.|+|||++....++.++|||||||++|||++|+.||....... ..+....+. ..+. ..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 12234579999999999998899999999999999999999999986532211 111111100 0000 00
Q ss_pred HHHHhh---hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1559 TDVIDA---NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1559 ~~~~d~---~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+.. ....................+.+++.+|+..+|++|||+.|++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000000000000011223457788999999999999999999875
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=321.35 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=196.5
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch----------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE----------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~----------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
|...+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|++++++++||||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 455689999999999999764 68899999875321 1124578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+++|+|.+++++.+ .+++..+..++.|++.|+.|||+ .+++||||||+||++++++.+|++|||+++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999998763 57888999999999999999996 79999999999999999999999999999765
Q ss_pred CCCCC-ccccccccccccccccccCCCC--cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1486 DGVDS-MKQTMTLATIGYMAPEYGSEGI--VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1486 ~~~~~-~~~~~~~gt~~y~APE~~~~~~--~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
..... .......|+..|+|||+..... ++.++|||||||++|||++|+.|+......+.. ... .
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~------------~ 225 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-FKL------------G 225 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH-HHh------------h
Confidence 43211 1122346889999999876544 899999999999999999999998643211110 000 0
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......... ......++..+.+++.+||+.+|++|||++|+++.
T Consensus 226 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NKRSAPPIP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccCCcCC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000000 00112345678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=318.11 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=200.5
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKALIL 1410 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~lV~ 1410 (1624)
+|...+.||+|+||.||+|... +++.+|+|.+... .....+++.+|++++++++||||+++++++.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3566788999999999999764 6788999988643 23445778999999999999999999998754 45678999
Q ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1411 QYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGY--STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
||+++++|.+++... ...+++..++.++.|++.||+|||..+ ..+|+||||||+||++++++.+||+|||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 456899999999999999999999433 489999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
..... ......|++.|+|||+.....++.++|||||||++|||++|+.||..... ..+.. .+...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~------------~~~~~ 225 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLAS------------KIKEG 225 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHH------------HHhcC
Confidence 54332 12334689999999999888899999999999999999999999865321 11111 11111
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.... .+...+..+.+++.+|++.+|++|||++||++.
T Consensus 226 ~~~~-------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 KFRR-------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCC-------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 011334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=325.07 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=198.8
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++++|...+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4567888899999999999999764 68899999986443 233356789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||++ +++.+++......+.+.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9996 78888776655567888888999999999999996 789999999999999999999999999997653221
Q ss_pred ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhh-hhhhhhcCChh--HHHHHh---
Q 047591 1491 MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL-KHWVEESLPDA--VTDVID--- 1563 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l-~~~~~~~~~~~--~~~~~d--- 1563 (1624)
.......+++.|+|||+..+ ..++.++|||||||++|||+||+.||+........+ ..|.....+.. ......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 11233457899999998765 457899999999999999999999997543211111 11110001100 000000
Q ss_pred --hhccCCchHHHH---HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 --ANLLSGEEEADI---AAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 --~~l~~~~~~~~~---~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
............ .........+.+++.+|++.+|++|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 000112456788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=338.53 Aligned_cols=200 Identities=27% Similarity=0.359 Sum_probs=173.6
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 68999999997532 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999997654 689999999999999999999984 599999999999999999999999999976532110
Q ss_pred ----------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 900 ----------------------------------VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 900 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
......+||+.|+|||++....++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012347999999999998888999999999999999999999998
Q ss_pred Cc
Q 047591 946 DE 947 (1624)
Q Consensus 946 ~~ 947 (1624)
..
T Consensus 237 ~~ 238 (363)
T cd05628 237 CS 238 (363)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=326.29 Aligned_cols=267 Identities=21% Similarity=0.257 Sum_probs=197.9
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|...+.||+|+||.||+|+.. +|+.+|+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 556688999999999999875 68899999886432 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+ ++|.+++......+++.....++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 156 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCY 156 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCc
Confidence 7 58988887666678999999999999999999996 799999999999999999999999999998654322 122
Q ss_pred cccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh---cCChhHH---HHHhhhc
Q 047591 1494 TMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE---SLPDAVT---DVIDANL 1566 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~---~~~~~~~---~~~d~~l 1566 (1624)
....+++.|+|||++.+. .++.++|||||||++|||+||+.|+.........+...... ...+... +..+...
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 334678999999987654 47999999999999999999999864332221111111000 0000000 0001000
Q ss_pred cCCch-H-HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1567 LSGEE-E-ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1567 ~~~~~-~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..... . ............+.+++.+|++.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0 000111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=309.66 Aligned_cols=198 Identities=24% Similarity=0.391 Sum_probs=175.8
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQ---LDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
+|...+.||+|.||+|-+|.. ..|+.||||.++.. .++..-...+|++||+.++||||+.++.+|+..+...+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 455557899999999999974 67999999998643 34455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|..+|.|++|+.+++ .+++.++..|+.||..|+.|+|.+ +++|||+|-+|||+|.++.+||+|||++-.+..+.
T Consensus 134 YaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-- 207 (668)
T KOG0611|consen 134 YASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-- 207 (668)
T ss_pred ecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence 999999999998765 799999999999999999999985 59999999999999999999999999998876543
Q ss_pred ccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.-.+.+|+|-|.+||...+..| .+.+|-||+||+||-++.|.+||+..
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 2334689999999999988777 67899999999999999999999863
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.60 Aligned_cols=199 Identities=29% Similarity=0.413 Sum_probs=179.6
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
-|++...||+|+||.||||.+ +.|+.||||.+... ...++..+|+.+|++.+.|++|++||.+-.+..+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 366778899999999999976 46999999998754 345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
.|+..+.++.+...+++++...|....+.||+|||.. .-||||||+.|||+.-+|.+|++|||+|..+..... ...
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRN 187 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRN 187 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhC
Confidence 9999999998888999999999999999999999984 479999999999999999999999999998865433 334
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
+++|||.|||||++.+-.|+.++||||+|+...||+.|+.||.+..
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 5789999999999999899999999999999999999999998653
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=323.47 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=202.7
Q ss_pred cCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeecc
Q 047591 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSN 1402 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~ 1402 (1624)
++..++..+...|...+.||+|+||.||+|+.. +++.+|+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456666667788888899999999999999874 57889999986543 2345688899999998 79999999999853
Q ss_pred ------CCeeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1403 ------PGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1403 ------~~~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
.+..++||||+++|+|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999999753 3457888889999999999999996 7999999999999999999999
Q ss_pred EeeecceeecCCCCCccccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh
Q 047591 1476 LGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV 1550 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~ 1550 (1624)
|+|||+++....... ......|++.|+|||.+. ...++.++|||||||++|||+||+.||.+........
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 999999876542211 223356899999999865 3568889999999999999999999986532111100
Q ss_pred hhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1551 EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. +....... .....++..+.+++.+||+.+|++|||+.|+++
T Consensus 237 ---------~-~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ---------L-IPRNPPPK------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---------h-HhhCCCCC------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00000000 001234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=324.20 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=197.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56777889999999999999875 67899999986432 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++ +|.+++......+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...... ..
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 984 9999998766678899999999999999999996 799999999999999999999999999987543211 11
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHHHhhh-cc
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDVIDAN-LL 1567 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~~d~~-l~ 1567 (1624)
.....++..|+|||+..+ ..++.++|||||||++|||++|+.||.........+..... ...++......+.. ..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 222357889999998754 55899999999999999999999998654311111111000 00011111110000 00
Q ss_pred ----CCchHHHH-HHHHHh--HHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 ----SGEEEADI-AAKKKC--MSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ----~~~~~~~~-~~~~~~--~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
........ ...... ...+.+++.+|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 000011 256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=331.64 Aligned_cols=266 Identities=22% Similarity=0.239 Sum_probs=195.7
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------ 1403 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------ 1403 (1624)
..+.|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467888899999999999999864 67889999986432 23446788999999999999999999987533
Q ss_pred CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
...+++|||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 3568999988 7899888754 347889999999999999999996 799999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh---cCChhHH
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE---SLPDAVT 1559 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~---~~~~~~~ 1559 (1624)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+... ..++...
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 76432 234578999999998766 57899999999999999999999998643211 111111110 0000000
Q ss_pred HHHh-------hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1560 DVID-------ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1560 ~~~d-------~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+.. ..+..................+.+++.+|++.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000000011233457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=318.10 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=199.3
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 566789999999999999875 688999999865433 36788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|.+++.+. ..+++..+..++.++++|++|||+ .+|+||||||+||++++++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 82 SGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999764 347888999999999999999996 7899999999999999999999999999987654322111
Q ss_pred c---ccccccccccccccCCCC---cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1494 T---MTLATIGYMAPEYGSEGI---VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1494 ~---~~~gt~~y~APE~~~~~~---~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
. ...+++.|+|||+..... ++.++|||||||++|||++|+.||...... ............ +.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~--------~~-- 226 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHK--------PP-- 226 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCCC--------CC--
Confidence 1 346789999999987766 899999999999999999999999653211 111100000000 00
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
......+...+.+++.+||+.+|++|||+.|++.
T Consensus 227 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 -------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001123455778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=323.48 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=196.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
+.|...+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|++++++++||||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34677789999999999999875 6889999988532 2234467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||++ |++.+++......+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++.....
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 68888777655678999999999999999999996 78999999999999999999999999999765432
Q ss_pred ccccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1491 MKQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
....|++.|+|||++. .+.++.++|||||||++|||+||+.|+........ .. ........
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~------------~~~~~~~~ 232 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY------------HIAQNDSP 232 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HH------------HHhcCCCC
Confidence 2346888999999863 46689999999999999999999999864321110 00 00000000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. . ....++..+.+++.+||+.+|++||+|.+++..
T Consensus 233 ~-~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 T-L------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C-C------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0 011245568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=318.16 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=203.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46778899999999999999875 57889999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1413 MPQGSLEKWLYSH--NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
+++++|.+++... ...+++.....++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999754 2467899999999999999999995 7999999999999999999999999999877654322
Q ss_pred c---cccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1491 M---KQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1491 ~---~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
. ......|+..|+|||++... .++.++|||||||++|||++|+.||........ ...+.... +. ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~--------~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQND-PP--------SL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcCC-CC--------Cc
Confidence 2 12334689999999988766 789999999999999999999999875422111 11111110 00 00
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
... ......+..+.+++.+||+.+|++|||++|+++
T Consensus 228 ~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETG------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCc------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 001234566789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=319.87 Aligned_cols=254 Identities=24% Similarity=0.281 Sum_probs=201.7
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+|...+.||+|+||.||+|... +++.+|+|.+.... ....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4566678999999999999886 58889999886543 344578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|.+++......++.....+++.|++.|++|||+ ..+++||||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--- 156 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--- 156 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence 9999999998765678889999999999999999994 37999999999999999999999999999876532211
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|+..|+|||+..+..++.++|||||||++|||++|+.|+.............+ ............
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~--- 225 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL--------QYIVNEPPPRLP--- 225 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH--------HHHhcCCCCCCC---
Confidence 115688999999999888999999999999999999999999865421111111110 001110000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+...+.+++.+||..+|++|||+.|++..
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 ----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01145568899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=325.25 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=198.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36777889999999999999875 47889999886442 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD- 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~- 1489 (1624)
||+++|+|.+++...+ .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997654 57888888999999999999996 799999999999999999999999999987421100
Q ss_pred -------------CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1490 -------------SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1490 -------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
........|+..|+|||+.....++.++|||||||++|||+||+.||.+.... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~---- 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISD---- 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc----
Confidence 00111235788999999988888999999999999999999999998643211 111111100
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
...... ....++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 232 --------~~~~~~------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 --------DIEWPE------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --------ccCCCC------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000 001234567899999999999999997666655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=323.12 Aligned_cols=267 Identities=25% Similarity=0.301 Sum_probs=198.8
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-----hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-----~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
|...+.||+|+||.||+|... +++.||||.+..... ...+.+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 566788999999999999875 688999999864432 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+ +|+|.+++......+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 999999997655468999999999999999999996 7999999999999999999999999999987654321
Q ss_pred ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc-CC--hhHHHH---Hh
Q 047591 1491 MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES-LP--DAVTDV---ID 1563 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~-~~--~~~~~~---~d 1563 (1624)
......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+....... .+ ....+. .+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccccc
Confidence 2223457889999998754 46789999999999999999997776542211 1111111100 00 000000 00
Q ss_pred hhccCC-chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANLLSG-EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~-~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...... ...............+.+++.+||+.+|++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000000112335678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=334.89 Aligned_cols=240 Identities=22% Similarity=0.230 Sum_probs=184.9
Q ss_pred EeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc---CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI---RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l---~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
||+|+||+||+|+.. +++.||||++.... ......+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 58899999986432 22344566777777765 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++.+. ..+++.....++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 9999998764 357888899999999999999996 799999999999999999999999999987543222 12234
Q ss_pred cccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1496 TLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
..||+.|||||++.+. .++.++|||||||++|||+||+.||......+ ..... ......- .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~~~~i------------~~~~~~~-~---- 217 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNI------------AFGKVRF-P---- 217 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-HHHHH------------HcCCCCC-C----
Confidence 5799999999987654 48999999999999999999999986532111 01110 0000000 0
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMN----VKDALA 1608 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt----~~evl~ 1608 (1624)
.......+.+++.+|++.+|++||+ +.|+++
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0112345678999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=323.37 Aligned_cols=198 Identities=24% Similarity=0.356 Sum_probs=172.8
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.|+..+.||+|+||+||+|.. .+|+.||||.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999986 579999999986432 2233467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 821 YMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999999999886543 3689999999999999999999984 599999999999999999999999999987643322
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|||||++....++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 2234699999999999988999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=315.46 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=192.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-----hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--Cee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-----DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-----~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~ 1406 (1624)
++|...++||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46778899999999999999875 58899999875321 23456889999999999999999999988663 467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++|+|.+++.+.. .+++....+++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999997653 46888889999999999999996 789999999999999999999999999998654
Q ss_pred CCCC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1487 GVDS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1487 ~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.... .......|+..|+|||+..+..++.++|||||||++|||++|+.||........ ... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~------------~~~~ 224 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IFK------------IATQ 224 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HHH------------HhcC
Confidence 2211 112234588999999998888899999999999999999999999864311110 000 0000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.... ..+......+.+++.+|+. +|++||+++|+++
T Consensus 225 ~~~~-------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 PTNP-------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCC-------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0000 0011223456677888884 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=315.28 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=201.8
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.+.|..-++||+|+||.||-++.+ +|+.+|.|.+..+ ..........|-+++.+++.|.||.+-..|++++..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356788899999999999999765 6899999987533 223345568899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1410 LQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|..|.+|+|.-+|+..+ ..++.+..+.+|.+|+.||+|||+ ..||.||+||+|||+|++|+++|+|.|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999998765 457888888999999999999996 89999999999999999999999999999988654
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.. ....+||.||||||++..+.|+..+|.||+||++|||+.|+.||...... .-.+.+|.....
T Consensus 341 ~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~eEvdrr~~~ 404 (591)
T KOG0986|consen 341 KP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKREEVDRRTLE 404 (591)
T ss_pred Cc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhHHHHHHHHhc
Confidence 43 33448999999999999999999999999999999999999998542110 011234443333
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVK 1604 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 1604 (1624)
..++. +.+.+++..++....++.||++|....
T Consensus 405 ~~~ey----~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 DPEEY----SDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred chhhc----ccccCHHHHHHHHHHHccCHHHhccCC
Confidence 32221 234556677788888899999998554
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=319.87 Aligned_cols=255 Identities=25% Similarity=0.267 Sum_probs=198.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~lV~ 1410 (1624)
++|...+.||+|++|.||+|... +++.+|+|.+.... ....+++.+|++++++++||||++++++|.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777789999999999999875 57889999886433 2445779999999999999999999998854 34689999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
||+++++|.+++.. ....+++.....++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 34557888999999999999999996 7999999999999999999999999999876532
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCc---cchhhhhhhhhcCChhHHHHHhh
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFT---GEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~---~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.. .....++..|+|||...+..++.++||||+||++|||+||+.|++.... .......|........
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 227 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE------- 227 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh-------
Confidence 21 1234578899999999888999999999999999999999999875421 1111222211100000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+.... ......+..+.+++.+||+.+|++|||+.|+++
T Consensus 228 -~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 -LKDEP-----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -hccCC-----CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00000 000112456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.08 Aligned_cols=270 Identities=20% Similarity=0.280 Sum_probs=217.8
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEee
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSS 1399 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~ 1399 (1624)
.+|+....+.+....++-+|.||.||+|.|.+ .+.|-||.++.. ++-....|..|.-.+..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 35666677788888899999999999998854 344666655422 33456788999999999999999999998
Q ss_pred ecc-CCeeEEEEEecCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC
Q 047591 1400 CSN-PGFKALILQYMPQGSLEKWLYSH-------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD 1471 (1624)
Q Consensus 1400 ~~~-~~~~~lV~ey~~~gsL~~~l~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 1471 (1624)
+.+ .+..+.+|.|+.-|+|..||... .+.+.-.+.+.+|.|++.|++|||. .+|||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 865 46788999999999999999832 2346667788899999999999996 899999999999999999
Q ss_pred CcEEEeeecceeecCCCCCccccc-cccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhh
Q 047591 1472 MVAHLGDFGIAKLLDGVDSMKQTM-TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHW 1549 (1624)
Q Consensus 1472 ~~~kl~DFGla~~~~~~~~~~~~~-~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~ 1549 (1624)
.++|++|=.++|.+.+.+...-.. .-....||+||.+....|+.++|||||||+||||+| |+.||.+....+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 999999999999887665433221 224568999999999999999999999999999998 899987643211
Q ss_pred hhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 047591 1550 VEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKD 1620 (1624)
Q Consensus 1550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~~ 1620 (1624)
....+ . ++.+.+.+..|+++++.+|.-||+..|++||+++|++.-|.++..++..+
T Consensus 507 --------m~~yl----k---dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~Y 562 (563)
T KOG1024|consen 507 --------MEHYL----K---DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRY 562 (563)
T ss_pred --------HHHHH----h---ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhc
Confidence 11111 1 12234556789999999999999999999999999999999998887654
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=325.76 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=196.1
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
..||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999874 57899999987655556678999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccccc
Q 047591 1420 KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499 (1624)
Q Consensus 1420 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 1499 (1624)
+++... .++++++..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++........ ......|+
T Consensus 108 ~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 108 DIVTHT--RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 988543 47889999999999999999996 7899999999999999999999999999876543221 22335689
Q ss_pred cccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHH
Q 047591 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579 (1624)
Q Consensus 1500 ~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 1579 (1624)
..|+|||+..+..++.++|||||||++|||++|+.||....... .... +.... ..... ...
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-~~~~~--------~~~~~---------~~~ 242 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR-IRDNL--------PPRVK---------DSH 242 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhcC--------CCccc---------ccc
Confidence 99999999988889999999999999999999999986421110 0000 00000 00000 001
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1580 KCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1580 ~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....+.+++.+||..+|++|||++|+++.
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 233456788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=323.07 Aligned_cols=269 Identities=25% Similarity=0.306 Sum_probs=201.8
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5777889999999999999876 57889999886432 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++++.+..+..+ ...+++.++..++.||+.|++|||+ .+|+||||||+||++++++.+||+|||+++.........
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 998777665544 3457899999999999999999996 789999999999999999999999999998775443323
Q ss_pred ccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchh-hhhhhhhcCChhHHHHHh--hhcc-
Q 047591 1493 QTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC-LKHWVEESLPDAVTDVID--ANLL- 1567 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~-l~~~~~~~~~~~~~~~~d--~~l~- 1567 (1624)
.....++..|+|||+..+. .++.++|||||||++|||++|+.||......+.. .........+........ ....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345688999999998877 8899999999999999999999998643211110 000000111111000000 0000
Q ss_pred ----CC--chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 ----SG--EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ----~~--~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. ........+..++.++.+++.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000111224677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=356.46 Aligned_cols=540 Identities=20% Similarity=0.219 Sum_probs=348.3
Q ss_pred CCCCcceeecCCccceEEEEec--CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP--YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~--~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 819 (1624)
.|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-+.+. |+|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4555677999999999887653 34556777665432 223344455777777776 999999999999999999999
Q ss_pred EecCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEeCcCCCCCeeeCCCC-ceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWL-YSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~IiHrDlKp~NILld~~~-~~kl~DFGla~~~~~ 896 (1624)
||..+|++.+.+ +......+......+..|+..|+.|+| + .++.|||+||+|.+++..+ ..|++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999988 443324555667779999999999999 5 3599999999999999999 999999999987765
Q ss_pred --CCCcccccccc-cccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHHHHHHHhhhhhhhccc
Q 047591 897 --EDSVTQTMTLA-TFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVD 972 (1624)
Q Consensus 897 --~~~~~~~~~~g-t~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 972 (1624)
+........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++...........|....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---------- 247 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---------- 247 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc----------
Confidence 22222334578 999999998766 4667889999999999999999999875433332222222210
Q ss_pred hhccCchhhhccccCCcccceeeecccccccCCchhhhhchhhhHHhhccCCCccccccccccccccCCcccCcccccee
Q 047591 973 AELLSSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFL 1052 (1624)
Q Consensus 973 ~~Ll~~~~~e~~~l~~~~~L~~Lal~~n~~~g~i~~~i~~l~~L~~l~l~~n~~~~~l~~n~~~~~~p~~~~~~~~l~~~ 1052 (1624)
. ......+...-+.....+.+ .+.
T Consensus 248 --~--------------------~~~~~~~~~~~~~~~~~l~k----------------------~l~------------ 271 (601)
T KOG0590|consen 248 --G--------------------RFTQLPWNSISDQAHDLLHK----------------------ILK------------ 271 (601)
T ss_pred --c--------------------ccccCccccCChhhhhcccc----------------------ccc------------
Confidence 0 00000001000001000000 000
Q ss_pred eeccceeecccccCCccccccccccccccccceeeccccccccCCCccccCCCccccccccccccccccCCccccccccc
Q 047591 1053 ILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132 (1624)
Q Consensus 1053 ~~~~n~~~~~~~~~~~~~g~~~~~~~~~~~l~~l~l~~n~l~G~ip~~~~~~l~~l~~L~L~~N~l~G~iP~~i~~l~~L 1132 (1624)
.+.+. .+.++ + ++. +|-+++
T Consensus 272 -~~~~~-----------------------------------r~s~~-~----~~~-------d~~~~~------------ 291 (601)
T KOG0590|consen 272 -ENPSN-----------------------------------RLSIE-E----LKL-------DNWLSS------------ 291 (601)
T ss_pred -CCchh-----------------------------------ccccc-c----ccc-------cccccc------------
Confidence 00000 00010 0 000 000000
Q ss_pred eEEeccccccccccCCcccCcCccceeeccCCcccCCCCCCCCcccccccccccceeeeccCCCCcccCCCccccccccc
Q 047591 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSL 1212 (1624)
Q Consensus 1133 ~~L~ls~N~lsG~iP~~l~~l~~L~~L~Ls~N~Ls~~~~~~~~~~p~~l~~~~~L~~l~ls~N~l~G~iP~~l~~l~~~l 1212 (1624)
..|.+.+ .
T Consensus 292 -----------------------------~~~~~~~-------------------------~------------------ 299 (601)
T KOG0590|consen 292 -----------------------------KRNGFSK-------------------------S------------------ 299 (601)
T ss_pred -----------------------------ccccccc-------------------------c------------------
Confidence 0011100 0
Q ss_pred ccccccCCccccCCCcccccCCCCCCCCcccCccccccccCCCCCCCCCCCCCCCCCCCCccccceeehhhHHHHHHHHH
Q 047591 1213 EYFFASSTELRGAIPVEFEGEIPSGGPFVNFTAESLMQNLVLGGSSRLQVPPCKTGSSQQSKATRLALRYILPAIATTMA 1292 (1624)
Q Consensus 1213 ~~~~~s~n~l~g~ip~~~~g~ip~~~~~~~~~~~s~~~n~~lcg~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1292 (1624)
| .|..+ .+..... ..
T Consensus 300 --------------------------------------n--~~~~~-----~~~~~~~-~~------------------- 314 (601)
T KOG0590|consen 300 --------------------------------------N--PCADS-----LTIAKSP-IG------------------- 314 (601)
T ss_pred --------------------------------------c--ccccc-----cccccCc-cc-------------------
Confidence 0 00000 0000000 00
Q ss_pred HHHHHHHHhhhccccCCCCcccccccchhccccCHHHHHHHhCCC-CcCCeEeecCceEEEEEEEc-CCceEEEEEec--
Q 047591 1293 VLALIIILLRRRKRDKSRPTENNLLNTAALRRISYQELRLATNGF-SESNLLGTGIFSSVYKATFA-DGTNAAIKIFS-- 1368 (1624)
Q Consensus 1293 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~l~~at~~f-~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~-- 1368 (1624)
-.+.| ...+++|.|++|.|+.+... .....+.|.++
T Consensus 315 ----------------------------------------~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~ 354 (601)
T KOG0590|consen 315 ----------------------------------------FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR 354 (601)
T ss_pred ----------------------------------------cccccCCccceeeecccCceEEEEecCCCccchhhhhhcc
Confidence 00000 12367999999988877543 33334444332
Q ss_pred ---cchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 047591 1369 ---LQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACA 1444 (1624)
Q Consensus 1369 ---~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~g 1444 (1624)
.... .....+..|..+-..+.|||++..+..+.+....+-+||||++ +|...+.+. ..+.-.++-.+..|+..|
T Consensus 355 ~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~G 432 (601)
T KOG0590|consen 355 VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRG 432 (601)
T ss_pred cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHH
Confidence 1111 1222366777778889999999888877776666666999999 999998765 245666777899999999
Q ss_pred HHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC---ccccccccccccccccccCCCCcCcc-cchH
Q 047591 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS---MKQTMTLATIGYMAPEYGSEGIVSTS-GDVY 1520 (1624)
Q Consensus 1445 l~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~k-~DV~ 1520 (1624)
++|+|. .+|.|||+|++|++++.++.+||+|||.+....-... ......+|+.+|+|||+....+|++. +|||
T Consensus 433 v~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiw 509 (601)
T KOG0590|consen 433 VKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVW 509 (601)
T ss_pred HHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhh
Confidence 999996 8999999999999999999999999999876543222 34456789999999999999988775 7999
Q ss_pred HHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCC
Q 047591 1521 SFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600 (1624)
Q Consensus 1521 SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R 1600 (1624)
|.||++..|++|+.||......+... .+.....-.... ..........+.....++.+.++.+|.+|
T Consensus 510 S~~ii~~~m~~~~~~Wk~a~~~~~~~------------~~~~~~~~~~~~-~~~~~~~~~lp~~~~~~~~~~l~~~P~~R 576 (601)
T KOG0590|consen 510 SCGIIYICMILGRFPWKVAKKSDNSF------------KTNNYSDQRNIF-EGPNRLLSLLPRETRIIIYRMLQLDPTKR 576 (601)
T ss_pred hccceEEEEecCCCccccccccccch------------hhhccccccccc-cChHHHHHhchhhHHHHHHHHccCChhhe
Confidence 99999999999999985432221110 000000000000 01111223345556678889999999999
Q ss_pred CCHHHHHH
Q 047591 1601 MNVKDALA 1608 (1624)
Q Consensus 1601 Pt~~evl~ 1608 (1624)
-|+++|++
T Consensus 577 ~ti~~i~~ 584 (601)
T KOG0590|consen 577 ITIEQILN 584 (601)
T ss_pred ecHHHHhh
Confidence 99999986
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.80 Aligned_cols=256 Identities=23% Similarity=0.265 Sum_probs=197.5
Q ss_pred ccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcC-CCceeEEEeee
Q 047591 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIR-HRNLAKIVSSC 1400 (1624)
Q Consensus 1324 ~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~ 1400 (1624)
.....|++.. ..||.|+.|+|+|+++. .|..+|||.+.... ....++....++++.+-+ .|.||+-+|||
T Consensus 88 ~~dindl~~l-------~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 88 QADINDLENL-------GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccChHHhhhH-------HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 3445566543 45999999999999876 58899999986543 345677888888877665 89999999999
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
..+...++.||.|.. .+++.++.-...+++.-.=++...+..||.||.+ ..+|||||+||+|||+|+.|++|+||||
T Consensus 161 i~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 161 ITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred eeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccc
Confidence 999999999999953 5666666555556655556788899999999987 5799999999999999999999999999
Q ss_pred ceeecCCCCCccccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
++..+-+ +...+...|.+.|||||.+. ...|+.++|||||||+++||+||+.||.....+-..+.
T Consensus 238 IsGrlvd--SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt---------- 305 (391)
T KOG0983|consen 238 ISGRLVD--SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT---------- 305 (391)
T ss_pred ccceeec--ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH----------
Confidence 9987743 33445567999999999764 45799999999999999999999999976433222222
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+++.+- .........+..+.++...|+..|+.+||...+++++
T Consensus 306 --kvln~eP------P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 --KVLNEEP------PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --HHHhcCC------CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2222100 0011112356778899999999999999999988764
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=322.71 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=201.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||++++++|...+..++||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 46777789999999999999764 67889999987555555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++.+. .+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 999999999754 46889999999999999999996 7999999999999999999999999999876643322 22
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|++.|+|||+.....++.++|||||||++||+++|+.||........ +..+.....+.
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~----------------- 234 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPE----------------- 234 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhcCCCCC-----------------
Confidence 334688999999998888899999999999999999999999964321111 00000000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+...+..+.+++.+||+.+|++||++.|++.+
T Consensus 235 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011223457789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=314.27 Aligned_cols=248 Identities=22% Similarity=0.398 Sum_probs=199.0
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|...+.||+|+||.||+|... +++.+|||.+... .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 3666789999999999999874 5788999988643 233457899999999999999999999999989999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC-CcEEEeeecceeecCCCCC
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~kl~DFGla~~~~~~~~ 1490 (1624)
+++++|.+++.+. +..+++..+.+++.+++.|++|||+ .+|+||||||+||+++++ +.+|++|||.++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999864 3458999999999999999999996 799999999999999855 568999999998764322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......|+..|+|||...+..++.++|||||||++|||++|+.||+...... ... .........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~-----------~~~~~~~~~-- 220 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVL-----------KIMSGTFAP-- 220 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHH-----------HHHhcCCCC--
Confidence 2223468899999999988889999999999999999999999986432111 110 001000000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+..++..+.+++.+||+.+|++|||+.|+++.
T Consensus 221 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=310.03 Aligned_cols=192 Identities=28% Similarity=0.482 Sum_probs=160.0
Q ss_pred CCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHh--cCCCceeeeeeeeccCC----eEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRR--VRHRNLVKIISSCSNHG----FKALI 818 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV 818 (1624)
.....+.||+|.||+||+|+|. |+.||||+|....+ +.+.+|.+|.+. ++|+||..++++-..+. .+|||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 3445688999999999999996 99999999975543 567788888876 59999999998765443 57999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH-----GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
.||.+.|||+|||.. ..++....++++..+|.||++||. .+.+.|.|||||+.|||+.+++++-|+|+|+|..
T Consensus 288 TdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred eecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999999976 478999999999999999999994 4567899999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccCccccCCCC----C--CcchhHHHHHHHHHHHHcCC
Q 047591 894 LDGEDSV---TQTMTLATFGYMAPEYGSEGI----V--STCGDVYSFGILMIETFTRK 942 (1624)
Q Consensus 894 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~----~--~~k~DvwS~Gvil~elltg~ 942 (1624)
....... .....+||.+|||||++.+.. + -..+||||||.|+||++.+-
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 7654322 233468999999999875432 2 24589999999999998653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=309.79 Aligned_cols=197 Identities=29% Similarity=0.444 Sum_probs=168.6
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCc-eeeeeeeeccCC------e
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRN-LVKIISSCSNHG------F 814 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~ 814 (1624)
.|...+.||+|+||+||+|+. .+|+.||+|++....+ +......+|+.++++++|+| ||+|++++.... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 355556799999999999985 5789999999986643 45567789999999999999 999999998877 7
Q ss_pred EEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeee
Q 047591 815 KALILEYMPQGSLEKWLYSHK---YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla 891 (1624)
.++|+||+.. +|.+++.... ..++...+..++.|+++||+|||++ +|+||||||+|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999975 9999998765 3577788999999999999999995 5999999999999999999999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
+...-. ....+..++|..|.|||++.+. .|++..||||+|||+.||++++.=|.
T Consensus 168 ra~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp 222 (323)
T KOG0594|consen 168 RAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP 222 (323)
T ss_pred HHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence 976522 2224566899999999987655 78999999999999999999875443
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=323.44 Aligned_cols=245 Identities=26% Similarity=0.350 Sum_probs=195.8
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|...+.||+|+||+||+|+.. ++..+|+|++... .....+.+.+|++++++++|||+++++++|.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 445678999999999999875 5788999988632 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++ |++.+++......+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 97 58888887666678999999999999999999996 79999999999999999999999999998765322
Q ss_pred cccccccccccccccc---CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1493 QTMTLATIGYMAPEYG---SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~---~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
....|++.|+|||++ ..+.++.++|||||||++|||++|+.||...... .....+..... ...
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~------------~~~ 244 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES------------PTL 244 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccC------------CCC
Confidence 234688999999986 3467899999999999999999999998643111 11111111100 000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
. ...++..+.+++.+||+.+|++||++.|+++..
T Consensus 245 ~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 245 Q-------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred C-------CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0 012345678899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=319.66 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=196.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4677889999999999999875 68899999886433 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++ ++|.+++... +..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 96 6899988753 4568999999999999999999996 789999999999999999999999999987654322 1
Q ss_pred cccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-cCCh-hH----HHHHhh
Q 047591 1492 KQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-SLPD-AV----TDVIDA 1564 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-~~~~-~~----~~~~d~ 1564 (1624)
......+++.|+|||+..+. .++.++|||||||++|||+||+.||....... ...+.... ..+. .. ....+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 22234578899999987654 46889999999999999999999986432111 11111110 0000 00 000000
Q ss_pred --hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 --NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 --~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
....................+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000001123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=352.48 Aligned_cols=199 Identities=30% Similarity=0.552 Sum_probs=171.7
Q ss_pred CCcceeecCCccceEEEEecC--CC----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 747 SESNLIGAGSFGSVYKATLPY--GM----NVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 747 ~~~~~iG~G~~G~Vy~~~~~~--g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
...+.||+|.||.||+|...+ |. .||||.+.... .+...+|.+|..+|++++|||||+++|.|.+.+..++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 345789999999999998643 43 48999886543 456789999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 820 EYMPQGSLEKWLYSH------KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
|||++|||..||++. ...++..+.+.|+.|||+|+.||++.+ +|||||.++|+|+++...+||+|||+||.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999987 557889999999999999999999954 99999999999999999999999999995
Q ss_pred cCCCCCcccccc-cccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 894 LDGEDSVTQTMT-LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 894 ~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
+-..+....... .-...|||||++..+.+|.|+|||||||++||++| |..||...
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~ 908 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR 908 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence 443333332222 23468999999999999999999999999999999 68888764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=319.20 Aligned_cols=253 Identities=26% Similarity=0.317 Sum_probs=205.2
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++.|...+.||+|+||.||+|.+. ++..+|+|++..... ..+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4556777788999999999999886 688899999875544 56778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++++|.+++......+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999998765578999999999999999999996 8999999999999999999999999999876543221
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......++..|+|||+..+..++.++|||||||++|||+||+.|+...... .....+... ....
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~------------~~~~--- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTK------------GIPP--- 235 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc------------CCCC---
Confidence 222345788999999988888999999999999999999999998643211 111111000 0000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......++..+.+++.+|++.+|++|||+.|+++.
T Consensus 236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 ---LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00112245668899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=324.79 Aligned_cols=196 Identities=27% Similarity=0.393 Sum_probs=173.5
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999865 68999999987532 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 9999999999997654 688999999999999999999984 59999999999999999999999999998764321
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 224699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=326.75 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=196.4
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
..||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999875 68899999986555455677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccccc
Q 047591 1420 KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499 (1624)
Q Consensus 1420 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 1499 (1624)
+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .......|+
T Consensus 107 ~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~ 180 (297)
T cd06659 107 DIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGT 180 (297)
T ss_pred HHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecC
Confidence 98754 347899999999999999999996 789999999999999999999999999987654322 222345689
Q ss_pred cccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHH
Q 047591 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579 (1624)
Q Consensus 1500 ~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 1579 (1624)
+.|+|||+..+..++.++|||||||++|||++|+.||...... ..+.. +....+.. . ....
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~-~~~~~~~~--------~---------~~~~ 241 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKR-LRDSPPPK--------L---------KNAH 241 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HhccCCCC--------c---------cccC
Confidence 9999999998888999999999999999999999998642211 11111 11000000 0 0011
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1580 KCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1580 ~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....+.+++.+|++.+|++||++.|+++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 233457789999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=313.01 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=205.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|++|.||+|+.. +++.||||++..... ...+.|.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35777889999999999999886 488999999875543 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++++|.+++... ..+++..+.+++.|+++|++|||+ ..+++||||+|+||+++.++.++|+|||.++....... .
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 9999999999765 457899999999999999999994 27999999999999999999999999999987653322 2
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCc-cchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFT-GEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~-~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....++..|+|||...+..++.++||||||+++|||+||+.|+..... ....... .+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-----------~~~~~~~~~--- 222 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-----------AICDGPPPS--- 222 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-----------HHhcCCCCC---
Confidence 2244688999999999888999999999999999999999999865432 1011111 111100000
Q ss_pred HHHHHHHHH-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKK-CMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.... ++..+.+++.+|++.+|++||++.|+++.
T Consensus 223 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 -----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011 45678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=319.37 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=198.0
Q ss_pred CCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc-hhhHHHHHHHHHHHHHhcC---CCceeEEEeeeccCCeeEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIR---HRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~---HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
.|+..+.||+|+||.||+|.+ .+++.+|+|.++.. .....+++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 355667899999999999987 46889999988644 2344567889999999997 999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++... .+++.....++.|++.|++|||+ .+|+||||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999998653 67899999999999999999996 799999999999999999999999999998775433
Q ss_pred ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.......|+..|+|||+..+ ..++.++|||||||++|||++|+.||+....... ..+.....+ +.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~--------~~~~~- 224 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MMLIPKSKP--------PRLED- 224 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hhccccCCC--------CCCCc-
Confidence 22334568999999998765 4468999999999999999999999865321110 000000000 00000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+..+.+++.+||+.+|++||++.|+++.
T Consensus 225 ---------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 ---------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0134567889999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=336.18 Aligned_cols=205 Identities=23% Similarity=0.331 Sum_probs=175.4
Q ss_pred HHHhhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC
Q 047591 738 ELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG 813 (1624)
Q Consensus 738 el~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 813 (1624)
++....++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999865 58899999986422 223456889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999999654 478888999999999999999984 599999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSEG----IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.............||+.|||||++... .++.++||||+||++|||+||+.||..
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 654333233345799999999987543 378899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=318.96 Aligned_cols=266 Identities=22% Similarity=0.288 Sum_probs=197.0
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 455678999999999999875 68999999886443 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+ ++|.+++.... ..+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 69999987654 468999999999999999999996 7999999999999999999999999999976542211 1
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-cCChh--HHH---HHh--
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-SLPDA--VTD---VID-- 1563 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-~~~~~--~~~---~~d-- 1563 (1624)
.....++..|+|||+..+ ..++.++|||||||++|||+||+.||....... .+...++. ..+.. +.. ..+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 223357889999998755 457899999999999999999999986432111 11111111 00000 000 000
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..................+..+.+++.+|++.+|++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000111223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=319.97 Aligned_cols=202 Identities=30% Similarity=0.388 Sum_probs=178.6
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.-|...+.||+|+||.||||.. .+++.||+|++..... ...++.++|+.++.+++|+||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999985 5789999999987653 4567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
|.+|++.+.++... .+.+.+..-|.+++..|+.|||.. +.||||||+.|||+..+|.+|++|||++...+......
T Consensus 93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999997543 446777777899999999999995 49999999999999999999999999999887665554
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCc
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFT 950 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~ 950 (1624)
.+.+|||.|||||++....|+.|+||||+||+.+||++|..|+....+
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 456799999999999988999999999999999999999999976544
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=319.35 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=192.9
Q ss_pred CCcCCeEeecCceEEEEEEEcCCceEEEEEecc--chhhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSL--QEDRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~--~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|.....||+||.+.|||+...+.+.+|.|++.. .+......|.+|++.|.+++ |.+||+|++|-..++..|+||||=
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 445578999999999999988888888887643 34566789999999999995 999999999999999999999975
Q ss_pred CCCCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-Cc
Q 047591 1414 PQGSLEKWLYSHNYLL-NIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-SM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l-~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-~~ 1491 (1624)
.-+|.++|.+..... +| .+..|..|++.|+.++|+ .+|||.||||.|.|+- .|.+||+|||+|..+.... +.
T Consensus 443 -d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 443 -DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred -cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence 459999998765444 46 566799999999999997 7999999999999986 4689999999999876533 33
Q ss_pred cccccccccccccccccCCC-----------CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHH
Q 047591 1492 KQTMTLATIGYMAPEYGSEG-----------IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~-----------~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~ 1560 (1624)
.....+||+.||+||.+... +.+.++||||+|||||+|+.|+.||.+.... |.. +..
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aK------l~a 584 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAK------LHA 584 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHH------HHh
Confidence 33456899999999965432 3578999999999999999999999753221 211 112
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.|+.-.-.... . ....++.++|..|++.||++|||+.|+++.
T Consensus 585 I~~P~~~Iefp~--~----~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ITDPNHEIEFPD--I----PENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hcCCCccccccC--C----CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222211100000 0 001237899999999999999999999874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=336.38 Aligned_cols=200 Identities=27% Similarity=0.376 Sum_probs=173.7
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999864 68999999997532 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++...+ .+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999997654 689999999999999999999984 599999999999999999999999999876532110
Q ss_pred c-------------------------------------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC
Q 047591 900 V-------------------------------------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRK 942 (1624)
Q Consensus 900 ~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~ 942 (1624)
. .....+||+.|||||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 001236999999999998888999999999999999999999
Q ss_pred CCCCc
Q 047591 943 MPTDE 947 (1624)
Q Consensus 943 ~P~~~ 947 (1624)
.||..
T Consensus 237 ~Pf~~ 241 (364)
T cd05599 237 PPFCS 241 (364)
T ss_pred CCCCC
Confidence 99864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=314.92 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=198.6
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
|...+.||+|+||.||+|... ++..+|+|+..... ....+.|.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 455678999999999999874 67899999876433 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++... .+++.....++.|++.|++|||+ .+|+|+||||+||+++.++.++|+|||+++.+.... ....
T Consensus 86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 86 GGSALDLLEPG--PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 99999998643 57899999999999999999996 899999999999999999999999999998764322 1223
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
...|+..|+|||+..+..++.++|||||||++|||++|+.|+....... .... +.......
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~------------~~~~~~~~----- 220 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFL------------IPKNNPPT----- 220 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHH------------HhcCCCCC-----
Confidence 3468899999999988889999999999999999999999986432110 0000 10000000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....++..+.+++.+||+.+|++||++.|+++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 --LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001234557789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=336.86 Aligned_cols=199 Identities=23% Similarity=0.315 Sum_probs=171.2
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 468999999997542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC-
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS- 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~- 899 (1624)
|+++|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999997654 688888889999999999999984 599999999999999999999999999864321000
Q ss_pred ---------------------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHH
Q 047591 900 ---------------------------------------------VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGIL 934 (1624)
Q Consensus 900 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvi 934 (1624)
......+||+.|||||++....++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00112469999999999988889999999999999
Q ss_pred HHHHHcCCCCCCc
Q 047591 935 MIETFTRKMPTDE 947 (1624)
Q Consensus 935 l~elltg~~P~~~ 947 (1624)
+|||+||+.||..
T Consensus 238 l~elltG~~Pf~~ 250 (381)
T cd05626 238 LFEMLVGQPPFLA 250 (381)
T ss_pred HHHHHhCCCCCcC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=322.79 Aligned_cols=252 Identities=25% Similarity=0.297 Sum_probs=192.0
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|.....||+|+||+||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..++||||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 334567999999999999875 57899999886432 344567899999999996 999999999999999999999998
Q ss_pred CCCCHHH---HHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1414 PQGSLEK---WLYS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1414 ~~gsL~~---~l~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
+. ++.+ ++.. ....+++....+++.+++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 74 5544 3332 23568899999999999999999996 3589999999999999999999999999997654321
Q ss_pred CccccccccccccccccccCCC---CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEG---IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~---~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
......|++.|+|||++.+. .++.++|||||||++|||++|+.||.........+........ +.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------~~~ 231 (288)
T cd06616 163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP---------PIL 231 (288)
T ss_pred --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC---------CcC
Confidence 22334689999999988765 6899999999999999999999998643210000000000000 000
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. ..+..++..+.+++.+||+.+|++|||++|+++.
T Consensus 232 ~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SN-------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC-------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0012345678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=319.38 Aligned_cols=268 Identities=19% Similarity=0.226 Sum_probs=198.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~lV 1409 (1624)
++|...+.||+|+||.||+|++. +++.+|+|.++... +.....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35667789999999999999886 57889999886432 23345678899999999999999999998777 889999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||++ ++|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99998 59999988766678999999999999999999996 789999999999999999999999999998765432
Q ss_pred CccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhh---hhhcCChhHHHHHhhh
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW---VEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~---~~~~~~~~~~~~~d~~ 1565 (1624)
.......+++.|+|||...+. .++.++|||||||++|||++|+.||........ .... +....+..+....+..
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccc
Confidence 122334678899999987654 468999999999999999999999865322111 1110 0000000011000000
Q ss_pred cc------CC-chHHHHHHHHH-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1566 LL------SG-EEEADIAAKKK-CMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1566 l~------~~-~~~~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. .. ........+.. ....+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00 00000000001 2556789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=331.01 Aligned_cols=196 Identities=27% Similarity=0.363 Sum_probs=172.5
Q ss_pred CCCCCcceeecCCccceEEEEecC--CCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPY--GMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~--g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||.||+|.... +..||||++.... ....+.+.+|+++++.++|||||++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999997543 3689999986432 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999999999997654 688999999999999999999984 5999999999999999999999999999876432
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 1234699999999999888889999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=330.22 Aligned_cols=203 Identities=26% Similarity=0.472 Sum_probs=169.3
Q ss_pred cCCCCCcceeecCCccceEEEEe------cCCCEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeccC-C
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNH-G 813 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 813 (1624)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++++ +|||||+++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788889999999999999974 235789999987443 23346789999999999 899999999988764 4
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------------------------------------------------
Q 047591 814 FKALILEYMPQGSLEKWLYSHK---------------------------------------------------------- 835 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 835 (1624)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5799999999999999997532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc-ccccccccccc
Q 047591 836 ---YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGY 911 (1624)
Q Consensus 836 ---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y 911 (1624)
..+++.++.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......+|+.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 2377888899999999999999984 5999999999999999999999999999876433221 12223467889
Q ss_pred cCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 912 MAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 912 ~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
||||++....++.++|||||||++|||+| |+.||...
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999988889999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=313.32 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=197.8
Q ss_pred CCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
+|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999976 468899999886432 2245789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeeecceeecCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DFGla~~~~~ 1487 (1624)
||||+++++|.+++.+.+ .+++..+.+++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||.++.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997643 57889999999999999999996 7999999999999998776 699999999887643
Q ss_pred CCC---ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1488 VDS---MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1488 ~~~---~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
... .......||..|+|||+..+..++.++||||+||++|||++|+.||........ ...+ .+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~---------~~~~~~ 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALI---------FKIASA 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHH---------HHHhcc
Confidence 211 111234688999999998888899999999999999999999999853211100 0000 000000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.... ..+......+.+++.+|++.+|++|||+.|+++
T Consensus 227 ~~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAP-------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCC-------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000 001123456788999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=304.23 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=194.2
Q ss_pred CCeEeecCceEEEEEEEcC-CceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1340 SNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
.+.||+|.-|+||.+++.+ +...|+|++.... .....+.+.|.+||+.++||.++.||+.++.++..++|||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 3679999999999999875 4789999996543 34467788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC-------
Q 047591 1416 GSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG------- 1487 (1624)
Q Consensus 1416 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~------- 1487 (1624)
|+|....+++ +..++.+....+|.+|..||+|||- .|||.|||||+||||.++|++-++||-++.....
T Consensus 162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 9999998855 5678888888899999999999995 8999999999999999999999999998643210
Q ss_pred --------------------------CCC----------------------ccccccccccccccccccCCCCcCcccch
Q 047591 1488 --------------------------VDS----------------------MKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519 (1624)
Q Consensus 1488 --------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~~~k~DV 1519 (1624)
... ......+||-.|+|||++.+...+.++|+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 000 01113579999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCC
Q 047591 1520 YSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEE 1599 (1624)
Q Consensus 1520 ~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~ 1599 (1624)
|+|||++|||+.|+.||.+....+ .+.. ++-..+.-.. ....+..+.+|+.+.+.+||.+
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~-Tl~N------------Iv~~~l~Fp~-------~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKE-TLRN------------IVGQPLKFPE-------EPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchh-hHHH------------HhcCCCcCCC-------CCcchhHHHHHHHHHhccChhh
Confidence 999999999999999997654332 2222 2221111100 0133566788999999999999
Q ss_pred CCCH
Q 047591 1600 RMNV 1603 (1624)
Q Consensus 1600 RPt~ 1603 (1624)
|...
T Consensus 379 Rlg~ 382 (459)
T KOG0610|consen 379 RLGS 382 (459)
T ss_pred hhcc
Confidence 9983
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=315.96 Aligned_cols=267 Identities=21% Similarity=0.298 Sum_probs=200.0
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+|+..+.||+|++|+||+|+.. +|..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4677789999999999999885 58889999886543 233467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1414 PQGSLEKWLYSHN--YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++ +|.+++.... ..++++++.+++.|++.||+|||+ .+|+||||||+||++++++.+|++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8999887543 458999999999999999999996 7899999999999999999999999999976543211
Q ss_pred cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHHHhh---
Q 047591 1492 KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDVIDA--- 1564 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~~d~--- 1564 (1624)
......++..|+|||+..+ ..++.++|||||||++|||++|+.||.+....+. .....+ ....+......+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchh
Confidence 1223457889999998754 4578999999999999999999999875432211 111100 0001111111110
Q ss_pred --hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 --NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 --~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
................++..+.+++.+|++.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000011111234677889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=310.13 Aligned_cols=245 Identities=21% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|+..+.||+|.|.+|-.|++- .|..||||++...+ +.......+|+++|+-++|||||+||.+.......|||+|+=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 555678999999999999764 79999999996543 345567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec-CCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
.+|+|++||.++...+..+-..++..||..|+.|+|+ ..+|||||||+||.+- .-|-+|++|||++-.+.+.. .
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--k 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--K 174 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--h
Confidence 9999999999888788888888999999999999997 7899999999999875 56899999999997665443 3
Q ss_pred ccccccccccccccccCCCCcC-cccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVS-TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~-~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.++.+|+..|-|||.+.+..|+ +++||||+|||||-|++|+.||......+ .+..++|-...
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCKYt---- 237 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCKYT---- 237 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhccccc----
Confidence 4556899999999998888775 67899999999999999999997643222 22223332111
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+.....+..+|+..++..||++|.+.+|++.
T Consensus 238 -----vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 -----VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11223445677889999999999999999874
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=316.53 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=198.5
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCC------
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPG------ 1404 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~------ 1404 (1624)
++++|...+.||+|+||.||+|... +++.+|+|++..... ..++|.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678888999999999999999885 578899998865433 346799999999999 7999999999986543
Q ss_pred eeEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecc
Q 047591 1405 FKALILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGI 1481 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGl 1481 (1624)
..++||||+++++|.+++... +..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988643 3568899999999999999999995 7999999999999999999999999999
Q ss_pred eeecCCCCCccccccccccccccccccCC-----CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGSE-----GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1482 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
+....... .......|+..|+|||++.. ..++.++|||||||++|||+||+.||...... ..+........
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-- 235 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNPP-- 235 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhccCC--
Confidence 98664322 22234568999999997643 35788999999999999999999998643211 11111100000
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+. ..........+.+++.+|++.||++|||+.|+++
T Consensus 236 -------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 -------PT---------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -------CC---------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 0011224556789999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=336.85 Aligned_cols=200 Identities=27% Similarity=0.346 Sum_probs=171.7
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688889999999999999985 478999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999997643 688888999999999999999984 599999999999999999999999999964321100
Q ss_pred c----------------------------------------------ccccccccccccCccccCCCCCCcchhHHHHHH
Q 047591 900 V----------------------------------------------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGI 933 (1624)
Q Consensus 900 ~----------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gv 933 (1624)
. .....+||+.|+|||++....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999998888999999999999
Q ss_pred HHHHHHcCCCCCCc
Q 047591 934 LMIETFTRKMPTDE 947 (1624)
Q Consensus 934 il~elltg~~P~~~ 947 (1624)
++|||+||+.||..
T Consensus 237 il~elltG~~Pf~~ 250 (377)
T cd05629 237 IMFECLIGWPPFCS 250 (377)
T ss_pred hhhhhhcCCCCCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=313.47 Aligned_cols=204 Identities=29% Similarity=0.405 Sum_probs=166.3
Q ss_pred HhhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--------------hhHHHHHHHHHHHHhcCCCceee
Q 047591 740 QRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--------------GAIKSFDAECEVLRRVRHRNLVK 804 (1624)
Q Consensus 740 ~~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~ 804 (1624)
.+..+.|...+.||+|.||+|-+|+. .+++.||||++..... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44567899999999999999999985 4689999999864321 11357889999999999999999
Q ss_pred eeeeeccC--CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc
Q 047591 805 IISSCSNH--GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV 882 (1624)
Q Consensus 805 l~~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~ 882 (1624)
|+.+..+. +.+|||+|||..|.+.. ....+..++..++.+|+.++..||+|||.. +||||||||+|+|++++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 99998654 57899999999998754 222222388999999999999999999984 5999999999999999999
Q ss_pred eEEEeeeeeeccCCCCCc----ccccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 883 AHLSDFGISKLLDGEDSV----TQTMTLATFGYMAPEYGSEGI----VSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 883 ~kl~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~----~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+||+|||.+......... .-...+|||.|||||...++. .+.+.||||+||+||.++.|+.||-.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 999999999876322111 112257999999999876532 35678999999999999999999854
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=314.31 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=198.5
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|...+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3666789999999999999875 57889999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeeecceeecCCCCC
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DFGla~~~~~~~~ 1490 (1624)
+++++|.+++... +..+++..+..++.|++.|++|||+ .+|+||||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999764 3457999999999999999999996 7899999999999999885 579999999987643221
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......|++.|+|||+.....++.++|||||||++|||++|+.|+..... ..++... ........
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~--------~~~~~~~~- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKI--------CQGYFAPI- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHH--------hcccCCCC-
Confidence 22234689999999998888899999999999999999999999864321 1111111 11000000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+..+.+++.+||+.+|++|||++|+++.
T Consensus 223 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01223457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=317.04 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=198.3
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
|...+.||+|++|.||+|... +++.+|+|++........+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 344578999999999999864 6788999988655555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
++|.+++.. ..++++++..++.|++.|++|||+ .+|+||||||+||+++.++.+|++|||+++...... .....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 999999876 357889999999999999999996 799999999999999999999999999987654322 12223
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..|++.|+|||+..+..++.++|||||||++|||++|+.||........ ... .....+ ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~~~-~~~~~~--------~~~--------- 235 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-MKR-IRDNLP--------PKL--------- 235 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-HHH-HHhcCC--------CCC---------
Confidence 4689999999999888899999999999999999999999864211100 000 000000 000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....++..+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001123456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=295.88 Aligned_cols=270 Identities=20% Similarity=0.297 Sum_probs=208.9
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEE-EcCCceEEEEEeccchhhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCC
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~-~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~ 1404 (1624)
++|+-+-| .++||+|+|+.|--+. ..+|.++|||++.++......+..+|++++.+.+ |+||++|+.+|++++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 56766666 3789999999999885 4689999999998776677788999999999984 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC---cEEEeeecc
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM---VAHLGDFGI 1481 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~kl~DFGl 1481 (1624)
..|||||-|.+|+|..+|+++.. ++..+.-+++.+||.||.|||. ++|.|||+||+|||-.+.. -+|||||.+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999987654 5666777899999999999996 8999999999999986543 489999988
Q ss_pred eeecCCC------CCcccccccccccccccccc-----CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh
Q 047591 1482 AKLLDGV------DSMKQTMTLATIGYMAPEYG-----SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV 1550 (1624)
Q Consensus 1482 a~~~~~~------~~~~~~~~~gt~~y~APE~~-----~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~ 1550 (1624)
+.-+... ......+.+|+..|||||+. ....|++++|.||+|||+|-|++|..||.+.-..+ --|-
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CGWd 302 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CGWD 302 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CCcc
Confidence 7543211 12222346799999999964 23568999999999999999999999997643211 1243
Q ss_pred hhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1551 EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+...=..-.+.+-..+..+..+-....|...+.+..+++...+..++.+|.++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3222222222222333333333334456667778888898999999999999888876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=316.07 Aligned_cols=263 Identities=22% Similarity=0.249 Sum_probs=194.8
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccC--CeeEEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNP--GFKALILQ 1411 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~--~~~~lV~e 1411 (1624)
|...+.||+|+||.||+|+.. +++.+|+|+++... ........+|+.+++++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 344578999999999999865 68899999886432 222334567899999985 99999999999877 88999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++ |++.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 68888887766678999999999999999999996 79999999999999999 9999999999987643221
Q ss_pred cccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC---ChhHHHHHhhhcc
Q 047591 1492 KQTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL---PDAVTDVIDANLL 1567 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~---~~~~~~~~d~~l~ 1567 (1624)
.....++..|+|||+.. .+.++.++|||||||++|||++|+.||...... ....+..... ++.+...+...-.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhccccc
Confidence 12346889999999754 456789999999999999999999999653211 1111111111 1111111110000
Q ss_pred CC------chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 SG------EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ~~------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. ....-......++..+.+++.+|++.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 000000111245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=321.82 Aligned_cols=272 Identities=22% Similarity=0.273 Sum_probs=201.1
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC----
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG---- 1404 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~---- 1404 (1624)
.+.++|...+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888899999999999999886 57889999986443 233457788999999999999999999887654
Q ss_pred ------eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEee
Q 047591 1405 ------FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGD 1478 (1624)
Q Consensus 1405 ------~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~D 1478 (1624)
..++||||+++ ++.+.+......++++.+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 7878777655578999999999999999999996 7999999999999999999999999
Q ss_pred ecceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhh---hhhhcC
Q 047591 1479 FGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH---WVEESL 1554 (1624)
Q Consensus 1479 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~---~~~~~~ 1554 (1624)
||+++..............++..|+|||...+ ..++.++|||||||++|||++|+.||...... ..+.. ......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence 99998765433222233456888999997754 45789999999999999999999998643211 11111 111111
Q ss_pred ChhHHHHHhhhccCC------chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1555 PDAVTDVIDANLLSG------EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+....++........ ............+..+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111000000 000000011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=328.90 Aligned_cols=196 Identities=26% Similarity=0.339 Sum_probs=173.8
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56788899999999999999875 68999999987532 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999997654 678888999999999999999984 59999999999999999999999999998764322
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 234699999999999888899999999999999999999999854
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=317.91 Aligned_cols=268 Identities=20% Similarity=0.234 Sum_probs=195.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--hHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCe-----
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--RALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGF----- 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~----- 1405 (1624)
++|...+.||+|+||.||+|... +++.||+|..+.... ...+.+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35778899999999999999875 688999998764432 23467889999999995 6999999999876655
Q ss_pred eEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeec
Q 047591 1406 KALILQYMPQGSLEKWLYSH----NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFG 1480 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFG 1480 (1624)
.++||||+++ +|.+++... ...+++.++..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 899888643 2357999999999999999999996 79999999999999998 8999999999
Q ss_pred ceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-cCCh--
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-SLPD-- 1556 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-~~~~-- 1556 (1624)
+++...... .......+++.|+|||++.+ ..++.++|||||||++|||+||+.||......... ...... ..+.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-LHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHhCCCChh
Confidence 998653221 11223357889999998754 45799999999999999999999998643211111 111000 0000
Q ss_pred hHHHHHhhh----ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1557 AVTDVIDAN----LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1557 ~~~~~~d~~----l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...+..... .............+.....+.+++.+|++.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 0000000001111235677889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=315.04 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=199.5
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKALILQ 1411 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~lV~e 1411 (1624)
|...+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 345678999999999999886 47889999987542 34456788999999999999999999999887 88999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++ +|.+++......+++.++..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9985 8999887665678999999999999999999996 78999999999999999999999999999877544322
Q ss_pred cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHHHh----
Q 047591 1492 KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDVID---- 1563 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~~d---- 1563 (1624)
..+...++..|+|||...+ ..++.++|||||||++|||+||+.||+...... .+..... ...+....+..+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchhh
Confidence 2333467889999997654 467899999999999999999999986532211 1111100 000000000000
Q ss_pred hhccCC-chHHHH-HH-HHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 ANLLSG-EEEADI-AA-KKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 ~~l~~~-~~~~~~-~~-~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...... ...... .. ...++..+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 000000 01 1113677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=328.97 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=174.5
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+++.. +++.||||++.... ......+.+|..++++++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999865 67899999986421 223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999998755578999999999999999999998 4599999999999999999999999999987654433
Q ss_pred cccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSE-----GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~-----~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.......||+.|||||++.. +.++.++|||||||++|||+||+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 33334569999999998764 5678999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=327.46 Aligned_cols=201 Identities=25% Similarity=0.358 Sum_probs=174.2
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+++.. +++.||||++.... ....+.|.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999864 68999999987422 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999976556789999999999999999999984 599999999999999999999999999987654433
Q ss_pred cccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGS-----EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~-----~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.......||+.|||||++. .+.++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 3333346999999999875 35578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=327.37 Aligned_cols=193 Identities=26% Similarity=0.373 Sum_probs=168.5
Q ss_pred ceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCC
Q 047591 750 NLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQG 825 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 825 (1624)
+.||+|+||+||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 468999999987542 233456789999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccc
Q 047591 826 SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905 (1624)
Q Consensus 826 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 905 (1624)
+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccce
Confidence 9999997644 689999999999999999999984 599999999999999999999999999986432221 12234
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 906 ~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.||+.|||||++....++.++|||||||++|||+||+.||..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 699999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=309.81 Aligned_cols=191 Identities=29% Similarity=0.421 Sum_probs=158.1
Q ss_pred CCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCC-----eEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG-----FKALI 818 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV 818 (1624)
.|...+++|.|+||.||+|... ++++||||+.-.+... -.+|+++|++++|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999864 5799999998644321 247999999999999999998875322 34589
Q ss_pred EEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC-CceEEEeeeeeecc
Q 047591 819 LEYMPQGSLEKWLYSH---KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD-TVAHLSDFGISKLL 894 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~~kl~DFGla~~~ 894 (1624)
|||||. +|+++++.. +..++.-.+.-+..|+.+||.|||+ .+|+||||||+|+|+|.+ |.+||||||-|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999997 999999752 3456766777799999999999999 469999999999999976 89999999999988
Q ss_pred CCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 895 DGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 895 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
...+.. .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|+.=|
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF 226 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF 226 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence 665443 33568999999997654 56899999999999999999999654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=321.30 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=199.0
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
+|...+.||+|+||+||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999876 48899999886432 2355789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1412 YMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|+++++|.+++... +..+++..+..++.|++.||+|||. .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998754 4568999999999999999999996 7999999999999999999999999999876532211
Q ss_pred c----------------------------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCcc
Q 047591 1491 M----------------------------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTG 1542 (1624)
Q Consensus 1491 ~----------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~ 1542 (1624)
. ......||..|+|||+..+..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 111246889999999998888999999999999999999999998653221
Q ss_pred chhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 047591 1543 EVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN----VKDALA 1608 (1624)
Q Consensus 1543 ~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt----~~evl~ 1608 (1624)
.. ..++.+....... ....+..+.+++.+|++.+|++||| ++|+++
T Consensus 239 ~~-------------~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ET-------------FSNILKKEVTFPG-------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH-------------HHHHhcCCccCCC-------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 1111111110000 0113456889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=321.53 Aligned_cols=252 Identities=23% Similarity=0.271 Sum_probs=195.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccch-hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQE-DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|++.+ ++.||||.++... ....+.+.+|++++.+.. ||||++++++|.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 456667899999999999999875 8899999986432 234456777888777775 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++ +++.+++......+++..+..++.|++.|++|||+ ..+|+||||||+||++++++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-- 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-- 169 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--
Confidence 985 47877776655578999999999999999999996 2589999999999999999999999999987654322
Q ss_pred cccccccccccccccccCCCC----cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGI----VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~----~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
......++..|+|||++.... ++.++|||||||++|||++|+.||.........+..+ ++....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------------~~~~~~ 237 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI------------LQEEPP 237 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH------------hcCCCC
Confidence 122335788999999876543 8899999999999999999999986432111111111 111000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
... ....++.++.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLP------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 001245568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=317.98 Aligned_cols=206 Identities=24% Similarity=0.351 Sum_probs=173.1
Q ss_pred hccccCHHHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccch---hHHHHHHHHHHHHhcCCCceeeee
Q 047591 730 TWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDG---AIKSFDAECEVLRRVRHRNLVKII 806 (1624)
Q Consensus 730 ~~~~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~ 806 (1624)
....++.++++. .....||+|++|.||+|.. +|+.||||+++..... ..+.|.+|+.+|++++|||||+++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 344566666632 2236799999999999988 6899999998754322 246788999999999999999999
Q ss_pred eeecc----CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc
Q 047591 807 SSCSN----HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV 882 (1624)
Q Consensus 807 ~~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~ 882 (1624)
|++.+ ....++||||+++|+|.++++... .+++..+.+++.|++.|++|||... +++||||||+||++++++.
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCc
Confidence 99876 456899999999999999997654 6899999999999999999999742 3779999999999999999
Q ss_pred eEEEeeeeeeccCCCCCcccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 883 AHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE--GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 883 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
+||+|||+++...... ....||..|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 9999999998764321 22468899999999865 67899999999999999999999999753
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=307.53 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=202.7
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
|...+.||+|++|.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 566789999999999999886 6888999998765555668899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
++|.+++......+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.+........ ...
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 99999998765678999999999999999999996 8999999999999999999999999999987654322 234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..|+..|+|||+.....++.++|||||||+++||++|+.|+.......... .... ......
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~-------------~~~~~~----- 217 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-KIAT-------------NGPPGL----- 217 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHh-------------cCCCCc-----
Confidence 568899999999888889999999999999999999999986431111100 0000 000000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
......+..+.+++.+||+.+|++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000112456788999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=332.92 Aligned_cols=207 Identities=22% Similarity=0.322 Sum_probs=177.5
Q ss_pred HHHHHhhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeecc
Q 047591 736 YQELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSN 811 (1624)
Q Consensus 736 ~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 811 (1624)
.+++....++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566789999999999999999999865 68899999986422 2234567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeee
Q 047591 812 HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891 (1624)
Q Consensus 812 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla 891 (1624)
++..|+||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999999754 478888889999999999999984 5999999999999999999999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEG----IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+..............||+.|||||++... .++.++|||||||++|||++|+.||..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 87754433333445799999999987543 378999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=315.22 Aligned_cols=242 Identities=20% Similarity=0.270 Sum_probs=185.5
Q ss_pred eEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHH---hcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1342 LLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMR---RIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~---~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
+||+|+||.||+|... +++.+|+|.+.... ....+.+.+|..+++ ..+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999885432 122234455554444 3479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++...+ .+++.+...|+.|++.||+|||+ .+|+||||||+||++++++.+|++|||++....... ..
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 999999987654 58999999999999999999996 789999999999999999999999999987654321 22
Q ss_pred ccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...||+.|||||... +..++.++|||||||++|||+||+.||......... . . ..... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~-~--------~~~~~-~~~------ 215 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E-I--------DRMTL-TVN------ 215 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--H-H--------HHHhh-cCC------
Confidence 346899999999876 456899999999999999999999999653221110 0 0 00000 000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
...+..++..+.+++.+|+..+|++|| +++|+++.
T Consensus 216 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 -VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000122445678899999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=316.19 Aligned_cols=244 Identities=26% Similarity=0.303 Sum_probs=197.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35677789999999999999875 57899999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++... ..++...+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999999765 457888999999999999999996 89999999999999999999999999999876433
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.....|++.|+|||...+...+.++|||||||++|||+||+.||...... ... .........
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~------------~~~~~~~~~--- 216 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIY------------EKILEGKVR--- 216 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHH------------HHHhcCCcc---
Confidence 23346899999999988888899999999999999999999998643210 000 011110000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
.+......+.+++.+||+.+|++|| +++|+++
T Consensus 217 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 ------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0011235677899999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=324.55 Aligned_cols=193 Identities=26% Similarity=0.380 Sum_probs=168.2
Q ss_pred ceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCC
Q 047591 750 NLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQG 825 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 825 (1624)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 468999999997542 234456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccc
Q 047591 826 SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905 (1624)
Q Consensus 826 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 905 (1624)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccc
Confidence 9999987643 689999999999999999999984 599999999999999999999999999886432221 12234
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 906 ~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.||+.|+|||++..+.++.++|||||||++|||+||+.||..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=319.67 Aligned_cols=201 Identities=28% Similarity=0.473 Sum_probs=173.9
Q ss_pred CCCcceeecCCccceEEEEecCCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 746 FSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
....+.||+|-||+|.++....+..||||.++.... ...++|.+|+++|.+++|||||+|+|+|..++..++|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 345678999999999999998889999999987654 3458899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc-cc
Q 047591 825 GSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQ 902 (1624)
Q Consensus 825 gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~-~~ 902 (1624)
|+|.+|+..+... ..-...++|+.|||.|++||.+. .++|||+.+.|+|+|.++++||+|||++|-+-..+.+ .+
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999999877433 35566778999999999999985 4999999999999999999999999999965444333 33
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc--CCCCCCccC
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT--RKMPTDEMF 949 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt--g~~P~~~~~ 949 (1624)
...+-..+|||||.+.-+.+|+++|||+|||++||+++ ...||.++.
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 33455779999999999999999999999999999765 789987653
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=324.43 Aligned_cols=268 Identities=24% Similarity=0.293 Sum_probs=197.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC--CeeE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP--GFKA 1407 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~--~~~~ 1407 (1624)
.++|...+.||+|+||.||+|... +++.+|||++... .....+.+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356777788999999999999875 5788999987432 223345678899999999 999999999988653 3679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||++ ++|.+++.+. .++|..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999997 5999988754 67899999999999999999996 7999999999999999999999999999987643
Q ss_pred CCCc----cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--hcCChh-H-
Q 047591 1488 VDSM----KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESLPDA-V- 1558 (1624)
Q Consensus 1488 ~~~~----~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--~~~~~~-~- 1558 (1624)
.... ......||..|+|||++.. ..++.++|||||||++|||+||+.||......+. ...... ...++. +
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHH
Confidence 3221 2223568999999997654 5678999999999999999999999865322111 111000 000110 0
Q ss_pred -------HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1559 -------TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1559 -------~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.++++ ................++..+.+++.+||+.+|++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00111 000000000001112246778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=327.88 Aligned_cols=196 Identities=27% Similarity=0.368 Sum_probs=173.9
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 58999999997542 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997644 688999999999999999999984 599999999999999999999999999986543
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 22334699999999999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=317.31 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=184.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccchhhH-----------HHHHHHHHHHHHhcCCCceeEEEee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQEDRA-----------LKSFDAECEVMRRIRHRNLAKIVSS 1399 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~~~~~-----------~~~f~~E~~~l~~l~HpNIv~l~g~ 1399 (1624)
+.|...++||+|+||+||+|.+.+ +..+|+|+........ ......+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 567888999999999999998754 3456777643222110 1122334445667799999999997
Q ss_pred eccCC----eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1400 CSNPG----FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1400 ~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
+.... ..+++||++.. ++.+.+... ...++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEE
Confidence 75543 45678887754 566655432 235678888999999999999996 7999999999999999999999
Q ss_pred EeeecceeecCCCCC------ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhh
Q 047591 1476 LGDFGIAKLLDGVDS------MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW 1549 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~ 1549 (1624)
|+|||+|+....... .......||+.|||||+..+..++.++|||||||++|||+||+.||.......... +.
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~-~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI-HA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH-HH
Confidence 999999987643211 11123469999999999999999999999999999999999999997542211111 00
Q ss_pred hhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1550 VEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
.. .+.+. .+.... .....++..+.+++..||..+|++||+++++.+.+
T Consensus 246 ~~-------~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AK-------CDFIK-RLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hH-------HHHHH-Hhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00 01110 000000 01124567789999999999999999999999875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=334.79 Aligned_cols=199 Identities=22% Similarity=0.317 Sum_probs=170.9
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 577889999999999999986 468899999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC--
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED-- 898 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~-- 898 (1624)
||++|+|.+++...+ .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997653 578888889999999999999984 59999999999999999999999999976431100
Q ss_pred --------------------------------------------CcccccccccccccCccccCCCCCCcchhHHHHHHH
Q 047591 899 --------------------------------------------SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGIL 934 (1624)
Q Consensus 899 --------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvi 934 (1624)
.......+||+.|||||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112369999999999988889999999999999
Q ss_pred HHHHHcCCCCCCc
Q 047591 935 MIETFTRKMPTDE 947 (1624)
Q Consensus 935 l~elltg~~P~~~ 947 (1624)
+|||+||+.||..
T Consensus 238 l~elltG~~Pf~~ 250 (382)
T cd05625 238 LYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=321.08 Aligned_cols=268 Identities=22% Similarity=0.276 Sum_probs=195.0
Q ss_pred CCcCCeEeecCceEEEEEEEcC---CceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFAD---GTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKAL 1408 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~---~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~l 1408 (1624)
|.....||+|+||.||+|+... ++.||+|.+.... +...+.+.+|++++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 5667889999999999998754 7889999987532 33456788999999999999999999999887 78999
Q ss_pred EEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC----CCcEEEeeec
Q 047591 1409 ILQYMPQGSLEKWLYSH----NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD----DMVAHLGDFG 1480 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~----~~~~kl~DFG 1480 (1624)
||||+++ ++.+++... ...++......|+.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999985 677766432 2357888899999999999999996 78999999999999999 9999999999
Q ss_pred ceeecCCCCC--ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccc--------hhhhhh
Q 047591 1481 IAKLLDGVDS--MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE--------VCLKHW 1549 (1624)
Q Consensus 1481 la~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~--------~~l~~~ 1549 (1624)
+++....... .......+|+.|+|||+..+ ..++.++|||||||+++||++|+.||....... ..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643221 12233468899999997755 458999999999999999999999986543221 001111
Q ss_pred hhhc---CChhH---------HHHHhhhc---cC-CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1550 VEES---LPDAV---------TDVIDANL---LS-GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1550 ~~~~---~~~~~---------~~~~d~~l---~~-~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+... .+... .+..+... .. ................+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1000 00000 00000000 00 0000001111134567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=333.02 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=172.6
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
..++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++...|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999864 68999999986432 2234567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999998754 477888888999999999999984 5999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSE----GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~----~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
........+||+.|||||++.. ..++.++|||||||++|||+||+.||..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 3222334579999999998754 3478999999999999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=326.36 Aligned_cols=201 Identities=23% Similarity=0.336 Sum_probs=173.5
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+++.+ +++.||+|++.... ....+.|.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999865 57889999986421 223345888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999987556789999999999999999999984 599999999999999999999999999986644333
Q ss_pred cccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGS-----EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~-----~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.......||+.|||||++. .+.++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 3333457999999999875 35678999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=323.87 Aligned_cols=269 Identities=23% Similarity=0.270 Sum_probs=197.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----Cee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-----GFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-----~~~ 1406 (1624)
+++|...+.||+|+||+||+|+.. +|+.||||.++.. .......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467888899999999999999864 6889999988642 233456788999999999999999999887543 357
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++ ++.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999974 88887754 357889999999999999999996 799999999999999999999999999998764
Q ss_pred CCCCc--cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh---hhcCChhHHH
Q 047591 1487 GVDSM--KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV---EESLPDAVTD 1560 (1624)
Q Consensus 1487 ~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~---~~~~~~~~~~ 1560 (1624)
..... ......||+.|||||.+.+ ..++.++|||||||++|||+||+.||.+..... ....+. ....++....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHH
Confidence 32211 1123468999999998644 568999999999999999999999986532111 111111 1111111111
Q ss_pred HHhhhc-------cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1561 VIDANL-------LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1561 ~~d~~l-------~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+... ..................+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100 0000000000112235668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=325.02 Aligned_cols=193 Identities=25% Similarity=0.338 Sum_probs=166.5
Q ss_pred CCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcC-C-----CceeEEEeeeccCCeeEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-H-----RNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-H-----pNIv~l~g~~~~~~~~~l 1408 (1624)
.|...++||+|+||.|-||.. .+++.||||+++.. .....+-..|+.+|..++ | -|+|++++|+...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 567789999999999999965 46899999999743 344567788999999997 4 389999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC--CcEEEeeecceeec
Q 047591 1409 ILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD--MVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~--~~~kl~DFGla~~~ 1485 (1624)
|+|.+.. +|+++++.+. ..++......|+.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.|...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9998865 9999999764 458889999999999999999996 899999999999999754 47999999999875
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTD 1537 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~ 1537 (1624)
... ....+-+..|+|||++.+..|+.+.||||||||+.||+||.+-|.
T Consensus 342 ~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 342 SQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred CCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 432 125677889999999999999999999999999999999966453
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=334.68 Aligned_cols=199 Identities=23% Similarity=0.313 Sum_probs=170.6
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
+|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 588889999999999999985 468999999986432 2234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC--
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED-- 898 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~-- 898 (1624)
|+++|+|.+++...+ .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999997654 578888888999999999999984 59999999999999999999999999985331000
Q ss_pred ----------------------------------------CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHH
Q 047591 899 ----------------------------------------SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIET 938 (1624)
Q Consensus 899 ----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~el 938 (1624)
.......+||+.|||||++....++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001124699999999999888899999999999999999
Q ss_pred HcCCCCCCc
Q 047591 939 FTRKMPTDE 947 (1624)
Q Consensus 939 ltg~~P~~~ 947 (1624)
+||+.||..
T Consensus 238 l~G~~Pf~~ 246 (376)
T cd05598 238 LVGQPPFLA 246 (376)
T ss_pred hhCCCCCCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=322.65 Aligned_cols=191 Identities=28% Similarity=0.317 Sum_probs=167.6
Q ss_pred eecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCCH
Q 047591 752 IGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL 827 (1624)
Q Consensus 752 iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 827 (1624)
||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999864 58899999987432 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccccc
Q 047591 828 EKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA 907 (1624)
Q Consensus 828 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 907 (1624)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ......|
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 99997643 689999999999999999999984 599999999999999999999999999986433222 2233569
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 908 TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 908 t~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
|+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 9999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=324.04 Aligned_cols=193 Identities=26% Similarity=0.389 Sum_probs=168.4
Q ss_pred ceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCC
Q 047591 750 NLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQG 825 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 825 (1624)
+.||+|+||.||+++. .+|+.||||++.... ......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987542 234467889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccc
Q 047591 826 SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905 (1624)
Q Consensus 826 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 905 (1624)
+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccc
Confidence 9999987643 689999999999999999999984 599999999999999999999999999986432211 22234
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 906 ~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=305.94 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=202.7
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKALIL 1410 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~lV~ 1410 (1624)
+|...+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3666789999999999999886 68899999986544 24567899999999999999999999999887 8899999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++.+.. .+++.++..++.|++.|++|||+ .+++||||+|+||+++.++.+||+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998655 78999999999999999999996 7999999999999999999999999999987754332
Q ss_pred c-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 M-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
. ......++..|+|||...+..++.++|||||||+++||++|+.||............ ........
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~- 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK------------IGSSGEPP- 223 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh------------ccccCCCc-
Confidence 1 123346889999999998888999999999999999999999998754311110000 00000000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..+...+..+.+++.+|++.+|++||++.|+++
T Consensus 224 ------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 001122456888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=312.08 Aligned_cols=247 Identities=25% Similarity=0.297 Sum_probs=199.7
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
+|...+.||+|+||.||+|+.. ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4667789999999999999876 58899999986432 2456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++++|.+++... ..+++.+...++.|+++||+|||+ .+|+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999765 467889999999999999999996 789999999999999999999999999987664322
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......|+..|+|||+.....++.++|||||||++|||++|+.||....... .. +. ........
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~-~~--------~~~~~~~~----- 218 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RD-QI--------RAKQETAD----- 218 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HH-HH--------HHHhcccc-----
Confidence 2233568889999999888889999999999999999999999987542210 00 00 00000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCH--HHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNV--KDAL 1607 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~--~evl 1607 (1624)
...+...+..+.+++.+||+.+|++||++ +|++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 ---VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00112234678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=318.69 Aligned_cols=270 Identities=20% Similarity=0.286 Sum_probs=194.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC-------
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG------- 1404 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~------- 1404 (1624)
++|...+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 45777889999999999999875 58899999885432 223346678999999999999999999986654
Q ss_pred -eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1405 -FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1405 -~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
..++||||+++ ++.+++......+++.+...++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 34999999974 8888887666678999999999999999999996 799999999999999999999999999998
Q ss_pred ecCCCCCc---cccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccch-hhhhhhhhcCChhH
Q 047591 1484 LLDGVDSM---KQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV-CLKHWVEESLPDAV 1558 (1624)
Q Consensus 1484 ~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~-~l~~~~~~~~~~~~ 1558 (1624)
........ ......++..|+|||+..+. .++.++|||||||++|||+||+.||........ .....+....+..+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 66432211 11234678899999987554 478999999999999999999999864321110 00001111111110
Q ss_pred -H-----HHHhhhccCCchHHHHHH---HHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1559 -T-----DVIDANLLSGEEEADIAA---KKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1559 -~-----~~~d~~l~~~~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. +..+.............. ...+...+.+++.+|+..+|++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000000000000000000 0012355678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=351.00 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=197.6
Q ss_pred HhCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.+-++...+.||.|.||.||-|.. .+|...|||-++.+. ....+...+|+.++..++|||+|+.+|.-.+++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677788999999999999975 468889999776543 44567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
||||++|+|.+.+... ...+......+..|++.|++|||+ .+||||||||+||+||.+|.+|.+|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999988643 334444444588999999999996 799999999999999999999999999998876432
Q ss_pred Cc---cccccccccccccccccCCCC---cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1490 SM---KQTMTLATIGYMAPEYGSEGI---VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1490 ~~---~~~~~~gt~~y~APE~~~~~~---~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
.. .-....||+.|||||++.+.. -..+.||||+|||++||+||++||......-..+-+....+-
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~--------- 1459 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK--------- 1459 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC---------
Confidence 11 112457999999999886543 456789999999999999999999765332111111111111
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+..++....+-.+++..|++.||++|.++.|+++.
T Consensus 1460 -----------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -----------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11122345566788999999999999999887764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=317.64 Aligned_cols=271 Identities=22% Similarity=0.232 Sum_probs=198.1
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--hHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~l 1408 (1624)
.++|...+.||+|+||+||+|+.. +|+.||+|.++.... .....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888899999999999999875 588999998864432 2234567899999999999999999998654 56899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||++ ++|.+++......+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999997 48999887655678999999999999999999996 78999999999999999999999999999876533
Q ss_pred CCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccch--hhhhhhhhcCChhHHHHHhhh
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV--CLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~--~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
. .......+++.|+|||...+ ..++.++|||||||++|||++|+.||......+. ....+..........+.-+..
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 2 12223356888999998754 5679999999999999999999999865322111 001111000000000000000
Q ss_pred ------ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1566 ------LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1566 ------l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+..................+.+++.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000001134567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=328.61 Aligned_cols=201 Identities=24% Similarity=0.368 Sum_probs=176.1
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD---GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999864 689999999975422 24467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999987756789999999999999999999984 599999999999999999999999999987754433
Q ss_pred cccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGS------EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~------~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.......||+.|+|||++. ...++.++|||||||++|||+||+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 3333457999999999875 45678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=308.78 Aligned_cols=246 Identities=22% Similarity=0.229 Sum_probs=189.7
Q ss_pred HHHhCCCCcCCeE--eecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1331 RLATNGFSESNLL--GTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1331 ~~at~~f~~~~~l--G~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
....++|...+.+ |+|+||.||+++.. ++..+|+|+......... |+.....+ +||||+++++++..++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3334555555555 99999999999864 578899998864321111 22222222 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeeecceeec
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLL 1485 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DFGla~~~ 1485 (1624)
++||||+++|+|.+++.... .++++++..++.|+++|++|||+ .+|+||||||+||+++.++ .++|+|||+++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999997654 78999999999999999999996 7899999999999999998 9999999999876
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
... ....|+..|+|||+..+..++.++|||||||++|||+||+.||............|.... ...
T Consensus 161 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~ 226 (267)
T PHA03390 161 GTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---------QKK 226 (267)
T ss_pred CCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---------ccc
Confidence 432 224688999999999888899999999999999999999999975433222222221110 000
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-VKDALA 1608 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-~~evl~ 1608 (1624)
......+...+.+++.+|++.+|++||+ ++|+++
T Consensus 227 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ---------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0011134566888999999999999996 688874
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=321.58 Aligned_cols=193 Identities=30% Similarity=0.390 Sum_probs=166.9
Q ss_pred ceeecCCccceEEEEe----cCCCEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 750 NLIGAGSFGSVYKATL----PYGMNVAIKVFNLQL----DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999987432 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
+++|+|.+++...+ .+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 99999999997654 578888888999999999999984 599999999999999999999999999985433222 1
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 2234699999999999888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=329.97 Aligned_cols=200 Identities=27% Similarity=0.371 Sum_probs=173.1
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999864 68999999987432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999997644 68899999999999999999998 4599999999999999999999999999875532110
Q ss_pred ----------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 900 ----------------------------------VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 900 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
......+||+.|||||++....++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011246999999999998888999999999999999999999998
Q ss_pred Cc
Q 047591 946 DE 947 (1624)
Q Consensus 946 ~~ 947 (1624)
..
T Consensus 237 ~~ 238 (360)
T cd05627 237 CS 238 (360)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=326.98 Aligned_cols=202 Identities=28% Similarity=0.491 Sum_probs=170.0
Q ss_pred CCCCCcceeecCCccceEEEEec------CCCEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 815 (1624)
++|+..+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +|||||+++++|.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46788899999999999998742 34579999997543 23346788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC------------------------------------------------------------
Q 047591 816 ALILEYMPQGSLEKWLYSHK------------------------------------------------------------ 835 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 835 (1624)
++||||+++|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999986421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc-cccc
Q 047591 836 ---------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT-QTMT 905 (1624)
Q Consensus 836 ---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~ 905 (1624)
..+++.++.+|+.||+.||+|||+ .+|+||||||+|||+++++++||+|||+++......... ....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 136788899999999999999998 469999999999999999999999999998764332211 1223
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 906 ~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.++..|||||+.....++.++|||||||++|||++ |+.||...
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 45678999999988889999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=315.27 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=194.3
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|+..+.||+|+||.||+|+.. ++..+|+|.+... .....+++.+|++++++++|||++++++++...+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 444577999999999999875 5788999987532 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+. |++.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 97 68888887666668999999999999999999996 79999999999999999999999999998876432
Q ss_pred ccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1493 QTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
....|++.|+|||+.. ...++.++|||||||++|||++|+.|+...... .....+.....+. .
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~---------~--- 234 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPA---------L--- 234 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCCC---------c---
Confidence 2346889999999863 456889999999999999999999998643211 1111111111000 0
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+...+.+++.+||+.+|++||++.++++.
T Consensus 235 -------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 001234567889999999999999999998875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=314.87 Aligned_cols=199 Identities=23% Similarity=0.366 Sum_probs=171.3
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
++|...+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 68999999987543 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
++ |+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 98 499999987666688999999999999999999984 599999999999999999999999999986543221 1
Q ss_pred cccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 902 QTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 223468999999998754 5689999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=310.59 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=194.3
Q ss_pred EeecCceEEEEEEEcC-CceEEEEEeccchh---hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~---~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
||+|+||.||+|+..+ |+.+|+|++..... ...+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999998864 89999999864432 4567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-------c
Q 047591 1419 EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-------M 1491 (1624)
Q Consensus 1419 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-------~ 1491 (1624)
.+++.+.+ .+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998755 67999999999999999999996 7999999999999999999999999999876432211 1
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......++..|+|||+.....++.++|||||||++|||+||+.||......+. . . ....... ...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~-~-----------~~~~~~~-~~~- 221 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-F-Q-----------NILNGKI-EWP- 221 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-H-H-----------HHhcCCc-CCC-
Confidence 22335688899999998888899999999999999999999999864321110 0 0 0000000 000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
.....+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 222 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 222 -----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -----ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0001256678999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=323.73 Aligned_cols=199 Identities=27% Similarity=0.351 Sum_probs=170.8
Q ss_pred CCCCcceeecCCccceEEEEe----cCCCEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeE
Q 047591 745 GFSESNLIGAGSFGSVYKATL----PYGMNVAIKVFNLQL----DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 815 (1624)
+|+..+.||+|+||+||+++. .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477789999999999999875 368899999986432 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997654 688999999999999999999984 59999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...........||+.|||||++... .++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 4333333345799999999988754 478899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=312.10 Aligned_cols=202 Identities=26% Similarity=0.374 Sum_probs=172.2
Q ss_pred CCCCCcceeecCCccceEEEEec----CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|+..+.||+|+||.||+|.+. .+..||+|+++.... ...+.|.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778899999999999999753 357899999875432 3346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++......+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999987666789999999999999999999984 59999999999999999999999999876543222
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
........++..|+|||+...+.++.++|||||||++||+++ |+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 111122345678999999988899999999999999999775 99998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=337.57 Aligned_cols=272 Identities=21% Similarity=0.233 Sum_probs=191.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcC--CceEEEEE--------------ec---cchhhHHHHHHHHHHHHHhcCCCcee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFAD--GTNAAIKI--------------FS---LQEDRALKSFDAECEVMRRIRHRNLA 1394 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~--~~~vAvK~--------------~~---~~~~~~~~~f~~E~~~l~~l~HpNIv 1394 (1624)
.++|...+.||+|+||+||+|.++. +..+++|. +. .........|.+|++++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3578888999999999999987642 22222221 10 01123456789999999999999999
Q ss_pred EEEeeeccCCeeEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC
Q 047591 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHN----YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD 1470 (1624)
Q Consensus 1395 ~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 1470 (1624)
++++++.+.+..++|+||+. +++.+++.... ......+...|+.|++.||+|||+ .+||||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999985 57888776432 122345567899999999999996 79999999999999999
Q ss_pred CCcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCC-CCCCCcc-chhhhh
Q 047591 1471 DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP-TDDMFTG-EVCLKH 1548 (1624)
Q Consensus 1471 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P-~~~~~~~-~~~l~~ 1548 (1624)
++.+||+|||+|+.+............||+.|+|||++.+..++.++|||||||++|||++|+.+ +...... ...+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999987754333333346799999999999988999999999999999999998764 4322111 111111
Q ss_pred hh------hhcCChhH---HHHHhhhccC-CchH-HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1549 WV------EESLPDAV---TDVIDANLLS-GEEE-ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1549 ~~------~~~~~~~~---~~~~d~~l~~-~~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+ ...+++.. .+.++..... .... ............+.+++.+|++.||++|||+.|+++.
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11 11122211 1111111000 0000 0001111234567788899999999999999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=313.42 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=195.6
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
..||+|+||.||+|... ++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 36999999999999874 68899999886555555678999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccccc
Q 047591 1420 KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499 (1624)
Q Consensus 1420 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 1499 (1624)
+++... .+++.....++.|++.|++|||+ .+|+||||||+||++++++.++|+|||++....... .......|+
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 179 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGT 179 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccC
Confidence 987543 47889999999999999999996 799999999999999999999999999987654322 122335689
Q ss_pred cccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHH
Q 047591 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579 (1624)
Q Consensus 1500 ~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 1579 (1624)
++|+|||+.....++.++|||||||++|||++|+.||...... ..........+.. .. ...
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~--------~~---------~~~ 240 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPK--------LK---------NLH 240 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcc--------cC---------Ccc
Confidence 9999999988888999999999999999999999998642111 0001111111100 00 001
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1580 KCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1580 ~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.++..+.+++.+||+.+|.+||++.|+++.
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 234456788999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=316.75 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=172.4
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999865 689999999875432 233467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|++ ++|.+++......+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 996 689998877666788999999999999999999984 59999999999999999999999999997653322 1
Q ss_pred ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2233468999999998754 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=315.16 Aligned_cols=200 Identities=23% Similarity=0.327 Sum_probs=172.7
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888899999999999999875 68899999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|++++.+..+. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99988776554 3344688999999999999999999984 5999999999999999999999999999876543332
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 33345689999999999888899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=308.86 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=195.4
Q ss_pred CCcCCeEeecCceEEEEEEEcC-CceEEEEEeccch--hhHHHHHHHHHHHHHhc---CCCceeEEEeeeccCCe-----
Q 047591 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQE--DRALKSFDAECEVMRRI---RHRNLAKIVSSCSNPGF----- 1405 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l---~HpNIv~l~g~~~~~~~----- 1405 (1624)
|...+.||+|+||.||+|++.. ++.+|+|+++... +.....+.+|+++++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4556789999999999999864 8899999986432 22345677788877766 59999999999987776
Q ss_pred eEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1406 KALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
.++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 48999887643 368999999999999999999996 7899999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC-ChhHHHHHh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL-PDAVTDVID 1563 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~-~~~~~~~~d 1563 (1624)
...... .....++..|+|||+..+..++.++|||||||++|||+||+.||..... ...+..+..... +........
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCC
Confidence 643321 1233578899999999888899999999999999999999988865322 112222221110 000000000
Q ss_pred ----hh-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 ----AN-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 ----~~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. ...................+.+++.+||+.+|++||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0000000001111233466788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=308.57 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=201.3
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|...+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345578999999999999875 688899998864432 34578889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++ ++.+++......+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 8988887765678999999999999999999996 789999999999999999999999999998775432 122
Q ss_pred cccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchh--hhhhhhhcCChhHHHHHh------h
Q 047591 1494 TMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC--LKHWVEESLPDAVTDVID------A 1564 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~--l~~~~~~~~~~~~~~~~d------~ 1564 (1624)
....++..|+|||...+. .++.++|||||||++|||+||+.||......+.. .........++......+ .
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 234688899999987766 7899999999999999999999998653221110 000000000110000000 0
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
................+..++.+++.+||+.+|.+||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000011122345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=311.83 Aligned_cols=240 Identities=24% Similarity=0.307 Sum_probs=189.0
Q ss_pred EeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
||+|+||+||+|... +|+.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 68899999886432 23355678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccc
Q 047591 1419 EKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL 1497 (1624)
Q Consensus 1419 ~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 1497 (1624)
.+++.+.. ..+++.++..++.|++.|+.|||+ .+|+||||||+||++++++.+||+|||+++..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99998654 358899999999999999999996 79999999999999999999999999998765431 1223346
Q ss_pred cccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHH
Q 047591 1498 ATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAA 1577 (1624)
Q Consensus 1498 gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 1577 (1624)
++..|+|||+..+..++.++|||||||++|||++|+.||....... .... +...+ .... ...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---------~~~~~----~~~~----~~~ 217 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEE---------LKRRT----LEMA----VEY 217 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHH---------HHhcc----cccc----ccC
Confidence 7889999999888889999999999999999999999986532110 0000 00000 0000 001
Q ss_pred HHHhHHHHHHHHHHccccCCCCCCCHHH
Q 047591 1578 KKKCMSSVMSLALKCSEEIPEERMNVKD 1605 (1624)
Q Consensus 1578 ~~~~~~~~~~l~~~C~~~~P~~RPt~~e 1605 (1624)
+......+.+++.+||+.+|++||++.|
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCc
Confidence 1123456788999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=319.86 Aligned_cols=198 Identities=25% Similarity=0.308 Sum_probs=170.4
Q ss_pred CCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
+|...+.||+|+||+||+|+.. +++.||||++.... ....+.+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999865 57899999987542 22345577788888877 5899999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 9999999999987654 688999999999999999999984 599999999999999999999999999986432221
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 22334699999999999988999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=324.42 Aligned_cols=223 Identities=27% Similarity=0.440 Sum_probs=179.2
Q ss_pred cceeecCCccceEEEEec-CCCEEE---EEEeec-ccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCe--EEEEEEe
Q 047591 749 SNLIGAGSFGSVYKATLP-YGMNVA---IKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGF--KALILEY 821 (1624)
Q Consensus 749 ~~~iG~G~~G~Vy~~~~~-~g~~vA---vK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~Ey 821 (1624)
..+||+|+|-+||||... +|.+|| ||.-+. +.....++|..|+.+|+.++|||||+++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999764 588887 333221 233456889999999999999999999999987655 7789999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC-CceEEEeeeeeeccCCCCCc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD-TVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~~kl~DFGla~~~~~~~~~ 900 (1624)
|..|+|..|+++++ .++....+.+++||++||.|||++. +||||||||.+||+|..+ |.+||+|.|+|.......
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 99999999998765 6888899999999999999999976 689999999999999854 899999999999875432
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHHHHHHHhhhhhhhccchhccC
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~Ll~ 977 (1624)
...++|||.|||||.+. ..|++.+||||||+.++||+|+.+||.+......-.++.....-+..+..+-|++...
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 22378999999999876 6889999999999999999999999988654433333333322233455555555443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=319.42 Aligned_cols=199 Identities=27% Similarity=0.379 Sum_probs=175.4
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
-++|+..+.||+|+||.||+++.. +|..||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999865 688999999876533 334679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 999999999997654 6889999999999999999999743 49999999999999999999999999998654321
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2234699999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-33 Score=290.40 Aligned_cols=200 Identities=22% Similarity=0.393 Sum_probs=172.7
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++.|+..+.||+|.|+.||++.. ++|+.+|+|++.... ....+.+.+|+.|-+.++|||||+|.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456777888999999999999864 579999999886442 33567789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC---CCceEEEeeeeeeccC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD---DTVAHLSDFGISKLLD 895 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~~kl~DFGla~~~~ 895 (1624)
+|+|.||+|..-|-.+ ...++..+-.++.||+.+|.|+|.. +|||||+||+|+|+-. .--+|++|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999998766544 3567778888999999999999995 5999999999999953 3357999999999887
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .......+|||+|||||++...+|+..+||||.|||||-++.|+.||.+
T Consensus 165 ~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 165 D--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred C--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 3 2334456899999999999999999999999999999999999999865
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=305.33 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=194.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-----hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--Cee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-----EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-----~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~ 1406 (1624)
.+|...+.||+|+||.||+|+.. ++..||+|.+... .....+.|.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46788899999999999999874 5889999987432 123456899999999999999999999998654 457
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++++|.+++...+ .+++....+++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999997654 37888899999999999999996 789999999999999999999999999998653
Q ss_pred CCC--CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1487 GVD--SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1487 ~~~--~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
... ........|+..|+|||+..+..++.++|||||||++|||++|+.||.+...... ..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---------- 226 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKIATQPT---------- 226 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHHHcCCC----------
Confidence 211 1111234689999999999888899999999999999999999999865321111 111000000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. ..+......+.+++.+|+. +|++|||..+++.
T Consensus 227 --~~-------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 --KP-------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CC-------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00 0011233557788999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=325.99 Aligned_cols=202 Identities=28% Similarity=0.452 Sum_probs=170.4
Q ss_pred CCCCCcceeecCCccceEEEEe------cCCCEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 815 (1624)
++|+..+.||+|+||+||+|++ .++..||||+++... ....+.+.+|+.+++.+ +|||||+++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4677889999999999999963 246689999986443 23456788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC------------------------------------------------------------
Q 047591 816 ALILEYMPQGSLEKWLYSHK------------------------------------------------------------ 835 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 835 (1624)
++|||||++|+|.++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999996532
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 836 --------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 836 --------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1468888999999999999999984 59999999999999999999999999998765432211
Q ss_pred -cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 902 -QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 902 -~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.....++..|+|||+.....++.++|||||||++|||+| |+.||...
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 122345678999999988899999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=327.84 Aligned_cols=200 Identities=28% Similarity=0.395 Sum_probs=176.1
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999865 68999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC-
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED- 898 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~- 898 (1624)
||+++|+|.+++... ..+++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 478899999999999999999998 469999999999999999999999999998765432
Q ss_pred ---------------------------CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 ---------------------------SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ---------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
........||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 1112234699999999999888999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=307.61 Aligned_cols=242 Identities=27% Similarity=0.308 Sum_probs=192.9
Q ss_pred EeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCH
Q 047591 1343 LGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSL 1418 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL 1418 (1624)
||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 48899999986432 23457899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccccc
Q 047591 1419 EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498 (1624)
Q Consensus 1419 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 1498 (1624)
.+++.+.. .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...... ......|
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 99997653 47888999999999999999996 899999999999999999999999999998765332 2233468
Q ss_pred ccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHH
Q 047591 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578 (1624)
Q Consensus 1499 t~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 1578 (1624)
+..|+|||+.....++.++|||||||++|||++|+.||.......... ...+.+...... .+
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----------~~~~~~~~~~~~-------~~ 216 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-----------YNDILKGNGKLE-------FP 216 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH-----------HHHHhccCCCCC-------CC
Confidence 899999999888889999999999999999999999986532111100 011111000000 01
Q ss_pred HHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1579 KKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1579 ~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
..+...+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 122456889999999999999999 555543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=311.94 Aligned_cols=270 Identities=20% Similarity=0.265 Sum_probs=195.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|++|+||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46777889999999999999875 68899999886432 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeecceeecCCCC
Q 047591 1412 YMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFGla~~~~~~~ 1489 (1624)
|++ +++.+++.... ...++.....++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 58888876433 336778888899999999999996 79999999999999985 5679999999997653221
Q ss_pred CccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh--hhcCChhHHH---HHh
Q 047591 1490 SMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV--EESLPDAVTD---VID 1563 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~--~~~~~~~~~~---~~d 1563 (1624)
.......+++.|+|||+..+ ..++.++|||||||++|||+||+.||......+.....+. .......+.+ ..+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 11223467899999998765 4578999999999999999999999865322111111100 0000000000 000
Q ss_pred hhc-cCC-chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANL-LSG-EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l-~~~-~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
... ... ............+..+.+++.+|++.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000 0000000112234567899999999999999999999864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=316.25 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=190.6
Q ss_pred EeecCceEEEEEEEcCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCCHHH
Q 047591 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEK 1420 (1624)
Q Consensus 1343 lG~G~~G~Vyk~~~~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~~ 1420 (1624)
+|.|+++.||+++. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44555555566544 6899999998654 34456789999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC------ccc
Q 047591 1421 WLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS------MKQ 1493 (1624)
Q Consensus 1421 ~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~------~~~ 1493 (1624)
++... ...+++.....++.|+++||+|||+ .+|+||||||+||+++.++.+|++|||.+..+..... ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 99854 3457888889999999999999996 7999999999999999999999999999876542211 111
Q ss_pred cccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhH----HHHHhhhcc
Q 047591 1494 TMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV----TDVIDANLL 1567 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~----~~~~d~~l~ 1567 (1624)
....++..|+|||++.. ..++.++|||||||++|||++|+.||............ .....+... .........
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcCCcC
Confidence 23457889999998765 35889999999999999999999999754222111111 110000000 000000000
Q ss_pred C---------CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 S---------GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ~---------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ................+.+++.+||+.+|++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00000111112334678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=318.54 Aligned_cols=193 Identities=26% Similarity=0.360 Sum_probs=165.4
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHh-cCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRR-VRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 58899999987542 2234456677777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 99999997654 688999999999999999999984 59999999999999999999999999998654322 22234
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 5699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=318.41 Aligned_cols=198 Identities=25% Similarity=0.299 Sum_probs=169.9
Q ss_pred CCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCC-ceeeeeeeeccCCeEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHR-NLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~ 819 (1624)
+|...+.||+|+||+||+|+.. +++.||||++.... ....+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999865 57899999987532 23456788899999999765 6888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 9999999999997644 688999999999999999999984 599999999999999999999999999875322211
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 12234699999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=300.41 Aligned_cols=199 Identities=29% Similarity=0.370 Sum_probs=168.6
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEee--cccchhHHHHHHHHHHHHhcCCCceeeeeeeecc-----CC
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFN--LQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN-----HG 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 813 (1624)
+...|...+.||+|+||.|+.|.. .+|+.||||++. .+..-..++..+|+.+|+.++|+|||.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345566568899999999999975 579999999987 3444456788999999999999999999998764 34
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+|+|+|+ .||.+.++... .++.+....++.|+++||.|+|+.. |+|||+||+|++++.+...||+|||+||.
T Consensus 100 DvYiV~elMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 6899999995 59999997654 5888888889999999999999965 99999999999999999999999999998
Q ss_pred cCCCC-CcccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 894 LDGED-SVTQTMTLATFGYMAPEYG-SEGIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 894 ~~~~~-~~~~~~~~gt~~Y~aPE~~-~~~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
..... ....+..+.|.+|.|||.+ ....||...||||.|||+.||++|+.=|
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 86431 1123556789999999975 5677999999999999999999999654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=320.38 Aligned_cols=266 Identities=23% Similarity=0.247 Sum_probs=196.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------C
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------G 1404 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~ 1404 (1624)
.+.|...+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467888899999999999999865 6889999988532 233456778899999999999999999988543 3
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++||||++ ++|.+.+... ++..++..++.|++.||+|||. .+|+||||||+||++++++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 4699999996 5888887643 7888899999999999999996 7999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh--cCChhHHHHH
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE--SLPDAVTDVI 1562 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~--~~~~~~~~~~ 1562 (1624)
..... ......||+.|+|||...+..++.++|||||||++|||++|+.||........ ....... ..+....+.+
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 168 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHh
Confidence 64322 22334688999999999888999999999999999999999999864321110 0000000 0001111111
Q ss_pred hhh--------ccCCchHH-H-----------HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DAN--------LLSGEEEA-D-----------IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~--------l~~~~~~~-~-----------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.. ........ . .......+..+.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 100 00000000 0 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=324.02 Aligned_cols=196 Identities=32% Similarity=0.507 Sum_probs=169.0
Q ss_pred CcceeecCCccceEEEE-ecCCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC------eEEEEE
Q 047591 748 ESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG------FKALIL 819 (1624)
Q Consensus 748 ~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 819 (1624)
-.+.||+|+||.||+|+ .++|+.||||.+.... ....+...+|+++|++++|||||++++.-++.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 35789999999999999 5689999999997643 234678899999999999999999999876544 568999
Q ss_pred EecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC--CCC--ceEEEeeeeeec
Q 047591 820 EYMPQGSLEKWLYSHK--YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD--DDT--VAHLSDFGISKL 893 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~--~~kl~DFGla~~ 893 (1624)
|||.+|||+..|.+.. ..+++.+.+.+..+++.||.|||++ +|+||||||.||++- ++| .-||+|||.||.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999997543 4699999999999999999999985 499999999999983 334 369999999998
Q ss_pred cCCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGS-EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.++.. ..+..+||+.|.+||.+. .+.|+..+|.|||||++||.+||..||...
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 86554 344568999999999988 488999999999999999999999999764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=319.24 Aligned_cols=196 Identities=32% Similarity=0.477 Sum_probs=171.7
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCCHH
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLE 828 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 828 (1624)
-++|+|.||+||.|+.. +...+|||-+..+..+..+.+..|+.+.++++|+|||+++|+|.++++.-+.||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999854 56779999998877777788899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC-CCCceEEEeeeeeeccCCCCCcccccc
Q 047591 829 KWLYSHKYTL--NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQTMT 905 (1624)
Q Consensus 829 ~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~ 905 (1624)
+.|+..=.++ ++.+.-.+.+||++||.|||+.+ |||||||-.|||+. -.|.+||+|||-++.+..-... ..+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc-cccc
Confidence 9998764455 67777889999999999999965 99999999999996 5789999999999887544332 3345
Q ss_pred cccccccCccccCCCC--CCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 906 LATFGYMAPEYGSEGI--VSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 906 ~gt~~Y~aPE~~~~~~--~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
.||..|||||++..|. |..++|||||||++.||+||++||.++.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 6999999999987654 7899999999999999999999997754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=297.25 Aligned_cols=259 Identities=26% Similarity=0.334 Sum_probs=194.7
Q ss_pred hccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHh-cCCCceeEEE
Q 047591 1321 ALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRR-IRHRNLAKIV 1397 (1624)
Q Consensus 1321 ~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~-l~HpNIv~l~ 1397 (1624)
....|+-++|+. ...||.|+||+|+|-.++ .|+..|||+++... +...++++.|.++..+ -+-||||+++
T Consensus 57 ~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 345565555553 246999999999999875 68999999997554 4667889999886554 5789999999
Q ss_pred eeeccCCeeEEEEEecCCCCHHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc
Q 047591 1398 SSCSNPGFKALILQYMPQGSLEKWL---YS-HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473 (1624)
Q Consensus 1398 g~~~~~~~~~lV~ey~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 1473 (1624)
|.+..++..++.||+|.- |++.+. +. ....++..-.-+|+..++.||.||-+ ...|||||+||+|||+|..|.
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 999999999999999964 665543 32 23456666666788888999999987 478999999999999999999
Q ss_pred EEEeeecceeecCCCCCccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh
Q 047591 1474 AHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1474 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~ 1551 (1624)
+|+||||++..+. ++...+.-+|...|||||.+.. ..|+.++||||+|++|+|+.||+.||.. |..
T Consensus 207 vKLCDFGIcGqLv--~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----------w~s 274 (361)
T KOG1006|consen 207 VKLCDFGICGQLV--DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----------WDS 274 (361)
T ss_pred EeeecccchHhHH--HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----------HHH
Confidence 9999999987664 3455566689999999997643 3489999999999999999999999864 211
Q ss_pred hcCChhHHHHH--hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1552 ESLPDAVTDVI--DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1552 ~~~~~~~~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+-+.+..++ |+.++....+ -......+..++-.|+-.|-.+||+..++.+
T Consensus 275 --vfeql~~Vv~gdpp~l~~~~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 275 --VFEQLCQVVIGDPPILLFDKE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --HHHHHHHHHcCCCCeecCccc-----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111222222 1111111100 0123456788888999999999999998765
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=323.56 Aligned_cols=195 Identities=31% Similarity=0.479 Sum_probs=168.5
Q ss_pred cCCeEeecCceEEEEEEE-cCCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------CeeEEEE
Q 047591 1339 ESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------GFKALIL 1410 (1624)
Q Consensus 1339 ~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~~~~lV~ 1410 (1624)
..+.||+||||.||+|+. ..|+.||||.++... .+..+...+|+++|++++|||||++++.-++. +...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 357899999999999985 479999999987543 34567889999999999999999999976543 3578999
Q ss_pred EecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec--CCC--cEEEeeecceee
Q 047591 1411 QYMPQGSLEKWLYSH--NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD--DDM--VAHLGDFGIAKL 1484 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld--~~~--~~kl~DFGla~~ 1484 (1624)
|||++|||...+.+. ...++..+.+.+..+++.||.|||+ .+||||||||.||++- ++| .-||+|||.||.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999854 3568899999999999999999996 7999999999999983 334 579999999999
Q ss_pred cCCCCCccccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
+++.. .-+..+||..|.|||... .+.|+..+|.|||||++||.+||..||-.
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 87544 445678999999999988 48899999999999999999999999853
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=322.33 Aligned_cols=194 Identities=26% Similarity=0.372 Sum_probs=168.1
Q ss_pred ceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCC
Q 047591 750 NLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQG 825 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 825 (1624)
+.||+|+||+||++.. .+|+.||+|++.... ......+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999997542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccc
Q 047591 826 SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905 (1624)
Q Consensus 826 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 905 (1624)
+|.+++.... .+++.++..++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 9999887543 689999999999999999999962 3599999999999999999999999999886432222 12234
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 906 ~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.||+.|||||++....++.++|||||||++|||+||+.||..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 699999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=319.48 Aligned_cols=267 Identities=25% Similarity=0.288 Sum_probs=198.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeecc----CCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSN----PGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----~~~~~ 1407 (1624)
++|...+.||+|+||.||+|+.. +|..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999875 58899999886432 2345678889999999999999999998753 34679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+. |+|.+++...+ .+++.....++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999996 68999887543 48899999999999999999996 7899999999999999999999999999987643
Q ss_pred CCCc---cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC---C-----
Q 047591 1488 VDSM---KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL---P----- 1555 (1624)
Q Consensus 1488 ~~~~---~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~---~----- 1555 (1624)
.... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.+...... +. ...... +
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~-~~~~~~g~~~~~~~~ 237 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LK-LILSVLGSPSEEVLN 237 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HH-HHHHHhCCChhHhhh
Confidence 2211 1123468999999998654 5689999999999999999999999965422111 11 111000 0
Q ss_pred ----hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 ----DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 ----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.+.+..+..-....... .......+..+.+++.+|++.+|++|||++|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPW-SKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCH-HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111110000000000 00112346778999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=318.84 Aligned_cols=269 Identities=22% Similarity=0.296 Sum_probs=195.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------Ce
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------GF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~~ 1405 (1624)
++|...+.||+|+||.||+|+.. +|+.||||++... .+...+.+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67888899999999999999874 6889999988643 223346788999999999999999999988654 24
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+.. ++.++.. ..++++.+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 6899999974 7776652 357889999999999999999996 78999999999999999999999999998865
Q ss_pred CCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC-hhHHHHHh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP-DAVTDVID 1563 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~-~~~~~~~d 1563 (1624)
... .....+|..|||||+..+ ..++.++|||||||++|||++|+.||............+.....+ ....+..+
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 321 223467889999998765 468999999999999999999999997532111111101000000 11111110
Q ss_pred hhc----c---CC-chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHH
Q 047591 1564 ANL----L---SG-EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKIK 1614 (1624)
Q Consensus 1564 ~~l----~---~~-~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~--L~~i~ 1614 (1624)
... . .. ...............+.+++.+|++.+|++||+++|++.. ++.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 0 00 0000000111244567899999999999999999999864 55544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=316.94 Aligned_cols=200 Identities=28% Similarity=0.422 Sum_probs=178.7
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCe-EEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGF-KALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~ 819 (1624)
++|...+++|+|+||.++.++.+ +++.+++|.+.... +...+....|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778899999999999998764 57899999987654 3344567899999999999999999999998887 99999
Q ss_pred EecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 820 EYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+||++.+.|...+ ..++++...+++.|++.|+.|||+. .|+|||||+.||++.+++.+|++|||+||....+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998765 5789999999999999999999974 49999999999999999999999999999998765
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. ...++||+.||.||.+.+..|..|+||||+||++|||.+-+.+|..
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 43 3346899999999999999999999999999999999999999865
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=302.13 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=199.9
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|...+.||+|++|.||+|+.. +++.+|+|.+..... ...+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 566789999999999999875 578899999865433 45678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++++|.+++... ..+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 156 (254)
T cd06627 82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DD 156 (254)
T ss_pred CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-cc
Confidence 999999998765 468999999999999999999995 7999999999999999999999999999987754332 12
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....|+..|+|||+..+..++.++||||+|+++|||++|+.|+........ .|. ...... .
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~----------~~~~~~-~----- 217 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFR----------IVQDDH-P----- 217 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHH----------HhccCC-C-----
Confidence 334688999999998877789999999999999999999999864321100 010 000000 0
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..+...+..+.+++.+|+..+|++|||+.|++.
T Consensus 218 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 --PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001123456788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=310.96 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=197.3
Q ss_pred CCcCCeEeecCceEEEEEEEc----CCceEEEEEeccch----hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQE----DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~~----~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~ 1407 (1624)
|...+.||+|+||.||+|+.. +++.+|||+++... ....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 556688999999999999753 46789999886322 23456789999999999 5999999999998889999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++... ..+++.....++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999998764 357888888999999999999996 7999999999999999999999999999987644
Q ss_pred CCCccccccccccccccccccCCCC--cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGI--VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
..........|+..|+|||...+.. .+.++||||||+++|||+||+.||...... .....+ ...+...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~--------~~~~~~~- 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEI--------SRRILKS- 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHH--------HHHHHcc-
Confidence 3322233346899999999876654 788999999999999999999998532110 000000 0011100
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
... .+..+...+.+++.+||+.+|++|||+++|.+.|+.
T Consensus 228 ~~~--------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPP--------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCC--------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 011234567889999999999999999988777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=315.67 Aligned_cols=272 Identities=22% Similarity=0.321 Sum_probs=196.4
Q ss_pred eEeec--CceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCC
Q 047591 1342 LLGTG--IFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQG 1416 (1624)
Q Consensus 1342 ~lG~G--~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~g 1416 (1624)
.||+| +||+||+|+.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999874 6899999998643 2344578999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc---
Q 047591 1417 SLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK--- 1492 (1624)
Q Consensus 1417 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~--- 1492 (1624)
++.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999987642 357888889999999999999995 799999999999999999999999998654322111100
Q ss_pred ---ccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--------hcCChhHH
Q 047591 1493 ---QTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--------ESLPDAVT 1559 (1624)
Q Consensus 1493 ---~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--------~~~~~~~~ 1559 (1624)
.....++..|||||++.+ ..++.++|||||||++|||++|+.||............... ...+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 011235667999999865 34789999999999999999999999764322211110000 00000000
Q ss_pred HHH------h-----hhcc----CC--chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHH
Q 047591 1560 DVI------D-----ANLL----SG--EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKIKTK 1616 (1624)
Q Consensus 1560 ~~~------d-----~~l~----~~--~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~--L~~i~~~ 1616 (1624)
... + .... .. ...........+...+.+++.+||+.+|++|||++|+++. ++.++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 000 0 0000 00 0000111233466788999999999999999999999854 5555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=311.65 Aligned_cols=244 Identities=27% Similarity=0.350 Sum_probs=193.0
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
|...+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 344567999999999999875 5788999988632 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++ |++.+++......+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 68888887666678999999999999999999996 7999999999999999999999999999864321
Q ss_pred ccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1493 QTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....|+..|+|||++. ...++.++|||||||++|||++|+.|+........ .........+. ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~---------~~-- 241 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDSPT---------LQ-- 241 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCC---------CC--
Confidence 22346889999999873 46688999999999999999999999865321111 11000000000 00
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+..+.+++.+||+.+|++||++.+++..
T Consensus 242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01123457789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=307.11 Aligned_cols=242 Identities=21% Similarity=0.262 Sum_probs=185.5
Q ss_pred eEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHH---HHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1342 LLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECE---VMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~---~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
+||+|+||+||+|... +++.||+|.+.... ......+..|.. .++...||||+++++++.+++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 57899999885432 122223444443 4445689999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++... ..+++.++..++.|+++|++|||+ .+|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 99999988754 468999999999999999999996 789999999999999999999999999987653221 22
Q ss_pred ccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...|+..|+|||+..++ .++.++|||||||++|||++|+.||.+............. ...+..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~-------- 217 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------LTMAVE-------- 217 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--------hccCCC--------
Confidence 34689999999998654 6899999999999999999999999753211110000000 000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
.+..++..+.+++.+|+..+|++|| ++.|+++.
T Consensus 218 ---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0112345678899999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=316.74 Aligned_cols=194 Identities=33% Similarity=0.409 Sum_probs=170.8
Q ss_pred CCCcceeecCCccceEEEEe-cCCCEEEEEEeecccch---hHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 746 FSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDG---AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
|+..+.||.|+||.||-|+. .+.+.||||++.....+ ...++..|+..|++++|||+|.+-|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55667899999999999985 46789999998754432 345788999999999999999999999998889999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
|- ||-.|.+.-++..+.+.++..|+.+++.||+|||+.. .||||||+.|||+.+.|.+|++|||.|.+..+..
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--- 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--- 180 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence 96 5888888777778889999999999999999999954 8999999999999999999999999998876543
Q ss_pred cccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYG---SEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~---~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
..+|||+|||||++ ..|.|+-|+||||+||++.|++.+++|+-.|
T Consensus 181 --sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 181 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred --cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 35799999999975 5789999999999999999999999997544
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=319.33 Aligned_cols=193 Identities=27% Similarity=0.336 Sum_probs=167.7
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
++||+|+||+||+|+.. +++.||||+++... ....+.+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 68999999997542 23345688999999998 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence 9999998754 3689999999999999999999984 599999999999999999999999999975322211 2223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++....++.++|||||||++|||+||+.||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 4699999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=308.44 Aligned_cols=266 Identities=20% Similarity=0.222 Sum_probs=195.7
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-hHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-RALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|...+.||+|+||+||+|+.. +++.||||.+..... .......+|+..+++++ ||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 445678999999999999986 478899998864322 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887654 568999999999999999999996 7999999999999999999999999999987653222
Q ss_pred ccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh--hhhhhhhcCChhHHHH------Hh
Q 047591 1493 QTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC--LKHWVEESLPDAVTDV------ID 1563 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~--l~~~~~~~~~~~~~~~------~d 1563 (1624)
.....|+..|+|||+.. ...++.++|||||||+++||++|+.||......+.. ...+......+...+. ++
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23346889999999764 456799999999999999999999998643221110 0001110000001000 00
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....................+.+++.+||+.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000001112466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=302.37 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=202.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|...+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3666788999999999999875 57889999986543 25567889999999999999999999999888999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1413 MPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
+++++|.+++.+. +..+++.++..++.+++.|++|||+ .+++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999864 3678999999999999999999996 699999999999999999999999999998765432
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.......|++.|+|||......++.++||||+|++++||++|+.||+...... ..... .......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~------------~~~~~~~- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-LALKI------------LKGQYPP- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-HHHHH------------hcCCCCC-
Confidence 12233468899999999888889999999999999999999999986432111 00111 1000000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..++..+.+++.+||..+|++|||+.|+++
T Consensus 223 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=319.26 Aligned_cols=193 Identities=28% Similarity=0.354 Sum_probs=167.0
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 68899999997542 23445678899988876 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++.... .+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 99999887543 689999999999999999999984 599999999999999999999999999985432221 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 4699999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=332.68 Aligned_cols=199 Identities=24% Similarity=0.295 Sum_probs=173.1
Q ss_pred CCCcceeecCCccceEEEEec-C-CCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 746 FSESNLIGAGSFGSVYKATLP-Y-GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~~-~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++|||||+++++|...+..|+||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777899999999999999753 3 67889998765555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 824 QGSLEKWLYSH---KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 824 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
+|+|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 33578889999999999999999984 5999999999999999999999999999876543221
Q ss_pred -ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 -TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 -~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....+||++|||||++....++.++|||||||++|||+||+.||..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 22344699999999999888999999999999999999999999864
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=318.42 Aligned_cols=193 Identities=28% Similarity=0.345 Sum_probs=166.9
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +++.||||++.... ....+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999864 57899999987532 23345678899999876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 99999987653 688999999999999999999984 599999999999999999999999999986433222 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 4699999999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=305.41 Aligned_cols=242 Identities=23% Similarity=0.280 Sum_probs=187.1
Q ss_pred CeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHH-HhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVM-RRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l-~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||.||+|+.. +++.||||++.... ......+..|..++ ...+||||+++++++.+.+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999875 58899999986432 22233455555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|+|.+++...+ .+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 99999997643 57888899999999999999996 7999999999999999999999999999876432 223
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..|++.|+|||...+..++.++|||||||++|||+||+.||....... .... +........ .
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-------------~~~~~~~~~----~ 214 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDN-------------ILSRRINWP----E 214 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHH-------------HHhcccCCC----C
Confidence 468899999999888889999999999999999999999986532111 0000 000000000 0
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....++..+.+++.+||+.+|++||++.++.+.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 0112355678899999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=309.57 Aligned_cols=192 Identities=26% Similarity=0.338 Sum_probs=166.7
Q ss_pred eecCCccceEEEEec-CCCEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCCH
Q 047591 752 IGAGSFGSVYKATLP-YGMNVAIKVFNLQLD---GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL 827 (1624)
Q Consensus 752 iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 827 (1624)
||+|+||+||+|... +|+.||||.+..... ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 689999999864321 2335678899999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 828 EKWLYS---HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 828 ~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988854 234689999999999999999999984 5999999999999999999999999999876543322 223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 4689999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=303.17 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=199.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+|...+.||+|+||.||+++.. ++..+|+|.+... ......++.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 3666789999999999999765 6788999988643 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1413 MPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
+++++|.+++.+. +..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998752 3568999999999999999999995 79999999999999999999999999999876543
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......|++.|+|||+..+..++.++||||||+++|||++|+.||...... .+... +.......
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~------------~~~~~~~~ 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK------------VQRGKYPP 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH------------HhcCCCCC
Confidence 222346889999999998888999999999999999999999998653211 11111 11000000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. .......+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 I-------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred C-------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=317.36 Aligned_cols=193 Identities=26% Similarity=0.367 Sum_probs=166.9
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68999999987432 23446678899998876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST 155 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence 99999997654 688999999999999999999984 599999999999999999999999999886432221 2223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|||||++....++.++|||||||++|||+||+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 4699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=307.91 Aligned_cols=251 Identities=23% Similarity=0.266 Sum_probs=193.5
Q ss_pred CCCcCCeEeecCceEEEEEEE----cCCceEEEEEeccch----hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1336 GFSESNLLGTGIFSSVYKATF----ADGTNAAIKIFSLQE----DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~----~~~~~vAvK~~~~~~----~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
+|...+.||+|+||.||+|+. .+|..||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 356678899999999999976 368889999986432 22346788999999999 599999999999988899
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++|+|.+++.... .+++.+...++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999997653 46788888899999999999996 799999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
...........|+..|+|||+... ..++.++|||||||++|||+||+.|+...... .....+ .+.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~---------~~~~~~ 226 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEI---------SRRILK 226 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHH---------HHHhhc
Confidence 433222334568999999998765 34688999999999999999999998532110 000000 000000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
... ..+..+...+.+++.+|++.+|++|| ++.++++
T Consensus 227 ---~~~-----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 ---SEP-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---cCC-----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000 00112345678899999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=305.13 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=172.6
Q ss_pred CCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 745 GFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
.|+..+.||+|+||.||+|++.++..+|+|.+... ....+.|.+|++++++++||||++++++|.+++..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46677889999999999999888889999987633 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.++++.....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 999999986555789999999999999999999984 59999999999999999999999999998654333222222
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
..++..|+|||+.....++.++||||||+++|||+| |+.||..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 345678999999888889999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=313.53 Aligned_cols=201 Identities=26% Similarity=0.462 Sum_probs=168.6
Q ss_pred CCCCCcceeecCCccceEEEEecC-----------------CCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeee
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPY-----------------GMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKI 805 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~-----------------g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 805 (1624)
++|...+.||+|+||.||+|.+.+ +..||||.+..... ...++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999997532 34799999875432 345679999999999999999999
Q ss_pred eeeeccCCeEEEEEEecCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 047591 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHK------------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867 (1624)
Q Consensus 806 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiH 867 (1624)
++++.+.+..++||||+++|+|.+++.... ..++|.++.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999986532 2367888999999999999999984 5999
Q ss_pred CcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc--CCCC
Q 047591 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT--RKMP 944 (1624)
Q Consensus 868 rDlKp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt--g~~P 944 (1624)
|||||+|||+++++.+||+|||+++........ ......++..|||||+...+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999866433221 1222346789999999888889999999999999999987 5667
Q ss_pred CCc
Q 047591 945 TDE 947 (1624)
Q Consensus 945 ~~~ 947 (1624)
|..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=316.75 Aligned_cols=198 Identities=25% Similarity=0.308 Sum_probs=169.9
Q ss_pred CCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 819 (1624)
+|...+.||+|+||+||+|... +|+.||||++.... ....+.+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677789999999999999864 68999999987532 233456788999998886 577888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999999997644 689999999999999999999984 599999999999999999999999999986433221
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 12234699999999999888899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=314.67 Aligned_cols=193 Identities=26% Similarity=0.368 Sum_probs=165.9
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHh-cCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRR-VRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..+++. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999997542 2334566778888876 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999999764 3688999999999999999999984 599999999999999999999999999875432221 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 4699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=288.26 Aligned_cols=205 Identities=23% Similarity=0.392 Sum_probs=175.2
Q ss_pred CHHHHHhhcCCCCCcceeecCCccceEEEE-ecCCCEEEEEEeecccchhHHHHHHHHHHHHhcC-CCceeeeeeeeccC
Q 047591 735 SYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSCSNH 812 (1624)
Q Consensus 735 ~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 812 (1624)
+++|+.+.|+ ++||+|+|+.|--+. +.+|.++|||++..+......+..+|++++.+.+ |+||++|+++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4678888875 789999999999886 6789999999998886667788899999999985 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc---eEEEeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV---AHLSDFG 889 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---~kl~DFG 889 (1624)
...|||||-|.||.|..+|+.++ .+++.++.++.++||.||.|||. ++|.|||+||+|||-.+... +|||||-
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999999998765 68999999999999999999999 56999999999999976553 6999998
Q ss_pred eeeccCC--CCC----cccccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 890 ISKLLDG--EDS----VTQTMTLATFGYMAPEYG-----SEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 890 la~~~~~--~~~----~~~~~~~gt~~Y~aPE~~-----~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
+...+.. +-+ ..-.+.+|+..|||||+. ....|+.++|.||+|||+|-|++|..||..+
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 8654321 111 122345788999999963 3346899999999999999999999999764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=317.48 Aligned_cols=196 Identities=24% Similarity=0.355 Sum_probs=167.0
Q ss_pred CCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHH---HhcCCCceeeeeeeeccCCeEEEE
Q 047591 746 FSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVL---RRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
|+..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999864 68999999997432 22345566776655 567899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|..+++. ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999998864 3689999999999999999999984 59999999999999999999999999987543222
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 156 D-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred C-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 2 22335699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=316.43 Aligned_cols=272 Identities=22% Similarity=0.251 Sum_probs=200.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----Cee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-----GFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-----~~~ 1406 (1624)
+.|.....||+|+||+||+|+.. +++.||||.++.. .....+++.+|++++++++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46778889999999999999864 6889999988642 233356778899999999999999999987643 347
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+. ++|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 99999996 6899888754 358899999999999999999996 799999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh---hhcCChhH----
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV---EESLPDAV---- 1558 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~---~~~~~~~~---- 1558 (1624)
... .......++..|+|||.... ..++.++|||||||++|||++|+.||....... ...... ....++..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcC
Confidence 322 22234468899999997654 468999999999999999999999986432111 011000 00000001
Q ss_pred ----HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHH
Q 047591 1559 ----TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKIK 1614 (1624)
Q Consensus 1559 ----~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~--L~~i~ 1614 (1624)
.+.++. +..............++..+.+++.+|++.+|++|||++|+++. ++.++
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 238 NEKARRYIRS-LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred chhhhHHHHh-cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 111110 00000000011123456778999999999999999999999976 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=313.89 Aligned_cols=270 Identities=23% Similarity=0.296 Sum_probs=195.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-------
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------- 1403 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------- 1403 (1624)
.++|...+.||+|+||.||+|+.. +++.+|||++.... +.....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888899999999999999875 57889999885432 22335678899999999999999999977443
Q ss_pred -CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1404 -GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1404 -~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
...++||||++. ++...+......+++.++..++.|+++||+|||. .+|+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999975 7888777666678999999999999999999996 79999999999999999999999999999
Q ss_pred eecCCCCCc----------cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh
Q 047591 1483 KLLDGVDSM----------KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1483 ~~~~~~~~~----------~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~ 1551 (1624)
+........ ..+...|++.|+|||+..+ ..++.++|||||||++|||++|+.||.+...... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 865432211 1123467889999997654 4589999999999999999999999865322111 111100
Q ss_pred ---hcCChhHH------HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1552 ---ESLPDAVT------DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1552 ---~~~~~~~~------~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...+.... ...+.....................+.+++.+|++.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 0000000000000000011223356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=316.06 Aligned_cols=199 Identities=27% Similarity=0.391 Sum_probs=174.6
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|+..+.||+|+||.||+|... +|..||+|++..... ...+.+.+|++++++++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999875 688999999876533 334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++|+|.+++...+ .+++.....++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999999999997654 5888899999999999999999742 49999999999999999999999999997654321
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1234689999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=323.29 Aligned_cols=193 Identities=23% Similarity=0.292 Sum_probs=168.4
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|+..+.||+|+||.||+|.. .+++.||||... .+.+.+|++++++++|||||++++++......++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999985 468999999753 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
+. ++|.+++.... .+++.+++.|+.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.........
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 96 79999887643 688999999999999999999984 59999999999999999999999999997643322222
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
.....||+.|+|||++....++.++|||||||++|||+||+.|+.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 233579999999999988889999999999999999999998864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=314.88 Aligned_cols=272 Identities=24% Similarity=0.278 Sum_probs=203.8
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC-----eeEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG-----FKAL 1408 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~-----~~~l 1408 (1624)
|...+.||+|+||.||+|+.. ++..+|||++.... ....+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 666789999999999999875 48899999886433 344578999999999999999999999987765 7899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||++ ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred Eecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 999998 58999887544 78999999999999999999996 79999999999999999999999999999876543
Q ss_pred CC--ccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCCh------
Q 047591 1489 DS--MKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPD------ 1556 (1624)
Q Consensus 1489 ~~--~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~------ 1556 (1624)
.. .......+|..|+|||++.+. .++.++|||||||++|||++|+.||......+. ...... ...++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhcc
Confidence 21 122334688999999998777 789999999999999999999999865432111 111000 00000
Q ss_pred --hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHH
Q 047591 1557 --AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKIKT 1615 (1624)
Q Consensus 1557 --~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~--L~~i~~ 1615 (1624)
...+.+.. ................+..+.+++.+||+.+|++|||+.++++. ++.++.
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 236 SEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00111110 00000000000112245678899999999999999999999974 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=316.26 Aligned_cols=193 Identities=28% Similarity=0.363 Sum_probs=167.6
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 57899999997542 23446688999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++...+ .+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST 155 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence 99999886543 689999999999999999999984 599999999999999999999999999985432211 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.+||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 5699999999999888999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=314.58 Aligned_cols=193 Identities=25% Similarity=0.351 Sum_probs=165.8
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|..++... +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 68999999997542 23345667788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceec
Confidence 9999999764 3688999999999999999999984 599999999999999999999999999875322211 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 5699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=307.36 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=199.4
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
|...+.||+|+||.||+|+.. +++.+|+|++.... +...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 344578999999999999886 48899999987542 344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+ ++|.+++.+....+++.++.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 8 59999998765578999999999999999999996 7899999999999999999999999999987643221 22
Q ss_pred cccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchh--hhhhhhhcCChhHHHHHhh-----h
Q 047591 1494 TMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC--LKHWVEESLPDAVTDVIDA-----N 1565 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~--l~~~~~~~~~~~~~~~~d~-----~ 1565 (1624)
....++..|+|||+.... .++.++|||||||++|||++|+.||......+.. .........++.+.+..+. .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 234567889999987666 7899999999999999999999998643211110 0000000001111111110 0
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...................+.+++.+|++.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000011122467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=313.31 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=198.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
...|.....||+|.|++|..|+.. .+..||+|+++... ......+.+|+++|+.++|||||+++.+.+.+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456777889999999999999875 68999999986442 334456899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+.+|.+++++.+++...+ .....+..|+.+|++|||+ +.|+|||||++|||||.++.+||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--
Confidence 99999999999998876666 5566789999999999996 89999999999999999999999999999988633
Q ss_pred ccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
....+.+|++.|.|||+..+..| ++++|+||+||++|-|+.|..||++..-.+. .. .++...+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L--r~-----------rvl~gk~--- 272 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL--RP-----------RVLRGKY--- 272 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc--cc-----------hheeeee---
Confidence 23345689999999998877655 7899999999999999999999986321110 00 0000000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+.-...+..+++.+.+..+|.+|++++++.+.
T Consensus 273 ------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 ------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ------cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0011112234567778888999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=282.87 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=172.3
Q ss_pred HhhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--------hhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 047591 740 QRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--------GAIKSFDAECEVLRRV-RHRNLVKIISSC 809 (1624)
Q Consensus 740 ~~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 809 (1624)
+...+.|..++++|.|..++|-++.. ++|++.|+|++..... ...+.-.+|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456788899999999999999875 5789999999864321 1234567899999998 699999999999
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 810 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
+.+...++|+|.|+.|.|.|+|.+. ..+++++..+|+.|+..|++|||.. .|+|||+||+|||+|++..+||+|||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999999653 4789999999999999999999984 59999999999999999999999999
Q ss_pred eeeccCCCCCcccccccccccccCccccCC------CCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 890 ISKLLDGEDSVTQTMTLATFGYMAPEYGSE------GIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 890 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
+|..+..++.. ...+|||||+|||.+.. ..|+..+|+||+|||+|.++.|..||
T Consensus 169 Fa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 169 FACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred eeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 99988766543 34589999999996542 34778899999999999999999997
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=316.62 Aligned_cols=193 Identities=30% Similarity=0.346 Sum_probs=164.3
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECE-VLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999864 68999999987532 222344555555 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTST 155 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cccc
Confidence 99999997643 688889999999999999999984 599999999999999999999999999875432221 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 4699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=303.01 Aligned_cols=207 Identities=26% Similarity=0.396 Sum_probs=180.2
Q ss_pred HHHHHhhc-CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 047591 736 YQELQRLT-DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCS 810 (1624)
Q Consensus 736 ~~el~~~t-~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 810 (1624)
+-|.+..| +.|+.-++||+|+||+||-++. .+|+-+|.|.+..+. .+...-..+|-.+|.+++.+.||.+--+|+
T Consensus 176 ~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 176 WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 34445444 4688899999999999999985 479999999875432 223345678999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 811 NHGFKALILEYMPQGSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 811 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
+.+.+++|+..|.||||.-||...+. .++++.+.-+|.+|+.||++||.. +||.||+||+|||+|+.|+++|+|.|
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence 99999999999999999999987653 588888999999999999999995 59999999999999999999999999
Q ss_pred eeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 890 ISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 890 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+|..+........ .+||.||||||++..+.|+..+|.||+||++|||+.|+.||..
T Consensus 333 LAvei~~g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 333 LAVEIPEGKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred eEEecCCCCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 9998877655433 3799999999999999999999999999999999999999853
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=336.17 Aligned_cols=201 Identities=27% Similarity=0.372 Sum_probs=171.9
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|... +|+.||||++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999864 68999999986432 223467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 820 EYMPQGSLEKWLYSH----------KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
||+++|+|.+++... ....++.++++++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 12356778899999999999999984 59999999999999999999999999
Q ss_pred eeeccCCCCC-----------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 890 ISKLLDGEDS-----------------VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 890 la~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+++....... ......+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9987621110 001124699999999999888999999999999999999999999865
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=308.78 Aligned_cols=199 Identities=27% Similarity=0.485 Sum_probs=173.2
Q ss_pred CCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 746 FSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
....+.||-|.||.||.|.|+ ....||||.++.+ ....++|.+|+.+|+.++|||+|+|+|+|......|+|+|||.+
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 344678999999999999986 4678999998744 34568999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 825 GSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 825 gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
|+|.+||++... .++.--.+.+|.||+.|++||...+ +|||||.++|+|+.++..+||+|||++|++.++......
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 999999998654 4666677889999999999999854 999999999999999999999999999999876544333
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
...-.+.|.|||-+....++.|+|||+|||+|||++| |..||...
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 3334678999999988899999999999999999998 77787653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=315.86 Aligned_cols=193 Identities=28% Similarity=0.325 Sum_probs=163.5
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECE-VLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
++||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68999999987432 122344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence 9999988754 3678888889999999999999984 599999999999999999999999999875422221 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 4699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=317.25 Aligned_cols=193 Identities=29% Similarity=0.338 Sum_probs=164.3
Q ss_pred ceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECE-VLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999987542 223345566655 46789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT 155 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence 9999998754 3688999999999999999999984 599999999999999999999999999875432211 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 4699999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=307.45 Aligned_cols=198 Identities=25% Similarity=0.361 Sum_probs=172.4
Q ss_pred CCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
+|+..+.||+|+||+||++... +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999864 68999999986532 1223457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 821 YMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999999987543 3689999999999999999999984 599999999999999999999999999987643322
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++....++.++||||+||++|||++|+.||..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 1234689999999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=312.83 Aligned_cols=200 Identities=28% Similarity=0.436 Sum_probs=170.6
Q ss_pred CCCCCcceeecCCccceEEEEec-CCC----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGM----NVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
.+|+..+.||+|+||+||+|.+. +|+ .||||++.... ....++|.+|+.++++++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 35888899999999999999863 333 48999986543 23456789999999999999999999999875 5689
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
|+||+++|+|.+++......+++..+++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 9999999999999987766789999999999999999999984 5999999999999999999999999999977543
Q ss_pred CCccc-ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 898 DSVTQ-TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 898 ~~~~~-~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
..... ....++..|+|||++....++.++|||||||++|||+| |+.||+.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 32211 12235678999999988899999999999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=313.53 Aligned_cols=272 Identities=22% Similarity=0.226 Sum_probs=198.8
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~ 1403 (1624)
..++...+++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345666789999999999999999999976 46889999988643 223356788999999999999999999987532
Q ss_pred ------CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEe
Q 047591 1404 ------GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477 (1624)
Q Consensus 1404 ------~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~ 1477 (1624)
...++|++|+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 78998887643 47899999999999999999996 799999999999999999999999
Q ss_pred eecceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--hcC
Q 047591 1478 DFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESL 1554 (1624)
Q Consensus 1478 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--~~~ 1554 (1624)
|||+++..... .....||..|+|||+..+ ..++.++|||||||++|||++|+.||...... ..+..... ...
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~ 237 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP 237 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 99998865321 223468899999998755 56889999999999999999999998643211 11111111 000
Q ss_pred ChhHH-HHHh-------hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 PDAVT-DVID-------ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 ~~~~~-~~~d-------~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.... .+.+ ..+..................+.+++.+|++.+|++||++.|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11110 0000 0000000000000001234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=312.46 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=192.0
Q ss_pred CCeEeecCceEEEEEEEc-CCceEEEEEeccchhhH--------------HHHHHHHHHHHHhcCCCceeEEEeeeccCC
Q 047591 1340 SNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRA--------------LKSFDAECEVMRRIRHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~--------------~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~ 1404 (1624)
.+.||+|+||+||+|... +++.||||+++...... ...+.+|++++++++||||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999865 68899999885432111 125789999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++||||++ |+|.+++... ..++++....++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 6999988653 357889999999999999999996 7999999999999999999999999999986
Q ss_pred cCCCC-------------CccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhh-
Q 047591 1485 LDGVD-------------SMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW- 1549 (1624)
Q Consensus 1485 ~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~- 1549 (1624)
..... ........+++.|+|||++.+. .++.++|||||||++|||+||+.||......+. +...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~i~ 247 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-LGRIF 247 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 64111 1111223578899999987654 478999999999999999999999865322111 1110
Q ss_pred --hhhcCChhHHHHHhhh----ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1550 --VEESLPDAVTDVIDAN----LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1550 --~~~~~~~~~~~~~d~~----l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....+..+.+..+.. ...............+...+.+++.+|++.+|++|||++|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 0000000000000000 0000000000111234567889999999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=310.98 Aligned_cols=270 Identities=23% Similarity=0.272 Sum_probs=198.9
Q ss_pred HHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-CC
Q 047591 1329 ELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-PG 1404 (1624)
Q Consensus 1329 ~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-~~ 1404 (1624)
++...+++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456788999999999999999999765 6889999987532 22345678899999999999999999998865 56
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++||||+ +++|.+++... .+++.....++.|+++||+|||+ .+|+||||||+||++++++.+||+|||.++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 789999998 56898888643 46778888899999999999996 7899999999999999999999999999875
Q ss_pred cCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccch--hhhhhhhhcCChhHH-H
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV--CLKHWVEESLPDAVT-D 1560 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~--~l~~~~~~~~~~~~~-~ 1560 (1624)
.... .....++..|+|||++.+ ..++.++|||||||++|||+||+.||........ .+..+.. ..++.+. .
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG-TPPDDVINT 232 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHHHh
Confidence 5321 123467889999998755 5689999999999999999999999865321110 0011100 0111111 0
Q ss_pred HHhh-------hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1561 VIDA-------NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1561 ~~d~-------~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+. .+..............+...+.+++.+|++.+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000000111345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=315.26 Aligned_cols=198 Identities=27% Similarity=0.360 Sum_probs=166.1
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccC-----CeEE
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNH-----GFKA 816 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 816 (1624)
+|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 367788999999999999985 468999999986432 22345688999999999999999999987533 3479
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+|||||+ ++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999996 69999987543 689999999999999999999984 599999999999999999999999999986533
Q ss_pred CCC--cccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDS--VTQTMTLATFGYMAPEYGSE--GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~--~~~~~~~gt~~Y~aPE~~~~--~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
... .......||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 221 11233469999999998765 6789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=302.47 Aligned_cols=200 Identities=26% Similarity=0.461 Sum_probs=174.2
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4677889999999999999998888899999986433 235688999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 824 QGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 824 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
+|+|.++++.. ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999764 34688999999999999999999984 599999999999999999999999999987654332222
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
....++..|+|||+...+.++.++|||||||++|||+| |+.||..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 23346778999999988889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=316.67 Aligned_cols=193 Identities=30% Similarity=0.400 Sum_probs=167.8
Q ss_pred ceeecCCccceEEEEe----cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 750 NLIGAGSFGSVYKATL----PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
+.||+|+||.||+++. .+|+.||||++..... .....+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3689999999975432 233567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 999999997543 689999999999999999999984 599999999999999999999999999986543322 122
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 34699999999999888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=293.99 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=172.0
Q ss_pred CCCCcceeecCCccceEEEEecC-CCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.|+..+.||.|.-|+||+++... +..+|+|++.... .....+...|.+||+.++||.++.||+.++.+...++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 35556789999999999999764 5899999997543 2345677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC---
Q 047591 821 YMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG--- 896 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~--- 896 (1624)
||+||+|....+.+. ..+++..+.-+|.+|+-||+|||. ++||.|||||+|||+.++|++.++||-++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999887654 478999999999999999999998 5699999999999999999999999998654311
Q ss_pred ------------------------------CCCc----------------------ccccccccccccCccccCCCCCCc
Q 047591 897 ------------------------------EDSV----------------------TQTMTLATFGYMAPEYGSEGIVST 924 (1624)
Q Consensus 897 ------------------------------~~~~----------------------~~~~~~gt~~Y~aPE~~~~~~~~~ 924 (1624)
.... .....+||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0000 001136999999999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCccC
Q 047591 925 CGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 925 k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
++|+|+|||++|||+.|+.||....
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999999999999999999997643
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=301.49 Aligned_cols=199 Identities=28% Similarity=0.442 Sum_probs=172.1
Q ss_pred CCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 745 GFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+|...+.||+|+||+||+|+...+..||||.+.... ...+.|.+|+.++++++||||++++++|.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 456678899999999999988777789999886432 2346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++......+++.++++++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++............
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 999999987555789999999999999999999984 59999999999999999999999999998664432222222
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
..++..|+|||+.....++.++|||||||++|||+| |+.||..
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 345678999999988889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=317.97 Aligned_cols=203 Identities=28% Similarity=0.479 Sum_probs=170.9
Q ss_pred cCCCCCcceeecCCccceEEEEec------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGF 814 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 814 (1624)
.++|...+.||+|+||+||+|+.. .+..||||++..... ...+.|.+|++++++++ |||||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888899999999999999752 235799999965432 34467999999999996 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-----------------------------------------------------------
Q 047591 815 KALILEYMPQGSLEKWLYSHK----------------------------------------------------------- 835 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 835 (1624)
.|+|||||++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999986421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC
Q 047591 836 ------------------------------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD 879 (1624)
Q Consensus 836 ------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~ 879 (1624)
..+++.++.+++.|+++||+|||+. +|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 1367888899999999999999984 5999999999999999
Q ss_pred CCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 880 DTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 880 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
++.+||+|||+++........ ......+++.|||||++....++.++|||||||++|||++ |+.||..+
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999876433221 1222357788999999988889999999999999999997 99998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=311.34 Aligned_cols=193 Identities=26% Similarity=0.339 Sum_probs=167.1
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|... +++.||||++.... ....+.+.+|.++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999997542 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 99999987653 689999999999999999999984 599999999999999999999999999875332221 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 4689999999999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=304.49 Aligned_cols=197 Identities=39% Similarity=0.632 Sum_probs=166.5
Q ss_pred cceeecCCccceEEEEec-----CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 749 SNLIGAGSFGSVYKATLP-----YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 749 ~~~iG~G~~G~Vy~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
.+.||+|+||.||+|.+. .+..||||.++.... ...+.|.+|++.+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999876 357899999965433 34678999999999999999999999999888899999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc-
Q 047591 823 PQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV- 900 (1624)
Q Consensus 823 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~- 900 (1624)
++|+|.++|+.. ...+++.++.+|+.|||+||+|||+. +|+|+||+++||++++++.+||+|||+++........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999987 56799999999999999999999984 4999999999999999999999999999877332221
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
......+...|+|||.+....++.++||||||+++|||+| |+.|+...
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2223457789999999988889999999999999999999 68887654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=300.75 Aligned_cols=201 Identities=27% Similarity=0.453 Sum_probs=173.7
Q ss_pred CCCCCcceeecCCccceEEEEecC----CCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||+||+|.+.. ...||||.++.... ...+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998742 45799999865433 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++......+++.++.+++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999987666789999999999999999999984 59999999999999999999999999999875222
Q ss_pred Cc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 899 SV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 899 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
.. ......+++.|+|||+.....++.++||||||+++|||++ |+.||..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 21 1122345678999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=313.56 Aligned_cols=193 Identities=28% Similarity=0.322 Sum_probs=162.5
Q ss_pred ceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHH-HHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAEC-EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|+.. +++.||+|++.... ......+.+|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 57889999987432 12223444444 456889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 99999997643 577788888999999999999984 599999999999999999999999999986432221 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 4699999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=305.95 Aligned_cols=197 Identities=29% Similarity=0.422 Sum_probs=165.5
Q ss_pred CCCCcceeecCCccceEEEEe-c-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhc---CCCceeeeeeeec-----cC
Q 047591 745 GFSESNLIGAGSFGSVYKATL-P-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRV---RHRNLVKIISSCS-----NH 812 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~ 812 (1624)
+|...+.||+|+||+||+|+. . .|+.||||+++... ......+.+|+.+++++ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 578889999999999999986 3 46889999987543 22334567788887766 6999999999885 34
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla 891 (1624)
...++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999997 69999987543 3588999999999999999999984 5999999999999999999999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+...... ......||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 158 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred EeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 8765331 22334689999999998888899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=310.57 Aligned_cols=199 Identities=25% Similarity=0.356 Sum_probs=176.1
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc---hhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD---GAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 817 (1624)
.+.|...+.||+|.||+||+++.+ +|+.+|+|++..... ...+...+|+.+|+++. |||||++++++++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456777789999999999999865 599999999975543 23467899999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC----CceEEEeeeeeec
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD----TVAHLSDFGISKL 893 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~----~~~kl~DFGla~~ 893 (1624)
|||++.||.|.+.+... .+++.++..++.|++.|+.|||+ .+|+|||+||+|+|+... +.+|++|||+|+.
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999776 38999999999999999999999 469999999999999643 4799999999998
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
... .......+||++|+|||++....|+..+||||.||++|.|++|..||...
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 876 23344568999999999999899999999999999999999999998653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=301.75 Aligned_cols=191 Identities=26% Similarity=0.375 Sum_probs=165.5
Q ss_pred eecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCCH
Q 047591 752 IGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL 827 (1624)
Q Consensus 752 iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 827 (1624)
||+|+||+||+++.. +|+.||+|++.... ....+.+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccccc
Q 047591 828 EKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL 906 (1624)
Q Consensus 828 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 906 (1624)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 99886543 358899999999999999999998 4599999999999999999999999999987654322 22346
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 907 ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 907 gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
||+.|+|||++....++.++||||+||++|||++|+.||..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 89999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=299.88 Aligned_cols=199 Identities=31% Similarity=0.467 Sum_probs=171.3
Q ss_pred CCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 745 GFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+|+..+.||+|+||.||+|.++++..+|||.+.... .....|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 366778999999999999998777889999986432 2335788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccccc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
++|.+++......+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 999999987666789999999999999999999984 59999999999999999999999999998664332221112
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
..++..|+|||+.....++.++|||||||++|||+| |+.||+.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 234567999999988889999999999999999999 7999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=309.80 Aligned_cols=265 Identities=21% Similarity=0.246 Sum_probs=196.4
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC-----
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG----- 1404 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~----- 1404 (1624)
..++|...+.||+|+||.||+|... ++..||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3567888899999999999999764 6889999988532 2334567889999999999999999999886543
Q ss_pred -eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1405 -FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1405 -~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+|++|||+++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 358999999 6799888864 357899999999999999999996 799999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--hcCChhHHH
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESLPDAVTD 1560 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--~~~~~~~~~ 1560 (1624)
..... .....+++.|+|||+..+ ..++.++|||||||++|||++|+.||........ ...... ...+....+
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 167 QTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 65432 223467899999998765 4588999999999999999999999865321111 111000 001111111
Q ss_pred HHhh--------hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1561 VIDA--------NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1561 ~~d~--------~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+.. .+..............+...+.+++.+|++.+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1100 00000000000111234567889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1624 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-39 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-19 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-39 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-18 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-16 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 9e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 4fcg_A | 328 | Structure Of The Leucine-Rich Repeat Domain Of The | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3p72_A | 269 | Structure Of Platelet Glycoprotein 1b Alpha With A | 4e-04 | ||
| 1p9a_G | 290 | Crystal Structure Of N-terminal Domain Of Human Pla | 4e-04 | ||
| 1u0n_D | 265 | The Ternary Von Willebrand Factor A1-Glycoprotein I | 4e-04 | ||
| 1m10_B | 290 | Crystal Structure Of The Complex Of Glycoprotein Ib | 4e-04 | ||
| 1m0z_A | 290 | Crystal Structure Of The Von Willebrand Factor Bind | 4e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-04 | ||
| 1p8v_A | 279 | Crystal Structure Of The Complex Of Platelet Recept | 4e-04 | ||
| 1sq0_B | 288 | Crystal Structure Of The Complex Of The Wild-Type V | 4e-04 | ||
| 1ook_G | 290 | Crystal Structure Of The Complex Of Platelet Recept | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3pmh_G | 290 | Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P72|A Chain A, Structure Of Platelet Glycoprotein 1b Alpha With A Bound Peptide Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1P9A|G Chain G, Crystal Structure Of N-terminal Domain Of Human Platelet Receptor Glycoprotein Ib-alpha At 1.7 Angstrom Resolution Length = 290 | Back alignment and structure |
|
| >pdb|1U0N|D Chain D, The Ternary Von Willebrand Factor A1-Glycoprotein Ibalpha- Botrocetin Complex Length = 265 | Back alignment and structure |
|
| >pdb|1M10|B Chain B, Crystal Structure Of The Complex Of Glycoprotein Ib Alpha And The Von Willebrand Factor A1 Domain Length = 290 | Back alignment and structure |
|
| >pdb|1M0Z|A Chain A, Crystal Structure Of The Von Willebrand Factor Binding Domain Of Glycoprotein Ib Alpha Length = 290 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279 | Back alignment and structure |
|
| >pdb|1SQ0|B Chain B, Crystal Structure Of The Complex Of The Wild-Type Von Willebrand Factor A1 Domain And Glycoprotein Ib Alpha At 2.6 Angstrom Resolution Length = 288 | Back alignment and structure |
|
| >pdb|1OOK|G Chain G, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Human Alpha-thrombin Length = 290 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3PMH|G Chain G, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib Interaction With Two Distinct Alpha-Thrombin Sites Length = 290 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-142
Identities = 163/643 (25%), Positives = 262/643 (40%), Gaps = 70/643 (10%)
Query: 36 ITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLS 95
+ + L+ K L +N +W+ S+ + C + GVTC R +VT +
Sbjct: 10 LYREIHQLISFKDV--LPDKNLL-PDWS--------SNKNPCTFDGVTC--RDDKVTSID 56
Query: 96 IPNLGL---GGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGN 152
+ + L + + +L+ L SL +S + +G++ L +DLS N +SG
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115
Query: 153 LFDDMC-NSLTELESFDVSSNQITGQLPSSLG-DCSKLKRLSVSFNELTGRIPQNI---G 207
+ S + L+ +VSSN + S G + L+ L +S N ++G
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 208 NLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267
EL L ++GN + G+ + +L + +++N+ +P +LQ L++
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP--FLGDCSALQHLDIS 231
Query: 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHL 327
+G + I CT L L + N G IP +++ + L N
Sbjct: 232 GNKLSGDFSRAISTCTELKLLNISSN--------QFVGPIPP--LPLKSLQYLSLAENKF 281
Query: 328 SGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLV-ANTFGN 386
+G +P L L L GN+ G +P + S L L LS N FSG + +T
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 387 CRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSL 446
R L++L+L++++ G LP S+ NLS SL
Sbjct: 342 MRGLKVLDLSFNEF-------------------------------SGELPESLTNLSASL 370
Query: 447 EYFYAGSCELGGGIPAEFGN--LSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNI 504
S G I + + L L N IP T+ L L LS+N +
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 505 QGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLE 564
G+IPS L L L L L N L+ +IP L + +L L L N L IPS +
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 565 YILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGF 624
+ + S N L+G +P+ IG L+ L L LS N S +IP+ +G + L +L L N F
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 625 QGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSL 667
G+IP A+ +G +V + G+L
Sbjct: 551 NGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 447 bits (1152), Expect = e-139
Identities = 172/611 (28%), Positives = 276/611 (45%), Gaps = 42/611 (6%)
Query: 90 RVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI 149
+ L+I + G + V+ L L++S N F +P L L+ +D+S N++
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 150 SGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GN 208
SG+ + TEL+ ++SSNQ G +P L+ LS++ N+ TG IP + G
Sbjct: 236 SGDFSRAIST-CTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 209 LTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
L L L+GN+ G PP + S L + L++N+ G LP+D ++ L+ L+L
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 269 CMTTGRIPKDIGNCTL-LNYLGLRDNQLTDFGANNLTGLIPSIIFNN--SNIEVIQLYGN 325
+G +P+ + N + L L D +NN +G I + N + ++ + L N
Sbjct: 353 NEFSGELPESLTNLSASLLTL--------DLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 326 HLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFG 385
+G +P + N L+ L+L N LSG IPSS+ + SKL L+L N+ G +
Sbjct: 405 GFTGKIPPTLS-NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 386 NCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKS 445
+ L+ L L ++ L TG + S L+NC L ++++ N G +P +G L +
Sbjct: 464 YVKTLETLILDFNDL-TGEIP------SGLSNCTNLNWISLSNNRLTGEIPKWIGRLE-N 515
Query: 446 LEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQ 505
L + G IPAE G+ ++I L L N TIP + K ++ N I
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIA 571
Query: 506 GSIPSELCQLESLNTLLLQGNALQN--QIPTCLANLTSLRALNLSSNRLNSTIPSTFWSL 563
G + GN L+ L L++ N++S TF +
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631
Query: 564 EYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNG 623
++ +D S N+LSG +P++IG++ L L L N +S SIP +G L+ L L L+ N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 624 FQGSIPEAIGSLISLE---------KGEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQAC 674
G IP+A+ +L L G IP G F F F+ N LCG +
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751
Query: 675 ETSSTQQSKSS 685
+ S
Sbjct: 752 NADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-52
Identities = 80/278 (28%), Positives = 119/278 (42%), Gaps = 43/278 (15%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------------Y 1029
+ +LK L+IS N+ G IP L L+ L L N
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLD 300
Query: 1030 LYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGV---------------RLASNKLIGRIP 1074
L N F G +P G+C+LL L L N +G L+ N+ G +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 1075 SMIFNNS-NIEAIQLYGNHFSGHLPSSIGP-YLPNLQGLILWGNNLSGIIPSSICNASQV 1132
+ N S ++ + L N+FSG + ++ LQ L L N +G IP ++ N S++
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420
Query: 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVL 1192
+ L LS N SG IP++ G+ +L+ L L LN L G L + L L+L
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML-EG------EIPQELMYVKTLETLIL 473
Query: 1193 QNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEF 1230
N L G +P+ + N T+L + S+ L G IP
Sbjct: 474 DFNDLTGEIPSGLSNC-TNLNWISLSNNRLTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-47
Identities = 77/295 (26%), Positives = 106/295 (35%), Gaps = 58/295 (19%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGN--LTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNC 1046
S L L +S N +G I + L+EL YL NN FTG+IP L NC
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL---------YLQNNGFTGKIPPTLSNC 417
Query: 1047 TLLNFLILRQNQLTG--------------VRLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
+ L L L N L+G ++L N L G IP + +E + L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
+G +PS + NL + L N L+G IP I + +L LS N FSG IP G+
Sbjct: 478 LTGEIPSGLS-NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 1153 CRQLQILDLSLNHLT-------------TGSSTQGHSFYTSLTNCRYLRRLVLQNNP--L 1197
CR L LDL+ N ++ Y + N + N
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596
Query: 1198 KGALPNSIGNLSTSLEYFFASSTELRGAIPVE----------------FEGEIPS 1236
+G + LS + +S G G IP
Sbjct: 597 QGIRSEQLNRLS-TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 7e-47
Identities = 79/320 (24%), Positives = 117/320 (36%), Gaps = 51/320 (15%)
Query: 984 ADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLE---------------A 1028
+L L+ L + N +TG IP + N T L + L N L
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGV----------RLASNKLIGRIPSMIF 1078
L NN F+G IP LG+C L +L L N G ++A+N + G+ I
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIK 579
Query: 1079 NNSNIEAIQLYGN--HFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLG 1136
N+ + GN F G + L + G + N ++ L
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLN-RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 1137 LSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGH--SFYTSLTNCRYLRRLVLQN 1194
+S N+ SG IP G+ L IL+L N ++ G + + R L L L +
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDIS------GSIPD---EVGDLRGLNILDLSS 689
Query: 1195 NPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEFEGEIPSGGPFVNFTAESLMQNLVL 1254
N L G +P ++ L T L S+ L G IP G F F + N L
Sbjct: 690 NKLDGRIPQAMSAL-TMLTEIDLSNNNL--------SGPIPEMGQFETFPPAKFLNNPGL 740
Query: 1255 GGSSRLQVPPCKTGSSQQSK 1274
G +P C ++
Sbjct: 741 CG---YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 3e-46
Identities = 73/246 (29%), Positives = 103/246 (41%), Gaps = 32/246 (13%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
+LK L+IS NKI+G + V L L + +N F+ IP LG+
Sbjct: 174 SDGCGELKHLAISGNKISGDVD--VSRCVNLEFL---------DVSSNNFSTGIPF-LGD 221
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYL 1105
C+ L L + N+L+ G I + ++ + + N F G +P L
Sbjct: 222 CSALQHLDISGNKLS----------GDFSRAISTCTELKLLNISSNQFVGPIPPLP---L 268
Query: 1106 PNLQGLILWGNNLSGIIPSSIC-NASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLN 1164
+LQ L L N +G IP + + L LS N F G +P FG+C L+ L LS N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 1165 HLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRG 1224
+ + G +L R L+ L L N G LP S+ NLS SL SS G
Sbjct: 329 NFS------GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 1225 AIPVEF 1230
I
Sbjct: 383 PILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-43
Identities = 66/281 (23%), Positives = 108/281 (38%), Gaps = 47/281 (16%)
Query: 985 DLGDSNKLKRLSISVNKITGTIP--RTVGNLTELRELHLHGNNLEA-------------- 1028
S L L +S N ++G + ++G+ + L+ L++ N L+
Sbjct: 95 GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE 154
Query: 1029 --YLYNNKFTGRIPQNL---GNCTLLNFLILRQNQLTG------------VRLASNKLIG 1071
L N +G C L L + N+++G + ++SN
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFST 214
Query: 1072 RIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQ 1131
IP + + S ++ + + GN SG +I L+ L + N G IP
Sbjct: 215 GIPF-LGDCSALQHLDISGNKLSGDFSRAIS-TCTELKLLNISSNQFVGPIPPLPL--KS 270
Query: 1132 VILLGLSENLFSGLIPNT-FGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRL 1190
+ L L+EN F+G IP+ G C L LDLS NH G + +C L L
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF-YG------AVPPFFGSCSLLESL 323
Query: 1191 VLQNNPLKGALP-NSIGNLSTSLEYFFASSTELRGAIPVEF 1230
L +N G LP +++ + L+ S E G +P
Sbjct: 324 ALSSNNFSGELPMDTLLKMR-GLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-38
Identities = 59/265 (22%), Positives = 97/265 (36%), Gaps = 43/265 (16%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIP--QNL 1043
L L+ L +S + I G++ L L L N+ +G + +L
Sbjct: 73 LLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNS---------LSGPVTTLTSL 122
Query: 1044 GNCTLLNFLILRQNQLTGV---------------RLASNKLIGRIPSMIF---NNSNIEA 1085
G+C+ L FL + N L L++N + G ++
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 1086 IQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGL 1145
+ + GN SG + S NL+ L + NN S IP + + S + L +S N SG
Sbjct: 183 LAISGNKISGDVDVS---RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGD 238
Query: 1146 IPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSI 1205
C +L++L++S N G + L+ L L N G +P+ +
Sbjct: 239 FSRAISTCTELKLLNISSNQF-VGP--------IPPLPLKSLQYLSLAENKFTGEIPDFL 289
Query: 1206 GNLSTSLEYFFASSTELRGAIPVEF 1230
+L S GA+P F
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFF 314
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-34
Identities = 58/260 (22%), Positives = 95/260 (36%), Gaps = 50/260 (19%)
Query: 996 SISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILR 1055
S +N + ++ +LT L L L ++ G + L L L
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSH---------INGSVSG-FKCSASLTSLDLS 108
Query: 1056 QNQLTGVRLASNKLIGRIPSM--IFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLIL 1113
+N L+G + ++ + + S ++ + + N S G L +L+ L L
Sbjct: 109 RNSLSG----------PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 1114 WGNNLSGIIPSSIC---NASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGS 1170
N++SG ++ L +S N SG + C L+ LD+S N+ +TG
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216
Query: 1171 STQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVE- 1229
L +C L+ L + N L G +I T L+ SS + G IP
Sbjct: 217 P--------FLGDCSALQHLDISGNKLSGDFSRAISTC-TELKLLNISSNQFVGPIPPLP 267
Query: 1230 -------------FEGEIPS 1236
F GEIP
Sbjct: 268 LKSLQYLSLAENKFTGEIPD 287
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-21
Identities = 37/120 (30%), Positives = 66/120 (55%), Gaps = 4/120 (3%)
Query: 89 GRVTDLSIPNLG---LGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLS 145
R++ + N+ GG P N ++ L++S N G +P E+ MP L I++L
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
Query: 146 SNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQN 205
N ISG++ D++ + L L D+SSN++ G++P ++ + L + +S N L+G IP+
Sbjct: 665 HNDISGSIPDEVGD-LRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = 7e-99
Identities = 102/623 (16%), Positives = 205/623 (32%), Gaps = 72/623 (11%)
Query: 28 LMSITEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWV---GVTC 84
+S T I D AL ++ AL+ +N+ ++ + N + + + W GV+
Sbjct: 21 KLSRTAEYIK-DYLALKEIWD--ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL 77
Query: 85 GSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHG----TLPNELWLMPRLR 140
S GRVT LS+ G G +P + L+ L L + + P +
Sbjct: 78 NSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 141 IIDLSSNRISGNLFDDMCN-SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELT 199
D ++L ++S+ + S K ++ N +T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 200 GRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLP 259
+ + + LT+L + Y+ + E + + + + + L
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDN-LK 249
Query: 260 SLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEV 319
L ++ + +C ++P + + + + N+ + I++
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 320 IQLYGNHL-SGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
I + N+L + + +S + L L N L G +P+ + KL L L+ N +
Sbjct: 310 IYIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE 367
Query: 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNS 438
+ AN G Q++ L+ A+++L + + + + N + +
Sbjct: 368 IPANFCGFTEQVENLSFAHNKL--KYIPNI----FDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 439 VGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLD 498
+ N+ +++L NQ++ L ++
Sbjct: 422 FDP------------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 499 LSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPS 558
L N + IP + N L +++L N+L
Sbjct: 464 LMGNMLTE-IPKNSLKD----------------ENENFKNTYLLTSIDLRFNKLTKLSDD 506
Query: 559 -TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYL------SGNQLSCSIPSSIGGL 611
+L Y++ +D S N S P N L G + GN+ P I
Sbjct: 507 FRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLC 565
Query: 612 KDLTYLALARNGFQGSIPEAIGS 634
LT L + N + + E I
Sbjct: 566 PSLTQLQIGSNDIR-KVNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 2e-78
Identities = 75/508 (14%), Positives = 160/508 (31%), Gaps = 69/508 (13%)
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG----RIPQNIGNLTELM 213
NS + + +G++P ++G ++L+ L++ + P+ I
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 214 ELYLNGNNLQGEFPPTIF--NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMT 271
+ + Q F + S L + ++ S+ R ++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS-RITLKDTQIGQLSNNI 195
Query: 272 TGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNL 331
T + K + T L + ++ + N N
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFV--------AENICEAWENEN-----SEYAQQYKTE 241
Query: 332 PSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANT-------- 383
NL +L + ++ +P+ + ++ ++ ++ N
Sbjct: 242 DLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 384 FGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLS 443
++QI+ + Y+ L T + +SL + L L N +G LP + G+
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVE------TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353
Query: 444 KSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTT--VGKLQNLQGLDLSY 501
L ++ G + LS N+L IP + + +D SY
Sbjct: 354 -KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSY 411
Query: 502 NNIQG-------SIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS 554
N I + + +++++ L N + + + L ++NL N L +
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML-T 470
Query: 555 TIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI--GGLK 612
IP ++ N +LT + L N+L+ + L
Sbjct: 471 EIPKNSLKD----------------ENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLP 513
Query: 613 DLTYLALARNGFQGSIPEAIGSLISLEK 640
L + L+ N F P + +L+
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-34
Identities = 33/285 (11%), Positives = 77/285 (27%), Gaps = 45/285 (15%)
Query: 980 EEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRI 1039
+ G L + ++ LS+ +G +P +G LTEL L L + +
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN-----ERLFG 125
Query: 1040 PQNLGNCTLLNFLILRQNQLTGV----------------RLASNKLIGRIPSMIFNNSNI 1083
P+ + + + S+ I
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 1084 EAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSG-------------------IIPS 1124
I N+ + + ++ L L+ + +
Sbjct: 186 TQIGQLSNNITF-VSKAVM-RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL 243
Query: 1125 SICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSS-TQGHSFYTSLTN 1183
N + + + +P ++Q+++++ N +G
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV 303
Query: 1184 CRYLRRLVLQNNPLK-GALPNSIGNLSTSLEYFFASSTELRGAIP 1227
++ + + N LK + S+ + L +L G +P
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKM-KKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-33
Identities = 32/264 (12%), Positives = 72/264 (27%), Gaps = 15/264 (5%)
Query: 974 ELLSSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNN 1033
E + E + L + + +P + L E++ +++ N +
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQL 291
Query: 1034 KFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHF 1093
K + + + + + N L + + + + ++ N
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKT---------FPVETSLQKMKKLGMLECLYNQL 342
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTF-GN 1152
G + G L L L N ++ I + QV L + N + +
Sbjct: 343 EG-KLPAFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKS 400
Query: 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSL 1212
+ +D S N + + + + + L NN + + L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG-SPL 459
Query: 1213 EYFFASSTELRGAIPVEFEGEIPS 1236
L IP +
Sbjct: 460 SSINLMGNMLTE-IPKNSLKDENE 482
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-33
Identities = 45/280 (16%), Positives = 84/280 (30%), Gaps = 33/280 (11%)
Query: 961 ESLRLAVTEVVDAELLSSEEEEGADLGDSNKLKRLSISVNKI-TGTIPRTVGNLTELREL 1019
+ + +A + E L + + AD K++ + I N + T + ++ + +L L
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGML 335
Query: 1020 HLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFN 1079
N LE G+ L L L NQ+T + +
Sbjct: 336 ECLYNQLEG----------KLPAFGSEIKLASLNLAYNQITEI----------PANFCGF 375
Query: 1080 NSNIEAIQLYGNHFSGHLPSSIG-PYLPNLQGLILWGNNLSGI-------IPSSICNASQ 1131
+E + N +P+ + + + N + + + +
Sbjct: 376 TEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 1132 VILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLV 1191
V + LS N S F L ++L N LT + N L +
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID 494
Query: 1192 LQNNPLKGALPNSIGNLS-TSLEYFFASSTELRGAIPVEF 1230
L+ N L L + + L S P +
Sbjct: 495 LRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-30
Identities = 42/265 (15%), Positives = 82/265 (30%), Gaps = 47/265 (17%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRT--VGNLTELRELHLHGNNLEA--------------- 1028
G + +++ LS + NK+ IP +++ + + N + +
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 1029 -------YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNS 1081
L NN+ + + + L+ + L N LT + + N
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI---PKNSLKDENENFKNTY 488
Query: 1082 NIEAIQLYGNHFSGHLPSSIGPY-LPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
+ +I L N + L LP L G+ L N+ S P+ N+S + G+
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQ 546
Query: 1141 L------FSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQN 1194
P C L L + N + + N + L +++
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNE-------KITPN---ISVLDIKD 596
Query: 1195 NPLKGALPNSIGNLSTSLEYFFASS 1219
NP + + + Y
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-14
Identities = 23/202 (11%), Positives = 52/202 (25%), Gaps = 33/202 (16%)
Query: 1053 ILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLI 1112
+ ++TG+ L GR+P I + +E + L + + +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 1113 ---LWGNNLSGIIPSSI--CNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLT 1167
+ + S +I ++ + I + + + N++T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 1168 TGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKG-------------------ALPNSIGNL 1208
S ++ LR+ + N+P NL
Sbjct: 197 FVSK--------AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248
Query: 1209 STSLEYFFASSTELRGAIPVEF 1230
L + +P
Sbjct: 249 -KDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-09
Identities = 15/116 (12%), Positives = 33/116 (28%), Gaps = 4/116 (3%)
Query: 1116 NNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGH 1175
+ S+ + +V L L SG +P+ G +L++L L +
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL--- 123
Query: 1176 SFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTS-LEYFFASSTELRGAIPVEF 1230
++ + + + S L +S + +I
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 4e-91
Identities = 127/575 (22%), Positives = 214/575 (37%), Gaps = 39/575 (6%)
Query: 89 GRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNR 148
V D S +L L +P + + + LN++ N+ +L +D+ N
Sbjct: 6 HEVADCS--HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 149 ISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGN 208
IS L ++C L L+ ++ N+++ + C+ L L + N +
Sbjct: 61 ISK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 209 LTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCR-RLPSLQELNLR 267
L+ L L+ N L T + +L+ ++L+NN + +L SL++L L
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIF---NNSNIEVIQLYG 324
P L L L + Q L + + N++I + L
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQ--------LGPSLTEKLCLELANTSIRNLSLSN 231
Query: 325 NHLSGNLPSS-TGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANT 383
+ LS ++ G+ NL L L NNL+ V S +L L N L +++
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
Query: 384 FGNCRQLQILNLAYSQLATGSLSQGQ---SFFSSLTNCRYLRYLAIQTNPWKGILPNSVG 440
++ LNL S S+S S + L +L ++ N GI N
Sbjct: 292 LHGLFNVRYLNLKRS-FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
Query: 441 NLSKSLEYFYAGSCELGGG--IPAEFGNL--SNIIALSLYQNQLASTIPTTVGKLQNLQG 496
L +L+Y + F +L S + L+L +N+++ L +L+
Sbjct: 351 GLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409
Query: 497 LDLSYNNIQGSIP-SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS- 554
LDL N I + E LE++ + L N A + SL+ L L L +
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469
Query: 555 -TIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS--------CSIP 605
+ PS F L + ++D S N ++ + L+ L L L N L+
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 606 SSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
+ GL L L L NGF E L L+
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 2e-88
Identities = 121/585 (20%), Positives = 200/585 (34%), Gaps = 58/585 (9%)
Query: 91 VTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS 150
+T L++ + L + S L SL++ N P +P L++++L N +S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 151 GNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLT 210
L D T L + SN I + L L +S N L+ L
Sbjct: 87 Q-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 211 ELMELYLNGNNLQGEFPPTIFNV---SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267
L EL L+ N +Q ++ SSL+ + L++N + P + L L L
Sbjct: 146 NLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGCF-HAIGRLFGLFLN 203
Query: 268 DCMTTGRIPKDIG---NCTLLNYLGLRDNQLT------------------DFGANNLTGL 306
+ + + + T + L L ++QL+ D NNL +
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 307 IPSIIFNNSNIEVIQLYGNHLSG-------NLPSSTGINLP-NLLRLYLWGNNLSGVIPS 358
+E L N++ L + +NL + + + +L +
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323
Query: 359 SICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNC 418
S L L + N G+ +N F L+ L+L+ S + +L+ F SL +
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET--FVSLAH- 380
Query: 419 RYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPA-EFGNLSNIIALSLYQ 477
L L + N I ++ L LE G E+G + E+ L NI + L
Sbjct: 381 SPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 478 NQLASTIPTTVGKLQNLQGLDLSYNNIQG--SIPSELCQLESLNTLLLQGNALQNQIPTC 535
N+ + + +LQ L L ++ S PS L +L L L N + N
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 536 LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYL 595
L L L L+L N L + G + L L L L
Sbjct: 500 LEGLEKLEILDLQHNNLAR----------------LWKHANPGGPIYFLKGLSHLHILNL 543
Query: 596 SGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
N L +L + L N + +SL+
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-84
Identities = 112/552 (20%), Positives = 201/552 (36%), Gaps = 57/552 (10%)
Query: 101 LGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCN- 159
+ L++L++S N T + L+ + LS+N+I +++
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIG---NLTELMELY 216
+ + L+ ++SSNQI P +L L ++ +L + + + T + L
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 217 LNGNNLQGEFPPTIF---NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273
L+ + L T F ++L ++ L+ N+L + D LP L+ L
Sbjct: 229 LSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 274 RIPKDIGNCTLLNYLGLRDNQLT-DFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLP 332
+ + YL L+ + +L + +E + + N + G +
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IK 345
Query: 333 SSTGINLPNLLRLYLWGNNLSGVIPSSI----CNASKLTVLELSRNLFSGLVANTFGNCR 388
S+ L NL L L + S ++ S L +L L++N S + ++ F
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 389 QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEY 448
L++L+L +++ L+ + + + N + + NS
Sbjct: 406 HLEVLDLGLNEI-GQELTG-----QEWRGLENIFEIYLSYNKYLQLTRNS---------- 449
Query: 449 FYAGSCELGGGIPAEFGNLSNIIALSLYQNQLAS--TIPTTVGKLQNLQGLDLSYNNIQG 506
F + ++ L L + L + + P+ L+NL LDLS NNI
Sbjct: 450 ---------------FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 507 SIPSELCQLESLNTLLLQGNALQ--------NQIPTCLANLTSLRALNLSSNRLNSTIPS 558
L LE L L LQ N L L L+ L LNL SN +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 559 TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIG-GLKDLTYL 617
F L + ++D LN L+ N L L L N ++ G ++LT L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 618 ALARNGFQGSIP 629
+ N F +
Sbjct: 615 DMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 6e-76
Identities = 95/491 (19%), Positives = 175/491 (35%), Gaps = 59/491 (12%)
Query: 111 NLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCN--SLTELESFD 168
S L L +S N+ P + RL + L++ ++ +L + +C + T + +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 169 VSSNQITGQLPSSLGDC--SKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF 226
+S++Q++ ++ + L L +S+N L + L +L +L NN+Q F
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 227 PPTIFNVSSLRVIVLANNSLFGSL--------PVDLCRRLPSLQELNLRDCMTTGRIPKD 278
++ + ++R + L + S+ + L L+ LN+ D G
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
Query: 279 IGNCTLLNYLGLRDNQLT--------------------DFGANNLTGLIPSIIFNNSNIE 318
L YL L ++ + + N ++ + ++E
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408
Query: 319 VIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
V+ L N + L L N+ +YL N + +S L L L R
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 379 L--VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILP 436
+ + F R L IL+L+ + +A + L L L +Q N
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANIN----DDMLEGLEK---LEILDLQHN------- 514
Query: 437 NSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQG 496
+L + + GG LS++ L+L N L L+
Sbjct: 515 --------NLARLWKHA--NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLA-NLTSLRALNLSSNRLNST 555
+DL NN+ S SL +L LQ N + + +L L++ N + T
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
Query: 556 IPSTFWSLEYI 566
S W + +I
Sbjct: 625 CESIAWFVNWI 635
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-31
Identities = 49/259 (18%), Positives = 83/259 (32%), Gaps = 33/259 (12%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFT 1036
+ L+++ N++ ++L L + N + L +N+ +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 1037 GRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH 1096
+ CT L L L N + + + N+ + L N S
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKI----------KNNPFVKQKNLITLDLSHNGLSST 136
Query: 1097 LPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVIL--LGLSENLFSGLIPNTFGNCR 1154
+ L NLQ L+L N + + + + L L LS N P F
Sbjct: 137 KLGTQVQ-LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 1155 QLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS-TSLE 1213
+L L L+ L S T+ + T+ +R L L N+ L + L T+L
Sbjct: 196 RLFGLFLNNVQL-GPSLTEKLCLELANTS---IRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 1214 YFFASSTELRGAIPVEFEG 1232
S L F
Sbjct: 252 MLDLSYNNLNVVGNDSFAW 270
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-30
Identities = 50/254 (19%), Positives = 83/254 (32%), Gaps = 28/254 (11%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------------- 1028
L L +S N ++ T T L L+EL L N ++A
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQL 1088
L +N+ P L L L QL + + N++I + L
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPS-------LTEKLCLELANTSIRNLSL 229
Query: 1089 YGNHFSGHLPSSIGP-YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP 1147
+ S ++ NL L L NNL+ + S Q+ L N L
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289
Query: 1148 NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYT--SLTNCRYLRRLVLQNNPLKGALPNSI 1205
++ ++ L+L + S S + L L +++N + G N
Sbjct: 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349
Query: 1206 GNLSTSLEYFFASS 1219
L +L+Y S+
Sbjct: 350 TGL-INLKYLSLSN 362
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-30
Identities = 64/306 (20%), Positives = 100/306 (32%), Gaps = 48/306 (15%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------------YLYN 1032
+ L L+++ NKI+ L L L L N + YL
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
NK+ + L L+LR+ L + PS N+ + L N+
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKN--------VDSSPSPFQPLRNLTILDLSNNN 491
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLS--------GIIPSSICNASQVILLGLSENLFSG 1144
+ + + L L+ L L NNL+ G + S + +L L N F
Sbjct: 492 IAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 1145 LIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNS 1204
+ F + +L+I+DL LN+L T ++ N L+ L LQ N +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPAS-------VFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 1205 IGNLSTSLEYFFASSTELRGAIPVEFEGEIPSGGPFVNFTAESLMQNLVLGGSSRLQVPP 1264
G +L F+ S FVN+ E+ L PP
Sbjct: 604 FGPAFRNLTELDMRFN--------PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 1265 CKTGSS 1270
G
Sbjct: 656 HYHGFP 661
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-30
Identities = 42/253 (16%), Positives = 79/253 (31%), Gaps = 24/253 (9%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
+L+ + N I ++ L +R L+L + + + +
Sbjct: 268 FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFS-GHLPSSIGPY 1104
L L + N + G+ +M N++ + L + S L +
Sbjct: 328 LKCLEHLNMEDNDIPGI----------KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377
Query: 1105 LPN--LQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP-NTFGNCRQLQILDL 1161
L + L L L N +S I + + +L L N + + + + L
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437
Query: 1162 SLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKG--ALPNSIGNLSTSLEYFFASS 1219
S N S L+RL+L+ LK + P+ L +L S+
Sbjct: 438 SYNKYLQ-------LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL-RNLTILDLSN 489
Query: 1220 TELRGAIPVEFEG 1232
+ EG
Sbjct: 490 NNIANINDDMLEG 502
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-28
Identities = 47/286 (16%), Positives = 78/286 (27%), Gaps = 49/286 (17%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNN 1033
+ SIS+ + + L L L++ N++ L N+
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 1034 KFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHF 1093
+L T F+ L + L + L NK+ ++E + L N
Sbjct: 364 FT------SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGL--IPNTFG 1151
L L N+ + L N + +S + L L + P+ F
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 1152 NCRQLQILDLSLNHLTT-------------------------GSSTQGHSFYTSLTNCRY 1186
R L ILDLS N++ L +
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 1187 LRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEFEG 1232
L L L++N +L L+ L F
Sbjct: 538 LHILNLESNGFDEIPVEVFKDL-FELKIIDLGLNNLNTLPASVFNN 582
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-25
Identities = 44/271 (16%), Positives = 90/271 (33%), Gaps = 38/271 (14%)
Query: 976 LSSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKF 1035
+ + + E D+ ++ LK+L +S N+I P + L L L+ L
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL--------- 207
Query: 1036 TGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFN--NSNIEAIQLYGNHF 1093
+ + L L L + + L++++L + +N+ + L N+
Sbjct: 208 GPSLTEKL-------CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENL---------FSG 1144
+ S +LP L+ L NN+ + S+ V L L +
Sbjct: 261 NVVGNDSFA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
Query: 1145 LIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNS 1204
+ +F + L+ L++ N + S T L+ L L N+ +
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKS-------NMFTGLINLKYLSLSNSFTSLRTLTN 372
Query: 1205 ---IGNLSTSLEYFFASSTELRGAIPVEFEG 1232
+ + L + ++ F
Sbjct: 373 ETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-22
Identities = 44/220 (20%), Positives = 74/220 (33%), Gaps = 31/220 (14%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRI 1073
L +P +L T + L L NQL +
Sbjct: 4 VSHEVADCSHLKLTQ----------VPDDLP--TNITVLNLTHNQLRRL----------P 41
Query: 1074 PSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVI 1133
+ S + ++ + N S P LP L+ L L N LS + + + +
Sbjct: 42 AANFTRYSQLTSLDVGFNTISKLEPELCQK-LPMLKVLNLQHNELSQLSDKTFAFCTNLT 100
Query: 1134 LLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQ 1193
L L N + N F + L LDLS N L+ + + L+ L+L
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS-------STKLGTQVQLENLQELLLS 153
Query: 1194 NNPLKGALPNSIGNLS-TSLEYFFASSTELRGAIPVEFEG 1232
NN ++ + + +SL+ SS +++ P F
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-11
Identities = 32/175 (18%), Positives = 52/175 (29%), Gaps = 29/175 (16%)
Query: 95 SIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLF 154
+ G + LS L LN+ N F + L+IIDL N ++ L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT-LP 576
Query: 155 DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELME 214
+ N+ L+S ++ N IT G L E
Sbjct: 577 ASVFNNQVSLKSLNLQKNLITSVEKKVFG-----------------------PAFRNLTE 613
Query: 215 LYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVD-LCRRLPSLQELNLRD 268
L + N T +++ + ++ L LC P +R
Sbjct: 614 LDMRFNPFDC----TCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRL 664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-07
Identities = 18/134 (13%), Positives = 41/134 (30%), Gaps = 7/134 (5%)
Query: 90 RVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI 149
+ L++ + G +L L +++ N + + L+ ++L N I
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 150 SGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNL 209
+ + L D+ N C + NE IP+ +
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFD-------CTCESIAWFVNWINETHTNIPELSSHY 649
Query: 210 TELMELYLNGNNLQ 223
+ +G ++
Sbjct: 650 LCNTPPHYHGFPVR 663
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 6e-85
Identities = 93/617 (15%), Positives = 186/617 (30%), Gaps = 63/617 (10%)
Query: 29 MSITEANITTDEAALLQVKAHIALDPQNFFERNWN-LSATTNTSSSNSVCNWVGVTCGS- 86
+ T I D AL + + ++ N + N + + + W
Sbjct: 261 LKETAEYIK-DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL 319
Query: 87 -RHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLS 145
+GRVT LS+ G G +P + L+ L L+ + + + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 146 SNRISGNLFDDMCNSLTELESFDVSSNQIT-----GQLPSSLGDCSKLKRLSVSFNELTG 200
+RI + + L D+ + I + K ++ N +T
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF 439
Query: 201 RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPS 260
I + I LT+L +Y + + + + + L
Sbjct: 440 -ISKAIQRLTKLQIIYFANSPFTY-DNIAVD----WEDANSDYAKQYENEELSW-SNLKD 492
Query: 261 LQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDF-GANNLTGLIPSIIFNNSNIEV 319
L ++ L +C ++P + + L L + N+ + I++
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 320 IQLYGNHLSGNLPSSTGI-NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
+ N+L P+S + + L L N + + KLT L+L N
Sbjct: 553 FYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE 609
Query: 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNS 438
+ + Q++ L ++++L + + + + + N N
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK--YIPNI----FNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 439 VGNLS----KSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLAS-------TIPTT 487
++ + E+ F S I + L N + S
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723
Query: 488 VGKLQNLQGLDLSYNNIQGSIPSEL--CQLESLNTLLLQGNALQNQIPTCLANLTSLRAL 545
L +DL +N + S+ + L L+ + + N + PT N + L+A
Sbjct: 724 YKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF 781
Query: 546 NLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIP 605
+ R D N + P I L L + N + +
Sbjct: 782 GIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD 822
Query: 606 SSIGGLKDLTYLALARN 622
+ L L +A N
Sbjct: 823 EKL--TPQLYILDIADN 837
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 4e-66
Identities = 78/541 (14%), Positives = 173/541 (31%), Gaps = 39/541 (7%)
Query: 120 ISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLP 179
I + + L +D + R + + +F+ + Q
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTIN--NTIHSLNWNFNKELDMWGDQPG 316
Query: 180 SSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVI 239
L + ++ LS++ GR+P IG LTEL L ++ + +
Sbjct: 317 VDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 240 VLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFG 299
+ + L +L ++ + + L+D Q+ +
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNL- 433
Query: 300 ANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSS 359
N I I + +++I + + + + + S
Sbjct: 434 -TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV------DWEDANSDYAKQYENEELS 486
Query: 360 ICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQ--SFFSSLTN 417
N LT +EL + + + +LQ LN+A ++ + + +
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 418 CRYLRYLAIQTNPWKGILPNSV-GNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLY 476
++ + N + ++ + L ++ + FG + L L
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKM-VKLGLLDCVHNKV-RHLE-AFGTNVKLTDLKLD 603
Query: 477 QNQLASTIPTTVGK-LQNLQGLDLSYNNIQGSIPS--ELCQLESLNTLLLQGNALQNQIP 533
NQ+ IP ++GL S+N ++ IP+ + + ++ N + ++
Sbjct: 604 YNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
Query: 534 TCLANL-----TSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS-------GCLP 581
++ + + LS N + F + I + S NL++
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD 721
Query: 582 QDIGNLKVLTGLYLSGNQLSCSIPSSI--GGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
+ N +LT + L N+L+ S+ L L+ + ++ N F S P + L+
Sbjct: 722 GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLK 779
Query: 640 K 640
Sbjct: 780 A 780
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-29
Identities = 36/269 (13%), Positives = 73/269 (27%), Gaps = 17/269 (6%)
Query: 969 EVVDAELLSSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA 1028
E +++ E E + L + + +P + +L EL+ L++ N +
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQL 1088
R+ + + + N L + + + +
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF---------PASASLQKMVKLGLLDC 580
Query: 1089 YGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPN 1148
N HL + L L L N + I QV LG S N +
Sbjct: 581 VHNKVR-HLEAFGT--NVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNI 637
Query: 1149 T-FGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGN 1207
+ + +D S N + + S + L N ++
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSM--DDYKGINASTVTLSYNEIQKFPTELFAT 695
Query: 1208 LSTSLEYFFASSTELRGAIPVEFEGEIPS 1236
+ + S+ + +IP
Sbjct: 696 G-SPISTIILSNNLM-TSIPENSLKPKDG 722
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-27
Identities = 42/279 (15%), Positives = 75/279 (26%), Gaps = 51/279 (18%)
Query: 986 LGDSNKLKRLSISVNKITG---------TIPRTVGNLTELRELHLHGNNLEA-------- 1028
L D +L+ L+I+ N+ + +++ ++ NNLE
Sbjct: 511 LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQ 570
Query: 1029 --------YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN 1080
+NK + G L L L NQ+ IP
Sbjct: 571 KMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-----------IPEDFCAF 617
Query: 1081 -SNIEAIQLYGNHFSGHLPSSIG-PYLPNLQGLILWGNNLSGIIPS-----SICNASQVI 1133
+E + N +P+ + + + N + +
Sbjct: 618 TDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676
Query: 1134 LLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQ 1193
+ LS N F + + LS N +T+ + N L + L+
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 1194 NNPLKGALPNSI--GNLSTSLEYFFASSTELRGAIPVEF 1230
N L L + L L S P +
Sbjct: 737 FNKLTS-LSDDFRATTL-PYLSNMDVSYNCFSS-FPTQP 772
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-26
Identities = 40/262 (15%), Positives = 75/262 (28%), Gaps = 49/262 (18%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTV--GNLTELRELHLHGNNLEA--------------- 1028
+++++ L S NK+ IP ++ + + N + +
Sbjct: 615 CAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI 673
Query: 1029 -----YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNI 1083
L N+ + + ++ +IL N +T + + N +
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI---PENSLKPKDGNYKNTYLL 730
Query: 1084 EAIQLYGNHFSGHLPSSIGP-YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENL- 1141
I L N + L LP L + + N S P+ N+SQ+ G+
Sbjct: 731 TTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRD 788
Query: 1142 -----FSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNP 1196
P C L L + N + L L + +NP
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE-------KLTPQ---LYILDIADNP 838
Query: 1197 LK----GALPNSIGNLSTSLEY 1214
++ I L Y
Sbjct: 839 NISIDVTSVCPYIEAGMYVLLY 860
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-26
Identities = 40/296 (13%), Positives = 83/296 (28%), Gaps = 36/296 (12%)
Query: 954 SLKKWVEESLRLAVTEVVDAELLSSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNL 1013
+ ++ + EL ++ G DL ++ ++ LS++ G +P +G L
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 1014 TELRELHLHGNNLEAY-----------LYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGV 1062
TEL+ L ++ + + RI + L L + L
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 1063 RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGII 1122
+ N + I + I N + + +I L LQ + + +
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPFTYDN 464
Query: 1123 PSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLT 1182
+ ++ N + L ++L T L
Sbjct: 465 IAVDWE-----DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT-------QLPDFLY 512
Query: 1183 NCRYLRRLVLQNNPLKG---------ALPNSIGNLSTSLEYFFASSTELRGAIPVE 1229
+ L+ L + N L + ++ F+ L P
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTG-PKIQIFYMGYNNLEE-FPAS 566
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 6e-16
Identities = 27/178 (15%), Positives = 56/178 (31%), Gaps = 32/178 (17%)
Query: 986 LGDSNKLKRLSISVNKIT-------GTIPRTVGNLTELRELHLHGNNLEA---------- 1028
+ + + +S N +T N L + L N L +
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTL 752
Query: 1029 ------YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSN 1082
+ N F+ P N + L +R + N+++ + P+ I +
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD----AEGNRILRQWPTGITTCPS 807
Query: 1083 IEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
+ +Q+ N + + P L L + N I +S+C + + L +
Sbjct: 808 LIQLQIGSNDIR-KVDEKL---TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 17/113 (15%), Positives = 34/113 (30%), Gaps = 15/113 (13%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
L + +S N + + P N ++L+ + N+ + P + C L
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRD---AEGNRILRQWPTGITTCPSLI 809
Query: 1051 FLILRQNQLTGV-----------RLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
L + N + V +A N I + + L +
Sbjct: 810 QLQIGSNDIRKVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 23/187 (12%), Positives = 53/187 (28%), Gaps = 8/187 (4%)
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLIL--RQNQLTGVRLASNKLIGRIPSMIFNNSNIEAI 1086
Y+ R + +F ++ + + V + + I + EA+
Sbjct: 222 TTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEAL 281
Query: 1087 QLYGNHFSGHL--PSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSG 1144
+ + + L +WG+ + N +V L L+ G
Sbjct: 282 DGKNWRYYSGTINNTIHSLNWNFNKELDMWGD----QPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 1145 LIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNS 1204
+P+ G +L++L + T G T + R+ + +
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 1205 IGNLSTS 1211
+
Sbjct: 398 LNLSDLL 404
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-83
Identities = 105/542 (19%), Positives = 183/542 (33%), Gaps = 34/542 (6%)
Query: 101 LGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNS 160
L + L L++S + L + L+ N I L +
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSG 98
Query: 161 LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNG 219
L+ L+ + +G LK L+V+ N + ++P+ NLT L L L+
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 220 NNLQGEFPPTIFNVSSLRVIV----LANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI 275
N +Q + + + + ++ L+ N + P + L +L LR+ + +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--KEIRLHKLTLRNNFDSLNV 216
Query: 276 PKD-IGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334
K I L L + + NL S + N+ + + +L L
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNE--GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274
Query: 335 TGI--NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392
+ L N+ L + V S LEL F + ++L
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLKSLKRLTF 332
Query: 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNP--WKGILPNSVGNLSKSLEYFY 450
+ S + L +L + N +KG S + SL+Y
Sbjct: 333 TSNKGGNA------------FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT-SLKYLD 379
Query: 451 AGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIP 509
+ + + F L + L + L +V L+NL LD+S+ + + +
Sbjct: 380 LSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 510 SELCQLESLNTLLLQGNALQNQIPTC-LANLTSLRALNLSSNRLNSTIPSTFWSLEYILV 568
L SL L + GN+ Q L +L L+LS +L P+ F SL + V
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 569 VDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGL-KDLTYLALARNGFQGS 627
++ S N L L L S N + S + L +L L +N F +
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
Query: 628 IP 629
Sbjct: 559 CE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 4e-81
Identities = 100/518 (19%), Positives = 176/518 (33%), Gaps = 35/518 (6%)
Query: 135 LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS 194
L + +DLS N + + EL+ D+S +I + S L L ++
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFS-FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 195 FNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDL 254
N + L+ L +L NL I ++ +L+ + +A+N + +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
L +L+ L+L D+ + L L D N + + P F
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL----DLSLNPMNFIQPGA-FKE 199
Query: 315 SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGN------NLSGVIPSSICNASKLTV 368
+ + L N S N+ + L L L NL S++ LT+
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 369 LELSRN---LFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLA 425
E + + + F + +L + + ++L
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI---------ERVKDFSYNFGWQHLE 310
Query: 426 IQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLA--ST 483
+ + + +L K L + GG +L ++ L L +N L+
Sbjct: 311 LVNCKFGQFPTLKLKSL-KRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 484 IPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPT-CLANLTSL 542
+ +L+ LDLS+N + + S LE L L Q + L+ +L +L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 543 RALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLS 601
L++S F L + V+ + N DI L+ LT L LS QL
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 602 CSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
P++ L L L ++ N F L SL+
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 3e-78
Identities = 100/555 (18%), Positives = 175/555 (31%), Gaps = 73/555 (13%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQI 174
+L++S N + P L+++DLS I + D SL+ L + ++ N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88
Query: 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQG-EFPPTIFNV 233
+ S L++L L IG+L L EL + N +Q + P N+
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 234 SSLRVIVLANNSLFGSLPVDLCR--------------------------RLPSLQELNLR 267
++L + L++N + DL + L +L LR
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 268 DCMTTGRIPKD-IGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNH 326
+ + + K I L L + + NL S + N+ + + +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE--GNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 327 LSGNLPSSTGI--NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTF 384
L L + L N+ L + V S LEL F
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKL 324
Query: 385 GNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSK 444
+ ++L + S + L +L +LS+
Sbjct: 325 KSLKRLTFTSNKGGNA------------FSEVDLPSLEFL----------------DLSR 356
Query: 445 SLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNI 504
+ G +++ L L N + T+ + L+ L+ LD ++N+
Sbjct: 357 N-------GLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNL 408
Query: 505 QGSIP-SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTI-PSTFWS 562
+ S L +L L + + L+SL L ++ N P F
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 563 LEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
L + +D S L P +L L L +S N L L L + N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 623 GFQGSIPEAIGSLIS 637
S + + S
Sbjct: 529 HIMTSKKQELQHFPS 543
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-42
Identities = 67/359 (18%), Positives = 121/359 (33%), Gaps = 34/359 (9%)
Query: 90 RVTDLSIPNLGLGGTIPPHVAN-LSFLVSLNISGNR------FHGTLPNELWLMPRLRII 142
V L + G + + L L +L I R + + + + +
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 143 DLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRI 202
L S I L ++ + + L +L +F G
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHL---ELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGN 339
Query: 203 PQNIGNLTELMELYLNGNNLQ--GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPS 260
+ +L L L L+ N L G + F +SL+ + L+ N + + + L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG-LEQ 397
Query: 261 LQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEV 319
L+ L+ + + + L YL + + I S++EV
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT--------HTRVAFNGIFNGLSSLEV 449
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
+++ GN N L NL L L L + P++ + S L VL +S N F L
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 380 VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNS 438
+ LQ+L+ + + + T + Q F SS L +L + N + +
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS------LAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-40
Identities = 64/340 (18%), Positives = 110/340 (32%), Gaps = 26/340 (7%)
Query: 325 NHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTF 384
+ N + L L N L + S + +L VL+LSR + +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 385 GNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSK 444
+ L L L + + + +L + + L+ L + +G+L K
Sbjct: 73 QSLSHLSTLILTGNPIQSLALG-------AFSGLSSLQKLVAVETNLASLENFPIGHL-K 124
Query: 445 SLEYFYAGSCEL-GGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQ----GLDL 499
+L+ + +P F NL+N+ L L N++ S T + L + LDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 500 SYNNIQGSIPSELCQLESLNTLLLQGNALQNQIP-TCLANLTSLRALNLSSNRLNST--- 555
S N + P ++ L+ L L+ N + TC+ L L L +
Sbjct: 185 SLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 556 ---IPSTFWSLEYILVVDFSLNLLS---GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIG 609
S L + + +F L L + L ++ L + S
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS-- 301
Query: 610 GLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPF 649
+L L F + SL L G F
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF 341
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-33
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 12/228 (5%)
Query: 441 NLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLS 500
NL S + L F + + L L + ++ + L +L L L+
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 501 YNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNST-IPST 559
N IQ L SL L+ L + + +L +L+ LN++ N + S +P
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 560 FWSLEYILVVDFSLNLLSGCLPQDIGNLKVLT----GLYLSGNQLSCSIPSSIGGLKDLT 615
F +L + +D S N + D+ L + L LS N ++ P + ++ L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LH 203
Query: 616 YLALARNGFQGSIPEAIG------SLISLEKGEIPSGGPFVNFTEGSF 657
L L N ++ + + L GE + G F + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-30
Identities = 51/261 (19%), Positives = 90/261 (34%), Gaps = 36/261 (13%)
Query: 991 KLKRLSISVNKIT--GTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTL 1048
L+ L +S N ++ G ++ T L+ L L N + + N
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI----------TMSSNFLGLEQ 397
Query: 1049 LNFLILRQNQLTGV---------------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHF 1093
L L + + L + ++ + S++E +++ GN F
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNC 1153
+ I L NL L L L + P++ + S + +L +S N F L +
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 517
Query: 1154 RQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNS--IGNLSTS 1211
LQ+LD SLNH+ T + F +S L L L N + + +
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSS------LAFLNLTQNDFACTCEHQSFLQWIK-D 570
Query: 1212 LEYFFASSTELRGAIPVEFEG 1232
+ A P + +G
Sbjct: 571 QRQLLVEVERMECATPSDKQG 591
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-27
Identities = 44/247 (17%), Positives = 77/247 (31%), Gaps = 33/247 (13%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTL 1048
K L +S N + + + EL+ L L + + +
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI---------QTIEDGAYQSLSH 77
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNL 1108
L+ LIL N + + S+++ + + + IG L L
Sbjct: 78 LSTLILTGNPIQSL----------ALGAFSGLSSLQKLVAVETNLASLENFPIGH-LKTL 126
Query: 1109 QGLILWGNNLSGI-IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQI----LDLSL 1163
+ L + N + +P N + + L LS N + Q+ + LDLSL
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 1164 NHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELR 1223
N + + R L +L L+NN + + LE E R
Sbjct: 187 NPMNFIQP-------GAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 1224 GAIPVEF 1230
+E
Sbjct: 239 NEGNLEK 245
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-25
Identities = 35/189 (18%), Positives = 65/189 (34%), Gaps = 3/189 (1%)
Query: 101 LGGTIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCN 159
L V +L L+ L+IS + L ++ ++ N N D+
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNG 219
L L D+S Q+ P++ S L+ L++S N L L L +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 220 NNLQGEFPPTIFNV-SSLRVIVLANNSLFGSLP-VDLCRRLPSLQELNLRDCMTTGRIPK 277
N++ + + SSL + L N + + + ++L + P
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587
Query: 278 DIGNCTLLN 286
D +L+
Sbjct: 588 DKQGMPVLS 596
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-24
Identities = 39/268 (14%), Positives = 79/268 (29%), Gaps = 34/268 (12%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------Y 1029
+L+ L +S +I +L+ L L L GN +++
Sbjct: 47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106
Query: 1030 LYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLY 1089
+G+ L L + N + ++P N +N+E + L
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQS---------FKLPEYFSNLTNLEHLDLS 157
Query: 1090 GNHFSGHLPSSIGPYLPNLQ----GLILWGNNLSGIIPSSICNASQVILLGLSENLFSG- 1144
N + + L + L L N ++ I P + ++ L L N S
Sbjct: 158 SNKIQSIYCTDLRV-LHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLN 215
Query: 1145 LIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYT--SLTNCRYLRRLVLQNNPLKGALP 1202
++ L++ L L + + L N + + +
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 1203 NSIGNLSTSLEYFFASSTELRGAIPVEF 1230
+ L T++ F S + +
Sbjct: 276 DLFNCL-TNVSSFSLVSVTIERVKDFSY 302
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-23
Identities = 33/185 (17%), Positives = 61/185 (32%), Gaps = 20/185 (10%)
Query: 1025 NLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIE 1084
N+ F +IP NL L L N L + F+ ++
Sbjct: 9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHL----------GSYSFFSFPELQ 55
Query: 1085 AIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSG 1144
+ L + L +L LIL GN + + + S + L E +
Sbjct: 56 VLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 1145 LIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNS 1204
L G+ + L+ L+++ N + + + +N L L L +N ++
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPE------YFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 1205 IGNLS 1209
+ L
Sbjct: 169 LRVLH 173
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-20
Identities = 43/261 (16%), Positives = 71/261 (27%), Gaps = 37/261 (14%)
Query: 991 KLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
+L +L++ N + + +T L L L L L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN---EGNLEKFDKSALEGLCNL 257
Query: 1050 NFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSS--------- 1100
R L + + I + +N+ + L S
Sbjct: 258 TIEEFRLAYL-------DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 1101 ---------IGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFG 1151
L +L+ L N + + + L + F G +
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 1152 NCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTS 1211
L+ LDLS N + T ++ L L Q++ LK S+ +
Sbjct: 371 GTTSLKYLDLSFNGVIT--------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 1212 LEYFFASSTELRGAIPVEFEG 1232
L Y S T R A F G
Sbjct: 423 LIYLDISHTHTRVAFNGIFNG 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 9e-79
Identities = 128/590 (21%), Positives = 203/590 (34%), Gaps = 60/590 (10%)
Query: 70 TSSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTL 129
T+SS+ C + + NLGL IP + + L S N
Sbjct: 1 TTSSDQKC-----IE-KEVNKTYNCE--NLGLN-EIPGTL--PNSTECLEFSFNVLPTIQ 49
Query: 130 PNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLK 189
+ L +DL+ +I + +D S L++ +++N + ++L LK
Sbjct: 50 NTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108
Query: 190 RLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSL--- 246
L ++ + N L LYL N++ P F L+V+ NN++
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 247 ----FGSLP-----------------VDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTL- 284
SL Q LN I K + N T+
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 285 -LNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLL 343
L D D GL ++E I L ++ + S+T L
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGL------CEMSVESINLQKHYFFN-ISSNTFHCFSGLQ 281
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
L L +LS +PS + S L L LS N F L + N L L++ +
Sbjct: 282 ELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGI--LPNSVGNLSKSLEYFYAGSCELGGGIP 461
+ +L N LR L + + + + NLS L+ E
Sbjct: 341 LGT---GCLENLEN---LRELDLSHDDIETSDCCNLQLRNLS-HLQSLNLSYNEPLSLKT 393
Query: 462 AEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQLESLNT 520
F + L L +L + L L+ L+LS++ + S L +L
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 521 LLLQGNALQNQIPTC---LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L LQGN L L L L LS L+S F SL+ + VD S N L+
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGS 627
+ + +LK + L L+ N +S +PS + L + L +N +
Sbjct: 514 SSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-65
Identities = 92/493 (18%), Positives = 163/493 (33%), Gaps = 27/493 (5%)
Query: 155 DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELME 214
D C ++++ + + ++P +L + + L SFN L L L
Sbjct: 5 DQKCIEKEVNKTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTF 61
Query: 215 LYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGR 274
L L + T + L +VL N L + +L+ L +
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL-IFMAETALSGPKALKHLFFIQTGISSI 120
Query: 275 IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334
+ N L L L N ++ + F ++V+ N + L
Sbjct: 121 DFIPLHNQKTLESLYLGSNHIS--------SIKLPKGFPTEKLKVLDFQNNAIH-YLSKE 171
Query: 335 TGINLPNLLRLYLW-GNNLSGVIPSSICNASKLTVLELSRNLFSGLV--ANTFGNCRQLQ 391
+L L L N I +++ L ++ + L
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231
Query: 392 ILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYA 451
+ + F L + + +Q + + I N+ S L+
Sbjct: 232 LGTFEDMDD----EDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFS-GLQELDL 285
Query: 452 GSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE 511
+ L +P+ LS + L L N+ + + +L L + N + + +
Sbjct: 286 TATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
Query: 512 -LCQLESLNTLLLQGNALQNQ--IPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILV 568
L LE+L L L + ++ L NL+ L++LNLS N S F + +
Sbjct: 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404
Query: 569 VDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGS 627
+D + L Q NL +L L LS + L S GL L +L L N F
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 628 IPEAIGSLISLEK 640
+ SL +L +
Sbjct: 465 NIQKTNSLQTLGR 477
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 9e-65
Identities = 107/531 (20%), Positives = 178/531 (33%), Gaps = 45/531 (8%)
Query: 101 LGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNS 160
L ++ L L L L + L SN IS ++
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFP 151
Query: 161 LTELESFDVSSNQITGQLPSSLGDCSKLKR--LSVSFNELTGRIPQNIGNLTELMELYLN 218
+L+ D +N I + + L+++ N++ G I + L
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 219 GNNLQGEFPPTIFN--VSSLRVIVLANNSL--FGSLPVDLCRRLPSLQELNLRDCMTTGR 274
G + N + SL + + + + S++ +NL+
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNI 269
Query: 275 IPKDIGNCTLLNYLGLRDNQLT---------------DFGANNLTGLIPSIIFNNSNIEV 319
+ L L L L+ AN L N ++
Sbjct: 270 SSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL--SGVIPSSICNASKLTVLELSRNLFS 377
+ + GN L + NL NL L L +++ S + N S L L LS N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 378 GLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPN 437
L F C QL++L+LA+++L + QS F +L L+ L + +
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRL---KVKDAQSPFQNLHL---LKVLNLSHSLLDISSEQ 443
Query: 438 SVGNLSKSLEYFYAGSCELGGGI---PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNL 494
L +L++ G L + L L L+S L+ +
Sbjct: 444 LFDGLP-ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 495 QGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS 554
+DLS+N + S L L+ + L L N + +P+ L L+ R +NL N L+
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
Query: 555 TIPSTFWSLEYILVVDFSLNLLSG--CLPQDIGNLKVLTGLYLSGNQLSCS 603
T + + LE+ L C N +L G+ LS LSCS
Sbjct: 562 TCSNI-YFLEWYKENMQKLEDTEDTLC-----ENPPLLRGVRLSDVTLSCS 606
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-27
Identities = 46/228 (20%), Positives = 78/228 (34%), Gaps = 6/228 (2%)
Query: 440 GNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDL 499
G L S E L F L N+ L L + Q+ T L L L
Sbjct: 29 GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88
Query: 500 SYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPST 559
+ N + + L ++L L + + L N +L +L L SN ++S
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
Query: 560 FWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYL--SGNQLSCSIPSSIGGLKDLTYL 617
+ E + V+DF N + +D+ +L+ T L L +GN ++ I L
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSL 207
Query: 618 ALARNGFQGSIPEAIG--SLISLEKGEIPSGGPFVNFTEGSFMQNYAL 663
I + + ++ SL G + + F +
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTF-EDMDDEDISPAVFEGLCEM 254
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-25
Identities = 42/238 (17%), Positives = 71/238 (29%), Gaps = 34/238 (14%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
LK+L +S NK + N L L + GN L N L
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL--------ENLENLR 353
Query: 1051 FLILRQNQLTGV----------------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFS 1094
L L + + L+ N+ + +E + L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413
Query: 1095 GHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLI---PNTFG 1151
S L L+ L L + L + L L N F N+
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ 473
Query: 1152 NCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
+L+IL LS L++ + T+ + + + L +N L + ++ +L
Sbjct: 474 TLGRLEILVLSFCDLSSIDQ-------HAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-25
Identities = 44/279 (15%), Positives = 82/279 (29%), Gaps = 44/279 (15%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YL 1030
++L L ++ N + + L+ L + + YL
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 1031 YNNKFTGRIPQNLGNCTLLNFLILRQNQLTGV----------------RLASNKLIGRIP 1074
+N + L L + N + + L N I I
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND-IAGIE 195
Query: 1075 SMIFNNSNIEAIQLYGNHFSGHLPSSIGPY-LPNLQGLILWGNNLSGIIPSSI--CNASQ 1131
F+++ +++ G + + + +L + I P+
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
Query: 1132 VILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLV 1191
V + L ++ F + NTF LQ LDL+ HL+ + L L++LV
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS--------ELPSGLVGLSTLKKLV 307
Query: 1192 LQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEF 1230
L N + S N SL + R +
Sbjct: 308 LSANKFENLCQISASNF-PSLTHLSIKGNTKRLELGTGC 345
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-22
Identities = 54/314 (17%), Positives = 83/314 (26%), Gaps = 68/314 (21%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------------- 1028
L + L+ L + N I+ +L+ L N +
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKL---------------IGRI 1073
L N G I + + L Q V K I
Sbjct: 185 NLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243
Query: 1074 PSMIFN---NSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNAS 1130
+F ++E+I L ++F ++ LQ L L +LS + PS + S
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHC-FSGLQELDLTATHLSEL-PSGLVGLS 301
Query: 1131 QVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSS------------------- 1171
+ L LS N F L + N L L + N
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 1172 -TQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEF 1230
L N +L+ L L N + LE + T L+
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC-PQLELLDLAFTRLKV------ 414
Query: 1231 EGEIPSGGPFVNFT 1244
+ PF N
Sbjct: 415 ---KDAQSPFQNLH 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-21
Identities = 37/245 (15%), Positives = 65/245 (26%), Gaps = 27/245 (11%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTL 1048
N + L S N + T L L L L + +
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQI---------YWIHEDTFQSQHR 82
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNL 1108
L+ L+L N L + + + ++ + S + L
Sbjct: 83 LDTLVLTANPLIFM----------AETALSGPKALKHLFFIQTGISSIDFIPLHN-QKTL 131
Query: 1109 QGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTT 1168
+ L L N++S I ++ +L N L + +Q L L+LN
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 1169 GSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS-TSLEYFFASSTELRGAIP 1227
+ + L + + N + SL + P
Sbjct: 192 A------GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 1228 VEFEG 1232
FEG
Sbjct: 246 AVFEG 250
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-21
Identities = 49/270 (18%), Positives = 78/270 (28%), Gaps = 41/270 (15%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGN--LTELRELHLHGNNLEA-------------- 1028
DS + L+ + I + + N + L + E
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 1029 ---YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEA 1085
L + F + L L L L+ +PS + S ++
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-----------ELPSGLVGLSTLKK 305
Query: 1086 IQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSG-IIPSSICNASQVILLGLSEN--LF 1142
+ L N F S P+L L + GN + + N + L LS +
Sbjct: 306 LVLSANKFENLCQISASN-FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 1143 SGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALP 1202
S N LQ L+LS N + + + C L L L LK
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTE-------AFKECPQLELLDLAFTRLKVKDA 417
Query: 1203 NSIGNLSTSLEYFFASSTELRGAIPVEFEG 1232
S L+ S + L + F+G
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-20
Identities = 31/208 (14%), Positives = 65/208 (31%), Gaps = 25/208 (12%)
Query: 976 LSSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------- 1028
+ + + L + + L+ L++S N+ +L L L L+
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 1029 ---------YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFN 1079
L ++ Q L L L+ N + + +
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK-------GNIQKTNSLQT 474
Query: 1080 NSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSE 1139
+E + L S + L + + L N L+ ++ + + L L+
Sbjct: 475 LGRLEILVLSFCDLS-SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLN-LAS 532
Query: 1140 NLFSGLIPNTFGNCRQLQILDLSLNHLT 1167
N S ++P+ Q + ++L N L
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-19
Identities = 37/252 (14%), Positives = 67/252 (26%), Gaps = 29/252 (11%)
Query: 984 ADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNL 1043
L L ++ +I T + L L L N L L
Sbjct: 51 TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL---------IFMAETAL 101
Query: 1044 GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP 1103
L L Q ++ + + N +E++ L NH S + G
Sbjct: 102 SGPKALKHLFFIQTGISSI----------DFIPLHNQKTLESLYLGSNHISS-IKLPKGF 150
Query: 1104 YLPNLQGLILWGNNLSGIIPSSICN--ASQVILLGLSENLFSGLIPNTFGNCRQLQILDL 1161
L+ L N + + + + + + L L+ N +G+ P F + Q L+
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNF 209
Query: 1162 SLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS-TSLEYFFASST 1220
+ + L ++ + P L S+E
Sbjct: 210 GGTQNLLVIFKG-----LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 1221 ELRGAIPVEFEG 1232
F
Sbjct: 265 YFFNISSNTFHC 276
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-17
Identities = 32/186 (17%), Positives = 54/186 (29%), Gaps = 23/186 (12%)
Query: 1025 NLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNI 1083
N N IP L N L N L I + F+ N+
Sbjct: 14 NKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPT-----------IQNTTFSRLINL 59
Query: 1084 EAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFS 1143
+ L + L L+L N L + +++ + L + S
Sbjct: 60 TFLDLTRCQIYWIHEDTFQS-QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 1144 GLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPN 1203
+ N + L+ L L NH+++ L+ L QNN +
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKL-------PKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 1204 SIGNLS 1209
+ +L
Sbjct: 172 DMSSLQ 177
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-12
Identities = 32/155 (20%), Positives = 57/155 (36%), Gaps = 20/155 (12%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
LK L++S + + + + L L+ L+L GN+ K + +L L
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP------KGNIQKTNSLQTLGRLE 479
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
L+L L+ I F + + + L N + +L +
Sbjct: 480 ILVLSFCDLSS-----------IDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGIY 527
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSG 1144
L L N++S I+PS + SQ + L +N
Sbjct: 528 -LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-07
Identities = 21/128 (16%), Positives = 39/128 (30%), Gaps = 29/128 (22%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVG---NLTELRELHLHGNNLEA-------------- 1028
L+ L++ N + L L L L +L +
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 1029 -YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQ 1087
L +N+ T + L + + +L L N ++ + +PS++ S I
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII----------LPSLLPILSQQRTIN 553
Query: 1088 LYGNHFSG 1095
L N
Sbjct: 554 LRQNPLDC 561
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 5e-72
Identities = 94/292 (32%), Positives = 152/292 (52%), Gaps = 15/292 (5%)
Query: 1317 LNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALK 1376
++ L+R S +EL++A++ FS N+LG G F VYK ADGT A+K + + +
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71
Query: 1377 S-FDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLY---SHNYLLNIE 1432
F E E++ HRNL ++ C P + L+ YM GS+ L L+
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 1433 QRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492
+R I + A L YLH IIH D+K +N+LLD++ A +GDFG+AKL+D D+
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE---VCLKHW 1549
T TIG++APEY S G S DV+ +G++++E +T ++ D V L W
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 1550 VEESLPD-AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
V+ L + + ++D +L ++ + + ++ +AL C++ P ER
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKD-------EEVEQLIQVALLCTQSSPMER 296
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 3e-71
Identities = 90/280 (32%), Positives = 141/280 (50%), Gaps = 18/280 (6%)
Query: 718 LPILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFN 777
+P E+ + L +R S +ELQ +D FS N++G G FG VYK L G VA+K
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK--- 60
Query: 778 LQLD-----GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY 832
+L G F E E++ HRNL+++ C + L+ YM GS+ L
Sbjct: 61 -RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
Query: 833 ---SHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889
+ L+ +R I + A L YLH +IH D+K +N+LLD++ A + DFG
Sbjct: 120 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 890 ISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
++KL+D +D+ VT T T G++APEY S G S DV+ +G++++E T + D
Sbjct: 180 LAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238
Query: 949 FTGETS---LKKWVEESLRL-AVTEVVDAELLSSEEEEGA 984
L WV+ L+ + +VD +L + ++E
Sbjct: 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 6e-71
Identities = 93/315 (29%), Positives = 149/315 (47%), Gaps = 16/315 (5%)
Query: 1303 RRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNA 1362
+ + ++ L R+ +L ATN F L+G G+F VYK DG
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 1363 AIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWL 1422
A+K + + + ++ F+ E E + RH +L ++ C LI +YM G+L++ L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 1423 Y---SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479
Y ++ EQRL+I I A L YLH +IIH D+K N+LLD++ V + DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183
Query: 1480 GIAKL-LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
GI+K + + T+ T+GY+ PEY +G ++ DVYSFG+++ E L R
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 1539 MF-TGEVCLKHWVEESLPD-AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEI 1596
V L W ES + + ++D NL I + + + A+KC
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNL-----ADKI--RPESLRKFGDTAVKCLALS 296
Query: 1597 PEERMNVKDALANLK 1611
E+R ++ D L L+
Sbjct: 297 SEDRPSMGDVLWKLE 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-69
Identities = 85/251 (33%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAEC 791
R+ +L+ T+ F LIG G FG VYK L G VA+K + I+ F+ E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY---SHKYTLNIQQRLDIMI 848
E L RH +LV +I C LI +YM G+L++ LY +++ +QRL+I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS--VTQTMTL 906
A L YLH +IH D+K N+LLD++ V ++DFGISK D ++ T+
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVK 202
Query: 907 ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF-TGETSLKKWVEESLRL 965
T GY+ PEY +G ++ DVYSFG+++ E + + +L +W ES
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 966 -AVTEVVDAEL 975
+ ++VD L
Sbjct: 263 GQLEQIVDPNL 273
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 8e-71
Identities = 107/531 (20%), Positives = 185/531 (34%), Gaps = 33/531 (6%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
+ + +N S L L++S + L + L+ N I + LT
Sbjct: 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLT 104
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNGNN 221
LE+ ++ +G LK+L+V+ N + ++P NLT L+ + L+ N
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164
Query: 222 LQGEFPPTIFNV-----SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIP 276
+Q + ++ N + + D + L EL LR + I
Sbjct: 165 IQT-ITVNDLQFLRENPQVNLSLDMSLNPI-DFIQ-DQAFQGIKLHELTLRGNFNSSNIM 221
Query: 277 KD-IGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGN-LPSS 334
K + N L+ L + D NL PSI+ ++ + + + +
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDE--RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279
Query: 335 TGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILN 394
L N+ + L G ++ + + K L + R + L+ L
Sbjct: 280 KFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLT 334
Query: 395 LAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLS-KSLEYFYAGS 453
L ++ S L YL + N S +L SL +
Sbjct: 335 LTMNKG---------SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 454 CELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSEL 512
+ A F L + L + L + L+ L LD+SY N +
Sbjct: 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 513 CQLESLNTLLLQGNALQNQIPTC-LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDF 571
L SLNTL + GN+ ++ + AN T+L L+LS +L F +L + +++
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 572 SLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
S N L L L+ L S N++ S K L + L N
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 5e-67
Identities = 96/554 (17%), Positives = 172/554 (31%), Gaps = 48/554 (8%)
Query: 103 GTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
G++ P + + + + + +P+++ + IDLS N + N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSN-FS 56
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNL 222
EL+ D+S +I + L L ++ N + P + LT L L L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 223 QGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGN- 281
I + +L+ + +A+N + L +L ++L D+
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 282 ---CTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGIN 338
+ L + N + I F + + L GN S N+ + N
Sbjct: 177 RENPQVNLSLDMSLNPIDF---------IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
Query: 339 LPNLLRLYLWGNNLSGVIPSSICNAS--------KLTVLELSRNLFSGLVANTFGNCRQL 390
L L L I S + L+ F +
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287
Query: 391 QILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSK-SLEYF 449
++LA + + + + L+I K + L +L
Sbjct: 288 SAMSLAGVSI---------KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMN 338
Query: 450 YAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTV--GKLQNLQGLDLSYNNIQGS 507
G I + L ++ L L +N L+ + + +L+ LDLS+N
Sbjct: 339 K-------GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-I 390
Query: 508 IPSELCQLESLNTLLLQGNALQNQIPT-CLANLTSLRALNLSSNRLNSTIPSTFWSLEYI 566
+ + LE L L Q + L+ +L L L++S F L +
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 567 LVVDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ 625
+ + N ++ N LT L LS QL L L L ++ N
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 626 GSIPEAIGSLISLE 639
L SL
Sbjct: 511 FLDSSHYNQLYSLS 524
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-56
Identities = 95/479 (19%), Positives = 157/479 (32%), Gaps = 39/479 (8%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
+ P + L+ L +L + + + L+ ++++ N I ++LT
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLK----RLSVSFNELTGRIPQNIGNLTELMELYLN 218
L D+S N I + L + L +S N + I +L EL L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLR 212
Query: 219 GNNLQGEFPPTIF-NVSSLRVIVLANNSLFG-----SLPVDLCRRLPSLQ--ELNLRDCM 270
GN T N++ L V L + L + E L
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 271 TTGRIPKDIGNCTLLNYLGLRDNQLTDF----GANNLTGL------IPSIIFNN-SNIEV 319
++ + L + L + + ++
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKS 332
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSS--ICNASKLTVLELSRNLFS 377
+ L N S + LP+L L L N LS S + L L+LS N
Sbjct: 333 LTLTMNKGSISFKKV---ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 378 GLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPN 437
+++ F +LQ L+ +S L + + FS+ + L YL I K
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTL------KRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 438 SVGNLSKSLEYFYAGSCELGGGIPAE-FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQG 496
L+ SL + F N +N+ L L + QL L LQ
Sbjct: 443 IFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNST 555
L++S+NN+ S QL SL+TL N ++ SL NL++N +
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-39
Identities = 46/313 (14%), Positives = 98/313 (31%), Gaps = 19/313 (6%)
Query: 90 RVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI 149
+ + + L+ + +++++G ++ + + + + ++
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 150 SGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNL 209
L L+S ++ N+ + + L L +S N L+ + +L
Sbjct: 320 KQFPT----LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 210 --TELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267
L L L+ N + L+ + +++L L L L++
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHL 327
T T LN L + N D + ++ N +N+ + L L
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN-------TLSNVFANTTNLTFLDLSKCQL 485
Query: 328 SGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNC 387
+ L L L + NNL + S L+ L+ S N
Sbjct: 486 EQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544
Query: 388 RQLQILNLAYSQL 400
+ L NL + +
Sbjct: 545 KSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-36
Identities = 74/480 (15%), Positives = 145/480 (30%), Gaps = 94/480 (19%)
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM 157
N + + NL+ L + F L I + S + + +
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKD--------ERNLEIFEPS-------IMEGL 258
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
C+ ++ F ++ + + +S++ + +++ + L +
Sbjct: 259 CD--VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSI 314
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM--TTGRI 275
L+ +FP ++ L+ + L N S LPSL L+L +G
Sbjct: 315 IRCQLK-QFPT--LDLPFLKSLTLTMNKGSISFKK---VALPSLSYLDLSRNALSFSGCC 368
Query: 276 PKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSST 335
L +L L N ++ + ++ + + L S
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI---------IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 336 GINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG-LVANTFGNCRQLQILN 394
++L LL L + N + L L+++ N F ++N F N L L+
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479
Query: 395 LAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSC 454
L+ QL + I L L+
Sbjct: 480 LSKCQL-------------------------------EQISWGVFDTLH-RLQL------ 501
Query: 455 ELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ 514
L++ N L + +L +L LD S+N I+ S
Sbjct: 502 ------------------LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 515 LESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLN 574
+SL L N++ I L ++ + +T + LV+DF+ +
Sbjct: 544 PKSLAFFNLTNNSVAC-ICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-24
Identities = 44/240 (18%), Positives = 72/240 (30%), Gaps = 42/240 (17%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-----------------YLYN 1032
LK L++++NK + I L L L L N L L
Sbjct: 328 PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGV---------------RLASNKLIGRIPSMI 1077
N + N L L + + L V ++ +
Sbjct: 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 1078 FNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGL 1137
+++ +++ GN F + S++ NL L L L I ++ LL +
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 1138 SENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
S N L + + L LD S N + T + L L NN +
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG-------ILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-21
Identities = 40/268 (14%), Positives = 69/268 (25%), Gaps = 55/268 (20%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKF 1035
L L ++ N I P + LT L L L + + +N
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 1036 TG-RIPQNLGNCTLLNFLILRQNQLTGVR------------------LASNKLIGRIPSM 1076
++P N T L + L N + + ++ N I I
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP-IDFIQDQ 199
Query: 1077 IFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNAS------ 1130
F + + L GN S ++ + L L L I S
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 1131 --QVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSL------- 1181
+ L+ F + + L+ + H + SL
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL 319
Query: 1182 -----TNCRYLRRLVLQNNPLKGALPNS 1204
+ +L+ L L N +
Sbjct: 320 KQFPTLDLPFLKSLTLTMNKGSISFKKV 347
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-21
Identities = 35/195 (17%), Positives = 57/195 (29%), Gaps = 29/195 (14%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------------YLYNN 1033
N L+ L +S N + L EL+ L + L+ +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 1034 KFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNH 1092
T LN L ++A N S +F N +N+ + L
Sbjct: 435 NTKIDFDGIFLGLTSLNTL----------KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
+ + L LQ L + NNL + S + L S N
Sbjct: 485 LEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 1153 CRQLQILDLSLNHLT 1167
+ L +L+ N +
Sbjct: 544 PKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-21
Identities = 42/272 (15%), Positives = 74/272 (27%), Gaps = 42/272 (15%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYNNKFTGR 1038
+ +S++ I + + L + L+ L NK +
Sbjct: 286 NVSAMSLAGVSIKYLEDVP--KHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS-- 341
Query: 1039 IPQNLGNCTLLNFLILRQNQLTGVR----------------LASNKLIGRIPSMIFNNSN 1082
I L++L L +N L+ L+ N I + +
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEE 400
Query: 1083 IEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLF 1142
++ + + S L L L + N + + L ++ N F
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460
Query: 1143 SGLIP-NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGAL 1201
N F N L LDLS L S L+ L + +N L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWG-------VFDTLHRLQLLNMSHNNLLFLD 513
Query: 1202 PNSIGNLSTSLEYFFASSTELRGAIPVEFEGE 1233
+ L SL S + + +
Sbjct: 514 SSHYNQL-YSLSTLDCSFNRIETSKGILQHFP 544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-21
Identities = 36/272 (13%), Positives = 71/272 (26%), Gaps = 40/272 (14%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYNNKF 1035
+ ++ L + + L G +++ + +
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL 319
Query: 1036 TGRIPQNLGNCTLLNFLILRQNQLTGV------------RLASNKL--IGRIPSMIFNNS 1081
+L L L L N+ + L+ N L G +
Sbjct: 320 KQFPTLDLPF---LKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 1082 NIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIP-SSICNASQVILLGLSEN 1140
++ + L N + S+ L LQ L + L + S+ + +++ L +S
Sbjct: 377 SLRHLDLSFNGAI--IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGA 1200
F L L ++ N ++ N L L L L+
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFK------DNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 1201 LPNSIGNLSTSLEYFFASSTELRGAIPVEFEG 1232
L L+ S L +
Sbjct: 489 SWGVFDTL-HRLQLLNMSHNNLLFLDSSHYNQ 519
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-20
Identities = 41/264 (15%), Positives = 79/264 (29%), Gaps = 31/264 (11%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNN 1033
+ K + +S N + + N +EL+ L L +E L N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 1034 KFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHF 1093
P + T L L+ + +L + I ++ + + N
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASL----------ESFPIGQLITLKKLNVAHNFI 140
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQ----VILLGLSENLFSGLIPNT 1149
+ L NL + L N + I + + + + L +S N +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA 200
Query: 1150 FGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL- 1208
F + L L L N ++ L R + L+ P+ + L
Sbjct: 201 FQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 1209 STSLEYFFASSTELRGAIPVEFEG 1232
+++ F + T V+F
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHC 283
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-18
Identities = 33/187 (17%), Positives = 64/187 (34%), Gaps = 22/187 (11%)
Query: 1024 NNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SN 1082
N+ + K + ++P ++ + + L N L + S F+N S
Sbjct: 12 PNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKI-----------LKSYSFSNFSE 57
Query: 1083 IEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLF 1142
++ + L + L +L LIL GN + P S + + L E
Sbjct: 58 LQWLDLSRCEIETIEDKAWHG-LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 1143 SGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALP 1202
+ L G L+ L+++ N + + +N L + L N ++
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLP------AYFSNLTNLVHVDLSYNYIQTITV 170
Query: 1203 NSIGNLS 1209
N + L
Sbjct: 171 NDLQFLR 177
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-17
Identities = 29/178 (16%), Positives = 54/178 (30%), Gaps = 7/178 (3%)
Query: 92 TDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELW-LMPRLRIIDLSSNRIS 150
L I L+ L +L ++GN F + ++ L +DLS ++
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 151 GNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLT 210
+ + ++L L+ ++S N + S L L SFN +
Sbjct: 487 Q-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 211 ELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
L L N++ I V ++ C + + D
Sbjct: 546 SLAFFNLTNNSVA-----CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLD 598
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 7e-69
Identities = 78/364 (21%), Positives = 131/364 (35%), Gaps = 73/364 (20%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRH--GRVTDLS 95
D+ ALLQ+K + +P +W ++ W+GV C + RV +L
Sbjct: 6 QDKQALLQIKKDLG-NPTTL--SSWL------PTTDCCNRTWLGVLCDTDTQTYRVNNLD 56
Query: 96 IPNLGLGGT--IPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNL 153
+ L L IP +ANL +L L I G
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGI------------------------------ 86
Query: 154 FDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELM 213
N + G +P ++ ++L L ++ ++G IP + + L+
Sbjct: 87 ------------------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 214 ELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273
L + N L G PP+I ++ +L I N + G++P + + TG
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 274 RIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPS 333
+IP N L ++ D N L G + ++ N + I L N L+ +L
Sbjct: 189 KIPPTFANLN-LAFV--------DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 334 STGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQIL 393
NL L L N + G +P + L L +S N G + GN ++ +
Sbjct: 240 V--GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 394 NLAY 397
A
Sbjct: 297 AYAN 300
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 8e-67
Identities = 78/325 (24%), Positives = 131/325 (40%), Gaps = 45/325 (13%)
Query: 356 IPSSICNASKL----TVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSF 411
I + N + L + + G++ +T ++ L+L+ L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL-PKPYP----- 67
Query: 412 FSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNII 471
+P+S+ NL + G L G IP L+ +
Sbjct: 68 -----------------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 472 ALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQ 531
L + ++ IP + +++ L LD SYN + G++P + L +L + GN +
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 532 IPTCLANLTSL-RALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVL 590
IP + + L ++ +S NRL IP TF +L + VD S N+L G G+ K
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 591 TGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK---------G 641
++L+ N L+ + +G K+L L L N G++P+ + L L G
Sbjct: 224 QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 642 EIPSGGPFVNFTEGSFMQNYALCGS 666
EIP GG F ++ N LCGS
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 3e-60
Identities = 74/335 (22%), Positives = 119/335 (35%), Gaps = 66/335 (19%)
Query: 272 TGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYG-NHLSGN 330
G + +N L L L IPS + N + + + G N+L G
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLP------KPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 331 LPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQL 390
+P + L L LY+ N+SG IP + L L+ S N SG + + + L
Sbjct: 93 IPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 391 QILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFY 450
+ +++ +G+ +P+S G+ SK
Sbjct: 152 VGITFDGNRI-SGA------------------------------IPDSYGSFSKLFTSMT 180
Query: 451 AGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPS 510
L G IP F NL N+ + L +N L G +N Q + L+ N++ +
Sbjct: 181 ISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVD 570
+ ++LN L L+ N + +P L L L +LN+S N L IP
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ------------ 286
Query: 571 FSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIP 605
GNL+ + N+ C P
Sbjct: 287 -------------GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-57
Identities = 79/353 (22%), Positives = 129/353 (36%), Gaps = 73/353 (20%)
Query: 165 ESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGR--IPQNIGNLTELMELYL-NGNN 221
+ D + G L + ++ L +S L IP ++ NL L LY+ NN
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 222 LQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGN 281
L G PP I ++ L + + + ++ +G IP +
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNV-------------------------SGAIPDFLSQ 123
Query: 282 CTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPN 341
L L DF N L+G +P I + N+ I GN +SG +P S G +
Sbjct: 124 IKTLVTL--------DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG-SFSK 174
Query: 342 LLR-LYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
L + + N L+G IP + N + L ++LSRN+ G + FG+ + Q ++LA + L
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI 460
L + + L L ++ N + G +
Sbjct: 234 -AFDLG-------KVGLSKNLNGLDLRNN-----------RIY--------------GTL 260
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC 513
P L + +L++ N L IP G LQ + N P C
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 7e-55
Identities = 74/283 (26%), Positives = 108/283 (38%), Gaps = 41/283 (14%)
Query: 984 ADLGDSNKLKRLSIS-VNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN 1042
+ L + L L I +N + G IP + LT+L L Y+ + +G IP
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL---------YITHTNVSGAIPDF 120
Query: 1043 LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIG 1102
L L L N L+ G +P I + N+ I GN SG +P S G
Sbjct: 121 LSQIKTLVTLDFSYNALS----------GTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 1103 PYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLS 1162
+ + + N L+G IP + N + + + LS N+ G FG+ + Q + L+
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 1163 LNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTEL 1222
N L + + L L L+NN + G LP + L L S L
Sbjct: 230 KNSL-AFD-------LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL-KFLHSLNVSFNNL 280
Query: 1223 RGAIPVEFEGEIPSGGPFVNFTAESLMQNLVLGGSSRLQVPPC 1265
GEIP GG F + N L GS +P C
Sbjct: 281 --------CGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 45/223 (20%), Positives = 76/223 (34%), Gaps = 36/223 (16%)
Query: 1032 NNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYG- 1090
N + G + +N L L L IPS + N + + + G
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP--------YPIPSSLANLPYLNFLYIGGI 86
Query: 1091 NHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTF 1150
N+ G +P +I L L L + N+SG IP + ++ L S N SG +P +
Sbjct: 87 NNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 1151 GNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRR-LVLQNNPLKGALPNSIGNLS 1209
+ L + N + +G + S + L + + N L G +P + NL
Sbjct: 146 SSLPNLVGITFDGNRI-SG------AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL- 197
Query: 1210 TSLEYFFASSTELRGAIPVE----------------FEGEIPS 1236
+L + S L G V ++
Sbjct: 198 -NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 28/117 (23%), Positives = 44/117 (37%), Gaps = 23/117 (19%)
Query: 1137 LSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQN-N 1195
+ G++ +T ++ LDLS +L +SL N YL L + N
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNL-PKPYP----IPSSLANLPYLNFLYIGGIN 87
Query: 1196 PLKGALPNSIGNLSTSLEYFFASSTELRGAIPVE----------------FEGEIPS 1236
L G +P +I L+ L Y + + T + GAIP G +P
Sbjct: 88 NLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-60
Identities = 84/307 (27%), Positives = 140/307 (45%), Gaps = 29/307 (9%)
Query: 1322 LRRISYQELRLATNGFSE------SNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRA- 1374
S+ EL+ TN F E N +G G F VYK + T A+K + D
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 1375 ---LKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL--L 1429
+ FD E +VM + +H NL +++ S+ L+ YMP GSL L + L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 1430 NIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD-GV 1488
+ R I A + +LH+ IH D+K +N+LLD+ A + DFG+A+ +
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH 1548
++ + + T YMAPE G ++ D+YSFG++++E +T D+ L
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLD 245
Query: 1549 WVEESLPD--AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDA 1606
EE + + D ID + +AD + ++ S+A +C E +R ++K
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM----NDAD----STSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 1607 LANLKKI 1613
L+++
Sbjct: 298 QQLLQEM 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-58
Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 722 ENDSLSLAT--WRRISYQELQRLTDGFSE------SNLIGAGSFGSVYKATLPYGMNVAI 773
EN SL ++ + S+ EL+ +T+ F E N +G G FG VYK + VA+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAV 59
Query: 774 KVFNLQLDGAI----KSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEK 829
K +D + FD E +V+ + +H NLV+++ S+ L+ YMP GSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 830 WLYSHKYT--LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSD 887
L T L+ R I A+ + +LH IH D+K +N+LLD+ A +SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 888 FGISKLLDGEDS--VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPT 945
FG+++ + +T + + T YMAPE G ++ D+YSFG++++E T
Sbjct: 177 FGLARASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 946 DEMFTGETSLKKWVEESL--RLAVTEVVDAELLSSEEEE 982
DE L EE + + +D ++ ++
Sbjct: 235 DEHR-EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 272
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-58
Identities = 71/247 (28%), Positives = 110/247 (44%), Gaps = 23/247 (9%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEV 793
I Y+E++ ++G G+FG V KA +VAIK + + K+F E
Sbjct: 5 IDYKEIE-------VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQ 54
Query: 794 LRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK--YTLNIQQRLDIMIDVA 851
L RV H N+VK+ +C N L++EY GSL L+ + + + +
Sbjct: 55 LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDD-TVAHLSDFGISKLLDGEDSVTQTMTLA--T 908
+ YLH P +IH DLKP N+LL TV + DFG + + MT +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------IQTHMTNNKGS 166
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVT 968
+MAPE S DV+S+GI++ E TR+ P DE+ + V R +
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226
Query: 969 EVVDAEL 975
+ + +
Sbjct: 227 KNLPKPI 233
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-51
Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 48/301 (15%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEV 1384
I Y+E+ + ++G G F V KA + + AIK + +R K+F E
Sbjct: 5 IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQ 54
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL--LNIEQRLDIMIDVA 1442
+ R+ H N+ K+ +C NP L+++Y GSL L+ L + + +
Sbjct: 55 LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVDSMKQTMTLA--T 1499
+ YLH ++IH DLKP N+LL V + DFG A ++ MT +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------IQTHMTNNKGS 166
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT 1559
+MAPE S DV+S+GI++ E +TRRKP D++ +
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI------------GGPAFRIM 214
Query: 1560 DVIDANL---LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616
+ L K + SL +C + P +R ++++ + + +
Sbjct: 215 WAVHNGTRPPLI----------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
Query: 1617 F 1617
F
Sbjct: 265 F 265
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-57
Identities = 69/313 (22%), Positives = 124/313 (39%), Gaps = 33/313 (10%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEV 1384
+ + L + + G F V+KA A+KIF +Q+ + S+ E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ---SWQNEYEV 69
Query: 1385 --MRRIRHRNLAKIVSSCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIM 1438
+ ++H N+ + + + LI + +GSL +L +++ + I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIA 127
Query: 1439 IDVACALEYLHQ-------GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491
+A L YLH+ G+ +I H D+K NVLL +++ A + DFG+A + S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 1492 KQTMTLA-TIGYMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKPTDDMFTG-EV 1544
T T YMAPE I D+Y+ G+++ E +R D +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 1545 CLKHWVEE--SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER-- 1600
+ + + SL D V+ D K M+ + +C + E R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKR--PVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 1601 -MNVKDALANLKK 1612
V + + +++
Sbjct: 306 AGCVGERITQMQR 318
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-57
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 25/234 (10%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEV 793
+ + L + + G FG V+KA L VA+K+F +Q +S+ E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEV 69
Query: 794 --LRRVRHRNLVKIISSCSNHGFKA----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIM 847
L ++H N+++ I + LI + +GSL +L ++ + I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIA 127
Query: 848 IDVASALEYLHHGHPT-------PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900
+A L YLH P + H D+K NVLL ++ A ++DFG++ + S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 901 TQTMTLA-TFGYMAPEYGSEGI-----VSTCGDVYSFGILMIETFTRKMPTDEM 948
T T YMAPE I D+Y+ G+++ E +R D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-56
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 34/273 (12%)
Query: 721 LENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFNLQ 779
+ + ++ E++ IG G FG V+K L VAIK L
Sbjct: 3 MGGSEFPKSRLPTLADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILG 55
Query: 780 LDGA-------IKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY 832
+ F E ++ + H N+VK+ N +++E++P G L L
Sbjct: 56 DSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLL 113
Query: 833 SHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD-----DDTVAHLSD 887
+ + +L +M+D+A +EY+ + +P P++H DL+ N+ L A ++D
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 888 FGISKLLDGEDSVTQTMTLA--TFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKM 943
FG+S+ +++ F +MAPE E + D YSF +++ T +
Sbjct: 173 FGLSQQ------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 944 PTDEMFTGETSLKKWV-EESLRLAVTEVVDAEL 975
P DE G+ + EE LR + E L
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-50
Identities = 54/254 (21%), Positives = 104/254 (40%), Gaps = 33/254 (12%)
Query: 1314 NNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQED 1372
+ + L ++ E+ +G G F V+K D + AIK L +
Sbjct: 5 GSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 1373 RA-------LKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH 1425
+ F E +M + H N+ K+ NP ++++++P G L L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDK 115
Query: 1426 NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-----DDMVAHLGDFG 1480
+ + +L +M+D+A +EY+ + I+H DL+ N+ L + A + DFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 1481 IAKLLDGVDSMKQTMTLA--TIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPT 1536
+++ +++ +MAPE E + D YSF +++ LT P
Sbjct: 175 LSQQ------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
Query: 1537 DDMFTGEVCLKHWV 1550
D+ G++ + +
Sbjct: 229 DEYSYGKIKFINMI 242
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-55
Identities = 113/541 (20%), Positives = 195/541 (36%), Gaps = 80/541 (14%)
Query: 89 GRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNR 148
G + +I I L+ + + T+ + ++ +
Sbjct: 1 GPLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG 57
Query: 149 ISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGN 208
I D + L L + S+NQ+T + L + +KL + ++ N++ P + N
Sbjct: 58 IKS--IDGVEY-LNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LAN 110
Query: 209 LTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
LT L L L N + + N+++L + L++N++ + L SLQ+L+ +
Sbjct: 111 LTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALS---GLTSLQQLSFGN 165
Query: 269 CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLS 328
+T K + N T L L + N+++D S++ +N+E + N +S
Sbjct: 166 QVTD---LKPLANLTTLERLDISSNKVSD----------ISVLAKLTNLESLIATNNQIS 212
Query: 329 GNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCR 388
P L NL L L GN L + ++ + + LT L+L+ N S L
Sbjct: 213 DITPLG---ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT 265
Query: 389 QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEY 448
+L L L +Q+ S S L L L + N + I P
Sbjct: 266 KLTELKLGANQI---------SNISPLAGLTALTNLELNENQLEDISP------------ 304
Query: 449 FYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSI 508
NL N+ L+LY N ++ P V L LQ L N + S
Sbjct: 305 ---------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SD 345
Query: 509 PSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILV 568
S L L ++N L N + + P LANLT + L L+ + + ++
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 569 VDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSI 628
V L P I + T ++ N S + F G++
Sbjct: 404 VKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 629 P 629
Sbjct: 461 T 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-50
Identities = 100/500 (20%), Positives = 181/500 (36%), Gaps = 80/500 (16%)
Query: 144 LSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIP 203
I+ +F D +L E + +T S D ++ L +
Sbjct: 9 TQDTPIN-QIFTD--TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK--SI 61
Query: 204 QNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQE 263
+ L L ++ + N L + N++ L I++ NN + P+ L +L
Sbjct: 62 DGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLA---NLTNLTG 116
Query: 264 LNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLY 323
L L + T P + N T LN L L N ++D S + ++++ +
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD----------ISALSGLTSLQQLSF- 163
Query: 324 GNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANT 383
GN ++ P + NL L RL + N +S S + + L L + N S +
Sbjct: 164 GNQVTDLKPLA---NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP-- 216
Query: 384 FGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLS 443
G L L+L +QL +L + L L + N + P
Sbjct: 217 LGILTNLDELSLNGNQL---------KDIGTLASLTNLTDLDLANNQISNLAP------- 260
Query: 444 KSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNN 503
L+ + L L NQ+++ P + L L L+L+ N
Sbjct: 261 --------------------LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298
Query: 504 IQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSL 563
++ P + L++L L L N + + P +++LT L+ L +N+++ S+ +L
Sbjct: 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANL 352
Query: 564 EYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNG 623
I + N +S P + NL +T L L+ + + P + + G
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTG 409
Query: 624 FQGSIPEAIGSLISLEKGEI 643
P I S + +I
Sbjct: 410 AL-IAPATISDGGSYTEPDI 428
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-20
Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 45/237 (18%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYN 1032
L L+ L + N+I+ P +G LT L EL L+GN L+ L N
Sbjct: 195 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLAN 252
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
N+ + P L T L L L NQ++ + S + + + ++L N
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQISNI------------SPLAGLTALTNLELNENQ 298
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
S I L NL L L+ NN+S I P + + +++ L N S + N
Sbjct: 299 LED--ISPIS-NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LAN 351
Query: 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
+ L N ++ T L N + +L L + A N N+S
Sbjct: 352 LTNINWLSAGHNQISD---------LTPLANLTRITQLGLNDQAWTNAPVNYKANVS 399
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-20
Identities = 63/271 (23%), Positives = 95/271 (35%), Gaps = 51/271 (18%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYN 1032
L L++LS N++T P + NLT L L + N + N
Sbjct: 152 LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIATN 208
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGV------------RLASNKLIGRIPSMIFNN 1080
N+ + P LG T L+ L L NQL + LA+N++ P +
Sbjct: 209 NQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGL 264
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
+ + ++L N S S + L L L L N L I P I N + L L N
Sbjct: 265 TKLTELKLGANQISN--ISPLA-GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 319
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGA 1200
S + P + +LQ L N ++ S SL N + L +N +
Sbjct: 320 NISDISP--VSSLTKLQRLFFYNNKVSDVS---------SLANLTNINWLSAGHNQISDL 368
Query: 1201 LPNSIGNLSTSLEYFFASSTELRGAIPVEFE 1231
P + NL T + + A
Sbjct: 369 TP--LANL-TRITQLGLNDQAWTNAPVNYKA 396
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-19
Identities = 59/258 (22%), Positives = 90/258 (34%), Gaps = 49/258 (18%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLY 1031
L + L L++ N+IT P + NLT L L L N +
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 164
Query: 1032 NNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGN 1091
N + L N T L L + N+++ S++ +N+E++ N
Sbjct: 165 NQVTD---LKPLANLTTLERLDISSNKVSD------------ISVLAKLTNLESLIATNN 209
Query: 1092 HFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFG 1151
S P L NL L L GN L I ++ + + + L L+ N S L P
Sbjct: 210 QISDITPLG---ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262
Query: 1152 NCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTS 1211
+L L L N ++ + L L L L N L+ + I NL +
Sbjct: 263 GLTKLTELKLGANQISN---------ISPLAGLTALTNLELNENQLED--ISPISNL-KN 310
Query: 1212 LEYFFASSTELRGAIPVE 1229
L Y + PV
Sbjct: 311 LTYLTLYFNNISDISPVS 328
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-18
Identities = 50/264 (18%), Positives = 99/264 (37%), Gaps = 51/264 (19%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYNNKFTG 1037
+ + + +T T+ +L ++ L +++ NN+ T
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTD 82
Query: 1038 RIPQNLGNCTLLNFLILRQNQLTGV------------RLASNKLIGRIPSMIFNNSNIEA 1085
P L N T L +++ NQ+ + L +N++ P + N +N+
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNR 138
Query: 1086 IQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGL 1145
++L N S S++ L +LQ L GN ++ + P + N + + L +S N S +
Sbjct: 139 LELSSNTISD--ISALS-GLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSDI 192
Query: 1146 IPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSI 1205
L+ L + N ++ T L L L L N LK ++
Sbjct: 193 SV--LAKLTNLESLIATNNQISD---------ITPLGILTNLDELSLNGNQLKD--IGTL 239
Query: 1206 GNLSTSLEYFFASSTELRGAIPVE 1229
+L T+L ++ ++ P+
Sbjct: 240 ASL-TNLTDLDLANNQISNLAPLS 262
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-15
Identities = 39/196 (19%), Positives = 63/196 (32%), Gaps = 34/196 (17%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLY 1031
L KL L + N+I+ P + LT L L L+ N LE LY
Sbjct: 260 PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 317
Query: 1032 NNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGN 1091
N + P + + T L L N+++ S + N +NI + N
Sbjct: 318 FNNISDISP--VSSLTKLQRLFFYNNKVSD------------VSSLANLTNINWLSAGHN 363
Query: 1092 HFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFG 1151
S P + L + L L + + N S + + P T
Sbjct: 364 QISDLTPLA---NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATIS 418
Query: 1152 NCRQLQILDLSLNHLT 1167
+ D++ N +
Sbjct: 419 DGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-09
Identities = 37/188 (19%), Positives = 62/188 (32%), Gaps = 33/188 (17%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLY 1031
L L L ++ N++ P + NL L L L+ NN+ + Y
Sbjct: 282 PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFY 339
Query: 1032 NNKFTGRIPQNLGNCTLLNFLILRQNQLTGVR------------LASNKLIGRIPSMIFN 1079
NNK + +L N T +N+L NQ++ + L P
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN-APVNYKA 396
Query: 1080 NSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSE 1139
N +I + + P++I + + N S SQ + +G
Sbjct: 397 NVSIP-NTVKNVTGALIAPATIS-DGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGT 453
Query: 1140 NLFSGLIP 1147
FSG +
Sbjct: 454 TTFSGTVT 461
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-55
Identities = 130/664 (19%), Positives = 240/664 (36%), Gaps = 64/664 (9%)
Query: 83 TCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRII 142
+C S GR+ NL +P L+ L +S N + + +L+++
Sbjct: 1 SC-SFDGRIAFYRFCNLT---QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 143 DLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRI 202
+L S + + +L L D+ S++I P + L L + F L+ +
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 203 PQN--IGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCR-RL 258
++ NL L L L+ N ++ + F ++SL+ I ++N +F +L +
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 259 PSLQELNLRDCMTTGRIPKDIGNC------TLLNYLGLRDNQLT----DFGANNLTGLIP 308
+L +L R+ D G C +L L + N T +N ++
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 309 SIIFNNSNIEVIQLYGNHLSGNLPSST--GINLPNLLRLYLWGNNLSGVIPSSICNASKL 366
+ +I +++ + +T G+ ++ L L + + L
Sbjct: 234 FSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDL 292
Query: 367 TVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAI 426
VL L+ N + + F LQ+LNL+Y+ L G L F L + Y+ +
Sbjct: 293 KVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL--GELYSS--NFYGLPK---VAYIDL 345
Query: 427 QTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPT 486
Q N I + L L+ L + +I + L N+L T+P
Sbjct: 346 QKNHIAIIQDQTFKFLE-KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL-VTLPK 398
Query: 487 TVGKLQNLQGLDLSYNNIQG-SIPSELCQLESLNTLLLQGNALQNQIPTCL-ANLTSLRA 544
+ LS N ++ I L ++ L L+L N + + SL
Sbjct: 399 IN---LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ 455
Query: 545 LNLSSNRLNSTI-----PSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQ 599
L L N L F L ++ V+ + N L+ P +L L GL L+ N+
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515
Query: 600 LSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIP-----SGGPFVNFTE 654
L+ + + +L L ++RN P+ SL L+ F+N+
Sbjct: 516 LTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLN 573
Query: 655 GSFMQNYALCGSLR---------LQVQACETSSTQQSKSSKLLRYVLPAVATAVVMLALI 705
+ + + + + + T + + K L++ L V T + L L+
Sbjct: 574 HTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLM 633
Query: 706 IIFI 709
I
Sbjct: 634 TILT 637
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 8e-18
Identities = 64/271 (23%), Positives = 92/271 (33%), Gaps = 44/271 (16%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKF 1035
LK L+++ NKI L L+ L+L N L L N
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 1036 TGRIPQNLGNCTLLNFLILRQNQLTGVR---------LASNKLIGRIPSMIFNNSNIEAI 1086
Q L L LR N LT + L+ NKL+ ++ N I
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV----TLPKINLTANLI 406
Query: 1087 QLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNA-SQVILLGLSENLF--- 1142
L N +P+LQ LIL N S + + L L EN+
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 1143 --SGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGA 1200
+ L + F LQ+L L+ N+L + ++ LR L L +N L
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPP-------GVFSHLTALRGLSLNSNRLT-V 518
Query: 1201 LPNSIGNLSTSLEYFFASSTELRGAIPVEFE 1231
L ++ L +LE S +L P F
Sbjct: 519 LSHND--LPANLEILDISRNQLLAPNPDVFV 547
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-17
Identities = 52/237 (21%), Positives = 85/237 (35%), Gaps = 37/237 (15%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNL----------EAYLYNNKFTGRIP 1040
K+ + + N I +T L +L+ L L N L + +L NK
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPK 398
Query: 1041 QNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSS 1100
NL N + L +N+L + I + +++ + L N FS
Sbjct: 399 INLT----ANLIHLSENRLENLD---------ILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 1101 IGPYLPNLQGLILWGNNLSGIIPSSIC-----NASQVILLGLSENLFSGLIPNTFGNCRQ 1155
P+L+ L L N L + +C S + +L L+ N + L P F +
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505
Query: 1156 LQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSL 1212
L+ L L+ N LT S + + L L + N L P+ +LS
Sbjct: 506 LRGLSLNSNRLTVLSH---NDLPAN------LEILDISRNQLLAPNPDVFVSLSVLD 553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-16
Identities = 40/230 (17%), Positives = 71/230 (30%), Gaps = 25/230 (10%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
+RL +S N I + L +L+ L L + F +NL N L
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF-----RNLPN---LR 76
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIF-NNSNIEAIQLYGNHFSGH-LPSSIGPYLPNL 1108
L L +++ + F ++ ++LY S L L L
Sbjct: 77 ILDLGSSKIY-----------FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 1109 QGLILWGNNLSGI-IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ--LQILDLSLNH 1165
L L N + + + S + + + S N + + + L L+ N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYF 1215
L + S N L L + N + + N + + F
Sbjct: 186 LYSRVSVDWGKCMNPFRN-MVLEILDVSGNGWTVDITGNFSNAISKSQAF 234
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-15
Identities = 37/216 (17%), Positives = 74/216 (34%), Gaps = 25/216 (11%)
Query: 1025 NLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNI 1083
A+ T ++PQ L L+L N + + + F +
Sbjct: 6 GRIAFYRFCNLT-QVPQVLNT---TERLLLSFNYIR-----------TVTASSFPFLEQL 50
Query: 1084 EAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFS 1143
+ ++L + + LPNL+ L L + + + P + + L L S
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 1144 --GLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGAL 1201
L F N + L LDLS N + + + S L+ + +N +
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSL------YLHPSFGKLNSLKSIDFSSNQIFLVC 164
Query: 1202 PNSIGNLS-TSLEYFFASSTELRGAIPVEFEGEIPS 1236
+ + L +L +F ++ L + V++ +
Sbjct: 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-15
Identities = 48/262 (18%), Positives = 84/262 (32%), Gaps = 32/262 (12%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTE------LRELHLHGNNLE---AYLYNNKFTGRI 1039
L S++ N + + G L L + GN ++N +
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 1040 PQNLGNCTLLNFLILRQNQLTGV----------------RLASNKLIGRIPSMIFNN-SN 1082
+L + + + L+ + + S +F +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF-VFSLNSRVFETLKD 291
Query: 1083 IEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLF 1142
++ + L N + + L NLQ L L N L + S+ +V + L +N
Sbjct: 292 LKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 1143 SGLIPNTFGNCRQLQILDLSLNHLTT-GSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGAL 1201
+ + TF +LQ LDL N LTT + S L ++ L N +
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH-LS 409
Query: 1202 PNSIGNLSTSLEYFFASSTELR 1223
N + NL YF L+
Sbjct: 410 ENRLENLDIL--YFLLRVPHLQ 429
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 7e-15
Identities = 52/271 (19%), Positives = 88/271 (32%), Gaps = 43/271 (15%)
Query: 981 EEGADLGDSNKLKRLSISVNKITGTIPRTVGNLT--ELRELHLHGNNLEA---------- 1028
G N LK + S N+I + L L L N+L +
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 1029 -----------YLYNNKFTGRIPQNLGNCT--LLNFLILRQNQLTGVRLASNKLIGRIPS 1075
+ N +T I N N F ++ + + G + I
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN-IKDPDQ 257
Query: 1076 MIFNN---SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132
F S++ + L L S + L +L+ L L N ++ I + +
Sbjct: 258 NTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNL 316
Query: 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVL 1192
+L LS NL L + F ++ +DL NH+ + L + L L
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA----IIQDQTFKFLEKLQTLD---L 369
Query: 1193 QNNPLKGALPNSIGNLSTSLEYFFASSTELR 1223
++N L +I + S+ F S +L
Sbjct: 370 RDNAL-----TTIHFI-PSIPDIFLSGNKLV 394
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 6e-55
Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 28/255 (10%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD----GAIKSFDA 789
I + EL +IG G FG VY+A G VA+K D I++
Sbjct: 4 IDFAELT-------LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMID 849
E ++ ++H N++ + C L++E+ G L + L + ++ +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ 113
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLD--------DDTVAHLSDFGISKLLDGEDSVT 901
+A + YLH P+IH DLK SN+L+ + + ++DFG+++ T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----T 169
Query: 902 QTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE 960
M+ A + +MAPE + S DV+S+G+L+ E T ++P + +
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-AM 228
Query: 961 ESLRLAVTEVVDAEL 975
L L +
Sbjct: 229 NKLALPIPSTCPEPF 243
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-50
Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 25/227 (11%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQED----RALKSFDA 1380
I + EL L ++G G F VY+A + G A+K D + +++
Sbjct: 4 IDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 1381 ECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMID 1440
E ++ ++H N+ + C L++++ G L + L + + ++ +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ 113
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH--------LGDFGIAKLLDGVDSMK 1492
+A + YLH IIH DLK SN+L+ + + DFG+A+ M
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
+MAPE + S DV+S+G+L+ E LT P +
Sbjct: 174 AA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-55
Identities = 65/219 (29%), Positives = 116/219 (52%), Gaps = 14/219 (6%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQ--LDGAIKSFDAEC 791
I + +L IGAGSFG+V++A +G +VA+K+ Q + F E
Sbjct: 34 IPWCDLN-------IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREV 85
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSH--KYTLNIQQRLDIMID 849
+++R+RH N+V + + + +++ EY+ +GSL + L+ + L+ ++RL + D
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF 909
VA + YLH+ +P P++H +LK N+L+D + DFG+S+L ++ T
Sbjct: 146 VAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTP 203
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
+MAPE + + DVYSFG+++ E T + P +
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-52
Identities = 65/241 (26%), Positives = 119/241 (49%), Gaps = 18/241 (7%)
Query: 1307 DKSRPTENNLLNTAALRR----ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNA 1362
D PT NL A+ I + +L + +G G F +V++A + G++
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWCDLNI-------KEKIGAGSFGTVHRAEW-HGSDV 63
Query: 1363 AIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEK 1420
A+KI Q+ + F E +M+R+RH N+ + + + P +++ +Y+ +GSL +
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 1421 WLYSHN--YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGD 1478
L+ L+ +RL + DVA + YLH + I+H +LK N+L+D + D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 1479 FGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
FG+++L ++ T +MAPE + + DVYSFG+++ E T ++P +
Sbjct: 183 FGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
Query: 1539 M 1539
+
Sbjct: 242 L 242
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 9e-55
Identities = 99/510 (19%), Positives = 171/510 (33%), Gaps = 41/510 (8%)
Query: 135 LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS 194
L + +DLS N + +L S EL+ D+S +I + S L L ++
Sbjct: 26 LPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 195 FNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDL 254
N + L+ L +L NL I ++ +L+ + +A+N + +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
L +L+ L+L D+ L+ + L + L D N + I F
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRV---LHQMPLLNLSL-DLSLNPMNF-IQPGAFKE 199
Query: 315 SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRN 374
+ + L N S N+ + L L L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF------------------RNEG 241
Query: 375 LFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGI 434
+ L I + L L F+ LTN + ++ + + +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYL-DYYLDDIIDLFNCLTN---VSSFSLVSVTIERV 297
Query: 435 LPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNL 494
S + LE + L ++ L+ N+ + V L +L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFP------TLKLKSLKRLTFTSNKG-GNAFSEVD-LPSL 349
Query: 495 QGLDLSYNNIQ--GSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
+ LDLS N + G SL L L N + + + L L L+ + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 553 NSTIP-STFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GG 610
S F SL ++ +D S L L L ++GN + I
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 611 LKDLTYLALARNGFQGSIPEAIGSLISLEK 640
L++LT+L L++ + P A SL SL+
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-54
Identities = 111/540 (20%), Positives = 189/540 (35%), Gaps = 61/540 (11%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQI 174
+L++S N + P L+++DLS I + D SL+ L + ++ N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NV 233
+ S L++L L IG+L L EL + N +Q P F N+
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 234 SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDN 293
++L + L++N + S+ R L + LNL L L N
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS--------------------LDLSLN 187
Query: 294 QLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWG---- 349
+ I F + + L N S N+ + L L L
Sbjct: 188 PMNF---------IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 350 --NNLSGVIPSSICNASKLTVLELSRN---LFSGLVANTFGNCRQLQILNLAYSQLATGS 404
NL S++ LT+ E + + + F + +L +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI---- 294
Query: 405 LSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEF 464
+ ++L + + + +L K L + + GG +
Sbjct: 295 -----ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL-KRLTF----TSNKGGNAFS-E 343
Query: 465 GNLSNIIALSLYQNQLA--STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLL 522
+L ++ L L +N L+ + +L+ LDLS+N + ++ S LE L L
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 402
Query: 523 LQGNALQNQIPTC-LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLP 581
Q + L+ +L +L L++S F L + V+ + N
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 582 QDI-GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
DI L+ LT L LS QL P++ L L L +A N + L SL+K
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQK 522
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-51
Identities = 93/513 (18%), Positives = 165/513 (32%), Gaps = 76/513 (14%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
++ + LS L L + + L+ ++++ N I + ++LT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNL 222
LE D+SSN+I + L ++ L + L L+ N +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLL--------------------NLSLDLSLNPM 189
Query: 223 QGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNL-----RDCMTTGRIPK 277
P F L + L NN ++ + L L+ L R+ + K
Sbjct: 190 N-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 278 DI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTG 336
L R L + I + +N+ L + S
Sbjct: 249 SALEGLCNLTIEEFRLAYL-----DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 337 INLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396
+L + + S L L + N + + L+ L+L+
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKS------LKRLTFTSNKGGNA--FSEVDLPSLEFLDLS 355
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCEL 456
+ L+ T+ L+YL + N +
Sbjct: 356 RNGLSFKGCCSQS--DFGTTS---LKYLDLSFN-----------GVIT------------ 387
Query: 457 GGGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQL 515
+ + F L + L + L +V L+NL LD+S+ + + + L
Sbjct: 388 ---MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 516 ESLNTLLLQGNALQNQIPT-CLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLN 574
SL L + GN+ Q L +L L+LS +L P+ F SL + V++ + N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 575 LLSGCLPQDI-GNLKVLTGLYLSGNQLSCSIPS 606
L +P I L L ++L N CS P
Sbjct: 505 QLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-50
Identities = 96/491 (19%), Positives = 178/491 (36%), Gaps = 40/491 (8%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
TI +LS L +L ++GN + L+ + ++ +L + L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLK 124
Query: 163 ELESFDVSSNQIT-GQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTEL----MELYL 217
L+ +V+ N I +LP + + L+ L +S N++ ++ L ++ + L L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNL-----RDCMTT 272
+ N + P F L + L NN ++ + L L+ L R+
Sbjct: 185 SLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 273 GRIPKDI-GNCTLLNYLGLRDNQLTDFGAN------NLTGLIPSIIFNNSNIEVIQLYGN 325
+ K L R L + + LT + + + + V N
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 326 H-------LSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNL--F 376
++ + L +L RL N + L L+LSRN F
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSF 361
Query: 377 SGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILP 436
G + + L+ L+L+++ + ++S F L L +L Q + K +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI--TMSSN---FLGLEQ---LEHLDFQHSNLKQMSE 413
Query: 437 NSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQ 495
SV ++L Y F LS++ L + N + +L+NL
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 496 GLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNST 555
LDLS ++ P+ L SL L + N L++ LTSL+ + L +N + +
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 556 IPSTFWSLEYI 566
P + ++
Sbjct: 534 CPRIDYLSRWL 544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-28
Identities = 61/335 (18%), Positives = 103/335 (30%), Gaps = 39/335 (11%)
Query: 90 RVTDLSIPNLGLGGTIPPHV-ANLSFLVSLNISGNRFH----------GTLPNELWLMPR 138
R+ L++ N + L+ L + F L L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL--T 258
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNEL 198
+ L+ + D+ N LT + SF + S I S + L + +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKF 316
Query: 199 TGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSL-FGSLPVDLCRR 257
+ P L L L N + ++ SL + L+ N L F
Sbjct: 317 G-QFPTL--KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 258 LPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT-----------------DFGA 300
SL+ L+L + + L +L + + L D
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
+ I S++EV+++ GN N L NL L L L + P++
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNL 395
+ S L VL ++ N + F LQ + L
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-24
Identities = 61/328 (18%), Positives = 114/328 (34%), Gaps = 20/328 (6%)
Query: 441 NLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLS 500
NL S + L F + + L L + ++ + L +L L L+
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 501 YNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS-TIPST 559
N IQ L SL L+ L + + +L +L+ LN++ N + S +P
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 560 FWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTG----LYLSGNQLSCSIPSSIGGLKDLT 615
F +L + +D S N + D+ L + L LS N ++ I L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLH 203
Query: 616 YLALARNGFQGSIPEAIGS------LISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLRL 669
L L N ++ + + L GE + G F + + L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI-EEF 262
Query: 670 QVQACETSSTQQSKSSKLLRYVLPAVATAVVMLALIIIFIRCCTRNKNLPILENDSLSLA 729
++ + L V ++ ++++ I ++ + N LE +
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNV-----SSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 730 TWRRISYQELQRLTDGFSESNLIGAGSF 757
+ + + L+RLT F+ + A S
Sbjct: 318 QFPTLKLKSLKRLT--FTSNKGGNAFSE 343
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-19
Identities = 52/227 (22%), Positives = 83/227 (36%), Gaps = 29/227 (12%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
LKRL+ + NK +L L L L N L F G Q+ T L
Sbjct: 325 KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLS-------FKGCCSQSDFGTTSL 375
Query: 1050 NFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
+L L N + + S +E + ++ S+ L NL
Sbjct: 376 KYLDLSFNGVI-----------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSEN-LFSGLIPNTFGNCRQLQILDLSLNHLTT 1168
L + + S + +L ++ N +P+ F R L LDLS L
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-- 482
Query: 1169 GSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYF 1215
+F SL++ L+ L + +N LK ++P+ I + TSL+
Sbjct: 483 -EQLSPTAF-NSLSS---LQVLNMASNQLK-SVPDGIFDRLTSLQKI 523
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-16
Identities = 40/177 (22%), Positives = 67/177 (37%), Gaps = 21/177 (11%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
LK L +S N + T+ L +L L +NL+ + F +L N L
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF-----LSLRN---LI 424
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
+L + + IFN S++E +++ GN F + I L NL
Sbjct: 425 YLDISHTHTRV-----------AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHL 1166
L L L + P++ + S + +L ++ N + F LQ + L N
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-16
Identities = 41/233 (17%), Positives = 76/233 (32%), Gaps = 37/233 (15%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCT 1047
K L +S N + + + EL+ L L ++ I + +
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ----------TIEDGAYQSLS 76
Query: 1048 LLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLP 1106
L+ LIL N + + F+ S+++ + + + L + +L
Sbjct: 77 HLSTLILTGNPIQ-----------SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLK 124
Query: 1107 NLQGLILWGNNLSGI-IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQI----LDL 1161
L+ L + N + +P N + + L LS N + Q+ + LDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 1162 SLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
SLN + L +L L+NN + + LE
Sbjct: 185 SLNPMNFIQPGAFKEI--------RLHKLTLRNNFDSLNVMKTCIQGLAGLEV 229
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-15
Identities = 34/187 (18%), Positives = 61/187 (32%), Gaps = 22/187 (11%)
Query: 1024 NNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SN 1082
N+ F +IP NL L L N L + S F +
Sbjct: 8 PNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-----------HLGSYSFFSFPE 53
Query: 1083 IEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLF 1142
++ + L + L +L LIL GN + + + S + L E
Sbjct: 54 LQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 1143 SGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALP 1202
+ L G+ + L+ L+++ N + + +N L L L +N ++
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLP------EYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 1203 NSIGNLS 1209
+ L
Sbjct: 167 TDLRVLH 173
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-13
Identities = 42/228 (18%), Positives = 71/228 (31%), Gaps = 16/228 (7%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTL 1048
+L L ++ I LT + L +E + G L NC
Sbjct: 261 EFRLAYLDYYLDDIIDLFN----CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSG-HLPSSIGPYLPN 1107
F L+ L + SNK + + ++E + L N S S +
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 1108 LQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP-NTFGNCRQLQILDLSLNHL 1166
L+ L L N + + S+ Q+ L + + + F + R L LD+S H
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 1167 TTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
+F L L + N + I +L +
Sbjct: 434 RV-------AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-12
Identities = 42/240 (17%), Positives = 71/240 (29%), Gaps = 40/240 (16%)
Query: 986 LGDSNKLKRLSISVNKIT-GTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLG 1044
+G LK L+++ N I +P NLT L L L N ++ +Y + L
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL-----RVLH 173
Query: 1045 NCTLLNF-LILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP 1103
LLN L L N + I F + + L N S ++ +
Sbjct: 174 QMPLLNLSLDLSLNPMN-----------FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 1104 YLPNLQGLILWG------NNLSGIIPSSICNASQVILLGLSEN---LFSGLIPNTFGNCR 1154
L L+ L NL S++ + + + I + F
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 1155 QLQILDLSLNHLTTGSSTQGHSFYTSLT------------NCRYLRRLVLQNNPLKGALP 1202
+ L + + + L + L+RL +N A
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-11
Identities = 37/168 (22%), Positives = 60/168 (35%), Gaps = 12/168 (7%)
Query: 1066 SNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSS 1125
+IP + + + + L N HL S P LQ L L + I +
Sbjct: 15 MELNFYKIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 1126 ICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCR 1185
+ S + L L+ N L F LQ L +L S + L
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA---SLENFPI-GHLKT-- 125
Query: 1186 YLRRLVLQNNPLK-GALPNSIGNLSTSLEYFFASSTELRGAIPVEFEG 1232
L+ L + +N ++ LP NL T+LE+ SS +++ +
Sbjct: 126 -LKELNVAHNLIQSFKLPEYFSNL-TNLEHLDLSSNKIQSIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-11
Identities = 46/262 (17%), Positives = 80/262 (30%), Gaps = 33/262 (12%)
Query: 988 DSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCT 1047
+L +L++ N + + +T + L L +H L + L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTC--IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 1048 LLNFLILRQNQ-----------------LTGVRLASNKLIGRIPSMIFNNSNIEAIQLYG 1090
L R ++ L S I R+ +N + ++L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT-IERVKDFSYN-FGWQHLELVN 313
Query: 1091 NHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTF 1150
F P+ L +L+ L N + + + L + F G +
Sbjct: 314 CKFG-QFPTL---KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 1151 GNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLST 1210
L+ LDLS N + + ++ L L Q++ LK S+
Sbjct: 370 FGTTSLKYLDLSFNGVI--------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 1211 SLEYFFASSTELRGAIPVEFEG 1232
+L Y S T R A F G
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNG 443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-11
Identities = 44/300 (14%), Positives = 84/300 (28%), Gaps = 58/300 (19%)
Query: 983 GADLGDSNKLKRLSISVNKITGTIPRTVGNLTELR----ELHLHGNNLEA---------- 1028
+ L+ L +S NKI + L ++ L L N +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 201
Query: 1029 ----YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFN---NS 1081
L NN + + + + L ++L + + + N
Sbjct: 202 LHKLTLRNNFDSLNVMKT----CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 1082 NIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVI-LLGLSEN 1140
IE +L + + L N+ L + + S Q + L+
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 1141 LFSGLIP----------------NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNC 1184
F L + + L+ LDLS N L+ S
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ-----SDFGT 372
Query: 1185 RYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEFEGEIPSGGPFVNFT 1244
L+ L L N + + ++ L LE+ + L+ ++ F++
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLK---------QMSEFSVFLSLR 421
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-54
Identities = 96/557 (17%), Positives = 196/557 (35%), Gaps = 81/557 (14%)
Query: 82 VTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRI 141
++C + V D + +IP + + + SL++S N+ +L L++
Sbjct: 2 LSCDASG--VCDGRSRSFT---SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQV 54
Query: 142 IDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG- 200
+ L S+RI+ + D SL LE D+S N ++ S G S LK L++ N
Sbjct: 55 LILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL 113
Query: 201 RIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLP 259
+ NLT L L + E F ++SL + + SL + + +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL-RNYQSQSLKSIR 172
Query: 260 SLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGL------------- 306
+ L L + + + + YL LRD L F + L
Sbjct: 173 DIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
Query: 307 ----------IPSIIFNNSNIEVIQLYGNHLSG----------NLPSSTGINLPNLLRLY 346
+ ++ + ++ L+G + + + RL+
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 347 LWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLS 406
+ L + + K+ + + + + + + + L+ L+L+ + + L
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 407 QGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGN 466
+ + + + L L+ N +S++
Sbjct: 353 N-SACKGAWPSLQTL-VLS--------------QNHLRSMQK-----------TGEILLT 385
Query: 467 LSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGN 526
L N+ +L + +N +P + + ++ L+LS I+ + + C ++L L + N
Sbjct: 386 LKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNN 441
Query: 527 ALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGN 586
L + L L+ L +S N+L + ++ +LV+ S N L
Sbjct: 442 NLDS-FS---LFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDR 495
Query: 587 LKVLTGLYLSGNQLSCS 603
L L ++L N CS
Sbjct: 496 LTSLQKIWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-50
Identities = 105/522 (20%), Positives = 194/522 (37%), Gaps = 45/522 (8%)
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFN 196
+ D S + ++ + ++ L D+S N+IT L C+ L+ L + +
Sbjct: 5 DASGVCDGRSRSFT-SIPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 197 ELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDL 254
+ I + +L L L L+ N+L + F +SSL+ + L N L
Sbjct: 61 RIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 255 CRRLPSLQELNLRDCMTTGRIPK-DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFN 313
L +LQ L + + T I + D T LN L ++ L ++ + +L +
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI------- 171
Query: 314 NSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSR 373
+I + L+ + + L L ++ L L NL+ S + + ++
Sbjct: 172 -RDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
Query: 374 NLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQ---------SFFSSLTN--CRYLR 422
S L +F +L L S++ + S L +R
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 423 YLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLAS 482
L I L L K ++ + ++ + +L ++ L L +N +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEK-VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 483 TIPTT---VGKLQNLQGLDLSYNNIQ--GSIPSELCQLESLNTLLLQGNALQNQIPTCLA 537
G +LQ L LS N+++ L L++L +L + N +P
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQ 407
Query: 538 NLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSG 597
+R LNLSS + +LE + V + +L+ S LP+ L LY+S
Sbjct: 408 WPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPR-------LQELYISR 460
Query: 598 NQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
N+L ++P + L + ++RN + L SL+
Sbjct: 461 NKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-48
Identities = 81/492 (16%), Positives = 171/492 (34%), Gaps = 47/492 (9%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
I + L L + +R + + + + L +DLS N +S +L L+
Sbjct: 40 YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLS 98
Query: 163 ELESFDVSSNQITG-QLPSSLGDCSKLKRLSVSFNELTGRIPQN-IGNLTELMELYLNGN 220
L+ ++ N + S + + L+ L + E I + LT L EL +
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 221 NLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG---RIP 276
+L+ + ++ + + L + L L S++ L LRD
Sbjct: 159 SLR-NYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 277 KDIGNCTLLNYLGLRDNQLTDFGANNLTGL------IPSIIFNNSNIEVIQLYGNHLSGN 330
+ + L R + LTD N L L + + F++ + + + S
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 331 LPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQL 390
+ + + RL++ L + + K+ + + + + + + + L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336
Query: 391 QILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGI--LPNSVGNLSKSLEY 448
+ L+L+ + + L + + + L+ L + N + + + L K+L
Sbjct: 337 EFLDLSENLMVEEYLKN-SACKGAWPS---LQTLVLSQNHLRSMQKTGEILLTL-KNLTS 391
Query: 449 FYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSI 508
+P + L+L + + T Q L+ LD+S NN+ S
Sbjct: 392 LDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKT--CIPQTLEVLDVSNNNLD-SF 446
Query: 509 PSELCQLESLN-------------------TLLLQGNALQNQIPTCLANLTSLRALNLSS 549
L +L+ L + + N L++ LTSL+ + L +
Sbjct: 447 SLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 550 NRLNSTIPSTFW 561
N + + P +
Sbjct: 507 NPWDCSCPRIDY 518
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-29
Identities = 67/381 (17%), Positives = 124/381 (32%), Gaps = 39/381 (10%)
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLP 340
+C R T IPS + + ++ + L N ++ +
Sbjct: 3 SCDASGVCDGRSRSFTS---------IPSGLT--AAMKSLDLSFNKIT-YIGHGDLRACA 50
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
NL L L + ++ + + + L L+LS N S L ++ FG L+ LNL +
Sbjct: 51 NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI 460
T ++ S F +LTN L+ L I + SL + L
Sbjct: 111 QTLGVT---SLFPNLTN---LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNT 520
++ +I L+L+ ++ A + L +++ L+L N+ S L E +
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 521 LLLQGNALQ-------NQIPTCLANLTSLRALNLSSNRLNSTIP-----------STFWS 562
+ N++ L + L + LN
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284
Query: 563 LEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
I + L L L+ + + + +++ S LK L +L L+ N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344
Query: 623 GFQGSI---PEAIGSLISLEK 640
G+ SL+
Sbjct: 345 LMVEEYLKNSACKGAWPSLQT 365
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-20
Identities = 45/270 (16%), Positives = 92/270 (34%), Gaps = 23/270 (8%)
Query: 62 WNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNIS 121
+ + + S + V + L IP L + + L + + +
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318
Query: 122 GNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMC--NSLTELESFDVSSNQIT--GQ 177
++ + + L +DLS N + + + L++ +S N + +
Sbjct: 319 NSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK 378
Query: 178 LPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLR 237
L L L +S N +P + ++ L L+ ++ I +L
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLE 434
Query: 238 VIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTD 297
V+ ++NN+L S + LP LQEL + +P +L + + NQL
Sbjct: 435 VLDVSNNNL-DSFSLF----LPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKS 487
Query: 298 FGANNLTGLIPSIIFNNSNIEVIQLYGNHL 327
L ++++ I L+ N
Sbjct: 488 VPDGIFDRL--------TSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-15
Identities = 43/228 (18%), Positives = 76/228 (33%), Gaps = 31/228 (13%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCT 1047
+ +K L +S NKIT + L+ L L + + I + +
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN----------TIEGDAFYSLG 74
Query: 1048 LLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLP 1106
L L L N L+ + S F S+++ + L GN + +S+ P L
Sbjct: 75 SLEHLDLSDNHLS-----------SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 1107 NLQGLILWGNN-LSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
NLQ L + S I + + L + + + R + L L L+
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLE 1213
F L++ +R L L++ L + + S
Sbjct: 184 SAFLL----EIFADILSS---VRYLELRDTNLARFQFSPLPVDEVSSP 224
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-15
Identities = 35/272 (12%), Positives = 78/272 (28%), Gaps = 30/272 (11%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------Y 1029
D L L I + +++ ++ ++ L LH +
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 1030 LYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLY 1089
L + L + + + + + + S + ++ I S +E
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 1090 GNHFSGHLPSSIGPY-------LPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLF 1142
N PS ++ L + L + + +V + + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 1143 SGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALP 1202
+ + + + L+ LDLS N + L+ LVL N L+ ++
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK----GAWPSLQTLVLSQNHLR-SMQ 377
Query: 1203 NSIGNLS--TSLEYFFASSTELRGAIPVEFEG 1232
+ L +L S +P +
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-14
Identities = 35/239 (14%), Positives = 68/239 (28%), Gaps = 50/239 (20%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFT 1036
++RL I + + L +++ + + + + L N
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
Query: 1037 GRIPQN---LGNCTLLNFLILRQNQLTGVRLA---------------SNKLIGRIPSMIF 1078
+N G L L+L QN L ++ S +P
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQ 407
Query: 1079 NNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLS 1138
+ + L + + I L+ L + NNL ++ L +S
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNLDSFSL----FLPRLQELYIS 459
Query: 1139 ENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
N L + L ++ +S N L + L+++ L NP
Sbjct: 460 RNKLKTLPDASL--FPVLLVMKISRNQLKSVPD-------GIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-13
Identities = 35/234 (14%), Positives = 72/234 (30%), Gaps = 27/234 (11%)
Query: 984 ADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN- 1042
DL L+ L + ++I +L L L L N+L + + +
Sbjct: 44 GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS----------LSSSW 93
Query: 1043 LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIG 1102
G + L +L L N + + S+ N +N++ +++ +
Sbjct: 94 FGPLSSLKYLNLMGNPYQTL---------GVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 1103 PYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLS 1162
L +L L + +L S+ + + L L + + L+ ++ L+L
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 1163 LNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFF 1216
+L ++ L + S L L Y
Sbjct: 205 DTNLA-------RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-12
Identities = 35/196 (17%), Positives = 64/196 (32%), Gaps = 41/196 (20%)
Query: 991 KLKRLSISVNKITGTIPRT---VGNLTELRELHLHGNNLEA-----------------YL 1030
L+ L +S N + + G L+ L L N+L + +
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 1031 YNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYG 1090
N F +P + + FL L + + + I +E + +
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-----------VVKTCIP--QTLEVLDVSN 440
Query: 1091 NHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTF 1150
N+ S +LP LQ L + N L + +S ++++ +S N + F
Sbjct: 441 NNLD-----SFSLFLPRLQELYISRNKLKTLPDAS--LFPVLLVMKISRNQLKSVPDGIF 493
Query: 1151 GNCRQLQILDLSLNHL 1166
LQ + L N
Sbjct: 494 DRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-10
Identities = 41/188 (21%), Positives = 68/188 (36%), Gaps = 20/188 (10%)
Query: 1045 NCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPY 1104
+C R T IPS + + ++++ L N + ++
Sbjct: 3 SCDASGVCDGRSRSFT-----------SIPSGLT--AAMKSLDLSFNKIT-YIGHGDLRA 48
Query: 1105 LPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLN 1164
NLQ LIL + ++ I + + + L LS+N S L + FG L+ L+L N
Sbjct: 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108
Query: 1165 HLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRG 1224
T T S + +LTN L+ L + N + TSL + LR
Sbjct: 109 PYQTLGVT---SLFPNLTN---LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162
Query: 1225 AIPVEFEG 1232
+
Sbjct: 163 YQSQSLKS 170
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-53
Identities = 53/250 (21%), Positives = 104/250 (41%), Gaps = 24/250 (9%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGA--IKSFDAEC 791
I +++L + G ++K G ++ +KV ++ + F+ EC
Sbjct: 7 IDFKQLN-------FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 792 EVLRRVRHRNLVKIISSCSN--HGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMI 848
LR H N++ ++ +C + LI +MP GSL L+ + ++ Q + +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 849 DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLAT 908
D+A + +LH P + L +V++D+D A +S + S +
Sbjct: 119 DMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYA 171
Query: 909 FGYMAPE---YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRL 965
++APE E D++SF +L+ E TR++P ++ E +K E LR
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-ALEGLRP 230
Query: 966 AVTEVVDAEL 975
+ + +
Sbjct: 231 TIPPGISPHV 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-51
Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAEC 1382
I +++L L ++K + G + +K+ +++ R + F+ EC
Sbjct: 7 IDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 1383 EVMRRIRHRNLAKIVSSCSNPGFK--ALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMI 1439
+R H N+ ++ +C +P LI +MP GSL L+ N++++ Q + +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT 1499
D+A + +LH I L +V++D+DM A + + S + +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYA 171
Query: 1500 IGYMAPE---YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
++APE E S D++SF +L+ E +TR P D+
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-51
Identities = 70/282 (24%), Positives = 128/282 (45%), Gaps = 35/282 (12%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQED--RALKSFDAEC 1382
I ++ + +G+G F +VYK + G A+K+ ++ + L++F E
Sbjct: 21 IPDGQITVG-------QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEV 71
Query: 1383 EVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA 1442
V+R+ RH N+ + + P A++ Q+ SL L++ +++ +DI A
Sbjct: 72 GVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIG 1501
++YLH + SIIH DLK +N+ L +D +GDFG+A Q L+ +I
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 1502 YMAPE---YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558
+MAPE S DVY+FGI++ E +T + P ++ + D +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------------NNRDQI 234
Query: 1559 TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+++ LS + + C + L +C ++ +ER
Sbjct: 235 IEMVGRGSLSPDLS---KVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-51
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGA--IKSFDAECEVLRRVRHRNLVKIISSC 809
IG+GSFG+VYK + +VA+K+ N+ +++F E VLR+ RH N++ +
Sbjct: 32 IGSGSFGTVYKGK--WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ A++ ++ SL L++ + +++ +DI A ++YLH +IH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPE---YGSEGIVSTC 925
LK +N+ L +D + DFG++ Q L+ + +MAPE S
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 926 GDVYSFGILMIETFTRKMPTDEM 948
DVY+FGI++ E T ++P +
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNI 228
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-50
Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 28/230 (12%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGA--IKSFDAEC 791
I +++L+ LIG G FG VY + VAI++ +++ D +K+F E
Sbjct: 30 IPFEQLEIG-------ELIGKGRFGQVYHGR--WHGEVAIRLIDIERDNEDQLKAFKREV 80
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
R+ RH N+V + +C + A+I +L + K L++ + I ++
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT--MTLA-- 907
+ YLH ++H DLK NV D+ V ++DFG+ + + + + +
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 908 TFGYMAPEY--GSEGIVSTCG-------DVYSFGILMIETFTRKMPTDEM 948
++APE DV++ G + E R+ P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 63/326 (19%), Positives = 121/326 (37%), Gaps = 41/326 (12%)
Query: 1306 RDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIK 1365
+ S + + A+ I QE + L+G G F VY + G AI+
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VAIR 61
Query: 1366 IFSLQED--RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLY 1423
+ ++ D LK+F E R+ RH N+ + +C +P A+I +L +
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 1424 SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483
+L++ + I ++ + YLH + I+H DLK NV D+ V + DFG+
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFS 177
Query: 1484 LLDGVDSMKQT--MTLA--TIGYMAPE---------YGSEGIVSTSGDVYSFGILMMETL 1530
+ + + ++ + + + ++APE + S DV++ G + E
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 1531 TRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLAL 1590
R P +A+ + + ++ + + L
Sbjct: 238 AREWPFKTQ--------------PAEAIIWQMGTGMKP------NLSQIGMGKEISDILL 277
Query: 1591 KCSEEIPEERMNVKDALANLKKIKTK 1616
C EER + L+K+ +
Sbjct: 278 FCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-49
Identities = 65/237 (27%), Positives = 96/237 (40%), Gaps = 35/237 (14%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEV 793
+ E D LIG G +G+VYK +L VA+KVF+ ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58
Query: 794 --LRRVRHRNLVKIISSC-----SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI 846
+ + H N+ + I L++EY P GSL K+L +T + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 847 MIDVASALEYLH-------HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD---- 895
V L YLH H P + H DL NVL+ +D +SDFG+S L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKP-AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 896 ---GEDSVTQTMTLATFGYMAPEYGSEGIVSTC-------GDVYSFGILMIETFTRK 942
GE+ + T YMAPE + D+Y+ G++ E F R
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-48
Identities = 69/327 (21%), Positives = 120/327 (36%), Gaps = 42/327 (12%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEV 1384
+ E L + L+G G + +VYK + D A+K+FS + +F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 1385 MR--RIRHRNLAKIVSSCSNPGFKA-----LILQYMPQGSLEKWLYSHNYLLNIEQRLDI 1437
R + H N+A+ + L+++Y P GSL K+L + + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 1438 MIDVACALEYLHQ------GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491
V L YLH Y +I H DL NVL+ +D + DFG++ L G +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 1492 KQ-------TMTLATIGYMAPEYGSEGI-------VSTSGDVYSFGILMMETLTRRK--- 1534
+ + TI YMAPE + D+Y+ G++ E R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 1535 PTDDMFTGEVCLKHWVEE--SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKC 1592
P + + ++ + V + D V + + S+ C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP-KFPEAWKENSLAVRSLKETIEDC 295
Query: 1593 SEEIPEER---MNVKDALANLKKIKTK 1616
++ E R ++ +A L I +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 55/240 (22%), Positives = 92/240 (38%), Gaps = 17/240 (7%)
Query: 752 IGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
+G G FG K T G + +K + ++F E +V+R + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 811 NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDL 870
I EY+ G+L + S QR+ D+AS + YLH + +IH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDL 134
Query: 871 KPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-------------TFGYMAPEYG 917
N L+ ++ ++DFG+++L+ E + + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
+ DV+SFGI++ E R + V L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFP 254
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 63/296 (21%), Positives = 109/296 (36%), Gaps = 36/296 (12%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F K T G +K ++ ++F E +VMR + H N+ K +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
I +Y+ G+L + S + QR+ D+A + YLH S +IIH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-------------TIGYMAPEYG 1508
N L+ ++ + DFG+A+L+ + + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568
+ DV+SFGI++ E + R D + + L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------------DFGLNVRGFL-- 240
Query: 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKDVQQA 1624
D C S + ++C + PE+R + L+ ++ +
Sbjct: 241 -----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEV--LRRVRHRNLVKIIS 807
+G G +G V++ + G NVA+K+F+ + + KS+ E E+ +RH N++ I+
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 808 SCSNHGFKA----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH----- 858
S + LI Y GSL +L TL+ L I++ +AS L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA---TFGYMAPE 915
+ H DLK N+L+ + ++D G++ + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 916 YGSEGIVSTCG------DVYSFGILMIETFTRKMPTDEM 948
E I C D+++FG+++ E R + +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-46
Identities = 68/323 (21%), Positives = 121/323 (37%), Gaps = 53/323 (16%)
Query: 1321 ALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDA 1380
+++R +++ L +G G + V++ ++ G N A+KIFS ++++ S+
Sbjct: 1 SMQRTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFR 49
Query: 1381 ECEV--MRRIRHRNLAKIVSSCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQR 1434
E E+ +RH N+ ++S + LI Y GSL +L L+
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSC 107
Query: 1435 LDIMIDVACALEYLH-----QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489
L I++ +A L +LH +I H DLK N+L+ + + D G+A +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 1490 SMKQTMTLATIG---YMAPE------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM- 1539
+ +G YMAPE D+++FG+++ E R +
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 1540 -----FTGEVCLKHWVEESLPDAVTD----VIDANLLSGEEEADIAAKKKCMSSVMSLAL 1590
F V E+ D I S ++S+ L
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP----------TLTSLAKLMK 277
Query: 1591 KCSEEIPEERMNVKDALANLKKI 1613
+C + P R+ L KI
Sbjct: 278 ECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-47
Identities = 56/244 (22%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 725 SLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI 784
L L R I+ + + IG G FG V++ G VA+K+F+ + +
Sbjct: 31 GLPLLVQRTIA-RTIVLQ-------ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--- 78
Query: 785 KSFDAECEV--LRRVRHRNLVKIISSCSNHGFKA----LILEYMPQGSLEKWLYSHKYTL 838
+S+ E E+ +RH N++ I++ + L+ +Y GSL +L ++YT+
Sbjct: 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTV 136
Query: 839 NIQQRLDIMIDVASALEYLH-----HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893
++ + + + AS L +LH + H DLK N+L+ + ++D G++
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 894 LDGEDSVTQTMTLA---TFGYMAPEYGSEGIVSTCG------DVYSFGILMIETFTRKMP 944
D T YMAPE + I D+Y+ G++ E R
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
Query: 945 TDEM 948
Sbjct: 257 GGIH 260
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-43
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEV--MRRIRHRNLAKIVS 1398
+G G F V++ + G A+KIFS +E+R S+ E E+ +RH N+ ++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 1399 SCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ---- 1450
+ + L+ Y GSL +L + Y + +E + + + A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 1451 -GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPE 1506
+I H DLK N+L+ + + D G+A D +G YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 1507 YGSEGIVSTSG------DVYSFGILMMETLTRRKPTDDM 1539
+ I D+Y+ G++ E R
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-46
Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 34/243 (13%)
Query: 726 LSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIK 785
L L R +++Q + IG G +G V+ G VA+KVF
Sbjct: 27 LPLLVQR-TIAKQIQMV-------KQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEA 74
Query: 786 SFDAECEV--LRRVRHRNLVKIISSCSNHGFK----ALILEYMPQGSLEKWLYSHKYTLN 839
S+ E E+ +RH N++ I++ LI +Y GSL +L TL+
Sbjct: 75 SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLD 132
Query: 840 IQQRLDIMIDVASALEYLH-----HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894
+ L + S L +LH + H DLK N+L+ + ++D G++
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 895 DGEDSVTQTMTLA---TFGYMAPEYGSEGIVSTCG------DVYSFGILMIETFTRKMPT 945
+ + T YM PE E + D+YSFG+++ E R +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 946 DEM 948
+
Sbjct: 253 GIV 255
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 4e-45
Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 37/314 (11%)
Query: 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECE 1383
R +++++ +G G + V+ + G A+K+F E+ S+ E E
Sbjct: 33 RTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETE 81
Query: 1384 V--MRRIRHRNLAKIVSSCSNPGFK----ALILQYMPQGSLEKWLYSHNYLLNIEQRLDI 1437
+ +RH N+ +++ LI Y GSL +L + L+ + L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKL 139
Query: 1438 MIDVACALEYLH-----QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492
L +LH +I H DLK N+L+ + + D G+A +
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 1493 QTMTLATIG---YMAPEYGSEGIVSTSG------DVYSFGILMMETLTRRKPTDDMFTGE 1543
+G YM PE E + D+YSFG+++ E R + +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 1544 VCLKHWVEESLPDAVTDVIDANLLSGE--EEADIAAKKKCMSSVMSLALKCSEEIPEERM 1601
+ V + D+ + + + + +C+ + L +C P R+
Sbjct: 260 LPYHDLVPSD--PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 1602 NVKDALANLKKIKT 1615
L K+
Sbjct: 318 TALRVKKTLAKMSE 331
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-46
Identities = 95/480 (19%), Positives = 155/480 (32%), Gaps = 86/480 (17%)
Query: 159 NSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLN 218
S T L+ S+ +T ++P + +++E P G E+ L
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 219 GNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKD 278
+ + L N L SLP P L+ L T +P+
Sbjct: 67 DCLDR-----------QAHELELNNLGL-SSLPEL----PPHLESLVASCNSLT-ELPEL 109
Query: 279 IGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGIN 338
+ L L+D +E + + N L LP N
Sbjct: 110 PQSLKSLLVDNNNLKALSDLP---------------PLLEYLGVSNNQLE-KLPELQ--N 151
Query: 339 LPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYS 398
L + + N+L +P + L + N L N L + +
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEEL--PELQNLPFLTAIYADNN 205
Query: 399 QLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGG 458
L + + L + N + + NL L YA + L
Sbjct: 206 SL--------KKLPDLPLS---LESIVAGNNILE--ELPELQNL-PFLTTIYADNNLL-K 250
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESL 518
+P +L L++ N L + +P Q+L LD+S N + L L
Sbjct: 251 TLPDLPPSLEA---LNVRDNYL-TDLPEL---PQSLTFLDVSENIFS-GLSELPPNLYYL 302
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
NA N+I + SL LN+S+N+L +P+ LE + S N L+
Sbjct: 303 -------NASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERL---IASFNHLA- 350
Query: 579 CLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISL 638
+P+ NLK L++ N L P ++DL N +PE +L L
Sbjct: 351 EVPELPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLKQL 401
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-45
Identities = 92/511 (18%), Positives = 166/511 (32%), Gaps = 114/511 (22%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTE 163
+P N+ + + + P +++ +R+ L E
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGN-----GEQREMAVSRLRDCL----DRQAHE 75
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223
L ++++ ++ LP L+ L S N LT +P+ +L L+ N L
Sbjct: 76 L---ELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127
Query: 224 GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCT 283
LP P L+ L + + ++P ++ N +
Sbjct: 128 -------------------------DLP-------PLLEYLGVSNNQLE-KLP-ELQNSS 153
Query: 284 LLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLL 343
L + + +N L +P + ++E I N L LP NLP L
Sbjct: 154 FLKIIDVDNNSLKK---------LPDLP---PSLEFIAAGNNQLE-ELPEL--QNLPFLT 198
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
+Y N+L +P + L + N+ L N L + + L
Sbjct: 199 AIYADNNSLK-KLPDLPLS---LESIVAGNNILEEL--PELQNLPFLTTIYADNNLL--- 249
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE 463
++ + L LP +L L+ L
Sbjct: 250 -----KTLPDLPPSLEALNVRDNYLTD----LPELPQSL-TFLDVSENIFSGL----SEL 295
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLL 523
NL L+ N++ ++ +L+ L++S N + +P+ +LE L
Sbjct: 296 PPNLYY---LNASSNEI-RSLC---DLPPSLEELNVSNNKLI-ELPALPPRLERLI---A 344
Query: 524 QGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQD 583
N L ++P NL L++ N L P S+E D +N +P+
Sbjct: 345 SFNHLA-EVPELPQNLKQ---LHVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPEL 394
Query: 584 IGNLKVLTGLYLSGNQLSCSIPSSIGGLKDL 614
NLK L++ N L P ++DL
Sbjct: 395 PQNLKQ---LHVETNPLR-EFPDIPESVEDL 421
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-38
Identities = 92/464 (19%), Positives = 158/464 (34%), Gaps = 82/464 (17%)
Query: 90 RVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI 149
+ +L + NLGL ++P +L SL S N LP + L + + + +
Sbjct: 72 QAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 150 SGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNL 209
S L L VS+NQ+ +LP L + S LK + V N L ++P +L
Sbjct: 127 SDLP-----PLLEYL---GVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSL 175
Query: 210 TELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDC 269
+ N L E P + N+ L I NNSL LP SL+ + +
Sbjct: 176 EFI---AAGNNQL--EELPELQNLPFLTAIYADNNSL-KKLPDLPL----SLESIVAGNN 225
Query: 270 MTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSG 329
+ ++ N L + +N L +P + ++E + + N+L+
Sbjct: 226 ILE--ELPELQNLPFLTTIYADNNLLKT---------LPDLP---PSLEALNVRDNYLT- 270
Query: 330 NLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQ 389
+LP +L L + N SG + N L L S N L
Sbjct: 271 DLPEL----PQSLTFLDVSENIFSG-LSELPPN---LYYLNASSNEIRSL----CDLPPS 318
Query: 390 LQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYF 449
L+ LN++ ++L + L L N +P NL +
Sbjct: 319 LEELNVSNNKL--------IELPALPPR---LERLIASFNHLAE-VPELPQNL----KQL 362
Query: 450 YAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIP 509
+ L P ++ + L N + +P QNL+ L + N ++ P
Sbjct: 363 HVEYNPLRE-FPDIPESVED-----LRMNSHLAEVPEL---PQNLKQLHVETNPLR-EFP 412
Query: 510 SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLN 553
+E L + + + L + +
Sbjct: 413 DIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-16
Identities = 41/258 (15%), Positives = 77/258 (29%), Gaps = 55/258 (21%)
Query: 984 ADLGDSNKLKRLSISVNKITGTIPRTVGNLTE-------------LRELHLHGNNLEA-- 1028
+ + + ++ P G E EL L+ L +
Sbjct: 28 VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLP 87
Query: 1029 ---------YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGV-------RLASNKLIGR 1072
N T +P+ + L L+ + +++N+L +
Sbjct: 88 ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-K 145
Query: 1073 IPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132
+P + N+S ++ I + N LP P+L+ + N L + + N +
Sbjct: 146 LPE-LQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEEL--PELQNLPFL 197
Query: 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVL 1192
+ N L L+ + N L L N +L +
Sbjct: 198 TAIYADNNSLKKLPD----LPLSLESIVAGNNILEE---------LPELQNLPFLTTIYA 244
Query: 1193 QNNPLKGALPNSIGNLST 1210
NN LK LP+ +L
Sbjct: 245 DNNLLK-TLPDLPPSLEA 261
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-13
Identities = 40/233 (17%), Positives = 70/233 (30%), Gaps = 47/233 (20%)
Query: 1007 PRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTG-VRLA 1065
PR V N L+E H +NL +P N ++
Sbjct: 5 PRNVSNTF-LQEPLRHSSNLT----------EMPVEAENVKSKTEYYNAWSEWERNAPPG 53
Query: 1066 SNKLIGRIPSMIFNN--SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIP 1123
+ + S + + ++L S LP +L+ L+ N+L+ +P
Sbjct: 54 NGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP----HLESLVASCNSLT-ELP 107
Query: 1124 SSICNASQVILLGLSENLFSGLIPN---------------TFGNCRQLQILDLSLNHLTT 1168
+ +++ + S L P N L+I+D+ N L
Sbjct: 108 ELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK 167
Query: 1169 GSSTQGH-----------SFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLST 1210
L N +L + NN LK LP+ +L +
Sbjct: 168 LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLSLES 219
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-13
Identities = 41/236 (17%), Positives = 84/236 (35%), Gaps = 51/236 (21%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-----------YLYNNKFTGRI 1039
L+ + N + + NL L ++ N L+ + +N T +
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLT-DL 272
Query: 1040 PQNLGNCTLLNFLILRQNQLTGV-------RLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
P+ + T L+ + L+ + +SN+ I + + ++E + + N
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNE-IRSLCDLP---PSLEELNVSNNK 328
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
LP+ L+ LI N+L+ +P N Q L + N P+ +
Sbjct: 329 LI-ELPALPP----RLERLIASFNHLAE-VPELPQNLKQ---LHVEYNPLREF-PDIPES 378
Query: 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL 1208
L++ +HL N L++L ++ NPL+ P+ ++
Sbjct: 379 VEDLRM----NSHLA--------EVPELPQN---LKQLHVETNPLR-EFPDIPESV 418
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 37/234 (15%), Positives = 70/234 (29%), Gaps = 53/234 (22%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA--------YLYNNKFTGRIPQN 1042
L+ L++ N +T +P +LT L + L +N+ +
Sbjct: 258 SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDL 315
Query: 1043 LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIG 1102
+ L L + N+L +P++ +E + NH + +P
Sbjct: 316 PPS---LEELNVSNNKLI-----------ELPALP---PRLERLIASFNHLA-EVPELPQ 357
Query: 1103 PYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLS 1162
NL+ L + N L P + + L N +P N L+ L +
Sbjct: 358 ----NLKQLHVEYNPLR-EFPDIPES-----VEDLRMNSHLAEVPELPQN---LKQLHVE 404
Query: 1163 LNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFF 1216
N L F + + L + + + + LE
Sbjct: 405 TNPLR--------EFPDIPES---VEDLRMNSERVV-DPYEFAHETTDKLEDDV 446
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-44
Identities = 76/414 (18%), Positives = 146/414 (35%), Gaps = 69/414 (16%)
Query: 188 LKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLF 247
L+ + P +L E + L ++ T + S+ +V+A +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 248 GSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLI 307
++ L +L+ LNL T P + N L L + N++TD
Sbjct: 58 SIQGIE---YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD---------- 102
Query: 308 PSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLT 367
S + N +N+ + L +++S P + NL + L L N+ S + N + L
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISPLA---NLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 368 VLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQ 427
L ++ + + N L L+L Y+Q+ S L + L Y
Sbjct: 159 YLTVTESKVKDV--TPIANLTDLYSLSLNYNQI---------EDISPLASLTSLHYFTAY 207
Query: 428 TNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTT 487
N I P N++ + +L + N++ P
Sbjct: 208 VNQITDITP---------------------------VANMTRLNSLKIGNNKITDLSP-- 238
Query: 488 VGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNL 547
+ L L L++ N I + + L L L + N + + + L NL+ L +L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 548 SSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
++N+L + L + + S N ++ P + +L + + +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-42
Identities = 83/391 (21%), Positives = 147/391 (37%), Gaps = 46/391 (11%)
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNEL 198
+ I+ +F D L E + +T + + + +L V+ ++
Sbjct: 2 AATLATLPAPIN-QIFPD--ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV 56
Query: 199 TGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRL 258
Q I LT L L LNGN + + N+ L + + N + + L
Sbjct: 57 AS--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDISALQ---NL 109
Query: 259 PSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIE 318
+L+EL L + + P + N T + L L N S + N + +
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS---------DLSPLSNMTGLN 158
Query: 319 VIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
+ + + + P + NL +L L L N + + P + + + L N +
Sbjct: 159 YLTVTESKVKDVTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
Query: 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNS 438
+ N +L L + +++ S L N L +L I TN I N+
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITD---------LSPLANLSQLTWLEIGTNQISDI--NA 260
Query: 439 VGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLD 498
V +L+K L+ GS ++ + NLS + +L L NQL + +G L NL L
Sbjct: 261 VKDLTK-LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317
Query: 499 LSYNNIQGSIPSELCQLESLNTLLLQGNALQ 529
LS N+I P L L +++ ++
Sbjct: 318 LSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-41
Identities = 82/414 (19%), Positives = 159/414 (38%), Gaps = 70/414 (16%)
Query: 92 TDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG 151
L+ + P A+L+ + + + E + + + ++ +++
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS 58
Query: 152 NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTE 211
+ LT LE +++ NQIT S L + KL L + N++T + NLT
Sbjct: 59 --IQGIEY-LTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 212 LMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMT 271
L ELYLN +N+ + LAN L + LNL
Sbjct: 112 LRELYLNEDNISD-------------ISPLAN--------------LTKMYSLNLGANHN 144
Query: 272 TGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNL 331
+ N T LNYL + ++++ D + L +++ + L N +
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKDV--TPIANL--------TDLYSLSLNYNQIEDIS 193
Query: 332 PSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQ 391
P + +L +L + N ++ + P + N ++L L++ N + L + N QL
Sbjct: 194 PLA---SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQLT 246
Query: 392 ILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYA 451
L + +Q++ +++ + L+ L + +N I + + NL L +
Sbjct: 247 WLEIGTNQISD---------INAVKDLTKLKMLNVGSNQISDI--SVLNNL-SQLNSLFL 294
Query: 452 GSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQ 505
+ +LG G L+N+ L L QN + P + L + D + I+
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-41
Identities = 86/381 (22%), Positives = 145/381 (38%), Gaps = 46/381 (12%)
Query: 261 LQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVI 320
L P + L+ +TD +I +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD----------VVTQEELESITKL 49
Query: 321 QLYGNHLSGNLPSSTGI-NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
+ G ++ S GI L NL L L GN ++ + P + N KLT L + N + +
Sbjct: 50 VVAGEKVA----SIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI 103
Query: 380 VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSV 439
+ N L+ L L ++ S L N + L + N L +
Sbjct: 104 --SALQNLTNLRELYLNEDNISD---------ISPLANLTKMYSLNLGANHNLSDLSP-L 151
Query: 440 GNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDL 499
N+ L Y ++ P NL+++ +LSL NQ+ P + L +L
Sbjct: 152 SNM-TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206
Query: 500 SYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPST 559
N I P + + LN+L + N + + P LANL+ L L + +N++ + +
Sbjct: 207 YVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINA 260
Query: 560 FWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLAL 619
L + +++ N +S + NL L L+L+ NQL IGGL +LT L L
Sbjct: 261 VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 620 ARNGFQGSIPEAIGSLISLEK 640
++N P + SL ++
Sbjct: 319 SQNHITDIRP--LASLSKMDS 337
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-22
Identities = 62/269 (23%), Positives = 105/269 (39%), Gaps = 47/269 (17%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYN 1032
L + KL L I NKIT + NLT LREL+L+ +N+ L
Sbjct: 84 LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGA 141
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGV------------RLASNKLIGRIPSMIFNN 1080
N L N T LN+L + ++++ V L N++ P + +
Sbjct: 142 NHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASL 198
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
+++ Y N + + + + L L + N ++ + P + N SQ+ L + N
Sbjct: 199 TSLHYFTAYVNQITD--ITPVA-NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGA 1200
S + N + +L++L++ N ++ + L N L L L NN L
Sbjct: 254 QISDI--NAVKDLTKLKMLNVGSNQISD---------ISVLNNLSQLNSLFLNNNQLGNE 302
Query: 1201 LPNSIGNLSTSLEYFFASSTELRGAIPVE 1229
IG L T+L F S + P+
Sbjct: 303 DMEVIGGL-TNLTTLFLSQNHITDIRPLA 330
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-22
Identities = 47/238 (19%), Positives = 86/238 (36%), Gaps = 44/238 (18%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYN 1032
L + K+ L++ N + + N+T L L + + ++ L
Sbjct: 128 LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNY 186
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGV------------RLASNKLIGRIPSMIFNN 1080
N+ L + T L++ NQ+T + ++ +NK+ P + N
Sbjct: 187 NQIED--ISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANL 242
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
S + +++ N S +++ L L+ L + N +S I S + N SQ+ L L+ N
Sbjct: 243 SQLTWLEIGTNQISD--INAVK-DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNN 297
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLK 1198
G L L LS NH+T L + + N +K
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITD---------IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 7e-20
Identities = 48/285 (16%), Positives = 99/285 (34%), Gaps = 53/285 (18%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYN 1032
+ + +L ++ K+ + LT L L+L+GN + Y+
Sbjct: 40 QEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGT 97
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGV------------RLASNKLIGRIPSMIFNN 1080
NK T L N T L L L ++ ++ + L +N + S + N
Sbjct: 98 NKIT--DISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLS-DLSPLSNM 154
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
+ + + + + + I L +L L L N + I P + + + + N
Sbjct: 155 TGLNYLTVTESKVKD--VTPIA-NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVN 209
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTT----GSSTQGHSFY---------TSLTNCRYL 1187
+ + P N +L L + N +T + +Q ++ + L
Sbjct: 210 QITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKL 267
Query: 1188 RRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEFEG 1232
+ L + +N + + + NL + L F ++ +L G
Sbjct: 268 KMLNVGSNQISD--ISVLNNL-SQLNSLFLNNNQLGNEDMEVIGG 309
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 3e-11
Identities = 38/238 (15%), Positives = 74/238 (31%), Gaps = 65/238 (27%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
L+ I P +L E L T + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRA---------VLQKASVTDVVT--QEELESITK 48
Query: 1052 LILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGL 1111
L++ ++ +I+ I+ YL NL+ L
Sbjct: 49 LVVAGEKVA---------------------SIQGIE----------------YLTNLEYL 71
Query: 1112 ILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSS 1171
L GN ++ I P + N ++ L + N + + N L+ L L+ ++++ S
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISDIS- 126
Query: 1172 TQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVE 1229
L N + L L N + + N+ T L Y + ++++ P+
Sbjct: 127 --------PLANLTKMYSLNLGANHNLS-DLSPLSNM-TGLNYLTVTESKVKDVTPIA 174
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-42
Identities = 76/424 (17%), Positives = 136/424 (32%), Gaps = 84/424 (19%)
Query: 202 IPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL 261
I N+ +++++ F +++ +++ N+++ LP L +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQV 71
Query: 262 QELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQ 321
+ LNL D Q+ + I+ +
Sbjct: 72 ELLNLND------------------------LQIEEIDTYAFAYA--------HTIQKLY 99
Query: 322 LYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVA 381
+ N + LP N+P L L L N+LS + N KLT L +S N +
Sbjct: 100 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 158
Query: 382 NTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGN 441
+TF LQ L L+ ++L LS SL + + Y + T
Sbjct: 159 DTFQATTSLQNLQLSSNRLTHVDLSL----IPSLFH-ANVSYNLLST------------- 200
Query: 442 LSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSY 501
+ L N + + + L L L +
Sbjct: 201 ----------------------LAIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQH 235
Query: 502 NNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFW 561
NN+ L L + L N L+ + + L L +S+NRL +
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQ 292
Query: 562 SLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALAR 621
+ + V+D S N L + ++ L LYL N + ++ + L L L+
Sbjct: 293 PIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348
Query: 622 NGFQ 625
N +
Sbjct: 349 NDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-37
Identities = 69/426 (16%), Positives = 145/426 (34%), Gaps = 69/426 (16%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTE 163
I ++ ++I E + +I+ ++ + L + +S +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNL 222
+E +++ QI + +++L + FN + +P ++ N+ L L L N+L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 223 QGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK-DIG 280
P IF N L + ++NN+L + D + SLQ L L R+ D+
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSN----RLTHVDLS 183
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLP 340
L + + N L+ +E + N ++ +
Sbjct: 184 LIPSLFHANVSYNLLSTLA-------------IPIAVEELDASHNSIN-VVRGPV---NV 226
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
L L L NNL+ + + N L ++LS N ++ + F ++L+ L ++ ++
Sbjct: 227 ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR- 283
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI 460
L + + L+ L + N +L +
Sbjct: 284 ----LVALNLYGQPIPT---LKVLDLSHN-----------HLLH---------------V 310
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNT 520
+ L L N + T+ + L+ L LS+N+ + L ++
Sbjct: 311 ERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVAR 365
Query: 521 LLLQGN 526
+
Sbjct: 366 PAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-36
Identities = 64/360 (17%), Positives = 121/360 (33%), Gaps = 51/360 (14%)
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLP 340
+ L D + + G +N +++ + + LP++ +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFED---ITLNNQKIVTFKNSTMR-KLPAALLDSFR 69
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
+ L L + + + A + L + N L + F N L +L L + L
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI 460
+ SL +G F + L L++ N + I ++ + SL+ S L +
Sbjct: 130 S--SLPRG--IFHNTPK---LTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLTH-V 180
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNT 520
+ ++ ++ N L +T+ ++ LD S+N+I + + L
Sbjct: 181 D--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNV--ELTI 230
Query: 521 LLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCL 580
L LQ N L L N L ++LS N L + F
Sbjct: 231 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPF-------------------- 268
Query: 581 PQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
++ L LY+S N+L ++ + L L L+ N + LE
Sbjct: 269 ----VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 61/352 (17%), Positives = 119/352 (33%), Gaps = 38/352 (10%)
Query: 93 DLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGN 152
D+ I L+ + + L ++ +++L+ +I
Sbjct: 25 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 153 LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTE 211
+ ++ + N I P + L L + N+L+ +P+ I N +
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 142
Query: 212 LMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM 270
L L ++ NNL+ F +SL+ + L++N L + + L +PSL N+ +
Sbjct: 143 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVDLSL---IPSLFHANVSYNL 197
Query: 271 TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLI-----------PSIIFNNSNIEV 319
+ + + L N + L + + N +
Sbjct: 198 LS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVE 252
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
+ L N L + + + L RLY+ N L + L VL+LS N +
Sbjct: 253 VDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHV 310
Query: 380 VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
N +L+ L L ++ + T S+ L+ L + N W
Sbjct: 311 ERNQP-QFDRLENLYLDHNSIVTLK-------LSTHHT---LKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 58/339 (17%), Positives = 111/339 (32%), Gaps = 53/339 (15%)
Query: 308 PSIIFNNSNIEV-IQLYGNHLSGNLPSSTG----INLPNLLRLYLWGNNLSGVIPSSICN 362
P +SN++ Y H+ I L N + + + + + + +
Sbjct: 8 PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDS 67
Query: 363 ASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLR 422
++ +L L+ + F +Q L + ++ + L F ++ L
Sbjct: 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR--YLPPH--VFQNVPL---LT 120
Query: 423 YLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE-FGNLSNIIALSLYQNQLA 481
L ++ N +LS +P F N + LS+ N L
Sbjct: 121 VLVLERN-----------DLSS---------------LPRGIFHNTPKLTTLSMSNNNLE 154
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTS 541
T +LQ L LS N + + L + SL + N L LA +
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLST-----LAIPIA 206
Query: 542 LRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
+ L+ S N +N L + N L+ + N L + LS N+L
Sbjct: 207 VEELDASHNSINVVRGPVNVELTIL---KLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 261
Query: 602 CSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
+ ++ L L ++ N ++ + +L+
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-18
Identities = 49/247 (19%), Positives = 86/247 (34%), Gaps = 39/247 (15%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNK 1034
+ +++L + N I P N+ L L L N+L + + NN
Sbjct: 93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 152
Query: 1035 FTGRIPQN-LGNCTLLNFLILRQNQLTGV------RLASNKLIGRIPSMIFNNSNIEAIQ 1087
RI + T L L L N+LT V L + + S + +E +
Sbjct: 153 LE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELD 211
Query: 1088 LYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP 1147
N + + + L L L NNL+ + + N ++ + LS N ++
Sbjct: 212 ASHNSIN-VVRGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMY 265
Query: 1148 NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGN 1207
+ F ++L+ L +S N L + L+ L L +N L + +
Sbjct: 266 HPFVKMQRLERLYISNNRLV--------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
Query: 1208 LSTSLEY 1214
LE
Sbjct: 317 F-DRLEN 322
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 38/230 (16%), Positives = 73/230 (31%), Gaps = 33/230 (14%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCTLLN 1050
+ I + L + + + + ++P L + +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR----------KLPAALLDSFRQVE 72
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
L L Q+ I + F I+ + + N +LP + +P L
Sbjct: 73 LLNLNDLQIE-----------EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 120
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTG 1169
L+L N+LS + N ++ L +S N + +TF LQ L LS N LT
Sbjct: 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180
Query: 1170 SSTQ---------GHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLST 1210
+ ++ ++L + L +N + L+
Sbjct: 181 DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTI 230
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 52/264 (19%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YL 1030
L +++ L+++ +I +++L++ N + L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 1031 YNNKFTGRIPQNL-GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQL 1088
N + +P+ + N L L + N L RI F ++++ +QL
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-----------RIEDDTFQATTSLQNLQL 172
Query: 1089 YGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPN 1148
N + H+ S+ +P+L + N L S++ V L S N + +
Sbjct: 173 SSNRLT-HVDLSL---IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGP 223
Query: 1149 TFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL 1208
L IL L N+LT + L N L + L N L+ + + +
Sbjct: 224 VNVE---LTILKLQHNNLTDTA---------WLLNYPGLVEVDLSYNELEKIMYHPFVKM 271
Query: 1209 STSLEYFFASSTELRGAIPVEFEG 1232
LE + S+ L A+ + +
Sbjct: 272 -QRLERLYISNNRLV-ALNLYGQP 293
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 33/207 (15%), Positives = 67/207 (32%), Gaps = 29/207 (14%)
Query: 1005 TIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRL 1064
I + ++H+ + + G L N + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQT------QDVYFGFEDITLNN---QKIVTFKNSTMR---- 58
Query: 1065 ASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIP 1123
++P+ + ++ +E + L + + Y +Q L + N + + P
Sbjct: 59 -------KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPP 110
Query: 1124 SSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTN 1183
N + +L L N S L F N +L L +S N+L +
Sbjct: 111 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED-------DTFQA 163
Query: 1184 CRYLRRLVLQNNPLKGALPNSIGNLST 1210
L+ L L +N L + I +L
Sbjct: 164 TTSLQNLQLSSNRLTHVDLSLIPSLFH 190
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-11
Identities = 38/190 (20%), Positives = 62/190 (32%), Gaps = 37/190 (19%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYNNKFTGR 1038
L ++S N ++ T+ + EL N++ L +N T
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD- 240
Query: 1039 IPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHL 1097
L N L + L N+L +I F +E + + N L
Sbjct: 241 -TAWLLNYPGLVEVDLSYNELE-----------KIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 1098 PSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQ 1157
P +P L+ L L N+L + + ++ L L N L +T L+
Sbjct: 288 NLYGQP-IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT---LK 342
Query: 1158 ILDLSLNHLT 1167
L LS N
Sbjct: 343 NLTLSHNDWD 352
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-42
Identities = 61/370 (16%), Positives = 104/370 (28%), Gaps = 64/370 (17%)
Query: 253 DLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIF 312
+ L + +
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS------------AWRQA 53
Query: 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELS 372
N++N ++ G L P + L L L P S L + +
Sbjct: 54 NSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID 112
Query: 373 RNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWK 432
L +T L+ L LA + L ++ +S+ + LR L+I+ P
Sbjct: 113 AAGLMEL-PDTMQQFAGLETLTLARNPL--------RALPASIASLNRLRELSIRACPEL 163
Query: 433 GILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQ 492
LP + + E L N+ +L L + ++P ++ LQ
Sbjct: 164 TELPEPLASTD----------------ASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQ 206
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
NL+ L + + + ++ + L L L L+G P L+ L L
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC-- 263
Query: 553 NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLK 612
+ L LP DI L L L L G +PS I L
Sbjct: 264 ---------------------SNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 613 DLTYLALARN 622
+ + +
Sbjct: 302 ANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-41
Identities = 61/352 (17%), Positives = 112/352 (31%), Gaps = 41/352 (11%)
Query: 203 PQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQ 262
+ + + LY G+ + + +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS------NNP 58
Query: 263 ELNLRDCMTTGRIPKDIGNCTLLN--YLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVI 320
++ R + + T L LR L P F S+++ +
Sbjct: 59 QIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ---------FPDQAFRLSHLQHM 109
Query: 321 QLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRN------ 374
+ L LP + L L L N L +P+SI + ++L L +
Sbjct: 110 TIDAAGLM-ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166
Query: 375 ---LFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
L S + LQ L L ++ + +S +S+ N + L+ L I+ +P
Sbjct: 167 PEPLASTDASGEHQGLVNLQSLRLEWTGI--------RSLPASIANLQNLKSLKIRNSPL 218
Query: 432 KGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLY-QNQLASTIPTTVGK 490
L ++ +L LE C P FG + + L L + L T+P + +
Sbjct: 219 SA-LGPAIHHL-PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHR 275
Query: 491 LQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSL 542
L L+ LDL +PS + QL + +L+ + +
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-39
Identities = 58/328 (17%), Positives = 104/328 (31%), Gaps = 42/328 (12%)
Query: 103 GTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM----- 157
G+ H + S +L G+ + L R D + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 158 ---CNSLTE------------LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRI 202
+L + ++ S + Q P S L+ +++ L +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 203 PQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCR------ 256
P + L L L N L+ P +I +++ LR + + LP L
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 257 --RLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
L +LQ L L +P I N L L +R++ L+ + I +
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA---------LGPAIHHL 228
Query: 315 SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRN 374
+E + L G N P G L RL L + +P I ++L L+L
Sbjct: 229 PKLEELDLRGCTALRNYPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 375 LFSGLVANTFGNCRQLQILNLAYSQLAT 402
+ + + I+ + A
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 48/266 (18%), Positives = 87/266 (32%), Gaps = 27/266 (10%)
Query: 385 GNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSK 444
+ + L + + + L+ + NS
Sbjct: 9 HHSSGRENLYFQ-------GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS------ 55
Query: 445 SLEYFYAGSCELGGGIPAEFGNLS--NIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYN 502
+ + + + +AL L L P +L +LQ + +
Sbjct: 56 NNPQIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAA 114
Query: 503 NIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWS 562
+ +P + Q L TL L N L+ +P +A+L LR L++ + + +P S
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 563 LEYILVVDFSLNL----LSGC----LPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDL 614
+ +NL L LP I NL+ L L + + LS ++ +I L L
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 615 TYLALARNGFQGSIPEAIGSLISLEK 640
L L + P G L++
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKR 257
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 43/242 (17%), Positives = 78/242 (32%), Gaps = 32/242 (13%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA--------------YLYNNK 1034
L + + P L+ L+ + + L L N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNP 138
Query: 1035 FTGRIPQNLGNCTLLNFLILR-QNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHF 1093
+P ++ + L L +R +LT L N+++++L
Sbjct: 139 LR-ALPASIASLNRLRELSIRACPELT--ELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNC 1153
LP+SI L NL+ L + + LS + +I + ++ L L P FG
Sbjct: 196 R-SLPASIA-NLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 1154 RQLQILDLS-LNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSL 1212
L+ L L ++L + + L +L L+ LP+ I L +
Sbjct: 253 APLKRLILKDCSNLL--------TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL-PAN 303
Query: 1213 EY 1214
Sbjct: 304 CI 305
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 35/183 (19%), Positives = 65/183 (35%), Gaps = 15/183 (8%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNEL---------WLMPRLRIIDLSSNRISGNLF 154
+P +A+L+ L L+I LP L + L+ + L I +L
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 155 DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS-FNELTGRIPQNIGNLTELM 213
+ N L L+S + ++ ++ L ++ KL+ L + L P G L
Sbjct: 200 ASIAN-LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLK 256
Query: 214 ELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273
L L + P I ++ L + L LP + +LP+ + + +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA-QLPANCIILVPPHLQAQ 315
Query: 274 RIP 276
Sbjct: 316 LDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-20
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 6/168 (3%)
Query: 95 SIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLF 154
+P L L SL + +LP + + L+ + + ++ +S L
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LG 222
Query: 155 DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS-FNELTGRIPQNIGNLTELM 213
+ + L +LE D+ P G + LKRL + + L +P +I LT+L
Sbjct: 223 PAIHH-LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLE 280
Query: 214 ELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL 261
+L L G P I + + +I++ + L P+
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ-AQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 31/192 (16%), Positives = 64/192 (33%), Gaps = 16/192 (8%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
L+ L+++ N + +P ++ +L LREL + L + L
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 1050 NFLILRQNQLTGV-------------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH 1096
L L + + ++ ++ L + I + +E + L G +
Sbjct: 186 QSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244
Query: 1097 LPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQL 1156
P G L+ LIL + +P I +Q+ L L + +P+
Sbjct: 245 YPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 1157 QILDLSLNHLTT 1168
I+ + +
Sbjct: 304 CIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 42/261 (16%), Positives = 77/261 (29%), Gaps = 47/261 (18%)
Query: 1004 GTIPRTVGNLTELRELHLHGNN-----------LEAYLYNNKFTGRIPQNLGNCTLLNFL 1052
G+ + + L+ G+ + + ++ N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 1053 ILRQNQLTGV-----RLASNKL---------IGRIPSMIFNNSNIEAIQLYGNHFSGHLP 1098
L + + P F S+++ + + LP
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 1099 SSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLS---------ENLFSGLIPNT 1149
++ L+ L L N L +P+SI + +++ L + E L S
Sbjct: 121 DTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 1150 FGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
LQ L L + S S+ N + L+ L ++N+PL AL +I +L
Sbjct: 179 HQGLVNLQSLRLEWTGIR--------SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL- 228
Query: 1210 TSLEYFFASSTELRGAIPVEF 1230
LE P F
Sbjct: 229 PKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 30/159 (18%), Positives = 55/159 (34%), Gaps = 24/159 (15%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
L+ L + I ++P ++ NL L+ L + + L A + + + L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA----------LGPAIHHLPKLE 232
Query: 1051 FLILRQ-NQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
L LR L P + + ++ + L LP I L L+
Sbjct: 233 ELDLRGCTALRN-----------YPPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLE 280
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPN 1148
L L G +PS I ++ + +L + L +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 24/155 (15%), Positives = 40/155 (25%), Gaps = 22/155 (14%)
Query: 506 GSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIP-------- 557
GS L QG+ L+ + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 558 ----STFWSLEYILVVDFSLNL----LSGC----LPQDIGNLKVLTGLYLSGNQLSCSIP 605
+ +L L P L L + + L +P
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 606 SSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
++ L L LARN + ++P +I SL L +
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-04
Identities = 13/92 (14%), Positives = 24/92 (26%), Gaps = 15/92 (16%)
Query: 984 ADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHG-NNLEA-------------- 1028
+ KL+ L + P G L+ L L +NL
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLT 1060
L R+P + +++ +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-41
Identities = 67/444 (15%), Positives = 142/444 (31%), Gaps = 32/444 (7%)
Query: 111 NLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVS 170
N + ++ + L + ++ +DLS N +S + T+LE ++S
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLS 66
Query: 171 SNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTI 230
SN + L S L+ L ++ N + + + L+ NN+ +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 231 FNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD-CMTTGRIPKDIGNCTLLNYLG 289
+ I LANN + L +Q L+L+ + T + + L +L
Sbjct: 119 G--QGKKNIYLANNKI-TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 290 LRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWG 349
L+ N + D + + + ++ + L N L+ + + + + L
Sbjct: 176 LQYNFIYD---------VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRN 223
Query: 350 NNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQ 409
N L +I ++ + L +L N F F + ++ +A + +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQN-- 279
Query: 410 SFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSN 469
T Y A + + L + +G + E N +
Sbjct: 280 --EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
Query: 470 IIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQ 529
+ + Q + I + Q L+ + + + L+ L Q Q
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-Q 396
Query: 530 NQIPTCLANLTSLRALNLSSNRLN 553
++ + L+ L R
Sbjct: 397 IELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 6e-40
Identities = 67/454 (14%), Positives = 146/454 (32%), Gaps = 42/454 (9%)
Query: 156 DMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMEL 215
++ + + V+ + + L S +K L +S N L+ ++ T+L L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 216 YLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI 275
L+ N L + ++S+LR + L NN + L PS++ L+ + + R+
Sbjct: 64 NLSSNVLYE--TLDLESLSTLRTLDLNNNYV-QELL-----VGPSIETLHAANNNIS-RV 114
Query: 276 PKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSST 335
G + L +N++T L S ++ + L N + +
Sbjct: 115 SCSRG--QGKKNIYLANNKITM--------LRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 336 GINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNL 395
+ L L L N + + + +KL L+LS N + + F + + ++L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLAFM-GPEFQSAAGVTWISL 221
Query: 396 AYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWK-GILPNSVGNLSKSLEYFYAGSC 454
++L +L + L + ++ N + G L + +
Sbjct: 222 RNNKL--------VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 455 ELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGS----IPS 510
+L G + +L L+ + + + QGS +
Sbjct: 274 KLTGQN---EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTF---WSLEYIL 567
E + + I + L L+ + + L+ L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 568 VVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
L ++ L++L + ++
Sbjct: 391 QQAVGQIELQH-ATEEQSPLQLLRAIVKRYEEMY 423
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-39
Identities = 64/467 (13%), Positives = 137/467 (29%), Gaps = 86/467 (18%)
Query: 178 LPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLR 237
+ + ++ K V+ + L + + + EL L+GN L + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 238 VIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTD 297
++ L++N L+ +L + L +L+ L+ L +N + +
Sbjct: 62 LLNLSSNVLYETLDL---ESLSTLRTLD------------------------LNNNYVQE 94
Query: 298 FGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIP 357
+ +IE + N++S + S +YL N ++ +
Sbjct: 95 -------------LLVGPSIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKITMLRD 137
Query: 358 SSICNASKLTVLELSRNLFSGL-VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLT 416
S++ L+L N + A + L+ LNL Y+ +
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI---------YDVKGQV 188
Query: 417 NCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLY 476
L+ L + +N L+ + EF + + + +SL
Sbjct: 189 VFAKLKTLDLSSN-----------KLAF---------------MGPEFQSAAGVTWISLR 222
Query: 477 QNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCL 536
N+L I + QNL+ DL N + ++ + ++
Sbjct: 223 NNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNE 280
Query: 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG----CLPQDIGNLKVLTG 592
T + + L + + +L G L + N
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 593 LYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
+ Q I + L + + + L+
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-29
Identities = 43/297 (14%), Positives = 83/297 (27%), Gaps = 13/297 (4%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTE 163
+ + ++ ++ N+ + R++ +DL N I F ++ S
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223
LE ++ N I + + +KLK L +S N+L + + + + L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 224 GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCT 283
+ +L L N D + +Q + + ++ CT
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT--VKKLTGQNEEECT 284
Query: 284 LLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLL 343
+ D A L I ++ G+ L N
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRL---IALKRKEHALLSGQGSETE-RLECER-ENQARQR 339
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
+ VI LE + V+N +L
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 38/183 (20%), Positives = 68/183 (37%), Gaps = 11/183 (6%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESL 518
I N + + + L + + N++ LDLS N + ++L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
L L N L + L +L++LR L+L++N + I + + N +S
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 579 CLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQG-SIPEAIGSLIS 637
+ G +YL+ N+++ G + YL L N + E S +
Sbjct: 114 -VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 638 LEK 640
LE
Sbjct: 171 LEH 173
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-20
Identities = 40/259 (15%), Positives = 78/259 (30%), Gaps = 43/259 (16%)
Query: 987 GDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNC 1046
+ N+ K ++ + + + + ++EL L GN L + +L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL---------SQISAADLAPF 57
Query: 1047 TLLNFLILRQNQLTGV------------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFS 1094
T L L L N L L +N + + +IE + N+ S
Sbjct: 58 TKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 1095 GHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGL-IPNTFGNC 1153
+ S + + L N ++ + S+V L L N + +
Sbjct: 113 -RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 1154 RQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLE 1213
L+ L+L N + L+ L L +N L + + +
Sbjct: 169 DTLEHLNLQYNFIYD---------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSA-AGVT 217
Query: 1214 YFFASSTELRGAIPVEFEG 1232
+ + +L I
Sbjct: 218 WISLRNNKLV-LIEKALRF 235
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 40/253 (15%), Positives = 77/253 (30%), Gaps = 40/253 (15%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYNNKFTG 1037
+K L +S N ++ + T+L L+L N L L NN
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ- 93
Query: 1038 RIPQNLGNCTLLNFLILRQNQLTGV-----------RLASNKLIGRIPSMIFNNSNIEAI 1086
L + L N ++ V LA+NK+ S ++ +
Sbjct: 94 ----ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 1087 QLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLI 1146
L N + + L+ L L N + + + +++ L LS N + +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVF--AKLKTLDLSSNKLAF-M 206
Query: 1147 PNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIG 1206
F + + + L N L +L + L L+ N
Sbjct: 207 GPEFQSAAGVTWISLRNNKLVLIEK--------ALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 1207 NLSTSLEYFFASS 1219
+ + ++ +
Sbjct: 259 SKNQRVQTVAKQT 271
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 6e-11
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 16/140 (11%)
Query: 1073 IPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132
I + N + + ++ + +S+ N++ L L GN LS I + + +++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVL 1192
LL LS N+ + + L+ LDL+ N++ L + L
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV------------QELLVGPSIETLHA 106
Query: 1193 QNNPLKGALPNSIGNLSTSL 1212
NN + + S G ++
Sbjct: 107 ANNNIS-RVSCSRGQGKKNI 125
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 31/229 (13%), Positives = 62/229 (27%), Gaps = 31/229 (13%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
KLK L +S NK+ + + + + L N L I + L L
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV----------LIEKALRFSQNLE 240
Query: 1051 FLILRQNQLTGVRLA------------SNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLP 1098
LR N L + + + ++ + + YG + LP
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300
Query: 1099 SSIGPYLPNLQGLILWGNNLSG----IIPSSICNASQVILLGLSENLFSGLIPNTFGNCR 1154
+ L L+ + G + N ++ + + + +I +
Sbjct: 301 APFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 1155 QLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPN 1203
L+ L S + + + L+ A
Sbjct: 361 AKITLEQKKKALDEQVSNGRR----AHAELDGTLQQAVGQIELQHATEE 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 5e-09
Identities = 26/125 (20%), Positives = 46/125 (36%), Gaps = 15/125 (12%)
Query: 1099 SSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQI 1158
I + + ++L + S +A V L LS N S + +L++
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 1159 LDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFAS 1218
L+LS N L + L+ LR L L NN ++ + S+E A+
Sbjct: 63 LNLSSNVLYETLDLES------LST---LRTLDLNNNYVQ-----ELLVG-PSIETLHAA 107
Query: 1219 STELR 1223
+ +
Sbjct: 108 NNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 10/93 (10%)
Query: 1122 IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSL 1181
I N ++ + ++++ + + + ++ LDLS N L+ S+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA-------ADL 54
Query: 1182 TNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
L L L +N L + +L ++L
Sbjct: 55 APFTKLELLNLSSNVLYE--TLDLESL-STLRT 84
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-38
Identities = 76/424 (17%), Positives = 136/424 (32%), Gaps = 84/424 (19%)
Query: 202 IPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL 261
I N+ +++++ F +++ +++ N+++ LP L +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQV 77
Query: 262 QELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQ 321
+ LNL D Q+ + I+ +
Sbjct: 78 ELLNLND------------------------LQIEEIDTYAFAYA--------HTIQKLY 105
Query: 322 LYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVA 381
+ N + LP N+P L L L N+LS + N KLT L +S N +
Sbjct: 106 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 164
Query: 382 NTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGN 441
+TF LQ L L+ ++L LS SL + + Y + T
Sbjct: 165 DTFQATTSLQNLQLSSNRLTHVDLSL----IPSLFH-ANVSYNLLST------------- 206
Query: 442 LSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSY 501
+ L N + + + L L L +
Sbjct: 207 ----------------------LAIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQH 241
Query: 502 NNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFW 561
NN+ L L + L N L+ + + L L +S+NRL +
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQ 298
Query: 562 SLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALAR 621
+ + V+D S N L + ++ L LYL N + ++ + L L L+
Sbjct: 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 354
Query: 622 NGFQ 625
N +
Sbjct: 355 NDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-34
Identities = 75/459 (16%), Positives = 155/459 (33%), Gaps = 68/459 (14%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTE 163
I ++ ++I E + +I+ ++ + L + +S +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNL 222
+E +++ QI + +++L + FN + +P ++ N+ L L L N+L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 223 QGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGN 281
P IF N L + ++NN+L + D + SLQ L L T + +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 190
Query: 282 CTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPN 341
L + + N L+ +E + N ++ +
Sbjct: 191 IPSLFHANVSYNLLSTLA-------------IPIAVEELDASHNSIN-VVRGPV---NVE 233
Query: 342 LLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLA 401
L L L NNL+ + + N L ++LS N ++ + F ++L+ L ++ ++
Sbjct: 234 LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-- 289
Query: 402 TGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIP 461
L + + L+ L + N +L +
Sbjct: 290 ---LVALNLYGQPIPT---LKVLDLSHN-----------HLLH---------------VE 317
Query: 462 AEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTL 521
+ L L N + T+ + L+ L LS+N+ + L ++
Sbjct: 318 RNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARP 372
Query: 522 LLQGNALQNQIPTCLAN-LTSLRALNLSSNRLNSTIPST 559
+ +I L + L + +RL I T
Sbjct: 373 AVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALT 411
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-34
Identities = 90/566 (15%), Positives = 175/566 (30%), Gaps = 61/566 (10%)
Query: 93 DLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGN 152
D+ I L+ + + L ++ +++L+ +I
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 153 LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTE 211
+ ++ + N I P + L L + N+L+ +P+ I N +
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 148
Query: 212 LMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM 270
L L ++ NNL+ F +SL+ + L++N L + + L +PSL N+ +
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVDLSL---IPSLFHANVSYNL 203
Query: 271 TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLI-----------PSIIFNNSNIEV 319
+ + + L N + L + + N +
Sbjct: 204 LS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVE 258
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
+ L N L + + + L RLY+ N L + L VL+LS N +
Sbjct: 259 VDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHV 316
Query: 380 VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW-------- 431
N +L+ L L ++ + T S+ L+ L + N W
Sbjct: 317 ERNQP-QFDRLENLYLDHNSIVTLK-------LSTHHT---LKNLTLSHNDWDCNSLRAL 365
Query: 432 -KGILPNSVGNLSKSLEYFY---AGSCELGGGIPAEFGNLSNIIALSLYQN-QLASTIPT 486
+ + +V + + + Y G C P L I S+ + Q A +
Sbjct: 366 FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS 425
Query: 487 TVGKLQNLQGLDLSYNNIQGSIPSELCQLE-SLNTLLLQGNALQNQI--------PTCLA 537
+ ++Q L G QLE +N L + L N+
Sbjct: 426 ATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAE 485
Query: 538 NLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGN-LKVLTGLYLS 596
T+LR L + L + + ++ + + K L
Sbjct: 486 IDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQE 545
Query: 597 GNQLSCSIPSSIGGLKDLTYLALARN 622
L + + +L +
Sbjct: 546 NIALEKQLDNKRAKQAELRQETSLKR 571
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 1e-17
Identities = 49/247 (19%), Positives = 86/247 (34%), Gaps = 39/247 (15%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNK 1034
+ +++L + N I P N+ L L L N+L + + NN
Sbjct: 99 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158
Query: 1035 FTGRIPQN-LGNCTLLNFLILRQNQLTGV------RLASNKLIGRIPSMIFNNSNIEAIQ 1087
RI + T L L L N+LT V L + + S + +E +
Sbjct: 159 LE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELD 217
Query: 1088 LYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP 1147
N + + + L L L NNL+ + + N ++ + LS N ++
Sbjct: 218 ASHNSIN-VVRGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMY 271
Query: 1148 NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGN 1207
+ F ++L+ L +S N L + L+ L L +N L + +
Sbjct: 272 HPFVKMQRLERLYISNNRLVALNLY--------GQPIPTLKVLDLSHNHLL-HVERNQPQ 322
Query: 1208 LSTSLEY 1214
LE
Sbjct: 323 F-DRLEN 328
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 4e-16
Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 52/264 (19%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YL 1030
L +++ L+++ +I +++L++ N + L
Sbjct: 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130
Query: 1031 YNNKFTGRIPQNL-GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQL 1088
N + +P+ + N L L + N L RI F ++++ +QL
Sbjct: 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-----------RIEDDTFQATTSLQNLQL 178
Query: 1089 YGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPN 1148
N + H+ S+ +P+L + N L S++ V L S N + +
Sbjct: 179 SSNRLT-HVDLSL---IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGP 229
Query: 1149 TFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL 1208
L IL L N+LT + L N L + L N L+ + + +
Sbjct: 230 VNVE---LTILKLQHNNLTDTA---------WLLNYPGLVEVDLSYNELEKIMYHPFVKM 277
Query: 1209 STSLEYFFASSTELRGAIPVEFEG 1232
LE + S+ L A+ + +
Sbjct: 278 -QRLERLYISNNRLV-ALNLYGQP 299
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 2e-15
Identities = 34/182 (18%), Positives = 59/182 (32%), Gaps = 6/182 (3%)
Query: 460 IPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESL 518
I + + + L N + + + ++ +P+ L +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
L L ++ A +++ L + N + P F ++ + V+ N LS
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 579 CLPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPEAIGSLI 636
LP+ I N LT L +S N L I L L L+ N I SL
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 195
Query: 637 SL 638
Sbjct: 196 HA 197
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 1e-14
Identities = 53/368 (14%), Positives = 104/368 (28%), Gaps = 46/368 (12%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYNNKFTGR 1038
KL LS+S N + T T L+ L L N L + N +
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-- 205
Query: 1039 IPQNLGNCTLLNFLILRQNQLTGV-----------RLASNKLIGRIPSMIFNNSNIEAIQ 1087
L + L N + V +L N L + + N + +
Sbjct: 206 ---TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVD 260
Query: 1088 LYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP 1147
L N + + L+ L + N L + + +L LS N +
Sbjct: 261 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VE 317
Query: 1148 NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGN 1207
+L+ L L N + T L+ L+ L L +N NS+
Sbjct: 318 RNQPQFDRLENLYLDHNSIVT----------LKLSTHHTLKNLTLSHNDWD---CNSLRA 364
Query: 1208 LSTSLEYFFASSTELRGAIPVEFEGEIPSGGPFVNFTAESLMQNLVLGGSSRLQVPPCKT 1267
L ++ + I + E + + L + ++Q +
Sbjct: 365 LFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRC 424
Query: 1268 GSSQQSKATRLALRYILPAIATTMAVLALIIILLRRRKRDKSRPTENNLLNTAALRRISY 1327
++ + + YI + + + + + + T + L+ +
Sbjct: 425 SATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHA 484
Query: 1328 QELRLATN 1335
+
Sbjct: 485 EIDTNLRR 492
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-13
Identities = 33/207 (15%), Positives = 67/207 (32%), Gaps = 29/207 (14%)
Query: 1005 TIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRL 1064
I + ++H+ + + G L N + + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQT------QDVYFGFEDITLNN---QKIVTFKNSTMR---- 64
Query: 1065 ASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIP 1123
++P+ + ++ +E + L + + Y +Q L + N + + P
Sbjct: 65 -------KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPP 116
Query: 1124 SSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTN 1183
N + +L L N S L F N +L L +S N+L +
Sbjct: 117 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED-------DTFQA 169
Query: 1184 CRYLRRLVLQNNPLKGALPNSIGNLST 1210
L+ L L +N L + I +L
Sbjct: 170 TTSLQNLQLSSNRLTHVDLSLIPSLFH 196
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 7e-13
Identities = 28/160 (17%), Positives = 55/160 (34%), Gaps = 2/160 (1%)
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTS 541
I + + + + E L + + + + ++ L +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 542 LRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
+ LNL+ ++ F I + N + P N+ +LT L L N LS
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 602 CSIPSSI-GGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
S+P I LT L+++ N + + + SL+
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-08
Identities = 31/178 (17%), Positives = 53/178 (29%), Gaps = 36/178 (20%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
L + L + +S N++ + + L L++ N L A +
Sbjct: 250 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA----------LNLYGQP 299
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYL 1105
L L L N L + +E + L N L S
Sbjct: 300 IPTLKVLDLSHNHLL-----------HVERNQPQFDRLENLYLDHNSIV-TLKLST---H 344
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSL 1163
L+ L L N+ CN+ L L N+ + + +C+ L+ L
Sbjct: 345 HTLKNLTLSHNDWD-------CNS----LRALFRNVARPAVDDADQHCKIDYQLEHGL 391
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 11/219 (5%)
Query: 752 IGAGSFGSVYKATL-PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSC 809
IG G+FG V+ L VA+K L F E +L++ H N+V++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ +++E + G +L + L ++ L ++ D A+ +EYL IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY--MAPEYGSEGIVSTCGD 927
L N L+ + V +SDFG+S+ + + L APE + G S+ D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 928 VYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
V+SFGIL+ ETF+ P + +T +++VE+ RL
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQT--REFVEKGGRL 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-33
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLAKI-- 1396
+G G F V+ AD T A+K +E F E ++++ H N+ ++
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS--CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
V + P + ++++ + G +L + L ++ L ++ D A +EYL S
Sbjct: 180 VCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLL-DGVDSMKQTMTLATIGYMAPEYGSEGIVST 1515
IH DL N L+ + V + DFG+++ DGV + + + + APE + G S+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 1516 SGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
DV+SFGIL+ ET + P ++ +
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQQT 324
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-38
Identities = 86/425 (20%), Positives = 142/425 (33%), Gaps = 61/425 (14%)
Query: 210 TELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
+ + L+ N++ E T F + L+ + + + + + R L SL L L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 269 CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHL 327
NQ + + FN +N+EV+ L +L
Sbjct: 89 ------------------------NQFLQ---------LETGAFNGLANLEVLTLTQCNL 115
Query: 328 -SGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI-CNASKLTVLELSRNLFSGLVANTFG 385
L + L +L L L NN+ + P+S N + VL+L+ N +
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175
Query: 386 NC--RQLQILNLAYSQLATGSLSQGQSF-FSSLTNCRYLRYLAIQTNPWKGILPNSVGNL 442
N + +L L+ L + + + L + N +K + +
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235
Query: 443 SKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQ--NLQGLDLS 500
+ I + + S + S T L+ ++ DLS
Sbjct: 236 IAGTK------------IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 501 YNNIQGSIPSELCQ-LESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPST 559
+ I ++ + L L L N + LT L LNLS N L S
Sbjct: 284 KSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM 342
Query: 560 FWSLEYILVVDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYL 617
F +L+ + V+D S N + L L L L L NQL S+P I L L +
Sbjct: 343 FENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKI 400
Query: 618 ALARN 622
L N
Sbjct: 401 WLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 74/428 (17%), Positives = 131/428 (30%), Gaps = 61/428 (14%)
Query: 188 LKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSL 246
+ + +S N + + L +L L + F +SSL ++ L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 247 FGSLPVDLCRRLPSLQELNLRDC-MTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLT 304
L L +L+ L L C + + + T L L LRDN +
Sbjct: 92 -LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK------- 143
Query: 305 GLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGINLP--NLLRLYLWGNNLSGVIPSSIC 361
+ P+ F N V+ L N + ++ +N + L L L
Sbjct: 144 -IQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITL--------- 192
Query: 362 NASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYL 421
+++ + L+L+ + F +
Sbjct: 193 -------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK----ESMAKRFFDAIAGTKI 241
Query: 422 RYLAIQ--TNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNL--SNIIALSLYQ 477
+ L + N + + F L S + L +
Sbjct: 242 QSLILSNSYNMGSSFGHTNFKDPDNFT-----------------FKGLEASGVKTCDLSK 284
Query: 478 NQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCL 536
+++ + + + +L+ L L+ N I I L L L L N L +
Sbjct: 285 SKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF 343
Query: 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI-GNLKVLTGLYL 595
NL L L+LS N + + +F L + + N L +P I L L ++L
Sbjct: 344 ENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402
Query: 596 SGNQLSCS 603
N CS
Sbjct: 403 HTNPWDCS 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-35
Identities = 79/427 (18%), Positives = 139/427 (32%), Gaps = 62/427 (14%)
Query: 95 SIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLF 154
+P +P H + +++S N + L+ + + +
Sbjct: 24 QVPE------LPAH------VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71
Query: 155 DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNI-GNLTEL 212
++ L+ L + NQ + + L+ L+++ L G + N LT L
Sbjct: 72 NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131
Query: 213 MELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMT 271
L L NN++ P + F N+ V+ L N + S+ +
Sbjct: 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKH--------- 181
Query: 272 TGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNL 331
L L L D L F N++I + L GN ++
Sbjct: 182 -------------FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228
Query: 332 PSSTGINLPNLLRLYLWGNNLSGVIPSSICN--------------ASKLTVLELSRNLFS 377
+ L +N + S AS + +LS++
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288
Query: 378 GLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPN 437
L+ + F + L+ L LA +++ + F LT+ L L + N I
Sbjct: 289 ALLKSVFSHFTDLEQLTLAQNEIN--KIDDNA--FWGLTH---LLKLNLSQNFLGSIDSR 341
Query: 438 SVGNLSKSLEYFYAGSCELGGGIPAE-FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQG 496
NL K LE + + + F L N+ L+L NQL S +L +LQ
Sbjct: 342 MFENLDK-LEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK 399
Query: 497 LDLSYNN 503
+ L N
Sbjct: 400 IWLHTNP 406
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-16
Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 19/223 (8%)
Query: 995 LSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLIL 1054
++ + T + L L GN + + F + T + LIL
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF------DAIAGTKIQSLIL 246
Query: 1055 RQNQLTGVRLASNKLIGRIPSMIFN---NSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGL 1111
+ G + F S ++ L + L S+ + +L+ L
Sbjct: 247 SNSYNMGSSFGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 1112 ILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSS 1171
L N ++ I ++ + ++ L LS+N + F N +L++LDLS NH+ +
Sbjct: 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR---A 361
Query: 1172 TQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
SF L N L+ L L N LK ++P+ I + TSL+
Sbjct: 362 LGDQSF-LGLPN---LKELALDTNQLK-SVPDGIFDRLTSLQK 399
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-16
Identities = 35/168 (20%), Positives = 55/168 (32%), Gaps = 27/168 (16%)
Query: 468 SNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ-LESLNTLLLQGN 526
+++ + L N +A T+ +LQ+LQ L + I + + L SL L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 527 ALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI-G 585
L +L L L+ L+ L +
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGA-----------------------VLSGNFFK 126
Query: 586 NLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPEAI 632
L L L L N + P+S ++ L L N + SI E
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEED 173
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-13
Identities = 44/228 (19%), Positives = 81/228 (35%), Gaps = 25/228 (10%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
+ + +S+N I + L +L+ L + + NN F + L + L
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF-----RGLSS---LII 83
Query: 1052 LILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHF-SGHLPSSIGPYLPNLQ 1109
L L NQ ++ + FN +N+E + L + L + L +L+
Sbjct: 84 LKLDYNQFL-----------QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132
Query: 1110 GLILWGNNLSGIIPSSI-CNASQVILLGLSENLFSGLIPNTFGNC--RQLQILDLSLNHL 1166
L+L NN+ I P+S N + +L L+ N + N + +L LS L
Sbjct: 133 MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192
Query: 1167 TTGSSTQ-GHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLE 1213
+ G + + L L N K ++ + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-13
Identities = 49/247 (19%), Positives = 89/247 (36%), Gaps = 40/247 (16%)
Query: 991 KLKRLSISVNKITGT-IPRTV-GNLTELRELHLHGNNLEA----------------YLYN 1032
L+ L+++ + G + LT L L L NN++ L
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
NK ++L N +F +LR + +T + L F N++I + L GN
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICN--------------ASQVILLGLS 1138
F + + + L +N + S AS V LS
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 1139 ENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLK 1198
++ L+ + F + L+ L L+ N + ++F+ LT+ L +L L N L
Sbjct: 284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDD---NAFW-GLTH---LLKLNLSQNFLG 336
Query: 1199 GALPNSI 1205
++ + +
Sbjct: 337 -SIDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-13
Identities = 37/223 (16%), Positives = 60/223 (26%), Gaps = 38/223 (17%)
Query: 991 KLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCTL 1048
L+ L + I L+ L L L N +
Sbjct: 55 DLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ----------LETGAFNGLAN 104
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPN 1107
L L L Q L G + F +++E + L N+ P+S +
Sbjct: 105 LEVLTLTQCNLDGA---------VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRR 155
Query: 1108 LQGLILWGNNLSGIIPSSI-----------CNASQVILLGLSENLFSGLIPNTFGNCRQL 1156
L L N + I S + L ++E +
Sbjct: 156 FHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 1157 QILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKG 1199
LDLS N + F+ ++ L+L N+ G
Sbjct: 215 TTLDLSGNGFK---ESMAKRFF-DAIAGTKIQSLILSNSYNMG 253
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 8e-08
Identities = 30/198 (15%), Positives = 60/198 (30%), Gaps = 29/198 (14%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
+ L +S N ++ + + ++ +L N + N +
Sbjct: 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQ----SLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 1051 FLILRQNQLTGVRLASNKL-----------------------IGRIPSMIFNN-SNIEAI 1086
F L + + L+ +K+ I +I F +++ +
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 1087 QLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLI 1146
L N + S + L L+ L L N++ + S + L L N +
Sbjct: 329 NLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVP 387
Query: 1147 PNTFGNCRQLQILDLSLN 1164
F LQ + L N
Sbjct: 388 DGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 27/124 (21%), Positives = 44/124 (35%), Gaps = 9/124 (7%)
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN-LFSGLIPNTFGNCRQLQILDLSLN 1164
++ + L N+++ + +S + L + + + NTF L IL L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 1165 HLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGA-LPNSIGNLSTSLEYFFASSTELR 1223
+ +F L N L L L L GA L + TSLE ++
Sbjct: 90 QFL---QLETGAF-NGLAN---LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 1224 GAIP 1227
P
Sbjct: 143 KIQP 146
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-04
Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 7/95 (7%)
Query: 548 SSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSS 607
+ L+ +P + Y+ D SLN ++ L+ L L + I ++
Sbjct: 18 INRGLHQ-VPELPAHVNYV---DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73
Query: 608 I-GGLKDLTYLALARNGFQGSIPEAI-GSLISLEK 640
GL L L L N F + L +LE
Sbjct: 74 TFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEV 107
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 14/233 (6%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNL--QLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG GSF +VYK + VA + F E E+L+ ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 808 SCSNHGFKA----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
S + L+ E M G+L+ +L K + I+ + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 864 PVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIV 922
P+IH DLK N+ + T + D G++ L S + + + T +MAPE E
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAV-IGTPEFMAPEMYEEK-Y 206
Query: 923 STCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
DVY+FG+ M+E T + P E ++ + +V E+
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 14/233 (6%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G G F +VYK A ++ + F E E+++ ++H N+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 1399 SCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
S + L+ + M G+L+ +L ++ I+ + L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 1455 SIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV 1513
IIH DLK N+ + +GD G+A L S + + + T +MAPE E
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAV-IGTPEFMAPEMYEEK-Y 206
Query: 1514 STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566
S DVY+FG+ M+E T P + + P + V +
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-38
Identities = 70/352 (19%), Positives = 127/352 (36%), Gaps = 30/352 (8%)
Query: 83 TCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRII 142
C S R +P + + L++ NR +E P L +
Sbjct: 8 EC-SAQDRAVLCH--RKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 143 DLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRI 202
+L+ N +S + N+L L + + SN++ S L +L +S N++ +
Sbjct: 62 ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-IL 119
Query: 203 PQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPS 260
+ +L L L + N+L F ++SL + L +L S+P + L
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHG 177
Query: 261 LQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEV 319
L L LR I L L + + N+
Sbjct: 178 LIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISH--------WPYLDTMTPNCLYGLNLTS 228
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
+ + +L+ +P +L L L L N +S + S + +L ++L + +
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287
Query: 380 VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
F L++LN++ +QL T L + F S+ N L L + +NP
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLTT--LEES--VFHSVGN---LETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 69/371 (18%), Positives = 121/371 (32%), Gaps = 49/371 (13%)
Query: 234 SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDN 293
+ R ++ ++P + + L+L + + L L L +N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 294 QLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLS 353
++ L N+ + L N L +P L NL +L + N +
Sbjct: 67 IVSAVEPGAFNNL--------FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV 117
Query: 354 GVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFS 413
++ + L LE+ N + F L+ L L L S+ S
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT--SIPTE--ALS 173
Query: 414 SLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIAL 473
L L L ++ I S F L + L
Sbjct: 174 HLHG---LIVLRLRHLNINAIRDYS-------------------------FKRLYRLKVL 205
Query: 474 SLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ-LESLNTLLLQGNALQNQI 532
+ T+ NL L +++ N+ ++P + L L L L N +
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIE 264
Query: 533 PTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI-GNLKVLT 591
+ L L L+ + L +L P F L Y+ V++ S N L+ L + + ++ L
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLE 323
Query: 592 GLYLSGNQLSC 602
L L N L+C
Sbjct: 324 TLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-34
Identities = 75/343 (21%), Positives = 125/343 (36%), Gaps = 42/343 (12%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
+P I + ++ L N + L + P+L L L N +S V P +
Sbjct: 21 KRFVA-VPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
N L L L N + F L L+++ +++ L F L N
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV--ILLDYM--FQDLYN--- 129
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE-FGNLSNIIALSLYQNQ 479
L+ L + N I + L+ SLE C L IP E +L +I L L
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLN-SLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLN 187
Query: 480 LASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTC-LAN 538
+ + + +L L+ L++S+ ++ +L +L + L +P + +
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRH 246
Query: 539 LTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGN 598
L LR LNLS N +++ S L L + L G
Sbjct: 247 LVYLRFLNLSYNPISTIEGSML------------------------HELLRLQEIQLVGG 282
Query: 599 QLSCSIPSSIGGLKDLTYLALARNGFQGSIPE-AIGSLISLEK 640
QL+ P + GL L L ++ N ++ E S+ +LE
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 46/255 (18%), Positives = 74/255 (29%), Gaps = 44/255 (17%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS---GNLFDDMCN 159
+ ++ +L L SL + N + L + L ++
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH--- 174
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNG 219
L L + I S +LK L +S + N L L +
Sbjct: 175 -LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233
Query: 220 NNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
NL ++P R L L+ LNL + I +
Sbjct: 234 CNLT-------------------------AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSM 267
Query: 280 -GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGIN 338
L + L QL GL + + V+ + GN L+ L S +
Sbjct: 268 LHELLRLQEIQLVGGQLAVVEPYAFRGL--------NYLRVLNVSGNQLT-TLEESVFHS 318
Query: 339 LPNLLRLYLWGNNLS 353
+ NL L L N L+
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-20
Identities = 51/237 (21%), Positives = 88/237 (37%), Gaps = 39/237 (16%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKF 1035
L +L IS NKI + +L L+ L + N+L L
Sbjct: 105 NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164
Query: 1036 TGRIPQN-LGNCTLLNFLILRQNQLTGVR--------------LASNKLIGRIPSMIFNN 1080
T IP L + L L LR + +R ++ + +
Sbjct: 165 T-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
N+ ++ + + + +P +L L+ L L N +S I S + ++ + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
+ + P F L++L++S N LTT S + S+ N L L+L +NPL
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLTTLE----ESVFHSVGN---LETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-18
Identities = 31/225 (13%), Positives = 68/225 (30%), Gaps = 37/225 (16%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKF 1035
L+ L + N++ L+ L +L + N + + +N
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 1036 TGRIPQN-LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHF 1093
I L L L + LT IP+ ++ + ++L +
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-----------SIPTEALSHLHGLIVLRLRHLNI 188
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNC 1153
+ + L L+ L + + + + L ++ + + +
Sbjct: 189 N-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL 247
Query: 1154 RQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLK 1198
L+ L+LS N ++T + L L+ + L L
Sbjct: 248 VYLRFLNLSYNPISTIEG-------SMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-17
Identities = 38/227 (16%), Positives = 84/227 (37%), Gaps = 31/227 (13%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-L 1043
+ L+ L ++ N ++ P NL LR L L N L+ IP
Sbjct: 51 EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL----------IPLGVF 100
Query: 1044 GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIG 1102
+ L L + +N++ + +F + N++++++ N ++
Sbjct: 101 TGLSNLTKLDISENKIV-----------ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 1103 PYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLS 1162
L +L+ L L NL+ I ++ + +I+L L + + +F +L++L++S
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 1163 LNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
+ + L L + + L ++ +L
Sbjct: 209 HWPYLDTMT-------PNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-15
Identities = 37/198 (18%), Positives = 69/198 (34%), Gaps = 31/198 (15%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCTLLNFLILRQNQLTGVRLASNKLIGR 1072
TE R L L N ++ + Q+ + L L L +N ++
Sbjct: 32 TETRLLDLGKNRIK----------TLNQDEFASFPHLEELELNENIVS-----------A 70
Query: 1073 IPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQ 1131
+ FNN N+ + L N +P + L NL L + N + ++ +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 1132 VILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLV 1191
+ L + +N + F L+ L L +LT+ + +L++ L L
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT-------EALSHLHGLIVLR 182
Query: 1192 LQNNPLKGALPNSIGNLS 1209
L++ + S L
Sbjct: 183 LRHLNINAIRDYSFKRLY 200
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-10
Identities = 36/185 (19%), Positives = 63/185 (34%), Gaps = 34/185 (18%)
Query: 990 NKLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEA---------------YLYNN 1033
N L++L++ +T +IP +L L L L N+ A + +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 1034 KFTGRIPQNLGNCTLLNFLILRQNQLTGVR--------------LASNKLIGRIPSMIFN 1079
+ + N L L + LT V L+ N I I + +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP-ISTIEGSMLH 269
Query: 1080 N-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLS 1138
++ IQL G + + L L+ L + GN L+ + S + + L L
Sbjct: 270 ELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328
Query: 1139 ENLFS 1143
N +
Sbjct: 329 SNPLA 333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-37
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKS--FDAECEVLRRVRHRNLVKIIS 807
+G G FG V+ T VAIK G + F E +V++++RH LV++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
S ++ EYM +GSL +L L + Q +D+ +AS + Y+ + +
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H DL+ +N+L+ ++ V ++DFG+++L++ + + + APE G +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 927 DVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFGIL+ E T+ ++P M E VE R+
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGYRM 400
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-32
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 7/206 (3%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G F V+ T+ T AIK + ++F E +VM+++RH L ++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
S ++ +YM +GSL +L L + Q +D+ +A + Y+ + +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL+ +N+L+ +++V + DFG+A+L++ + + I + APE G + DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 1520 YSFGILMMETLTR-RKPTDDMFTGEV 1544
+SFGIL+ E T+ R P M EV
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV 390
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-37
Identities = 91/501 (18%), Positives = 178/501 (35%), Gaps = 58/501 (11%)
Query: 118 LNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQ 177
LNIS N +++ + +LRI+ +S NRI L + ELE D+S N++
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK- 83
Query: 178 LPSSLGDCSKLKRLSVSFNELTGRIPQN--IGNLTELMELYLNGNNLQGEFPPTIFNVSS 235
+ LK L +SFN +P GN+++L L L+ +L+ I +++
Sbjct: 84 ISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 236 LRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQL 295
+V+++ + + L +L T + I + ++ L + +
Sbjct: 141 SKVLLVLGETYGEKEDPEG---LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 296 TDFGANNLTGLIPSIIFN---NSNIEVIQLYGNHLSGNLPSS--TGINLPNLLRLYLWGN 350
+N SI+ N + + L + N + + +
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 351 NLSGVIPSSICNAS-----KLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSL 405
L G + + S L++ ++ ++F + + + I N S +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317
Query: 406 SQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG--GGIPAE 463
S ++ +L N + + G+L+ LE +L I
Sbjct: 318 L----CPSKISP---FLHLDFSNNLLTDTVFENCGHLT-ELETLILQMNQLKELSKIAEM 369
Query: 464 FGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLL 522
+ ++ L + QN ++ ++L L++S N + +I L + L
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLD 427
Query: 523 LQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQ 582
L N ++ IP + L +L+ LN++SN+L S F
Sbjct: 428 LHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF---------------------- 464
Query: 583 DIGNLKVLTGLYLSGNQLSCS 603
L L ++L N CS
Sbjct: 465 --DRLTSLQKIWLHTNPWDCS 483
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-37
Identities = 98/511 (19%), Positives = 177/511 (34%), Gaps = 55/511 (10%)
Query: 141 IIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG 200
++D S N + ++ D+ T L ++S N I+ S + SKL+ L +S N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 201 RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPS 260
EL L L+ N L + C +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-------------------------KIS---CHPTVN 91
Query: 261 LQELNLRDCM-TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEV 319
L+ L+L I K+ GN + L +LGL L + L S +
Sbjct: 92 LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG--- 148
Query: 320 IQLYGNHLSGNLPSS-TGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
+ P N +L ++ ++ S+ + L + + L
Sbjct: 149 ----ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY--LRYLAIQTNPWKGILP 436
+ +LQ + + SF L + + Y +I +G L
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264
Query: 437 NSVGNLS----KSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQ 492
+ S K+L S G + SN+ + + K+
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQN--QIPTCLANLTSLRALNLSSN 550
LD S N + ++ L L TL+LQ N L+ +I + SL+ L++S N
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384
Query: 551 RLNSTIPS-TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIG 609
++ + +L ++ S N+L+ + + + + L L N++ SIP +
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV 441
Query: 610 GLKDLTYLALARNGFQGSIPE-AIGSLISLE 639
L+ L L +A N + S+P+ L SL+
Sbjct: 442 KLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 86/454 (18%), Positives = 142/454 (31%), Gaps = 63/454 (13%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
+ +LS L L IS NR + L +DLS N++ + +L
Sbjct: 35 ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLK 93
Query: 163 ELESFDVSSNQITG-QLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNN 221
L D+S N + G+ S+LK L +S L I +L L + G
Sbjct: 94 HL---DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 222 LQGEFPPTIFNVSSLRV--IVLANNSLFGSLPVDLCRRLPSLQELNLRD------CMTTG 273
+ P + IV N F + + + +L+ N++ C
Sbjct: 151 YGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210
Query: 274 RIPKDIGNCTLLNYLGLRDNQLTD-------------------FGANNLTGLIPSIIFNN 314
I + L+ L L + + T L G + F+
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY 270
Query: 315 SNIEVIQLYGNHLSGN----LPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLE 370
S + L + + + S N+ + V S L+
Sbjct: 271 SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330
Query: 371 LSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNP 430
S NL + V G+ +L+ L L +QL LS+ + + + L+ L I N
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLK--ELSKIAEMTTQMKS---LQQLDISQNS 385
Query: 431 WKGILPNSVGNLSKSLEYFYAGSCELGGG---------------------IPAEFGNLSN 469
+ +KSL S L IP + L
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEA 445
Query: 470 IIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNN 503
+ L++ NQL S +L +LQ + L N
Sbjct: 446 LQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-20
Identities = 57/343 (16%), Positives = 112/343 (32%), Gaps = 32/343 (9%)
Query: 20 LAILFMAKLMSITEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNW 79
L L + N + VK L+ N + + S +
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 80 VGVTCGS-RHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPR 138
++ + + T S + + + + +IS + G L +
Sbjct: 220 PKLSNLTLNNIETTWNSFIRI-------LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 139 LRIIDLSSNRISGNLF----DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS 194
+ LS +++ ++F + + + + + + S L S
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 195 FNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF---NVSSLRVIVLANNSLFGSLP 251
N LT + +N G+LTEL L L N L+ E + SL+ + ++ NS+
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 252 VDLCRRLPSLQELNLRDCMTTGRIPKDIGNC--TLLNYLGLRDNQLTDFGANNLTGLIPS 309
C SL LN+ + I C + L L N++ IP
Sbjct: 392 KGDCSWTKSLLSLNMSSN----ILTDTIFRCLPPRIKVLDLHSNKIKS---------IPK 438
Query: 310 IIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352
+ ++ + + N L ++P L +L +++L N
Sbjct: 439 QVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 39/208 (18%), Positives = 75/208 (36%), Gaps = 27/208 (12%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
+ + + +V+ ++ L NN T + +N G+ T L
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHL---------DFSNNLLTDTVFENCGHLTEL 350
Query: 1050 NFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
LIL+ NQL K + +I M +++ + + N S + +L
Sbjct: 351 ETLILQMNQL--------KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTG 1169
L + N L+ I + ++ +L L N + LQ L+++ N L +
Sbjct: 403 SLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVV-KLEALQELNVASNQLKSV 459
Query: 1170 SSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
+ LT+ L+++ L NP
Sbjct: 460 P----DGIFDRLTS---LQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 40/237 (16%), Positives = 76/237 (32%), Gaps = 16/237 (6%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
+ L +S K + L+ L +L + L N + T N +
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW-------NSFIR 239
Query: 1050 NFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH----LPSSIGPYL 1105
++ + +++ KL G++ F+ S L + S I
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
N+ + + S + L S NL + + G+ +L+ L L +N
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTEL 1222
L S T + + L++L + N + + + SL SS L
Sbjct: 360 LKELSKIAE--MTTQMKS---LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 46/242 (19%), Positives = 69/242 (28%), Gaps = 26/242 (10%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYNNKFTGR 1038
KL+ L IS N+I EL L L N L L N F
Sbjct: 46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFD-A 104
Query: 1039 IPQN--LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH 1096
+P GN + L FL L L + + ++ YG
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET------YGEKEDPE 158
Query: 1097 LPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQL 1156
+L + I+ S+ + + L + L +L
Sbjct: 159 GLQDF--NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216
Query: 1157 QILDLSLNHLTTGSSTQGHSFYTSLTNCRY--LRRLVLQNNPLKGALPNSIGNLS-TSLE 1213
Q N T +SF L + + + N L+G L + S TSL+
Sbjct: 217 QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK 276
Query: 1214 YF 1215
Sbjct: 277 AL 278
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 43/256 (16%), Positives = 83/256 (32%), Gaps = 28/256 (10%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCTLLN 1050
L+IS N I+ + +L++LR L + N ++ + + L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQY----------LDISVFKFNQELE 72
Query: 1051 FLILRQNQLTGV-----------RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLP 1098
+L L N+L + L+ N F N S ++ + L H
Sbjct: 73 YLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSV 132
Query: 1099 SSIGPYLPNLQGLILWGNNLSGIIPSSICN--ASQVILLGLSENLFSGLIPNTFGNCRQL 1156
I + L+L P + + + ++ + F ++ + L
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 1157 QILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL--STSLEY 1214
++ ++ L + S L L L L N I L T++ Y
Sbjct: 193 ELSNIKCV-LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 1215 FFASSTELRGAIPVEF 1230
F S+ +L+G +
Sbjct: 252 FSISNVKLQGQLDFRD 267
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 15/136 (11%)
Query: 1096 HLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ 1155
H+P + L + N +S + S I + S++ +L +S N L + F ++
Sbjct: 14 HVPKDLSQ---KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE 70
Query: 1156 LQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKG-ALPNSIGNLSTSLEY 1214
L+ LDLS N L S N L+ L L N + GN+ + L++
Sbjct: 71 LEYLDLSHNKLVKISC-------HPTVN---LKHLDLSFNAFDALPICKEFGNM-SQLKF 119
Query: 1215 FFASSTELRGAIPVEF 1230
S+T L + +
Sbjct: 120 LGLSTTHLEKSSVLPI 135
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-37
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKS--FDAECEVLRRVRHRNLVKIIS 807
+G G FG V+ T VAIK G + F E +V++++RH LV++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
S ++ EYM +GSL +L L + Q +D+ +AS + Y+ + +
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 385
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H DL+ +N+L+ ++ V ++DFG+++L++ + + + APE G +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 927 DVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFGIL+ E T+ ++P M E VE R+
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGYRM 483
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 7/206 (3%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G F V+ T+ T AIK + ++F E +VM+++RH L ++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
S ++ +YM +GSL +L L + Q +D+ +A + Y+ + +H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL+ +N+L+ +++V + DFG+A+L++ + + I + APE G + DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 1520 YSFGILMMETLTR-RKPTDDMFTGEV 1544
+SFGIL+ E T+ R P M EV
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREV 473
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 14/207 (6%)
Query: 752 IGAGSFGSVYKATL--PYG--MNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVK 804
+G GSFG V + P G ++VA+K L A+ F E + + HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
+ K ++ E P GSL L H+ + + VA + YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 141
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY--MAPEYGSEGIV 922
IH DL N+LL + + DFG+ + L D + APE
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 923 STCGDVYSFGILMIETFTR-KMPTDEM 948
S D + FG+ + E FT + P +
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 25/239 (10%)
Query: 1318 NTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATF----ADGTNAAIKIF---SLQ 1370
+ I ++LRL LG G F V + + + A+K L
Sbjct: 8 LQSLTCLIGEKDLRL-------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 1371 EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLN 1430
+ A+ F E M + HRNL ++ P K ++ + P GSL L H
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL 119
Query: 1431 IEQRLDIMIDVACALEYL-HQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489
+ + VA + YL + + IH DL N+LL + +GDFG+ + L D
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 1490 SMKQTMTLAT---IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
M + APE S + D + FG+ + E T ++P + ++
Sbjct: 176 D-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-36
Identities = 54/221 (24%), Positives = 106/221 (47%), Gaps = 13/221 (5%)
Query: 750 NLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKII 806
+ +G G +G VY+ Y + VA+K + + + F E V++ ++H NLV+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
C+ +I E+M G+L +L + ++ L + ++SA+EYL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC 925
IH +L N L+ ++ + ++DFG+S+L+ G+ + APE + S
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 926 GDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV++FG+L+ E T P + + + +E+ R+
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLEKDYRM 438
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVS 1398
+ LG G + VY+ + A+K +L+ED ++ F E VM+ I+H NL +++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
C+ +I ++M G+L +L N ++ L + ++ A+EYL + I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSG 1517
H +L N L+ ++ + + DFG+++L+ G I + APE + S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 1518 DVYSFGILMMETLTR-RKPTDDMFTGEV 1544
DV++FG+L+ E T P + +V
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQV 428
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 752 IGAGSFGSVYKATLP-----YGMNVAIKVFNLQ---LDGAIKSFDAECEVLRRVRHRNLV 803
+G G FG V G VA+K L+ I E E+LR + H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 804 KIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
K C+ G LI+E++P GSL+++L +K +N++Q+L + + ++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSE 919
+H DL NVL++ + + DFG++K ++ + + APE +
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 920 GIVSTCGDVYSFGILMIETFT 940
DV+SFG+ + E T
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 66/271 (24%), Positives = 117/271 (43%), Gaps = 25/271 (9%)
Query: 1343 LGTGIFSSVYKATFA-----DGTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLA 1394
LG G F V + G A+K SL+ + + E E++R + H N+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 1395 KIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
K C+ G LI++++P GSL+++L + +N++Q+L + + ++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATIGYMAPEYGSE 1510
S +H DL NVL++ + +GDFG+ K ++ + + + + APE +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 1511 GIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569
+ DV+SFG+ + E LT + M + + VT +++ L G
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM---TVTRLVNT-LKEG 259
Query: 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ + C V L KC E P R
Sbjct: 260 KR---LPCPPNCPDEVYQLMRKCWEFQPSNR 287
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 11/217 (5%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
IG+G FG V+ VAIK +GA+ + F E EV+ ++ H LV++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
L+ E+M G L +L + + + L + +DV + YL VIH D
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 129
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L+ ++ V +SDFG+++ + + + T T + +PE S S+ DV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 930 SFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
SFG+LM E F+ K+P + E + + RL
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSNSEV--VEDISTGFRL 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 9/205 (4%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G+G F V+ + + AIK +++E + + F E EVM ++ H L ++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYSTSIIHCD 1460
L+ ++M G L +L + L E L + +DV + YL IH D
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV----IHRD 129
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L N L+ ++ V + DFG+ + + T T + + +PE S S+ DV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEV 1544
SFG+LM E + + P ++ EV
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSNSEV 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 29/249 (11%)
Query: 729 ATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATL-----PYGMNVAIKVFNL-QLDG 782
A R + E +++ ++G+G+FG+VYK + VAIK
Sbjct: 7 ALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 783 AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQ 842
A K E V+ V + ++ +++ C + LI + MP G L ++ HK + Q
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 843 RLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902
L+ + +A + YL ++H DL NVL+ ++DFG++KLL E+
Sbjct: 119 LLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 903 TMTLATFG-----YMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMPTDEMFTGETSLK 956
G +MA E I + DV+S+G+ + E T P D + E +
Sbjct: 176 A----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS 229
Query: 957 KWVEESLRL 965
+E+ RL
Sbjct: 230 SILEKGERL 238
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-32
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 23/237 (9%)
Query: 1318 NTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNA-----AIKIFSLQED 1372
N A LR + E + +LG+G F +VYK + AIK L+E
Sbjct: 5 NQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREA 55
Query: 1373 ---RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLL 1429
+A K E VM + + ++ +++ C + LI Q MP G L ++ H +
Sbjct: 56 TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI 114
Query: 1430 NIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489
+ L+ + +A + YL ++H DL NVL+ + DFG+AKLL +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 1490 S-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
I +MA E I + DV+S+G+ + E +T KP D + E+
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 752 IGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G G+FGSV G VA+K + ++ F+ E E+L+ ++H N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 807 SSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
C + G + LI+EY+P GSL +L HK ++ + L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSEGIV 922
IH DL N+L++++ + DFG++K+L + + + APE +E
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 923 STCGDVYSFGILMIETFT 940
S DV+SFG+++ E FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 1343 LGTGIFSSVYKATF---ADGTNA--AIKIFSLQED--RALKSFDAECEVMRRIRHRNLAK 1395
LG G F SV + D T A+K LQ L+ F+ E E+++ ++H N+ K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 1396 IVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
C + G + LI++Y+P GSL +L H ++ + L + +EYL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 132
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATIGYMAPEYGSEG 1511
IH DL N+L++++ +GDFG+ K+L + + I + APE +E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 1512 IVSTSGDVYSFGILMMETLT 1531
S + DV+SFG+++ E T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 746 FSESNL-----IGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDGAIKSFDAECEVLR 795
F E +L +G G+FGSV G VA+K + ++ F+ E E+L+
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 796 RVRHRNLVKIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASA 853
++H N+VK C + G + LI+EY+P GSL +L HK ++ + L +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GY 911
+EYL IH DL N+L++++ + DFG++K+L + + +
Sbjct: 158 MEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 912 MAPEYGSEGIVSTCGDVYSFGILMIETFT 940
APE +E S DV+SFG+++ E FT
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 1337 FSESNL-----LGTGIFSSVYKATF-----ADGTNAAIKIFSLQED--RALKSFDAECEV 1384
F E +L LG G F SV + G A+K LQ L+ F+ E E+
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEI 95
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA 1442
++ ++H N+ K C + G + LI++Y+P GSL +L H ++ + L +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATI 1500
+EYL + IH DL N+L++++ +GDFG+ K+L + + I
Sbjct: 156 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 1501 GYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ APE +E S + DV+SFG+++ E T
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-36
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 746 FSESNL-----IGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDG--AIKSFDAECEV 793
F E +L +G G+FGSV G VA+K LQ G + F E ++
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQI 77
Query: 794 LRRVRHRNLVKIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
L+ + +VK G ++ L++EY+P G L +L H+ L+ + L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF-- 909
+EYL +H DL N+L++ + ++DFG++KLL +
Sbjct: 138 KGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+ APE S+ I S DV+SFG+++ E FT
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 1337 FSESNL-----LGTGIFSSVYKATF-----ADGTNAAIKIFSLQED--RALKSFDAECEV 1384
F E +L LG G F SV + G A+K LQ + F E ++
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQREIQI 77
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA 1442
++ + + K PG ++ L+++Y+P G L +L H L+ + L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATI 1500
+EYL S +H DL N+L++ + + DFG+AKLL + + + I
Sbjct: 138 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 1501 GYMAPEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPD-AV 1558
+ APE S+ I S DV+SFG+++ E T K + + A+
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPAL 250
Query: 1559 TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER 1600
+ +++ L G+ + A C + V L C P++R
Sbjct: 251 SRLLEL-LEEGQR---LPAPPACPAEVHELMKLCWAPSPQDR 288
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-35
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
+G G FG V +VAIK+ +G++ F E +V+ + H LV++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ +I EYM G L +L ++ QQ L++ DV A+EYL +H D
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRD 145
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L++D V +SDFG+S+ + ++ + + + PE S+ D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 930 SFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
+FG+LM E ++ KMP + ET + + + LRL
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSET--AEHIAQGLRL 240
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 9/205 (4%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LGTG F V + + AIK ++E + F E +VM + H L ++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYSTSIIHCD 1460
+I +YM G L +L + +Q L++ DV A+EYL + + +H D
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF----LHRD 145
Query: 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
L N L++D V + DFG+++ + + + + + PE S+ D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEV 1544
+FG+LM E + + P + E
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSET 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
++G G++G VY L + +AIK + + E + + ++H+N+V+ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL--DIMIDVASALEYLHHGHPTPVIH 867
S +GF + +E +P GSL L S L ++ + L+YLH ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 868 CDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE--YGSEGIVST 924
D+K NVL++ + V +SDFG SK L G + T+T T T YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204
Query: 925 CGDVYSFGILMIETFTRKMP 944
D++S G +IE T K P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
+LG G + VY AIK ++ R + E + + ++H+N+ + + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL--DIMIDVACALEYLHQGYSTSIIH 1458
S GF + ++ +P GSL L S L ++ + L+YLH I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 1459 CDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVST 1515
D+K NVL++ V + DFG +K L G++ +T T T+ YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204
Query: 1516 SGDVYSFGILMMETLTRRKP 1535
+ D++S G ++E T + P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 55/287 (19%), Positives = 102/287 (35%), Gaps = 24/287 (8%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
N + ++L + S +A + L+LS N S + A +L++LNL+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+ L SL+ LR L + N + S+E +A + +
Sbjct: 68 NVLY--ETLD----LESLST---LRTLDLNNN-----YVQELLVGP-SIETLHAANNNI- 111
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQG-SIPSELCQLE 516
+ + L N++ G +Q LDL N I + +
Sbjct: 112 SRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
+L L LQ N + + + L+ L+LSSN+L + + F S + + N L
Sbjct: 170 TLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL 226
Query: 577 SGCLPQDIGNLKVLTGLYLSGNQLSC-SIPSSIGGLKDLTYLALARN 622
+ + + + L L GN C ++ + + +A
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 48/293 (16%), Positives = 103/293 (35%), Gaps = 27/293 (9%)
Query: 111 NLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVS 170
N + ++ + L + ++ +DLS N +S + T+LE ++S
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLS 66
Query: 171 SNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTI 230
SN + L S L+ L ++ N + + + L+ NN+ +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 231 FNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD-CMTTGRIPKDIGNCTLLNYLG 289
+ I LANN + L +Q L+L+ + T + + L +L
Sbjct: 119 G--QGKKNIYLANNKI-TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 290 LRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWG 349
L+ N + D + + + ++ + L N L+ + + + + L
Sbjct: 176 LQYNFIYD---------VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRN 223
Query: 350 NNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLAT 402
N L +I ++ + L +L N F + ++ +A +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-31
Identities = 57/371 (15%), Positives = 114/371 (30%), Gaps = 82/371 (22%)
Query: 178 LPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLR 237
+ + ++ K V+ + L + + + EL L+GN L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-------------- 47
Query: 238 VIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTD 297
+ L+ LNL + D+ + + L L L +N + +
Sbjct: 48 -----------QISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQE 94
Query: 298 FGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIP 357
+ +IE + N++S + S +YL N ++ +
Sbjct: 95 -------------LLVGPSIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKITMLRD 137
Query: 358 SSICNASKLTVLELSRNLFSGL-VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLT 416
S++ L+L N + A + L+ LNL Y+ +
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD---------VKGQV 188
Query: 417 NCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLY 476
L+ L + +N L+ + EF + + + +SL
Sbjct: 189 VFAKLKTLDLSSN-----------KLAF---------------MGPEFQSAAGVTWISLR 222
Query: 477 QNQLASTIPTTVGKLQNLQGLDLSYNNIQ-GSIPSELCQLESLNTLLLQGNALQNQIPTC 535
N+L I + QNL+ DL N G++ + + + T+ Q
Sbjct: 223 NNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 536 LANLTSLRALN 546
+ +L
Sbjct: 282 ECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 41/285 (14%), Positives = 97/285 (34%), Gaps = 47/285 (16%)
Query: 356 IPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSL 415
I N ++ + +++ + +A+ + ++ L+L+ + L+ +S +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS--QISAAD--LAPF 57
Query: 416 TNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSL 475
T L L + +N L +LS + L L
Sbjct: 58 TK---LELLNLSSNVLYETLD---------------------------LESLSTLRTLDL 87
Query: 476 YQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTC 535
N + + +++ L + NNI + + + L N +
Sbjct: 88 NNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLD 139
Query: 536 LANLTSLRALNLSSNRLNS-TIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLY 594
+ ++ L+L N +++ S + + ++ N + + + L L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLD 197
Query: 595 LSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
LS N+L+ + +T+++L N I +A+ +LE
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 48/275 (17%), Positives = 100/275 (36%), Gaps = 33/275 (12%)
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNG 219
+ + V+ + + L S +K L +S N L+ ++ T+L L L+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 220 NNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
N L + ++S+LR + L NN + L PS++ L+ + + R+
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYV-QELL-----VGPSIETLHAANNNIS-RVSCSR 118
Query: 280 GNCTLLNYLGLRDNQLT----------------DFGANNLTGLIPSIIFNN-SNIEVIQL 322
G + L +N++T D N + + + + + +E + L
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 323 YGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVAN 382
N + ++ + L L L N L+ + +A+ +T + L N +
Sbjct: 177 QYNFIY-DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI-EK 231
Query: 383 TFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTN 417
+ L+ +L + G+L S +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 47/293 (16%), Positives = 98/293 (33%), Gaps = 26/293 (8%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
+ + + L++SGN +L +L +++LSSN + D+ + L+
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLES-LS 80
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNL 222
L + D+++N + L ++ L + N ++ R+ + +YL N +
Sbjct: 81 TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKI 132
Query: 223 QGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNC 282
S ++ + L N + +L +L+ LNL+ + +
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VF 190
Query: 283 TLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNL 342
L L L N+L + + + + I L N L + + NL
Sbjct: 191 AKLKTLDLSSNKLAF---------MGPEFQSAAGVTWISLRNNKLV-LIEKALR-FSQNL 239
Query: 343 LRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNL 395
L GN + V +++ L C + +
Sbjct: 240 EHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 38/183 (20%), Positives = 68/183 (37%), Gaps = 11/183 (6%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESL 518
I N + + + L + + N++ LDLS N + ++L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
L L N L + L +L++LR L+L++N + I + + N +S
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 579 CLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQG-SIPEAIGSLIS 637
+ G +YL+ N+++ G + YL L N + E S +
Sbjct: 114 -VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 638 LEK 640
LE
Sbjct: 171 LEH 173
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 40/256 (15%), Positives = 77/256 (30%), Gaps = 43/256 (16%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
N+ K ++ + + + + ++EL L GN L + +L T L
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL---------SQISAADLAPFTKL 60
Query: 1050 NFLILRQNQLTGV------------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHL 1097
L L N L L +N + + +IE + N+ S +
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RV 114
Query: 1098 PSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGL-IPNTFGNCRQL 1156
S + + L N ++ + S+V L L N + + L
Sbjct: 115 SCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 1157 QILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFF 1216
+ L+L N + L+ L L +N L + + + +
Sbjct: 172 EHLNLQYNFIYD---------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSA-AGVTWIS 220
Query: 1217 ASSTELRGAIPVEFEG 1232
+ +L I
Sbjct: 221 LRNNKLV-LIEKALRF 235
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 34/205 (16%), Positives = 66/205 (32%), Gaps = 10/205 (4%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTE 163
+ ++ ++ N+ + R++ +DL N I F ++ S
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223
LE ++ N I + + +KLK L +S N+L + + + + L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 224 GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIG-NC 282
+ +L L N D + +Q + + T ++ C
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ---TVKKLTGQNEEEC 283
Query: 283 TLLNYLGLRDNQLTDFGANNLTGLI 307
T+ D A LI
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLI 308
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 39/211 (18%), Positives = 71/211 (33%), Gaps = 31/211 (14%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYN 1032
DL + L+ L ++ N + + + LH NN+ YL N
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLAN 129
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
NK T + G + + +L L+ N++ V + ++ +E + L N
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF---------AELAASSDTLEHLNLQYNF 180
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
+ + L+ L L N L+ + +A+ V + L N I
Sbjct: 181 IY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRF 235
Query: 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTN 1183
+ L+ DL N G+ S +
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 42/251 (16%), Positives = 84/251 (33%), Gaps = 39/251 (15%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------YLYNNKF 1035
L KL+ L++S N + + +L+ LR L L+ N ++ + NN
Sbjct: 54 LAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111
Query: 1036 TGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFS 1094
+ R+ + G + L N++T + + S ++ + L N
Sbjct: 112 S-RVSCSRG--QGKKNIYLANNKIT-----------MLRDLDEGCRSRVQYLDLKLNEID 157
Query: 1095 GHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCR 1154
+ + L+ L L N + + + +++ L LS N + + F +
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIYDVKGQVVF--AKLKTLDLSSNKLAF-MGPEFQSAA 214
Query: 1155 QLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLK-GALPNSIGNLSTSLE 1213
+ + L N L +L + L L+ N G L +
Sbjct: 215 GVTWISLRNNKLVLIEK--------ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
Query: 1214 YFFASSTELRG 1224
+ +L G
Sbjct: 267 VAKQTVKKLTG 277
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 16/140 (11%)
Query: 1073 IPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132
I + N + + ++ + +S+ N++ L L GN LS I + + +++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVL 1192
LL LS N+ + + L+ LDL+ N++ L + L
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV------------QELLVGPSIETLHA 106
Query: 1193 QNNPLKGALPNSIGNLSTSL 1212
NN + + S G ++
Sbjct: 107 ANNNIS-RVSCSRGQGKKNI 125
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 28/190 (14%), Positives = 55/190 (28%), Gaps = 33/190 (17%)
Query: 991 KLKRLSISVNKITG-TIPRTVGNLTELRELHLHGNNLEA-------------YLYNNKFT 1036
+++ L + +N+I + L L+L N + L +NK
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA 204
Query: 1037 GRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH 1096
+ + + ++ LR N+L I + + N+E L GN F
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-----------LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 1097 LPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQL 1156
+Q + C + G +P F
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG---AYCCEDLPAPFA----D 305
Query: 1157 QILDLSLNHL 1166
+++ L +H
Sbjct: 306 RLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 10/93 (10%)
Query: 1122 IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSL 1181
I N ++ + ++++ + + + ++ LDLS N L+ S+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA-------ADL 54
Query: 1182 TNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
L L L +N L + +L ++L
Sbjct: 55 APFTKLELLNLSSNVLYE--TLDLESL-STLRT 84
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 13/221 (5%)
Query: 752 IGAGSFGSVYKATLPYG---MNVAIKVF-NLQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
+G G+FGSV + ++VAIKV + E +++ ++ + +V++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
C L++E G L K+L + + + +++ V+ ++YL + +H
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 133
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSEGIVSTC 925
DL NVLL + A +SDFG+SK L +DS + + + APE + S+
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 926 GDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+S+G+ M E + + P +M E ++E+ R+
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIEQGKRM 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 1343 LGTGIFSSVYKATFADGTNA---AIKIFSLQEDRALKS---FDAECEVMRRIRHRNLAKI 1396
LG G F SV + + AIK L++ E ++M ++ + + ++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYSTS 1455
+ C L+++ G L K+L + + +++ V+ ++YL + +
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATIGYMAPEYGSEGIV 1513
+H DL NVLL + A + DFG++K L DS ++ + + APE +
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 1514 STSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
S+ DV+S+G+ M E L+ +KP M EV
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
+G+G FG V +VA+K+ +G++ F E + + ++ H LVK C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
S ++ EY+ G L +L SH L Q L++ DV + +L IH D
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRD 129
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVY 929
L N L+D D +SDFG+++ + + V+ T + APE S+ DV+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 930 SFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
+FGILM E F+ KMP D E V + RL
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEV--VLKVSQGHRL 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKI--VSS 1399
LG+G F V + + A+K ++E + F E + M ++ H L K V S
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVK--MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYSTSIIH 1458
P + ++ +Y+ G L +L SH L Q L++ DV + +L + IH
Sbjct: 74 KEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF----IH 127
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
DL N L+D D+ + DFG+ + + + T + + APE S+ D
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 1519 VYSFGILMMETLTR-RKPTDDMFTGEV 1544
V++FGILM E + + P D EV
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTNSEV 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-35
Identities = 58/220 (26%), Positives = 111/220 (50%), Gaps = 13/220 (5%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIIS 807
+GAG FG V+ AT VA+K G++ ++F AE V++ ++H LVK+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+ +I E+M +GSL +L S + + + + +D +A + ++ + I
Sbjct: 251 VVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H DL+ +N+L+ V ++DFG++++++ + + + APE + G +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 927 DVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFGIL++E T ++P M E + +E R+
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEV--IRALERGYRM 404
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 7/206 (3%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G F V+ AT+ T A+K ++++F AE VM+ ++H L K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNY-LLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ +I ++M +GSL +L S + + +D +A + ++ + IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL+ +N+L+ +V + DFG+A++++ + + I + APE + G + DV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 1520 YSFGILMMETLTR-RKPTDDMFTGEV 1544
+SFGIL+ME +T R P M EV
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEV 394
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 12/220 (5%)
Query: 752 IGAGSFGSVYKATLPYGMN----VAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKII 806
IG G FG V++ N VAIK D + F E +R+ H ++VK+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+ + +I+E G L +L KY+L++ + +++AL YL +
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H D+ NVL+ + L DFG+S+ ++ + +MAPE + ++
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 198
Query: 927 DVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+ FG+ M E P + + + +E RL
Sbjct: 199 DVWMFGVCMWEILMHGVKPFQGV-KNNDVIGR-IENGERL 236
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 1343 LGTGIFSSVYKATFADGTNA----AIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAK 1395
+G G F V++ + N AIK + + D + F E MR+ H ++ K
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 1396 IVSSCS-NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYS 1453
++ + NP + +I++ G L +L Y L++ + ++ AL YL + +
Sbjct: 81 LIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF- 137
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV 1513
+H D+ NVL+ + LGDFG+++ ++ K + I +MAPE +
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 1514 STSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+++ DV+ FG+ M E L KP + +V
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAI--KSFDAECEVLRRVRHRNLVKIISSC 809
+GAG FG V+ VA+K G++ +F AE ++++++H+ LV++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
+ +I EYM GSL +L + L I + LD+ +A + ++ + IH
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDV 928
DL+ +N+L+ D ++DFG+++L++ + + + APE + G + DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 929 YSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
+SFGIL+ E T ++P M E + +E R+
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV--IQNLERGYRM 229
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKS-FDAECEVMRRIRHRNLAKIVSSCS 1401
LG G F V+ + T A+K SL++ F AE +M++++H+ L ++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 1402 -NPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
P + +I +YM GSL +L + + L I + LD+ +A + ++ + IH
Sbjct: 79 QEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL+ +N+L+ D + + DFG+A+L++ + + I + APE + G + DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 1520 YSFGILMMETLTR-RKPTDDMFTGEV 1544
+SFGIL+ E +T R P M EV
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 12/220 (5%)
Query: 752 IGAGSFGSVYKATL----PYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G G FG VY+ +NVA+K + F +E +++ + H ++VK+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+I+E P G L +L +K +L + + + + A+ YL + +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H D+ N+L+ L DFG+S+ ++ ED ++T +M+PE + +T
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTAS 195
Query: 927 DVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+ F + M E + K P + + + +E+ RL
Sbjct: 196 DVWMFAVCMWEILSFGKQPFFWL-ENKDVIGV-LEKGDRL 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 49/212 (23%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 1343 LGTGIFSSVYKATF----ADGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAK 1395
LG G F VY+ + + N A+K + ++ + F +E +M+ + H ++ K
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 1396 IVSSCS-NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYS 1453
++ P + +I++ P G L +L + L + + + + A+ YL
Sbjct: 78 LIGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 134
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV 1513
+H D+ N+L+ LGDFG+++ ++ D K ++T I +M+PE +
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 1514 STSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+T+ DV+ F + M E L+ ++P + +V
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-34
Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 752 IGAGSFGSVYKATLPYG---MNVAIKVF-NLQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
+G G+FGSV + ++VAIKV + E +++ ++ + +V++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
C L++E G L K+L + + + +++ V+ ++YL + +H
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 459
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY--MAPEYGSEGIVSTC 925
+L NVLL + A +SDFG+SK L +DS + + APE + S+
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 926 GDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+S+G+ M E + + P +M E ++E+ R+
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIEQGKRM 558
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-29
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 1343 LGTGIFSSVYKATFADGTNA---AIKIFSLQEDRALKS---FDAECEVMRRIRHRNLAKI 1396
LG G F SV + + AIK L++ E ++M ++ + + ++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYSTS 1455
+ C L+++ G L K+L + + +++ V+ ++YL + +
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATIGYMAPEYGSEGIV 1513
+H +L NVLL + A + DFG++K L DS ++ + + APE +
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 1514 STSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
S+ DV+S+G+ M E L+ +KP M EV
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 29/249 (11%)
Query: 729 ATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATL-----PYGMNVAIKVFNL-QLDG 782
A R + E +++ ++G+G+FG+VYK + VAIK
Sbjct: 7 ALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 783 AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQ 842
A K E V+ V + ++ +++ C + LI + MP G L ++ HK + Q
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 843 RLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902
L+ + +A + YL ++H DL NVL+ ++DFG++KLL E+
Sbjct: 119 LLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 903 TMTLATFG-----YMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMPTDEMFTGETSLK 956
G +MA E I + DV+S+G+ + E T P D + E +
Sbjct: 176 A----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS 229
Query: 957 KWVEESLRL 965
+E+ RL
Sbjct: 230 SILEKGERL 238
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 23/237 (9%)
Query: 1318 NTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNA-----AIKIFSLQED 1372
N A LR + E + +LG+G F +VYK + AIK L+E
Sbjct: 5 NQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREA 55
Query: 1373 ---RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLL 1429
+A K E VM + + ++ +++ C + LI Q MP G L ++ H +
Sbjct: 56 TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI 114
Query: 1430 NIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489
+ L+ + +A + YL ++H DL NVL+ + DFG+AKLL +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 1490 SMKQTMTLAT-IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
I +MA E I + DV+S+G+ + E +T KP D + E+
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 16/223 (7%)
Query: 752 IGAGSFGSVYKATL-PYGMN----VAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKI 805
+G+G FG+V+K P G + V IKV + + ++ + + H ++V++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ C + L+ +Y+P GSL + H+ L Q L+ + +A + YL +
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---M 136
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSEGIVS 923
+H +L NVLL + ++DFG++ LL +D + A +MA E G +
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-SEAKTPIKWMALESIHFGKYT 195
Query: 924 TCGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+S+G+ + E T P + E + +E+ RL
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERL 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 1343 LGTGIFSSVYKATFADG-----TNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLA 1394
LG+G+F +V+K + IK+ +++ ++ ++ + + H ++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
+++ C + L+ QY+P GSL + H L + L+ + +A + YL
Sbjct: 79 RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIV 1513
++H +L NVLL + DFG+A LL D + + I +MA E G
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 1514 STSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+ DV+S+G+ + E +T +P + EV
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-34
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 13/222 (5%)
Query: 752 IGAGSFGSVYKATLPYGMN----VAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKII 806
IG+G G V L VAIK + + F +E ++ + H N++++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+ ++ EYM GSL+ +L +H I Q + ++ V + + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY--MAPEYGSEGIVST 924
H DL NVL+D + V +SDFG+S++L+ + T T APE + S+
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFG++M E + P M + VEE RL
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMTNRDV--ISSVEEGYRL 273
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 31/265 (11%)
Query: 1296 LIIILLRRRKRDKSRPTENNLLNTAAL---RRISYQELRLATNGFSESNLLGTGIFSSVY 1352
L + + P A R I + + ++G+G V
Sbjct: 14 LYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHI-------EKIIGSGDSGEVC 66
Query: 1353 KATFADGTNA----AIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKI--VSSCSNP 1403
AIK +L+ +R + F +E +M + H N+ ++ V +
Sbjct: 67 YGRLRVPGQRDVPVAIK--ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124
Query: 1404 GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYSTSIIHCDLK 1462
++ +YM GSL+ +L +H+ I Q + ++ V + YL GY +H DL
Sbjct: 125 AM--IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLA 178
Query: 1463 PSNVLLDDDMVAHLGDFGIAKLL--DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVY 1520
NVL+D ++V + DFG++++L D + T I + APE + S++ DV+
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVW 238
Query: 1521 SFGILMMETLTR-RKPTDDMFTGEV 1544
SFG++M E L +P +M +V
Sbjct: 239 SFGVVMWEVLAYGERPYWNMTNRDV 263
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 58/222 (26%), Positives = 108/222 (48%), Gaps = 15/222 (6%)
Query: 752 IGAGSFGSVYKATLP---YGMNVAIKVF--NLQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G+G+FG+V K VA+K+ AE V++++ + +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
C + L++E G L K+L +++ + + ++++ V+ ++YL + +
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN---FV 139
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSEGIVST 924
H DL NVLL A +SDFG+SK L +++ + T + + APE + S+
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+SFG+LM E F+ + P M E + +E+ R+
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--AMLEKGERM 239
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 1343 LGTGIFSSVYKATF---ADGTNAAIKIFSLQED----RALKSFDAECEVMRRIRHRNLAK 1395
LG+G F +V K + A+K L+ + AE VM+++ + + +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVK--ILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGYST 1454
++ C + L+++ G L K+L + ++ + ++++ V+ ++YL +
Sbjct: 83 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNF-- 138
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATIGYMAPEYGSEGI 1512
+H DL NVLL A + DFG++K L ++ QT + + APE +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 1513 VSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
S+ DV+SFG+LM E + +KP M EV
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKII 806
L+G G G VY+A VA+K+ + L E R++ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
G + + + L L L + + I+ + SAL+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---AT 156
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYMAPEYGSEGIVSTC 925
H D+KP N+L+ D A+L DFGI+ ++ +TQ T+ T YMAPE SE +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 926 GDVYSFGILMIETFTRKMPTDEMFTGET 953
D+Y+ ++ E T P + G+
Sbjct: 216 ADIYALTCVLYECLTGSPP----YQGDQ 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 59/240 (24%), Positives = 95/240 (39%), Gaps = 30/240 (12%)
Query: 1342 LLGTGIFSSVYKATFAD---GTNAAIKI--FSLQEDRALKS-FDAECEVMRRIRHRNLAK 1395
L+G G VY+A D A+K+ +L D ++ E R++ ++
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
I G + ++ + L L L + + I+ + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHA---AG 154
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT-MTLATIGYMAPEYGSEGIVS 1514
H D+KP N+L+ D A+L DFGIA + Q T+ T+ YMAPE SE +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFTGE---VCLKHWVEE---------SLPDAVTDVI 1562
D+Y+ ++ E LT P + G+ V H + +P A VI
Sbjct: 214 YRADIYALTCVLYECLTGSPP----YQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 13/217 (5%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATLPYGMN----VAIKVFN-LQLDGAIKSFDAECE 792
+ +IG G FG VY AIK + + +++F E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 793 VLRRVRHRNLVKIISSCS-NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
++R + H N++ +I G ++L YM G L +++ S + ++ + + VA
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATF- 909
+EYL +H DL N +LD+ ++DFG+++ + + Q A
Sbjct: 135 RGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 910 -GYMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
+ A E +T DV+SFG+L+ E TR P
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 17/218 (7%)
Query: 1339 ESNLLGTGIFSSVYKATFADGTNA----AIKIFSLQE---DRALKSFDAECEVMRRIRHR 1391
++G G F VY + D AIK SL + +++F E +MR + H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 1392 NLAKIVSSCSNP-GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
N+ ++ P G ++L YM G L +++ S ++ + + VA +EYL
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA- 141
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD---SMKQTMTLATIGYMAPEY 1507
+H DL N +LD+ + DFG+A+ + + + + + A E
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 1508 GSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+T DV+SFG+L+ E LTR P + ++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-33
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 12/220 (5%)
Query: 752 IGAGSFGSVYKATLPYGMN----VAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKII 806
IG G FG V++ N VAIK D + F E +R+ H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+ + +I+E G L +L K++L++ + +++AL YL +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 513
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H D+ NVL+ + L DFG+S+ ++ + +MAPE + ++
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 927 DVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+ FG+ M E P + + + +E RL
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGV-KNNDVIGR-IENGERL 611
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-29
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 1343 LGTGIFSSVYKATFADGTNA----AIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAK 1395
+G G F V++ + N AIK + D + F E MR+ H ++ K
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 1396 IVSSCS-NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
++ + NP + +I++ G L +L + L++ + ++ AL YL S
Sbjct: 456 LIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SK 510
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
+H D+ NVL+ + LGDFG+++ ++ K + I +MAPE + +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 1515 TSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
++ DV+ FG+ M E L KP + +V
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 750 NLIGAGSFGSVYKATLPYG----MNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVK 804
+IG G FG VY TL ++ A+K N G + F E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 805 IISSCSNHGFKAL-ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
++ C L +L YM G L ++ + + ++ + + VA ++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-- 148
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG-----YMAPEYGS 918
+H DL N +LD+ ++DFG+++ + ++ + T +MA E
Sbjct: 149 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK--TGAKLPVKWMALESLQ 205
Query: 919 EGIVSTCGDVYSFGILMIETFTR-KMP 944
+T DV+SFG+L+ E TR P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 1341 NLLGTGIFSSVYKATFADGTNA----AIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
++G G F VY T D A+K SL + F E +M+ H N+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 1394 AKIVSSCSNPGFKAL-ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
++ C L +L YM G L ++ + + ++ + + VA ++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--- 145
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT---IGYMAPEYGS 1509
S +H DL N +LD+ + DFG+A+ + + + +MA E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 1510 EGIVSTSGDVYSFGILMMETLTR 1532
+T DV+SFG+L+ E +TR
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTR 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 752 IGAGSFGSVYKATL-----PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKI 805
IGAG FG VYK L + VAIK + F E ++ + H N++++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
S + +I EYM G+L+K+L ++ Q + ++ +A+ ++YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY--MAPEYGSEGIVS 923
+H DL N+L++ + V +SDFG+S++L+ + T T + APE S +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 924 TCGDVYSFGILMIETFTR-KMPTDEM 948
+ DV+SFGI+M E T + P E+
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 1343 LGTGIFSSVYKATFADGTNA-----AIKIFSLQE---DRALKSFDAECEVMRRIRHRNLA 1394
+G G F VYK + AIK +L+ ++ F E +M + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIK--TLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 1395 KI--VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQG 1451
++ V S P +I +YM G+L+K+L + ++ Q + ++ +A ++YL +
Sbjct: 110 RLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL-DGVDSMKQTM-TLATIGYMAPEYGS 1509
Y +H DL N+L++ ++V + DFG++++L D ++ T I + APE S
Sbjct: 168 Y----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 1510 EGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+++ DV+SFGI+M E +T +P ++ EV
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKII 806
+G G +VY A + VAIK + + +K F+ E ++ H+N+V +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
L++EY+ +L +++ SH L++ ++ + +++ H ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYMAPEYGSEGIVSTC 925
H D+KP N+L+D + + DFGI+K L E S+TQT L T Y +PE C
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 926 GDVYSFGILMIETFTRKMPTDEMFTGETSL 955
D+YS GI++ E + P F GET++
Sbjct: 193 TDIYSIGIVLYEMLVGEPP----FNGETAV 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 1342 LLGTGIFSSVYKATFAD---GTNAAIKI--FSLQEDRA-LKSFDAECEVMRRIRHRNLAK 1395
LG G S+VY A D AIK +E LK F+ E ++ H+N+
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
++ L+++Y+ +L +++ SH L+++ ++ + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT-MTLATIGYMAPEYGSEGIVS 1514
I+H D+KP N+L+D + + DFGIAK L S+ QT L T+ Y +PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFTGE----VCLKHWVEESLPDAVTDV 1561
D+YS GI++ E L P F GE + +KH +++S+P+ TDV
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDV 236
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 13/222 (5%)
Query: 752 IGAGSFGSVYKATLPYG----MNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKII 806
+GAG FG V L ++VAIK + + + F E ++ + H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+ ++ EYM GSL+ +L H + Q + ++ +AS ++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY--MAPEYGSEGIVST 924
H DL N+L++ + V +SDFG+ ++L+ + T +PE + ++
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 925 CGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
DV+S+GI++ E + + P EM + +K V+E RL
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKA-VDEGYRL 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 52/215 (24%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 1343 LGTGIFSSVYKATFADGTNA----AIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAK 1395
+G G F V + AIK +L+ ++ + F E +M + H N+ +
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIK--TLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 1396 I--VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-HQGY 1452
+ V + S P ++ +YM GSL+ +L H+ + Q + ++ +A ++YL GY
Sbjct: 111 LEGVVTKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL--DGVDSMKQTMTLATIGYMAPEYGSE 1510
+H DL N+L++ ++V + DFG+ ++L D + I + +PE +
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 1511 GIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+++ DV+S+GI++ E ++ +P +M +V
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-33
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS- 810
IG G FG V G VA+K ++ D ++F AE V+ ++RH NLV+++
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 811 NHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
G ++ EYM +GSL +L S + L L +DV A+EYL + +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY--MAPEYGSEGIVSTCGD 927
L NVL+ +D VA +SDFG++K + APE E ST D
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALREKKFSTKSD 368
Query: 928 VYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
V+SFGIL+ E ++ ++P + + VE+ ++
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGYKM 405
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-30
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI--VSSC 1400
+G G F V + G A+K ++ D ++F AE VM ++RH NL ++ V
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
G ++ +YM +GSL +L S +L + L +DV A+EYL + +H
Sbjct: 258 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL NVL+ +D VA + DFG+ K + + + APE E ST DV
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEALREKKFSTKSDV 369
Query: 1520 YSFGILMMETLTR-RKPTDDMFTGEV 1544
+SFGIL+ E + R P + +V
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKDV 395
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 752 IGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGA--IKSFDAECEVLRRVRHRNLVKIISS 808
+G G +G VY+ Y + VA+K + ++ F E V++ ++H NLV+++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
C+ +I E+M G+L +L + ++ L + ++SA+EYL + IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
DL N L+ ++ + ++DFG+S+L+ G+ + APE + S D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 928 VYSFGILMIETFTR-KMP 944
V++FG+L+ E T P
Sbjct: 195 VWAFGVLLWEIATYGMSP 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G + VY+ + A+K +L+ED ++ F E VM+ I+H NL +++ C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ +I ++M G+L +L N ++ L + ++ A+EYL + IH
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL N L+ ++ + + DFG+++L+ G I + APE + S DV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 1520 YSFGILMMETLTR-RKPTDDMFTGEV 1544
++FG+L+ E T P + +V
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQV 221
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-33
Identities = 74/455 (16%), Positives = 139/455 (30%), Gaps = 76/455 (16%)
Query: 110 ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDV 169
N + V+ T + L +D ++ I+ + LT L
Sbjct: 18 DNFASEVAAAFEMQ---ATDTISEEQLATLTSLDCHNSSITD--MTGIEK-LTGLTKLIC 71
Query: 170 SSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPT 229
+SN IT L L + L L+ N+LT ++ LT+L L + N L
Sbjct: 72 TSNNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLD 122
Query: 230 IFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLG 289
+ L + A N+L + V L EL+ D+ T L L
Sbjct: 123 VSQNPLLTYLNCARNTL-TEIDV---SHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLD 176
Query: 290 LRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWG 349
N++T+ + N + + N+++ L + L L
Sbjct: 177 CSFNKITEL-----------DVSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSS 221
Query: 350 NNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQ 409
N L+ + + ++LT + S N + L +L L+ + L L+
Sbjct: 222 NKLTEI---DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLLEIDLTHNT 275
Query: 410 SFFS-SLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLS 468
CR ++ L + N L + + +
Sbjct: 276 QLIYFQAEGCRKIKELDVTHNT--------------QLYLLDCQAAGI---TELDLSQNP 318
Query: 469 NIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNAL 528
++ L L +L + + V L+ L +IQ + ++ +LN
Sbjct: 319 KLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEG-- 371
Query: 529 QNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSL 563
++ L++N L +
Sbjct: 372 ---------QTITMPKETLTNNSLTIAVSPDLLDQ 397
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 69/425 (16%), Positives = 139/425 (32%), Gaps = 59/425 (13%)
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223
S ++ ++ S + L L + +T + I LT L +L NN+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNIT 77
Query: 224 GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCT 283
+ ++L + +N L +L V L L LN T D+
Sbjct: 78 T---LDLSQNTNLTYLACDSNKL-TNLDVT---PLTKLTYLNCDTNKLT---KLDVSQNP 127
Query: 284 LLNYLGLRDNQLTDFGANNLTGLI-----------PSIIFNNSNIEVIQLYGNHLSGNLP 332
LL YL N LT+ ++ T L + + + + N ++ L
Sbjct: 128 LLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD 186
Query: 333 SSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392
S L RL NN++ + + +LT L+ S N + + QL
Sbjct: 187 VS---QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTY 237
Query: 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAG 452
+ + + L ++ L L +L + + ++ L YF A
Sbjct: 238 FDCSVNPLTE----------LDVSTLSKLTTLHCIQTD---LLEIDLTHNTQ-LIYFQAE 283
Query: 453 SCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL 512
C + + + + + L + + + + + L L L+ + + +
Sbjct: 284 GCRKIKEL--DVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD--V 335
Query: 513 CQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFS 572
L +L +Q+ + + +L + + + T + L + S
Sbjct: 336 SHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNS--LTIAVS 391
Query: 573 LNLLS 577
+LL
Sbjct: 392 PDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 66/453 (14%), Positives = 129/453 (28%), Gaps = 84/453 (18%)
Query: 186 SKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNS 245
+ E+ + L L L + +++ I ++ L ++ +N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75
Query: 246 LFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTG 305
+ +L + + +L L T D+ T L YL N+LT +
Sbjct: 76 I-TTLDL---SQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDVSQNPL 128
Query: 306 LIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASK 365
L + N L+ + S + L L N + + ++
Sbjct: 129 L-----------TYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQ 171
Query: 366 LTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLA 425
LT L+ S N + L + L LN + + L+ L +L
Sbjct: 172 LTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKLDLN----------QNIQLTFLD 218
Query: 426 IQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIP 485
+N I + L+ + N L + +
Sbjct: 219 CSSNKLTEI----------------------------DVTPLTQLTYFDCSVNPL-TELD 249
Query: 486 TTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRAL 545
V L L L ++ + QL + + + T L L
Sbjct: 250 --VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA-----EGCRKIKELDVTHNTQLYLL 302
Query: 546 NLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIP 605
+ + + S L Y+ + L+ D+ + L L +
Sbjct: 303 DCQAAGITELDLSQNPKLVYL---YLNNTELTE---LDVSHNTKLKSLSCVNAHIQ-DFS 355
Query: 606 SSIGGLKDLTYLALARNGFQGSIPEAIGSLISL 638
S+G + L A ++P+ + SL
Sbjct: 356 -SVGKIPALNNNFEAEGQTI-TMPKETLTNNSL 386
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 64/394 (16%), Positives = 111/394 (28%), Gaps = 58/394 (14%)
Query: 259 PSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIE 318
+ L L ++ +TD + I + +
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM----------TGIEKLTGLT 67
Query: 319 VIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
+ N+++ L S NL L N L+ + + +KLT L N +
Sbjct: 68 KLICTSNNIT-TLDLS---QNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTK 120
Query: 379 LVANTFGNCRQLQILNLAYSQLATGSLSQ------------GQSFFSSLTNCRYLRYLAI 426
L L LN A + L +S + +T L L
Sbjct: 121 L---DVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDC 177
Query: 427 QTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPT 486
N + V K L + + + + L N+L + I
Sbjct: 178 SFNKITEL---DVSQN-KLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKL-TEID- 228
Query: 487 TVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALN 546
V L L D S N + + + L L TL L I L + T L
Sbjct: 229 -VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQ 281
Query: 547 LSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPS 606
R + + ++D ++ D+ L LYL+ +L+ +
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD- 334
Query: 607 SIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
+ L L+ Q +G + +L
Sbjct: 335 -VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNN 365
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-21
Identities = 65/337 (19%), Positives = 109/337 (32%), Gaps = 44/337 (13%)
Query: 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFD 168
V+ L LN + N + + +L +D N+ L LT L D
Sbjct: 123 VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTL---D 176
Query: 169 VSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPP 228
S N+IT + L RL+ N +T ++ + +L L + N L E
Sbjct: 177 CSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID- 228
Query: 229 TIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYL 288
+ ++ L + N L L V L L L+ D+ + T L Y
Sbjct: 229 -VTPLTQLTYFDCSVNPL-TELDVST---LSKLTTLHCIQTDLLE---IDLTHNTQLIYF 280
Query: 289 GLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLW 348
+ + +N+ + ++ ++ L S P L+ LYL
Sbjct: 281 QA----------EGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLS---QNPKLVYLYLN 326
Query: 349 GNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQG 408
L+ + + + +KL L ++ G L A Q T
Sbjct: 327 NTELTEL---DVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETL 381
Query: 409 QSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKS 445
+ +SLT L NP I P G ++
Sbjct: 382 TN--NSLTIAVSPDLLDQFGNP-MNIEPGDGGVYDQA 415
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-19
Identities = 54/304 (17%), Positives = 106/304 (34%), Gaps = 45/304 (14%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG-NLFDDMCNSLT 162
V + L +L+ S N+ L + L ++ +N I+ +L N
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKLDL-----NQNI 212
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNL 222
+L D SSN++T ++ + ++L S N LT ++ L++L L+ +L
Sbjct: 213 QLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDL 266
Query: 223 QGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNC 282
E + + + L L V L L+ + T D+
Sbjct: 267 L-EID--LTHNTQLIYFQAEGCRKIKELDV---THNTQLYLLDCQAAGIT---ELDLSQN 317
Query: 283 TLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNL 342
L YL L + +LT+ ++ T ++ + H+ + S +P L
Sbjct: 318 PKLVYLYLNNTELTELDVSHNT-----------KLKSLSCVNAHIQ-DFSSVG--KIPAL 363
Query: 343 LRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLAT 402
+ +P + LT+ L + FGN ++ + AT
Sbjct: 364 NNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLL------DQFGNPMNIEPGDGGVYDQAT 416
Query: 403 GSLS 406
+++
Sbjct: 417 NTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-12
Identities = 42/250 (16%), Positives = 70/250 (28%), Gaps = 53/250 (21%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYN 1032
D+ + +L L +NK + V T+L L N +
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDT 200
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
N T ++ L L FL N+LT + + + + N
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKLTEIDVT-------------PLTQLTYFDCSVNP 244
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
+ L S L L L +L I + L+ + +
Sbjct: 245 LT-ELDVST---LSKLTTLHCIQTDLLEIDLTHNTQ-----LIYFQAEGCRKIKELDVTH 295
Query: 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSL 1212
QL +LD +T L+ L L L N L L + + T L
Sbjct: 296 NTQLYLLDCQAAGITE----------LDLSQNPKLVYLYLNNTELT-ELD--VSHN-TKL 341
Query: 1213 EYFFASSTEL 1222
+ + +
Sbjct: 342 KSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-11
Identities = 34/240 (14%), Positives = 69/240 (28%), Gaps = 49/240 (20%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYN 1032
D+ + L RL+ N IT + + +L L N L
Sbjct: 186 DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSV 242
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNH 1092
N T ++ + L L Q L + L +N+ + Q G
Sbjct: 243 NPLT---ELDVSTLSKLTTLHCIQTDLLEIDLT-------------HNTQLIYFQAEGCR 286
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
L + + L L ++ + + +++ L L+ + L +
Sbjct: 287 KIKELDVT---HNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELTEL---DVSH 337
Query: 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSL 1212
+L+ L H+ ++S+ L ++ N S ++
Sbjct: 338 NTKLKSLSCVNAHIQD---------FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-11
Identities = 45/238 (18%), Positives = 72/238 (30%), Gaps = 50/238 (21%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLG 1044
L L + IT + LT L +L NN+ +L
Sbjct: 37 SEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNITTL------------DLS 82
Query: 1045 NCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPY 1104
T L +L N+LT + + + + + N + L S
Sbjct: 83 QNTNLTYLACDSNKLTNLDVT-------------PLTKLTYLNCDTNKLT-KLDVSQ--- 125
Query: 1105 LPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLN 1164
P L L N L+ I + + +Q+ L N + QL LD S N
Sbjct: 126 NPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 1165 HLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTEL 1222
+T ++ + L RL N + L + L + SS +L
Sbjct: 181 KITE----------LDVSQNKLLNRLNCDTNNIT-KLD--LNQN-IQLTFLDCSSNKL 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 7e-11
Identities = 43/258 (16%), Positives = 77/258 (29%), Gaps = 52/258 (20%)
Query: 988 DSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYNNK 1034
D N + ++ T + L L L H +++ +N
Sbjct: 17 DDN-FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNN 75
Query: 1035 FTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNK----------LIGRIPSMIFNNSNIE 1084
T +L T L +L N+LT + + + ++ + N +
Sbjct: 76 ITT---LDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTKLD--VSQNPLLT 130
Query: 1085 AIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSG 1144
+ N + + S + L L N + + +Q+ L S N +
Sbjct: 131 YLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184
Query: 1145 LIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNS 1204
L + L L+ N++T L L L +N L +
Sbjct: 185 L---DVSQNKLLNRLNCDTNNITK----------LDLNQNIQLTFLDCSSNKLT-EID-- 228
Query: 1205 IGNLSTSLEYFFASSTEL 1222
+ L T L YF S L
Sbjct: 229 VTPL-TQLTYFDCSVNPL 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 31/198 (15%), Positives = 58/198 (29%), Gaps = 37/198 (18%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA----------YLYNNK 1034
D+ +L SVN +T + V L++L LH +L Y
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEG 284
Query: 1035 FTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFS 1094
++ + T L L + +T + + N + + L +
Sbjct: 285 CRKIKELDVTHNTQLYLLDCQAAGIT-----------ELD--LSQNPKLVYLYLNNTELT 331
Query: 1095 GHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN-- 1152
L S + L+ L ++ SS+ + +E + T N
Sbjct: 332 -ELDVS---HNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNS 385
Query: 1153 ---CRQLQILDLSLNHLT 1167
+LD N +
Sbjct: 386 LTIAVSPDLLDQFGNPMN 403
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 24/212 (11%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNL--VKI 805
IG+G V++ AIK NL+ + + S+ E L +++ + +++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTP 864
+ +++E L WL K +++ +R ++ A+ +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPE-------- 915
++H DLKP+N L+ D + L DFGI+ + + + + T YM PE
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 916 YGSEGIVSTCG---DVYSFGILMIETFTRKMP 944
+ S DV+S G ++ K P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 53/251 (21%), Positives = 100/251 (39%), Gaps = 34/251 (13%)
Query: 1302 RRRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTN 1361
TEN + +++ Y L+ +G+G S V++
Sbjct: 5 HHHSSGVDLGTENLYFQSMSVKGRIYSILKQ----------IGSGGSSKVFQVLNEKKQI 54
Query: 1362 AAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVS---SCSNPGFKALILQYMPQG 1416
AIK +L+ +++ L S+ E + +++ + KI+ + ++++
Sbjct: 55 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLYDYEITDQYIYMVMECG-NI 112
Query: 1417 SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHL 1476
L WL + + +R ++ A+ +HQ I+H DLKP+N L+ D M+ L
Sbjct: 113 DLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KL 167
Query: 1477 GDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE-----------YGSEGIVSTSGDVYSFGI 1524
DFGIA + + + T+ YM PE S+ +S DV+S G
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227
Query: 1525 LMMETLTRRKP 1535
++ + P
Sbjct: 228 ILYYMTYGKTP 238
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 752 IGAGSFGSVYKATL-----PYGMNVAIKVFNLQLDG---AIKSFDAECEVLRRVRHRNLV 803
+G G FG V G VA+K L+ D + E ++LR + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 804 KIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
K C + G + L++EY+P GSL +L H + + Q L + + YLH H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF--GYMAPEYGSE 919
IH DL NVLLD+D + + DFG++K + + + APE E
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 920 GIVSTCGDVYSFGILMIETFT 940
DV+SFG+ + E T
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 25/287 (8%)
Query: 1343 LGTGIFSSVYKATF-----ADGTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLA 1394
LG G F V + G A+K +L+ D + + E +++R + H ++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 1395 KIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
K C + G + L+++Y+P GSL +L H+ + + Q L + + YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH--- 151
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQTMTLATIGYMAPEYGSE 1510
+ IH DL NVLLD+D + +GDFG+AK + + + + + APE E
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570
+ DV+SFG+ + E LT + T + L + + V + + L GE
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT--VLRLTEL-LERGE 268
Query: 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617
+ KC + V L C E R ++ + LK + K+
Sbjct: 269 R---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 46/232 (19%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRH 799
R F E ++G G+FG V KA AIK + + + +E +L + H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 800 RNLVKIISSCSNHGFKA-------------LILEYMPQGSLEKWLYSHKYTLNIQQRLDI 846
+ +V+ ++ + +EY G+L ++S + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 847 MIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905
+ AL Y+H G +IH DLKP N+ +D+ + DFG++K + + + +
Sbjct: 122 FRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 906 LA-------------TFGYMAPE-------YGSEGIVSTCGDVYSFGILMIE 937
T Y+A E Y + D+YS GI+ E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK-----I-DMYSLGIIFFE 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 55/267 (20%), Positives = 101/267 (37%), Gaps = 51/267 (19%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
F E +LG G F V KA D AIK E++ L + +E ++ + H+ + +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 1396 I-------------VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA 1442
+++ + ++Y G+L ++S N ++ + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG- 1501
AL Y+H S IIH DLKP N+ +D+ +GDFG+AK + + + + G
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 1502 ------------YMAPE-------YGSEGIVSTSGDVYSFGILMMETL-------TRRKP 1535
Y+A E Y + D+YS GI+ E + R
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 1536 TDDMFTGEVCLKHWVEESLPDAVTDVI 1562
+ + + +++ +I
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKII 264
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 88/498 (17%), Positives = 154/498 (30%), Gaps = 48/498 (9%)
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSF 195
PR + + LS N IS L + L+EL +S N+I L + L+ L VS
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109
Query: 196 NELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDL 254
N L I + L L L+ N+ F N++ L + L+ L +
Sbjct: 110 NRLQN-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF-RQLDLLP 165
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
L L + L L + + F +
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225
Query: 315 SNIEVIQLYGNHL-SGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSR 373
SNI++ L + + G L N+ ++ V + L +
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285
Query: 374 NLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSF-FSSLTNCRYLRYLAIQTNPWK 432
+ + + + +L + + +S T
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP--- 342
Query: 433 GILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQ 492
+ S + + L + L L +N L + +
Sbjct: 343 -FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTK 400
Query: 493 NLQGL---DLSYNNIQGSIPSELCQL-ESLNTLLLQGNALQNQIPTCLANLTSLRALNLS 548
N+ L D+S N++ C ES+ L L N L + CL ++ L+L
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLH 458
Query: 549 SNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI 608
+NR+ S +P+D+ +L+ L L ++ NQL S+P +
Sbjct: 459 NNRIMS-------------------------IPKDVTHLQALQELNVASNQLK-SVPDGV 492
Query: 609 -GGLKDLTYLALARNGFQ 625
L L Y+ L N +
Sbjct: 493 FDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-30
Identities = 93/499 (18%), Positives = 159/499 (31%), Gaps = 71/499 (14%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
++ +S N I+ + S+L+ L +S N + + ++ +L L ++ N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110
Query: 221 NLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR----DCMTTGRIP 276
LQ ++ C + SL+ L+L D +
Sbjct: 111 RLQ-------------------------NIS---CCPMASLRHLDLSFNDFDVLPVC--- 139
Query: 277 KDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTG 336
K+ GN T L +LGL + + L S I + L H+ G S
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD-------LVSYHIKGGETES-- 190
Query: 337 INLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396
+ +PN L+L + S + + L L+LS +
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250
Query: 397 YSQLATGSLSQGQSFFSSLTNC---RYLRYLAIQTNPWKGILPNSVGNLS----KSLEYF 449
+ + L R + YL I + S KSL
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310
Query: 450 YAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIP 509
+ + A + + + L + + L+ + N S+
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 510 SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVV 569
L+ L TL+LQ N L+N ++ +L LNS +
Sbjct: 371 QGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
Query: 570 DFSLNLLS--------GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALAR 621
LNL S CLP + L L N++ SIP + L+ L L +A
Sbjct: 430 ILVLNLSSNMLTGSVFRCLPPK------VKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482
Query: 622 NGFQGSIPE-AIGSLISLE 639
N + S+P+ L SL+
Sbjct: 483 NQLK-SVPDGVFDRLTSLQ 500
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 1e-20
Identities = 74/447 (16%), Positives = 137/447 (30%), Gaps = 81/447 (18%)
Query: 184 DCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLA 242
D S + L+ +P+++ L L+ N++ E +S LRV+ L+
Sbjct: 37 DYSN-RNLT--------HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLS 84
Query: 243 NNSLFGSLPVDLCRRLPSLQELNLRD-CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGAN 301
+N + SL + L+ L++ + I L +L L N
Sbjct: 85 HNRI-RSLDFHVFLFNQDLEYLDVSHNRLQN--IS--CCPMASLRHLDLSFNDFDVLP-- 137
Query: 302 NLTGLIPSIIFNN-SNIEVIQLYGNHL-SGNLPSSTGINLPNLLRLYLWGNNLSGVIPSS 359
F N + + + L +L ++L +L L L ++ G S
Sbjct: 138 ------VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCIL-LDLVSYHIKGGETES 190
Query: 360 IC--NASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTN 417
+ N + L ++ +LFS V + LQ+ N+ + L +F S LT
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRL---MTFLSELTR 247
Query: 418 CRYLRYLAIQTNP--WKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSL 475
L + +Q WK + + +EY + + I E S
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE------ 301
Query: 476 YQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTC 535
L++L + S + +N +L + C
Sbjct: 302 -------------TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 536 LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYL 595
+ +S LN + N ++ L + L L L
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGC-----------------STLKR-------LQTLIL 384
Query: 596 SGNQLSCSIPSSIGGLKDLTYLALARN 622
N L + K+++ L
Sbjct: 385 QRNGLK-NFFKVALMTKNMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-17
Identities = 63/389 (16%), Positives = 123/389 (31%), Gaps = 53/389 (13%)
Query: 275 IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334
+PKD+ L L N +++ +++ L S + V++L N + +L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFL--------SELRVLRLSHNRIR-SLDFH 94
Query: 335 TGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL-VANTFGNCRQLQIL 393
+ +L L + N L + S C + L L+LS N F L V FGN +L L
Sbjct: 95 VFLFNQDLEYLDVSHNRLQNI---SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFL 151
Query: 394 NLAYSQLAT---GSLSQGQSFFSSLTNCRY--------------LRYLAIQTNPWKGILP 436
L+ ++ ++ L Y L + +P +
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS-LFS 210
Query: 437 NSVGNLSKSLEYFYAGSCELGGGIPAEFGNLS-----NIIALSLYQNQLASTIPTTVGKL 491
V +L + + +L L++ + +T +V
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270
Query: 492 QNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNR 551
Q + Y NI L + + + L SL ++ +
Sbjct: 271 QFFWPRPVEYLNIYN--------------LTITERIDREEFTYSETALKSLMIEHVKNQV 316
Query: 552 LNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGL 611
+ + + + + S++ + T L + N + S+ L
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376
Query: 612 KDLTYLALARNGFQGSIPEAIGSLISLEK 640
K L L L RNG + + + ++
Sbjct: 377 KRLQTLILQRNGLK-NFFKVALMTKNMSS 404
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 5e-16
Identities = 51/300 (17%), Positives = 93/300 (31%), Gaps = 25/300 (8%)
Query: 60 RNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLN 119
N L+ + +T G VT I + LN
Sbjct: 226 SNIKLNDENCQRLMTFLSE---LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282
Query: 120 ISGNRFHGTLPNELW-----LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQI 174
I + E + + L I + + + + + E+ +S +
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDT 341
Query: 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVS 234
S L+ + N T + Q L L L L N L+ F
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400
Query: 235 SLRVIVLANNSL--FGSLPVD-LCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLR 291
++ + + SL S D C S+ LNL M TG + + + + L L
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLH 458
Query: 292 DNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNN 351
+N++ IP + + ++ + + N L ++P L +L ++L N
Sbjct: 459 NNRIMS---------IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 8e-15
Identities = 42/290 (14%), Positives = 86/290 (29%), Gaps = 19/290 (6%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDD----MCNSLTELESFDVS 170
L ++ ++ + L +++++ I +E ++
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284
Query: 171 SNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGN-----LTELMELYLNGNNLQGE 225
+ IT ++ S+ S+ + ++ E+ L+ ++
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344
Query: 226 FPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLL 285
+ SS + N C L LQ L L+ K +
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 286 NYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRL 345
+ L D L + +I V+ L N L+G++ P + L
Sbjct: 403 SSLETLDVSLNSLNS----HAYDRTCAWAESILVLNLSSNMLTGSVFRCL---PPKVKVL 455
Query: 346 YLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNL 395
L N + IP + + L L ++ N + F LQ + L
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWL 504
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 5e-09
Identities = 37/222 (16%), Positives = 65/222 (29%), Gaps = 33/222 (14%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNK 1034
L + + E+ L ++ N
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364
Query: 1035 FTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFS 1094
FT + Q L LIL++N L + + S N +
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL--------NSLN 416
Query: 1095 GHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCR 1154
H + ++ L L N L+G + + +V +L L N + P + +
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSI-PKDVTHLQ 473
Query: 1155 QLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNP 1196
LQ L+++ N L S G L+ + L +NP
Sbjct: 474 ALQELNVASNQLK--SVPDG-----VFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-06
Identities = 46/257 (17%), Positives = 85/257 (33%), Gaps = 32/257 (12%)
Query: 992 LKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQNL-GNCTLL 1049
K LS+S N I+ + L+ELR L L N + + + ++ L
Sbjct: 54 TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS----------LDFHVFLFNQDL 102
Query: 1050 NFLILRQNQLTGV-----------RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHL 1097
+L + N+L + L+ N F N + + + L F
Sbjct: 103 EYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 1098 PSSIGPYLPNLQGLILWGNNLSGIIPSSIC--NASQVILLGLSENLFSGLIPNTFGNCRQ 1155
+ + L L ++ G S+ N + + L+ +LFS + +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222
Query: 1156 LQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL--STSLE 1213
LQ+ ++ LN +F + LT L + LQ+ + +E
Sbjct: 223 LQLSNIKLNDENCQRL---MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 1214 YFFASSTELRGAIPVEF 1230
Y + + I E
Sbjct: 280 YLNIYNLTITERIDREE 296
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 42/179 (23%), Positives = 64/179 (35%), Gaps = 29/179 (16%)
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
P + L L N++S + I S++ +L LS N L + F + L+ LD+S N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNS--IGNLSTSLEYFFASSTELR 1223
L S + + LR L L N LP GNL T L + S+ + R
Sbjct: 112 LQNISC-------CPMAS---LRHLDLSFNDFD-VLPVCKEFGNL-TKLTFLGLSAAKFR 159
Query: 1224 GAIPVEFEGEIPSGGPFVNFTAESLMQNLVLGGSSRLQVPPCKTGSSQQSKATRLALRY 1282
+ L + +L + +T S Q T L L +
Sbjct: 160 -------------QLDLLPVA--HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 28/255 (10%), Positives = 73/255 (28%), Gaps = 33/255 (12%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNL------- 1043
KL L +S K + + + L + + + ++ + N
Sbjct: 147 KLTFLGLSAAKFR-QLD--LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 1044 -GNCTLLNFLILRQNQLTGVRLASNKL-------IGRIPSMIFNNSNIEAIQLYGNHFSG 1095
N + + N L ++L++ KL + S + + + L +
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 1096 HLPSSIGPYL--PNLQGLILWGNNLSGIIPSSICNAS-----QVILLGLSENLFSGLIPN 1148
+ + ++ L ++ ++ I S +++ + +F
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323
Query: 1149 TFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL 1208
+ ++ I LS++ S ++ L N ++ L
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMV----CPPSPSS---FTFLNFTQNVFTDSVFQGCSTL 376
Query: 1209 STSLEYFFASSTELR 1223
L+ L+
Sbjct: 377 -KRLQTLILQRNGLK 390
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 750 NLIGAGSFGSVYKATLPYG----MNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVK 804
+IG G FG VY TL ++ A+K N G + F E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 805 IISSCSNHGFKAL-ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
++ C L +L YM G L ++ + + ++ + + VA +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG-----YMAPEYGS 918
+H DL N +LD+ ++DFG+++ + ++ + T +MA E
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK--TGAKLPVKWMALESLQ 269
Query: 919 EGIVSTCGDVYSFGILMIETFTR-KMP 944
+T DV+SFG+L+ E TR P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-30
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 1341 NLLGTGIFSSVYKATFADGTNA----AIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
++G G F VY T D A+K SL + F E +M+ H N+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 1394 AKIVSSCSNPGFKAL-ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
++ C L +L YM G L ++ + + ++ + + VA +++L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--- 209
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM---KQTMTLATIGYMAPEYGS 1509
S +H DL N +LD+ + DFG+A+ + + +T + +MA E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 1510 EGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
+T DV+SFG+L+ E +TR P D+ T ++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 752 IGAGSFGSVYKATL----PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRNLV 803
+G G FGSV + L + VA+K ++LD + I+ F +E ++ H N++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 804 KIISSCSNHGFKA-----LILEYMPQGSLEKWLYSHK-----YTLNIQQRLDIMIDVASA 853
+++ C + +IL +M G L +L + + +Q L M+D+A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG--- 910
+EYL + + +H DL N +L DD ++DFG+SK + D Q
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG----RIAKMP 212
Query: 911 --YMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
++A E ++ + ++ DV++FG+ M E TR P
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 1343 LGTGIFSSVYKATFADG----TNAAIKIFSLQEDRA----LKSFDAECEVMRRIRHRNLA 1394
LG G F SV + A+K +++ D + ++ F +E M+ H N+
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVK--TMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 1395 KIVSSCSNPGFKA-----LILQYMPQGSLEKWLYSH-----NYLLNIEQRLDIMIDVACA 1444
+++ C + +IL +M G L +L + ++ L M+D+A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYM 1503
+EYL + + +H DL N +L DDM + DFG++K + D + + + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTR 1532
A E ++ + ++ DV++FG+ M E TR
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 24/212 (11%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNL--VKI 805
IG+G V++ AIK NL+ + + S+ E L +++ + +++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTP 864
+ +++E L WL K +++ +R ++ A+ +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPE-------- 915
++H DLKP+N L+ D + L DFGI+ + + + + T YM PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 916 ---YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
S+ +S DV+S G ++ K P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 24/212 (11%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G+G S V++ AIK +L+ +++ L S+ E + +++ + KI+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 73
Query: 1399 ---SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ ++++ L WL + + +R ++ A+ +HQ
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ---HG 128
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE-------- 1506
I+H DLKP+N L+ D M+ L DFGIA + + + T+ YM PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 1507 ---YGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
S+ +S DV+S G ++ + P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-32
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNL--VKI 805
IG+G V++ AIK NL+ + + S+ E L +++ + +++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTP 864
+ +++E L WL K +++ +R ++ A+ +H HG
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPE-------- 915
++H DLKP+N L+ D + L DFGI+ + + + + YM PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 916 ---YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
S+ +S DV+S G ++ K P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 52/254 (20%), Positives = 102/254 (40%), Gaps = 26/254 (10%)
Query: 1305 KRDKSRPTENNLLNTAALRRISYQELRLATNG--FSESNLLGTGIFSSVYKATFADGTNA 1362
K ++ +L + S ++ G +S +G+G S V++
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY 83
Query: 1363 AIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVS---SCSNPGFKALILQYMPQGS 1417
AIK +L+ +++ L S+ E + +++ + KI+ + ++++
Sbjct: 84 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLYDYEITDQYIYMVMEC-GNID 141
Query: 1418 LEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477
L WL + + +R ++ A+ +HQ I+H DLKP+N L+ D M+ L
Sbjct: 142 LNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLI 196
Query: 1478 DFGIAKLLDGVDSMKQTMTLA-TIGYMAPE-----------YGSEGIVSTSGDVYSFGIL 1525
DFGIA + + + + YM PE S+ +S DV+S G +
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
Query: 1526 MMETLTRRKPTDDM 1539
+ + P +
Sbjct: 257 LYYMTYGKTPFQQI 270
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 752 IGAGSFGSVYKATLPYG----MNVAIKVF--NLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G FGSV +A L + VA+K+ ++ I+ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 806 ISSCSNHGFKA------LILEYMPQGSLEKWLYSHK-----YTLNIQQRLDIMIDVASAL 854
+ K +IL +M G L +L + + + L +Q + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMA 913
EYL + IH DL N +L +D ++DFG+S+ + D + ++A
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
E ++ + + DV++FG+ M E TR + P
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 1343 LGTGIFSSVYKATFADG----TNAAIKIFSLQED----RALKSFDAECEVMRRIRHRNLA 1394
LG G F SV +A A+K L+ D ++ F E M+ H ++A
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVK--MLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 1395 KIVSSCSNPGFKA------LILQYMPQGSLEKWLYSH-----NYLLNIEQRLDIMIDVAC 1443
K+V K +IL +M G L +L + + L ++ + M+D+AC
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGY 1502
+EYL S + IH DL N +L +DM + DFG+++ + D + + + +
Sbjct: 149 GMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 1503 MAPEYGSEGIVSTSGDVYSFGILMMETLTR 1532
+A E ++ + + DV++FG+ M E +TR
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 15/219 (6%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
IG G FG V G VA+K ++ D ++F AE V+ ++RH NLV+++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 810 S-NHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
G ++ EYM +GSL +L S + L L +DV A+EYL + +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
DL NVL+ +D VA +SDFG++K E S TQ + APE E ST D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 928 VYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRL 965
V+SFGIL+ E ++ ++P + + + VE+ ++
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKM 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
+G G F V G A+K ++ D ++F AE VM ++RH NL +++
Sbjct: 27 QTIGKGEFGDVMLGD-YRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 1401 S-NPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
G ++ +YM +GSL +L S +L + L +DV A+EYL + +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
DL NVL+ +D VA + DFG+ K S Q + + APE E ST D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 1519 VYSFGILMMETLTR-RKPTDDMFTGEV 1544
V+SFGIL+ E + R P + +V
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIPLKDV 223
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-31
Identities = 82/431 (19%), Positives = 148/431 (34%), Gaps = 94/431 (21%)
Query: 132 ELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRL 191
L ++++ + ++ L D + +T L + N +T LP+ +L+ L
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCLPAHITTL---VIPDNNLT-SLPALPP---ELRTL 86
Query: 192 SVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLP 251
VS N+LT +P L EL +L S L + + N L SLP
Sbjct: 87 EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQL-TSLP 137
Query: 252 VDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSII 311
V P LQEL++ D +P L +NQLT +P +
Sbjct: 138 VLP----PGLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLTS---------LPMLP 180
Query: 312 FNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLEL 371
S ++ + + N L+ +LP+ L +L+ + N L+ +P+ L L +
Sbjct: 181 ---SGLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLT-SLPALPSG---LKELIV 228
Query: 372 SRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
S N + L +L+ L ++ ++L +
Sbjct: 229 SGNRLTSLPVL----PSELKELMVSGNRLTS----------------------------- 255
Query: 432 KGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKL 491
LP L +L +P +LS+ ++L N L+ + ++
Sbjct: 256 ---LPMLPSGL----LSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREI 307
Query: 492 QNLQGLD---LSYNNIQGSIPSELCQLESLNTLLL----QGNALQNQIPTCLANLTSLRA 544
+ G + ++ S P E L L +G + A
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADA 367
Query: 545 LNLSSNRLNST 555
+L +RL+ T
Sbjct: 368 FSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-31
Identities = 74/326 (22%), Positives = 120/326 (36%), Gaps = 53/326 (16%)
Query: 314 NSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSR 373
N+ V+ + + L+ LP ++ L + NNL+ +P+ L LE+S
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLEVSG 90
Query: 374 NLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKG 433
N + L +L I + + L + L L I N
Sbjct: 91 NQLTSL-PVLPPGLLELSIFSNPLTHLPA-----------LPSG---LCKLWIFGNQLTS 135
Query: 434 ILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQN 493
LP L + +L +PA L L Y NQL +++P
Sbjct: 136 -LPVLPPGL----QELSVSDNQLAS-LPALPSELCK---LWAYNNQL-TSLPML---PSG 182
Query: 494 LQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLN 553
LQ L +S N + S+P+ +L L N++ + A + L+ L +S NRL
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKLWAY-------NNRLTSLPALPSGLKELIVSGNRLT 234
Query: 554 STIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKD 613
S +P L+ + S N L+ LP L L + NQL+ +P S+ L
Sbjct: 235 S-LPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSS 285
Query: 614 LTYLALARNGFQGSIPEAIGSLISLE 639
T + L N +A+ + S
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAP 311
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-30
Identities = 76/437 (17%), Positives = 125/437 (28%), Gaps = 115/437 (26%)
Query: 157 MCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELY 216
+ N L +V + +T LP L + + L + N LT +P L L
Sbjct: 38 LNNGNAVL---NVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---E 87
Query: 217 LNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIP 276
++GN L P + L + L +LP L +L + T +P
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHL-PALP-------SGLCKLWIFGNQLT-SLP 137
Query: 277 KDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTG 336
L L + DNQL +LP+
Sbjct: 138 VLPPG---LQELSVSDNQLA---------------------------------SLPAL-- 159
Query: 337 INLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396
L +L+ + N L+ +P L L +S N + L +L N
Sbjct: 160 --PSELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLASL-PTLPSELYKLWAYNN- 211
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCEL 456
+L + LP L + L
Sbjct: 212 --RLTS--------------------------------LPALPSGL----KELIVSGNRL 233
Query: 457 GGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLE 516
+P L L + N+L +++P L L + N + +P L L
Sbjct: 234 TS-LPVLPSELKE---LMVSGNRL-TSLPML---PSGLLSLSVYRNQLT-RLPESLIHLS 284
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
S T+ L+GN L + L +TS + R + S E + + + L
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR--ETRALHLAAADWL 342
Query: 577 SGCLPQDIGNLKVLTGL 593
+
Sbjct: 343 VPAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-30
Identities = 78/385 (20%), Positives = 137/385 (35%), Gaps = 68/385 (17%)
Query: 256 RRLPSLQELNLRDCMTTGRIPKDIGNCTL--LNYLGLRDNQLTDFGANNLTGLIPSIIFN 313
RR +E R + + + C L + ++ LT +P +
Sbjct: 16 RRAAPAEESRGRA-----AVVQKMRACLNNGNAVLNVGESGLTT---------LPDCLPA 61
Query: 314 NSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSR 373
+ I + + N+L+ +LP+ P L L + GN L+ +P +L++
Sbjct: 62 H--ITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPL 113
Query: 374 NLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKG 433
L + L L + +QL S + L Q
Sbjct: 114 THLPALPSG-------LCKLWIFGNQL--------TSLPVLPPGLQELSVSDNQLA---- 154
Query: 434 ILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQN 493
LP L L +A + +L +P L LS+ NQL +++PT +L
Sbjct: 155 SLPALPSEL-CKL---WAYNNQLTS-LPMLPSGLQE---LSVSDNQL-ASLPTLPSELYK 205
Query: 494 LQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLN 553
L N + S+P+ L+ L + GN L +P + L+ L +S NRL
Sbjct: 206 L---WAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLP---VLPSELKELMVSGNRL- 253
Query: 554 STIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKD 613
+++P L + N L+ LP+ + +L T + L GN LS ++ +
Sbjct: 254 TSLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309
Query: 614 LTYLALARNGFQGSIPEAIGSLISL 638
+ F + A +L
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRAL 334
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-28
Identities = 67/320 (20%), Positives = 105/320 (32%), Gaps = 48/320 (15%)
Query: 110 ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI------------SGNLFDDM 157
A L +L +SGN+ +LP + L I + GN +
Sbjct: 78 ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSL 136
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
L+ VS NQ+ LP+ +L +L N+LT +P L EL +
Sbjct: 137 PVLPPGLQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQEL---SV 188
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK 277
+ N L P + L NN L SLP L+EL + T +P
Sbjct: 189 SDNQLA-SLPTLPSELYKLW---AYNNRL-TSLPALP----SGLKELIVSGNRLT-SLPV 238
Query: 278 DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI 337
L L + N+LT +P + S + + +Y N L+ LP S
Sbjct: 239 LPSE---LKELMVSGNRLTS---------LPMLP---SGLLSLSVYRNQLT-RLPESLI- 281
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
+L + + L GN LS ++ + F A+ R L + +
Sbjct: 282 HLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
Query: 398 SQLATGSLSQGQSFFSSLTN 417
A +
Sbjct: 342 LVPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 5e-18
Identities = 41/237 (17%), Positives = 79/237 (33%), Gaps = 51/237 (21%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-----------YLYNNKFTGR 1038
N L++ + +T T+P + + L + NNL + + N+ T
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-S 95
Query: 1039 IPQNLGNCTLLNFLILRQNQLTGV-------RLASNKLIGRIPSMIFNNSNIEAIQLYGN 1091
+P L+ L + + N+L +P + ++ + + N
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVLP---PGLQELSVSDN 151
Query: 1092 HFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFG 1151
+ LP+ L L + N L+ +P S + L +S+N + L P
Sbjct: 152 QLA-SLPALPS----ELCKLWAYNNQLTS-LPMLP---SGLQELSVSDNQLASL-PTLPS 201
Query: 1152 NCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL 1208
+L + L L + L+ L++ N L +LP L
Sbjct: 202 ELYKLWAYNNRLTSLP-----------ALPSG---LKELIVSGNRLT-SLPVLPSEL 243
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 7e-15
Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 53/228 (23%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-----------YLYNNKFTGRI 1039
L +L I N++T ++P L EL + N L + + YNN+ T +
Sbjct: 122 GLCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQLASLPALPSELCKLWAYNNQLT-SL 176
Query: 1040 PQNLGNCTLLNFLILRQNQLTGV----------RLASNKLIGRIPSMIFNNSNIEAIQLY 1089
P L L + NQL + +N+L +P++ S ++ + +
Sbjct: 177 PMLPSG---LQELSVSDNQLASLPTLPSELYKLWAYNNRLT-SLPALP---SGLKELIVS 229
Query: 1090 GNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNT 1149
GN + LP L+ L++ GN L+ +P ++ L + N + L P +
Sbjct: 230 GNRLT-SLPVLPS----ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLTRL-PES 279
Query: 1150 FGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
+ ++L N L+ +L R + + P+
Sbjct: 280 LIHLSSETTVNLEGNPLSE----------RTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-12
Identities = 42/246 (17%), Positives = 80/246 (32%), Gaps = 44/246 (17%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-----------YLYNNKFTGRI 1039
+L +L N++T ++P L EL + N L + + YNN+ T +
Sbjct: 162 ELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLASLPTLPSELYKLWAYNNRLT-SL 216
Query: 1040 PQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPS 1099
P L LI+ N+LT +P + S ++ + + GN + LP
Sbjct: 217 PALPSG---LKELIVSGNRLT-----------SLPVLP---SELKELMVSGNRLT-SLPM 258
Query: 1100 SIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQIL 1159
L L ++ N L+ + P S+ + S + L N S T R++
Sbjct: 259 LPS----GLLSLSVYRNQLTRL-PESLIHLSSETTVNLEGNPLSER---TLQALREITSA 310
Query: 1160 DLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS--TSLEYFFA 1217
+ + + ++ + A + + + F
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSL 370
Query: 1218 SSTELR 1223
L
Sbjct: 371 FLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 3e-09
Identities = 25/129 (19%), Positives = 47/129 (36%), Gaps = 24/129 (18%)
Query: 1080 NSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSE 1139
N+ + + + + LP + ++ L++ NNL+ +P+ ++ L +S
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA---HITTLVIPDNNLT-SLPALP---PELRTLEVSG 90
Query: 1140 NLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKG 1199
N + L P +L I L HL + L +L + N L
Sbjct: 91 NQLTSL-PVLPPGLLELSIFSNPLTHLP-----------ALPSG---LCKLWIFGNQLT- 134
Query: 1200 ALPNSIGNL 1208
+LP L
Sbjct: 135 SLPVLPPGL 143
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR 798
+R F E LIG+G FG V+KA G IK + A + E + L ++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 799 HRNLVKIISSCSNHGFKA----------------LILEYMPQGSLEKWLYSHKYT-LNIQ 841
H N+V + + +E+ +G+LE+W+ + L+
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
L++ + ++Y+H +I+ DLKPSN+ L D + DFG+ L + T
Sbjct: 123 LALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 902 QTMTLATFGYMAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
++ T YM+PE YG E D+Y+ G+++ E E
Sbjct: 180 RSK--GTLRYMSPEQISSQDYGKE------VDLYALGLILAELLHVCDTAFET 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRN--- 1392
F E L+G+G F V+KA DG IK ++A + E + + ++ H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 1393 -------------LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIM 1438
+ SS S + +++ +G+LE+W+ L+ L++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
+ ++Y+H S +I+ DLKPSN+ L D +GDFG+ L D +
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRSK-G 183
Query: 1499 TIGYMAPE------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
T+ YM+PE YG E D+Y+ G+++ E L +
Sbjct: 184 TLRYMSPEQISSQDYGKE------VDLYALGLILAELLHVCDTAFET 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 42/219 (19%)
Query: 752 IGAGSFGSVYKATL--------PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV 803
+G G+F ++K + V +KV + +SF ++ ++ H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
C L+ E++ GSL+ +L +K +NI +L++ +A+A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 864 PVIHCDLKPSNVLLD--------DDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY---- 911
+IH ++ N+LL + LSD GIS + +D
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQERI 181
Query: 912 --MAPE---YGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
+ PE ++ D +SFG + E + P
Sbjct: 182 PWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 46/227 (20%), Positives = 91/227 (40%), Gaps = 40/227 (17%)
Query: 1343 LGTGIFSSVYKATF--------ADGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRN 1392
LG G F+ ++K T +K+ L + +SF +M ++ H++
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKV--LDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 1393 LAKI--VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL-H 1449
L V C + L+ +++ GSL+ +L + +NI +L++ +A A+ +L
Sbjct: 74 LVLNYGVCVCGDENI--LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 1450 QGYSTSIIHCDLKPSNVLLD--------DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG 1501
IH ++ N+LL + L D GI+ + D ++ I
Sbjct: 132 NTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ-----ERIP 182
Query: 1502 YMAPE---YGSEGIVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEV 1544
++ PE ++ + D +SFG + E + KP + +
Sbjct: 183 WVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG GS+G K G + K + + + +E +LR ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 808 SCSNHGFKAL--ILEYMPQGSLEKWLYSHKYT---LNIQQRLDIMIDVASALEYLHHGHP 862
+ L ++EY G L + L+ + L +M + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 863 TP--VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE----- 915
V+H DLKP+NV LD L DFG++++L+ + S +T + T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNRM 191
Query: 916 -YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
Y + D++S G L+ E P FT +
Sbjct: 192 SYNEK------SDIWSLGCLLYELCALMPP----FTAFS 220
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVS 1398
+GTG + K +DG K + + +E ++R ++H N+ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 1399 SCSNPGFKAL--ILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQ--G 1451
+ L +++Y G L + L+ E L +M + AL+ H+
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE----- 1506
+++H DLKP+NV LD LGDFG+A++L+ S +T + T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNRM 191
Query: 1507 -YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y + D++S G L+ E P FT
Sbjct: 192 SYNEK------SDIWSLGCLLYELCALMPP----FTAF 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHR 800
+ + IG GSFG G IK N+ + E VL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHH 859
N+V+ S +G ++++Y G L K + + K Q LD + + AL+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE---- 915
++H D+K N+ L D L DFGI+++L+ + + T Y++PE
Sbjct: 144 RK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 916 --YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
Y ++ D+++ G ++ E T K F +
Sbjct: 200 KPYNNK------SDIWALGCVLYELCTLKHA----FEAGS 229
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 8/198 (4%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G G F DG IK ++ + + E V+ ++H N+ +
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
S G +++ Y G L K + + L +Q LD + + AL+++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSG 1517
H D+K N+ L D LGDFGIA++L+ + + T Y++PE +
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKS 206
Query: 1518 DVYSFGILMMETLTRRKP 1535
D+++ G ++ E T +
Sbjct: 207 DIWALGCVLYELCTLKHA 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-31
Identities = 51/240 (21%), Positives = 88/240 (36%), Gaps = 38/240 (15%)
Query: 751 LIGAGSFGSVYKA--TLPYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKII- 806
I G G +Y A G V +K D A AE + L V H ++V+I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 807 ------SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-H 859
G+ +++EY+ SL++ L + + + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI 201
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT-MTLATFGYMAPEYGS 918
G +++ DLKP N++L ++ + L D G + T G+ APE
Sbjct: 202 G----LVYNDLKPENIMLTEEQLK-LIDLGAVS------RINSFGYLYGTPGFQAPEIVR 250
Query: 919 EGIV--STCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELL 976
G + D+Y+ G + G + E+ L + L
Sbjct: 251 TGPTVAT---DIYTVGRTLAALTLDLPT----RNGR-YVDGLPEDDPVLKTYDSYGRLLR 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-29
Identities = 43/235 (18%), Positives = 85/235 (36%), Gaps = 34/235 (14%)
Query: 1342 LLGTGIFSSVYKA--TFADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKI-- 1396
+ G +Y A +G +K D A AE + + + H ++ +I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 1397 -----VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLH-Q 1450
G+ ++++Y+ SL++ L + + + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI 201
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT-MTLATIGYMAPEYGS 1509
G +++ DLKP N++L ++ + L D G ++ T G+ APE
Sbjct: 202 G----LVYNDLKPENIMLTEEQLK-LIDLGAVSRIN------SFGYLYGTPGFQAPEIVR 250
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564
G + D+Y+ G + G + E+ D
Sbjct: 251 TGPTVAT-DIYTVGRTLAALTLDLPT----RNGRY-VDGLPEDDPVLKTYDSYGR 299
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 52/239 (21%), Positives = 86/239 (35%), Gaps = 25/239 (10%)
Query: 720 ILENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL 778
+N+ + L + E + + +G GSFG V++ G A+K L
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 779 QLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTL 838
+ E + +V + + + + +E + GSL + L L
Sbjct: 94 E-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCL 147
Query: 839 NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD-TVAHLSDFGISKLLDGE 897
+ L + LEYLH ++H D+K NVLL D + A L DFG + L +
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 898 DSVTQTMTLATF-G---YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
+T G +MAPE D++S +M+ M G
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML----------HMLNGC 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 54/245 (22%), Positives = 89/245 (36%), Gaps = 25/245 (10%)
Query: 1302 RRRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFAD-GT 1360
+ +R +N + + E R + + +G G F V++ G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 1361 NAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEK 1420
A+K L+ R E + + + + + + ++ + GSL +
Sbjct: 85 QCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 1421 WLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDF 1479
L L ++ L + LEYLH + I+H D+K NVLL D A L DF
Sbjct: 140 -LIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 1480 GIAKLLDGVDSMKQTMTLAT-IG---YMAPEYGSEGIVSTSG-----DVYSFGILMMETL 1530
G A L K +T G +MAPE +V D++S +M+ L
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHML 250
Query: 1531 TRRKP 1535
P
Sbjct: 251 NGCHP 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-31
Identities = 42/211 (19%), Positives = 88/211 (41%), Gaps = 20/211 (9%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVK 804
F +++G G+ G++ + +VA+K + D E ++LR H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPT 863
+ + F+ + +E +L++++ + + + ++ S L +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--- 138
Query: 864 PVIHCDLKPSNVLL-----DDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPEY 916
++H DLKP N+L+ A +SDFG+ K L + T G++APE
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 917 ---GSEGIVSTCGDVYSFGILMIETFTRKMP 944
+ + D++S G + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 40/210 (19%), Positives = 88/210 (41%), Gaps = 18/210 (8%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAK 1395
F ++LG G ++ D + A+K + D E +++R H N+ +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ + F+ + ++ +L++++ ++ + + ++ L +LH S +
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 1456 IIHCDLKPSNVLL-----DDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGYMAPEY- 1507
I+H DLKP N+L+ + A + DFG+ K L + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 1508 --GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ + + D++S G + ++
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIK---VFNLQLDGAIKSFDAECEVLRRVRH 799
F IG G F VY+A L G+ VA+K +F+L A E ++L+++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK---YTLNIQQRLDIMIDVASALEY 856
N++K +S ++LE G L + + K + + + + SALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG---YMA 913
+H V+H D+KP+NV + V L D G+ + + + ++ G YM+
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMS 204
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
PE E + D++S G L+ E + P
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIK---IFSLQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
+G G FS VY+A DG A+K IF L + +A E ++++++ H N+ K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYST 1454
+S ++L+ G L + + L+ + + ALE++H S
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
++H D+KP+NV + V LGD G+ + + ++ T YM+PE E +
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 1515 TSGDVYSFGILMMETLTRRKP 1535
D++S G L+ E + P
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 42/230 (18%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVR 798
R F +G G FG V++A N AIK L + A + E + L ++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 799 HRNLVKIISSC------------SNHGFKALILEYMPQGSLEKWLYSHKYTLNI--QQRL 844
H +V+ ++ S + + ++ + +L+ W+ L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 845 DIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904
I + +A A+E+LH ++H DLKPSN+ D V + DFG+ +D ++ +
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 905 TLATFG-----------YMAPE------YGSEGIVSTCGDVYSFGILMIE 937
T YM+PE Y + D++S G+++ E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK------VDIFSLGLILFE 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLA 1394
F LG G F V++A D N AIK L + A + E + + ++ H
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG-- 64
Query: 1395 KIV-------------SSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLLNIEQR--LDI 1437
IV + L +Q + +L+ W+ + E+ L I
Sbjct: 65 -IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 1438 MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL 1497
+ +A A+E+LH S ++H DLKPSN+ D V +GDFG+ +D + + +T
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 1498 AT--------IG---YMAPEYGSEGIVSTSGDVYSFGILMME 1528
+G YM+PE S D++S G+++ E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 64/353 (18%), Positives = 115/353 (32%), Gaps = 73/353 (20%)
Query: 274 RIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPS 333
+PK+I L L++N +++ ++ GL ++ + L N +S +
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGL--------QHLYALVLVNNKIS-KIHE 95
Query: 334 STGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQIL 393
L L +LY+ N+L IP ++ S L L + N + F R + +
Sbjct: 96 KAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 394 NLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGS 453
+ + L G F L L YL I L+
Sbjct: 153 EMGGNPLENSGFEPG--AFDGLK----LNYLRISEA-----------KLTG--------- 186
Query: 454 CELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSEL 512
IP + L L N++ I + L L L +N I+ I +
Sbjct: 187 ------IPK--DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIR-MIENGS 236
Query: 513 CQ-LESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDF 571
L +L L L N L ++P L +L L+ + L +N + + F + + +
Sbjct: 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV---- 291
Query: 572 SLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSI--PSSIGGLKDLTYLALARN 622
G+ L N + P++ + D +
Sbjct: 292 --------------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 61/351 (17%), Positives = 113/351 (32%), Gaps = 63/351 (17%)
Query: 211 ELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM 270
L + + L+ P I ++ L NN + L D + L L L L +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNK 89
Query: 271 TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGN 330
+ K L L + N L + IP + S++ ++++ N +
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLVE---------IPPNLP--SSLVELRIHDNRIR-K 137
Query: 331 LPSSTGINLPNLLRLYLWGNNLSGV-IPSSICNASKLTVLELSRNLFSGLVANTFGNCRQ 389
+P L N+ + + GN L + KL L +S +G+ +
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPET--- 194
Query: 390 LQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYF 449
L L+L ++++ ++ + L L + N + I S
Sbjct: 195 LNELHLDHNKIQ--AIELE--DLLRYSK---LYRLGLGHNQIRMIENGS----------- 236
Query: 450 YAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIP 509
L + L L N+L S +P + L+ LQ + L NNI +
Sbjct: 237 --------------LSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT-KVG 280
Query: 510 SE-------LCQLESLNTLLLQGNALQNQI--PTCLANLTSLRALNLSSNR 551
+ N + L N + P +T A+ + +
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 68/320 (21%), Positives = 126/320 (39%), Gaps = 36/320 (11%)
Query: 88 HGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSN 147
H RV S +LGL +P ++ L++ N ++ + L + L +N
Sbjct: 34 HLRVVQCS--DLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88
Query: 148 RISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI- 206
+IS + + + L +L+ +S N + ++P +L S L L + N + ++P+ +
Sbjct: 89 KIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVF 143
Query: 207 GNLTELMELYLNGNNLQ-GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELN 265
L + + + GN L+ F P F+ L + ++ L +P DL +L EL+
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL---PETLNELH 199
Query: 266 LRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYG 324
L I + + L LGL NQ+ +L+ L + + L
Sbjct: 200 LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL--------PTLRELHLDN 250
Query: 325 NHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSIC------NASKLTVLELSRNL--F 376
N LS +P+ +L L +YL NN++ V + C + + L N +
Sbjct: 251 NKLS-RVPAGLP-DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308
Query: 377 SGLVANTFGNCRQLQILNLA 396
+ TF +
Sbjct: 309 WEVQPATFRCVTDRLAIQFG 328
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 51/343 (14%), Positives = 110/343 (32%), Gaps = 68/343 (19%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNN 221
+ D+ +N I+ L L + N+++ + L +L +LY++ N+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 222 LQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGN 281
L E PP + SSL + + +N + +P + L ++ + +
Sbjct: 114 LV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGG------------- 156
Query: 282 CTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPN 341
N L + G F+ + +++ L+ +P
Sbjct: 157 -----------NPLENSG-------FEPGAFDGLKLNYLRISEAKLT-GIPKDL---PET 194
Query: 342 LLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLA 401
L L+L N + + + SKL L L N + + L+ L+L ++L
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL- 253
Query: 402 TGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIP 461
+ L + + L+ + + TN + N + +
Sbjct: 254 -------SRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV--------------- 291
Query: 462 AEFGNLSNIIALSLYQNQLASTI--PTTVGKLQNLQGLDLSYN 502
+ +SL+ N + P T + + +
Sbjct: 292 ----KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 52/272 (19%), Positives = 93/272 (34%), Gaps = 57/272 (20%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFH----GTLPN--ELWL---------------MPRLRI 141
I + L L L IS N + EL + + +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNC 151
Query: 142 IDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGR 201
I++ N + D KL L +S +LT
Sbjct: 152 IEMGGNPLE------------------------NSGFEPGAFDGLKLNYLRISEAKLT-G 186
Query: 202 IPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPS 260
IP+++ L EL+L+ N +Q S L + L +N + + LP+
Sbjct: 187 IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPT 242
Query: 261 LQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVI 320
L+EL+L + + R+P + + LL + L N +T G N+ + + + I
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV--KRAYYNGI 299
Query: 321 QLYGNHLS-GNLPSSTGINLPNLLRLYLWGNN 351
L+ N + + +T + + L + GN
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQF-GNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 37/237 (15%), Positives = 80/237 (33%), Gaps = 35/237 (14%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYNNKFTGR 1038
L L + NKI+ + L +L++L++ N+L +++N+ +
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIR-K 137
Query: 1039 IPQN-LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHL 1097
+P+ +N + + N L F+ + +++ + +
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSG---------FEPGAFDGLKLNYLRISEAKLT-GI 187
Query: 1098 PSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQ 1157
P + L L L N + I + S++ LGL N + + L+
Sbjct: 188 PKDL---PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR 244
Query: 1158 ILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
L L N L+ L + + L+ + L N + N + ++
Sbjct: 245 ELHLDNNKLS--------RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR 293
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 42/223 (18%), Positives = 73/223 (32%), Gaps = 34/223 (15%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
L L I N+I L + + + GN LE + LN
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE--------NSGFEPGAFDGLKLN 175
Query: 1051 FLILRQNQLTGV-----------RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLP 1098
+L + + +LTG+ L NK I I S + + L N +
Sbjct: 176 YLRISEAKLTGIPKDLPETLNELHLDHNK-IQAIELEDLLRYSKLYRLGLGHNQIR-MIE 233
Query: 1099 SSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCR---- 1154
+ +LP L+ L L N LS +P+ + + + ++ L N + + N F
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVK 292
Query: 1155 --QLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNN 1195
+ L N + +F +T+ + N
Sbjct: 293 RAYYNGISLFNNPVPYWEVQPA-TF-RCVTD---RLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 36/159 (22%), Positives = 59/159 (37%), Gaps = 8/159 (5%)
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTS 541
+P + + LDL N+I + L+ L L+L N + + L
Sbjct: 46 KAVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 542 LRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
L+ L +S N L P+ SL + N + L+ + + + GN L
Sbjct: 104 LQKLYISKNHLVEIPPNLPSSLVEL---RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 602 CSI--PSSIGGLKDLTYLALARNGFQGSIPEAIGSLISL 638
S P + GLK L YL ++ G + +L L
Sbjct: 161 NSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLPETLNEL 198
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 41/257 (15%), Positives = 90/257 (35%), Gaps = 45/257 (17%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCTLLN 1050
L+ + S + +P+ + + L L N++ + ++ L
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS----------ELRKDDFKGLQHLY 81
Query: 1051 FLILRQNQLTGV--------------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH 1096
L+L N+++ + ++ N L+ IP + S++ ++++ N
Sbjct: 82 ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-K 137
Query: 1097 LPSSIGPYLPNLQGLILWGNNL-SGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ 1155
+P + L N+ + + GN L + + ++ L +SE +G+ +
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPET--- 194
Query: 1156 LQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYF 1215
L L L N + L L RL L +N ++ S+ L +L
Sbjct: 195 LNELHLDHNKIQAIEL-------EDLLRYSKLYRLGLGHNQIRMIENGSLSFL-PTLREL 246
Query: 1216 FASSTELRGAIPVEFEG 1232
+ +L +P
Sbjct: 247 HLDNNKLS-RVPAGLPD 262
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 58/275 (21%), Positives = 114/275 (41%), Gaps = 21/275 (7%)
Query: 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQ 399
+ L L N ++ + S + L L L+ N + + ++F + L+ L+L+Y+
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGG 459
L+ +LS +F L++ L +L + NP+K + S+ + L+ G+ +
Sbjct: 112 LS--NLSSS--WFKPLSS---LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
Query: 460 IPAE-FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL-CQLES 517
I + F L+ + L + + L S P ++ +QN+ L L + S
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSS 223
Query: 518 LNTLLLQGNALQ----NQIPTC----LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVV 569
+ L L+ L +++ T L + R + ++ L + + +L +
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLEL 282
Query: 570 DFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLSCS 603
+FS N L +P I L L ++L N CS
Sbjct: 283 EFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 316
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 53/334 (15%), Positives = 108/334 (32%), Gaps = 44/334 (13%)
Query: 176 GQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVS 234
+ C + S L IP + + L L+ N + +
Sbjct: 21 ESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCV 76
Query: 235 SLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDN 293
+L+ +VL +N + ++ D L SL+ L+L + + + L +L L N
Sbjct: 77 NLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGN 134
Query: 294 QLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352
L + +F++ + ++++++ + L L L + ++L
Sbjct: 135 PYKT--------LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 353 SGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQS-F 411
P S+ + ++ L L L+ ++ L L + L T S+ +
Sbjct: 187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246
Query: 412 FSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNII 471
+SL R + I + +S ++
Sbjct: 247 TNSLIKKFTFRNVKITDESLF--------------------------QVMKLLNQISGLL 280
Query: 472 ALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQ 505
L +NQL S +L +LQ + L N
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 62/306 (20%), Positives = 111/306 (36%), Gaps = 34/306 (11%)
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFN 196
R I SS ++ ++ + ++ L D+S+N+IT S L C L+ L ++ N
Sbjct: 31 DRNGICKGSSGSLN-SIPSGLTEAVKSL---DLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 197 ELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDL 254
+ I ++ +L L L L+ N L + F +SSL + L N L
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFN 313
L LQ L + + T +I + T L L + + L + +L +
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI------- 197
Query: 314 NSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSIC--------NASK 365
N+ + L+ L ++ L L +L S +
Sbjct: 198 -QNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 366 LTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLA 425
++++ + L L + +QL S+ G F LT+ L+ +
Sbjct: 256 FRNVKITDESLFQV-MKLLNQISGLLELEFSRNQLK--SVPDG--IFDRLTS---LQKIW 307
Query: 426 IQTNPW 431
+ TNPW
Sbjct: 308 LHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 39/239 (16%), Positives = 79/239 (33%), Gaps = 27/239 (11%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
+K L +S N+IT + L+ L L N + +LG+ L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT------IEEDSFSSLGS---LEH 104
Query: 1052 LILRQNQLTGV--------------RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGH 1096
L L N L+ + L N + +F++ + ++ +++
Sbjct: 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
Query: 1097 LPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQL 1156
+ L L+ L + ++L P S+ + V L L L+ +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 1157 QILDLSLNHLTTGSSTQ-GHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
+ L+L L T ++ SL R + + + L + + + + L
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQI-SGLLE 281
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-16
Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 6/177 (3%)
Query: 468 SNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL-CQLESLNTLLLQGN 526
+ +L L N++ + + + NLQ L L+ N I +I + L SL L L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 527 ALQNQIPTCLANLTSLRALNLSSNRLNSTIP-STFWSLEYILVVDFSLNLLSGCLPQDI- 584
L N + L+SL LNL N + S F L + ++ + +
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 585 GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPE-AIGSLISLEK 640
L L L + + L P S+ ++++++L L + E + S+E
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVEC 226
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 35/233 (15%), Positives = 68/233 (29%), Gaps = 46/233 (19%)
Query: 991 KLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEA-----------------YLYN 1032
L+ L +S N ++ + + L+ L L+L GN +
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159
Query: 1033 NKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGN 1091
+ FT ++ T L L + + L + N+ + L+
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQ-----------SYEPKSLKSIQNVSHLILHMK 208
Query: 1092 HFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGL------ 1145
L +++ L L +L S + L+ +
Sbjct: 209 QHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 1146 -IPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
+ L L+ S N L + + LT+ L+++ L NP
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLKS----VPDGIFDRLTS---LQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 42/233 (18%), Positives = 82/233 (35%), Gaps = 42/233 (18%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWL--MPRLRIIDLSSN----RISGNLFDD 156
+ LS L LN+ GN + TL + +L+I+ + + +I F
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA- 171
Query: 157 MCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMEL 215
LT LE ++ ++ + P SL + L + + + + + + L
Sbjct: 172 ---GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 216 YLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI 275
L +L F+ S L SL + + + + + D ++
Sbjct: 228 ELRDTDLDT------FHFSELSTGE------TNSLI-----KKFTFRNVKITDESLF-QV 269
Query: 276 PKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHL 327
K + + L L NQL +P IF+ ++++ I L+ N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKS---------VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 36/168 (21%), Positives = 64/168 (38%), Gaps = 23/168 (13%)
Query: 1066 SNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSS 1125
S+ + IPS + ++++ L N + ++ +S NLQ L+L N ++ I S
Sbjct: 39 SSGSLNSIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDS 95
Query: 1126 ICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSL---- 1181
+ + L LS N S L + F L L+L N T T S T L
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 1182 ---------------TNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
+L L + + L+ P S+ ++ ++ +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI-QNVSH 202
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKII 806
++G G V+ A L +VA+KV L F E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 807 SSCSNHGFKA----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHP 862
+ +++EY+ +L +++ + ++ ++++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG- 136
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISK-LLDGEDSVTQT-MTLATFGYMAPEYGSEG 920
+IH D+KP+N+++ + DFGI++ + D +SVTQT + T Y++PE
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 921 IVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSL 955
V DVYS G ++ E T + P FTG++ +
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPV 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 59/246 (23%), Positives = 107/246 (43%), Gaps = 35/246 (14%)
Query: 1342 LLGTGIFSSVYKATFAD---GTNAAIKI--FSLQEDRA-LKSFDAECEVMRRIRHRNLAK 1395
+LG G S V+ A D + A+K+ L D + F E + + H +
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 1396 IVSSCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
+ + ++++Y+ +L +++ + ++ ++++ D AL + HQ
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNFSHQ- 134
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDGVDSMKQT-MTLATIGYMAPEYGS 1509
IIH D+KP+N+++ + DFGIA+ + D +S+ QT + T Y++PE
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE----VCLKHWVEE---------SLPD 1556
V DVYS G ++ E LT P FTG+ V +H E+ L
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 1557 AVTDVI 1562
+ V+
Sbjct: 249 DLDAVV 254
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 7e-30
Identities = 54/329 (16%), Positives = 100/329 (30%), Gaps = 66/329 (20%)
Query: 1297 IIILLRRRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSES------------NLLG 1344
+I L R + T + + +AA +S ES +LG
Sbjct: 28 VIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLG 87
Query: 1345 TGIFSSVYKAT-FADGTNAAIKIFSLQE---DRALKSFDAECEVMRRIR----------H 1390
+ +AT G + + + E A+K E +R +R H
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 1391 RNLAKIVSSCSNPGFKALI----------------LQYMPQGSLE---KWLYSH---NYL 1428
+P K +I L Q +L+ + L SH +
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488
L RL + + V L LH ++H L+P +++LD L F
Sbjct: 208 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 1489 DSMKQTMTLATIGYMAPE-----YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
A A +++ + D ++ G+ + P T +
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDD 320
Query: 1544 --VCLKHWV---EESLPDAVTDVIDANLL 1567
+ W+ +++P V +++ L
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLEG-FL 348
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 45/282 (15%), Positives = 87/282 (30%), Gaps = 64/282 (22%)
Query: 723 NDSLSLATWRRISYQELQRLTDG----FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN 777
+ +S + W ++ ++G + +AT G + + V
Sbjct: 53 DSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPY 112
Query: 778 LQL---DGAIKSFDAECEVLRRVR----------HRNLVKIISSCSNHGFKALI------ 818
AIK E LR +R H + + K +I
Sbjct: 113 FTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE 172
Query: 819 ----------LEYMPQGSLE---KWLYSHK---YTLNIQQRLDIMIDVASALEYLH-HGH 861
L Q +L+ + L SH +L RL + + V L LH +G
Sbjct: 173 RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY----- 916
++H L+P +++LD L+ F ++ G+ PE
Sbjct: 232 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIGRGFAPPETTAERM 283
Query: 917 -----GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+++ D ++ G+ + + +P T +
Sbjct: 284 LPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDA 321
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 61/265 (23%), Positives = 103/265 (38%), Gaps = 17/265 (6%)
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
+ L+ +P+ I S T LEL N L F QL L+L+ + L+
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE 463
T+ L+YL + N + ++ L LE+ L +
Sbjct: 68 GCCSQS--DFGTTS---LKYLDLSFNGVI-TMSSNFLGLE-QLEHLDFQHSNLKQ-MSEF 119
Query: 464 --FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNT 520
F +L N+I L + L +L+ L ++ N+ Q + + +L +L
Sbjct: 120 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 521 LLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCL 580
L L L+ PT +L+SL+ LN+S N S + L + V+D+SLN +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-S 238
Query: 581 PQDI--GNLKVLTGLYLSGNQLSCS 603
+ L L L+ N +C+
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFACT 263
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 51/272 (18%), Positives = 96/272 (35%), Gaps = 41/272 (15%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGR--IPQNIGNLTELMELYLNG 219
+ ++ SN++ ++L +LS+S N L+ + Q+ T L L L+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 220 NNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
N + + L + +++L + L +L L++
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH----------- 135
Query: 280 GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINL 339
GL S++EV+++ GN N L
Sbjct: 136 -------------THTRVAFNGIFNGL--------SSLEVLKMAGNSFQENFLPDIFTEL 174
Query: 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQ 399
NL L L L + P++ + S L VL +S N F L + LQ+L+ + +
Sbjct: 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234
Query: 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
+ T S+ Q ++ L +L + N +
Sbjct: 235 IMT---SKKQELQHFPSS---LAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 58/306 (18%), Positives = 107/306 (34%), Gaps = 54/306 (17%)
Query: 76 VCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWL 135
C+ + C S+ S+P IP L + N+
Sbjct: 6 SCSGTEIRCNSKGLT----SVP-----TGIPSS------ATRLELESNKLQSLPHGVFDK 50
Query: 136 MPRLRIIDLSSNRIS-GNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS 194
+ +L + LSSN +S T L+ D+S N + + S+ +L+ L
Sbjct: 51 LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 109
Query: 195 FNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPV 252
+ L ++ +L L+ L ++ + + IF +SSL V+ +A NS +
Sbjct: 110 HSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 253 DLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIF 312
D+ L +L L+ L QL L
Sbjct: 169 DIFTELRNLTFLD------------------------LSQCQLEQLSPTAFNSL------ 198
Query: 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICN-ASKLTVLEL 371
S+++V+ + N+ +L + L +L L N++ + + S L L L
Sbjct: 199 --SSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
Query: 372 SRNLFS 377
++N F+
Sbjct: 256 TQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 52/239 (21%), Positives = 83/239 (34%), Gaps = 41/239 (17%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-----------------YLYNNK 1034
RL + NK+ LT+L +L L N L L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 1035 FTGRIPQNLGNCTLLNFLILRQNQLTGV---------------RLASNKLIGRIPSMIFN 1079
+ N L L + + L + ++ + IFN
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH-TRVAFNGIFN 147
Query: 1080 N-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLS 1138
S++E +++ GN F + I L NL L L L + P++ + S + +L +S
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 1139 ENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
N F L + LQ+LD SLNH+ T ++ ++ L L L N
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMT---SKKQELQHFPSS---LAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 7/184 (3%)
Query: 461 PAEFGNLSNIIALSLYQNQLA--STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESL 518
F L+ + LSL N L+ + +L+ LDLS+N + ++ S LE L
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL 103
Query: 519 NTLLLQGNALQNQIPTCL-ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L Q + L+ + +L +L L++S F L + V+ + N
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 578 GCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPEAIGSL 635
DI L+ LT L LS QL + + L L L ++ N F L
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222
Query: 636 ISLE 639
SL+
Sbjct: 223 NSLQ 226
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 44/172 (25%), Positives = 67/172 (38%), Gaps = 10/172 (5%)
Query: 473 LSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQ- 531
+ L S +PT + + L+L N +Q +L L L L N L +
Sbjct: 12 IRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 532 -IPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI-GNLKV 589
TSL+ L+LS N + T+ S F LE + +DF + L + +L+
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 590 LTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPE-AIGSLISLE 639
L L +S + I GL L L +A N FQ + L +L
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 45/237 (18%), Positives = 76/237 (32%), Gaps = 39/237 (16%)
Query: 1005 TIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCTLLNFLILRQNQLTGV- 1062
++P + + L L N L+ +P T L L L N L+
Sbjct: 21 SVPTGI--PSSATRLELESNKLQ----------SLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 1063 ---------------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPN 1107
L+ N +I + S +E + ++ S+ L N
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 1108 LQGLILWGNNLSGIIPSSICNASQVILLGLSENLF-SGLIPNTFGNCRQLQILDLSLNHL 1166
L L + + S + +L ++ N F +P+ F R L LDLS L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 1167 TTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELR 1223
+F SL++ L+ L + +N L SL+ S +
Sbjct: 188 E---QLSPTAF-NSLSS---LQVLNMSHNNFFSLDTFPYKCL-NSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 27/137 (19%), Positives = 43/137 (31%), Gaps = 25/137 (18%)
Query: 1111 LILWGNNLSGI---IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLT 1167
+ L+ + IPSS L L N L F QL L LS N L+
Sbjct: 12 IRCNSKGLTSVPTGIPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 1168 TGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIP 1227
S L+ L L N + + ++ L LE+ + L+
Sbjct: 66 FKGCCSQ-----SDFGTTSLKYLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLK---- 114
Query: 1228 VEFEGEIPSGGPFVNFT 1244
++ F++
Sbjct: 115 -----QMSEFSVFLSLR 126
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 25/229 (10%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN-LQLDGAIKSFDAECEVLRRVRHRN 801
+ S+++G G+ +V++ G AIKVFN + + E EVL+++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 802 LVKI--ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQR--LDIMIDVASALEYL 857
+VK+ I + K LI+E+ P GSL L + + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 858 H-HGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
+G ++H ++KP N++ D +V L+DFG ++ L+ +D ++ T Y+
Sbjct: 129 RENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSL-YGTEEYL 182
Query: 913 APEYGSEGIVSTCG--------DVYSFGILMIETFTRKMPTDEMFTGET 953
P+ ++ D++S G+ T +P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 59/300 (19%), Positives = 111/300 (37%), Gaps = 30/300 (10%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKI--V 1397
+LG G ++V++ G AIK+F+ R + E EV++++ H+N+ K+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQR--LDIMIDVACALEYLHQGYSTS 1455
+ K LI+++ P GSL L + + + L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 1456 IIHCDLKPSNVLL----DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG 1511
I+H ++KP N++ D V L DFG A+ L+ D ++ T Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSL-YGTEEYLHPDMYERA 190
Query: 1512 IVSTSG--------DVYSFGILMMETLTRRKPTDDMFTGEVC---LKHWVEESLPDAVTD 1560
++ D++S G+ T P + + A++
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLAL----KCSEEIPEERMNVKDALANLKKIKTK 1616
V A + D+ + L E E+ A I +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 50/213 (23%), Positives = 78/213 (36%), Gaps = 21/213 (9%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEV---LRR 796
F + +G GS+G V+K G A+K G EV +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+H V++ + G L E SL++ + +L Q + D AL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE- 915
LH ++H D+KP+N+ L L DFG+ L + YMAPE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPEL 227
Query: 916 ----YGSEGIVSTCGDVYSFGILMIETFTRKMP 944
YG+ DV+S G+ ++E
Sbjct: 228 LQGSYGTA------ADVFSLGLTILEVACNMEL 254
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 50/208 (24%), Positives = 81/208 (38%), Gaps = 21/208 (10%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKI--FSLQEDRALKSFDAECEVMRRI-RHRN 1392
F + LG G + V+K DG A+K + + AE ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
++ + G L + SL++ + L Q + D AL +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-----Y 1507
S ++H D+KP+N+ L LGDFG+ L + YMAPE Y
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQE-GDPRYMAPELLQGSY 232
Query: 1508 GSEGIVSTSGDVYSFGILMMETLTRRKP 1535
G T+ DV+S G+ ++E +
Sbjct: 233 G------TAADVFSLGLTILEVACNMEL 254
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 56/348 (16%), Positives = 118/348 (33%), Gaps = 64/348 (18%)
Query: 215 LYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGR 274
+ + L+ + P + ++ L NN + + + L +L L L + +
Sbjct: 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNKISKI 91
Query: 275 IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334
P L L L NQL + +P + ++ ++++ N ++ + S
Sbjct: 92 SPGAFAPLVKLERLYLSKNQLKE---------LPEKMP--KTLQELRVHENEIT-KVRKS 139
Query: 335 TGINLPNLLRLYLWGNNL--SGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392
L ++ + L N L SG+ + KL+ + ++ + + + L
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTE 196
Query: 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAG 452
L+L +++ + L N L L + N + S
Sbjct: 197 LHLDGNKIT--KVDAA--SLKGLNN---LAKLGLSFNSISAVDNGS-------------- 235
Query: 453 SCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE- 511
N ++ L L N+L +P + + +Q + L NNI +I S
Sbjct: 236 -----------LANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNIS-AIGSND 282
Query: 512 ------LCQLESLNTLLLQGNALQNQI--PTCLANLTSLRALNLSSNR 551
+ S + + L N +Q P+ + A+ L + +
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 67/322 (20%), Positives = 126/322 (39%), Gaps = 37/322 (11%)
Query: 88 HGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSN 147
H RV S +LGL +P + L++ N+ + + L + L +N
Sbjct: 32 HLRVVQCS--DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 148 RISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI- 206
+IS + L +LE +S NQ+ +LP + L+ L V NE+T ++ +++
Sbjct: 87 KIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVF 141
Query: 207 GNLTELMELYLNGNNLQ-GEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQEL 264
L +++ + L N L+ F + L I +A+ ++ ++P L PSL EL
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL---PPSLTEL 197
Query: 265 NLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLY 323
+L T ++ L LGL N ++ +L ++ + L
Sbjct: 198 HLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT--------PHLRELHLN 248
Query: 324 GNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSIC------NASKLTVLELSRN--L 375
N L +P + + +YL NN+S + + C + + + L N
Sbjct: 249 NNKLV-KVPGGLA-DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
Query: 376 FSGLVANTFGNCRQLQILNLAY 397
+ + +TF + L
Sbjct: 307 YWEIQPSTFRCVYVRAAVQLGN 328
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 65/371 (17%), Positives = 126/371 (33%), Gaps = 81/371 (21%)
Query: 139 LRIIDLSSNRIS---GNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSF 195
LR++ S + +L D L D+ +N+IT + L L +
Sbjct: 33 LRVVQCSDLGLEKVPKDLPPD----TALL---DLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 196 NELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDL 254
N+++ +I L +L LYL+ N L+ E P + +L+ + + N + + +
Sbjct: 86 NKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSV 140
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
L + + L N L G I + F
Sbjct: 141 FNGLNQMIVVELGT------------------------NPLKSSG-------IENGAFQG 169
Query: 315 -SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSR 373
+ I++ +++ +P P+L L+L GN ++ V +S+ + L L LS
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 374 NLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKG 433
N S + + N L+ L+L ++L L + +Y++ + + N
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKL--------VKVPGGLADHKYIQVVYLHNNNISA 277
Query: 434 ILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTI--PTTVGKL 491
I N P ++ +SL+ N + P+T +
Sbjct: 278 IGSNDFCP-------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 492 QNLQGLDLSYN 502
+ L
Sbjct: 319 YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 30/292 (10%)
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
+L + L +P + +L+L N + + F N + L L L +++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI 460
+ +S G F+ L L L + N L + K+L+ E+ +
Sbjct: 89 S--KISPG--AFAPLVK---LERLYLSKNQ----LKELPEKMPKTLQELRVHENEITK-V 136
Query: 461 PAE-FGNLSNIIALSLYQNQLAST-IPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQLES 517
F L+ +I + L N L S+ I ++ L + ++ NI +IP L S
Sbjct: 137 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L L L GN + L L +L L LS N +++ + + ++ + + N L
Sbjct: 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCSIPSS-------IGGLKDLTYLALARN 622
+P + + K + +YL N +S +I S+ + ++L N
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSN 303
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 45/239 (18%), Positives = 90/239 (37%), Gaps = 40/239 (16%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYNNKFTGR 1038
L L + NKI+ P L +L L+L N L+ ++ N+ T +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT-K 135
Query: 1039 IPQN-LGNCTLLNFLILRQNQLTGV----------------RLASNKLIGRIPSMIFNNS 1081
+ ++ + + L N L R+A I IP +
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGLP--P 192
Query: 1082 NIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENL 1141
++ + L GN + + ++ L NL L L N++S + S+ N + L L+ N
Sbjct: 193 SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
Query: 1142 FSGLIPNTFGNCRQLQILDLSLNHLTT--GSSTQGHSFYTSLTNCRYLRRLVLQNNPLK 1198
+P + + +Q++ L N+++ + + T + + L +NP++
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS---YSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 54/265 (20%), Positives = 94/265 (35%), Gaps = 53/265 (20%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFT 1036
L + NKIT NL L L L N + YL N+
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 1037 GRIPQNL-GNCTLLNFLILRQNQLTGVR--------------LASNKL-IGRIPSMIFNN 1080
+P+ + L + +N++T VR L +N L I + F
Sbjct: 114 -ELPEKMPKTLQELR---VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 1081 -SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSE 1139
+ I++ + + +P + P+L L L GN ++ + +S+ + + LGLS
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 1140 NLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKG 1199
N S + + N L+ L L+ N L L + +Y++ + L NN +
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGG--------LADHKYIQVVYLHNNNIS- 276
Query: 1200 ALPNSIGNLSTSLEYFFASSTELRG 1224
+IG+ + G
Sbjct: 277 ----AIGSNDFCPPGYNTKKASYSG 297
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 39/224 (17%), Positives = 77/224 (34%), Gaps = 37/224 (16%)
Query: 992 LKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNL-EAYLYNNKFTGRIPQNLGNCTLL 1049
L+ L + N+IT + ++V L ++ + L N L + + N F G L
Sbjct: 123 LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG--------MKKL 173
Query: 1050 NFLILRQNQLTGV-----------RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHL 1097
+++ + +T + L NK I ++ + +N+ + L N S +
Sbjct: 174 SYIRIADTNITTIPQGLPPSLTELHLDGNK-ITKVDAASLKGLNNLAKLGLSFNSIS-AV 231
Query: 1098 PSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFG------ 1151
+ P+L+ L L N L +P + + + ++ L N S + N F
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290
Query: 1152 NCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNN 1195
+ L N + + + L N
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPS-----TFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 8/150 (5%)
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
+ LDL N I + L++L+TL+L N + P A L L L LS N+L
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 553 NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQL-SCSIPSSI-GG 610
+L+ + N ++ L + + L N L S I + G
Sbjct: 113 KELPEKMPKTLQEL---RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 611 LKDLTYLALARNGFQGSIPEAIGSLISLEK 640
+K L+Y+ +A +IP+ G SL +
Sbjct: 170 MKKLSYIRIADTNIT-TIPQ--GLPPSLTE 196
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 44/229 (19%), Positives = 80/229 (34%), Gaps = 41/229 (17%)
Query: 1014 TELRELHLHGNNLEA---------------YLYNNKFTGRIPQNLGNCTLLNFLILRQNQ 1058
+ L L N + L NNK + P L L L +NQ
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 1059 LTGV-----------RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHF-SGHLPSSIGPYL 1105
L + R+ N+ I ++ +FN + + ++L N S + + +
Sbjct: 112 LKELPEKMPKTLQELRVHENE-ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
L + + N++ I + ++ L L N + + + L L LS N
Sbjct: 171 KKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLAKLGLSFNS 227
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
++ + SL N +LR L L NN L +P + + ++
Sbjct: 228 ISAVDN-------GSLANTPHLRELHLNNNKLV-KVPGGLADH-KYIQV 267
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 26/147 (17%), Positives = 44/147 (29%), Gaps = 29/147 (19%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS---GNLFDDMCN 159
+ L+ L L +S N L P LR + L++N++ G L D
Sbjct: 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD---- 261
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNG 219
++ + +N I+ + P + L
Sbjct: 262 -HKYIQVVYLHNNNIS------------------AIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 220 NNLQ-GEFPPTIF-NVSSLRVIVLANN 244
N +Q E P+ F V + L N
Sbjct: 303 NPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 24/128 (18%), Positives = 45/128 (35%), Gaps = 15/128 (11%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
N L +L +S N I+ ++ N LRELHL+ N L ++P L + +
Sbjct: 216 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV----------KVPGGLADHKYI 265
Query: 1050 NFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH-LPSSIGPYLPNL 1108
+ L N ++ + G ++ + L+ N + S +
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKK----ASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 1109 QGLILWGN 1116
+ L
Sbjct: 322 AAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 24/133 (18%), Positives = 42/133 (31%), Gaps = 15/133 (11%)
Query: 1082 NIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENL 1141
++ +Q +P + P + L L N ++ I N + L L N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP---DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 1142 FSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGAL 1201
S + P F +L+ L LS N L + L+ L + N +
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLK---ELPEKMP-------KTLQELRVHENEITKVR 137
Query: 1202 PNSIGNLSTSLEY 1214
+ L +
Sbjct: 138 KSVFNGL-NQMIV 149
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRN 801
+G GSFG VY+ VAIK N + A F E V++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK---------YTLNIQQRLDIMIDVAS 852
+V+++ S +I+E M +G L+ +L S + ++ + + + ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGY 911
+ YL+ +H DL N ++ +D + DFG+++ + D L +
Sbjct: 150 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 912 MAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
M+PE +G+ +T DV+SFG+++ E T + P
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 1343 LGTGIFSSVYKATFADG------TNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
LG G F VY+ T AIK ++ E R F E VM+ ++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSH---------NYLLNIEQRLDIMIDVACA 1444
+++ S +I++ M +G L+ +L S ++ + + + ++A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYM 1503
+ YL+ + +H DL N ++ +D +GDFG+ + + D K L + +M
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTR 1532
+PE +G+ +T DV+SFG+++ E T
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 31/214 (14%)
Query: 750 NLIGAGSFGSVYKATL---PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-RHRN 801
++IG G+FG V KA + M+ AIK + A + F E EVL ++ H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSH---------------KYTLNIQQRLDI 846
++ ++ +C + G+ L +EY P G+L +L TL+ QQ L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 847 MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL 906
DVA ++YL IH DL N+L+ ++ VA ++DFG+S+ E V +TM
Sbjct: 148 AADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202
Query: 907 ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+MA E + + +T DV+S+G+L+ E +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 1341 NLLGTGIFSSVYKATFADG---TNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNL 1393
+++G G F V KA +AAIK ++E + F E EV+ ++ H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRLDIM 1438
++ +C + G+ L ++Y P G+L +L L+ +Q L
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
DVA ++YL IH DL N+L+ ++ VA + DFG+++ + +K+TM
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKTMGRL 203
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MA E + + +T+ DV+S+G+L+ E ++
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-29
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN-LQLDGAIKSFDAECEVLRRVRHRNLVKI--I 806
++G G+ +V++ G AIKVFN + + E EVL+++ H+N+VK+ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQR--LDIMIDVASALEYLH-HGHPT 863
+ K LI+E+ P GSL L + + L ++ DV + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 864 PVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
++H ++KP N++ D +V L+DFG ++ L+ +D ++ T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSL-YGTEEYLHPDMYER 189
Query: 920 GIVSTCG--------DVYSFGILMIETFTRKMPTDEMFTGET 953
++ D++S G+ T +P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 60/305 (19%), Positives = 114/305 (37%), Gaps = 30/305 (9%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS-LQEDRALKSFDAECEVMRRIRHRNLAKI--V 1397
+LG G ++V++ G AIK+F+ + R + E EV++++ H+N+ K+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQR--LDIMIDVACALEYLHQGYSTS 1455
+ K LI+++ P GSL L + + + L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 1456 IIHCDLKPSNVLL----DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG 1511
I+H ++KP N++ D V L DFG A+ L+ D ++ T Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSL-YGTEEYLHPDMYERA 190
Query: 1512 IVSTSG--------DVYSFGILMMETLTRRKPTDDMFTGEVC---LKHWVEESLPDAVTD 1560
++ D++S G+ T P + + A++
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLAL----KCSEEIPEERMNVKDALANLKKIKTK 1616
V A + D+ + L E E+ A I +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
Query: 1617 FLKDV 1621
+ V
Sbjct: 311 MVIHV 315
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 51/228 (22%), Positives = 84/228 (36%), Gaps = 24/228 (10%)
Query: 1328 QELRLATNGFSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMR 1386
+ + + LG G FS V DG A+K E + + E ++ R
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 1387 RIRHRNLAKIVSSCSNPGFKA----LILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMI 1439
H N+ ++V+ C L+L + +G+L + L +Q L +++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA- 1498
+ LE +H + H DLKP+N+LL D+ L D G +
Sbjct: 142 GICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 1499 -------TIGYMAPE----YGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
TI Y APE I + DV+S G ++ + P
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERT-DVWSLGCVLYAMMFGEGP 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 50/227 (22%), Positives = 83/227 (36%), Gaps = 24/227 (10%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G G F V L G A+K + E ++ R H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 810 ---SNHGFKALIL-EYMPQGSLEKWLYSHKYT---LNIQQRLDIMIDVASALEYLHHGHP 862
+A +L + +G+L + K L Q L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA--------TFGYMAP 914
H DLKP+N+LL D+ L D G ++ T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 915 E----YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957
E I DV+S G ++ + P D +F S+
Sbjct: 213 ELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 39/227 (17%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-R 798
Q L + ++G GS G+V G VA+K + E ++L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDD 67
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL------DIMIDVAS 852
H N+++ S + F + LE +L+ + S + + ++ +AS
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLD-------------DDTVAHLSDFGISKLLD-GE 897
+ +LH +IH DLKP N+L+ ++ +SDFG+ K LD G+
Sbjct: 127 GVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 898 DSVTQTMTLA--TFGYMAPEY--GSEGIVSTCG-----DVYSFGILM 935
S + T G+ APE S + + D++S G +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 62/328 (18%), Positives = 107/328 (32%), Gaps = 73/328 (22%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAK 1395
+LG G +V G A+K + E +++ H N+ +
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 1396 IVSSCSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLH 1449
S + F + L+ +L K + N L E + ++ +A + +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 1450 QGYSTSIIHCDLKPSNVLLD-------------DDMVAHLGDFGIAKLLD-GVDSMKQTM 1495
S IIH DLKP N+L+ +++ + DFG+ K LD G S + +
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 1496 TLA--TIGYMAPEYGSEGIVSTSG-------DVYSFGILMMETLTRRKP--------TDD 1538
T G+ APE E + D++S G + L++ K +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 1539 MFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPE 1598
+ G L + + D L+ + + P
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATD--LI-----------SQMIDHD-----------PL 285
Query: 1599 ERMNVKDALA----NLKKIKTKFLKDVQ 1622
+R L K K +FL V
Sbjct: 286 KRPTAMKVLRHPLFWPKSKKLEFLLKVS 313
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 63/319 (19%), Positives = 113/319 (35%), Gaps = 42/319 (13%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
NL +P I +N ++ L+ N + + ++ +L +L L L N++ + +
Sbjct: 53 KNLRE-VPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAF 108
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
+ L LEL N + + F +L+ L L + + S+ F+ + +
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE--SIPSYA--FNRIPS--- 161
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480
LR L + + F LSN+ L+L L
Sbjct: 162 LRRLDLGELKRLSYISEGA------------------------FEGLSNLRYLNLAMCNL 197
Query: 481 ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCLANL 539
IP + L L LDLS N++ +I L L L + + +Q NL
Sbjct: 198 -REIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254
Query: 540 TSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS-GCLPQDIGNLKVLTGLYLSGN 598
SL +NL+ N L F L ++ + N + C + +
Sbjct: 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWIKDMAPSNTAC 314
Query: 599 QLSCSIPSSIGG--LKDLT 615
C+ P ++ G + +L
Sbjct: 315 CARCNTPPNLKGRYIGELD 333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 67/287 (23%), Positives = 110/287 (38%), Gaps = 44/287 (15%)
Query: 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQ 399
++ NL +P I ++ +L L N + N+F + R L+IL L+ +
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGG 459
+ T + G F+ L N L L + N L+
Sbjct: 100 IRT--IEIG--AFNGLAN---LNTLELFDN-----------RLTT--------------- 126
Query: 460 IPAE-FGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSE-LCQLE 516
IP F LS + L L N + +IP+ ++ +L+ LDL I L
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
+L L L L+ IP L L L L+LS N L++ P +F L ++ + + +
Sbjct: 186 NLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 577 SGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARN 622
NL+ L + L+ N L+ +P + L L + L N
Sbjct: 244 QVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 56/241 (23%), Positives = 87/241 (36%), Gaps = 18/241 (7%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQI 174
LN+ N+ N + L I+ LS N I + N L L + ++ N++
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124
Query: 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-N 232
T + SKLK L + N + IP + L L L F
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 233 VSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLR 291
+S+LR + LA +L +P L L EL+L + I L L +
Sbjct: 184 LSNLRYLNLAMCNL-REIPNL--TPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMI 239
Query: 292 DNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNN 351
+Q+ N L ++ I L N+L+ LP L +L R++L N
Sbjct: 240 QSQIQVIERNAFDNL--------QSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNP 290
Query: 352 L 352
Sbjct: 291 W 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 54/237 (22%), Positives = 89/237 (37%), Gaps = 42/237 (17%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFT 1036
+ L++ N+I + +L L L L N++ L++N+ T
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 1037 GRIPQN-LGNCTLLNFLILRQNQLTGV--------------RLASNKLIGRIPSMIFNN- 1080
IP + L L LR N + + L K + I F
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
SN+ + L + +P+ L L L L GN+LS I P S + L + ++
Sbjct: 185 SNLRYLNLAMCNLR-EIPNLTP--LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
+ N F N + L ++L+ N+LT H +T L + L R+ L +NP
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLP----HDLFTPLHH---LERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-18
Identities = 57/274 (20%), Positives = 94/274 (34%), Gaps = 48/274 (17%)
Query: 184 DCS-KLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVL 241
CS + ++ L +P I T L L+ N +Q F ++ L ++ L
Sbjct: 40 SCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQL 95
Query: 242 ANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGA 300
+ N + ++ + L +L L L D T IP + L L LR+N + +
Sbjct: 96 SRNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPS 153
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYG-NHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSS 359
+ ++ + L LS + L NL L L NL + +
Sbjct: 154 YAFNRI--------PSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLREI--PN 202
Query: 360 ICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLAT----------------- 402
+ KL L+LS N S + +F LQ L + SQ+
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 403 -----GSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
L F+ L + L + + NPW
Sbjct: 263 AHNNLTLLPHD--LFTPLHH---LERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-18
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 7/176 (3%)
Query: 468 SNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGN 526
+N L+L++NQ+ + L++L+ L LS N+I+ +I L +LNTL L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122
Query: 527 ALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFS-LNLLSGCLPQDI- 584
L L+ L+ L L +N + S F + + +D L LS + +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY-ISEGAF 181
Query: 585 GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
L L L L+ L IP+ + L L L L+ N P + L+ L+K
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-13
Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 36/237 (15%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTL 1048
SN+ ++ + +P + T R L+LH N ++ + N F ++L +
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQI-IKVNSF-----KHLRH--- 89
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPN 1107
L L L +N + I FN +N+ ++L+ N + +P+ YL
Sbjct: 90 LEILQLSRNHIR-----------TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSK 137
Query: 1108 LQGLILWGNNLSGIIPSSICNASQVILLGLSE-NLFSGLIPNTFGNCRQLQILDLSLNHL 1166
L+ L L N + I + + L L E S + F L+ L+L++ +L
Sbjct: 138 LKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197
Query: 1167 TTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELR 1223
+LT L L L N L P S L L+ + ++++
Sbjct: 198 RE---------IPNLTPLIKLDELDLSGNHLSAIRPGSFQGL-MHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 33/150 (22%), Positives = 51/150 (34%), Gaps = 6/150 (4%)
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
+ N++ +P + + L L N +Q +L L L LS N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 553 NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GGL 611
+ F L + ++ N L+ L L L+L N + SIPS +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRI 159
Query: 612 KDLTYLALARNGFQGSIPE-AIGSLISLEK 640
L L L I E A L +L
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRY 189
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 20/93 (21%), Positives = 38/93 (40%), Gaps = 7/93 (7%)
Query: 107 PHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS---GNLFDDMCNSLTE 163
P++ L L L++SGN P + L+ + + ++I N FD+ L
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN----LQS 256
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFN 196
L +++ N +T L+R+ + N
Sbjct: 257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-28
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 8/225 (3%)
Query: 722 ENDSLSLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL 780
E L + + + D F + + +GAG+ G V+K + P G+ +A K+ +L++
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 781 DGA-IKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLN 839
A E +VL +V + + G ++ +E+M GSL++ + +
Sbjct: 71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIP 129
Query: 840 IQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899
Q + I V L YL H ++H D+KPSN+L++ L DFG+S L DS
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS 185
Query: 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+ + T YM+PE S D++S G+ ++E + P
Sbjct: 186 MANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 8/234 (3%)
Query: 1304 RKRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATF-ADGTNA 1362
+K ++ E A + L + F + + LG G V+K + G
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 1363 AIKIFSLQEDRA-LKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKW 1421
A K+ L+ A E +V+ + + + G ++ +++M GSL++
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ- 120
Query: 1422 LYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGI 1481
+ + + + I V L YL + + I+H D+KPSN+L++ L DFG+
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ L +DSM + T YM+PE S D++S G+ ++E R P
Sbjct: 179 SGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 62/319 (19%), Positives = 112/319 (35%), Gaps = 42/319 (13%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
L+ +P I SN + L N++ + + T +L +L L L N++ + +
Sbjct: 64 RGLSE-VPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
+ L LEL N + + + F +L+ L L + + S+ F+ + +
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE--SIPSYA--FNRVPS--- 172
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480
L L + + +S F L N+ L+L +
Sbjct: 173 LMRLDLGEL-------KKLEYIS-----------------EGAFEGLFNLKYLNLGMCNI 208
Query: 481 ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCLANL 539
+P + L L+ L++S N+ I L SL L + + + L
Sbjct: 209 -KDMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265
Query: 540 TSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS-GCLPQDIGNLKVLTGLYLSGN 598
SL LNL+ N L+S F L Y++ + N + C + S
Sbjct: 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAWWLREYIPTNSTC 325
Query: 599 QLSCSIPSSIGG--LKDLT 615
C P + G L ++
Sbjct: 326 CGRCHAPMHMRGRYLVEVD 344
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 65/287 (22%), Positives = 103/287 (35%), Gaps = 44/287 (15%)
Query: 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQ 399
++ LS +P I S L L N + A+TF + L++L L +
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGG 459
+ + G F+ L + L L + N L+
Sbjct: 111 IRQ--IEVG--AFNGLAS---LNTLELFDN-----------WLTV--------------- 137
Query: 460 IPAE-FGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSE-LCQLE 516
IP+ F LS + L L N + +IP+ ++ +L LDL I L
Sbjct: 138 IPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
+L L L +++ +P L L L L +S N P +F L + + + +
Sbjct: 197 NLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254
Query: 577 SGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARN 622
S L L L L+ N LS S+P + L+ L L L N
Sbjct: 255 SLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 66/297 (22%), Positives = 98/297 (32%), Gaps = 71/297 (23%)
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFN 196
R ++L N I + D L LE + N I
Sbjct: 75 SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR--------------------- 112
Query: 197 ELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDL 254
+I L L L L N L P F +S LR + L NN + S+P
Sbjct: 113 ----QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYA 166
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
R+PSL L+L + +L GL
Sbjct: 167 FNRVPSLMRLDLGEL-----------------------KKLEYISEGAFEGL-------- 195
Query: 315 SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRN 374
N++ + L ++ ++P L L L + GN+ + P S S L L + +
Sbjct: 196 FNLKYLNLGMCNIK-DMP--NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 375 LFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
S + N F L LNLA++ L++ L F+ L L L + NPW
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSS--LPHD--LFTPLRY---LVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-22
Identities = 49/240 (20%), Positives = 87/240 (36%), Gaps = 16/240 (6%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQI 174
LN+ N + + L ++ L N I + N L L + ++ N +
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135
Query: 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-N 232
T + SKL+ L + N + IP + LM L L F
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 233 VSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRD 292
+ +L+ + L ++ +P L L+EL + P + L L + +
Sbjct: 195 LFNLKYLNLGMCNIK-DMPNL--TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 293 NQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352
+Q++ N GL +++ + L N+LS +LP L L+ L+L N
Sbjct: 252 SQVSLIERNAFDGL--------ASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 9e-20
Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 42/237 (17%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFT 1036
+ L++ N I T +L L L L N++ L++N T
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136
Query: 1037 GRIPQN-LGNCTLLNFLILRQNQLTGV--------------RLASNKLIGRIPSMIFNN- 1080
IP + L L LR N + + L K + I F
Sbjct: 137 -VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSEN 1140
N++ + L + +P+ L L+ L + GN+ I P S S + L + +
Sbjct: 196 FNLKYLNLGMCNIK-DMPNLTP--LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 1141 LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
S + N F L L+L+ N+L++ H +T L L L L +NP
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLP----HDLFTPLRY---LVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-18
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 18/173 (10%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWL-MPRLRIIDLSSN----RISGNLFDDM 157
IP LS L L + N ++P+ + +P L +DL IS F+
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG- 194
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQN-IGNLTELMELY 216
L L+ ++ I +P+ L L+ L +S N I L+ L +L+
Sbjct: 195 ---LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLW 248
Query: 217 LNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
+ + + F ++SL + LA+N+L SLP DL L L EL+L
Sbjct: 249 VMNSQVS-LIERNAFDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-13
Identities = 44/238 (18%), Positives = 90/238 (37%), Gaps = 38/238 (15%)
Query: 989 SNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCT 1047
SN+ ++ + ++ +P+ + + R L+L NN++ I + +
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ----------MIQADTFRHLH 99
Query: 1048 LLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLP 1106
L L L +N + +I FN +++ ++L+ N + +PS YL
Sbjct: 100 HLEVLQLGRNSIR-----------QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLS 147
Query: 1107 NLQGLILWGNNLSGIIPSSICNASQVILLGLSE-NLFSGLIPNTFGNCRQLQILDLSLNH 1165
L+ L L N + I + ++ L L E + F L+ L+L + +
Sbjct: 148 KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELR 1223
+ +LT L L + N P S L +SL+ + ++++
Sbjct: 208 IKD---------MPNLTPLVGLEELEMSGNHFPEIRPGSFHGL-SSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-11
Identities = 31/149 (20%), Positives = 49/149 (32%), Gaps = 6/149 (4%)
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
+ + + +P + + L L N +Q +L L L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 553 NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GGL 611
F L + ++ N L+ L L L+L N + SIPS +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170
Query: 612 KDLTYLALARNGFQGSIPE-AIGSLISLE 639
L L L I E A L +L+
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLK 199
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 49/211 (23%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G FG+VY A +A+KV L+ G E E+ +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 806 ISSCSNHGFKA------LILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASA 853
+G+ LILEY P G++ Y L + D + ++A+A
Sbjct: 75 ------YGYFHDATRVYLILEYAPLGTV----YRE---LQKLSKFDEQRTATYITELANA 121
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM--TLATFGY 911
L Y H VIH D+KP N+LL ++DFG S S + TL Y
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLCGTLD---Y 173
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIE 937
+ PE ++ D++S G+L E
Sbjct: 174 LPPE-----MIEGRMHDEKVDLWSLGVLCYE 199
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 1341 NLLGTGIFSSVYKATFAD-GTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKI 1396
LG G F +VY A A+K+ L++ E E+ +RH N+ ++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+ LIL+Y P G++ + L + + ++A AL Y H S +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-YITELANALSYCH---SKRV 130
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM--TLATIGYMAPEYGSEGIVS 1514
IH D+KP N+LL + DFG + S + + TL Y+ PE ++
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLCGTLD---YLPPE-----MIE 180
Query: 1515 TSG-----DVYSFGILMMETLTRRKPTDD 1538
D++S G+L E L + P +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G+FG V+ A M VA+K A K F E E+L ++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSH---------------KYTLNIQQRLDIMIDV 850
C + ++ EYM G L K+L +H K L + Q L I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF- 909
AS + YL H +H DL N L+ + + + DFG+S+ + D +
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-YYRVGGHTMLP 198
Query: 910 -GYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M PE +T DV+SFG+++ E FT
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLA 1394
LG G F V+ A D A+K +L++ A K F E E++ ++H ++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRLDIMI 1439
K C + ++ +YM G L K+L +H L + Q L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLA 1498
+A + YL S +H DL N L+ +++ +GDFG+++ + D T+
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
I +M PE +T DV+SFG+++ E T
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+G G+FG V+ A M VA+K + A + F E E+L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSH--------------KYTLNIQQRLDIMIDVA 851
C+ ++ EYM G L ++L SH L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF-- 909
+ + YL H +H DL N L+ V + DFG+S+ + D +
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPI 224
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+M PE +T DV+SFG+++ E FT
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 1343 LGTGIFSSVYKATFADG------TNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLA 1394
LG G F V+ A + A+K +L+E + A + F E E++ ++H+++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSH--------------NYLLNIEQRLDIMID 1440
+ C+ ++ +YM G L ++L SH L + Q L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLAT 1499
VA + YL +H DL N L+ +V +GDFG+++ + D T+
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
I +M PE +T DV+SFG+++ E T
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRN 801
+G G FG V KAT VA+K+ + A ++ +E VL++V H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK-----------------------YTL 838
++K+ +CS G LI+EY GSL +L + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 839 NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898
+ + ++ ++YL ++H DL N+L+ + +SDFG+S+ + ED
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 899 S-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
S V ++ +MA E + I +T DV+SFG+L+ E T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 1343 LGTGIFSSVYKATFADG------TNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
LG G F V KAT T A+K L+E L+ +E V++++ H ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-----------------------NYLLN 1430
K+ +CS G LI++Y GSL +L L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 1431 IEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490
+ + ++ ++YL ++H DL N+L+ + + DFG+++ + DS
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 1491 -MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+K++ + +MA E + I +T DV+SFG+L+ E +T
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRN 801
+G G+FG VY+ + P + VA+K + F E ++ + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK------YTLNIQQRLDIMIDVASALE 855
+V+ I + +++E M G L+ +L + +L + L + D+A +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 856 YLHHGHPTPVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLDGEDSVTQTMTLATFG-- 910
YL H IH D+ N LL VA + DFG+++ + S + A
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVK 210
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
+M PE EGI ++ D +SFG+L+ E F+ MP
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 1343 LGTGIFSSVYKATFADG------TNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
LG G F VY+ + A+K +L E ++ F E ++ + H+N+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSH------NYLLNIEQRLDIMIDVACALEY 1447
+ + + ++++ M G L+ +L L + L + D+AC +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 1448 LHQGYSTSIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYM 1503
L IH D+ N LL VA +GDFG+A+ + K + + +M
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLT 1531
PE EGI ++ D +SFG+L+ E +
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 736 YQELQRLTD---GFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAEC 791
Y+ ++R D + +G G+FG VYKA G A KV + + ++ + E
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
E+L H +VK++ + + G +++E+ P G+++ + L Q + +
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
AL +LH +IH DLK NVL+ + L+DFG+S + + T +
Sbjct: 128 EALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYW 183
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIE 937
MAPE + D++S GI +IE
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
+ LG G F VYKA G AA K+ + + L+ + E E++ H + K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
++ + + G +++++ P G+++ + + L Q + + AL +LH S
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEGI 1512
IIH DLK NVL+ + L DFG++ + + IG +MAPE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF----IGTPYWMAPEVVMCET 193
Query: 1513 VSTSG-----DVYSFGILMMETLTRRKPTDDM 1539
+ + D++S GI ++E P ++
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 47/203 (23%), Positives = 92/203 (45%), Gaps = 36/203 (17%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVKII 806
L+G GSF VY+A + G+ VAIK+ + + G ++ E ++ +++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL- 76
Query: 807 SSCSNHGFKA------LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
+ + L+LE G + ++L + + + M + + + YLH
Sbjct: 77 -----YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM--TLATFGYMAPE--- 915
++H DL SN+LL + ++DFG++ L T+ T Y++PE
Sbjct: 132 G---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN---YISPEIAT 185
Query: 916 ---YGSEGIVSTCGDVYSFGILM 935
+G E DV+S G +
Sbjct: 186 RSAHGLE------SDVWSLGCMF 202
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LLG G F+ VY+A G AIK+ + + ++ E ++ +++H ++ ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
+ + + L+L+ G + ++L + + + M + + YLH S I+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM--TLATIGYMAPE------YGS 1509
H DL SN+LL +M + DFG+A L T+ T Y++PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN---YISPEIATRSAHGL 191
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
E DV+S G + L R P D
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDT 214
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-RHR 800
+G G+FG V +A VA+K+ +GA ++ +E ++L + H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 801 NLVKIISSCSNHGFKA-LILEYMPQGSLEKWLYSH---------------KYTLNIQQRL 844
N+V ++ +C+ G +I+E+ G+L +L S K L ++ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 845 DIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQT 903
VA +E+L IH DL N+LL + V + DFG+++ + + V +
Sbjct: 152 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
+MAPE + + + DV+SFG+L+ E F+ P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRN 1392
LG G F V +A A A+K L+E ++ +E +++ I H N
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 1393 LAKIVSSCSNPGFKA-LILQYMPQGSLEKWLYSH---------------NYLLNIEQRLD 1436
+ ++ +C+ PG +I+++ G+L +L S L +E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTM 1495
VA +E+L S IH DL N+LL + V + DFG+A+ + +++
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + + DV+SFG+L+ E +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-27
Identities = 59/229 (25%), Positives = 89/229 (38%), Gaps = 38/229 (16%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA-IKSFDAECEVLRRVRHRNLVKII--- 806
+G G FG V + G VAIK +L + + E ++++++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 807 ---SSCSNHGFKALILEYMPQGSLEKWLYSHK--YTLNIQQRLDIMIDVASALEYLHHGH 861
+ + L +EY G L K+L + L ++ D++SAL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 862 PTPVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAP 914
+IH DLKP N++L + + D G +K LD Q F Y+AP
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD------QGELCTEFVGTLQYLAP 192
Query: 915 E------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957
E Y D +SFG L E T P + K
Sbjct: 193 ELLEQKKYTVT------VDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 5e-23
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIV--- 1397
LGTG F V + G AIK + + + + E ++M+++ H N+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 1398 ---SSCSNPGFKALILQYMPQGSLEKWLYSH--NYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ L ++Y G L K+L L ++ D++ AL YLH+
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-- 139
Query: 1453 STSIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--- 1506
IIH DLKP N++L ++ + D G AK LD + + T+ Y+APE
Sbjct: 140 -NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEF-VGTLQYLAPELLE 196
Query: 1507 ---YGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
Y D +SFG L E +T +P
Sbjct: 197 QKKYTVT------VDYWSFGTLAFECITGFRPFLP 225
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-RHR 800
+GAG+FG V +AT M VA+K+ A ++ +E +VL + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK-----------------YTLNIQQR 843
N+V ++ +C+ G +I EY G L +L + L+++
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQ 902
L VA + +L + IH DL N+LL + + DFG+++ + + + V +
Sbjct: 148 LSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
+MAPE + + DV+S+GI + E F+ P
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRN 1392
LG G F V +AT A+K L+ ++ +E +V+ + H N
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-----------------NYLLNIEQRL 1435
+ ++ +C+ G +I +Y G L +L L++E L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 1436 DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQT 1494
VA + +L S + IH DL N+LL + + DFG+A+ + + + +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + DV+S+GI + E +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRN 801
+G FG VYK L VAIK D A + F E + R++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSH---------------KYTLNIQQRLDI 846
+V ++ + ++I Y G L ++L K L + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 847 MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMT 905
+ +A+ +EYL H V+H DL NVL+ D +SD G+ + + D +
Sbjct: 134 VAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 906 LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
L +MAPE G S D++S+G+++ E F+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 1343 LGTGIFSSVYKATFADG------TNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
LG F VYK AIK +L++ + F E + R++H N+
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 1394 AKI--VSSCSNPGFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRLD 1436
+ V + P +I Y G L ++L L +
Sbjct: 75 VCLLGVVTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTM 1495
++ +A +EYL S ++H DL NVL+ D + + D G+ + + D
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+L I +MAPE G S D++S+G+++ E +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
++ IG G+ G+VY A + G VAI+ NLQ + E V+R ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
+ S +++EY+ GSL + + ++ Q + + ALE+LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------YGS 918
VIH D+K N+LL D L+DFG + E S TM + T +MAPE YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGP 195
Query: 919 EGIVSTCGDVYSFGILMIE 937
+ D++S GI+ IE
Sbjct: 196 K------VDIWSLGIMAIE 208
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
++ +G G +VY A A G AI+ +LQ+ + E VMR ++ N+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ S ++++Y+ GSL + ++ Q + + ALE+LH S
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEGI 1512
+IH D+K N+LL D L DFG + S + TM +G +MAPE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----VGTPYWMAPEVVTRKA 192
Query: 1513 VSTSGDVYSFGILMME 1528
D++S GI+ +E
Sbjct: 193 YGPKVDIWSLGIMAIE 208
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 752 IGAGSFGSVYKATLP--------YGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-R 798
+G G+FG V A + VA+K+ D A + +E E+++ + +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK---------------YTLNIQQR 843
H+N++ ++ +C+ G +I+EY +G+L ++L + + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
+ +A +EYL IH DL NVL+ ++ V ++DFG+++ ++ D +T
Sbjct: 160 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 904 MTLATFG-----YMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
T G +MAPE + + + DV+SFG+LM E FT P
Sbjct: 217 ----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 1343 LGTGIFSSVYKATFAD--------GTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RH 1390
LG G F V A A+K L++ ++ L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRL 1435
+N+ ++ +C+ G +I++Y +G+L ++L + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 1436 DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQT 1494
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D K T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + + DV+SFG+LM E T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 43/222 (19%)
Query: 752 IGAGSFGSVYKATLP--------YGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-R 798
+G G+FG V A VA+K+ A + +E E+++ + +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK---------------YTLNIQQR 843
H+N++ ++ +C+ G +I+EY +G+L ++L + + L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
+ VA +EYL IH DL NVL+ +D V ++DFG+++ + D +T
Sbjct: 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 904 MTLATFG-----YMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
T G +MAPE + I + DV+SFG+L+ E FT
Sbjct: 251 ----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 71/266 (26%), Positives = 111/266 (41%), Gaps = 39/266 (14%)
Query: 1300 LLRRRKRDKSRPTENNLLNTAALRRISYQELRLATNG-FSESNL-----LGTGIFSSVYK 1353
D PT NL L +S EL L LG G F V
Sbjct: 28 YHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVL 87
Query: 1354 ATFAD--------GTNAAIKIFSLQED---RALKSFDAECEVMRRI-RHRNLAKIVSSCS 1401
A T A+K L+ D + L +E E+M+ I +H+N+ ++ +C+
Sbjct: 88 AEAIGLDKDKPNRVTKVAVK--MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145
Query: 1402 NPGFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRLDIMIDVACALE 1446
G +I++Y +G+L ++L + L+ + + VA +E
Sbjct: 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME 205
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAP 1505
YL S IH DL NVL+ +D V + DFG+A+ + +D K T + +MAP
Sbjct: 206 YLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262
Query: 1506 EYGSEGIVSTSGDVYSFGILMMETLT 1531
E + I + DV+SFG+L+ E T
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRN 801
+G G+FG VY+ + P + VA+K + F E ++ + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK------YTLNIQQRLDIMIDVASALE 855
+V+ I + ++LE M G L+ +L + +L + L + D+A +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 856 YLHHGHPTPVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGY 911
YL H IH D+ N LL VA + DFG+++ + + +
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 912 MAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
M PE EGI ++ D +SFG+L+ E F+ MP
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
LG G F VY+ A+K +L E ++ F E ++ + H+N+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSH------NYLLNIEQRLDIMIDVACALEY 1447
+ + + ++L+ M G L+ +L L + L + D+AC +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 1448 LHQGYSTSIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYM 1503
L IH D+ N LL VA +GDFG+A+ + K + + +M
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLT 1531
PE EGI ++ D +SFG+L+ E +
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
IG GS G V A G VA+K+ +L+ + E ++R +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
+ S +++E++ G+L + S LN +Q + V AL YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTD-IVSQV-RLNEEQIATVCEAVLQALAYLHAQG--- 161
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------YGS 918
VIH D+K ++LL D LSDFG + + +++ + T +MAPE Y +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSLYAT 220
Query: 919 EGIVSTCGDVYSFGILMIE 937
E D++S GI++IE
Sbjct: 221 E------VDIWSLGIMVIE 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
+G G V A G A+K+ L++ + + E +MR +H N+ +
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ S ++++++ G+L + S L N EQ + V AL YLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTD-IVSQVRL-NEEQIATVCEAVLQALAYLH---AQG 161
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEGI 1512
+IH D+K ++LL D L DFG + ++++ +G +MAPE S +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----VGTPYWMAPEVISRSL 217
Query: 1513 VSTSGDVYSFGILMME 1528
+T D++S GI+++E
Sbjct: 218 YATEVDIWSLGIMVIE 233
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 43/222 (19%)
Query: 752 IGAGSFGSVYKATL--------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-R 798
+G G FG V A + VA+K+ D A + +E E+++ + +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK---------------YTLNIQQR 843
H+N++ ++ +C+ G +I+EY +G+L ++L + + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
+ +A +EYL IH DL NVL+ ++ V ++DFG+++ ++ D +T
Sbjct: 206 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 904 MTLATFG-----YMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
T G +MAPE + + + DV+SFG+LM E FT
Sbjct: 263 ----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 1343 LGTGIFSSVYKAT--------FADGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RH 1390
LG G F V A + A+K L++ ++ L +E E+M+ I +H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRL 1435
+N+ ++ +C+ G +I++Y +G+L ++L + + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 1436 DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQT 1494
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D K T
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + + DV+SFG+LM E T
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 49/210 (23%)
Query: 751 LIGAGSFGSVYKA-TLPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G G FG+VY A +A+KV L+ +G E E+ +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM- 79
Query: 807 SSCSNHGFKA------LILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASAL 854
+ + L+LE+ P+G L Y L R D M ++A AL
Sbjct: 80 -----YNYFHDRKRIYLMLEFAPRGEL----YKE---LQKHGRFDEQRSATFMEELADAL 127
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM--TLATFGYM 912
Y H VIH D+KP N+L+ ++DFG S +TM TL Y+
Sbjct: 128 HYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMCGTLD---YL 179
Query: 913 APEYGSEGIVSTCG-----DVYSFGILMIE 937
PE ++ D++ G+L E
Sbjct: 180 PPE-----MIEGKTHDEKVDLWCAGVLCYE 204
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-23
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 23/207 (11%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LG G F +VY A A+K+ L+++ E E+ +RH N+ ++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
+ + L+L++ P+G L K L H M ++A AL Y H +I
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT-FMEELADALHYCH---ERKVI 136
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSEGIVSTS 1516
H D+KP N+L+ + DFG + + T+ T+ Y+ PE ++
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPPE-----MIEGK 187
Query: 1517 G-----DVYSFGILMMETLTRRKPTDD 1538
D++ G+L E L P D
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDS 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 57/199 (28%), Positives = 83/199 (41%), Gaps = 20/199 (10%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA-IKSFDAECEVLRR-VRHRNLVKIISS 808
IG G++GSV K P G +A+K +D K + +V+ R +V+ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLHHGHP 862
G + +E M S +K+ + + I + AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE----YGS 918
+IH D+KPSN+LLD L DFGIS L DS+ +T YMAPE S
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 919 EGIVSTCGDVYSFGILMIE 937
DV+S GI + E
Sbjct: 203 RQGYDVRSDVWSLGITLYE 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 20/227 (8%)
Query: 1315 NLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDR 1373
++ ++ L+ Q + +G G + SV K G A+K D
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 1374 A-LKSFDAECEV-MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNI 1431
K + +V MR + + + G + ++ M S +K Y + Y +
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDK-FYKYVYSVL- 118
Query: 1432 EQRLD------IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485
+ + I + AL +L + IIH D+KPSN+LLD L DFGI+ L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 1486 DGVDSMKQTMTLATIGYMAPE----YGSEGIVSTSGDVYSFGILMME 1528
VDS+ +T YMAPE S DV+S GI + E
Sbjct: 177 --VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 35/201 (17%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
++G+G+F V+ G A+K S + E VL++++H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 810 SNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPT 863
+ L+++ + G L E+ +Y+ K ++ V SA++YLH +G
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDA------SLVIQQVLSAVKYLHENG--- 126
Query: 864 PVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE----- 915
++H DLKP N+L ++++ ++DFG+SK+ ++ + T T GY+APE
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTA-CGTPGYVAPEVLAQK 182
Query: 916 -YGSEGIVSTCGDVYSFGILM 935
Y D +S G++
Sbjct: 183 PYSKA-----V-DCWSIGVIT 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 37/202 (18%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
+LG+G FS V+ G A+K S + E V+++I+H N+ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 1401 SNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYST 1454
+ L++Q + G L E+ +Y+ E+ ++ V A++YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYT-------EKDASLVIQQVLSAVKYLH---EN 125
Query: 1455 SIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE---- 1506
I+H DLKP N+L +++ + DFG++K+ T T GY+APE
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQ 181
Query: 1507 --YGSEGIVSTSGDVYSFGILM 1526
Y D +S G++
Sbjct: 182 KPYSKA------VDCWSIGVIT 197
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-26
Identities = 43/247 (17%), Positives = 75/247 (30%), Gaps = 35/247 (14%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKAT------LPYGMNVAIKVFNLQLDGAIKSFDAEC 791
E Q + +L+G G+F VY+AT +KV
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT----LNIQQRLDIM 847
E L+ +K S+ L+ E G+L + +K T + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 848 IDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH-----------LSDFGISKLLDG 896
+ + +E +H +IH D+KP N +L + + L D G S +
Sbjct: 179 MRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 897 EDSVTQTMTLA-TFGYMAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMPTDEMFT 950
T T G+ E ++S D + + +
Sbjct: 236 FPKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 951 GETSLKK 957
GE +
Sbjct: 291 GECKPEG 297
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 44/244 (18%), Positives = 81/244 (33%), Gaps = 31/244 (12%)
Query: 1329 ELRLATNGFSESNLLGTGIFSSVYKATFADGTNA------AIKIFSLQEDRALKSFDAEC 1382
E +L + +LLG G F+ VY+AT D +A +K+ Q+ F
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV---QKPANPWEFYIGT 115
Query: 1383 EVMRRIR---HRNLAKIVSSCSNPGFKALILQYMPQGSL----EKWLYSHNYLLNIEQRL 1435
++M R++ K S+ L+ + G+L + + ++ +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 1436 DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH-----------LGDFGIAKL 1484
+ + +E +H IIH D+KP N +L + + L D G +
Sbjct: 176 SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 1485 LDGVDSMKQTMTLA-TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
+ T G+ E S + D + + L GE
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 1544 VCLK 1547
+
Sbjct: 293 CKPE 296
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 41/203 (20%), Positives = 75/203 (36%), Gaps = 27/203 (13%)
Query: 753 GAGSFGSVYKAT-LPYGMNVAIKVFNL--QLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
G +V A P G V ++ NL + + E V + H N+V ++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
++ +M GS + + +H +N I+ V AL+Y+HH +H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHR 152
Query: 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY------MAPE------- 915
+K S++L+ D +LS + + + + ++PE
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 916 -YGSEGIVSTCGDVYSFGILMIE 937
Y ++ D+YS GI E
Sbjct: 213 GYDAK------SDIYSVGITACE 229
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-20
Identities = 37/208 (17%), Positives = 75/208 (36%), Gaps = 15/208 (7%)
Query: 1344 GTGIFSSVYKATF-ADGTNAAIKIFSL--QEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
G +V A + G ++ +L + + E V + H N+ ++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
++ +M GS + + +H +N I+ V AL+Y+H +H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHR 152
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLAT---IG---YMAPEYGSEGIV 1513
+K S++L+ D +L + ++ + + +++PE + +
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 1514 --STSGDVYSFGILMMETLTRRKPTDDM 1539
D+YS GI E P DM
Sbjct: 213 GYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-26
Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 750 NLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-R 798
+GAG+FG V +AT + VA+K+ A ++ +E +++ + +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQ 108
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK-------------YTLNIQQRLD 845
H N+V ++ +C++ G +I EY G L +L T + + L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTM 904
VA + +L + IH D+ NVLL + VA + DFG+++ + + + + +
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+MAPE + + + DV+S+GIL+ E F+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 1341 NLLGTGIFSSVYKATFAD------GTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RH 1390
LG G F V +AT A+K L+ ++ +E ++M + +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-------------NYLLNIEQRLDI 1437
N+ ++ +C++ G +I +Y G L +L N + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 1438 MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMT 1496
VA + +L S + IH D+ NVLL + VA +GDFG+A+ + + + +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 1497 LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ +MAPE + + + DV+S+GIL+ E +
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 21/199 (10%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA-IKSFDAECEV-LRRVRHRNLVKIISS 808
+G G++G V K +P G +A+K ++ K + ++ +R V V +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLHHGHP 862
G + +E M SL+K+ K ++ Q + I + + ALE+LH
Sbjct: 75 LFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE----YGS 918
VIH D+KPSNVL++ + DFGIS L D V + + YMAPE +
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELN 186
Query: 919 EGIVSTCGDVYSFGILMIE 937
+ S D++S GI MIE
Sbjct: 187 QKGYSVKSDIWSLGITMIE 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 15/196 (7%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRA-LKSFDAECEV-MRRIRHRNLAKIVSS 1399
LG G + V K G A+K + K + ++ MR + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 1400 CSNPGFKALILQYMPQGSLE---KWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
G + ++ M SL+ K + + + I + + ALE+LH S +
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE----YGSEGI 1512
IH D+KPSNVL++ + DFGI+ L VD + + + YMAPE ++
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 1513 VSTSGDVYSFGILMME 1528
S D++S GI M+E
Sbjct: 190 YSVKSDIWSLGITMIE 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
F +G GS+GSVYKA G VAIK ++ D ++ E ++++ ++VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
S + +++EY GS+ + TL + I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--- 145
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
IH D+K N+LL+ + A L+DFG++ L + T+ + T +MAPE E +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTPFWMAPEVIQEIGYNC 204
Query: 925 CGDVYSFGILMIE 937
D++S GI IE
Sbjct: 205 VADIWSLGITAIE 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
F LG G + SVYKA G AIK ++ D L+ E +M++ ++ K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
S ++++Y GS+ + N L ++ I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEGI 1512
IH D+K N+LL+ + A L DFG+A L + + T+ IG +MAPE E
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV----IGTPFWMAPEVIQEIG 201
Query: 1513 VSTSGDVYSFGILMME 1528
+ D++S GI +E
Sbjct: 202 YNCVADIWSLGITAIE 217
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 36/234 (15%)
Query: 751 LIGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISS 808
++ G F VY+A G A+K + ++ E ++++ H N+V+ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 809 CS-------NHGFKALILEYMPQGSLEKWL--YSHKYTLNIQQRLDIMIDVASALEYLHH 859
S + L+L + +G L ++L + L+ L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG--------------EDSVTQTMT 905
P P+IH DLK N+LL + L DFG + + E+ +T+ T
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 906 LATFGYMAPE---YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
Y PE S + D+++ G ++ R+ P F L+
Sbjct: 214 PM---YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSS 1399
+L G F+ VY+A G A+K E+ ++ E M+++ H N+ + S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 1400 CS-------NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQR--------LDIMIDVACA 1444
S + L+L + +G L +L +E R L I A
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQL------VEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL----DGVDSMKQTMTLA-- 1498
++++H+ IIH DLK N+LL + L DFG A + D S ++ +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 1499 -----TIGYMAPE---YGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
T Y PE S + D+++ G ++ R+ P +D
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 41/228 (17%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRVRHRN 801
IG G+FG V++A VA+K+ + A F E ++ + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK-----------------------YTL 838
+VK++ C+ L+ EYM G L ++L S L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 839 NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898
+ ++L I VA+ + YL +H DL N L+ ++ V ++DFG+S+ + D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 899 S-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMP 944
+M PE +T DV+++G+++ E F+ P
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 50/222 (22%), Positives = 87/222 (39%), Gaps = 38/222 (17%)
Query: 1343 LGTGIFSSVYKATFADG------TNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNL 1393
+G G F V++A T A+K L+E F E +M + N+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSH-----------------------NYLLN 1430
K++ C+ L+ +YM G L ++L S L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 1431 IEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490
++L I VA + YL +H DL N L+ ++MV + DFG+++ + D
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 1491 -MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
I +M PE +T DV+++G+++ E +
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 48/227 (21%)
Query: 752 IGAGSFGSVYKATL------PYGMNVAIKVFNLQLDGA----IKSFDAECEVLRRV-RHR 800
+G+G+FG V AT + VA+K+ + A ++ +E +++ ++ H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHK----------------------YTL 838
N+V ++ +C+ G LI EY G L +L S + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 839 NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898
+ L VA +E+L +H DL NVL+ V + DFG+++ + +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 899 SVTQTMTLATFG-----YMAPEYGSEGIVSTCGDVYSFGILMIETFT 940
+ +MAPE EGI + DV+S+GIL+ E F+
Sbjct: 227 NYVVR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-24
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 38/222 (17%)
Query: 1343 LGTGIFSSVYKAT------FADGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRN 1392
LG+G F V AT A+K L+E ++ +E ++M ++ H N
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH----------------------NYLLN 1430
+ ++ +C+ G LI +Y G L +L S +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 1431 IEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490
E L VA +E+L S +H DL NVL+ V + DFG+A+ + +
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 1491 -MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT 1531
+ + + +MAPE EGI + DV+S+GIL+ E +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 49/328 (14%), Positives = 99/328 (30%), Gaps = 72/328 (21%)
Query: 1297 IIILLRRRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSES------------NLLG 1344
+I L R + T + + +AA +S ES +LG
Sbjct: 23 VIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLG 82
Query: 1345 TGIFSSVYKAT-FADGTNAAIKIFSLQED----------------RALKSFDAECEVMRR 1387
+ +AT G + + + E R L+ + +
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 1388 IRHRNLAKIVSSCSNPGFKAL-------------ILQYMPQGSLE---KWLYSH---NYL 1428
+R +V + L Q +L+ + L SH +
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488
L RL + + V L LH ++H L+P +++LD L F
Sbjct: 203 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 257
Query: 1489 DSMKQTMTLATIGYMAPEY-----------GSEGIVSTSGDVYSFGILMMETLTRRKPTD 1537
+ ++ + G+ PE +++ S D ++ G+++ P
Sbjct: 258 ---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 1538 D---MFTGEVCLKHWVEESLPDAVTDVI 1562
+ E + +++P V ++
Sbjct: 315 KDAALGGSEWIFRSC--KNIPQPVRALL 340
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 5e-25
Identities = 37/250 (14%), Positives = 83/250 (33%), Gaps = 59/250 (23%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKS----------------------- 786
++G + +AT G + + V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 787 -----FDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM-PQGSLE---KWLYSH--- 834
F ++++ + + ++++ + + Y Q +L+ + L SH
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 835 KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894
+L RL + + V L LHH ++H L+P +++LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-R 255
Query: 895 DGEDSVTQTMTLATFGYMAPEY-----------GSEGIVSTCGDVYSFGILMIETFTRKM 943
DG V+ + G+ PE +++ D ++ G+++ + +
Sbjct: 256 DGARVVSSV----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 944 PTDEMFTGET 953
P T +
Sbjct: 312 P----ITKDA 317
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 53/264 (20%), Positives = 93/264 (35%), Gaps = 47/264 (17%)
Query: 170 SSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPT 229
+ +P + + +R+ + N ++ + L L+L+ N L
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 230 IF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNY 287
F ++ L + L++N+ S+ L L L+L C + + L Y
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 288 LGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL 347
L L+DN L +P F +L NL L+L
Sbjct: 134 LYLQDNALQA---------LPDDTFR------------------------DLGNLTHLFL 160
Query: 348 WGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQ 407
GN +S V + L L L +N + + + F + +L L L + L+ +L
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS--ALPT 218
Query: 408 GQSFFSSLTNCRYLRYLAIQTNPW 431
+ L L+YL + NPW
Sbjct: 219 E--ALAPLRA---LQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 61/266 (22%), Positives = 92/266 (34%), Gaps = 40/266 (15%)
Query: 341 NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
+ L +P I + + L N S + A +F CR L IL L + L
Sbjct: 12 PKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI 460
A + F+ L L L + N + +
Sbjct: 69 A--RIDAA--AFTGLAL---LEQLDLSDNAQLRSVDPAT--------------------- 100
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQ-LESL 518
F L + L L + L + + L LQ L L N +Q ++P + + L +L
Sbjct: 101 ---FHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNL 155
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
L L GN + + L SL L L NR+ P F L ++ + N LS
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 579 CLPQDI-GNLKVLTGLYLSGNQLSCS 603
LP + L+ L L L+ N C
Sbjct: 216 -LPTEALAPLRALQYLRLNDNPWVCD 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 44/223 (19%), Positives = 74/223 (33%), Gaps = 36/223 (16%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFT 1036
+R+ + N+I+ + L L LH N L L +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 1037 GRIPQN-LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFS 1094
+ L+ L L + L + +F + ++ + L N
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-----------ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 1095 GHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCR 1154
LP L NL L L GN +S + + + L L +N + + P+ F +
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 1155 QLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
+L L L N+L+ L L+ L L +NP
Sbjct: 202 RLMTLYLFANNLSALP----TEALAPLRA---LQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 53/248 (21%), Positives = 86/248 (34%), Gaps = 24/248 (9%)
Query: 83 TCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRII 142
C + T GL +P + + + + GNR L I+
Sbjct: 7 VCYNEPKVTTSCP--QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 143 DLSSNRISGNLFDDMCNSLTELESFDVSSN-QITGQLPSSLGDCSKLKRLSVSFNELTGR 201
L SN ++ + L LE D+S N Q+ P++ +L L + L
Sbjct: 62 WLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-E 119
Query: 202 IPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLP 259
+ + L L LYL N LQ P F ++ +L + L N + S+P R L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLH 177
Query: 260 SLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNI 317
SL L L + + L L L N L+ +P+ +
Sbjct: 178 SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSA---------LPTEALAPLRAL 227
Query: 318 EVIQLYGN 325
+ ++L N
Sbjct: 228 QYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 52/183 (28%), Positives = 74/183 (40%), Gaps = 7/183 (3%)
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLN 519
A F N+ L L+ N LA L L+ LDLS N S+ L L+
Sbjct: 49 AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPS-TFWSLEYILVVDFSLNLLSG 578
TL L LQ P L +L+ L L N L +P TF L + + N +S
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 579 CLPQDI-GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPE-AIGSLI 636
+P+ L L L L N+++ P + L L L L N ++P A+ L
Sbjct: 168 -VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLR 225
Query: 637 SLE 639
+L+
Sbjct: 226 ALQ 228
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 55/277 (19%), Positives = 94/277 (33%), Gaps = 46/277 (16%)
Query: 259 PSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIE 318
+ Q + L + C L L L N L A TGL + +E
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL--------ALLE 83
Query: 319 VIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
+ L N ++ +T L L L+L L + P + L L L N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNS 438
L +TF + L L L ++++ S+ + F L + L L + N + P++
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRIS--SVPER--AFRGLHS---LDRLLLHQNRVAHVHPHA 196
Query: 439 VGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLD 498
F +L ++ L L+ N L++ + L+ LQ L
Sbjct: 197 -------------------------FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 499 LSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTC 535
L+ N C+ L L + +++ C
Sbjct: 232 LNDNPWVCD-----CRARPLWAWLQKFRGSSSEV-PC 262
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 42/222 (18%), Positives = 65/222 (29%), Gaps = 35/222 (15%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCTLLNFLILRQNQLTGV---------- 1062
+ + LHGN + +P C L L L N L +
Sbjct: 32 AASQRIFLHGNRIS----------HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 1063 ----RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNN 1117
L+ N + + F+ + + L L + L LQ L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 1118 LSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSF 1177
L + + + + L L N S + F L L L N +
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP------ 194
Query: 1178 YTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASS 1219
+ + L L L N L ALP +L+Y +
Sbjct: 195 -HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 41/152 (26%), Positives = 57/152 (37%), Gaps = 7/152 (4%)
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
Q + L N I + +L L L N L L L L+LS N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 553 NSTIPS-TFWSLEYILVVDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-G 609
++ TF L + + L L + L L LYL N L ++P
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 610 GLKDLTYLALARNGFQGSIPE-AIGSLISLEK 640
L +LT+L L N S+PE A L SL++
Sbjct: 151 DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDR 181
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 33/147 (22%), Positives = 57/147 (38%), Gaps = 8/147 (5%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWL-MPRLRIIDLSSNRISGNLFDDMCNSL 161
++ P L L +L++ L L+ + L+ + L N + L DD L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
L + N+I+ + L RL + N + + + +L LM LYL N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFAN 211
Query: 221 NLQGEFPPTIF-NVSSLRVIVLANNSL 246
NL P + +L+ + L +N
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 29/123 (23%), Positives = 50/123 (40%), Gaps = 6/123 (4%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWL-MPRLRIIDLSSNRISGNLFDDMCNSL 161
+ P + L+ L L + N LP++ + + L + L NRIS ++ + L
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGL 176
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
L+ + N++ P + D +L L + N L+ +P L L L LN N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
Query: 221 NLQ 223
Sbjct: 236 PWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 27/120 (22%), Positives = 43/120 (35%), Gaps = 12/120 (10%)
Query: 1096 HLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ 1155
+P I Q + L GN +S + +S + +L L N+ + + F
Sbjct: 25 AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 1156 LQILDLSLN-HLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
L+ LDLS N L + + L L L L+ P L +L+Y
Sbjct: 82 LEQLDLSDNAQLRSVDP-------ATFHGLGRLHTLHLDRCGLQELGPGLFRGL-AALQY 133
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 43/203 (21%), Positives = 78/203 (38%), Gaps = 37/203 (18%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G G F ++ + A K+ L + E + R + H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLHHG 860
++ F ++LE + SL + K L + + +YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEARYYLRQIVLGCQYLHRN 134
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM--TLATFGYMAPE--- 915
VIH DLK N+ L++D + DFG++ ++ + + + T Y+APE
Sbjct: 135 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPEVLS 188
Query: 916 ---YGSEGIVSTCGDVYSFGILM 935
+ E DV+S G +M
Sbjct: 189 KKGHSFE------VDVWSIGCIM 205
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LG G F+ ++ + A KI L + + E + R + H+++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
+ F ++L+ + SL + L E R + + +YLH +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVI 137
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM--TLATIGYMAPEYGSEGIVST 1515
H DLK N+ L++D+ +GDFG+A ++ K+ + T Y+APE ++S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPE-----VLSK 189
Query: 1516 SG-----DVYSFGILMMETLTRRKPTDD 1538
G DV+S G +M L + P +
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFET 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 43/203 (21%), Positives = 78/203 (38%), Gaps = 37/203 (18%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G G F ++ + A K+ L + E + R + H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLHHG 860
++ F ++LE + SL + K L + + +YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEARYYLRQIVLGCQYLHRN 160
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM--TLATFGYMAPE--- 915
VIH DLK N+ L++D + DFG++ ++ + + + T Y+APE
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPEVLS 214
Query: 916 ---YGSEGIVSTCGDVYSFGILM 935
+ E DV+S G +M
Sbjct: 215 KKGHSFE------VDVWSIGCIM 231
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LG G F+ ++ + A KI L + + E + R + H+++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
+ F ++L+ + SL + L E R + + +YLH +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVI 163
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM--TLATIGYMAPEYGSEGIVST 1515
H DLK N+ L++D+ +GDFG+A ++ K+ + T Y+APE ++S
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPE-----VLSK 215
Query: 1516 SG-----DVYSFGILMMETLTRRKPTDD 1538
G DV+S G +M L + P +
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFET 243
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRN 801
D + +IG+G+ V A P VAIK NL + ++ E + + + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWL-YSHKYTLNIQQRLD------IMIDVASAL 854
+V +S L+++ + GS+ + + + LD I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF-G--- 910
EYLH IH D+K N+LL +D ++DFG+S L +T+ TF G
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 911 YMAPE-------YGSEGIVSTCGDVYSFGILMIE 937
+MAPE Y + D++SFGI IE
Sbjct: 192 WMAPEVMEQVRGYDFK------ADIWSFGITAIE 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRA-LKSFDAECEVMRRIRHRNLAKIVSSC 1400
+G+G + V A A AIK +L++ + + E + M + H N+ +S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 1401 SNPGFKALILQYMPQGSLEKWL-YSHNYLLNIEQRLD------IMIDVACALEYLHQGYS 1453
L+++ + GS+ + + + LD I+ +V LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGI-AKLLDGVDSMKQTMTLATIG---YMAPEYGS 1509
IH D+K N+LL +D + DFG+ A L G D + + +G +MAPE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV-- 197
Query: 1510 EGIVSTSG-----DVYSFGILMME 1528
+ G D++SFGI +E
Sbjct: 198 --MEQVRGYDFKADIWSFGITAIE 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 35/214 (16%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQ--LDGAIKSFDAECEVLRR 796
R T+ + +G G+F V + + G A + N + + + E + R
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVA 851
++H N+V++ S S G LI + + G L + YS + +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA------SHCIQQIL 120
Query: 852 SALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLA 907
A+ + H G V+H +LKP N+LL L+DFG++ ++GE
Sbjct: 121 EAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AG 175
Query: 908 TFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
T GY++PE YG D+++ G+++
Sbjct: 176 TPGYLSPEVLRKDPYGKP------VDLWACGVIL 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-20
Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 41/205 (20%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA-----ECEVMRRIRHRNLAKI 1396
LG G FS V + G A I + + L + D E + R ++H N+ ++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINT---KKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 1397 VSSCSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQ 1450
S S G LI + G L + YS E + + A+ + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-------EADASHCIQQILEAVLHCH- 127
Query: 1451 GYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE- 1506
++H +LKP N+LL L DFG+A ++G T GY++PE
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLSPEV 184
Query: 1507 -----YGSEGIVSTSGDVYSFGILM 1526
YG D+++ G+++
Sbjct: 185 LRKDPYGKP------VDLWACGVIL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 13/212 (6%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA-IKSFDAEC 791
I Q Q + +G+G+ G V+K G +A+K + K +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL 74
Query: 792 EVLRR-VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDV 850
+V+ + +V+ + + + +E M EK + + + + + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG 910
AL YL H VIH D+KPSN+LLD+ L DFGIS L D + +
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAA 189
Query: 911 YMAPE-----YGSEGIVSTCGDVYSFGILMIE 937
YMAPE ++ DV+S GI ++E
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 51/236 (21%), Positives = 90/236 (38%), Gaps = 13/236 (5%)
Query: 1312 TENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ 1370
+ + I Q + N +G+G V+K F G A+K
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 1371 EDRA-LKSFDAECEV-MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL 1428
++ K + +V ++ + + + + ++ M EK
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP 120
Query: 1429 LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488
+ + + + AL YL + + +IH D+KPSN+LLD+ L DFGI+ L V
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL--V 176
Query: 1489 DSMKQTMTLATIGYMAPE-----YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
D + + YMAPE ++ DV+S GI ++E T + P +
Sbjct: 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 42/304 (13%), Positives = 79/304 (25%), Gaps = 57/304 (18%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIF---SLQEDRALKSFDAECEVMRRIRHRNLAK-- 1395
L G S V+ + A+K+F + L+ R+ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 1396 ----------IVSSCSNPGFKALILQY-----------MP--QGSLE------KWLYSHN 1426
V+ S P F L MP LE ++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 1427 YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486
I + + L S ++H P N+ + D LGD +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 1487 GVDSMKQTMTLATIGYMAPEY--GSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV 1544
+ Y E+ S + + + + G+ + P F
Sbjct: 246 TRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLV- 296
Query: 1545 CLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVK 1604
++ S V + L+ + V +L + R+
Sbjct: 297 --TPGIKGSWKRPSLRVPGTDSLAFGSCTPLP------DFVKTLIGRFLNFDRRRRLLPL 348
Query: 1605 DALA 1608
+A+
Sbjct: 349 EAME 352
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 34/260 (13%), Positives = 66/260 (25%), Gaps = 50/260 (19%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVKI- 805
+ G V+ + + A+KVF ++ R+ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 806 ----------------------ISSCSNHGFKALILEYMP--QGSLE------KWLYSHK 835
+S + A L MP LE ++Y +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 836 YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895
I + + L ++H P N+ + D L D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 896 GEDSVTQTMTLATFGYMAPE---YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
T+ + AP S + + + G+ + + +P F
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLV 296
Query: 953 TSLKKWVEESLRLAVTEVVD 972
T K + L V
Sbjct: 297 TPGIKGSWKRPSLRVPGTDS 316
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 8/194 (4%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLV 803
F++ IG GSFG V+K VAIK+ +L + + I+ E VL + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
K S +I+EY+ GS L L+ Q I+ ++ L+YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG-PLDETQIATILREILKGLDYLHSEK-- 139
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
IH D+K +NVLL + L+DFG++ L T + T +MAPE +
Sbjct: 140 -KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAYD 197
Query: 924 TCGDVYSFGILMIE 937
+ D++S GI IE
Sbjct: 198 SKADIWSLGITAIE 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSL-QEDRALKSFDAECEVMRRIRHRNLA 1394
F++ +G G F V+K AIKI L + + ++ E V+ + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
K S +I++Y+ GS L L+ Q I+ ++ L+YLH S
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SE 138
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPEYGSEG 1511
IH D+K +NVLL + L DFG+A L + T +G +MAPE +
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF----VGTPFWMAPEVIKQS 194
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDM 1539
+ D++S GI +E P ++
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 46/234 (19%), Positives = 86/234 (36%), Gaps = 40/234 (17%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFN-----------------LQLDGAIKSFDAECEVL 794
+ G F + A+K + + + F E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 795 RRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLD------IM 847
+++ + +N+ +I EYM S+ K+ N + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 848 IDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM--T 905
V ++ Y+H+ + H D+KPSN+L+D + LSDFG S+ + D + T
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGSRGT 213
Query: 906 LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957
+M PE D++S GI + F +P F+ + SL +
Sbjct: 214 YE---FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 44/224 (19%), Positives = 77/224 (34%), Gaps = 36/224 (16%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFS---LQEDRALKSFDA--------------ECEVM 1385
L G F+ + D A+K + L++ R + E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 1386 RRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRL-------DIM 1438
I++ +N +I +YM S+ K+ L I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM--T 1496
V + Y+H +I H D+KPSN+L+D + L DFG ++ + D + T
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGT 213
Query: 1497 LATIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
+M PE D++S GI + P
Sbjct: 214 YE---FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 46/232 (19%), Positives = 85/232 (36%), Gaps = 41/232 (17%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRV 797
R T F E IG+G FGSV+K G AIK L G++ +A E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 798 -RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNI---QQRLDIMIDVASA 853
+H ++V+ S+ + + EY GSL + + ++ + D+++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDD-------------------TVAHLSDFGISKLL 894
L Y+H ++H D+KPSN+ + + + D G +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 895 DGEDSVTQTMTLATFG---YMAPEYGSEGIVSTC-GDVYSFGILMIETFTRK 942
G ++A E E D+++ + ++ +
Sbjct: 185 SSPQVEE--------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 43/226 (19%), Positives = 84/226 (37%), Gaps = 35/226 (15%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKI--FSLQEDRALKSFDAECEVMRRI-RHRN 1392
F E +G+G F SV+K DG AIK L ++ E + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNI--EQRL-DIMIDVACALEYLH 1449
+ + S+ + + +Y GSL + + +++ E L D+++ V L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 1450 QGYSTSIIHCDLKPSNVLLDDD-------------------MVAHLGDFGIAKLLDGVDS 1490
S S++H D+KPSN+ + ++ +GD G +
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 1491 MKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKP 1535
+ ++A E E D+++ + ++
Sbjct: 190 EE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 47/225 (20%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA--------- 789
+ + ++G G V + P A+K+ ++ G+ + +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 790 ECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQR 843
E ++LR+V H N++++ + + F L+ + M +G L EK S K T
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR----- 127
Query: 844 LDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902
IM + + LH ++H DLKP N+LLDDD L+DFG S LD +
Sbjct: 128 -KIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLR 181
Query: 903 TMTLATFGYMAPE------------YGSEGIVSTCGDVYSFGILM 935
+ T Y+APE YG E D++S G++M
Sbjct: 182 EV-CGTPSYLAPEIIECSMNDNHPGYGKE-----V-DMWSTGVIM 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 17/175 (9%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA---------ECEVMRRI-RHR 1391
LG G+ S V + A+KI + + + + E +++R++ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
N+ ++ + F L+ M +G L +L L E R IM + + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIMRALLEVICALH-- 141
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
+I+H DLKP N+LLDDDM L DFG + LD + +++ T Y+APE
Sbjct: 142 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAPE 193
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECE 792
I L+D F + +G G+ VY+ A+KV +D K E
Sbjct: 43 IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIG 100
Query: 793 VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIM 847
VL R+ H N++K+ +L+LE + G L EK YS + D +
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA------DAV 154
Query: 848 IDVASALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQT 903
+ A+ YLH +G ++H DLKP N+L D ++DFG+SK+++ + +T
Sbjct: 155 KQILEAVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKT 209
Query: 904 MTLATFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
+ T GY APE YG E D++S GI+
Sbjct: 210 V-CGTPGYCAPEILRGCAYGPE-----V-DMWSVGIIT 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G S VY+ A+K+ D+ K E V+ R+ H N+ K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 1401 SNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYST 1454
P +L+L+ + G L EK YS E+ D + + A+ YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYS-------ERDAADAVKQILEAVAYLH---EN 167
Query: 1455 SIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE---- 1506
I+H DLKP N+L D + DFG++K+++ MK T+ T GY APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TVCGTPGYCAPEILRG 224
Query: 1507 --YGSEGIVSTSGDVYSFGILM 1526
YG E V D++S GI+
Sbjct: 225 CAYGPE--V----DMWSVGIIT 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 46/231 (19%), Positives = 97/231 (41%), Gaps = 14/231 (6%)
Query: 713 TRNKNLPILENDSLSLATWRRISYQELQRLTDGFSE----SNLIGAGSFGSVYKAT-LPY 767
+ I + D W++ Q ++ + +G+G+FG V++
Sbjct: 16 GKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 768 GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL 827
G K N + E ++ ++ H L+ + + + LILE++ G L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 828 EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHL- 885
+ + Y ++ + ++ M L+++H H ++H D+KP N++ + + +
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVK 191
Query: 886 -SDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILM 935
DFG++ L+ ++ V T AT + APE V D+++ G+L
Sbjct: 192 IIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 48/231 (20%), Positives = 97/231 (41%), Gaps = 12/231 (5%)
Query: 1303 RRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSE----SNLLGTGIFSSVYKATF-A 1357
R K D + + + ++ Q + + + LG+G F V++ A
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 1358 DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417
G K + + E +M ++ H L + + + LIL+++ G
Sbjct: 75 TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 1418 LEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHL- 1476
L + + +Y ++ + ++ M L+++H SI+H D+KP N++ + + +
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVK 191
Query: 1477 -GDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILM 1526
DFG+A L+ + +K T AT + APE V D+++ G+L
Sbjct: 192 IIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 22/228 (9%)
Query: 727 SLATWRRISYQELQRLTD---GFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDG 782
S + R + +L L D F L+G G++G VYK + G AIKV ++ D
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD- 62
Query: 783 AIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKA------LILEYMPQGSLEKWLYSHK 835
+ E +L++ HRN+ + L++E+ GS+ + + K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 836 Y-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894
TL + I ++ L +LH VIH D+K NVLL ++ L DFG+S L
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 895 DGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG-----DVYSFGILMIE 937
D T + T +MAPE + D++S GI IE
Sbjct: 180 DRTVGRRNTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLA 1394
F L+G G + VYK G AAIK+ + D + E ++++ HRN+A
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 84
Query: 1395 K-----IVSSCSNPGFKA-LILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEY 1447
I + + L++++ GS+ + + L E I ++ L +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMA 1504
LH +IH D+K NVLL ++ L DFG++ LD + T IG +MA
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IGTPYWMA 197
Query: 1505 PEYGSEGIVSTSG-----DVYSFGILMMETLTRRKPTDDM 1539
PE + + D++S GI +E P DM
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 48/257 (18%)
Query: 714 RNKNLPILENDSLSLATWRRISY-------QELQRLTDGFSE----SNLIGAGSFGSVYK 762
+ K P+ N ++L+ R + + + S +G+G+ G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 763 AT-LPYGMNVAIKVFN--------LQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG 813
A VAI++ + + + + E E+L+++ H ++KI +
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213
Query: 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKP 872
+ ++LE M G L + +K L + A++YLH +G +IH DLKP
Sbjct: 214 Y-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENG----IIHRDLKP 267
Query: 873 SNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE---------YGSEG 920
NVLL ++D + ++DFG SK+L GE S+ +T+ T Y+APE Y
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRA- 324
Query: 921 IVSTCGDVYSFG-ILMI 936
V D +S G IL I
Sbjct: 325 -V----DCWSLGVILFI 336
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-20
Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 48/255 (18%)
Query: 1306 RDKSRPTENN---LLNTAALRRISYQELRLATNGFSESNL---------LGTGIFSSVYK 1353
+ K RP NN L+ + + + +L + L LG+G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 1354 ATF-ADGTNAAIKIFS--------LQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG 1404
A AI+I S +E + + E E+++++ H + KI +
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213
Query: 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPS 1464
+ ++L+ M G L + + L + + A++YLH IIH DLKP
Sbjct: 214 Y-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFYQMLLAVQYLH---ENGIIHRDLKPE 268
Query: 1465 NVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE---------YGSEG 1511
NVLL ++D + + DFG +K+L M+ TL T Y+APE Y
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRA- 324
Query: 1512 IVSTSGDVYSFGILM 1526
V D +S G+++
Sbjct: 325 -V----DCWSLGVIL 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 18/166 (10%)
Query: 1378 FDAECEVMRRIRHRNLAKIVSSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLLNIEQR- 1434
++ R + + L +Q + +L+ W+ L + E
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165
Query: 1435 -LDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493
L I I +A A+E+LH S ++H DLKPSN+ D V +GDFG+ +D + +
Sbjct: 166 CLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 1494 TMTLA-----------TIGYMAPEYGSEGIVSTSGDVYSFGILMME 1528
+T T YM+PE S D++S G+++ E
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 4e-22
Identities = 57/280 (20%), Positives = 94/280 (33%), Gaps = 75/280 (26%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVR 798
R F +G G FG V++A N AIK L + A + E + L ++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 799 HRNLVKIISSCSNHGFKAL----------------------------------------- 817
H +V+ ++ +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 818 ILEYMPQGSLEKWLYS-----HKYTLN--IQQR-----------LDIMIDVASALEYLHH 859
+ + S + +LY K L + +R L I I +A A+E+LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-----------T 908
++H DLKPSN+ D V + DFG+ +D ++ +T T
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
YM+PE S D++S G+++ E E
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-24
Identities = 60/319 (18%), Positives = 111/319 (34%), Gaps = 44/319 (13%)
Query: 110 ANLSFLVSLNISGNRFHG--TLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESF 167
+ + G + +L E + + + L+ +S +L D++ +T L
Sbjct: 31 SAWDKWEKQALPGENRNEAVSLLKECLI-NQFSELQLNRLNLS-SLPDNLPPQITVL--- 85
Query: 168 DVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFP 227
+++ N + LP L+ L N L+ +P+ +L L ++ N L P
Sbjct: 86 EITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLK---HLDVDNNQLT-MLP 136
Query: 228 PTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNY 287
+ L I NN L LP SL+ L++R+ T +P+ + L
Sbjct: 137 ELP---ALLEYINADNNQL-TMLP----ELPTSLEVLSVRNNQLT-FLPELPES---LEA 184
Query: 288 LGLRDNQLTDFGANNLTGLIPSIIFNNSNIE----VIQLYGNHLSGNLPSSTGINLPNLL 343
L + N L +P++ N + E + N ++ ++P + +L
Sbjct: 185 LDVSTNLLES---------LPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL-SLDPTC 233
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY-SQLAT 402
+ L N LS I S+ + R FS R L A+ +
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293
Query: 403 GSLSQGQSFFSSLTNCRYL 421
+SQ F +
Sbjct: 294 SDVSQIWHAFEHEEHANTF 312
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-22
Identities = 55/311 (17%), Positives = 107/311 (34%), Gaps = 37/311 (11%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
N ++G E L G + + + + L L NLS +P ++
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNL 78
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
++TVLE+++N L + L+ L+ ++L + + ++
Sbjct: 79 P--PQITVLEITQNALISL-PELPAS---LEYLDACDNRL--------STLPELPASLKH 124
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480
L + N +LP L EY A + +L +P +L LS+ NQL
Sbjct: 125 LD---VDNNQLT-MLPELPALL----EYINADNNQLTM-LPELPTSLEV---LSVRNNQL 172
Query: 481 ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQI---PTCLA 537
+ +P ++L+ LD+S N ++ S+P+ + + +N+I P +
Sbjct: 173 -TFLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENIL 227
Query: 538 NLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSG 597
+L + L N L S+ S + + N
Sbjct: 228 SLDPTCTIILEDNPL-SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ-NTLHRPLADAVT 285
Query: 598 NQLSCSIPSSI 608
+ S +
Sbjct: 286 AWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-22
Identities = 60/319 (18%), Positives = 110/319 (34%), Gaps = 68/319 (21%)
Query: 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWG---NNLSGVIPSSICNASKLTVL 369
NN ++ Y N +S + + L G N ++ C ++ + L
Sbjct: 9 NNFSLSQNSFY-NTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSEL 64
Query: 370 ELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTN 429
+L+R S L N Q+ +L + + L +
Sbjct: 65 QLNRLNLSSLPDNLP---PQITVLEITQNALIS--------------------------- 94
Query: 430 PWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVG 489
LP +L EY A L +P +L + L + NQL + +P
Sbjct: 95 -----LPELPASL----EYLDACDNRLST-LPELPASLKH---LDVDNNQL-TMLPELPA 140
Query: 490 KLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSS 549
L+ ++ N + +P LE L+ ++ N L +P +L +L ++S+
Sbjct: 141 ---LLEYINADNNQLT-MLPELPTSLEVLS---VRNNQL-TFLPELPESLEAL---DVST 189
Query: 550 NRLNSTIPSTFWSL----EYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIP 605
N L ++P+ E + N ++ +P++I +L + L N LS I
Sbjct: 190 NLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247
Query: 606 SSIGGLKDLTYLALARNGF 624
S+ R F
Sbjct: 248 ESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 2e-21
Identities = 63/409 (15%), Positives = 131/409 (32%), Gaps = 60/409 (14%)
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS---FNELTGRIPQNIGNLTELME 214
N+ L + N I+G K ++ ++ NE + + + + + E
Sbjct: 7 INNNFSLSQ-NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSE 63
Query: 215 LYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGR 274
L LN NL P + + V+ + N+L SLP SL+ L+ D +
Sbjct: 64 LQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPA----SLEYLDACDNRLS-T 114
Query: 275 IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334
+P+ + L+ + +NQLT +P + + +E I N L+ LP
Sbjct: 115 LPELPASLKHLD---VDNNQLTM---------LPELP---ALLEYINADNNQLT-MLPEL 158
Query: 335 TGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQ--- 391
+L L + N L+ +P L L++S NL L +
Sbjct: 159 ----PTSLEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLESL-PAVPVRNHHSEETE 209
Query: 392 -ILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFY 450
+++ + ++ + + ++ NP + S+ + +Y
Sbjct: 210 IFFRCRENRITH--IP------ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH- 260
Query: 451 AGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPS 510
+ + N + + V ++ + + N +
Sbjct: 261 --GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLD 317
Query: 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPST 559
L S + Q+ L L++ L S + + +
Sbjct: 318 RLSDTVSARNTS----GFREQVAAWLEKLSASAELRQQSFAVAADATES 362
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-21
Identities = 51/293 (17%), Positives = 92/293 (31%), Gaps = 46/293 (15%)
Query: 274 RIPKDIGNC-TLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLP 332
D + L N L+ + N +QL +LS +LP
Sbjct: 24 GTYADYFSAWDKWEKQALPGENR-----NEAVSLLKECLINQ--FSELQLNRLNLS-SLP 75
Query: 333 SSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392
+ P + L + N L +P + L L+ N S L + L+
Sbjct: 76 DNLP---PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLSTL-PELPAS---LKH 124
Query: 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAG 452
L++ +QL L Y+ N LP +L E
Sbjct: 125 LDVDNNQL--------TMLPELPAL---LEYINADNNQLTM-LPELPTSL----EVLSVR 168
Query: 453 SCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQ----GLDLSYNNIQGSI 508
+ +L +P +L L + N L ++P + + + N I I
Sbjct: 169 NNQLTF-LPELPESLEA---LDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 509 PSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFW 561
P + L+ T++L+ N L ++I L+ T+ + + +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 4e-21
Identities = 61/314 (19%), Positives = 98/314 (31%), Gaps = 66/314 (21%)
Query: 331 LPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVAN-TFGNCRQ 389
LP + +L N +SG K L + V+ Q
Sbjct: 5 LPINNNFSLSQNSFY----NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 390 LQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYF 449
L L L++ LP+++ +
Sbjct: 61 FSELQLNRLNLSS--------------------------------LPDNLP---PQITVL 85
Query: 450 YAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIP 509
L +P +L L N+L ST+P +L+ LD+ N + +P
Sbjct: 86 EITQNALIS-LPELPASLEY---LDACDNRL-STLPEL---PASLKHLDVDNNQLT-MLP 136
Query: 510 SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVV 569
LE +N N L +P TSL L++ +N+L +P SLE +
Sbjct: 137 ELPALLEYIN---ADNNQLT-MLP---ELPTSLEVLSVRNNQLTF-LPELPESLEAL--- 185
Query: 570 DFSLNLLSGCLPQDIGNL----KVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ 625
D S NLL LP + N+++ IP +I L + L N
Sbjct: 186 DVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243
Query: 626 GSIPEAIGSLISLE 639
I E++ +
Sbjct: 244 SRIRESLSQQTAQP 257
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 3e-20
Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 31/245 (12%)
Query: 92 TDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG 151
++L + L L ++P ++ + L I+ N +LP L +D NR+S
Sbjct: 62 SELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELP---ASLEYLDACDNRLS- 113
Query: 152 NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTE 211
+ L+ DV +NQ+T LP L+ ++ N+LT +P+ +L
Sbjct: 114 ----TLPELPASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSLEV 164
Query: 212 LMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQE----LNLR 267
L + N L P SL + ++ N L SLP R +E R
Sbjct: 165 L---SVRNNQLT-FLPELP---ESLEALDVSTNLL-ESLPAVPVR-NHHSEETEIFFRCR 215
Query: 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHL 327
+ T IP++I + + L DN L+ +L+ ++ I G
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274
Query: 328 SGNLP 332
+ + P
Sbjct: 275 TLHRP 279
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 1e-19
Identities = 51/258 (19%), Positives = 84/258 (32%), Gaps = 32/258 (12%)
Query: 387 CRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSL 446
+L+ + +FS+ N +L L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC---LINQF 61
Query: 447 EYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQG 506
L +P I L + QN L ++P +L+ LD N +
Sbjct: 62 SELQLNRLNLSS-LPDNLP--PQITVLEITQNAL-ISLPELPA---SLEYLDACDNRLS- 113
Query: 507 SIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYI 566
++P L+ L+ + N L +P A L + N +N+L + +P SLE +
Sbjct: 114 TLPELPASLKHLD---VDNNQLT-MLPELPALLEYI---NADNNQL-TMLPELPTSLEVL 165
Query: 567 LVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLT----YLALARN 622
N L+ LP+ +L+ L +S N L S+P+ + N
Sbjct: 166 ---SVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 623 GFQGSIPEAIGSLISLEK 640
IPE I SL
Sbjct: 218 RIT-HIPENILSLDPTCT 234
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 5e-16
Identities = 38/240 (15%), Positives = 83/240 (34%), Gaps = 54/240 (22%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-----------YLYNNKFTGR 1038
N+ L ++ ++ ++P + ++ L + N L + +N+ +
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALISLPELPASLEYLDACDNRLS-T 114
Query: 1039 IPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLP 1098
+P+ + L+ + NQLT +P + + +E I N + LP
Sbjct: 115 LPELPASLKHLD---VDNNQLT-----------MLPELP---ALLEYINADNNQLT-MLP 156
Query: 1099 SSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQ- 1157
+L+ L + N L+ + P + L +S NL L P +
Sbjct: 157 ELPT----SLEVLSVRNNQLTFL-PELPESLEA---LDVSTNLLESL-PAVPVRNHHSEE 207
Query: 1158 ---ILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
N +T ++ + ++L++NPL + S+ + +Y
Sbjct: 208 TEIFFRCRENRITH--------IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-12
Identities = 43/223 (19%), Positives = 70/223 (31%), Gaps = 48/223 (21%)
Query: 988 DSNKLKRLSI--SVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
N LS N I+GT + + L G N N+ + + L
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGEN------RNEAVSLLKECL-- 57
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYL 1105
+ L L + L+ +P + I +++ N LP
Sbjct: 58 INQFSELQLNRLNLS-----------SLPDNLP--PQITVLEITQNALI-SLPELPA--- 100
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
+L+ L N LS +P + L + N + L P L+ ++ N
Sbjct: 101 -SLEYLDACDNRLS-TLPELPASLKH---LDVDNNQLTML-PELPAL---LEYINADNNQ 151
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL 1208
LT T+ L L ++NN L LP +L
Sbjct: 152 LTMLPE--------LPTS---LEVLSVRNNQLT-FLPELPESL 182
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 6e-11
Identities = 41/210 (19%), Positives = 70/210 (33%), Gaps = 50/210 (23%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTEL-----------------RELHLHGNNLEA---- 1028
++ L I+ N + ++P +L L + L + N L
Sbjct: 80 PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTMLPEL 138
Query: 1029 -------YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGV----------RLASNKLIG 1071
NN+ T +P+ + L L +R NQLT + +++N L
Sbjct: 139 PALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTFLPELPESLEALDVSTNLLE- 193
Query: 1072 RIPSMIFNNSNIEAIQ----LYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSIC 1127
+P++ N + E + N + H+P +I L +IL N LS I S+
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL-SLDPTCTIILEDNPLSSRIRESLS 251
Query: 1128 NASQVILLGLSENLFSGLIPNTFGNCRQLQ 1157
+ FS R L
Sbjct: 252 QQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-06
Identities = 20/124 (16%), Positives = 37/124 (29%), Gaps = 7/124 (5%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
L+ L +S N + ++P E + N+ T IP+N+ +
Sbjct: 180 ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF-----FRCRENRIT-HIPENILSLDPT 232
Query: 1050 NFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
+IL N L+ S P N L ++ + P +
Sbjct: 233 CTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENK 292
Query: 1110 GLIL 1113
+
Sbjct: 293 QSDV 296
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 46/207 (22%), Positives = 83/207 (40%), Gaps = 38/207 (18%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKV-----FNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
IG G F V + G A+K+ F + + E + ++H ++V++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 806 ISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRL--DIMIDVASALEYLH 858
+ + S+ G ++ E+M L ++ Y+ + + M + AL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS----EAVASHYMRQILEALRYCH 147
Query: 859 -HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
+ +IH D+KP VLL ++ L FG++ L V + T +MAP
Sbjct: 148 DNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAP 202
Query: 915 E------YGSEGIVSTCGDVYSFGILM 935
E YG DV+ G+++
Sbjct: 203 EVVKREPYGKP------VDVWGCGVIL 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 32/204 (15%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKI-----FSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
+G G FS V + G A+KI F+ + + E + ++H ++ ++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 1397 VSSCSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
+ + S+ G ++ ++M L ++ Y + M + AL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--SEAVASHYMRQILEALRYCH-- 147
Query: 1452 YSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-- 1506
+IIH D+KP VLL ++ LG FG+A L + + T +MAPE
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVV 205
Query: 1507 ----YGSEGIVSTSGDVYSFGILM 1526
YG DV+ G+++
Sbjct: 206 KREPYGKP------VDVWGCGVIL 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN-LQLDGA-IKSFDAECEVLRRV 797
+ ++ ++G GSFG V K A+KV N + E E+L+++
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 798 RHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVAS 852
H N++K+ + ++ E G L ++ +S I+ V S
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA------ARIIKQVFS 132
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLAT 908
+ Y+H H ++H DLKP N+LL + D + DFG+S +++ + + T
Sbjct: 133 GITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR-IGT 186
Query: 909 FGYMAPE-----YGSEGIVSTCGDVYSFG-ILMI 936
Y+APE Y + C DV+S G IL I
Sbjct: 187 AYYIAPEVLRGTYDEK-----C-DVWSAGVILYI 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 35/201 (17%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIF--SLQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG G F V K A+K+ + +++ + E E+++++ H N+ K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 1400 CSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYS 1453
+ ++ + G L ++ +S E I+ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS-------EHDAARIIKQVFSGITYMH---K 139
Query: 1454 TSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE---- 1506
+I+H DLKP N+LL + D + DFG++ MK + T Y+APE
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLRG 197
Query: 1507 -YGSEGIVSTSGDVYSFGILM 1526
Y + DV+S G+++
Sbjct: 198 TYDEK------CDVWSAGVIL 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 47/223 (21%)
Query: 737 QELQRLTDGFSE----SNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-- 789
Q+L R + F++ IG GS+ + M A+K+ + D
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------KSKRDPTE 64
Query: 790 ECEVLRR-VRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQR 843
E E+L R +H N++ + + + ++ E M G L + +S +
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS----- 119
Query: 844 LDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGED 898
++ + +EYLH G V+H DLKPSN+L + + DFG +K L E+
Sbjct: 120 -AVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 899 SVTQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
+ T T ++APE Y + C D++S G+L+
Sbjct: 175 GLLMTP-CYTANFVAPEVLERQGYDAA-----C-DIWSLGVLL 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-19
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 39/202 (19%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRR-IRHRNLAKIVSSC 1400
+G G +S + A A+KI + E E++ R +H N+ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTE-EIEILLRYGQHPNIITLKDVY 85
Query: 1401 SNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYST 1454
+ + ++ + M G L + +S E+ ++ + +EYLH +
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFS-------EREASAVLFTITKTVEYLH---AQ 135
Query: 1455 SIIHCDLKPSNVLL----DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE---- 1506
++H DLKPSN+L + + DFG AK L + + T T ++APE
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-CYTANFVAPEVLER 194
Query: 1507 --YGSEGIVSTSGDVYSFGILM 1526
Y + D++S G+L+
Sbjct: 195 QGYDAA--C----DIWSLGVLL 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 33/199 (16%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
IG GS+G V A + A K + F E E+++ + H N++++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 811 NHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTP 864
++ L++E G L K ++ IM DV SA+ Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDA------ARIMKDVLSAVAYCHKLN---- 126
Query: 865 VIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-----Y 916
V H DLKP N L D+ L DFG++ + +T + T Y++P+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTK-VGTPYYVSPQVLEGLY 184
Query: 917 GSEGIVSTCGDVYSFGILM 935
G E C D +S G++M
Sbjct: 185 GPE-----C-DEWSAGVMM 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 48/199 (24%), Positives = 76/199 (38%), Gaps = 33/199 (16%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
+G G + V A A K + F E E+M+ + H N+ ++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 1402 NPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYSTS 1455
+ L+++ G L K ++ E IM DV A+ Y H +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFR-------ESDAARIMKDVLSAVAYCH---KLN 126
Query: 1456 IIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-----Y 1507
+ H DLKP N L D L DFG+A M+ + T Y++P+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLEGLY 184
Query: 1508 GSEGIVSTSGDVYSFGILM 1526
G E D +S G++M
Sbjct: 185 GPE------CDEWSAGVMM 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 44/214 (20%), Positives = 89/214 (41%), Gaps = 36/214 (16%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN-LQLDGA-IKSFDAECEVLRR 796
+ +D + +G G+F V + G+ A K+ N +L + + E + R+
Sbjct: 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVA 851
++H N+V++ S F L+ + + G L + YS + +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA------SHCIQQIL 138
Query: 852 SALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLA 907
++ Y H +G ++H +LKP N+LL L+DFG++ ++ +
Sbjct: 139 ESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF-AG 192
Query: 908 TFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
T GY++PE Y D+++ G+++
Sbjct: 193 TPGYLSPEVLKKDPYSKP------VDIWACGVIL 220
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-20
Identities = 47/202 (23%), Positives = 80/202 (39%), Gaps = 36/202 (17%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIF--SLQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG G FS V + G A KI R + + E + R+++H N+ ++ S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 1400 CSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYS 1453
F L+ + G L + YS E + + ++ Y H S
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQILESIAYCH---S 146
Query: 1454 TSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE---- 1506
I+H +LKP N+LL L DFG+A ++ ++ T GY++PE
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLKK 204
Query: 1507 --YGSEGIVSTSGDVYSFGILM 1526
Y D+++ G+++
Sbjct: 205 DPYSKP------VDIWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA--IKSFDAECEVLRRV 797
+ +D + +G G+F V + G+ A K+ N + A + + E + R++
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 798 RHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVAS 852
+H N+V++ S F L+ + + G L + YS + +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA------SHCIQQILE 116
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLAT 908
++ Y H +G ++H +LKP N+LL L+DFG++ ++ + T
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF-AGT 170
Query: 909 FGYMAPE------YGSEGIVSTCGDVYSFG-ILMI 936
GY++PE Y D+++ G IL I
Sbjct: 171 PGYLSPEVLKKDPYSKP-----V-DIWACGVILYI 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 48/202 (23%), Positives = 83/202 (41%), Gaps = 36/202 (17%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG G FS V + G A KI + + R + + E + R+++H N+ ++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 1400 CSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYS 1453
F L+ + G L + YS E + + ++ Y H S
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQILESIAYCH---S 123
Query: 1454 TSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE---- 1506
I+H +LKP N+LL L DFG+A ++ ++ T GY++PE
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLKK 181
Query: 1507 --YGSEGIVSTSGDVYSFGILM 1526
Y V D+++ G+++
Sbjct: 182 DPYSKP--V----DIWACGVIL 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 37/201 (18%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSC 809
+G GSF K A+K+ + +++ + E L+ H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 810 SNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPT 863
+ L++E + G L +K +S IM + SA+ ++H G
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEAS------YIMRKLVSAVSHMHDVG--- 126
Query: 864 PVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE----- 915
V+H DLKP N+L +D+ + DFG ++L ++ +T T Y APE
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQN 184
Query: 916 -YGSEGIVSTCGDVYSFGILM 935
Y C D++S G+++
Sbjct: 185 GYDES-----C-DLWSLGVIL 199
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 37/201 (18%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSC 1400
LG G FS K A+KI S R + E ++ H N+ K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 1401 SNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYST 1454
+ L+++ + G L +K +S E IM + A+ ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFS-------ETEASYIMRKLVSAVSHMH---DV 125
Query: 1455 SIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE----- 1506
++H DLKP N+L +D++ + DFG A+L + +T T+ Y APE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQN 184
Query: 1507 -YGSEGIVSTSGDVYSFGILM 1526
Y D++S G+++
Sbjct: 185 GYDES------CDLWSLGVIL 199
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL--------QLDGAIKSFDAE 790
+ + ++IG G V + G A+K+ + QL+ ++ E
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 791 CEVLRRVR-HRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRL 844
+LR+V H +++ +I S + F L+ + M +G L EK S K T
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR------ 203
Query: 845 DIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
IM + A+ +LH + ++H DLKP N+LLDD+ LSDFG S L+ +
Sbjct: 204 SIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRE 258
Query: 904 MTLATFGYMAPE 915
+ T GY+APE
Sbjct: 259 L-CGTPGYLAPE 269
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 1302 RRRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSE----SNLLGTGIFSSVYKATF- 1356
+K + ++P L ++ A F + +++G G+ S V +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 1357 ADGTNAAIKIFSL--------QEDRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKA 1407
A G A+KI + Q + ++ E ++R++ H ++ ++ S + F
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467
L+ M +G L +L L E R IM + A+ +LH + +I+H DLKP N+L
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETR-SIMRSLLEAVSFLH---ANNIVHRDLKPENIL 232
Query: 1468 LDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE 1506
LDD+M L DFG + L+ + ++ L T GY+APE
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPE 269
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-23
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQ--LDGAIKSFDAECEVLRR 796
L++ + +G+G++G V + AIK+ + E VL+
Sbjct: 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+ H N++K+ + L++E G L + N I+ V S + Y
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTY 151
Query: 857 LH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
LH H ++H DLKP N+LL + D + + DFG+S + + + + + L T Y+
Sbjct: 152 LHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYI 205
Query: 913 APE-----YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
APE Y + C DV+S G+++ P F G+T
Sbjct: 206 APEVLRKKYDEK-----C-DVWSIGVILFILLAGYPP----FGGQT 241
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-20
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 27/212 (12%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG+G + V AIKI + E V++ + H N+ K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ L+++ G L + N I+ V + YLH +I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKF-NEVDAAVIIKQVLSGVTYLH---KHNIVHR 160
Query: 1460 DLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-----YGSEG 1511
DLKP N+LL + D + + DFG++ + + MK+ L T Y+APE Y +
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLRKKYDEK- 217
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
DV+S G+++ L P F G+
Sbjct: 218 -----CDVWSIGVILFILLAGYPP----FGGQ 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-23
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLR 795
+D + ++G GSFG V G A+KV + ++ +S E ++L+
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 796 RVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALE 855
++ H N++K+ + G+ L+ E G L + S K + I+ V S +
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGIT 140
Query: 856 YLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
Y+H + ++H DLKP N+LL D + DFG+S + + + T Y
Sbjct: 141 YMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYY 194
Query: 912 MAPE-----YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+APE Y + C DV+S G+++ + P F G
Sbjct: 195 IAPEVLHGTYDEK-----C-DVWSTGVILYILLSGCPP----FNGAN 231
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-20
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
LG G F V G A+K+ S +++ +S E ++++++ H N+ K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
+ G+ L+ + G L + S + I+ V + Y+H I+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYMH---KNKIVH 149
Query: 1459 CDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-----YGSE 1510
DLKP N+LL D + DFG++ + MK + T Y+APE Y +
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVLHGTYDEK 207
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
DV+S G+++ L+ P F G
Sbjct: 208 ------CDVWSTGVILYILLSGCPP----FNGA 230
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 31/206 (15%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFD---AECEVMRRIRHRNLAKIV 1397
+LG G FS+V A A AIKI + E +VM R+ H K+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALEYLHQG 1451
+ + L Y G L + + D ++ ALEYLH
Sbjct: 97 FTFQDDEKLYFGLSYAKNGEL----LKY---IRKIGSFDETCTRFYTAEIVSALEYLH-- 147
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYGSE 1510
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE---- 202
Query: 1511 GIVSTSG-----DVYSFGILMMETLT 1531
+++ D+++ G ++ + +
Sbjct: 203 -LLTEKSACKSSDLWALGCIIYQLVA 227
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-21
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 40/217 (18%)
Query: 741 RLTDGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFN----LQLDGAIKSFDAECE 792
R D F ++G GSF +V AT AIK+ ++ + + E +
Sbjct: 28 RPED-FKFGKILGEGSFSTVVLARELATSRE---YAIKILEKRHIIKEN-KVPYVTRERD 82
Query: 793 VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI------ 846
V+ R+ H VK+ + + L Y G L + + D
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL----LKY---IRKIGSFDETCTRFY 135
Query: 847 MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL 906
++ SALEYLH +IH DLKP N+LL++D ++DFG +K+L E + +
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 907 -ATFGYMAPEYGSEGIVSTCG-----DVYSFGILMIE 937
T Y++PE +++ D+++ G ++ +
Sbjct: 193 VGTAQYVSPE-----LLTEKSACKSSDLWALGCIIYQ 224
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 28/205 (13%)
Query: 746 FSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA---IKSFDAECEVLRRVRHRN 801
FS+ IG GSFG+VY A + VAIK + + + E L+++RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
++ L++EY GS L HK L + + L YLH +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE------ 915
+IH D+K N+LL + + L DFG + ++ +S T + +MAPE
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT----PY-WMAPEVILAMD 226
Query: 916 ---YGSEGIVSTCGDVYSFGILMIE 937
Y + DV+S GI IE
Sbjct: 227 EGQYDGK------VDVWSLGITCIE 245
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 22/213 (10%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRA---LKSFDAECEVMRRIRHRN 1392
FS+ +G G F +VY A + AIK S ++ + E ++++RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ L+++Y GS L H L + + L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG---YMAPE--- 1506
S ++IH D+K N+LL + + LGDFG A ++ + + +G +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSF----VGTPYWMAPEVIL 223
Query: 1507 YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539
EG DV+S GI +E R+ P +M
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 47/225 (20%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN--------LQLDGAIKSFDAE 790
+ L D + S +G+G+ G V A VAIK+ + + + + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 791 CEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLD 845
E+L+++ H ++KI + + ++LE M G L
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK------L 118
Query: 846 IMIDVASALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVT 901
+ A++YLH +G +IH DLKP NVLL ++D + ++DFG SK+L GE S+
Sbjct: 119 YFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM 173
Query: 902 QTMTLATFGYMAPE---------YGSEGIVSTCGDVYSFG-ILMI 936
+T+ T Y+APE Y V D +S G IL I
Sbjct: 174 RTL-CGTPTYLAPEVLVSVGTAGYNRA--V----DCWSLGVILFI 211
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-19
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFS--------LQEDRALKSFDAECEVMRRIRHRNL 1393
LG+G V A AIKI S +E + + E E+++++ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
KI + + ++L+ M G L + + L + + A++YLH
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFYQMLLAVQYLH---E 132
Query: 1454 TSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE--- 1506
IIH DLKP NVLL ++D + + DFG +K+L M+ TL T Y+APE
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAPEVLV 189
Query: 1507 ------YGSEGIVSTSGDVYSFGILM 1526
Y V D +S G+++
Sbjct: 190 SVGTAGYNRA--V----DCWSLGVIL 209
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-22
Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 28/279 (10%)
Query: 135 LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSS---LGDCSKLKRL 191
L L+ +D ++ F D+ SL+ L+ V + +I ++ + S L+ L
Sbjct: 45 LEYLLKRVDTEADLGQ---FTDIIKSLS-LKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 192 SVSFNELTGRIPQNIGNLT--ELMELYLNGNNLQGE--FPPTIFNVS--SLRVIVLANNS 245
++ E+TG P + T +L L L + + + L+V+ +A
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 246 LFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNC----TLLNYLGLRDNQLTDFGAN 301
+ + R P+L L+L D G C L L LR+ +
Sbjct: 161 SL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM-----E 214
Query: 302 NLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSIC 361
+G+ ++ ++ + L N L + + L L L L V
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK---G 271
Query: 362 NASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400
+KL+VL+LS N + Q+ L+L +
Sbjct: 272 LPAKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 58/353 (16%), Positives = 91/353 (25%), Gaps = 73/353 (20%)
Query: 290 LRDNQLTDFGANNLTGLIP-SIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLW 348
D + A N G + ++E + + + + I +L RL +
Sbjct: 17 FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76
Query: 349 GNNLSGVIPSS---ICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSL 405
+ I + S L L L +G + L + S
Sbjct: 77 AARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV---SW 133
Query: 406 SQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFG 465
+ ++ + L
Sbjct: 134 ATRDAWLAELQQWL---------------------------------------------- 147
Query: 466 NLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSI-------PSELCQLESL 518
+ LS+ Q + V L LDLS N G P + L+ L
Sbjct: 148 -KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIP-STFWSLEYILVVDFSLNLLS 577
A L+ L+LS N L + + ++ S L
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
Query: 578 ---GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGS 627
LP L V L LS N+L P S L + L+L N F S
Sbjct: 267 QVPKGLPA---KLSV---LDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 68/348 (19%), Positives = 99/348 (28%), Gaps = 71/348 (20%)
Query: 192 SVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPT-IFNVSSLRVIVLANNSLFGSL 250
S +FN L + G L L + T I SL+ + + + +
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84
Query: 251 PVDLCRRL--PSLQELNLRDCMTTGRIPKDIGNCTL--LNYLGLRDNQLTDFGANNLTGL 306
R L LQEL L + TG P + T LN L LR+ A
Sbjct: 85 LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA------ 138
Query: 307 IPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKL 366
L P L L + + + L
Sbjct: 139 -----------------------WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175
Query: 367 TVLELSRNLFSGLVANTFGNC----RQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLR 422
+ L+LS N G C LQ+L L + + T S + L+
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS----GVCSALAAARVQLQ 231
Query: 423 YLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLAS 482
L + N + + L L+L L
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNS------------------------LNLSFTGL-K 266
Query: 483 TIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQN 530
+P G L LDLSYN + PS +L + L L+GN +
Sbjct: 267 QVPK--GLPAKLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 7e-16
Identities = 48/284 (16%), Positives = 76/284 (26%), Gaps = 53/284 (18%)
Query: 86 SRHGRVTDLSIPNLGLGGTIPPHVA---NLSFLVSLNISGNRFHGTLPNEL--WLMPRLR 140
+ + L++ + I +S L L + GT P L P L
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 141 IIDLSSNRISGN---LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNE 197
I++L + + L + L+ ++ + L L +S N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 198 LTGRI-------PQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSL 250
G P L L G L+ + L++NSL +
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 251 PVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSI 310
C L LN L L +P
Sbjct: 245 GAPSCDWPSQLNSLN------------------------LSFTGLKQ---------VPKG 271
Query: 311 IFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSG 354
+ + + V+ L N L PS LP + L L GN
Sbjct: 272 LP--AKLSVLDLSYNRLDR-NPSPDE--LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 38/194 (19%), Positives = 72/194 (37%), Gaps = 19/194 (9%)
Query: 63 NLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISG 122
N+S T + + W+ + LSI V L +L++S
Sbjct: 130 NVSWATRDAWLAELQQWL-------KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 123 NRFHGTLPNELWL----MPRLRIIDLSSNRIS--GNLFDDMCNSLTELESFDVSSNQITG 176
N G L P L+++ L + + + + + +L+ D+S N +
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 177 QLPSSLGD-CSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSS 235
+ D S+L L++SF L ++P+ + +L L L+ N L P+ +
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR--NPSPDELPQ 297
Query: 236 LRVIVLANNSLFGS 249
+ + L N S
Sbjct: 298 VGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 48/258 (18%), Positives = 77/258 (29%), Gaps = 33/258 (12%)
Query: 976 LSSEEEEGADLGDSNKLKRLSISVNKITGTIPRT---VGNLTELRELHLHGNNLEAYLYN 1032
++ + D+ S LKRL++ +I I V ++ L+EL L +
Sbjct: 54 TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113
Query: 1033 NKFTGRIPQ----NLGNCTLLNFL-------ILRQNQLTGVRLASNKLIGRIPSMIFNNS 1081
P NL N + + L + +A + +
Sbjct: 114 PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
Query: 1082 NIEAIQLYGNHFSG--HLPSSIGPY-LPNLQGLILWGNN---LSGIIPSSICNASQVILL 1135
+ + L N G L S++ P P LQ L L SG+ + Q+ L
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 1136 GLSENLFSGLIPN-TFGNCRQLQILDLSLNHLTTGSSTQGHSFYT------------SLT 1182
LS N + QL L+LS L S
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPSPD 293
Query: 1183 NCRYLRRLVLQNNPLKGA 1200
+ L L+ NP +
Sbjct: 294 ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 36/218 (16%), Positives = 61/218 (27%), Gaps = 11/218 (5%)
Query: 1018 ELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMI 1077
EL+ G +LE YL T + ++ L L++ + R+ S L G +
Sbjct: 37 ELYGGGRSLE-YLLKRVDTEADLGQFTD--IIKSLSLKRLTVRAARIPSRILFG--ALRV 91
Query: 1078 FNNSNIEAIQLYGNHFSGHLPSSIGP-YLPNLQGLILWGNNLSGIIPS----SICNASQV 1132
S ++ + L +G P + P+L L L + + +
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
Query: 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVL 1192
+L +++ L LDLS N + L
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
Query: 1193 QNNPLKGALPNSIGNLSTSLEYFFASSTELRGAIPVEF 1230
G L+ S LR A
Sbjct: 212 GMETPSGVCSALAAAR-VQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 29/174 (16%), Positives = 51/174 (29%), Gaps = 23/174 (13%)
Query: 463 EFGNLSNIIALSLYQNQLASTIPTTVGKLQ--NLQGLDLSYNNIQG--SIPSEL--CQLE 516
+S + L+L ++ T P + + +L L+L + + +EL
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
L L + N + +L L+LS N L+
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-----------------LI 192
Query: 577 SGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPE 630
S P L+VL S + L L L+ N + +
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 752 IGAGSFGSVYKATLPY-GMNVAIKVFN-LQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G+G+FG V+ G+ IK N + ++ +AE EVL+ + H N++KI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 810 SNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPT 863
++ +++E G L + ++M + +AL Y H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSE--GYVAELMKQMMNALAYFHSQH--- 144
Query: 864 PVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE----- 915
V+H DLKP N+L + + DFG+++L D + T YMAPE
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNA-AGTALYMAPEVFKRD 201
Query: 916 YGSEGIVSTCGDVYSFGILM 935
+ C D++S G++M
Sbjct: 202 VTFK-----C-DIWSAGVVM 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 48/202 (23%), Positives = 78/202 (38%), Gaps = 34/202 (16%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
LG+G F V+ + G IK + Q + +AE EV++ + H N+ KI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHPNIIKIFE 87
Query: 1399 SCSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGY 1452
+ ++++ G L E ++M + AL Y H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALS---EGYVAELMKQMMNALAYFH--- 141
Query: 1453 STSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--- 1506
S ++H DLKP N+L + DFG+A+L + T YMAPE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK 199
Query: 1507 --YGSEGIVSTSGDVYSFGILM 1526
+ D++S G++M
Sbjct: 200 RDVTFK------CDIWSAGVVM 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-22
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQ--LDGAIKSFDAECEVLRRV 797
+ ++ ++G GSFG V K A+KV N + + E E+L+++
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 798 RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYL 857
H N++K+ + ++ E G L + K + I+ V S + Y+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYM 137
Query: 858 H-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
H H ++H DLKP N+LL + D + DFG+S + + T Y+A
Sbjct: 138 HKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIA 191
Query: 914 PE-----YGSEGIVSTCGDVYSFGILM 935
PE Y + C DV+S G+++
Sbjct: 192 PEVLRGTYDEK-----C-DVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-19
Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 27/212 (12%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG G F V K A+K+ + +++ + E E+++++ H N+ K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ ++ + G L + + I+ V + Y+H +I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRF-SEHDAARIIKQVFSGITYMH---KHNIVHR 145
Query: 1460 DLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-----YGSEG 1511
DLKP N+LL + D + DFG++ MK + T Y+APE Y +
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLRGTYDEK- 202
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
DV+S G+++ L+ P F G+
Sbjct: 203 -----CDVWSAGVILYILLSGTPP----FYGK 225
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 14/231 (6%)
Query: 713 TRNKNLPILENDSLSLATWRRISYQELQRLTDGFSE----SNLIGAGSFGSVYKAT-LPY 767
R K D+ W++ Q ++ D + +G G+FG V++ T
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181
Query: 768 GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL 827
G N A K + ++ E + + +RH LV + + + +I E+M G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 828 EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHL- 885
+ + ++ + ++ M V L ++H + +H DLKP N++ L
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELK 297
Query: 886 -SDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILM 935
DFG++ LD + SV T T + APE V D++S G+L
Sbjct: 298 LIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-19
Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 8/187 (4%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LGTG F V++ T A G N A K + ++ E + M +RH L + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 1402 NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461
+ +I ++M G L + + + ++ ++ ++ M V L ++H + +H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 281
Query: 1462 KPSNVLLDDDMVAHL--GDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
KP N++ L DFG+ LD S+K T T + APE V D+
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEGKPVGYYTDM 339
Query: 1520 YSFGILM 1526
+S G+L
Sbjct: 340 WSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-21
Identities = 51/239 (21%), Positives = 98/239 (41%), Gaps = 38/239 (15%)
Query: 737 QELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKV-------------FNLQLDG 782
++ ++ + + + +G+G++G V AIKV N ++
Sbjct: 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 783 AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQ 842
+ E +L+ + H N++K+ + + L+ E+ G L + + + +
Sbjct: 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECD 147
Query: 843 RLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDS 899
+IM + S + YLH + ++H D+KP N+LL + + DFG+S +
Sbjct: 148 AANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 900 VTQTMTLATFGYMAPE-----YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ L T Y+APE Y + C DV+S G++M P F G+
Sbjct: 205 LRD--RLGTAYYIAPEVLKKKYNEK-----C-DVWSCGVIMYILLCGYPP----FGGQN 251
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-18
Identities = 46/225 (20%), Positives = 90/225 (40%), Gaps = 38/225 (16%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKI-------------FSLQEDRALKSFDAECEVMR 1386
LG+G + V + AIK+ + ++ + E +++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 1387 RIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALE 1446
+ H N+ K+ + + L+ ++ G L + + + + + +IM + +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSGIC 160
Query: 1447 YLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
YLH +I+H D+KP N+LL + + + DFG++ ++ L T Y+
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYYI 215
Query: 1504 APE-----YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
APE Y + DV+S G++M L P F G+
Sbjct: 216 APEVLKKKYNEK------CDVWSCGVIMYILLCGYPP----FGGQ 250
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 44/213 (20%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISS 808
++G G+ V L A+K+ Q E E+L + + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 809 CSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHP 862
L+ E M GS+ ++ ++ ++ DVASAL++LH G
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS------VVVQDVASALDFLHNKG-- 131
Query: 863 TPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLD--GEDSVTQTMTLATF----GYMA 913
+ H DLKP N+L + + + DF + + G+ S T L T YMA
Sbjct: 132 --IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 914 PE-----------YGSEGIVSTCGDVYSFGILM 935
PE Y C D++S G+++
Sbjct: 190 PEVVEAFSEEASIYDKR-----C-DLWSLGVIL 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 27/182 (14%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSS 1399
+LG G + V A+KI Q E E++ + + HRN+ +++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 1400 CSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLHQGYS 1453
L+ + M GS+ ++ ++ E ++ DVA AL++LH +
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFN-------ELEASVVVQDVASALDFLH---N 129
Query: 1454 TSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLD--GVDSMKQTMTLATI----GYMA 1504
I H DLKP N+L + + DF + + G S T L T YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 1505 PE 1506
PE
Sbjct: 190 PE 191
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 4e-21
Identities = 54/261 (20%), Positives = 87/261 (33%), Gaps = 69/261 (26%)
Query: 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA--- 789
L L + IG GS+G V A AIK+ N I D
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 790 --ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL-------------------- 827
E +++++ H N+ ++ + + L++E G L
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 828 -------------------EKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HGHPTPVIH 867
+ S + + +IM + SAL YLH G + H
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICH 191
Query: 868 CDLKPSNVLLDDDTVAHL--SDFGISKLLDGEDSVTQTMTLATFG---YMAPE------- 915
D+KP N L + + DFG+SK ++ G ++APE
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 916 -YGSEGIVSTCGDVYSFGILM 935
YG + C D +S G+L+
Sbjct: 252 SYGPK-----C-DAWSAGVLL 266
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 49/242 (20%), Positives = 89/242 (36%), Gaps = 67/242 (27%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA-----ECEVMRRIRHRNLAKI 1396
+G G + V A AIKI + + R + D E +M+++ H N+A++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 1397 VSSCSNPGFKALILQYMPQGSL-------------------------------------- 1418
+ + L+++ G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 1419 -EKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHL- 1476
+ S +++ + +IM + AL YLH + I H D+KP N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 1477 -GDFGIAKLLDGVDSMKQTM--TLA-TIGYMAPE--------YGSEGIVSTSGDVYSFGI 1524
DFG++K +++ + T A T ++APE YG + D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGV 264
Query: 1525 LM 1526
L+
Sbjct: 265 LL 266
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-21
Identities = 76/505 (15%), Positives = 151/505 (29%), Gaps = 111/505 (21%)
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQ----LPSSLGDCSKLKRLSVS 194
++ +D+ +S + ++ L + + + +T + S+L L L++
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 195 FNELTGRIPQNIGNL-----TELMELYLNGNNLQGEFPPTIFNVSSLRVI--VLANNSLF 247
NEL + ++ +L L L G V+ L
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---------GCGVLSSTLRTL--- 112
Query: 248 GSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIG-----NCTLLNYLGLRDNQLTDFGANN 302
P+LQEL+L D + + + L L L L+
Sbjct: 113 -----------PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161
Query: 303 LTGLIPSIIFNNSNIEVIQLYGNHLSG----NLPSSTGINLPNLLRLYLWGNNLS----G 354
L ++ + + + + + N ++ L + L L L ++
Sbjct: 162 LASVLRA----KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217
Query: 355 VIPSSICNASKLTVLELSRNLFSG-----LVANTFGNCRQLQILNLAYSQLATGSLSQGQ 409
+ + + + L L L N L +L+ L + + +
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI---TAKGCG 274
Query: 410 SFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSN 469
L L+ L++ N + L ++L
Sbjct: 275 DLCRVLRAKESLKELSLAGNE---LGDEGARLLCETLLE-----------------PGCQ 314
Query: 470 IIALSLYQNQL----ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ-LESLNTLL-- 522
+ +L + S + + + + L L +S N ++ + ELCQ L ++L
Sbjct: 315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374
Query: 523 --LQGNALQNQ----IPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
L + + + L SLR L+LS+N L D + L
Sbjct: 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG----------------DAGILQL 418
Query: 577 SGCLPQDIGNLKVLTGLYLSGNQLS 601
+ Q L+ L L S
Sbjct: 419 VESVRQPGCLLEQ---LVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-16
Identities = 80/463 (17%), Positives = 146/463 (31%), Gaps = 65/463 (14%)
Query: 115 LVSLNISGNRF-HGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSL---TELESFDVS 170
+ SL+I L L+ + +++ L ++ D+ ++L L ++
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 171 SNQITGQLPSSLGDC-----SKLKRLSVSFNELTGR----IPQNIGNLTELMELYLNGNN 221
SN++ + K+++LS+ LTG + + L L EL+L+ N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 222 LQGEFPPTIFNV-----SSLRVIVLANNSLFGSLPVDLC---RRLPSLQELNLRDCMTTG 273
L + L + L SL + L R P +EL + +
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 274 RIPKDIG-----NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHL- 327
+ + + L L L +T +L I+ + +++ + L N L
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC----GIVASKASLRELALGSNKLG 240
Query: 328 -SGNLPSSTGINLPN--LLRLYLWGNNLSGV----IPSSICNASKLTVLELSRNLFSGLV 380
G G+ P+ L L++W ++ + + L L L+ N
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300
Query: 381 ANTFG-----NCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKG-- 433
A QL+ L + F S L R+L L I N +
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAACC---SHFSSVLAQNRFLLELQISNNRLEDAG 357
Query: 434 --ILPNSVGNLSKSLEYFYAGSCELG----GGIPAEFGNLSNIIALSLYQNQ-------- 479
L +G L + C++ + A ++ L L N
Sbjct: 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 417
Query: 480 LASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLL 522
L ++ L+ L L + L LE L
Sbjct: 418 LVESVRQPGCLLEQL---VLYDIYWSEEMEDRLQALEKDKPSL 457
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-06
Identities = 28/145 (19%), Positives = 48/145 (33%), Gaps = 28/145 (19%)
Query: 492 QNLQGLDLSYNNIQGSIPSELCQ-LESLNTLLLQGNALQNQ----IPTCLANLTSLRALN 546
++Q LD+ + + +EL L+ + L L I + L +L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 547 LSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS----C 602
L SN L D ++ + L + L L L+
Sbjct: 63 LRSNELG----------------DVGVHCVLQGLQT---PSCKIQKLSLQNCCLTGAGCG 103
Query: 603 SIPSSIGGLKDLTYLALARNGFQGS 627
+ S++ L L L L+ N +
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDA 128
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-06
Identities = 47/233 (20%), Positives = 81/233 (34%), Gaps = 42/233 (18%)
Query: 110 ANLSFLVSLNISGNRFHGT-----LPNELWLMPRLRIIDLSSNRISGNLFDDMCNSL--- 161
A+ + L L + N+ P L RLR + + I+ D+C L
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 162 TELESFDVSSNQITGQLPSSLGD-----CSKLKRLSVSFNELTGRIPQNIGNL----TEL 212
L+ ++ N++ + L + +L+ L V T + ++ L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 213 MELYLNGNNLQGEFPPTIFNV-----SSLRVIVLANNSL----FGSLPVDLCRRLPSLQE 263
+EL ++ N L+ + S LRV+ LA+ + SL SL+E
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL-AATLLANHSLRE 402
Query: 264 LNLRDCMTTGRIPKDIG----------NCTLLNYLGLRDNQLTDFGANNLTGL 306
L+L + D G LL L L D ++ + L L
Sbjct: 403 LDLSNNC-----LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-05
Identities = 43/244 (17%), Positives = 76/244 (31%), Gaps = 47/244 (19%)
Query: 980 EEEGADLGDSNK-LKRLSISVNKITGT----IPRTVGNLTELRELHLHGNNLEAYLYNNK 1034
+ A+L + + + + +T I + L EL+L N L
Sbjct: 17 DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL-------- 68
Query: 1035 FTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKL----IGRIPSMIFNNSNIEAIQLYG 1090
++G +L L ++ + L + L G + S + ++ + L
Sbjct: 69 ------GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 1091 NHFSG----HLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNA----SQVILLGLSEN-- 1140
N L + L+ L L +LS + + L +S N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 1141 -------LFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQ 1193
L GL + QL+ L L +T S + + LR L L
Sbjct: 183 NEAGVRVLCQGLKDSPC----QLEALKLESCGVT---SDNCRDLCGIVASKASLRELALG 235
Query: 1194 NNPL 1197
+N L
Sbjct: 236 SNKL 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 7e-04
Identities = 43/219 (19%), Positives = 70/219 (31%), Gaps = 49/219 (22%)
Query: 991 KLKRLSISVNKIT----GTIPRTVGNLTELRELHLHGNNLEA------------------ 1028
+L+ L + +T + V + LREL L N L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 1029 --YLYNNKFTGR----IPQNLGNCTLLNFLILRQNQLT--GVRLASNKLIGRIPSMIFNN 1080
+++ T + + + L L L L N+L G RL L+
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL-------EPG 312
Query: 1081 SNIEAIQLYGNHFSGHLPSSIGPYL---PNLQGLILWGNNLSGIIPSSICNA-----SQV 1132
+E++ + F+ S L L L + N L +C S +
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 1133 ILLGLSENLFS----GLIPNTFGNCRQLQILDLSLNHLT 1167
+L L++ S + T L+ LDLS N L
Sbjct: 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 46/219 (21%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN--------------------LQLDGAIKSFDA 789
IG GS+G V A A+KV + G I+
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 790 ------ECEVLRRVRHRNLVK----IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLN 839
E +L+++ H N+VK + +H + ++ E + QG + L+
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY--MVFELVNQGPV--MEVPTLKPLS 135
Query: 840 IQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899
Q D+ +EYLH+ +IH D+KPSN+L+ +D ++DFG+S G D+
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 900 VTQTM--TLATFGYMAPEYGSEGIVSTCG---DVYSFGI 933
+ T A +MAPE SE G DV++ G+
Sbjct: 193 LLSNTVGTPA---FMAPESLSETRKIFSGKALDVWAMGV 228
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 38/229 (16%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS--------------------LQEDRALKSFDA 1380
+G G + V A D T A+K+ S ++
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 1381 ------ECEVMRRIRHRNLAKIVSSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLLNIE 1432
E +++++ H N+ K+V +P L + + + QG + L+ +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLKPLSED 137
Query: 1433 QRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492
Q D+ +EYLH IIH D+KPSN+L+ +D + DFG++ G D++
Sbjct: 138 QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
Query: 1493 QTMTLATIGYMAPEYGSEGIVSTSG---DVYSFGILMMETLTRRKPTDD 1538
T+ T +MAPE SE SG DV++ G+ + + + P D
Sbjct: 195 SN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-21
Identities = 44/200 (22%), Positives = 87/200 (43%), Gaps = 11/200 (5%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR 798
+ L + + + +G G FG V++ K ++ E +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIAR 59
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
HRN++ + S + +I E++ + + + + + LN ++ + + V AL++LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 859 -HGHPTPVIHCDLKPSNVLLDDDTVAHL--SDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
H + H D++P N++ + + +FG ++ L D+ T Y APE
Sbjct: 120 SHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPE 173
Query: 916 YGSEGIVSTCGDVYSFGILM 935
+VST D++S G L+
Sbjct: 174 VHQHDVVSTATDMWSLGTLV 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-18
Identities = 44/188 (23%), Positives = 85/188 (45%), Gaps = 11/188 (5%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G F V++ + K ++ D+ E ++ RHRN+ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNILHLHESF 70
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
+ +I +++ + + + + + LN + + + V AL++LH S +I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 1461 LKPSNVLLDDDMVAHL--GDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
++P N++ + + +FG A+ L D+ + T Y APE +VST+ D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVVSTATD 185
Query: 1519 VYSFGILM 1526
++S G L+
Sbjct: 186 MWSLGTLV 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-21
Identities = 44/197 (22%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 746 FSESNLIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRN 801
S++ ++G G FG V+ AT G+ +A K+ + + E V+ ++ H N
Sbjct: 91 VSKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HG 860
L+++ + + L++EY+ G L + Y L + M + + ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHL--SDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS 918
++H DLKP N+L + + DFG+++ + + T ++APE +
Sbjct: 208 ----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG--TPEFLAPEVVN 261
Query: 919 EGIVSTCGDVYSFGILM 935
VS D++S G++
Sbjct: 262 YDFVSFPTDMWSVGVIA 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 10/194 (5%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
S++ +LG G F V+K A G A KI + + + E VM ++ H NL +
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ + + L+++Y+ G L + +Y L + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMY 207
Query: 1456 IIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI 1512
I+H DLKP N+L D + + DFG+A+ + +K T ++APE +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVNFG--TPEFLAPEVVNYDF 264
Query: 1513 VSTSGDVYSFGILM 1526
VS D++S G++
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 17/220 (7%)
Query: 338 NLP-NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396
NLP + L L N L + S + +L VL+LSR + + + L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCEL 456
+ + SL+ G FS L++ L+ L + +G+L +L+ +
Sbjct: 85 GNPIQ--SLALG--AFSGLSS---LQKLVAVETNLASLENFPIGHLK-TLKELNVAHNLI 136
Query: 457 GGGIPAE-FGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQG----LDLSYNNIQGSIPS 510
E F NL+N+ L L N++ +I T L + LDLS N + I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSN 550
+ L L L N L++ LTSL+ + L +N
Sbjct: 195 GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 48/241 (19%), Positives = 80/241 (33%), Gaps = 44/241 (18%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
++ D+S N + S +L+ L +S E+ I +L+ L L L GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 221 NLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI- 279
+Q SL + L SLQ+L + +
Sbjct: 87 PIQ-------------------------SLALGAFSGLSSLQKLVAVETNLA-SLENFPI 120
Query: 280 GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGIN 338
G+ L L + N + F F+N +N+E + L N + ++ +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPE--------YFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
Query: 339 LPNL----LRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILN 394
L + L L L N ++ I +L L L N + F LQ +
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIW 230
Query: 395 L 395
L
Sbjct: 231 L 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 35/216 (16%)
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFN 196
P L+++DLS I + D SL+ L + ++ N I + S L++L
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 197 ELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDL 254
L + G+L L EL + N +Q P F N+++L + L++N + S+
Sbjct: 111 NLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTD 168
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
R L + LNL L L N + I F
Sbjct: 169 LRVLHQMPLLNLS--------------------LDLSLNPMNF---------IQPGAFKE 199
Query: 315 SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGN 350
++ + L N L ++P L +L +++L N
Sbjct: 200 IRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 47/230 (20%), Positives = 88/230 (38%), Gaps = 38/230 (16%)
Query: 992 LKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
K L +S N + + + EL+ L L ++ + + + Q+L + L+
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAY-----QSLSH---LS 79
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
LIL N + + F+ S+++ + + + L + +L L+
Sbjct: 80 TLILTGNPIQ-----------SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLK 127
Query: 1110 GLILWGNNLSGIIPSSIC-NASQVILLGLSENLFSGLIPNTFGNCRQLQI----LDLSLN 1164
L + N + N + + L LS N + Q+ + LDLSLN
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 1165 HLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
+ Q +F + L+ L L N LK ++P+ I + TSL+
Sbjct: 188 PMN---FIQPGAF-KEIR----LKELALDTNQLK-SVPDGIFDRLTSLQK 228
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 41/188 (21%), Positives = 64/188 (34%), Gaps = 28/188 (14%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRI 1073
+ L L N L +L + F + L L L + ++ I
Sbjct: 28 FSTKNLDLSFNPL-RHLGSYSFF--------SFPELQVLDLSRCEIQ-----------TI 67
Query: 1074 PSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132
+ + S++ + L GN L L +LQ L+ NL+ + I + +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 1133 ILLGLSENLFSGLI-PNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLR-RL 1190
L ++ NL P F N L+ LDLS N + S L L L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ---SIYCTDL-RVLHQMPLLNLSL 182
Query: 1191 VLQNNPLK 1198
L NP+
Sbjct: 183 DLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 43/205 (20%), Positives = 75/205 (36%), Gaps = 42/205 (20%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
++ + LS L L + + L+ ++++ N I + ++LT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTEL-MELYLNGNN 221
LE D+SSN+I + + L + L + L L+ N
Sbjct: 150 NLEHLDLSSNKIQ-SIYCT------------DLRVLH--------QMPLLNLSLDLSLNP 188
Query: 222 LQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR----DCMTTGRIPK 277
+ P F L+ + L N L S+P + RL SLQ++ L DC
Sbjct: 189 MN-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPWDC-------- 238
Query: 278 DIGNCTLLNYLG--LRDNQLTDFGA 300
+C ++YL L N + G+
Sbjct: 239 ---SCPRIDYLSRWLNKNSQKEQGS 260
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 30/127 (23%), Positives = 47/127 (37%), Gaps = 7/127 (5%)
Query: 507 SIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYI 566
IP L S L L N L++ + L+ L+LS + + + SL ++
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 567 LVVDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGF 624
+ + N + L L L L L+ S+ + G LK L L +A N
Sbjct: 79 STLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 625 QGSIPEA 631
Q S
Sbjct: 137 Q-SFKLP 142
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 36/196 (18%), Positives = 63/196 (32%), Gaps = 36/196 (18%)
Query: 991 KLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEA---------------YLYNNK 1034
+L+ L +S +I TI +L+ L L L GN +++
Sbjct: 53 ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 1035 FTGRIPQNL-GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNH 1092
+ G+ L L + N + +L F+N +N+E + L N
Sbjct: 112 LA-SLENFPIGHLKTLKELNVAHNLIQSFKLPE----------YFSNLTNLEHLDLSSNK 160
Query: 1093 FSGHLPSSIGPYLPNLQG----LILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPN 1148
+ + L + L L N ++ I ++ L L N +
Sbjct: 161 IQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLKELALDTNQLKSVPDG 218
Query: 1149 TFGNCRQLQILDLSLN 1164
F LQ + L N
Sbjct: 219 IFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 20/109 (18%), Positives = 41/109 (37%), Gaps = 8/109 (7%)
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
+ + L L N L + S + ++ +L LS + + + L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
+ + + + + L++LV L IG+L +L+
Sbjct: 88 IQSLAL-------GAFSGLSSLQKLVAVETNLASLENFPIGHL-KTLKE 128
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 3e-20
Identities = 54/374 (14%), Positives = 118/374 (31%), Gaps = 40/374 (10%)
Query: 144 LSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIP 203
S I +F D ++ E ++ +T + + + + ++ + +++ +
Sbjct: 6 TVSTPIK-QIFPD--DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV- 58
Query: 204 QNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLC--RRLPSL 261
Q I L + +L+LNGN L P + N+ +L + L N + DL + L L
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI-----KDLSSLKDLKKL 111
Query: 262 QELNLRDCMTTGRIPK--DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEV 319
+ L+L I + + L L L +N++TD +++ + ++
Sbjct: 112 KSLSLEHN----GISDINGLVHLPQLESLYLGNNKITDI----------TVLSRLTKLDT 157
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
+ L N +S ++ L L LYL N++S + ++ L VLEL
Sbjct: 158 LSLEDNQIS-DIVPLA--GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212
Query: 380 VANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQ---TNPWKGILP 436
N N + L T + + +L + +
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272
Query: 437 NSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQG 496
+ + + + + + + +
Sbjct: 273 KAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKN 332
Query: 497 LDLSYNNIQGSIPS 510
+N +
Sbjct: 333 GGHEWNFNTDYMSG 346
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 5e-17
Identities = 53/318 (16%), Positives = 103/318 (32%), Gaps = 59/318 (18%)
Query: 257 RLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSN 316
+ NL+ T + ++ + ++ + I N
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV----------QGIQYLPN 66
Query: 317 IEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLF 376
+ + L GN L+ P + NL NL L+L N + + SS+ + KL L L N
Sbjct: 67 VTKLFLNGNKLTDIKPLT---NLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGI 121
Query: 377 SGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILP 436
S + N + QL+ L L +++ + L+ L L+++ N I+P
Sbjct: 122 SDI--NGLVHLPQLESLYLGNNKITD---------ITVLSRLTKLDTLSLEDNQISDIVP 170
Query: 437 NSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQG 496
L+ + L L +N ++ + L+NL
Sbjct: 171 ---------------------------LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDV 201
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTI 556
L+L + L NT+ +L P +++ N+ + T
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTN 259
Query: 557 PSTFWSLEYILVVDFSLN 574
+F + + +
Sbjct: 260 EVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 6e-17
Identities = 48/266 (18%), Positives = 92/266 (34%), Gaps = 30/266 (11%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
++ L +++ + + + + + + + + L L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 74
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
++L + LTN + L +L + N K + +S+ +L K L+ +
Sbjct: 75 NKL---------TDIKPLTNLKNLGWLFLDENKIKDL--SSLKDLKK-LKSLSLEHNGIS 122
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
I +L + +L L N++ T T + +L L L L N I I L L
Sbjct: 123 D-ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTK 176
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L L L N + + LA L +L L L S + + + LVV ++
Sbjct: 177 LQNLYLSKNHISD--LRALAGLKNLDVLELFSQ----ECLNKPINHQSNLVVPNTVKNTD 230
Query: 578 G--CLPQDIGNLKVLTGLYLSGNQLS 601
G P+ I + + +
Sbjct: 231 GSLVTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 2e-16
Identities = 53/271 (19%), Positives = 98/271 (36%), Gaps = 59/271 (21%)
Query: 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCN--SLTELES 166
L+ + + + + ++ + +P + + L+ N+++ D+ +L L
Sbjct: 39 QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-----DIKPLTNLKNLGW 91
Query: 167 FDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF 226
+ N+I L SSL D KLK LS+ N ++ I + +L +L LYL N
Sbjct: 92 LFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNK----- 142
Query: 227 PPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK--DIGNCTL 284
I +++ L RL L L+L D +I + T
Sbjct: 143 ---ITDITVL-------------------SRLTKLDTLSLEDN----QISDIVPLAGLTK 176
Query: 285 LNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLR 344
L L L N ++D + N++V++L+ N P + NL
Sbjct: 177 LQNLYLSKNHISDL----------RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNT 225
Query: 345 LYLWGNNLSGVIPSSICNASKLTVLELSRNL 375
+ +L P I + + +L
Sbjct: 226 VKNTDGSLV--TPEIISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 4e-16
Identities = 53/296 (17%), Positives = 89/296 (30%), Gaps = 74/296 (25%)
Query: 345 LYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGS 404
+ + P ++ L + + V T + + S + +
Sbjct: 4 TITVSTPIKQIFPDDAF--AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-- 57
Query: 405 LSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEF 464
+ + L + N I P
Sbjct: 58 -------VQGIQYLPNVTKLFLNGNKLTDIKP---------------------------L 83
Query: 465 GNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQ 524
NL N+ L L +N++ + L+ L+ L L +N I I L L L +L L
Sbjct: 84 TNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLG 139
Query: 525 GNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI 584
N + + T L+ LT L L+L N++ S I +
Sbjct: 140 NNKITD--ITVLSRLTKLDTLSLEDNQI-SDIVP-------------------------L 171
Query: 585 GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
L L LYLS N +S + ++ GLK+L L L +L+
Sbjct: 172 AGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 3e-12
Identities = 32/210 (15%), Positives = 68/210 (32%), Gaps = 45/210 (21%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
+ + ++ +T + L + ++ + ++++ + Q + +
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK----------SV-QGIQYLPNVT 68
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP--YLPNL 1108
L L N+LT + + N N+ + L N + L L
Sbjct: 69 KLFLNGNKLTDI------------KPLTNLKNLGWLFLDENKIK-----DLSSLKDLKKL 111
Query: 1109 QGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTT 1168
+ L L N +S I + + + Q+ L L N + + +L L L N ++
Sbjct: 112 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD 167
Query: 1169 GSSTQGHSFYTSLTNCRYLRRLVLQNNPLK 1198
L L+ L L N +
Sbjct: 168 ---------IVPLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 1e-11
Identities = 46/226 (20%), Positives = 86/226 (38%), Gaps = 45/226 (19%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
+ N + ++ + + I + L + +L L+GN L I + L N
Sbjct: 39 QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT----------DI-KPLTN 85
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP-- 1103
L +L L +N++ + S + + ++++ L N S I
Sbjct: 86 LKNLGWLFLDENKIKDL------------SSLKDLKKLKSLSLEHNGI-----SDINGLV 128
Query: 1104 YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSL 1163
+LP L+ L L N ++ I + + +++ L L +N S ++P +LQ L LS
Sbjct: 129 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 184
Query: 1164 NHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
NH++ +L + L L L + N NL
Sbjct: 185 NHISD---------LRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 1e-08
Identities = 27/138 (19%), Positives = 51/138 (36%), Gaps = 9/138 (6%)
Query: 107 PHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELES 166
+ +L L SL + N+ T L + +L + L N+IS ++ LT+L++
Sbjct: 125 NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI--VPLAGLTKLQN 179
Query: 167 FDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF 226
+S N I+ +L L L + E + + NL + +L
Sbjct: 180 LYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--T 235
Query: 227 PPTIFNVSSLRVIVLANN 244
P I + + +
Sbjct: 236 PEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 1e-07
Identities = 34/192 (17%), Positives = 60/192 (31%), Gaps = 38/192 (19%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNL-------------EAYLYNNKFTG 1037
L L + NKI + +L +L+ L L N + YL NNK T
Sbjct: 88 NLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT- 144
Query: 1038 RIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHL 1097
L T L+ L L NQ++ + + + ++ + L NH S
Sbjct: 145 -DITVLSRLTKLDTLSLEDNQISDI------------VPLAGLTKLQNLYLSKNHIS--- 188
Query: 1098 PSSIGP--YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ 1155
+ L NL L L+ + N + ++ P +
Sbjct: 189 --DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGD 244
Query: 1156 LQILDLSLNHLT 1167
+ ++ +
Sbjct: 245 YEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 5e-07
Identities = 38/234 (16%), Positives = 66/234 (28%), Gaps = 70/234 (29%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
+ I P E + +L ++ ++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTD-----------AVTQNELNSIDQ 47
Query: 1052 LILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGL 1111
+I + + +++ IQ YLPN+ L
Sbjct: 48 IIANNSDIK---------------------SVQGIQ----------------YLPNVTKL 70
Query: 1112 ILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSS 1171
L GN L+ I + N + L L EN L + ++L+ L L N ++
Sbjct: 71 FLNGNKLTDI--KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD--- 123
Query: 1172 TQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS--TSLEYFFASSTELR 1223
L + L L L NN + I LS T L+ ++
Sbjct: 124 ------INGLVHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 2e-06
Identities = 21/105 (20%), Positives = 39/105 (37%), Gaps = 8/105 (7%)
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
+ + ++ P NL + + L I + + + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
Q I L +T L+L+GN+L+ I + LK+L +L L N
Sbjct: 57 SV--QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN 97
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 61/323 (18%), Positives = 106/323 (32%), Gaps = 61/323 (18%)
Query: 329 GNLPSSTGI-------NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVA 381
G++ T I L N +++ +N++ + + +T L + +
Sbjct: 1 GSITQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI-- 56
Query: 382 NTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGN 441
L L L +Q+ + L N + L + NP K +
Sbjct: 57 EGVQYLNNLIGLELKDNQITD---------LAPLKNLTKITELELSGNPLKNVSA----- 102
Query: 442 LSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSY 501
L +I L L Q+ P + L NLQ L L
Sbjct: 103 ----------------------IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDL 138
Query: 502 NNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFW 561
N I +I S L L +L L + + + P LANL+ L L N+++ S
Sbjct: 139 NQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI--SPLA 192
Query: 562 SLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALAR 621
SL ++ V N +S P + N L + L+ ++ + P +L + +
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT-NQPVFY--NNNLVVPNVVK 247
Query: 622 NGFQGSI-PEAIGSLISLEKGEI 643
I P I + +
Sbjct: 248 GPSGAPIAPATISDNGTYASPNL 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 57/298 (19%), Positives = 108/298 (36%), Gaps = 37/298 (12%)
Query: 258 LPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNI 317
L + ++ T + + + L +T + +N+
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI----------EGVQYLNNL 65
Query: 318 EVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377
++L N ++ +L NL + L L GN L V S+I + L+L+ +
Sbjct: 66 IGLELKDNQIT-DLAPLK--NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQIT 120
Query: 378 GLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPN 437
+ LQ+L L +Q+ + S L L+YL+I + P
Sbjct: 121 DV--TPLAGLSNLQVLYLDLNQI---------TNISPLAGLTNLQYLSIGNAQVSDLTP- 168
Query: 438 SVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGL 497
+ NLSK L A ++ I +L N+I + L NQ++ P + NL +
Sbjct: 169 -LANLSK-LTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 498 DLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNST 555
L+ I L N +++G + P +++ + + NL+ N +
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPN--VVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 52/259 (20%), Positives = 104/259 (40%), Gaps = 29/259 (11%)
Query: 136 MPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSF 195
+ I + ++ + + +T L +T + + L L +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTL---SAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 196 NELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLC 255
N++T + + NLT++ EL L+GN L+ I + S++ + L + + P+
Sbjct: 73 NQIT-DLA-PLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPLA-- 126
Query: 256 RRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNS 315
L +LQ L L T P + T L YL + + Q++D + + N S
Sbjct: 127 -GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL----------TPLANLS 173
Query: 316 NIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNL 375
+ ++ N +S ++ +LPNL+ ++L N +S V S + N S L ++ L+
Sbjct: 174 KLTTLKADDNKIS-DISPLA--SLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQT 228
Query: 376 FSGLVANTFGNCRQLQILN 394
+ N ++
Sbjct: 229 ITNQPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 31/257 (12%)
Query: 144 LSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIP 203
I+ +F D +L + +T + D + LS +T I
Sbjct: 4 TQPTAIN-VIFPD--PALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE 57
Query: 204 QNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQE 263
+ L L+ L L N + + P + N++ + + L+ N L + L S++
Sbjct: 58 -GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIA---GLQSIKT 111
Query: 264 LNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLY 323
L+L T + + L L L NQ+T+ + L GL +N++ + +
Sbjct: 112 LDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGL--------TNLQYLSIG 159
Query: 324 GNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANT 383
+S +L NL L L N +S + S + + L + L N S + +
Sbjct: 160 NAQVS-DLTPLA--NLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDV--SP 212
Query: 384 FGNCRQLQILNLAYSQL 400
N L I+ L +
Sbjct: 213 LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 46/215 (21%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 107 PHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELES 166
V L+ L+ L + N+ T L + ++ ++LS N + N+ L +++
Sbjct: 57 EGVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLK-NVSAI--AGLQSIKT 111
Query: 167 FDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF 226
D++S QIT + L S L+ L + N++T I + LT L L + + +
Sbjct: 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DL 166
Query: 227 PPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLN 286
P + N+S L + +N + P+ LP+L E++L++ + P + N + L
Sbjct: 167 TP-LANLSKLTTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLF 220
Query: 287 YLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQ 321
+ L + +T+ L+ + + I
Sbjct: 221 IVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 49/257 (19%), Positives = 82/257 (31%), Gaps = 48/257 (18%)
Query: 968 TEVVDAELLSSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLE 1027
+ S + D + + LS +T V L L L L N +
Sbjct: 19 ANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQIT 76
Query: 1028 AYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQ 1087
+ L N T + L L N L V S I +I+ +
Sbjct: 77 ----------DLA-PLKNLTKITELELSGNPLKNV------------SAIAGLQSIKTLD 113
Query: 1088 LYGNHFSGHLPSSIGP--YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGL 1145
L + + P L NLQ L L N ++ I S + + + L + S L
Sbjct: 114 LTSTQI-----TDVTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL 166
Query: 1146 IPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSI 1205
P N +L L N ++ + L + L + L+NN + P +
Sbjct: 167 TP--LANLSKLTTLKADDNKISD---------ISPLASLPNLIEVHLKNNQISDVSP--L 213
Query: 1206 GNLSTSLEYFFASSTEL 1222
N ++L ++ +
Sbjct: 214 ANT-SNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 36/184 (19%), Positives = 63/184 (34%), Gaps = 36/184 (19%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
L + K+ L +S N + + L ++ L L + L
Sbjct: 81 LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQI-----------TDVTPLAG 127
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP-- 1103
+ L L L NQ+T + S + +N++ + + S + P
Sbjct: 128 LSNLQVLYLDLNQITNI------------SPLAGLTNLQYLSIGNAQV-----SDLTPLA 170
Query: 1104 YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSL 1163
L L L N +S I S + + +I + L N S + P N L I+ L+
Sbjct: 171 NLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
Query: 1164 NHLT 1167
+T
Sbjct: 227 QTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 31/184 (16%), Positives = 62/184 (33%), Gaps = 30/184 (16%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLG 1044
L + L+ L + +N+IT P + LT L+ L + + L
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-----------TPLA 170
Query: 1045 NCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPY 1104
N + L L N+++ + S + + N+ + L N S P +
Sbjct: 171 NLSKLTTLKADDNKISDI------------SPLASLPNLIEVHLKNNQISDVSPLA---N 215
Query: 1105 LPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLN 1164
NL + L ++ N + V+ + + + P T + +L+ N
Sbjct: 216 TSNLFIVTLTNQTITNQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273
Query: 1165 HLTT 1168
+
Sbjct: 274 LTSF 277
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 37/225 (16%), Positives = 68/225 (30%), Gaps = 70/225 (31%)
Query: 1000 NKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQL 1059
I P L ++ +N+ + + L +
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTD-----------TVTQADLDGITTLSAFGTGV 53
Query: 1060 TGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLS 1119
T IE +Q YL NL GL L N ++
Sbjct: 54 T---------------------TIEGVQ----------------YLNNLIGLELKDNQIT 76
Query: 1120 GIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYT 1179
+ + + N +++ L LS N + + ++ LDL+ +T T
Sbjct: 77 DL--APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD---------VT 123
Query: 1180 SLTNCRYLRRLVLQNNPLKGALPNSIGNLS--TSLEYFFASSTEL 1222
L L+ L L N + +I L+ T+L+Y + ++
Sbjct: 124 PLAGLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQV 163
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 46/245 (18%), Positives = 90/245 (36%), Gaps = 25/245 (10%)
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELY 216
C+ + V+ I ++PS + L + L IP + NL + +Y
Sbjct: 10 CHQEEDF---RVTCKDIQ-RIPSLPPS---TQTLKLIETHLR-TIPSHAFSNLPNISRIY 61
Query: 217 LNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI 275
++ + + F N+S + I + N + D + LP L+ L + +
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120
Query: 276 PKD--IGNCTLLNYLGLRDN-QLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLP 332
P + + + L + DN +T N GL + ++LY N + ++
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL-------CNETLTLKLYNNGFT-SVQ 172
Query: 333 SSTGINLPNLLRLYLWGNNLSGVIPSSICN--ASKLTVLELSRNLFSGLVANTFGNCRQL 390
N L +YL N VI S ++L++S+ + L + + ++L
Sbjct: 173 GYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231
Query: 391 QILNL 395
N
Sbjct: 232 IARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 44/288 (15%), Positives = 85/288 (29%), Gaps = 79/288 (27%)
Query: 341 NLLRLYLWGNNLSGV--IPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY- 397
+ ++ + +P S L+L + ++ F N + + ++
Sbjct: 12 QEEDFRVTCKDIQRIPSLPPS------TQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 398 ---SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSC 454
QL + S F +L+ + ++ I+ +
Sbjct: 66 VTLQQLESHS-------FYNLSK---VTHIEIRNTRNLTYIDPDA--------------- 100
Query: 455 ELGGGIPAEFGNLSNIIALSLYQNQLASTIP--TTVGKLQNLQGLDLSYNNIQGSIPSEL 512
L + L ++ L P T V L+++ N SIP
Sbjct: 101 ---------LKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 513 CQ--LESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPS-TFWSLEYILVV 569
Q TL L N + + N T L A+ L+ N+ + I F +
Sbjct: 151 FQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY----- 204
Query: 570 DFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYL 617
+ L +S ++ ++PS GL+ L L
Sbjct: 205 ------------------SGPSLLDVSQTSVT-ALPS--KGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 32/172 (18%), Positives = 61/172 (35%), Gaps = 9/172 (5%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNEL-WLMPRLRIIDLSSNRISGNLFDDMCNSL 161
TIP H +NL + + +S + L + + + ++ I++ + R + D L
Sbjct: 45 TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL 104
Query: 162 TELESFDVSSNQITGQLP--SSLGDCSKLKRLSVSFNELTGRIPQNI-GNLT-ELMELYL 217
L+ + + + P + + L ++ N IP N L E + L L
Sbjct: 105 PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPS-LQELNLRD 268
N FN + L + L N + D + S L++
Sbjct: 164 YNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ 214
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 39/243 (16%), Positives = 72/243 (29%), Gaps = 76/243 (31%)
Query: 992 LKRLSISVNKITGTIPRTV-GNLTELRELHLHGNN----LEA------------YLYNNK 1034
+ L + + TIP NL + +++ + LE+ + N +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 1035 FTGRIPQN-LGNCTLLNFLILRQNQLTGV---------------RLASNKLIGRIPSMIF 1078
I + L LL FL + L + N + IP F
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 1079 NN--SNIEAIQLYGNHFSGHLPSSIGPY---LPNLQGLILWGNNLSGIIPSSICNASQVI 1133
+ ++LY N F +S+ Y L + L N
Sbjct: 152 QGLCNETLTLKLYNNGF-----TSVQGYAFNGTKLDAVYLNKNKY--------------- 191
Query: 1134 LLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQ 1193
L + ++ F G+ +LD+S +T + +L+ L+ +
Sbjct: 192 LTVIDKDAFGGV-------YSGPSLLDVSQTSVT---ALPSKGL-------EHLKELIAR 234
Query: 1194 NNP 1196
N
Sbjct: 235 NTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 41/239 (17%), Positives = 86/239 (35%), Gaps = 36/239 (15%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
++ + ++ I IP + L L +L IP +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR----------TIPSH----AFS 52
Query: 1050 NFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNL 1108
N ++ + ++ + + ++ S F N S + I++ ++ LP L
Sbjct: 53 NL-----PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107
Query: 1109 QGLILWGNNLSGIIPSSICNASQV-ILLGLSENLFSGLIP-NTFGN-CRQLQILDLSLNH 1165
+ L ++ L + ++ + +L +++N + IP N F C + L L N
Sbjct: 108 KFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALP-NSIGNLSTSLEYFFASSTELR 1223
T S QG++F + T L + L N + ++ G + + S T +
Sbjct: 168 FT---SVQGYAF--NGTK---LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 27/142 (19%), Positives = 52/142 (36%), Gaps = 9/142 (6%)
Query: 493 NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552
+ ++ +IQ IPS S TL L L+ +NL ++ + +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 553 NSTIPS-TFWSLEYILVVDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQLSCSIP--SSI 608
+ S +F++L + ++ + D L +L L + L P + +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126
Query: 609 GGLKDLTYLALARNGFQGSIPE 630
L + N + SIP
Sbjct: 127 YSTDIFFILEITDNPYMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 23/134 (17%), Positives = 41/134 (30%), Gaps = 22/134 (16%)
Query: 991 KLKRLSISVNKITGTIP--RTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTL 1048
LK L I + P V + L + N + N F G L N
Sbjct: 106 LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG-----LCN--E 157
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPN- 1107
L L N T + FN + ++A+ L N + + + +
Sbjct: 158 TLTLKLYNNGFT-----------SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 1108 LQGLILWGNNLSGI 1121
L + +++ +
Sbjct: 207 PSLLDVSQTSVTAL 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 7e-20
Identities = 64/259 (24%), Positives = 100/259 (38%), Gaps = 53/259 (20%)
Query: 724 DSLSLATWRRISYQELQRLT-DGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFNL 778
DSL + + + E Q + D F + ++G G FG V+ KAT G A K L
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKK--L 218
Query: 779 QLDGAIKSFDAEC-----EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYS 833
K + ++L +V R +V + + L++ M G +
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI----RY 274
Query: 834 HKYTLNIQQRL---DIMI----DVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHL 885
H Y ++ I + S LE+LH +I+ DLKP NVLLDDD +
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN----IIYRDLKPENVLLDDDGNVRI 330
Query: 886 SDFGISKLLDGEDSVTQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFGILMIETF 939
SD G++ L + T+ T G+MAPE Y D ++ G+ + E
Sbjct: 331 SDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDF------SVDYFALGVTLYEMI 383
Query: 940 T---------RKMPTDEMF 949
K+ E+
Sbjct: 384 AARGPFRARGEKVENKELK 402
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-17
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 33/223 (14%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAEC-----EVMRRIRH 1390
F + +LG G F V+ G A K L + R K + +++ ++
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNI--EQRLDIMI-DVACALEY 1447
R + + + L++ M G + +Y+ + E R + LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE 1506
LH +II+ DLKP NVLLDDD + D G+A + +T A T G+MAPE
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPE 359
Query: 1507 ------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y S D ++ G+ + E + R P F
Sbjct: 360 LLLGEEYDF------SVDYFALGVTLYEMIAARGP----FRAR 392
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-20
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 47/228 (20%)
Query: 746 FSESNLIGAGSFGSVY----KATLPYGMNVAIKVFN----LQLDGAIKSFDAECEVLRRV 797
+ +IG G+FG V K+T A+K+ + ++ F E +++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRS-DSAFFWEERDIMAFA 126
Query: 798 RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA------ 851
+V++ + + + +++EYMP G L +N+ D+ A
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAE 176
Query: 852 --SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF 909
AL+ +H IH D+KP N+LLD L+DFG ++ E V + T
Sbjct: 177 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 910 GYMAPE-YGSEGIVSTCG---DVYSFGILMIETFTRKMPTDEMFTGET 953
Y++PE S+G G D +S G+ + EM G+T
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLY----------EMLVGDT 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-18
Identities = 61/298 (20%), Positives = 113/298 (37%), Gaps = 52/298 (17%)
Query: 1305 KRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVY----KATFADGT 1360
+++K+ +N L+ ++LR+ + ++G G F V K+T
Sbjct: 42 RKNKNI---DNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RK 95
Query: 1361 NAAIKIFSLQEDRALKS---FDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417
A+K+ S E F E ++M + ++ + + + ++++YMP G
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 1418 LEKWLYSHNYLLNIEQRLDIMIDVA--------CALEYLHQGYSTSIIHCDLKPSNVLLD 1469
L +N+ D+ A AL+ +H S IH D+KP N+LLD
Sbjct: 156 L----------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLD 202
Query: 1470 DDMVAH--LGDFGIAKLLDGVDSMKQTMTLATIGYMAPE----YGSEGIVSTSGDVYSFG 1523
H L DFG ++ ++ + T Y++PE G +G D +S G
Sbjct: 203 KS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 1524 ILMMETLTRRKP-----TDDMF----TGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572
+ + E L P + + L + + ++I A L+ E
Sbjct: 261 VFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREV 317
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 45/266 (16%), Positives = 92/266 (34%), Gaps = 30/266 (11%)
Query: 140 RIIDLSSNRIS---GNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFN 196
R+ ++++ +L + EL ++ + L+++ +S N
Sbjct: 12 RVFLCQESKVTEIPSDLPRN----AIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQN 64
Query: 197 ELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDL 254
++ I ++ NL +L E+ + N P F N+ +L+ ++++N + LP
Sbjct: 65 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVH 123
Query: 255 CRRLPSLQELNLRDCMTTGRIPKDI--GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIF 312
L+++D + I ++ G L L N + + I + F
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE---------IHNSAF 174
Query: 313 NN-SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLEL 371
N E+ N+L LP+ + L + + + + N KL
Sbjct: 175 NGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 233
Query: 372 SRNLFSGLVANTFGNCRQLQILNLAY 397
NL T L +L Y
Sbjct: 234 Y-NLKK---LPTLEKLVALMEASLTY 255
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 46/261 (17%), Positives = 83/261 (31%), Gaps = 25/261 (9%)
Query: 345 LYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGS 404
+ ++ IPS + L + F L+ + ++ + +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-V 69
Query: 405 LSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE- 463
+ FS+L +R + N I P + NL L+Y + + +P
Sbjct: 70 IEAD--VFSNLPKLHEIRIE--KANNLLYINPEAFQNLPN-LQYLLISNTGIKH-LPDVH 123
Query: 464 FGNLSNIIALSLYQNQLASTIPTTV--GKLQNLQGLDLSYNNIQGSIPSELCQLESLNTL 521
+ + L + N TI G L L+ N IQ I + L+ L
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDEL 182
Query: 522 LLQGNALQNQI----PTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L N N + + L++S R++S +L+ + S L
Sbjct: 183 NLSDN---NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK 237
Query: 578 GCLPQDIGNLKVLTGLYLSGN 598
LP + L L L+
Sbjct: 238 -KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 55/281 (19%), Positives = 87/281 (30%), Gaps = 49/281 (17%)
Query: 274 RIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLP 332
IP D+ N L +L +G ++E I++ N + +
Sbjct: 23 EIPSDLPRNAIELR---FVLTKLRVIQKGAFSGF--------GDLEKIEISQNDVLEVIE 71
Query: 333 SSTGINLPNLLRLYLWGNNLSGVIPSSIC-NASKLTVLELSRNLFSGLVANTFGNCRQLQ 391
+ NLP L + + N I N L L +S L + Q
Sbjct: 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131
Query: 392 ILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYA 451
+L++ N I T I NS LS +
Sbjct: 132 LLDIQD-------------------NIN------IHT-----IERNSFVGLSFESVILWL 161
Query: 452 GSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPS 510
+ I N + + L+L N +P V LD+S I S+PS
Sbjct: 162 NKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS 219
Query: 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNR 551
LE+L L + ++PT L L +L +L+
Sbjct: 220 YG--LENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 41/220 (18%), Positives = 78/220 (35%), Gaps = 12/220 (5%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWL-MPRLRIIDLS-SNRISGNLFDDMCNS 160
I + L + IS N + +++ +P+L I + +N + + + +
Sbjct: 44 VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQN 102
Query: 161 LTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI--GNLTELMELYLN 218
L L+ +S+ I + L + N I +N G E + L+LN
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 219 GNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKD 278
N +Q E + FN + L + L++N+ LP D+ L++ +P
Sbjct: 163 KNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY 220
Query: 279 I-GNCTLLNYLGLRDNQLTDFGA-NNLTGLIPSIIFNNSN 316
N L L L L+ + + S+
Sbjct: 221 GLENLKKLRARST--YNLKKLPTLEKLVALMEASLTYPSH 258
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 31/203 (15%), Positives = 60/203 (29%), Gaps = 11/203 (5%)
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQ-LESL 518
F ++ + + QN + I V L L + + N I E Q L +L
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPS-TFWSLEYILVV-DFSLNLL 576
LL+ +++ + L++ N TI +F L + V+ + N +
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 577 SGCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEA---- 631
+ ++ N L G L ++R S+P
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 224
Query: 632 IGSLISLEKGEIPSGGPFVNFTE 654
+ L + +
Sbjct: 225 LKKLRARSTYNLKKLPTLEKLVA 247
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 37/223 (16%), Positives = 65/223 (29%), Gaps = 37/223 (16%)
Query: 990 NKLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTL 1048
L+++ IS N + I V NL +L E+ + N Y+ F
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQN--------LPN 105
Query: 1049 LNFLILRQNQLTGVR--------------LASNKLIGRIPSMIFNN--SNIEAIQLYGNH 1092
L +L++ + + + N I I F + L N
Sbjct: 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 1093 FSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGN 1152
+ +S + + NNL + AS ++L +S L N
Sbjct: 166 IQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224
Query: 1153 CRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNN 1195
++L+ S +L +L L L
Sbjct: 225 LKKLRA--RSTYNLKK---------LPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 30/210 (14%), Positives = 67/210 (31%), Gaps = 31/210 (14%)
Query: 992 LKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
L + K+ I + +L ++ + N++ + + F NL +
Sbjct: 32 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVF-----SNLPKLHEI- 84
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
I + N L I F N N++ + + HLP +
Sbjct: 85 -RIEKANNLL-----------YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKV 131
Query: 1110 GLILWGNN-LSGIIPSSICN-ASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLT 1167
L + N + I +S + + ++L L++N + + F + ++ N+L
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191
Query: 1168 TGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
F+ + L + +
Sbjct: 192 ---ELPNDVFHG-ASG---PVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 7/137 (5%)
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTI 556
+ + IPS+L + L L+ + L + +S N + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 557 PS-TFWSLEYILVVDFS-LNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GGLKD 613
+ F +L + + N L P+ NL L L +S + +P
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129
Query: 614 LTYLALARNGFQGSIPE 630
L + N +I
Sbjct: 130 KVLLDIQDNINIHTIER 146
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 24/135 (17%), Positives = 47/135 (34%), Gaps = 14/135 (10%)
Query: 1082 NIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENL 1141
+ + + +PS + N L L I + + + +S+N
Sbjct: 10 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 1142 FSGLIP-NTFGNCRQLQILDLS-LNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKG 1199
+I + F N +L + + N+L +F +L N L+ L++ N +K
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLL---YINPEAF-QNLPN---LQYLLISNTGIK- 117
Query: 1200 ALPNSIGNLSTSLEY 1214
LP+ S
Sbjct: 118 HLPDVHKIHSLQKVL 132
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 32/228 (14%), Positives = 62/228 (27%), Gaps = 51/228 (22%)
Query: 751 LIGAGSFGSVYKAT---LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVK 804
G ++A L VA+ + Q D ++ + L R+ + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
++ ++ E++ GSL++ + + + M +A+A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--- 149
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVST 924
V PS V + D G LA M +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV-------------LAYPATMPD-------ANP 181
Query: 925 CGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVD 972
D+ G + + P V L A +
Sbjct: 182 QDDIRGIGASLYALLVNRWP----LPEAG-----VRSGLAPAERDTAG 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 30/200 (15%), Positives = 58/200 (29%), Gaps = 42/200 (21%)
Query: 1342 LLGTGIFSSVYKATFAD---GTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAK 1395
G ++A D A+ Q D L+ + + RI +A+
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
++ ++ +++ GSL++ + + + M +A A + H+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR---AG 149
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVST 1515
+ PS V + D G LA M +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV-------------LAYPATMPD-------ANP 181
Query: 1516 SGDVYSFGILMMETLTRRKP 1535
D+ G + L R P
Sbjct: 182 QDDIRGIGASLYALLVNRWP 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 59/214 (27%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA--ECEVLRRV-RHRNLVKII 806
++G G G V + G A+K+ S A E + + ++V I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 807 ----SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL----------DIMIDVAS 852
+ +I+E M G L +S IQ+R +IM D+ +
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----FSR-----IQERGDQAFTEREAAEIMRDIGT 139
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLA- 907
A+++LH H + H D+KP N+L + D V L+DFG +K T
Sbjct: 140 AIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCY 191
Query: 908 TFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
T Y+APE Y C D++S G++M
Sbjct: 192 TPYYVAPEVLGPEKYDKS-----C-DMWSLGVIM 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 57/213 (26%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRI-RHRNLAKIV 1397
+LG G+ V + G A+K+ S A E + + ++ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 1398 SSCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRL----------DIMIDVAC 1443
N +I++ M G L I++R +IM D+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-T 1499
A+++LH S +I H D+KP N+L + D V L DFG AK T T
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYT 192
Query: 1500 IGYMAPE------YGSEGIVSTSGDVYSFGILM 1526
Y+APE Y S D++S G++M
Sbjct: 193 PYYVAPEVLGPEKYD------KSCDMWSLGVIM 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 46/199 (23%), Positives = 83/199 (41%), Gaps = 25/199 (12%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA----ECEVLRRVRHRNLVK- 804
L+G GS+G V + A+K+ + I + +A E ++LRR+RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 805 ---IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HG 860
+ + + +++EY G E + + Q + LEYLH G
Sbjct: 72 VDVLYNEEKQKMY--MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPE- 915
++H D+KP N+LL +S G+++ L T T + PE
Sbjct: 130 ----IVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAADDTCRTSQGSPAFQPPEI 182
Query: 916 -YGSEGIVSTCGDVYSFGI 933
G + D++S G+
Sbjct: 183 ANGLDTFSGFKVDIWSAGV 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 35/218 (16%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDA----ECEVMRRIRHRNLAKI 1396
LLG G + V + A+KI ++ R + + +A E +++RR+RH+N+ ++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 1397 --VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC--------ALE 1446
V ++++Y G E + + + E+R + A LE
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--ML--DSV--PEKRFPV--CQAHGYFCQLIDGLE 123
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI----GY 1502
YLH S I+H D+KP N+LL + G+A+ L T T +
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAADDTCRTSQGSPAF 177
Query: 1503 MAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
PE G + D++S G+ + T P +
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 59/253 (23%)
Query: 731 WRRISYQELQRLT---DGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFN---LQL 780
W L+ + D F +IG G+F V K T G A+K+ N +
Sbjct: 45 WAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLK 101
Query: 781 DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNI 840
G + F E +VL R + ++ + + + L++EY G L L
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--------- 152
Query: 841 QQRLDIMID----------VASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAH--LSD 887
+ I + A++ +H G +H D+KP N+LLD H L+D
Sbjct: 153 -SKFGERIPAEMARFYLAEIVMAIDSVHRLG----YVHRDIKPDNILLDRC--GHIRLAD 205
Query: 888 FGISKLLDGEDSVTQTMTLATFGYMAPE-YGSEGIVSTCG------DVYSFGILMIETFT 940
FG L + +V + + T Y++PE + G G D ++ G+
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY---- 261
Query: 941 RKMPTDEMFTGET 953
EMF G+T
Sbjct: 262 ------EMFYGQT 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 43/261 (16%)
Query: 1305 KRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVY----KATFADGT 1360
+DK + L A + +E+RL + F ++G G FS V K T G
Sbjct: 34 AQDKY---VADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT---GQ 87
Query: 1361 NAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417
A+KI + + + + F E +V+ R + ++ + + + L+++Y G
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147
Query: 1418 LEKWLYSHNYLLNIEQRLDI------MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD 1471
L + L +R+ + ++ A++ +H +H D+KP N+LLD
Sbjct: 148 L----LTL--LSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC 198
Query: 1472 MVAH--LGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-------YGSEGIVSTSGDVYSF 1522
H L DFG L +++ + + T Y++PE G D ++
Sbjct: 199 --GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 1523 GILMMETLTRRKPTDDMFTGE 1543
G+ E + P F +
Sbjct: 257 GVFAYEMFYGQTP----FYAD 273
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 35/204 (17%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFN------LQLDGAIKSFDAECEVLRRVRHRN 801
+G+G F V K T G A K + + + + E +LR +RH N
Sbjct: 13 LGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 802 LVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRLDIMIDVASALEY 856
++ + N LILE + G L EK + + + + Y
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA------TQFLKQILDGVHY 123
Query: 857 LH-HGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
LH + H DLKP N++L + L DFGI+ ++ + T +
Sbjct: 124 LHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEF 177
Query: 912 MAPEYGSEGIVSTCGDVYSFGILM 935
+APE + + D++S G++
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 53/201 (26%), Positives = 80/201 (39%), Gaps = 29/201 (14%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDA---ECEVMRRIRHRNLAK 1395
LG+G F+ V K G A K L R S + E ++R IRH N+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 1396 IVSSCSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLH 1449
+ N LIL+ + G L EK + E + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT-------EDEATQFLKQILDGVHYLH 125
Query: 1450 QGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAP 1505
S I H DLKP N++L + L DFGIA ++ + K T ++AP
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAP 180
Query: 1506 EYGSEGIVSTSGDVYSFGILM 1526
E + + D++S G++
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 37/206 (17%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLV 803
IG GSFG V T A+K N Q +++ E ++++ + H LV
Sbjct: 22 AIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------SALE 855
+ S + ++++ + G L H +QQ + + AL+
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDL----RYH-----LQQNVHFKEETVKLFICELVMALD 129
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAP 914
YL + +IH D+KP N+LLD+ H++DF I+ +L E TQ T+A T YMAP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAP 183
Query: 915 EYGSEGIVSTCG---DVYSFGILMIE 937
E S + D +S G+ E
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYE 209
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-19
Identities = 59/261 (22%), Positives = 101/261 (38%), Gaps = 44/261 (16%)
Query: 1342 LLGTGIFSSVYKATFADGTNA--AIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKI 1396
+G G F V D T A+K + E +++ E ++M+ + H L +
Sbjct: 22 AIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALEYLHQ 1450
S + +++ + G L Y L + ++ AL+YL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLR-------YHLQQNVHFKEETVKLFICELVMALDYLQ- 132
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE-YG 1508
+ IIH D+KP N+LLD+ H+ DF IA +L T+A T YMAPE +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFS 187
Query: 1509 SEGIV--STSGDVYSFGILMMETLTRRKP--------TDDMF----TGEVCLKHWVEESL 1554
S S + D +S G+ E L R+P + ++ T V + +
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM 247
Query: 1555 PDAVTDVIDANL---LSGEEE 1572
+ +++ N S +
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSD 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 45/221 (20%)
Query: 740 QRLTDGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFN------LQLDGAIKSFDA 789
Q++ D + +G+G F V K+T G+ A K + + +
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRL 844
E +LR+V H N++ + N LILE + G L +K S +
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA------T 118
Query: 845 DIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH----LSDFGISKLLDGEDSV 900
+ + + YLH + H DLKP N++L D + L DFG++ ++
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 901 TQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
T ++APE G E D++S G++
Sbjct: 176 KNIF--GTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 17/195 (8%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDA---ECEVMRRIRHRNLAK 1395
LG+G F+ V K + G A K + R + E ++R++ H N+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ N LIL+ + G L +L L E + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGVNYLH---TKK 135
Query: 1456 IIHCDLKPSNVLL----DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG 1511
I H DLKP N++L L DFG+A ++ K T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYE 193
Query: 1512 IVSTSGDVYSFGILM 1526
+ D++S G++
Sbjct: 194 PLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-19
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 35/216 (16%)
Query: 740 QRLTDGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFN------LQLDGAIKSFDA 789
Q++ D + +G+G F V K+T G+ A K + + + +
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRL 844
E +LR+V H N++ + N LILE + G L +K S +
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA------T 118
Query: 845 DIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGEDS 899
+ + + YLH + H DLKP N++L L DFG++ ++
Sbjct: 119 SFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILM 935
T ++APE + + D++S G++
Sbjct: 175 FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-18
Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 29/201 (14%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDA---ECEVMRRIRHRNLAK 1395
LG+G F+ V K + G A K + R S + E ++R++ H N+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 1396 IVSSCSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQRL-DIMIDVACALEYLH 1449
+ N LIL+ + G L +K S E+ + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-------EEEATSFIKQILDGVNYLH 132
Query: 1450 QGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAP 1505
+ I H DLKP N++L L DFG+A ++ K T ++AP
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAP 187
Query: 1506 EYGSEGIVSTSGDVYSFGILM 1526
E + + D++S G++
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 48/203 (23%), Positives = 68/203 (33%), Gaps = 31/203 (15%)
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480
L + N ++ ++ L EL + G L + L L NQL
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTR-LTQLNLDRAELTK-LQV-DGTLPVLGTLDLSHNQL 89
Query: 481 ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL-CQLESLNTLLLQGNALQNQIPTCLANL 539
S +P L L LD+S+N + S+P L L L L+GN L+ P L
Sbjct: 90 QS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 540 TSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQ 599
L L+L++N L L+ L L L N
Sbjct: 148 PKLEKLSLANNNLTELPAGLL------------------------NGLENLDTLLLQENS 183
Query: 600 LSCSIPSSIGGLKDLTYLALARN 622
L +IP G L + L N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 56/225 (24%), Positives = 83/225 (36%), Gaps = 27/225 (12%)
Query: 332 PSSTGINLPNLLRLYLWGNNLSGV---IPSSICNASKLTVLELSRNLFSGLVANTFGNCR 388
P + + L + NL+ + +P T+L LS NL T
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDLPKD------TTILHLSENLLYTFSLATLMPYT 55
Query: 389 QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEY 448
+L LNL ++L + +L L L + N + LP L L
Sbjct: 56 RLTQLNLDRAELTKLQV------DGTLPV---LGTLDLSHNQLQS-LPLLGQTLPA-LTV 104
Query: 449 FYAGSCELGGGIPAE-FGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQG 506
L +P L + L L N+L T+P + L+ L L+ NN+
Sbjct: 105 LDVSFNRLTS-LPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT- 161
Query: 507 SIPSELCQ-LESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSN 550
+P+ L LE+L+TLLLQ N+L IP L L N
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 54/211 (25%), Positives = 81/211 (38%), Gaps = 44/211 (20%)
Query: 118 LNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG-NLFDDMCNSLTELESFDVSSNQITG 176
L++S N + L RL ++L ++ + +L L + D+S NQ+
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG----TLPVLGTLDLSHNQLQ- 90
Query: 177 QLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIFNVSS 235
LP L L VSFN LT +P L EL ELYL GN L+
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK------------ 137
Query: 236 LRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQ 294
+LP L P L++L+L + T +P + L+ L L++N
Sbjct: 138 -------------TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENS 183
Query: 295 LTDFGANNLTGLIPSIIFNNSNIEVIQLYGN 325
L IP F + + L+GN
Sbjct: 184 LYT---------IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 58/275 (21%), Positives = 83/275 (30%), Gaps = 74/275 (26%)
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
+ + + +T LP L L +S N L + T L +L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK 277
+ L L VD LP L L+L +P
Sbjct: 63 DRAELT-------------------------KLQVD--GTLPVLGTLDLSHNQLQ-SLPL 94
Query: 278 DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTG 336
L L + N+LT +P ++ + L GN L LP
Sbjct: 95 LGQTLPALTVLDVSFNRLTS---------LPLGALRGLGELQELYLKGNELK-TLPPGLL 144
Query: 337 INLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396
P L +L L NNL+ EL L +GL L L L
Sbjct: 145 TPTPKLEKLSLANNNLT----------------ELPAGLLNGLE--------NLDTLLLQ 180
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
+ L ++ +G FF S L + + NPW
Sbjct: 181 ENSLY--TIPKG--FFGSHL----LPFAFLHGNPW 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 9/141 (6%)
Query: 491 LQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSN 550
+ + ++ N+ ++P +L + L L N L L T L LNL
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 551 RLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-G 609
L + + +L + +D S N L LP L LT L +S N+L+ S+P
Sbjct: 66 EL-TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 610 GLKDLTYLALARNGFQGSIPE 630
GL +L L L N + ++P
Sbjct: 122 GLGELQELYLKGNELK-TLPP 141
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 46/219 (21%), Positives = 65/219 (29%), Gaps = 59/219 (26%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYNNKFTGR 1038
L +S N + T+ T L +L+L L L +N+
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-S 91
Query: 1039 IPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHL 1097
+P L L + N+LT +P ++ + L GN L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-----------SLPLGALRGLGELQELYLKGNELK-TL 139
Query: 1098 PSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQ 1157
P + P L+ L L NNL+ L L +GL L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT----------------ELPAGLLNGL--------ENLD 175
Query: 1158 ILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNP 1196
L L N L T F+ S L L NP
Sbjct: 176 TLLLQENSLYTIP----KGFFGSHL----LPFAFLHGNP 206
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 40/195 (20%), Positives = 58/195 (29%), Gaps = 36/195 (18%)
Query: 1012 NLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIG 1071
+ E++ NL A +P +L L L +N L
Sbjct: 8 KVASHLEVNCDKRNLTA----------LPPDLP--KDTTILHLSENLLY----------- 44
Query: 1072 RIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNAS 1130
+ + + L + L LP L L L N L + P
Sbjct: 45 TFSLATLMPYTRLTQLNLDRAELT-KLQVDGT--LPVLGTLDLSHNQLQSL-PLLGQTLP 100
Query: 1131 QVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRL 1190
+ +L +S N + L +LQ L L N L T T L +L
Sbjct: 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP----PGLLTPTPK---LEKL 153
Query: 1191 VLQNNPLKGALPNSI 1205
L NN L LP +
Sbjct: 154 SLANNNLT-ELPAGL 167
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-19
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DG----AIKSFDAECEV 793
Q L + + + +G G++G VYKA G VA+K L +G AI+ E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72
Query: 794 LRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASA 853
L+ + H N+V +I + L+ E+M + L+K L +K L Q + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
+ + H ++H DLKP N+L++ D L+DFG+++ G + T + T Y A
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRA 187
Query: 914 PE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
P+ GS+ ST D++S G + E T K P +F G T
Sbjct: 188 PDVLMGSK-KYSTSVDIWSIGCIFAEMITGK-P---LFPGVT 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRNLAKI 1396
+G G + VYKA + G A+K L + A++ E +++ + H N+ +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+ + L+ ++M + L+K L + L Q + + + + HQ I
Sbjct: 85 IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---I 140
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVS 1514
+H DLKP N+L++ D L DFG+A+ G+ T + T+ Y AP+ GS+ S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSK-KYS 198
Query: 1515 TSGDVYSFGILMMETLTRR 1533
TS D++S G + E +T +
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 46/222 (20%), Positives = 86/222 (38%), Gaps = 47/222 (21%)
Query: 740 QRLTDGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFN------LQLDGAIKSFDA 789
+ + D + +G+G F V K+T G+ A K + + + +
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKST---GLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 790 ECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSL-----EKWLYSHKYTLNIQQRL 844
E +L+ ++H N++ + N LILE + G L EK + +
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA------T 117
Query: 845 DIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKLLDGEDS 899
+ + + + + YLH + H DLKP N++L + DFG++ +D +
Sbjct: 118 EFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 900 VTQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
T ++APE G E D++S G++
Sbjct: 174 FKNIF--GTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-17
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 29/201 (14%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDA---ECEVMRRIRHRNLAK 1395
LG+G F+ V K + G A K + R S + E +++ I+H N+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 1396 IVSSCSNPGFKALILQYMPQGSL-----EKWLYSHNYLLNIEQR-LDIMIDVACALEYLH 1449
+ N LIL+ + G L EK + E+ + + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT-------EEEATEFLKQILNGVYYLH 131
Query: 1450 QGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAP 1505
S I H DLKP N++L + DFG+A +D + K T ++AP
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAP 186
Query: 1506 EYGSEGIVSTSGDVYSFGILM 1526
E + + D++S G++
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-18
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 51/220 (23%)
Query: 741 RLTDGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAEC----- 791
L D F +G GSFG V+ + Y A+KV L+ + ++ E
Sbjct: 4 SLQD-FQILRTLGTGSFGRVHLIRSRHNGRY---YAMKV--LKKEIVVRLKQVEHTNDER 57
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
+L V H ++++ + + +I++Y+ G L +S L QR VA
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSL---LRKSQRFPN--PVA 108
Query: 852 --------SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
ALEYLH +I+ DLKP N+LLD + ++DFG +K + T
Sbjct: 109 KFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVT 160
Query: 904 MTL-ATFGYMAPEYGSEGIVSTCG-----DVYSFGILMIE 937
TL T Y+APE +VST D +SFGIL+ E
Sbjct: 161 YTLCGTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYE 195
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 5e-18
Identities = 67/226 (29%), Positives = 97/226 (42%), Gaps = 53/226 (23%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAEC-----EVMRRIRHRNLAK 1395
LGTG F V+ G A+K+ L+++ ++ E ++ + H + +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA--------CALEY 1447
+ + + +I+ Y+ G L +S L QR VA ALEY
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGEL----FSL---LRKSQRFPN--PVAKFYAAEVCLALEY 121
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTL-ATIGYMA 1504
LH S II+ DLKP N+LLD + H + DFG AK + V T TL T Y+A
Sbjct: 122 LH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPDV-----TYTLCGTPDYIA 171
Query: 1505 PEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP-----TDDMF 1540
PE +VST D +SFGIL+ E L P T +
Sbjct: 172 PE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-18
Identities = 60/253 (23%), Positives = 99/253 (39%), Gaps = 44/253 (17%)
Query: 724 DSLSLATWRRISYQELQRLT-DGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFNL 778
DS+ + + + E Q +T + F + ++G G FG V +AT G A K L
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--L 217
Query: 779 QLDGAIKSFDAEC-----EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYS 833
+ K ++L +V R +V + + L+L M G L+ +Y
Sbjct: 218 EKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 277
Query: 834 HKYTLNIQQRLDIMI-DVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891
+ R ++ LE LH +++ DLKP N+LLDD +SD G++
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 892 KLLDGEDSVTQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFGILMIETFT----- 940
+ E + T GYMAPE Y D ++ G L+ E
Sbjct: 334 VHV-PEGQTIKGRV-GTVGYMAPEVVKNERYTF------SPDWWALGCLLYEMIAGQSPF 385
Query: 941 ----RKMPTDEMF 949
+K+ +E+
Sbjct: 386 QQRKKKIKREEVE 398
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 8e-18
Identities = 55/222 (24%), Positives = 86/222 (38%), Gaps = 34/222 (15%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAEC-----EVMRRIRH 1390
F + +LG G F V G A K L++ R K +++ ++
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI-DVACALEYLH 1449
R + + + L+L M G L+ +Y E R ++ C LE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK-LLDGVDSMKQTMTLA-TIGYMAPE- 1506
I++ DLKP N+LLDD + D G+A + +G + T+GYMAPE
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----QTIKGRVGTVGYMAPEV 356
Query: 1507 -----YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y S D ++ G L+ E + + P F
Sbjct: 357 VKNERYTF------SPDWWALGCLLYEMIAGQSP----FQQR 388
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 60/214 (28%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEV---LRRVRHRNLVKIIS 807
+G G G V + A+K+ A EV R + ++V+I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 808 SCSNHGFKA----LILEYMPQGSL-EKWLYSHKYTLNIQQRLD----------IMIDVAS 852
N +++E + G L + IQ R D IM +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSR----------IQDRGDQAFTEREASEIMKSIGE 172
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGEDSVTQTMTLA- 907
A++YLH + H D+KP N+L + + L+DFG +K +S+ T
Sbjct: 173 AIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCY 225
Query: 908 TFGYMAPE------YGSEGIVSTCGDVYSFGILM 935
T Y+APE Y C D++S G++M
Sbjct: 226 TPYYVAPEVLGPEKYDKS-----C-DMWSLGVIM 253
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 56/212 (26%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDA--ECEVMRRI-RHRNLAKIVS 1398
LG GI V + A+K+ A E E+ R + ++ +IV
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 1399 SCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRLD----------IMIDVACA 1444
N ++++ + G L I+ R D IM + A
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 1445 LEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TI 1500
++YLH S +I H D+KP N+L + + L DFG AK +S+ T T
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTP 227
Query: 1501 GYMAPE------YGSEGIVSTSGDVYSFGILM 1526
Y+APE Y S D++S G++M
Sbjct: 228 YYVAPEVLGPEKYD------KSCDMWSLGVIM 253
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 51/243 (20%)
Query: 737 QELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIK-VFNLQLDGAIKSFDAECEVLR 795
+ ++ ++ +IG GSFG V++A L VAIK V D K+ E +++R
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN--RELQIMR 87
Query: 796 RVRHRNLVK----IISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDI--- 846
V+H N+V S+ L+LEY+P+ ++ + + ++Q + +
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA---KLKQTMPMLLI 143
Query: 847 ---MIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVT 901
M + +L Y+H G + H D+KP N+LLD + V L DFG +K+L
Sbjct: 144 KLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA----G 195
Query: 902 QTMT--LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
+ + + Y APE Y +T D++S G +M E + P +F GE
Sbjct: 196 EPNVSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ-P---LFPGE 245
Query: 953 TSL 955
+ +
Sbjct: 246 SGI 248
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 53/241 (21%)
Query: 1323 RRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAEC 1382
R I+Y ++ +G G F V++A + AIK + + E
Sbjct: 38 REIAYTNCKV----------IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----EL 83
Query: 1383 EVMRRIRHRNLAK----IVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLD 1436
++MR ++H N+ S+ L+L+Y+P+ ++ + + ++Q +
Sbjct: 84 QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA---KLKQTMP 139
Query: 1437 I------MIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVD 1489
+ M + +L Y+H S I H D+KP N+LLD V L DFG AK+L +
Sbjct: 140 MLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 1490 SMKQTMTLATIGYMAPE-------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTG 1542
+ + Y APE Y +T+ D++S G +M E + +P +F G
Sbjct: 197 PN--VSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQ-GQP---LFPG 244
Query: 1543 E 1543
E
Sbjct: 245 E 245
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 4e-18
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDG------AIKSFDAECEVLRRV 797
+ + IG G++G VYKA YG A+K L+ + I+ E +L+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 798 RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYL 857
+H N+VK+ L+ E++ Q L+K L + L ++ + + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-- 915
H V+H DLKP N+L++ + ++DFG+++ G T + T Y AP+
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVL 172
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
GS+ ST D++S G + E P +F G +
Sbjct: 173 MGSK-KYSTTIDIWSVGCIFAEMVNGT-P---LFPGVS 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 1e-14
Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRNLAKI 1396
+G G + VYKA G A+K L+++ ++ E +++ ++H N+ K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
L+ +++ Q L+K L L ++ + + Y H +
Sbjct: 66 YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVS 1514
+H DLKP N+L++ + + DFG+A+ G+ K T + T+ Y AP+ GS+ S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSK-KYS 179
Query: 1515 TSGDVYSFGILMMETLTRR 1533
T+ D++S G + E +
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 4e-18
Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DG----AIKSFDAECEVLRR 796
+ + IG G++G+V+KA VA+K L +G A++ E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
++H+N+V++ + L+ E+ Q L+K+ S L+ + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE- 915
H + V+H DLKP N+L++ + L++FG+++ G + + T Y P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDV 172
Query: 916 -YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+G++ + ST D++S G + E P +F G
Sbjct: 173 LFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGND 207
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 6e-16
Identities = 50/210 (23%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRNLAK 1395
+G G + +V+KA A+K L +D AL+ E +++ ++H+N+ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ + L+ ++ Q L+K+ S N L+ E + + L + H
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIV 1513
++H DLKP N+L++ + L +FG+A+ G+ + + T+ Y P+ +G++ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAK-LY 179
Query: 1514 STSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
STS D++S G + E +P +F G
Sbjct: 180 STSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNA-AIKIFSLQEDRALKSFD---AECEVMRRIRHRN 1392
F LGTG F V + N A+KI Q+ LK + E +++ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI------DVACALE 1446
L K+ S + ++++Y+ G + +SH L R + E
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEM----FSH---LRRIGRFSEPHARFYAAQIVLTFE 155
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAP 1505
YLH S +I+ DLKP N+L+D + DFG AK + G T TL T +AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAP 207
Query: 1506 EYGSEGIVSTSG-----DVYSFGILMMETLTRRKP 1535
E I+ + G D ++ G+L+ E P
Sbjct: 208 E-----IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-17
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 47/218 (21%)
Query: 741 RLTDGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAEC----- 791
+L F +G GSFG V K + + A+K+ L +K E
Sbjct: 39 QLDQ-FDRIKTLGTGSFGRVMLVKHKESGNH---YAMKI--LDKQKVVKLKQIEHTLNEK 92
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMI--- 848
+L+ V LVK+ S ++ +++EY+ G + +SH L R
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSH---LRRIGRFSEPHARF 145
Query: 849 ---DVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905
+ EYLH +I+ DLKP N+L+D ++DFG +K + G +T T
Sbjct: 146 YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWT 197
Query: 906 L-ATFGYMAPEYGSEGIVSTCG-----DVYSFGILMIE 937
L T +APE I+ + G D ++ G+L+ E
Sbjct: 198 LCGTPEALAPE-----IILSKGYNKAVDWWALGVLIYE 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-18
Identities = 60/262 (22%), Positives = 98/262 (37%), Gaps = 47/262 (17%)
Query: 1305 KRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVY----KATFADGT 1360
+R+K+ L A +++RL F ++G G F V K
Sbjct: 47 RREKN---ILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DK 100
Query: 1361 NAAIKIFSLQEDRALKSFDAEC-----EVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415
A+KI L + LK + C +V+ + + + + + L++ Y
Sbjct: 101 VFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158
Query: 1416 GSLEKWLYSHNYLLNIEQRLDI------MIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469
G L + L E RL + ++ A++ +H +H D+KP N+L+D
Sbjct: 159 GDL----LTL--LSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMD 209
Query: 1470 DDMVAH--LGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPE-----YGSEGIVSTSGDVYS 1521
+ H L DFG L D Q+ T Y++PE G +G D +S
Sbjct: 210 MN--GHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 1522 FGILMMETLTRRKPTDDMFTGE 1543
G+ M E L P F E
Sbjct: 267 LGVCMYEMLYGETP----FYAE 284
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-18
Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVFN----LQLDGAIKSFDAECEVLRRVRHRNL 802
+IG G+FG V K A+K+ N L+ F E +VL + +
Sbjct: 81 VIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRA-ETACFREERDVLVNGDSKWI 136
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMID----------VAS 852
+ + + L+++Y G L L + + + +
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVI 186
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
A++ +H +H D+KP N+L+D + L+DFG L + +V ++ + T Y
Sbjct: 187 AIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 912 MAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
++PE G C D +S G+ M EM GET
Sbjct: 243 ISPEILQAMEGGKGRYGPEC-DWWSLGVCMY----------EMLYGET 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 47/210 (22%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDA-----ECEVLRRVRHRNL 802
+G+G+FG V+ A V +K + D I+ E +L RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEY 856
+K++ N GF L++E G L+ L++ ++ RLD I + SA+ Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAF---IDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYM 912
L +IH D+K N+++ +D L DFG + L+ TF Y
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK------LFYTFCGTIEYC 196
Query: 913 APE------Y-GSEGIVSTCGDVYSFGILM 935
APE Y G E +++S G+ +
Sbjct: 197 APEVLMGNPYRGPE------LEMWSLGVTL 220
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 29/213 (13%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKI--------FSLQEDRALKSFDAECEVMRRIRHRNL 1393
LG+G F V+ A +K ED L E ++ R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 1394 AKIVSSCSNPGFKALIL-QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
K++ N GF L++ ++ L ++ H L I + A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY-IFRQLVSAVGYLRLK- 149
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE------ 1506
IIH D+K N+++ +D L DFG A L+ + T TI Y APE
Sbjct: 150 --DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYT-FCGTIEYCAPEVLMGNP 205
Query: 1507 Y-GSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
Y G E +++S G+ + + P +
Sbjct: 206 YRGPE------LEMWSLGVTLYTLVFEENPFCE 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 8e-18
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVF---NLQLDGAIKSFDAECEVLRRVRHRNLV 803
L+G G+FG V KAT G A+K+ + + E VL+ RH L
Sbjct: 155 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDI------MIDVASALEYL 857
+ S H ++EY G L + H L+ ++ ++ SAL+YL
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGEL----FFH---LSRERVFSEDRARFYGAEIVSALDYL 264
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYG 917
H V++ DLK N++LD D ++DFG+ K + + +T T Y+APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPE-- 319
Query: 918 SEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
++ D + G++M E ++P +++F
Sbjct: 320 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 43/235 (18%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LLG G F V G A+KI + + E V++ RH L +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALEYLHQG 1451
S +++Y G L + H L+ E+ ++ AL+YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGEL----FFH---LSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPE---- 1506
+ +++ DLK N++LD D + DFG+ K +G+ T T Y+APE
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 1507 --YGSEGIVSTSGDVYSFGILMMETLTRRKP-----TDDMF----TGEVCLKHWV 1550
YG + D + G++M E + R P + +F E+ +
Sbjct: 324 NDYG------RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 372
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-18
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFNLQL-DG----AIKSFDAECEVLRRV 797
+ + + + +G G++ +VYK VA+K L+ +G AI+ E +L+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 798 RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYL 857
+H N+V + L+ EY+ + L+++L +N+ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE 915
H V+H DLKP N+L+++ L+DFG+++ T+T + T Y P+
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYDNEVVTLWYRPPD 170
Query: 916 --YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
GS ST D++ G + E T + P +F G T
Sbjct: 171 ILLGST-DYSTQIDMWGVGCIFYEMATGR-P---LFPGST 205
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-13
Identities = 45/205 (21%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQED-----RALKSFDAECEVMRRIRH 1390
+ + + LG G +++VYK A+K L+ + A++ E +++ ++H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKH 59
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
N+ + L+ +Y+ + L+++L ++N+ + + L Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH- 117
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YG 1508
++H DLKP N+L+++ L DFG+A+ + + + T+ Y P+ G
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVVTLWYRPPDILLG 174
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRR 1533
S ST D++ G + E T R
Sbjct: 175 ST-DYSTQIDMWGVGCIFYEMATGR 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-18
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 36/201 (17%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFN-LQLDGA-IKSFDAECEVLRRVRHRNLVK---I 805
IG G+F V A + G VAIK+ + QL+ ++ E +++ + H N+VK +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
I + + LI+EY G + +L +H + ++ + SA++Y H +
Sbjct: 83 IET-EKTLY--LIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPE------ 915
+H DLK N+LLD D ++DFG S T L F Y APE
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNE------FTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 916 Y-GSEGIVSTCGDVYSFGILM 935
Y G E DV+S G+++
Sbjct: 190 YDGPE------VDVWSLGVIL 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 18/204 (8%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSS 1399
+G G F+ V A G AIKI + +L+ E +M+ + H N+ K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
LI++Y G + +L +H + E R + A++Y HQ I+H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQ---KRIVHR 138
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI----GYMAPE-YGSEGIVS 1514
DLK N+LLD DM + DFG + L Y APE + +
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNE------FTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 1515 TSGDVYSFGILMMETLTRRKPTDD 1538
DV+S G+++ ++ P D
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDG 216
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 27/159 (16%), Positives = 48/159 (30%), Gaps = 29/159 (18%)
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLL 523
NI L++ + P + L NL+ L + ++ L L SL L +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 524 QGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQD 583
+A + I T + L + +++LS N + I
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP------------------------- 154
Query: 584 IGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
+ L L L + + + I L L
Sbjct: 155 LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 29/202 (14%), Positives = 63/202 (31%), Gaps = 37/202 (18%)
Query: 98 NLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS--GNLFD 155
LG T A ++ L + ++ + ++ + +++ + +
Sbjct: 29 LLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPI-- 84
Query: 156 DMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMEL 215
+ L+ LE + +T +L + L L +S + I I L ++ +
Sbjct: 85 ---SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141
Query: 216 YLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI 275
L+ N I ++ L + LP L+ LN++
Sbjct: 142 DLSYNGA-------ITDIMPL-------------------KTLPELKSLNIQFDGVHDYR 175
Query: 276 PKDIGNCTLLNYLGLRDNQLTD 297
I + LN L +
Sbjct: 176 G--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 9e-16
Identities = 31/217 (14%), Positives = 64/217 (29%), Gaps = 42/217 (19%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
L L ++ + + + + LT + L+ + L ++ L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+ S L+N LE ++
Sbjct: 76 IHATN------YNPISGLSN----------------------------LERLRIMGKDVT 101
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
L+++ L + + +I T + L + +DLSYN I L L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPE 160
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS 554
L +L +Q + + + + + L L S +
Sbjct: 161 LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 27/220 (12%), Positives = 60/220 (27%), Gaps = 44/220 (20%)
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNG 219
+ + + + + + L ++++ +T + I + +L +N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 220 NNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
+ N + + L +L+ L + T ++
Sbjct: 76 IH--------ATNYNPIS-------------------GLSNLERLRIMGKDVTSDKIPNL 108
Query: 280 GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINL 339
T L L + + D + L + I L N ++ L
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTL--------PKVNSIDLSYNGAITDIMPLK--TL 158
Query: 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
P L L + + + I + KL L G
Sbjct: 159 PELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 26/174 (14%), Positives = 52/174 (29%), Gaps = 55/174 (31%)
Query: 466 NLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQG 525
+ L Q+ ST T ++ +L + L+ N+ L G
Sbjct: 21 TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTD----------------LTG 61
Query: 526 NALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIG 585
+ +++ L +++ + P I
Sbjct: 62 ----------IEYAHNIKDLTINNIHATNYNP--------------------------IS 85
Query: 586 NLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
L L L + G ++ ++ GL LT L ++ + SI I +L +
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 35/174 (20%), Positives = 66/174 (37%), Gaps = 24/174 (13%)
Query: 285 LNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLR 344
L Y+ L + +TD + NI+ + + H + P S L NL R
Sbjct: 46 LTYITLANINVTDL--TGIEYA--------HNIKDLTINNIHATNYNPIS---GLSNLER 92
Query: 345 LYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGS 404
L + G +++ ++ + LT+L++S + + ++ ++L+Y+ T
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD- 151
Query: 405 LSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGG 458
L L+ L IQ + + + K L YA S +GG
Sbjct: 152 -------IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPK-LNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 32/232 (13%), Positives = 61/232 (26%), Gaps = 62/232 (26%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
+ + T + L + L N+ TG + +
Sbjct: 24 AYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT------DLTG-----IEYAHNIK 69
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQG 1110
L + T N I L NL+
Sbjct: 70 DLTINNIHAT---------------------NYNPIS----------------GLSNLER 92
Query: 1111 LILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGS 1170
L + G +++ ++ + + LL +S + I ++ +DLS N T
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD- 151
Query: 1171 STQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTEL 1222
L L+ L +Q + + I + L +A S +
Sbjct: 152 -------IMPLKTLPELKSLNIQFDGVHDYRG--IEDF-PKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 18/138 (13%), Positives = 40/138 (28%), Gaps = 27/138 (19%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
+ + L+RL I +T + LT L L + ++ I +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL---------DISHSAHDDSILTKINT 134
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP-- 1103
++ + L+ N I I + ++++ + +
Sbjct: 135 LP----------KVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGV-----HDYRGIE 178
Query: 1104 YLPNLQGLILWGNNLSGI 1121
P L L + + G
Sbjct: 179 DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 26/134 (19%), Positives = 50/134 (37%), Gaps = 28/134 (20%)
Query: 92 TDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG 151
L I + P+++ L+ L L+IS + ++ ++ +P++ IDLS N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN---- 146
Query: 152 NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTE 211
IT L +LK L++ F+ + I + +
Sbjct: 147 --------------------GAITD--IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPK 182
Query: 212 LMELYLNGNNLQGE 225
L +LY + G+
Sbjct: 183 LNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 17/104 (16%), Positives = 36/104 (34%), Gaps = 7/104 (6%)
Query: 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLS 596
+ + L + + + SL YI + + ++ L+G I + L ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTIN 74
Query: 597 GNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK 640
+ + + I GL +L L + + L SL
Sbjct: 75 NIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 22/111 (19%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLG 1044
+L L L IS + +I + L ++ + L N L
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI----------TDIMPLK 156
Query: 1045 NCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSG 1095
L L ++ + + I + + + + G
Sbjct: 157 TLPELKSLNIQFDGVHDY------------RGIEDFPKLNQLYAFSQTIGG 195
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-18
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 35/214 (16%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIK-VFNLQLDGAI-----KSFDA-----ECEVLRRVRHR 800
I +GS+G+V G+ VAIK VFN DG SF E +L H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 801 NLVK---IISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALE 855
N++ I L+ E M + L + ++ + ++ Q M + L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
LH V+H DL P N+LL D+ + DF +++ + + T + Y APE
Sbjct: 149 VLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH--YVTHRWYRAPE 203
Query: 916 -------YGSEGIVSTCGDVYSFGILMIETFTRK 942
+ ++ + D++S G +M E F RK
Sbjct: 204 LVMQFKGF-TKLV-----DMWSAGCVMAEMFNRK 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 45/208 (21%), Positives = 80/208 (38%), Gaps = 23/208 (11%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIK-IFSLQEDRAL-----KSFDA-----ECEVMRRIRHR 1391
+ +G + +V ++G AIK +F+ D SF E ++ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 1392 N---LAKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALE 1446
N L I P L+ + M + L + ++ +++ + M + L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
LH ++H DL P N+LL D+ + DF +A+ + T + Y APE
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWYRAPE 203
Query: 1507 Y-GSEGIVSTSGDVYSFGILMMETLTRR 1533
+ D++S G +M E R+
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 50/235 (21%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVKI--I 806
+G G++G V A VA+K+ ++ + ++ E + + + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSH---------KYTLNIQQRLDIMIDVASALEYL 857
N + L LEY G L + ++ Q ++ + + YL
Sbjct: 74 RREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRF---FHQ----LM---AGVVYL 121
Query: 858 H-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYM 912
H G + H D+KP N+LLD+ +SDFG++ + + + L Y+
Sbjct: 122 HGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RERLLNKMCGTLPYV 174
Query: 913 APE------Y-GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE 960
APE + DV+S GI++ ++P D+ W E
Sbjct: 175 APELLKRREFHAEP------VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 51/229 (22%), Positives = 83/229 (36%), Gaps = 38/229 (16%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDA---ECEVMRRIRHRNLAKIV 1397
LG G + V A A+KI + RA+ + E + + + H N+ K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKI--VDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA--------CALEYLH 1449
+ L L+Y G L + + + + A + YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL------FDRIEP-DIGMPE--PDAQRFFHQLMAGVVYLH 122
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYG 1508
I H D+KP N+LLD+ + DFG+A + + + + T+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-- 177
Query: 1509 SEGIVSTSG------DVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE 1551
++ DV+S GI++ L P D W E
Sbjct: 178 ---LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-17
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 62/240 (25%)
Query: 746 FSESNLIGAGSFGSVYKATL-PYGMNVAIK-VFNLQLDGAIKSFDA-----ECEVLRRVR 798
++++ +IG GSFG VY+A L G VAIK V D E +++R++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----------DKRFKNRELQIMRKLD 105
Query: 799 HRNLVK----IISSCSNHGFKAL--ILEYMPQGSLEKWLYSHKYTLNIQQRLDI------ 846
H N+V+ SS L +L+Y+P+ ++ + ++ +Q L +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA---RHYSRAKQTLPVIYVKLY 161
Query: 847 MIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQTM 904
M + +L Y+H G + H D+KP N+LLD DT V L DFG +K L +
Sbjct: 162 MYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR----GEPN 213
Query: 905 T--LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSL 955
+ + Y APE Y ++ DV+S G ++ E + P +F G++ +
Sbjct: 214 VSYICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ-P---IFPGDSGV 263
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-16
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
++++ ++G G F VY+A D G AIK + + E ++MR++ H N+ +
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 1396 ----IVSSCSNPGFKAL--ILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVAC 1443
SS L +L Y+P+ ++ + ++ +Q L + M +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS---RAKQTLPVIYVKLYMYQLFR 167
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVDSMKQTMTLATIGY 1502
+L Y+H S I H D+KP N+LLD D V L DFG AK L + + + Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYY 222
Query: 1503 MAPE-------YGSEGIVSTSGDVYSFGILMMETLTRR 1533
APE Y ++S DV+S G ++ E L +
Sbjct: 223 RAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-17
Identities = 57/241 (23%), Positives = 92/241 (38%), Gaps = 30/241 (12%)
Query: 730 TWRRISYQELQRLTDGFSESNLIGAGSFGSVY----KATLPYGMNVAIKVFN----LQLD 781
W+ + + D FS +IG G FG VY T G A+K +
Sbjct: 176 QWKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQ 231
Query: 782 GAIKSFDAECEVLRRV---RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTL 838
G E +L V +V + + + IL+ M G L L H
Sbjct: 232 G-ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 839 NIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898
R ++ LE++H+ V++ DLKP+N+LLD+ +SD G++ +
Sbjct: 291 EADMRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345
Query: 899 SVTQTMTLA-TFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
+ T GYMAPE +G+ + D +S G ++ + P F +
Sbjct: 346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKD 398
Query: 957 K 957
K
Sbjct: 399 K 399
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 3e-17
Identities = 56/256 (21%), Positives = 96/256 (37%), Gaps = 31/256 (12%)
Query: 1304 RKRDKSRPTENNLLNTAALRRISYQEL----RLATNGFSESNLLGTGIFSSVYKATFAD- 1358
+ + + + + R ++ + L N FS ++G G F VY AD
Sbjct: 154 CQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT 213
Query: 1359 GTNAAIKIFSLQEDRALKSFDAEC--------EVMRRIRHRNLAKIVSSCSNPGFKALIL 1410
G A+K L + R ++ + + + P + IL
Sbjct: 214 GKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271
Query: 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMI-DVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469
M G L L H E + ++ LE++H + +++ DLKP+N+LLD
Sbjct: 272 DLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLD 326
Query: 1470 DDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYGSEGIV-STSGDVYSFGILMM 1527
+ + D G+A K+ T GYMAPE +G+ +S D +S G ++
Sbjct: 327 EHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 1528 ETLTRRKPTDDMFTGE 1543
+ L P F
Sbjct: 383 KLLRGHSP----FRQH 394
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 68/229 (29%), Positives = 89/229 (38%), Gaps = 42/229 (18%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
LT IPS I ++ + + L N LS +LPS L L LYL N L +P+ I
Sbjct: 26 KKLTA-IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80
Query: 361 CNA-SKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCR 419
L L ++ N L F L L L +QL SL F SLT
Sbjct: 81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK--SLPPR--VFDSLTK-- 134
Query: 420 YLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQ 479
L YL++ N + LP V F L+++ L LY NQ
Sbjct: 135 -LTYLSLGYNELQ-SLPKGV------------------------FDKLTSLKELRLYNNQ 168
Query: 480 LASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSEL-CQLESLNTLLLQGN 526
L +P KL L+ L L N ++ +P LE L L LQ N
Sbjct: 169 LKR-VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 56/185 (30%), Positives = 82/185 (44%), Gaps = 14/185 (7%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
IPA + L L N+L+S +L L+ L L+ N +Q ++P+ + +L++
Sbjct: 34 NIPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L TL + N LQ L +L L L N+L S P F SL + + N L
Sbjct: 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 578 GCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPE-AIGS 634
LP+ + L L L L NQL +P L +L L L N + +PE A S
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDS 203
Query: 635 LISLE 639
L L+
Sbjct: 204 LEKLK 208
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 58/268 (21%), Positives = 89/268 (33%), Gaps = 69/268 (25%)
Query: 341 NLLRLYLWGNNLSGV---IPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
N + L+ + IP+ L+L N S L + F +L++L L
Sbjct: 17 NKNSVDCSSKKLTAIPSNIPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLND 70
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
++L T LP +
Sbjct: 71 NKLQT--------------------------------LPAGI------------------ 80
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELC-QL 515
F L N+ L + N+L + +P V +L NL L L N ++ S+P + L
Sbjct: 81 ------FKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSL 132
Query: 516 ESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNL 575
L L L N LQ+ LTSL+ L L +N+L F L + + N
Sbjct: 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 576 LSGCLPQDIGNLKVLTGLYLSGNQLSCS 603
L +L+ L L L N C+
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQENPWDCT 220
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 20/192 (10%)
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSFNE 197
+ +DL SN++S +L + LT+L ++ N++ LP+ + L+ L V+ N+
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 198 LTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLC 255
L +P + L L EL L+ N L+ PP +F +++ L + L N L SLP +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVF 153
Query: 256 RRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
+L SL+EL L + R+P+ T L L L +NQL +P F++
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR---------VPEGAFDS 203
Query: 315 -SNIEVIQLYGN 325
++++QL N
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 18/193 (9%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
+ + D+ SN+++ + +KL+ L ++ N+L +P I L L L++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 221 NLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
LQ P +F + +L + L N L SLP + L L L+L +PK +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 280 -GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGI 337
T L L L +NQL +P F+ + ++ ++L N L +P
Sbjct: 153 FDKLTSLKELRLYNNQLKR---------VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFD 202
Query: 338 NLPNLLRLYLWGN 350
+L L L L N
Sbjct: 203 SLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 50/206 (24%), Positives = 76/206 (36%), Gaps = 29/206 (14%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
K+L + NK++ + LT+LR L+L+ N L+ L F L N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKE-----LKN---LET 89
Query: 1052 LILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQG 1110
L + N+L +P +F+ N+ ++L N LP + L L
Sbjct: 90 LWVTDNKLQ-----------ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137
Query: 1111 LILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGS 1170
L L N L + + + L L N + F +L+ L L N L
Sbjct: 138 LSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 1171 STQGHSFYTSLTNCRYLRRLVLQNNP 1196
+ SL L+ L LQ NP
Sbjct: 198 ----EGAFDSLEK---LKMLQLQENP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMP-RLRIIDLSSNRIS---GNLFDDMC 158
T+P + L L +L ++ N+ LP ++ L + L N++ +FD
Sbjct: 75 TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD--- 130
Query: 159 NSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSFNELTGRIPQNI-GNLTELMELY 216
SLT+L + N++ LP + D + LK L + N+L R+P+ LTEL L
Sbjct: 131 -SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLK 187
Query: 217 LNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
L+ N L+ P F ++ L+++ L N
Sbjct: 188 LDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 11/109 (10%)
Query: 1097 LPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQL 1156
+PS+I P + + L L N LS + + +++ LL L++N L F + L
Sbjct: 31 IPSNI-P--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 1157 QILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSI 1205
+ L ++ N L + L N L L L N LK +LP +
Sbjct: 88 ETLWVTDNKLQALPI----GVFDQLVN---LAELRLDRNQLK-SLPPRV 128
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 2e-17
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 52/228 (22%)
Query: 751 LIGAGSFGSVYKATLPYGMNV----AIKVFNLQLDGAIKSFDAEC----EVLRRVRHRNL 802
++G GSFG V+ G + A+KV L+ ++L V H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------SAL 854
VK+ + G LIL+++ G L ++ + + + + AL
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDL----FTR-----LSKEVMFTEEDVKFYLAELALAL 139
Query: 855 EYLH-HGHPTPVIHCDLKPSNVLLDDDTVAH--LSDFGISKLLDGEDSVTQTMTLATFGY 911
++LH G +I+ DLKP N+LLD++ H L+DFG+SK + + T Y
Sbjct: 140 DHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSF-CGTVEY 192
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
MAPE +V+ G D +SFG+LM E T +P E
Sbjct: 193 MAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 5e-15
Identities = 42/113 (37%), Positives = 60/113 (53%), Gaps = 25/113 (22%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTL- 1497
+A AL++LH S II+ DLKP N+LLD++ H L DFG++K +D K+ +
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKE--SIDHEKKAYSFC 187
Query: 1498 ATIGYMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP-----TDDMF 1540
T+ YMAPE +V+ G D +SFG+LM E LT P +
Sbjct: 188 GTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 45/208 (21%), Positives = 75/208 (36%), Gaps = 45/208 (21%)
Query: 752 IGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGA--IKSFDAECEVLRRVRHR-NLVK 804
+G G F V K+T G A K + G E VL + ++
Sbjct: 37 LGRGKFAVVRQCISKST---GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 805 IISSCSNHGFKALILEYMPQGSL-----EKWL--YSHKYTLNIQQRLDIMIDVASALEYL 857
+ N LILEY G + + S + ++ + + YL
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIKQILEGVYYL 147
Query: 858 H-HGHPTPVIHCDLKPSNVLLDDDTVAH---LSDFGISKLLDGEDSVTQTMTLATFGYMA 913
H + ++H DLKP N+LL + DFG+S+ + + + M T Y+A
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLA 201
Query: 914 PE------YGSEGIVSTCGDVYSFGILM 935
PE + D+++ GI+
Sbjct: 202 PEILNYDPITTA------TDMWNIGIIA 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-15
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 31/201 (15%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFS----LQEDRALKSFDAECEVMRRIRHR-NLAKI 1396
LG G F+ V + + G A K Q+ RA E V+ + + +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA--EILHEIAVLELAKSCPRVINL 94
Query: 1397 VSSCSNPGFKALILQYMPQGSL-----EKWL--YSHNYLLNIEQR-LDIMIDVACALEYL 1448
N LIL+Y G + + S E + ++ + + YL
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS-------ENDVIRLIKQILEGVYYL 147
Query: 1449 HQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAP 1505
H +I+H DLKP N+LL + DFG+++ + +++ M T Y+AP
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAP 202
Query: 1506 EYGSEGIVSTSGDVYSFGILM 1526
E + ++T+ D+++ GI+
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 52/236 (22%), Positives = 92/236 (38%), Gaps = 52/236 (22%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRNLVK---I 805
+G G++G V A VA+K+ ++ + ++ E + + + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSH---------KYTLNIQQRLDIMIDVASALEY 856
N + L LEY G L + ++ Q ++ + + Y
Sbjct: 74 RRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRF---FHQ----LM---AGVVY 120
Query: 857 LH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF-G---Y 911
LH G + H D+KP N+LLD+ +SDFG++ + + + L G Y
Sbjct: 121 LHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RERLLNKMCGTLPY 173
Query: 912 MAPE------Y-GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE 960
+APE + DV+S GI++ ++P D+ W E
Sbjct: 174 VAPELLKRREFHAEP------VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 51/229 (22%), Positives = 83/229 (36%), Gaps = 38/229 (16%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDA---ECEVMRRIRHRNLAKIV 1397
LG G + V A A+KI + RA+ + E + + + H N+ K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKI--VDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA--------CALEYLH 1449
+ L L+Y G L + + + + A + YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL------FDRIEP-DIGMPE--PDAQRFFHQLMAGVVYLH 122
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPEYG 1508
I H D+KP N+LLD+ + DFG+A + + + + T+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-- 177
Query: 1509 SEGIVSTSG------DVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE 1551
++ DV+S GI++ L P D W E
Sbjct: 178 ---LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 37/203 (18%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVK-- 804
+G G+FG V G VA+K+ N ++ + E + L+ RH +++K
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 805 -IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+IS+ F +++EY+ G L ++ H + + + + SA++Y H
Sbjct: 78 QVIST-PTDFF--MVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPE---- 915
V+H DLKP NVLLD A ++DFG+S ++ + L T Y APE
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRTSCGSPNYAAPEVISG 184
Query: 916 --Y-GSEGIVSTCGDVYSFGILM 935
Y G E D++S G+++
Sbjct: 185 RLYAGPE------VDIWSCGVIL 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LG G F V G A+KI + ++ + E + ++ RH ++ K+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
S P ++++Y+ G L ++ H + +E R + + A++Y H ++
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVV 133
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI----GYMAPE------Y 1507
H DLKP NVLLD M A + DFG++ + M L T Y APE Y
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 1508 -GSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
G E D++S G+++ L P DD
Sbjct: 188 AGPE------VDIWSCGVILYALLCGTLPFDD 213
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 49/213 (23%), Positives = 76/213 (35%), Gaps = 53/213 (24%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN-LQLDGAIKSFDA-----ECEVLRRVRHR--N 801
L+G+G FGSVY + + VAIK ++ + + E +L++V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 802 LVKIISSCSNHGFKALILEY-MPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASAL 854
+++++ LILE P L ++ L V A+
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAV 162
Query: 855 EYLH-HGHPTPVIHCDLKPSNVLLDDDTV-AHLSDFGISKLLDGEDSVTQTMTLATF--- 909
+ H G V+H D+K N+L+D + L DFG LL F
Sbjct: 163 RHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-------VYTDFDGT 211
Query: 910 -GYMAPEY-------GSEGIVSTCGDVYSFGIL 934
Y PE+ G V+S GIL
Sbjct: 212 RVYSPPEWIRYHRYHGRS------AAVWSLGIL 238
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 52/230 (22%), Positives = 86/230 (37%), Gaps = 34/230 (14%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKI------FSLQEDRALKSFDAECEVMRRIRHR--N 1392
LLG+G F SVY +D AIK E E +++++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 1393 LAKIVSSCSNPGFKALILQY-MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
+ +++ P LIL+ P L ++ L R V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166
Query: 1452 YSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY--- 1507
+ ++H D+K N+L+D + L DFG LL D++ T Y PE+
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTD-FDGTRVYSPPEWIRY 222
Query: 1508 ----GSEGIVSTSGDVYSFGILMMETLTRRKPTDD---MFTGEVCLKHWV 1550
G V+S GIL+ + + P + + G+V + V
Sbjct: 223 HRYHGRS------AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-17
Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 54/230 (23%)
Query: 751 LIGAGSFGSVYKATLPYGMNV----AIKVFNLQLDGAIKSFD------AECEVLRRVRHR 800
++G G +G V++ G N A+KV L+ +++ AE +L V+H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------S 852
+V +I + G LILEY+ G L + +++ M D A
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGEL----FMQ-----LEREGIFMEDTACFYLAEISM 132
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAH--LSDFGISKLLDGEDSVTQTMTLATF 909
AL +LH G +I+ DLKP N++L+ H L+DFG+ K + +VT T T
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTF-CGTI 185
Query: 910 GYMAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
YMAPE I+ G D +S G LM + T P +
Sbjct: 186 EYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 8e-15
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 46/226 (20%)
Query: 1342 LLGTGIFSSVYKATFADGTNA----AIKIFS----LQEDRALKSFDAECEVMRRIRHRNL 1393
+LG G + V++ G N A+K+ ++ + AE ++ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALEY 1447
++ + G LIL+Y+ G L + L E + +++ AL +
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGEL----FMQ---LEREGIFMEDTACFYLAEISMALGH 136
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTLA-TIGYMA 1504
LH II+ DLKP N++L+ H L DFG+ K + T T TI YMA
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYMA 189
Query: 1505 PEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP-----TDDMF 1540
PE I+ SG D +S G LM + LT P
Sbjct: 190 PE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 48/178 (26%), Positives = 68/178 (38%), Gaps = 30/178 (16%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN--LQLDGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG+G+FG VA+K +D ++ E R +RH N+V+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKE 83
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------SALEYLHH 859
A+I+EY G L + + + R D A S + Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNA-------GRFSE--DEARFFFQQLLSGVSYCHS 134
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHL--SDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
+ H DLK N LLD L DFG SK S ++ T+ T Y+APE
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKS-TVGTPAYIAPE 187
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 45/179 (25%), Positives = 64/179 (35%), Gaps = 32/179 (17%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDA---ECEVMRRIRHRNLAKIV 1397
+G+G F A+K +R + E R +RH N+ +
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA--------CALEYLH 1449
P A+I++Y G L + + N R D A + Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGEL------YERICN-AGRFSE--DEARFFFQQLLSGVSYCH 133
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHL--GDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
S I H DLK N LLD L DFG +K S ++ T+ T Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKS-TVGTPAYIAPE 187
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 1e-16
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 752 IGAGSFGSVYKA----TLPYGMNVAIKVFNLQLDG------AIKSFDAECEVLRRVRHRN 801
IG GS+G V+K T G VAIK F D A++ E +L++++H N
Sbjct: 11 IGEGSYGVVFKCRNRDT---GQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPN 63
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH-HG 860
LV ++ L+ EY ++ L ++ + I A+ + H H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE--Y 916
IH D+KP N+L+ +V L DFG ++LL G + +AT Y +PE
Sbjct: 123 ----CIHRDVKPENILITKHSVIKLCDFGFARLLTGP---SDYYDDEVATRWYRSPELLV 175
Query: 917 GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
G DV++ G + E + P ++ G++
Sbjct: 176 GDT-QYGPPVDVWAIGCVFAELLSGV-P---LWPGKS 207
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 1343 LGTGIFSSVYKATFADGTNA--AIKIFSLQEDR------ALKSFDAECEVMRRIRHRNLA 1394
+G G + V+K D T AIK F ED AL+ E ++++++H NL
Sbjct: 11 IGEGSYGVVFKCRNRD-TGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLV 65
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
++ L+ +Y ++ L + + I A+ + H
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KH 121
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGI 1512
+ IH D+KP N+L+ V L DFG A+LL S +AT Y +PE G
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDT-Q 179
Query: 1513 VSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
DV++ G + E L P ++ G+
Sbjct: 180 YGPPVDVWAIGCVFAE-LLSGVP---LWPGK 206
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 34/208 (16%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDAECEVLRRVRHRNLVKI- 805
IG+G+ G V A NVAIK F Q A +++ E +++ V H+N++ +
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAY-RELVLMKCVNHKNIIGLL 90
Query: 806 ---ISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASAL 854
S F+ +++E M +L + IQ LD ++ + +
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELM-DANL------CQV---IQMELDHERMSYLLYQMLCGI 140
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
++LH +IH DLKPSN+++ D + DFG+++ +T + T Y AP
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP--YVVTRYYRAP 195
Query: 915 EYGSEGIVSTCGDVYSFGILMIETFTRK 942
E D++S G +M E
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 38/210 (18%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK----IFSLQED--RALKSFDAECEVMRRIRHRNLAK 1395
+G+G V A N AIK F Q RA + E +M+ + H+N+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 1396 IV----SSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVAC 1443
++ S F+ ++++ M +L I+ LD ++ + C
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELM-DANL------CQV---IQMELDHERMSYLLYQMLC 138
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
+++LH S IIH DLKPSN+++ D + DFG+A+ M T + T Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYR 193
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTRR 1533
APE + D++S G +M E +
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-16
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 44/225 (19%)
Query: 742 LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIK---VFNLQLDGAIKSFDAECEVLRRV 797
+ ++ + IG G++G V A + VAIK F Q ++ E ++L R
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTL-REIKILLRF 82
Query: 798 RHRNLVK---IISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLD------I 846
RH N++ II + + K ++ + M + L K L + Q L
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT--------QHLSNDHICYF 133
Query: 847 MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT- 905
+ + L+Y+H + V+H DLKPSN+LL+ + DFG++++ D + T +T
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 906 -LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRK 942
+AT Y APE Y ++ I D++S G ++ E + +
Sbjct: 191 YVATRWYRAPEIMLNSKGY-TKSI-----DIWSVGCILAEMLSNR 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-15
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIK---IFSLQED--RALKSFDAECEVMRRIRH 1390
++ + +G G + V A + AIK F Q R L+ E +++ R RH
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 84
Query: 1391 RN---LAKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACAL 1445
N + I+ + + K ++ M + L K L + +L N + + L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICY-FLYQILRGL 141
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGYM 1503
+Y+H S +++H DLKPSN+LL+ + DFG+A++ D +T +AT Y
Sbjct: 142 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 1504 APEY-GSEGIVSTSGDVYSFGILMMETLTRR 1533
APE + + S D++S G ++ E L+ R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 52/227 (22%)
Query: 751 LIGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAIKSFDAEC-----EVLRRVRHRN 801
L+G G+FG V KAT G A+K+ L+ + I + VL+ RH
Sbjct: 12 LLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMID--------VASA 853
L + + H ++EY G L + H + + + + SA
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGEL----FFH-----LSRERVFTEERARFYGAEIVSA 117
Query: 854 LEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
LEYLH V++ D+K N++LD D ++DFG+ K + + +T T Y+
Sbjct: 118 LEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYL 172
Query: 913 APEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
APE ++ D + G++M E ++P + +F
Sbjct: 173 APE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-14
Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 50/238 (21%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAEC-----EVMRRIRHRNLAK 1395
LLG G F V A G A+KI L+++ + + V++ RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALEYLH 1449
+ + +++Y G L + H L+ E+ ++ ALEYLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGEL----FFH---LSRERVFTEERARFYGAEIVSALEYLH 122
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTL-ATIGYMAPE 1506
S +++ D+K N++LD D H + DFG+ K +G+ T T Y+APE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 175
Query: 1507 YGSEGIVSTSG-----DVYSFGILMMETLTRRKP-----TDDMF----TGEVCLKHWV 1550
++ + D + G++M E + R P + +F E+ +
Sbjct: 176 -----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 228
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKS---FDA--EC 791
+++ + + + +G G F +VYKA VAIK L K A E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
++L+ + H N++ ++ + + +L+ ++M LE + + L M+
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATF 909
LEYLH ++H DLKP+N+LLD++ V L+DFG++K S + T + T
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTR 176
Query: 910 GYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
Y APE +G+ + D+++ G ++ E R P G++
Sbjct: 177 WYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV-P---FLPGDS 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-13
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK-IFSLQEDRALKSFDA----ECEVMRRIRHRN---L 1393
LG G F++VYKA AIK I A + E ++++ + H N L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
SN +L+ +M LE + ++ +L M+ LEYLHQ +
Sbjct: 78 LDAFGHKSN---ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGYMAPE--YGS 1509
I+H DLKP+N+LLD++ V L DFG+AK S + T + T Y APE +G+
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKS---FGSPNRAYTHQVVTRWYRAPELLFGA 187
Query: 1510 EGIVSTSGDVYSFGILMMETLTRR 1533
+ D+++ G ++ E L R
Sbjct: 188 R-MYGVGVDMWAVGCILAELLLRV 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-16
Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 26/177 (14%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRHRNLVK-- 804
+G G+FG V G VA+K+ N ++ + E + L+ RH +++K
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 805 -IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
+IS+ + F +++EY+ G L ++ + L+ ++ + + S ++Y H
Sbjct: 83 QVIST-PSDIF--MVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLL-DGEDSVTQTMTLATF----GYMAPE 915
V+H DLKP NVLLD A ++DFG+S ++ DGE L T Y APE
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGSPNYAAPE 185
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-14
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 31/212 (14%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LG G F V G A+KI + ++ + E + ++ RH ++ K+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
S P ++++Y+ G L ++ + L E R + + ++Y H ++
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR-RLFQQILSGVDYCH---RHMVV 138
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI----GYMAPE------Y 1507
H DLKP NVLLD M A + DFG++ + M L T Y APE Y
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 1508 -GSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
G E D++S G+++ L P DD
Sbjct: 193 AGPE------VDIWSSGVILYALLCGTLPFDD 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-16
Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA----ECEVLR 795
+ + IG G+FG V+KA G VA+K + ++ + F E ++L+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQ 71
Query: 796 RVRHRNLVK---IISSCSNHGFKA-----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIM 847
++H N+V I + ++ + L+ ++ L L + + + +M
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 848 IDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD-GEDSVTQTMT- 905
+ + L Y+H ++H D+K +NVL+ D V L+DFG+++ ++S T
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 906 -LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ T Y PE G D++ G +M E +TR P + G T
Sbjct: 188 RVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRS-P---IMQGNT 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-12
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRN--- 1392
+G G F V+KA G A+K ++ ++ AL+ E ++++ ++H N
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80
Query: 1393 LAKIVSSCSNPGFKA-----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEY 1447
L +I + ++P + L+ + L L + + + +M + L Y
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD-GVDSMKQTMT--LATIGYMA 1504
+H I+H D+K +NVL+ D V L DFG+A+ +S T + T+ Y
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196
Query: 1505 PE--YGSEGIVSTSGDVYSFGILMMETLTRR 1533
PE G D++ G +M E TR
Sbjct: 197 PELLLGER-DYGPPIDLWGAGCIMAEMWTRS 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 60/278 (21%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQL-DG----AIKSFDAECEVLRRVRHRNLVKI 805
+G G++ +VYK G+ VA+K L +G AI+ E +++ ++H N+V++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVASALEYLHH 859
L+ E+M L+K++ + N + L+ + L + H
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE-- 915
++H DLKP N+L++ L DFG+++ T + + T Y AP+
Sbjct: 127 NK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP---VNTFSSEVVTLWYRAPDVL 180
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRK--------------------MPTDEMFTGETSL 955
GS ST D++S G ++ E T K P + ++ T L
Sbjct: 181 MGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 956 -------KKWVEESLRLAVTEVVDAELLSSEEEEGADL 986
++ LR + L + D
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDF 273
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDR-----ALKSFDAECEVMRRIRHRNLAKI 1396
LG G +++VYK G A+K L + A++ E +M+ ++H N+ ++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVACALEYLHQ 1450
L+ ++M L+K++ S + N + L+ + L + H+
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYMDSRT-VGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YG 1508
I+H DLKP N+L++ LGDFG+A+ G+ + + T+ Y AP+ G
Sbjct: 127 NK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRR 1533
S STS D++S G ++ E +T +
Sbjct: 183 SR-TYSTSIDIWSCGCILAEMITGK 206
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 51/263 (19%), Positives = 100/263 (38%), Gaps = 37/263 (14%)
Query: 144 LSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIP 203
I +F D ++ E ++ +T + + + + ++ + +++ +
Sbjct: 9 TVPTPIK-QIFSD--DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV- 61
Query: 204 QNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLC--RRLPSL 261
Q I L + +L+LNGN L P + N+ +L + L N + DL + L L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV-----KDLSSLKDLKKL 114
Query: 262 QELNLRDCMTTGRIPK--DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEV 319
+ L+L I + + L L L +N++TD +++ + ++
Sbjct: 115 KSLSLEHN----GISDINGLVHLPQLESLYLGNNKITDI----------TVLSRLTKLDT 160
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGL 379
+ L N +S ++ L L LYL N++S + ++ L VLEL
Sbjct: 161 LSLEDNQIS-DIVPLA--GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 215
Query: 380 VANTFGNCRQLQILNLAYSQLAT 402
N N + L T
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 52/269 (19%), Positives = 99/269 (36%), Gaps = 55/269 (20%)
Query: 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFD 168
L+ + + + + ++ + +P + + L+ N+++ ++ +L L
Sbjct: 42 QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKPL--ANLKNLGWLF 96
Query: 169 VSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPP 228
+ N++ L SSL D KLK LS+ N ++ I + +L +L LYL N
Sbjct: 97 LDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNK------- 145
Query: 229 TIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK--DIGNCTLLN 286
I +++ L RL L L+L D +I + T L
Sbjct: 146 -ITDITVL-------------------SRLTKLDTLSLEDN----QISDIVPLAGLTKLQ 181
Query: 287 YLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLY 346
L L N ++D + N++V++L+ N P + NL +
Sbjct: 182 NLYLSKNHISDL----------RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVK 230
Query: 347 LWGNNLSGVIPSSICNASKLTVLELSRNL 375
+L V P I + + +L
Sbjct: 231 NTDGSL--VTPEIISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 46/261 (17%), Positives = 88/261 (33%), Gaps = 26/261 (9%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
++ L +++ + + + + + + + + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
++L L N + L +L + N K + +S+ +L K L+ +
Sbjct: 78 NKLTD---------IKPLANLKNLGWLFLDENKVKDL--SSLKDL-KKLKSLSLEHNGIS 125
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
I +L + +L L N++ T T + +L L L L N I I L L
Sbjct: 126 D-ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTK 179
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L L L N + + LA L +L L L S + + +L V + L
Sbjct: 180 LQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
Query: 578 GCLPQDIGNLKVLTGLYLSGN 598
P+ I + + +
Sbjct: 238 T--PEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 52/299 (17%), Positives = 98/299 (32%), Gaps = 59/299 (19%)
Query: 257 RLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSN 316
+ NL+ T + ++ + ++ + I N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV----------QGIQYLPN 69
Query: 317 IEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLF 376
+ + L GN L+ P + NL NL L+L N + + SS+ + KL L L N
Sbjct: 70 VTKLFLNGNKLTDIKPLA---NLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGI 124
Query: 377 SGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILP 436
S + N + QL+ L L +++ + L+ L L+++ N I+P
Sbjct: 125 SDI--NGLVHLPQLESLYLGNNKITD---------ITVLSRLTKLDTLSLEDNQISDIVP 173
Query: 437 NSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQG 496
L+ + L L +N ++ + L+NL
Sbjct: 174 ---------------------------LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDV 204
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNST 555
L+L + L NT+ +L P +++ N+ + T
Sbjct: 205 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 12/159 (7%)
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLL 523
L++I + + + S + L N+ L L+ N + I L L++L L L
Sbjct: 42 QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFL 97
Query: 524 QGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQD 583
N +++ L +L L++L+L N ++ L + + N ++
Sbjct: 98 DENKVKDLSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD--ITV 151
Query: 584 IGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
+ L L L L NQ+S I + GL L L L++N
Sbjct: 152 LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 44/234 (18%), Positives = 89/234 (38%), Gaps = 49/234 (20%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYNNKFTG 1037
+ + ++ +T + L + ++ + +++++ +L NK T
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT- 81
Query: 1038 RIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHL 1097
I L N L +L L +N++ + S + + ++++ L N
Sbjct: 82 DIK-PLANLKNLGWLFLDENKVKDL------------SSLKDLKKLKSLSLEHNGI---- 124
Query: 1098 PSSIGP--YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ 1155
S I +LP L+ L L N ++ I + + +++ L L +N S ++P +
Sbjct: 125 -SDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTK 179
Query: 1156 LQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
LQ L LS NH++ +L + L L L + N NL
Sbjct: 180 LQNLYLSKNHISD---------LRALAGLKNLDVLELFSQECLNKPINHQSNLV 224
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 32/181 (17%), Positives = 60/181 (33%), Gaps = 34/181 (18%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
L D KLK LS+ N I+ + +L +L L+L N + L
Sbjct: 108 LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-----------DITVLSR 154
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP-- 1103
T L+ L L NQ++ + + + ++ + L NH S +
Sbjct: 155 LTKLDTLSLEDNQISDI------------VPLAGLTKLQNLYLSKNHI-----SDLRALA 197
Query: 1104 YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSL 1163
L NL L L+ + N + ++ + P + + ++
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKW 255
Query: 1164 N 1164
+
Sbjct: 256 H 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 36/186 (19%), Positives = 60/186 (32%), Gaps = 39/186 (20%)
Query: 1042 NLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSI 1101
+ L++ +T ++I+ I + S+
Sbjct: 19 SDDAFAETIKDNLKKKSVTDA------------VTQNELNSIDQIIANNSDIK-----SV 61
Query: 1102 GP--YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQIL 1159
YLPN+ L L GN L+ I + N + L L EN L + ++L+ L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSL 117
Query: 1160 DLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS--TSLEYFFA 1217
L N ++ L + L L L NN + I LS T L+
Sbjct: 118 SLEHNGISD---------INGLVHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSL 163
Query: 1218 SSTELR 1223
++
Sbjct: 164 EDNQIS 169
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-16
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 750 NLIGAGSFGSVYKA----TLPYGMNVAIKVFNLQLDG------AIKSFDAECEVLRRVRH 799
L+G GS+G V K T G VAIK F D A++ E ++L+++RH
Sbjct: 31 GLVGEGSYGMVMKCRNKDT---GRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRH 83
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
NLV ++ C L+ E++ ++ L L+ Q + + + + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE-- 915
+ +IH D+KP N+L+ V L DFG ++ L + +AT Y APE
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---GEVYDDEVATRWYRAPELL 196
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
G DV++ G L+ E F + P +F G++
Sbjct: 197 VGDV-KYGKAVDVWAIGCLVTEMFMGE-P---LFPGDS 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-12
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 1341 NLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRNL 1393
L+G G + V K D G AIK F +D A++ E ++++++RH NL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENL 86
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
++ C L+ +++ ++ L L+ + + + + + H S
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---S 142
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YGSEG 1511
+IIH D+KP N+L+ V L DFG A+ L +AT Y APE G
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVGDV- 200
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
+ DV++ G L+ E + +P +F G+
Sbjct: 201 KYGKAVDVWAIGCLVTE-MFMGEP---LFPGD 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-16
Identities = 56/244 (22%), Positives = 100/244 (40%), Gaps = 52/244 (21%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIK-VFN--------LQLDGAIKSFDA 789
++ D F + G G+FG+V GM+VAIK V LQ+ ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI---MQ---- 71
Query: 790 ECEVLRRVRHRNLVK---IISSCSNHGFK----ALILEYMPQGSLEKWLYSHKYTLNIQQ 842
L + H N+V+ + + +++EY+P +L + + Q
Sbjct: 72 ---DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC---RNYYRRQV 124
Query: 843 RLDI------MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLD 895
+ + ++ LH V H D+KP NVL+++ L DFG +K L
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL- 182
Query: 896 GEDSVTQTMT--LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTG 951
S ++ + + Y APE +G++ +T D++S G + E + P +F G
Sbjct: 183 ---SPSEPNVAYICSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLGE-P---IFRG 234
Query: 952 ETSL 955
+ S
Sbjct: 235 DNSA 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 48/233 (20%), Positives = 94/233 (40%), Gaps = 42/233 (18%)
Query: 1334 TNGFSESNLLGTGIFSSVYKATFAD-GTNAAIK------IFSLQEDRALKSFDAECEVMR 1386
+ F + G G F +V G + AIK F +E + ++ +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-------DLA 74
Query: 1387 RIRHRN---LAKIVSSCSNPGFK----ALILQYMPQGSLEKWLYSHNYLLNIEQRLDI-- 1437
+ H N L + + ++++Y+P +L + ++ +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY---RRQVAPPPIL 130
Query: 1438 ----MIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMK 1492
+ + ++ LH S ++ H D+KP NVL++ D L DFG AK L +
Sbjct: 131 IKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN- 188
Query: 1493 QTMTLATIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
+ + Y APE +G++ +T+ D++S G + E + +P +F G+
Sbjct: 189 -VAYICSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMML-GEP---IFRGD 235
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 45/227 (19%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK--VFNLQLDGAIKSFDAECEVLRRVRHRNLVKII-- 806
+G G G V+ A VAIK V + E +++RR+ H N+VK+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKHAL-REIKIIRRLDHDNIVKVFEI 76
Query: 807 ----------SSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
S + ++ EYM + L L + M + L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARL--FMYQLLRGL 133
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGY 911
+Y+H + V+H DLKP+N+ ++ +D V + DFG+++++D S ++ L T Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 912 MAPE-------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTG 951
+P Y ++ I D+++ G + E T K +F G
Sbjct: 191 RSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLTGKT----LFAG 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 45/220 (20%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIK--IFSLQED--RALKSFDAECEVMRRIRHRNLAKI- 1396
LG G V+ A D AIK + + + AL+ E +++RR+ H N+ K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 1397 -----------VSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVAC 1443
S + ++ +YM + L L L E M +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP--LLEEHARLFMYQLLR 131
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMT--LATI 1500
L+Y+H S +++H DLKP+N+ ++ +D+V +GDFG+A+++D S K ++ L T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 1501 GYMAPE-------YGSEGIVSTSGDVYSFGILMMETLTRR 1533
Y +P Y ++ I D+++ G + E LT +
Sbjct: 189 WYRSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLTGK 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 6e-16
Identities = 54/247 (21%), Positives = 99/247 (40%), Gaps = 49/247 (19%)
Query: 737 QELQRLTDGFSESNL-IGAGSFGSVYKA---TLPYGMNVAIKVFNLQLDGAIKSFDAECE 792
E +R+ D F +G G++G VYKA + A+K G S E
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIA 70
Query: 793 VLRRVRHRNLVKIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDI---- 846
+LR ++H N++ + +H + L+ +Y L + H+ + ++ + +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 847 ----MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH----LSDFGISKLLDGED 898
+ + + YLH V+H DLKP+N+L+ + ++D G ++L +
Sbjct: 130 VKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF---N 183
Query: 899 SVTQTMTLA-----TFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946
S + + TF Y APE Y I D+++ G + E T + P
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTK-AI-----DIWAIGCIFAELLTSE-P-- 234
Query: 947 EMFTGET 953
+F
Sbjct: 235 -IFHCRQ 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 49/222 (22%), Positives = 89/222 (40%), Gaps = 48/222 (21%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAE-------CEV--MRRIRHRN- 1392
+G G + VYKA DG + +D ALK + E+ +R ++H N
Sbjct: 29 VGRGTYGHVYKAKRKDGKD--------DKDYALKQIEGTGISMSACREIALLRELKHPNV 80
Query: 1393 --LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI--------MIDVA 1442
L K+ S ++ L+ Y L + H ++ + + + +
Sbjct: 81 ISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH----LGDFGIAKLLDGVDSMKQTMTLA 1498
+ YLH + ++H DLKP+N+L+ + + D G A+L +S + +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL---FNSPLKPLADL 192
Query: 1499 -----TIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRR 1533
T Y APE G+ + + D+++ G + E LT
Sbjct: 193 DPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSE 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-16
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 47/214 (21%)
Query: 751 LIGAGSFGSVYKATLPYGMNV----AIKVFN----LQLDGAIKSFDAECEVLRRVRHRN- 801
++G G++G V+ G + A+KV +Q + E +VL +R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------SA 853
LV + + LIL+Y+ G L ++H + QR A
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL----FTH-----LSQRERFTEHEVQIYVGEIVLA 171
Query: 854 LEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAH--LSDFGISKL-LDGEDSVTQTMTLATF 909
LE+LH G +I+ D+K N+LLD + H L+DFG+SK + E T
Sbjct: 172 LEHLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDF-CGTI 224
Query: 910 GYMAPE------YGSEGIVSTCGDVYSFGILMIE 937
YMAP+ G + V D +S G+LM E
Sbjct: 225 EYMAPDIVRGGDSGHDKAV----DWWSLGVLMYE 254
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 45/226 (19%)
Query: 1342 LLGTGIFSSVYKATFADGTNA----AIKIFS----LQEDRALKSFDAECEVMRRIRHRN- 1392
+LGTG + V+ G + A+K+ +Q+ + + E +V+ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALE 1446
L + + LIL Y+ G L ++H L+ +R + ++ ALE
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL----FTH---LSQRERFTEHEVQIYVGEIVLALE 173
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTLA-TIGYM 1503
+LH II+ D+K N+LLD + H L DFG++K D ++ TI YM
Sbjct: 174 HLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSK-EFVADETERAYDFCGTIEYM 227
Query: 1504 APE------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
AP+ G + V D +S G+LM E LT P FT +
Sbjct: 228 APDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP----FTVD 265
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 50/217 (23%), Positives = 75/217 (34%), Gaps = 59/217 (27%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN---------LQLDGAIKSFDAECEVLRRVR-- 798
L+G G FG+V+ L + VAIKV L E +L +V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGAG 94
Query: 799 --HRNLVKIISSCSNHGFKALILEY-MPQGSLEKWLYSHKYTLNIQQRLD------IMID 849
H +++++ L+LE +P L ++ L
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQ 147
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQTMTLAT 908
V +A+++ H V+H D+K N+L+D A L DFG LL E
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-------YTD 197
Query: 909 F----GYMAPEY-------GSEGIVSTCGDVYSFGIL 934
F Y PE+ V+S GIL
Sbjct: 198 FDGTRVYSPPEWISRHQYHALP------ATVWSLGIL 228
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 48/232 (20%), Positives = 81/232 (34%), Gaps = 36/232 (15%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKI------FSLQEDRALKSFDAECEVMRRIR----H 1390
LLG G F +V+ D AIK+ + E ++ ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 1391 RNLAKIVSSCSNPGFKALILQY-MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLH 1449
+ +++ L+L+ +P L ++ L R V A+++ H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY- 1507
S ++H D+K N+L+D A L DFG LL D T Y PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTD-FDGTRVYSPPEWI 210
Query: 1508 ------GSEGIVSTSGDVYSFGILMMETLTRRKPTDD---MFTGEVCLKHWV 1550
V+S GIL+ + + P + + E+ V
Sbjct: 211 SRHQYHALP------ATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 46/224 (20%)
Query: 742 LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDAECEVLRR 796
+ + IG+G+ G V A NVAIK F Q A +++ E +++
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAY-RELVLMKC 117
Query: 797 VRHRNLVKII----SSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLD----- 845
V H+N++ ++ + F+ L++E M + L + IQ LD
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANL--CQV---IQMELDHERMS 167
Query: 846 -IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904
++ + +++LH +IH DLKPSN+++ D + DFG+++ +T
Sbjct: 168 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-- 222
Query: 905 TLATFGYMAPE------YGSEGIVSTCGDVYSFGILMIETFTRK 942
+ T Y APE Y E + D++S G +M E K
Sbjct: 223 YVVTRYYRAPEVILGMGY-KENV-----DIWSVGCIMGEMVRHK 260
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 4e-14
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 34/208 (16%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK----IFSLQED--RALKSFDAECEVMRRIRHRNLAK 1395
+G+G V A N AIK F Q RA + E +M+ + H+N+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125
Query: 1396 IV----SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVACAL 1445
++ + F+ + Y+ ++ L I+ LD ++ + C +
Sbjct: 126 LLNVFTPQKTLEEFQDV---YLVMELMDANL--CQV---IQMELDHERMSYLLYQMLCGI 177
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAP 1505
++LH S IIH DLKPSN+++ D + DFG+A+ M T + T Y AP
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAP 232
Query: 1506 EYGSEGIVSTSGDVYSFGILMMETLTRR 1533
E + D++S G +M E + +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 39/167 (23%), Positives = 63/167 (37%), Gaps = 14/167 (8%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSE-LCQLE 516
+P+ L L N L+ +L NL L LS+N++ I SE +
Sbjct: 36 SLPS------YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
+L L L N L ++L +L L L +N + + F + + + S N +
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148
Query: 577 SGCLPQDI----GNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLAL 619
S P ++ L L L LS N+L + + L L
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 43/217 (19%), Positives = 65/217 (29%), Gaps = 17/217 (7%)
Query: 419 RYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE-FGNLSNIIALSLYQ 477
Y L + N + +L L I +E F + N+ L L
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSS 97
Query: 478 NQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIP--- 533
N L + LQ L+ L L N+I + + L L L N + + P
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 534 -TCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSL--NLLSGCLPQDIGNLKVL 590
L L L+LSSN+L + L + L N L C +
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE-CDCKLYQLFSHW 214
Query: 591 TGLYLSG-----NQLSCSIPSSIGGLKDLTYLALARN 622
LS L C + + L + +
Sbjct: 215 QYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEY 251
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 38/173 (21%), Positives = 71/173 (41%), Gaps = 24/173 (13%)
Query: 105 IPPHVANLSFLVSLNISGNRFHGTLPNELWL--MPRLRIIDLSSNRIS---GNLFDDMCN 159
+P + A L ++S N L E + L + LS N ++ F
Sbjct: 37 LPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP--- 86
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLN 218
+ L D+SSN + D L+ L + N + + +N ++ +L +LYL+
Sbjct: 87 -VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 219 GNNLQGEFPPTIF----NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267
N + FP + + L ++ L++N L LP+ ++LP+ + L
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL-KKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 40/203 (19%), Positives = 69/203 (33%), Gaps = 32/203 (15%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
L +P + S ++ L N+LS T L NL L L N+L+ + +
Sbjct: 28 QQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF 84
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
L L+LS N L F + + L++L L + + + + F +
Sbjct: 85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV--VVDRNA--FEDMAQ--- 137
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480
L+ L + N + + +K L ++ L L N+L
Sbjct: 138 LQKLYLSQNQISRFPVELIKDGNK----------------------LPKLMLLDLSSNKL 175
Query: 481 ASTIPTTVGKLQNLQGLDLSYNN 503
T + KL L +N
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 46/188 (24%), Positives = 68/188 (36%), Gaps = 29/188 (15%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRI 1073
+ L L NNL T L N L+ L+L N L I
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTR-----LTN---LHSLLLSHNHLN-----------FI 79
Query: 1074 PSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132
S F N+ + L NH L + L L+ L+L+ N++ + ++ + +Q+
Sbjct: 80 SSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL 138
Query: 1133 ILLGLSENLFSGLIPNTFGNC---RQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRR 1189
L LS+N S + +L +LDLS N L + L
Sbjct: 139 QKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP----LTDLQKLPAWV-KNG 193
Query: 1190 LVLQNNPL 1197
L L NNPL
Sbjct: 194 LYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 16/171 (9%)
Query: 188 LKRLSVSFNELTGRIPQNI--GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
L +S N L+ R+ LT L L L+ N+L F V +LR + L++N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 245 SLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNL 303
L +L L L +L+ L L + + ++ + L L L NQ++ F +
Sbjct: 99 HL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156
Query: 304 TGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLR--LYLWGNNL 352
+ ++ L N L LP + LP ++ LYL N L
Sbjct: 157 KDG-----NKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 35/169 (20%), Positives = 63/169 (37%), Gaps = 11/169 (6%)
Query: 1066 SNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSS 1125
S + + +P + S + L N+ S L NL L+L N+L+ I +
Sbjct: 26 SKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEA 83
Query: 1126 ICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCR 1185
+ L LS N L F + + L++L L NH+ ++F +
Sbjct: 84 FVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV---VVDRNAF-EDMAQ-- 137
Query: 1186 YLRRLVLQNNPLKGALPNSIGNLS--TSLEYFFASSTELRGAIPVEFEG 1232
L++L L N + I + + L SS +L+ + +
Sbjct: 138 -LQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 30/155 (19%), Positives = 50/155 (32%), Gaps = 29/155 (18%)
Query: 990 NKLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQN-LGNCT 1047
L L +S N + I + LR L L N+L + + +
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH----------TLDEFLFSDLQ 112
Query: 1048 LLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSI---GP 1103
L L+L N + + F + + ++ + L N S P + G
Sbjct: 113 ALEVLLLYNNHIV-----------VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN 160
Query: 1104 YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLS 1138
LP L L L N L + + + + GL
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDG------AIKSFDAECEV 793
D + +G G++G VYKA VAIK L+ + AI+ E +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 794 LRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASA 853
L+ ++HRN++++ S ++ LI EY L+K++ + ++++ + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLING 144
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH-----LSDFGISKLLDGEDSVTQTMTLAT 908
+ + H +H DLKP N+LL + + DFG+++ G T + T
Sbjct: 145 VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIIT 200
Query: 909 FGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
Y PE GS ST D++S + E + P +F G++
Sbjct: 201 LWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT-P---LFPGDS 242
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDR------ALKSFDAECEVMRRIRHRNLAK 1395
LG G + VYKA AIK L+ + A++ E +++ ++HRN+ +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ S + LI +Y L+K++ + + + + + + + H
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKS-FLYQLINGVNFCHSRR--- 152
Query: 1456 IIHCDLKPSNVLLDDDMVAH-----LGDFGIAKLLDGVDSMKQTMTLATIGYMAPE--YG 1508
+H DLKP N+LL + +GDFG+A+ G+ + T + T+ Y PE G
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLWYRPPEILLG 211
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
S STS D++S + E L + P +F G+
Sbjct: 212 SR-HYSTSVDIWSIACIWAEMLM-KTP---LFPGD 241
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 35/146 (23%), Positives = 60/146 (41%), Gaps = 8/146 (5%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
+P I + L QN + P + L+ +DLS N I + + L S
Sbjct: 29 NLPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
LN+L+L GN + + L SL+ L L++N++N F L + ++ N L
Sbjct: 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCS 603
L+ + ++L+ N C
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPFICD 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 33/145 (22%), Positives = 61/145 (42%), Gaps = 18/145 (12%)
Query: 288 LGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLY 346
+ L N + IP F+ + I L N +S L L +L L
Sbjct: 37 IRLEQNTIKV---------IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV 86
Query: 347 LWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLS 406
L+GN ++ + S L +L L+ N + L + F + L +L+L ++L +++
Sbjct: 87 LYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ--TIA 144
Query: 407 QGQSFFSSLTNCRYLRYLAIQTNPW 431
+G FS L ++ + + NP+
Sbjct: 145 KG--TFSPLRA---IQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 35/172 (20%), Positives = 62/172 (36%), Gaps = 40/172 (23%)
Query: 356 IPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSL 415
+P +I T + L +N + F ++L+ ++L+ +Q++ L+ F L
Sbjct: 30 LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--LAPD--AFQGL 79
Query: 416 TNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSL 475
+ L L + N LP S+ F L ++ L L
Sbjct: 80 RS---LNSLVLYGNKITE-LPKSL------------------------FEGLFSLQLLLL 111
Query: 476 YQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGN 526
N++ L NL L L N +Q +I L ++ T+ L N
Sbjct: 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 30/159 (18%), Positives = 51/159 (32%), Gaps = 32/159 (20%)
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTS 541
+ +P T+ + L N I+ P + L + L N + P L S
Sbjct: 28 TNLPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS 81
Query: 542 LRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
L +L L N++ S F L L L L+ N+++
Sbjct: 82 LNSLVLYGNKITELPKSLF------------------------EGLFSLQLLLLNANKIN 117
Query: 602 CSIPSSI-GGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
+ L +L L+L N Q L +++
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 36/141 (25%), Positives = 52/141 (36%), Gaps = 17/141 (12%)
Query: 189 KRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIFN-VSSLRVIVLANNSL 246
+ + N + IP +L + L+ N + E P F + SL +VL N +
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 247 FGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTG 305
LP L L SLQ L L + D + LN L L DN+L
Sbjct: 93 -TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT-------- 142
Query: 306 LIPSIIFNN-SNIEVIQLYGN 325
I F+ I+ + L N
Sbjct: 143 -IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 22/171 (12%)
Query: 77 CNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLM 136
C+ V C + +T IP +P + + N P
Sbjct: 11 CSNNIVDCRGK--GLT--EIPT-----NLPETITEIRL------EQNTIKVIPPGAFSPY 55
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSF 195
+LR IDLS+N+IS L D L L S + N+IT +LP SL + L+ L ++
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNA 113
Query: 196 NELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
N++ + + +L L L L N LQ F + +++ + LA N
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 35/136 (25%), Positives = 55/136 (40%), Gaps = 10/136 (7%)
Query: 1063 RLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGI 1121
RL N I IP F+ + I L N S L L +L L+L+GN ++ +
Sbjct: 38 RLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 1122 IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSL 1181
S + LL L+ N + L + F + L +L L N L T + ++ L
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIA----KGTFSPL 151
Query: 1182 TNCRYLRRLVLQNNPL 1197
++ + L NP
Sbjct: 152 RA---IQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 28/142 (19%), Positives = 46/142 (32%), Gaps = 32/142 (22%)
Query: 993 KRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEA---------------YLYNNKFT 1036
+ + N I IP +LR + L N + LY NK T
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 1037 GRIPQNL-GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFS 1094
+P++L L L+L N++ + F + N+ + LY N
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-----------CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 1095 GHLPSSIGPYLPNLQGLILWGN 1116
+ L +Q + L N
Sbjct: 142 -TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 24/106 (22%), Positives = 39/106 (36%), Gaps = 25/106 (23%)
Query: 991 KLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQNL-GNCTL 1048
L L + NKIT +P+++ L L+ L L+ N + + + +
Sbjct: 81 SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN----------CLRVDAFQDLHN 129
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHF 1093
LN L L N+L I F+ I+ + L N F
Sbjct: 130 LNLLSLYDNKLQ-----------TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 26/118 (22%), Positives = 42/118 (35%), Gaps = 8/118 (6%)
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
+ + L N + I P + ++ + LS N S L P+ F R L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 1166 LTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEYFFASSTELR 1223
+T F L + L+ L+L N + L +L +L+
Sbjct: 92 IT---ELPKSLFE-GLFS---LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 53/227 (23%)
Query: 742 LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDAECEVLRR 796
L + +G+G++GSV A G VAIK F ++ A +++ E +L+
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF-AKRAY-RELLLLKH 79
Query: 797 VRHRNLVKI----ISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLD----- 845
++H N++ + + S F L++ +M Q L K + +
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL------QKI---MGLKFSEEKIQ 129
Query: 846 -IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904
++ + L+Y+H V+H DLKP N+ +++D + DFG+++ D E M
Sbjct: 130 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE------M 180
Query: 905 T--LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRK 942
T + T Y APE Y ++ + D++S G +M E T K
Sbjct: 181 TGYVVTRWYRAPEVILSWMHY-NQTV-----DIWSVGCIMAEMLTGK 221
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIK----IFSLQED--RALKSFDAECEVMRRIR 1389
+ +G+G + SV A G AIK F + RA + E +++ ++
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQ 81
Query: 1390 HRNLAKIV----SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMI 1439
H N+ ++ + S F Y+ ++ L + + ++
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDF---YLVMPFMQTDL--QKI---MGLKFSEEKIQYLVY 133
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--L 1497
+ L+Y+H S ++H DLKP N+ +++D + DFG+A+ D MT +
Sbjct: 134 QMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD------AEMTGYV 184
Query: 1498 ATIGYMAPE-YGSEGIVSTSGDVYSFGILMMETLTRR 1533
T Y APE S + + D++S G +M E LT +
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 31/179 (17%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFN------LQLDGAIKSFDAECEVLRRVRHRNLV 803
+G GSFG V AT VA+K + + ++ E L+ +RH +++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER---EISYLKLLRHPHII 72
Query: 804 K---IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
K +I++ +++EY G L ++ K + + + A+EY H
Sbjct: 73 KLYDVITT-PTDIV--MVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRH 127
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF----GYMAPE 915
++H DLKP N+LLDD+ ++DFG+S ++ T L T Y APE
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIM------TDGNFLKTSCGSPNYAAPE 177
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-13
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
LG G F V AT + A+K S L++ + E ++ +RH ++ K+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
+ P ++++Y G L ++ + E R + CA+EY H I+
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIV 130
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI----GYMAPE------Y 1507
H DLKP N+LLDD++ + DFG++ + M L T Y APE Y
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNI------MTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 1508 -GSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
G E DV+S GI++ L R P DD
Sbjct: 185 AGPE------VDVWSCGIVLYVMLVGRLPFDD 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 31/121 (25%), Positives = 54/121 (44%), Gaps = 4/121 (3%)
Query: 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD 1471
E + L +E + VA +E+L S IH DL N+LL +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 229
Query: 1472 MVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETL 1530
V + DFG+A+ + +++ + +MAPE + + + DV+SFG+L+ E
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
Query: 1531 T 1531
+
Sbjct: 290 S 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 7e-13
Identities = 31/121 (25%), Positives = 54/121 (44%), Gaps = 4/121 (3%)
Query: 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD 880
E +K L ++ + VA +E+L IH DL N+LL +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 229
Query: 881 TVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETF 939
V + DFG+++ + + V + +MAPE + + + DV+SFG+L+ E F
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
Query: 940 T 940
+
Sbjct: 290 S 290
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 44/213 (20%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIK----IFSLQED--RALKSFDAECEVMRRIRHRNLAK 1395
+G+G + SV A G A+K F R + E +++ ++H N+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 1396 IV----SSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVAC 1443
++ + S F L+ M L + Q+L ++ +
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILR 143
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIG 1501
L+Y+H S IIH DLKPSN+ +++D + DFG+A+ MT +AT
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD------EMTGYVATRW 194
Query: 1502 YMAPE-YGSEGIVSTSGDVYSFGILMMETLTRR 1533
Y APE + + + D++S G +M E LT R
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 40/211 (18%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDAECEVLRRVRHRNLVKI- 805
+G+G++GSV A G+ VA+K F + A +++ E +L+ ++H N++ +
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTY-RELRLLKHMKHENVIGLL 94
Query: 806 ---ISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
+ S F L+ M L + K T + Q ++ + L+Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF--LIYQILRGLKYIHSA 151
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE--- 915
+IH DLKPSN+ +++D + DFG+++ E MT +AT Y APE
Sbjct: 152 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGYVATRWYRAPEIML 202
Query: 916 ----YGSEGIVSTCGDVYSFGILMIETFTRK 942
Y ++ + D++S G +M E T +
Sbjct: 203 NWMHY-NQTV-----DIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-14
Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 55/242 (22%)
Query: 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIK---VFNLQLDGAIKSF 787
+RI Y F +L+G G++G V AT P G VAIK F+ L A+++
Sbjct: 3 KRIVYNISSD----FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTL 57
Query: 788 DAECEVLRRVRHRNLVK---IISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQ 842
E ++L+ +H N++ I S F +I E M Q L + + + Q
Sbjct: 58 -REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST--------Q 107
Query: 843 RLD------IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896
L + A++ LH + VIH DLKPSN+L++ + + DFG+++++D
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 897 EDSVTQT-------MT--LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFT 940
+ M +AT Y APE Y S + DV+S G ++ E F
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY-SRAM-----DVWSCGCILAELFL 218
Query: 941 RK 942
R+
Sbjct: 219 RR 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-13
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIK---IFSLQED--RALKSFDAECEVMRRIRHRN---L 1393
LG G + V AT G AIK F R L+ E ++++ +H N +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 1394 AKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG 1451
I S F +I + M Q L + + S L + + + A++ LH
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-QTDLHR-VISTQMLSDDHIQY-FIYQTLRAVKVLH-- 129
Query: 1452 YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT-------MT--LATIGY 1502
+++IH DLKPSN+L++ + + DFG+A+++D + M +AT Y
Sbjct: 130 -GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 1503 MAPEY-GSEGIVSTSGDVYSFGILMMETLTRR 1533
APE + S + DV+S G ++ E RR
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-14
Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 53/228 (23%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAEC-----EVL-RRVRHR 800
+IG GSFG V KA + A+KV LQ +K + + VL + V+H
Sbjct: 45 VIGKGSFGKVLLARHKAE---EVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMID--------VAS 852
LV + S +L+Y+ G L + H +Q+ + +AS
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGEL----FYH-----LQRERCFLEPRARFYAAEIAS 150
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
AL YLH +++ DLKP N+LLD L+DFG+ K +S T T T Y
Sbjct: 151 ALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEY 205
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
+APE ++ D + G ++ E P T EM+
Sbjct: 206 LAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-14
Identities = 36/113 (31%), Positives = 53/113 (46%), Gaps = 25/113 (22%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTL- 1497
+A AL YLH S +I++ DLKP N+LLD H L DFG+ K + ++ T T
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK--ENIEHNSTTSTFC 200
Query: 1498 ATIGYMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP-----TDDMF 1540
T Y+APE ++ D + G ++ E L P T +M+
Sbjct: 201 GTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 43/236 (18%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKA--TLPYGMNVAIKVFNLQL--DG----AIKSFDAECE 792
R + IG G++G V+KA G VA+K +Q +G I+ E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 793 V-----LRRVRHRNLVK----IISSCSNHGFKA-LILEYMPQGSLEKWLYSHKYT-LNIQ 841
V L H N+V+ S ++ K L+ E++ Q L +L + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
D+M + L++LH V+H DLKP N+L+ L+DFG++++ S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQ 173
Query: 902 QTMT--LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+T + T Y APE S +T D++S G + E F RK P +F G +
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK-P---LFRGSS 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-12
Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 41/225 (18%)
Query: 1341 NLLGTGIFSSVYKATFADGTNA--AIK------------IFSLQEDRALKSFDAECEVMR 1386
+G G + V+KA A+K + +++E L+ +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-------LE 69
Query: 1387 RIRHRN---LAKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYL-LNIEQRLDIMID 1440
H N L + + L+ +++ Q L +L + E D+M
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI 1500
+ L++LH S ++H DLKP N+L+ L DFG+A++ M T + T+
Sbjct: 129 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTL 183
Query: 1501 GYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y APE S +T D++S G + E + RRKP +F G
Sbjct: 184 WYRAPEVLLQSS--YATPVDLWSVGCIFAE-MFRRKP---LFRGS 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 3e-14
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 751 LIGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVL-RRV-----RHR 800
++G GSFG V K T A+K+ L+ D I+ D EC ++ +RV +
Sbjct: 348 VLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------S 852
L ++ S ++EY+ G L H IQQ A
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDL----MYH-----IQQVGRFKEPHAVFYAAEIAI 453
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
L +L G +I+ DLK NV+LD + ++DFG+ K + T+T T Y
Sbjct: 454 GLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 508
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
+APE I++ D ++FG+L+ E + P DE+F
Sbjct: 509 IAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 1e-13
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 1342 LLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVM-RRI-----RHRNLA 1394
+LG G F V + A+KI L++D ++ D EC ++ +R+ + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMI-DVACALEYLHQGYS 1453
++ S +++Y+ G L + E ++A L +L S
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIGLFFLQ---S 460
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPE------ 1506
II+ DLK NV+LD + + DFG+ K + + T T T Y+APE
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 1507 YGSEGIVSTSGDVYSFGILMMETLTRRKP-----TDDMF 1540
YG S D ++FG+L+ E L + P D++F
Sbjct: 519 YG------KSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 4e-14
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 56/284 (19%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL-DGAIKSFDAEC--EV--- 793
T + IG G++G+VYKA G VA+K + G EV
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 794 --LRRVRHRNLVK----IISSCSNHGFKA-LILEYMPQGSLEKWLYSHKYT-LNIQQRLD 845
L H N+V+ +S ++ K L+ E++ Q L +L L + D
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT 905
+M L++LH ++H DLKP N+L+ L+DFG++++ S +T
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALT 177
Query: 906 --LATFGYMAPE--YGSEGIVSTCGDVYSFGILMIETFTRK------------------- 942
+ T Y APE S +T D++S G + E F RK
Sbjct: 178 PVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 943 -MPTDEMFTGETSL-----KKWVEESLRLAVTEVVDA--ELLSS 978
+P ++ + + SL ++ V E+ ++ +LL
Sbjct: 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLE 279
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 1341 NLLGTGIFSSVYKAT-FADGTNAAIK---------------IFSLQEDRALKSFDAECEV 1384
+G G + +VYKA G A+K I +++E L+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR------- 67
Query: 1385 MRRIRHRN---LAKIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHN-YLLNIEQRLDIM 1438
+ H N L + ++ L+ +++ Q L +L L E D+M
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA 1498
L++LH + I+H DLKP N+L+ L DFG+A++ M T +
Sbjct: 127 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVV 181
Query: 1499 TIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRR 1533
T+ Y APE S +T D++S G + E R+
Sbjct: 182 TLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-14
Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 17/178 (9%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDAECEVLRRVRHRNLVK-- 804
IG GS+G V +A VAIK VF +D + E +L R+ H ++VK
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-CKRIL-REIAILNRLNHDHVVKVL 118
Query: 805 -IISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
I+ F ++LE +K + Y L ++ ++ ++Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY-LTELHIKTLLYNLLVGVKYVHSAG 176
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
++H DLKP+N L++ D + DFG+++ +D ++ + ++
Sbjct: 177 ---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 73/279 (26%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK-IFSLQED-----RALKSFDAECEVMRRIRHRNLAK 1395
+GTG + V +A + AIK I + ED R L+ E ++ R+ H ++ K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 1396 ---IVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
IV F ++L+ +K + YL + + ++ ++ ++Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-------------------- 1490
S I+H DLKP+N L++ D + DFG+A+ +D ++
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 1491 ----MKQTMT--LATIGYMAPE-------YGSEGIVSTSGDVYSFGILMMETLT------ 1531
+K+ +T + T Y APE Y + + DV+S G + E L
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENY------TEAIDVWSIGCIFAELLNMIKENV 285
Query: 1532 ----RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566
R P +F G C ++ + N
Sbjct: 286 AYHADRGP---LFPGSSCFPLSPDQKAGNDFKFHTRGNR 321
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-14
Identities = 61/228 (26%), Positives = 92/228 (40%), Gaps = 53/228 (23%)
Query: 751 LIGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAIKSFDAEC-----EVLRRV-RHR 800
++G GSFG V K T A+K+ L+ D I+ D EC VL +
Sbjct: 27 VLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------S 852
L ++ S ++EY+ G L H IQQ A
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDL----MYH-----IQQVGRFKEPHAVFYAAEIAI 132
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
L +L G +I+ DLK NV+LD + ++DFG+ K + T+T T Y
Sbjct: 133 GLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
+APE I++ D ++FG+L+ E + P DE+F
Sbjct: 188 IAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 25/113 (22%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTL- 1497
+A L +L S II+ DLK NV+LD + H + DFG+ K + + T T
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK--ENIWDGVTTKTFC 182
Query: 1498 ATIGYMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP-----TDDMF 1540
T Y+APE I++ D ++FG+L+ E L + P D++F
Sbjct: 183 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-14
Identities = 62/228 (27%), Positives = 90/228 (39%), Gaps = 53/228 (23%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAEC-----EVLRRV-RHR 800
++G GSFG V K T G A+KV L+ D ++ D EC +L H
Sbjct: 30 VLGKGSFGKVMLARVKET---GDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------S 852
L ++ ++E++ G L H IQ+ A S
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDL----MFH-----IQKSRRFDEARARFYAAEIIS 135
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
AL +LH G +I+ DLK NVLLD + L+DFG+ K T T T Y
Sbjct: 136 ALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDY 190
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMP-----TDEMF 949
+APE I+ D ++ G+L+ E P D++F
Sbjct: 191 IAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-13
Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 21/111 (18%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-AT 1499
+ AL +LH II+ DLK NVLLD + L DFG+ K +G+ + T T T
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGT 187
Query: 1500 IGYMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP-----TDDMF 1540
Y+APE I+ D ++ G+L+ E L P DD+F
Sbjct: 188 PDYIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 44/213 (20%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK----IFSLQED--RALKSFDAECEVMRRIRHRNLAK 1395
+G+G + +V A G AIK F + RA + E +++ +RH N+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 1396 IV----SSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVAC 1443
++ + F L++ +M L K + ++L ++ +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLK 139
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIG 1501
L Y+H + IIH DLKP N+ +++D + DFG+A+ D MT + T
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD------SEMTGYVVTRW 190
Query: 1502 YMAPEY-GSEGIVSTSGDVYSFGILMMETLTRR 1533
Y APE + + + D++S G +M E +T +
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 40/211 (18%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDAECEVLRRVRHRNLVKII 806
+G+G++G+V A G VAIK F +L A +++ E +L+ +RH N++ ++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAY-RELRLLKHMRHENVIGLL 90
Query: 807 ----SSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
+ F L++ +M L K + K + Q ++ + L Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQF--LVYQMLKGLRYIHAA 147
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE--- 915
+IH DLKP N+ +++D + DFG+++ D E MT + T Y APE
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVIL 198
Query: 916 ----YGSEGIVSTCGDVYSFGILMIETFTRK 942
Y ++ + D++S G +M E T K
Sbjct: 199 NWMRY-TQTV-----DIWSVGCIMAEMITGK 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-13
Identities = 63/231 (27%), Positives = 92/231 (39%), Gaps = 59/231 (25%)
Query: 751 LIGAGSFGSV----YKATLPYGMNVAIKVFNLQLDGAIKSFDAEC-----EVLRRV-RHR 800
++G GSFG V +K T AIK L+ D + D EC VL H
Sbjct: 24 MLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 801 NLVKIISS--CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA------- 851
L + + + F ++EY+ G L H IQ + A
Sbjct: 79 FLTHMFCTFQTKENLF--FVMEYLNGGDL----MYH-----IQSCHKFDLSRATFYAAEI 127
Query: 852 -SALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF 909
L++LH G +++ DLK N+LLD D ++DFG+ K D+ T T T
Sbjct: 128 ILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTP 182
Query: 910 GYMAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMP-----TDEMF 949
Y+APE Y D +SFG+L+ E + P +E+F
Sbjct: 183 DYIAPEILLGQKYN------HSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-13
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 53/228 (23%)
Query: 1342 LLGTGIFSSVYKATFADGTNA--AIKIFSLQEDRALKSFDAECEVM--RRI-----RHRN 1392
+LG G F V+ A F TN AIK L++D L D EC M +R+ H
Sbjct: 24 MLGKGSFGKVFLAEFKK-TNQFFAIKA--LKKDVVLMDDDVEC-TMVEKRVLSLAWEHPF 79
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDI------MIDVACALE 1446
L + + +++Y+ G L Y + + D+ ++ L+
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDLM-------YHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTL-ATIGYM 1503
+LH S I++ DLK N+LLD D H + DFG+ K + + +T T T Y+
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK--ENMLGDAKTNTFCGTPDYI 185
Query: 1504 APE------YGSEGIVSTSGDVYSFGILMMETLTRRKP-----TDDMF 1540
APE Y S D +SFG+L+ E L + P +++F
Sbjct: 186 APEILLGQKYN------HSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-13
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 27/188 (14%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDA-----ECEVLRRVRHRN 801
IG GS+G VY A NVAIK +F D E +L R++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-------DLIDCKRILREITILNRLKSDY 86
Query: 802 LVK---IISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+++ +I F ++LE L+K + + L + I+ ++ +
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF-LTEEHIKTILYNLLLGENF 144
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
+H +IH DLKP+N LL+ D + DFG+++ ++ E L P
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 917 GSEGIVST 924
+ T
Sbjct: 202 KNLKKQLT 209
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-13
Identities = 57/272 (20%), Positives = 102/272 (37%), Gaps = 69/272 (25%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK----IFSLQED--RALKSFDAECEVMRRIRHRNLAK 1395
+G G + VY A N AIK +F D R L+ E ++ R++ + +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 1396 ---IVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
++ F ++L+ L+K + +L + I+ ++ ++H
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH- 146
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD-------------------GVDSM 1491
+ IIH DLKP+N LL+ D + DFG+A+ ++ ++
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 1492 KQTMT--LATIGYMAPE-------YGSEGIVSTSGDVYSFGILMMETLT----------R 1532
K+ +T + T Y APE Y ++ I D++S G + E L
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENY-TKSI-----DIWSTGCIFAELLNMLQSHINDPTN 258
Query: 1533 RKPTDDMFTGEVCLKHWVEESLPDAVT-DVID 1563
R P +F G C + + D
Sbjct: 259 RFP---LFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 44/164 (26%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEV---LRRVRHRNLVKII- 806
+G G G V + A+K+ A EV R + ++V+I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 807 ---SSCSNHGFKALILEYMPQGSL-EKWLYSHKYTLNIQQRL----------DIMIDVAS 852
+ + +++E + G L + IQ R +IM +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSR----------IQDRGDQAFTEREASEIMKSIGE 128
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISK 892
A++YLH + H D+KP N+L + + L+DFG +K
Sbjct: 129 AIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 32/158 (20%)
Query: 1343 LGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIV--- 1397
LG GI V + A+K+ E E+ R + ++ +IV
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVY 80
Query: 1398 -SSCSNPGFKALILQYMPQGSL-------EKWLYSHNYLLNIEQR-LDIMIDVACALEYL 1448
+ + ++++ + G L ++ E+ +IM + A++YL
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-------EREASEIMKSIGEAIQYL 133
Query: 1449 HQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAK 1483
H S +I H D+KP N+L + + L DFG AK
Sbjct: 134 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 2e-13
Identities = 106/707 (14%), Positives = 211/707 (29%), Gaps = 220/707 (31%)
Query: 858 HHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDG---EDSVTQTMTLATFGYMA 913
HH H H D + D ++ D D +D ++
Sbjct: 2 HHHH-----HMDFETGEHQYQYKDILSVFED-AFVDNFDCKDVQDMPKSILSKEEI---- 51
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD--EMFTGETSLKK---WVEESLRLAVT 968
+ I+ + D S + + T K + + F E L+ ++ ++ T
Sbjct: 52 -----DHIIMS-KDAVSGTLRLFWTLLSK-QEEMVQKFVEE-VLRINYKFLMSPIK---T 100
Query: 969 EVVDAELLSSEEEEGAD--LGDSNKLKRLSIS----VNKITGTIPRTVGNLTELRE---L 1019
E +++ E D D+ + ++S K+ R L ELR +
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL-----RQA--LLELRPAKNV 153
Query: 1020 HLHG-----------NNLEAYLYNNKFTGRIP-QNLGNCTLLNFLILRQNQLTGVRLASN 1067
+ G + +Y K +I NL NC ++ +L ++ N
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-YQIDPN 212
Query: 1068 KLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSIC 1127
R I +IQ L S PY L L+L ++
Sbjct: 213 -WTSRSDHSSNIKLRIHSIQ---AELRRLLKSK--PYENCL--LVL----------LNVQ 254
Query: 1128 NASQVILLGLSENLFSGLIPNTFG-NCRQL------QILD---------LSLNHLTTG-S 1170
NA + N F +C+ L Q+ D +SL+H + +
Sbjct: 255 NA-KAW--------------NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 1171 STQGHSFYTSLTNCRY--LRRLVLQNNPLK----GAL----PNSIGN--------LSTSL 1212
+ S +CR L R VL NP + + N L+T +
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 1213 EYFFA--SSTELRG-----AIPVEFEGE--IPSG------GPFVNFTAESLMQNLVLGGS 1257
E E R ++ F IP+ + ++ L
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSV---FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH--KY 414
Query: 1258 SRLQVPPCKTGSSQQSKATRLALRYILPAIATTMAVLALIIILLRRRKRDKSRPTENNLL 1317
S ++ +Q K +P+ I L + K + +++
Sbjct: 415 SLVE---------KQPK----ESTISIPS-----------IYLELKVKLENEYALHRSIV 450
Query: 1318 NTAALRRISYQELR-LATNGFSESNLLGTGIFSSV-Y---KATFADGTNAAIKIFSLQED 1372
+ Y + ++ L +S + + + +F +
Sbjct: 451 D-------HYNIPKTFDSDDLIPPYLDQY-FYSHIGHHLKNIEHPERMTLFRMVF--LDF 500
Query: 1373 RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIE 1432
R L+ ++IRH + A ++ + Q L+ Y Y+ + +
Sbjct: 501 RFLE---------QKIRHDSTA----WNASGSILNTLQQ------LKF--YK-PYICDND 538
Query: 1433 QRLDIMIDVACALEYLHQGYSTSII---HCDL------KPSNVLLDD 1470
+ + +++ L++L + ++I + DL + ++
Sbjct: 539 PKYERLVNA--ILDFLPK-IEENLICSKYTDLLRIALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 6e-10
Identities = 88/555 (15%), Positives = 155/555 (27%), Gaps = 158/555 (28%)
Query: 106 PPHVANLSFLV-SLNISGN----RFHGTL--PNELWLMPRLRIIDLSSNRISGNLF---- 154
V+ L +L +F + N +LM ++ + ++ ++
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT-RMYIEQR 116
Query: 155 DDMCNSLTELESFDVSSNQITGQLPSSL--------------GDCSK--LKRLSVSFNEL 198
D + N ++VS Q +L +L K + ++
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV 176
Query: 199 TGRIPQNI-----GNLTELMELYLNGNNLQGEF-PPTIFNVSSLRVIVLANNSLFGSLPV 252
++ I N + L + P I L +S+ L
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL-- 234
Query: 253 DLCRRLPSLQELN-----LRDCMTTGRIPK--DIGNCTLLNYLGLRDNQLTDFGANNLTG 305
RRL + L + + + ++ C +L L R Q+TDF + T
Sbjct: 235 ---RRLLKSKPYENCLLVLLN-VQNAKAWNAFNLS-CKIL--LTTRFKQVTDFLSAATTT 287
Query: 306 LIPSIIFNN--SNIEVIQLYGNHLS---GNLPSS-TGINLPNLLRLY---------LWGN 350
I + + EV L +L +LP N P L + W N
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-PRRLSIIAESIRDGLATWDN 346
Query: 351 -------NLSGVIPSSICNASKLTVLELSRNLFSGLV---------ANTFGNCRQLQIL- 393
L+ +I SS+ + L E R +F L L ++
Sbjct: 347 WKHVNCDKLTTIIESSL---NVLEPAEY-RKMFDRLSVFPPSAHIPTIL------LSLIW 396
Query: 394 -NLAY-------SQLATGSLSQGQS----------FFSSLTNCRYL---------RYLAI 426
++ ++L SL + Q + Y
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP 456
Query: 427 QTNPWKGILPNSVGNLSKSLEYFY---------AGSCELGGGIPAEFGNLS----NIIAL 473
+T ++P + YFY E F + I
Sbjct: 457 KTFDSDDLIPPYLDQ------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHD 510
Query: 474 SLYQNQLASTIPTTVGKLQNLQGLDLSYNN-IQGSIPSELCQLESLNTLLLQGNALQNQI 532
S N S + T LQ L+ Y I + P L+ NA+ + +
Sbjct: 511 STAWNASGSILNT----LQQLK----FYKPYICDNDPK--------YERLV--NAILDFL 552
Query: 533 PTCLANLTSLRALNL 547
P NL + +L
Sbjct: 553 PKIEENLICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 5e-06
Identities = 68/513 (13%), Positives = 149/513 (29%), Gaps = 172/513 (33%)
Query: 706 IIFIRCCTRNKNLPILENDSLSLATWRRISYQELQRLTDGFSE------------SNLIG 753
+ C + L +L+ +I +D S L+
Sbjct: 187 LNLKNCNSPETVLEMLQK------LLYQID-PNWTSRSDHSSNIKLRIHSIQAELRRLL- 238
Query: 754 AGSFGSVYKATLPYGMNVAIKVFNLQLD-----GAIKSFDAECEVLRRVRHRNLVKIISS 808
Y+ L L L A +F+ C++L + R ++
Sbjct: 239 ---KSKPYENCL------------LVLLNVQNAKAWNAFNLSCKIL--LTTRF-KQVTDF 280
Query: 809 CSNHGFKALILEYMPQG-----SLE---KWLYSHKYTLNIQQR----LDI-MI-----DV 850
S + L++ K+L L + + +I D
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFG 910
+ + H ++CD K + ++ + ++ L K+ D L+ F
Sbjct: 341 LATWDNWKH------VNCD-KLTTII--ESSLNVLEPAEYRKMFD---------RLSVF- 381
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD--EMFTGETSLKKW---VEESLRL 965
P +PT + W ++ + +
Sbjct: 382 ---PP-----------SA-------------HIPTILLSLI--------WFDVIKSDVMV 406
Query: 966 AVTEVVDAELLSSEEEEGA----DLGDSNKLKRLS-ISVNKITGTIPRTVGNLTELRELH 1020
V ++ L+ + +E + K+K + ++++ V + +
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR------SIVDHYNIPKTFD 460
Query: 1021 LHG---NNLEAYLYNNKFTG---RIPQNLGNCTLLN--FLILR--QNQLTGVRLASNKLI 1070
L+ Y Y+ G + ++ TL FL R + ++ A N
Sbjct: 461 SDDLIPPYLDQYFYS--HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA-- 516
Query: 1071 GRIPSMIFNNSNIEAIQLYGNHFSGHLP------SSIGPYLPNLQGLILWGNNLSGIIPS 1124
I N ++ ++ Y + + P ++I +LP + NL I S
Sbjct: 517 ---SGSILN--TLQQLKFYKPYICDNDPKYERLVNAILDFLPKI------EENL---ICS 562
Query: 1125 SICNASQVILLGLSENLFSGLIPNTFGNCRQLQ 1157
+ ++ L ++E+ + +Q+Q
Sbjct: 563 KYTDLLRIAL--MAED--EAIFEEAH---KQVQ 588
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 35/241 (14%), Positives = 83/241 (34%), Gaps = 31/241 (12%)
Query: 144 LSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIP 203
I+ +F D L ++ +T S + S ++ + + + +
Sbjct: 4 QRPTPIN-QVFPD--PGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL- 56
Query: 204 QNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQE 263
+ T L EL+L+ N + + P + +++ L + + N L + L
Sbjct: 57 AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSA----CLSR 110
Query: 264 LNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLY 323
L L + + + L L +R+N+L ++ S +EV+ L+
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSI----------VMLGFLSKLEVLDLH 158
Query: 324 GNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANT 383
GN ++ + L + + L G + +L + ++ ++
Sbjct: 159 GNEITNTGGLT---RLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGRWISPY 212
Query: 384 F 384
+
Sbjct: 213 Y 213
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 45/225 (20%), Positives = 82/225 (36%), Gaps = 26/225 (11%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
L N ++ L +++ + S S + + L L+ L+L++
Sbjct: 17 GLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSH 72
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+Q++ S L + L L++ N K + S L + + EL
Sbjct: 73 NQISD---------LSPLKDLTKLEELSVNRNRLKNLNGIP----SACLSRLFLDNNELR 119
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
+L N+ LS+ N+L S + +G L L+ LDL N I + L +L+
Sbjct: 120 DTDS--LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-GGLTRLKK 173
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWS 562
+N + L G N+ + L N + I + S
Sbjct: 174 VNWIDLTGQKCVNE---PVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 40/217 (18%), Positives = 83/217 (38%), Gaps = 21/217 (9%)
Query: 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCN--SLTELES 166
L+ V N+ + + + ++ + ++ I + T L+
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-----SLAGMQFFTNLKE 67
Query: 167 FDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF 226
+S NQI+ S L D +KL+ LSV+ N L + I + L L+L+ N L+
Sbjct: 68 LHLSHNQISD--LSPLKDLTKLEELSVNRNRLK-NLN-GIPSAC-LSRLFLDNNELRD-- 120
Query: 227 PPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLN 286
++ ++ +L ++ + NN L + + L L+ L+L T + +N
Sbjct: 121 TDSLIHLKNLEILSIRNNKLKS---IVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVN 175
Query: 287 YLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLY 323
++ L + + L + + + I Y
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 32/159 (20%), Positives = 60/159 (37%), Gaps = 35/159 (22%)
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLL 523
+N+ L L NQ++ P + L L+ L ++ N ++ L L L
Sbjct: 59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---L 113
Query: 524 QGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQD 583
N L++ L +L +L L++ +N+L S +
Sbjct: 114 DNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM-------------------------- 145
Query: 584 IGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
+G L L L L GN+++ + + LK + ++ L
Sbjct: 146 LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 50/279 (17%), Positives = 90/279 (32%), Gaps = 62/279 (22%)
Query: 279 IGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI- 337
L +TD + L S ++ +++ S G+
Sbjct: 15 DPGLANAVKQNLGKQSVTDLV--SQKEL--------SGVQNFNGDNSNIQ----SLAGMQ 60
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
NL L+L N +S + S + + +KL L ++RN L L L L
Sbjct: 61 FFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDN 115
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
++L SL + + L L+I+ N K I+
Sbjct: 116 NELRD---------TDSLIHLKNLEILSIRNNKLKSIVM--------------------- 145
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
G LS + L L+ N++ +T + +L+ + +DL+ +L
Sbjct: 146 ------LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYI 197
Query: 518 LNTL-LLQGNALQNQIPTCLANLTSLRALNLSSNRLNST 555
NT+ G + P ++N S + T
Sbjct: 198 TNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 30/209 (14%), Positives = 69/209 (33%), Gaps = 44/209 (21%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
+ ++ +T + L+ ++ + +N+++ + T L
Sbjct: 20 NAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL-----------AGMQFFTNLK 66
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGP-YLPNLQ 1109
L L NQ++ + S + + + +E + + N ++ L
Sbjct: 67 ELHLSHNQISDL------------SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLS 109
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTG 1169
L L N L S+ + + +L + N ++ G +L++LDL N +T
Sbjct: 110 RLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITN- 164
Query: 1170 SSTQGHSFYTSLTNCRYLRRLVLQNNPLK 1198
LT + + + L
Sbjct: 165 --------TGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 41/212 (19%), Positives = 68/212 (32%), Gaps = 35/212 (16%)
Query: 109 VANLSFLVSLNISGNRFH-----GTLPN--ELWL-------------MPRLRIIDLSSNR 148
LS + + N + N EL L + +L + ++ NR
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNR 96
Query: 149 ISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGN 208
+ NL L+ L + +N++ SL L+ LS+ N+L I +G
Sbjct: 97 LK-NLNGIPSACLSRL---FLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGF 148
Query: 209 LTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
L++L L L+GN + + + + I L + PV P L N
Sbjct: 149 LSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV-NEPVK---YQPELYITNTVK 202
Query: 269 CMTTGRI-PKDIGNCTLLNYLGLRDNQLTDFG 299
I P I N +
Sbjct: 203 DPDGRWISPYYISNGGSYVDGCVLWELPVYTD 234
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 36/197 (18%), Positives = 69/197 (35%), Gaps = 39/197 (19%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA------------YLYNN 1033
+ LK L +S N+I+ P + +LT+L EL ++ N L+ +L NN
Sbjct: 59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNN 116
Query: 1034 KFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHF 1093
+ +L + L L +R N+L + M+ S +E + L+GN
Sbjct: 117 ELRD--TDSLIHLKNLEILSIRNNKLKSI------------VMLGFLSKLEVLDLHGNEI 162
Query: 1094 SGHLPSSIGP--YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLI-PNTF 1150
++ G L + + L G + + ++ + ++ I P
Sbjct: 163 -----TNTGGLTRLKKVNWIDLTGQK---CVNEPVKYQPELYITNTVKDPDGRWISPYYI 214
Query: 1151 GNCRQLQILDLSLNHLT 1167
N +
Sbjct: 215 SNGGSYVDGCVLWELPV 231
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 60/185 (32%), Positives = 77/185 (41%), Gaps = 36/185 (19%)
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
+L L L+ + ++ +KLT L L N L A F + +L L LA +QLA
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-- 96
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE 463
SL G F LT L L + N K LP+ V
Sbjct: 97 SLPLG--VFDHLTQ---LDKLYLGGNQLKS-LPSGV------------------------ 126
Query: 464 FGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIP-SELCQLESLNTL 521
F L+ + L L NQL S IP KL NLQ L LS N +Q S+P +L L T+
Sbjct: 127 FDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTI 184
Query: 522 LLQGN 526
L GN
Sbjct: 185 TLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 58/197 (29%), Positives = 81/197 (41%), Gaps = 38/197 (19%)
Query: 356 IPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSL 415
+PS I + L+L + L TF +L LNL Y+QL +LS G F L
Sbjct: 29 VPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ--TLSAG--VFDDL 82
Query: 416 TNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSL 475
T L L + N LP V F +L+ + L L
Sbjct: 83 TE---LGTLGLANNQLAS-LPLGV------------------------FDHLTQLDKLYL 114
Query: 476 YQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELC-QLESLNTLLLQGNALQNQIP 533
NQL S +P+ V +L L+ L L+ N +Q SIP+ +L +L TL L N LQ+
Sbjct: 115 GGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPH 172
Query: 534 TCLANLTSLRALNLSSN 550
L L+ + L N
Sbjct: 173 GAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 43/144 (29%), Positives = 61/144 (42%), Gaps = 2/144 (1%)
Query: 461 PAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL-CQLESLN 519
A F L+ + L+L NQL + L L L L+ N + S+P + L L+
Sbjct: 52 DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLD 110
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579
L L GN L++ LT L+ L L++N+L S F L + + S N L
Sbjct: 111 KLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170
Query: 580 LPQDIGNLKVLTGLYLSGNQLSCS 603
L L + L GNQ CS
Sbjct: 171 PHGAFDRLGKLQTITLFGNQFDCS 194
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 50/167 (29%), Positives = 67/167 (40%), Gaps = 12/167 (7%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL-CQLES 517
GIPA+ L L LA+ T L L L+L YN +Q ++ + + L
Sbjct: 32 GIPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L TL L N L + +LT L L L N+L S F L + + + N L
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 578 GCLPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARN 622
+P L L L LS NQL S+P L L + L N
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 17/168 (10%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
+ E D+ S + ++ +KL L++ +N+L + + +LTEL L L N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN 93
Query: 221 NLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
L P +F +++ L + L N L SLP + RL L+EL L IP
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 280 -GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGN 325
T L L L NQL +P F+ ++ I L+GN
Sbjct: 151 FDKLTNLQTLSLSTNQLQS---------VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 16/165 (9%)
Query: 189 KRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFN-VSSLRVIVLANNSLF 247
++L + L LT+L L L+ N LQ +F+ ++ L + LANN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL- 95
Query: 248 GSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGL 306
SLP+ + L L +L L +P + T L L L NQL
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS--------- 145
Query: 307 IPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGN 350
IP+ F+ +N++ + L N L ++P L L + L+GN
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 44/149 (29%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 104 TIPPHV-ANLSFLVSLNISGNRFHGTLPNELWLMPR-LRIIDLSSNRIS---GNLFDDMC 158
T+ L+ L LN+ N+ TL ++ L + L++N+++ +FD
Sbjct: 49 TLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLASLPLGVFD--- 104
Query: 159 NSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSFNELTGRIPQNI-GNLTELMELY 216
LT+L+ + NQ+ LPS + D +KLK L ++ N+L IP LT L L
Sbjct: 105 -HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLS 161
Query: 217 LNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
L+ N LQ P F + L+ I L N
Sbjct: 162 LSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 39/112 (34%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 521 LLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCL 580
L LQ L LT L LNL N+L + F L + + + N L+ L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-L 98
Query: 581 PQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPE 630
P + +L L LYL GNQL S+PS + L L L L N Q SIP
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 34/148 (22%), Positives = 56/148 (37%), Gaps = 34/148 (22%)
Query: 993 KRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFT- 1036
++L + + T LT+L L+L N L+ L NN+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 1037 --GRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHF 1093
+ +L T L+ L L NQL +PS +F+ + ++ ++L N
Sbjct: 98 LPLGVFDHL---TQLDKLYLGGNQLK-----------SLPSGVFDRLTKLKELRLNTNQL 143
Query: 1094 SGHLPSSIGPYLPNLQGLILWGNNLSGI 1121
+P+ L NLQ L L N L +
Sbjct: 144 QS-IPAGAFDKLTNLQTLSLSTNQLQSV 170
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 38/189 (20%), Positives = 64/189 (33%), Gaps = 45/189 (23%)
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQ 1087
L + T L +L L NQL + + +F++ + + +
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-----------SAGVFDDLTELGTLG 89
Query: 1088 LYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIP 1147
L N + LP + +L L L L GN L L +F L
Sbjct: 90 LANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKS----------------LPSGVFDRLT- 131
Query: 1148 NTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGN 1207
+L+ L L+ N L + + LTN L+ L L N L+ ++P+ +
Sbjct: 132 -------KLKELRLNTNQLQSIP----AGAFDKLTN---LQTLSLSTNQLQ-SVPHGAFD 176
Query: 1208 LSTSLEYFF 1216
L+
Sbjct: 177 RLGKLQTIT 185
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-13
Identities = 57/226 (25%), Positives = 85/226 (37%), Gaps = 58/226 (25%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAEC-----EVLRRV-RHR 800
+IG GS+ V K T A+KV ++ + D + V + H
Sbjct: 16 VIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------S 852
LV + S ++EY+ G L H +Q++ + + A
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDL----MFH-----MQRQRKLPEEHARFYSAEISL 121
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
AL YLH G +I+ DLK NVLLD + L+D+G+ K T T T Y
Sbjct: 122 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNY 176
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMPTDEMFTGE 952
+APE I+ D ++ G+LM EM G
Sbjct: 177 IAPE-----ILRGEDYGFSVDWWALGVLMF----------EMMAGR 207
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-13
Identities = 36/103 (34%), Positives = 50/103 (48%), Gaps = 20/103 (19%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTL- 1497
++ AL YLH II+ DLK NVLLD + H L D+G+ K +G+ T T
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--EGLRPGDTTSTFC 171
Query: 1498 ATIGYMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP 1535
T Y+APE I+ D ++ G+LM E + R P
Sbjct: 172 GTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-13
Identities = 56/226 (24%), Positives = 85/226 (37%), Gaps = 58/226 (25%)
Query: 751 LIGAGSFGSVY----KATLPYGMNVAIKVFNLQLDGAIKSFDAEC-----EVLRRV-RHR 800
+IG GS+ V K T A++V ++ + D + V + H
Sbjct: 59 VIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA--------S 852
LV + S ++EY+ G L H +Q++ + + A
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDL----MFH-----MQRQRKLPEEHARFYSAEISL 164
Query: 853 ALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
AL YLH G +I+ DLK NVLLD + L+D+G+ K T T T Y
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNY 219
Query: 912 MAPEYGSEGIVSTCG-----DVYSFGILMIETFTRKMPTDEMFTGE 952
+APE I+ D ++ G+LM EM G
Sbjct: 220 IAPE-----ILRGEDYGFSVDWWALGVLMF----------EMMAGR 250
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 16/101 (15%)
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTL-AT 1499
++ AL YLH II+ DLK NVLLD + L D+G+ K +G+ T T T
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 1500 IGYMAPEYGSEGIVSTSG-----DVYSFGILMMETLTRRKP 1535
Y+APE I+ D ++ G+LM E + R P
Sbjct: 217 PNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 36/169 (21%), Positives = 65/169 (38%), Gaps = 23/169 (13%)
Query: 140 RIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELT 199
+ L++N + + L +L + S+N+IT + S + + ++ N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 200 GRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRR 257
+ + L L L L N + F +SS+R++ L +N + ++
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDT 151
Query: 258 LPSLQELNLR----DCMTTGRIPKDIGNCTLLNYLG--LRDNQLTDFGA 300
L SL LNL +C NC L +LG LR ++
Sbjct: 152 LHSLSTLNLLANPFNC-----------NCYLA-WLGEWLRKKRIVTGNP 188
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 28/144 (19%), Positives = 56/144 (38%), Gaps = 28/144 (19%)
Query: 462 AEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQ-LESLN 519
F L + ++ N++ + I + + L+ N ++ ++ ++ + LESL
Sbjct: 51 GIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLK 108
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579
TL+L+ N + L+S+R L+L N++ + P F
Sbjct: 109 TLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF------------------- 149
Query: 580 LPQDIGNLKVLTGLYLSGNQLSCS 603
L L+ L L N +C+
Sbjct: 150 -----DTLHSLSTLNLLANPFNCN 168
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 37/178 (20%), Positives = 67/178 (37%), Gaps = 35/178 (19%)
Query: 77 CNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSF----LVSLNISGNRFHGTLPNE 132
C V C ++ ++ IP IP + A L L +G F
Sbjct: 11 CEGTTVDCSNQ--KLN--KIPE-----HIPQYTAELRLNNNEFTVLEATG-IFKK----- 55
Query: 133 LWLMPRLRIIDLSSNRISG---NLFDDMCNSLTELESFDVSSNQITGQLPSSLGD-CSKL 188
+P+LR I+ S+N+I+ F+ + + ++SN++ + + L
Sbjct: 56 ---LPQLRKINFSNNKITDIEEGAFE----GASGVNEILLTSNRLEN-VQHKMFKGLESL 107
Query: 189 KRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
K L + N +T + + L+ + L L N + P F + SL + L N
Sbjct: 108 KTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 31/159 (19%), Positives = 51/159 (32%), Gaps = 35/159 (22%)
Query: 484 IPTTVGKLQNLQGLDLSYNNIQGSIPSE--LCQLESLNTLLLQGNALQNQIPTCLANLTS 541
IP L L+ N + + +L L + N + + +
Sbjct: 30 IPQYT------AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 542 LRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
+ + L+SNRL + F LE L L L N+++
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLES------------------------LKTLMLRSNRIT 118
Query: 602 CSIPSSIGGLKDLTYLALARNGFQGSIPE-AIGSLISLE 639
C S GL + L+L N ++ A +L SL
Sbjct: 119 CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLS 156
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 24/138 (17%), Positives = 50/138 (36%), Gaps = 9/138 (6%)
Query: 307 IPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKL 366
IP I ++L N + + LP L ++ N ++ + + AS +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 367 TVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAI 426
+ L+ N + F L+ L L +++ + F L++ +R L++
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT--CVGNDS--FIGLSS---VRLLSL 136
Query: 427 QTNPWKGILPNSVGNLSK 444
N + P + L
Sbjct: 137 YDNQITTVAPGAFDTLHS 154
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 14/149 (9%)
Query: 1066 SNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSS 1125
SN+ + +IP I ++L N F+ + I LP L+ + N ++ I +
Sbjct: 19 SNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA 76
Query: 1126 ICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCR 1185
AS V + L+ N + F L+ L L N +T SF L++
Sbjct: 77 FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT---CVGNDSF-IGLSS-- 130
Query: 1186 YLRRLVLQNNPLK----GALPNSIGNLST 1210
+R L L +N + GA +++ +LST
Sbjct: 131 -VRLLSLYDNQITTVAPGAF-DTLHSLST 157
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 32/138 (23%), Positives = 46/138 (33%), Gaps = 10/138 (7%)
Query: 259 PSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNI 317
EL L + T I L + +N++TD G S +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA--------SGV 83
Query: 318 EVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377
I L N L N+ L +L L L N ++ V S S + +L L N +
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 378 GLVANTFGNCRQLQILNL 395
+ F L LNL
Sbjct: 143 TVAPGAFDTLHSLSTLNL 160
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 28/145 (19%), Positives = 60/145 (41%), Gaps = 13/145 (8%)
Query: 234 SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRD 292
+ L NN + ++LP L+++N + T I + + +N + L
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 293 NQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNN 351
N+L + + +F +++ + L N ++ + + + I L ++ L L+ N
Sbjct: 91 NRLEN---------VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 352 LSGVIPSSICNASKLTVLELSRNLF 376
++ V P + L+ L L N F
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 24/122 (19%), Positives = 44/122 (36%), Gaps = 31/122 (25%)
Query: 990 NKLKRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEA---------------YLYNN 1033
+L++++ S NKIT I + + E+ L N LE L +N
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 1034 KFTGRIPQNL-GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGN 1091
+ T + + + + L L NQ+T + F+ ++ + L N
Sbjct: 116 RIT-CVGNDSFIGLSSVRLLSLYDNQIT-----------TVAPGAFDTLHSLSTLNLLAN 163
Query: 1092 HF 1093
F
Sbjct: 164 PF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 32/152 (21%), Positives = 49/152 (32%), Gaps = 21/152 (13%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRI 1073
EL L+ N F L + N++T I
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKK--------LPQLRKINFSNNKIT-----------DI 72
Query: 1074 PSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQV 1132
F S + I L N + + L +L+ L+L N ++ + S S V
Sbjct: 73 EEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV 131
Query: 1133 ILLGLSENLFSGLIPNTFGNCRQLQILDLSLN 1164
LL L +N + + P F L L+L N
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 20/131 (15%), Positives = 50/131 (38%), Gaps = 23/131 (17%)
Query: 993 KRLSISVNKITGTIPRTV-GNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
L ++ N+ T + L +LR+++ N + + F G +N
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEG-----ASG---VNE 85
Query: 1052 LILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQG 1110
++L N+L + +F +++ + L N + + + L +++
Sbjct: 86 ILLTSNRLE-----------NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRL 133
Query: 1111 LILWGNNLSGI 1121
L L+ N ++ +
Sbjct: 134 LSLYDNQITTV 144
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-12
Identities = 48/220 (21%), Positives = 93/220 (42%), Gaps = 47/220 (21%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSL-QEDRALKSFDAECEVMRRIR-HRNLAKIVSS 1399
LG G +S V++A + +KI ++ + + E +++ +R N+ +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 1400 CSNPGFK--ALILQYMPQGSLEKWLYSHNYLLNIEQRL---DI---MIDVACALEYLHQG 1451
+P + AL+ +++ ++ Q L DI M ++ AL+Y H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCH-- 147
Query: 1452 YSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE---- 1506
S I+H D+KP NV++D + L D+G+A+ + +A+ + PE
Sbjct: 148 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVD 204
Query: 1507 ---YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Y S D++S G ++ + R++P F G
Sbjct: 205 YQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 61/227 (26%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-----ECEVLRRVR-HRNLVK 804
+G G + V++A + V +K+ +K E ++L +R N++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKKKIKREIKILENLRGGPNIIT 95
Query: 805 I--ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL---DI---MIDVASALEY 856
+ I AL+ E++ ++ + Q L DI M ++ AL+Y
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQ----------LYQTLTDYDIRFYMYEILKALDY 145
Query: 857 LH-HGHPTPVIHCDLKPSNVLLDDDTVA-HLSDFGISKLLDGEDSVTQTMTL--ATFGYM 912
H G ++H D+KP NV++D + L D+G+++ Q + A+ +
Sbjct: 146 CHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFK 197
Query: 913 APE-------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
PE Y D++S G ++ RK P F G
Sbjct: 198 GPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 58/325 (17%), Positives = 100/325 (30%), Gaps = 65/325 (20%)
Query: 109 VANLSFLVSLNISGNRF--HGT--LPNELWLMPRLRIIDLSSNRISGNLFDDMCNSL--- 161
+A S + ++ + + L ++ I LS N I + L
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG----TEAARWLSEN 55
Query: 162 ----TELESFDVSSNQI----------TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIG 207
+LE + S L +L C KL + +S N + +
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 208 NL----TELMELYLNGNNL-------------QGEFPPTIFNVSSLRVIVLANNSLFGSL 250
+ T L LYL+ N L + N LR I+ N L
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175
Query: 251 PVDLCRRL---PSLQELNL-----RDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANN 302
+ + L + + R + + + C L L L+DN T G++
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235
Query: 303 LTGLIPSIIFNNSNIEVIQLYGNHLSGN-----LPSSTGINLPNLLRLYLWGNNLSGVIP 357
L + + N+ + L LS + + + + L L L N +
Sbjct: 236 LAIALK----SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291
Query: 358 SSICNA-----SKLTVLELSRNLFS 377
++ L LEL+ N FS
Sbjct: 292 RTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 50/357 (14%), Positives = 116/357 (32%), Gaps = 75/357 (21%)
Query: 279 IGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI- 337
+ ++ L+ + +T ++ +++ + +++ I L GN + ++ +
Sbjct: 1 MARFSIEG-KSLKLDAITTEDEKSVF----AVLLEDDSVKEIVLSGNTIG--TEAARWLS 53
Query: 338 ----NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQIL 393
+ +L K + E R L L+ +L +
Sbjct: 54 ENIASKKDLEIAEFSDIFT---------GRVKDEIPEALRLLLQALLKCP-----KLHTV 99
Query: 394 NLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGS 453
L+ + + + L+ L +L + N G+ P + ++++L+
Sbjct: 100 RLSDNAF---GPTAQEPLIDFLSKHTPLEHLYLHNN---GLGPQAGAKIARALQELAVNK 153
Query: 454 CELGGGIPAEFGNLSNIIALSLYQNQL----ASTIPTTVGKLQNLQGLDLSYNNI----- 504
+ N + ++ +N+L T + L + + N I
Sbjct: 154 ---------KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 505 QGSIPSELCQLESLNTLLLQGNALQNQ----IPTCLANLTSLRALNLSSNRL-------- 552
+ + L + L L LQ N + + L + +LR L L+ L
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 553 --------NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601
N + L+Y + ++ L + + + L L L+GN+ S
Sbjct: 265 VDAFSKLENIGL--QTLRLQYNEIELDAVRTLKTVIDE---KMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-06
Identities = 37/221 (16%), Positives = 61/221 (27%), Gaps = 49/221 (22%)
Query: 110 ANLSFLVSLNISGNRF-------------HGTLPNELWLMPRLRIIDLSSNRI---SGNL 153
+ + L L + N + + P LR I NR+ S
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 154 FDDMCNSLTELESFDVSSNQITGQ-----LPSSLGDCSKLKRLSVSFNELTGR----IPQ 204
+ S L + + N I + L L C +LK L + N T +
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238
Query: 205 NIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQEL 264
+ + L EL LN L + + N LQ L
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAV-----VDAFSKLEN--------------IGLQTL 279
Query: 265 NLRDCMTTGRIPKDIG-----NCTLLNYLGLRDNQLTDFGA 300
L+ + + L +L L N+ ++
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 7e-05
Identities = 43/259 (16%), Positives = 85/259 (32%), Gaps = 53/259 (20%)
Query: 992 LKRLSISVNKITG----TIPRTVGNLTELRELHLHGNNL-------------------EA 1028
++ S+ ++ IT ++ + ++E+ L GN + A
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKL----IGRIPSMIFNNSNIE 1084
+ + LL +L+ +L VRL+ N + + ++ +E
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 1085 AIQLYGNHFSGHLPSSIGPYL------------PNLQGLILWGNNLSGIIPSSICNA--- 1129
+ L+ N + I L P L+ +I N L
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 1130 -SQVILLGLSENLF-----SGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTN 1183
+ + + +N L+ C++L++LDL N T + +L +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT---HLGSSALAIALKS 242
Query: 1184 CRYLRRLVLQNNPL--KGA 1200
LR L L + L +GA
Sbjct: 243 WPNLRELGLNDCLLSARGA 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 53/259 (20%), Positives = 97/259 (37%), Gaps = 80/259 (30%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK-VFNLQLDGAIKSFDA-----ECEVLRRVRHRNLVK 804
+G GSFG V + + G A+K V D E ++++ + H N++K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ----------DPRYKNRELDIMKVLDHVNIIK 64
Query: 805 IISSCSNHGFKA--------------------------------------LILEYMPQGS 826
++ G + +I+EY+P +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-T 123
Query: 827 LEKWLYSHKYTLNIQQRLDIMID-----VASALEYLHHGHPTPVIHCDLKPSNVLLDDDT 881
L K + + + +I + A+ ++H + H D+KP N+L++
Sbjct: 124 LHK--VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKD 178
Query: 882 -VAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE--YGSEGIVSTCGDVYSFGILMI 936
L DFG +K L ++ + + Y APE G+ + D++S G +
Sbjct: 179 NTLKLCDFGSAKKLI----PSEPSVAYICSRFYRAPELMLGATE-YTPSIDLWSIGCVFG 233
Query: 937 ETFTRKMPTDEMFTGETSL 955
E K P +F+GETS+
Sbjct: 234 ELILGK-P---LFSGETSI 248
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 50/245 (20%), Positives = 83/245 (33%), Gaps = 58/245 (23%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRN---LAKIVS 1398
LGTG F V + + G A+K + E ++M+ + H N L
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDV----------------- 1441
+ + K K +N+ ++ +
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 1442 --------------------ACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFG 1480
A+ ++H S I H D+KP N+L++ D L DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 1481 IAKLLDGVDSMKQTMTLATIGYMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDD 1538
AK L + + + Y APE G+ + S D++S G + E + KP
Sbjct: 188 SAKKLIPSEPS--VAYICSRFYRAPELMLGATE-YTPSIDLWSIGCVFGELIL-GKP--- 240
Query: 1539 MFTGE 1543
+F+GE
Sbjct: 241 LFSGE 245
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 6e-12
Identities = 62/443 (13%), Positives = 139/443 (31%), Gaps = 56/443 (12%)
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSS-NQITGQ-LPSSLGDCSKLKRLSVS 194
L I L ++ + + + S + +SS + L + C LK L +
Sbjct: 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLR 164
Query: 195 FNELTGRIPQNIG----NLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSL 250
+++ + T L+ L ++ + + S+L +V
Sbjct: 165 ESDVDDVSGHWLSHFPDTYTSLVSLNISCLASE-------VSFSALERLV---------- 207
Query: 251 PVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSI 310
R P+L+ L L + ++ + L LG T ++ +
Sbjct: 208 -----TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGG--YTAEVRPDVYSGLSVA 260
Query: 311 IFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGV-IPSSICNASKLTVL 369
+ + + + + + LP+ L L L + + +C KL L
Sbjct: 261 LSGCKELRCLSGFWDAVPAYLPAVYS-VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRL 319
Query: 370 ELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQG---QSFFSSLTNCRYLRYLAI 426
+ + + C+ L+ L + S+ + Q S C L +
Sbjct: 320 WVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLY 379
Query: 427 Q----TNPWKGILPNSVGNLSKSLEYFYAGSCELGG-----------GIPAEFGNLSNII 471
TN ++ ++ ++ F E G A + ++
Sbjct: 380 FCRQMTN--AALI--TIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLR 435
Query: 472 ALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNI-QGSIPSELCQLESLNTLLLQGNALQN 530
LSL + ++ L +++ + L +SL L ++ +
Sbjct: 436 RLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495
Query: 531 Q-IPTCLANLTSLRALNLSSNRL 552
+ + + L ++R+L +SS +
Sbjct: 496 KALLANASKLETMRSLWMSSCSV 518
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 7e-12
Identities = 76/504 (15%), Positives = 148/504 (29%), Gaps = 54/504 (10%)
Query: 137 PRLRIIDLSSNRISG---NLFDDMCNSLTELESFDVSSNQIT--GQLPSSLGDCSKLKRL 191
PR + +L G ++ N+L +L+S ++ + L+ L
Sbjct: 84 PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143
Query: 192 SVSF-NELTGRIPQNIG-NLTELMELYLNGNNLQGEFPPTIFNVS----SLRVIVLANNS 245
+ + T +I + ++ L + ++ + + ++ SL V+
Sbjct: 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTE 203
Query: 246 LFGSLPVDL---CRRLPSLQELNLRDC--MTTGRIPKDIGNCTLLNYLGLRDNQLTDFGA 300
P DL R SL + + D + K N L ++
Sbjct: 204 FAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKY 263
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL-WGNNLSGVIPSS 359
NL S + N + +L L + + +
Sbjct: 264 MNLVFPRKLCRLGLSYM----------GPNEMPILFPFAAQIRKLDLLYALLETEDHCTL 313
Query: 360 ICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQG-----QSFFSS 414
I L VLE + + C+QL+ L + G + + +
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373
Query: 415 LTNCRYLRYLAIQ----TNPWKGILPNSVGNLSKSLEYFYAGSCE------LGGGIPAEF 464
C+ L Y+A+ TN + + NL E L G+ +
Sbjct: 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNL-CDFRLVLLDREERITDLPLDNGVRSLL 432
Query: 465 GNLSNIIALSLYQNQLA---STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ-LESLNT 520
+ + Y Q + N++ + L Y E + +L
Sbjct: 433 IGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQK 492
Query: 521 LLLQGNALQNQIPTCLA-NLTSLRALNLSSNRLNST------IPSTFWSLEYILVVDFSL 573
L ++G + L SLR L + R + T + +W++E I
Sbjct: 493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPE 552
Query: 574 NLLSGCLPQDIGNLKVLTGLYLSG 597
G + + +L L+G
Sbjct: 553 VNQQGEIREMEHPAHILAYYSLAG 576
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 9e-11
Identities = 59/395 (14%), Positives = 122/395 (30%), Gaps = 66/395 (16%)
Query: 250 LPVDLCRRLPSLQELNLRDC---------------MTTGRIPKDIGNCTLLNYLGLRDNQ 294
P L RR P+L+ L L+ T + + N L + R
Sbjct: 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMI 123
Query: 295 LTDFGANNLTGLIPSIIFNNSNIEVIQLYG-NHLSGNLPSSTGINLPNLLRLYLWGNNLS 353
++D + L ++E ++L + + + S + + L + ++ S
Sbjct: 124 VSDLDLDRLAKA------RADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFS 177
Query: 354 GVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFS 413
+ ++ + L++LN ++ A S +
Sbjct: 178 EKDGKWLHELAQ--------------------HNTSLEVLNFYMTEFAKISPK---DLET 214
Query: 414 SLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIAL 473
NCR L + + ++ + + +LE F GS G+P ++ NL L
Sbjct: 215 IARNCRSLVSVKV--GDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL 272
Query: 474 SLYQNQLAS--TIPTTVGKLQNLQGLDLSYNNIQG-SIPSELCQLESLNTLLLQGNALQN 530
+P ++ LDL Y ++ + + + +L L +
Sbjct: 273 CRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDR 332
Query: 531 QIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVL 590
+ L+ L + E LV L L+ + L
Sbjct: 333 GLEVLAQYCKQLKRLRIERGA-----DEQGMEDEEGLVSQRGLIALAQGCQE-------L 380
Query: 591 TGLYLSGNQLS----CSIPSSIGGLKDLTYLALAR 621
+ + + ++ SI + + L D + L R
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDR 415
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-09
Identities = 54/391 (13%), Positives = 111/391 (28%), Gaps = 64/391 (16%)
Query: 87 RHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNR--FHGTLPNELWLMPRLRIIDL 144
R V+DL + L L +L + L + + +++ + +
Sbjct: 120 RRMIVSDLDLDRLAKA--------RADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLM 171
Query: 145 SSNRI---SGNLFDDMCNSLTELESFDVSSNQITGQLPSSL----GDCSKLKRLSVSFNE 197
+ G ++ T LE + + P L +C L + V E
Sbjct: 172 EESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE 231
Query: 198 LT--GRIPQNIGNLTELMELYLNGN----------------------NLQGEFPPTIFNV 233
+ + NL E LN + + P +F
Sbjct: 232 ILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF 291
Query: 234 -SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRD 292
+ +R + L L L ++ P+L+ L R+ + + C L L +
Sbjct: 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351
Query: 293 NQLTDFGANNLTGL----IPSIIFNNSNIEVIQLYGN--------HLSGNLPSSTGINLP 340
+ + + ++ +E + +Y + + L + L
Sbjct: 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411
Query: 341 NLLRLYLWGNN-LSGVIPSSICNASKLTVLELSRN--LFSGLVANTFG-NCRQLQILNLA 396
L R + L + S + KL + L + G ++ + L
Sbjct: 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLG 471
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQ 427
Y + L C L+ L ++
Sbjct: 472 YVGESDEGLM------EFSRGCPNLQKLEMR 496
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 41/286 (14%), Positives = 87/286 (30%), Gaps = 42/286 (14%)
Query: 961 ESLRLAVTEVVDAELLSSEEEEGADLGDSNKLKRLSIS-VNKITGTIPRTVG-NLTELRE 1018
+S+ V D +L ++ L+ L + + T ++ + +++
Sbjct: 115 KSVHFRRMIVSDLDLDR------LAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168
Query: 1019 LHLHGNNLEAYLYNNKFTGRIPQNLG-NCTLLNFLILRQNQLTGVRLASNKLIGRIPSMI 1077
L + ++ G+ L + T L L + + + I R
Sbjct: 169 LLMEESSFSE------KDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR----- 217
Query: 1078 FNNSNIEAIQLYGNHF-SGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLG 1136
N ++ ++++ L G L + ++ ++ LG
Sbjct: 218 -NCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276
Query: 1137 LSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLT-------------- 1182
LS + + P F Q++ LDL L T +L
Sbjct: 277 LSYMGPNEM-PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE 335
Query: 1183 ----NCRYLRRLVLQNNPLKGALPNSIGNLS-TSLEYFFASSTELR 1223
C+ L+RL ++ + + + G +S L EL
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELE 381
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 52/357 (14%), Positives = 113/357 (31%), Gaps = 52/357 (14%)
Query: 182 LGDCSKLKRLSVSFNELTGRIPQNIG-----NLTELMELYLNGNNLQGEFPPTIFNV--- 233
+ L +S N L + + L L+GN+L + + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 234 --SSLRVIVLANNSLFGSLPVDLCRRLPS----LQELNLRDCMTTGRIPKDIG------N 281
+++ + L+ N L +L + L + + L+L + + +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 282 CTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLS--GNLPSSTGINL 339
++ + L LR N L ++ L ++ + +N+ + L GN+L+ + +
Sbjct: 138 ASITS-LNLRGNDLGIKSSDELIQILAA---IPANVNSLNLRGNNLASKNCAELAKFLAS 193
Query: 340 PN--LLRLYLWGNNLSGVIPSSICNA-----SKLTVLELSRNLFSG----LVANTFGNCR 388
+ L L N L + + + + L L N G + + +
Sbjct: 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253
Query: 389 QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEY 448
LQ + L Y + S Q ++ ++ N + + + I P+ +S +
Sbjct: 254 HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK---EIHPSHSIPISNLIRE 310
Query: 449 FYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQ 505
+ N I A N IP L+ + +
Sbjct: 311 LSGKADVPS------LLNQCLIFAQKHQTNIEDLNIPDE------LRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 47/339 (13%), Positives = 92/339 (27%), Gaps = 51/339 (15%)
Query: 259 PSLQELNLRDCMTTGRIPKDIG-----NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFN 313
+ L+L ++ + L L N L ++ L ++ +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA---I 78
Query: 314 NSNIEVIQLYGNHLS--GNLPSSTGINLPN--LLRLYLWGNNLSGVIPSSICNA-----S 364
+N+ + L GN LS + + + L L N+ S S A +
Sbjct: 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138
Query: 365 KLTVLELSRNLFSGLVANTFG-----NCRQLQILNLAYSQLATGSLSQGQSFFSSL-TNC 418
+T L L N ++ + LNL + L + L +
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL---ASKNCAELAKFLASIP 195
Query: 419 RYLRYLAIQTNPW--KGI--LPNSVGNLSKSLEYFYAGSCELGG----GIPAEFGNLSNI 470
+ L + N K L ++ + L G + +L ++
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 471 IALSLYQNQL-------ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQL-----ESL 518
+ L + + + +Q + +D + I S + L
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 519 NTLLLQGNAL-----QNQIPTCLANLTSLRALNLSSNRL 552
+ L L L LR + L
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 9e-10
Identities = 60/367 (16%), Positives = 109/367 (29%), Gaps = 79/367 (21%)
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLS----GNLPSSTG 336
+ L L N L L + +++ + L GN L L
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFAN---TPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 337 INLPNLLRLYLWGNNLSGVIPSSICNA-----SKLTVLELSRNLFSGLVANTFG-----N 386
N+ L L GN LS + +TVL+L N FS ++ F
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 387 CRQLQILNLAYSQLATGSLSQGQSFFSSLTNC-RYLRYLAIQTNPWKGILPNSVGNLSKS 445
+ LNL + L S L + L ++ N + + L+K
Sbjct: 137 PASITSLNLRGNDLGIKS---SDELIQILAAIPANVNSLNLRGN---NLASKNCAELAKF 190
Query: 446 LEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQ--------LASTIPTTVGKLQNLQGL 497
L +++ +L L N LA + + + L
Sbjct: 191 LA-----------------SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVS---L 230
Query: 498 DLSYNNIQGSIPSELCQLE----SLNTLLLQGNALQNQIPTC-------LANLTSLRALN 546
+L N + G L L+ L T+ L + ++N N+ + ++
Sbjct: 231 NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290
Query: 547 LSSNRLNSTIPSTFWSL-EYILVVDFSLNLLS---------GCLPQDIGNLKV---LTGL 593
+ ++ PS + I + ++ S +I +L + L
Sbjct: 291 KNGKEIH---PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRES 347
Query: 594 YLSGNQL 600
+ L
Sbjct: 348 IQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 42/307 (13%), Positives = 96/307 (31%), Gaps = 48/307 (15%)
Query: 138 RLRIIDLSSNRISGNLFDDMCNSL----TELESFDVSSNQITGQ----LPSSLGDC-SKL 188
+ ++LS N + D++ L + S ++S N ++ + L +L +
Sbjct: 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111
Query: 189 KRLSVSFNELTGRIPQNIGNL-----TELMELYLNGNNLQGEFPPTIFNV-----SSLRV 238
L + +N+ + + + L L GN+L + + + +++
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNS 171
Query: 239 IVLANNSLFGSLPVDLCRRLP----SLQELNLRDCMTTGRIPKDIG-----NCTLLNYLG 289
+ L N+L +L + L S+ L+L + + ++ + L
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLN 231
Query: 290 LRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLP------SSTGINLPNLL 343
L N L NL L + +++ + L + + + N+ ++
Sbjct: 232 LCLNCLHGPSLENLKLLKD----SLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
Query: 344 RLYLWGNNLSGVIPSSICNA-----SKLTVLELSRNLFSGLVANTF-----GNCRQLQIL 393
+ G + I N K V L + +L+
Sbjct: 288 LVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRES 347
Query: 394 NLAYSQL 400
L
Sbjct: 348 IQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 37/253 (14%), Positives = 74/253 (29%), Gaps = 54/253 (21%)
Query: 991 KLKRLSISVNKITGTIPRTVG-----NLTELRELHLHGNNLEA----------------- 1028
+ L++S N + + + L+L GN L
Sbjct: 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111
Query: 1029 ---YLYNNKFTGRIPQNLG------NCTLLNFLILRQNQLT--GVRLASNKLIGRIPSMI 1077
L N F+ + ++ + L LR N L L
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITS-LNLRGNDLGIKSSDELIQILAA------ 164
Query: 1078 FNNSNIEAIQLYGNHFS----GHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNA---- 1129
+N+ ++ L GN+ + L + ++ L L N L + +
Sbjct: 165 -IPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 1130 -SQVILLGLSENLFSG----LIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNC 1184
+ V+ L L N G + + + LQ + L + + S Q + + N
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283
Query: 1185 RYLRRLVLQNNPL 1197
+ + + +
Sbjct: 284 QKIILVDKNGKEI 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 55/237 (23%), Positives = 98/237 (41%), Gaps = 71/237 (29%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIK----VFNLQLDGAIKSFDA-----ECEVLRRVR-HR 800
+G G++G V+K+ G VA+K F S DA E +L + H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-------NSTDAQRTFREIMILTELSGHE 69
Query: 801 NLVKIISSCSNHGFKA--LILEYMPQGSLEKWLYSHKYTLNIQQRLD------IMIDVAS 852
N+V +++ + L+ +YM + L + + L+ ++ +
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA--------NILEPVHKQYVVYQLIK 120
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG------------------ISKLL 894
++YLH G ++H D+KPSN+LL+ + ++DFG I++
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 895 DGEDSVTQTMT--LATFGYMAPE-------YGSEGIVSTCGDVYSFGILMIETFTRK 942
+ D +T +AT Y APE Y ++GI D++S G ++ E K
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILCGK 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-11
Identities = 50/234 (21%), Positives = 94/234 (40%), Gaps = 65/234 (27%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIK----IFSLQED--RALKSFDAECEVMRRIR-HRNLA 1394
LG G + V+K+ G A+K F D R + E ++ + H N+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 1395 KIVSSCSNPGFKA--LILQYMPQGSLEKWLYSHNYLLNIEQRLD------IMIDVACALE 1446
+++ + L+ YM + L + + L+ ++ + ++
Sbjct: 73 NLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA--------NILEPVHKQYVVYQLIKVIK 123
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA------------------KLLDGV 1488
YLH S ++H D+KPSN+LL+ + + DFG++ + +
Sbjct: 124 YLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 1489 DSMKQTMT--LATIGYMAPE-------YGSEGIVSTSGDVYSFGILMMETLTRR 1533
D + +T +AT Y APE Y ++GI D++S G ++ E L +
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILCGK 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRH-RNLVKIISSC 809
IG+GSFG +Y T + G VAIK+ + E ++ + ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 810 SNHGFKALILEYMPQG-SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
+ + +++E + G SLE +++ L + + S +EY+H + IH
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 869 DLKPSNVLL---DDDTVAHLSDFGISK 892
D+KP N L+ + ++ DFG++K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 33/147 (22%), Positives = 67/147 (45%), Gaps = 13/147 (8%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRH-RNLAKIVSSC 1400
+G+G F +Y T A G AIK+ ++ E ++ + ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 1401 SNPGFKALILQYMPQG-SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ + ++++ + G SLE + +++ L + + +EY+H S + IH
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 1460 DLKPSNVLL---DDDMVAHLGDFGIAK 1483
D+KP N L+ + ++ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-------ECEVLRRVRHR-- 800
+IG GSFG V KA +VA+K+ +++ E +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM--------VRNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 801 ----NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALE 855
N++ ++ + + + E + +L + + +K+ ++ + L+
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 856 YLHHGHPTPVIHCDLKPSNVLL--DDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGY 911
LH +IHCDLKP N+LL + + DFG S Q + + + Y
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH------QRVYTYIQSRFY 265
Query: 912 MAPE------YGSEGIVSTCGDVYSFGILMIETFT 940
APE Y I D++S G ++ E T
Sbjct: 266 RAPEVILGARY-GMPI-----DMWSLGCILAELLT 294
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-06
Identities = 42/234 (17%), Positives = 74/234 (31%), Gaps = 71/234 (30%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSF----DAECEVMRRIRHRNLAKI 1396
++G G F V KA + A+K+ R K F E ++ +R ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQD---- 154
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYL----------------------LNIEQR 1434
++ + + N++ ++
Sbjct: 155 ------KDNTMNVIH------MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLV 202
Query: 1435 LDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMK 1492
+ L+ LH IIHCDLKP N+LL + + DFG +
Sbjct: 203 RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH------ 253
Query: 1493 QTMT--LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV 1544
Q + + + Y APE D++S G ++ E + TG
Sbjct: 254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAE----------LLTGYP 297
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 18/183 (9%)
Query: 464 FGNLSNIIALSLYQNQLAST--IPTTVGKLQNLQGLDLSYNNIQGSIPS--ELCQLESLN 519
L++I + + + S I N++ L L N + I + EL L L
Sbjct: 37 QNELNSIDQIIANNSDIKSVQGIQYLP----NVRYLALGGNKLH-DISALKELTNLTYLI 91
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579
L GN LQ+ LT+L+ L L N+L S F L + ++ + N L
Sbjct: 92 ---LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS- 147
Query: 580 LPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPE-AIGSLI 636
LP+ + L LT L LS NQL S+P + L L L L +N + S+P+ L
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 205
Query: 637 SLE 639
SL+
Sbjct: 206 SLQ 208
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 159 NSLTELESFDVSSNQITGQLPSSLG---DCSKLKRLSVSFNELTGRIPQNI-GNLTELME 214
L + + N++ + + + L L ++ N+L +P + LT L E
Sbjct: 60 QYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKE 113
Query: 215 LYLNGNNLQGEFPPTIFN-VSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273
L L N LQ P +F+ +++L + LA+N L SLP + +L +L EL+L
Sbjct: 114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQ- 170
Query: 274 RIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGN 325
+P+ + T L L L NQL +P +F+ ++++ I L+ N
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQLKS---------VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 53/165 (32%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVG---KLQNLQGLDLSYNNIQGSIPSELCQ-LESLN 519
L N+ L+L N+L + +L NL L L+ N +Q S+P+ + L +L
Sbjct: 59 IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLK 112
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579
L+L N LQ+ LT+L LNL+ N+L S F L + +D S N L
Sbjct: 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS- 171
Query: 580 LPQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARN 622
LP+ + L L L L NQL S+P + L L Y+ L N
Sbjct: 172 LPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 59/263 (22%), Positives = 97/263 (36%), Gaps = 68/263 (25%)
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
+ L +++ + + + + + + + + ++ L L ++L
Sbjct: 23 KANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH-- 76
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE 463
+S LTN L YL + N + LPN V
Sbjct: 77 DIS----ALKELTN---LTYLILTGNQLQS-LPNGV------------------------ 104
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLESLNTLL 522
F L+N+ L L +NQL S KL NL L+L++N +Q S+P + +L +L L
Sbjct: 105 FDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELD 163
Query: 523 LQGNALQNQIPT-CLANLTSLRALNLSSNRLNSTIPS-TFWSLEYILVVDFSLNLLSGCL 580
L N LQ+ +P LT L+ L L N+L S +P F D
Sbjct: 164 LSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS-VPDGVF---------D---------- 202
Query: 581 PQDIGNLKVLTGLYLSGNQLSCS 603
L L ++L N C+
Sbjct: 203 -----RLTSLQYIWLHDNPWDCT 220
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 24/217 (11%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNN 221
E ++ +T + + + ++ + +++ I L + L L GN
Sbjct: 19 AETIKANLKKKSVT-DAVTQNEL-NSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNK 74
Query: 222 LQ--GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
L +++L ++L N L SLP + +L +L+EL L + +P +
Sbjct: 75 LHDISALK----ELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGV 128
Query: 280 GNC-TLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVIQLYGNHLSGNLPSSTGI 337
+ T L YL L NQL +P +F+ +N+ + L N L +LP
Sbjct: 129 FDKLTNLTYLNLAHNQLQS---------LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRN 374
L L L L+ N L V + L + L N
Sbjct: 179 KLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 65/227 (28%), Positives = 86/227 (37%), Gaps = 44/227 (19%)
Query: 287 YLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVI-------QLYGNHLSGNLPSSTGI-- 337
L+ +TD N I II NNS+I+ + + L GN
Sbjct: 23 KANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALK 82
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
L NL L L GN L + + L L L N L F L LNLA+
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAH 142
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+QL SL +G F LTN L L + N + LP V
Sbjct: 143 NQLQ--SLPKG--VFDKLTN---LTELDLSYNQLQS-LPEGV------------------ 176
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNN 503
F L+ + L LYQNQL S +P V +L +LQ + L ++N
Sbjct: 177 ------FDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWL-HDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 43/141 (30%), Positives = 70/141 (49%), Gaps = 18/141 (12%)
Query: 139 LRIIDLSSNR---ISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVS 194
L + L+ N+ + +FD LT L+ + NQ+ LP + D + L L+++
Sbjct: 87 LTYLILTGNQLQSLPNGVFD----KLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 195 FNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIFN-VSSLRVIVLANNSLFGSLPV 252
N+L +P+ + LT L EL L+ N LQ P +F+ ++ L+ + L N L S+P
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPD 198
Query: 253 DLCRRLPSLQELNLR----DC 269
+ RL SLQ + L DC
Sbjct: 199 GVFDRLTSLQYIWLHDNPWDC 219
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 37/122 (30%)
Query: 991 KLKRLSISVNKITGTIPRTVGN-LTELRELHLHGNNLEA---------------YLYNNK 1034
LK L + N++ ++P V + LT L L+L N L++ L N+
Sbjct: 110 NLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ 168
Query: 1035 FTGRIPQ----NLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLY 1089
+P+ L T L L L QNQL +P +F+ ++++ I L+
Sbjct: 169 LQ-SLPEGVFDKL---TQLKDLRLYQNQLK-----------SVPDGVFDRLTSLQYIWLH 213
Query: 1090 GN 1091
N
Sbjct: 214 DN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 46/190 (24%), Positives = 72/190 (37%), Gaps = 19/190 (10%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFL-ILRQNQLTGVRLASNKL--I 1070
E + +L ++ + N+ N + + I + + L NKL I
Sbjct: 19 AETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI 78
Query: 1071 GRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNA 1129
+N+ + L GN LP+ + L NL+ L+L N L + P + +
Sbjct: 79 S-----ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSL-PDGVFDK 131
Query: 1130 -SQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLR 1188
+ + L L+ N L F L LDLS N L S +G + LT L+
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ--SLPEG--VFDKLTQ---LK 184
Query: 1189 RLVLQNNPLK 1198
L L N LK
Sbjct: 185 DLRLYQNQLK 194
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 3e-11
Identities = 31/141 (21%), Positives = 57/141 (40%), Gaps = 10/141 (7%)
Query: 75 SVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELW 134
S + V L + + L T+ H+ L + L++S NR LP L
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 135 LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPS--SLGDCSKLKRLS 192
+ L ++ S N + N+ D +L L+ + +N++ Q + L C +L L+
Sbjct: 484 ALRCLEVLQASDNALE-NV--DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLN 539
Query: 193 VSFNELTGRIPQNIGNLTELM 213
+ N L + L E++
Sbjct: 540 LQGNSLC-QEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 5e-11
Identities = 48/340 (14%), Positives = 101/340 (29%), Gaps = 38/340 (11%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
L+ + S + + L + ++ T ++ + + + +
Sbjct: 255 ACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVW-LCDLPAASLNDQL 313
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
+ + S + ++ C S+ + S L +C+
Sbjct: 314 PQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKE 373
Query: 421 LRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480
L+ L P ++ L ++L+ L + + L +++
Sbjct: 374 LQEL----EPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKF 429
Query: 481 ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLT 540
+ +++ L L++ ++ ++ L QL + L L N L+ +P LA L
Sbjct: 430 LLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALR 486
Query: 541 SLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQL 600
L L S N L + + G + NL L L L N+L
Sbjct: 487 CLEVLQASDNALEN---------------------VDG-----VANLPRLQELLLCNNRL 520
Query: 601 SCSIPS--SIGGLKDLTYLALARNGFQGSIPEAIGSLISL 638
+ + L L L N L +
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 8e-11
Identities = 39/236 (16%), Positives = 84/236 (35%), Gaps = 33/236 (13%)
Query: 106 PPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDM-------- 157
A L +S + L +EL L+ ++ + + M
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 158 ----CNSLTELESFD--------VSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQN 205
+ L++ D ++ + + + ++ L ++ +LT + +
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-H 458
Query: 206 IGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELN 265
+ L + L L+ N L+ PP + + L V+ ++N+L ++ LP LQEL
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELL 514
Query: 266 LRD-CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVI 320
L + + + + +C L L L+ N L G+ + ++ I
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-----EEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 1e-10
Identities = 40/215 (18%), Positives = 73/215 (33%), Gaps = 15/215 (6%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNN--LEAYLYNNKFTGRIPQN 1042
D +L R +SV K T + + + EL+EL L L + +
Sbjct: 344 DSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEK 402
Query: 1043 LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIG 1102
+ + + +K + + +++ + L + + +
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLE 460
Query: 1103 PYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLS 1162
L + L L N L + P ++ + +L S+N + N +LQ L L
Sbjct: 461 -QLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLC 516
Query: 1163 LNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
N L ++ Q L +C L L LQ N L
Sbjct: 517 NNRLQQSAAIQ------PLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 1e-05
Identities = 24/99 (24%), Positives = 35/99 (35%), Gaps = 15/99 (15%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA-------------YLYNNKFTG 1037
+ L +S N++ +P + L L L N LE L NN+
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQ 522
Query: 1038 -RIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPS 1075
Q L +C L L L+ N L +L +PS
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 3e-04
Identities = 33/180 (18%), Positives = 55/180 (30%), Gaps = 48/180 (26%)
Query: 988 DSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCT 1047
D + L +K ++R LHL +L + +L
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT----------VLC-HLEQLL 463
Query: 1048 LLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPN 1107
L+ L L N+L +P + +E +Q N ++ LP
Sbjct: 464 LVTHLDLSHNRLR-----------ALPPALAALRCLEVLQASDNALE-NVDGV--ANLPR 509
Query: 1108 LQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLT 1167
LQ L+L N L + + P +C +L +L+L N L
Sbjct: 510 LQELLLCNNRLQQ---------------------SAAIQP--LVSCPRLVLLNLQGNSLC 546
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 3e-11
Identities = 37/262 (14%), Positives = 72/262 (27%), Gaps = 72/262 (27%)
Query: 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKV--------FNLQLDGAIKSFDAECEVL 794
T+ IG G FG V++ + VAIK+ N + E +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 795 RRV---------RHRNLVKIISSCSNHG------------------------------FK 815
+ + R + + S G
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 816 ALILEYMPQG-SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSN 874
++LE+ G LE+ ++ I+ + ++L H DL N
Sbjct: 138 FIVLEFEFGGIDLEQMRTKL---SSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192
Query: 875 VLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGIL 934
VLL ++ L K + T+ + G + ++
Sbjct: 193 VLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDY----TLSRLERDGIVV 238
Query: 935 MIETFTRKMPTDEMFTGETSLK 956
+ + ++FTG+ +
Sbjct: 239 FCDVSMDE----DLFTGDGDYQ 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 33/200 (16%), Positives = 56/200 (28%), Gaps = 54/200 (27%)
Query: 1332 LATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRA--------LKSFDAECE 1383
L T +G G+F V++ AD T AIKI +++ + E
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 1384 VMRRI---------RHRNLAKIVSSCSNPG------------------------------ 1404
+ + + R + S G
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 1405 FKALILQYMPQG-SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKP 1463
++L++ G LE+ L ++ I+ + +L H DL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 1464 SNVLLDDDMVAHLGDFGIAK 1483
NVLL + L K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 44/247 (17%), Positives = 95/247 (38%), Gaps = 61/247 (24%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-------ECEVLRRVR---- 798
+G G F +V+ A + +VA+K+ ++ E ++L+RV
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKI--------VRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 799 -------HRNLVKIISSCSNHGFKA----LILEYMPQGSLEKWLYSHKYT-LNIQQRLDI 846
+++K++ ++ G ++ E + + +L + +++ + + I
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQI 136
Query: 847 MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH------LSDFGISKLLDGEDSV 900
+ L+Y+H +IH D+KP NVL++ ++D G + D
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--- 191
Query: 901 TQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETS 954
T ++ T Y +PE +G G D++S L+ E T +F +
Sbjct: 192 -YTNSIQTREYRSPEVLLGAPWGC-GA-----DIWSTACLIFELITGDF----LFEPDEG 240
Query: 955 LKKWVEE 961
++
Sbjct: 241 HSYTKDD 247
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-09
Identities = 51/239 (21%), Positives = 91/239 (38%), Gaps = 63/239 (26%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSF----DAECEVMRRIRHRNLAKI 1396
LG G FS+V+ A + T+ A+KI R K + + E ++++R+ + K
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTK- 79
Query: 1397 VSSCSNPGFKALILQYM-------PQG------------SLEKWLYSHNYL-LNIEQRLD 1436
+ IL+ + P G +L + + + + +
Sbjct: 80 ----EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH------LGDFGIAKLLDGVDS 1490
I + L+Y+H+ IIH D+KP NVL++ + D G A D
Sbjct: 136 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--- 190
Query: 1491 MKQTMTLATIGYMAPE------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
T ++ T Y +PE +G D++S L+ E +T D +F +
Sbjct: 191 -HYTNSIQTREYRSPEVLLGAPWG------CGADIWSTACLIFELITG----DFLFEPD 238
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 38/146 (26%), Positives = 52/146 (35%), Gaps = 9/146 (6%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
GIP L L+ NQ+ P L NL+ L L N + ++P + L
Sbjct: 37 GIPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L L L N L L L+ L + N+L +P L ++ + N L
Sbjct: 90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCS 603
L LT YL GN C
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGNPWDCE 174
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 14/139 (10%)
Query: 189 KRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFN-VSSLRVIVLANNSLF 247
+ L + N++T P +L L ELYL N L P +F+ ++ L V+ L N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL- 100
Query: 248 GSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLI 307
LP + RL L+EL + T +P+ I T L +L L NQL I
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS---------I 150
Query: 308 PSIIFNN-SNIEVIQLYGN 325
P F+ S++ L+GN
Sbjct: 151 PHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 45/160 (28%), Positives = 60/160 (37%), Gaps = 35/160 (21%)
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTS 541
+ IPT Q L L N I P L +L L L N L +LT
Sbjct: 36 AGIPTNA------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89
Query: 542 LRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI-GNLKVLTGLYLSGNQL 600
L L+L +N+L LP + L L L++ N+L
Sbjct: 90 LTVLDLGTNQLTV-------------------------LPSAVFDRLVHLKELFMCCNKL 124
Query: 601 SCSIPSSIGGLKDLTYLALARNGFQGSIPE-AIGSLISLE 639
+ +P I L LT+LAL +N + SIP A L SL
Sbjct: 125 T-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLT 162
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 117 SLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS---GNLFDDMCNSLTELESFDVSSNQ 173
L + N+ P + L+ + L SN++ +FD SLT+L D+ +NQ
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD----SLTQLTVLDLGTNQ 99
Query: 174 ITGQLPSSLGDC-SKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF- 231
+T LPS++ D LK L + N+LT +P+ I LT L L L+ N L+ P F
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFD 156
Query: 232 NVSSLRVIVLANN 244
+SSL L N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 40/184 (21%), Positives = 61/184 (33%), Gaps = 59/184 (32%)
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
LYL N ++ + P + L L L N L F + QL +L+L +QL
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV- 102
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE 463
LP++V
Sbjct: 103 -------------------------------LPSAV------------------------ 107
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLL 522
F L ++ L + N+L +P + +L +L L L N ++ SIP +L SL
Sbjct: 108 FDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAY 165
Query: 523 LQGN 526
L GN
Sbjct: 166 LFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 33/132 (25%), Positives = 50/132 (37%), Gaps = 38/132 (28%)
Query: 993 KRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFTG 1037
+ L + N+IT P +L L+EL+L N L A L N+ T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 1038 RIPQ----NLGNCTLLNFLILRQNQLT----GV---------RLASNKLIGRIPSMIFNN 1080
+P L + L + N+LT G+ L N+L IP F+
Sbjct: 102 VLPSAVFDRLVHLKELF---MCCNKLTELPRGIERLTHLTHLALDQNQL-KSIPHGAFDR 157
Query: 1081 -SNIEAIQLYGN 1091
S++ L+GN
Sbjct: 158 LSSLTHAYLFGN 169
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 37/149 (24%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRH-RNLVKIISSC 809
IG G+FG + L VAIK+ + E +++ + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 810 SNHGFKALILEYMPQG-SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
+ A++LE + G SLE T +++ L I I + S +EY+H + +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129
Query: 869 DLKPSNVLL-----DDDTVAHLSDFGISK 892
D+KP N L+ V H+ DF ++K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 15/149 (10%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRH-RNLAKIVSSC 1400
+G G F + AIK+ E +++ + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 1401 SNPGFKALILQYMPQG-SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ A++L+ + G SLE + +++ L I I + +EY+H S ++I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 1460 DLKPSNVLL-----DDDMVAHLGDFGIAK 1483
D+KP N L+ V H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 27/165 (16%), Positives = 60/165 (36%), Gaps = 29/165 (17%)
Query: 752 IGAGSFGSVYKAT---------LPYGMNVAIKV--FNLQLDGAIKSFDAECEV------- 793
+ G +Y+A P ++K+ + +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 794 -LRRVRHRNLVKIISSCSNHG-FKALILEYMPQG-SLEK-WLYSHKYTLNIQQRLDIMID 849
L + + + ++ L+L + G SL+ S K+ L+ + L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLL--DDDTVAHLSDFGISK 892
+ ALE+LH +H ++ N+ + +D + L+ +G +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 5e-05
Identities = 25/165 (15%), Positives = 52/165 (31%), Gaps = 29/165 (17%)
Query: 1343 LGTGIFSSVYKAT---------FADGTNAAIKI---------FSLQEDRALKSFDAECEV 1384
+Y+A ++K+ RA K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 1385 -MRRIRHRNLAKIVSSCSNPG-FKALILQYMPQG-SLEK-WLYSHNYLLNIEQRLDIMID 1440
+ + + + ++ L+L + G SL+ S ++L+ L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLL--DDDMVAHLGDFGIAK 1483
+ ALE+LH +H ++ N+ + +D L +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 28/148 (18%), Positives = 57/148 (38%), Gaps = 13/148 (8%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRH-RNLVKIISSC 809
IG GSFG +++ T L VAIK E + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
L+++ + SLE L +++ + + ++ +H +++ D
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 131
Query: 870 LKPSNVLL-----DDDTVAHLSDFGISK 892
+KP N L+ + + ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 25/148 (16%), Positives = 54/148 (36%), Gaps = 13/148 (8%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRH-RNLAKIVSSC 1400
+G G F +++ T + AIK + D E + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
L++ + SLE L +++ + ++ +H S+++ D
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 1461 LKPSNVLLDDDM-----VAHLGDFGIAK 1483
+KP N L+ + ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 43/222 (19%)
Query: 742 LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDA-------ECEV 793
D + +LIG GSFG V KA VAIK+ IK+ A E +
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKI--------IKNKKAFLNQAQIEVRL 103
Query: 794 LRRVRHR------NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDI 846
L + +V + L+ E + +L L + + +++
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKF 162
Query: 847 MIDVASALEYLHHGHPTPVIHCDLKPSNVLL--DDDTVAHLSDFGISKLLDGEDSVTQTM 904
+ +AL +L + +IHCDLKP N+LL + + DFG S G+
Sbjct: 163 AQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQ--- 217
Query: 905 TLATFGYMAPE------YGSEGIVSTCGDVYSFGILMIETFT 940
+ + Y +PE Y I D++S G +++E T
Sbjct: 218 YIQSRFYRSPEVLLGMPY-DLAI-----DMWSLGCILVEMHT 253
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 51/241 (21%), Positives = 84/241 (34%), Gaps = 81/241 (33%)
Query: 1341 NLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSF----DAECEVMRRIRHRNLAK 1395
+L+G G F V KA + AIKI + K+F E ++ + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHD--- 111
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL----------------------LNIEQ 1433
K I+ L++ N+L +++
Sbjct: 112 -------TEMKYYIVH------LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL 158
Query: 1434 RLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSM 1491
+ AL +L SIIHCDLKP N+LL + + + DFG + L
Sbjct: 159 TRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----- 212
Query: 1492 KQTMT--LATIGYMAPE------YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
Q + + + Y +PE Y + D++S G +++E M TGE
Sbjct: 213 -QRIYQYIQSRFYRSPEVLLGMPY------DLAIDMWSLGCILVE----------MHTGE 255
Query: 1544 V 1544
Sbjct: 256 P 256
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-10
Identities = 51/245 (20%), Positives = 88/245 (35%), Gaps = 71/245 (28%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKS----FDA---ECEVLRRVRHR-- 800
+G G+FG V + A+KV +++ + E ++L+++++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKV--------VRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 801 ---NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEY 856
N+VK + LI E + SL + + + Y +I+ I++ AL Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT----LATFG-- 910
L + H DLKP N+LLDD + + +T + L FG
Sbjct: 153 LRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 911 ---------------YMAPE------YGSEGIVSTCGDVYSFG-ILMIETFTRKMPTDEM 948
Y APE + D++SFG +L E+
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGW-DVSS-----DMWSFGCVLA-----------EL 252
Query: 949 FTGET 953
+TG
Sbjct: 253 YTGSL 257
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 34/153 (22%), Positives = 61/153 (39%), Gaps = 44/153 (28%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSF-DA---ECEVMRRIR------- 1389
+G G F V + A+K+ R +K + + E +++++I+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 1390 ----------HRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL-LNIEQRLDIM 1438
+ + ++ F+ L SL + + +NY +IE
Sbjct: 97 NIVKYHGKFMYYDHMCLI-------FEPLGP------SLYEIITRNNYNGFHIEDIKLYC 143
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD 1471
I++ AL YL + S+ H DLKP N+LLDD
Sbjct: 144 IEILKALNYLRK---MSLTHTDLKPENILLDDP 173
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 8e-10
Identities = 30/171 (17%), Positives = 62/171 (36%), Gaps = 39/171 (22%)
Query: 751 LIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDA-------ECEVLRRVRHRNLV 803
IG G FG +Y A + +V +K + E + +R +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSD-----APCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 804 KIISSCSNHG-------------------FKALILEYMPQG-SLEKWLYSHKYTLNIQQR 843
+ ++ +I++ G L+K ++ + +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV 154
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD--DDTVAHLSDFGISK 892
L + + + LEY+H +H D+K SN+LL+ + +L D+G++
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 28/171 (16%), Positives = 62/171 (36%), Gaps = 39/171 (22%)
Query: 1342 LLGTGIFSSVYKATFADGTNAAIKI-----FSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
+G G F +Y A + ++ L + E + +R +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT---ELKFYQRAAKPEQIQK 98
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLL------NIEQRLDI------------- 1437
+ + +Y G +K S+ +++ ++++ +
Sbjct: 99 WIRTRKLKYLG-VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQL 157
Query: 1438 ---MIDVACALEYLHQGYSTSIIHCDLKPSNVLLD--DDMVAHLGDFGIAK 1483
++D+ LEY+H +H D+K SN+LL+ + +L D+G+A
Sbjct: 158 SLRILDI---LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 1e-09
Identities = 32/146 (21%), Positives = 64/146 (43%), Gaps = 11/146 (7%)
Query: 752 IGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV-KIISSC 809
IG+GSFG +Y T + VAIK+ + E ++ R ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ L+++ + SLE L+++ L + + + +E++H +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRD 128
Query: 870 LKPSNVLL---DDDTVAHLSDFGISK 892
+KP N L+ ++ DFG++K
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 32/146 (21%), Positives = 64/146 (43%), Gaps = 11/146 (7%)
Query: 1343 LGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSC 1400
+G+G F +Y T AIK+ +++ E ++ R ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
+ L++ + SLE + L+++ L + + +E++H S S +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 1461 LKPSNVLLDDDMVAH---LGDFGIAK 1483
+KP N L+ A+ + DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 29/127 (22%), Positives = 36/127 (28%), Gaps = 26/127 (20%)
Query: 478 NQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCL 536
A + +NL L + + L L L L + + L+ P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLS 596
L LNLS N L S T L L L LS
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLS-------------------------LQELVLS 111
Query: 597 GNQLSCS 603
GN L CS
Sbjct: 112 GNPLHCS 118
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 9/95 (9%)
Query: 338 NLPNLLRLYLWGNNLSGVIPS-SICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396
NL LY+ + + +L L + ++ + + F +L LNL+
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
++ L + LS L+ L+ L + NP
Sbjct: 89 FNALES--LSWK--TVQGLS----LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 19/113 (16%), Positives = 30/113 (26%), Gaps = 4/113 (3%)
Query: 185 CSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLAN 243
L + + ++ L ELY+ + LR + +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 244 NSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT 296
+ L + D P L LNL + L L L N L
Sbjct: 66 SGL-RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 1/101 (0%)
Query: 123 NRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSL 182
+ L L + + + + +L L EL + + + + P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 183 GDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223
+L RL++SFN L + L EL L+GN L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 2e-06
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 460 IPAEFGNLSNIIALSLYQNQLASTIPT-TVGKLQNLQGLDLSYNNIQGSIPSE-LCQLES 517
N+ L + Q + + L L+ L + + ++ + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLN 553
L+ L L NAL++ + L SL+ L LS N L+
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 19/89 (21%), Positives = 29/89 (32%), Gaps = 1/89 (1%)
Query: 307 IPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKL 366
+ N+ + + +L L L L + + L V P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 367 TVLELSRNLFSGLVANTFGNCRQLQILNL 395
+ L LS N L T LQ L L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLS-LQELVL 110
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 21/98 (21%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLL 523
L + L++ ++ L P L L+LS+N ++ S+ + Q SL L+L
Sbjct: 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110
Query: 524 QGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFW 561
GN L C L L+
Sbjct: 111 SGNPL-----HCSCALRWLQRWEEEGLGGVPEQKLQCH 143
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 18/97 (18%), Positives = 32/97 (32%), Gaps = 3/97 (3%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNE-LWLMPRLRIIDLSSNRISGNLFDDMCNSLT 162
H+ L L I + L L + LR + + + + + D +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 163 ELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELT 199
L ++S N + L L+ L +S N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 4e-05
Identities = 18/111 (16%), Positives = 32/111 (28%), Gaps = 23/111 (20%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPR-TVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQN- 1042
L + L L I + + + L ELR L + + L + +
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR----------FVAPDA 75
Query: 1043 LGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHF 1093
L+ L L N L + +++ + L GN
Sbjct: 76 FHFTPRLSRLNLSFNALE-----------SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 26/141 (18%), Positives = 45/141 (31%), Gaps = 33/141 (23%)
Query: 1057 NQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGN 1116
+ +G+R + + + N+ + + HL L L+ L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 1117 NLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHS 1176
L + P+ F +L L+LS N L + S
Sbjct: 67 GLR-FVA-----------------------PDAFHFTPRLSRLNLSFNALESLS----WK 98
Query: 1177 FYTSLTNCRYLRRLVLQNNPL 1197
L+ L+ LVL NPL
Sbjct: 99 TVQGLS----LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 16/112 (14%), Positives = 34/112 (30%), Gaps = 24/112 (21%)
Query: 532 IPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLT 591
L +L L + + + + +D+ L L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLE-----------------------LRDLRGLGELR 59
Query: 592 GLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEI 643
L + + L P + L+ L L+ N + S+ +SL++ +
Sbjct: 60 NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 21/115 (18%), Positives = 34/115 (29%), Gaps = 22/115 (19%)
Query: 1005 TIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRL 1064
+ L EL++ +L + LG L L + ++ L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDL-----RGLGE---LRNLTIVKSGLR---- 69
Query: 1065 ASNKLIGRIPSMIFNN-SNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNL 1118
+ F+ + + L N L L LQ L+L GN L
Sbjct: 70 -------FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPL 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 35/147 (23%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
GIP ++ L L NQ + +P + ++L +DLS N I ++ ++ +
Sbjct: 28 GIPR------DVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIP-STFWSLEYILVVDFSLNLL 576
L TL+L N L+ P L SLR L+L N ++ +P F
Sbjct: 80 LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAF---------------- 122
Query: 577 SGCLPQDIGNLKVLTGLYLSGNQLSCS 603
+L L+ L + N L C
Sbjct: 123 --------NDLSALSHLAIGANPLYCD 141
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 5/104 (4%)
Query: 521 LLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCL 580
L L GN +P L+N L ++LS+NR+++ +F ++ +L + S N L C+
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 581 PQDI-GNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARN 622
P LK L L L GN +S +P L L++LA+ N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 140 RIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSFNEL 198
+ L N+ + L ++ L D+S+N+I+ L + ++L L +S+N L
Sbjct: 34 TELYLDGNQFT--LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL 90
Query: 199 TGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
IP L L L L+GN++ P F ++S+L + + N
Sbjct: 91 R-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 28/114 (24%), Positives = 51/114 (44%), Gaps = 10/114 (8%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
++ + NQ T +P L + L + +S N ++ + N+T+L+ L L+ N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
Query: 221 NLQGEFPPTIFN-VSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR----DC 269
L+ PP F+ + SLR++ L N + +P L +L L + C
Sbjct: 89 RLR-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGANPLYC 140
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 9/110 (8%)
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
LYL GN + ++P + N LT+++LS N S L +F N QL L L+Y++L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-- 91
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGS 453
+ F L + LR L++ N + P N +L + G+
Sbjct: 92 CIPPRT--FDGLKS---LRLLSLHGNDISVV-PEGAFNDLSALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 22/104 (21%), Positives = 37/104 (35%), Gaps = 23/104 (22%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNL-GNCTL 1048
L + +S N+I+ ++ N+T+L L L N L IP
Sbjct: 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC----------IPPRTFDGLKS 103
Query: 1049 LNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGN 1091
L L L N ++ +P FN+ S + + + N
Sbjct: 104 LRLLSLHGNDIS-----------VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 117 SLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG---NLFDDMCNSLTELESFDVSSNQ 173
L + GN+F +P EL L +IDLS+NRIS F ++T+L + +S N+
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFS----NMTQLLTLILSYNR 89
Query: 174 ITGQLPSSLGD-CSKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGN 220
+ +P D L+ LS+ N+++ +P+ +L+ L L + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 28/90 (31%), Positives = 38/90 (42%), Gaps = 8/90 (8%)
Query: 1109 QGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTT 1168
L L GN + ++P + N + L+ LS N S L +F N QL L LS N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 1169 GSSTQGHSFYTSLTNCRYLRRLVLQNNPLK 1198
+F L + LR L L N +
Sbjct: 92 --CIPPRTF-DGLKS---LRLLSLHGNDIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 32/148 (21%), Positives = 53/148 (35%), Gaps = 35/148 (23%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELC-QLE 516
IP + L L N+L + G+L +L L+L N + I
Sbjct: 26 DIPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 517 SLNTLLLQGNALQNQIPT-CLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNL 575
+ L L N ++ I L L+ LNL N+++ +P +F +
Sbjct: 79 HIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSF---------E----- 123
Query: 576 LSGCLPQDIGNLKVLTGLYLSGNQLSCS 603
+L LT L L+ N +C+
Sbjct: 124 ----------HLNSLTSLNLASNPFNCN 141
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 140 RIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSFNEL 198
+ L+ N + D + L L ++ NQ+TG + + + S ++ L + N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90
Query: 199 TGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
I + L +L L L N + P F +++SL + LA+N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 7/114 (6%)
Query: 318 EVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377
+ L N L LP+L++L L N L+G+ P++ AS + L+L N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 378 GLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPW 431
+ F QL+ LNL +Q++ + G F L + L L + +NP+
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS--CVMPGS--FEHLNS---LTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 32/145 (22%), Positives = 52/145 (35%), Gaps = 25/145 (17%)
Query: 184 DCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFN-VSSLRVIVLA 242
DC+ + L IP++I T EL LN N L +F + L + L
Sbjct: 14 DCTG-RGLK--------EIPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELK 62
Query: 243 NNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGAN 301
N L + + +QEL L + I + L L L DNQ++
Sbjct: 63 RNQL-TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC---- 116
Query: 302 NLTGLIPSIIFNN-SNIEVIQLYGN 325
+ F + +++ + L N
Sbjct: 117 -----VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 22/104 (21%), Positives = 41/104 (39%), Gaps = 21/104 (20%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
L +L + N++TG P + ++EL L N ++ + N F G L
Sbjct: 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLG--------LHQLK 105
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGNHF 1093
L L NQ++ + F + +++ ++ L N F
Sbjct: 106 TLNLYDNQIS-----------CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 27/122 (22%), Positives = 36/122 (29%), Gaps = 29/122 (23%)
Query: 521 LLLQGNALQNQIPTCL-ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579
LLL N L L L L L L N+L P+ F
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF------------------- 74
Query: 580 LPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARNGFQGSIPE-AIGSLIS 637
+ L L N++ I + + GL L L L N + + L S
Sbjct: 75 -----EGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNS 127
Query: 638 LE 639
L
Sbjct: 128 LT 129
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 36/132 (27%), Positives = 54/132 (40%), Gaps = 9/132 (6%)
Query: 1066 SNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSS 1125
+ + + IP I + + L N + LP+L L L N L+GI P++
Sbjct: 16 TGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 1126 ICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCR 1185
AS + L L EN + F QL+ L+L N ++ G SF L +
Sbjct: 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS--CVMPG-SF-EHLNS-- 127
Query: 1186 YLRRLVLQNNPL 1197
L L L +NP
Sbjct: 128 -LTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 29/122 (23%), Positives = 45/122 (36%), Gaps = 16/122 (13%)
Query: 330 NLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNA-SKLTVLELSRNLFSGLVANTFGNCR 388
++P T L L N L + + L LEL RN +G+ N F
Sbjct: 26 DIPLHT-------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 389 QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEY 448
+Q L L +++ +S F L L+ L + N ++P S +L SL
Sbjct: 79 HIQELQLGENKIK--EISNK--MFLGLHQ---LKTLNLYDNQISCVMPGSFEHL-NSLTS 130
Query: 449 FY 450
Sbjct: 131 LN 132
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (143), Expect = 3e-09
Identities = 37/238 (15%), Positives = 71/238 (29%), Gaps = 36/238 (15%)
Query: 121 SGNRFHGTLPNELWLMPRLRI-----IDLSSNRISGNLFDDMCNSLTELESFDVSSNQIT 175
+ + ID IS D+ L + + + T
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 176 GQLPSSLGDCSKLKRLSVSFNELTGRIPQNIG-----NLTELMELYLNGNNLQGEFPPTI 230
L LK L + L + ++I NL +L LY+ +
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL-VLYVGVEDYGF------ 235
Query: 231 FNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLN---Y 287
+ + P+ R P+L+ L + D + + +L
Sbjct: 236 ------------DGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLET 283
Query: 288 LGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRL 345
+ + LTD GA L + +++ I + N+LS + +LP + +
Sbjct: 284 MDISAGVLTDEGARLLLDHVD----KIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 1e-04
Identities = 25/193 (12%), Positives = 57/193 (29%), Gaps = 16/193 (8%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNL-FSGLVANTFGNCRQLQILNLA 396
+ L+ + S I VL+ L + + + NL
Sbjct: 137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK 196
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLS--------KSLEY 448
++ +G L ++ L L + + +L++
Sbjct: 197 SLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKW 256
Query: 449 FYAGSCELGGGIP---AEFGNLSNIIALSLYQNQL----ASTIPTTVGKLQNLQGLDLSY 501
E + E L + + + L A + V K+++L+ +++ Y
Sbjct: 257 LGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316
Query: 502 NNIQGSIPSELCQ 514
N + + EL +
Sbjct: 317 NYLSDEMKKELQK 329
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-09
Identities = 47/247 (19%), Positives = 85/247 (34%), Gaps = 79/247 (31%)
Query: 751 LIGAGSFGSVYKA--TLPYGMNVAIKVFNLQLDGAIKSFDA-------ECEVLRRVRHR- 800
+G G+FG V + VA+K+ I++ E VL++++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKI--------IRNVGKYREAARLEINVLKKIKEKD 77
Query: 801 -----NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASAL 854
V + + HG + E + + + ++L + + + + + AL
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAH-------------------LSDFGISKLLD 895
+LH + H DLKP N+L + ++DFG S D
Sbjct: 137 RFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFD 192
Query: 896 GED--SVTQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFG-ILMIETFTRKMPTD 946
E ++ T Y PE + ++ DV+S G IL
Sbjct: 193 HEHHTTIVAT----RH-YRPPEVILELGW-AQPC-----DVWSIGCILF----------- 230
Query: 947 EMFTGET 953
E + G T
Sbjct: 231 EYYRGFT 237
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 44/245 (17%), Positives = 83/245 (33%), Gaps = 75/245 (30%)
Query: 1342 LLGTGIFSSVYKA--TFADGTNAAIKIFSLQEDRALKSF-DA---ECEVMRRIRHRNLAK 1395
LG G F V + + A+KI R + + +A E V+++I+ ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKD--- 77
Query: 1396 IVSSCSNPGFKALILQY---------------MPQGSLEKWLYSHNYL-LNIEQRLDIMI 1439
K L + + + ++L +N+ + +
Sbjct: 78 -------KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA-----------KLLD-G 1487
+ AL +LH+ + H DLKP N+L + L + + ++ D G
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 1488 ---VDSMKQTMTLATIGYMAPEYGSEGIV-----STSGDVYSFGILMMETLTRRKPTDDM 1539
D T +AT Y PE ++ + DV+S G ++ E
Sbjct: 188 SATFDHEHHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFE----------Y 232
Query: 1540 FTGEV 1544
+ G
Sbjct: 233 YRGFT 237
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 33/164 (20%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 115 LVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS--GNLFDDMCNSLTELESFDVSSN 172
V L+ + L + + + LS+N I +L + + L + N
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSL-----SGMENLRILSLGRN 80
Query: 173 QITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ--GEFPPTI 230
I ++ + L+ L +S+N++ + I L L LY++ N + GE +
Sbjct: 81 LIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK-L 136
Query: 231 FNVSSLRVIVLANNSLFGSLPVD---------LCRRLPSLQELN 265
+ L ++LA N L+ + + +RLP+L++L+
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 30/129 (23%), Positives = 51/129 (39%), Gaps = 11/129 (8%)
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTC--LANLTSLRALNLSSNRLNS 554
L I+ + + L L++ L L N I L+ + +LR L+L N +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLI-K 83
Query: 555 TIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS-CSIPSSIGGLKD 613
I + + + + S N ++ I L L LY+S N+++ + L
Sbjct: 84 KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141
Query: 614 LTYLALARN 622
L L LA N
Sbjct: 142 LEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 32/168 (19%), Positives = 64/168 (38%), Gaps = 38/168 (22%)
Query: 460 IPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLN 519
+ A L L+L N + I +++ ++NL+ L L N I+ I + ++L
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579
L + N + + + + L +LR L +S+N++ + + ++
Sbjct: 97 ELWISYNQIAS--LSGIEKLVNLRVLYMSNNKI-----TNWGEIDK-------------- 135
Query: 580 LPQDIGNLKVLTGLYLSGNQLSCSIPSS----------IGGLKDLTYL 617
+ L L L L+GN L + + L +L L
Sbjct: 136 ----LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 25/151 (16%), Positives = 55/151 (36%), Gaps = 9/151 (5%)
Query: 148 RISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIG 207
RI + ++E I + ++L K L++S N + +I ++
Sbjct: 12 RIFEERKSVVATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLS 67
Query: 208 NLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267
+ L L L N ++ + +L + ++ N + + +L +L+ L +
Sbjct: 68 GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRVLYMS 123
Query: 268 D-CMTTGRIPKDIGNCTLLNYLGLRDNQLTD 297
+ +T + L L L N L +
Sbjct: 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 35/198 (17%), Positives = 55/198 (27%), Gaps = 54/198 (27%)
Query: 1000 NKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQL 1059
+ I R TE ++ LHG ++ L L L N +
Sbjct: 9 DAIRIFEERKSVVATEAEKVELHGMI-------PPIE-KMDATLSTLKACKHLALSTNNI 60
Query: 1060 TGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLS 1119
I ++ + NL+ L L N +
Sbjct: 61 E---------------------KISSLS----------------GMENLRILSLGRNLIK 83
Query: 1120 GIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYT 1179
I A + L +S N + L + L++L +S N +T
Sbjct: 84 KIENLD-AVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEID------ 134
Query: 1180 SLTNCRYLRRLVLQNNPL 1197
L L L+L NPL
Sbjct: 135 KLAALDKLEDLLLAGNPL 152
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 34/164 (20%), Positives = 67/164 (40%), Gaps = 28/164 (17%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNL------QLDGAIKSFD--AECEVLRRVRHRN 801
IG+G FG +Y A A V + L +K + A+ + +++ R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 802 LVKII----------SSCSNHGFKALILEYMPQG-SLEKWLYSHKYTLNIQQRLDIMIDV 850
+ + + ++ +++E + G L+K + T L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLLD--DDTVAHLSDFGISK 892
LEY+H +H D+K +N+LL + +L+D+G+S
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 31/167 (18%), Positives = 62/167 (37%), Gaps = 34/167 (20%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
+G+G F +Y A A + + E + +E + +R +AK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKV-EYQENGPLFSELKFYQR-----VAKKDCIK 97
Query: 1401 SNPGFKALILQYMPQ----GSLEKWLYSHNYLL------NIEQRLD------------IM 1438
K L +P G E S+ +++ ++++ +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 1439 IDVACALEYLHQGYSTSIIHCDLKPSNVLLD--DDMVAHLGDFGIAK 1483
I + LEY+H +H D+K +N+LL + +L D+G++
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 25/129 (19%), Positives = 45/129 (34%), Gaps = 6/129 (4%)
Query: 141 IIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG 200
++ L++ I EL D+ +I + + + + S NE+
Sbjct: 1 MVKLTAELIEQAAQYTNAVRDREL---DLRGYKIP-VIENLGATLDQFDAIDFSDNEIR- 55
Query: 201 RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPS 260
++ L L L +N N + + L ++L NNSL +D L S
Sbjct: 56 KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 261 LQELNLRDC 269
L L +
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 3/93 (3%)
Query: 462 AEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTL 521
A++ N L L ++ I L +D S N I+ + L L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 522 LLQGNALQNQIPTCLANLTSLRALNLSSNRLNS 554
L+ N + L L L L++N L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 22/136 (16%), Positives = 42/136 (30%), Gaps = 12/136 (8%)
Query: 1062 VRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGI 1121
V+L + LI + N + L G + ++G L + N + +
Sbjct: 2 VKLTAE-LIEQAAQYT-NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKL 57
Query: 1122 IPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSL 1181
+ + L ++ N + L L L+ N L L
Sbjct: 58 DGFPLLRRLKT--LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD------PL 109
Query: 1182 TNCRYLRRLVLQNNPL 1197
+ + L L + NP+
Sbjct: 110 ASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 23/120 (19%), Positives = 35/120 (29%), Gaps = 14/120 (11%)
Query: 313 NNSNIEVIQLYGNHLS--GNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLE 370
N + L G + NL G L + N + + +L L
Sbjct: 17 NAVRDRELDLRGYKIPVIENL----GATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70
Query: 371 LSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNP 430
++ N + L L L + L L L + + L YL I NP
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLV--ELGD----LDPLASLKSLTYLCILRNP 124
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 23/126 (18%), Positives = 40/126 (31%), Gaps = 29/126 (23%)
Query: 497 LDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTI 556
+ L+ I+ + ++ L L+G + I A L A++ S N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-- 56
Query: 557 PSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTY 616
L+ L+ L L ++ N++ L DLT
Sbjct: 57 ------LD------------------GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92
Query: 617 LALARN 622
L L N
Sbjct: 93 LILTNN 98
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 49/247 (19%), Positives = 86/247 (34%), Gaps = 79/247 (31%)
Query: 751 LIGAGSFGSVYKA--TLPYGMNVAIKVFNLQLDGAIKS----FDA---ECEVLRRVRHR- 800
+G G+FG V + G +VA+K+ +K+ +A E +VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKI--------VKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 801 -----NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASAL 854
V+++ +HG ++ E + S ++ + + + + + ++
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLS-------------------DFGISKLLD 895
+LH + H DLKP N+L DFG S D
Sbjct: 132 NFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYD 187
Query: 896 GED--SVTQTMTLATFGYMAPE------YGSEGIVSTCGDVYSFG-ILMIETFTRKMPTD 946
E ++ T Y APE + S+ DV+S G IL+
Sbjct: 188 DEHHSTLVST----RH-YRAPEVILALGW-SQPC-----DVWSIGCILI----------- 225
Query: 947 EMFTGET 953
E + G T
Sbjct: 226 EYYLGFT 232
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 5e-04
Identities = 26/158 (16%), Positives = 51/158 (32%), Gaps = 52/158 (32%)
Query: 1342 LLGTGIFSSVYKA--TFADGTNAAIKIFSLQEDRALKSF-DA---ECEVMRRIRHRNLAK 1395
LG G F V + A G + A+KI + + + +A E +V+ + +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTD--- 72
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL----------------------LNIEQ 1433
P +Q + +W H ++ ++
Sbjct: 73 -------PNSTFRCVQ------MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDH 119
Query: 1434 RLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD 1471
+ + ++ +LH + H DLKP N+L
Sbjct: 120 IRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQS 154
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 15/140 (10%)
Query: 189 KRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFN-VSSLRVIVLANNSLF 247
L + N L LT L +LYL GN LQ P +FN ++SL + L+ N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL- 88
Query: 248 GSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI-GNCTLLNYLGLRDNQLTDFGANNLTGL 306
SLP + +L L+EL L +P + T L L L NQL
Sbjct: 89 QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS--------- 138
Query: 307 IPSIIFNN-SNIEVIQLYGN 325
+P +F+ ++++ I L+ N
Sbjct: 139 VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 50/166 (30%), Positives = 67/166 (40%), Gaps = 34/166 (20%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
GIPA+ L L N L S +L +L L L N +Q S+P+ + +L S
Sbjct: 25 GIPAQTTYLD------LETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L L L N LQ+ LT L+ L L++N+L S +P V D
Sbjct: 78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDG--------VFD------- 121
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI-GGLKDLTYLALARN 622
L L L L NQL S+P + L L Y+ L N
Sbjct: 122 --------KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 13/134 (9%)
Query: 117 SLNISGNRFHGTLPNELWLMPRLRIIDLSSNRIS---GNLFDDMCNSLTELESFDVSSNQ 173
L++ N + L + L N++ +F+ LT L ++S+NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN----KLTSLTYLNLSTNQ 87
Query: 174 ITGQLPSSLGDC-SKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF 231
+ LP+ + D ++LK L+++ N+L +P + LT+L +L L N L+ P +F
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVF 144
Query: 232 -NVSSLRVIVLANN 244
++SL+ I L +N
Sbjct: 145 DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 46/160 (28%), Positives = 62/160 (38%), Gaps = 33/160 (20%)
Query: 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATG 403
L L N+L + + LT L L N L F L LNL+ +QL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-- 89
Query: 404 SLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAE 463
SL G F LT L+ LA+ TN + LP+ V
Sbjct: 90 SLPNG--VFDKLTQ---LKELALNTNQLQS-LPDGV------------------------ 119
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNN 503
F L+ + L LYQNQL S +L +LQ + L ++N
Sbjct: 120 FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL-HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 39/150 (26%), Positives = 60/150 (40%), Gaps = 14/150 (9%)
Query: 202 IPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL 261
+P I T L L N+L+ ++SL + L N L SLP + +L SL
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSL 78
Query: 262 QELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN-SNIEVI 320
LNL T L L L NQL +P +F+ + ++ +
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS---------LPDGVFDKLTQLKDL 129
Query: 321 QLYGNHLSGNLPSSTGINLPNLLRLYLWGN 350
+LY N L ++P L +L ++L N
Sbjct: 130 RLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 30/129 (23%), Positives = 46/129 (35%), Gaps = 31/129 (24%)
Query: 993 KRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFTG 1037
L + N + LT L +L+L GN L++ L N+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 1038 RIPQNLGNCTLLNFLILRQNQLT----GV----------RLASNKLIGRIPSMIFNN-SN 1082
T L L L NQL GV RL N+L +P +F+ ++
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTS 149
Query: 1083 IEAIQLYGN 1091
++ I L+ N
Sbjct: 150 LQYIWLHDN 158
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 42/147 (28%), Positives = 54/147 (36%), Gaps = 34/147 (23%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
GIP+ L L N+L S KL L L LS N IQ S+P + +L
Sbjct: 25 GIPSSATRLE------LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 518 LNTLLLQGNALQNQIPT-CLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
L L L N LQ+ +P LT L+ L L +N+L S F
Sbjct: 78 LTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIF---------------- 120
Query: 577 SGCLPQDIGNLKVLTGLYLSGNQLSCS 603
L L ++L N CS
Sbjct: 121 --------DRLTSLQKIWLHTNPWDCS 139
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 37/111 (33%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 140 RIIDLSSNRISG---NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSF 195
++L SN++ +FD LT+L +S NQI LP + D +KL L +
Sbjct: 31 TRLELESNKLQSLPHGVFD----KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHE 85
Query: 196 NELTGRIPQNI-GNLTELMELYLNGNNLQGEFPPTIF-NVSSLRVIVLANN 244
N+L +P + LT+L EL L+ N L+ P IF ++SL+ I L N
Sbjct: 86 NKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 36/115 (31%), Positives = 61/115 (53%), Gaps = 11/115 (9%)
Query: 162 TELESFDVSSNQITGQLPSSLGDC-SKLKRLSVSFNELTGRIPQNI-GNLTELMELYLNG 219
+ ++ SN++ LP + D ++L +LS+S N++ +P + LT+L LYL+
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHE 85
Query: 220 NNLQGEFPPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR----DC 269
N LQ P +F ++ L+ + L N L S+P + RL SLQ++ L DC
Sbjct: 86 NKLQ-SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPWDC 138
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 28/116 (24%), Positives = 45/116 (38%), Gaps = 29/116 (25%)
Query: 993 KRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEA---------------YLYNNKFTG 1037
RL + NK+ LT+L +L L N +++ YL+ NK
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 1038 RIPQNL-GNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNN-SNIEAIQLYGN 1091
+P + T L L L NQL +P IF+ ++++ I L+ N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLK-----------SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 41/148 (27%), Positives = 56/148 (37%), Gaps = 35/148 (23%)
Query: 356 IPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSL 415
+P+ I S T LEL N L F QL L+L+ +Q+ SL G F L
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ--SLPDG--VFDKL 75
Query: 416 TNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSL 475
T L L + N + LPN V F L+ + L+L
Sbjct: 76 TK---LTILYLHENKLQS-LPNGV------------------------FDKLTQLKELAL 107
Query: 476 YQNQLASTIPTTVGKLQNLQGLDLSYNN 503
NQL S +L +LQ + L + N
Sbjct: 108 DTNQLKSVPDGIFDRLTSLQKIWL-HTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 38/126 (30%), Positives = 58/126 (46%), Gaps = 12/126 (9%)
Query: 307 IPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNA-SK 365
+P+ I S+ ++L N L +LP L L +L L N + +P + + +K
Sbjct: 22 VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 366 LTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLA 425
LT+L L N L F QL+ L L +QL S+ G F LT+ L+ +
Sbjct: 78 LTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK--SVPDGI--FDRLTS---LQKIW 130
Query: 426 IQTNPW 431
+ TNPW
Sbjct: 131 LHTNPW 136
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 25/119 (21%), Positives = 42/119 (35%), Gaps = 8/119 (6%)
Query: 1079 NNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLS 1138
+ + + L + + NL+ L L L + S++ ++ L LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 1139 ENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
EN G + L L+LS N L S+ + L L+ L L N +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLE------PLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 465 GNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQ 524
N+ LSL L S + + KL L+ L+LS N I G + +L +L L L
Sbjct: 46 AEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 525 GNALQN-QIPTCLANLTSLRALNLSSN 550
GN L++ L L L++L+L +
Sbjct: 104 GNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 30/140 (21%), Positives = 55/140 (39%), Gaps = 19/140 (13%)
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNEL 198
+R + L + + + + + LE + + + + S+L KLK+L +S N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRI 83
Query: 199 TGRIPQNIGNLTELMELYLNGNNLQ--GEFPPTIFNVSSLRVIVLANNSLFGSLPVD--- 253
G + L L L L+GN L+ P + + L+ + L N V
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC------EVTNLN 136
Query: 254 -----LCRRLPSLQELNLRD 268
+ + LP L L+ D
Sbjct: 137 DYRESVFKLLPQLTYLDGYD 156
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 25/118 (21%), Positives = 38/118 (32%), Gaps = 8/118 (6%)
Query: 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELS 372
+ + + L + NL L L L V S++ KL LELS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 373 RNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNP 430
N G + L LNL+ ++L +S L L+ L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK--DIST----LEPLKKLECLKSLDLFNCE 131
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 34/157 (21%), Positives = 54/157 (34%), Gaps = 31/157 (19%)
Query: 466 NLSNIIALSLYQNQLA-STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQ 524
+ + L L + I + NL+ L L + S+ + L +L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 525 GNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI 584
N + + L +L LNLS N+L +LE +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-----ISTLEP------------------L 116
Query: 585 GNLKVLTGLYLSGNQLSCSIP----SSIGGLKDLTYL 617
L+ L L L ++ ++ S L LTYL
Sbjct: 117 KKLECLKSLDLFNCEV-TNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 23/86 (26%), Positives = 35/86 (40%), Gaps = 4/86 (4%)
Query: 464 FGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQG-SIPSELCQLESLNTLL 522
L + L L +N++ + KL NL L+LS N ++ S L +LE L +L
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126
Query: 523 LQGNALQNQI---PTCLANLTSLRAL 545
L + N + L L L
Sbjct: 127 LFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 24/119 (20%), Positives = 47/119 (39%), Gaps = 8/119 (6%)
Query: 1079 NNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLS 1138
S+++ + L + + + L+ L L+ I +++ +++ L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 1139 ENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
+N SG + C L L+LS N + S+ + L L+ L L N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE------PLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 24/118 (20%), Positives = 43/118 (36%), Gaps = 8/118 (6%)
Query: 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELS 372
S+++ + L + + L L L+ + +++ +KL LELS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 373 RNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNP 430
N SG + C L LNL+ +++ LS L L+ L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK--DLST----IEPLKKLENLKSLDLFNCE 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 22/86 (25%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 466 NLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQG 525
+ LS L S + KL L+ L+LS N + G + + +L L L G
Sbjct: 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 526 NALQN-QIPTCLANLTSLRALNLSSN 550
N +++ L L +L++L+L +
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 31/157 (19%), Positives = 54/157 (34%), Gaps = 31/157 (19%)
Query: 466 NLSNIIALSLYQNQLAS-TIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQ 524
S++ L L ++ + + + L+ L + SI + L +L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 525 GNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDI 584
N + + +L LNLS N++ ST L+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLK-------------------- 110
Query: 585 GNLKVLTGLYLSGNQLSCSIP----SSIGGLKDLTYL 617
L+ L L L ++ ++ + L LTYL
Sbjct: 111 -KLENLKSLDLFNCEV-TNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 22/107 (20%), Positives = 50/107 (46%), Gaps = 3/107 (2%)
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNEL 198
++ + L ++R + + + + ELE + +T + ++L +KLK+L +S N +
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRV 76
Query: 199 TGRIPQNIGNLTELMELYLNGNNLQG-EFPPTIFNVSSLRVIVLANN 244
+G + L L L+GN ++ + + +L+ + L N
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/112 (22%), Positives = 45/112 (40%), Gaps = 7/112 (6%)
Query: 91 VTDLSIPNLGLG-GTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI 149
V +L + N G + L L+ ++ N L + +L+ ++LS NR+
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRV 76
Query: 150 SGNLFDDMCNSLTELESFDVSSNQIT--GQLPSSLGDCSKLKRLSVSFNELT 199
SG + + L ++S N+I + L LK L + E+T
Sbjct: 77 SG-GLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVT 126
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 32/179 (17%), Positives = 73/179 (40%), Gaps = 9/179 (5%)
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSF- 195
R++ +DLS++ I + + + ++L++ + +++ + ++L S L RL++S
Sbjct: 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 152
Query: 196 NELTGRIPQNIG-NLTELMELYLNGNNL---QGEFPPTIFNVSSLRVIVLA--NNSLFGS 249
+ + Q + + + L EL L+ + ++ + L+ +L S
Sbjct: 153 SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS 212
Query: 250 LPVDLCRRLPSLQELNLRDCMT-TGRIPKDIGNCTLLNYLGLRD-NQLTDFGANNLTGL 306
L RR P+L L+L D + ++ L +L L + L +
Sbjct: 213 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 271
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 36/204 (17%), Positives = 67/204 (32%), Gaps = 28/204 (13%)
Query: 90 RVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRF--HGTLPNELWLMPRLRIIDLSSN 147
++ +LS+ L L I +A S LV LN+SG L L RL ++LS
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW- 177
Query: 148 RISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS--FNELTGRIPQN 205
C T + + + +L++S L
Sbjct: 178 ----------CFDFT-----EKHVQVAVAHV------SETITQLNLSGYRKNLQKSDLST 216
Query: 206 IG-NLTELMELYLNG-NNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQE 263
+ L+ L L+ L+ + F ++ L+ + L+ + +P+L+
Sbjct: 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 276
Query: 264 LNLRDCMTTGRIPKDIGNCTLLNY 287
L + + G + L
Sbjct: 277 LQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 56/338 (16%), Positives = 102/338 (30%), Gaps = 35/338 (10%)
Query: 243 NNSLFGSLPVDLCRR-LPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGAN 301
+ SLP +L L L C L D L
Sbjct: 5 PGVSWDSLPDELLLGIFSCLCLPELLKVSGV---------CKRWYRL-ASDESLWQTLDL 54
Query: 302 NLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLS-GVIPSSI 360
L P + + VI + P + + + + L + + + +
Sbjct: 55 TGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGIL 114
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRY 420
SKL L L S + NT L LNL+ + + + L++C
Sbjct: 115 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF-----ALQTLLSSCSR 169
Query: 421 LRYLAIQTNPW---KGILPNSVGNLSKSLEYFYAGSCELG---GGIPAEFGNLSNIIALS 474
L L + K + +V ++S+++ + N++ L
Sbjct: 170 LDELNLSWCFDFTEKHVQ-VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228
Query: 475 LYQ-NQLASTIPTTVGKLQNLQGLDLSY-NNIQGSIPSELCQLESLNTLLLQG------- 525
L L + +L LQ L LS +I EL ++ +L TL + G
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 288
Query: 526 NALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSL 563
L+ +P N + + + + + W +
Sbjct: 289 QLLKEALPHLQINCSHFTTIARPT--IGNKKNQEIWGI 324
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 65/371 (17%), Positives = 111/371 (29%), Gaps = 131/371 (35%)
Query: 1343 LGTGIFSSVYKA-TFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS 1401
LG G FS+V+ + A+K+ E + D E +++ +R+ + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDP-------N 96
Query: 1402 NPGFKALILQYM-------PQG------------SLEKWLYSHNY-LLNIEQRLDIMIDV 1441
+P + +++Q + G L KW+ NY L + I+ V
Sbjct: 97 DPN-REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 1442 ACALEYLHQGYSTSIIHCDLKPSNVLL--------------------------------- 1468
L+YLH IIH D+KP N+LL
Sbjct: 156 LQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 1469 ----------------DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI 1512
+ + + D G A + T + T Y + E
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGSG 269
Query: 1513 VSTSGDVYSFGIL----------------------------MMETL--------TRRKPT 1536
+T D++S + ++E L K +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 1537 DDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEI 1596
+ FT + LKH + +++ S EE A L E I
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT----------DFLLPMLELI 379
Query: 1597 PEERMNVKDAL 1607
PE+R + L
Sbjct: 380 PEKRATAAECL 390
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 34/147 (23%), Positives = 58/147 (39%), Gaps = 32/147 (21%)
Query: 752 IGAGSFGSVYKA-TLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS 810
+G G F +V+ + + VA+KV + D E +L+ VR+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSD--------P 95
Query: 811 NHGFKALILEYM-------PQG------------SLEKWLYSHKY-TLNIQQRLDIMIDV 850
N + ++++ + G L KW+ Y L + I+ V
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 851 ASALEYLHHGHPTPVIHCDLKPSNVLL 877
L+YLH +IH D+KP N+LL
Sbjct: 156 LQGLDYLHT--KCRIIHTDIKPENILL 180
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 30/94 (31%), Positives = 41/94 (43%), Gaps = 10/94 (10%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
GIP L LY NQ+ P +L L LDL N + +P+ + +L
Sbjct: 27 GIPT------TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 518 LNTLLLQGNALQNQIPT-CLANLTSLRALNLSSN 550
L L L N L++ IP NL SL + L +N
Sbjct: 80 LTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 30/94 (31%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 459 GIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELC-QLES 517
GIP + L L NQ+ P L NLQ L + N + +IP+ + +L
Sbjct: 30 GIPT------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 518 LNTLLLQGNALQNQIPT-CLANLTSLRALNLSSN 550
L L L N L++ IP NL SL + L +N
Sbjct: 83 LTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 35/121 (28%), Positives = 40/121 (33%), Gaps = 32/121 (26%)
Query: 484 IPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLR 543
IPT Q L L+ N I P L +L L N L LT L
Sbjct: 31 IPTD------KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLT 84
Query: 544 ALNLSSNRLNSTIPS-TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSC 602
L+L+ N L S IP F D NLK LT +YL N C
Sbjct: 85 QLDLNDNHLKS-IPRGAF----------------------D--NLKSLTHIYLYNNPWDC 119
Query: 603 S 603
Sbjct: 120 E 120
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 32/160 (20%), Positives = 57/160 (35%), Gaps = 44/160 (27%)
Query: 107 PHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG-NLFDDMCNSLTELE 165
P + + V LN + TL +P L ++LS+NR+ + + L+
Sbjct: 141 PDLVAQNIDVVLN-RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 199
Query: 166 SFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGE 225
++S N++ S + K+K L +L EL+L+GN+L
Sbjct: 200 ILNLSGNEL-----KSERELDKIKGL-------------------KLEELWLDGNSLCDT 235
Query: 226 FPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELN 265
F + S+ + R P L L+
Sbjct: 236 FR----DQSTYISAIR--------------ERFPKLLRLD 257
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-04
Identities = 50/307 (16%), Positives = 89/307 (28%), Gaps = 66/307 (21%)
Query: 285 LNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGN-----LPSSTGINL 339
L L L ++T + ++ S ++ + L L LP
Sbjct: 74 LRQLNLAGVRMTPVKCTVVAAVLGS---GRHALDEVNLASCQLDPAGLRTLLPV-----F 125
Query: 340 PNLLRLYLWGNNLSGVIPSSIC-----NASKLTVLELSRN---------LFSGLVANTFG 385
+L L N+L + + ++T L LS N L GL NT
Sbjct: 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNT-- 183
Query: 386 NCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLS-- 443
+ L+L ++ L + + L R L+ L + N G + L+
Sbjct: 184 ---SVTHLSLLHTGLGDEG---LELLAAQLDRNRQLQELNVAYN---GAGDTAALALARA 234
Query: 444 ----KSLEYFYAGSCELG-------GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGK-L 491
SLE + EL + + ++ ++ + +
Sbjct: 235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQ 294
Query: 492 QNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANL----TSLRALNL 547
+NL D + + L L+ + P A L +RAL
Sbjct: 295 RNLNSWDRARVQ----------RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLE 344
Query: 548 SSNRLNS 554
S
Sbjct: 345 QLGSSGS 351
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 6e-04
Identities = 41/280 (14%), Positives = 84/280 (30%), Gaps = 38/280 (13%)
Query: 112 LSFLVSLNISGNRF---HGTLPNELWLMPR--LRIIDLSSNRISGNLFDDMCNSLTELES 166
LS L LN++G R T+ + R L ++L+S ++ +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 167 FDVSSNQITGQLPSSLGD-----CSKLKRLSVSFNELTGRIPQNIGNL----TELMELYL 217
+ N + + L D ++ L +S N LT + T + L L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 218 NGNNLQGEFPPTIFNV----SSLRVIVLANNSLFGSLPVDLCRRL---PSLQELNLRDCM 270
L E + L+ + +A N + + L R PSL+ L+L
Sbjct: 191 LHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250
Query: 271 TT-------GRIPKDIGNCTLLNYLGLRDNQLTDFGA-------NNLTGLIPSIIFNNSN 316
+ + + ++++ + NL + + +
Sbjct: 251 LSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLE 310
Query: 317 IEVIQLYGNHLSGNLPSSTGINL---PNLLRLYLWGNNLS 353
+ + L + + P L + L +
Sbjct: 311 LLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-04
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 8/112 (7%)
Query: 1383 EVMRRIRHRNLAKIVSSCSNPGFKA-LILQYMPQGSLEKWLYSHNYLLN--IEQRLDIMI 1439
E +R+ R A+ ++ + G A I Y + L IE LDI
Sbjct: 379 ENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAY 438
Query: 1440 DVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491
+ + LH+ +IH DL SN + D D+ + DFG+ K+ + +
Sbjct: 439 KIGEIVGKLHKN---DVIHNDLTTSNFIFDKDLY--IIDFGLGKISNLDEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1624 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.98 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.98 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.98 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.98 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.98 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.98 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.98 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.98 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.98 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.98 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.98 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.98 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.98 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.98 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-87 Score=891.96 Aligned_cols=542 Identities=29% Similarity=0.418 Sum_probs=481.5
Q ss_pred cccCChhhHHHHHHHHHHhccCCccccccCCCCCCCCCCCCCCCCccceeeEecCCCCcEEEEecCCCCCCcc---CCcc
Q 047591 32 TEANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGT---IPPH 108 (1624)
Q Consensus 32 ~~~~~~~d~~aLl~~k~~~~~~p~~~~~~~W~~~~~~~~~~~~~~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~---ip~~ 108 (1624)
+.++.++|++|||+||+++. ||. .+ ++|+ .+++||.|.||+|+ ++||+.|+|++.++.|. +|++
T Consensus 6 ~~~~~~~~~~all~~k~~~~-~~~-~l-~~W~--------~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~ 72 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLP-DKN-LL-PDWS--------SNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSS 72 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCS-CTT-SS-TTCC--------TTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHH
T ss_pred cccCCHHHHHHHHHHHhhCC-Ccc-cc-cCCC--------CCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChh
Confidence 33456889999999999996 887 44 6896 24589999999998 69999999999999999 9999
Q ss_pred ccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccch-hhhccCCCcCEEEccCCcccccCCccc-cCCC
Q 047591 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFD-DMCNSLTELESFDVSSNQITGQLPSSL-GDCS 186 (1624)
Q Consensus 109 i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~-~~~~~l~~L~~L~Ls~N~l~g~iP~~l-~~l~ 186 (1624)
+++|++|+.++++.|.+. .+|..++.+++|++|||++|.++|.+|. ..++++++|++|+|++|++++.+|..+ ++++
T Consensus 73 l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~ 151 (768)
T 3rgz_A 73 LLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN 151 (768)
T ss_dssp TTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCT
T ss_pred HhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCC
Confidence 999999999999999886 5789999999999999999999998876 145789999999999999999999887 8999
Q ss_pred cccccccccccccccccCc---ccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcE
Q 047591 187 KLKRLSVSFNELTGRIPQN---IGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQE 263 (1624)
Q Consensus 187 ~L~~L~Ls~N~l~g~ip~~---~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~ 263 (1624)
+|++|||++|++++.+|.. ++++++|++|+|++|++++.+|. .++++|++|+|++|++++.+|. ++.+++|++
T Consensus 152 ~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~--l~~l~~L~~ 227 (768)
T 3rgz_A 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF--LGDCSALQH 227 (768)
T ss_dssp TCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB--CTTCCSCCE
T ss_pred CCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc--cccCCCCCE
Confidence 9999999999999998887 88999999999999999987765 7899999999999999988876 678999999
Q ss_pred eecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCcc
Q 047591 264 LNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLL 343 (1624)
Q Consensus 264 L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~ 343 (1624)
|+|++|++++.+|..++++++|++|+|++|+ ++|.+|.. .+++|++|+|++|+++|.+|..++..+++|+
T Consensus 228 L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~--------l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~ 297 (768)
T 3rgz_A 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQ--------FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297 (768)
T ss_dssp EECCSSCCCSCHHHHTTTCSSCCEEECCSSC--------CEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCS
T ss_pred EECcCCcCCCcccHHHhcCCCCCEEECCCCc--------ccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCC
Confidence 9999999999999999999999999988775 44566664 7788899999999998888888875568889
Q ss_pred EEEecCCccCCcCcccccCCCCCcEEecCCccccccCccc-ccccccccEEEccccccccCCCCCCcccccccccccccc
Q 047591 344 RLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANT-FGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLR 422 (1624)
Q Consensus 344 ~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~-f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~ 422 (1624)
+|+|++|++++.+|..|+++++|++|+|++|+++|.+|.. |+++++|++|+|++|++.
T Consensus 298 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~--------------------- 356 (768)
T 3rgz_A 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS--------------------- 356 (768)
T ss_dssp EEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEE---------------------
T ss_pred EEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccC---------------------
Confidence 9999999888888888888888999999988888777755 788888888777777664
Q ss_pred eeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCC--CCcccEEeccCCccCCCccchhccccccceeccc
Q 047591 423 YLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGN--LSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLS 500 (1624)
Q Consensus 423 ~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~--l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls 500 (1624)
|.+|..+.++..+|++|++++|++.|.+|..+.. +++|++|+|++|++++.+|..++.+++|++|+|+
T Consensus 357 ----------~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 426 (768)
T 3rgz_A 357 ----------GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426 (768)
T ss_dssp ----------ECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECC
T ss_pred ----------ccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECc
Confidence 4455555555546777777777777777777776 8899999999999999999999999999999999
Q ss_pred ccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCC
Q 047591 501 YNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCL 580 (1624)
Q Consensus 501 ~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~i 580 (1624)
+|+++|.+|..++++++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|||++|+++|.+
T Consensus 427 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 506 (768)
T 3rgz_A 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506 (768)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred CCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhh
Q 047591 581 PQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAI 632 (1624)
Q Consensus 581 P~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~ 632 (1624)
|.+++.+++|+.|+|++|+++|.+|..++++++|+.|++++|+++|.+|..+
T Consensus 507 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~ 558 (768)
T 3rgz_A 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred ChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence 9999999999999999999999999999999999999999999999999764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-73 Score=756.06 Aligned_cols=564 Identities=33% Similarity=0.486 Sum_probs=381.1
Q ss_pred CcEEEEecCCCCCCccCCc--cccCCCcccEEEecCCCccccCCccc-CCCCCCcEEEccCCCCCCccchhh--hccCCC
Q 047591 89 GRVTDLSIPNLGLGGTIPP--HVANLSFLVSLNISGNRFHGTLPNEL-WLMPRLRIIDLSSNRISGNLFDDM--CNSLTE 163 (1624)
Q Consensus 89 ~~v~~l~l~~~~l~g~ip~--~i~~L~~L~~L~Ls~N~l~g~iP~~~-~~l~~L~~L~Ls~N~l~g~~~~~~--~~~l~~ 163 (1624)
.+++.|+|+++.+.|.+|+ .+++|++|++|+|++|.+++.+|..+ +.+++|++|||++|++++..|..+ +.++++
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~ 179 (768)
T 3rgz_A 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179 (768)
T ss_dssp TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence 4567778888888888877 78888888888888888887777766 677888888888888776555442 456666
Q ss_pred cCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheecc
Q 047591 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLAN 243 (1624)
Q Consensus 164 L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~ 243 (1624)
|++|++++|++++.+|. +.+++|++|+|++|++++.+|. ++++++|++|+|++|+++|.+|..++++++|++|+|++
T Consensus 180 L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~ 256 (768)
T 3rgz_A 180 LKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256 (768)
T ss_dssp CCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCS
T ss_pred CCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCC
Confidence 77777777766665543 5667777777777777766665 77777777777777777777777777777777777777
Q ss_pred ccccCCCCccccccCCCCcEeecccccccCcCCcccccc-CcCCeeeccCCcccccCccccccccccccccCCCccEEEe
Q 047591 244 NSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNC-TLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQL 322 (1624)
Q Consensus 244 N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~L 322 (1624)
|+++|.+|.. .+++|++|+|++|+++|.+|..++.+ ++|++|+|++|+ ++|.+|..+.++++|++|+|
T Consensus 257 n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~--------l~~~~p~~~~~l~~L~~L~L 325 (768)
T 3rgz_A 257 NQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH--------FYGAVPPFFGSCSLLESLAL 325 (768)
T ss_dssp SCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSE--------EEECCCGGGGGCTTCCEEEC
T ss_pred CcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCc--------CCCccchHHhcCCCccEEEC
Confidence 7776666653 56667777777777777777666654 677777666654 33445555555555555555
Q ss_pred ecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCC-CCcEEecCCccccccCcccccc--cccccEEEccccc
Q 047591 323 YGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNAS-KLTVLELSRNLFSGLVANTFGN--CRQLQILNLAYSQ 399 (1624)
Q Consensus 323 s~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-~L~~L~Ls~N~l~g~~~~~f~~--l~~L~~L~L~~N~ 399 (1624)
++|+++|.+|......+++|++|+|++|+++|.+|..+.++. +|++|+|++|+++|.+|..+.. +++|++|+|++|+
T Consensus 326 ~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~ 405 (768)
T 3rgz_A 326 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405 (768)
T ss_dssp CSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSE
T ss_pred CCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCc
Confidence 555555555554333455555555555555555555555554 5555555555555555554444 4555555555555
Q ss_pred cccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCc
Q 047591 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQ 479 (1624)
Q Consensus 400 l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~ 479 (1624)
++. ..+..+.++++|++|++++|.+++.+|..++++. +|++|++++|.+.|.+|..|+.+++|++|+|++|+
T Consensus 406 l~~-------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 477 (768)
T 3rgz_A 406 FTG-------KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477 (768)
T ss_dssp EEE-------ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccc-------ccCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence 532 1233444555555555555555555555555554 45555555555555555555555555555555555
Q ss_pred cCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCc--
Q 047591 480 LASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIP-- 557 (1624)
Q Consensus 480 l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP-- 557 (1624)
++|.+|.+++.+++|++|+|++|+++|.+|.+++++++|++|+|++|+++|.+|..++++++|+.|+|++|+++|.+|
T Consensus 478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence 555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred --------------------------------------------------------------------hhhcccccccee
Q 047591 558 --------------------------------------------------------------------STFWSLEYILVV 569 (1624)
Q Consensus 558 --------------------------------------------------------------------~~~~~l~~L~~l 569 (1624)
..++.+.+|+.|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 445556788999
Q ss_pred ecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhhhccccccC---------
Q 047591 570 DFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEK--------- 640 (1624)
Q Consensus 570 dLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~~--------- 640 (1624)
||++|+++|.||.++++++.|+.|+|++|+++|.||.+++++++|+.|||++|+++|.||..++++++|+.
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999988873
Q ss_pred CCCCCCCCccccCCccccccccccccccccccccccc
Q 047591 641 GEIPSGGPFVNFTEGSFMQNYALCGSLRLQVQACETS 677 (1624)
Q Consensus 641 ~~i~~~~~~~~~~~~~~~~n~~lcg~~~~~l~~c~~~ 677 (1624)
|.||.+++|.+|+..+|.||++|||+++. +|...
T Consensus 718 g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~---~C~~~ 751 (768)
T 3rgz_A 718 GPIPEMGQFETFPPAKFLNNPGLCGYPLP---RCDPS 751 (768)
T ss_dssp EECCSSSSGGGSCGGGGCSCTEEESTTSC---CCCSC
T ss_pred ccCCCchhhccCCHHHhcCCchhcCCCCc---CCCCC
Confidence 78899999999999999999999998753 78654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=611.58 Aligned_cols=500 Identities=21% Similarity=0.317 Sum_probs=284.7
Q ss_pred hhhHHHHHHHHHHhccCCccccccCCCCCC-----CCCCCCCCCCccc---eeeEecCCCCcEEEEecCCCCCCccCCcc
Q 047591 37 TTDEAALLQVKAHIALDPQNFFERNWNLSA-----TTNTSSSNSVCNW---VGVTCGSRHGRVTDLSIPNLGLGGTIPPH 108 (1624)
Q Consensus 37 ~~d~~aLl~~k~~~~~~p~~~~~~~W~~~~-----~~~~~~~~~~C~W---~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~ 108 (1624)
..|++||.+||+++..+ +|+.+. ...|..+.+||.| .||+|+.. |||++|+|+++++.|++|++
T Consensus 29 ~~d~~aL~~~~~~~~~~-------~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~ 100 (636)
T 4eco_A 29 IKDYLALKEIWDALNGK-------NWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDA 100 (636)
T ss_dssp HHHHHHHHHHHHHTTGG-------GCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGG
T ss_pred HHHHHHHHHHHHHcCCC-------CcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChH
Confidence 56899999999998533 333211 1133346799999 99999865 89999999999999999999
Q ss_pred ccCCCcccEEEecCCCc------cc------cCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccc
Q 047591 109 VANLSFLVSLNISGNRF------HG------TLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176 (1624)
Q Consensus 109 i~~L~~L~~L~Ls~N~l------~g------~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g 176 (1624)
|++|++|++|+|++|++ .| .+|.+. +.+|+ ++++.|.+.+.+|..+...+..+..+++....+..
T Consensus 101 l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~ 177 (636)
T 4eco_A 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177 (636)
T ss_dssp GGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC
T ss_pred HhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc
Confidence 99999999999999987 34 555555 56677 88888888887766554333333334443222211
Q ss_pred cCCccccCCCcccccccc--cccccccccCcccccccccceeccCCcCCCC-----------------CCCccc--ccCc
Q 047591 177 QLPSSLGDCSKLKRLSVS--FNELTGRIPQNIGNLTELMELYLNGNNLQGE-----------------FPPTIF--NVSS 235 (1624)
Q Consensus 177 ~iP~~l~~l~~L~~L~Ls--~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~-----------------~p~~~~--~l~~ 235 (1624)
.....++.+.+. .|+++| ||+.|+++++|++|+|++|+|+|. +|..++ ++++
T Consensus 178 ------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~ 250 (636)
T 4eco_A 178 ------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD 250 (636)
T ss_dssp ------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred ------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCC
Confidence 111122222222 345554 555555555555555555555543 555555 5555
Q ss_pred cchheeccccccCCCCccccccCCCCcEeeccccc-ccC-cCCcccccc------CcCCeeeccCCcccccCcccccccc
Q 047591 236 LRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM-TTG-RIPKDIGNC------TLLNYLGLRDNQLTDFGANNLTGLI 307 (1624)
Q Consensus 236 L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~-l~g-~ip~~~~~l------~~L~~L~Ls~N~l~~l~~n~l~g~i 307 (1624)
|++|+|++|+++|.+|..+ .++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .|
T Consensus 251 L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~---------~i 320 (636)
T 4eco_A 251 LTDVEVYNCPNLTKLPTFL-KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK---------TF 320 (636)
T ss_dssp CCEEEEECCTTCSSCCTTT-TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS---------SC
T ss_pred CCEEEecCCcCCccChHHH-hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC---------cc
Confidence 5555555555555555332 345555555555554 555 555555544 55555555544432 24
Q ss_pred cc--ccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCC-CcEEecCCccccccCcccc
Q 047591 308 PS--IIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASK-LTVLELSRNLFSGLVANTF 384 (1624)
Q Consensus 308 p~--~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~-L~~L~Ls~N~l~g~~~~~f 384 (1624)
|. .+.++++|++|+|++|+++|.+| .+ ..+++|++|+|++|+++ .+|..++++++ |++|+|++|.++ .+|..|
T Consensus 321 p~~~~l~~l~~L~~L~L~~N~l~g~ip-~~-~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~ 396 (636)
T 4eco_A 321 PVETSLQKMKKLGMLECLYNQLEGKLP-AF-GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396 (636)
T ss_dssp CCHHHHTTCTTCCEEECCSCCCEEECC-CC-EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred CchhhhccCCCCCEEeCcCCcCccchh-hh-CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence 44 45555555555555555555555 22 24555555555555555 45555555555 555555555555 344445
Q ss_pred cccc--cccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCccc-------CccccchhhccCCcc
Q 047591 385 GNCR--QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVG-------NLSKSLEYFYAGSCE 455 (1624)
Q Consensus 385 ~~l~--~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~-------~l~~~L~~L~l~~n~ 455 (1624)
+.++ +|++|+|++|++.. .+|..+. .+. +|++|++++|+
T Consensus 397 ~~~~l~~L~~L~Ls~N~l~~-------------------------------~~p~~l~~~~~~~~~~~-~L~~L~Ls~N~ 444 (636)
T 4eco_A 397 DAKSVSVMSAIDFSYNEIGS-------------------------------VDGKNFDPLDPTPFKGI-NVSSINLSNNQ 444 (636)
T ss_dssp CTTCSSCEEEEECCSSCTTT-------------------------------TTTCSSCTTCSSCCCCC-CEEEEECCSSC
T ss_pred hhcccCccCEEECcCCcCCC-------------------------------cchhhhcccccccccCC-CCCEEECcCCc
Confidence 4433 55555555554431 1111111 000 12222222222
Q ss_pred cCCCCCCC-cCCCCcccEEeccCCccCCCccchhcc--------ccccceecccccccccCCCcccc--CCCCCceeecc
Q 047591 456 LGGGIPAE-FGNLSNIIALSLYQNQLASTIPTTVGK--------LQNLQGLDLSYNNIQGSIPSELC--QLESLNTLLLQ 524 (1624)
Q Consensus 456 l~g~ip~~-~~~l~~L~~L~L~~N~l~g~iP~~~~~--------l~~L~~L~Ls~N~l~g~iP~~l~--~l~~L~~L~L~ 524 (1624)
+. .+|.. +..+++|++|+|++|+++ .+|..+.. +++|++|+|++|+++ .+|..+. .+++|+.|+|+
T Consensus 445 l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls 521 (636)
T 4eco_A 445 IS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLS 521 (636)
T ss_dssp CC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECC
T ss_pred cC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECC
Confidence 22 11211 223444445555555544 33332221 125555555555555 4555554 55555555555
Q ss_pred cccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCc
Q 047591 525 GNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSI 604 (1624)
Q Consensus 525 ~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~i 604 (1624)
+|++++ +|..++++++|+.|+|++|+ ++++|++.+.+|.+++++++|+.|+|++|++ +.|
T Consensus 522 ~N~l~~-ip~~~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~i 581 (636)
T 4eco_A 522 YNSFSK-FPTQPLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKV 581 (636)
T ss_dssp SSCCSS-CCCGGGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBC
T ss_pred CCCCCC-cChhhhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-Ccc
Confidence 555554 55555555555555555444 3366778888888888888888888888888 578
Q ss_pred cccccCCccccccccccCCCC
Q 047591 605 PSSIGGLKDLTYLALARNGFQ 625 (1624)
Q Consensus 605 P~~~~~l~~L~~L~ls~N~l~ 625 (1624)
|..+. ++|+.|||++|++.
T Consensus 582 p~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 582 NEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp CSCCC--TTCCEEECCSCTTC
T ss_pred CHhHh--CcCCEEECcCCCCc
Confidence 87766 68888888888654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=594.35 Aligned_cols=550 Identities=22% Similarity=0.217 Sum_probs=468.9
Q ss_pred CccceeeEecCC---------CCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccC
Q 047591 76 VCNWVGVTCGSR---------HGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSS 146 (1624)
Q Consensus 76 ~C~W~Gv~C~~~---------~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 146 (1624)
.|.++-|.|... ..+++.|+|+++++.+..+..|+++++|++|+|++|++++..|..++.+++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 356666777642 25789999999999997777899999999999999999998999999999999999999
Q ss_pred CCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCC
Q 047591 147 NRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF 226 (1624)
Q Consensus 147 N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~ 226 (1624)
|+++ .+|+..+.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|++++..
T Consensus 83 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 83 NELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 9998 478777889999999999999999877789999999999999999999999999999999999999999999877
Q ss_pred CCccc--ccCccchheeccccccCCCCccccccC---------------------------CCCcEeecccccccCcCCc
Q 047591 227 PPTIF--NVSSLRVIVLANNSLFGSLPVDLCRRL---------------------------PSLQELNLRDCMTTGRIPK 277 (1624)
Q Consensus 227 p~~~~--~l~~L~~L~L~~N~l~g~ip~~~~~~l---------------------------~~L~~L~Ls~N~l~g~ip~ 277 (1624)
|..+. .+++|++|++++|++++..|.. +..+ ++|+.|++++|.+++..|.
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKEFSPGC-FHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCCBCTTG-GGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred HHHhhccccccccEEECCCCcccccChhh-hhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 77654 5689999999999998655543 3332 5678888999999999999
Q ss_pred cccccCc--CCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCC-
Q 047591 278 DIGNCTL--LNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSG- 354 (1624)
Q Consensus 278 ~~~~l~~--L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g- 354 (1624)
.+..++. |+.|+|++|++. +..|..+.++++|++|+|++|++++..|..+. .+++|++|+|++|...+
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~--------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~~~~~~~ 311 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLN--------VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQS 311 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCC--------EECTTTTTTCTTCCEEECCSCCBSEECTTTTT-TCTTCCEEECTTCBCCC-
T ss_pred HhhccCcCCCCEEECCCCCcC--------ccCcccccCcccccEeeCCCCccCccChhhhc-CCCCccEEeccchhhhcc
Confidence 9998866 999999887654 44567788899999999999999987776665 78999999999887665
Q ss_pred ----cCcc----cccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeee
Q 047591 355 ----VIPS----SICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAI 426 (1624)
Q Consensus 355 ----~iP~----~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l 426 (1624)
.+|. .|..+++|++|+|++|++++..+..|.++++|++|+|++|.+....++.. .+..+ ....|+.|++
T Consensus 312 ~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~--~f~~~-~~~~L~~L~L 388 (680)
T 1ziw_A 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE--TFVSL-AHSPLHILNL 388 (680)
T ss_dssp -----CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTT--TTGGG-TTSCCCEEEC
T ss_pred cccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchh--hhccc-ccCcCceEEC
Confidence 3444 78889999999999999999999999999999999999998643222211 11111 1257999999
Q ss_pred ccCCCCccCCCcccCccccchhhccCCcccCCCCC-CCcCCCCcccEEeccCCccCCCccchhccccccceecccccccc
Q 047591 427 QTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIP-AEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQ 505 (1624)
Q Consensus 427 ~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip-~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 505 (1624)
++|++++..|..+..+. +|++|++++|.+.+.+| ..|.++++|++|+|++|++++..|..+..+++|+.|++++|.++
T Consensus 389 ~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 467 (680)
T 1ziw_A 389 TKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467 (680)
T ss_dssp TTSCCCEECTTTTTTCT-TCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCB
T ss_pred CCCCCCeEChhhhhCCC-CCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccc
Confidence 99999999998888886 89999999999998777 68999999999999999999888899999999999999999997
Q ss_pred --cCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCc--------hhhccccccceeeccccc
Q 047591 506 --GSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIP--------STFWSLEYILVVDFSLNL 575 (1624)
Q Consensus 506 --g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP--------~~~~~l~~L~~ldLs~N~ 575 (1624)
+.+|..+.++++|+.|+|++|++++..|..|+++++|++|+|++|++++..+ ..|..+.+|+.|||++|+
T Consensus 468 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 547 (680)
T 1ziw_A 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547 (680)
T ss_dssp CTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSC
T ss_pred ccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCC
Confidence 6789999999999999999999998878889999999999999999986422 247899999999999999
Q ss_pred ccCCCC-cccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhhh-ccccccCC
Q 047591 576 LSGCLP-QDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIG-SLISLEKG 641 (1624)
Q Consensus 576 l~g~iP-~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~-~l~~L~~~ 641 (1624)
++. +| ..++++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+. .+++|+..
T Consensus 548 l~~-i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l 614 (680)
T 1ziw_A 548 FDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614 (680)
T ss_dssp CCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEE
T ss_pred CCC-CCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEE
Confidence 995 55 4689999999999999999976666678999999999999999998887776 56666653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=597.57 Aligned_cols=518 Identities=18% Similarity=0.227 Sum_probs=355.1
Q ss_pred CChhhHHHHHHHHHHhccCCccccccCCCCCCCCCCCCCCCCccc------------eeeEecCCCCcEEEEecCCCCCC
Q 047591 35 NITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNW------------VGVTCGSRHGRVTDLSIPNLGLG 102 (1624)
Q Consensus 35 ~~~~d~~aLl~~k~~~~~~p~~~~~~~W~~~~~~~~~~~~~~C~W------------~Gv~C~~~~~~v~~l~l~~~~l~ 102 (1624)
+..+|++||++||+++. +| +|+.+.+.+ ....++|.| .||+|+. ++||+.|+|+++++.
T Consensus 266 ~~~~d~~ALl~~k~~l~-~~------~W~~~~~~~-~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALD-GK------NWRYYSGTI-NNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK 336 (876)
T ss_dssp HHHHHHHHHHHHHHHTT-GG------GCCCCCSSC-SSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred cchHHHHHHHHHHHHcC-CC------CCCcCCCcc-cccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence 34679999999999994 55 787543111 112334999 9999987 699999999999999
Q ss_pred ccCCccccCCCcccEEEe-cCCCccccCCcccCCCC-CCcE--------------EE-ccCCCCCCccchhh--------
Q 047591 103 GTIPPHVANLSFLVSLNI-SGNRFHGTLPNELWLMP-RLRI--------------ID-LSSNRISGNLFDDM-------- 157 (1624)
Q Consensus 103 g~ip~~i~~L~~L~~L~L-s~N~l~g~iP~~~~~l~-~L~~--------------L~-Ls~N~l~g~~~~~~-------- 157 (1624)
|.+|++|++|++|++|+| ++|.++|..|-...... .+.. ++ .....+++.++..+
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 99999988654322110 0000 00 00001110000000
Q ss_pred --hccCCCcCEEEccC--CcccccCCccccCCCcccccccccccccc-----------------cccCccc--ccccccc
Q 047591 158 --CNSLTELESFDVSS--NQITGQLPSSLGDCSKLKRLSVSFNELTG-----------------RIPQNIG--NLTELME 214 (1624)
Q Consensus 158 --~~~l~~L~~L~Ls~--N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g-----------------~ip~~~~--~l~~L~~ 214 (1624)
..+...++.+.+.. |+|+| ||.+|++|++|++|+|++|+|+| .+|+.++ ++++|++
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 01122333334433 77777 77777777777777777777777 4888887 8899999
Q ss_pred eeccCCcCCCCCCCcccccCccchheecccc-ccC-CCCcccc------ccCCCCcEeecccccccCcCCc--cccccCc
Q 047591 215 LYLNGNNLQGEFPPTIFNVSSLRVIVLANNS-LFG-SLPVDLC------RRLPSLQELNLRDCMTTGRIPK--DIGNCTL 284 (1624)
Q Consensus 215 L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~-l~g-~ip~~~~------~~l~~L~~L~Ls~N~l~g~ip~--~~~~l~~ 284 (1624)
|+|++|++.|.+|..++++++|++|+|++|+ ++| .+|..+. ..+++|++|+|++|+++ .+|. .|+++++
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 9999999888899888889999999999998 887 7887552 23448999999999988 8888 8899999
Q ss_pred CCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCC-ccEEEecCCccCCcCcccccCC
Q 047591 285 LNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPN-LLRLYLWGNNLSGVIPSSICNA 363 (1624)
Q Consensus 285 L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~-L~~L~Ls~N~l~g~iP~~~~~l 363 (1624)
|+.|+|++|++. .|| .+.++++|+.|+|++|+++ .+|..++ .+++ |+.|+|++|+|+ .+|..+..+
T Consensus 575 L~~L~Ls~N~l~---------~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~-~l~~~L~~L~Ls~N~L~-~lp~~~~~~ 641 (876)
T 4ecn_A 575 LGLLDCVHNKVR---------HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFC-AFTDQVEGLGFSHNKLK-YIPNIFNAK 641 (876)
T ss_dssp CCEEECTTSCCC---------BCC-CCCTTSEESEEECCSSCCS-CCCTTSC-EECTTCCEEECCSSCCC-SCCSCCCTT
T ss_pred CCEEECCCCCcc---------cch-hhcCCCcceEEECcCCccc-cchHHHh-hccccCCEEECcCCCCC-cCchhhhcc
Confidence 999988887654 366 7778888999999999988 8888765 6777 999999999988 678888777
Q ss_pred CC--CcEEecCCccccccCcccc---c--ccccccEEEccccccccCCCCCCccccccc-ccccccceeeeccCCCCccC
Q 047591 364 SK--LTVLELSRNLFSGLVANTF---G--NCRQLQILNLAYSQLATGSLSQGQSFFSSL-TNCRYLRYLAIQTNPWKGIL 435 (1624)
Q Consensus 364 ~~--L~~L~Ls~N~l~g~~~~~f---~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l-~~l~~L~~L~l~~N~~~g~~ 435 (1624)
+. |+.|+|++|+++|.+|... + .+++|+.|+|++|++.. ++..+ ..+++|+.|++++|.++ .+
T Consensus 642 ~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~--------lp~~~~~~l~~L~~L~Ls~N~L~-~i 712 (876)
T 4ecn_A 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK--------FPTELFATGSPISTIILSNNLMT-SI 712 (876)
T ss_dssp CSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS--------CCHHHHHTTCCCSEEECCSCCCS-CC
T ss_pred ccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc--------cCHHHHccCCCCCEEECCCCcCC-cc
Confidence 55 9999999999988776433 2 34478888888887753 11222 24455555666655554 33
Q ss_pred CCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhc--cccccceecccccccccCCCcccc
Q 047591 436 PNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVG--KLQNLQGLDLSYNNIQGSIPSELC 513 (1624)
Q Consensus 436 p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~--~l~~L~~L~Ls~N~l~g~iP~~l~ 513 (1624)
|..+.... +..+.++++|++|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..++
T Consensus 713 p~~~~~~~-----------------~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~ 773 (876)
T 4ecn_A 713 PENSLKPK-----------------DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773 (876)
T ss_dssp CTTSSSCT-----------------TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGG
T ss_pred ChHHhccc-----------------cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhh
Confidence 33222110 112334556666666666666 5666665 66666666666666665 566666
Q ss_pred CCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCccccccccccee
Q 047591 514 QLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGL 593 (1624)
Q Consensus 514 ~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L 593 (1624)
++++|+.|+|++|+ ++++|++.+.+|..|.++.+|+.|+|++|++ +.||..+. ++|+.|
T Consensus 774 ~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~L 832 (876)
T 4ecn_A 774 NSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYIL 832 (876)
T ss_dssp GCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEE
T ss_pred cCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEE
Confidence 66666666666655 4455666666666666666666666666666 56676655 467777
Q ss_pred eccCCcCCCCccccccCCccccccccccCCCC
Q 047591 594 YLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ 625 (1624)
Q Consensus 594 ~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 625 (1624)
||++|++...-+..+.....+..+.|++|++.
T Consensus 833 dLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 833 DIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp ECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred ECCCCCCCccChHHccccccchheeecCCCcc
Confidence 77777776544555555555566666666554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=575.72 Aligned_cols=548 Identities=20% Similarity=0.225 Sum_probs=461.5
Q ss_pred EEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCC
Q 047591 93 DLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSN 172 (1624)
Q Consensus 93 ~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N 172 (1624)
.++.++++++ .+|..+. ++|++|+|++|++++..|..|+.+++|++|||++|++++ ++++.+.++++|++|+|++|
T Consensus 8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCC-CCTTHHHHCTTCCEEECCSS
T ss_pred eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCc-cCHHHHhcccCcCEEECCCC
Confidence 4677888875 4787765 789999999999998777889999999999999999986 45566788999999999999
Q ss_pred cccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCc
Q 047591 173 QITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPV 252 (1624)
Q Consensus 173 ~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~ 252 (1624)
++++..+.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|.+++..|.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99965555799999999999999999977778999999999999999999999999999999999999999999865554
Q ss_pred cc-cccCCCCcEeecccccccCcCCccccccCcCCeeeccCCccc-------------------ccCccccccccccccc
Q 047591 253 DL-CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT-------------------DFGANNLTGLIPSIIF 312 (1624)
Q Consensus 253 ~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~-------------------~l~~n~l~g~ip~~~~ 312 (1624)
.+ +..+++|++|++++|++++..|..++.+.+|+.|++++|++. +++.|.+++..|..+.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 33 125689999999999999999999999999988888877542 4566777887888887
Q ss_pred cCCC--ccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccc-----cCc----
Q 047591 313 NNSN--IEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG-----LVA---- 381 (1624)
Q Consensus 313 ~~~~--L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-----~~~---- 381 (1624)
++.. |+.|+|++|++++..|..+. .+++|++|+|++|++++.+|..|.++++|++|+|++|...+ .+|
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred ccCcCCCCEEECCCCCcCccCccccc-CcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 7754 99999999998876666554 78889999999999988888888889999999998876554 222
Q ss_pred ccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCcc-CC-CcccCcc-ccchhhccCCcccCC
Q 047591 382 NTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGI-LP-NSVGNLS-KSLEYFYAGSCELGG 458 (1624)
Q Consensus 382 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~-~p-~~~~~l~-~~L~~L~l~~n~l~g 458 (1624)
..|+.+++|++|+|++|++.... +..+..+++|++|++++|.+.+. ++ ..+..+. ..|+.|++++|++.+
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~-------~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~ 395 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIK-------SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCC-------TTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCE
T ss_pred hhcccCCCCCEEECCCCccCCCC-------hhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCe
Confidence 37888899999999999886522 23466788899999998876543 22 2232221 368899999999999
Q ss_pred CCCCCcCCCCcccEEeccCCccCCCcc-chhccccccceecccccccccCCCccccCCCCCceeeccccccc--CCCccc
Q 047591 459 GIPAEFGNLSNIIALSLYQNQLASTIP-TTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQ--NQIPTC 535 (1624)
Q Consensus 459 ~ip~~~~~l~~L~~L~L~~N~l~g~iP-~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~--g~iP~~ 535 (1624)
..|.+|..+++|++|+|++|++++.+| ..+..+++|++|+|++|++++..|..+..+++|+.|++++|.++ +.+|..
T Consensus 396 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~ 475 (680)
T 1ziw_A 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCT
T ss_pred EChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcc
Confidence 999999999999999999999998777 68899999999999999999888999999999999999999997 678999
Q ss_pred cccccCCccccccCccccccCchhhccccccceeecccccccCCC--------CcccccccccceeeccCCcCCCCccc-
Q 047591 536 LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCL--------PQDIGNLKVLTGLYLSGNQLSCSIPS- 606 (1624)
Q Consensus 536 ~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~i--------P~~l~~l~~L~~L~Ls~N~l~g~iP~- 606 (1624)
|+++++|+.|+|++|++++..|..|..+.+|+.|||++|++++.. +..++++++|+.|+|++|+++ .||.
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~ 554 (680)
T 1ziw_A 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVE 554 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTT
T ss_pred cccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHH
Confidence 999999999999999999888888999999999999999998632 234789999999999999999 5665
Q ss_pred cccCCccccccccccCCCCCCCchhhhccccccCCCCCCCCCccccCC
Q 047591 607 SIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTE 654 (1624)
Q Consensus 607 ~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~~~~i~~~~~~~~~~~ 654 (1624)
.|+++++|+.|+|++|++++..|..+..+.+|+...+. ++++...++
T Consensus 555 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~-~N~l~~~~~ 601 (680)
T 1ziw_A 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ-KNLITSVEK 601 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECT-TSCCCBCCH
T ss_pred HcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECC-CCcCCccCh
Confidence 68999999999999999997666667888888876553 345544443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=573.79 Aligned_cols=510 Identities=23% Similarity=0.219 Sum_probs=404.5
Q ss_pred cCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCcccc
Q 047591 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLG 183 (1624)
Q Consensus 104 ~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~ 183 (1624)
.+|..+.. .+++|+|++|++++..|..|+.+++|++|+|++|++++ ++++.+.++++|++|+|++|++++..|..|+
T Consensus 26 ~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 102 (606)
T 3t6q_A 26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALS 102 (606)
T ss_dssp SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCSEECTTTTS
T ss_pred cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccce-eChhhccCccccCeeeCCCCcccccChhhhc
Confidence 35555543 57888999999888778888888999999999988875 4555567888899999999988888888888
Q ss_pred CCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCc-
Q 047591 184 DCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQ- 262 (1624)
Q Consensus 184 ~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~- 262 (1624)
++++|++|+|++|++++..|..++++++|++|+|++|++++..++.+..+++|++|+|++|.+++ ++...+..+++|+
T Consensus 103 ~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~ 181 (606)
T 3t6q_A 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATN 181 (606)
T ss_dssp SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE-ECHHHHHTTTTCCS
T ss_pred ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc-cChhhhhhhcccce
Confidence 88999999999998887667888888889999999998887444445558889999999988874 4445567788888
Q ss_pred -EeecccccccCcCCccccccCcCCeeeccCCc---------------------ccccCccccccccccccccCCCccEE
Q 047591 263 -ELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQ---------------------LTDFGANNLTGLIPSIIFNNSNIEVI 320 (1624)
Q Consensus 263 -~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~---------------------l~~l~~n~l~g~ip~~~~~~~~L~~L 320 (1624)
.|++++|.+++..|..+.. .+|+.|++++|. +.+.....++......+.. .+|+.|
T Consensus 182 l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~-~~L~~L 259 (606)
T 3t6q_A 182 LSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE-MSVESI 259 (606)
T ss_dssp EEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGG-SEEEEE
T ss_pred eEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhc-CceeEE
Confidence 8888888888877776654 578888888774 1111112222222222221 278889
Q ss_pred EeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEcccccc
Q 047591 321 QLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400 (1624)
Q Consensus 321 ~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l 400 (1624)
++++|++++ +|...+..+++|++|+|++|+++ .+|..+.++++|++|+|++|.+++.+|..|+++++|++|++++|++
T Consensus 260 ~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~ 337 (606)
T 3t6q_A 260 NLQKHYFFN-ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337 (606)
T ss_dssp ECTTCCCSS-CCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSS
T ss_pred EeecCccCc-cCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCc
Confidence 999999885 44444457889999999999988 6788888899999999999999988888899999999999999887
Q ss_pred ccCCCCCCcccccccccccccceeeeccCCCCccC--CCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCC
Q 047591 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGIL--PNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQN 478 (1624)
Q Consensus 401 ~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~--p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N 478 (1624)
... + ....+..+++|++|++++|.+.+.. |..+..+. +|++|++++|.+.+..|..|+++++|++|+|++|
T Consensus 338 ~~~-~-----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 410 (606)
T 3t6q_A 338 RLE-L-----GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS-HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410 (606)
T ss_dssp CCB-C-----CSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCT-TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTC
T ss_pred ccc-c-----chhhhhccCcCCEEECCCCccccccCcchhcccCC-CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCC
Confidence 521 1 1234667888889999999888765 66777776 7888888888888888888888888888888888
Q ss_pred ccCCCccc-hhccccccceecccccccccCCCccccCCCCCceeecccccccCC---CccccccccCCccccccCccccc
Q 047591 479 QLASTIPT-TVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQ---IPTCLANLTSLRALNLSSNRLNS 554 (1624)
Q Consensus 479 ~l~g~iP~-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~---iP~~~~~l~~L~~L~Ls~N~l~g 554 (1624)
++++..|. .+..+++|++|++++|.+++..|..+.++++|+.|+|++|++++. .+..+..+++|+.|+|++|++++
T Consensus 411 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 490 (606)
T 3t6q_A 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490 (606)
T ss_dssp CEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCE
T ss_pred cCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCc
Confidence 88877655 478888888888888888888888888888888888888888762 33668888888888888888888
Q ss_pred cCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCc
Q 047591 555 TIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIP 629 (1624)
Q Consensus 555 ~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP 629 (1624)
..|..|..+++|+.|||++|++++.+|..+.+++.| .|+|++|++++.+|..++.+++|+.|++++|++++..+
T Consensus 491 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 888888888888888888888888888888888888 88888888888888888888888888888888887666
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=558.40 Aligned_cols=500 Identities=19% Similarity=0.200 Sum_probs=436.6
Q ss_pred EecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccc
Q 047591 119 NISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNEL 198 (1624)
Q Consensus 119 ~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l 198 (1624)
+.++..++ .+|..+. +++++|||++|+|++ +++..+.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 18 ~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 18 NCENLGLN-EIPGTLP--NSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp ECTTSCCS-SCCTTSC--TTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred ECCCCCcc-cCcCCCC--CcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 33445555 6777665 379999999999985 5566678999999999999999999999999999999999999999
Q ss_pred cccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccC-CCCccccccCCCCcEeecccccccCcCCc
Q 047591 199 TGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFG-SLPVDLCRRLPSLQELNLRDCMTTGRIPK 277 (1624)
Q Consensus 199 ~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~ 277 (1624)
++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|++++ .+|. . ..+++|++|++++|.+++..|.
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~-~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK-G-FPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCT-T-CCCTTCCEEECCSSCCCEECHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCccc-c-cCCcccCEEEcccCcccccChh
Confidence 99999999999999999999999998778889999999999999999986 3343 3 3499999999999999999999
Q ss_pred cccccCcCC--eeeccCCcccccCccccccccccccccCCCccEEEeecccC---------------------C----CC
Q 047591 278 DIGNCTLLN--YLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHL---------------------S----GN 330 (1624)
Q Consensus 278 ~~~~l~~L~--~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l---------------------~----g~ 330 (1624)
.++.+++|+ .|++++|++.. ..|. .+...+|+.|++++|.- . ..
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~--------~~~~-~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~ 242 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAG--------IEPG-AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCE--------ECTT-TTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCC
T ss_pred hhhhhcccceeEEecCCCccCc--------cChh-HhhhccccccccCCchhHHHHhhhccccchhheechhhccccccc
Confidence 999999999 88988887654 3333 34456788888887751 0 12
Q ss_pred CCCcccccCC--CccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCC
Q 047591 331 LPSSTGINLP--NLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQG 408 (1624)
Q Consensus 331 ip~~~~~~l~--~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~ 408 (1624)
++...+..+. +|+.|++++|++++..|..|.++++|++|+|++|+++ .+|..|+++++|++|+|++|++...
T Consensus 243 i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~----- 316 (606)
T 3t6q_A 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENL----- 316 (606)
T ss_dssp CCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBG-----
T ss_pred cChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcC-----
Confidence 2222222222 7999999999999988888999999999999999999 5677899999999999999998642
Q ss_pred cccccccccccccceeeeccCCCCccCCCc-ccCccccchhhccCCcccCCCC--CCCcCCCCcccEEeccCCccCCCcc
Q 047591 409 QSFFSSLTNCRYLRYLAIQTNPWKGILPNS-VGNLSKSLEYFYAGSCELGGGI--PAEFGNLSNIIALSLYQNQLASTIP 485 (1624)
Q Consensus 409 ~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~-~~~l~~~L~~L~l~~n~l~g~i--p~~~~~l~~L~~L~L~~N~l~g~iP 485 (1624)
.+..+..+++|++|++++|.+.+.+|.. +..+. +|++|++++|.+.+.. |..++++++|++|+|++|++++..|
T Consensus 317 --~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 393 (606)
T 3t6q_A 317 --CQISASNFPSLTHLSIKGNTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393 (606)
T ss_dssp --GGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT-TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECT
T ss_pred --chhhhhccCcCCEEECCCCCcccccchhhhhccC-cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCH
Confidence 2346778899999999999999888765 66665 8999999999999876 8899999999999999999999899
Q ss_pred chhccccccceecccccccccCCCcc-ccCCCCCceeecccccccCCCccccccccCCccccccCcccccc---Cchhhc
Q 047591 486 TTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNST---IPSTFW 561 (1624)
Q Consensus 486 ~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~---iP~~~~ 561 (1624)
..++.+++|++|+|++|++++..|.. +.++++|+.|+|++|++++..|..++.+++|++|+|++|++++. .+..+.
T Consensus 394 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 473 (606)
T 3t6q_A 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ 473 (606)
T ss_dssp TTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGG
T ss_pred HHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhc
Confidence 99999999999999999999887654 89999999999999999999999999999999999999999873 336799
Q ss_pred cccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhhhccccccCC
Q 047591 562 SLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLEKG 641 (1624)
Q Consensus 562 ~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~~~ 641 (1624)
.+.+|+.|++++|.+++.+|..++.+++|+.|+|++|++++.+|..+.+++.| +|++++|++++.+|..+..+++|+..
T Consensus 474 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L 552 (606)
T 3t6q_A 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTI 552 (606)
T ss_dssp GCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEE
T ss_pred cCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEE
Confidence 99999999999999999999999999999999999999999999999999999 99999999999999888888888765
Q ss_pred CC
Q 047591 642 EI 643 (1624)
Q Consensus 642 ~i 643 (1624)
.+
T Consensus 553 ~l 554 (606)
T 3t6q_A 553 NL 554 (606)
T ss_dssp EC
T ss_pred eC
Confidence 44
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=573.77 Aligned_cols=526 Identities=21% Similarity=0.205 Sum_probs=423.5
Q ss_pred ccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccC-CcccCCCCCCcEEEccCCCCCCccch
Q 047591 77 CNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTL-PNELWLMPRLRIIDLSSNRISGNLFD 155 (1624)
Q Consensus 77 C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~i-P~~~~~l~~L~~L~Ls~N~l~g~~~~ 155 (1624)
|+|..|-+ ...+++.|+|+++.+++..|..|.+|++|++|+|++|.+.+.+ |..|+.+++|++|+|++|++++. ++
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~-~p 90 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL-HP 90 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEE-CT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCccc-CH
Confidence 45666666 4467888888888888888888888888888888888776676 77788888888888888888754 44
Q ss_pred hhhccCCCcCEEEccCCcccccCCcc--ccCCCccccccccccccccccc-CcccccccccceeccCCcCCCCCCCcccc
Q 047591 156 DMCNSLTELESFDVSSNQITGQLPSS--LGDCSKLKRLSVSFNELTGRIP-QNIGNLTELMELYLNGNNLQGEFPPTIFN 232 (1624)
Q Consensus 156 ~~~~~l~~L~~L~Ls~N~l~g~iP~~--l~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 232 (1624)
+.+.++++|++|+|++|++++.+|.. |+++++|++|||++|.+++..| ..|+++++|++|+|++|++++..|..+..
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 55678888888888888888877765 8888888888888888887655 46888888888888888888888888887
Q ss_pred c--CccchheeccccccCCCCccccccCC------CCcEeecccccccCcCCcccccc---CcCCeeeccCCccc-ccCc
Q 047591 233 V--SSLRVIVLANNSLFGSLPVDLCRRLP------SLQELNLRDCMTTGRIPKDIGNC---TLLNYLGLRDNQLT-DFGA 300 (1624)
Q Consensus 233 l--~~L~~L~L~~N~l~g~ip~~~~~~l~------~L~~L~Ls~N~l~g~ip~~~~~l---~~L~~L~Ls~N~l~-~l~~ 300 (1624)
+ ++|+.|+|++|.+++.+|..+. .++ +|++|++++|.+++.+|..+... ++++.|+++++.+. +++.
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~ 249 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred ccCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccc
Confidence 7 7888888888888887776542 333 38888888888888888877654 56777777744332 2334
Q ss_pred cccccccccccccC--CCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccc
Q 047591 301 NNLTGLIPSIIFNN--SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378 (1624)
Q Consensus 301 n~l~g~ip~~~~~~--~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 378 (1624)
+.+.+..+..+..+ ++|+.|+|++|.+++..|..+ ..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++
T Consensus 250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 328 (844)
T 3j0a_A 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF-ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328 (844)
T ss_dssp SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS-SSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSC
T ss_pred cccCCCChhhhhccccCCccEEECCCCcccccChhhh-hcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCc
Confidence 44544444444443 689999999999987666555 479999999999999999989999999999999999999999
Q ss_pred cCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCC
Q 047591 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGG 458 (1624)
Q Consensus 379 ~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g 458 (1624)
..|..|.++++|++|+|++|++.... ...+..+++|++|++++|.+++... + .+|+.|++++|++.
T Consensus 329 ~~~~~~~~l~~L~~L~L~~N~i~~~~-------~~~~~~l~~L~~L~Ls~N~l~~i~~-----~-~~L~~L~l~~N~l~- 394 (844)
T 3j0a_A 329 LYSSNFYGLPKVAYIDLQKNHIAIIQ-------DQTFKFLEKLQTLDLRDNALTTIHF-----I-PSIPDIFLSGNKLV- 394 (844)
T ss_dssp CCSCSCSSCTTCCEEECCSCCCCCCC-------SSCSCSCCCCCEEEEETCCSCCCSS-----C-CSCSEEEEESCCCC-
T ss_pred cCHHHhcCCCCCCEEECCCCCCCccC-------hhhhcCCCCCCEEECCCCCCCcccC-----C-CCcchhccCCCCcc-
Confidence 99999999999999999999986432 2346778899999999999875322 2 37889999999998
Q ss_pred CCCCCcCCCCcccEEeccCCccCCC-ccchhccccccceecccccccccCCCc-cccCCCCCceeeccccccc-----CC
Q 047591 459 GIPAEFGNLSNIIALSLYQNQLAST-IPTTVGKLQNLQGLDLSYNNIQGSIPS-ELCQLESLNTLLLQGNALQ-----NQ 531 (1624)
Q Consensus 459 ~ip~~~~~l~~L~~L~L~~N~l~g~-iP~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~L~~N~l~-----g~ 531 (1624)
.+|.. ..+++.|++++|++++. .+..++.+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +.
T Consensus 395 ~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~ 471 (844)
T 3j0a_A 395 TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471 (844)
T ss_dssp CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCC
T ss_pred ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccccccc
Confidence 45654 46788999999999863 334567899999999999999975543 3566889999999999997 45
Q ss_pred CccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCC
Q 047591 532 IPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGL 611 (1624)
Q Consensus 532 iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l 611 (1624)
.|..|.++++|+.|+|++|++++.+|..|..+++|+.|||++|+|++..|..+. ++|+.|+|++|+|++.+|..+.
T Consensus 472 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~-- 547 (844)
T 3j0a_A 472 CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV-- 547 (844)
T ss_dssp CSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS--
T ss_pred chhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC--
Confidence 567788999999999999999998888899999999999999999986666665 8899999999999998887764
Q ss_pred ccccccccccCCCCCCCc
Q 047591 612 KDLTYLALARNGFQGSIP 629 (1624)
Q Consensus 612 ~~L~~L~ls~N~l~g~iP 629 (1624)
+|+.|++++|.+.+..+
T Consensus 548 -~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 548 -SLSVLDITHNKFICECE 564 (844)
T ss_dssp -SCCEEEEEEECCCCSSS
T ss_pred -CcCEEEecCCCcccccc
Confidence 67889999999987655
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=563.02 Aligned_cols=519 Identities=20% Similarity=0.182 Sum_probs=416.8
Q ss_pred CcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEE
Q 047591 89 GRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFD 168 (1624)
Q Consensus 89 ~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~ 168 (1624)
.+++.|+|+++.+.+..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++ ++++.++++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~-~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC-CCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc-cChhhcCCcccCCEEE
Confidence 457788888888887777788888888888888888887777788888888888888888875 3444557788888888
Q ss_pred ccCCcccccCCccccCCCcccccccccccccc-cccCcccccccccceeccCCcCCCCCCCcccccCccc----hheecc
Q 047591 169 VSSNQITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLR----VIVLAN 243 (1624)
Q Consensus 169 Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~----~L~L~~ 243 (1624)
|++|++++..|..++++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..++.+++|+ +|++++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 88888887666778888888888888888875 5688888888888888888888877777777777665 688888
Q ss_pred ccccCCCCccccccCCCCcEeeccccccc-CcCCccccccCcCCeeeccCCcccccCc-cccccccccccccCCCccEEE
Q 047591 244 NSLFGSLPVDLCRRLPSLQELNLRDCMTT-GRIPKDIGNCTLLNYLGLRDNQLTDFGA-NNLTGLIPSIIFNNSNIEVIQ 321 (1624)
Q Consensus 244 N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~L~~L~Ls~N~l~~l~~-n~l~g~ip~~~~~~~~L~~L~ 321 (1624)
|.++ .+|...+... +|++|++++|.++ +.+|..+++++.|+.+++..+.+..... ..+.+..+..+..+ +++.++
T Consensus 191 n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l-~l~~l~ 267 (606)
T 3vq2_A 191 NPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV-TIDEFR 267 (606)
T ss_dssp CCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS-EEEEEE
T ss_pred CCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhc-cHhhee
Confidence 8886 5666665444 7888888888776 4667777888888887776554332110 01122222223332 466777
Q ss_pred e-ecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEcccccc
Q 047591 322 L-YGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400 (1624)
Q Consensus 322 L-s~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l 400 (1624)
+ +.|.++|.+|. +..+++|+.|++++|.+.. +| .+..+++|+.|++++|.+ +.+| .+ .+++|++|++++|+.
T Consensus 268 l~~~~~~~~~~~~--~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~ 340 (606)
T 3vq2_A 268 LTYTNDFSDDIVK--FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKG 340 (606)
T ss_dssp ECCCTTCCGGGGS--CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSS
T ss_pred ccccccccccccc--cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcC
Confidence 7 77888888887 4478899999999999874 66 888889999999999999 5666 45 899999999999854
Q ss_pred ccCCCCCCcccccccccccccceeeeccCCCCcc--CCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCC
Q 047591 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGI--LPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQN 478 (1624)
Q Consensus 401 ~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~--~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N 478 (1624)
.. ...+..+++|++|++++|.+++. +|..+..+. .|++|++++|.+.+ +|..|..+++|++|++++|
T Consensus 341 ~~---------~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~-~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n 409 (606)
T 3vq2_A 341 SI---------SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN-SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHS 409 (606)
T ss_dssp CE---------ECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCS-CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTS
T ss_pred cc---------chhhccCCCCCEEECcCCccCCCcchhhhhccCC-cccEeECCCCcccc-chhhccCCCCCCeeECCCC
Confidence 32 11455788899999999998876 477777776 79999999999876 6688999999999999999
Q ss_pred ccCCCcc-chhccccccceecccccccccCCCccccCCCCCceeecccccccC-CCccccccccCCccccccCccccccC
Q 047591 479 QLASTIP-TTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQN-QIPTCLANLTSLRALNLSSNRLNSTI 556 (1624)
Q Consensus 479 ~l~g~iP-~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g-~iP~~~~~l~~L~~L~Ls~N~l~g~i 556 (1624)
++++..| ..+..+++|++|++++|++++.+|..++++++|+.|+|++|++++ .+|..++++++|+.|+|++|++++.+
T Consensus 410 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 489 (606)
T 3vq2_A 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489 (606)
T ss_dssp EEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred ccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccC
Confidence 9998877 688999999999999999999899999999999999999999998 47889999999999999999999988
Q ss_pred chhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCc-cccccccccCCCCCCCch
Q 047591 557 PSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLK-DLTYLALARNGFQGSIPE 630 (1624)
Q Consensus 557 P~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-~L~~L~ls~N~l~g~iP~ 630 (1624)
|..|..+++|+.|+|++|++++.+|..++++++|+.|+|++|+++ .+|..+..++ +|++|++++|++.+..+.
T Consensus 490 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred hhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999999999999999988999999999999999999999 7888898887 599999999999876663
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=547.66 Aligned_cols=517 Identities=19% Similarity=0.157 Sum_probs=447.8
Q ss_pred EecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCc
Q 047591 94 LSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQ 173 (1624)
Q Consensus 94 l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~ 173 (1624)
++.++.+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|||++|++++ +++..+.++++|++|+|++|+
T Consensus 16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCC
T ss_pred eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccc-cCHHHhhchhhcCEeECCCCc
Confidence 344444543 4666554 789999999999998888899999999999999999985 566667899999999999999
Q ss_pred ccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCC-CCCCcccccCccchheeccccccCCCCc
Q 047591 174 ITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQG-EFPPTIFNVSSLRVIVLANNSLFGSLPV 252 (1624)
Q Consensus 174 l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~ip~ 252 (1624)
+++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|+|++|++++..|
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~- 170 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV- 170 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT-
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh-
Confidence 999889999999999999999999998777899999999999999999986 689999999999999999999986444
Q ss_pred cccccCCCCc----EeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCC
Q 047591 253 DLCRRLPSLQ----ELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLS 328 (1624)
Q Consensus 253 ~~~~~l~~L~----~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~ 328 (1624)
..+..+++|+ +|++++|.+++..+..+... +|+.|+|++|.+.. +.+|..+.++++|+.+++..+.+.
T Consensus 171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~-------~~~~~~~~~l~~L~~l~l~~~~~~ 242 (606)
T 3vq2_A 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSS-------NIMKTCLQNLAGLHVHRLILGEFK 242 (606)
T ss_dssp TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCH-------HHHHHHHHTTTTCEEEEEEEECCT
T ss_pred hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccch-------hHHHHHhccccccccccccccccc
Confidence 4445666554 89999999997766666555 89999999887542 457888999999999999877765
Q ss_pred CC-----CCCcccccCC--CccEEEe-cCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEcccccc
Q 047591 329 GN-----LPSSTGINLP--NLLRLYL-WGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400 (1624)
Q Consensus 329 g~-----ip~~~~~~l~--~L~~L~L-s~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l 400 (1624)
+. ++......+. .++.+++ ..|.+++.+|. +..+++|+.|++++|.+...+ .+..+++|++|++++|++
T Consensus 243 ~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l 319 (606)
T 3vq2_A 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQL 319 (606)
T ss_dssp TSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCC
T ss_pred cCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh--hccccccCCEEEcccccC
Confidence 42 1111111111 5677888 88899999988 999999999999999997754 899999999999999999
Q ss_pred ccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCC--CCCCcCCCCcccEEeccCC
Q 047591 401 ATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGG--IPAEFGNLSNIIALSLYQN 478 (1624)
Q Consensus 401 ~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~--ip~~~~~l~~L~~L~L~~N 478 (1624)
... + .+ .+++|++|++++|...+.+ .++.+. .|++|++++|++++. +|..+..+++|++|+|++|
T Consensus 320 ~~l--------p-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n 386 (606)
T 3vq2_A 320 KQF--------P-TL-DLPFLKSLTLTMNKGSISF--KKVALP-SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386 (606)
T ss_dssp SSC--------C-CC-CCSSCCEEEEESCSSCEEC--CCCCCT-TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSC
T ss_pred ccc--------c-cC-CCCccceeeccCCcCccch--hhccCC-CCCEEECcCCccCCCcchhhhhccCCcccEeECCCC
Confidence 432 2 34 7889999999999776655 455665 899999999999877 4888999999999999999
Q ss_pred ccCCCccchhccccccceecccccccccCCC-ccccCCCCCceeecccccccCCCccccccccCCccccccCccccc-cC
Q 047591 479 QLASTIPTTVGKLQNLQGLDLSYNNIQGSIP-SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS-TI 556 (1624)
Q Consensus 479 ~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-~i 556 (1624)
++++ +|..+..+++|++|++++|++++..| ..+.++++|+.|++++|++++.+|..++++++|++|+|++|++++ .+
T Consensus 387 ~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 465 (606)
T 3vq2_A 387 GAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465 (606)
T ss_dssp SEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEE
T ss_pred cccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcch
Confidence 9985 77899999999999999999998888 689999999999999999999999999999999999999999998 47
Q ss_pred chhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhhhccc
Q 047591 557 PSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLI 636 (1624)
Q Consensus 557 P~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~ 636 (1624)
|..|..+.+|+.||+++|++++.+|..++.+++|+.|+|++|++++.+|..++++++|++|++++|+++ .+|..+..++
T Consensus 466 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~ 544 (606)
T 3vq2_A 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFP 544 (606)
T ss_dssp CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSC
T ss_pred HHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999 7888777775
Q ss_pred -cccCC
Q 047591 637 -SLEKG 641 (1624)
Q Consensus 637 -~L~~~ 641 (1624)
+|+..
T Consensus 545 ~~L~~l 550 (606)
T 3vq2_A 545 KSLAFF 550 (606)
T ss_dssp TTCCEE
T ss_pred ccCcEE
Confidence 46653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=549.66 Aligned_cols=511 Identities=22% Similarity=0.250 Sum_probs=437.2
Q ss_pred CCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccc
Q 047591 97 PNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176 (1624)
Q Consensus 97 ~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g 176 (1624)
++++++. +|. ..++|++|||++|++++..|..|..+++|++|||++|.+.+.++++.+.++++|++|+|++|++++
T Consensus 12 s~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~ 87 (844)
T 3j0a_A 12 RFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF 87 (844)
T ss_dssp SCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCE
T ss_pred cCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcc
Confidence 4445544 555 457899999999999999999999999999999999988888988888999999999999999999
Q ss_pred cCCccccCCCcccccccccccccccccCc--ccccccccceeccCCcCCCCCC-CcccccCccchheeccccccCCCCcc
Q 047591 177 QLPSSLGDCSKLKRLSVSFNELTGRIPQN--IGNLTELMELYLNGNNLQGEFP-PTIFNVSSLRVIVLANNSLFGSLPVD 253 (1624)
Q Consensus 177 ~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~--~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~ 253 (1624)
..|..|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|++++..| ..|+++++|++|+|++|.+++..|..
T Consensus 88 ~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~ 167 (844)
T 3j0a_A 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE 167 (844)
T ss_dssp ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGG
T ss_pred cCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHH
Confidence 99999999999999999999999888776 9999999999999999998765 57999999999999999999877765
Q ss_pred ccccC--CCCcEeecccccccCcCCccccccCc------CCeeeccCCcccccCcccccccccccccc---CCCccEEEe
Q 047591 254 LCRRL--PSLQELNLRDCMTTGRIPKDIGNCTL------LNYLGLRDNQLTDFGANNLTGLIPSIIFN---NSNIEVIQL 322 (1624)
Q Consensus 254 ~~~~l--~~L~~L~Ls~N~l~g~ip~~~~~l~~------L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~---~~~L~~L~L 322 (1624)
+ ..+ ++|+.|+|++|.+.+.+|..++.+.+ |+.|+|++|++. +.+|..+.. ..+++.+++
T Consensus 168 l-~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~--------~~~~~~~~~~l~~~~l~~L~l 238 (844)
T 3j0a_A 168 L-EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT--------VDITGNFSNAISKSQAFSLIL 238 (844)
T ss_dssp G-HHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSS--------TTTTSGGGGTSCSCCBSEEEC
T ss_pred c-ccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCc--------hhHHHHHHhhcCcccccceec
Confidence 5 455 89999999999999999999888877 999999988654 444554443 357888888
Q ss_pred ecccC---------CCCCCCcc-cccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccE
Q 047591 323 YGNHL---------SGNLPSST-GINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392 (1624)
Q Consensus 323 s~N~l---------~g~ip~~~-~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~ 392 (1624)
+.+.+ .+..+..+ +...++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|++
T Consensus 239 ~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 318 (844)
T 3j0a_A 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQV 318 (844)
T ss_dssp CSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCE
T ss_pred ccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCE
Confidence 74433 22111111 112378999999999999999999999999999999999999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccE
Q 047591 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIA 472 (1624)
Q Consensus 393 L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~ 472 (1624)
|+|++|++... .+..+..+++|++|++++|.+.+..+..+..+. +|++|++++|.+++ +..+++|+.
T Consensus 319 L~Ls~N~l~~~-------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~-----i~~~~~L~~ 385 (844)
T 3j0a_A 319 LNLSYNLLGEL-------YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE-KLQTLDLRDNALTT-----IHFIPSIPD 385 (844)
T ss_dssp EEEESCCCSCC-------CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCC-CCCEEEEETCCSCC-----CSSCCSCSE
T ss_pred EECCCCCCCcc-------CHHHhcCCCCCCEEECCCCCCCccChhhhcCCC-CCCEEECCCCCCCc-----ccCCCCcch
Confidence 99999999642 234677889999999999999988888888886 89999999999985 333889999
Q ss_pred EeccCCccCCCccchhccccccceecccccccccC-CCccccCCCCCceeecccccccCCCcc-ccccccCCccccccCc
Q 047591 473 LSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGS-IPSELCQLESLNTLLLQGNALQNQIPT-CLANLTSLRALNLSSN 550 (1624)
Q Consensus 473 L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~-iP~~l~~l~~L~~L~L~~N~l~g~iP~-~~~~l~~L~~L~Ls~N 550 (1624)
|++++|+++ .+|.. ..+++.|++++|++++. .+..++++++|+.|+|++|++++..+. .+..+++|+.|+|++|
T Consensus 386 L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N 461 (844)
T 3j0a_A 386 IFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461 (844)
T ss_dssp EEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESC
T ss_pred hccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCC
Confidence 999999998 56764 56899999999999963 234567899999999999999975543 4667899999999999
Q ss_pred ccc-----ccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCC
Q 047591 551 RLN-----STIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ 625 (1624)
Q Consensus 551 ~l~-----g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 625 (1624)
+++ +..|..|..+++|+.|||++|++++.+|..++.+++|+.|+|++|+|++..|..+. ++|+.|||++|+|+
T Consensus 462 ~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~ 539 (844)
T 3j0a_A 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLL 539 (844)
T ss_dssp CCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCC
T ss_pred ccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCC
Confidence 997 55567789999999999999999999999999999999999999999986666665 89999999999999
Q ss_pred CCCchhhhcccccc
Q 047591 626 GSIPEAIGSLISLE 639 (1624)
Q Consensus 626 g~iP~~~~~l~~L~ 639 (1624)
|.+|..+.++..|.
T Consensus 540 ~~~~~~~~~L~~l~ 553 (844)
T 3j0a_A 540 APNPDVFVSLSVLD 553 (844)
T ss_dssp CCCSCCCSSCCEEE
T ss_pred CCChhHhCCcCEEE
Confidence 99998876665544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=483.88 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=213.4
Q ss_pred CCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 4556688999999999999874 4678999999876666778999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEe
Q 047591 1410 LQYMPQGSLEKWLYSHN------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~ 1477 (1624)
||||++|+|.++|++.+ ..++|.++++|+.|||+||+|||+ ++||||||||+|||+|+++++||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 99999999999998643 468999999999999999999996 799999999999999999999999
Q ss_pred eecceeecCCCCCcc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCC
Q 047591 1478 DFGIAKLLDGVDSMK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLP 1555 (1624)
Q Consensus 1478 DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~ 1555 (1624)
|||+|+.....+... .....||++|||||++.++.|+.|+|||||||++|||+| |+.||.+....+. +.
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~-~~-------- 241 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IE-------- 241 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HH--------
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HH--------
Confidence 999998765433222 233579999999999999999999999999999999999 8999976432211 11
Q ss_pred hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1556 DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1556 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+....... .+..|+.++.+++.+||+.||++||||+|+++.|+++.+.
T Consensus 242 ----~i~~~~~~~--------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 ----CITQGRVLQ--------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----HHHHTCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHcCCCCC--------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111111111 1134677889999999999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=486.00 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=207.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3455678999999999999874 4678999999876666778999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1410 LQYMPQGSLEKWLYSHN--------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
||||++|+|.+++++.+ ..++|.++++|+.|||+||+|||+ .+||||||||+|||+|+++++|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEE
Confidence 99999999999998642 358999999999999999999996 7899999999999999999999
Q ss_pred EeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhc
Q 047591 1476 LGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
|+|||+|+.+...+.. ..+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+.
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--------- 269 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--------- 269 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---------
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---------
Confidence 9999999976543322 2334679999999999999999999999999999999999 8999976432111
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+.+...... ..+..|+.++.+++.+||+.||++||||+||++.|+.+...
T Consensus 270 -----~~~i~~g~~~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 -----IDCITQGREL-------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -----HHHHHHTCCC-------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHcCCCC-------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111000 01134677889999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=480.22 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=207.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+++...+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 455567889999999999998753 6999998643 34456889999999999999999999999864 568999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-Cc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-SM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-~~ 1491 (1624)
|++|+|.++|+.....++|.++++|+.|||+||+|||+ .+||||||||+|||+|+++++||+|||+|+...... ..
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 99999999999877789999999999999999999996 799999999999999999999999999998765332 22
Q ss_pred cccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1492 KQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.....+||+.|||||++. .+.|+.|+|||||||++|||+||+.||.+....... ...+.. ....
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-~~~~~~------------~~~~ 256 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-IFMVGR------------GYAS 256 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHHT------------TCCC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-HHHHhc------------CCCC
Confidence 334568999999999875 346999999999999999999999999764322111 111111 1000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
... ...+..|+..+.+++.+||+.+|++||||+||++.|+.++..+.
T Consensus 257 p~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 257 PDL---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCS---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCc---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 000 00113466778999999999999999999999999998876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=478.79 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=206.8
Q ss_pred CCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1340 SNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+++..++||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 467999999999999873 46789999986443 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEe
Q 047591 1413 MPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~ 1477 (1624)
|++|||.++|+... ..++|.++++|+.|||+||+|||+ .+||||||||+|||+|+++++||+
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~ 187 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKIS 187 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEEC
Confidence 99999999997532 358999999999999999999996 789999999999999999999999
Q ss_pred eecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCC
Q 047591 1478 DFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLP 1555 (1624)
Q Consensus 1478 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~ 1555 (1624)
|||+|+.+...+.. ......||++|||||++.++.|+.++|||||||++|||+| |+.||.+....+ +
T Consensus 188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~--------- 256 (308)
T 4gt4_A 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--V--------- 256 (308)
T ss_dssp CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--H---------
T ss_pred CcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--H---------
Confidence 99999976543322 2344679999999999999999999999999999999999 899997643211 1
Q ss_pred hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1556 DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1556 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.+.+...... +.+..|+..+.+++.+||+.||++||||+||++.|+.+
T Consensus 257 ---~~~i~~~~~~-------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 ---VEMIRNRQVL-------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHHHHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHHHHcCCCC-------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111111100 01235677899999999999999999999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=515.37 Aligned_cols=494 Identities=22% Similarity=0.253 Sum_probs=355.7
Q ss_pred CccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccch
Q 047591 76 VCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFD 155 (1624)
Q Consensus 76 ~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~ 155 (1624)
.|.|.|| |+.. +++++ ++|+.+. ++|++|+|++|++++..|..|+.+++|++|+|++|++++ +++
T Consensus 3 ~C~~~~~-c~~~----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~ 67 (549)
T 2z81_A 3 SCDASGV-CDGR----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEG 67 (549)
T ss_dssp EECTTSE-EECT----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCE-ECT
T ss_pred cCCCCce-EECC----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCc-cCh
Confidence 4999999 9643 23332 4565553 567777777777776666677776667766666666653 333
Q ss_pred hhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCc
Q 047591 156 DMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSS 235 (1624)
Q Consensus 156 ~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 235 (1624)
+.+.++++|++|+|++|++++..|..|+++++|++|+|++|++++. .+|..++++++
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-----------------------~~~~~~~~l~~ 124 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL-----------------------GVTSLFPNLTN 124 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSS-----------------------CSSCSCTTCTT
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCccccc-----------------------chhhhhhccCC
Confidence 3344455555555555555544444444444444444444444431 23444555555
Q ss_pred cchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCcccccccccccc-ccC
Q 047591 236 LRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSII-FNN 314 (1624)
Q Consensus 236 L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~-~~~ 314 (1624)
|++|++++|.+.+.+|...+..+++|++|++++|++++.+|..++.+++|+.|++++|.+.. +|..+ ..+
T Consensus 125 L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~---------~~~~~~~~l 195 (549)
T 2z81_A 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF---------LLEIFADIL 195 (549)
T ss_dssp CCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT---------HHHHHHHST
T ss_pred ccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccc---------cchhhHhhc
Confidence 55555555554445555555566667777777777777777777777778888777776432 34333 346
Q ss_pred CCccEEEeecccCCCCC--CCcccccCCCccEEEecCCccCCcCcc----cccCCCCCcEEecCCccccccC------cc
Q 047591 315 SNIEVIQLYGNHLSGNL--PSSTGINLPNLLRLYLWGNNLSGVIPS----SICNASKLTVLELSRNLFSGLV------AN 382 (1624)
Q Consensus 315 ~~L~~L~Ls~N~l~g~i--p~~~~~~l~~L~~L~Ls~N~l~g~iP~----~~~~l~~L~~L~Ls~N~l~g~~------~~ 382 (1624)
++|++|+|++|++++.. |..+...+++|+.|++++|++++..+. .+..+.+|+.|++++|.+.+.. ..
T Consensus 196 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~ 275 (549)
T 2z81_A 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275 (549)
T ss_dssp TTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTT
T ss_pred ccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchh
Confidence 78888888888887642 333444577888999999888876544 3456788899999999888753 23
Q ss_pred cccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCccc-CccccchhhccCCcccCCCCC
Q 047591 383 TFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVG-NLSKSLEYFYAGSCELGGGIP 461 (1624)
Q Consensus 383 ~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~-~l~~~L~~L~l~~n~l~g~ip 461 (1624)
.+..+.+|+.|++.++.+...... ...........+|+.|++++|.+. .+|..+. .+. +|++|++++|++.+.+|
T Consensus 276 ~~~~l~~L~~L~l~~~~i~~~~~~--~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~-~L~~L~Ls~N~l~~~~~ 351 (549)
T 2z81_A 276 VVSELGKVETVTIRRLHIPQFYLF--YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLK-SLEFLDLSENLMVEEYL 351 (549)
T ss_dssp CCCCCTTCCEEEEESCBCSCGGGS--CCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCT-TCCEEECCSSCCCHHHH
T ss_pred hhhhhcccccccccccccchhhhc--ccchhhhhhcccceEEEeccCccc-cCCHHHHhcCc-cccEEEccCCccccccc
Confidence 456778888898888876431100 001111233467889999999986 5776664 454 89999999999998774
Q ss_pred ---CCcCCCCcccEEeccCCccCCCcc--chhccccccceecccccccccCCCccccCCCCCceeecccccccCCCcccc
Q 047591 462 ---AEFGNLSNIIALSLYQNQLASTIP--TTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCL 536 (1624)
Q Consensus 462 ---~~~~~l~~L~~L~L~~N~l~g~iP--~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~ 536 (1624)
..++.+++|++|+|++|++++..+ ..++.+++|++|||++|+++ .+|..+..+++|++|+|++|+++ .+|..+
T Consensus 352 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~ 429 (549)
T 2z81_A 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI 429 (549)
T ss_dssp HHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS
T ss_pred cchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh
Confidence 458899999999999999986533 56899999999999999999 79999999999999999999998 466555
Q ss_pred ccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccc
Q 047591 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTY 616 (1624)
Q Consensus 537 ~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ 616 (1624)
. ++|+.|+|++|++++.+ ..+++|+.|||++|+++ .||. .+.+++|+.|+|++|++++.+|..++.+++|+.
T Consensus 430 ~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 501 (549)
T 2z81_A 430 P--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501 (549)
T ss_dssp C--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCE
T ss_pred c--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCE
Confidence 3 68999999999999853 57889999999999998 6887 578999999999999999988889999999999
Q ss_pred cccccCCCCCCCch
Q 047591 617 LALARNGFQGSIPE 630 (1624)
Q Consensus 617 L~ls~N~l~g~iP~ 630 (1624)
|++++|++++..|.
T Consensus 502 L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 502 IWLHTNPWDCSCPR 515 (549)
T ss_dssp EECCSSCBCCCHHH
T ss_pred EEecCCCccCCCcc
Confidence 99999999999883
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=509.66 Aligned_cols=498 Identities=20% Similarity=0.203 Sum_probs=421.9
Q ss_pred CCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccC
Q 047591 105 IPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGD 184 (1624)
Q Consensus 105 ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~ 184 (1624)
+|..+. +++++|+|++|++++..|..|..+++|++|||++|++++ ++++.+.++++|++|+|++|++++..|..|++
T Consensus 22 ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (570)
T 2z63_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (570)
T ss_dssp CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCc-cCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence 555443 468999999999998888899999999999999999985 66777788999999999999999888889999
Q ss_pred CCcccccccccccccccccCcccccccccceeccCCcCCC-CCCCcccccCccchheeccccccCCCCccccccCCCC--
Q 047591 185 CSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQG-EFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL-- 261 (1624)
Q Consensus 185 l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L-- 261 (1624)
+++|++|++++|++++..+..|+++++|++|+|++|++++ .+|..++++++|++|++++|++++ ++...++.+++|
T Consensus 99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~ 177 (570)
T 2z63_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPL 177 (570)
T ss_dssp CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE-ECGGGGHHHHTCTT
T ss_pred ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce-ecHHHccchhccch
Confidence 9999999999999996555579999999999999999987 589999999999999999999985 444555677788
Q ss_pred --cEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCC-----CCCCc
Q 047591 262 --QELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSG-----NLPSS 334 (1624)
Q Consensus 262 --~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g-----~ip~~ 334 (1624)
+.|++++|.+++..|..+..+ +|+.|+|++|... ...+|..+.++.+++.+++..+.+.. .++..
T Consensus 178 ~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~-------~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 249 (570)
T 2z63_A 178 LNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDS-------LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249 (570)
T ss_dssp CCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSC-------TTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTT
T ss_pred hhhhcccCCCCceecCHHHhccC-cceeEeccccccc-------ccchhhhhcCccccceeeeccccccCchhhhhcchh
Confidence 899999999999888888776 7999999987432 12456677777888877766544332 22332
Q ss_pred ccccCC--CccEEEecCC-ccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCccc
Q 047591 335 TGINLP--NLLRLYLWGN-NLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSF 411 (1624)
Q Consensus 335 ~~~~l~--~L~~L~Ls~N-~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~ 411 (1624)
.+..++ .++.+++++| .+.+.+|..+..+++|+.|++++|.+++ +|..+..+ +|++|++++|++...+
T Consensus 250 ~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~~l~------- 320 (570)
T 2z63_A 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFGQFP------- 320 (570)
T ss_dssp TTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCSSCC-------
T ss_pred hhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCcccccC-------
Confidence 222222 3677888888 8888899999999999999999999985 56677888 9999999999886321
Q ss_pred ccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCC--CCCcCCCCcccEEeccCCccCCCccchhc
Q 047591 412 FSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGI--PAEFGNLSNIIALSLYQNQLASTIPTTVG 489 (1624)
Q Consensus 412 ~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~i--p~~~~~l~~L~~L~L~~N~l~g~iP~~~~ 489 (1624)
. ..+++|+.|++++|.+.+.++. ..+. +|++|++++|++++.. |..+.++++|++|+|++|++++. |..+.
T Consensus 321 -~--~~l~~L~~L~l~~n~~~~~~~~--~~~~-~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~ 393 (570)
T 2z63_A 321 -T--LKLKSLKRLTFTSNKGGNAFSE--VDLP-SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFL 393 (570)
T ss_dssp -B--CBCSSCCEEEEESCBSCCBCCC--CBCT-TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEE
T ss_pred -c--ccccccCEEeCcCCcccccccc--ccCC-CCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-ccccc
Confidence 1 3567889999999998887765 4444 7899999999988664 77889999999999999999864 44599
Q ss_pred cccccceecccccccccCCC-ccccCCCCCceeecccccccCCCccccccccCCccccccCcccc-ccCchhhccccccc
Q 047591 490 KLQNLQGLDLSYNNIQGSIP-SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLN-STIPSTFWSLEYIL 567 (1624)
Q Consensus 490 ~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~-g~iP~~~~~l~~L~ 567 (1624)
.+++|++|++++|++++..| ..+.++++|++|++++|++++.+|..+.++++|+.|+|++|+++ +.+|..+..+++|+
T Consensus 394 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~ 473 (570)
T 2z63_A 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473 (570)
T ss_dssp TCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred ccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC
Confidence 99999999999999998776 57899999999999999999999999999999999999999998 68999999999999
Q ss_pred eeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCch
Q 047591 568 VVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPE 630 (1624)
Q Consensus 568 ~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~ 630 (1624)
.||+++|++++.+|.+++++++|+.|+|++|++++.+|..++++++|+.|++++|++++.+|.
T Consensus 474 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999999998899999999999999999999998888899999999999999999999885
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=465.23 Aligned_cols=274 Identities=20% Similarity=0.292 Sum_probs=201.7
Q ss_pred CCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC----eeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG----FKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~----~~~lV~ey 1412 (1624)
+...+.||+|+||+||+|++ +|+.||||+++..... ...+.+|+..+.+++|||||+++|+|.+++ ..+|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 44567899999999999998 5899999999654322 223345666667899999999999997654 57999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG-----YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
|++|+|.++++.. .++|+++++|+.|+|+||+|||+. +.++||||||||+|||+|+++++||+|||+|+....
T Consensus 83 ~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 9999999999865 489999999999999999999963 245999999999999999999999999999998764
Q ss_pred CCCc---cccccccccccccccccCCC------CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC-hh
Q 047591 1488 VDSM---KQTMTLATIGYMAPEYGSEG------IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP-DA 1557 (1624)
Q Consensus 1488 ~~~~---~~~~~~gt~~y~APE~~~~~------~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~-~~ 1557 (1624)
.... .....+||+.|||||++.+. .++.|+|||||||++|||+||+.|+............+...... +.
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3322 22345799999999987653 57889999999999999999988875432221111111110000 11
Q ss_pred HHHHH-hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1558 VTDVI-DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1558 ~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+...+ +..+....+.. ....+++..+.+++.+||+.||++||||.||++.|+++..+
T Consensus 241 ~~~~~~~~~~rp~~p~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTTSCCCCCCCGG--GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCCcc--ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111 11111111000 01124567789999999999999999999999999998753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=519.34 Aligned_cols=461 Identities=20% Similarity=0.289 Sum_probs=323.1
Q ss_pred CcccEEEecCCCccccCCcccCCCCCCcEEEccCCCC------CC------ccchhhhccCCCcCEEEccCCcccccCCc
Q 047591 113 SFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRI------SG------NLFDDMCNSLTELESFDVSSNQITGQLPS 180 (1624)
Q Consensus 113 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l------~g------~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~ 180 (1624)
.+++.|+|++|+++|.+|++++.|++|++|||++|.+ .| .+|+.. +..|+ ++++.|.+.+.+|.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~---~~~l~-l~l~~~~l~~~~~~ 156 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ---KQKMR-MHYQKTFVDYDPRE 156 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH---HHHHH-THHHHHHTCCCGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH---HHHHH-hhHHHhhhccCchh
Confidence 4689999999999999999999999999999999987 22 233332 23344 55555555555554
Q ss_pred cccC-CCcccccccccccccccccCcccccccccceecc--CCcCCCCCCCcccccCccchheeccccccCC--------
Q 047591 181 SLGD-CSKLKRLSVSFNELTGRIPQNIGNLTELMELYLN--GNNLQGEFPPTIFNVSSLRVIVLANNSLFGS-------- 249 (1624)
Q Consensus 181 ~l~~-l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls--~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~-------- 249 (1624)
.++. +..+..+++....+.. .....++.+++. +|+++| +|.+++++++|++|+|++|+|+|.
T Consensus 157 ~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 229 (636)
T 4eco_A 157 DFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229 (636)
T ss_dssp GSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred hHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence 4442 2333333433332221 112234444443 689999 999999999999999999999986
Q ss_pred ---------CCcccc-ccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCcccccc-ccccccccC----
Q 047591 250 ---------LPVDLC-RRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTG-LIPSIIFNN---- 314 (1624)
Q Consensus 250 ---------ip~~~~-~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g-~ip~~~~~~---- 314 (1624)
+|..+. .++++|++|+|++|++.|.+|+.|+++++|++|+|++|+ .++| .+|..++++
T Consensus 230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~-------~l~~~~lp~~~~~L~~~~ 302 (636)
T 4eco_A 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR-------GISGEQLKDDWQALADAP 302 (636)
T ss_dssp TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT-------TSCHHHHHHHHHHHHHSG
T ss_pred cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC-------CCccccchHHHHhhhccc
Confidence 898763 389999999999999999999999999999999999875 1567 799998887
Q ss_pred --CCccEEEeecccCCCCCCC--cccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCccccccccc-
Q 047591 315 --SNIEVIQLYGNHLSGNLPS--STGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQ- 389 (1624)
Q Consensus 315 --~~L~~L~Ls~N~l~g~ip~--~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~- 389 (1624)
++|++|+|++|+++ .+|. .++ ++++|++|+|++|+++|.+| .|+++++|++|+|++|+++ .+|..|+++++
T Consensus 303 ~l~~L~~L~L~~n~l~-~ip~~~~l~-~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~ 378 (636)
T 4eco_A 303 VGEKIQIIYIGYNNLK-TFPVETSLQ-KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQ 378 (636)
T ss_dssp GGGTCCEEECCSSCCS-SCCCHHHHT-TCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTT
T ss_pred cCCCCCEEECCCCcCC-ccCchhhhc-cCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhccc
Confidence 99999999999999 8998 665 79999999999999999999 9999999999999999999 67788999999
Q ss_pred ccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCcc-ccchhhccCCcccCCCCCCCcC---
Q 047591 390 LQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLS-KSLEYFYAGSCELGGGIPAEFG--- 465 (1624)
Q Consensus 390 L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~-~~L~~L~l~~n~l~g~ip~~~~--- 465 (1624)
|++|+|++|+++. +|..+.... ..|++|++++|++.+.+|.+|.
T Consensus 379 L~~L~Ls~N~l~~--------------------------------lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~ 426 (636)
T 4eco_A 379 VENLSFAHNKLKY--------------------------------IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426 (636)
T ss_dssp CCEEECCSSCCSS--------------------------------CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTC
T ss_pred CcEEEccCCcCcc--------------------------------cchhhhhcccCccCEEECcCCcCCCcchhhhcccc
Confidence 9999999888742 222222211 1344555555555555555555
Q ss_pred ----CCCcccEEeccCCccCCCccch-hccccccceecccccccccCCCccccCCCCCceeecccccccCCCcccccccc
Q 047591 466 ----NLSNIIALSLYQNQLASTIPTT-VGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLT 540 (1624)
Q Consensus 466 ----~l~~L~~L~L~~N~l~g~iP~~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~ 540 (1624)
.+.+|++|+|++|+++ .+|.. +..+++|++|+|++|+++ .+|..+.... +..+.+++
T Consensus 427 ~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~----------------~~~~~~l~ 488 (636)
T 4eco_A 427 PTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE----------------NENFKNTY 488 (636)
T ss_dssp SSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET----------------TEECTTGG
T ss_pred cccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc----------------cccccccC
Confidence 4445555555555554 23332 223455555555555555 3443322111 00011122
Q ss_pred CCccccccCccccccCchhhc--cccccceeecccccccCCCCcccccccccceeec------cCCcCCCCccccccCCc
Q 047591 541 SLRALNLSSNRLNSTIPSTFW--SLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYL------SGNQLSCSIPSSIGGLK 612 (1624)
Q Consensus 541 ~L~~L~Ls~N~l~g~iP~~~~--~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~L------s~N~l~g~iP~~~~~l~ 612 (1624)
+|+.|+|++|+++ .+|..+. .+++|+.|||++|++++ +|..++++++|+.|+| ++|++.+.+|..+++++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 5555555555555 4555554 55555555555555555 5666666666666666 78999999999999999
Q ss_pred cccccccccCCCCCCCchhhhccccccCCCCCCCCCccc
Q 047591 613 DLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVN 651 (1624)
Q Consensus 613 ~L~~L~ls~N~l~g~iP~~~~~l~~L~~~~i~~~~~~~~ 651 (1624)
+|++|+|++|++ +.||..+. ++|+...+ +++++..
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~L-s~N~l~~ 601 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKIT--PNISVLDI-KDNPNIS 601 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCC--TTCCEEEC-CSCTTCE
T ss_pred CCCEEECCCCcC-CccCHhHh--CcCCEEEC-cCCCCcc
Confidence 999999999999 78998754 56665444 3444443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=496.92 Aligned_cols=476 Identities=20% Similarity=0.219 Sum_probs=398.2
Q ss_pred CcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEE
Q 047591 89 GRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFD 168 (1624)
Q Consensus 89 ~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~ 168 (1624)
.+++.|+|+++.+.+..+..|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++ ++++.+..+++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc-cCHhhhcCcccccccc
Confidence 468899999999999888899999999999999999998888899999999999999999985 6667778999999999
Q ss_pred ccCCcccccCCccccCCCcccccccccccccc-cccCcccccccccceeccCCcCCCCCCCcccccCcc----chheecc
Q 047591 169 VSSNQITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSL----RVIVLAN 243 (1624)
Q Consensus 169 Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L----~~L~L~~ 243 (1624)
+++|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..++.+++| +.|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 99999997666689999999999999999997 589999999999999999999998888899999999 8999999
Q ss_pred ccccCCCCccccccCCCCcEeecccccccC-cCCccccccCcCCeeeccCCcc------cc------------------c
Q 047591 244 NSLFGSLPVDLCRRLPSLQELNLRDCMTTG-RIPKDIGNCTLLNYLGLRDNQL------TD------------------F 298 (1624)
Q Consensus 244 N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l------~~------------------l 298 (1624)
|.+++ ++...+..+ +|++|++++|.... .+|..++.++.|+.+++.-+.+ .. +
T Consensus 187 n~l~~-~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 264 (570)
T 2z63_A 187 NPMNF-IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264 (570)
T ss_dssp CCCCE-ECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred CCcee-cCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence 99985 455566554 89999999985432 3444455555554443321111 01 1
Q ss_pred Ccc-ccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCcccc
Q 047591 299 GAN-NLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377 (1624)
Q Consensus 299 ~~n-~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 377 (1624)
..+ .+.+.+|..+..+.+|+.|++++|.++ .+|..+. .+ +|++|++++|++. .+|. ..+++|+.|++++|.+.
T Consensus 265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~-~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~ 338 (570)
T 2z63_A 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY-NF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGG 338 (570)
T ss_dssp EETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCS-CC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSC
T ss_pred hcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhc-cC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccc
Confidence 111 567778899999999999999999998 6888876 56 9999999999999 6676 57889999999999999
Q ss_pred ccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccC
Q 047591 378 GLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457 (1624)
Q Consensus 378 g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~ 457 (1624)
+..+. ..+++|++|++++|+++... ..+..+..+++|++|++++|.+.
T Consensus 339 ~~~~~--~~~~~L~~L~l~~n~l~~~~-----~~~~~~~~~~~L~~L~l~~n~l~------------------------- 386 (570)
T 2z63_A 339 NAFSE--VDLPSLEFLDLSRNGLSFKG-----CCSQSDFGTTSLKYLDLSFNGVI------------------------- 386 (570)
T ss_dssp CBCCC--CBCTTCCEEECCSSCCBEEE-----EEEHHHHTCSCCCEEECCSCSEE-------------------------
T ss_pred ccccc--ccCCCCCEEeCcCCccCccc-----cccccccccCccCEEECCCCccc-------------------------
Confidence 87776 88999999999999886411 01233455566666666665543
Q ss_pred CCCCCCcCCCCcccEEeccCCccCCCcc-chhccccccceecccccccccCCCccccCCCCCceeeccccccc-CCCccc
Q 047591 458 GGIPAEFGNLSNIIALSLYQNQLASTIP-TTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQ-NQIPTC 535 (1624)
Q Consensus 458 g~ip~~~~~l~~L~~L~L~~N~l~g~iP-~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~-g~iP~~ 535 (1624)
+..+ .+..+++|++|++++|++++..| ..+..+++|++|+|++|++++.+|..+.++++|+.|+|++|+++ +.+|..
T Consensus 387 ~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~ 465 (570)
T 2z63_A 387 TMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465 (570)
T ss_dssp EEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred cccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhh
Confidence 3223 37778889999999999988766 57888999999999999999888999999999999999999998 678999
Q ss_pred cccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccc
Q 047591 536 LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPS 606 (1624)
Q Consensus 536 ~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 606 (1624)
++.+++|+.|+|++|++++..|..|..+++|+.|++++|++++.+|..++++++|+.|+|++|+++|.+|.
T Consensus 466 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred hhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999999999999998899999999999999999999998888899999999999999999998775
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=516.18 Aligned_cols=443 Identities=19% Similarity=0.224 Sum_probs=326.8
Q ss_pred CcccEEEecCCCccccCCcccCCCCCCcEEEc-cCCCCCCccchhhhcc---CCCcC--EE---------E-ccCCcccc
Q 047591 113 SFLVSLNISGNRFHGTLPNELWLMPRLRIIDL-SSNRISGNLFDDMCNS---LTELE--SF---------D-VSSNQITG 176 (1624)
Q Consensus 113 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~L-s~N~l~g~~~~~~~~~---l~~L~--~L---------~-Ls~N~l~g 176 (1624)
.+++.|+|++|+++|.+|++|+.|++|++||| ++|.++|..|-..... +..++ .+ + .....+++
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 56899999999999999999999999999999 9999988644321110 00000 00 0 00011111
Q ss_pred -----------cCCccccCCCccccccccc--ccccccccCcccccccccceeccCCcCCC-----------------CC
Q 047591 177 -----------QLPSSLGDCSKLKRLSVSF--NELTGRIPQNIGNLTELMELYLNGNNLQG-----------------EF 226 (1624)
Q Consensus 177 -----------~iP~~l~~l~~L~~L~Ls~--N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-----------------~~ 226 (1624)
..+........++.+.++. |+++| ||..|++|++|++|+|++|+|+| .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1122223445566666665 99998 99999999999999999999999 49
Q ss_pred CCccc--ccCccchheeccccccCCCCccccccCCCCcEeeccccc-ccC-cCCccccccC-------cCCeeeccCCcc
Q 047591 227 PPTIF--NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM-TTG-RIPKDIGNCT-------LLNYLGLRDNQL 295 (1624)
Q Consensus 227 p~~~~--~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~-l~g-~ip~~~~~l~-------~L~~L~Ls~N~l 295 (1624)
|+.++ ++++|++|+|++|++.|.+|..+ .++++|++|+|++|+ ++| .+|..+++++ +|+.|+|++|++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l-~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFL-YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGG-GGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHH-hCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 99988 99999999999999999999654 689999999999998 999 9999988887 999999998875
Q ss_pred cccCcccccccccc--ccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCC-CcEEecC
Q 047591 296 TDFGANNLTGLIPS--IIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASK-LTVLELS 372 (1624)
Q Consensus 296 ~~l~~n~l~g~ip~--~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~-L~~L~Ls 372 (1624)
. .||. .+.++++|+.|+|++|+++ .+| .+ ..+++|+.|+|++|+++ .+|..++++++ |+.|+|+
T Consensus 561 ~---------~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~-~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls 627 (876)
T 4ecn_A 561 E---------EFPASASLQKMVKLGLLDCVHNKVR-HLE-AF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFS 627 (876)
T ss_dssp C---------BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC-CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECC
T ss_pred C---------ccCChhhhhcCCCCCEEECCCCCcc-cch-hh-cCCCcceEEECcCCccc-cchHHHhhccccCCEEECc
Confidence 4 4788 8999999999999999999 999 44 48999999999999999 89999999999 9999999
Q ss_pred CccccccCccccccccc--ccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhc
Q 047591 373 RNLFSGLVANTFGNCRQ--LQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFY 450 (1624)
Q Consensus 373 ~N~l~g~~~~~f~~l~~--L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~ 450 (1624)
+|.|+ .+|..|..++. |+.|+|++|++... +|.
T Consensus 628 ~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~-------------------------------ip~------------- 662 (876)
T 4ecn_A 628 HNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSE-------------------------------GRN------------- 662 (876)
T ss_dssp SSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTT-------------------------------SSS-------------
T ss_pred CCCCC-cCchhhhccccCCCCEEECcCCcCCCc-------------------------------ccc-------------
Confidence 99999 66788888765 99999999888531 111
Q ss_pred cCCcccCCCCCCCcC--CCCcccEEeccCCccCCCccchhc-cccccceecccccccccCCCccccCCC--------CCc
Q 047591 451 AGSCELGGGIPAEFG--NLSNIIALSLYQNQLASTIPTTVG-KLQNLQGLDLSYNNIQGSIPSELCQLE--------SLN 519 (1624)
Q Consensus 451 l~~n~l~g~ip~~~~--~l~~L~~L~L~~N~l~g~iP~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~--------~L~ 519 (1624)
+|..++ .+.+|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|+ .+|..+.... +|+
T Consensus 663 ---------l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~ 731 (876)
T 4ecn_A 663 ---------ISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLT 731 (876)
T ss_dssp ---------CSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCC
T ss_pred ---------chhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCcc
Confidence 001111 1224555555555554 3333332 4455555555555555 4444333221 555
Q ss_pred eeecccccccCCCccccc--cccCCccccccCccccccCchhhccccccceeec------ccccccCCCCcccccccccc
Q 047591 520 TLLLQGNALQNQIPTCLA--NLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDF------SLNLLSGCLPQDIGNLKVLT 591 (1624)
Q Consensus 520 ~L~L~~N~l~g~iP~~~~--~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldL------s~N~l~g~iP~~l~~l~~L~ 591 (1624)
.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..++.+++|+.|+| ++|++.+.+|..++++++|+
T Consensus 732 ~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~ 809 (876)
T 4ecn_A 732 TIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI 809 (876)
T ss_dssp EEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCC
T ss_pred EEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCC
Confidence 5555555555 4555554 55555555555555554 4555555555555555 55999999999999999999
Q ss_pred eeeccCCcCCCCccccccCCccccccccccCCCCCCCchh
Q 047591 592 GLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEA 631 (1624)
Q Consensus 592 ~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~ 631 (1624)
.|+|++|++ +.||..+. ++|+.|||++|++...-+..
T Consensus 810 ~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~ 846 (876)
T 4ecn_A 810 QLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTS 846 (876)
T ss_dssp EEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGG
T ss_pred EEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHH
Confidence 999999999 79999987 69999999999997544443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=465.87 Aligned_cols=266 Identities=21% Similarity=0.360 Sum_probs=216.1
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccch-hhHHHHHHHHHHHHHhcCC-CceeEEEe
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQE-DRALKSFDAECEVMRRIRH-RNLAKIVS 1398 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~H-pNIv~l~g 1398 (1624)
.++++...++|...+.||+|+||+||+|++.. ++.||||+++... ....+.|.+|+++|++++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34555666788888999999999999998743 3579999986433 3456789999999999965 89999999
Q ss_pred eeccC-CeeEEEEEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCC
Q 047591 1399 SCSNP-GFKALILQYMPQGSLEKWLYSH---------------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLK 1462 (1624)
Q Consensus 1399 ~~~~~-~~~~lV~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK 1462 (1624)
+|.++ +..++|||||++|+|.++|++. ...++|.+++.|+.|||+||+|||+ ++|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccC
Confidence 99765 5689999999999999999853 2348999999999999999999996 799999999
Q ss_pred CCcEEecCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 047591 1463 PSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMF 1540 (1624)
Q Consensus 1463 ~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~ 1540 (1624)
|+|||+++++++||+|||+|+.+..... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999997754332 23345679999999999999999999999999999999998 899997653
Q ss_pred ccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1541 TGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1541 ~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
..+... ..+....... .+..|+.++.+++.+||+.||++||||+|++++|+++..
T Consensus 293 ~~~~~~-------------~~i~~g~~~~-------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 293 IDEEFC-------------RRLKEGTRMR-------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CSHHHH-------------HHHHHTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH-------------HHHHcCCCCC-------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 322211 1111111000 112356678999999999999999999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=489.12 Aligned_cols=455 Identities=22% Similarity=0.210 Sum_probs=345.1
Q ss_pred cEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCccccccccc
Q 047591 116 VSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSF 195 (1624)
Q Consensus 116 ~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~ 195 (1624)
++||+++|+++ .+|..+. ++|++|||++|++++ +++..+.++++|++|+|++|++++..|..|+++++|++|||++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCC-CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccc-cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 47889999998 6888776 889999999999885 5555667899999999999999988888999999999999999
Q ss_pred ccccccccCcccccccccceeccCCcCCC-CCCCcccccCccchheeccccccCCCCccccccCCCC--cEeecccccc-
Q 047591 196 NELTGRIPQNIGNLTELMELYLNGNNLQG-EFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL--QELNLRDCMT- 271 (1624)
Q Consensus 196 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L--~~L~Ls~N~l- 271 (1624)
|+++ .+|.. .+++|++|+|++|++++ .+|..++++++|++|+|++|.+++ ..+..+++| ++|++++|.+
T Consensus 79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~ 151 (520)
T 2z7x_B 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETY 151 (520)
T ss_dssp SCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTT
T ss_pred Ccee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeeccccc
Confidence 9998 68877 89999999999999987 588999999999999999999875 234667788 9999999999
Q ss_pred -cCcCCccccccCc-CCeeeccCCcccccCcccccccccc-ccccCCCccEEEeeccc-------CCCCCCCcccccCCC
Q 047591 272 -TGRIPKDIGNCTL-LNYLGLRDNQLTDFGANNLTGLIPS-IIFNNSNIEVIQLYGNH-------LSGNLPSSTGINLPN 341 (1624)
Q Consensus 272 -~g~ip~~~~~l~~-L~~L~Ls~N~l~~l~~n~l~g~ip~-~~~~~~~L~~L~Ls~N~-------l~g~ip~~~~~~l~~ 341 (1624)
.+.+|..+..++. ...+++++| .+.+.+|. .+.++.+|+.|++++|. +.|.+| .+ ..+++
T Consensus 152 ~~~~~~~~l~~l~~~~l~l~l~~n--------~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l-~~l~~ 221 (520)
T 2z7x_B 152 GEKEDPEGLQDFNTESLHIVFPTN--------KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KL-QTNPK 221 (520)
T ss_dssp TSSCCTTTTTTCCEEEEEEECCSS--------SCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GG-GGCTT
T ss_pred ccccccccccccccceEEEEeccC--------cchhhhhhhhhhcccceeeccccccccccccceeecchh-hh-ccccc
Confidence 8888888887763 223444444 34444443 44566777777777776 666665 23 25777
Q ss_pred ccEEEecCCccCCcCccccc---CCCCCcEEecCCccccccCcccc-----cccccccEEEccccccccCCCCCCccccc
Q 047591 342 LLRLYLWGNNLSGVIPSSIC---NASKLTVLELSRNLFSGLVANTF-----GNCRQLQILNLAYSQLATGSLSQGQSFFS 413 (1624)
Q Consensus 342 L~~L~Ls~N~l~g~iP~~~~---~l~~L~~L~Ls~N~l~g~~~~~f-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 413 (1624)
|+.|++++|++++..+..+. ..++|++|++++|+++|.+|..+ +++++|+.+++++|.+ . ++. .
T Consensus 222 L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~--~p~-----~ 293 (520)
T 2z7x_B 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-G--FPQ-----S 293 (520)
T ss_dssp CCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-C--SCT-----H
T ss_pred hhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-e--cch-----h
Confidence 77777777777664333222 13577777777777777777766 6777777777776665 1 110 1
Q ss_pred ccccc---cccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhcc
Q 047591 414 SLTNC---RYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGK 490 (1624)
Q Consensus 414 ~l~~l---~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~ 490 (1624)
.+..+ .+|+.|++++|. +.+.. .+..+++|++|+|++|++++.+|..++.
T Consensus 294 ~~~~~~~~~~L~~L~l~~n~-------------------------l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 346 (520)
T 2z7x_B 294 YIYEIFSNMNIKNFTVSGTR-------------------------MVHML--CPSKISPFLHLDFSNNLLTDTVFENCGH 346 (520)
T ss_dssp HHHHHHHTCCCSEEEEESSC-------------------------CCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCC
T ss_pred hhhcccccCceeEEEcCCCc-------------------------ccccc--chhhCCcccEEEeECCccChhhhhhhcc
Confidence 11111 334555555544 33211 1256778888888888888888888888
Q ss_pred ccccceeccccccccc--CCCccccCCCCCceeecccccccCCCccc-cccccCCccccccCccccccCchhhccccccc
Q 047591 491 LQNLQGLDLSYNNIQG--SIPSELCQLESLNTLLLQGNALQNQIPTC-LANLTSLRALNLSSNRLNSTIPSTFWSLEYIL 567 (1624)
Q Consensus 491 l~~L~~L~Ls~N~l~g--~iP~~l~~l~~L~~L~L~~N~l~g~iP~~-~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~ 567 (1624)
+++|++|+|++|++++ .+|..++++++|++|+|++|++++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~ 424 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK 424 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC
T ss_pred CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCC
Confidence 8888888888888886 56677888888888888888888767664 77888888888888888888777665 6788
Q ss_pred eeecccccccCCCCcccccccccceeeccCCcCCCCcccc-ccCCccccccccccCCCCCCCch
Q 047591 568 VVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSS-IGGLKDLTYLALARNGFQGSIPE 630 (1624)
Q Consensus 568 ~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~~L~~L~ls~N~l~g~iP~ 630 (1624)
.||+++|+++ .+|.++..+++|+.|+|++|+++ .+|.. +..+++|++|++++|++++..+.
T Consensus 425 ~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred EEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 8999999988 78988889999999999999999 57776 88899999999999999987663
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=455.38 Aligned_cols=249 Identities=23% Similarity=0.299 Sum_probs=206.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
.|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 4677788999999999999885 689999999976655556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++.+. .+++++...|+.||+.||+|||+ .+||||||||+|||+++++++||+|||+|+.+.... ....
T Consensus 155 gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~ 228 (346)
T 4fih_A 155 GGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK 228 (346)
T ss_dssp TEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred CCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cccc
Confidence 99999999764 48899999999999999999996 799999999999999999999999999999875432 2334
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
..+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+.. +....+. .+ .
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~-i~~~~~~--------~~-~------ 291 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKM-IRDNLPP--------RL-K------ 291 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH-HHHSSCC--------CC-S------
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH-HHcCCCC--------CC-C------
Confidence 5689999999999999999999999999999999999999997532111 1111 1111000 00 0
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+..++..+.+++.+||+.||++|||++|+++.
T Consensus 292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 012345678899999999999999999999863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=489.94 Aligned_cols=485 Identities=17% Similarity=0.179 Sum_probs=386.9
Q ss_pred CccceeeEecC--CCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCcc
Q 047591 76 VCNWVGVTCGS--RHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNL 153 (1624)
Q Consensus 76 ~C~W~Gv~C~~--~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~ 153 (1624)
-|++.+++.-. ...+++.|+|+++.+++..|..+.++++|++|+|++|++++..|..|+.+++|++|||++|++++ +
T Consensus 11 ~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-~ 89 (549)
T 2z81_A 11 DGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-L 89 (549)
T ss_dssp ECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCS-C
T ss_pred ECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCc-c
Confidence 35566665432 22578999999999999999999999999999999999999889999999999999999999996 5
Q ss_pred chhhhccCCCcCEEEccCCcccc-cCCccccCCCccccccccccccccccc-CcccccccccceeccCCcCCCCCCCccc
Q 047591 154 FDDMCNSLTELESFDVSSNQITG-QLPSSLGDCSKLKRLSVSFNELTGRIP-QNIGNLTELMELYLNGNNLQGEFPPTIF 231 (1624)
Q Consensus 154 ~~~~~~~l~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 231 (1624)
++..++++++|++|+|++|++++ .+|..++++++|++|++++|++.+.+| ..|+++++|++|+|++|++++.+|..++
T Consensus 90 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 169 (549)
T 2z81_A 90 SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169 (549)
T ss_dssp CHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred CHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhh
Confidence 66667899999999999999997 578899999999999999999666776 5899999999999999999999999999
Q ss_pred ccCccchheeccccccCCCCccccccCCCCcEeecccccccCcC--Cc-cccccCcCCeeeccCCcccccCccccccccc
Q 047591 232 NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI--PK-DIGNCTLLNYLGLRDNQLTDFGANNLTGLIP 308 (1624)
Q Consensus 232 ~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~i--p~-~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip 308 (1624)
++++|++|+++.|.+. .+|...+..+++|++|++++|++++.. |. ....+++|+.|++++|++.+... ..++
T Consensus 170 ~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~----~~l~ 244 (549)
T 2z81_A 170 SIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF----NELL 244 (549)
T ss_dssp TCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH----HHHH
T ss_pred ccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH----HHHH
Confidence 9999999999999985 678777778999999999999999853 22 33568899999999887654221 1244
Q ss_pred cccccCCCccEEEeecccCCCC--CCC---cccccCCCccEEEecCCccCCc-----CcccccCCCCCcEEecCCccccc
Q 047591 309 SIIFNNSNIEVIQLYGNHLSGN--LPS---STGINLPNLLRLYLWGNNLSGV-----IPSSICNASKLTVLELSRNLFSG 378 (1624)
Q Consensus 309 ~~~~~~~~L~~L~Ls~N~l~g~--ip~---~~~~~l~~L~~L~Ls~N~l~g~-----iP~~~~~l~~L~~L~Ls~N~l~g 378 (1624)
..+..+.+|+.+++++|.+.|. ++. .....+++|+.|++.+|.+... ++..+..+.+|+.|++++|.++.
T Consensus 245 ~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ 324 (549)
T 2z81_A 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324 (549)
T ss_dssp GGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC
T ss_pred HHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcccc
Confidence 5556778999999999998763 111 1123577888999988876532 22233445678888888888875
Q ss_pred cCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCC
Q 047591 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGG 458 (1624)
Q Consensus 379 ~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g 458 (1624)
.+...+.++++|++|+|++|++...... ....+..+++|++|++++|+++ +
T Consensus 325 ip~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~~~~l~~L~~L~Ls~N~l~-------------------------~ 375 (549)
T 2z81_A 325 VPCSFSQHLKSLEFLDLSENLMVEEYLK----NSACKGAWPSLQTLVLSQNHLR-------------------------S 375 (549)
T ss_dssp CCHHHHHHCTTCCEEECCSSCCCHHHHH----HHTCTTSSTTCCEEECTTSCCC-------------------------C
T ss_pred CCHHHHhcCccccEEEccCCcccccccc----chhhhhccccCcEEEccCCccc-------------------------c
Confidence 5544456788888888888877531000 0112344455555555555543 3
Q ss_pred CCC--CCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCcccc
Q 047591 459 GIP--AEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCL 536 (1624)
Q Consensus 459 ~ip--~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~ 536 (1624)
..+ ..++.+++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++.+
T Consensus 376 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~---- 447 (549)
T 2z81_A 376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS---- 447 (549)
T ss_dssp HHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----
T ss_pred cccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----
Confidence 221 34677889999999999998 68888888999999999999988 4665543 68999999999998743
Q ss_pred ccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCcc
Q 047591 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIP 605 (1624)
Q Consensus 537 ~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP 605 (1624)
+++++|++|+|++|+++ .+|. ...+++|+.|||++|++++.+|..++.+++|+.|+|++|+++|.+|
T Consensus 448 ~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 448 LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 57889999999999998 6776 5678999999999999999888899999999999999999999887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=456.42 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=201.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57888899999999999999875 6899999998643 33456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1412 YMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||++|+|.++|...+ ..+++.+...|+.||+.||+|||+ .+||||||||+|||+++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999998653 457888899999999999999996 899999999999999999999999999999764321
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+........+ ..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~------------~~- 245 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFP------------PV- 245 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC------------CC-
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCC------------CC-
Confidence 12234679999999999999999999999999999999999999997532211 11111111111 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+..++..+.+++.+||+.||++|||++|+++.
T Consensus 246 -------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 -------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11245567899999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=452.45 Aligned_cols=254 Identities=21% Similarity=0.254 Sum_probs=205.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||+++.+. .+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45666778999999999999875 68999999997432 2257999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeeecceeecCCCCCc-
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVDSM- 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DFGla~~~~~~~~~- 1491 (1624)
++|+|.+++++.+ .+++.+...|+.||+.||+|||+ .+||||||||+|||++.++ ++||+|||+|+.+......
T Consensus 133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999999998654 58999999999999999999995 8999999999999999988 6999999999987543211
Q ss_pred ---cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1492 ---KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1492 ---~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+.. ....... +. ..
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~~~-~~---------~~- 276 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-LKIASEP-PP---------IR- 276 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-HHHHHSC-CG---------GG-
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHcCC-CC---------ch-
Confidence 122357999999999999999999999999999999999999999764333221 1111110 00 00
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..+..++..+.+++.+||+.||++|||+.|+++.|.+....
T Consensus 277 -------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 -------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 01123556788999999999999999999999998876554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=442.78 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=194.8
Q ss_pred cCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc----CCeeEEEEE
Q 047591 1339 ESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN----PGFKALILQ 1411 (1624)
Q Consensus 1339 ~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----~~~~~lV~e 1411 (1624)
..+.||+|+||+||+|++. ++..||||++... .....+.|.+|+++|++++|||||+++++|.+ ++..+||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 3457999999999999875 5888999998643 23456789999999999999999999999864 345799999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeecceeecCCCCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||++|+|.+++++. ..+++..+..|+.||+.||+|||+. .++||||||||+|||++. ++.+||+|||+|+.....
T Consensus 110 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-- 185 (290)
T 3fpq_A 110 LMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence 99999999999865 3589999999999999999999962 234999999999999984 799999999999865322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+................+..
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~------------- 250 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 250 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG-------------
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC-------------
Confidence 2345689999999998864 6999999999999999999999999754322111111111111100
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..+++++.+++.+||+.||++|||++|+++
T Consensus 251 ------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 ------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01123456788999999999999999999986
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=488.06 Aligned_cols=461 Identities=20% Similarity=0.253 Sum_probs=381.5
Q ss_pred EEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCC
Q 047591 93 DLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSN 172 (1624)
Q Consensus 93 ~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N 172 (1624)
.+++++++++ .+|+.+. ++|++|+|++|++++..|..|..+++|++|+|++|++++ ++++.+.++++|++|||++|
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCE-EEGGGGTTCTTCCEEECCSS
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCC-cChHHhhcccCCCEEecCCC
Confidence 4788899998 5888777 899999999999998778899999999999999999986 44556688999999999999
Q ss_pred cccccCCccccCCCcccccccccccccc-cccCcccccccccceeccCCcCCCCCCCcccccCcc--chheeccccc--c
Q 047591 173 QITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSL--RVIVLANNSL--F 247 (1624)
Q Consensus 173 ~l~g~iP~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L--~~L~L~~N~l--~ 247 (1624)
+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| ++|+|++|.+ +
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 57777 89999999999999987 578999999999999999999986 467778888 9999999999 7
Q ss_pred CCCCccccccCC-CCcEeecccccccCcCCc-cccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecc
Q 047591 248 GSLPVDLCRRLP-SLQELNLRDCMTTGRIPK-DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGN 325 (1624)
Q Consensus 248 g~ip~~~~~~l~-~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N 325 (1624)
+.+|..+ ..+. +...+++++|.+.+.+++ .+.++++|+.|++++|+.. .....+.|.+| .+..+.+|+.|++++|
T Consensus 154 ~~~~~~l-~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~-~l~~l~~L~~L~l~~~ 230 (520)
T 2z7x_B 154 KEDPEGL-QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED-NKCSYFLSILA-KLQTNPKLSNLTLNNI 230 (520)
T ss_dssp SCCTTTT-TTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCST-TTTHHHHHHHH-GGGGCTTCCEEEEEEE
T ss_pred ccccccc-cccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccc-cccceeecchh-hhccccchhhcccccc
Confidence 7777554 2333 344678889998887765 5778999999999887521 11223667777 7888999999999999
Q ss_pred cCCCCCCCccc--ccCCCccEEEecCCccCCcCcccc-----cCCCCCcEEecCCccccccCccccccc---ccccEEEc
Q 047591 326 HLSGNLPSSTG--INLPNLLRLYLWGNNLSGVIPSSI-----CNASKLTVLELSRNLFSGLVANTFGNC---RQLQILNL 395 (1624)
Q Consensus 326 ~l~g~ip~~~~--~~l~~L~~L~Ls~N~l~g~iP~~~-----~~l~~L~~L~Ls~N~l~g~~~~~f~~l---~~L~~L~L 395 (1624)
.+++..+..+. ...++|++|++++|+++|.+|..+ +++++|+.+++++|.+ ..++..+..+ .+|+.|++
T Consensus 231 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l 309 (520)
T 2z7x_B 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTV 309 (520)
T ss_dssp EEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEE
T ss_pred ccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEc
Confidence 98865333221 124689999999999999999998 8999999999999999 4433566666 67999999
Q ss_pred cccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEec
Q 047591 396 AYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSL 475 (1624)
Q Consensus 396 ~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L 475 (1624)
++|++..... ...++ .|++|++++|++++.+|.+++++++|++|+|
T Consensus 310 ~~n~l~~~~~---------~~~l~-------------------------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 355 (520)
T 2z7x_B 310 SGTRMVHMLC---------PSKIS-------------------------PFLHLDFSNNLLTDTVFENCGHLTELETLIL 355 (520)
T ss_dssp ESSCCCCCCC---------CSSCC-------------------------CCCEEECCSSCCCTTTTTTCCCCSSCCEEEC
T ss_pred CCCccccccc---------hhhCC-------------------------cccEEEeECCccChhhhhhhccCCCCCEEEc
Confidence 9998854211 02233 4555666666666777888889999999999
Q ss_pred cCCccCC--CccchhccccccceecccccccccCCCcc-ccCCCCCceeecccccccCCCccccccccCCccccccCccc
Q 047591 476 YQNQLAS--TIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552 (1624)
Q Consensus 476 ~~N~l~g--~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l 552 (1624)
++|++++ .+|..++.+++|++|+|++|++++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+.|+|++|++
T Consensus 356 ~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l 433 (520)
T 2z7x_B 356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433 (520)
T ss_dssp CSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCC
T ss_pred cCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcc
Confidence 9999997 67788999999999999999999878875 78899999999999999998888776 7899999999999
Q ss_pred cccCchhhccccccceeecccccccCCCCcc-cccccccceeeccCCcCCCCcc
Q 047591 553 NSTIPSTFWSLEYILVVDFSLNLLSGCLPQD-IGNLKVLTGLYLSGNQLSCSIP 605 (1624)
Q Consensus 553 ~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~-l~~l~~L~~L~Ls~N~l~g~iP 605 (1624)
+ .+|..+..+++|+.||+++|+++ .+|.. +..+++|+.|+|++|+++|..+
T Consensus 434 ~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 434 K-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp C-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred c-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 8 78998889999999999999999 47776 9999999999999999999765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=455.40 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=207.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 45777889999999999999885 68999999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.++++.. .+++.+...|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+|+.+.... ...
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 999999999754 47899999999999999999996 799999999999999999999999999999875432 234
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+ .+.. +....+ ..+.
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~-i~~~~~--------~~~~------ 368 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKM-IRDNLP--------PRLK------ 368 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH-HHHSCC--------CCCS------
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH-HHcCCC--------CCCc------
Confidence 45689999999999999999999999999999999999999997532111 1111 111100 0000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+..++..+.+++.+||+.||++|||++|+++.
T Consensus 369 ---~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ---CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 012345567899999999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=441.88 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=205.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45888899999999999999875 6899999999643 2334678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|||++|+|.+++.+.+ .+++.+...|+.||+.||+|||+ .+||||||||+|||+++++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998654 57888889999999999999996 8999999999999999999999999999998754332
Q ss_pred -ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 -MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 -~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ ..... ...... -
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i------------~~~~~~-~ 253 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKI------------IKLEYD-F 253 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH------------HHTCCC-C
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH------------HcCCCC-C
Confidence 23445689999999999999999999999999999999999999997532111 11111 111110 0
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+...+.++.+++.+|++.||++|||++|+..
T Consensus 254 --------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 --------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0123456788999999999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=424.74 Aligned_cols=246 Identities=22% Similarity=0.371 Sum_probs=189.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....++|.+|+++|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57888899999999999999874 6899999998643 2334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||| +|+|.+++.+.+ .+++.+...|+.||+.||+|||+ .+||||||||+|||+++++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 689999998654 58899999999999999999996 799999999999999999999999999998765332
Q ss_pred ccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.... ...... .... ..-
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i------------~~~~-~~~ 231 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNI------------SNGV-YTL 231 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH------------HHTC-CCC
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHH------------HcCC-CCC
Confidence 2334689999999999887765 68999999999999999999999753211 111111 1100 000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+..++..+.+++.+|++.||++|||++|+++.
T Consensus 232 --------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 232 --------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01234567889999999999999999999863
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=473.62 Aligned_cols=494 Identities=22% Similarity=0.204 Sum_probs=353.1
Q ss_pred cccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCccccccc
Q 047591 114 FLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSV 193 (1624)
Q Consensus 114 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L 193 (1624)
.+++|||++|+|++..|.+|..+++|++|||++|+|++ ++++.|.+|++|++|+|++|+|++..|..|++|++|++|+|
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~-i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC-cChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 56777777777776556667777777777777777763 56666667777777777777777655566777777777777
Q ss_pred ccccccccccCcccccccccceeccCCcCCC-CCCCcccccCccchheeccccccCCCCccccccCCCC----cEeeccc
Q 047591 194 SFNELTGRIPQNIGNLTELMELYLNGNNLQG-EFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSL----QELNLRD 268 (1624)
Q Consensus 194 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L----~~L~Ls~ 268 (1624)
++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|+|++|++++..| ..+..+.++ ..++++.
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC-TDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG-GGGHHHHTCTTCCCEEECTT
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc-ccccchhhhhhhhhhhhccc
Confidence 7777775555567777777777777777764 356666777777777777777764333 333333332 3566677
Q ss_pred ccccCcCCccccccCcCCeeeccCCcccc-----------------------cCccccccccccccccCCCccEEEeecc
Q 047591 269 CMTTGRIPKDIGNCTLLNYLGLRDNQLTD-----------------------FGANNLTGLIPSIIFNNSNIEVIQLYGN 325 (1624)
Q Consensus 269 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~-----------------------l~~n~l~g~ip~~~~~~~~L~~L~Ls~N 325 (1624)
|.++...|..+ ....++.|++++|...- .....+....+..+.....+...++..+
T Consensus 211 n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 211 NPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred CcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 76665444333 33345566666553210 0011122222333344445555555544
Q ss_pred cCCCC---CCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEcccccccc
Q 047591 326 HLSGN---LPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLAT 402 (1624)
Q Consensus 326 ~l~g~---ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~ 402 (1624)
..... ++.. +..+.+++.+++.+|.+.... .+....+|+.|++++|.+.+..+. .+..|+.+++..|.+..
T Consensus 290 ~~~~~~~~~~~~-~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~ 363 (635)
T 4g8a_A 290 YLDYYLDGIIDL-FNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGN 363 (635)
T ss_dssp CCCSCEEECTTT-TGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCC
T ss_pred hhcccccchhhh-hhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCC
Confidence 43221 1111 224667888888888877543 355667888999999988877654 45677788888887643
Q ss_pred CCCCCCcccccccccccccceeeeccCCCCc--cCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCcc
Q 047591 403 GSLSQGQSFFSSLTNCRYLRYLAIQTNPWKG--ILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQL 480 (1624)
Q Consensus 403 ~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g--~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l 480 (1624)
......+++|+++++++|.+.. ..+..+..+. +++++++..|...+ ++..+..+++|+.++++.|+.
T Consensus 364 ---------~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~-~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~ 432 (635)
T 4g8a_A 364 ---------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTI-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 432 (635)
T ss_dssp ---------BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCS-CCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEE
T ss_pred ---------Ccccccccccccchhhccccccccccccchhhhh-hhhhhhcccccccc-ccccccccccccchhhhhccc
Confidence 1233467889999999998854 3444444544 78888888888765 456788899999999998887
Q ss_pred CCCcc-chhccccccceecccccccccCCCccccCCCCCceeeccccccc-CCCccccccccCCccccccCccccccCch
Q 047591 481 ASTIP-TTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQ-NQIPTCLANLTSLRALNLSSNRLNSTIPS 558 (1624)
Q Consensus 481 ~g~iP-~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~-g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~ 558 (1624)
....+ ..+..+.+|+.++++.|++++..|..+..+++|+.|+|++|++. +.+|..|..+++|+.|+|++|+|++.+|.
T Consensus 433 ~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~ 512 (635)
T 4g8a_A 433 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 512 (635)
T ss_dssp ESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChH
Confidence 76554 46788999999999999999888989999999999999999854 45788899999999999999999998899
Q ss_pred hhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCC-ccccccccccCCCCCC
Q 047591 559 TFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGL-KDLTYLALARNGFQGS 627 (1624)
Q Consensus 559 ~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l-~~L~~L~ls~N~l~g~ 627 (1624)
.|.++++|+.|+|++|+|++..|..++.+++|+.|||++|+|++.+|..+..+ ++|++|+|++|+++..
T Consensus 513 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred HHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999999999999999999888889999999999999999999999999888 6899999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=429.03 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=186.6
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC---------
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG--------- 1404 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~--------- 1404 (1624)
+|...+.||+|+||+||+|+.. +|+.||||+++... +...++|.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4777889999999999999875 68999999986543 345678999999999999999999999986543
Q ss_pred ---eeEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeee
Q 047591 1405 ---FKALILQYMPQGSLEKWLYSHNY--LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1405 ---~~~lV~ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
..|+|||||++|+|.+++.+... ..++...+.|+.||+.||+|||+ .+||||||||+|||++.++++||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999986542 35677788999999999999996 79999999999999999999999999
Q ss_pred cceeecCCCCCc-----------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhh
Q 047591 1480 GIAKLLDGVDSM-----------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH 1548 (1624)
Q Consensus 1480 Gla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~ 1548 (1624)
|+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.........+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 999987543211 1234579999999999999999999999999999999996 76431100000000
Q ss_pred hhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1549 WVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1549 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
......| .......+...+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~p--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 240 VRNLKFP--------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHTTCCC--------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCCCC--------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000111 011222345677999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=434.16 Aligned_cols=247 Identities=27% Similarity=0.322 Sum_probs=194.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
++|...+.||+|+||+||+|+.. .++.||||+++... .....++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35778899999999999999763 36789999986432 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|||||++|+|.+++.+.+ .+++.+...|+.||+.||+|||+ .+||||||||+|||+++++++||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999998654 57889999999999999999996 79999999999999999999999999999876433
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+... ..... .
T Consensus 180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i------------~~~~~-~ 244 (304)
T 3ubd_A 180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMI------------LKAKL-G 244 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH------------HHCCC-C
T ss_pred C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHH------------HcCCC-C
Confidence 2 23345689999999999999999999999999999999999999997532211 11111 11110 0
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
. +..++.++.+++.+||+.||++||| ++|+++
T Consensus 245 ~--------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 M--------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C--------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 1124456788999999999999998 456654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=469.97 Aligned_cols=466 Identities=21% Similarity=0.240 Sum_probs=285.3
Q ss_pred EEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccC
Q 047591 92 TDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSS 171 (1624)
Q Consensus 92 ~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~ 171 (1624)
..++++++++++ +|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++ ++++.+..+++|++|||++
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCc-CCHHHhCCCCCCCEEECCC
Confidence 557777778775 777664 778888888888887666788888888888888888874 4455566778888888888
Q ss_pred CcccccCCccccCCCcccccccccccccc-cccCcccccccccceeccCCcCCCCCCCcccccCcc--chheeccccc--
Q 047591 172 NQITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSL--RVIVLANNSL-- 246 (1624)
Q Consensus 172 N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L--~~L~L~~N~l-- 246 (1624)
|+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++| ++|+|++|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 8877 56666 67788888888888775 3456777778888888888777752 34444555 7777777777
Q ss_pred cCCCCccccccCC-CCcEeecccccccCcCCc-cccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeec
Q 047591 247 FGSLPVDLCRRLP-SLQELNLRDCMTTGRIPK-DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYG 324 (1624)
Q Consensus 247 ~g~ip~~~~~~l~-~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~ 324 (1624)
++..|..+. .+. +.-.+++++|.+.+.+++ .+..+++|+.|++++|+.. ...+.+.+ ..+..+.+|+.++|++
T Consensus 184 ~~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~---~~~l~~~~-~~l~~l~~L~~L~L~~ 258 (562)
T 3a79_B 184 KGGETESLQ-IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN---CQRLMTFL-SELTRGPTLLNVTLQH 258 (562)
T ss_dssp CSSSCCEEE-ECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTT---HHHHHHHH-HHHHSCSSCEEEEEEE
T ss_pred cccCccccc-ccCcceEEEEecCccchhhhhhhcccccceEEEecccccccc---cchHHHHH-HHHhccCcceEEEecC
Confidence 665554432 222 122456667766665554 3455666777776666411 11122222 2344455555555555
Q ss_pred ccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccc-----cccccccEEEccccc
Q 047591 325 NHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTF-----GNCRQLQILNLAYSQ 399 (1624)
Q Consensus 325 N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f-----~~l~~L~~L~L~~N~ 399 (1624)
|.+++. .+.+ +|..+ ...+|++|++++|.++|.+|..+ .+++.|+.++++.|.
T Consensus 259 ~~l~~~--------------------~~~~-~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~ 316 (562)
T 3a79_B 259 IETTWK--------------------CSVK-LFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316 (562)
T ss_dssp EEECHH--------------------HHHH-HHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECC
T ss_pred CcCcHH--------------------HHHH-HHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhcccce
Confidence 544432 1111 11111 12244555555555554444443 444444444444443
Q ss_pred cccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCc
Q 047591 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQ 479 (1624)
Q Consensus 400 l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~ 479 (1624)
+ . ++ ...+..+....+|++|++++|.+.... ..+.+++|++|+|++|+
T Consensus 317 ~-~--~p--~~~~~~~~~~~~L~~L~l~~n~~~~~~---------------------------~~~~l~~L~~L~l~~n~ 364 (562)
T 3a79_B 317 F-L--FS--KEALYSVFAEMNIKMLSISDTPFIHMV---------------------------CPPSPSSFTFLNFTQNV 364 (562)
T ss_dssp C-S--SC--HHHHHHHHHTCCCSEEEEESSCCCCCC---------------------------CCSSCCCCCEEECCSSC
T ss_pred e-e--cC--hhhhhhhhccCcceEEEccCCCccccc---------------------------CccCCCCceEEECCCCc
Confidence 3 0 00 000000111123444455544432110 01455666666777776
Q ss_pred cCCCccchhccccccceeccccccccc--CCCccccCCCCCceeecccccccCCCcc-ccccccCCccccccCccccccC
Q 047591 480 LASTIPTTVGKLQNLQGLDLSYNNIQG--SIPSELCQLESLNTLLLQGNALQNQIPT-CLANLTSLRALNLSSNRLNSTI 556 (1624)
Q Consensus 480 l~g~iP~~~~~l~~L~~L~Ls~N~l~g--~iP~~l~~l~~L~~L~L~~N~l~g~iP~-~~~~l~~L~~L~Ls~N~l~g~i 556 (1624)
+++.+|..++.+++|++|+|++|++++ .+|..+.++++|+.|+|++|++++.+|. .+..+++|+.|+|++|++++.+
T Consensus 365 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 444 (562)
T 3a79_B 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444 (562)
T ss_dssp CCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGG
T ss_pred cccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcch
Confidence 666666666666777777777777665 2345566677777777777777764554 3666777777777777777666
Q ss_pred chhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCcccc-ccCCccccccccccCCCCCCCch
Q 047591 557 PSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSS-IGGLKDLTYLALARNGFQGSIPE 630 (1624)
Q Consensus 557 P~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~~L~~L~ls~N~l~g~iP~ 630 (1624)
|..+. .+|+.|||++|+++ .||..+..+++|+.|+|++|+++ .+|.. +..+++|+.|++++|++++..|.
T Consensus 445 ~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 445 FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp GSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred hhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 65554 56777777777777 57777778888888888888888 56666 77888888888888888877664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=427.51 Aligned_cols=202 Identities=29% Similarity=0.459 Sum_probs=176.9
Q ss_pred CCCCCcceeecCCccceEEEEec------CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667789999999999999863 478899999986666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEE
Q 047591 818 ILEYMPQGSLEKWLYSHK------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHL 885 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl 885 (1624)
|||||++|+|.++|+..+ ..++|.++++|+.|||+||+|||+. +||||||||+|||+|+++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 3689999999999999999999984 5999999999999999999999
Q ss_pred EeeeeeeccCCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 886 SDFGISKLLDGEDSVT-QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 886 ~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
+|||+|+.....+... .....||+.|||||++..+.++.++|||||||++|||+| |+.||...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999765443322 233469999999999999999999999999999999999 89999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=429.37 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=170.0
Q ss_pred CCCCcceeecCCccceEEEEec------CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
+|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..|+|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4556688999999999999864 4789999999866556678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceE
Q 047591 819 LEYMPQGSLEKWLYSHK--------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH 884 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~k 884 (1624)
||||++|+|.++++... ..++|.++++|+.|||+||+|||+. +||||||||+|||+|+++++|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEE
Confidence 99999999999997642 3589999999999999999999984 599999999999999999999
Q ss_pred EEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 885 LSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 885 l~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
|+|||+|+.....+.. ..+...||+.|||||++....++.++|||||||++|||+| |+.||...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 9999999976544322 2334579999999999999999999999999999999999 89999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=421.69 Aligned_cols=199 Identities=28% Similarity=0.459 Sum_probs=168.7
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
++|...+.||+|+||+||+|++. ..||||+++... ....+.|.+|+++|++++|||||+++|+|.+ +..|+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 45667789999999999999875 469999987443 3345789999999999999999999999875 457999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC-c
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-V 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~-~ 900 (1624)
|++|+|.++|+.....++|.++++|+.|||+||+|||+. +||||||||+|||+|+++.+||+|||+|+....... .
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999988777899999999999999999999984 599999999999999999999999999997654322 2
Q ss_pred ccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGS---EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~---~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....+||+.|||||++. .+.|+.|+|||||||++|||+||+.||...
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 234457999999999874 346899999999999999999999999754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=458.66 Aligned_cols=439 Identities=19% Similarity=0.245 Sum_probs=353.5
Q ss_pred CcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEE
Q 047591 89 GRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFD 168 (1624)
Q Consensus 89 ~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~ 168 (1624)
.+++.|+|+++.+.+..|..|.++++|++|+|++|++++..|..|+.+++|++|||++|+|+ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC---CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc---ccccCCEEE
Confidence 57899999999999988889999999999999999999988999999999999999999998 67766 799999999
Q ss_pred ccCCcccc-cCCccccCCCcccccccccccccccccCcccccccc--cceeccCCcC--CCCCCCcccccC--ccchhee
Q 047591 169 VSSNQITG-QLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTEL--MELYLNGNNL--QGEFPPTIFNVS--SLRVIVL 241 (1624)
Q Consensus 169 Ls~N~l~g-~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L--~~L~Ls~N~l--~g~~p~~~~~l~--~L~~L~L 241 (1624)
|++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| ++|+|++|++ ++..|..+.++. .| .+++
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l 203 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVF 203 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEE
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEe
Confidence 99999997 567899999999999999999986 346666666 9999999999 999999998865 44 5689
Q ss_pred ccccccCCCCccccccCCCCcEeeccccc-----ccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCC
Q 047591 242 ANNSLFGSLPVDLCRRLPSLQELNLRDCM-----TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSN 316 (1624)
Q Consensus 242 ~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~-----l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~ 316 (1624)
++|.+.+.++...+..+++|+.|++++|+ +.+.+ +.+..+++|+.|+|++|.+. .|.+.+..+. + ...+
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l~~L~~L~L~~~~l~---~~~~~~~~~~-~-~~~~ 277 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRGPTLLNVTLQHIETT---WKCSVKLFQF-F-WPRP 277 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSCSSCEEEEEEEEEEC---HHHHHHHHHH-H-TTSS
T ss_pred cCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHhccCcceEEEecCCcCc---HHHHHHHHHh-h-hccc
Confidence 99999999999888999999999999985 33333 46788999999999988654 3555554332 2 2348
Q ss_pred ccEEEeecccCCCCCCCccc----ccCCCccEEEecCCccCCcCc-ccccCC---CCCcEEecCCccccccCcccccccc
Q 047591 317 IEVIQLYGNHLSGNLPSSTG----INLPNLLRLYLWGNNLSGVIP-SSICNA---SKLTVLELSRNLFSGLVANTFGNCR 388 (1624)
Q Consensus 317 L~~L~Ls~N~l~g~ip~~~~----~~l~~L~~L~Ls~N~l~g~iP-~~~~~l---~~L~~L~Ls~N~l~g~~~~~f~~l~ 388 (1624)
|++|++++|+++|.+|..++ .+++.|+.++++.|.+ .+| ..+..+ .+|+.|++++|.+.... .++.++
T Consensus 278 L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~ 353 (562)
T 3a79_B 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPS 353 (562)
T ss_dssp EEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCC
T ss_pred ccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCC
Confidence 88888888888888887763 3566666666666666 344 222222 34666666666554221 012333
Q ss_pred cccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCC
Q 047591 389 QLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLS 468 (1624)
Q Consensus 389 ~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~ 468 (1624)
+|+ +|++++|++++.+|.+|++++
T Consensus 354 ~L~--------------------------------------------------------~L~l~~n~l~~~~~~~~~~l~ 377 (562)
T 3a79_B 354 SFT--------------------------------------------------------FLNFTQNVFTDSVFQGCSTLK 377 (562)
T ss_dssp CCC--------------------------------------------------------EEECCSSCCCTTTTTTCCSCS
T ss_pred Cce--------------------------------------------------------EEECCCCccccchhhhhcccC
Confidence 333 333334444455677788889
Q ss_pred cccEEeccCCccCC--CccchhccccccceecccccccccCCCcc-ccCCCCCceeecccccccCCCccccccccCCccc
Q 047591 469 NIIALSLYQNQLAS--TIPTTVGKLQNLQGLDLSYNNIQGSIPSE-LCQLESLNTLLLQGNALQNQIPTCLANLTSLRAL 545 (1624)
Q Consensus 469 ~L~~L~L~~N~l~g--~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L 545 (1624)
+|++|+|++|++++ .+|..++.+++|++|+|++|++++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+.|
T Consensus 378 ~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L 455 (562)
T 3a79_B 378 RLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVL 455 (562)
T ss_dssp SCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEE
T ss_pred CCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEE
Confidence 99999999999987 45677899999999999999999867764 77889999999999999988887765 789999
Q ss_pred cccCccccccCchhhccccccceeecccccccCCCCcc-cccccccceeeccCCcCCCCcc
Q 047591 546 NLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQD-IGNLKVLTGLYLSGNQLSCSIP 605 (1624)
Q Consensus 546 ~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~-l~~l~~L~~L~Ls~N~l~g~iP 605 (1624)
+|++|+++ .+|..+..+++|+.|||++|+++ .+|.. ++.+++|+.|+|++|+++|..|
T Consensus 456 ~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp ECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred ECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 99999998 68888889999999999999999 57776 9999999999999999999776
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=459.09 Aligned_cols=488 Identities=19% Similarity=0.151 Sum_probs=388.4
Q ss_pred cCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCccc
Q 047591 128 TLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIG 207 (1624)
Q Consensus 128 ~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~ 207 (1624)
.+|..+- +++++|||++|+|+ .+|+..|.++++|++|||++|+|++..|.+|.+|++|++|+|++|+|++..|..|.
T Consensus 45 ~vP~~lp--~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~ 121 (635)
T 4g8a_A 45 KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 121 (635)
T ss_dssp SCCSSSC--TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGT
T ss_pred ccCCCCC--cCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhc
Confidence 4565442 57999999999998 47888889999999999999999987788999999999999999999977777899
Q ss_pred ccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCC-
Q 047591 208 NLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLN- 286 (1624)
Q Consensus 208 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~- 286 (1624)
+|++|++|+|++|+|++..+..|+++++|++|+|++|.+++.-....+..+++|++|+|++|++++..|..+..+.+++
T Consensus 122 ~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~ 201 (635)
T 4g8a_A 122 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 201 (635)
T ss_dssp TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTT
T ss_pred CCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhh
Confidence 9999999999999999877778999999999999999998633334567899999999999999999999998887765
Q ss_pred ---eeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccC------------------------
Q 047591 287 ---YLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINL------------------------ 339 (1624)
Q Consensus 287 ---~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l------------------------ 339 (1624)
.++++.|++..+ +...+....++.+++++|..+..++......+
T Consensus 202 ~~~~~~ls~n~l~~i---------~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~ 272 (635)
T 4g8a_A 202 LNLSLDLSLNPMNFI---------QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 272 (635)
T ss_dssp CCCEEECTTCCCCEE---------CTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCT
T ss_pred hhhhhhcccCccccc---------CcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccc
Confidence 577787776543 22333334455555555544433222222223
Q ss_pred ------CCccEEEecCCccCC---cCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcc
Q 047591 340 ------PNLLRLYLWGNNLSG---VIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQS 410 (1624)
Q Consensus 340 ------~~L~~L~Ls~N~l~g---~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~ 410 (1624)
..+..+++..+.... .++..+..+.+++.+++.+|.+....+ +....+|+.|++.+|++....
T Consensus 273 ~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~~~~~~~~------ 344 (635)
T 4g8a_A 273 SALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFP------ 344 (635)
T ss_dssp TTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG--GGSCCCCSEEEEESCEESSCC------
T ss_pred cccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccc--cccchhhhhhhcccccccCcC------
Confidence 333444443333222 223445556678888888888876543 556678888888888875422
Q ss_pred cccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccC--CCCCCCcCCCCcccEEeccCCccCCCccchh
Q 047591 411 FFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG--GGIPAEFGNLSNIIALSLYQNQLASTIPTTV 488 (1624)
Q Consensus 411 ~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~--g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~ 488 (1624)
...+..|+.+++..|......+ ...+. +++.++++.|.+. +..|..+..+.+|++|++..|.+.+ ++..+
T Consensus 345 ----~~~l~~L~~l~l~~n~~~~~~~--~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~ 416 (635)
T 4g8a_A 345 ----TLKLKSLKRLTFTSNKGGNAFS--EVDLP-SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNF 416 (635)
T ss_dssp ----CCBCTTCCEEEEESCCSCCBCC--CCBCT-TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCC
T ss_pred ----cccchhhhhcccccccCCCCcc--ccccc-ccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccc
Confidence 1245667888888887765433 23444 7889999999885 4456677788899999999998864 56678
Q ss_pred ccccccceecccccccccCCC-ccccCCCCCceeecccccccCCCccccccccCCccccccCccc-cccCchhhcccccc
Q 047591 489 GKLQNLQGLDLSYNNIQGSIP-SELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL-NSTIPSTFWSLEYI 566 (1624)
Q Consensus 489 ~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l-~g~iP~~~~~l~~L 566 (1624)
..+++|+.++++.|++.+..+ ..+.++.+++.++++.|++++..|..+..+++|+.|+|++|++ .+.+|..|..+.+|
T Consensus 417 ~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L 496 (635)
T 4g8a_A 417 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 496 (635)
T ss_dssp TTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred cccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhcccc
Confidence 889999999999999887665 4678899999999999999999999999999999999999985 45678899999999
Q ss_pred ceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhhhcc-ccccCCCC
Q 047591 567 LVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSL-ISLEKGEI 643 (1624)
Q Consensus 567 ~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~~~l-~~L~~~~i 643 (1624)
+.|||++|+|++.+|..|+++++|+.|+|++|+|++..|..|+.+++|++|||++|++++.+|..+..+ ++|+...+
T Consensus 497 ~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L 574 (635)
T 4g8a_A 497 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 574 (635)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEEC
T ss_pred CEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEe
Confidence 999999999999999999999999999999999999888999999999999999999999999988776 46665433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=422.14 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=173.5
Q ss_pred CCCcceeecCCccceEEEEec------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 746 FSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++..+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 344578999999999999863 468899999975433 3457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCce
Q 047591 819 LEYMPQGSLEKWLYSHK---------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVA 883 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~ 883 (1624)
||||++|||.++|+.+. ..++|.++++|+.|||+||+|||+. +||||||||+|||+|+++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 99999999999997532 3589999999999999999999984 59999999999999999999
Q ss_pred EEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 884 HLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 884 kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
||+|||+|+.....+.. ..+...||++|||||++..+.++.++|||||||++|||+| |+.||...
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999976543322 2334579999999999999999999999999999999999 89999754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=417.05 Aligned_cols=198 Identities=28% Similarity=0.342 Sum_probs=179.0
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45778889999999999999864 79999999998765555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
++|+|.+++... .+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+.+...... .
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 227 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 227 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence 999999999753 589999999999999999999994 5999999999999999999999999999987654332 3
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...+||+.|||||++....|+.++||||+||++|||+||+.||..
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 345799999999999999999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=418.24 Aligned_cols=200 Identities=25% Similarity=0.401 Sum_probs=172.4
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|+++|++++|||||++++++++++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6788999999999999999986 479999999997543 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 821 YMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||++|+|.++|..++ ..+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997654 3578899999999999999999994 59999999999999999999999999999764321
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...+..+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 122345799999999999999999999999999999999999999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=410.82 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=179.5
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999986 579999999997532 334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|||++|+|.+++...+ .+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+.+..+..
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998654 689999999999999999999994 599999999999999999999999999998764432
Q ss_pred -cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 -VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 -~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 223456899999999999988999999999999999999999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=406.53 Aligned_cols=195 Identities=28% Similarity=0.433 Sum_probs=168.4
Q ss_pred CCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc----CCeEEEEE
Q 047591 747 SESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN----HGFKALIL 819 (1624)
Q Consensus 747 ~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 819 (1624)
...+.||+|+||+||+|... +++.||||++.... ....+.|.+|+++|++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999864 68999999997543 2345679999999999999999999999864 35689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC-CCceEEEeeeeeeccCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD-DTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~~kl~DFGla~~~~~~~ 898 (1624)
|||++|+|.++++... .+++..+..|+.||+.||+|||+.+ ++||||||||+|||++. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999998654 7899999999999999999999864 46999999999999984 789999999999865432
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2334579999999998864 699999999999999999999999965
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=426.79 Aligned_cols=372 Identities=19% Similarity=0.217 Sum_probs=227.7
Q ss_pred CcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccc
Q 047591 113 SFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLS 192 (1624)
Q Consensus 113 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 192 (1624)
++|++|+|++|++++..|..|+.+++|++|+|++|.+.+.+++..+.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 67999999999999888999999999999999999998888888888889999999999998888888888888888888
Q ss_pred cccccccccccCc--ccccccccceeccCCcCCCCCCCc-ccccCccchheeccccccCCCCccccccCCCCcEeecccc
Q 047591 193 VSFNELTGRIPQN--IGNLTELMELYLNGNNLQGEFPPT-IFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDC 269 (1624)
Q Consensus 193 Ls~N~l~g~ip~~--~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N 269 (1624)
|++|++++.+|.. |+++++|++|+|++|++++..|.. +.++++|++|+|++|++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l----------------------- 166 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV----------------------- 166 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB-----------------------
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc-----------------------
Confidence 8888888766655 777888888888888777665654 44555555555555554
Q ss_pred cccCcCCcccccc--CcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEe
Q 047591 270 MTTGRIPKDIGNC--TLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL 347 (1624)
Q Consensus 270 ~l~g~ip~~~~~l--~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 347 (1624)
++..|..+..+ .+|+.|++++|++.+++...+.......++ .+++|++|+|
T Consensus 167 --~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~-------------------------~~~~L~~L~L 219 (455)
T 3v47_A 167 --KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF-------------------------KNTSITTLDL 219 (455)
T ss_dssp --SCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTT-------------------------TTCEEEEEEC
T ss_pred --cccChhhhhccccccccccccccCcccccchhhcccccccccc-------------------------ccceeeeEec
Confidence 44444444444 456666666665554332222211111111 3455666666
Q ss_pred cCCccCCcCcccccCC---CCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCccccccccccccccee
Q 047591 348 WGNNLSGVIPSSICNA---SKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYL 424 (1624)
Q Consensus 348 s~N~l~g~iP~~~~~l---~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L 424 (1624)
++|++++.+|..+..+ .+|+.|++++|.+.+...
T Consensus 220 s~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~------------------------------------------- 256 (455)
T 3v47_A 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF------------------------------------------- 256 (455)
T ss_dssp TTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-------------------------------------------
T ss_pred CCCcccccchhhhhccccccceeeEeecccccccccc-------------------------------------------
Confidence 6666666666555443 455555555554432210
Q ss_pred eeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCC--CCcccEEeccCCccCCCccchhccccccceeccccc
Q 047591 425 AIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGN--LSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYN 502 (1624)
Q Consensus 425 ~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~--l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N 502 (1624)
..+.+ .+..+..+.. .++|++|+|++|++++.+|..++.+++|++|+|++|
T Consensus 257 --~~~~~-------------------------~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 309 (455)
T 3v47_A 257 --GHTNF-------------------------KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN 309 (455)
T ss_dssp --TCCSS-------------------------CCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred --chhhh-------------------------ccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCC
Confidence 00001 1111111211 245666666666666666666666666666666666
Q ss_pred ccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCc
Q 047591 503 NIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQ 582 (1624)
Q Consensus 503 ~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~ 582 (1624)
++++..|..|.++++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..|..+++|+.|||++|++++..+.
T Consensus 310 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 389 (455)
T 3v47_A 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDG 389 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHh
Confidence 66665566666666666666666666655555666666666666666666554444444444444444444444433333
Q ss_pred ccccccccceeeccCCcCCCCc
Q 047591 583 DIGNLKVLTGLYLSGNQLSCSI 604 (1624)
Q Consensus 583 ~l~~l~~L~~L~Ls~N~l~g~i 604 (1624)
.++.+++|+.|+|++|+++|.+
T Consensus 390 ~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 390 IFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp TTTTCTTCCEEECCSSCBCCCT
T ss_pred HhccCCcccEEEccCCCcccCC
Confidence 3344444444444444444433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=418.81 Aligned_cols=198 Identities=28% Similarity=0.344 Sum_probs=179.5
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
+.|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5688889999999999999986 469999999998766556677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
++|+|.++++.. .+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.+...... .
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence 999999999754 589999999999999999999994 5999999999999999999999999999987654332 3
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...+||+.|||||++....|+.++|||||||++|||+||+.||..
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 345799999999999999999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=414.93 Aligned_cols=198 Identities=25% Similarity=0.368 Sum_probs=162.9
Q ss_pred CCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCC----eEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG----FKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~E 820 (1624)
++...+.||+|+||+||+|++ +|+.||||+++..... ...+.+|+..+.+++|||||+++|+|.+++ ..|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 345568899999999999988 5899999999754321 223345666667899999999999997653 5799999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG-----HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
||++|+|.++|+.. .++|+++.+|+.|+|+||+|||+. +.++||||||||+|||+|+++++||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999764 589999999999999999999975 24589999999999999999999999999999875
Q ss_pred CCCCcc---cccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 896 GEDSVT---QTMTLATFGYMAPEYGSEG------IVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 896 ~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
...... ....+||+.|||||++.+. .++.|+|||||||++|||+||+.|+.
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 543322 2235799999999988653 46889999999999999999987764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=424.31 Aligned_cols=405 Identities=23% Similarity=0.261 Sum_probs=164.5
Q ss_pred CCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccce
Q 047591 136 MPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMEL 215 (1624)
Q Consensus 136 l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 215 (1624)
.++|++|++++|.+ |.+|+++ +++++|++|++++|+++|.+|.+++++++|+.++++.+.. .+|++|
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i-~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEA-ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred cccchhhhcccCch-hhCChhH-hcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 35555555555555 4454443 4455555555555555555555555555441111111100 112455
Q ss_pred eccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcc
Q 047591 216 YLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQL 295 (1624)
Q Consensus 216 ~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 295 (1624)
++++|++++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|+|++|++
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL 143 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCC
Confidence 555555543 2321 1345555555555543 4421 2445555555555543 1211 13455555544433
Q ss_pred cccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCcc
Q 047591 296 TDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNL 375 (1624)
Q Consensus 296 ~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 375 (1624)
+. +| .+.++++|++|++++|++++ +|... ++|++|++++|++++ +| .++++++|++|++++|+
T Consensus 144 ~~---------lp-~~~~l~~L~~L~l~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~ 206 (454)
T 1jl5_A 144 EK---------LP-ELQNSSFLKIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNS 206 (454)
T ss_dssp SS---------CC-CCTTCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSC
T ss_pred CC---------Cc-ccCCCCCCCEEECCCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCc
Confidence 21 33 24445555555555555543 44321 245555555555554 33 34555555555555555
Q ss_pred ccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcc
Q 047591 376 FSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCE 455 (1624)
Q Consensus 376 l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~ 455 (1624)
+++.+. . .++|++|++++|+++.. + .+..+++|++|++++|++++ +|... .+|+.|++++|+
T Consensus 207 l~~l~~-~---~~~L~~L~l~~n~l~~l--------p-~~~~l~~L~~L~l~~N~l~~-l~~~~----~~L~~L~l~~N~ 268 (454)
T 1jl5_A 207 LKKLPD-L---PLSLESIVAGNNILEEL--------P-ELQNLPFLTTIYADNNLLKT-LPDLP----PSLEALNVRDNY 268 (454)
T ss_dssp CSSCCC-C---CTTCCEEECCSSCCSSC--------C-CCTTCTTCCEEECCSSCCSS-CCSCC----TTCCEEECCSSC
T ss_pred CCcCCC-C---cCcccEEECcCCcCCcc--------c-ccCCCCCCCEEECCCCcCCc-ccccc----cccCEEECCCCc
Confidence 554221 1 13455555555554321 1 13344455555555555543 22211 245555555555
Q ss_pred cCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCC-CCCceeecccccccCCCcc
Q 047591 456 LGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQL-ESLNTLLLQGNALQNQIPT 534 (1624)
Q Consensus 456 l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l-~~L~~L~L~~N~l~g~iP~ 534 (1624)
+.+ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .+ ++|+.|+|++|++++ +|.
T Consensus 269 l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~ 334 (454)
T 1jl5_A 269 LTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPA 334 (454)
T ss_dssp CSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCC
T ss_pred ccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-ccc
Confidence 554 3432 2456666666666654 2211 1456666666666653 22 12 356666666666664 444
Q ss_pred ccccccCCccccccCccccccCchhhccccccceeecccccccC--CCCcccccccccceeeccCCcCCCCccccccCCc
Q 047591 535 CLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG--CLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLK 612 (1624)
Q Consensus 535 ~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g--~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~ 612 (1624)
. +++|+.|+|++|++++ +|. .+.+|+.||+++|++++ .+|.+++.+ +.|++.|.+|.. ++
T Consensus 335 ~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~ 396 (454)
T 1jl5_A 335 L---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQ 396 (454)
T ss_dssp C---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC-------------
T ss_pred c---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cC
Confidence 3 3556666666666653 444 34556666666666666 555554432 234555555542 35
Q ss_pred cccccccccCCCCC--CCchhhh
Q 047591 613 DLTYLALARNGFQG--SIPEAIG 633 (1624)
Q Consensus 613 ~L~~L~ls~N~l~g--~iP~~~~ 633 (1624)
+|++|++++|+++| .||.++.
T Consensus 397 ~L~~L~ls~N~l~~~~~iP~sl~ 419 (454)
T 1jl5_A 397 NLKQLHVETNPLREFPDIPESVE 419 (454)
T ss_dssp -----------------------
T ss_pred cCCEEECCCCcCCccccchhhHh
Confidence 56666666666665 5665443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=427.43 Aligned_cols=412 Identities=24% Similarity=0.296 Sum_probs=200.5
Q ss_pred CcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCC-------------cEEEccCCCCCCccch
Q 047591 89 GRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRL-------------RIIDLSSNRISGNLFD 155 (1624)
Q Consensus 89 ~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L-------------~~L~Ls~N~l~g~~~~ 155 (1624)
.++..|+++++++ |++|++|++|++|++|++++|+++|.+|.+++.+++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4577788888888 8999999999999999999999999999999988875 777777777765 333
Q ss_pred hhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCc
Q 047591 156 DMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSS 235 (1624)
Q Consensus 156 ~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 235 (1624)
-.++|++|++++|++++ +|.. +++|++|++++|++++ +|... ++|++|+|++|++++ +| .++++++
T Consensus 89 ----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~~---~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 89 ----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDLP---PLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp ----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSCC---TTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred ----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCCC---CCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 13567777777777775 6653 2567777777777763 33321 567777777777775 66 4677777
Q ss_pred cchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCC
Q 047591 236 LRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNS 315 (1624)
Q Consensus 236 L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~ 315 (1624)
|++|++++|++++ +|.. .++|++|++++|++++ +| .++++++|+.|++++|++..+ |... .
T Consensus 155 L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l---------~~~~---~ 215 (454)
T 1jl5_A 155 LKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL---------PDLP---L 215 (454)
T ss_dssp CCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC---------CCCC---T
T ss_pred CCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC---------CCCc---C
Confidence 7777777777764 5532 2466666666666665 44 466666666666666654432 2111 2
Q ss_pred CccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEc
Q 047591 316 NIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNL 395 (1624)
Q Consensus 316 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L 395 (1624)
+|++|++++|+++ .+|. + ..+++|++|++++|++++ +|.. +++|++|++++|++++.+ .. +++|++|++
T Consensus 216 ~L~~L~l~~n~l~-~lp~-~-~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~-~~---~~~L~~L~l 284 (454)
T 1jl5_A 216 SLESIVAGNNILE-ELPE-L-QNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLP-EL---PQSLTFLDV 284 (454)
T ss_dssp TCCEEECCSSCCS-SCCC-C-TTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCC-CC---CTTCCEEEC
T ss_pred cccEEECcCCcCC-cccc-c-CCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccC-cc---cCcCCEEEC
Confidence 4555555555555 4443 2 245555555555555553 3322 244455555555554422 11 133334443
Q ss_pred cccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEec
Q 047591 396 AYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSL 475 (1624)
Q Consensus 396 ~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L 475 (1624)
+ +|.+++. | .+| ++|++|++
T Consensus 285 s-------------------------------~N~l~~l-~----------------------~~~------~~L~~L~l 304 (454)
T 1jl5_A 285 S-------------------------------ENIFSGL-S----------------------ELP------PNLYYLNA 304 (454)
T ss_dssp C-------------------------------SSCCSEE-S----------------------CCC------TTCCEEEC
T ss_pred c-------------------------------CCccCcc-c----------------------CcC------CcCCEEEC
Confidence 3 3333321 0 111 35566666
Q ss_pred cCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccc-
Q 047591 476 YQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNS- 554 (1624)
Q Consensus 476 ~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g- 554 (1624)
++|++++ +|.. .++|++|++++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|++|+|++|++++
T Consensus 305 ~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l 372 (454)
T 1jl5_A 305 SSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREF 372 (454)
T ss_dssp CSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSC
T ss_pred cCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcC
Confidence 6666654 2211 1467777777777775 5654 467777777777777 4665 36777777777777777
Q ss_pred -cCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCC--CccccccCCccccccccccCCCCCCCchh
Q 047591 555 -TIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSC--SIPSSIGGLKDLTYLALARNGFQGSIPEA 631 (1624)
Q Consensus 555 -~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g--~iP~~~~~l~~L~~L~ls~N~l~g~iP~~ 631 (1624)
.+|..++. |+.|.+.|.+|.. +++|+.|+|++|+++| .||.+ |+.|.+.+|.+.+.+|..
T Consensus 373 ~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 373 PDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp CCCCTTCCE--------EECCC----------------------------------------------------------
T ss_pred CCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCccccC
Confidence 66666543 3457777778874 4788889999999987 77765 455678888888888866
Q ss_pred hhcc
Q 047591 632 IGSL 635 (1624)
Q Consensus 632 ~~~l 635 (1624)
....
T Consensus 436 ~~~~ 439 (454)
T 1jl5_A 436 HETT 439 (454)
T ss_dssp ----
T ss_pred HHHh
Confidence 5443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=417.33 Aligned_cols=267 Identities=23% Similarity=0.252 Sum_probs=200.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc------CCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN------PGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~------~~~ 1405 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56888899999999999999875 6899999999643 23456789999999999999999999998753 367
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.|+|||||+ |+|.+++.+. ..+++.+...|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 7899999764 468999999999999999999996 89999999999999999999999999999876
Q ss_pred CCCC---CccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh--cCChh--
Q 047591 1486 DGVD---SMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE--SLPDA-- 1557 (1624)
Q Consensus 1486 ~~~~---~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~--~~~~~-- 1557 (1624)
.... .......+||+.|||||++.+ ..++.++||||+||++|||+||+.||.+....+. +...... ..+..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHHh
Confidence 4321 223345689999999998766 4579999999999999999999999975422111 1111110 00000
Q ss_pred -------HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1558 -------VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1558 -------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
....+. .+..................+.+|+.+|++.||++|||++|+++
T Consensus 288 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00000000000011123466789999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=407.95 Aligned_cols=198 Identities=24% Similarity=0.297 Sum_probs=171.7
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
+.|...+.||+|+||+||+|+. .+|+.||||+++.+.. +.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577778899999999999986 4699999999975422 247999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC-ceEEEeeeeeeccCCCCCc-
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSV- 900 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~~kl~DFGla~~~~~~~~~- 900 (1624)
++|+|.++|+..+ .+++.++..|+.||+.||+|||+. +||||||||+|||++.++ .+||+|||+|+.+......
T Consensus 133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999999998654 699999999999999999999984 599999999999999987 6999999999987543221
Q ss_pred ---ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCc
Q 047591 901 ---TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFT 950 (1624)
Q Consensus 901 ---~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~ 950 (1624)
.....+||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 12235799999999999999999999999999999999999999976443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=413.14 Aligned_cols=198 Identities=25% Similarity=0.325 Sum_probs=168.9
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~ 1407 (1624)
..+.|...+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+++ +|||||++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4577999999999999999999753 36789999885432 345688999999998 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC-CcEEEeeecceeecC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~kl~DFGla~~~~ 1486 (1624)
+|||||++|+|.+++. .+++.+...|+.|++.||+|||+ .+||||||||+|||++.+ +.+||+|||+|+...
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999999984 37888999999999999999996 899999999999999977 799999999998764
Q ss_pred CCCC---------------------------ccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1487 GVDS---------------------------MKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1487 ~~~~---------------------------~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
.... ...+..+||+.|||||++.+. .|+.++||||+||++|||+||+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 3211 112235799999999988664 589999999999999999999999964
Q ss_pred C
Q 047591 1539 M 1539 (1624)
Q Consensus 1539 ~ 1539 (1624)
.
T Consensus 250 ~ 250 (361)
T 4f9c_A 250 A 250 (361)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=405.43 Aligned_cols=199 Identities=29% Similarity=0.375 Sum_probs=168.6
Q ss_pred CCCCCcceeecCCccceEEEEe----cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL----PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
++|+..+.||+|+||+||+|+. .+++.||||+++... ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688899999999999999975 247899999986542 2233568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
|||||++|+|.+++...+ .+++.++..|+.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999998654 689999999999999999999994 5999999999999999999999999999976443
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
... ....+||+.|||||++....++.++||||+||++|||+||+.||..
T Consensus 180 ~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 180 EKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp -CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Ccc-ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 322 2345799999999999989999999999999999999999999964
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=409.74 Aligned_cols=210 Identities=25% Similarity=0.417 Sum_probs=179.1
Q ss_pred HHHHhhcCCCCCcceeecCCccceEEEEec------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCC-Cceeeeeee
Q 047591 737 QELQRLTDGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRH-RNLVKIISS 808 (1624)
Q Consensus 737 ~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~~~ 808 (1624)
++.+...++|...+.||+|+||+||+|++. .++.||||++..... ...+.|.+|+++|++++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 344445678888999999999999999864 236899999975443 345679999999999965 899999999
Q ss_pred eccC-CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCC
Q 047591 809 CSNH-GFKALILEYMPQGSLEKWLYSHK---------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKP 872 (1624)
Q Consensus 809 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp 872 (1624)
|.+. +..|+|||||++|+|.++|+... ..++|.++..|+.|||+||+|||+. +||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCc
Confidence 9764 56899999999999999997642 2489999999999999999999994 599999999
Q ss_pred CCeeeCCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccC
Q 047591 873 SNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEMF 949 (1624)
Q Consensus 873 ~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~~ 949 (1624)
+|||+++++++||+|||+|+....+... .....+||+.|||||++..+.++.++|||||||++|||+| |+.||....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999977554332 3344579999999999999999999999999999999998 899997643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=407.59 Aligned_cols=286 Identities=34% Similarity=0.555 Sum_probs=232.4
Q ss_pred hhccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEe
Q 047591 1320 AALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVS 1398 (1624)
Q Consensus 1320 ~~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g 1398 (1624)
.....++++++..++++|...+.||+|+||+||+|+..+++.||||++..... .....|.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34678899999999999999999999999999999988899999999865432 23347899999999999999999999
Q ss_pred eeccCCeeEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEE
Q 047591 1399 SCSNPGFKALILQYMPQGSLEKWLYSHN---YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475 (1624)
Q Consensus 1399 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 1475 (1624)
+|.+++..++||||+++|+|.++++... ..+++..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998643 3489999999999999999999985445999999999999999999999
Q ss_pred EeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCC---Cccchhhhhhhhh
Q 047591 1476 LGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM---FTGEVCLKHWVEE 1552 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~---~~~~~~l~~~~~~ 1552 (1624)
|+|||+|+..............||+.|+|||++.+..++.++|||||||++|||+||+.||+.. .........|+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999999987654444444556999999999998888999999999999999999999999631 1122233444433
Q ss_pred cCChh-HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 047591 1553 SLPDA-VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKK 1612 (1624)
Q Consensus 1553 ~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~ 1612 (1624)
..... ....++..+.... ...++..+.+++.+||+.+|++|||++||+++|+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNY-------KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSC-------CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhhchhhhhhcChhhcccc-------CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 32221 1222222221111 13456778999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=390.96 Aligned_cols=197 Identities=26% Similarity=0.466 Sum_probs=161.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 479999999997542 234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||| +|+|.+++..++ .+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 689999998654 699999999999999999999994 59999999999999999999999999998765432
Q ss_pred cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 2234579999999999887765 6899999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=431.13 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=208.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 56888899999999999999875 68999999987666666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC--CcEEEeeecceeecCCCCCc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD--MVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~--~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++|+|.+++.+....+++.+...|+.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-- 311 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence 9999999997666678999999999999999999996 799999999999999854 899999999999886433
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+. +........ ....
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~------------~~~~- 377 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDW------------NMDD- 377 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCC------------CCCS-
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCC------------CCCc-
Confidence 23345799999999999999999999999999999999999999975432111 111111000 0000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....++..+.+|+.+|++.||++|||++|+++
T Consensus 378 ----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001223456788999999999999999999987
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=401.97 Aligned_cols=298 Identities=29% Similarity=0.469 Sum_probs=225.3
Q ss_pred cCChhhHHHHHHHHHHhccCCccccccCCCCCCCCCCCCCCCCcc--ceeeEecCCC--CcEEEEecCCCCCCc--cCCc
Q 047591 34 ANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCN--WVGVTCGSRH--GRVTDLSIPNLGLGG--TIPP 107 (1624)
Q Consensus 34 ~~~~~d~~aLl~~k~~~~~~p~~~~~~~W~~~~~~~~~~~~~~C~--W~Gv~C~~~~--~~v~~l~l~~~~l~g--~ip~ 107 (1624)
.|.++|++||++||++++ ||. . .++|+. +.+||. |.||+|+..+ ++|+.|+|+++++.| .+|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~-~~~-~-l~~W~~--------~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~ 70 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLG-NPT-T-LSSWLP--------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS 70 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-G-GTTCCT--------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG
T ss_pred CCCHHHHHHHHHHHHhcC-Ccc-c-ccCCCC--------CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh
Confidence 478999999999999995 775 3 358863 357888 9999998765 899999999999999 9999
Q ss_pred cccCCCcccEEEecC-CCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCC
Q 047591 108 HVANLSFLVSLNISG-NRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCS 186 (1624)
Q Consensus 108 ~i~~L~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 186 (1624)
.++++++|++|+|++ |++.+.+|..|+.+++|++|+|++|++++.+|.. +..+++|++|+|++|++++.+|..|+.++
T Consensus 71 ~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 149 (313)
T 1ogq_A 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG-GGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH-HhCCCCCCEEeCCCCccCCcCChHHhcCC
Confidence 999999999999995 9999999999999999999999999998766654 46788888888888888888888888888
Q ss_pred cccccccccccccccccCcccccc-cccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEee
Q 047591 187 KLKRLSVSFNELTGRIPQNIGNLT-ELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELN 265 (1624)
Q Consensus 187 ~L~~L~Ls~N~l~g~ip~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~ 265 (1624)
+|++|+|++|+++|.+|..+++++ +|++|+|++|+++|.+|..+..++ |++|+|++|++++.+|. .+..+++|++|+
T Consensus 150 ~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~ 227 (313)
T 1ogq_A 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV-LFGSDKNTQKIH 227 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGG-GCCTTSCCSEEE
T ss_pred CCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCH-HHhcCCCCCEEE
Confidence 888888888888888888888887 788888888888777777776665 66666666665543332 223444444444
Q ss_pred cccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEE
Q 047591 266 LRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRL 345 (1624)
Q Consensus 266 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L 345 (1624)
|++|++++.+|. +..+++|++|+|++|+++|.+|..+. .+++|++|
T Consensus 228 L~~N~l~~~~~~---------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L 273 (313)
T 1ogq_A 228 LAKNSLAFDLGK---------------------------------VGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSL 273 (313)
T ss_dssp CCSSEECCBGGG---------------------------------CCCCTTCCEEECCSSCCEECCCGGGG-GCTTCCEE
T ss_pred CCCCceeeecCc---------------------------------ccccCCCCEEECcCCcccCcCChHHh-cCcCCCEE
Confidence 444444443333 44455566666666666666666554 57777777
Q ss_pred EecCCccCCcCcccccCCCCCcEEecCCcc-ccccC
Q 047591 346 YLWGNNLSGVIPSSICNASKLTVLELSRNL-FSGLV 380 (1624)
Q Consensus 346 ~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~-l~g~~ 380 (1624)
+|++|+++|.+|.. .++++|+.|++++|. +.|.+
T Consensus 274 ~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 274 NVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp ECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTT
T ss_pred ECcCCcccccCCCC-ccccccChHHhcCCCCccCCC
Confidence 77777777777765 677778888888876 66643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=396.16 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=216.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||+||+|+.. +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45677789999999999999885 58899999887666667789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc-
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK- 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~- 1492 (1624)
++|+|.+++......+++.++..|+.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 9999999999877779999999999999999999996 799999999999999999999999999998765332211
Q ss_pred ------------ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHH
Q 047591 1493 ------------QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560 (1624)
Q Consensus 1493 ------------~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~ 1560 (1624)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+............ ....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------~~~~ 238 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVRG 238 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------CHHH
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------hhhc
Confidence 11457999999999999999999999999999999999999998654322211100 0111
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
..+... +..++..+.+++.+||+.||++|||+.|+++.|++++....
T Consensus 239 ~~~~~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 239 FLDRYC-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHHHTC-----------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccccC-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111111 12345567889999999999999999999999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=422.99 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=196.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHH---HHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSF---DAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f---~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...++||+|+||+||+|+.. +|+.||||+++... ......+ .+++++++.++|||||++++++.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56888899999999999999875 68999999986432 1122233 44466777889999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+|||||++|+|.++|.+.+ .+++.....|+.||+.||+|||+ .+||||||||+|||||.+|++||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999999998754 57888888999999999999995 8999999999999999999999999999998753
Q ss_pred CCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccch-hhhhhhhhcCChhHHHHHhhh
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV-CLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~-~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
. ...+.+||+.|||||++.. ..|+.++||||+||++|||+||+.||.+...... .+.. .+....
T Consensus 345 ~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~-----------~i~~~~ 410 (689)
T 3v5w_A 345 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------MTLTMA 410 (689)
T ss_dssp C---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH-----------HHHHCC
T ss_pred C---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----------hhcCCC
Confidence 3 2344689999999999864 5799999999999999999999999965321111 0000 011110
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
.. .+...+..+.+++.+|++.||++|++ ++||.+
T Consensus 411 ~~---------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 VE---------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC---------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC---------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00 01123456788999999999999998 577654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=411.88 Aligned_cols=366 Identities=18% Similarity=0.153 Sum_probs=232.7
Q ss_pred CCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCC
Q 047591 100 GLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLP 179 (1624)
Q Consensus 100 ~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP 179 (1624)
+..+..+..++++++|++|++++|++++ +| .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|+|++ +|
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~---~~~l~~L~~L~Ls~N~l~~-~~ 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD---LSQNTNLTYLACDSNKLTN-LD 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSC-CC
T ss_pred CcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec---cccCCCCCEEECcCCCCce-ee
Confidence 3445556677888888888888888886 45 68888888888888888876 33 4677888888888888876 33
Q ss_pred ccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCC
Q 047591 180 SSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLP 259 (1624)
Q Consensus 180 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~ 259 (1624)
++++++|++|+|++|++++ +| ++++++|++|++++|++++ +| ++++++|++|++++|+..+.++ +..++
T Consensus 102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~---~~~l~ 170 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD---VTPQT 170 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC---CTTCT
T ss_pred --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccc---cccCC
Confidence 7777888888888888775 44 7777777777777777776 33 5666666666666665555443 23455
Q ss_pred CCcEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccC
Q 047591 260 SLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINL 339 (1624)
Q Consensus 260 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l 339 (1624)
+|++|++++|++++ +| ++.+++ |+.|++++|++++. + + ..+
T Consensus 171 ~L~~L~ls~n~l~~-l~--l~~l~~--------------------------------L~~L~l~~N~l~~~-~--l-~~l 211 (457)
T 3bz5_A 171 QLTTLDCSFNKITE-LD--VSQNKL--------------------------------LNRLNCDTNNITKL-D--L-NQN 211 (457)
T ss_dssp TCCEEECCSSCCCC-CC--CTTCTT--------------------------------CCEEECCSSCCSCC-C--C-TTC
T ss_pred cCCEEECCCCccce-ec--cccCCC--------------------------------CCEEECcCCcCCee-c--c-ccC
Confidence 55555555555554 22 444444 44444444444432 1 1 256
Q ss_pred CCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCccccccccccc
Q 047591 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCR 419 (1624)
Q Consensus 340 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 419 (1624)
++|++|+|++|++++ +| ++.+++|++|+|++|++++.+ ++.+++|+.|++++|++
T Consensus 212 ~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L------------------- 266 (457)
T 3bz5_A 212 IQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL------------------- 266 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCC-------------------
T ss_pred CCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCC-------------------
Confidence 777777777777776 45 677777888888888777764 34556667776665533
Q ss_pred ccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecc
Q 047591 420 YLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDL 499 (1624)
Q Consensus 420 ~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~L 499 (1624)
+.+++++|.+.|.+| ++.+++|+.|+|++|.+.+.+|. ...+|+.|++
T Consensus 267 ---------------------------~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l 314 (457)
T 3bz5_A 267 ---------------------------LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDL 314 (457)
T ss_dssp ---------------------------SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCC
T ss_pred ---------------------------CEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEech
Confidence 223333444444444 34566677777777776666664 3355666665
Q ss_pred cccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCC
Q 047591 500 SYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579 (1624)
Q Consensus 500 s~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~ 579 (1624)
++| ++|+.|+|++|+|+| +| ++++++|+.|++++|+++| ++.|..|++++|.++|.
T Consensus 315 ~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~ 370 (457)
T 3bz5_A 315 SQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE 370 (457)
T ss_dssp TTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE
T ss_pred hhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec
Confidence 555 466777777777776 33 6667777777777777765 13445555666666654
Q ss_pred CCcccccccccceeeccCCcCCCCccccc
Q 047591 580 LPQDIGNLKVLTGLYLSGNQLSCSIPSSI 608 (1624)
Q Consensus 580 iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~ 608 (1624)
+++..|+.++|++|+|+|.||..+
T Consensus 371 -----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 371 -----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp -----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred -----ceeeecCccccccCcEEEEcChhH
Confidence 244455555566666555555543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=401.46 Aligned_cols=282 Identities=33% Similarity=0.566 Sum_probs=226.2
Q ss_pred ccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC
Q 047591 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1324 ~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~ 1403 (1624)
++++.++..++++|...+.||+|+||+||+|++.+++.||||++........+.|.+|++++++++||||++++++|.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34445566688999999999999999999999888999999998766556678899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHN---YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
+..++||||+++|+|.+++.... ..++|.++++++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999987543 358999999999999999999996 799999999999999999999999999
Q ss_pred ceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccc-hhhhhhhhhcC-Chh
Q 047591 1481 IAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE-VCLKHWVEESL-PDA 1557 (1624)
Q Consensus 1481 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~-~~l~~~~~~~~-~~~ 1557 (1624)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .....|..... ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9987643222 22234569999999999888899999999999999999999999987543221 22223322111 001
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
....+++.+... ....++..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 265 ~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNLADK-------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSCTTC-------SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhhccc-------cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 111122221111 113456788999999999999999999999999998764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=415.64 Aligned_cols=376 Identities=20% Similarity=0.159 Sum_probs=255.4
Q ss_pred ccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeee
Q 047591 210 TELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLG 289 (1624)
Q Consensus 210 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 289 (1624)
++|++|+|++|++++..|..+.++++|++|+|++|.+.+.+|...+.++++|++|+|++|++++.+|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 34444444444444444444444444455555555444455555555666666666666666666677777777777777
Q ss_pred ccCCcccccCccccccccccc--cccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCC--CC
Q 047591 290 LRDNQLTDFGANNLTGLIPSI--IFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNA--SK 365 (1624)
Q Consensus 290 Ls~N~l~~l~~n~l~g~ip~~--~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l--~~ 365 (1624)
|++|+++ +.+|.. +.++.+|++|+|++|++++..|..++.++++|++|+|++|++++..|..+..+ .+
T Consensus 110 L~~n~l~--------~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~ 181 (455)
T 3v47_A 110 LTQCNLD--------GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKH 181 (455)
T ss_dssp CTTSCCB--------THHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCE
T ss_pred CCCCCCC--------ccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccc
Confidence 7666543 333333 55556666666666666655555544456666666666666666666666554 45
Q ss_pred CcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCcc--
Q 047591 366 LTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLS-- 443 (1624)
Q Consensus 366 L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~-- 443 (1624)
|+.|++++|.+.+..+..++. .....+..+++|++|++++|.+.+.+|..+....
T Consensus 182 L~~L~l~~n~l~~~~~~~~~~-----------------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 238 (455)
T 3v47_A 182 FTLLRLSSITLQDMNEYWLGW-----------------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238 (455)
T ss_dssp EEEEECTTCBCTTCSTTCTTH-----------------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTT
T ss_pred ccccccccCcccccchhhccc-----------------------cccccccccceeeeEecCCCcccccchhhhhccccc
Confidence 666666666666554433220 0011122334455555555555544444333220
Q ss_pred ccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccc--cccceecccccccccCCCccccCCCCCcee
Q 047591 444 KSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKL--QNLQGLDLSYNNIQGSIPSELCQLESLNTL 521 (1624)
Q Consensus 444 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l--~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 521 (1624)
..++.|++++|.+.+.. +..+.+.+..+..+..+ ++|++|+|++|++++.+|..++.+++|+.|
T Consensus 239 ~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 304 (455)
T 3v47_A 239 TKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQL 304 (455)
T ss_dssp CCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEE
Confidence 13444555554443321 12223333333344433 689999999999999999999999999999
Q ss_pred ecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCC
Q 047591 522 LLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLS 601 (1624)
Q Consensus 522 ~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~ 601 (1624)
+|++|++++..|..|+++++|++|+|++|++++..|..|..+.+|+.|||++|++++..|.+++.+++|+.|+|++|+++
T Consensus 305 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 384 (455)
T 3v47_A 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384 (455)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccc
Confidence 99999999988999999999999999999999988999999999999999999999988999999999999999999999
Q ss_pred CCccccccCCccccccccccCCCCCCCch
Q 047591 602 CSIPSSIGGLKDLTYLALARNGFQGSIPE 630 (1624)
Q Consensus 602 g~iP~~~~~l~~L~~L~ls~N~l~g~iP~ 630 (1624)
+..+..++.+++|++|++++|++++.+|.
T Consensus 385 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 385 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 86666789999999999999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=389.24 Aligned_cols=197 Identities=26% Similarity=0.429 Sum_probs=159.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCC--------
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHG-------- 813 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------- 813 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588889999999999999986 4799999999975543 34567999999999999999999999986543
Q ss_pred ----eEEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEe
Q 047591 814 ----FKALILEYMPQGSLEKWLYSHKY--TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSD 887 (1624)
Q Consensus 814 ----~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~D 887 (1624)
..|+|||||++|+|.+++..... ..++..+..|+.||++||+|||+. +||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999986542 345667889999999999999994 599999999999999999999999
Q ss_pred eeeeeccCCCCCc-----------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 888 FGISKLLDGEDSV-----------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 888 FGla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 9999987543221 1233579999999999999999999999999999999996 764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=382.06 Aligned_cols=281 Identities=28% Similarity=0.459 Sum_probs=226.3
Q ss_pred hccccCHHHHHHHhCCCCcC------CeEeecCceEEEEEEEcCCceEEEEEeccc----hhhHHHHHHHHHHHHHhcCC
Q 047591 1321 ALRRISYQELRLATNGFSES------NLLGTGIFSSVYKATFADGTNAAIKIFSLQ----EDRALKSFDAECEVMRRIRH 1390 (1624)
Q Consensus 1321 ~~~~~~~~~l~~at~~f~~~------~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~----~~~~~~~f~~E~~~l~~l~H 1390 (1624)
....|++.++..++++|+.. +.||+|+||+||+|++ +++.||||++... .....+.|.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35779999999999999988 8999999999999987 6889999998642 23456789999999999999
Q ss_pred CceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSH--NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1391 pNIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
|||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999999743 3468999999999999999999996 799999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~ 1547 (1624)
++++.+||+|||+++....... .......||+.|+|||...+ .++.++|||||||++|||+||+.||+...... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence 9999999999999987654322 12234579999999998764 58999999999999999999999997643221 111
Q ss_pred hhhhh--cCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1548 HWVEE--SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1548 ~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.+... .....+.+.++..+... ...++..+.+++.+||+.+|++|||++|+++.|++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDA--------DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCC--------CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhcccccccc--------chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 12111 11112233333322111 12346678899999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=392.24 Aligned_cols=277 Identities=21% Similarity=0.286 Sum_probs=209.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC----eeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG----FKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~----~~~lV 1409 (1624)
.++|...+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++|||||++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 356777889999999999999875 7899999996543 33455677999999999999999999997644 36999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhc-------CCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG-------YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
|||+++|+|.++++.. .+++..+..|+.|+++||+|||+. +.++|+||||||+|||++.++.+||+|||+|
T Consensus 101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 9999999999999764 489999999999999999999962 1129999999999999999999999999999
Q ss_pred eecCCCCCc-cccccccccccccccccCC-----CCcCcccchHHHHHHHHHHHcCCCCCCCCCccch-hhhhhhhhcC-
Q 047591 1483 KLLDGVDSM-KQTMTLATIGYMAPEYGSE-----GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV-CLKHWVEESL- 1554 (1624)
Q Consensus 1483 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~-~l~~~~~~~~- 1554 (1624)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ..........
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 877543322 2234579999999998876 4677889999999999999999999975432211 1111111000
Q ss_pred ChhHHHHHhhh-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1555 PDAVTDVIDAN-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1555 ~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+...+.+... ....... ......++..+.+++.+||+.||++|||++||++.|+++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRD--YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCG--GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCccc--cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01111111111 1111000 001123566789999999999999999999999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=395.46 Aligned_cols=259 Identities=25% Similarity=0.455 Sum_probs=212.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc--------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA--------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~--------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~ 1404 (1624)
++|...+.||+|+||+||+|++. ++..||||+++.. .....+.+.+|+++++++ +|||||+++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 56777889999999999999863 3456999998644 344567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1405 FKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
..++||||+++|+|.+++.... ..+++.+++.++.||++||+|||+ .+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 9999999999999999998643 347899999999999999999996 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~ 1547 (1624)
.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+. .
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--~ 315 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--F 315 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--H
Confidence 9999999999999977543322 2234567899999999988899999999999999999999 9999875422111 1
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
..+....... .+..++..+.+++.+||+.+|++|||+.|+++.|+++.+..
T Consensus 316 ------------~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 316 ------------KLLKEGHRMD-------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ------------HHHHTTCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------HHHhcCCCCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111000 01234567889999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=401.89 Aligned_cols=260 Identities=21% Similarity=0.366 Sum_probs=213.8
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
..++|...+.||+|+||+||+|++. +++.||||+++... ....+.|.+|+++|++++|||||+++++|.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3456777889999999999999986 68899999986432 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|||++|+|.++++..+..+++.+++.++.|||+||+|||+ .+|+||||||+|||+++++.+||+|||+|+.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999998777778999999999999999999996 7999999999999999999999999999987543221
Q ss_pred cc-ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1491 MK-QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1491 ~~-~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.. .....+++.|+|||.+..+.++.++|||||||++|||+| |+.||......+ . .+.+......
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~------------~~~~~~~~~~ 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--T------------REFVEKGGRL 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--H------------HHHHHTTCCC
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H------------HHHHHcCCCC
Confidence 11 122346788999999988899999999999999999999 999987543211 1 1111111100
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
. .+..++..+.+++.+||+.+|++|||++|+++.|++++.+
T Consensus 335 ~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 P-------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0 0123566788999999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=378.43 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=213.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.++|...+.||+|+||+||+|++.++..||||+++... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45677788999999999999999888899999986433 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++...+..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 9999999998776678999999999999999999996 7999999999999999999999999999987765443334
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....+|+.|+|||...+..++.++|||||||++|||+| |+.||+........ ... ........
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~------------~~~~~~~~--- 226 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKV------------SQGHRLYR--- 226 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHH------------HTTCCCCC---
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-HHH------------HcCCCCCC---
Confidence 44567888999999988889999999999999999999 99998754322111 000 00000000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+..++..+.+++.+||+.+|++|||++|+++.|++++.+
T Consensus 227 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 -----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011345678899999999999999999999999988655
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=388.60 Aligned_cols=258 Identities=23% Similarity=0.400 Sum_probs=209.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+.|...+.||+|+||+||+|++. .+..||||+++.. .....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 35666789999999999999884 3445999998754 344567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.++++.....+++.+++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 99999999999998776779999999999999999999996 799999999999999999999999999999875432
Q ss_pred Cc--cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1490 SM--KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1490 ~~--~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.. ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+. .+.+....
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------------~~~~~~~~ 271 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--------------ISSVEEGY 271 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------------HHHHHTTC
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--------------HHHHHcCC
Confidence 21 2223456889999999988899999999999999999999 9999865422111 11111110
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
... .+..++..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 272 ~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 RLP-------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCC-------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 000 0123456788999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=397.18 Aligned_cols=258 Identities=21% Similarity=0.416 Sum_probs=201.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|++. ++..||||+++.. .....+.|.+|++++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46788899999999999999875 4678999998754 344567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++++.+..+++.+++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999998877779999999999999999999996 799999999999999999999999999998765432
Q ss_pred Ccc--ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1490 SMK--QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1490 ~~~--~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ +.+.++...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------------~~~~i~~~~ 267 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------------VIKAVDEGY 267 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------------HHHHHHTTE
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCC
Confidence 211 122346788999999988899999999999999999998 999986542211 111122111
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.... +..++..+.+++.+||+.+|++||+|.|+++.|+++...
T Consensus 268 ~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 RLPP-------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ECCC-------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCC-------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1100 123456788999999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=379.95 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=207.0
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 5688889999999999999986 468899999997665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++.+. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 173 (297)
T 3fxz_A 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (297)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-cc
Confidence 999999999765 47899999999999999999997 7999999999999999999999999999987754332 33
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....||+.|+|||++.+..++.++|||||||++|||+||+.||........ .........+ . ..
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~---------~-~~----- 237 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP---------E-LQ----- 237 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC---------C-CS-----
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC---------C-CC-----
Confidence 446799999999999889999999999999999999999999965322111 0000000000 0 00
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+..++..+.+++.+||+.||++|||++|+++.
T Consensus 238 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 012345567889999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=386.49 Aligned_cols=264 Identities=24% Similarity=0.410 Sum_probs=203.5
Q ss_pred HHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1328 QELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1328 ~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
.++....++|...+.||+|+||+||+|++ +|+.||||++.... ....++|.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33344456788889999999999999987 68889999986442 3456789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEEcCCCCCcEEecCCCcEEEeeecc
Q 047591 1406 KALILQYMPQGSLEKWLYSHNY--LLNIEQRLDIMIDVACALEYLHQGYSTS--IIHCDLKPSNVLLDDDMVAHLGDFGI 1481 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~--iiHrDlK~~NILld~~~~~kl~DFGl 1481 (1624)
.++||||+++|+|.+++...+. .+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999986542 38999999999999999999996 56 99999999999999999999999999
Q ss_pred eeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1482 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
|+...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......+. ...+.
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~---------- 252 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVG---------- 252 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHH----------
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH----------
Confidence 98654322 223345799999999999999999999999999999999999999975422111 00000
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
....... .+..++..+.+++.+||+.+|++|||++|+++.|+++.+.
T Consensus 253 -~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 -FKCKRLE-------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -HSCCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -hcCCCCC-------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000000 0113445688999999999999999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=378.42 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=212.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4567778999999999999999888899999986432 234679999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++......+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 999999998777779999999999999999999996 78999999999999999999999999999876543333334
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...||+.|+|||......++.++||||+||++|||+| |+.||......+. ... +........
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-~~~-------------~~~~~~~~~--- 228 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VED-------------ISTGFRLYK--- 228 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHH-------------HHTTCCCCC---
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-HHH-------------HhcCccCCC---
Confidence 4567889999999988899999999999999999999 8999875322111 110 111000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+..++..+.+++.+||+.+|++|||++|+++.|+++..+
T Consensus 229 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 ----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 012345678899999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=383.77 Aligned_cols=270 Identities=23% Similarity=0.392 Sum_probs=209.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-----CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-----DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-----~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~ 1407 (1624)
+.|...+.||+|+||+||+|++. +++.||||++........+.|.+|++++++++||||++++++|.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 45667789999999999999852 578899999986666667889999999999999999999999854 35689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999998877778999999999999999999996 7999999999999999999999999999987653
Q ss_pred CCC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc-CChh----HHH
Q 047591 1488 VDS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES-LPDA----VTD 1560 (1624)
Q Consensus 1488 ~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~-~~~~----~~~ 1560 (1624)
... .......||+.|+|||.+.+..++.++|||||||++|||+||..|+...... ...+.... .... ..+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHHH
Confidence 321 1122345788899999998889999999999999999999999998642111 11111111 1111 111
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.+...... ..+..++..+.+++.+||+.+|++|||++|+++.|++++..+
T Consensus 244 ~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNGRL-------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTCCC-------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccCcC-------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111000 011245678899999999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=383.04 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=213.8
Q ss_pred cccCHHHHHHHhCC----------CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCC
Q 047591 1323 RRISYQELRLATNG----------FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHR 1391 (1624)
Q Consensus 1323 ~~~~~~~l~~at~~----------f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~Hp 1391 (1624)
..+++++++.+++. |...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888764 555678999999999999886 6899999999766555567899999999999999
Q ss_pred ceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC
Q 047591 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD 1471 (1624)
Q Consensus 1392 NIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 1471 (1624)
||+++++++...+..++||||+++|+|.+++.+ ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999999864 358999999999999999999997 799999999999999999
Q ss_pred CcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh
Q 047591 1472 MVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1472 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~ 1551 (1624)
+.+||+|||+++...... .......||+.|+|||+..+..++.++|||||||++|||+||+.||....... ....+.
T Consensus 178 ~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~ 254 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLR 254 (321)
T ss_dssp CCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH
T ss_pred CcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh
Confidence 999999999998775432 22344579999999999999999999999999999999999999996532111 111111
Q ss_pred hcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1552 ESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+ +.+ . ....++..+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~--------~~~-~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 255 DSPP--------PKL-K--------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HSSC--------CCC-T--------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCC--------CCc-C--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1000 000 0 011234567889999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=379.64 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=200.9
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHh--cCCCceeEEEeeecc----CCeeE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRR--IRHRNLAKIVSSCSN----PGFKA 1407 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~--l~HpNIv~l~g~~~~----~~~~~ 1407 (1624)
.++|...+.||+|+||+||+|++ +++.||||++.... .+.+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35677889999999999999988 68899999986432 3556677777776 799999999998643 34579
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG-----YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
+||||+++|+|.++++. ..+++..+++|+.|++.||+|||.. +..+|+||||||+|||++.++.+||+|||+|
T Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999999954 3589999999999999999999931 1389999999999999999999999999999
Q ss_pred eecCCCCCcc---ccccccccccccccccCCC------CcCcccchHHHHHHHHHHHcC----------CCCCCCCCccc
Q 047591 1483 KLLDGVDSMK---QTMTLATIGYMAPEYGSEG------IVSTSGDVYSFGILMMETLTR----------RKPTDDMFTGE 1543 (1624)
Q Consensus 1483 ~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~~~k~DV~SfGvil~Elltg----------~~P~~~~~~~~ 1543 (1624)
+......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8765433211 2234799999999988766 566899999999999999999 77775433222
Q ss_pred hhhhhhhhhcCChhHHHHHhhh-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1544 VCLKHWVEESLPDAVTDVIDAN-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1544 ~~l~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
...... ...+... ........ .....++..+.+++.+||+.||++|||++|+++.|+++
T Consensus 241 ~~~~~~---------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDM---------RKVVCVDQQRPNIPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHH---------HHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhh---------hHHHhccCCCCCCChh--hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111111 1111000 00000000 01123567789999999999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=399.36 Aligned_cols=264 Identities=19% Similarity=0.253 Sum_probs=212.3
Q ss_pred cCHHHHHHHhCCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccchh---hHHHHHHHHHHHHHhcCCCceeEEEeee
Q 047591 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQED---RALKSFDAECEVMRRIRHRNLAKIVSSC 1400 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~---~~~~~f~~E~~~l~~l~HpNIv~l~g~~ 1400 (1624)
..+.+++..+++|...++||+|+||+||+|+... ++.||||+++.... ...+.+.+|+.+++.++|||||+++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456777788999999999999999999999864 78899999864322 2234589999999999999999999999
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
.+++..++|||||++|+|.+++.+....+++..+..|+.||+.||+|||+ .+||||||||+|||+|.++++||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999998766678999999999999999999996 799999999999999999999999999
Q ss_pred ceeecCCCCCccccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP 1555 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~ 1555 (1624)
+|+.............+||+.|||||++. .+.++.++|||||||++|||+||+.||......+. ...
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~------- 292 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGK------- 292 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH-------
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHh-------
Confidence 99877654444444568999999999876 56799999999999999999999999975322111 111
Q ss_pred hhHHHHHhhh-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 047591 1556 DAVTDVIDAN-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEE--RMNVKDALAN 1609 (1624)
Q Consensus 1556 ~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPt~~evl~~ 1609 (1624)
++... ...-... ...++..+.+++.+|+..+|++ ||+++|+++.
T Consensus 293 -----i~~~~~~~~~p~~-----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 -----IMNHKERFQFPTQ-----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -----HHTHHHHCCCCSS-----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -----hhhccccccCCcc-----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11100 0000000 0113456778999999888888 9999998763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=409.31 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=212.9
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
..++|...+.||+|+||+||+|++.++..||||+++... ...+.|.+|+++|++++|||||++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345677788999999999999999888899999987433 34678999999999999999999999986 5678999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++|+|.++++.. +..+++.++++++.|||.||+|||+ .+|+||||||+|||++.++.+||+|||+|+........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999854 3467899999999999999999996 79999999999999999999999999999876543222
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+|+.|+|||++..+.++.++|||||||++|||+| |+.||.+....+. .+.+.......
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~~~~~- 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------------IRALERGYRMP- 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------------HHHHHHTCCCC-
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcCCCCC-
Confidence 2334457889999999988899999999999999999999 9999975432111 11111111100
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
.+..++..+.+++.+||+.+|++||||+++++.|+++.+....
T Consensus 406 ------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 406 ------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 0124567789999999999999999999999999987654433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=390.49 Aligned_cols=270 Identities=21% Similarity=0.352 Sum_probs=216.1
Q ss_pred ccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeE
Q 047591 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAK 1395 (1624)
Q Consensus 1324 ~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~ 1395 (1624)
.+...++....++|...+.||+|+||+||+|++. +++.||||+++.. .....+.|.+|+++++++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455666777888999999999999999999752 3578999999653 334467899999999999 8999999
Q ss_pred EEeeeccCCe-eEEEEEecCCCCHHHHHHhcCC-----------------------------------------------
Q 047591 1396 IVSSCSNPGF-KALILQYMPQGSLEKWLYSHNY----------------------------------------------- 1427 (1624)
Q Consensus 1396 l~g~~~~~~~-~~lV~ey~~~gsL~~~l~~~~~----------------------------------------------- 1427 (1624)
++++|.+++. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987554 8999999999999999986432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1428 ------------------LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1428 ------------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
.+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 18899999999999999999996 799999999999999999999999999998764322
Q ss_pred -CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1490 -SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1490 -~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
........||+.|||||++.+..++.++|||||||++|||+| |+.||......+.... .+.....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------------~~~~~~~ 314 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------------RLKEGTR 314 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-------------HHHHTCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-------------HHHcCCC
Confidence 223344578999999999988899999999999999999999 9999975432221111 1111100
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
... +..++..+.+++.+||+.+|++|||+.|++++|+++...
T Consensus 315 ~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 MRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 000 012345688899999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=375.71 Aligned_cols=259 Identities=23% Similarity=0.427 Sum_probs=205.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
+.|...+.||+|+||+||+|+.. +++.||+|++... .....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 56778899999999999999875 6889999988532 3445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+|+.......
T Consensus 91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999997654 58999999999999999999996 7999999999999999999999999999987654333
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ......+...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~------------ 233 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-HIQDSVPNVT------------ 233 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-HHSSCCCCHH------------
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhhccCCCcc------------
Confidence 333445799999999999888999999999999999999999999976432211111 1111111110
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM-NVKDALANLKKIK 1614 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-t~~evl~~L~~i~ 1614 (1624)
......++..+.+++.+|++.+|++|| +++++.+.|+++.
T Consensus 234 ----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 ----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 011123456788999999999999999 8999999988753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=375.57 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=209.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.++|...+.||+|+||+||+|++.++..||||+++... ...++|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34677778999999999999999888899999986432 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 9999999998766678999999999999999999996 7999999999999999999999999999987654332333
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....+|+.|+|||...+..++.++|||||||++|||+| |+.||........ . +.+........
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-~-------------~~~~~~~~~~~-- 242 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-A-------------EHIAQGLRLYR-- 242 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-H-------------HHHHTTCCCCC--
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-H-------------HHHhcccCCCC--
Confidence 34567889999999988889999999999999999999 9999875422111 1 11111110000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+..++..+.+++.+||+.+|++|||++|+++.|+++..+
T Consensus 243 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 243 -----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 012345678899999999999999999999999988654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=388.92 Aligned_cols=270 Identities=16% Similarity=0.178 Sum_probs=210.4
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcC------CceEEEEEeccchhh-----------HHHHHHHHHHHHHhcCCCceeE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFAD------GTNAAIKIFSLQEDR-----------ALKSFDAECEVMRRIRHRNLAK 1395 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~------~~~vAvK~~~~~~~~-----------~~~~f~~E~~~l~~l~HpNIv~ 1395 (1624)
..++|...+.||+|+||+||+|++.. ++.||||++...... ....+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34678888999999999999998864 478999998643211 1123455666778889999999
Q ss_pred EEeeeccC----CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec--
Q 047591 1396 IVSSCSNP----GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-- 1469 (1624)
Q Consensus 1396 l~g~~~~~----~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-- 1469 (1624)
+++++... ...++||||+ +|+|.+++......+++.+++.|+.||+.||+|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 99998764 4579999999 999999998876789999999999999999999996 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccc
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~ 1543 (1624)
.++.+||+|||+|+.+...... ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876532211 1133459999999999999899999999999999999999999997533222
Q ss_pred hhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1544 VCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1544 ~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
. ...+........+.+.++..+.. ..++..+.+++..||+.+|++||+++++++.|+++....
T Consensus 269 ~-~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 K-YVRDSKIRYRENIASLMDKCFPA----------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp H-HHHHHHHHHHHCHHHHHHHHSCT----------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-HHHHHHHHhhhhHHHHHHHhccc----------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1 11222222222233333332211 134667889999999999999999999999999887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=372.40 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=198.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.++|...+.||+|+||+||+|++.. +..||+|++... .....+.|.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3467778899999999999998743 456999988643 3445678999999999999999999999984 567899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.+++...+..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999998777779999999999999999999996 79999999999999999999999999999877544
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.........+|+.|+|||......++.++|||||||++|||++ |+.||......+. ...+ ......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i-----------~~~~~~ 236 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRI-----------ENGERL 236 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH-----------HTTCCC
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHH-----------HcCCCC
Confidence 3333344567889999999988889999999999999999997 9999875432211 1111 110000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.. +..++..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 237 ~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 PM--------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 123456788999999999999999999999999998664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=396.33 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=208.0
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC-eeEEEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG-FKALILQ 1411 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~-~~~lV~e 1411 (1624)
..++|...+.||+|+||+||+|++. ++.||||+++... ..+.|.+|+++|++++|||||+++++|.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3456777789999999999999885 7899999987543 4578999999999999999999999987655 7899999
Q ss_pred ecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1412 YMPQGSLEKWLYSHNY-LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||++|+|.+++++.+. .+++..++.++.|||+||+|||+ .+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999986543 47999999999999999999996 79999999999999999999999999999865322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....+|+.|||||.+.+..++.++|||||||++|||+| |+.||......+. ...+......
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~~~~- 405 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------------VPRVEKGYKM- 405 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--------------HHHHHTTCCC-
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcCCCC-
Confidence 122367899999999998999999999999999999999 9999976432211 1111111100
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..+..|+..+.+++.+||+.+|++|||+.|+++.|+++++.
T Consensus 406 ------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 ------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01124567789999999999999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=382.35 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=202.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCce----EEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTN----AAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~----vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
++|...+.||+|+||+||+|++. +++. ||+|.+... .....+.|.+|++++++++||||++++++|.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45777889999999999999874 3443 578877533 2345678999999999999999999999998754 789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.++++.....+++..++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 999999999999999877789999999999999999999997 79999999999999999999999999999877543
Q ss_pred CC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||+...... + .+.+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~------------~~~~~~~~ 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I------------SSILEKGE 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H------------HHHHHTTC
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--H------------HHHHHcCC
Confidence 32 22233457889999999999999999999999999999999 999997543221 1 11111111
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.... +..++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 237 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 RLPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC-------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC-------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0000 12345568899999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=378.92 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=203.8
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788889999999999999987 57899999998643 3345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 9999999999997653 47889999999999999999996 799999999999999999999999999998765332
Q ss_pred ccccccccccccccccccCCCCcC-cccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVS-TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~-~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......||+.|+|||++.+..++ .++||||+||++|||+||+.||++....+ +.. .+..... ..
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~-----------~i~~~~~-~~ 233 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LRE-----------RVLRGKY-RI 233 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-----------HHHHCCC-CC
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HHH-----------HHHhCCC-CC
Confidence 23446799999999998777764 89999999999999999999997532111 000 1111100 00
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ..++..+.+++.+|++.||++|||++|+++.
T Consensus 234 p--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 P--------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C--------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C--------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 1234557789999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=373.15 Aligned_cols=269 Identities=22% Similarity=0.276 Sum_probs=205.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 5677889999999999999999889999999986432 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++ |+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 101 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 101 ME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp CS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred CC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 98 58999988777778999999999999999999996 799999999999999999999999999998765322 22
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHH------H
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDV------I 1562 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~------~ 1562 (1624)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+. +..... ...+..+... .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccchhh
Confidence 334578999999998765 5689999999999999999999999976433222 111111 1111110000 0
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.................+..++.+++.+|++.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000000011112345678899999999999999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=377.39 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=208.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.+.|...+.||+|+||+||+|+.. +++.+|+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 356788899999999999999875 57889999986443 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC--CCcEEEeeecceeecCCCCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD--DMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--~~~~kl~DFGla~~~~~~~~ 1490 (1624)
+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 99999999998766678999999999999999999996 79999999999999997 7899999999999875432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||+..+..++.++|||||||++|||+||+.||......+ .... +....... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~------------i~~~~~~~-~ 223 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIEN------------IMNAEYTF-D 223 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH------------HHHTCCCC-C
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHH------------HHcCCCCC-C
Confidence 2334579999999999988889999999999999999999999997532211 1111 11111100 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......++..+.+++.+|++.||++|||+.|+++.
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123456678899999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=404.03 Aligned_cols=255 Identities=22% Similarity=0.393 Sum_probs=211.9
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.++|...+.||+|+||+||+|++.. +..||||+++... ...+.|.+|+++|++++|||||+++++|.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3456777899999999999999874 7889999986433 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++|+|.++++.. ...+++..++.|+.|||+||+|||+ .+|+||||||+|||+++++.+||+|||+|+........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999864 3568999999999999999999996 79999999999999999999999999999987544333
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+|+.|+|||++....++.++|||||||++|||+| |+.||......+. .+.+.......
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~~~~~- 439 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------YELLEKDYRME- 439 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------------HHHHHTTCCCC-
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcCCCCC-
Confidence 3334557889999999988899999999999999999999 9999875432211 11111111100
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.+..++..+.+++.+||+.+|++||||.|+++.|+.+
T Consensus 440 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 440 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 0124566788999999999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=385.20 Aligned_cols=265 Identities=24% Similarity=0.380 Sum_probs=212.3
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~ 1403 (1624)
....++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.|.+|++++++++||||++++++|.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344567888899999999999999874 3478999998754 334567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcC
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHN-----------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 1460 (1624)
+..++||||+++|+|.+++.... ..+++.+++.|+.||++||+|||+ .+|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 99999999999999999998642 468999999999999999999996 7999999
Q ss_pred CCCCcEEecCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCC
Q 047591 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDD 1538 (1624)
Q Consensus 1461 lK~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~ 1538 (1624)
|||+|||+++++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987643221 12234568999999999888889999999999999999999 9999875
Q ss_pred CCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1539 MFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1539 ~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
....+. .. .+.+...... +..++..+.+++.+||+.+|++|||+.|+++.|+++..+..
T Consensus 280 ~~~~~~--~~-----------~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 280 MAHEEV--IY-----------YVRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp SCHHHH--HH-----------HHHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CChHHH--HH-----------HHhCCCcCCC--------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 422111 11 1111111110 12345678899999999999999999999999999876654
Q ss_pred h
Q 047591 1619 K 1619 (1624)
Q Consensus 1619 ~ 1619 (1624)
.
T Consensus 339 ~ 339 (343)
T 1luf_A 339 G 339 (343)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=388.06 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=207.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...+.||+|+||+||+|++. +++.||||+++.. ......+|.+|+.++++++|||||++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 45677789999999999999863 3567999998643 3445568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC---cEEEee
Q 047591 1408 LILQYMPQGSLEKWLYSHN------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM---VAHLGD 1478 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~kl~D 1478 (1624)
+||||+++|+|.+++...+ ..+++.+++.|+.||++||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999998643 458999999999999999999996 7999999999999999554 599999
Q ss_pred ecceeecCCCC-CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1479 FGIAKLLDGVD-SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1479 FGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
||+|+...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||......+ +.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~--------- 296 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL--------- 296 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH---------
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---------
Confidence 99998653222 222334568999999999988899999999999999999998 999986532211 11
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+.+........ +..++..+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 297 ---~~i~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 297 ---EFVTSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ---HHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHHHcCCCCCC-------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11111100000 123456688999999999999999999999999988653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=369.64 Aligned_cols=265 Identities=13% Similarity=0.125 Sum_probs=213.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688889999999999999986 468999999886432 235688899999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc-----EEEeeecceeecC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV-----AHLGDFGIAKLLD 1486 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-----~kl~DFGla~~~~ 1486 (1624)
|+ +|+|.+++...+..+++.++..|+.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+|+...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 999999998777779999999999999999999995 79999999999999988776 9999999999875
Q ss_pred CCCCc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHH
Q 047591 1487 GVDSM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560 (1624)
Q Consensus 1487 ~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~ 1560 (1624)
..... ......||+.|+|||+..+..++.++|||||||++|||+||+.||......... .. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~---------~~~ 232 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QK---------YER 232 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HH---------HHH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HH---------HHH
Confidence 43221 223457999999999999889999999999999999999999999764321110 00 000
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
+......... ......++..+.+++.+||+.+|++|||++++++.|+++..+..
T Consensus 233 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 233 IGEKKQSTPL----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHSCH----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhhccCccH----HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0000000000 00112456778999999999999999999999999999987644
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=393.32 Aligned_cols=369 Identities=18% Similarity=0.195 Sum_probs=304.3
Q ss_pred cCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCC
Q 047591 170 SSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGS 249 (1624)
Q Consensus 170 s~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 249 (1624)
......+..+.+++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++ +| ++++++|++|+|++|++++
T Consensus 26 ~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~- 99 (457)
T 3bz5_A 26 AAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN- 99 (457)
T ss_dssp HHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-
T ss_pred HhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-
Confidence 3445566667789999999999999999996 46 69999999999999999997 44 8899999999999999986
Q ss_pred CCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCC
Q 047591 250 LPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSG 329 (1624)
Q Consensus 250 ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g 329 (1624)
+| ++.+++|++|++++|++++ +| ++.+++|++|++++|+++.+ | +.++++|++|++++|+..|
T Consensus 100 ~~---~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---------~--l~~l~~L~~L~l~~n~~~~ 162 (457)
T 3bz5_A 100 LD---VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---------D--VSHNTQLTELDCHLNKKIT 162 (457)
T ss_dssp CC---CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---------C--CTTCTTCCEEECTTCSCCC
T ss_pred ee---cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---------c--cccCCcCCEEECCCCCccc
Confidence 45 5789999999999999998 44 89999999999998876643 2 6678899999999998777
Q ss_pred CCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCc
Q 047591 330 NLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQ 409 (1624)
Q Consensus 330 ~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~ 409 (1624)
.++ + ..+++|++|++++|++++ +| ++.+++|+.|++++|++++. .|+.+++|++|+|++|+++..+
T Consensus 163 ~~~--~-~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip----- 228 (457)
T 3bz5_A 163 KLD--V-TPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID----- 228 (457)
T ss_dssp CCC--C-TTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC-----
T ss_pred ccc--c-ccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC-----
Confidence 774 2 368999999999999997 45 88899999999999999987 3889999999999999987521
Q ss_pred ccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhc
Q 047591 410 SFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVG 489 (1624)
Q Consensus 410 ~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~ 489 (1624)
+..+++|++|++++|++++..+.. +. .|+.|+++.| +|+.|++++|++.|.+| ++
T Consensus 229 -----~~~l~~L~~L~l~~N~l~~~~~~~---l~-~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~ 283 (457)
T 3bz5_A 229 -----VTPLTQLTYFDCSVNPLTELDVST---LS-KLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AE 283 (457)
T ss_dssp -----CTTCTTCSEEECCSSCCSCCCCTT---CT-TCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CT
T ss_pred -----ccccCCCCEEEeeCCcCCCcCHHH---CC-CCCEEeccCC--------------CCCEEECCCCccCCccc--cc
Confidence 556788888888888888764333 22 4556666554 46778888888888887 46
Q ss_pred cccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhcccccccee
Q 047591 490 KLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVV 569 (1624)
Q Consensus 490 ~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~l 569 (1624)
.+++|+.|+|++|.+.|.+|. ...+|+.|++++| ++|+.|+|++|+|+|. | ++.+++|+.|
T Consensus 284 ~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L 344 (457)
T 3bz5_A 284 GCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSL 344 (457)
T ss_dssp TCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEE
T ss_pred ccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEE
Confidence 788899999999988888884 4456777766655 6899999999999984 4 8999999999
Q ss_pred ecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCCCCchhh
Q 047591 570 DFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAI 632 (1624)
Q Consensus 570 dLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g~iP~~~ 632 (1624)
|+++|+|+| ++.|+.|++++|+++|. +++..|..+++++|+|+|.||..+
T Consensus 345 ~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 345 SCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp ECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred ECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 999999986 35688889999999986 466788999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=378.12 Aligned_cols=262 Identities=16% Similarity=0.166 Sum_probs=210.6
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5688889999999999999986 4688999999864322 34688999999999 999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc-----EEEeeecceeecCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV-----AHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-----~kl~DFGla~~~~~ 1487 (1624)
+ +|+|.+++...+..+++.+++.|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+|+....
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 999999998766679999999999999999999996 79999999999999999887 99999999997654
Q ss_pred CCCc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1488 VDSM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1488 ~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......... .. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~--~~--------~~~i 232 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--ER--------YQKI 232 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH--HH--------HHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH--HH--------HHHH
Confidence 3221 123467999999999999999999999999999999999999999764322110 00 0001
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.+....... ......++ .+.+++.+||+.+|++||+++++.+.|+++..+.
T Consensus 233 ~~~~~~~~~----~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 233 GDTKRATPI----EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHSCH----HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhhhccCCH----HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000000000 00011234 7899999999999999999999999999887654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=375.08 Aligned_cols=244 Identities=23% Similarity=0.266 Sum_probs=195.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... .......+.+|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46888889999999999999886 6899999987542 233445566666666665 9999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+ +|+|.+++...+..++|..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 779999998777789999999999999999999997 789999999999999999999999999998765322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||++|+|||++.+ .++.++|||||||++|||++|..|+... .....+.....+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~-------------- 271 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPP-------------- 271 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCH--------------
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCc--------------
Confidence 2334569999999998765 7899999999999999999997775431 1111111111111
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....++..+.+++.+|++.+|++|||++|+++
T Consensus 272 -----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 -----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111234567889999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=401.82 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=204.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.++|...+.||+|+||+||+|++.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 34567778999999999999999888889999987433 235689999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.++++.. +..+++.++++++.|||.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999753 3568999999999999999999996 799999999999999999999999999998765433333
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....+|+.|+|||.+..+.++.++|||||||++|||+| |+.||.+....+. .+.+.......
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~~~~~-- 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGYRMP-- 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHTTCCCC--
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcCCCCC--
Confidence 334567889999999988899999999999999999999 9999875432111 11111111000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+..++..+.+++.+||+.+|++|||++++++.|+++.+.
T Consensus 402 -----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 -----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0124566788999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=398.31 Aligned_cols=198 Identities=23% Similarity=0.328 Sum_probs=171.5
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHH---HHHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFD---AECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
++|...++||+|+||+||+|+.. +|+.||||++.... ......+. +|+.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999864 69999999997432 12222333 4466777889999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+|||||+||+|.++|...+ .+++..+..|+.||+.||+|||+. +||||||||+|||+|++|++||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999999998654 689999999999999999999984 599999999999999999999999999998754
Q ss_pred CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.. ....+||+.|||||++.. ..|+.++||||+||++|||+||+.||...
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33 234579999999999865 57899999999999999999999999653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=367.28 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=211.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 45677789999999999999998888999999874432 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...........
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 999999998876778999999999999999999996 79999999999999999999999999999876433222233
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...||+.|+|||......++.++|||||||++|||+| |+.||......+. .. .+........
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~------------~i~~~~~~~~--- 226 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VE------------DISTGFRLYK--- 226 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH------------HHHTTCCCCC---
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--HH------------HHhcCCcCCC---
Confidence 4567889999999988889999999999999999999 8999865321110 00 0110000000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+..++..+.+++.+||+.+|++|||++|+++.|+++..+
T Consensus 227 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 ----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 012345678899999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=384.73 Aligned_cols=259 Identities=26% Similarity=0.449 Sum_probs=211.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc--------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA--------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~--------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~ 1403 (1624)
.++|...+.||+|+||+||+|+.. .+..||||+++.. .....+++.+|+++++++ +|||||+++++|.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 346777789999999999999863 2356999998644 344567899999999999 999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
+..++||||+++|+|.+++.... ..+++.++++|+.||+.||+|||+ .+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999998653 358999999999999999999996 799999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l 1546 (1624)
++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999987654332 22334567899999999988999999999999999999999 999986532111 1
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+.+........ +..++..+.+++.+||+.+|++|||++|+++.|+++...
T Consensus 303 ------------~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 303 ------------FKLLKEGHRMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ------------HHHHHTTCCCCC-------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------HHHHHcCCCCCC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111111110000 113456788999999999999999999999999998764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=385.59 Aligned_cols=200 Identities=26% Similarity=0.344 Sum_probs=170.7
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc------CC
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN------HG 813 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 813 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46788999999999999999986 479999999996543 2345678999999999999999999998753 36
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+|||||+ |+|.+++... ..+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999996 7899999764 4799999999999999999999994 599999999999999999999999999987
Q ss_pred cCCCC---CcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGED---SVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+.... .......+||+.|||||++.+ ..++.++||||+|||+|||+||+.||..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 64322 122334689999999998765 4579999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=379.49 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=171.7
Q ss_pred HHHHhhcCCCCCcceeecCCccceEEEEec----CCCEEEEEEeecccchhHHHHHHHHHHHHhc-CCCceeeeeeeecc
Q 047591 737 QELQRLTDGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISSCSN 811 (1624)
Q Consensus 737 ~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 811 (1624)
+.+-+..+.|+..+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++|+++ +|||||++++++.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 334456788999999999999999999753 46889999986443 345688999999998 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC-CceEEEeeee
Q 047591 812 HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD-TVAHLSDFGI 890 (1624)
Q Consensus 812 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~~kl~DFGl 890 (1624)
++..|+|||||++|+|.+++. .+++.++..|+.|++.||+|||+. +||||||||+|||++.+ +.+||+|||+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999999984 488999999999999999999994 59999999999999877 7999999999
Q ss_pred eeccCCCCCc---------------------------ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCC
Q 047591 891 SKLLDGEDSV---------------------------TQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRK 942 (1624)
Q Consensus 891 a~~~~~~~~~---------------------------~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~ 942 (1624)
|+........ ..+..+||+.|||||++.+. .++.++||||+|||+|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9865432210 11234799999999988664 5899999999999999999999
Q ss_pred CCCCc
Q 047591 943 MPTDE 947 (1624)
Q Consensus 943 ~P~~~ 947 (1624)
.||..
T Consensus 245 ~Pf~~ 249 (361)
T 4f9c_A 245 YPFYK 249 (361)
T ss_dssp SSSSC
T ss_pred CCCCC
Confidence 99854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=390.51 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=210.9
Q ss_pred cCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeee
Q 047591 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSC 1400 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~ 1400 (1624)
+.+.+.+...++|...++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|.+++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566677889999999999999999999885 68999999986432 22345688999999999999999999999
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
.+++..++|||||++|+|.+++.+.+..+++..+..++.||+.||+|||+ .+||||||||+|||+|.++++||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999998766678999999999999999999996 799999999999999999999999999
Q ss_pred ceeecCCCCCccccccccccccccccccC-------CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGS-------EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
+|+.............+||+.|||||++. ...++.++|||||||++|||+||+.||......+. ....+..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~- 285 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIVHY- 285 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTH-
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhc-
Confidence 99987654433344568999999999876 46789999999999999999999999975322111 1111100
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER---MNVKDALA 1608 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R---Pt~~evl~ 1608 (1624)
...+.- . .....++..+.+++.+|+. +|++| |+++|+.+
T Consensus 286 ---------~~~~~~-p-----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 ---------KEHLSL-P-----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---------HHHCCC-C---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---------ccCcCC-C-----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000000 0 0012345678899999999 99998 58888865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=374.00 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=199.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||+||+|++. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 35667789999999999999884 788999998633 345789999999999999999999999874 4789999999
Q ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc-EEEeeecceeecCCCCCc
Q 047591 1415 QGSLEKWLYSHNY--LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV-AHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-~kl~DFGla~~~~~~~~~ 1491 (1624)
+|+|.++++.... .+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986542 4788999999999999999999754479999999999999998886 799999999765422
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....||+.|+|||+..+..++.++|||||||++|||+||+.||+.......... |. +........
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~-----------~~~~~~~~~- 225 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WA-----------VHNGTRPPL- 225 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH-HH-----------HHTTCCCCC-
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH-HH-----------HhcCCCCCc-
Confidence 2234699999999999988999999999999999999999999975422211111 10 000000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
...++..+.+++.+||+.+|++|||++|+++.|+++...+
T Consensus 226 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 226 ------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 0124456788999999999999999999999999886543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=378.39 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=203.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-----hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-----~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
+.|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 35777889999999999999875 689999999864321 135789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc---EEEeeecce
Q 047591 1409 ILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV---AHLGDFGIA 1482 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~kl~DFGla 1482 (1624)
|||||++|+|.+++.+. +..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+|
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888643 3458999999999999999999996 79999999999999987654 999999999
Q ss_pred eecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..... .+.
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~------------~i~ 245 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFE------------GII 245 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHH------------HHH
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHH------------HHH
Confidence 8875432 22334579999999999998899999999999999999999999997531 11111 111
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...... ....+..++..+.+++.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 246 KGKYKM-----NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HTCCCC-----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCC-----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111100 01112334567889999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=366.63 Aligned_cols=258 Identities=21% Similarity=0.375 Sum_probs=206.1
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.++|...+.||+|+||+||+|++.. +..||||++... .....+.|.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4567778999999999999998753 235999998654 33456789999999999999999999999865 45689
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.+++...+..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999998777778999999999999999999996 79999999999999999999999999999876544
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.........+|+.|+|||...+..++.++|||||||++|||+| |+.||........ .. .+.....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~------------~~~~~~~ 232 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IG------------VLEKGDR 232 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HH------------HHHHTCC
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HH------------HHhcCCC
Confidence 3333344567889999999988889999999999999999999 9999865322211 11 1110000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
... +..++..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 233 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 LPK-------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 000 012345688899999999999999999999999998765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=378.24 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=204.9
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh------hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED------RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~------~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
.+.|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356778899999999999999875 588999999864332 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC----cEEEeeecce
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM----VAHLGDFGIA 1482 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~kl~DFGla 1482 (1624)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999754 468999999999999999999996 7999999999999998877 7999999999
Q ss_pred eecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+.......
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~--------- 234 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAVS--------- 234 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTC---------
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcC---------
Confidence 9875432 2334579999999999988899999999999999999999999997532111 111111100
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
... ....+..++..+.+++.+|+..||++|||+.|+++
T Consensus 235 ----~~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 ----YDF----DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCC----CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 01112334567889999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=373.68 Aligned_cols=254 Identities=21% Similarity=0.348 Sum_probs=203.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-C-------ceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-G-------TNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-~-------~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||+||+|+... + ..||+|++........+.|.+|++++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 456777899999999999998753 3 46999999766666678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc--------EEEee
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV--------AHLGD 1478 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--------~kl~D 1478 (1624)
++||||+++|+|.+++...+..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999999999999998877678999999999999999999996 78999999999999998887 99999
Q ss_pred ecceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1479 FGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1479 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
||+++.... .....||+.|+|||.+.+ ..++.++|||||||++|||+||..|+............+ .
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~------ 232 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-E------ 232 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-H------
T ss_pred CcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-h------
Confidence 999875432 223468999999998876 779999999999999999999665543322111111100 0
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
+..... ..++..+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 233 -----~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 233 -----DRHQLP----------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp -----TTCCCC----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred -----ccCCCC----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 000000 0112346789999999999999999999999998866544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=373.24 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=203.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46778899999999999999875 58999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+ .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+......
T Consensus 85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 9999999999997643 57889999999999999999996 799999999999999999999999999998643222
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+||+.|||||++.+..++.++|||||||++|||+||+.||....... ... .+......-
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~------------~i~~~~~~~-- 224 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFE------------LILMEEIRF-- 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH------------HHHHCCCCC--
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-HHH------------HHHcCCCCC--
Confidence 22345679999999999999999999999999999999999999996532111 000 111111100
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
+..++..+.+++.+|++.+|++|| +++|+++.
T Consensus 225 -------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 012345678899999999999999 89988764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=373.91 Aligned_cols=266 Identities=23% Similarity=0.368 Sum_probs=200.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhc--CCCceeEEEeeeccC----CeeE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRI--RHRNLAKIVSSCSNP----GFKA 1407 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l--~HpNIv~l~g~~~~~----~~~~ 1407 (1624)
.++|...+.||+|+||+||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 356788899999999999999885 8899999986432 23445566666554 999999999998776 6889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY-----STSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
+||||+++|+|.++++.. .+++.+++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+|
T Consensus 112 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 999999999999999764 5899999999999999999999621 239999999999999999999999999999
Q ss_pred eecCCCCCc---cccccccccccccccccCCCCcCcc------cchHHHHHHHHHHHcCC----------CCCCCCCccc
Q 047591 1483 KLLDGVDSM---KQTMTLATIGYMAPEYGSEGIVSTS------GDVYSFGILMMETLTRR----------KPTDDMFTGE 1543 (1624)
Q Consensus 1483 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~k------~DV~SfGvil~Elltg~----------~P~~~~~~~~ 1543 (1624)
+........ ......||+.|+|||++.+..++.+ +|||||||++|||+||+ .||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 876533221 1124579999999999877766655 99999999999999994 4443322111
Q ss_pred hhhhhhhhhcCChhHHHHHhhh-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1544 VCLKHWVEESLPDAVTDVIDAN-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1544 ~~l~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.... ...+.+... ....... ......++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 270 ~~~~---------~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 270 PSYE---------DMREIVCIKKLRPSFPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CCHH---------HHHHHHTTSCCCCCCCG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred Cchh---------hhHHHHhhhccCccccc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 1110 111111111 1111100 001135677899999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=376.13 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=202.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888899999999999999876 68899999986443 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-Cc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-SM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-~~ 1491 (1624)
+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999988654 358999999999999999999996 799999999999999999999999999998764222 12
Q ss_pred cccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||++.+..+ +.++|||||||++|||+||+.||............|...... ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~-- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-----------LN-- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-----------ST--
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-----------CC--
Confidence 2234579999999999877665 789999999999999999999997643332222222221110 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+...+.+++.+|++.||++|||++|+++.
T Consensus 230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011234567789999999999999999999763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=378.15 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=209.0
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~ 1403 (1624)
...++|...+.||+|+||+||+|++. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34567888899999999999999862 35679999986442 34457899999999999 999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCC
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHNY----------------------LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDL 1461 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 1461 (1624)
+..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 999999999999999999986532 37899999999999999999996 79999999
Q ss_pred CCCcEEecCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCC
Q 047591 1462 KPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDM 1539 (1624)
Q Consensus 1462 K~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~ 1539 (1624)
||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987643322 12234568899999999888889999999999999999998 99999764
Q ss_pred CccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1540 FTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1540 ~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
..... ... .+........ +..++..+.+++.+||+.+|++|||+.|+++.|+.+......
T Consensus 279 ~~~~~-~~~------------~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 279 PVDAN-FYK------------LIQNGFKMDQ-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CCSHH-HHH------------HHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred CcHHH-HHH------------HHhcCCCCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 32211 111 1111111000 012345688899999999999999999999999988665443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=365.57 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=203.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|++. ++.||||+++... ....+.|.+|++++++++||||+++++++.++ +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 35667789999999999999984 8889999987542 34567899999999999999999999999876 7789999
Q ss_pred EecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYSHNY-LLNIEQRLDIMIDVACALEYLHQGYSTS--IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~--iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
||+++|+|.++++.... .+++.++..|+.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999999999986543 58999999999999999999996 55 9999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccCCCCcCc---ccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVST---SGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~---k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.....||+.|+|||.+.+..++. ++|||||||++|||+||+.||.+........ .....
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------------~~~~~ 226 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-------------KVALE 226 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-------------HHHHS
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-------------HHHhc
Confidence 22346899999999887655444 8999999999999999999997543221111 11111
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
...... +..++..+.+++.+||+.+|++|||++|+++.|+++++
T Consensus 227 ~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GLRPTI-------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 100000 01245568899999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=371.95 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=212.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEE------cCCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF------ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~------~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~ 1405 (1624)
.++|...+.||+|+||+||+|++ .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35677788999999999999985 246789999986443 34467899999999999 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1406 KALILQYMPQGSLEKWLYSHNY-----------------LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
.++||||+++|+|.+++..... .+++.++..++.|+++||+|||+ .+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999986542 48999999999999999999996 799999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l 1546 (1624)
+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 99999999999999876543221 2233467889999999888899999999999999999999 9999875432211
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
....+........ +..++..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 257 -----------~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 -----------FYKMIKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp -----------HHHHHHHTCCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred -----------HHHHhccCCCCCC-------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1111111111000 01234568889999999999999999999999998876643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=371.43 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=211.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
.++|...+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 456777889999999999999862 3578999998643 344567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCC
Q 047591 1407 ALILQYMPQGSLEKWLYSHN-----------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKP 1463 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~ 1463 (1624)
++||||+++|+|.+++.... ..+++.++.+++.|+++||+|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 99999999999999998643 237899999999999999999996 7999999999
Q ss_pred CcEEecCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCc
Q 047591 1464 SNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFT 1541 (1624)
Q Consensus 1464 ~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~ 1541 (1624)
+||++++++.+||+|||+++....... .......+|+.|+|||...+..++.++|||||||++|||+| |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987754332 12234467889999999988889999999999999999999 9999875432
Q ss_pred cchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1542 GEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1542 ~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
... .+.+........ +..++..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 259 ~~~--------------~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ERL--------------FNLLKTGHRMER-------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGH--------------HHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH--------------HHHhhcCCcCCC-------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 211 111111100000 013456688999999999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=376.81 Aligned_cols=261 Identities=26% Similarity=0.467 Sum_probs=195.7
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEEcCC----ceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATFADG----TNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~~~~----~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~ 1404 (1624)
....++|...+.||+|+||+||+|++... ..||||+++.. .....+.|.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34456788889999999999999987543 27999998654 3345688999999999999999999999998766
Q ss_pred ee------EEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc
Q 047591 1405 FK------ALILQYMPQGSLEKWLYSHN-----YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473 (1624)
Q Consensus 1405 ~~------~lV~ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 1473 (1624)
.. ++||||+++|+|.+++.... ..+++.++.+|+.|+++||+|||+ .+|+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence 55 99999999999999996432 258999999999999999999997 79999999999999999999
Q ss_pred EEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhh
Q 047591 1474 AHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1474 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~ 1551 (1624)
+||+|||+|+....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. ....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~-- 252 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYL-- 252 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHH--
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHH--
Confidence 99999999987644322 12233457889999999988899999999999999999999 8999875432211 1111
Q ss_pred hcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1552 ESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
........ +..++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 253 ----------~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 253 ----------IGGNRLKQ--------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ----------HTTCCCCC--------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------hcCCCCCC--------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11110000 01344568899999999999999999999999998865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=369.80 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=196.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.+.|...+.||+|+||+||+|++. ..||||+++.. .....+.|.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 456788899999999999999864 36999998643 344567899999999999999999999976 4556899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-C
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-S 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-~ 1490 (1624)
|+++|+|.+++......+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 999999999998777779999999999999999999996 799999999999999999999999999998654321 2
Q ss_pred ccccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1491 MKQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.......||+.|+|||.+. ...++.++|||||||++|||+||+.||......+.... .+.....
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------------~~~~~~~ 243 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE-------------MVGRGSL 243 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH-------------HHHHTSC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH-------------Hhccccc
Confidence 2223457999999999875 66789999999999999999999999976433221111 1111110
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
..... .....++..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 244 ~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLS---KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTT---SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccchh---hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00000 001234567889999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=380.23 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=199.4
Q ss_pred cCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCC
Q 047591 1339 ESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417 (1624)
Q Consensus 1339 ~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gs 1417 (1624)
..++||+|+||+||+|+.. +|+.||||+++.......+.|.+|++++++++|||||++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3567999999999999875 689999999976655667889999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe--cCCCcEEEeeecceeecCCCCCccccc
Q 047591 1418 LEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL--DDDMVAHLGDFGIAKLLDGVDSMKQTM 1495 (1624)
Q Consensus 1418 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl--d~~~~~kl~DFGla~~~~~~~~~~~~~ 1495 (1624)
|.+++......+++.++..++.||++||+|||+ .+|+||||||+|||+ ++++.+||+|||+|+....... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 999998776778999999999999999999996 799999999999999 6778999999999998754332 234
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 1575 (1624)
..||+.|+|||++....++.++|||||||++|||+||+.||...... ..+..+..... .....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~------------~~~~~---- 310 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRW------------DLEDE---- 310 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCC------------CSCSG----
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccC------------CCChh----
Confidence 56999999999998889999999999999999999999999753221 11111111110 00000
Q ss_pred HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1576 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
....++..+.+++.+|++.+|++|||+.|+++
T Consensus 311 -~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 -EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01123456889999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=390.57 Aligned_cols=259 Identities=19% Similarity=0.258 Sum_probs=208.4
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeecc
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~ 1402 (1624)
+.+++...++|...++||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.+++.++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4566677889999999999999999999886 57889999986432 1233568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1403 PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
++..++|||||++|+|.++++.. .+++..+..++.||+.||+|||+ .+||||||||+|||++.++++||+|||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999764 47888899999999999999996 79999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccccccCCCC----cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEGI----VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~ 1558 (1624)
+.............+||+.|||||++.... ++.++|||||||++|||+||+.||......+ ....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~---------- 284 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSK---------- 284 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH----------
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHH----------
Confidence 887654433344568999999999876554 8899999999999999999999997532111 1111
Q ss_pred HHHHhhh-ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 047591 1559 TDVIDAN-LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEE--RMNVKDALAN 1609 (1624)
Q Consensus 1559 ~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPt~~evl~~ 1609 (1624)
++... ..... ....++..+.+++.+|+..+|++ ||+++|++++
T Consensus 285 --i~~~~~~~~~p------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 --IMNHKNSLTFP------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --HHTHHHHCCCC------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --HHhccccccCC------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11100 00000 00123456788999999999988 9999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=368.33 Aligned_cols=253 Identities=24% Similarity=0.418 Sum_probs=203.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-------hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-------RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-------~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++..... ...+.|.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 356777889999999999999884 688999999854321 11278999999999999999999999997665
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEEcCCCCCcEEecCCCc-----EEEee
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS--IIHCDLKPSNVLLDDDMV-----AHLGD 1478 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~--iiHrDlK~~NILld~~~~-----~kl~D 1478 (1624)
++||||+++|+|.+++.+....+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999999998877789999999999999999999996 56 999999999999988776 99999
Q ss_pred ecceeecCCCCCcccccccccccccccccc--CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1479 FGIAKLLDGVDSMKQTMTLATIGYMAPEYG--SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1479 FGla~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
||+|+.... ......||+.|+|||++ ....++.++|||||||++|||+||+.||...............
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----- 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR----- 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH-----
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh-----
Confidence 999985432 23345799999999987 4566899999999999999999999999754332221111111
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
........ +..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus 244 ------~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 ------EEGLRPTI-------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------HSCCCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------ccCCCCCC-------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11110000 123456788999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=364.33 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=193.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchh----hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQED----RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~----~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|++. ++.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56778899999999999999874 88999999864322 23578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC--------CCcEEEeeecce
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD--------DMVAHLGDFGIA 1482 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--------~~~~kl~DFGla 1482 (1624)
||+++|+|.+++.. ..+++..+..++.|+++||+|||+....+|+||||||+||+++. ++.+||+|||++
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 86 EFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp ECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999999999853 46889999999999999999999732234999999999999986 778999999999
Q ss_pred eecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
+...... .....||+.|+|||...+..++.++|||||||++|||+||+.||.......... . ..
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~------------~~ 227 (271)
T 3dtc_A 164 REWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-G------------VA 227 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-H------------HH
T ss_pred ccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-h------------hh
Confidence 8664322 224579999999999988889999999999999999999999997542211110 0 00
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
........ +..++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 228 ~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 MNKLALPI-------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TSCCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCCCCCCC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00000000 123456688999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=384.33 Aligned_cols=258 Identities=23% Similarity=0.412 Sum_probs=197.1
Q ss_pred CCcCCeEeecCceEEEEEEEc--CC--ceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-CCeeEEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA--DG--TNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-PGFKALIL 1410 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~--~~--~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-~~~~~lV~ 1410 (1624)
|...++||+|+||+||+|++. ++ ..||||.++.. .....++|.+|++++++++||||++++++|.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 445678999999999999874 22 35899988643 33556889999999999999999999998754 56789999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.++++.....+++.+++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+|+.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999998777778999999999999999999996 7999999999999999999999999999987643221
Q ss_pred ---ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1491 ---MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1491 ---~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.......+|+.|+|||.+.+..++.++|||||||++|||+| |..||......+.. ..+. ....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~~~-----------~~~~ 314 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VYLL-----------QGRR 314 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HHHH-----------TTCC
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HHHH-----------cCCC
Confidence 11233467889999999988899999999999999999999 56677543222111 1110 0000
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
... +..++..+.+++.+||+.+|++|||++|+++.|+++...+.
T Consensus 315 ~~~--------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 315 LLQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 12345678899999999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=379.12 Aligned_cols=280 Identities=22% Similarity=0.337 Sum_probs=199.8
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHH--HHhcCCCceeEEEeeec-----cCCee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEV--MRRIRHRNLAKIVSSCS-----NPGFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~--l~~l~HpNIv~l~g~~~-----~~~~~ 1406 (1624)
.++|...+.||+|+||+||+|++ +++.||||++..... ..+..|.++ +..++||||+++++++. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35778889999999999999987 688999999864332 334444444 45689999999998542 23467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY------STSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
++||||+++|+|.+++.... .++..+.+|+.||++||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 89999999999999997654 488999999999999999999621 1299999999999999999999999999
Q ss_pred ceeecCCCCC-------ccccccccccccccccccCC-------CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhh
Q 047591 1481 IAKLLDGVDS-------MKQTMTLATIGYMAPEYGSE-------GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1481 la~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l 1546 (1624)
+|+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987653221 11224569999999998876 467789999999999999999988764321111111
Q ss_pred hhhhhh--cCC--hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1547 KHWVEE--SLP--DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1547 ~~~~~~--~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
..+... ..+ +.....+..................++..+.+++.+||+.||++|||++|+++.|+++...+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 111100 001 0111111111000000000000123456789999999999999999999999999998876544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=376.07 Aligned_cols=270 Identities=23% Similarity=0.324 Sum_probs=212.1
Q ss_pred CCCCcCCeEeecCceEEEEEEE-----cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeec--cCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-----ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS--NPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-----~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~--~~~~~~ 1407 (1624)
++|...+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4577778999999999999985 357889999997666666788999999999999999999999886 456689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++......+++.+++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999998766678999999999999999999996 7999999999999999999999999999997754
Q ss_pred CCC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh---HHHHH
Q 047591 1488 VDS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA---VTDVI 1562 (1624)
Q Consensus 1488 ~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~---~~~~~ 1562 (1624)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....+........ ..+.+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE--FLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHCC----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch--hhhhcccccccccHHHHHHHh
Confidence 322 1223356888999999998888999999999999999999999998642111 0111100000111 11122
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
....... .+..++..+.+++.+||+.+|++|||++|+++.|+++...
T Consensus 258 ~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 258 EEGQRLP-------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HTTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hcccCCC-------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111110 0124567789999999999999999999999999988653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=367.09 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=210.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.++|...+.||+|+||+||+|+..++..||||++.... ...+.|.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 45677788999999999999998888899999986432 23578999999999999999999999986 45689999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.+++.... ..+++.++.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999997532 368999999999999999999996 799999999999999999999999999999876543333
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....+|+.|+|||...+..++.++|||||||++|||+| |+.||......+ .... +........
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~------------~~~~~~~~~- 231 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN------------LERGYRMVR- 231 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH------------HHTTCCCCC-
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHH------------HhcccCCCC-
Confidence 344567889999999988889999999999999999999 899986532211 1111 110000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
+..++..+.+++.+|++.+|++|||++|+++.|+++.....
T Consensus 232 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 232 ------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 01345668899999999999999999999999999877644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=371.70 Aligned_cols=271 Identities=25% Similarity=0.382 Sum_probs=210.7
Q ss_pred CCcCCeEeecCceEEEEEEEc-----CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-----DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKAL 1408 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-----~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~l 1408 (1624)
|...+.||+|+||+||+|.+. +++.||||+++... ....+.|.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 356688999999999998763 57889999997543 3456789999999999999999999999976 467899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.+++.... +++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999997653 8999999999999999999997 79999999999999999999999999999987543
Q ss_pred CC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC-hhHHHHHhhh
Q 047591 1489 DS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP-DAVTDVIDAN 1565 (1624)
Q Consensus 1489 ~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~-~~~~~~~d~~ 1565 (1624)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||............+...... ....+.++..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 32 12233468889999999988889999999999999999999999986422111111111000000 0111222211
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
.... .+..++..+.+++.+||+.+|++|||++|+++.|+++.+++..
T Consensus 268 ~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 268 ERLP-------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cCCC-------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 1110 0123567789999999999999999999999999999887653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=373.39 Aligned_cols=266 Identities=21% Similarity=0.388 Sum_probs=206.8
Q ss_pred CCCcCCeEeecCceEEEEEEE-----cCCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC--CeeE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-----ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP--GFKA 1407 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-----~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~--~~~~ 1407 (1624)
.|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.++ ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 356678999999999999985 357889999987443 33457899999999999999999999999876 6689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+|+....
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 9999999999999998776779999999999999999999996 7999999999999999999999999999988754
Q ss_pred CCC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh----hHHHH
Q 047591 1488 VDS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD----AVTDV 1561 (1624)
Q Consensus 1488 ~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~----~~~~~ 1561 (1624)
... .......||..|+|||.+.+..++.++|||||||++|||+||+.|+...... ........... .....
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHHHH
Confidence 332 2223456888999999998888999999999999999999999986432110 00110000000 01111
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
+....... .+..++..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 256 ~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLP-------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCC-------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCC-------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11110000 01234567889999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=371.70 Aligned_cols=258 Identities=24% Similarity=0.424 Sum_probs=203.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
+.|...+.||+|+||+||+|++.. +..||||+++.. .....+.|.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 345567899999999999998753 235999998643 33455689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.+++......+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 999999999999998876779999999999999999999997 79999999999999999999999999999876533
Q ss_pred CCc--cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1489 DSM--KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1489 ~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
... ......+|+.|+|||.+....++.++|||||||++|||+| |+.||......+. .+.+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--------------~~~~~~~ 266 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--------------MKAINDG 266 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHHTT
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--------------HHHHHCC
Confidence 211 1223356889999999988899999999999999999999 9999865322111 1111111
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..... +..++..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 267 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 FRLPT-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCCCC-------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CcCCC-------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 113456688999999999999999999999999988654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=371.68 Aligned_cols=260 Identities=25% Similarity=0.458 Sum_probs=210.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc--------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA--------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~--------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~ 1403 (1624)
.++|...+.||+|+||+||+|++. ++..||||+++.. .....+.+.+|+++++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 356777889999999999999873 4677999998644 334567899999999999 999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
+..++||||+++|+|.+++.... ..+++.+++.++.||++||+|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 99999999999999999998643 248899999999999999999996 799999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l 1546 (1624)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--H
Confidence 99999999999999877543321 2233467889999999888889999999999999999999 999986532111 1
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
. +.+........ +..++..+.+++.+||+.+|++|||+.|+++.|+++.+..
T Consensus 269 ~------------~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 269 F------------KLLKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp H------------HHHHHTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H------------HHHhcCCCCCC-------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 11111100000 1134566889999999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=404.55 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=204.0
Q ss_pred eEeecCceEEEEEEEc---CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCCCC
Q 047591 1342 LLGTGIFSSVYKATFA---DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGS 1417 (1624)
Q Consensus 1342 ~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~gs 1417 (1624)
.||+|+||+||+|.+. ++..||||+++... ....+.|.+|+++|++++|||||+++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 45679999987542 3456889999999999999999999999976 56899999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc--cccc
Q 047591 1418 LEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM--KQTM 1495 (1624)
Q Consensus 1418 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~--~~~~ 1495 (1624)
|.+++......+++.++..|+.|||.||+|||+ .+||||||||+|||+++++.+||+|||+|+.+...... ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 999998777779999999999999999999996 79999999999999999999999999999876433221 1223
Q ss_pred cccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1496 TLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1496 ~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
..+|+.|||||++....++.++|||||||++|||+| |+.||......+. .+.+.......
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--------------~~~i~~~~~~~----- 559 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------------MAFIEQGKRME----- 559 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--------------HHHHHTTCCCC-----
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHcCCCCC-----
Confidence 346789999999988899999999999999999998 9999976432211 11111111000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
.+..|+..+.+++.+||+.+|++||+|.|+++.|+.+......
T Consensus 560 --~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 560 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred --CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 1124567789999999999999999999999999998776544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=376.85 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=202.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCce----EEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTN----AAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~----vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
++|...+.||+|+||+||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46777789999999999999875 4444 7777764332 233457789999999999999999999986 456889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.+++......+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 999999999999998776678999999999999999999996 79999999999999999999999999999877543
Q ss_pred CC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.. .......||++|+|||++.+..++.++|||||||++|||+| |+.||......+. .+.+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------------~~~~~~~~ 234 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--------------PDLLEKGE 234 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--------------HHHHHTTC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--------------HHHHHcCC
Confidence 32 22334568889999999988899999999999999999999 9999976432211 11111110
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.... +..++..+.+++.+||+.+|++|||++|+++.|+++..
T Consensus 235 ~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 RLAQ-------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BCCC-------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCC-------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 01234457789999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=370.09 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=204.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh------hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED------RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~------~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34777889999999999999875 588999999864321 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC----cEEEeeeccee
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM----VAHLGDFGIAK 1483 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~kl~DFGla~ 1483 (1624)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+|+
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999754 458899999999999999999996 7999999999999999887 89999999998
Q ss_pred ecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
...... ......||+.|+|||++....++.++|||||||++|||+||+.||......+ .+... ..
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~------------~~ 231 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANV------------SA 231 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHH------------HH
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHH------------Hh
Confidence 875332 2234579999999999988899999999999999999999999996532111 11110 00
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
... ... ......++..+.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~-~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 VNY-EFE----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TCC-CCC----HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCC-CcC----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000 11122345668899999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=381.11 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=206.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. +|+.||+|++..........+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 46888899999999999999875 68899999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC--CCcEEEeeecceeecCCCCCc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD--DMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++|+|.+++...+..+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+......
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 205 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc--
Confidence 9999999998766678999999999999999999996 79999999999999974 5789999999999875432
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..+....... .....
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~------------~~~~~- 271 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCD------------WEFDE- 271 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCC------------CCCCS-
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC------------CCCCc-
Confidence 223457999999999999889999999999999999999999999753211 1111111100 00000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....++..+.+++.+|++.||++|||+.|+++.
T Consensus 272 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 ----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0001234567899999999999999999999873
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=369.66 Aligned_cols=261 Identities=21% Similarity=0.388 Sum_probs=215.2
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
+...++|...+.||+|+||+||+|++.. +..||||++... ....+.|.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3455678888899999999999998864 788999998643 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1410 LQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999864 3568999999999999999999997 78999999999999999999999999999877644
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.........+|+.|+|||...+..++.++|||||||++|||++ |+.||....... . .+.+.....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~------------~~~~~~~~~ 230 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V------------YELLEKDYR 230 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H------------HHHHHTTCC
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H------------HHHHhccCC
Confidence 4334445568889999999988899999999999999999999 999986532211 1 111111111
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
... +..++..+.+++.+|++.+|++|||++|+++.|+++...
T Consensus 231 ~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 MER-------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 000 123456688999999999999999999999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=371.73 Aligned_cols=269 Identities=21% Similarity=0.346 Sum_probs=208.2
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHh--cCCCceeEEEeeeccCC----e
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRR--IRHRNLAKIVSSCSNPG----F 1405 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~--l~HpNIv~l~g~~~~~~----~ 1405 (1624)
...++|...+.||+|+||+||+|++ +++.||||++.... .+.+.+|+++++. ++||||+++++++...+ .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3446788889999999999999988 58999999986432 3567889999988 79999999999998765 7
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG-----YSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
.++||||+++|+|.+++.+. .+++.+++.++.|++.||+|||.. +..+|+||||||+|||++.++.+||+|||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999764 589999999999999999999931 13799999999999999999999999999
Q ss_pred ceeecCCCCCc---cccccccccccccccccCCC------CcCcccchHHHHHHHHHHHcC----------CCCCCCCCc
Q 047591 1481 IAKLLDGVDSM---KQTMTLATIGYMAPEYGSEG------IVSTSGDVYSFGILMMETLTR----------RKPTDDMFT 1541 (1624)
Q Consensus 1481 la~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~~~k~DV~SfGvil~Elltg----------~~P~~~~~~ 1541 (1624)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99877543321 22345799999999987665 345789999999999999999 667654322
Q ss_pred cchhhhhhhhhcCChhHHHHH-hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1542 GEVCLKHWVEESLPDAVTDVI-DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1542 ~~~~l~~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.......+ .+.+ ...+....... .....++..+.+++.+||+.+|++|||+.||++.|+++..+.
T Consensus 273 ~~~~~~~~---------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 273 SDPSVEEM---------RKVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SSCCHHHH---------HHHHTTSCCCCCCCGG--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CcccHHHH---------HHHHHHHHhCCCCccc--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 21111111 1111 11111111000 011245677899999999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=375.66 Aligned_cols=248 Identities=21% Similarity=0.298 Sum_probs=198.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.++|...++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+++..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467888899999999999999875 5889999998643 233456788999999988 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|||||++|+|.+++.+.+ .+++.++..|+.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+.....
T Consensus 102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999997653 57899999999999999999996 79999999999999999999999999999864322
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.......+||+.|||||++.+..++.++|||||||++|||+||+.||......+ ... .+......-
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~------------~i~~~~~~~ 243 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFE------------AILNDEVVY 243 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH------------HHHHCCCCC
T ss_pred -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHH------------HHHcCCCCC
Confidence 223345679999999999988889999999999999999999999997532211 111 111111100
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV------KDALA 1608 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~------~evl~ 1608 (1624)
. ......+.+++.+|++.+|++||++ +|+++
T Consensus 244 -p--------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 -P--------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -C--------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -C--------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 1134457789999999999999998 66654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=364.75 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=206.4
Q ss_pred CCcCCeEeecCceEEEEEEEcC-C---ceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee-EEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFAD-G---TNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK-ALIL 1410 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~-~---~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~-~lV~ 1410 (1624)
|...++||+|+||+||+|++.+ + ..||+|++... .....+.|.+|++++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 3445789999999999998643 2 36999998643 334568899999999999999999999999776654 9999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD- 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~- 1489 (1624)
||+.+|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+|+......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 9999999999998877778999999999999999999997 799999999999999999999999999998654322
Q ss_pred --CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1490 --SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1490 --~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
........||+.|+|||...+..++.++|||||||++|||+||+.|+........ .... +.....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~------------~~~~~~ 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHF------------LAQGRR 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHH------------HHTTCC
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHH------------hhcCCC
Confidence 1122345688999999999999999999999999999999997666533222111 1111 111100
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
... +..++..+.+++.+||+.+|++|||++|+++.|+++...+.
T Consensus 247 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 247 LPQ-------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCC-------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 000 01234568899999999999999999999999999987754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=361.85 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=208.8
Q ss_pred CCcCC-eEeecCceEEEEEEEc---CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1337 FSESN-LLGTGIFSSVYKATFA---DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1337 f~~~~-~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
|...+ .||+|+||+||+|++. ++..||||+++.. .....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 33344 8999999999999864 5778999999754 344567899999999999999999999999 5567899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++|+|.+++......+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 999999999998776779999999999999999999996 79999999999999999999999999999887543221
Q ss_pred --cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1492 --KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1492 --~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
......||+.|+|||...+..++.++|||||||++|||+| |+.||......+ .... +......
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~------------i~~~~~~ 232 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAF------------IEQGKRM 232 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHH------------HHTTCCC
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHH------------HhcCCcC
Confidence 1223457899999999988889999999999999999999 999987543211 1111 1111000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.. +..++..+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 233 ~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 EC-------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CC-------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 12345678899999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=377.77 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=203.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46788899999999999999875 5889999998643 23455789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC---CcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD---MVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~kl~DFGla~~~~~~ 1488 (1624)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 109 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999999999754 457899999999999999999997 799999999999999865 45999999999876533
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+ ..... .......
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i------------~~~~~~~ 249 (362)
T 2bdw_A 185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQI------------KAGAYDY 249 (362)
T ss_dssp C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH------------HHTCCCC
T ss_pred c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH------------HhCCCCC
Confidence 2 2334579999999999998899999999999999999999999986532111 11111 0000000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. ..+..++..+.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0012345667899999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=375.78 Aligned_cols=252 Identities=22% Similarity=0.262 Sum_probs=197.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.++|...++||+|+||+||+|+.. +++.||||+++... ....+.+.+|..+++++ +|||||++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888899999999999999886 57889999986542 23345688999999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+++|+|.+++.+.+ .+++..+..|+.||+.||+|||+ .+||||||||+|||++.++++||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999997653 57899999999999999999996 79999999999999999999999999999864322
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
. ......+||+.|||||++.+..++.++|||||||++|||+||+.||......+.... ...+...+.+......
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-----~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----NTEDYLFQVILEKQIR 280 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------CCHHHHHHHHHHCCCC
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-----hhHHHHHHHHhccccC
Confidence 2 233456899999999999999999999999999999999999999964321111000 0000111111111000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
- +..++..+.+++.+|++.||++||++
T Consensus 281 ~--------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 I--------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred C--------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 01234567889999999999999995
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=365.82 Aligned_cols=273 Identities=21% Similarity=0.301 Sum_probs=206.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC--eeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG--FKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~--~~~lV~ 1410 (1624)
+.|...++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 45777889999999999999886 48899999987433 334577889999999999999999999987654 779999
Q ss_pred EecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe----cCCCcEEEeeecceee
Q 047591 1411 QYMPQGSLEKWLYSHN--YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~kl~DFGla~~ 1484 (1624)
||+++|+|.+++.... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999998643 338999999999999999999996 799999999999999 8888999999999998
Q ss_pred cCCCCCccccccccccccccccccC--------CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccch---hhhhhhhhc
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGS--------EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV---CLKHWVEES 1553 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~---~l~~~~~~~ 1553 (1624)
..... ......||+.|+|||++. +..++.++|||||||++|||+||+.||........ .+.......
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 75433 223457999999999865 57889999999999999999999999864322111 111111111
Q ss_pred CChhHHH---HHhhhc--cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1554 LPDAVTD---VIDANL--LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1554 ~~~~~~~---~~d~~l--~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.+..+.. ...... .... .............+.+++.+|++.||++|||++|+++...+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSC-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccC-CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0000000 000000 0000 000001134456788999999999999999999999987754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=369.43 Aligned_cols=270 Identities=21% Similarity=0.363 Sum_probs=215.4
Q ss_pred cCHHHHHHHhCCCCcCCeEeecCceEEEEEEE------cCCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEE
Q 047591 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATF------ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKI 1396 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~------~~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l 1396 (1624)
....+.....++|...+.||+|+||+||+|++ .+++.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455666677899999999999999999975 245789999986532 34457899999999999 79999999
Q ss_pred EeeeccCC-eeEEEEEecCCCCHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcC
Q 047591 1397 VSSCSNPG-FKALILQYMPQGSLEKWLYSHNY---------------LLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460 (1624)
Q Consensus 1397 ~g~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 1460 (1624)
+++|..++ ..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+ .+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987654 58999999999999999986543 27899999999999999999996 7999999
Q ss_pred CCCCcEEecCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCC
Q 047591 1461 LKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDD 1538 (1624)
Q Consensus 1461 lK~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~ 1538 (1624)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987643322 22334568999999999988899999999999999999999 9999875
Q ss_pred CCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1539 MFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1539 ~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.......... +........ +..++..+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 254 ~~~~~~~~~~-------------~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEEFCRR-------------LKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHHHHHH-------------HHHTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHH-------------hccCccCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 4322211111 111100000 0123456788999999999999999999999999987653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=371.61 Aligned_cols=271 Identities=23% Similarity=0.398 Sum_probs=213.6
Q ss_pred CCCCcCCeEeecCceEEEEEEE-----cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC--eeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-----ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG--FKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-----~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~--~~~ 1407 (1624)
+.|...+.||+|+||.||+|++ .+++.||||++........+.|.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3466678999999999999985 357889999997666666788999999999999999999999987654 679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++......+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 9999999999999998877778999999999999999999996 7999999999999999999999999999988754
Q ss_pred CCCc--cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC-h----hHHH
Q 047591 1488 VDSM--KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP-D----AVTD 1560 (1624)
Q Consensus 1488 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~-~----~~~~ 1560 (1624)
.... ......+|..|+|||...+..++.++|||||||++|||+||+.|+..... ........... . .+.+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTCCTHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhccccchhhhHHHHHH
Confidence 3221 12234578889999999888899999999999999999999998753210 00111100000 0 1111
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.+....... .+..++..+.+++.+||+.+|++|||+.|+++.|++++.++.
T Consensus 275 ~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 275 LLKNNGRLP-------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHTTCCCC-------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhhcCCCCC-------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111111000 012456778999999999999999999999999999988753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=367.27 Aligned_cols=268 Identities=22% Similarity=0.277 Sum_probs=200.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4577788999999999999998889999999986433 23347789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++ +|.+++......+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 985 9999998766678999999999999999999996 799999999999999999999999999998764322 12
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---hcCChhHHHH-----Hh
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---ESLPDAVTDV-----ID 1563 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~~~~~~~~~~-----~d 1563 (1624)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+. +..... .......... .+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhcccccc
Confidence 234578999999998765 4689999999999999999999999976432211 111110 0000000000 00
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+................++..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000000123456789999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=360.99 Aligned_cols=265 Identities=16% Similarity=0.213 Sum_probs=207.9
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeee-ccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC-SNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~-~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|++++++++|++++..++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46788899999999999999987 468899999875432 234688999999999999888777766 56778899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe---cCCCcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~kl~DFGla~~~~~~ 1488 (1624)
|+ +|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+|+.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 999999998766679999999999999999999996 799999999999999 78999999999999987543
Q ss_pred CCc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1489 DSM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1489 ~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
... ......||+.|+|||...+..++.++|||||||++|||+||+.||......... .....+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~~~ 231 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----------QKYERIS 231 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS----------SHHHHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh----------hhhhhhh
Confidence 321 223457999999999999989999999999999999999999999764322110 0011111
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
........ ......++..+.+++.+||+.+|++|||++|+++.|+++..+..
T Consensus 232 ~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 232 EKKMSTPI----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHSCH----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cccccchh----hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 11100000 00112345678899999999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=372.44 Aligned_cols=267 Identities=22% Similarity=0.359 Sum_probs=213.9
Q ss_pred HHHHHhCCCCcCCeEeecCceEEEEEEEcC-C-----ceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeee
Q 047591 1329 ELRLATNGFSESNLLGTGIFSSVYKATFAD-G-----TNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSC 1400 (1624)
Q Consensus 1329 ~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~-~-----~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~ 1400 (1624)
+++...++|...+.||+|+||+||+|+... + ..||||++.... ....+.+.+|+++++++ +||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556788889999999999999998743 2 469999986442 34567899999999999 899999999999
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEE
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSH-------------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVL 1467 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NIL 1467 (1624)
.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence 9999999999999999999999753 2357899999999999999999996 79999999999999
Q ss_pred ecCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchh
Q 047591 1468 LDDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVC 1545 (1624)
Q Consensus 1468 ld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~ 1545 (1624)
++.++.+||+|||+|+....... .......||+.|+|||...+..++.++|||||||++|||+| |+.||.+......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 99999999999999986643222 12234567889999999888889999999999999999999 8999875432211
Q ss_pred hhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1546 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.. ..+........ +..++..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 276 ~~------------~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 276 FY------------KLVKDGYQMAQ-------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HH------------HHHHHTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HH------------HHHhcCCCCCC-------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 11 11111111000 01234567889999999999999999999999999876644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=385.84 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=203.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
.+.|...+.||+|+||+||+|... +|+.+|+|++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 346778899999999999999874 68899999986432 345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec---CCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~kl~DFGla~~~~~ 1487 (1624)
|||++|+|.+++...+ .+++.++..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 90 E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999998654 58899999999999999999996 7999999999999998 467899999999987654
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.. .......||++|||||++.+..++.++||||+||++|||++|+.||.+....+ ......... .
T Consensus 166 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~------------~- 230 (444)
T 3soa_A 166 EQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGA------------Y- 230 (444)
T ss_dssp TC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTC------------C-
T ss_pred CC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCC------------C-
Confidence 32 22334679999999999998899999999999999999999999996532111 111111100 0
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.... ..+..++..+.+++.+|++.||++|||+.|+++.
T Consensus 231 ~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 DFPS----PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCCT----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCc----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 0012345568899999999999999999999873
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=369.35 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=196.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC--------
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG-------- 1404 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~-------- 1404 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||+++++|.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 35777889999999999999986 78999999986433 345678999999999999999999999885433
Q ss_pred -------------------------------------------------eeEEEEEecCCCCHHHHHHhcC--CCCCHHH
Q 047591 1405 -------------------------------------------------FKALILQYMPQGSLEKWLYSHN--YLLNIEQ 1433 (1624)
Q Consensus 1405 -------------------------------------------------~~~lV~ey~~~gsL~~~l~~~~--~~l~~~~ 1433 (1624)
..++||||+++|+|.+++.... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999998653 3457778
Q ss_pred HHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-----------cccccccccccc
Q 047591 1434 RLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS-----------MKQTMTLATIGY 1502 (1624)
Q Consensus 1434 ~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~y 1502 (1624)
+++++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999996 7999999999999999999999999999998754321 122345799999
Q ss_pred ccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhH
Q 047591 1503 MAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCM 1582 (1624)
Q Consensus 1503 ~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~ 1582 (1624)
+|||++.+..++.++|||||||++|||+||..|+... .... .+.... ... .......
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~-----------~~~~~~----~~~----~~~~~~~ 299 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRII-----------TDVRNL----KFP----LLFTQKY 299 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHH-----------HHHHTT----CCC----HHHHHHC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHH-----------HHhhcc----CCC----cccccCC
Confidence 9999998889999999999999999999987764210 0000 000000 000 1112334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1583 SSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1583 ~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+.+++.+||+.||++|||++|+++.
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 566889999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=364.75 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=203.9
Q ss_pred CCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeec-cCCeeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCS-NPGFKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~-~~~~~~lV 1409 (1624)
.|...+.||+|+||+||+|++.+ ...+|||.+... .....+.|.+|++++++++||||++++++|. .++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 45667899999999999998743 235889988643 3445678999999999999999999999864 45678999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.++++.....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+|+......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999999998777778999999999999999999996 799999999999999999999999999998765432
Q ss_pred C---ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCC-CCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1490 S---MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRR-KPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1490 ~---~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~-~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
. .......||+.|+|||...+..++.++|||||||++|||+||. .||......+. ....... .
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~~~------------~ 249 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQG------------R 249 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHHTT------------C
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhcC------------C
Confidence 1 1223456788999999998889999999999999999999954 45543322111 1111110 0
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.... +..++..+.+++.+||+.+|++|||++|+++.|+++...+.
T Consensus 250 ~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 RLLQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCCC--------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0000 01234568889999999999999999999999999877543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=402.00 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=209.5
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
..++|...+.||+|+||+||+|++.++..||||+++... ...+.|.+|+++|++++|||||+++++|.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 345567778999999999999999888889999987433 235689999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++|+|.++++.. +..+++.++++|+.||++||+|||+ .+||||||||+|||+++++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999753 3568999999999999999999996 79999999999999999999999999999876432222
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+|+.|||||++....++.++|||||||++|||+| |+.||.+....+. .+.+.......
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~~~~~- 484 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGYRMP- 484 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--------------HHHHHTTCCCC-
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcCCCCC-
Confidence 2233457889999999988899999999999999999999 8999876432111 11111111000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.+..|+..+.+++.+||+.+|++|||++++++.|+++..
T Consensus 485 ------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 ------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 012456678899999999999999999999999987644
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=359.30 Aligned_cols=265 Identities=16% Similarity=0.214 Sum_probs=210.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeee-ccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC-SNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~-~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+. .+++.||||++..... .+.+.+|++++++++|+++++.++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788889999999999999987 5789999999864332 34688999999999999877766665 56778899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe---cCCCcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~kl~DFGla~~~~~~ 1488 (1624)
|+ +|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+|+.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 999999998666679999999999999999999996 799999999999999 58899999999999887543
Q ss_pred CCc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1489 DSM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1489 ~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
... ......||+.|+|||...+..++.++|||||||++|||+||+.||......... .....+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~~~ 231 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----------QKYERIS 231 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS----------SHHHHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh----------hhhhhhc
Confidence 321 123457999999999999989999999999999999999999999754221110 0001111
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
........ ......++..+.+++.+||+.+|++|||+.|+++.|+++..+..
T Consensus 232 ~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 232 EKKMSTPI----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHSCH----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccCCch----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 10000000 00112345678999999999999999999999999999877643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=363.63 Aligned_cols=270 Identities=19% Similarity=0.239 Sum_probs=202.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46777889999999999999885 58899999986432 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++ ++.+++......+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence 9985 6777776666678999999999999999999997 799999999999999999999999999998765322 2
Q ss_pred cccccccccccccccccCCCC-cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc---CChhHHHHHh---h
Q 047591 1492 KQTMTLATIGYMAPEYGSEGI-VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES---LPDAVTDVID---A 1564 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~-~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~---~~~~~~~~~d---~ 1564 (1624)
......||+.|+|||++.+.. ++.++|||||||++|||+||+.|+.........+....... ..+.+....+ .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 234457899999999887655 89999999999999999999998643322222222211100 0000000000 0
Q ss_pred hccCCc--hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1565 NLLSGE--EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1565 ~l~~~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...... ..........+...+.+++.+|++.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 000000011244567899999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=371.60 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=196.0
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe----e
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF----K 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~----~ 1406 (1624)
+.|...+.||+|+||+||+|+. .+++.||||+++.. .....+.|.+|++++++++||||+++++++...+. .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5678889999999999999987 46889999999653 23445789999999999999999999999865443 4
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++|+|.++++..+ .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 99999999999999997654 57999999999999999999996 799999999999999999999999999998765
Q ss_pred CCCC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1487 GVDS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1487 ~~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~--------- 237 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVREDPI--------- 237 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCCCC---------
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCCC---------
Confidence 3321 12233569999999999988899999999999999999999999997543221111 11111000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHH-HHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDAL-ANLKKI 1613 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl-~~L~~i 1613 (1624)
. .......++..+.+++.+||+.||++||+..+++ ..+.++
T Consensus 238 -----~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 -----P---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -----C---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----C---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 0011123456788999999999999999766655 445444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=379.99 Aligned_cols=346 Identities=26% Similarity=0.385 Sum_probs=185.3
Q ss_pred CCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccc
Q 047591 111 NLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKR 190 (1624)
Q Consensus 111 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 190 (1624)
.+++|+.|++++|.++ .+|. +..+++|++|||++|.+++. ++ +.++++|++|++++|++++..| ++++++|++
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDI-TP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCc-hh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 4566777777777776 3553 66677777777777777642 32 4566666666666666664333 666666666
Q ss_pred cccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeeccccc
Q 047591 191 LSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM 270 (1624)
Q Consensus 191 L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~ 270 (1624)
|+|++|++++. |. ++++++|++|+|++|++++ +| .+.++++|++|+++ |.+.
T Consensus 117 L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~----------------------- 168 (466)
T 1o6v_A 117 LTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVT----------------------- 168 (466)
T ss_dssp EECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCC-----------------------
T ss_pred EECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-Cccc-----------------------
Confidence 66666666643 22 5666666666666666653 22 24455555555553 2332
Q ss_pred ccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCC
Q 047591 271 TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGN 350 (1624)
Q Consensus 271 l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N 350 (1624)
+..| ++++++|+.|++++|++.++ + .+.++.+|+.|++++|++++..| + ..+++|++|++++|
T Consensus 169 --~~~~--~~~l~~L~~L~l~~n~l~~~---------~-~l~~l~~L~~L~l~~n~l~~~~~--~-~~l~~L~~L~l~~n 231 (466)
T 1o6v_A 169 --DLKP--LANLTTLERLDISSNKVSDI---------S-VLAKLTNLESLIATNNQISDITP--L-GILTNLDELSLNGN 231 (466)
T ss_dssp --CCGG--GTTCTTCCEEECCSSCCCCC---------G-GGGGCTTCSEEECCSSCCCCCGG--G-GGCTTCCEEECCSS
T ss_pred --Cchh--hccCCCCCEEECcCCcCCCC---------h-hhccCCCCCEEEecCCccccccc--c-cccCCCCEEECCCC
Confidence 2211 44555555555555544332 1 13344445555555555544333 1 23555666666666
Q ss_pred ccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCC
Q 047591 351 NLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNP 430 (1624)
Q Consensus 351 ~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~ 430 (1624)
++++. ..+..+++|++|++++|.+++..+ +..+++|++|+|++|+++.
T Consensus 232 ~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~---------------------------- 279 (466)
T 1o6v_A 232 QLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN---------------------------- 279 (466)
T ss_dssp CCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC----------------------------
T ss_pred Ccccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc----------------------------
Confidence 55542 245555666666666666655544 4555555555555444421
Q ss_pred CCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCc
Q 047591 431 WKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPS 510 (1624)
Q Consensus 431 ~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~ 510 (1624)
..| +..+++|++|+|++|++++..| ++.+++|+.|+|++|++++..|
T Consensus 280 ----------------------------~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~- 326 (466)
T 1o6v_A 280 ----------------------------ISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP- 326 (466)
T ss_dssp ----------------------------CGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-
T ss_pred ----------------------------ccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-
Confidence 111 3344455555555555554322 4455555555555555554433
Q ss_pred cccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccC
Q 047591 511 ELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578 (1624)
Q Consensus 511 ~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g 578 (1624)
+..+++|+.|++++|++++. ..++++++|+.|++++|++++.+| +..+++|+.|++++|.+++
T Consensus 327 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 327 -VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp -GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred -hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 44555555555555555542 345555555555555555555444 5555555555555555554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=374.48 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=188.1
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.+.|...+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|++++++++||||++++++|.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 456888899999999999999886 47889999986433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeecceeecCCCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~~~~~~~ 1489 (1624)
+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 130 VTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999999764 358899999999999999999996 79999999999999975 8899999999998764322
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.+............... ....
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~------------~~~~ 271 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE------------YYFI 271 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC------------CCCC
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC------------CccC
Confidence 22345799999999999988999999999999999999999999965432221111111111 0000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. .....++..+.+++.+|++.||++|||+.|+++
T Consensus 272 ~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 S-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp T-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 001123456788999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=370.77 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=201.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCce----EEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTN----AAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~----vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
.++|...+.||+|+||+||+|++. +++. ||+|.+... .....+.|.+|++++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 356888899999999999999874 4554 466666432 2345678999999999999999999999998654 78
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++......+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999999999877789999999999999999999996 7999999999999999999999999999987643
Q ss_pred CCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1488 VDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1488 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. .+.+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------------~~~~~~~ 235 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSILEKG 235 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------------HHHHHTT
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHcC
Confidence 322 22233457889999999988899999999999999999999 9999976432211 1111111
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..... +..++..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 236 ~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 ERLPQ-------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCC-------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 10000 112455688899999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=373.89 Aligned_cols=271 Identities=17% Similarity=0.259 Sum_probs=204.1
Q ss_pred CCCCcCCeEeec--CceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTG--IFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G--~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+| +||+||+|+.. +++.||||+++... ....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 457778899999 99999999886 68999999986543 34567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1410 LQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||++|+|.+++... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999864 3568999999999999999999996 79999999999999999999999999998754321
Q ss_pred CC------ccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHH-
Q 047591 1489 DS------MKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT- 1559 (1624)
Q Consensus 1489 ~~------~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~- 1559 (1624)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.......... .....+....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 260 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDT 260 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-hcCCCCccccc
Confidence 11 11223478999999999877 67999999999999999999999999764332221111 1111100000
Q ss_pred -----HH-------------Hhhhcc------CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1560 -----DV-------------IDANLL------SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1560 -----~~-------------~d~~l~------~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+. ...... .............++..+.+++.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 000000 000000111223456778999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=365.30 Aligned_cols=270 Identities=23% Similarity=0.320 Sum_probs=190.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356778899999999999999875 58899999986543 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1412 YMPQGSLEKWLYSHN-----YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
|++ |+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999987532 358899999999999999999996 799999999999999999999999999998765
Q ss_pred CCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh--cCCh-hHHHHH
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE--SLPD-AVTDVI 1562 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~--~~~~-~~~~~~ 1562 (1624)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+ .+...... ..++ .+..+.
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhhh
Confidence 322 12234578999999998865 468999999999999999999999997543221 11111100 0000 000000
Q ss_pred h-----hhccCC----chH-HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 D-----ANLLSG----EEE-ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d-----~~l~~~----~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ...... ... .........+..+.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000000 000 0000001234578899999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=394.34 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=180.6
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46789999999999999999986 47999999999766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC--CceEEEeeeeeeccCCCCC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD--TVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~--~~~kl~DFGla~~~~~~~~ 899 (1624)
|++|+|.++|......+++.++..|+.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 999999999976666799999999999999999999995 59999999999999854 7999999999998765432
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2345799999999999999999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=371.76 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=202.0
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCe
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~ 1405 (1624)
....++|...++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|.++++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678889999999999999999886 58899999986432 23456788999999987 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+++|+|.+++.+.+ .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999997643 57899999999999999999996 79999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDAN 1565 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 1565 (1624)
.... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ... +....
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~------------i~~~~ 234 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHS------------IRMDN 234 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHHCC
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-HHH------------HHhCC
Confidence 3222 223456799999999999988999999999999999999999999975321110 110 11000
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVK-DAL 1607 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~-evl 1607 (1624)
.. - +..++..+.+++.+|++.+|++||++. |+.
T Consensus 235 ~~-~--------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 PF-Y--------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CC-C--------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CC-C--------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00 0 012345678899999999999999997 554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=372.52 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=199.8
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4677789999999999999987 468899999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+ +|+|.+++.+.+ .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 999 789999987653 58899999999999999999997 789999999999999999999999999998765432
Q ss_pred ccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....+||+.|+|||.+.+..+ +.++|||||||++|||+||+.||++....... .. +... ....
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~~-i~~~------------~~~~ 227 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-KK-VNSC------------VYVM 227 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-CC-CCSS------------CCCC
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-HH-HHcC------------CCCC
Confidence 2234579999999999887766 78999999999999999999999753221110 00 0000 0000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+..++..+.+++.+|++.||++|||++|+++.
T Consensus 228 --------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 --------PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --------CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --------cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01123457789999999999999999999763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=371.12 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=199.9
Q ss_pred CCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.|...+.||+|+||+||+|+. .+++.||||++... .....+.|.+|++++++++|||||++++++.+++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 367778999999999999987 46889999998643 33445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++ |++.+++......+++.++..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 997 78999887666778999999999999999999997 78999999999999999999999999999876432
Q ss_pred ccccccccccccccccc---CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1492 KQTMTLATIGYMAPEYG---SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~---~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
....||+.|+|||++ ..+.++.++|||||||++|||+||+.||....... .+........+ ....
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~---------~~~~ 275 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------ALQS 275 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------CCCC
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCC---------CCCC
Confidence 235799999999987 35779999999999999999999999986532211 11111111000 0000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++..+.+++.+||+.+|++|||++|+++.
T Consensus 276 ----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 ----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1234567889999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=371.36 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=200.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45777889999999999999876 57889999986432 234578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 999999999999764 458899999999999999999996 799999999999999999999999999999875332
Q ss_pred ccccccccccccccccccCC---CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1491 MKQTMTLATIGYMAPEYGSE---GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~---~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
......||+.|||||++.. ..++.++|||||||++|||+||+.||........ .. ....+.....
T Consensus 170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~---------~~~~~~~~~~ 237 (384)
T 4fr4_A 170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KE---------IVHTFETTVV 237 (384)
T ss_dssp -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HH---------HHHHHHHCCC
T ss_pred -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HH---------HHHHHhhccc
Confidence 3345679999999998763 4589999999999999999999999964322111 00 0011111111
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-VKDALA 1608 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-~~evl~ 1608 (1624)
... ..++..+.+++.+|++.+|++||+ ++++.+
T Consensus 238 ~~p--------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYP--------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCC--------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCC--------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 100 123456788999999999999998 666653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=374.92 Aligned_cols=261 Identities=16% Similarity=0.185 Sum_probs=199.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccchhh-----------HHHHHHHHHHHHHhcCCCceeEEEee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQEDR-----------ALKSFDAECEVMRRIRHRNLAKIVSS 1399 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~~~~-----------~~~~f~~E~~~l~~l~HpNIv~l~g~ 1399 (1624)
++|...+.||+|+||+||+|+.. ++..||||++...... ..+.+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56777889999999999999885 5678999988643211 12357789999999999999999999
Q ss_pred ecc----CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC--c
Q 047591 1400 CSN----PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM--V 1473 (1624)
Q Consensus 1400 ~~~----~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~--~ 1473 (1624)
+.. ....++||||+ +|+|.+++...+ .+++.+++.|+.||+.||+|||+ .+|+||||||+|||++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCc
Confidence 877 67889999999 999999997654 78999999999999999999996 7999999999999999887 9
Q ss_pred EEEeeecceeecCCCCC------ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhh
Q 047591 1474 AHLGDFGIAKLLDGVDS------MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1474 ~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~ 1547 (1624)
+||+|||+|+.+..... .......||+.|+|||+..+..++.++|||||||++|||+||+.||...........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999987643221 111345799999999999888999999999999999999999999964322221111
Q ss_pred hhh---hhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1548 HWV---EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1548 ~~~---~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
... ....++...+. .. ...++..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~----~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKW----AP----------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHTTTHHHHHH----SC----------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHhhcccccHHHHhh----cc----------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111 01111111000 00 0134567899999999999999999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=363.45 Aligned_cols=244 Identities=26% Similarity=0.311 Sum_probs=201.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46777899999999999999875 68999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+.....
T Consensus 86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 9999999999998653 57889999999999999999995 79999999999999999999999999999876432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
....+||+.|||||++.+..++.++|||||||++|||++|+.||.+..... .. ..++.....- .
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~------------~~i~~~~~~~-p 223 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TY------------EKILNAELRF-P 223 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH------------HHHHHCCCCC-C
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HH------------HHHHhCCCCC-C
Confidence 234579999999999999999999999999999999999999996532111 11 1111111100 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
...+..+.+++.+|++.+|++|| +++|+++
T Consensus 224 --------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 --------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12335678899999999999999 8888875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=366.09 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=197.9
Q ss_pred CCCc-CCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSE-SNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~-~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.|.. .++||+|+||+||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 4554 368999999999999864 6889999999765555567899999999995 799999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc---EEEeeecceeecCCCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV---AHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~kl~DFGla~~~~~~~ 1489 (1624)
+++|+|.+++...+ .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 93 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 93 MRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred CCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 99999999997653 57899999999999999999997 79999999999999998776 9999999998654221
Q ss_pred C------ccccccccccccccccccCC-----CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh--
Q 047591 1490 S------MKQTMTLATIGYMAPEYGSE-----GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD-- 1556 (1624)
Q Consensus 1490 ~------~~~~~~~gt~~y~APE~~~~-----~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~-- 1556 (1624)
. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||......+. .|.......
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~ 245 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC---GWDRGEACPAC 245 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS---CC----CCHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc---cccccccchhH
Confidence 1 11223469999999998764 5689999999999999999999999975432211 111111100
Q ss_pred --hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1557 --AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1557 --~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+.+........ ......++..+.+++.+|++.||++|||++|+++.
T Consensus 246 ~~~~~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCCCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcccC----chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111111111 11122356678899999999999999999999873
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=371.96 Aligned_cols=280 Identities=23% Similarity=0.252 Sum_probs=214.7
Q ss_pred chhccccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC-----CCc
Q 047591 1319 TAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-----HRN 1392 (1624)
Q Consensus 1319 ~~~~~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-----HpN 1392 (1624)
......+++.+.....++|...+.||+|+||+||+|+.. +++.||||+++.. ....+.+..|++++++++ |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 345677888888888899999999999999999999884 6889999998632 344567788999999997 999
Q ss_pred eeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-
Q 047591 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD- 1470 (1624)
Q Consensus 1393 Iv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~- 1470 (1624)
||++++++...+..++||||+ +|+|.+++.... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDP 173 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCT
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccc
Confidence 999999999999999999999 999999998654 458999999999999999999996 79999999999999986
Q ss_pred ------------------------CCcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHH
Q 047591 1471 ------------------------DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILM 1526 (1624)
Q Consensus 1471 ------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil 1526 (1624)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999875432 2345799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCccchhhhhh--hhhcCChhHH-HHHhhhc---------c---C-Cch-HHHHH--------HHHHh
Q 047591 1527 METLTRRKPTDDMFTGEVCLKHW--VEESLPDAVT-DVIDANL---------L---S-GEE-EADIA--------AKKKC 1581 (1624)
Q Consensus 1527 ~Elltg~~P~~~~~~~~~~l~~~--~~~~~~~~~~-~~~d~~l---------~---~-~~~-~~~~~--------~~~~~ 1581 (1624)
|||+||+.||......+ .+... .....+.... +...... . . ... ..... .....
T Consensus 250 ~ell~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 250 AELYTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 99999999997532211 11111 1111121111 1000000 0 0 000 00000 00112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1582 MSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1582 ~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...+.+++.+|++.||++|||++|+++
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 256789999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=366.19 Aligned_cols=251 Identities=23% Similarity=0.273 Sum_probs=198.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..+++++ +|||||++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 45777889999999999999886 5788999998643 234457788999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+......
T Consensus 89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999997643 57899999999999999999996 799999999999999999999999999998643222
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ....+.....+......-
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~i~~~~~~~ 238 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNTEDYLFQVILEKQIRI 238 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------CHHHHHHHHHHCCCCC
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-----cccHHHHHHHHHcCCCCC
Confidence 22344679999999999998899999999999999999999999996432111000 000001111111110000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
+...+..+.+++.+|++.||++||++
T Consensus 239 --------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 --------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 01234567889999999999999995
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=373.61 Aligned_cols=265 Identities=24% Similarity=0.409 Sum_probs=212.6
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEee
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSS 1399 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~ 1399 (1624)
.++++...++|...+.||+|+||+||+|++. +++.||||++.... ......|.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3445556678888999999999999999764 36789999986432 3445679999999999999999999999
Q ss_pred eccCCeeEEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC
Q 047591 1400 CSNPGFKALILQYMPQGSLEKWLYSHN---------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD 1470 (1624)
Q Consensus 1400 ~~~~~~~~lV~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 1470 (1624)
+.+.+..++||||+++|+|.+++...+ ..+++..+++++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcC
Confidence 999999999999999999999997532 346899999999999999999997 79999999999999999
Q ss_pred CCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhh
Q 047591 1471 DMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKH 1548 (1624)
Q Consensus 1471 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~ 1548 (1624)
++.+||+|||+++....... .......||+.|+|||+..+..++.++|||||||++|||+| |+.||....... ....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~ 252 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRF 252 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-HHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-HHHH
Confidence 99999999999986643222 12233467899999999988889999999999999999999 888886532211 1111
Q ss_pred hhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1549 WVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1549 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
+........ +..++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 253 ------------~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 ------------VMEGGLLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------------HHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------------HHcCCcCCC--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111110 01345668899999999999999999999999987644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=357.04 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=183.3
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4577788999999999999987 468999999986432 223478999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++......+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999998776778999999999999999999996 7999999999999999999999999999987653221
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||...+..++.++|||||||++|||+||+.||........ +........ ..
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~----------~~---- 231 (278)
T 3cok_A 168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLADY----------EM---- 231 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSCC----------CC----
T ss_pred -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhccc----------CC----
Confidence 22335799999999999888899999999999999999999999865322111 100000000 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+..++..+.+++.+|++.||++|||++|+++
T Consensus 232 -------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 -------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0113345778999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=366.38 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=180.0
Q ss_pred CCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEEEEecCCCC
Q 047591 1340 SNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALILQYMPQGS 1417 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV~ey~~~gs 1417 (1624)
.+.||+|+||+||+|+.. +++.||||++... ....+.+|+++++++. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999885 5889999998643 3456788999999997 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC---cEEEeeecceeecCCCCCcccc
Q 047591 1418 LEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM---VAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1418 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
|.+++... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+|+...... ....
T Consensus 93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 99999875 458999999999999999999996 7999999999999998765 89999999998765332 2233
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ......+.+...... ..
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~i~~~~~~----~~ 236 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT-------SAVEIMKKIKKGDFS----FE 236 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC-------CHHHHHHHHTTTCCC----CC
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc-------cHHHHHHHHHcCCCC----CC
Confidence 4578999999999999999999999999999999999999997532110000 000011111111000 01
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...+..++..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1122345677899999999999999999998873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=362.90 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=193.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh--------------------------hHHHHHHHHHHHHHh
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED--------------------------RALKSFDAECEVMRR 1387 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~--------------------------~~~~~f~~E~~~l~~ 1387 (1624)
++|...+.||+|+||+||+|+.. +++.||||++..... ...+.|.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 56888899999999999999875 588899999864321 123578999999999
Q ss_pred cCCCceeEEEeeecc--CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCc
Q 047591 1388 IRHRNLAKIVSSCSN--PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSN 1465 (1624)
Q Consensus 1388 l~HpNIv~l~g~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~N 1465 (1624)
++||||+++++++.+ .+..++||||+++|+|.+++. ...+++.++..++.|+++||+|||+ .+|+||||||+|
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 999999999999976 567899999999999987653 3468999999999999999999997 799999999999
Q ss_pred EEecCCCcEEEeeecceeecCCCCCccccccccccccccccccCCCC---cCcccchHHHHHHHHHHHcCCCCCCCCCcc
Q 047591 1466 VLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI---VSTSGDVYSFGILMMETLTRRKPTDDMFTG 1542 (1624)
Q Consensus 1466 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DV~SfGvil~Elltg~~P~~~~~~~ 1542 (1624)
||++.++.+||+|||+|+....... ......||+.|+|||...+.. ++.++|||||||++|||++|+.||.+....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999987754322 223457999999999887654 478999999999999999999999653211
Q ss_pred chhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1543 EVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1543 ~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+.. .+..... .... ...++..+.+++.+||+.||++|||++|+++
T Consensus 247 --~~~~-----------~~~~~~~-~~~~------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 --CLHS-----------KIKSQAL-EFPD------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp --HHHH-----------HHHHCCC-CCCS------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --HHHH-----------HHhcccC-CCCC------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1100 0000000 0000 0123456788999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=362.14 Aligned_cols=262 Identities=22% Similarity=0.329 Sum_probs=199.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 35777889999999999999874 6899999998642 3445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999874 34568999999999999999999996 7999999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
... ......||+.|+|||...+..++.++|||||||++|||+||+.||.........+... +.....
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~ 255 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------------IEQCDY 255 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH------------HHTTCS
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH------------hhcccC
Confidence 221 2234568999999999988899999999999999999999999986432211111111 110000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.... ...++..+.+++.+||+.||++|||++|+++.|++++....
T Consensus 256 ~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 256 PPLP------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CCCC------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCc------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0000 01234568889999999999999999999999999987644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=352.70 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=203.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. ++..||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45777889999999999999876 46789999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe---cCCCcEEEeeecceeecCCCCC
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
++|+|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++......
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 89 TGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9999999987643 47899999999999999999996 799999999999999 788999999999998775432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||...+ .++.++|||||||++|||+||+.||......+. ........ ....
T Consensus 164 -~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~-------------~~~~ 227 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGT-------------FTFP 227 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC-------------CCCC
T ss_pred -chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCC-------------CCCC
Confidence 2234579999999998765 489999999999999999999999975432111 11111110 0000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......++..+.+++.+|++.+|++|||+.|+++.
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 228 ----EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112345678899999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=366.58 Aligned_cols=264 Identities=23% Similarity=0.421 Sum_probs=200.1
Q ss_pred HHHHhCCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC
Q 047591 1330 LRLATNGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1330 l~~at~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~ 1403 (1624)
+....++|...+.||+|+||+||+|++.. +..||||+++.. .....+.|.+|++++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 33445677888899999999999997742 347999998643 344567899999999999999999999999765
Q ss_pred Ce-----eEEEEEecCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc
Q 047591 1404 GF-----KALILQYMPQGSLEKWLYS-----HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473 (1624)
Q Consensus 1404 ~~-----~~lV~ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 1473 (1624)
+. .++||||+++|+|.+++.. ....+++.+++.|+.|+++||+|||+ .+|+||||||+||++++++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCc
Confidence 53 4999999999999999953 23568999999999999999999996 79999999999999999999
Q ss_pred EEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhh
Q 047591 1474 AHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1474 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~ 1551 (1624)
+||+|||+++....... .......+++.|+|||...+..++.++|||||||++|||+| |+.||........ ....
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~-- 262 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-YDYL-- 262 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHH--
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHH--
Confidence 99999999987643321 12233467889999999988899999999999999999999 8888865432211 1111
Q ss_pred hcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1552 ESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
........ +..++..+.+++.+||+.+|++|||+.|+++.|+++..++
T Consensus 263 ----------~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 ----------LHGHRLKQ--------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ----------HTTCCCCC--------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------HcCCCCCC--------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11000000 0234556889999999999999999999999999987764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=367.53 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=204.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeec----cCCeeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS----NPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~----~~~~~~l 1408 (1624)
.++|...+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35677789999999999999987 468999999987666666788999999999999999999999986 3447899
Q ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1409 ILQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
||||+++|+|.+++.. .+..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999975 35678999999999999999999997 79999999999999999999999999998865
Q ss_pred CCCCCc--------cccccccccccccccccCCCC---cCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC
Q 047591 1486 DGVDSM--------KQTMTLATIGYMAPEYGSEGI---VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL 1554 (1624)
Q Consensus 1486 ~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~ 1554 (1624)
...... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||+..........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------- 257 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA------- 257 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-------
Confidence 321110 012345799999999876543 78999999999999999999999853211111111
Q ss_pred ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
..+........ ...++..+.+++.+||+.+|++|||+.|+++.|++++.
T Consensus 258 -----~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 -----LAVQNQLSIPQ-------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -----HHHHCC--CCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -----HHhhccCCCCc-------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11110000000 01234568899999999999999999999999998754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=379.88 Aligned_cols=357 Identities=24% Similarity=0.351 Sum_probs=188.7
Q ss_pred CCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCC
Q 047591 146 SNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGE 225 (1624)
Q Consensus 146 ~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 225 (1624)
.+.+.+.++.. .+++|+.|++++|.++. +|. +..+++|++|||++|++++..| ++++++|++|+|++|++++.
T Consensus 33 ~~~~~~~i~~~---~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 105 (466)
T 1o6v_A 33 KTNVTDTVSQT---DLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI 105 (466)
T ss_dssp CSSTTSEECHH---HHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred ccccccccChh---HhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccC
Confidence 34444444432 35567778888887763 553 6777778888888887774433 77777777777777777754
Q ss_pred CCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCcccccc
Q 047591 226 FPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTG 305 (1624)
Q Consensus 226 ~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g 305 (1624)
.| ++++++|++|+|++|.+++ +|. +..+++|++|++++|.+++. | .++.+++|+.|+++ |
T Consensus 106 ~~--~~~l~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~------------ 165 (466)
T 1o6v_A 106 TP--LANLTNLTGLTLFNNQITD-IDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-N------------ 165 (466)
T ss_dssp GG--GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-E------------
T ss_pred hh--hcCCCCCCEEECCCCCCCC-ChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-C------------
Confidence 43 6677777777777777663 332 45666666666666666542 2 35555555555553 2
Q ss_pred ccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCccccc
Q 047591 306 LIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFG 385 (1624)
Q Consensus 306 ~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~ 385 (1624)
.+.+. +. ..++++|++|++++|++++. + .+..+++|++|++++|.+++..| ++
T Consensus 166 --------------------~~~~~-~~--~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--~~ 218 (466)
T 1o6v_A 166 --------------------QVTDL-KP--LANLTTLERLDISSNKVSDI-S-VLAKLTNLESLIATNNQISDITP--LG 218 (466)
T ss_dssp --------------------SCCCC-GG--GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGG--GG
T ss_pred --------------------cccCc-hh--hccCCCCCEEECcCCcCCCC-h-hhccCCCCCEEEecCCccccccc--cc
Confidence 22211 11 12445555555555555532 2 35555666666666666655544 45
Q ss_pred ccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcC
Q 047591 386 NCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFG 465 (1624)
Q Consensus 386 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~ 465 (1624)
.+++|++|++++|++... ..+..+++|++|++++|.+ .+..| +.
T Consensus 219 ~l~~L~~L~l~~n~l~~~---------~~l~~l~~L~~L~l~~n~l-------------------------~~~~~--~~ 262 (466)
T 1o6v_A 219 ILTNLDELSLNGNQLKDI---------GTLASLTNLTDLDLANNQI-------------------------SNLAP--LS 262 (466)
T ss_dssp GCTTCCEEECCSSCCCCC---------GGGGGCTTCSEEECCSSCC-------------------------CCCGG--GT
T ss_pred ccCCCCEEECCCCCcccc---------hhhhcCCCCCEEECCCCcc-------------------------ccchh--hh
Confidence 555555555555554320 1112222222222222222 11111 34
Q ss_pred CCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccc
Q 047591 466 NLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRAL 545 (1624)
Q Consensus 466 ~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L 545 (1624)
.+++|++|+|++|++++..| +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..| ++.+++|+.|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 44555555555555554322 4455555555555555553222 4445555555555555554333 4444555555
Q ss_pred cccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCC
Q 047591 546 NLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQ 625 (1624)
Q Consensus 546 ~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~ 625 (1624)
++++|++++. ..++++++|+.|++++|++++.+| ++.+++|+.|++++|+++
T Consensus 337 ~l~~n~l~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 337 FFYNNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCCCC--------------------------GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECCCCccCCc--------------------------hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 5555555442 244555555555555555555444 555555555555555555
Q ss_pred C
Q 047591 626 G 626 (1624)
Q Consensus 626 g 626 (1624)
+
T Consensus 389 ~ 389 (466)
T 1o6v_A 389 N 389 (466)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=370.60 Aligned_cols=253 Identities=17% Similarity=0.136 Sum_probs=202.0
Q ss_pred HHhCCCCcCCeEeecCceEEEEEE------EcCCceEEEEEeccchhhHHHHHHHHHHHHHhcC---CCceeEEEeeecc
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKAT------FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR---HRNLAKIVSSCSN 1402 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~------~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~---HpNIv~l~g~~~~ 1402 (1624)
...+.|...+.||+|+||+||+|+ ..+++.||||+++... ..+|.+|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345678888999999999999994 3468899999986443 356778888888886 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC--------
Q 047591 1403 PGFKALILQYMPQGSLEKWLYS----HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-------- 1470 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-------- 1470 (1624)
.+..++|||||++|+|.+++.. ....+++..++.|+.||++||+|||+ .+||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999975 34569999999999999999999996 79999999999999998
Q ss_pred ---CCcEEEeeecceeecCCC-CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhh
Q 047591 1471 ---DMVAHLGDFGIAKLLDGV-DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1471 ---~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l 1546 (1624)
++.+||+|||+|+.+... .........||++|||||++.+..++.++|||||||++|||+||+.||.....+....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 295 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee
Confidence 899999999999875421 2223345679999999999999999999999999999999999999985422211110
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHHH
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEER-MNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R-Pt~~evl~~L~~i~~~ 1616 (1624)
... . ... .....+.+++.+|++.+|.+| |+++++.+.|+++..+
T Consensus 296 ~~~----~-------------~~~---------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 296 EGL----F-------------RRL---------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp CSC----C-------------TTC---------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred chh----c-------------ccc---------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 000 0 000 012234567889999999998 5788888888876544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=367.28 Aligned_cols=244 Identities=21% Similarity=0.250 Sum_probs=202.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46777889999999999999885 68999999986432 234578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999998654 47889999999999999999996 79999999999999999999999999999976432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
....+||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..... +...... -
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~------------i~~~~~~-~- 257 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEK------------IVSGKVR-F- 257 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH------------HHHCCCC-C-
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHH------------HHcCCCC-C-
Confidence 23457999999999998889999999999999999999999999653211 11111 1111110 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
+..++..+.+++.+|++.||++||+ ++|+++
T Consensus 258 -------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 -------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0123456788999999999999998 777765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=397.63 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=200.5
Q ss_pred CeEeecCceEEEEEEEc---CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFA---DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||+||+|.+. .++.||||+++... ....++|.+|+++|++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 35789999987543 2346789999999999999999999999964 457899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC--ccc
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS--MKQ 1493 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~--~~~ 1493 (1624)
|+|.+++... ..+++.++..|+.||+.||+|||+ .+||||||||+|||+++++.+||+|||+|+.+..... ...
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999764 458999999999999999999996 7999999999999999999999999999987754322 122
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....||+.|+|||++....++.++|||||||++|||+| |+.||......+ +.+.+.......
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------------~~~~i~~~~~~~--- 592 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERMG--- 592 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------HHHHHHTTCCCC---
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCCCCC---
Confidence 33457889999999988899999999999999999999 999997643211 111111111100
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.+..++..+.+++.+||+.||++|||++++++.|+++...+
T Consensus 593 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 593 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 01235677899999999999999999999999999876553
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=371.05 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=196.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCC--CceeEEEeeeccCCeeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRH--RNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~H--pNIv~l~g~~~~~~~~~lV 1409 (1624)
.+.|...+.||+|+||+||+|...+++.||||++... .....+.|.+|++++++++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3567788999999999999999888999999998643 33456789999999999987 9999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|| +.+|+|.+++... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+|+......
T Consensus 88 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred Ee-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 99 5688999999875 457899999999999999999997 7999999999999997 5789999999998765332
Q ss_pred C-ccccccccccccccccccCC-----------CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1490 S-MKQTMTLATIGYMAPEYGSE-----------GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1490 ~-~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........+.
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------- 231 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---------- 231 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH----------
Confidence 2 12334579999999998754 6789999999999999999999999975432211111
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++........ ..++..+.+++.+||+.||++|||+.|+++.
T Consensus 232 --~~~~~~~~~~~~-------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 --AIIDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --HHHCTTSCCCCC-------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHhcCCcccCCc-------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 112211110000 0123457789999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=375.42 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=196.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcC--CCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIR--HRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~--HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
+.|...+.||+|+||+||+|...+++.||||++... .....+.|.+|++++++++ |||||++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 347788999999999999999888999999998643 3445678999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
| +.+|+|.+++.... .+++.++..|+.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+|+.+.....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 67889999998754 67888999999999999999996 7999999999999996 58999999999987653322
Q ss_pred -ccccccccccccccccccCC-----------CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhH
Q 047591 1491 -MKQTMTLATIGYMAPEYGSE-----------GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAV 1558 (1624)
Q Consensus 1491 -~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~ 1558 (1624)
......+||+.|||||++.+ ..++.++|||||||++|||+||+.||.........+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------------ 277 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------------ 277 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH------------
Confidence 12334579999999998754 468999999999999999999999997543211111
Q ss_pred HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1559 TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1559 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+++........ ..++..+.+++.+||+.||++|||+.|+++.
T Consensus 278 ~~~~~~~~~~~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 HAIIDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHCTTSCCCCC-------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCccccCCCC-------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1122211110000 0123457789999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=379.61 Aligned_cols=251 Identities=18% Similarity=0.246 Sum_probs=194.3
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc---hhhHHHHHHHHH---HHHHhcCCCceeEEE-------ee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ---EDRALKSFDAEC---EVMRRIRHRNLAKIV-------SS 1399 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~---~~~~~~~f~~E~---~~l~~l~HpNIv~l~-------g~ 1399 (1624)
.+.|...+.||+|+||+||+|+. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35677788999999999999987 46899999998632 334568899999 555666899999998 55
Q ss_pred eccCC-----------------eeEEEEEecCCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 047591 1400 CSNPG-----------------FKALILQYMPQGSLEKWLYSHNYL------LNIEQRLDIMIDVACALEYLHQGYSTSI 1456 (1624)
Q Consensus 1400 ~~~~~-----------------~~~lV~ey~~~gsL~~~l~~~~~~------l~~~~~~~i~~~ia~gl~yLH~~~~~~i 1456 (1624)
+.+++ ..++||||+ +|+|.+++...+.. +++..++.|+.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 44442 278999999 68999999864322 3368889999999999999997 799
Q ss_pred EEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccccccccccccccCCC-----------CcCcccchHHHHHH
Q 047591 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG-----------IVSTSGDVYSFGIL 1525 (1624)
Q Consensus 1457 iHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~k~DV~SfGvi 1525 (1624)
+||||||+|||++.++.+||+|||+|+.... ......| +.|||||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999998877 89999999999999
Q ss_pred HHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHH
Q 047591 1526 MMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKD 1605 (1624)
Q Consensus 1526 l~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~e 1605 (1624)
+|||+||+.||........ ..++... . ..++..+.+++.+||+.||++|||+.|
T Consensus 303 l~elltg~~Pf~~~~~~~~--~~~~~~~----------------~--------~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG--SEWIFRS----------------C--------KNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHSSCCC------CC--SGGGGSS----------------C--------CCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHCCCCCcccccccc--hhhhhhh----------------c--------cCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 9999999999865321111 0000000 0 123456788999999999999999999
Q ss_pred HHH--HHHHHHHHHhh
Q 047591 1606 ALA--NLKKIKTKFLK 1619 (1624)
Q Consensus 1606 vl~--~L~~i~~~~~~ 1619 (1624)
+++ .+++++.....
T Consensus 357 ~l~hp~f~~~~~~~~~ 372 (377)
T 3byv_A 357 AMETPEYEQLRTELSA 372 (377)
T ss_dssp HHTSHHHHHHHHHHHH
T ss_pred HhhChHHHHHHHHHHH
Confidence 996 56666655443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=364.61 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=191.3
Q ss_pred CCCCcCCeEeecCceEEEEEEE----cCCceEEEEEeccch----hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF----ADGTNAAIKIFSLQE----DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~----~~~~~vAvK~~~~~~----~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||+||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4677789999999999999987 468899999986432 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999997643 57888999999999999999997 799999999999999999999999999998653
Q ss_pred CCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
... .......||+.|||||++.+..++.++|||||||++|||++|+.||........ . ..+.....
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~------------~~i~~~~~ 238 (327)
T 3a62_A 173 HDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-I------------DKILKCKL 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H------------HHHHHTCC
T ss_pred cCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-H------------HHHHhCCC
Confidence 222 122345799999999999888999999999999999999999999975322111 1 11111111
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
... ..++..+.+++.+|++.+|++|| ++.|+++
T Consensus 239 -~~p--------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 -NLP--------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CCC--------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CCC--------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 000 12345678899999999999999 6777765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=359.25 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=205.6
Q ss_pred hCCCCcCC-eEeecCceEEEEEEEc---CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1334 TNGFSESN-LLGTGIFSSVYKATFA---DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1334 t~~f~~~~-~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
.+.|...+ .||+|+||+||+|.+. +++.||||+++... ....+.|.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34566666 8999999999999653 36789999986442 23467899999999999999999999999 567789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999865 358899999999999999999997 7999999999999999999999999999987754
Q ss_pred CCCcc--ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1488 VDSMK--QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1488 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
..... .....||+.|+|||...+..++.++|||||||++|||+| |+.||......+ .. +.+..
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~------------~~~~~ 235 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT------------AMLEK 235 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH------------HHHHT
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH------------HHHHc
Confidence 33221 223456789999999988889999999999999999999 999987532211 11 11111
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
...... +..++..+.+++.+||+.+|++||++.|+++.|+++-....
T Consensus 236 ~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 236 GERMGC-------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp TCCCCC-------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 100000 12345678899999999999999999999999999876644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=370.26 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=199.2
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-----hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-----DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-----~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~ 1404 (1624)
....++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 334567888899999999999999875 57889999986432 345678999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 047591 1405 FKALILQYMPQGSLEKWLYSH---------------------------------------NYLLNIEQRLDIMIDVACAL 1445 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~gl 1445 (1624)
..++||||+++|+|.+++... ...+++..+..|+.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999988521 11235667788999999999
Q ss_pred HHhhhcCCCceEEcCCCCCcEEecCCC--cEEEeeecceeecCCCC---CccccccccccccccccccCC--CCcCcccc
Q 047591 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDM--VAHLGDFGIAKLLDGVD---SMKQTMTLATIGYMAPEYGSE--GIVSTSGD 1518 (1624)
Q Consensus 1446 ~yLH~~~~~~iiHrDlK~~NILld~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~APE~~~~--~~~~~k~D 1518 (1624)
+|||+ .+|+||||||+||+++.++ .+||+|||+|+.+.... ........||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 99997 7999999999999998776 89999999998764322 112334579999999998764 67899999
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCC
Q 047591 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPE 1598 (1624)
Q Consensus 1519 V~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~ 1598 (1624)
||||||++|||+||+.||......+. .. .++......... ....++..+.+++.+|++.+|+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~-~~------------~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADT-IS------------QVLNKKLCFENP-----NYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHH-HH------------HHHHCCCCTTSG-----GGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHH-HH------------HHHhcccccCCc-----ccccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999975432211 11 111111100000 0112345678899999999999
Q ss_pred CCCCHHHHHHH
Q 047591 1599 ERMNVKDALAN 1609 (1624)
Q Consensus 1599 ~RPt~~evl~~ 1609 (1624)
+|||+.|+++.
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=366.91 Aligned_cols=249 Identities=21% Similarity=0.258 Sum_probs=201.3
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcC-CceEEEEEeccch---hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQE---DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~ 1407 (1624)
..++|...++||+|+||+||+|+... ++.||||+++... ....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34678888999999999999998864 7889999986442 23456788999999987 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999998654 57899999999999999999996 7999999999999999999999999999986432
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.. ......+||+.|||||++.+..++.++|||||||++|||++|+.||......+ ... .+......
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~------------~i~~~~~~ 239 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQ------------SIMEHNVA 239 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH------------HHHHCCCC
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHH------------HHHhCCCC
Confidence 22 22345679999999999998999999999999999999999999997532111 111 11111110
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV-----KDALA 1608 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~-----~evl~ 1608 (1624)
- +...+..+.+++.+|++.+|++||++ +|+.+
T Consensus 240 ~---------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 Y---------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp C---------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C---------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 01234567889999999999999964 55554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=361.15 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=198.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 57888899999999999999875 68899999986442 234578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 114 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp ECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999998643 57899999999999999999997 7999999999999999999999999999987654333
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.......||+.|+|||...+..++.++|||||||++|||+||+.||...... .+...+....+. .
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-------------~ 254 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR-------------P 254 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-------------G
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-------------c
Confidence 3334457999999999999899999999999999999999999999753211 111111111100 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM-NVKDALANLKKIK 1614 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-t~~evl~~L~~i~ 1614 (1624)
. .....++..+.+++.+||+.+|++|| +++++++.|++..
T Consensus 255 ~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 S----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp G----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred c----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0 00123455688899999999999999 9999999998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=367.09 Aligned_cols=269 Identities=20% Similarity=0.290 Sum_probs=198.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46777889999999999999886 688999999864432 2223566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++ |+|.+++...+..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 98 69999998877789999999999999999999996 799999999999999999999999999998654322 22
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---h----cCChhHH--HHH
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---E----SLPDAVT--DVI 1562 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~----~~~~~~~--~~~ 1562 (1624)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+. +..... . .++.... +..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhc
Confidence 234578999999998765 5689999999999999999999999976432211 111110 0 0111000 000
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..................+...+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000011111223345678899999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=373.04 Aligned_cols=269 Identities=20% Similarity=0.287 Sum_probs=192.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCC--eeE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPG--FKA 1407 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~--~~~ 1407 (1624)
.++|...+.||+|+||+||+|... +|+.||||++... .....+++.+|+.+++++. |||||++++++..++ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 467888899999999999999875 6889999988532 3445677889999999997 999999999987544 689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+|||||+ |+|.++++.. .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 9999998 6999999763 57889999999999999999996 7999999999999999999999999999987643
Q ss_pred CC--------------------CccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhh
Q 047591 1488 VD--------------------SMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1488 ~~--------------------~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l 1546 (1624)
.. ....+..+||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+....+. +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~ 240 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-L 240 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 11 111234579999999998865 6789999999999999999999999975432111 1
Q ss_pred hhhhhh-cCChh----------HHHHHhh---h-------ccCCchHHHHH-----HHHHhHHHHHHHHHHccccCCCCC
Q 047591 1547 KHWVEE-SLPDA----------VTDVIDA---N-------LLSGEEEADIA-----AKKKCMSSVMSLALKCSEEIPEER 1600 (1624)
Q Consensus 1547 ~~~~~~-~~~~~----------~~~~~d~---~-------l~~~~~~~~~~-----~~~~~~~~~~~l~~~C~~~~P~~R 1600 (1624)
...... ..|.. ....++. . ........... ....++..+.+++.+|++.||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 111110 00100 0000000 0 00000000000 001345678999999999999999
Q ss_pred CCHHHHHHH
Q 047591 1601 MNVKDALAN 1609 (1624)
Q Consensus 1601 Pt~~evl~~ 1609 (1624)
||++|+++.
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=357.69 Aligned_cols=252 Identities=29% Similarity=0.413 Sum_probs=198.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-CeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-GFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||+||+|++ .|+.||||+++... ..+.|.+|++++++++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4677788999999999999987 48899999986433 457899999999999999999999987554 5789999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.+++.+.+ ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 9999999997643 237889999999999999999996 79999999999999999999999999999865432
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....+|+.|+|||...+..++.++|||||||++|||+| |+.||......+. .. .+.......
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~------------~~~~~~~~~-- 234 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP------------RVEKGYKMD-- 234 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HH------------HHTTTCCCC--
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH------------HHhcCCCCC--
Confidence 223457899999999988889999999999999999999 9999865322111 11 011000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.+..++..+.+++.+||+.+|++|||+.|+++.|++++...
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 235 -----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 01234566889999999999999999999999999998753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=368.61 Aligned_cols=262 Identities=13% Similarity=0.126 Sum_probs=205.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC---------CceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeE----------
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD---------GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK---------- 1395 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~---------~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~---------- 1395 (1624)
++|...+.||+|+||+||+|+... ++.||||++... +.+.+|++++++++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 567888999999999999998763 788999998643 46889999999999999998
Q ss_pred -----EEeeecc-CCeeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1396 -----IVSSCSN-PGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1396 -----l~g~~~~-~~~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
+++++.. .+..++||||+ +|+|.+++... +..+++.+++.|+.||+.||+|||+ .+|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 5666655 67889999999 99999999865 4578999999999999999999997 799999999999999
Q ss_pred cCCC--cEEEeeecceeecCCCCCc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCC
Q 047591 1469 DDDM--VAHLGDFGIAKLLDGVDSM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMF 1540 (1624)
Q Consensus 1469 d~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~ 1540 (1624)
+.++ .+||+|||+|+.+...... ......||+.|+|||+..+..++.++|||||||++|||+||+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999876532211 1233479999999999998899999999999999999999999997543
Q ss_pred ccchhhhhhhhhcCChhHHHHHhh--hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1541 TGEVCLKHWVEESLPDAVTDVIDA--NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1541 ~~~~~l~~~~~~~~~~~~~~~~d~--~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.....+..... ..... .+..... ....++..+.+++.+||+.+|++|||++|+++.|+++..+..
T Consensus 273 ~~~~~~~~~~~--------~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNTEDIMKQKQ--------KFVDKPGPFVGPCG-----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCHHHHHHHHH--------HHHHSCCCEECTTS-----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHHHHHHHHH--------hccCChhhhhhhcc-----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 22111111110 00000 0000000 001124568899999999999999999999999999877644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=360.05 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=204.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh------hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED------RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~------~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45777889999999999999876 588999999864322 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC----cEEEeeeccee
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM----VAHLGDFGIAK 1483 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~kl~DFGla~ 1483 (1624)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999764 457899999999999999999996 7999999999999999888 79999999998
Q ss_pred ecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
...... ......||+.|+|||...+..++.++|||||||++|||+||+.||......+ .+.......
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~---------- 234 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITSVS---------- 234 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTC----------
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcc----------
Confidence 775432 2234569999999999988899999999999999999999999996532211 111111000
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.... ......++..+.+++.+|++.||++|||+.|+++.
T Consensus 235 ---~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 ---YDFD----EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---CCCC----HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---cccC----hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 01112345668899999999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=354.61 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=204.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
.++|...+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888899999999999999875 58899999986442 345578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc---EEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV---AHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~kl~DFGla~~~~~ 1487 (1624)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999988765 357899999999999999999996 79999999999999987655 99999999987654
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.. ......||+.|+|||...+..++.++|||||||++|||++|+.||....... ......... .
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~------------~- 224 (284)
T 3kk8_A 161 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGA------------Y- 224 (284)
T ss_dssp SC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC------------C-
T ss_pred Cc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhcc------------c-
Confidence 32 2234579999999999999999999999999999999999999996532211 111111000 0
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.... .....++..+.+++.+|++.+|++|||+.|+++.
T Consensus 225 ~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 DYPS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCCT----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCc----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 0011234567889999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=365.68 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=204.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCce--EEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTN--AAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~--vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|+.. ++.. ||||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 45667789999999999999875 4554 488988643 234456799999999999 999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1410 LQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
|||+++|+|.+++...+ ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 468999999999999999999996 799999999999999999999
Q ss_pred EEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhc
Q 047591 1475 HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~ 1553 (1624)
||+|||+++.... ........+|+.|+|||+.....++.++|||||||++|||+| |+.||......+. ..
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~----- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE----- 252 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH-----
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HH-----
Confidence 9999999985432 112233467889999999988889999999999999999998 9999875422111 00
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.+........ +..++..+.+++.+||+.+|++|||+.|+++.|+++..+..
T Consensus 253 -------~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 -------KLPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -------HGGGTCCCCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -------HhhcCCCCCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0110000000 01345568899999999999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=382.85 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=204.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.++|...++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356777889999999999999885 68999999986432 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1410 LQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||++|+|.+++...+ ..+++..+..|+.||+.||+|||+ .+||||||||+|||++.++++||+|||+|+.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999998654 348999999999999999999997 79999999999999999999999999999987543
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
. .....+||+.|||||++.+..++.++|||||||++|||+||+.||......... ..+...+...-..
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----------~~i~~~i~~~~~~ 407 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----------EEVERLVKEVPEE 407 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----------HHHHHHHHHCCCC
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH----------HHHHHHhhccccc
Confidence 2 223457999999999999889999999999999999999999999753221100 0111111100000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
- +...+..+.+++.+|++.||++|| +++|++++
T Consensus 408 ~--------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 Y--------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred C--------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 012345678899999999999999 67888753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=357.78 Aligned_cols=269 Identities=22% Similarity=0.260 Sum_probs=200.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46778899999999999999886 58899999885432 3345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 99999999987654 457899999999999999999996 7999999999999999999999999999987753322
Q ss_pred cccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhh--hhhhhhcCChhHHHHHhhh-cc
Q 047591 1492 KQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL--KHWVEESLPDAVTDVIDAN-LL 1567 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l--~~~~~~~~~~~~~~~~d~~-l~ 1567 (1624)
......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+... ..... ............. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG-DLIPRHQQVFSTNQYF 236 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SCCHHHHHHHHTCGGG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhc-cccccccccccccccc
Confidence 2234579999999998765 678999999999999999999999997643222110 01111 1111111111100 00
Q ss_pred C-----Cch--HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 S-----GEE--EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ~-----~~~--~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ... .........++..+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000 00011112356678899999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=366.68 Aligned_cols=277 Identities=20% Similarity=0.225 Sum_probs=205.0
Q ss_pred CHHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch-----------hhHHHHHHHHHHHHHhcCCCcee
Q 047591 1326 SYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE-----------DRALKSFDAECEVMRRIRHRNLA 1394 (1624)
Q Consensus 1326 ~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~-----------~~~~~~f~~E~~~l~~l~HpNIv 1394 (1624)
..+++....++|...+.||+|+||.||+|+..+|+.||||++.... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3577888899999999999999999999998889999999885321 22347899999999999999999
Q ss_pred EEEeeecc-----CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1395 KIVSSCSN-----PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1395 ~l~g~~~~-----~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
++++++.. ....++||||++ |+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence 99999843 346799999998 69999998777779999999999999999999997 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH 1548 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~ 1548 (1624)
.++.+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+ .+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~ 245 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNK 245 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 99999999999998654322 2334579999999998766 678999999999999999999999997643211 1111
Q ss_pred hhhhcC-C----------hhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1549 WVEESL-P----------DAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1549 ~~~~~~-~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+.... + ....+.+..................+...+.+++.+|++.||++|||+.|+++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111100 0 001111111111111111111122345678899999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=355.50 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=197.2
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
.|....+||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555669999999999999874 678899999876655566889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeecceeecCCCCCc
Q 047591 1415 QGSLEKWLYSHN--YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1415 ~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999998653 346788889999999999999996 79999999999999997 89999999999987654321
Q ss_pred cccccccccccccccccCCC--CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1492 KQTMTLATIGYMAPEYGSEG--IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~--~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......||+.|+|||+.... .++.++|||||||++|||+||+.||............. ........
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------~~~~~~~~ 246 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV------------GMFKVHPE 246 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH------------HHHCCCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh------------cccccccc
Confidence 22345799999999987654 38899999999999999999999986432111110000 00000000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. +..++..+.+++.+||+.+|++|||+.|+++
T Consensus 247 ~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 I-------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C-------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c-------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0123456788999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=376.44 Aligned_cols=263 Identities=17% Similarity=0.221 Sum_probs=209.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCC-ceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHR-NLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~Hp-NIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...++||+|+||+||+|+. .+++.||||++..... .+++.+|+++++.++|+ +|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35788889999999999999987 4689999998764332 24578999999999875 55566666677888999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe---cCCCcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~kl~DFGla~~~~~~ 1488 (1624)
|+ +|+|.+++......+++.+++.|+.||+.||+|||+ .+||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 999999998766779999999999999999999996 799999999999999 68899999999999987643
Q ss_pred CCc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1489 DSM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1489 ~~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~----------~~~i~ 229 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK----------YEKIS 229 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH----------HHHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH----------HHHHh
Confidence 321 12245799999999999999999999999999999999999999976433211100 00111
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
........ ......++.++.+++.+||+.+|++||+++++++.|+++..+
T Consensus 230 ~~~~~~~~----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 230 EKKVATSI----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHSCH----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hccccccH----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 11110000 111134567889999999999999999999999999998664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=377.16 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=202.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46777889999999999999886 68999999986432 223568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 999999999999754 458999999999999999999996 799999999999999999999999999999875432
Q ss_pred ccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||++...... . ..+.+... ..
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~------------~~i~~~~~-~~ 235 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-F------------KKICDGIF-YT 235 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-H------------HHHHTTCC-CC
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-H------------HHHhcCCc-CC
Confidence 2334579999999999887665 7899999999999999999999975322111 1 11111110 00
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. ..+...+.+++.+|++.||++|||++|+++
T Consensus 236 p--------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 P--------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp C--------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 123446788999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=365.76 Aligned_cols=251 Identities=33% Similarity=0.541 Sum_probs=207.4
Q ss_pred cchhccccCHHHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeee
Q 047591 727 SLATWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKI 805 (1624)
Q Consensus 727 ~~~~~~~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 805 (1624)
.......+++++++.++++|+..+.||+|+||+||+|+..+|+.||||++..... .....|.+|++++++++||||+++
T Consensus 13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 3344568999999999999999999999999999999988899999999875432 233478999999999999999999
Q ss_pred eeeeccCCeEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc
Q 047591 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHK---YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV 882 (1624)
Q Consensus 806 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~ 882 (1624)
+++|.+.+..++||||+++|+|.++++... ..+++..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998653 24899999999999999999999975557999999999999999999
Q ss_pred eEEEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc---CcCcchHHHHH
Q 047591 883 AHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM---FTGETSLKKWV 959 (1624)
Q Consensus 883 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~---~~~~~~l~~~~ 959 (1624)
+||+|||+++..............||+.|+|||++..+.++.++|||||||++|||+||+.||+.. .........|+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999999987655444445556999999999988888999999999999999999999999632 12234455666
Q ss_pred HHHhhhh-hhhccchhccC
Q 047591 960 EESLRLA-VTEVVDAELLS 977 (1624)
Q Consensus 960 ~~~~~~~-~~~~~d~~Ll~ 977 (1624)
....... ...+++..+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~ 271 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQG 271 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTT
T ss_pred HHHhhchhhhhhcChhhcc
Confidence 5443332 44555554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=369.88 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=188.9
Q ss_pred CCCcC-CeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHh-cCCCceeEEEeeecc----CCeeEE
Q 047591 1336 GFSES-NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRR-IRHRNLAKIVSSCSN----PGFKAL 1408 (1624)
Q Consensus 1336 ~f~~~-~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~-l~HpNIv~l~g~~~~----~~~~~l 1408 (1624)
+|... ++||+|+||+||+|+.. +++.||||+++.. ..+.+|++++.+ .+||||+++++++.. .+..++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 44443 68999999999999875 5889999998632 356788888754 589999999998864 567899
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeecceee
Q 047591 1409 ILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~~ 1484 (1624)
|||||++|+|.+++...+ ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999998653 468999999999999999999996 79999999999999997 78999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
..... .....+||+.|||||++.+..++.++|||||||++|||+||+.||......... +.....+...
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------~~~~~~i~~~ 282 (400)
T 1nxk_A 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------PGMKTRIRMG 282 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---------CSHHHHHHHT
T ss_pred cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---------HHHHHHHHcC
Confidence 64322 233467999999999999999999999999999999999999999653221110 0000001000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...... ..+..++..+.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 0012345668899999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=376.81 Aligned_cols=266 Identities=24% Similarity=0.267 Sum_probs=195.8
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------C
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------G 1404 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~ 1404 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++... .....+++.+|++++++++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888899999999999999875 5889999998643 344567899999999999999999999998654 4
Q ss_pred eeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1405 FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++|||||+++ +.+.+.. .+++.++..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 579999999864 6666643 37899999999999999999996 7999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh----------hcC
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE----------ESL 1554 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~----------~~~ 1554 (1624)
.... ...+..+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. +...+. ...
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTS
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHc
Confidence 6532 233456899999999999999999999999999999999999999975422111 111111 001
Q ss_pred ChhHHHHHhhhcc-CCch----------HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 PDAVTDVIDANLL-SGEE----------EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~-~~~~----------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.......++.... .... .............+.+++.+|++.||++|||++|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111110000 0000 00001112235678999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=360.40 Aligned_cols=270 Identities=24% Similarity=0.316 Sum_probs=199.7
Q ss_pred HhCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch-----hhHHHHHHHHHHHHHhcC---CCceeEEEeeeccC
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE-----DRALKSFDAECEVMRRIR---HRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~-----~~~~~~f~~E~~~l~~l~---HpNIv~l~g~~~~~ 1403 (1624)
.+++|...+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999987 468899999986432 122356777888877765 99999999999765
Q ss_pred C-----eeEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEe
Q 047591 1404 G-----FKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477 (1624)
Q Consensus 1404 ~-----~~~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~ 1477 (1624)
. ..++||||++ |+|.+++.... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 4789999997 69999998654 348999999999999999999997 789999999999999999999999
Q ss_pred eecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc-CC-
Q 047591 1478 DFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES-LP- 1555 (1624)
Q Consensus 1478 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~-~~- 1555 (1624)
|||+|+...... ......||+.|||||++.+..++.++|||||||++|||+||+.||......+. +....... .+
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCCC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCC
Confidence 999998664322 23446799999999999888999999999999999999999999975432211 11111100 00
Q ss_pred -hhHHHHH---hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 -DAVTDVI---DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 -~~~~~~~---d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.+.... ..................+...+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 00000000000011112345678899999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=355.70 Aligned_cols=249 Identities=25% Similarity=0.324 Sum_probs=195.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.|...+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 35677789999999999999875 58899999986543 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe---cCCCcEEEeeecceeecC
Q 047591 1413 MPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~kl~DFGla~~~~ 1486 (1624)
+++|+|.+++... +..+++..+..|+.|+++||+|||+ .+|+||||||+||++ +.++.+||+|||+|+...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998643 4668999999999999999999996 799999999999999 456889999999998764
Q ss_pred CCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
... ......||+.|+|||.+. +.++.++|||||||++|||+||+.||......+. ........+ ..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~---------~~ 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEP---------NY 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCC---------CC
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCc---------cc
Confidence 322 233457999999999875 5689999999999999999999999975422111 110000000 00
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. . ....+..+.+++.+|++.||++|||+.|+++
T Consensus 245 ~~-~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AV-E-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-c-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 0112456778999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=374.46 Aligned_cols=277 Identities=22% Similarity=0.314 Sum_probs=207.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC--eeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG--FKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~--~~~lV~ 1410 (1624)
+.|...++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 45777889999999999999886 48899999987433 334577889999999999999999999987655 679999
Q ss_pred EecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe----cCCCcEEEeeecceee
Q 047591 1411 QYMPQGSLEKWLYSHN--YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~kl~DFGla~~ 1484 (1624)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997543 338999999999999999999996 799999999999999 8888999999999998
Q ss_pred cCCCCCccccccccccccccccccCC--------CCcCcccchHHHHHHHHHHHcCCCCCCCCCccc---hhhhhhhhhc
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSE--------GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE---VCLKHWVEES 1553 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~---~~l~~~~~~~ 1553 (1624)
..... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ..+.......
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 75432 2234579999999998754 568899999999999999999999986432111 1111111111
Q ss_pred CChhHHHH---Hhhhc-cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1554 LPDAVTDV---IDANL-LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1554 ~~~~~~~~---~d~~l-~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+..+..+ .+... ..................+.+++.+|++.||++|||++|+++.++++..+
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00000000 00000 00000000001134456788999999999999999999999999887553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=363.77 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=188.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC-CCceeEEEeee--------ccC
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSC--------SNP 1403 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~--------~~~ 1403 (1624)
..+|...++||+|+||+||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346777889999999999999875 68899999986666666788999999999996 99999999998 334
Q ss_pred CeeEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEEcCCCCCcEEecCCCcEEEeee
Q 047591 1404 GFKALILQYMPQGSLEKWLYS--HNYLLNIEQRLDIMIDVACALEYLHQGYSTS--IIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~--iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
...++||||+. |+|.+++.. ....+++.++..|+.||+.||+|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 45799999996 799998874 34568999999999999999999996 56 999999999999999999999999
Q ss_pred cceeecCCCCCc-----------ccccccccccccccccc---CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh
Q 047591 1480 GIAKLLDGVDSM-----------KQTMTLATIGYMAPEYG---SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC 1545 (1624)
Q Consensus 1480 Gla~~~~~~~~~-----------~~~~~~gt~~y~APE~~---~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~ 1545 (1624)
|+++........ ......||+.|+|||++ .+..++.++|||||||++|||+||+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 999876532211 11134699999999987 567789999999999999999999999864321110
Q ss_pred hhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1546 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..... .... ...+...+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 262 ----~~~~~------------~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 262 ----VNGKY------------SIPP-------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------C------------CCCT-------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----hcCcc------------cCCc-------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 0000 001123467789999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=351.79 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=199.2
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456778899999999999999876 46789999985432 22356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 99999999999997653 57899999999999999999995 79999999999999999999999999998654322
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ... +..... ..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~------------~~~~~~-~~ 226 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKR------------ISRVEF-TF 226 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH------------HHHTCC-CC
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHH------------HHhCCC-CC
Confidence 22345799999999999988999999999999999999999999975321111 000 000000 00
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ..++..+.+++.+|++.+|++|||++|+++.
T Consensus 227 ~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 P--------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp C--------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred C--------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 1134557789999999999999999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=379.76 Aligned_cols=211 Identities=22% Similarity=0.321 Sum_probs=186.1
Q ss_pred cCHHHHHhhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeee
Q 047591 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSC 809 (1624)
Q Consensus 734 ~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 809 (1624)
+.++++...+++|...++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||+++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 455677778899999999999999999999975 57899999997432 12234588999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 810 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
.+.+..|+|||||++|+|.+++......+++..+..|+.|++.||+|||+. +||||||||+|||+|.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999987666799999999999999999999984 59999999999999999999999999
Q ss_pred eeeccCCCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 890 ISKLLDGEDSVTQTMTLATFGYMAPEYGS-----EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 890 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+|+.............+||+.|||||++. .+.++.++|||||||++|||+||+.||..
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 99877655444444568999999999876 56789999999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=356.13 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=202.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-----------
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN----------- 1402 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----------- 1402 (1624)
++|...+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 35777889999999999999886 68999999986543 356789999999999999999998754
Q ss_pred -----CCeeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEE
Q 047591 1403 -----PGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHL 1476 (1624)
Q Consensus 1403 -----~~~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl 1476 (1624)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEE
Confidence 34579999999999999999754 3568999999999999999999996 79999999999999999999999
Q ss_pred eeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1477 GDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1477 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
+|||+++...... ......||+.|+|||...+..++.++|||||||++|||+||+.|+... . .+
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~---~~------- 227 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----S---KF------- 227 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----H---HH-------
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----H---HH-------
Confidence 9999998775432 233456999999999998888999999999999999999999886321 0 00
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~ 1619 (1624)
..+ +...... ..++..+.+++.+||+.||++|||+.|+++.|+.++....+
T Consensus 228 -~~~-~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 228 -FTD-LRDGIIS----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -HHH-HHTTCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -HHH-hhccccc----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 000 1111111 11234567899999999999999999999999988765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=381.69 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=193.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++||||++++++|.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999875 6889999998643 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
||||++|+|.+++...+ .+++..+..++.||++||+|||+ ..+||||||||+|||++.++.+||+|||+|+......
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999999997653 57899999999999999999995 2689999999999999999999999999998643222
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......+||+.|||||++.+..++.++|||||||++|||+||+.||........ .. .+...... .
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~------------~i~~~~~~-~ 368 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FE------------LILMEEIR-F 368 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH------------HHHHCCCC-C
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HH------------HHHhCCCC-C
Confidence 223446799999999999999999999999999999999999999965321110 00 01111100 0
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
+..++..+.+++.+|++.||++|| |++|+++.
T Consensus 369 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 --------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 012345678899999999999999 99999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=363.47 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=205.9
Q ss_pred HHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--------hhHHHHHHHHHHHHHhc-CCCceeEEE
Q 047591 1328 QELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--------DRALKSFDAECEVMRRI-RHRNLAKIV 1397 (1624)
Q Consensus 1328 ~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--------~~~~~~f~~E~~~l~~l-~HpNIv~l~ 1397 (1624)
.......++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 333444567888899999999999999985 68999999986432 12356789999999999 799999999
Q ss_pred eeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEe
Q 047591 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLG 1477 (1624)
Q Consensus 1398 g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~ 1477 (1624)
+++...+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999999754 358999999999999999999996 799999999999999999999999
Q ss_pred eecceeecCCCCCccccccccccccccccccC------CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh
Q 047591 1478 DFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS------EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE 1551 (1624)
Q Consensus 1478 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~ 1551 (1624)
|||+++.+.... ......||+.|+|||++. ...++.++|||||||++|||+||+.||...... ..+..
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~--- 316 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRM--- 316 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH---
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHH---
Confidence 999998875432 233457999999999875 336899999999999999999999999653211 11111
Q ss_pred hcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1552 ESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+..... .. ....+..++..+.+++.+|++.||++|||+.|+++
T Consensus 317 ---------i~~~~~-~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 ---------IMEGQY-QF----SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---------HHHTCC-CC----CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---------HHhCCC-CC----CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111000 00 01112234566889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=373.21 Aligned_cols=264 Identities=13% Similarity=0.129 Sum_probs=188.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhc--CCCceeEEEe-------eec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRI--RHRNLAKIVS-------SCS 1401 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l--~HpNIv~l~g-------~~~ 1401 (1624)
..|...+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+++++.+ +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34777889999999999999875 68899999997532 34566788886655555 6999888653 332
Q ss_pred cC-----------------CeeEEEEEecCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCceEE
Q 047591 1402 NP-----------------GFKALILQYMPQGSLEKWLYSHNYLLNIEQR------LDIMIDVACALEYLHQGYSTSIIH 1458 (1624)
Q Consensus 1402 ~~-----------------~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~gl~yLH~~~~~~iiH 1458 (1624)
.+ ...++|||||+ |+|.+++...+..+++..+ ..++.||++||+|||+ .+|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 22 33799999999 8999999875555566777 7888999999999996 79999
Q ss_pred cCCCCCcEEecCCCcEEEeeecceeecCCCCCccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCC
Q 047591 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPT 1536 (1624)
Q Consensus 1459 rDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~ 1536 (1624)
|||||+|||++.++.+||+|||+|+..... .....||+.|||||++.+ ..++.++|||||||++|||+||+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976432 113467799999999877 78999999999999999999999999
Q ss_pred CCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHHH
Q 047591 1537 DDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA--NLKKIK 1614 (1624)
Q Consensus 1537 ~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~--~L~~i~ 1614 (1624)
......... .|........ ...... ......++..+.+++.+||+.||++|||+.|+++ .++++.
T Consensus 294 ~~~~~~~~~--~~~~~~~~~~----~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 294 GLVTPGIKG--SWKRPSLRVP----GTDSLA-------FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TBCCTTCTT--CCCBCCTTSC----CCCSCC-------CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCcCccccc--chhhhhhhhc----cccccc-------hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 764322110 1110000000 000000 0000133556888999999999999999999985 456655
Q ss_pred HHHhh
Q 047591 1615 TKFLK 1619 (1624)
Q Consensus 1615 ~~~~~ 1619 (1624)
.....
T Consensus 361 ~~~~~ 365 (371)
T 3q60_A 361 NEISS 365 (371)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 54443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=358.69 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=198.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. +++.||+|++........+.|.+|++++++++||||+++++++..++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 46777889999999999999986 58899999987665556788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...... ....
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 174 (302)
T 2j7t_A 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKR 174 (302)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC-
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cccc
Confidence 9999999998766678999999999999999999996 79999999999999999999999999997643211 1112
Q ss_pred ccccccccccccccc-----CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1494 TMTLATIGYMAPEYG-----SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~-----~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
....||+.|+|||+. ....++.++|||||||++|||+||+.||........ .........+. . .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~---------~-~ 243 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSDPPT---------L-L 243 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCC---------C-S
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhccCCcc---------c-C
Confidence 234699999999987 467789999999999999999999999875422111 11111110000 0 0
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..++..+.+++.+||+.+|++|||+.|+++
T Consensus 244 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 --------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01223456788999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=366.15 Aligned_cols=253 Identities=19% Similarity=0.234 Sum_probs=191.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 356888899999999999999886 68899999986432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc--EEEeeecceeecCCCCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV--AHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--~kl~DFGla~~~~~~~~ 1490 (1624)
+++|+|.+++...+ .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++. +||+|||+|+.....
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 99999999997644 58899999999999999999996 79999999999999987765 999999999854322
Q ss_pred ccccccccccccccccccCCCCcCcc-cchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTS-GDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k-~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.......||+.|+|||++.+..++.+ +|||||||++|||+||+.||......... ... ...+.......
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~--------~~~~~~~~~~~- 241 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKT--------IQRILSVKYSI- 241 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHH--------HHHHHTTCCCC-
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHH--------HHHHhcCCCCC-
Confidence 12234579999999999877777655 89999999999999999999753221111 110 01111111000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. ...++..+.+++.+||+.+|++|||+.|+++.
T Consensus 242 ~~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PD------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CT------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 01234567889999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=351.76 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=204.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh------hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED------RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~------~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.|.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 35777889999999999999886 689999999864321 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC----cEEEeeeccee
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM----VAHLGDFGIAK 1483 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~kl~DFGla~ 1483 (1624)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999764 357999999999999999999996 7999999999999999877 89999999998
Q ss_pred ecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
...... ......||+.|+|||+.....++.++|||||||++|||+||+.||......+ ....+....
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~---------- 227 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAVN---------- 227 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC----------
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhcc----------
Confidence 765332 2234569999999999988899999999999999999999999997532211 111110000
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA--NLKKIKT 1615 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~--~L~~i~~ 1615 (1624)
... .......++..+.+++.+|++.+|++|||+.|+++ .++.++.
T Consensus 228 ---~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 228 ---YDF----DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---CCC----CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---cCC----cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 000 01112234566889999999999999999999997 3555543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=358.15 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=197.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc--CCc--eEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA--DGT--NAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~--~~~--~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...+.||+|+||+||+|++. +++ .||||+++.. .....+.|.+|++++++++||||+++++++.+++ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45777789999999999999864 233 5899988643 2345678999999999999999999999997765 78
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++......+++.++.+++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 9999999999999998766678999999999999999999996 7999999999999999999999999999988754
Q ss_pred CCCc--cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1488 VDSM--KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1488 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.... ......+|+.|+|||+..+..++.++|||||||++|||+| |+.||......+ ..... ...
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~------------~~~ 240 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKI------------DKE 240 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHH------------HTS
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-HHHHH------------Hcc
Confidence 3321 1223467889999999988889999999999999999999 999987542211 11110 000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..... ....++..+.+++.+||+.+|++|||+.|+++.|++++..
T Consensus 241 ~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 241 GERLP-------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCCC-------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00000 0123456788999999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=351.77 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=203.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45777889999999999999886 68899999986443 34467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-Cc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-SM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-~~ 1491 (1624)
+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999988643 457899999999999999999996 799999999999999999999999999998764322 11
Q ss_pred cccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||...+..+ +.++|||||||++|||+||+.||+...........|...... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~-- 229 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-----------LN-- 229 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-----------ST--
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-----------cC--
Confidence 2234579999999999877665 789999999999999999999997643332223333221100 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
....++..+.+++.+|++.+|++|||++|+++
T Consensus 230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01123456788999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=393.74 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=206.8
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
..+.|...+.||+|+||+||+|++.. +..||||+++.. .....+.|.+|+.++++++|||||++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34567778899999999999998743 456899988643 3345578999999999999999999999985 45689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.+++...+..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 9999999999999998777779999999999999999999996 7999999999999999999999999999987754
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
..........||+.|||||++....++.++|||||||++|||++ |+.||.+....+. ... +.+...
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~~~-----------i~~~~~ 610 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGR-----------IENGER 610 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH-----------HHHTCC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-----------HHcCCC
Confidence 44333344567889999999988899999999999999999997 9999875422111 111 111100
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.. .+..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 611 ~~--------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 LP--------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC--------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 0123456788999999999999999999999999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=362.74 Aligned_cols=258 Identities=23% Similarity=0.390 Sum_probs=203.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...+.||+|+||+||+|++. ++..||||++... .....++|.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 56777889999999999999842 4678999998643 3445678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEee
Q 047591 1408 LILQYMPQGSLEKWLYSHN------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGD 1478 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~D 1478 (1624)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999998653 358899999999999999999996 79999999999999994 45699999
Q ss_pred ecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1479 FGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1479 FGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
||+++....... .......||+.|+|||...+..++.++|||||||++|||+| |+.||...... ....+
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~------- 257 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEF------- 257 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH-------
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHH-------
Confidence 999986543221 22234568999999999888889999999999999999999 88998653211 11111
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
+........ +..++..+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 258 -----~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 258 -----VTSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -----HHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----HhcCCCCCC-------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111000000 013455688999999999999999999999999988653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=370.64 Aligned_cols=199 Identities=24% Similarity=0.331 Sum_probs=167.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----Ce
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-----GF 1405 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-----~~ 1405 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++... .....+++.+|++++++++|||||++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357888899999999999999875 5788999998642 334567899999999999999999999998765 56
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||++ |+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999997 5999999754 458999999999999999999996 79999999999999999999999999999976
Q ss_pred CCCCCc---------------------ccccccccccccccccc-CCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 047591 1486 DGVDSM---------------------KQTMTLATIGYMAPEYG-SEGIVSTSGDVYSFGILMMETLTRRKPTD 1537 (1624)
Q Consensus 1486 ~~~~~~---------------------~~~~~~gt~~y~APE~~-~~~~~~~k~DV~SfGvil~Elltg~~P~~ 1537 (1624)
...... ..+..+||+.|+|||++ ....++.++||||+||++|||+||..|+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 533211 12456899999999975 56679999999999999999999766654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=369.91 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=191.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHH-HHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEV-MRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~-l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...++||+|+||+||+|+.. +++.||||+++... ....+.+.+|..+ ++.++|||||++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46777899999999999999886 57889999986442 2334567777776 5778999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++.+.+ .+++.....++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+......
T Consensus 118 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999997653 56788888999999999999996 799999999999999999999999999998643222
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......+||+.|||||++.+..++.++|||||||++|||++|+.||......+ .. ..++.....-
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~------------~~i~~~~~~~- 258 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MY------------DNILNKPLQL- 258 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HH------------HHHHHSCCCC-
T ss_pred -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HH------------HHHHhcccCC-
Confidence 23345679999999999999999999999999999999999999997532111 11 1111111100
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
. ..++..+.+++.+|++.||++||++.+.++.+
T Consensus 259 ~--------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 259 K--------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp C--------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred C--------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 0 12345578899999999999999986544433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=358.09 Aligned_cols=263 Identities=18% Similarity=0.272 Sum_probs=201.1
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcC-CCceeEEEeeecc--CCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSCSN--PGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~--~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 4677788999999999999987 468899999986432 367899999999997 9999999999987 56789999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeeecceeecCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DFGla~~~~~~~ 1489 (1624)
||+++++|.+++.. +++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+|+......
T Consensus 113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999998853 7888999999999999999996 7999999999999999776 89999999998775433
Q ss_pred CccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
. .....||+.|+|||...+ ..++.++|||||||++|||+||+.||.........+.......-.....+.++..-..
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2 334579999999998766 6789999999999999999999999854333222222221111111122222111100
Q ss_pred CchHH----------------HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEA----------------DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~----------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..... .......++..+.+++.+|++.||++|||++|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 000011245678999999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=350.31 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=194.9
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc----CCeeEEE
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN----PGFKALI 1409 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----~~~~~lV 1409 (1624)
|...+.||+|+||+||+|... ++..||+|++... .....+.|.+|++++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 445568999999999999875 5778999988643 24456789999999999999999999998764 4568999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEEcCCCCCcEEec-CCCcEEEeeecceeecC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS--IIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~--iiHrDlK~~NILld-~~~~~kl~DFGla~~~~ 1486 (1624)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++ +++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999764 357899999999999999999996 45 99999999999998 78999999999997543
Q ss_pred CCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.. ......||+.|+|||.+. +.++.++|||||||++|||+||+.||..................+..
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 250 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--------- 250 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG---------
T ss_pred cc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc---------
Confidence 32 223456999999999876 45899999999999999999999999754322221111111111100
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....++..+.+++.+||+.+|++|||+.|+++.
T Consensus 251 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 ----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001223467889999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=373.51 Aligned_cols=253 Identities=23% Similarity=0.273 Sum_probs=192.2
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccC
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~ 1403 (1624)
..++|...+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++|||||++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3568888999999999999999875 57899999986432 112235889999999999999999999985 4
Q ss_pred CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC---CcEEEeeec
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD---MVAHLGDFG 1480 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~kl~DFG 1480 (1624)
+..++|||||++|+|.+++... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 5579999999999999988654 458999999999999999999996 789999999999999754 459999999
Q ss_pred ceeecCCCCCccccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
+|+...... ......||+.|||||++. ...++.++|||||||++|||+||+.||...............
T Consensus 288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~------ 359 (419)
T 3i6u_A 288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS------ 359 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT------
T ss_pred cceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc------
Confidence 998765322 233457999999999875 367889999999999999999999999753322111111111
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..... .......++..+.+++.+|++.+|++|||++|+++.
T Consensus 360 -------~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 -------GKYNF----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -------TCCCC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------CCCCC----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 10000 011123345678899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=355.22 Aligned_cols=250 Identities=24% Similarity=0.262 Sum_probs=187.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
.++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 456778899999999999999874 68899999986432 233344556666688899999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-ceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1411 QYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGYST-SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
||++ |+|.+++.. .+..+++..+..|+.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+|+...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 588887764 45678999999999999999999996 5 89999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccccc----CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYG----SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
... ......||+.|+|||++ .+..++.++|||||||++|||+||+.||+........+........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-------- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--------
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--------
Confidence 332 22334699999999985 5667899999999999999999999999753222222222111111
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.... ...++..+.+++.+|++.+|++|||++|+++
T Consensus 232 ----~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ----PQLP-------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCC-------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCcc-------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0000 0123456889999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=366.97 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=200.1
Q ss_pred CCCCcCCeEeecCceEEEEEEE----cCCceEEEEEeccch----hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF----ADGTNAAIKIFSLQE----DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~----~~~~~vAvK~~~~~~----~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~ 1405 (1624)
++|...+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5678889999999999999987 368899999986432 23346678899999999 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+++|+|.+++...+ .+++.++..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999999998653 57899999999999999999996 79999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccCC--CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE--GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+. ..+..
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~--------~~~~~ 280 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEIS--------RRILK 280 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHH--------HHHHH
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHH--------HHHhc
Confidence 5433333445679999999999875 4578999999999999999999999964321111 00000 00111
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
.. ... +..++..+.+++.+||+.||++|| |++|+++.
T Consensus 281 ~~-~~~--------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 281 SE-PPY--------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CC-CCC--------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cC-CCC--------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 00 000 012345678899999999999999 99999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=365.88 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=199.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 46788899999999999999864 68889999986432 1234567889999999999999999999999999
Q ss_pred eEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1406 KALILQYMPQG-SLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1406 ~~lV~ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
.++||||+..| +|.+++...+ .+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 99999999887 9999997653 58999999999999999999997 7999999999999999999999999999988
Q ss_pred cCCCCCccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ......
T Consensus 180 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~--------- 241 (335)
T 3dls_A 180 LERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEAAI--------- 241 (335)
T ss_dssp CCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTTCC---------
T ss_pred CCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhhcc---------
Confidence 75432 2234579999999999887776 8899999999999999999999965211 000000
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. . ..++..+.+++.+|++.+|++|||+.|+++.
T Consensus 242 ---~~-~--------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 ---HP-P--------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---CC-S--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---CC-C--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 0123457889999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=377.25 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=200.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56777889999999999999885 68999999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
||+++|+|.+++... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999864 3468999999999999999999996 7999999999999999999999999999998754
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
... .....+||+.|||||++.+..++.++|||||||++|||+||+.||........ ...+ ...+.....
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~--------~~~i~~~~~- 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKEL--------KQRVLEQAV- 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHH--------HHHHHHCCC-
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHH--------HHHHhhccc-
Confidence 322 23345799999999999999999999999999999999999999975321100 0000 001111111
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
.. +..++..+.+++.+|++.+|++||++
T Consensus 411 ~~--------p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 TY--------PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CC--------CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CC--------CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 00 01234567889999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=351.84 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=203.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45677789999999999999886 4788999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++... ..+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp ECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 999999999988754 357899999999999999999997 799999999999999999999999999998765322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.......||+.|+|||...+..++.++|||||||++|||+||+.||......+. .... ..... ...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~------------~~~~~-~~~ 235 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRI------------KKNEY-SIP 235 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH------------HTTCC-CCC
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH------------hhccC-CCc
Confidence 223345799999999999888899999999999999999999999975322111 1110 00000 000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++..+.+++.+||+.+|++|||++|+++.
T Consensus 236 --------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 --------KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1233457789999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=350.24 Aligned_cols=243 Identities=19% Similarity=0.265 Sum_probs=197.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45777889999999999999886 6899999998643 234567888999999999 9999999999999999999999
Q ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-----------------
Q 047591 1411 QYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD----------------- 1470 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~----------------- 1470 (1624)
||+++|+|.+++... ...+++.++..|+.||+.||+|||+ .+|+||||||+||+++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999754 2568999999999999999999997 79999999999999984
Q ss_pred --CCcEEEeeecceeecCCCCCccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhh
Q 047591 1471 --DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1471 --~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~ 1547 (1624)
...+||+|||.++...... ...||+.|+|||.+.+. .++.++|||||||++|||++|+.|+... ....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~ 238 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWH 238 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHH
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHH
Confidence 4489999999998775322 23599999999988765 6678999999999999999998875431 1111
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.......+. + +..++..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~---------~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 EIRQGRLPR---------I-----------PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHTTCCCC---------C-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHcCCCCC---------C-----------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111111100 0 01234567889999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=367.23 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=197.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|+.. +++.||||+++.... .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 346778899999999999999875 588999999864332 345788889888 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC----CcEEEeeecceeecCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD----MVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~----~~~kl~DFGla~~~~~ 1487 (1624)
|+++|+|.+++.+.+ .+++.++..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+|+....
T Consensus 97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999997653 58899999999999999999996 799999999999998433 3599999999997654
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .+.+.+.....
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~---------~~~~~i~~~~~ 240 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--E---------EILARIGSGKF 240 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--H---------HHHHHHHHCCC
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--H---------HHHHHHccCCc
Confidence 322 23345799999999998888899999999999999999999999975321110 0 01111111100
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.... ..+..++..+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 SLSG----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCS----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 0012245567889999999999999999998863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=373.52 Aligned_cols=194 Identities=23% Similarity=0.326 Sum_probs=154.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-----CCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-----PGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-----~~~~ 1406 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... .....+++.+|++++++++|||||++++++.. .+..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57888999999999999999875 6889999988542 33456789999999999999999999999843 3568
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+. |+|.+++... ..+++..+..|+.||++||+|||+ .+||||||||+|||++.++.+||+|||+|+...
T Consensus 133 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999985 7999988754 458999999999999999999996 799999999999999999999999999998764
Q ss_pred CCCC--------------------------cccccccccccccccccc-CCCCcCcccchHHHHHHHHHHHcCC
Q 047591 1487 GVDS--------------------------MKQTMTLATIGYMAPEYG-SEGIVSTSGDVYSFGILMMETLTRR 1533 (1624)
Q Consensus 1487 ~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~~~k~DV~SfGvil~Elltg~ 1533 (1624)
.... ...+..+||+.|||||++ ....++.++|||||||++|||+||.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 3211 122345789999999975 5667999999999999999999943
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=358.31 Aligned_cols=248 Identities=22% Similarity=0.302 Sum_probs=203.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|+.. +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45677789999999999999886 4788999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++... ..+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 121 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp CCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred ecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 999999999988754 358899999999999999999996 799999999999999999999999999998765322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ... +..... ...
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~------------~~~~~~-~~~ 261 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLR------------IKKNEY-SIP 261 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH------------HHHTCC-CCC
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHH------------HhcCCC-CCC
Confidence 223345799999999999888899999999999999999999999975321111 000 001000 000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+...+.+++.+||+.||++|||++|+++.
T Consensus 262 --------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 --------KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1233457789999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=363.18 Aligned_cols=271 Identities=24% Similarity=0.293 Sum_probs=199.6
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-----hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-----~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~ 1406 (1624)
..+.|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467888899999999999999875 588999999864321 1235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++ +|.+++......+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999986 8999998776678889999999999999999996 789999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-cCC--hhHHHH-
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-SLP--DAVTDV- 1561 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-~~~--~~~~~~- 1561 (1624)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+...... ..+ +.+.+.
T Consensus 164 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 164 SPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp SCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTT
T ss_pred CCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhhhc
Confidence 322 22334579999999998865 458999999999999999999999986542211 11111110 000 000000
Q ss_pred --HhhhccCCchH-HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1562 --IDANLLSGEEE-ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1562 --~d~~l~~~~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+......... ........++..+.+++.+|++.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000 0000112345678899999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=353.69 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=199.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeec--cCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCS--NPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~--~~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++. ..+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46777889999999999999885 6889999998643 2345678999999999999999999999874 46788999
Q ss_pred EEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1410 LQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGY--STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+.. ..+|+||||||+||++++++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999999999753 345899999999999999999999731 12399999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
...... ......||+.|+|||...+..++.++|||||||++|||+||+.||....... +... +...
T Consensus 166 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~-----------i~~~ 231 (279)
T 2w5a_A 166 LNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGK-----------IREG 231 (279)
T ss_dssp C---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----------HHHT
T ss_pred eccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHH-----------Hhhc
Confidence 643221 1223568999999999988889999999999999999999999987542111 1110 1110
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L 1610 (1624)
..... +..++..+.+++.+||+.+|++|||+.|+++.+
T Consensus 232 ~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 232 KFRRI--------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ccccC--------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 00000 012345688999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=352.30 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=203.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45777789999999999999875 68899999986443 34467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 999999999864 358899999999999999999997 799999999999999999999999999998765432 22
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
.....||+.|+|||+..+..++.++|||||||++|||+||+.||....... ....+....+ ..+.
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------~~~~----- 240 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNP--------PTLE----- 240 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC--------CCCC-----
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCC--------CCCc-----
Confidence 344579999999999998899999999999999999999999987532211 1111100000 0000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++..+.+++.+||+.+|++|||+.|+++.
T Consensus 241 ------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1234567889999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=355.13 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=199.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||+||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45777889999999999999875 68999999997654445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe---cCCCcEEEeeecceeecCCCCC
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
++|+|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 89 SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999997643 57899999999999999999996 799999999999999 78899999999999765322
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||...+..++.++|||||||++|||+||+.||....... ......... ....
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~-------------~~~~ 227 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGY-------------YEFE 227 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCC-------------CCCC
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCC-------------CCCC
Confidence 2234569999999999999999999999999999999999999986532111 111111100 0000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. .....++..+.+++.+|++.||++|||++|+++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 S----PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 001123456889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=365.70 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=203.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56777889999999999999886 6889999998754 344567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++|+|.+++...+ .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 186 (360)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 99999999997653 578999999999999999999961 37999999999999999999999999998765321 1
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhh--hhh------------------
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW--VEE------------------ 1552 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~--~~~------------------ 1552 (1624)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......+.....- ...
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 234579999999999999999999999999999999999999997533221110000 000
Q ss_pred -----cCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1553 -----SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1553 -----~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+....+.++......... .....++..+.+++.+|++.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000001111000000000 0001235578899999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=361.35 Aligned_cols=268 Identities=23% Similarity=0.295 Sum_probs=192.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
.++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 356788899999999999999865 68899999986443 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe-----cCCCcEEEeeecceeec
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL-----DDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl-----d~~~~~kl~DFGla~~~ 1485 (1624)
||++ |+|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+|||+ ++++.+||+|||+|+..
T Consensus 113 e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9998 59999997654 47899999999999999999997 799999999999999 45566999999999876
Q ss_pred CCCCCccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-cCChh--HHHH
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-SLPDA--VTDV 1561 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-~~~~~--~~~~ 1561 (1624)
.... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||......+. +...... ..++. ....
T Consensus 188 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 188 GIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSTTG
T ss_pred CCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchhhhhhh
Confidence 4322 223345789999999988764 589999999999999999999999975432211 1111110 00000 0000
Q ss_pred Hh-h----hccC-CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1562 ID-A----NLLS-GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1562 ~d-~----~l~~-~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.. + .... ............+...+.+++.+|++.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0 0000 0000011111224567889999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=359.59 Aligned_cols=241 Identities=35% Similarity=0.589 Sum_probs=199.5
Q ss_pred ccCHHHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccC
Q 047591 733 RISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNH 812 (1624)
Q Consensus 733 ~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 812 (1624)
++++.++..++++|+..+.||+|+||+||+|+..+|+.||||++........+.+.+|++++++++||||++++++|.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 45566677889999999999999999999999888999999998766656677899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHK---YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
+..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999986543 2589999999999999999999994 59999999999999999999999999
Q ss_pred eeeccCCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCcC-cchHHHHHHHHhh-hh
Q 047591 890 ISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTG-ETSLKKWVEESLR-LA 966 (1624)
Q Consensus 890 la~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~-~~~l~~~~~~~~~-~~ 966 (1624)
+++....... .......||+.|+|||++..+.++.++|||||||++|||+||+.||...... ......|...... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9987543222 2233446999999999988888999999999999999999999998754332 2344555443322 22
Q ss_pred hhhccchhcc
Q 047591 967 VTEVVDAELL 976 (1624)
Q Consensus 967 ~~~~~d~~Ll 976 (1624)
+.+.+++...
T Consensus 265 ~~~~~~~~~~ 274 (321)
T 2qkw_B 265 LEQIVDPNLA 274 (321)
T ss_dssp CCSSSSSSCT
T ss_pred HHHhcChhhc
Confidence 4455555443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=346.85 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=202.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46777889999999999999886 57789999986432 223567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 9999999999997654 57899999999999999999996 79999999999999999999999999999766432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||+..+..++.++|||||||++|||++|+.||......+. .. .+......-
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~------------~~~~~~~~~-- 231 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HR------------RIVNVDLKF-- 231 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH------------HHHTTCCCC--
T ss_pred -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HH------------HHhccccCC--
Confidence 22345799999999999988999999999999999999999999975321111 11 111111000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+...+..+.+++.+|++.+|++|||++|+++.
T Consensus 232 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 -------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 01234567889999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=352.93 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=200.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.+.|...+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 467888899999999999999886 58899999986432 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 181 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AK 181 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cc
Confidence 99999999998666678999999999999999999996 799999999999999999999999999998765332 22
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
.....||+.|+|||...+..++.++|||||||++|||+||+.||........ .. ......+ . ...
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-~~~~~~~--------~-~~~---- 246 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-IF-MIPTNPP--------P-TFR---- 246 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HH-HHHHSCC--------C-CCS----
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-HH-HHhcCCC--------c-ccC----
Confidence 3345799999999999888999999999999999999999999975321111 00 0000000 0 000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..++..+.+++.+||+.+|++|||+.|+++
T Consensus 247 ----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01123456888999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=361.98 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=194.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC------e
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG------F 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~------~ 1405 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||++... .....+++.+|++++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 56777889999999999999874 6899999998532 3345678999999999999999999999987653 4
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+ +++|.+++... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 59999999 88999999763 57889999999999999999996 79999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--hcCChhH----
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESLPDAV---- 1558 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--~~~~~~~---- 1558 (1624)
... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+..... ...+...
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHTC
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHh
Confidence 432 334578999999998766 679999999999999999999999997542211 1111111 0011111
Q ss_pred -----HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1559 -----TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1559 -----~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...+. .+..............+...+.+++.+|++.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMK-GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHH-HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHH-hCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 11110 000000000000001235668899999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=356.15 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=186.2
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
...++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34567888899999999999999864 68899999886443 34457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1410 LQYMPQGSLEKWLYS-------HNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999974 23458999999999999999999996 79999999999999999999999999999
Q ss_pred eecCCCCC----ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1483 KLLDGVDS----MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1483 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
+....... .......||+.|+|||+... ..++.++|||||||++|||+||+.||........... ......+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~ 247 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-TLQNDPPSL 247 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-HHTSSCCCT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-HhccCCCcc
Confidence 76643221 11233579999999998765 5689999999999999999999999976432221111 111111100
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....+.... ..++..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEML-----------KKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCC-----------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhh-----------hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000011111 1234567889999999999999999999873
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=374.69 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=200.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh-------------hHHHHHHHHHHHHHhcCCCceeEEEee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-------------RALKSFDAECEVMRRIRHRNLAKIVSS 1399 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-------------~~~~~f~~E~~~l~~l~HpNIv~l~g~ 1399 (1624)
.+.|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 356888899999999999999875 578899999864321 235678999999999999999999999
Q ss_pred eccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC---cEEE
Q 047591 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM---VAHL 1476 (1624)
Q Consensus 1400 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~kl 1476 (1624)
|.+.+..++|||||++|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999765 358999999999999999999996 7999999999999998775 6999
Q ss_pred eeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1477 GDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1477 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
+|||+|+...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||......+ .+..
T Consensus 191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~-------- 258 (504)
T 3q5i_A 191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-IIKK-------- 258 (504)
T ss_dssp CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH--------
T ss_pred EECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH--------
Confidence 9999999875432 233457999999999876 468999999999999999999999997532211 1111
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+....... ....+..++..+.+++.+|++.+|++|||+.|+++.
T Consensus 259 ----i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 ----VEKGKYYF-----DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----HHHCCCCC-----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHcCCCCC-----CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11110000 111223456678899999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=344.11 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=194.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56778899999999999999886 68999999986432 233568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred eccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 9999999999997653 47899999999999999999997 789999999999999999999999999998764322
Q ss_pred ccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......||+.|+|||...+..+ +.++|||||||++|||++|+.||+...... . .+.+.......
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~------------~~~~~~~~~~~ 230 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--L------------FKKIRGGVFYI 230 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H------------HHHHHHCCCCC
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--H------------HHHhhcCcccC
Confidence 2234568999999999877665 689999999999999999999987532111 0 01111111000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ..++..+.+++.+|++.+|++|||+.|+++.
T Consensus 231 ~--------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 P--------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c--------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 1234567889999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=365.87 Aligned_cols=196 Identities=20% Similarity=0.258 Sum_probs=171.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc------CCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI------RHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l------~HpNIv~l~g~~~~~~~~~ 1407 (1624)
..|...+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46788899999999999999875 5789999998643 33456788899999887 5779999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc--EEEeeecceee
Q 047591 1408 LILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV--AHLGDFGIAKL 1484 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--~kl~DFGla~~ 1484 (1624)
+||||++ |+|.+++.... ..+++..+..|+.||+.||+|||+ .+||||||||+|||++.++. +||+|||+|+.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 69999998654 458999999999999999999997 69999999999999999887 99999999986
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCC
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~ 1539 (1624)
.... .....||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 5432 23457999999999999889999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=358.35 Aligned_cols=270 Identities=22% Similarity=0.299 Sum_probs=201.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeecc--------C
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSN--------P 1403 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--------~ 1403 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 45777889999999999999884 68999999885432 2335678899999999999999999999876 3
Q ss_pred CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
+..++||||+++ ++.+.+......+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999985 8888887766678999999999999999999996 799999999999999999999999999998
Q ss_pred ecCCCC---CccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh--hhcCChh
Q 047591 1484 LLDGVD---SMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV--EESLPDA 1557 (1624)
Q Consensus 1484 ~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~--~~~~~~~ 1557 (1624)
.+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ +.... ....+..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChh
Confidence 765322 122234578999999998765 5689999999999999999999999976432211 11110 0011110
Q ss_pred -HHHHHhhhc------cCC--chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 -VTDVIDANL------LSG--EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 -~~~~~d~~l------~~~--~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....-+... ... ...............+.+++.+|++.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000 000 0000011111234568899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=355.71 Aligned_cols=265 Identities=23% Similarity=0.247 Sum_probs=192.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC------e
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG------F 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~------~ 1405 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 56888899999999999999875 6888999998643 3345678899999999999999999999987654 7
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||++ |+|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred eEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 899999997 478888853 47889999999999999999996 79999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh----------cCC
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE----------SLP 1555 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~----------~~~ 1555 (1624)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+. +...+.. .+.
T Consensus 178 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 178 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTTSC
T ss_pred ccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHhh
Confidence 432 123345799999999999888999999999999999999999999975422111 1111100 001
Q ss_pred hhHHHHHhhhcc-CCc-h---------HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 DAVTDVIDANLL-SGE-E---------EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 ~~~~~~~d~~l~-~~~-~---------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......+..... ... . .............+.+++.+|++.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 111111110000 000 0 00001122346678999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=353.31 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=195.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~ 1405 (1624)
++|...+.||+|+||.||+|+.. +++.||||++.... ......|.+|++++++++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 45777899999999999999875 57899999986432 122346889999999999999999999987655
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc---EEEeeecce
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV---AHLGDFGIA 1482 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~kl~DFGla 1482 (1624)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 79999999999999998754 457899999999999999999996 79999999999999987654 999999999
Q ss_pred eecCCCCCcccccccccccccccccc---CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHH
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYG---SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT 1559 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~---~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~ 1559 (1624)
+...... ......||+.|+|||++ ....++.++|||||||++|||+||+.||........ +...+
T Consensus 165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~--------- 232 (322)
T 2ycf_A 165 KILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQI--------- 232 (322)
T ss_dssp EECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHH---------
T ss_pred eeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHH---------
Confidence 8764321 22345699999999985 356789999999999999999999999975432211 11111
Q ss_pred HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1560 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
........ ......++..+.+++.+|++.||++|||+.|+++
T Consensus 233 ---~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 ---TSGKYNFI----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHTCCCCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HhCccccC----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 10000000 1112234567889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=366.43 Aligned_cols=277 Identities=21% Similarity=0.210 Sum_probs=203.1
Q ss_pred CCCc--cceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCC
Q 047591 74 NSVC--NWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG 151 (1624)
Q Consensus 74 ~~~C--~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 151 (1624)
.+.| .|..|.|... ++. .+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|.+++
T Consensus 6 ~C~C~~~~~~v~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 70 (477)
T 2id5_A 6 RCECSAQDRAVLCHRK------------RFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70 (477)
T ss_dssp TCEEETTTTEEECCSC------------CCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE
T ss_pred CCeECCCCCEEEeCCC------------CcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCE
Confidence 3445 3667777542 222 3555543 578999999999998888999999999999999999986
Q ss_pred ccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCccc
Q 047591 152 NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIF 231 (1624)
Q Consensus 152 ~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 231 (1624)
+++..+.++++|++|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.
T Consensus 71 -~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 149 (477)
T 2id5_A 71 -VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS 149 (477)
T ss_dssp -ECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSST
T ss_pred -eChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhcc
Confidence 4455667899999999999999965556788999999999999999988888999999999999999999988888888
Q ss_pred ccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCcccccccccccc
Q 047591 232 NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSII 311 (1624)
Q Consensus 232 ~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~ 311 (1624)
++++|++|+|++|+++ .+|...+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.. .+.+|...
T Consensus 150 ~l~~L~~L~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~--------~~~~~~~~ 220 (477)
T 2id5_A 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY--------LDTMTPNC 220 (477)
T ss_dssp TCTTCCEEEEESCCCS-SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTT--------CCEECTTT
T ss_pred CCCCCCEEECCCCcCc-ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcc--------ccccCccc
Confidence 8999999999999887 56666677788888888888888777777777777777777665532 23344433
Q ss_pred ccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCccccccccccc
Q 047591 312 FNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQ 391 (1624)
Q Consensus 312 ~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~ 391 (1624)
+... +|++|+|++|++++..+..+.++++|+.|+|++|.+++..+..|.++++|+
T Consensus 221 ~~~~-------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (477)
T 2id5_A 221 LYGL-------------------------NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275 (477)
T ss_dssp TTTC-------------------------CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCC
T ss_pred ccCc-------------------------cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCC
Confidence 3333 555555555555544334555555666666666666655555555555555
Q ss_pred EEEcccccc
Q 047591 392 ILNLAYSQL 400 (1624)
Q Consensus 392 ~L~L~~N~l 400 (1624)
+|+|++|++
T Consensus 276 ~L~L~~n~l 284 (477)
T 2id5_A 276 EIQLVGGQL 284 (477)
T ss_dssp EEECCSSCC
T ss_pred EEECCCCcc
Confidence 555555444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=361.70 Aligned_cols=274 Identities=21% Similarity=0.265 Sum_probs=199.5
Q ss_pred HHHhCCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-------
Q 047591 1331 RLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN------- 1402 (1624)
Q Consensus 1331 ~~at~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~------- 1402 (1624)
....++|...+.||+|+||+||+|+. .+|+.||||++..... .+.+|++++++++|||||++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567889999999999999999987 4689999998854322 23479999999999999999999843
Q ss_pred -------------------------------CCeeEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHh
Q 047591 1403 -------------------------------PGFKALILQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYL 1448 (1624)
Q Consensus 1403 -------------------------------~~~~~lV~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yL 1448 (1624)
....++||||++ |+|.+.+.. .+..+++..+..|+.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999998 588887763 456789999999999999999999
Q ss_pred hhcCCCceEEcCCCCCcEEec-CCCcEEEeeecceeecCCCCCccccccccccccccccccCCC-CcCcccchHHHHHHH
Q 047591 1449 HQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILM 1526 (1624)
Q Consensus 1449 H~~~~~~iiHrDlK~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil 1526 (1624)
|+ .+|+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 95 7999999999999998 68999999999999775433 23345789999999987654 589999999999999
Q ss_pred HHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH--hhhcc----C--CchHHHHHHHHHhHHHHHHHHHHccccCCC
Q 047591 1527 METLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI--DANLL----S--GEEEADIAAKKKCMSSVMSLALKCSEEIPE 1598 (1624)
Q Consensus 1527 ~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~--d~~l~----~--~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~ 1598 (1624)
|||++|+.||......+ .+...+...-.....++. ++... . .........+..++..+.+++.+|++.+|+
T Consensus 233 ~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999997643221 111111110000000110 00000 0 000001111123556789999999999999
Q ss_pred CCCCHHHHHHH--HHHHHH
Q 047591 1599 ERMNVKDALAN--LKKIKT 1615 (1624)
Q Consensus 1599 ~RPt~~evl~~--L~~i~~ 1615 (1624)
+|||+.|+++. +++++.
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 99999999853 444433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=355.93 Aligned_cols=267 Identities=24% Similarity=0.268 Sum_probs=201.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----Cee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-----GFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-----~~~ 1406 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888899999999999999875 6788999998643 334457899999999999999999999998654 468
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||++ |+|.+++... .+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99999998 5999999764 48899999999999999999996 799999999999999999999999999998765
Q ss_pred CCCCcc--ccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh--cCChh-H--
Q 047591 1487 GVDSMK--QTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE--SLPDA-V-- 1558 (1624)
Q Consensus 1487 ~~~~~~--~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~--~~~~~-~-- 1558 (1624)
...... .....||+.|+|||++. ...++.++|||||||++|||+||+.||......+. +...... ..+.. .
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence 332211 23457999999999754 45589999999999999999999999976432221 1111110 00000 0
Q ss_pred ------HHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1559 ------TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1559 ------~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..... ................+...+.+++.+|++.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLL-SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHH-TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHH-hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 00000000000111234567889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=357.35 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=200.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 45677789999999999999886 48899999885432 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 105 FVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp CCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 99999998876543 358999999999999999999997 7999999999999999999999999999987643222
Q ss_pred cccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--hcCChhHHHHHhhh-cc
Q 047591 1492 KQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESLPDAVTDVIDAN-LL 1567 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--~~~~~~~~~~~d~~-l~ 1567 (1624)
......||+.|+|||++.+. .++.++|||||||++|||+||+.||......+. +..... ........+..... ..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcccc
Confidence 22345799999999988765 789999999999999999999999975432211 111111 11111111111110 00
Q ss_pred -----CC--chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 -----SG--EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 -----~~--~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. ...........++..+.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000111122456778999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=347.42 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=202.4
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---------hhHHHHHHHHHHHHHhcC-CCceeEEEeeecc
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---------DRALKSFDAECEVMRRIR-HRNLAKIVSSCSN 1402 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---------~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~ 1402 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888899999999999999885 58899999986432 233567899999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1403 PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
.+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999764 457899999999999999999996 79999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccccccC------CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGS------EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
+...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~-------- 240 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRM-------- 240 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH--------
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHH--------
Confidence 8775432 223457999999999864 4568999999999999999999999986532111 1111
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+......... .....++..+.+++.+|++.+|++|||+.|+++
T Consensus 241 ----~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 ----IMSGNYQFGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ----HHHTCCCCCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----HhcCCcccCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111100000 001234566889999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=357.52 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=198.4
Q ss_pred hCCCCcC-CeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEE
Q 047591 1334 TNGFSES-NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1334 t~~f~~~-~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~l 1408 (1624)
.+.|... +.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3445544 78999999999999876 58999999986432 234578899999999994 6999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeecceee
Q 047591 1409 ILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~~ 1484 (1624)
||||+++|+|.+++... ...+++.++..|+.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+.
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999988643 4568999999999999999999996 79999999999999998 78999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
..... ......||+.|+|||++....++.++|||||||++|||+||+.||......+. ... +...
T Consensus 184 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~------------i~~~ 248 (327)
T 3lm5_A 184 IGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLN------------ISQV 248 (327)
T ss_dssp C-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHHT
T ss_pred cCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHH------------HHhc
Confidence 75332 22345799999999999989999999999999999999999999965322111 100 0000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...... .....++..+.+++.+|++.+|++|||++|+++.
T Consensus 249 ~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSE-----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCT-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCc-----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 0012345567889999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=375.05 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=196.3
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
.|...+.||+|+||+||+|+.. ++..||||++.... ....+.+.+|++++++++|||||+++++|.+.+..++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 4677789999999999999885 67889999986442 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeecceeecCCCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~~~~~~~ 1489 (1624)
|++|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+......
T Consensus 118 ~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 118 YKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999988765 357889999999999999999996 79999999999999976 4559999999998875432
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
......||+.|+|||++. +.++.++||||+||++|||++|+.||......+ .+...... .....
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~------------~~~~~ 257 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVEKG------------KYTFD 257 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT------------CCCCC
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC------------CCCCC
Confidence 233457999999999876 569999999999999999999999997542211 11111110 00000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. .+..++..+.+++.+|++.+|++|||+.|+++.
T Consensus 258 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00 012345567899999999999999999999864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=367.98 Aligned_cols=331 Identities=23% Similarity=0.230 Sum_probs=192.0
Q ss_pred cccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeec
Q 047591 187 KLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNL 266 (1624)
Q Consensus 187 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~L 266 (1624)
+|+.|||++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|...+.++++|++|+|
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEEC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEEC
Confidence 4455555555555444445555555555555555555444555555555555555555554 445555555666666666
Q ss_pred ccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEE
Q 047591 267 RDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLY 346 (1624)
Q Consensus 267 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~ 346 (1624)
++|++++..|..|..+++|+.|+|++|++..+ .|..+ ..+++|++|+
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~--------~~~~~-------------------------~~l~~L~~L~ 158 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYI--------SHRAF-------------------------SGLNSLEQLT 158 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEE--------CTTSS-------------------------TTCTTCCEEE
T ss_pred CCCccccCChhHccccccCCEEECCCCcccee--------Chhhc-------------------------cCCCCCCEEE
Confidence 66666666666666666666666666554322 12222 2455666666
Q ss_pred ecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeee
Q 047591 347 LWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAI 426 (1624)
Q Consensus 347 Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l 426 (1624)
|++|++++..+..|.++++|+.|+|++|.+++..+..|.++++|++|++++|+..
T Consensus 159 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~------------------------- 213 (477)
T 2id5_A 159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL------------------------- 213 (477)
T ss_dssp EESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC-------------------------
T ss_pred CCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc-------------------------
Confidence 6666666655666777777777777777777776666666666666666554331
Q ss_pred ccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceeccccccccc
Q 047591 427 QTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQG 506 (1624)
Q Consensus 427 ~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 506 (1624)
+. +|..+....+|++|+|++|++++..+..+..+++|++|+|++|++++
T Consensus 214 ------~~-------------------------~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 262 (477)
T 2id5_A 214 ------DT-------------------------MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST 262 (477)
T ss_dssp ------CE-------------------------ECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCE
T ss_pred ------cc-------------------------cCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCc
Confidence 11 12222223356677777777764444566667777777777777776
Q ss_pred CCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCccccc
Q 047591 507 SIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGN 586 (1624)
Q Consensus 507 ~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~ 586 (1624)
..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+.+|+.|+|++|.++...+.. .-
T Consensus 263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~-~~ 341 (477)
T 2id5_A 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLL-WV 341 (477)
T ss_dssp ECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGH-HH
T ss_pred cChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchH-hH
Confidence 66666666777777777777777666666777777777777777776655555556666666666666665432211 11
Q ss_pred ccccceeeccCCcCCCCccccc
Q 047591 587 LKVLTGLYLSGNQLSCSIPSSI 608 (1624)
Q Consensus 587 l~~L~~L~Ls~N~l~g~iP~~~ 608 (1624)
...+..+.+.+|...|.-|..+
T Consensus 342 ~~~~~~~~~~~~~~~C~~p~~~ 363 (477)
T 2id5_A 342 FRRRWRLNFNRQQPTCATPEFV 363 (477)
T ss_dssp HTTTTSSCCTTCCCBEEESGGG
T ss_pred HhhhhccccCccCceeCCchHH
Confidence 1223334445555555444443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=384.95 Aligned_cols=244 Identities=21% Similarity=0.261 Sum_probs=200.2
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~ 1407 (1624)
..++|...++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567888899999999999999875 5788999998643 233456788999999987 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+||||+++|+|.++++..+ .+++.++..|+.||+.||+|||+ .+||||||||+|||+|.++++||+|||+|+....
T Consensus 419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999998654 58899999999999999999996 7999999999999999999999999999986533
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+ .... ++.....
T Consensus 495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~------------i~~~~~~ 560 (674)
T 3pfq_A 495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQS------------IMEHNVA 560 (674)
T ss_dssp TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH------------HHSSCCC
T ss_pred CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHH------------HHhCCCC
Confidence 22 23345689999999999999999999999999999999999999997532211 1111 1111110
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
- +...+..+.+++.+|++.||++||++
T Consensus 561 ~---------p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 561 Y---------PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp C---------CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred C---------CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 0 01234567889999999999999997
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=365.33 Aligned_cols=211 Identities=24% Similarity=0.368 Sum_probs=185.2
Q ss_pred cCHHHHHhhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeee
Q 047591 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSC 809 (1624)
Q Consensus 734 ~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 809 (1624)
+.+++.....++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345666667889999999999999999999874 79999999997432 22345688999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 810 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
.+.+..|+|||||++|+|.+++...+..+++..+..++.||+.||+|||+. +||||||||+|||+|.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999999987666799999999999999999999984 59999999999999999999999999
Q ss_pred eeeccCCCCCcccccccccccccCccccC-------CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 890 ISKLLDGEDSVTQTMTLATFGYMAPEYGS-------EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 890 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+|+.............+||+.|||||++. .+.++.++|||||||++|||+||+.||..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99987655443344457999999999876 45789999999999999999999999865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=354.93 Aligned_cols=268 Identities=22% Similarity=0.247 Sum_probs=200.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC-----Cee
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP-----GFK 1406 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~-----~~~ 1406 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888899999999999999885 5889999998643 334567889999999999999999999987654 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999998 6999998763 58899999999999999999996 799999999999999999999999999998765
Q ss_pred CCCCc---------cccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh---h-
Q 047591 1487 GVDSM---------KQTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE---E- 1552 (1624)
Q Consensus 1487 ~~~~~---------~~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~---~- 1552 (1624)
..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +..... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCC
Confidence 32211 112346899999999764 47789999999999999999999999975422111 110000 0
Q ss_pred --------cCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1553 --------SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1553 --------~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.......+.+.. +..............++..+.+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKS-LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHT-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhc-ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000011111110 00000000011112456778899999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=358.44 Aligned_cols=262 Identities=22% Similarity=0.277 Sum_probs=197.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCee-----
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFK----- 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~----- 1406 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 56777889999999999999875 6889999998643 334567899999999999999999999999876654
Q ss_pred -EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1407 -ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1407 -~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
++||||++ |+|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 688887743 48999999999999999999997 79999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh----------cC
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE----------SL 1554 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~----------~~ 1554 (1624)
... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+. +...... .+
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTC
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCcHHHHHHh
Confidence 432 234578999999998876 7899999999999999999999999976432111 1111110 00
Q ss_pred Chh-HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 PDA-VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 ~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+. ....+. .+..............++..+.+++.+|++.||++|||++|+++.
T Consensus 270 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQ-SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHH-HSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhh-ccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 011111 111100000011112346778999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=356.57 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=198.6
Q ss_pred cccCHHHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeee
Q 047591 1323 RRISYQELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSC 1400 (1624)
Q Consensus 1323 ~~~~~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~ 1400 (1624)
..+++.++....+.|...+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34445555566788999999999999999999884 68899999986432 2346789999999999 899999999998
Q ss_pred cc------CCeeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc
Q 047591 1401 SN------PGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV 1473 (1624)
Q Consensus 1401 ~~------~~~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 1473 (1624)
.. .+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCC
Confidence 76 46789999999999999999864 3568899999999999999999997 79999999999999999999
Q ss_pred EEEeeecceeecCCCCCccccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhh
Q 047591 1474 AHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH 1548 (1624)
Q Consensus 1474 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~ 1548 (1624)
+||+|||+++...... .......||+.|+|||++. ...++.++|||||||++|||+||+.||.+...... ...
T Consensus 168 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~ 245 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFL 245 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH
T ss_pred EEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHH
Confidence 9999999998764322 1223457999999999876 56789999999999999999999999865422111 100
Q ss_pred hhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1549 WVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1549 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
......+ .... ..++..+.+++.+||+.+|++|||+.|+++
T Consensus 246 ~~~~~~~---------~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNPAP---------RLKS----------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSCCC---------CCSC----------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCccc---------cCCc----------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 0000 123456788999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=373.42 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=199.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
+.|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 35777889999999999999875 68899999986432 2345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec---CCCcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~kl~DFGla~~~~~~ 1488 (1624)
|+++|+|.+++...+ .+++.++..|+.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 102 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999887653 57899999999999999999996 7999999999999995 4568999999999876433
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......+ .+....... ...
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~------------~~~ 241 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGK------------YAF 241 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC------------CCS
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC------------CCC
Confidence 2 2334579999999998865 58999999999999999999999997532211 111111110 000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. ..+..++..+.+++.+|++.+|++|||+.|+++.
T Consensus 242 ~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DL-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CS-----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC-----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0112345668899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=359.32 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=204.7
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhH-----------------HHHHHHHHHHHHhcCCCceeEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRA-----------------LKSFDAECEVMRRIRHRNLAKI 1396 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~-----------------~~~f~~E~~~l~~l~HpNIv~l 1396 (1624)
.++|...+.||+|+||.||+|+. +++.||||++....... .+.|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788889999999999999998 89999999986433211 1789999999999999999999
Q ss_pred EeeeccCCeeEEEEEecCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1397 VSSCSNPGFKALILQYMPQGSLEKW------LYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1397 ~g~~~~~~~~~lV~ey~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||+|||+ ..+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999998 5542 4578999999999999999999995 37999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCccccccccccccccccccCCC-CcCc-ccchHHHHHHHHHHHcCCCCCCCCCccchhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG-IVST-SGDVYSFGILMMETLTRRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~ 1547 (1624)
.++.+||+|||+++..... ......||+.|+|||...+. .++. ++|||||||++|||+||+.||...........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999999999999876432 23345799999999998876 6666 99999999999999999999975433121111
Q ss_pred hhhhhc--CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1548 HWVEES--LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1548 ~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...... .+........ ... ..........++..+.+++.+||+.+|++|||+.|+++
T Consensus 264 ~i~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLY-PLT---NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHTSCCCCCCCSSSSSTT-TTC---C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhccCcCCccchhhhhc-ccc---ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 0100000000 000 00001111335667889999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=347.52 Aligned_cols=202 Identities=26% Similarity=0.395 Sum_probs=178.5
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
++|...+.||+|+||+||+|... +++.||||++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56778899999999999999864 68999999986655566778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc-
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT- 901 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~- 901 (1624)
++|+|.++++.....+++.++..|+.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999988767899999999999999999999994 59999999999999999999999999998765432211
Q ss_pred ------------cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 902 ------------QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 902 ------------~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....||+.|+|||++....++.++|||||||++|||++|..|+...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11346999999999999999999999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=359.82 Aligned_cols=263 Identities=22% Similarity=0.248 Sum_probs=183.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccC------Ce
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNP------GF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~------~~ 1405 (1624)
++|...+.||+|+||+||+|... +|+.||||++... .....+++.+|++++++++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 67888899999999999999864 6889999998643 334567889999999999999999999998654 56
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 79999999 6899998865 358999999999999999999996 79999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh----------cC
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE----------SL 1554 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~----------~~ 1554 (1624)
... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+....+ .+...... .+
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHTTC
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHh
Confidence 422 234579999999998766 678999999999999999999999997542211 11111110 00
Q ss_pred -ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 -PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 -~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....+.+. .+..............+...+.+++.+|++.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 001111111 000000000001112335668899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=358.83 Aligned_cols=265 Identities=20% Similarity=0.260 Sum_probs=198.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC--------CCceeEEEeeec----
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR--------HRNLAKIVSSCS---- 1401 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~--------HpNIv~l~g~~~---- 1401 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|++++++++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 56888899999999999999874 5788999998643 344578899999999986 788999999987
Q ss_pred cCCeeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCC-ceEEcCCCCCcEEecCCC-------
Q 047591 1402 NPGFKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYST-SIIHCDLKPSNVLLDDDM------- 1472 (1624)
Q Consensus 1402 ~~~~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld~~~------- 1472 (1624)
+....++||||+ +|++.+++... ...+++..+..|+.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 556789999999 56666666544 3568999999999999999999997 5 899999999999999775
Q ss_pred ------------------------------------------cEEEeeecceeecCCCCCccccccccccccccccccCC
Q 047591 1473 ------------------------------------------VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE 1510 (1624)
Q Consensus 1473 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 1510 (1624)
.+||+|||+|+..... .....||+.|||||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 8999999999876432 234579999999999988
Q ss_pred CCcCcccchHHHHHHHHHHHcCCCCCCCCCccch-----hhhhhhh--hcCChhHHHH--HhhhccC-------------
Q 047591 1511 GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEV-----CLKHWVE--ESLPDAVTDV--IDANLLS------------- 1568 (1624)
Q Consensus 1511 ~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~-----~l~~~~~--~~~~~~~~~~--~d~~l~~------------- 1568 (1624)
..++.++|||||||++|||+||+.||........ .+..... ...+...... .......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 8899999999999999999999999975322111 0111100 0111110000 0000000
Q ss_pred -CchHH---HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1569 -GEEEA---DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1569 -~~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...+. .......+...+.+++.+||+.||++|||++|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000 00001345667889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=375.77 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=201.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 35677789999999999999886 68999999985432 334678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe---cCCCcEEEeeecceeecCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL---DDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~kl~DFGla~~~~~ 1487 (1624)
||+++|+|.+++...+ .+++..+..|+.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+|+....
T Consensus 106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999997654 57899999999999999999997 799999999999999 5678999999999987654
Q ss_pred CCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.. ......||+.|+|||++.+ .++.++||||+||++|||+||+.||......+ .+...... ...
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~------------~~~ 245 (484)
T 3nyv_A 182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVEKG------------KYT 245 (484)
T ss_dssp CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC------------CCC
T ss_pred cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcC------------CCC
Confidence 32 2334579999999998765 68999999999999999999999997532211 11111111 000
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
... +.+..++..+.+++.+|++.+|++|||+.|+++
T Consensus 246 ~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FEL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 011234566889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=348.44 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=190.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-----------
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN----------- 1402 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----------- 1402 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45777889999999999999875 6899999998643 3445789999999999999999999998754
Q ss_pred --CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1403 --PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1403 --~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
.+..++||||+++|+|.+++...+..+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 356799999999999999998777778889999999999999999997 799999999999999999999999999
Q ss_pred ceeecCCCC-------------CccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhh
Q 047591 1481 IAKLLDGVD-------------SMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1481 la~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l 1546 (1624)
+++...... ........||+.|+|||++.+ +.++.++|||||||++|||++ |+..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 998664221 112234569999999998865 478999999999999999998 543211110001
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
... ... ........ ...++..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~-~~~---------~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 239 KKL-RSV---------SIEFPPDF-------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHH-HST---------TCCCCTTC-------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Hhc-ccc---------ccccCccc-------cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 100 000 00000000 01234557889999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=353.90 Aligned_cols=258 Identities=21% Similarity=0.347 Sum_probs=199.0
Q ss_pred HHHHHHHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcC--CCceeEEEeeecc
Q 047591 1327 YQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIR--HRNLAKIVSSCSN 1402 (1624)
Q Consensus 1327 ~~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~--HpNIv~l~g~~~~ 1402 (1624)
++.+....+.|...+.||+|+||.||+|+..+++.||||++... .....+.|.+|++++++++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33444455678888999999999999999888999999998643 3445678999999999997 5999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecce
Q 047591 1403 PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla 1482 (1624)
++..++||| +.+|+|.+++...+ .+++.++..++.|+++||+|||+ .+|+||||||+||++++ +.+||+|||++
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999999 67889999998654 57889999999999999999996 79999999999999975 89999999999
Q ss_pred eecCCCCC-ccccccccccccccccccCC-----------CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh
Q 047591 1483 KLLDGVDS-MKQTMTLATIGYMAPEYGSE-----------GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV 1550 (1624)
Q Consensus 1483 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~ 1550 (1624)
+....... .......||+.|+|||.... ..++.++|||||||++|||+||+.||.........+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--- 250 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--- 250 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH---
Confidence 87643322 12234579999999998765 4788999999999999999999999975432211111
Q ss_pred hhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1551 EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..++........ ..++..+.+++.+||+.+|++|||++|+++.
T Consensus 251 ---------~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 ---------AIIDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---------HHHCTTSCCCCC-------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHHhcccccCCc-------ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111110000 1123457889999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=349.25 Aligned_cols=267 Identities=21% Similarity=0.299 Sum_probs=195.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeec------------
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCS------------ 1401 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~------------ 1401 (1624)
++|...+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56777889999999999999886 48899999987666667788999999999999999999999873
Q ss_pred --cCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec-CCCcEEEee
Q 047591 1402 --NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGD 1478 (1624)
Q Consensus 1402 --~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~kl~D 1478 (1624)
+.+..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999998 699999864 357889999999999999999996 7999999999999997 567999999
Q ss_pred ecceeecCCCCC--ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc--
Q 047591 1479 FGIAKLLDGVDS--MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES-- 1553 (1624)
Q Consensus 1479 FGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~-- 1553 (1624)
||+++....... .......||+.|+|||.... ..++.++|||||||++|||+||+.||......+ .........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 243 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIPV 243 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 999987643211 12234568999999997654 678999999999999999999999997643211 111111110
Q ss_pred CChh-HHHHH-------hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1554 LPDA-VTDVI-------DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1554 ~~~~-~~~~~-------d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.... ..+.. ........ .........++..+.+++.+|++.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPH-KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCC-CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhcCcccccccccCCC-CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 00100 00000000 00001112356778999999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=360.60 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=200.4
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
...++|...+.||+|+||+||+|++.+ .+|+|+++... ....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345678888999999999999998753 59999986432 23346688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||+++|+|.+++...+..+++.++..++.|++.||+|||+ .+|+||||||+||+++ ++.+||+|||+++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999998776678999999999999999999997 7999999999999998 6799999999987653211
Q ss_pred ----CccccccccccccccccccCC---------CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCCh
Q 047591 1490 ----SMKQTMTLATIGYMAPEYGSE---------GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1490 ----~~~~~~~~gt~~y~APE~~~~---------~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
........||+.|+|||.... ..++.++|||||||++|||+||+.||........ .........
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~-- 260 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMK-- 260 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHHTTCC--
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhccCCC--
Confidence 112233469999999998754 4578999999999999999999999975422111 100000000
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
+.... ..++..+.+++.+||+.+|++|||+.|+++.|+++..+.
T Consensus 261 -------~~~~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 261 -------PNLSQ----------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -------CCCCC----------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -------CCCCc----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00000 013345788999999999999999999999999987653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=342.02 Aligned_cols=249 Identities=20% Similarity=0.295 Sum_probs=196.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch----hhHHHHHHHHHHHHHhcCCCceeEEEeeec--cCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE----DRALKSFDAECEVMRRIRHRNLAKIVSSCS--NPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~----~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~--~~~~~~ 1407 (1624)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++. +.+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 57888999999999999999875 57899999986543 234578999999999999999999999984 456789
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1408 LILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
+||||+++| +.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999987 77777643 4568999999999999999999996 799999999999999999999999999998765
Q ss_pred CCC-CccccccccccccccccccCCC--CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1487 GVD-SMKQTMTLATIGYMAPEYGSEG--IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1487 ~~~-~~~~~~~~gt~~y~APE~~~~~--~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
... ........||+.|+|||+..+. .++.++|||||||++|||+||+.||......+ . .+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~------------~~~i~ 226 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--L------------FENIG 226 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H------------HHHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--H------------HHHHh
Confidence 322 1222345699999999987653 34789999999999999999999997532110 0 00111
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...... +..++..+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 KGSYAI--------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HCCCCC--------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCCCCC--------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100000 01234567889999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=365.21 Aligned_cols=193 Identities=22% Similarity=0.295 Sum_probs=151.3
Q ss_pred CCeEeecCceEEEEEEEc---CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeee--ccCCeeEEEEEecC
Q 047591 1340 SNLLGTGIFSSVYKATFA---DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC--SNPGFKALILQYMP 1414 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~--~~~~~~~lV~ey~~ 1414 (1624)
.++||+|+||+||+|++. +++.||||++.... ..+.+.+|++++++++|||||++++++ ......++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 458999999999999976 47889999986432 235788999999999999999999998 45778999999997
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe----cCCCcEEEeeecce
Q 047591 1415 QGSLEKWLYSH--------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL----DDDMVAHLGDFGIA 1482 (1624)
Q Consensus 1415 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~kl~DFGla 1482 (1624)
|+|.+++... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+|
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5888877532 1248899999999999999999996 789999999999999 77899999999999
Q ss_pred eecCCCCC--ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCC
Q 047591 1483 KLLDGVDS--MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDD 1538 (1624)
Q Consensus 1483 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~ 1538 (1624)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 87653221 22234679999999998876 4589999999999999999999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=362.09 Aligned_cols=207 Identities=22% Similarity=0.316 Sum_probs=180.7
Q ss_pred HHHHHhhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeecc
Q 047591 736 YQELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSN 811 (1624)
Q Consensus 736 ~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 811 (1624)
++++....++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4556667889999999999999999999875 58999999987432 1233568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeee
Q 047591 812 HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891 (1624)
Q Consensus 812 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla 891 (1624)
++..|+|||||++|+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+|||+|.++.+||+|||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999764 588999999999999999999994 5999999999999999999999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGI----VSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+.............+||+.|||||++.... ++.++|||||||++|||+||+.||..
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 887655433344567999999999876544 78999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=358.32 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=192.2
Q ss_pred CCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC------eeEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG------FKALI 1409 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~------~~~lV 1409 (1624)
.|...++||+|+||+||+|+...+..||+|++..... ...+|+++++.++|||||++++++...+ ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4677789999999999999997777789887753321 2246999999999999999999985432 37899
Q ss_pred EEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec-CCCcEEEeeecceeecC
Q 047591 1410 LQYMPQGSLEKWLY--SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~kl~DFGla~~~~ 1486 (1624)
|||++++.+....+ .....+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||+|+...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99998754443332 235578999999999999999999996 7999999999999999 79999999999999875
Q ss_pred CCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc-CC-hhHHHHHh
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES-LP-DAVTDVID 1563 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~-~~-~~~~~~~d 1563 (1624)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+...+... .+ .......+
T Consensus 194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 194 AGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHC
T ss_pred CCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhC
Confidence 332 2334578999999998765 458999999999999999999999997643221 111111100 00 00001111
Q ss_pred hhccCC------chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1564 ANLLSG------EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1564 ~~l~~~------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+..... ........+..++..+.+++.+|++.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 111000 0000000111245678999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=346.34 Aligned_cols=265 Identities=20% Similarity=0.276 Sum_probs=202.3
Q ss_pred CCCCcCCeEeecCceEEEEEEE--cCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCc------eeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF--ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRN------LAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~--~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpN------Iv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|++++++++|++ ++++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5678889999999999999987 35788999998643 344577899999999998765 99999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---------------
Q 047591 1407 ALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD--------------- 1470 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--------------- 1470 (1624)
++||||+ +++|.+++...+ ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 899999998654 358899999999999999999996 79999999999999987
Q ss_pred ----CCcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhh
Q 047591 1471 ----DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCL 1546 (1624)
Q Consensus 1471 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l 1546 (1624)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+. .
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-L 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-H
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-H
Confidence 668999999999875432 2345799999999999888999999999999999999999999975422211 1
Q ss_pred hhh--hhhcCChhHHHHHh-hhc--------cCCchHHH------------HHHHHHhHHHHHHHHHHccccCCCCCCCH
Q 047591 1547 KHW--VEESLPDAVTDVID-ANL--------LSGEEEAD------------IAAKKKCMSSVMSLALKCSEEIPEERMNV 1603 (1624)
Q Consensus 1547 ~~~--~~~~~~~~~~~~~d-~~l--------~~~~~~~~------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 1603 (1624)
... .....+........ ... ........ ......++..+.+++.+|++.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111 11111211110000 000 00000000 00011345678999999999999999999
Q ss_pred HHHHHH
Q 047591 1604 KDALAN 1609 (1624)
Q Consensus 1604 ~evl~~ 1609 (1624)
+|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=346.38 Aligned_cols=210 Identities=27% Similarity=0.338 Sum_probs=186.0
Q ss_pred cccCHHHHHhhcCC----------CCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCC
Q 047591 732 RRISYQELQRLTDG----------FSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHR 800 (1624)
Q Consensus 732 ~~~~~~el~~~t~~----------f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ 800 (1624)
..+++++++.+++. |...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46888898888865 566679999999999999875 7999999999876666667899999999999999
Q ss_pred ceeeeeeeeccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC
Q 047591 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD 880 (1624)
Q Consensus 801 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 880 (1624)
||+++++++...+..++||||+++|+|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 999999999999999999999999999999864 3689999999999999999999984 59999999999999999
Q ss_pred CceEEEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 881 TVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 881 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+.+||+|||+++........ .....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999876543222 2345799999999999988999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=360.03 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=191.9
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc----C--CeeEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN----P--GFKAL 1408 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----~--~~~~l 1408 (1624)
.|...++||+|+||+||+|++. +|+.||||++.... +.+.+|++++++++|||||+++++|.. . ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4667789999999999999985 58999999885432 223579999999999999999998843 2 23679
Q ss_pred EEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC-CcEEEeeecceee
Q 047591 1409 ILQYMPQGSLEKWLY---SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKL 1484 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~kl~DFGla~~ 1484 (1624)
||||+++ ++.+.+. .....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 6666654 345678999999999999999999995 799999999999999965 6789999999997
Q ss_pred cCCCCCccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC-C--hhHHH
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL-P--DAVTD 1560 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~-~--~~~~~ 1560 (1624)
+.... ......||+.|||||++.+. .++.++|||||||++|||++|+.||.+....+ .+..++...- + +.+.+
T Consensus 207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHHH
T ss_pred cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence 65332 22345799999999988654 79999999999999999999999997642211 1222211100 0 11111
Q ss_pred HHhhhccCC------chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1561 VIDANLLSG------EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1561 ~~d~~l~~~------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.++..... ............+..+.+|+.+|++.||++|||+.|+++.
T Consensus 284 -~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp -HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11100000 0000000011235678899999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=350.03 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=199.9
Q ss_pred HhCCCCcCCeEeecCceEEEEEEE--cCCceEEEEEeccch--hhHHHHHHHHHHHHHhc---CCCceeEEEeeec----
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATF--ADGTNAAIKIFSLQE--DRALKSFDAECEVMRRI---RHRNLAKIVSSCS---- 1401 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~--~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l---~HpNIv~l~g~~~---- 1401 (1624)
+.++|...+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+++++++ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456788899999999999999988 357889999986432 22234567788887776 8999999999986
Q ss_pred -cCCeeEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeee
Q 047591 1402 -NPGFKALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDF 1479 (1624)
Q Consensus 1402 -~~~~~~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DF 1479 (1624)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999998 69999998653 458999999999999999999997 79999999999999999999999999
Q ss_pred cceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-cCCh--
Q 047591 1480 GIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-SLPD-- 1556 (1624)
Q Consensus 1480 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-~~~~-- 1556 (1624)
|+++..... .......||+.|+|||+..+..++.++|||||||++|||+||+.||........ +...+.. ..+.
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGG
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcc
Confidence 999876422 123345789999999999888999999999999999999999999975432111 1111100 0000
Q ss_pred hHHHHH---hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1557 AVTDVI---DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1557 ~~~~~~---d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+.... ..................++..+.+++.+||+.+|++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000000000000001124566789999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=353.15 Aligned_cols=276 Identities=21% Similarity=0.234 Sum_probs=191.4
Q ss_pred HHHHHHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe-
Q 047591 1328 QELRLATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF- 1405 (1624)
Q Consensus 1328 ~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~- 1405 (1624)
.+.....++|...+.||+|+||+||+|+.. +++.||||++... ......+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566788999999999999999999885 6889999988533 2233567788888999999999999999865332
Q ss_pred ------eEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEE
Q 047591 1406 ------KALILQYMPQGSLEKWLY---SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAH 1475 (1624)
Q Consensus 1406 ------~~lV~ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~k 1475 (1624)
.++||||+++ +|.+.+. .....+++..+..++.|++.||+|||. +..+|+||||||+|||++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 5555444 245568889999999999999999993 2489999999999999997 89999
Q ss_pred EeeecceeecCCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc-
Q 047591 1476 LGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES- 1553 (1624)
Q Consensus 1476 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~- 1553 (1624)
|+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..+..++...
T Consensus 173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHcC
Confidence 99999998765432 2334578999999998755 45899999999999999999999999764322 1122221110
Q ss_pred -CChhHHHHHhhhccC-------CchHHHH--HHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1554 -LPDAVTDVIDANLLS-------GEEEADI--AAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1554 -~~~~~~~~~d~~l~~-------~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+......+++.... ....... .....++..+.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111111111000 0000000 0001245678999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=353.01 Aligned_cols=200 Identities=23% Similarity=0.266 Sum_probs=172.5
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC-CC-----ceeEEEeeeccCCe
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HR-----NLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-Hp-----NIv~l~g~~~~~~~ 1405 (1624)
..++|...+.||+|+||+||+|+.. +++.||||+++.. ....+++.+|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578888999999999999999875 5788999998643 334567888999999885 55 49999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec--CCCcEEEeeecce
Q 047591 1406 KALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD--DDMVAHLGDFGIA 1482 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld--~~~~~kl~DFGla 1482 (1624)
.++||||++ |+|.+++.... ..+++..+..++.|++.||+|||. +..+||||||||+|||++ .++.+||+|||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 59999998654 458999999999999999999994 247899999999999994 5788999999999
Q ss_pred eecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCC
Q 047591 1483 KLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDM 1539 (1624)
Q Consensus 1483 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~ 1539 (1624)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876432 23457999999999999989999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=340.68 Aligned_cols=199 Identities=29% Similarity=0.399 Sum_probs=179.5
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 57899999999876655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999999764 588999999999999999999994 5999999999999999999999999999877554332
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3345799999999999888999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=351.70 Aligned_cols=254 Identities=25% Similarity=0.294 Sum_probs=177.8
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHH-HHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECE-VMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~-~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 356777899999999999999885 68899999986542 334455666666 677889999999999999999999999
Q ss_pred EecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-ceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1411 QYMPQGSLEKWLYS----HNYLLNIEQRLDIMIDVACALEYLHQGYST-SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 88877753 24568999999999999999999997 5 8999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccccccc----CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYG----SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
.... ......||+.|+|||++ .+..++.++|||||||++|||+||+.||.........+........+
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 248 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP------ 248 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC------
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC------
Confidence 4322 22334699999999987 46678999999999999999999999997532111111111110000
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.+.... ...++..+.+++.+||+.||++|||+.|+++.
T Consensus 249 ---~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 ---QLSNSE-------EREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---CCCCCS-------SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCCCcc-------cccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000000 01234568899999999999999999999763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=345.81 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=176.3
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888899999999999999865 68999999997542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999999997643 689999999999999999999984 599999999999999999999999999986433222
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....+||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 22345799999999999988999999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=361.56 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=184.4
Q ss_pred CCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
|...++||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +|||||++++++.+.+..++|||||.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 34457899999999987766689999999986432 35678999999987 89999999999999999999999996
Q ss_pred CCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC-------------CcEEE
Q 047591 1416 GSLEKWLYSHNYL------LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD-------------MVAHL 1476 (1624)
Q Consensus 1416 gsL~~~l~~~~~~------l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-------------~~~kl 1476 (1624)
|+|.+++...... ..+..+++|+.||+.||+|||+ .+|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999865321 1223457899999999999996 799999999999999754 48999
Q ss_pred eeecceeecCCCCCc---cccccccccccccccccCC-------CCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchh
Q 047591 1477 GDFGIAKLLDGVDSM---KQTMTLATIGYMAPEYGSE-------GIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVC 1545 (1624)
Q Consensus 1477 ~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~-------~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~ 1545 (1624)
+|||+|+........ ......||++|||||++.+ ..++.++|||||||++|||+| |+.||.+....+..
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~ 249 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH
Confidence 999999987543221 1234579999999998765 678999999999999999999 99999754322211
Q ss_pred hhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1546 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+....... ... ... ....++..+.+++.+|++.||++|||+.||++
T Consensus 250 ---i~~~~~~~-------~~~-~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 ---IIRGIFSL-------DEM-KCL------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHTCCCC-------CCC-TTC------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HhcCCCCc-------ccc-ccc------ccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11110000 000 000 01234567889999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=346.36 Aligned_cols=202 Identities=25% Similarity=0.381 Sum_probs=178.4
Q ss_pred HhhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 740 QRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 740 ~~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
+...++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34567899999999999999999986 579999999997543 234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+||||+++|+|.+++...+ .+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999999997654 689999999999999999999984 599999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSEGIVS-TCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .....+||+.|+|||++.+..++ .++||||+||++|||+||+.||..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 32 23345799999999998776664 899999999999999999999965
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=347.74 Aligned_cols=309 Identities=19% Similarity=0.216 Sum_probs=178.4
Q ss_pred cCCCcccEEEecCCCccccCCc-ccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcc
Q 047591 110 ANLSFLVSLNISGNRFHGTLPN-ELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKL 188 (1624)
Q Consensus 110 ~~L~~L~~L~Ls~N~l~g~iP~-~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 188 (1624)
..+++|+.|++++|.++. +|. .+..+++|++|+|++|++++ +++..+..+++|++|+|++|++++..|..|+++++|
T Consensus 42 ~~l~~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 119 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119 (390)
T ss_dssp GGGCCCSEEEEESCEESE-ECTHHHHHCCCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred cccCCceEEEecCCchhh-CChhHhcccccCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCC
Confidence 346677777777777763 443 35666777777777777653 444445566666666666666666556666666666
Q ss_pred cccccccccccccccC-cccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecc
Q 047591 189 KRLSVSFNELTGRIPQ-NIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267 (1624)
Q Consensus 189 ~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls 267 (1624)
++|+|++|+++ .+|. .|+++++|++|+|++|++++..|..+.++++|++|++++|++++ ++
T Consensus 120 ~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~---------------- 181 (390)
T 3o6n_A 120 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---------------- 181 (390)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-CC----------------
T ss_pred CEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc-cc----------------
Confidence 66666666666 3333 34666666666666666665555556666666666666666542 22
Q ss_pred cccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEe
Q 047591 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL 347 (1624)
Q Consensus 268 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 347 (1624)
++.+++|+.|++++|.+..++ ...+|+.|++++|++++ +|... .++|+.|+|
T Consensus 182 -----------~~~l~~L~~L~l~~n~l~~~~-------------~~~~L~~L~l~~n~l~~-~~~~~---~~~L~~L~l 233 (390)
T 3o6n_A 182 -----------LSLIPSLFHANVSYNLLSTLA-------------IPIAVEELDASHNSINV-VRGPV---NVELTILKL 233 (390)
T ss_dssp -----------GGGCTTCSEEECCSSCCSEEE-------------CCSSCSEEECCSSCCCE-EECCC---CSSCCEEEC
T ss_pred -----------cccccccceeecccccccccC-------------CCCcceEEECCCCeeee-ccccc---cccccEEEC
Confidence 233344444444444333211 11244555555555542 23222 356777777
Q ss_pred cCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeec
Q 047591 348 WGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQ 427 (1624)
Q Consensus 348 s~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~ 427 (1624)
++|++++. ..+.++++|++|+|++|.+++.+|..|.++++|++|+|++|+++.
T Consensus 234 ~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------------------- 286 (390)
T 3o6n_A 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA------------------------- 286 (390)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-------------------------
T ss_pred CCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-------------------------
Confidence 77777653 466777777777777777777766667666666666666665531
Q ss_pred cCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccC
Q 047591 428 TNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGS 507 (1624)
Q Consensus 428 ~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~ 507 (1624)
+|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++.
T Consensus 287 --------------------------------~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~- 332 (390)
T 3o6n_A 287 --------------------------------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT- 332 (390)
T ss_dssp --------------------------------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-
T ss_pred --------------------------------cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-
Confidence 1222334555666666666665 355555666666666666666653
Q ss_pred CCccccCCCCCceeeccccccc
Q 047591 508 IPSELCQLESLNTLLLQGNALQ 529 (1624)
Q Consensus 508 iP~~l~~l~~L~~L~L~~N~l~ 529 (1624)
+| +..+++|+.|++++|.++
T Consensus 333 ~~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 333 LK--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp CC--CCTTCCCSEEECCSSCEE
T ss_pred eC--chhhccCCEEEcCCCCcc
Confidence 22 444455555555555554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=339.33 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=200.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 46778899999999999999886 68899999986432 2346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC---CcEEEeeecceeecCCC
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD---MVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~kl~DFGla~~~~~~ 1488 (1624)
|+++++|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+||+++.+ +.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999887643 57899999999999999999996 799999999999999764 47999999999866433
Q ss_pred CCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1489 DSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1489 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
. ......||+.|+|||...+ .++.++|||||||++|||+||+.||......+ .......... ..
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~------------~~ 241 (287)
T 2wei_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKY------------AF 241 (287)
T ss_dssp S--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC------------CC
T ss_pred C--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC------------CC
Confidence 2 2233468999999998765 48999999999999999999999987532211 1111111000 00
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.. .....++..+.+++.+|++.+|++|||+.|+++.
T Consensus 242 ~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DL-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CS-----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc-----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 0012234568899999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=349.32 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=170.6
Q ss_pred CCCCc-CCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc----CCeeEE
Q 047591 1335 NGFSE-SNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN----PGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~-~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----~~~~~l 1408 (1624)
++|.. .++||+|+||+||+|+.. +++.||||++.... .. ..+....++.++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 45666 357999999999999886 68999999986432 11 1222334667799999999999865 445799
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeecceee
Q 047591 1409 ILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~~ 1484 (1624)
||||+++|+|.+++...+ ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999998654 468999999999999999999997 79999999999999986 45699999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.... ......||+.|+|||++....++.++|||||||++|||+||+.||.......... . ....+..
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~---------~~~~~~~ 247 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-G---------MKRRIRL 247 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-h---------HHHhhhc
Confidence 6432 2234578999999999988899999999999999999999999996532211100 0 0000000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...... ......++..+.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 GQYGFP----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---CCC----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccC----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0001234566889999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=346.76 Aligned_cols=252 Identities=23% Similarity=0.271 Sum_probs=180.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.++..+++.++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 45677789999999999999885 68999999986432 2233445566667888999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+ ++.+..+.......+++..+..++.|+++||+|||+. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 99 4556555555456789999999999999999999961 389999999999999999999999999998664322
Q ss_pred cccccccccccccccccC-----CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1492 KQTMTLATIGYMAPEYGS-----EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~-----~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
......||+.|+|||++. ...++.++|||||||++|||+||+.||.........+........+ .
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------~ 249 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP----------L 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC----------C
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC----------C
Confidence 223456999999999874 5678999999999999999999999997532221111111111000 0
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
... ...++..+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LPG--------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCc--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 01234567889999999999999999999863
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=367.39 Aligned_cols=242 Identities=18% Similarity=0.174 Sum_probs=149.4
Q ss_pred CCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccc
Q 047591 111 NLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKR 190 (1624)
Q Consensus 111 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 190 (1624)
.+++++.|++++|.++...|..+..+++|++|+|++|.|++ +++..+..+++|++|+|++|.|++..|..|+++++|++
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence 45677777777777764444445667777777777777764 44444566777777777777777666666677777777
Q ss_pred cccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeeccccc
Q 047591 191 LSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM 270 (1624)
Q Consensus 191 L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~ 270 (1624)
|+|++|.+++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|.+++ +| ++.+++|+.|++++|.
T Consensus 128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~---~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSYNL 203 (597)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB-CC---GGGCTTCSEEECCSSC
T ss_pred EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC-cC---hhhhhhhhhhhcccCc
Confidence 7777777764444445667777777777777776666666666666666666666653 22 1234455555555554
Q ss_pred ccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCC
Q 047591 271 TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGN 350 (1624)
Q Consensus 271 l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N 350 (1624)
+++ +...+ +|+.|++++|.++. +|... .++|+.|+|++|
T Consensus 204 l~~-----l~~~~--------------------------------~L~~L~ls~n~l~~-~~~~~---~~~L~~L~L~~n 242 (597)
T 3oja_B 204 LST-----LAIPI--------------------------------AVEELDASHNSINV-VRGPV---NVELTILKLQHN 242 (597)
T ss_dssp CSE-----EECCT--------------------------------TCSEEECCSSCCCE-EECSC---CSCCCEEECCSS
T ss_pred ccc-----ccCCc--------------------------------hhheeeccCCcccc-ccccc---CCCCCEEECCCC
Confidence 432 12222 34444444444432 22221 245777777777
Q ss_pred ccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEcccccc
Q 047591 351 NLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQL 400 (1624)
Q Consensus 351 ~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l 400 (1624)
++++ +..++.+++|+.|+|++|.+++.+|..|+++++|++|+|++|++
T Consensus 243 ~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 290 (597)
T 3oja_B 243 NLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290 (597)
T ss_dssp CCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCC
T ss_pred CCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCC
Confidence 7775 35677777777777777777777776666666666666665554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=342.17 Aligned_cols=265 Identities=19% Similarity=0.261 Sum_probs=199.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CC-ceEEEEEeccchhhHHHHHHHHHHHHHhcCCCc------eeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DG-TNAAIKIFSLQEDRALKSFDAECEVMRRIRHRN------LAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~-~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpN------Iv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||+||+|+.. ++ +.||||+++.. ....+.+.+|++++++++|++ ++++++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57888899999999999999875 34 68999998643 344577889999999998876 99999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe-----------------
Q 047591 1407 ALILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL----------------- 1468 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----------------- 1468 (1624)
++||||+ +|++.+++.... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 667777776543 568999999999999999999996 799999999999999
Q ss_pred --cCCCcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh-
Q 047591 1469 --DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC- 1545 (1624)
Q Consensus 1469 --d~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~- 1545 (1624)
+.++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+..
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 67889999999999875432 23457999999999998889999999999999999999999999754322110
Q ss_pred hhhhhhhcCChhHHHHHh-hh------c-cCC-chHHHHH------------HHHHhHHHHHHHHHHccccCCCCCCCHH
Q 047591 1546 LKHWVEESLPDAVTDVID-AN------L-LSG-EEEADIA------------AKKKCMSSVMSLALKCSEEIPEERMNVK 1604 (1624)
Q Consensus 1546 l~~~~~~~~~~~~~~~~d-~~------l-~~~-~~~~~~~------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 1604 (1624)
.........|........ .. . ... ....... ....+...+.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 000011111211110000 00 0 000 0000000 0012245788999999999999999999
Q ss_pred HHHH
Q 047591 1605 DALA 1608 (1624)
Q Consensus 1605 evl~ 1608 (1624)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=351.18 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=194.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe------
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF------ 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~------ 1405 (1624)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56777889999999999999875 6889999998643 33446789999999999999999999999977654
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||++ |+|.+++.. .+++.++..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999998 688877643 48899999999999999999996 79999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh--cCCh------
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE--SLPD------ 1556 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~--~~~~------ 1556 (1624)
... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+ .+...... ..+.
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHTTC
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHH
Confidence 422 234578999999998766 678999999999999999999999997542211 11111100 0000
Q ss_pred --h-HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1557 --A-VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1557 --~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. ....+. .+..............++..+.+++.+|++.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQ-SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHH-TSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHH-hCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 001110 000000000000011345678899999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=348.69 Aligned_cols=203 Identities=27% Similarity=0.496 Sum_probs=176.0
Q ss_pred cCCCCCcceeecCCccceEEEEec--------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeccC
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP--------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKIISSCSNH 812 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 812 (1624)
.++|...+.||+|+||+||+|+.. ++..||||+++.... ...+.+.+|+++++++ +|||||+++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888899999999999999752 356799999975533 3457899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHK---------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
+..|+||||+++|+|.+++.... ..+++.++..++.||++||+|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999998653 2478999999999999999999984 59999999999999
Q ss_pred CCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 878 DDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 878 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
+.++.+||+|||+|+........ ......+|+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999976543322 2233467899999999988889999999999999999999 99998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=361.57 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=185.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEEEEe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
..+|...++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 345777889999999986655556789999999864322 2356899999999 799999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-----CCcEEEeeecceeecCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-----DMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-----~~~~kl~DFGla~~~~~ 1487 (1624)
|+ |+|.+++........+.++..++.||++||+|||+ .+|+||||||+|||++. ...+||+|||+|+....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 97 69999998766555555677899999999999996 79999999999999943 34689999999987653
Q ss_pred CCC--ccccccccccccccccccC---CCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1488 VDS--MKQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1488 ~~~--~~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
... .......||++|||||++. ...++.++|||||||++|||+| |+.||......... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~--~~~~~~~~------ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSL------ 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH--HHTTCCCC------
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH--HHhccCCc------
Confidence 321 2233467999999999987 4667889999999999999999 88898543221110 00000000
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...... ......+.+++.+||+.||++|||+.||++
T Consensus 248 ---~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 ---DCLHPE--------KHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---TTSCTT--------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cccCcc--------ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000 112344678999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=337.56 Aligned_cols=215 Identities=32% Similarity=0.515 Sum_probs=187.2
Q ss_pred hccccCHHHHHhhcCCCCCc------ceeecCCccceEEEEecCCCEEEEEEeeccc----chhHHHHHHHHHHHHhcCC
Q 047591 730 TWRRISYQELQRLTDGFSES------NLIGAGSFGSVYKATLPYGMNVAIKVFNLQL----DGAIKSFDAECEVLRRVRH 799 (1624)
Q Consensus 730 ~~~~~~~~el~~~t~~f~~~------~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H 799 (1624)
....|+++++.++|++|... +.||+|+||+||+|.. +++.||||++.... ....+.|.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34679999999999999988 8999999999999987 58899999986432 2345679999999999999
Q ss_pred CceeeeeeeeccCCeEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSH--KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 800 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
|||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999999743 23589999999999999999999984 59999999999999
Q ss_pred CCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 878 DDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 878 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
++++.+||+|||+++........ ......||+.|+|||...+ .++.++|||||||++|||+||+.||....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999876543222 2233469999999998764 58999999999999999999999997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=348.93 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=172.5
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 817 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|..+++++ +|||||++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999864 68999999997542 23456788999999998 69999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
|||||++|+|.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999997654 689999999999999999999994 5999999999999999999999999999864432
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .....+||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 178 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 178 GV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 22 23345799999999999888899999999999999999999999965
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=338.51 Aligned_cols=202 Identities=25% Similarity=0.478 Sum_probs=172.5
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|+..+.||+|+||+||+|+. .+++.||||++.... ....+.|.+|+.++++++||||+++++++.+++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46788899999999999999985 468999999986432 23456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999997654 689999999999999999999984 59999999999999999999999999998765443
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
........||+.|+|||.+....++.++|||||||++|||+||+.||...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 33334457999999999998888999999999999999999999999653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=349.65 Aligned_cols=201 Identities=18% Similarity=0.173 Sum_probs=173.8
Q ss_pred hhcCCCCCcceeecCCccceEEEE------ecCCCEEEEEEeecccchhHHHHHHHHHHHHhcC---CCceeeeeeeecc
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKAT------LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR---HRNLVKIISSCSN 811 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~------~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 811 (1624)
...++|...+.||+|+||+||+|. ..+++.||||++... ...++.+|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345778889999999999999994 456899999998744 3456888899988887 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC--------
Q 047591 812 HGFKALILEYMPQGSLEKWLYS----HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD-------- 879 (1624)
Q Consensus 812 ~~~~~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-------- 879 (1624)
.+..|+|||||++|+|.+++.. ....+++.++..|+.|+++||+|||+. +||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999975 234699999999999999999999984 5999999999999998
Q ss_pred ---CCceEEEeeeeeeccCCC-CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 880 ---DTVAHLSDFGISKLLDGE-DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 880 ---~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
++.+||+|||+|+..... ........+||++|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999865421 22233445799999999999988899999999999999999999999854
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=350.14 Aligned_cols=200 Identities=27% Similarity=0.346 Sum_probs=174.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 817 (1624)
.++|...++||+|+||+||+|+.. +++.||||+++... ....+.+.+|..+++++ +|||||++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888999999999999999865 58899999997543 22345688999999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999997654 689999999999999999999984 5999999999999999999999999999864332
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .....+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 207 ~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 207 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 22 23345799999999999999999999999999999999999999964
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=334.04 Aligned_cols=200 Identities=29% Similarity=0.455 Sum_probs=178.2
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|...+.||+|+||+||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46778899999999999999988899999999975433 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9999999987776799999999999999999999984 5999999999999999999999999999876543333333
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
...+|+.|+|||++....++.++||||+|+++|||+| |+.||..
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 4467889999999988889999999999999999999 9999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=352.31 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=197.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC-----------CCceeEEEeeecc
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-----------HRNLAKIVSSCSN 1402 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-----------HpNIv~l~g~~~~ 1402 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 56778899999999999999874 6889999998643 334567889999999887 8999999999875
Q ss_pred CC----eeEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCC-ceEEcCCCCCcEEec------C
Q 047591 1403 PG----FKALILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYST-SIIHCDLKPSNVLLD------D 1470 (1624)
Q Consensus 1403 ~~----~~~lV~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld------~ 1470 (1624)
.+ ..++||||+ +++|.+++... ...+++..+..|+.||+.||+|||+ . +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 43 789999999 89999999864 3458999999999999999999997 5 899999999999994 4
Q ss_pred CCcEEEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCcc-----chh
Q 047591 1471 DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTG-----EVC 1545 (1624)
Q Consensus 1471 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~-----~~~ 1545 (1624)
.+.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999876432 23357999999999998888999999999999999999999999753211 011
Q ss_pred hhhhhh--hcCChhHHH-------HHhh-hccCC-------chHHH----HHHHHHhHHHHHHHHHHccccCCCCCCCHH
Q 047591 1546 LKHWVE--ESLPDAVTD-------VIDA-NLLSG-------EEEAD----IAAKKKCMSSVMSLALKCSEEIPEERMNVK 1604 (1624)
Q Consensus 1546 l~~~~~--~~~~~~~~~-------~~d~-~l~~~-------~~~~~----~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 1604 (1624)
+..... ...|..... .++. ..... ..... ......++..+.+++.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 111110 011111000 0000 00000 00000 001134567888999999999999999999
Q ss_pred HHHHH
Q 047591 1605 DALAN 1609 (1624)
Q Consensus 1605 evl~~ 1609 (1624)
|+++.
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=342.84 Aligned_cols=202 Identities=25% Similarity=0.357 Sum_probs=176.7
Q ss_pred hhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeE
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 815 (1624)
...++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|..+++++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999875 68999999997542 23456788999999987 999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
|+||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999997643 689999999999999999999994 59999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 3222 23345799999999999888899999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=338.45 Aligned_cols=196 Identities=28% Similarity=0.375 Sum_probs=175.5
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999864 68999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 9999999999998654 689999999999999999999984 5999999999999999999999999999876432
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....+||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 2235799999999999988999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=340.43 Aligned_cols=243 Identities=21% Similarity=0.300 Sum_probs=190.1
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh------hHHHHHHHHHHHHHhc----CCCceeEEEeee
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED------RALKSFDAECEVMRRI----RHRNLAKIVSSC 1400 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~------~~~~~f~~E~~~l~~l----~HpNIv~l~g~~ 1400 (1624)
...++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34567888999999999999999874 688999999864322 1234567899999999 899999999999
Q ss_pred ccCCeeEEEEEe-cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec-CCCcEEEee
Q 047591 1401 SNPGFKALILQY-MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGD 1478 (1624)
Q Consensus 1401 ~~~~~~~lV~ey-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~kl~D 1478 (1624)
...+..++|||| +++++|.+++.+.+ .+++..+..++.||+.||+|||+ .+|+||||||+||+++ +++.+||+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999999 89999999998643 58999999999999999999997 6999999999999999 889999999
Q ss_pred ecceeecCCCCCccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1479 FGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1479 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
||+++...... .....||+.|+|||+..+..+ +.++|||||||++|||+||+.||.... .
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~--------- 244 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------E--------- 244 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H---------
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------H---------
Confidence 99998775432 234569999999998876665 458999999999999999999986421 0
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..+..... . ..++..+.+++.+||+.+|++|||++|+++.
T Consensus 245 ---~~~~~~~~-~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ---ILEAELHF-P--------AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---HHHTCCCC-C--------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---HhhhccCC-c--------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01100000 0 1233457789999999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=343.98 Aligned_cols=242 Identities=22% Similarity=0.270 Sum_probs=197.2
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh------hHHHHHHHHHHHHHhcC--CCceeEEEeeeccC
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED------RALKSFDAECEVMRRIR--HRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~------~~~~~f~~E~~~l~~l~--HpNIv~l~g~~~~~ 1403 (1624)
..++|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++ ||||+++++++.++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3467888899999999999999864 688999999864421 12356778999999996 59999999999999
Q ss_pred CeeEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec-CCCcEEEeeecc
Q 047591 1404 GFKALILQYMPQ-GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGI 1481 (1624)
Q Consensus 1404 ~~~~lV~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~kl~DFGl 1481 (1624)
+..++||||+.+ ++|.+++.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999986 8999999764 357899999999999999999996 7999999999999999 789999999999
Q ss_pred eeecCCCCCccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHH
Q 047591 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560 (1624)
Q Consensus 1482 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~ 1560 (1624)
++..... ......||+.|+|||++....+ +.++|||||||++|||+||+.||.... ..
T Consensus 197 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~----------- 255 (320)
T 3a99_A 197 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI----------- 255 (320)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH-----------
T ss_pred ccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh-----------
Confidence 9877532 2234569999999998876655 788999999999999999999986421 00
Q ss_pred HHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1561 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....... ...++..+.+++.+||+.+|++|||++|+++.
T Consensus 256 -~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 -IRGQVFF---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hcccccc---------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 01234567889999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=341.05 Aligned_cols=202 Identities=28% Similarity=0.463 Sum_probs=173.8
Q ss_pred CCCCCcceeecCCccceEEEEec----CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||+||+|... .+..||||++.... ....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 45777899999999999999874 34569999997543 33456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.++++.....+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 999999999999987766899999999999999999999994 59999999999999999999999999999875432
Q ss_pred Cc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SV--TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.. ......+|+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 22 1223356889999999988889999999999999999999 99998653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=339.63 Aligned_cols=200 Identities=22% Similarity=0.354 Sum_probs=178.5
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
..++|...+.||+|+||+||+|... +|+.||+|++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578889999999999999999865 68899999987543 344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC--CCceEEEeeeeeeccCCCC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD--DTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~--~~~~kl~DFGla~~~~~~~ 898 (1624)
|+++|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999987666799999999999999999999984 5999999999999997 7899999999999875443
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 2 2345799999999999888899999999999999999999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=336.65 Aligned_cols=205 Identities=27% Similarity=0.387 Sum_probs=176.9
Q ss_pred HhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 740 QRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 740 ~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
+...++|+..+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34567899999999999999999998889999999986543 2234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||++ |+|.+++......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 97 VFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 999998 589999987776799999999999999999999984 5999999999999999999999999999876533
Q ss_pred CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 898 DSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
.. ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||....
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2233468999999998765 568999999999999999999999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=341.76 Aligned_cols=199 Identities=28% Similarity=0.351 Sum_probs=175.4
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|..+++++ +|||||++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999875 68999999997543 23456788999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999997654 689999999999999999999984 59999999999999999999999999998643322
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....+||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 165 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 D-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 2 23345799999999999888899999999999999999999999964
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=366.40 Aligned_cols=336 Identities=22% Similarity=0.237 Sum_probs=187.8
Q ss_pred cccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCee
Q 047591 209 LTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYL 288 (1624)
Q Consensus 209 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 288 (1624)
+++++.|++++|.++. +|..++..+++|++|+|++|.+++..|..|+.+++|++|
T Consensus 50 l~~l~~l~l~~~~l~~-------------------------lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 104 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRK-------------------------LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKL 104 (597)
T ss_dssp GCCCSEEEESSCEESE-------------------------ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCCCCC-------------------------cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEE
Confidence 4566777777777663 333334444445555555555554445555555555555
Q ss_pred eccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcE
Q 047591 289 GLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTV 368 (1624)
Q Consensus 289 ~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ 368 (1624)
+|++|.+. +..|..+.++++|++|+|++|.|+ .+|..++.++++|++|+|++|++++.+|..|+++++|++
T Consensus 105 ~L~~n~l~--------~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 175 (597)
T 3oja_B 105 YMGFNAIR--------YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175 (597)
T ss_dssp ECCSSCCC--------CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred ECCCCcCC--------CCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcE
Confidence 55544332 223333444455555555555555 345444446677777777777777766667777777777
Q ss_pred EecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchh
Q 047591 369 LELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEY 448 (1624)
Q Consensus 369 L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~ 448 (1624)
|+|++|.+++.. ++.+++|+.|++++|.+.. +.....
T Consensus 176 L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~------------l~~~~~---------------------------- 212 (597)
T 3oja_B 176 LQLSSNRLTHVD---LSLIPSLFHANVSYNLLST------------LAIPIA---------------------------- 212 (597)
T ss_dssp EECTTSCCSBCC---GGGCTTCSEEECCSSCCSE------------EECCTT----------------------------
T ss_pred EECcCCCCCCcC---hhhhhhhhhhhcccCcccc------------ccCCch----------------------------
Confidence 777777777653 4455666666666665532 111122
Q ss_pred hccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccc
Q 047591 449 FYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNAL 528 (1624)
Q Consensus 449 L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l 528 (1624)
|+.|++++|.++. +|..+ ..+|+.|+|++|++++ +..++.+++|+.|+|++|++
T Consensus 213 ---------------------L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l 266 (597)
T 3oja_B 213 ---------------------VEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266 (597)
T ss_dssp ---------------------CSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred ---------------------hheeeccCCcccc-ccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCcc
Confidence 3333333333332 11111 1344445555555443 23444555555555555555
Q ss_pred cCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccc
Q 047591 529 QNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSI 608 (1624)
Q Consensus 529 ~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~ 608 (1624)
++.+|..|+++++|+.|+|++|++++ +|..+..+++|+.|||++|.++ .+|..++.+++|+.|+|++|++++ +| +
T Consensus 267 ~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~-~~--~ 341 (597)
T 3oja_B 267 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--L 341 (597)
T ss_dssp CEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--C
T ss_pred CCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC-cC--h
Confidence 55555555555555555555555544 3444455555666666666665 367777777777777777777774 33 5
Q ss_pred cCCccccccccccCCCCCCCchhhhccccccCCCCCCCCCccccCCcccccccccccccc
Q 047591 609 GGLKDLTYLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGSLR 668 (1624)
Q Consensus 609 ~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~~~~i~~~~~~~~~~~~~~~~n~~lcg~~~ 668 (1624)
+.+++|+.|++++|++++..+..+ |..+....+.++...|+...
T Consensus 342 ~~~~~L~~L~l~~N~~~~~~~~~~----------------~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 342 STHHTLKNLTLSHNDWDCNSLRAL----------------FRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp CTTCCCSEEECCSSCEEHHHHHHH----------------TTTCCTTTBCCCCCCCCTTC
T ss_pred hhcCCCCEEEeeCCCCCChhHHHH----------------HHHHhhhccccccccCCcch
Confidence 667778888888888876433321 33444556677888898743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=342.05 Aligned_cols=200 Identities=24% Similarity=0.367 Sum_probs=177.1
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccch------hHHHHHHHHHHHHhcCCCceeeeeeeeccCCe
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDG------AIKSFDAECEVLRRVRHRNLVKIISSCSNHGF 814 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 814 (1624)
..+.|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4577889999999999999999865 6899999999754321 24678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC----ceEEEeeee
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT----VAHLSDFGI 890 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~~kl~DFGl 890 (1624)
.|+||||+++|+|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999754 4789999999999999999999984 599999999999998877 799999999
Q ss_pred eeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 891 SKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 891 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
++....... ....+||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 166 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 988754322 2335799999999999888899999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=342.32 Aligned_cols=198 Identities=27% Similarity=0.372 Sum_probs=174.7
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999864 68999999987542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 999999999999764 3689999999999999999999984 59999999999999999999999999999765432
Q ss_pred cccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSE---GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~---~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....+||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 2334579999999998763 4589999999999999999999999964
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=351.29 Aligned_cols=203 Identities=28% Similarity=0.445 Sum_probs=176.3
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|++. +++.||||++..... ...+.|.+|+++|++++|||||+++++|.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356777899999999999999975 789999999875432 234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++|+|.++++..+..+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999999987766799999999999999999999994 5999999999999999999999999999875432211
Q ss_pred c-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 901 T-QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 901 ~-~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
. .....+|+.|+|||.+..+.++.++|||||||++|||+| |+.||...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 112346788999999988889999999999999999999 99998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=338.67 Aligned_cols=209 Identities=30% Similarity=0.484 Sum_probs=170.5
Q ss_pred HHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCe
Q 047591 737 QELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGF 814 (1624)
Q Consensus 737 ~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 814 (1624)
.+.....++|+..+.||+|+||+||+|+. +|+.||||++.... ....+.|.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33334456788899999999999999987 58899999987543 2345679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 815 KALILEYMPQGSLEKWLYSHKY--TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
.++||||+++|+|.+++..... .+++..+..++.|+++||+|||+.+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999976542 3899999999999999999999854 349999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
....... ......||+.|+|||++....++.++|||||||++|||+||+.||...
T Consensus 188 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 188 LKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred ccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6543321 223357999999999999888999999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=347.28 Aligned_cols=202 Identities=25% Similarity=0.473 Sum_probs=165.3
Q ss_pred CCCCCcceeecCCccceEEEEec----CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||+||+|+.. ++..||||+++... ....+.|.+|+.++++++|||||+++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999864 57789999997543 33456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.++++.....+++.++..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999999999987776799999999999999999999984 59999999999999999999999999998775432
Q ss_pred Ccc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SVT--QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
... .....+|+.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 112246788999999988889999999999999999998 99998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=342.02 Aligned_cols=200 Identities=23% Similarity=0.292 Sum_probs=176.2
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 817 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467899999999999999999875 47899999997542 23456788999999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999997654 689999999999999999999984 5999999999999999999999999999864332
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .....+||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 175 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 175 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 22 23345799999999999888999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=329.03 Aligned_cols=201 Identities=30% Similarity=0.424 Sum_probs=179.5
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
.++|...+.||+|+||+||+|+..++..||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 356888899999999999999988888999999975433 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 99999999987766799999999999999999999994 599999999999999999999999999987765544333
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
....+|+.|+|||......++.++||||||+++|||+| |+.||..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 44457788999999888889999999999999999999 9999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=341.85 Aligned_cols=201 Identities=27% Similarity=0.367 Sum_probs=170.7
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCC----eEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG----FKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+.. ++.||||++..... ....+.+|+.++++++|||||++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 56888899999999999999875 89999999975432 3345677999999999999999999998643 479999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG-------HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
||+++|+|.++++.. .+++.++..|+.|+++||+|||+. +.++|+||||||+|||++.++.+||+|||+|+
T Consensus 102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 999999999999764 489999999999999999999985 12369999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 893 LLDGEDSV-TQTMTLATFGYMAPEYGSE-----GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 893 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-----~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
........ ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 77544332 2233579999999998875 35677899999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=341.30 Aligned_cols=204 Identities=23% Similarity=0.355 Sum_probs=174.0
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468889999999999999999865 789999999875432 234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC-
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS- 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~- 899 (1624)
|+++|+|.+++... ..+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999998654 3689999999999999999999984 599999999999999999999999999987643221
Q ss_pred cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDEMFT 950 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~~~~ 950 (1624)
.......||+.|+|||++....+ +.++|||||||++|||+||+.||.....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 12234579999999999876665 7889999999999999999999975433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=340.01 Aligned_cols=196 Identities=26% Similarity=0.317 Sum_probs=175.9
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888899999999999999865 68999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999998654 689999999999999999999984 5999999999999999999999999999976543
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....+||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 2234799999999999888899999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=343.22 Aligned_cols=195 Identities=23% Similarity=0.400 Sum_probs=169.7
Q ss_pred CcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCC
Q 047591 748 ESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGS 826 (1624)
Q Consensus 748 ~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 826 (1624)
..+.||+|+||+||+|.. .+|+.||||++........+.|.+|++++++++|||||++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999986 4689999999987655566789999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee--CCCCceEEEeeeeeeccCCCCCccccc
Q 047591 827 LEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL--DDDTVAHLSDFGISKLLDGEDSVTQTM 904 (1624)
Q Consensus 827 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl--d~~~~~kl~DFGla~~~~~~~~~~~~~ 904 (1624)
|.+++......+++.++..++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 9999987766799999999999999999999984 59999999999999 6778999999999998754332 223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 4699999999999888999999999999999999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=338.21 Aligned_cols=284 Identities=21% Similarity=0.300 Sum_probs=178.4
Q ss_pred cCChhhHHHHHHHHHHhccCCccccccCCCCCCCCCCCCCCCCccceeeEecC--------CCCcEEEEecCCCCCCccC
Q 047591 34 ANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTCGS--------RHGRVTDLSIPNLGLGGTI 105 (1624)
Q Consensus 34 ~~~~~d~~aLl~~k~~~~~~p~~~~~~~W~~~~~~~~~~~~~~C~W~Gv~C~~--------~~~~v~~l~l~~~~l~g~i 105 (1624)
+...+|++||++||+++..||.++. ++|..+. ....++|.|.||+|+. ...+|+.|+|+++++. .+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~-~~w~~~~----~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~l 96 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWH-SAWRQAN----SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QF 96 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHH-HHHHHHT----TTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred ccCchHHHHHHHHHHhccCCchhhh-hhhcccc----cccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hc
Confidence 4678899999999999988887765 5785221 1246889999999953 3467788888887777 77
Q ss_pred CccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCC
Q 047591 106 PPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDC 185 (1624)
Q Consensus 106 p~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l 185 (1624)
|+.+++|++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|+. +..+++|++|+|++|++.+.+|..++..
T Consensus 97 p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~-l~~l~~L~~L~L~~n~~~~~~p~~~~~~ 173 (328)
T 4fcg_A 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPAS-IASLNRLRELSIRACPELTELPEPLAST 173 (328)
T ss_dssp CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGG-GGGCTTCCEEEEEEETTCCCCCSCSEEE
T ss_pred ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHH-HhcCcCCCEEECCCCCCccccChhHhhc
Confidence 777888888888888888887 77877777778888888877777 55554 4567777777777777777777665540
Q ss_pred CcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEee
Q 047591 186 SKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELN 265 (1624)
Q Consensus 186 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~ 265 (1624)
.++..|+++++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|.. +..+++|++|+
T Consensus 174 ---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~-l~~l~~L~~L~ 235 (328)
T 4fcg_A 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPA-IHHLPKLEELD 235 (328)
T ss_dssp ---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGG-GGGCTTCCEEE
T ss_pred ---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchh-hccCCCCCEEE
Confidence 01111223444555555555444 444444445555555555555442 3333 23455555555
Q ss_pred cccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEE
Q 047591 266 LRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRL 345 (1624)
Q Consensus 266 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L 345 (1624)
|++|.+.+.+|..++.+++|++|+|++|. +.+.+|..+.++++|+.|+|++|++.|.+|+.++ ++++|+.+
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~--------~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~-~L~~L~~l 306 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCS--------NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA-QLPANCII 306 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCT--------TCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG-GSCTTCEE
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCC--------chhhcchhhhcCCCCCEEeCCCCCchhhccHHHh-hccCceEE
Confidence 55555555555555555555555555443 3344555555555566666666666666666554 56666666
Q ss_pred EecCCccC
Q 047591 346 YLWGNNLS 353 (1624)
Q Consensus 346 ~Ls~N~l~ 353 (1624)
++..|.+.
T Consensus 307 ~l~~~~~~ 314 (328)
T 4fcg_A 307 LVPPHLQA 314 (328)
T ss_dssp ECCGGGSC
T ss_pred eCCHHHHH
Confidence 66655444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=343.35 Aligned_cols=200 Identities=21% Similarity=0.363 Sum_probs=178.5
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|... +|+.||+|++..........+.+|++++++++|||||++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467889999999999999999864 6899999999766544556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC--CCceEEEeeeeeeccCCCCC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD--DTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~--~~~~kl~DFGla~~~~~~~~ 899 (1624)
+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999999987666799999999999999999999984 5999999999999984 46799999999998754432
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 2234699999999999988999999999999999999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=337.93 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=166.0
Q ss_pred cCCCCCcceeecCCccceEEEEe----cCCCEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL----PYGMNVAIKVFNLQL----DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGF 814 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 814 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999986 478999999987542 2234568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeecc
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~ 894 (1624)
.|+||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999997654 688999999999999999999994 5999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 895 DGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 895 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 43322 22334699999999999888899999999999999999999999865
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=341.47 Aligned_cols=310 Identities=23% Similarity=0.256 Sum_probs=183.6
Q ss_pred cCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccc
Q 047591 233 VSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIF 312 (1624)
Q Consensus 233 l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~ 312 (1624)
++++++|++++|.++ .+|..++..+++|++|+|++|.+++..|..|+.+++|++|+|++|++.. ..|..+.
T Consensus 44 l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--------~~~~~~~ 114 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY--------LPPHVFQ 114 (390)
T ss_dssp GCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC--------CCTTTTT
T ss_pred cCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc--------CCHHHhc
Confidence 455666666666654 5666666667777777777777776666677777777777777665433 3344455
Q ss_pred cCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccE
Q 047591 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392 (1624)
Q Consensus 313 ~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~ 392 (1624)
++.+|++|+|++|+++ .+|..++..+++|++|+|++|++++..|..|.++++|++|+|++|++++.. ++.+++|+.
T Consensus 115 ~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~ 190 (390)
T 3o6n_A 115 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFH 190 (390)
T ss_dssp TCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSE
T ss_pred CCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccce
Confidence 5666666666666666 456555456777777777777777666666777777777777777776652 445566666
Q ss_pred EEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccE
Q 047591 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIA 472 (1624)
Q Consensus 393 L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~ 472 (1624)
|++++|.+... .... +|++
T Consensus 191 L~l~~n~l~~~------------~~~~-------------------------------------------------~L~~ 209 (390)
T 3o6n_A 191 ANVSYNLLSTL------------AIPI-------------------------------------------------AVEE 209 (390)
T ss_dssp EECCSSCCSEE------------ECCS-------------------------------------------------SCSE
T ss_pred eeccccccccc------------CCCC-------------------------------------------------cceE
Confidence 66666655321 1111 2333
Q ss_pred EeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccc
Q 047591 473 LSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRL 552 (1624)
Q Consensus 473 L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l 552 (1624)
|++++|+++. +|... .++|+.|+|++|++++. +.+..+++|+.|+|++|++++..|..|+++++|+.|+|++|++
T Consensus 210 L~l~~n~l~~-~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 284 (390)
T 3o6n_A 210 LDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284 (390)
T ss_dssp EECCSSCCCE-EECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCC
T ss_pred EECCCCeeee-ccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcC
Confidence 4444444432 12211 23444444444444432 3444455555555555555544455555555555555555555
Q ss_pred cccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCC
Q 047591 553 NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQG 626 (1624)
Q Consensus 553 ~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g 626 (1624)
++ +|..+..+++|+.||+++|+++ .+|..++.+++|+.|+|++|+++. +| +..+++|+.|++++|++++
T Consensus 285 ~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 285 VA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEH
T ss_pred cc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccc
Confidence 43 3444455555555555555555 366667777777777777777763 44 5667777777888887765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=334.01 Aligned_cols=199 Identities=23% Similarity=0.364 Sum_probs=175.8
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccch------hHHHHHHHHHHHHhcCCCceeeeeeeeccCCeE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDG------AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 815 (1624)
.+.|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888899999999999999865 6899999998754321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC----ceEEEeeeee
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT----VAHLSDFGIS 891 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~~kl~DFGla 891 (1624)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999754 4689999999999999999999984 599999999999999887 7999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... .....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 88754322 2234699999999999888899999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=335.63 Aligned_cols=196 Identities=25% Similarity=0.293 Sum_probs=166.5
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc--hhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD--GAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+..+.++ +|||||+++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999875 799999999864332 2334556666666665 8999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+ +|+|.+++......++|.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 6799999988777899999999999999999999984 59999999999999999999999999998765432
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
......||++|+|||++.+ .++.++|||||||++|||++|+.|+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2334469999999998765 78999999999999999999976653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=369.98 Aligned_cols=241 Identities=19% Similarity=0.315 Sum_probs=194.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc--CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCe-----e
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA--DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGF-----K 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~--~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~-----~ 1406 (1624)
++|...+.||+|+||+||+|++. +++.||||++... .....+.|.+|++++++++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67888899999999999999885 5889999988643 33456789999999999999999999999977655 6
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
++||||+++++|.+++.. .+++.+++.|+.||++||+|||+ .+||||||||+|||++++ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999988754 58999999999999999999996 799999999999999986 89999999998765
Q ss_pred CCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1487 GVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1487 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.. ....||++|||||++.++ ++.++|||||||++|||++|..|+....... .+..
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~--------- 287 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPED--------- 287 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTT---------
T ss_pred cC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------cccc---------
Confidence 32 345799999999987655 4899999999999999999998876422110 0100
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-VKDALANLKKIKTK 1616 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-~~evl~~L~~i~~~ 1616 (1624)
. ....+...+.+++.+||+.||++||+ ++++...|..+...
T Consensus 288 ---~------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 288 ---D------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ---C------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ---c------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0 00122356788999999999999995 66677777776543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=339.71 Aligned_cols=200 Identities=22% Similarity=0.355 Sum_probs=173.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL-----DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
+.|...+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4688889999999999999986 468999999986432 1135679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc---eEEEeeeee
Q 047591 818 ILEYMPQGSLEKWLYSH---KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV---AHLSDFGIS 891 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---~kl~DFGla 891 (1624)
|||||++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888643 23589999999999999999999984 5999999999999987654 999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... ......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 88754332 22345799999999999888899999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=342.77 Aligned_cols=213 Identities=25% Similarity=0.429 Sum_probs=180.4
Q ss_pred ccCHHHHHhhcCCCCCcceeecCCccceEEEEe------cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceee
Q 047591 733 RISYQELQRLTDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVK 804 (1624)
Q Consensus 733 ~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~ 804 (1624)
.+...+.+...++|...+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+++++++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344556666778999999999999999999973 2468999999975433 3456799999999999 7999999
Q ss_pred eeeeeccCC-eEEEEEEecCCCCHHHHHHhcCC-----------------------------------------------
Q 047591 805 IISSCSNHG-FKALILEYMPQGSLEKWLYSHKY----------------------------------------------- 836 (1624)
Q Consensus 805 l~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------- 836 (1624)
++++|.+.+ ..++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988755 48999999999999999976532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 837 ------------------TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 837 ------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
.+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 188999999999999999999994 59999999999999999999999999998764432
Q ss_pred C-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 S-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
. .......||+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 2 22334568999999999888889999999999999999999 99998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=340.20 Aligned_cols=201 Identities=20% Similarity=0.401 Sum_probs=176.3
Q ss_pred hhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
...++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567889999999999999999864 68999999997543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC---CceEEEeeeeeecc
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD---TVAHLSDFGISKLL 894 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~~kl~DFGla~~~ 894 (1624)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 106 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999999997643 689999999999999999999995 59999999999999865 45999999999876
Q ss_pred CCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 895 DGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 895 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... .....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 182 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 182 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp TTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 54322 2335799999999999888899999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=335.53 Aligned_cols=200 Identities=21% Similarity=0.284 Sum_probs=176.1
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788999999999999999985 5789999999875432 34688999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc-----eEEEeeeeeeccC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV-----AHLSDFGISKLLD 895 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-----~kl~DFGla~~~~ 895 (1624)
|+ +|+|.+++......+++.++..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+|+...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 9999999987666899999999999999999999985 5999999999999999887 9999999999765
Q ss_pred CCCCcc------cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 896 GEDSVT------QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 896 ~~~~~~------~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 433211 23457999999999999989999999999999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=330.55 Aligned_cols=208 Identities=28% Similarity=0.421 Sum_probs=170.6
Q ss_pred hcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHh--cCCCceeeeeeeecc----CCeE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRR--VRHRNLVKIISSCSN----HGFK 815 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~~ 815 (1624)
..++|...+.||+|+||+||+|+. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356788999999999999999987 6899999998643 33556677777776 799999999998643 3568
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEeCcCCCCCeeeCCCCceEEEeeee
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG-----HPTPVIHCDLKPSNVLLDDDTVAHLSDFGI 890 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IiHrDlKp~NILld~~~~~kl~DFGl 890 (1624)
++||||+++|+|.++++. ..+++..+.+|+.|++.||+|||.. +..+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999999999999954 3689999999999999999999932 125799999999999999999999999999
Q ss_pred eeccCCCCCcc---cccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCccCcC
Q 047591 891 SKLLDGEDSVT---QTMTLATFGYMAPEYGSEG------IVSTCGDVYSFGILMIETFTR----------KMPTDEMFTG 951 (1624)
Q Consensus 891 a~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~~~k~DvwS~Gvil~elltg----------~~P~~~~~~~ 951 (1624)
|+......... .....||+.|+|||++... .++.++|||||||++|||+|| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98765433221 2234799999999988766 456799999999999999999 7887665444
Q ss_pred cchH
Q 047591 952 ETSL 955 (1624)
Q Consensus 952 ~~~l 955 (1624)
....
T Consensus 240 ~~~~ 243 (301)
T 3q4u_A 240 DPSF 243 (301)
T ss_dssp SCCH
T ss_pred Ccch
Confidence 4333
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=341.80 Aligned_cols=199 Identities=29% Similarity=0.330 Sum_probs=166.0
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHH-HHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEV-LRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|..+ ++.++|||||++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888899999999999999875 58899999997543 2234556777776 5778999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999997644 688899999999999999999984 59999999999999999999999999998643322
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....+||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 194 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 194 S-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp C-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred C-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 2 23345799999999999988999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=346.87 Aligned_cols=201 Identities=22% Similarity=0.332 Sum_probs=175.5
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
..++|...+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456788999999999999999985 4789999999975532 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC---CCCceEEEeeeeeeccC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~~kl~DFGla~~~~ 895 (1624)
||||++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+|+...
T Consensus 89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999998754 689999999999999999999994 599999999999998 46789999999998775
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... .....||++|+|||++....++.++||||+||++|||++|+.||..
T Consensus 165 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 165 GEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp TTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 44322 2335799999999999888999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=335.33 Aligned_cols=198 Identities=26% Similarity=0.441 Sum_probs=174.2
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46788899999999999999986 578999999987542 22345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+ +|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 789999987654 689999999999999999999985 59999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. ....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||+.
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 2 233479999999999887665 7899999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=330.08 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=172.1
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
++|...+.||+|+||+||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999988899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
+++ +|.+++......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 985 99999987666799999999999999999999984 599999999999999999999999999987653322 2
Q ss_pred cccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 233468999999998865 45899999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=354.22 Aligned_cols=201 Identities=24% Similarity=0.355 Sum_probs=178.0
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|++++|||||++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457888899999999999999874 79999999997532 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 819 LEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||++|+|.+++.... ..+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997654 2489999999999999999999994 5999999999999999999999999999887543
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.. ....+||+.|+|||++....++.++|||||||++|||+||+.||...
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 32 23347999999999998888999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=351.82 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=178.3
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999874 69999999997542 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 819 LEYMPQGSLEKWLYSHK---YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
|||+++|+|.+++.... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 3689999999999999999999984 59999999999999999999999999999875
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
..... ....+||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 44322 23347999999999999889999999999999999999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=350.02 Aligned_cols=248 Identities=19% Similarity=0.199 Sum_probs=183.0
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCC-Ccee--------------
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRH-RNLA-------------- 1394 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~H-pNIv-------------- 1394 (1624)
+..|...++||+|+||+||+|++. +|+.||||++.... ....+.|.+|+.+++.++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345666789999999999999864 68999999987332 2336789999999999987 3211
Q ss_pred -EE------Eeeecc-----CCeeEEEEEecCCCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 047591 1395 -KI------VSSCSN-----PGFKALILQYMPQGSLEKWLY------SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456 (1624)
Q Consensus 1395 -~l------~g~~~~-----~~~~~lV~ey~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 1456 (1624)
.+ +.++.. ....+++|+++ +|+|.+++. ..+..+++..++.|+.||++||+|||+ .+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 11 111111 12345666654 689999884 224457888999999999999999996 799
Q ss_pred EEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccccccccccccccccc----------CCCCcCcccchHHHHHHH
Q 047591 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYG----------SEGIVSTSGDVYSFGILM 1526 (1624)
Q Consensus 1457 iHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~k~DV~SfGvil 1526 (1624)
|||||||+|||++.++.+||+|||+|+..... .....| +.|||||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999875432 334567 999999988 666789999999999999
Q ss_pred HHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHH
Q 047591 1527 METLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDA 1606 (1624)
Q Consensus 1527 ~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ev 1606 (1624)
|||+||+.||......+.. ... + ... ..++..+.+++.+||+.+|++|||+.|+
T Consensus 308 ~elltg~~Pf~~~~~~~~~-----~~~--------~-----~~~--------~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS-----EWI--------F-----RSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS-----GGG--------G-----SSC--------CCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHCCCCCCCcchhhhH-----HHH--------H-----hhc--------ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999999999753221110 000 0 000 0123567889999999999999999998
Q ss_pred HHH--HHHHHHH
Q 047591 1607 LAN--LKKIKTK 1616 (1624)
Q Consensus 1607 l~~--L~~i~~~ 1616 (1624)
++. +++++..
T Consensus 362 l~~~~~~~~~~~ 373 (413)
T 3dzo_A 362 METPEYEQLRTE 373 (413)
T ss_dssp TTSHHHHHHHHH
T ss_pred HhCHHHHHHHHH
Confidence 764 4554443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=362.64 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=196.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc------CCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN------PGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~------~~~~ 1406 (1624)
++|...+.||+|+||+||+|... +|+.||||+++.. .....+.|.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56888899999999999999874 6889999988643 34456789999999999999999999998765 6678
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCc---EEEeeecc
Q 047591 1407 ALILQYMPQGSLEKWLYSHN--YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMV---AHLGDFGI 1481 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~kl~DFGl 1481 (1624)
++||||+++|+|.+++.... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 357888999999999999999996 79999999999999997664 99999999
Q ss_pred eeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1482 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
|+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...|..........+.
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------C
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchhh
Confidence 98765432 22345799999999999999999999999999999999999999965321 1122211110000000
Q ss_pred H-hhhccC-----CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHH
Q 047591 1562 I-DANLLS-----GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDAL 1607 (1624)
Q Consensus 1562 ~-d~~l~~-----~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl 1607 (1624)
. ...... .............+..+.+++.+|++.||++|||+.|++
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0 000000 000000000112456788999999999999999998843
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=341.47 Aligned_cols=229 Identities=18% Similarity=0.250 Sum_probs=181.2
Q ss_pred hcCCCCCcceeecCCccceEEEEecC------CCEEEEEEeecccchh-----------HHHHHHHHHHHHhcCCCceee
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLPY------GMNVAIKVFNLQLDGA-----------IKSFDAECEVLRRVRHRNLVK 804 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~~------g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 804 (1624)
..++|...+.||+|+||+||+|.... ++.||||++....... ...+..|+..+++++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 4789999987543211 123445666777889999999
Q ss_pred eeeeeccC----CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC--
Q 047591 805 IISSCSNH----GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD-- 878 (1624)
Q Consensus 805 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-- 878 (1624)
+++++... ...|+||||+ +|+|.+++......+++.++..|+.|++.||+|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 99998764 4589999999 9999999988767899999999999999999999994 599999999999999
Q ss_pred CCCceEEEeeeeeeccCCCCCcc------cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCcCc
Q 047591 879 DDTVAHLSDFGISKLLDGEDSVT------QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952 (1624)
Q Consensus 879 ~~~~~kl~DFGla~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~ 952 (1624)
.++.+||+|||+|+.+....... .....||+.|||||++.+..++.++|||||||++|||+||+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 88999999999998765332211 12345999999999999888999999999999999999999999754332
Q ss_pred chHHHHHHHHhhhhhhhccchhc
Q 047591 953 TSLKKWVEESLRLAVTEVVDAEL 975 (1624)
Q Consensus 953 ~~l~~~~~~~~~~~~~~~~d~~L 975 (1624)
.....+.....+..+.++++.++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~ 290 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCF 290 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHS
T ss_pred HHHHHHHHHHhhhhHHHHHHHhc
Confidence 22333344444445556666554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=332.40 Aligned_cols=201 Identities=29% Similarity=0.486 Sum_probs=171.6
Q ss_pred CCCCCcceeecCCccceEEEEe-----cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeecc--CCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-----PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN--HGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 816 (1624)
++|+..+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||++++++|.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5677889999999999999984 3689999999986655666789999999999999999999999854 35589
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+||||+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 99999999999999988776799999999999999999999984 599999999999999999999999999987654
Q ss_pred CCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSV--TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... ......+|..|+|||.+....++.++|||||||++|||+||..|+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 3221 12234578889999999888899999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=329.69 Aligned_cols=202 Identities=28% Similarity=0.447 Sum_probs=175.8
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
.++|...+.||+|+||+||+|...++..||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 356788899999999999999998888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999987666799999999999999999999984 599999999999999999999999999987654332223
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
....+|+.|+|||++....++.++||||||+++|||+| |+.||...
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 33457889999999888889999999999999999999 99998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=325.43 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=172.6
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999864 689999999975432 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++ ++.+++......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9985 77777766666799999999999999999999995 599999999999999999999999999987653322
Q ss_pred ccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEGI-VSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~-~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++.+.. ++.++|||||||++|||+||+.|+..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 223457899999999886655 79999999999999999999988643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=324.94 Aligned_cols=230 Identities=13% Similarity=0.081 Sum_probs=183.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
+.|...+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46777889999999999999886 48999999996432 344578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++++|.+++... ....+..+|+.|++.||+|||+ .+|+||||||+|||++.++.+||+++
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~----------- 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP----------- 173 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC-----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec-----------
Confidence 999999999999542 3556788899999999999997 79999999999999999999999744
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchh--hhhhhhhcCChhHHHHHhhhccC
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVC--LKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~--l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
+|++| ++.++|||||||++|||+||+.||......... .........+. .
T Consensus 174 ----------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~---------- 225 (286)
T 3uqc_A 174 ----------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-P---------- 225 (286)
T ss_dssp ----------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCC-H----------
T ss_pred ----------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCC-h----------
Confidence 34443 689999999999999999999999764322110 00000110000 0
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
......++..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 226 ------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 226 ------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp ------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 01112345668899999999999999 999999999987643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=332.87 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=169.1
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC-------
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG------- 813 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 813 (1624)
.++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456888899999999999999975 79999999997543 335578999999999999999999999885433
Q ss_pred --------------------------------------------------eEEEEEEecCCCCHHHHHHhcCC--CCCHH
Q 047591 814 --------------------------------------------------FKALILEYMPQGSLEKWLYSHKY--TLNIQ 841 (1624)
Q Consensus 814 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~ 841 (1624)
..++||||+++|+|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999986542 35666
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC-----------ccccccccccc
Q 047591 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-----------VTQTMTLATFG 910 (1624)
Q Consensus 842 ~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~ 910 (1624)
.+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999984 599999999999999999999999999998765421 11233469999
Q ss_pred ccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 911 Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
|+|||++....++.++|||||||++|||+||..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999998888999999999999999999998774
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=329.60 Aligned_cols=196 Identities=32% Similarity=0.488 Sum_probs=165.1
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|...+.||+|+||+||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++.+. .++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCC
Confidence 45777899999999999999875 789999998643 3457899999999999999999999998854 799999999
Q ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc-eEEEeeeeeeccCCCCCc
Q 047591 824 QGSLEKWLYSHKY--TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV-AHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 824 ~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-~kl~DFGla~~~~~~~~~ 900 (1624)
+|+|.+++..... .+++..++.++.|+++||+|||+.++.+|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986543 4688899999999999999999976567999999999999998886 799999999865432
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....||+.|+|||++....++.++|||||||++|||+||+.||...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 12346999999999998889999999999999999999999999754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=353.75 Aligned_cols=202 Identities=26% Similarity=0.470 Sum_probs=177.6
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|.+. ++..||||+++... ...+.|.+|+++|++++|||||+++++|.+.+..|+||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 355777899999999999999976 48899999997543 2457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 822 MPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|++|+|.++++... ..+++..+..|+.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 99999999998643 4689999999999999999999994 5999999999999999999999999999987554333
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
......+|+.|+|||++..+.++.++|||||||++|||+| |+.||...
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 3333457789999999988889999999999999999999 99998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=330.18 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=160.4
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888899999999999999864 689999999975432 344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 821 YMPQGSLEKWLYSHK-----YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
|++ |+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999987542 3588999999999999999999984 59999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3322 2233468999999998865 4689999999999999999999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=330.72 Aligned_cols=200 Identities=26% Similarity=0.405 Sum_probs=173.1
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC--eEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG--FKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888899999999999999875 58999999997543 234577889999999999999999999987655 789999
Q ss_pred EecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee----CCCCceEEEeeeeeec
Q 047591 820 EYMPQGSLEKWLYSHKY--TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKL 893 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl----d~~~~~kl~DFGla~~ 893 (1624)
||+++|+|.+++..... .+++.++..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986542 389999999999999999999994 59999999999999 8888899999999998
Q ss_pred cCCCCCcccccccccccccCccccC--------CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGS--------EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
...... .....||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 755432 22346999999999865 567899999999999999999999999653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=352.66 Aligned_cols=202 Identities=27% Similarity=0.470 Sum_probs=175.7
Q ss_pred hcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
..++|...+.||+|+||+||+|.+..+..||||+++... ...+.|.+|+.+|++++|||||++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346677889999999999999999888999999997543 34578999999999999999999999987 5568999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 822 MPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|++|+|.++++... ..+++.++.+++.|||.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 99999999997543 3688999999999999999999984 5999999999999999999999999999876543222
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
......+|+.|+|||++..+.++.++|||||||++|||+| |+.||...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 2233457889999999988889999999999999999999 99998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=339.17 Aligned_cols=202 Identities=28% Similarity=0.480 Sum_probs=175.7
Q ss_pred cCCCCCcceeecCCccceEEEEec--------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeccC
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP--------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKIISSCSNH 812 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 812 (1624)
.++|...+.||+|+||+||+|+.. .+..||||++..... ...+.+.+|+++++++ +|||||+++++|.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888899999999999999852 246799999975533 3457799999999999 999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHK---------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
+..++||||+++|+|.+++.... ..+++.++..|+.|++.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999998654 3489999999999999999999984 59999999999999
Q ss_pred CCCCceEEEeeeeeeccCCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 878 DDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 878 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
++++.+||+|||+|+....... .......||+.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999987654332 22233467899999999988899999999999999999999 9999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=340.64 Aligned_cols=201 Identities=26% Similarity=0.430 Sum_probs=172.1
Q ss_pred CCCCCcceeecCCccceEEEEec------CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
++|...+.||+|+||+||+|++. +++.||||++.... ......+.+|+.++++++|||||++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56778899999999999999843 46789999986443 334567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC---ceEEEe
Q 047591 817 LILEYMPQGSLEKWLYSHK------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT---VAHLSD 887 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~~kl~D 887 (1624)
+||||+++|+|.+++.... ..+++.+++.|+.|+++||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999998643 3589999999999999999999995 599999999999999554 599999
Q ss_pred eeeeeccCCCC-CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 888 FGISKLLDGED-SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 888 FGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
||+|+...... ........||+.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998653221 112233468999999999988889999999999999999998 9999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=335.77 Aligned_cols=200 Identities=26% Similarity=0.357 Sum_probs=161.1
Q ss_pred hhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
.+.++|...+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||++++++|.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 35678899999999999999999875 58899999997543 3356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC---CCceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD---DTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~~kl~DFGla~~~~~ 896 (1624)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 128 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999997654 689999999999999999999984 5999999999999975 88999999999987643
Q ss_pred CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 32 223356999999999999888999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=351.51 Aligned_cols=201 Identities=26% Similarity=0.359 Sum_probs=166.5
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQ---LDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++... .......+.+|+.++++++||||++++++|.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46788899999999999999986 46899999999753 223446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
||||++|+|.+++.... .+++..+..|+.|+++||+|||+. .+||||||||+|||++.++.+||+|||+|+......
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999999997654 689999999999999999999972 249999999999999999999999999998654332
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....+||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 304 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 304 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 2 22345799999999999888999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-33 Score=323.63 Aligned_cols=200 Identities=29% Similarity=0.449 Sum_probs=177.2
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|...+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46778899999999999999988889999999975433 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 9999999987766789999999999999999999984 5999999999999999999999999999876543222223
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
...+|+.|+|||......++.++||||||+++|||+| |+.||..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 3457889999999888889999999999999999999 8999864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=331.03 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=149.3
Q ss_pred CccEEEeecccCCC--CCCCcccccCCCccEEEecC-CccCCcCcccccCCCCCcEEecCCccccccCcccccccccccE
Q 047591 316 NIEVIQLYGNHLSG--NLPSSTGINLPNLLRLYLWG-NNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392 (1624)
Q Consensus 316 ~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~ 392 (1624)
+++.|+|++|+++| .+|..+. ++++|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|+++++|++
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~-~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred eEEEEECCCCCccCCcccChhHh-CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 45555555555555 5555443 455555555553 5555555555555555555555555555555555555555555
Q ss_pred EEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccE
Q 047591 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIA 472 (1624)
Q Consensus 393 L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~ 472 (1624)
|+|++|++ .+.+|..|+++++|++
T Consensus 130 L~Ls~N~l--------------------------------------------------------~~~~p~~~~~l~~L~~ 153 (313)
T 1ogq_A 130 LDFSYNAL--------------------------------------------------------SGTLPPSISSLPNLVG 153 (313)
T ss_dssp EECCSSEE--------------------------------------------------------ESCCCGGGGGCTTCCE
T ss_pred EeCCCCcc--------------------------------------------------------CCcCChHHhcCCCCCe
Confidence 55444433 2234445555566666
Q ss_pred EeccCCccCCCccchhcccc-ccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCcc
Q 047591 473 LSLYQNQLASTIPTTVGKLQ-NLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNR 551 (1624)
Q Consensus 473 L~L~~N~l~g~iP~~~~~l~-~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 551 (1624)
|+|++|+++|.+|..++.+. +|++|+|++|+++|.+|..+..++ |+.|+|++|++++.+|..|+.+++|+.|+|++|+
T Consensus 154 L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 232 (313)
T 1ogq_A 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred EECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCc
Confidence 66666666666666666665 666666666666666666666665 6666666666666666666666666666666666
Q ss_pred ccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCC-CCC
Q 047591 552 LNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNG-FQG 626 (1624)
Q Consensus 552 l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~-l~g 626 (1624)
+++.+|. +..+.+|+.|||++|+++|.+|.+++.+++|+.|+|++|+++|.+|.. +++++|+.|++++|+ +.|
T Consensus 233 l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 233 LAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp ECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred eeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 6655444 555666666666666666666666666666666666666666666654 556666666666665 443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-33 Score=333.91 Aligned_cols=201 Identities=28% Similarity=0.441 Sum_probs=168.0
Q ss_pred CCCCCcceeecCCccceEEEEec-CCC----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGM----NVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
++|+..+.||+|+||+||+|+.. +|+ +||+|.+.... ....+.|.+|+.++++++|||||+++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888899999999999999853 444 46888775433 234578999999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++......+++..++.|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999988777899999999999999999999985 5999999999999999999999999999877544
Q ss_pred CCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 898 DSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 898 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 322 2223457889999999988899999999999999999999 99999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=327.49 Aligned_cols=199 Identities=28% Similarity=0.405 Sum_probs=167.4
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--------------------------hhHHHHHHHHHHHH
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--------------------------GAIKSFDAECEVLR 795 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~ 795 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46788899999999999999986 4689999999864321 12356899999999
Q ss_pred hcCCCceeeeeeeecc--CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCC
Q 047591 796 RVRHRNLVKIISSCSN--HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPS 873 (1624)
Q Consensus 796 ~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~ 873 (1624)
+++||||+++++++.+ .+..|+||||+++|+|.+++. ...+++.++..++.|+++||+|||+. +|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999999986 568899999999999988653 34689999999999999999999995 5999999999
Q ss_pred CeeeCCCCceEEEeeeeeeccCCCCCcccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 874 NVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGI---VSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 874 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
|||++.++.+||+|||+++........ .....||+.|+|||.+.... ++.++|||||||++|||+||+.||..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999877544322 23357999999999986654 47889999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=344.64 Aligned_cols=197 Identities=33% Similarity=0.485 Sum_probs=171.3
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCC-eEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG-FKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|.+. |+.||||+++... ..+.|.+|+++|++++|||||+++++|.+.+ ..|+||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456778899999999999999875 7899999997543 4578999999999999999999999987654 78999999
Q ss_pred cCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 822 MPQGSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|++|+|.++++.... .+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999987654 378999999999999999999994 5999999999999999999999999999865322
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCccC
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEMF 949 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~~ 949 (1624)
.....+|+.|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 122357889999999988899999999999999999999 999997643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-33 Score=334.45 Aligned_cols=202 Identities=22% Similarity=0.421 Sum_probs=167.5
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeccCC----
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD---GAIKSFDAECEVLRRVRHRNLVKIISSCSNHG---- 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 813 (1624)
..++|...+.||+|+||+||+|+. .+++.||||++..... ...+.|.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346788999999999999999986 5789999999975432 33467899999999999999999999987554
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+||||+++|+|.++++... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3499999999999999997654 689999999999999999999984 599999999999999999999999999987
Q ss_pred cCCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSV--TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....... ......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 6543221 12234699999999999888899999999999999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=325.32 Aligned_cols=202 Identities=25% Similarity=0.402 Sum_probs=163.1
Q ss_pred cCCCCCcceeecCCccceEEEEec----CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
.++|...+.||+|+||+||+|... .+..||||++.... ....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEE
Confidence 457888899999999999999864 24579999986543 2345679999999999999999999999854 56799
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 9999999999999987766799999999999999999999994 5999999999999999999999999999877554
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.........+|+.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 3333334467889999999888889999999999999999997 99998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=335.46 Aligned_cols=206 Identities=26% Similarity=0.424 Sum_probs=177.3
Q ss_pred HHhhcCCCCCcceeecCCccceEEEEec------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeecc
Q 047591 739 LQRLTDGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSN 811 (1624)
Q Consensus 739 l~~~t~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 811 (1624)
+....++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.|.+|++++++++||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999864 348899999975533 345679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 047591 812 HGFKALILEYMPQGSLEKWLYSHK-----------------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868 (1624)
Q Consensus 812 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHr 868 (1624)
.+..++||||+++|+|.+++.... ..+++.+++.|+.|+++||+|||+. +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 999999999999999999998642 4689999999999999999999984 59999
Q ss_pred cCCCCCeeeCCCCceEEEeeeeeeccCCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 047591 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTD 946 (1624)
Q Consensus 869 DlKp~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~ 946 (1624)
||||+||++++++.+||+|||+++....... .......||+.|+|||++....++.++|||||||++|||+| |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643321 12233468999999999888889999999999999999999 999986
Q ss_pred c
Q 047591 947 E 947 (1624)
Q Consensus 947 ~ 947 (1624)
.
T Consensus 279 ~ 279 (343)
T 1luf_A 279 G 279 (343)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=327.56 Aligned_cols=192 Identities=23% Similarity=0.371 Sum_probs=151.7
Q ss_pred cceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeEEEEEEecCCCC
Q 047591 749 SNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFKALILEYMPQGS 826 (1624)
Q Consensus 749 ~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gs 826 (1624)
.+.||+|+||+||+|... +|+.||||++... ....+.+|+.+++++. |||||++++++.++...|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999874 6899999999743 3456789999999997 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC---ceEEEeeeeeeccCCCCCcccc
Q 047591 827 LEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT---VAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 827 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
|.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 999998754 689999999999999999999984 599999999999998765 899999999987654332 223
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
...||+.|+|||++....++.++|||||||++|||+||+.||...
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 346899999999999889999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=337.80 Aligned_cols=200 Identities=26% Similarity=0.343 Sum_probs=172.8
Q ss_pred CCCCCcceeecCCccceEEEEe----cCCCEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCe
Q 047591 744 DGFSESNLIGAGSFGSVYKATL----PYGMNVAIKVFNLQL----DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGF 814 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 814 (1624)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788889999999999999986 378999999986432 23345678899999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeecc
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~ 894 (1624)
.++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999999997654 689999999999999999999984 5999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 895 DGEDSVTQTMTLATFGYMAPEYGSE--GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 895 ~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
............||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 5443333444579999999999874 4578999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=334.19 Aligned_cols=209 Identities=26% Similarity=0.336 Sum_probs=184.2
Q ss_pred hccccCHHHHHhhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcC-----CCcee
Q 047591 730 TWRRISYQELQRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-----HRNLV 803 (1624)
Q Consensus 730 ~~~~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv 803 (1624)
....+++++.....++|...+.||+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++ |||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 456778888888899999999999999999999986 46899999998743 234466788999999996 99999
Q ss_pred eeeeeeccCCeEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC---
Q 047591 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD--- 879 (1624)
Q Consensus 804 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~--- 879 (1624)
++++++...+..++||||+ +++|.+++.... ..+++.++..|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 9999999999999999999 899999998654 3589999999999999999999984 5999999999999986
Q ss_pred ----------------------CCceEEEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHH
Q 047591 880 ----------------------DTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIE 937 (1624)
Q Consensus 880 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~e 937 (1624)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 788999999999875432 223469999999999998899999999999999999
Q ss_pred HHcCCCCCCc
Q 047591 938 TFTRKMPTDE 947 (1624)
Q Consensus 938 lltg~~P~~~ 947 (1624)
|+||+.||..
T Consensus 252 ll~g~~pf~~ 261 (360)
T 3llt_A 252 LYTGSLLFRT 261 (360)
T ss_dssp HHHSSCSCCC
T ss_pred HHHCCCCCCC
Confidence 9999999965
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=343.57 Aligned_cols=199 Identities=26% Similarity=0.437 Sum_probs=175.6
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367888899999999999999875 79999999997542 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999999754 4689999999999999999999984 59999999999999999999999999999875432
Q ss_pred CcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. ....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||+.
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 2 233579999999999877665 7899999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=333.48 Aligned_cols=195 Identities=31% Similarity=0.389 Sum_probs=172.3
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
+.|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577889999999999999985 578999999997543 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||++ |+|.+++......+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9998 689998876666899999999999999999999995 5999999999999999999999999999876432
Q ss_pred cccccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYG---SEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~---~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....||+.|+|||++ ..+.++.++|||||||++|||+||+.||..
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 234699999999987 357789999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=333.73 Aligned_cols=199 Identities=24% Similarity=0.286 Sum_probs=164.6
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467888999999999999999875 789999999975432 336788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc--eEEEeeeeeeccCCCCC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV--AHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~--~kl~DFGla~~~~~~~~ 899 (1624)
+++|+|.+++...+ .+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+|||+|+......
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 99999999997654 689999999999999999999984 5999999999999987765 9999999998543222
Q ss_pred cccccccccccccCccccCCCCCCcc-hhHHHHHHHHHHHHcCCCCCCcc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTC-GDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k-~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
......||+.|+|||++.+..++.+ +|||||||++|||+||+.||...
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 1233469999999999877777655 89999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-33 Score=335.53 Aligned_cols=200 Identities=23% Similarity=0.392 Sum_probs=167.7
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCC--CceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRH--RNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV 818 (1624)
.+.|+..+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++.+++..|+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35688889999999999999998889999999987543 2345779999999999987 9999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|| +.+|+|.+++.... .+++.++..|+.|+++||+|||+. +|+||||||+|||++ ++.+||+|||+|+......
T Consensus 88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 99 56789999998754 689999999999999999999984 599999999999997 5789999999998775433
Q ss_pred Cc-ccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 899 SV-TQTMTLATFGYMAPEYGSE-----------GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 899 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.. ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 22 2234579999999998753 67899999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=335.59 Aligned_cols=203 Identities=21% Similarity=0.283 Sum_probs=175.8
Q ss_pred cCCCCCcceeecC--CccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAG--SFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G--~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
.++|+..+.||+| +||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568888999999 99999999875 69999999997653 2345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 818 ILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
|||||++|+|.+++.... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999997652 4689999999999999999999984 599999999999999999999999998865432
Q ss_pred CCC------cccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 897 EDS------VTQTMTLATFGYMAPEYGSE--GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 897 ~~~------~~~~~~~gt~~Y~aPE~~~~--~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
... .......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 111 11123468999999999876 67899999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=320.36 Aligned_cols=201 Identities=24% Similarity=0.452 Sum_probs=157.9
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46788899999999999999986 579999999997542 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999987766799999999999999999999984 59999999999999999999999999998765332
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .....||+.|+|||......++.++|||||||++|||+||+.||..
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 2234689999999999888899999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=320.89 Aligned_cols=202 Identities=25% Similarity=0.417 Sum_probs=171.1
Q ss_pred cCCCCCcceeecCCccceEEEEecC----CCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
.++|...+.||+|+||+||+|+... +..||||++.... ....+.|.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4678888999999999999998542 3469999987553 23457899999999999999999999998764 4689
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 9999999999999987766799999999999999999999984 5999999999999999999999999999876554
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.........+|+.|+|||......++.++|||||||++|||+| |+.||...
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 3333344567889999999888889999999999999999999 99998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=357.65 Aligned_cols=200 Identities=23% Similarity=0.292 Sum_probs=176.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 817 (1624)
.++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467889999999999999999864 68899999997532 23456788999999987 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.++++..+ .+++.++..|+.||+.||+|||+. +||||||||+|||+|.++.+||+|||+|+.....
T Consensus 420 V~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999999998654 689999999999999999999994 5999999999999999999999999999865433
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. .....+||+.|||||++....++.++|||||||++|||+||+.||..
T Consensus 496 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 496 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp TC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 22 23345799999999999999999999999999999999999999965
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-32 Score=319.15 Aligned_cols=200 Identities=29% Similarity=0.461 Sum_probs=172.0
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccch-------hHHHHHHHHHHHHhcCCCceeeeeeeeccCCe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDG-------AIKSFDAECEVLRRVRHRNLVKIISSCSNHGF 814 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 814 (1624)
.++|...+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788889999999999999986 47899999998654321 1267899999999999999999999997765
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc-----eEEEeee
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV-----AHLSDFG 889 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-----~kl~DFG 889 (1624)
++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ .+|+||||||+||+++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999999999877778999999999999999999999853 34999999999999988776 9999999
Q ss_pred eeeccCCCCCcccccccccccccCcccc--CCCCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 890 ISKLLDGEDSVTQTMTLATFGYMAPEYG--SEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 890 la~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
+++..... .....||+.|+|||++ ....++.++|||||||++|||+||+.||....
T Consensus 175 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 175 LSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp TCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99854332 2335699999999987 45567899999999999999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=318.78 Aligned_cols=200 Identities=24% Similarity=0.343 Sum_probs=176.4
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
..++|...+.||+|+||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467888899999999999999865 578999999986655566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee---CCCCceEEEeeeeeeccCCC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~~kl~DFGla~~~~~~ 897 (1624)
|+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999987654 689999999999999999999984 59999999999999 78899999999999876543
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.. .....||+.|+|||.+.+ .++.++||||||+++|||+||+.||...
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 163 KM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp SC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 32 233469999999998765 4899999999999999999999998653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=329.98 Aligned_cols=201 Identities=25% Similarity=0.409 Sum_probs=169.7
Q ss_pred CCCCCcceeecCCccceEEEEec-CCC----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGM----NVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
++|...+.||+|+||+||+|+.. +++ +||+|.+.... ....+.+.+|+.++++++||||++++++|.+ +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 46778899999999999999864 444 37888775432 2334567889999999999999999999874 56899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++......+++..+..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 9999999999999987666799999999999999999999995 5999999999999999999999999999987544
Q ss_pred CCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 898 DSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 898 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 322 2234568889999999988889999999999999999999 99999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=335.67 Aligned_cols=201 Identities=23% Similarity=0.321 Sum_probs=162.5
Q ss_pred hhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecc--cchhHHHHHHHHHHHHhcC-CCceeeeeeeeccC--Ce
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQ--LDGAIKSFDAECEVLRRVR-HRNLVKIISSCSNH--GF 814 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~ 814 (1624)
...++|...+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+++++. |||||++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 47899999998543 2334567889999999997 99999999998654 36
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeecc
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~ 894 (1624)
.|+|||||+ |+|.++++.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999998 6999999763 688999999999999999999985 5999999999999999999999999999876
Q ss_pred CCCC--------------------CcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 895 DGED--------------------SVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 895 ~~~~--------------------~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... ....+..+||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 4311 111233579999999998865 6789999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=347.34 Aligned_cols=201 Identities=28% Similarity=0.472 Sum_probs=168.9
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
.++|...+.||+|+||+||+|.+..+..||||+++.... ..+.|.+|+++|++++|||||++++++.+ +..++|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 356777889999999999999998888899999975432 34689999999999999999999999976 6689999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 823 PQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 823 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
++|+|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999753 34589999999999999999999984 59999999999999999999999999998765433322
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.....+|+.|+|||++..+.++.++|||||||++|||+| |+.||...
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 333457889999999888889999999999999999999 99998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=331.20 Aligned_cols=200 Identities=25% Similarity=0.369 Sum_probs=174.7
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeeccC
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--------GAIKSFDAECEVLRRVRHRNLVKIISSCSNH 812 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 812 (1624)
..++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356788999999999999999985 5689999999875421 1334677899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeee
Q 047591 813 GFKALILEYMPQG-SLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891 (1624)
Q Consensus 813 ~~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla 891 (1624)
+..++||||+.+| +|.+++.... .+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999877 9999997654 689999999999999999999994 5999999999999999999999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... .....||+.|+|||++....+ +.++|||||||++|||++|+.||..
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 87754332 223569999999999877766 8899999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=338.36 Aligned_cols=199 Identities=23% Similarity=0.390 Sum_probs=168.0
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcC--CCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVR--HRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~ 819 (1624)
+.|...+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++ |||||++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3588889999999999999998889999999997543 234578999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
| +.+|+|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+|+.......
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 56889999998754 788889999999999999999984 599999999999996 57899999999987754332
Q ss_pred c-ccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 900 V-TQTMTLATFGYMAPEYGSE-----------GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 900 ~-~~~~~~gt~~Y~aPE~~~~-----------~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
. .....+||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 2 2234579999999998753 46899999999999999999999999653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=322.28 Aligned_cols=229 Identities=21% Similarity=0.291 Sum_probs=177.2
Q ss_pred CCCcC-CeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHH-HhcCCCceeEEEeeecc----CCeeEE
Q 047591 1336 GFSES-NLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVM-RRIRHRNLAKIVSSCSN----PGFKAL 1408 (1624)
Q Consensus 1336 ~f~~~-~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l-~~l~HpNIv~l~g~~~~----~~~~~l 1408 (1624)
+|... ++||+|+||+||+|... +++.||||+++.. ..+.+|++++ +..+||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 34444 67999999999999874 6889999998632 4567888888 56699999999999876 667899
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeecceee
Q 047591 1409 ILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~~ 1484 (1624)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+|+.
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999998754 468999999999999999999996 79999999999999998 78999999999875
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
.. +..++.++|||||||++|||+||+.||......... ......
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~----------- 213 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTR----------- 213 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCCS-----------
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--HHHHHH-----------
Confidence 43 134688999999999999999999999653211100 000000
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
...............++..+.+++.+||+.||++|||+.|+++.
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 -IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000011123456678899999999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=321.35 Aligned_cols=200 Identities=17% Similarity=0.219 Sum_probs=176.0
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46788999999999999999985 578999999986443 234678999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc-----eEEEeeeeeeccC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV-----AHLSDFGISKLLD 895 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-----~kl~DFGla~~~~ 895 (1624)
|+ +|+|.+++......+++.++..|+.|+++||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 9999999987766799999999999999999999984 5999999999999987776 9999999998775
Q ss_pred CCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 896 GEDSV------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 896 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 43321 123456999999999998888999999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=331.15 Aligned_cols=204 Identities=27% Similarity=0.476 Sum_probs=174.4
Q ss_pred hcCCCCCcceeecCCccceEEEEe------cCCCEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCC
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHG 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 813 (1624)
..++|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999985 245689999997543 23457899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCC
Q 047591 814 FKALILEYMPQGSLEKWLYSHKY----------------------TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLK 871 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlK 871 (1624)
..++||||+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999986542 378999999999999999999994 59999999
Q ss_pred CCCeeeCCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 872 PSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 872 p~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
|+||+++.++.+||+|||+++........ ......||+.|+|||.+..+.++.++|||||||++|||+| |+.||...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999876543322 2233468899999999888889999999999999999998 99998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=335.73 Aligned_cols=195 Identities=22% Similarity=0.327 Sum_probs=161.5
Q ss_pred CCCCCc-ceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHH-hcCCCceeeeeeeecc----CCeEE
Q 047591 744 DGFSES-NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLR-RVRHRNLVKIISSCSN----HGFKA 816 (1624)
Q Consensus 744 ~~f~~~-~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~----~~~~~ 816 (1624)
++|... +.||+|+||+||+|... +|+.||||++... ..+.+|++++. ..+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456554 68999999999999864 6899999998632 45678998874 4589999999998865 56789
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC---CCceEEEeeeeee
Q 047591 817 LILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD---DTVAHLSDFGISK 892 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~~kl~DFGla~ 892 (1624)
+|||||++|+|.+++.... ..+++.++..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998654 3689999999999999999999984 5999999999999998 7899999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
...... .....+||+.|+|||++....++.++|||||||++|||+||+.||...
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 765332 223457999999999999899999999999999999999999999653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=332.18 Aligned_cols=207 Identities=25% Similarity=0.354 Sum_probs=171.9
Q ss_pred HHhhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCceeeeeeeeccC
Q 047591 739 LQRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL-----DGAIKSFDAECEVLRRVRHRNLVKIISSCSNH 812 (1624)
Q Consensus 739 l~~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 812 (1624)
+..+.++|...+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999986 468899999986432 23457899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 047591 813 GFKALILEYMPQGSLEKWLYSH---------------------------------------KYTLNIQQRLDIMIDVASA 853 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~g 853 (1624)
+..++||||+++|+|.+++... ...+++..+..|+.|+++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521 1123567788899999999
Q ss_pred HHHHhcCCCCCeEeCcCCCCCeeeCCCC--ceEEEeeeeeeccCCCCC---cccccccccccccCccccCC--CCCCcch
Q 047591 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDT--VAHLSDFGISKLLDGEDS---VTQTMTLATFGYMAPEYGSE--GIVSTCG 926 (1624)
Q Consensus 854 L~yLH~~~~~~IiHrDlKp~NILld~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~--~~~~~k~ 926 (1624)
|+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... .......||+.|+|||++.. ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999995 599999999999998776 899999999987543211 12234579999999998764 6789999
Q ss_pred hHHHHHHHHHHHHcCCCCCCcc
Q 047591 927 DVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 927 DvwS~Gvil~elltg~~P~~~~ 948 (1624)
|||||||++|||+||+.||...
T Consensus 258 DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=319.78 Aligned_cols=198 Identities=26% Similarity=0.496 Sum_probs=163.2
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccc----hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD----GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||.||+|... |+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999875 89999999865432 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC--------CCceEEEeeeee
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD--------DTVAHLSDFGIS 891 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~--------~~~~kl~DFGla 891 (1624)
||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+..+|+||||||+||+++. ++.+||+|||++
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 86 EFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp ECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999999999853 36899999999999999999999966455999999999999986 678999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... ....||+.|+|||++....++.++||||||+++|||+||+.||..
T Consensus 164 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 164 REWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred cccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 87654322 234699999999998888899999999999999999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=325.37 Aligned_cols=199 Identities=24% Similarity=0.368 Sum_probs=176.2
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccch------hHHHHHHHHHHHHhcCCCceeeeeeeeccCCeE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDG------AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 815 (1624)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888899999999999999865 6899999998754321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC----ceEEEeeeee
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT----VAHLSDFGIS 891 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~~kl~DFGla 891 (1624)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999764 4689999999999999999999984 599999999999999888 7999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... .....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 87654322 2334699999999999888899999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=322.79 Aligned_cols=200 Identities=29% Similarity=0.427 Sum_probs=169.5
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc-----hhHHHHHHHHHHHHhcC---CCceeeeeeeeccC
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD-----GAIKSFDAECEVLRRVR---HRNLVKIISSCSNH 812 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 812 (1624)
++++|+..+.||+|+||+||+|+. .+|+.||||++..... .....+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999986 5789999999874321 12346778888877765 99999999999765
Q ss_pred C-----eEEEEEEecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEE
Q 047591 813 G-----FKALILEYMPQGSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLS 886 (1624)
Q Consensus 813 ~-----~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~ 886 (1624)
. ..++||||++ |+|.+++..... .+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5799999997 699999986543 489999999999999999999995 49999999999999999999999
Q ss_pred eeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 887 DFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 887 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
|||+|+....... .....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999987654322 2345799999999999888899999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=323.19 Aligned_cols=194 Identities=23% Similarity=0.369 Sum_probs=170.6
Q ss_pred CCCCCcceeecCCccceEEEEec-CC-------CEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YG-------MNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 815 (1624)
++|...+.||+|+||+||+|+.. ++ ..||+|++........+.|.+|++++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56778899999999999999864 23 57999999766556668899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc--------eEEEe
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV--------AHLSD 887 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~--------~kl~D 887 (1624)
++||||+++|+|.+++......+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999988766699999999999999999999984 5999999999999998887 99999
Q ss_pred eeeeeccCCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 888 FGISKLLDGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 888 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
||+++..... ....||+.|+|||++.. ..++.++|||||||++|||+||..|+
T Consensus 165 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 165 PGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp CCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9998765332 23458999999998876 67899999999999999999965554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=327.41 Aligned_cols=203 Identities=29% Similarity=0.454 Sum_probs=176.0
Q ss_pred cCCCCCcceeecCCccceEEEEe------cCCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 815 (1624)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999975 245889999997543 23457789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCC
Q 047591 816 ALILEYMPQGSLEKWLYSHK-----------------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKP 872 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp 872 (1624)
++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 99999999999999998643 2388999999999999999999984 599999999
Q ss_pred CCeeeCCCCceEEEeeeeeeccCCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 873 SNVLLDDDTVAHLSDFGISKLLDGEDSVT-QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 873 ~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
+||++++++.+||+|||+++......... .....+|+.|+|||......++.++|||||||++|||+| |+.||...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998775443322 233457889999999888889999999999999999999 99998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=329.24 Aligned_cols=200 Identities=23% Similarity=0.343 Sum_probs=166.9
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccch-hHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDG-AIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
++|...+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56888899999999999999875 7899999998654322 223456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
++ |+|.+++......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 98 599999988777799999999999999999999984 599999999999999999999999999986543322 2
Q ss_pred cccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 233468999999998765 56899999999999999999999999653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=326.35 Aligned_cols=202 Identities=27% Similarity=0.497 Sum_probs=174.2
Q ss_pred cCCCCCcceeecCCccceEEEEe--------cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeccC
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL--------PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKIISSCSNH 812 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~--------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 812 (1624)
.++|...+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 36788889999999999999986 3467899999975432 3456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHKY---------------TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
+..++||||+++|+|.+++..... .+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986532 388999999999999999999984 59999999999999
Q ss_pred CCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 878 DDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 878 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
+.++.+||+|||+++........ ......+|+.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 99999999999999876544322 1233457889999999888889999999999999999999 9999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=324.57 Aligned_cols=203 Identities=27% Similarity=0.454 Sum_probs=176.9
Q ss_pred cCCCCCcceeecCCccceEEEEe------cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGF 814 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 814 (1624)
.++|...+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788889999999999999974 3568999999975543 3457799999999999 99999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 815 KALILEYMPQGSLEKWLYSHKY-----------------TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
.++||||+++|+|.+++..... .+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999986542 489999999999999999999994 59999999999999
Q ss_pred CCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 878 DDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 878 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
+.++.+||+|||+++........ ......||+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999877554332 2233457889999999888889999999999999999999 99998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=324.63 Aligned_cols=211 Identities=27% Similarity=0.420 Sum_probs=170.3
Q ss_pred HHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhc--CCCceeeeeeeeccC--
Q 047591 737 QELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV--RHRNLVKIISSCSNH-- 812 (1624)
Q Consensus 737 ~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~-- 812 (1624)
..-....++|+..+.||+|+||+||+|+.. |+.||||++.... ...+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 333445678999999999999999999875 8999999986432 24455666666654 899999999998876
Q ss_pred --CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEeCcCCCCCeeeCCCCceEE
Q 047591 813 --GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH-----PTPVIHCDLKPSNVLLDDDTVAHL 885 (1624)
Q Consensus 813 --~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~IiHrDlKp~NILld~~~~~kl 885 (1624)
...++||||+++|+|.++++.. .+++.++..++.|++.||+|||+.. .++|+||||||+|||++.++.+||
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6889999999999999999764 5899999999999999999999851 236999999999999999999999
Q ss_pred EeeeeeeccCCCCCcc---cccccccccccCccccCCCCCCcc------hhHHHHHHHHHHHHcC----------CCCCC
Q 047591 886 SDFGISKLLDGEDSVT---QTMTLATFGYMAPEYGSEGIVSTC------GDVYSFGILMIETFTR----------KMPTD 946 (1624)
Q Consensus 886 ~DFGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~k------~DvwS~Gvil~elltg----------~~P~~ 946 (1624)
+|||+|+......... .....||+.|+|||++.....+.+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998765433221 123479999999999877666554 9999999999999999 66665
Q ss_pred ccCcCcc
Q 047591 947 EMFTGET 953 (1624)
Q Consensus 947 ~~~~~~~ 953 (1624)
.......
T Consensus 264 ~~~~~~~ 270 (337)
T 3mdy_A 264 DLVPSDP 270 (337)
T ss_dssp TTSCSSC
T ss_pred hhcCCCC
Confidence 5444333
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=322.52 Aligned_cols=201 Identities=26% Similarity=0.327 Sum_probs=165.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD---GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478899999999999999999865 689999999875432 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++++|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999997653 689999999999999999999994 59999999999999999999999999998765543
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
........||+.|+|||++....++.++||||||+++|||+||+.||..
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 3333345799999999999888999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=341.58 Aligned_cols=197 Identities=24% Similarity=0.297 Sum_probs=165.2
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccC------
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNH------ 812 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 812 (1624)
..++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999985 468999999997542 33456789999999999999999999998644
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
...|+|||||++ +|.+.+.. .+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 467999999986 57776643 488999999999999999999995 59999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...... ..+..+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 765432 23345799999999999888999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=322.80 Aligned_cols=204 Identities=26% Similarity=0.462 Sum_probs=180.1
Q ss_pred hhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
...++|...+.||+|+||+||+|... ++..||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567888899999999999999875 48899999997543 34578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 820 EYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999998643 4589999999999999999999985 59999999999999999999999999998876554
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
........+|+.|+|||+.....++.++||||||+++|||+| |+.||...
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 444444568889999999988889999999999999999999 99998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=328.79 Aligned_cols=207 Identities=26% Similarity=0.475 Sum_probs=161.3
Q ss_pred HHhhcCCCCCcceeecCCccceEEEEecC-C---CEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCceeeeeeeeccC
Q 047591 739 LQRLTDGFSESNLIGAGSFGSVYKATLPY-G---MNVAIKVFNLQ--LDGAIKSFDAECEVLRRVRHRNLVKIISSCSNH 812 (1624)
Q Consensus 739 l~~~t~~f~~~~~iG~G~~G~Vy~~~~~~-g---~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 812 (1624)
+....++|...+.||+|+||+||+|+... + ..||||++... .....+.|.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33446789999999999999999998653 3 37999998754 234567899999999999999999999999876
Q ss_pred CeE------EEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC
Q 047591 813 GFK------ALILEYMPQGSLEKWLYSHK-----YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT 881 (1624)
Q Consensus 813 ~~~------~lV~Ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 881 (1624)
... ++||||+++|+|.+++.... ..+++.++..|+.|+++||+|||+. +|+||||||+|||+++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 99999999999999996532 2589999999999999999999994 599999999999999999
Q ss_pred ceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 882 VAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 882 ~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.+||+|||+|+........ ......+|+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 9999999999876543322 1223457889999999988889999999999999999999 89998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=315.69 Aligned_cols=200 Identities=21% Similarity=0.396 Sum_probs=176.1
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
..++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999864 68999999997543 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc---eEEEeeeeeeccC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV---AHLSDFGISKLLD 895 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---~kl~DFGla~~~~ 895 (1624)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 84 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999987654 689999999999999999999994 5999999999999986654 9999999998765
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... .....||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 4322 2335699999999999988899999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=329.92 Aligned_cols=209 Identities=24% Similarity=0.306 Sum_probs=173.5
Q ss_pred ccCHHHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccc-----------hhHHHHHHHHHHHHhcCCCc
Q 047591 733 RISYQELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD-----------GAIKSFDAECEVLRRVRHRN 801 (1624)
Q Consensus 733 ~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~n 801 (1624)
+...+++..+.++|...+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456788899999999999999999999999988899999999854321 12367999999999999999
Q ss_pred eeeeeeeec-----cCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCee
Q 047591 802 LVKIISSCS-----NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVL 876 (1624)
Q Consensus 802 iv~l~~~~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NIL 876 (1624)
|+++++++. .....|+||||++ |+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 999999983 3446899999998 699999987766799999999999999999999995 5999999999999
Q ss_pred eCCCCceEEEeeeeeeccCCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 877 LDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 877 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
++.++.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999998654332 2233568999999998766 6789999999999999999999999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=331.83 Aligned_cols=200 Identities=26% Similarity=0.454 Sum_probs=160.4
Q ss_pred CCCcceeecCCccceEEEEec--CC--CEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeecc-CCeEEEEE
Q 047591 746 FSESNLIGAGSFGSVYKATLP--YG--MNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSN-HGFKALIL 819 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~~--~g--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~ 819 (1624)
|...+.||+|+||+||+|+.. ++ ..||||.+.... ....+.|.+|+.++++++|||||+++++|.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 455689999999999999863 22 468999986433 3456789999999999999999999998754 56789999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.++++.....+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999987777789999999999999999999984 599999999999999999999999999987643321
Q ss_pred c---ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 900 V---TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 900 ~---~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
. ......+|+.|+|||++....++.++|||||||++|||+| |..||...
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 1 1223457889999999988899999999999999999999 66777543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=354.00 Aligned_cols=194 Identities=27% Similarity=0.462 Sum_probs=165.5
Q ss_pred eeecCCccceEEEEec---CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCCCC
Q 047591 751 LIGAGSFGSVYKATLP---YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGS 826 (1624)
Q Consensus 751 ~iG~G~~G~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 826 (1624)
.||+|+||+||+|.+. ++..||||+++... ....+.|.+|+++|++++|||||+++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 46789999997543 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc--ccc
Q 047591 827 LEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT--QTM 904 (1624)
Q Consensus 827 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~--~~~ 904 (1624)
|.+++......+++.++..|+.||++||+|||+. +||||||||+|||+++++.+||+|||+|+......... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 9999987766799999999999999999999984 59999999999999999999999999998765433221 122
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 905 ~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
..+|+.|+|||++..+.++.++|||||||++|||+| |+.||...
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 346789999999988899999999999999999998 99999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=341.37 Aligned_cols=197 Identities=25% Similarity=0.335 Sum_probs=155.8
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeec-----cCCe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCS-----NHGF 814 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-----~~~~ 814 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467899999999999999999864 68999999986532 234577899999999999999999999984 3357
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeecc
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~ 894 (1624)
.|+||||+. |+|.+++... ..+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999985 7999999754 4689999999999999999999995 5999999999999999999999999999876
Q ss_pred CCCCC--------------------------cccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHcCCCC
Q 047591 895 DGEDS--------------------------VTQTMTLATFGYMAPEYG-SEGIVSTCGDVYSFGILMIETFTRKMP 944 (1624)
Q Consensus 895 ~~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~~~k~DvwS~Gvil~elltg~~P 944 (1624)
..... ...+..+||+.|+|||++ ....++.++|||||||++|||+||..|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 43211 112335789999999975 566799999999999999999995444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=324.54 Aligned_cols=201 Identities=23% Similarity=0.328 Sum_probs=167.9
Q ss_pred CCCCC-cceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSE-SNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~-~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
+.|.. .+.||+|+||+||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45665 37899999999999985 47899999999766555567899999999985 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc---eEEEeeeeeeccCCC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV---AHLSDFGISKLLDGE 897 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---~kl~DFGla~~~~~~ 897 (1624)
|+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 999999999997654 689999999999999999999995 5999999999999998775 999999999865422
Q ss_pred CC------cccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 898 DS------VTQTMTLATFGYMAPEYGSE-----GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 898 ~~------~~~~~~~gt~~Y~aPE~~~~-----~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 11 11123469999999998754 56889999999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=325.29 Aligned_cols=201 Identities=23% Similarity=0.267 Sum_probs=170.4
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeec----cCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS----NHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~lV 818 (1624)
++|...+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 5688889999999999999986 578999999987665556678999999999999999999999986 34578999
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 819 LEYMPQGSLEKWLYS---HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
|||+++|+|.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999976 345689999999999999999999995 59999999999999999999999999987653
Q ss_pred CCCCc--------ccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSV--------TQTMTLATFGYMAPEYGSEGI---VSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ......||+.|+|||.+.... ++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 21110 012235799999999876543 68999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=316.46 Aligned_cols=212 Identities=22% Similarity=0.357 Sum_probs=178.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888899999999999999875 68999999997543 2345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC-
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS- 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~- 899 (1624)
|+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999998653 3689999999999999999999984 599999999999999999999999999986543221
Q ss_pred cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHHH
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKW 958 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~~ 958 (1624)
.......||+.|+|||......+ +.++||||||+++|||+||+.||............|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh
Confidence 11233569999999999876665 789999999999999999999997644333333333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=323.24 Aligned_cols=200 Identities=27% Similarity=0.454 Sum_probs=172.1
Q ss_pred CCCCCcceeecCCccceEEEEe-----cCCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccC--CeE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-----PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNH--GFK 815 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 815 (1624)
+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3467788999999999999983 468999999997543 23457899999999999999999999999876 668
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
++||||+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999999999999977666799999999999999999999984 59999999999999999999999999998876
Q ss_pred CCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 896 GEDSV--TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 896 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
..... ......||..|+|||++....++.++|||||||++|||+||+.|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 54321 2233468889999999888889999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=328.16 Aligned_cols=205 Identities=25% Similarity=0.427 Sum_probs=177.6
Q ss_pred HHHHhhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc--------hhHHHHHHHHHHHHhc-CCCceeeee
Q 047591 737 QELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD--------GAIKSFDAECEVLRRV-RHRNLVKII 806 (1624)
Q Consensus 737 ~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~ 806 (1624)
.......++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999875 799999999875431 1245688999999999 799999999
Q ss_pred eeeccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEE
Q 047591 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLS 886 (1624)
Q Consensus 807 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~ 886 (1624)
+++......|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999999764 3689999999999999999999984 59999999999999999999999
Q ss_pred eeeeeeccCCCCCcccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 887 DFGISKLLDGEDSVTQTMTLATFGYMAPEYGS------EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 887 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
|||+++....... .....||+.|+|||++. ...++.++|||||||++|||+||+.||..
T Consensus 243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999987754332 23357999999999864 33588999999999999999999999864
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=319.68 Aligned_cols=305 Identities=25% Similarity=0.407 Sum_probs=147.5
Q ss_pred CCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCccccccccc
Q 047591 134 WLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELM 213 (1624)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 213 (1624)
..+++|++|++++|.++. ++. +..+++|++|++++|++++ +|. +..+++|++|+|++|.++. +| .+.++++|+
T Consensus 41 ~~l~~L~~L~l~~~~i~~-~~~--~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 41 EELESITKLVVAGEKVAS-IQG--IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHTTCSEEECCSSCCCC-CTT--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred hhcccccEEEEeCCcccc-chh--hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 355666666666666653 221 3456666666666666653 333 5566666666666666553 33 355555555
Q ss_pred ceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCC
Q 047591 214 ELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDN 293 (1624)
Q Consensus 214 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N 293 (1624)
+|+|++|++++ +|. +.++++|++|++++|.....++ . +..+++|++|++++|
T Consensus 114 ~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-------------------------~-~~~l~~L~~L~l~~~ 165 (347)
T 4fmz_A 114 ELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-------------------------P-LSNMTGLNYLTVTES 165 (347)
T ss_dssp EEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-------------------------G-GTTCTTCCEEECCSS
T ss_pred EEECcCCcccC-chh-hccCCceeEEECCCCCCccccc-------------------------c-hhhCCCCcEEEecCC
Confidence 55555555553 222 4444444444444443332222 2 444444444444444
Q ss_pred cccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCC
Q 047591 294 QLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSR 373 (1624)
Q Consensus 294 ~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 373 (1624)
++.++. . +.++.+|+.|++++|.+++ ++. ...+++|+.|++++|++++..+ +..+++|++|+|++
T Consensus 166 ~~~~~~---------~-~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 230 (347)
T 4fmz_A 166 KVKDVT---------P-IANLTDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230 (347)
T ss_dssp CCCCCG---------G-GGGCTTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred CcCCch---------h-hccCCCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccC
Confidence 433211 0 2233333333333333332 111 1234455555555555554322 44555555555555
Q ss_pred ccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCC
Q 047591 374 NLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGS 453 (1624)
Q Consensus 374 N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~ 453 (1624)
|.+++..+ +..+++|++|++++|+++.
T Consensus 231 n~l~~~~~--~~~l~~L~~L~l~~n~l~~--------------------------------------------------- 257 (347)
T 4fmz_A 231 NKITDLSP--LANLSQLTWLEIGTNQISD--------------------------------------------------- 257 (347)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCC---------------------------------------------------
T ss_pred CccCCCcc--hhcCCCCCEEECCCCccCC---------------------------------------------------
Confidence 55554433 4444444444444443321
Q ss_pred cccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCc
Q 047591 454 CELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIP 533 (1624)
Q Consensus 454 n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP 533 (1624)
+ +.+..+++|++|++++|++++. +.+..+++|++|+|++|++++..|..++++++|+.|+|++|++++..|
T Consensus 258 ------~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 258 ------I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp ------C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred ------C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 0 1233444555555555555432 234555555555555555555555555555555555555555554333
Q ss_pred cccccccCCccccccCccc
Q 047591 534 TCLANLTSLRALNLSSNRL 552 (1624)
Q Consensus 534 ~~~~~l~~L~~L~Ls~N~l 552 (1624)
+..+++|+.|++++|.+
T Consensus 329 --~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 329 --LASLSKMDSADFANQVI 345 (347)
T ss_dssp --GGGCTTCSEESSSCC--
T ss_pred --hhhhhccceeehhhhcc
Confidence 55555555555555554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=320.61 Aligned_cols=201 Identities=26% Similarity=0.462 Sum_probs=174.7
Q ss_pred hcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
..++|...+.||+|+||.||+|...++..||||++.... ...+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 346788889999999999999998888899999987543 235789999999999999999999999875 457999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 822 MPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999996532 2589999999999999999999984 5999999999999999999999999999887654333
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
......+|+.|+|||....+.++.++|||||||++|||+| |+.||..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 3334457889999999888889999999999999999999 8999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=316.60 Aligned_cols=197 Identities=22% Similarity=0.395 Sum_probs=170.1
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccC--CeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNH--GFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. |+.||||++.... ....+.|.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46778899999999999999985 8999999997653 23456799999999999999999999999877 7789999
Q ss_pred EecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 820 EYMPQGSLEKWLYSHKY-TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
||+++|+|.+++..... .+++.++..|+.|++.||+|||+.+ .+|+||||||+||++++++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~- 166 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP- 166 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeeccc-
Confidence 99999999999987543 5899999999999999999999853 34999999999999999999999999987653322
Q ss_pred CcccccccccccccCccccCCCCCC---cchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVS---TCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~---~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
...||+.|+|||.+.....+ .++|||||||++|||+||+.||...
T Consensus 167 -----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 167 -----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp -----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred -----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 23689999999988765444 3899999999999999999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=327.22 Aligned_cols=201 Identities=26% Similarity=0.411 Sum_probs=176.4
Q ss_pred CCCCCcceeecCCccceEEEEe-----cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeec--cCCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-----PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCS--NHGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~ 816 (1624)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4677889999999999999984 468899999998665556678999999999999999999999886 556789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+||||+++|+|.+++......+++.++..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999987666799999999999999999999984 599999999999999999999999999997754
Q ss_pred CCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSV--TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... ......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 3322 22334688899999998888899999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=315.99 Aligned_cols=199 Identities=28% Similarity=0.421 Sum_probs=172.7
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
+.++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4567889999999999999999864 57899999986432 2234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999997653 689999999999999999999984 5999999999999999999999999998765432
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....||+.|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 2 2334689999999999888899999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=317.60 Aligned_cols=198 Identities=28% Similarity=0.407 Sum_probs=168.8
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
++|...+.||+|+||+||+|+.. ++..||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888899999999999999864 689999999876542 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee---CCCCceEEEeeeeeeccC
Q 047591 822 MPQGSLEKWLYSH---KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 822 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~~kl~DFGla~~~~ 895 (1624)
+++|+|.+++... ...+++..+..|+.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998643 35789999999999999999999984 59999999999999 456789999999998765
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... .....||+.|+|||.+. +.++.++|||||||++|||+||+.||..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 4322 23346999999999875 5689999999999999999999999865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=336.56 Aligned_cols=200 Identities=26% Similarity=0.347 Sum_probs=168.4
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccC-----C
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNH-----G 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 813 (1624)
..++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999864 68899999997532 23456889999999999999999999998766 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+||||++ |+|.+++... ..+++..+..|+.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 6899999997 5999999754 4689999999999999999999995 599999999999999999999999999997
Q ss_pred cCCCCCc---------------------ccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 894 LDGEDSV---------------------TQTMTLATFGYMAPEYG-SEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 894 ~~~~~~~---------------------~~~~~~gt~~Y~aPE~~-~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
....... ..+..+||+.|+|||++ ....++.++||||+||++|||+||..|+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6543211 12445799999999975 56679999999999999999999877764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=326.78 Aligned_cols=206 Identities=26% Similarity=0.428 Sum_probs=176.4
Q ss_pred HhhcCCCCCcceeecCCccceEEEEec-C-----CCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeecc
Q 047591 740 QRLTDGFSESNLIGAGSFGSVYKATLP-Y-----GMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKIISSCSN 811 (1624)
Q Consensus 740 ~~~t~~f~~~~~iG~G~~G~Vy~~~~~-~-----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 811 (1624)
+...++|...+.||+|+||+||+|... + +..||||++..... ...+.+.+|+.+++++ +||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 344578889999999999999999864 2 24899999975533 3456799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC
Q 047591 812 HGFKALILEYMPQGSLEKWLYSHK-------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD 878 (1624)
Q Consensus 812 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 878 (1624)
.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 999999999999999999997532 3578999999999999999999984 599999999999999
Q ss_pred CCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 879 DDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 879 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.++.+||+|||+++........ ......||+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999866433222 2233467889999999888889999999999999999999 89998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=316.17 Aligned_cols=199 Identities=23% Similarity=0.332 Sum_probs=175.8
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56788899999999999999875 58899999987543 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++++|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp ECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999987643 689999999999999999999994 599999999999999999999999999987653322
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||.+....++.++||||||+++|||+||+.||..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22335699999999999888899999999999999999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=329.78 Aligned_cols=197 Identities=26% Similarity=0.435 Sum_probs=170.3
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
..++|...+.||+|+||+||+|... +|+.||||++..... .+.+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567888999999999999999865 689999999975432 245788889888 7999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC----CceEEEeeeeeeccC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD----TVAHLSDFGISKLLD 895 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~----~~~kl~DFGla~~~~ 895 (1624)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||+++...
T Consensus 96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999997654 689999999999999999999995 59999999999998433 359999999999765
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ....+||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 172 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 172 AENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp CTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 44322 2335799999999998877789999999999999999999999964
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=320.54 Aligned_cols=200 Identities=26% Similarity=0.331 Sum_probs=169.1
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67888999999999999999875 589999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999988654 4689999999999999999999984 5999999999999999999999999999876543222
Q ss_pred ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 233479999999998754 67899999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=326.98 Aligned_cols=200 Identities=25% Similarity=0.384 Sum_probs=164.0
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
..++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 456788999999999999999985 4789999999865432 2345678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee-----CCCCceEEEeeeeeec
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL-----DDDTVAHLSDFGISKL 893 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl-----d~~~~~kl~DFGla~~ 893 (1624)
|||++ |+|.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+|+.
T Consensus 112 ~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 99998 59999997654 689999999999999999999994 59999999999999 4556699999999987
Q ss_pred cCCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 653322 2233468999999998876 4589999999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-33 Score=338.19 Aligned_cols=196 Identities=18% Similarity=0.286 Sum_probs=162.1
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecc---cchhHHHHHHHH---HHHHhcCCCceeeee-------ee
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQ---LDGAIKSFDAEC---EVLRRVRHRNLVKII-------SS 808 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~ 808 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 56999999999743 234557899999 555566899999998 55
Q ss_pred eccCC-----------------eEEEEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 047591 809 CSNHG-----------------FKALILEYMPQGSLEKWLYSHKY------TLNIQQRLDIMIDVASALEYLHHGHPTPV 865 (1624)
Q Consensus 809 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~------~l~~~~~~~i~~~ia~gL~yLH~~~~~~I 865 (1624)
+..++ ..|+||||+ +|+|.+++..... .+++..+..|+.||++||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 54443 278999999 6899999976431 244688889999999999999995 59
Q ss_pred EeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccccccccccCccccCCC-----------CCCcchhHHHHHHH
Q 047591 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEG-----------IVSTCGDVYSFGIL 934 (1624)
Q Consensus 866 iHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~k~DvwS~Gvi 934 (1624)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++... .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2233467 999999998776 79999999999999
Q ss_pred HHHHHcCCCCCCc
Q 047591 935 MIETFTRKMPTDE 947 (1624)
Q Consensus 935 l~elltg~~P~~~ 947 (1624)
+|||+||+.||..
T Consensus 303 l~elltg~~Pf~~ 315 (377)
T 3byv_A 303 IYWIWCADLPITK 315 (377)
T ss_dssp HHHHHHSSCCC--
T ss_pred HHHHHHCCCCCcc
Confidence 9999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=314.49 Aligned_cols=198 Identities=24% Similarity=0.378 Sum_probs=172.4
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc------hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD------GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999875 689999999875431 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC----ceEEEeeeeee
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT----VAHLSDFGISK 892 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~~kl~DFGla~ 892 (1624)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999764 3689999999999999999999984 599999999999999877 79999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....... .....||+.|+|||++....++.++||||||+++|||+||+.||..
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 7654322 2234699999999999888899999999999999999999999865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=329.39 Aligned_cols=200 Identities=20% Similarity=0.242 Sum_probs=165.3
Q ss_pred CCCCCcceeecCCccceEEEEec----CCCEEEEEEeecccch-----------hHHHHHHHHHHHHhcCCCceeeeeee
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQLDG-----------AIKSFDAECEVLRRVRHRNLVKIISS 808 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~ 808 (1624)
++|...+.||+|+||+||+|... ++..||||++...... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999875 5788999998754321 12347788999999999999999999
Q ss_pred ecc----CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC--c
Q 047591 809 CSN----HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT--V 882 (1624)
Q Consensus 809 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~--~ 882 (1624)
+.. ....|+||||+ +|+|.+++...+ .+++.++..|+.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 877 67899999999 999999997655 789999999999999999999984 599999999999999887 9
Q ss_pred eEEEeeeeeeccCCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 883 AHLSDFGISKLLDGEDSV------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 883 ~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
+||+|||+|+.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999876432211 113347999999999998888999999999999999999999999653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=335.62 Aligned_cols=200 Identities=27% Similarity=0.357 Sum_probs=163.2
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCceeeeeeeeccC
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--------GAIKSFDAECEVLRRVRHRNLVKIISSCSNH 812 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 812 (1624)
..++|...+.||+|+||+||+|.. .+++.||||++..... .....+.+|+++|++++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 467899999999999999999986 4689999999875421 122358899999999999999999999865
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC---CceEEEeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD---TVAHLSDFG 889 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~~kl~DFG 889 (1624)
+..|+|||||++|+|.+++... ..+++.++..|+.|++.||+|||+. +|+||||||+|||++.+ ..+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 4579999999999999988654 3689999999999999999999984 59999999999999754 459999999
Q ss_pred eeeccCCCCCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 890 ISKLLDGEDSVTQTMTLATFGYMAPEYGS---EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 890 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
+|+...... ......||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred cceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 998765332 223457999999999874 367889999999999999999999999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=323.42 Aligned_cols=201 Identities=29% Similarity=0.479 Sum_probs=167.0
Q ss_pred CCCCcceeecCCccceEEEEecC-----CCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLPY-----GMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~-----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
+|...+.||+|+||+||+|.... +..||||++..... .....|.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 45557899999999999998642 24699999975433 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 999999999999987766899999999999999999999995 59999999999999999999999999998765432
Q ss_pred Ccc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SVT--QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
... .....+|+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 211 122346889999999988889999999999999999999 99998653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=317.11 Aligned_cols=128 Identities=22% Similarity=0.352 Sum_probs=57.2
Q ss_pred CCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCcc
Q 047591 465 GNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRA 544 (1624)
Q Consensus 465 ~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~ 544 (1624)
..+++|++|+|++|++++..+ +..+++|++|++++|++++ + +.+..+++|+.|++++|++++ + +.+..+++|+.
T Consensus 218 ~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~ 291 (347)
T 4fmz_A 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNS 291 (347)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSE
T ss_pred hcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCE
Confidence 334445555555555543222 4445555555555555543 2 234445555555555555543 2 23444455555
Q ss_pred ccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcC
Q 047591 545 LNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQL 600 (1624)
Q Consensus 545 L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l 600 (1624)
|+|++|++++..|..+..+++|+.|++++|.+++..| ++.+++|+.|++++|++
T Consensus 292 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp EECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred EECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 5555555544444444444444444444444433222 33344444444444433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=322.35 Aligned_cols=212 Identities=25% Similarity=0.436 Sum_probs=180.0
Q ss_pred cCHHHHHhhcCCCCCcceeecCCccceEEEEe------cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeee
Q 047591 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKI 805 (1624)
Q Consensus 734 ~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 805 (1624)
+...+.....++|...+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455555678899999999999999999974 3568999999975443 3456789999999999 79999999
Q ss_pred eeeeccCC-eEEEEEEecCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCc
Q 047591 806 ISSCSNHG-FKALILEYMPQGSLEKWLYSHKYT---------------LNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869 (1624)
Q Consensus 806 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrD 869 (1624)
++++...+ ..++||||+++|+|.+++...... +++.++..++.|+++||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987654 589999999999999999865432 78999999999999999999994 599999
Q ss_pred CCCCCeeeCCCCceEEEeeeeeeccCCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 870 LKPSNVLLDDDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 870 lKp~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654332 22234568999999999888889999999999999999999 9999865
Q ss_pred c
Q 047591 948 M 948 (1624)
Q Consensus 948 ~ 948 (1624)
.
T Consensus 254 ~ 254 (316)
T 2xir_A 254 V 254 (316)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=319.77 Aligned_cols=200 Identities=29% Similarity=0.476 Sum_probs=160.9
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|+.. ..||||++.... ....+.|.+|++++++++||||+++++++. .+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 467888999999999999999864 469999987543 234577999999999999999999999764 456799999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC-C
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED-S 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~-~ 899 (1624)
|+++++|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999999999987767799999999999999999999984 59999999999999999999999999998654321 1
Q ss_pred cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 900 VTQTMTLATFGYMAPEYGS---EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~---~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.......||+.|+|||.+. ...++.++|||||||++|||+||+.||...
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 2223346999999999875 567889999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=323.60 Aligned_cols=214 Identities=24% Similarity=0.434 Sum_probs=176.3
Q ss_pred HhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHh--cCCCceeeeeeeeccCC----
Q 047591 740 QRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRR--VRHRNLVKIISSCSNHG---- 813 (1624)
Q Consensus 740 ~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~---- 813 (1624)
....++|...+.||+|+||+||+|+. +|+.||||++... ..+.+.+|+++++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567899999999999999999987 5899999998643 33567889999988 78999999999998775
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEeCcCCCCCeeeCCCCceEEEee
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG-----HPTPVIHCDLKPSNVLLDDDTVAHLSDF 888 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IiHrDlKp~NILld~~~~~kl~DF 888 (1624)
..++||||+++|+|.+++... .+++.++..++.|++.||+|||.. +..+|+||||||+||++++++.+||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 789999999999999999764 589999999999999999999932 1256999999999999999999999999
Q ss_pred eeeeccCCCCCc---ccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCccC
Q 047591 889 GISKLLDGEDSV---TQTMTLATFGYMAPEYGSEG------IVSTCGDVYSFGILMIETFTR----------KMPTDEMF 949 (1624)
Q Consensus 889 Gla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~~~k~DvwS~Gvil~elltg----------~~P~~~~~ 949 (1624)
|+++........ ......||+.|+|||++... .++.++|||||||++|||+|| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876544322 12334799999999987665 234789999999999999999 77876654
Q ss_pred cCcchHHHHH
Q 047591 950 TGETSLKKWV 959 (1624)
Q Consensus 950 ~~~~~l~~~~ 959 (1624)
........+.
T Consensus 272 ~~~~~~~~~~ 281 (342)
T 1b6c_B 272 PSDPSVEEMR 281 (342)
T ss_dssp CSSCCHHHHH
T ss_pred cCcccHHHHH
Confidence 4443444443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=351.01 Aligned_cols=201 Identities=28% Similarity=0.472 Sum_probs=174.3
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
.++|...+.||+|+||+||+|.+..+..||||+++.... ..+.|.+|+++|++++|||||+++++|.+ +..|+|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456778899999999999999998888899999975432 34689999999999999999999999976 6689999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 823 PQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 823 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
++|+|.++++.. ...+++.+++.|+.||++||+|||+. +||||||||+|||+++++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999753 24589999999999999999999984 59999999999999999999999999998765332222
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.....+|..|+|||++..+.++.++|||||||++|||+| |+.||..+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223457889999999888889999999999999999999 99998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=325.03 Aligned_cols=201 Identities=25% Similarity=0.400 Sum_probs=171.9
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeecc--------
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSN-------- 811 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 811 (1624)
.++|...+.||+|+||+||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35788899999999999999987 5789999999865432 234678899999999999999999999876
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeee
Q 047591 812 HGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGIS 891 (1624)
Q Consensus 812 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla 891 (1624)
.+..++||||+++ +|.+.+......+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4468999999985 88888877666799999999999999999999984 5999999999999999999999999999
Q ss_pred eccCCCCC---cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDS---VTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 87653221 12234578999999998765 5679999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=322.68 Aligned_cols=199 Identities=23% Similarity=0.323 Sum_probs=175.8
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56788899999999999999865 58899999987542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++++|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999998764 3689999999999999999999984 599999999999999999999999999987653322
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 22335699999999999888899999999999999999999999865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=316.47 Aligned_cols=200 Identities=31% Similarity=0.446 Sum_probs=169.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
+.|....+||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455667999999999999986 468999999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC-CCceEEEeeeeeeccCCCCC
Q 047591 823 PQGSLEKWLYSHKY--TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD-DTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~~kl~DFGla~~~~~~~~ 899 (1624)
++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999986532 456888899999999999999984 5999999999999997 89999999999987654322
Q ss_pred cccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGI--VSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~--~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++..+. ++.++|||||||++|||+||+.||..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 123346999999999876543 78999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=326.23 Aligned_cols=211 Identities=25% Similarity=0.411 Sum_probs=179.9
Q ss_pred cCHHHHHhhcCCCCCcceeecCCccceEEEEec------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeee
Q 047591 734 ISYQELQRLTDGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKII 806 (1624)
Q Consensus 734 ~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~ 806 (1624)
+..++.+...++|...+.||+|+||+||+|... +++.||||++..... .....|.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455666788999999999999999999754 368899999875432 3446789999999999999999999
Q ss_pred eeeccCCeEEEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 807 SSCSNHGFKALILEYMPQGSLEKWLYSHK---------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 807 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
+++.+.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999997532 3568999999999999999999995 59999999999999
Q ss_pred CCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 878 DDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 878 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
+.++.+||+|||+++........ ......||+.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 99999999999999876443221 1223467899999999888889999999999999999999 8899865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=331.96 Aligned_cols=241 Identities=15% Similarity=0.188 Sum_probs=181.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--------hhHHHHHHHHHHHHHhcC---------CCceeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--------DRALKSFDAECEVMRRIR---------HRNLAKIV 1397 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--------~~~~~~f~~E~~~l~~l~---------HpNIv~l~ 1397 (1624)
++|...+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3456678999999999999988 78999999986542 223478999999999986 66666665
Q ss_pred ee-----------------ecc-------------CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 047591 1398 SS-----------------CSN-------------PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEY 1447 (1624)
Q Consensus 1398 g~-----------------~~~-------------~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~y 1447 (1624)
+. +.+ .+..++|||||++|++.+.+.+ ..+++.++..|+.||+.||+|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence 54 332 6789999999999977666643 457899999999999999999
Q ss_pred hh-hcCCCceEEcCCCCCcEEecCCC--------------------cEEEeeecceeecCCCCCcccccccccccccccc
Q 047591 1448 LH-QGYSTSIIHCDLKPSNVLLDDDM--------------------VAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506 (1624)
Q Consensus 1448 LH-~~~~~~iiHrDlK~~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE 1506 (1624)
|| + .+||||||||+|||++.++ .+||+|||+|+..... ..+||+.|||||
T Consensus 177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE 247 (336)
T 2vuw_A 177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED 247 (336)
T ss_dssp HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence 99 6 7899999999999999887 9999999999876532 347999999999
Q ss_pred ccCCCCcCcccchHHHHHH-HHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHH
Q 047591 1507 YGSEGIVSTSGDVYSFGIL-MMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSV 1585 (1624)
Q Consensus 1507 ~~~~~~~~~k~DV~SfGvi-l~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~ 1585 (1624)
++.+.. +.++||||+|++ .+++++|..||.+. .|.... ...++......... .......++..+
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~s~~~ 312 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYL----TDKMLKQMTFKTKC--NTPAMKQIKRKI 312 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHH----HHHHHHTCCCSSCC--CSHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHH----HHhhhhhhccCccc--chhhhhhcCHHH
Confidence 987665 899999998877 77888899887421 121110 01111110111100 111234567789
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 047591 1586 MSLALKCSEEIPEERMNVKDAL 1607 (1624)
Q Consensus 1586 ~~l~~~C~~~~P~~RPt~~evl 1607 (1624)
.+++.+|++.+ |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999965 888887
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=319.00 Aligned_cols=198 Identities=24% Similarity=0.386 Sum_probs=172.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888899999999999999865 7899999999865444456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee---CCCCceEEEeeeeeeccCCCC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~~kl~DFGla~~~~~~~ 898 (1624)
+++|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999999997654 689999999999999999999984 59999999999999 78899999999999865432
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 22234699999999999988999999999999999999999999865
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=328.30 Aligned_cols=196 Identities=26% Similarity=0.366 Sum_probs=164.7
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC-----
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG----- 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 813 (1624)
..++|...+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 356788899999999999999986 479999999985432 234567899999999999999999999987653
Q ss_pred -eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 814 -FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 814 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
..|+||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 78999999763 588999999999999999999985 59999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... .+...||+.|+|||++.. ..++.++||||+||++|||+||+.||..
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 76432 233478999999998765 6789999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=326.30 Aligned_cols=202 Identities=26% Similarity=0.404 Sum_probs=168.8
Q ss_pred hhcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCe
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-----GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGF 814 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 814 (1624)
...++|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999864 689999999864321 123568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeecc
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~ 894 (1624)
.++||||+++ +|.+++......+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 89999987766789999999999999999999995 5999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 895 DGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 895 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 54322 2234579999999998865 4589999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=317.67 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=163.9
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688889999999999999986 578999999987532 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 819 LEYMPQGSLEKWLYS---HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
|||+++|+|.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 244689999999999999999999984 59999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... ......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 4322 12234689999999999888999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=316.64 Aligned_cols=201 Identities=27% Similarity=0.459 Sum_probs=172.6
Q ss_pred CCCCCcc-eeecCCccceEEEEec---CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESN-LIGAGSFGSVYKATLP---YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~-~iG~G~~G~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+ .||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444555 8999999999999753 57889999997643 33467899999999999999999999999 45568999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999987666799999999999999999999984 59999999999999999999999999998775443
Q ss_pred Ccc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SVT--QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
... .....||+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 322 223357899999999888889999999999999999999 99998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-32 Score=322.57 Aligned_cols=201 Identities=28% Similarity=0.441 Sum_probs=166.0
Q ss_pred CCCCCcceeecCCccceEEEEec-CCC----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGM----NVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
++|+..+.||+|+||+||+|+.. +++ +||+|.+.... ....+.+.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888999999999999999853 454 35777765332 335678999999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
|+||+++|+|.+++......+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999988777899999999999999999999984 5999999999999999999999999999876543
Q ss_pred CCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 898 DSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 898 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 222 2223457889999999988899999999999999999999 99999754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=327.11 Aligned_cols=198 Identities=31% Similarity=0.454 Sum_probs=160.9
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHH--HHhcCCCceeeeeeeec-----cCCeE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEV--LRRVRHRNLVKIISSCS-----NHGFK 815 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~-----~~~~~ 815 (1624)
.++|...+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36788899999999999999976 68999999997543 2344455555 44589999999997542 33467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH------PTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
++||||+++|+|.+++.... .++..+.+|+.|+++||+|||+.. .++|+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 89999999999999997654 588999999999999999999852 1269999999999999999999999999
Q ss_pred eeeccCCCCC-------cccccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 890 ISKLLDGEDS-------VTQTMTLATFGYMAPEYGSE-------GIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 890 la~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~-------~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
+|+....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.|+.
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 9987654321 11223469999999998876 456789999999999999999987764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=334.89 Aligned_cols=200 Identities=26% Similarity=0.403 Sum_probs=171.9
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC--eEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG--FKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888899999999999999875 58999999997543 234567889999999999999999999987655 789999
Q ss_pred EecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee----CCCCceEEEeeeeeec
Q 047591 820 EYMPQGSLEKWLYSHKY--TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL----DDDTVAHLSDFGISKL 893 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl----d~~~~~kl~DFGla~~ 893 (1624)
||+++|+|.+++..... .+++.++..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999975432 389999999999999999999994 59999999999999 7888899999999987
Q ss_pred cCCCCCcccccccccccccCccccCC--------CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSE--------GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 654322 223469999999998654 56788999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=329.42 Aligned_cols=199 Identities=27% Similarity=0.397 Sum_probs=174.9
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999875 689999999976533 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999999997654 6899999999999999999999842 4999999999999999999999999999765322
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12234699999999999988999999999999999999999999865
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=314.94 Aligned_cols=202 Identities=21% Similarity=0.320 Sum_probs=170.3
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeee-ccCCeEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC-SNHGFKALIL 819 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 819 (1624)
..++|...+.||+|+||+||+|+. .+++.||||++..... .+.+.+|++++++++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 467899999999999999999986 5789999998764432 24578999999999988877777665 6677889999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee---CCCCceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~~kl~DFGla~~~~~ 896 (1624)
||+ +|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 9999999987666799999999999999999999985 59999999999999 7889999999999987754
Q ss_pred CCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 897 EDSV------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 897 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
.... ......||+.|+|||.+....++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 4321 1224579999999999998899999999999999999999999997643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=312.93 Aligned_cols=197 Identities=28% Similarity=0.423 Sum_probs=174.6
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999865 57899999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999999997654 689999999999999999999984 59999999999999999999999999997654322
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++....++.++||||||+++|||+||+.||..
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 2234699999999999888899999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=319.71 Aligned_cols=203 Identities=27% Similarity=0.381 Sum_probs=171.9
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
..++|+..+.||+|+||+||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467888899999999999999875 589999999976655566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 9999999999987666799999999999999999999984 59999999999999999999999999976432111 1
Q ss_pred ccccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYG-----SEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~-----~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
......||+.|+|||++ ....++.++|||||||++|||+||+.||...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 11234689999999987 4667899999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=331.23 Aligned_cols=197 Identities=11% Similarity=0.137 Sum_probs=153.8
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc---hhHHHHHHHHHHHHhc--CCCceeeee-------eeec
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD---GAIKSFDAECEVLRRV--RHRNLVKII-------SSCS 810 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~~ 810 (1624)
..|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45778899999999999999864 789999999986542 3345678885555444 699988865 3332
Q ss_pred cC-----------------CeEEEEEEecCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEe
Q 047591 811 NH-----------------GFKALILEYMPQGSLEKWLYSHKYTLNIQQR------LDIMIDVASALEYLHHGHPTPVIH 867 (1624)
Q Consensus 811 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~IiH 867 (1624)
.. ...|+|||||+ |+|.+++...+..+++..+ ..++.|+++||+|||+. +|+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 22 34799999999 8999999875545666666 78889999999999984 5999
Q ss_pred CcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE--GIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 868 rDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
|||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.. ..++.++|||||||++|||+||+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976432 113457899999999877 67899999999999999999999999
Q ss_pred Ccc
Q 047591 946 DEM 948 (1624)
Q Consensus 946 ~~~ 948 (1624)
...
T Consensus 294 ~~~ 296 (371)
T 3q60_A 294 GLV 296 (371)
T ss_dssp TBC
T ss_pred CCc
Confidence 764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=315.20 Aligned_cols=198 Identities=25% Similarity=0.388 Sum_probs=168.4
Q ss_pred CCCcceeecCCccceEEEEec-CC---CEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeE-EEEE
Q 047591 746 FSESNLIGAGSFGSVYKATLP-YG---MNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK-ALIL 819 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~~-~g---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV~ 819 (1624)
|...+.||+|+||+||+|... ++ ..||||++..... ...+.|.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 444588999999999999853 22 3799999875433 3457899999999999999999999999876654 9999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+.+|+|.+++......+++.++..|+.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999987667789999999999999999999995 599999999999999999999999999986643221
Q ss_pred ---cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 900 ---VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 900 ---~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
.......+|+.|+|||......++.++|||||||++|||+||+.|+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 11223468899999999998899999999999999999999766643
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=316.68 Aligned_cols=218 Identities=22% Similarity=0.300 Sum_probs=124.4
Q ss_pred CCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceec
Q 047591 138 RLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217 (1624)
Q Consensus 138 ~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~L 217 (1624)
+|+.+++++|.++ .+|..+ .++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCC---CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 5777777777776 455544 246677777777777655666777777777777777777666666667777777777
Q ss_pred cCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeeccccccc--CcCCccccccCcCCeeeccCCcc
Q 047591 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTT--GRIPKDIGNCTLLNYLGLRDNQL 295 (1624)
Q Consensus 218 s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~--g~ip~~~~~l~~L~~L~Ls~N~l 295 (1624)
++|+++ .+|..+. ++|++|++++|+++ .+|...+..+++|++|++++|.++ +..|..++.+ +|+.|+
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~------ 178 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR------ 178 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCB------
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEE------
Confidence 777666 4555444 45555555555554 344444444455555555554443 2333344333 444444
Q ss_pred cccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCcc
Q 047591 296 TDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNL 375 (1624)
Q Consensus 296 ~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 375 (1624)
+++|++++ +|..++ ++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 179 --------------------------l~~n~l~~-l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~ 228 (332)
T 2ft3_A 179 --------------------------ISEAKLTG-IPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228 (332)
T ss_dssp --------------------------CCSSBCSS-CCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSC
T ss_pred --------------------------CcCCCCCc-cCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence 44444432 343332 455566666666665555566666666666666666
Q ss_pred ccccCcccccccccccEEEcccccc
Q 047591 376 FSGLVANTFGNCRQLQILNLAYSQL 400 (1624)
Q Consensus 376 l~g~~~~~f~~l~~L~~L~L~~N~l 400 (1624)
+++.++..|+.+++|++|+|++|++
T Consensus 229 l~~~~~~~~~~l~~L~~L~L~~N~l 253 (332)
T 2ft3_A 229 IRMIENGSLSFLPTLRELHLDNNKL 253 (332)
T ss_dssp CCCCCTTGGGGCTTCCEEECCSSCC
T ss_pred CCcCChhHhhCCCCCCEEECCCCcC
Confidence 6655555555555555555554444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=312.90 Aligned_cols=197 Identities=27% Similarity=0.417 Sum_probs=168.4
Q ss_pred CCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc----CCeEEEE
Q 047591 746 FSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN----HGFKALI 818 (1624)
Q Consensus 746 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV 818 (1624)
|...+.||+|+||+||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 55667899999999999986 468899999987543 3345678999999999999999999998764 4568999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC-CCCceEEEeeeeeeccCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~~kl~DFGla~~~~~~ 897 (1624)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ .+|+||||||+||+++ +++.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999999999997643 6899999999999999999999854 3499999999999998 7899999999999765433
Q ss_pred CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 898 DSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 898 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
. .....||+.|+|||++. +.++.++|||||||++|||+||+.||...
T Consensus 186 ~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 186 F---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp S---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 2 22346999999999876 45899999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=314.07 Aligned_cols=199 Identities=30% Similarity=0.414 Sum_probs=176.6
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
+.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5688889999999999999985 468999999997554 34467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
+++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 999999999864 3689999999999999999999994 599999999999999999999999999987654332 2
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....||+.|+|||++....++.++|||||||++|||+||+.||...
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 23346999999999998889999999999999999999999998653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=328.36 Aligned_cols=197 Identities=16% Similarity=0.214 Sum_probs=168.9
Q ss_pred CCCCCcceeecCCccceEEEEecC---------CCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceee----------
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPY---------GMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK---------- 804 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 804 (1624)
++|...+.||+|+||+||+|+... ++.||||++... +.+.+|++++++++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578888999999999999998753 789999998743 45789999999999999998
Q ss_pred -----eeeeecc-CCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee
Q 047591 805 -----IISSCSN-HGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL 877 (1624)
Q Consensus 805 -----l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 877 (1624)
+++++.. +...|+||||+ +|+|.+++... ...+++.++..|+.|++.||+|||+. +|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 5666655 67889999999 99999999875 34799999999999999999999995 59999999999999
Q ss_pred CCCC--ceEEEeeeeeeccCCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 878 DDDT--VAHLSDFGISKLLDGEDSV------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 878 d~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999876533211 1133479999999999988899999999999999999999999997644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=316.11 Aligned_cols=200 Identities=29% Similarity=0.388 Sum_probs=172.6
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
..++|...+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888999999999999999875 58999999997543 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 9999999999986666799999999999999999999984 599999999999999999999999999987654322
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||++....++.++||||||+++|||+||+.||..
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 22334699999999999888899999999999999999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=315.81 Aligned_cols=205 Identities=25% Similarity=0.376 Sum_probs=171.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeee--ccCCeEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSC--SNHGFKAL 817 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~--~~~~~~~l 817 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888899999999999999875 68999999997543 23456789999999999999999999987 45678999
Q ss_pred EEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 818 ILEYMPQGSLEKWLYSHK---YTLNIQQRLDIMIDVASALEYLHHGH--PTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ ..+|+||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997532 34899999999999999999999854 1349999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
....... ......||+.|+|||.+....++.++||||||+++|||+||+.||...
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 7654322 122346899999999988888999999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=349.01 Aligned_cols=194 Identities=29% Similarity=0.458 Sum_probs=164.1
Q ss_pred ceeecCCccceEEEEec---CCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP---YGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|.+. .++.||||+++.... ...++|.+|+++|++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999653 467899999975432 345789999999999999999999999975 457999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc--cc
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV--TQ 902 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~--~~ 902 (1624)
|+|.+++... ..+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+........ ..
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999764 3689999999999999999999984 5999999999999999999999999999987544322 22
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
....||+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33457889999999988899999999999999999999 99999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=338.24 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=168.8
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
.+.|...+.||+|+||+||+|+.. ++..||||++.... ......+.+|+.++++++|||||+++++|.+....|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888899999999999999865 68999999987543 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC---CCceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD---DTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~~kl~DFGla~~~~~ 896 (1624)
|||++|+|.+++.... .+++.++..|+.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999987653 689999999999999999999984 5999999999999976 45599999999988754
Q ss_pred CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
... ....+||+.|+|||++. +.++.++||||+||++|||++|+.||..
T Consensus 192 ~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 192 QKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp TBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Ccc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 322 23357999999999876 5689999999999999999999999865
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=312.42 Aligned_cols=291 Identities=22% Similarity=0.307 Sum_probs=237.4
Q ss_pred CCccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccc
Q 047591 75 SVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLF 154 (1624)
Q Consensus 75 ~~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~ 154 (1624)
+.|.|+.+.|.. +++. .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++ ++
T Consensus 31 c~c~l~~l~~~~------------~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~ 94 (332)
T 2ft3_A 31 CHCHLRVVQCSD------------LGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IH 94 (332)
T ss_dssp CEEETTEEECCS------------SCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE-EC
T ss_pred CcccCCEEECCC------------CCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCc-cC
Confidence 446677666643 3343 5676664 689999999999998888899999999999999999986 44
Q ss_pred hhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCC--CCCCCcccc
Q 047591 155 DDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ--GEFPPTIFN 232 (1624)
Q Consensus 155 ~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~--g~~p~~~~~ 232 (1624)
+..+.++++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..|+++++|++|++++|+++ +..|..+..
T Consensus 95 ~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 171 (332)
T 2ft3_A 95 EKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171 (332)
T ss_dssp GGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS
T ss_pred HhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC
Confidence 556688999999999999999 6888776 89999999999999666667999999999999999996 477888888
Q ss_pred cCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccc
Q 047591 233 VSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIF 312 (1624)
Q Consensus 233 l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~ 312 (1624)
+ +|++|++++|+++ .+|..++ ++|++|++++|.+++..|..+..+++|+.|+|++|++.+ ..|..+.
T Consensus 172 l-~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~--------~~~~~~~ 238 (332)
T 2ft3_A 172 L-KLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM--------IENGSLS 238 (332)
T ss_dssp C-CCSCCBCCSSBCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC--------CCTTGGG
T ss_pred C-ccCEEECcCCCCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc--------CChhHhh
Confidence 8 9999999999998 4887664 689999999999999988999999999999999887654 3455677
Q ss_pred cCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCC------CCCcEEecCCcccc--ccCcccc
Q 047591 313 NNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNA------SKLTVLELSRNLFS--GLVANTF 384 (1624)
Q Consensus 313 ~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l------~~L~~L~Ls~N~l~--g~~~~~f 384 (1624)
.+.+|+.|+|++|+++ .+|..+. .+++|++|+|++|++++..+..|+.. .+|+.|++++|.+. +..|..|
T Consensus 239 ~l~~L~~L~L~~N~l~-~lp~~l~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~ 316 (332)
T 2ft3_A 239 FLPTLRELHLDNNKLS-RVPAGLP-DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316 (332)
T ss_dssp GCTTCCEEECCSSCCC-BCCTTGG-GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGG
T ss_pred CCCCCCEEECCCCcCe-ecChhhh-cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccc
Confidence 7888888888888888 7887764 68888888888888887777766653 56788888888877 6677778
Q ss_pred cccccccEEEccccc
Q 047591 385 GNCRQLQILNLAYSQ 399 (1624)
Q Consensus 385 ~~l~~L~~L~L~~N~ 399 (1624)
..+++|+.|+|++|+
T Consensus 317 ~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 317 RCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTBCCSTTEEC----
T ss_pred cccchhhhhhccccc
Confidence 888888888877663
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=312.50 Aligned_cols=197 Identities=21% Similarity=0.309 Sum_probs=169.7
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 817 (1624)
.+++|...+.||+|+||+||+|... +++.||||++.... ......+.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467888999999999999999875 79999999987543 33456788999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC--------------
Q 047591 818 ILEYMPQGSLEKWLYSHK---YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD-------------- 880 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-------------- 880 (1624)
||||+++|+|.+++.... ..+++.++..|+.|+++||+|||+. +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997642 4689999999999999999999994 59999999999999844
Q ss_pred -----CceEEEeeeeeeccCCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 881 -----TVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 881 -----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
..+||+|||+++...... ...||+.|+|||.+... .++.++|||||||++|||++|+.|+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 478999999998765432 23599999999988765 56789999999999999999987753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=314.26 Aligned_cols=201 Identities=21% Similarity=0.327 Sum_probs=173.7
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeee-ccCCeEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC-SNHGFKALIL 819 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 819 (1624)
..++|...+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|+.++++++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999986 5789999999875432 35688999999999998877776665 5667889999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee---CCCCceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~~kl~DFGla~~~~~ 896 (1624)
||+ +|+|.+++......+++.++..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 8999999986666799999999999999999999984 59999999999999 4888999999999987755
Q ss_pred CCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 897 EDSV------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 897 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.... ......||+.|+|||...+..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 4321 123457999999999999889999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=337.73 Aligned_cols=198 Identities=25% Similarity=0.377 Sum_probs=172.1
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+....|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888999999999999999864 78999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC---CCCceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~~kl~DFGla~~~~~ 896 (1624)
||+++|+|.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999987654 689999999999999999999984 599999999999995 456799999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
... ....+||+.|+|||++.+ .++.++||||+||++|||+||+.||..
T Consensus 177 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 177 NTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 233479999999999865 589999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=322.16 Aligned_cols=200 Identities=30% Similarity=0.493 Sum_probs=174.5
Q ss_pred CCCCCcceeecCCccceEEEEe-----cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCC--eEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-----PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG--FKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~ 816 (1624)
++|...+.||+|+||.||+|+. .+|+.||||++........+.|.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577789999999999999984 368999999998766666678999999999999999999999987654 679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+||||+++|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 99999999999999988766799999999999999999999984 599999999999999999999999999988754
Q ss_pred CCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 897 EDSVT--QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 897 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
..... .....+|..|+|||.+....++.++|||||||++|||+||+.|+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 43221 223457888999999888888999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=337.16 Aligned_cols=199 Identities=23% Similarity=0.369 Sum_probs=171.8
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc-------------hhHHHHHHHHHHHHhcCCCceeeeee
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD-------------GAIKSFDAECEVLRRVRHRNLVKIIS 807 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~ 807 (1624)
..++|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999864 689999999864321 23467899999999999999999999
Q ss_pred eeccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC---ceE
Q 047591 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT---VAH 884 (1624)
Q Consensus 808 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~~k 884 (1624)
+|.+....|+|||||++|+|.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999997654 689999999999999999999994 599999999999999776 699
Q ss_pred EEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 885 LSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 885 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
|+|||+|+....... .....||+.|+|||++. +.++.++||||+||++|||++|+.||..
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999988754322 23356999999999876 4689999999999999999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=320.46 Aligned_cols=200 Identities=27% Similarity=0.384 Sum_probs=168.3
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999875 589999999865432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 105 FVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp CCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 99999998877543 3689999999999999999999994 599999999999999999999999999987654322
Q ss_pred ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 901 TQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
......||+.|+|||++... .++.++|||||||++|||+||+.||...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22334699999999988765 6899999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=321.77 Aligned_cols=212 Identities=29% Similarity=0.401 Sum_probs=172.8
Q ss_pred cccCHHHHHhhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 047591 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISSC 809 (1624)
Q Consensus 732 ~~~~~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 809 (1624)
..+++.++....++|...+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 4456666777889999999999999999999986 4789999999975433 346789999999999 899999999998
Q ss_pred cc------CCeEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCc
Q 047591 810 SN------HGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTV 882 (1624)
Q Consensus 810 ~~------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~ 882 (1624)
.. .+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 76 467899999999999999998653 4688999999999999999999995 5999999999999999999
Q ss_pred eEEEeeeeeeccCCCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 883 AHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS-----EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 883 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
+||+|||+++....... ......||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999987643221 123346999999999876 567899999999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=326.30 Aligned_cols=198 Identities=23% Similarity=0.335 Sum_probs=164.9
Q ss_pred HhhcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeecc-------
Q 047591 740 QRLTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN------- 811 (1624)
Q Consensus 740 ~~~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------- 811 (1624)
+...++|...+.||+|+||+||+|+. .+|+.||||++..... ...+|++++++++|||||++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999985 5799999999864422 23479999999999999999999843
Q ss_pred -------------------------------CCeEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 047591 812 -------------------------------HGFKALILEYMPQGSLEKWLYS---HKYTLNIQQRLDIMIDVASALEYL 857 (1624)
Q Consensus 812 -------------------------------~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yL 857 (1624)
....++||||++ |+|.+.+.. ....+++..+..|+.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 344889999998 588887763 345789999999999999999999
Q ss_pred hcCCCCCeEeCcCCCCCeeeC-CCCceEEEeeeeeeccCCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHH
Q 047591 858 HHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILM 935 (1624)
Q Consensus 858 H~~~~~~IiHrDlKp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil 935 (1624)
|+. +|+||||||+|||++ +++.+||+|||+|+....... .....||+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 984 599999999999998 688999999999997654332 2334689999999987654 589999999999999
Q ss_pred HHHHcCCCCCCc
Q 047591 936 IETFTRKMPTDE 947 (1624)
Q Consensus 936 ~elltg~~P~~~ 947 (1624)
|||++|+.||..
T Consensus 233 ~ell~g~~pf~~ 244 (383)
T 3eb0_A 233 GELILGKPLFSG 244 (383)
T ss_dssp HHHHHSSCSSCC
T ss_pred HHHHhCCCCCCC
Confidence 999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=315.07 Aligned_cols=200 Identities=29% Similarity=0.349 Sum_probs=158.0
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
.++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999986 5789999999975432 22234455556688899999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWLYS---HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
||++ |+|.+++.. ....+++..+..|+.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9998 589888754 345799999999999999999999984 1599999999999999999999999999987654
Q ss_pred CCCcccccccccccccCcccc----CCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSVTQTMTLATFGYMAPEYG----SEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
... .....||+.|+|||++ ....++.++|||||||++|||+||+.||..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 322 2234699999999985 566789999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=313.03 Aligned_cols=195 Identities=27% Similarity=0.446 Sum_probs=170.7
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeecc----------
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN---------- 811 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 811 (1624)
.++|...+.||+|+||.||+|... +|+.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456888999999999999999875 79999999997543 356789999999999999999998854
Q ss_pred ------CCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceE
Q 047591 812 ------HGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH 884 (1624)
Q Consensus 812 ------~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~k 884 (1624)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 44579999999999999999764 34689999999999999999999984 599999999999999999999
Q ss_pred EEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 885 LSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 885 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
|+|||+++....... .....||+.|+|||++....++.++|||||||++|||+||+.|+.
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999987754332 223469999999999988889999999999999999999998863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=339.41 Aligned_cols=198 Identities=26% Similarity=0.417 Sum_probs=174.3
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456888899999999999999865 78999999986542 23457799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeee---CCCCceEEEeeeeeeccC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLL---DDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~~kl~DFGla~~~~ 895 (1624)
|||+++|+|.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+|+...
T Consensus 105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999997654 689999999999999999999995 59999999999999 567899999999998775
Q ss_pred CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... .....||+.|+|||++.+ .++.++||||+||++|||+||+.||..
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 4432 233469999999998765 689999999999999999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=309.83 Aligned_cols=199 Identities=26% Similarity=0.444 Sum_probs=167.4
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467888999999999999999875 79999999997542 22356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999997654 689999999999999999999985 59999999999999999999999999998765432
Q ss_pred CcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....||+.|+|||.+....+ +.++||||||+++|||+||+.||..
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2 223468999999999877655 6899999999999999999999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=313.61 Aligned_cols=201 Identities=26% Similarity=0.455 Sum_probs=168.0
Q ss_pred CCCCCcceeecCCccceEEEEecC----CCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeec-cCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCS-NHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~l 817 (1624)
..|...+.||+|+||+||+|+... +..||||.+..... ...+.+.+|+.++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 356777899999999999998642 23689999875433 34578999999999999999999999864 5567899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+++|+|.++++.....+++.++..|+.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999987666789999999999999999999984 5999999999999999999999999999876543
Q ss_pred CC---cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcC-CCCCCc
Q 047591 898 DS---VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMPTDE 947 (1624)
Q Consensus 898 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg-~~P~~~ 947 (1624)
.. .......||+.|+|||.+....++.++||||||+++|||+|| ..||..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 21 112334678899999999888899999999999999999995 555543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=310.91 Aligned_cols=222 Identities=23% Similarity=0.324 Sum_probs=134.1
Q ss_pred CCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceec
Q 047591 138 RLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217 (1624)
Q Consensus 138 ~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~L 217 (1624)
+|+.++++++.++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSC---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccC---CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 5666777766665 344433 245556666666666544445555666666666666655555555555555555555
Q ss_pred cCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccc
Q 047591 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTD 297 (1624)
Q Consensus 218 s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~ 297 (1624)
++|+++ .+|..+. ++|++|++++|++++..+..++++++|+.|+|++|++..
T Consensus 108 s~n~l~-~l~~~~~---------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 159 (330)
T 1xku_A 108 SKNQLK-ELPEKMP---------------------------KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159 (330)
T ss_dssp CSSCCS-BCCSSCC---------------------------TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred CCCcCC-ccChhhc---------------------------ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence 555555 3443332 355555555555555555555666666666666655432
Q ss_pred cCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCcccc
Q 047591 298 FGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377 (1624)
Q Consensus 298 l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 377 (1624)
.|..|..+.++++|++|++++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|.++
T Consensus 160 ------~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 229 (330)
T 1xku_A 160 ------SGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229 (330)
T ss_dssp ------GGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred ------cCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence 1233445555566666666666665 3555442 56777777777777777777777777777777777777
Q ss_pred ccCcccccccccccEEEccccccc
Q 047591 378 GLVANTFGNCRQLQILNLAYSQLA 401 (1624)
Q Consensus 378 g~~~~~f~~l~~L~~L~L~~N~l~ 401 (1624)
+.++..|.++++|++|+|++|+++
T Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 230 AVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp EECTTTGGGSTTCCEEECCSSCCS
T ss_pred eeChhhccCCCCCCEEECCCCcCc
Confidence 777666777776666666666553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=319.32 Aligned_cols=203 Identities=22% Similarity=0.326 Sum_probs=158.7
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcC-CCceeeeeeee--------ccC
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSC--------SNH 812 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~--------~~~ 812 (1624)
..+|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35688889999999999999986 478999999987665556678899999999996 99999999998 344
Q ss_pred CeEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeee
Q 047591 813 GFKALILEYMPQGSLEKWLYS--HKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGI 890 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGl 890 (1624)
...++||||++ |+|.+++.. ....+++.++..|+.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 56899999996 799999865 3346899999999999999999999853 3499999999999999999999999999
Q ss_pred eeccCCCCCcc-----------cccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 891 SKLLDGEDSVT-----------QTMTLATFGYMAPEYG---SEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 891 a~~~~~~~~~~-----------~~~~~gt~~Y~aPE~~---~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
++......... .....||+.|+|||++ ....++.++|||||||++|||+||+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 98765432211 1134589999999987 566789999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=318.10 Aligned_cols=196 Identities=28% Similarity=0.446 Sum_probs=169.9
Q ss_pred CCcceeecCCccceEEEEec-----CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeecc--CCeEEEE
Q 047591 747 SESNLIGAGSFGSVYKATLP-----YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSN--HGFKALI 818 (1624)
Q Consensus 747 ~~~~~iG~G~~G~Vy~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 818 (1624)
...+.||+|+||+||+|.+. +|+.||||++..... ...+.|.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 77789999999999998642 688999999976543 345679999999999999999999999986 4678999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999754 489999999999999999999994 59999999999999999999999999999876543
Q ss_pred Cc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SV--TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.. ......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 22 12334688899999999888899999999999999999999999854
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=323.03 Aligned_cols=196 Identities=23% Similarity=0.285 Sum_probs=161.8
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC------
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG------ 813 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 813 (1624)
.++|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467889999999999999999864 68999999997542 234567889999999999999999999987654
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+||||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999998 579888853 588999999999999999999984 599999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ......||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 64322 22335799999999999888899999999999999999999999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=316.67 Aligned_cols=192 Identities=21% Similarity=0.362 Sum_probs=168.3
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcC-CCceeeeeeeecc--CCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSCSN--HGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999985 57899999998743 3467899999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC-ceEEEeeeeeeccCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGED 898 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~~kl~DFGla~~~~~~~ 898 (1624)
||+++++|.+++. .+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999999874 478899999999999999999984 599999999999999776 89999999998765433
Q ss_pred CcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 2 233468999999998766 6789999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=319.73 Aligned_cols=209 Identities=21% Similarity=0.330 Sum_probs=175.6
Q ss_pred cCHHHHHhhcCCCCCc-ceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcC-CCceeeeeee
Q 047591 734 ISYQELQRLTDGFSES-NLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVR-HRNLVKIISS 808 (1624)
Q Consensus 734 ~~~~el~~~t~~f~~~-~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~ 808 (1624)
+.++..+...+.|... +.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444455556667766 88999999999999865 68999999987543 233567899999999995 6999999999
Q ss_pred eccCCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC---CCceE
Q 047591 809 CSNHGFKALILEYMPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD---DTVAH 884 (1624)
Q Consensus 809 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~~k 884 (1624)
+.+.+..++||||+++|+|.+++... ...+++.++..|+.|++.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998643 34689999999999999999999984 5999999999999998 78999
Q ss_pred EEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 885 LSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 885 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
|+|||+++....... .....||+.|+|||++....++.++|||||||++|||+||+.||..
T Consensus 175 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999987654322 2234699999999999988999999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=317.69 Aligned_cols=205 Identities=26% Similarity=0.453 Sum_probs=162.9
Q ss_pred hhcCCCCCcceeecCCccceEEEEec----CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC-
Q 047591 741 RLTDGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG- 813 (1624)
Q Consensus 741 ~~t~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~- 813 (1624)
...++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888899999999999999754 34589999987543 234567999999999999999999999997655
Q ss_pred ----eEEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceE
Q 047591 814 ----FKALILEYMPQGSLEKWLYSH-----KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH 884 (1624)
Q Consensus 814 ----~~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~k 884 (1624)
..++||||+++|+|.+++... ...+++.+++.|+.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 359999999999999999532 24689999999999999999999984 599999999999999999999
Q ss_pred EEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 885 LSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 885 l~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
|+|||+++........ ......+|+.|+|||......++.++|||||||++|||+| |+.||...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999999876543221 2233457889999999988889999999999999999999 88888653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1624 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.003 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 4e-59
Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 28/280 (10%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G+G F +VYK + A+K+ ++ + L++F E V+R+ RH N+ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
+ P A++ Q+ SL L+ + + +DI A ++YLH SIIH
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEY---GSEGIVS 1514
DLK +N+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574
DVY+FGI++ E +T + P ++ + + L ++ V
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------- 236
Query: 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614
C ++ L +C ++ +ER LA+++ +
Sbjct: 237 -----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-57
Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 12/229 (5%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGA--IKSFDAECEVLRRVRHRNLVKIIS 807
IG+GSFG+VYK +VA+K+ N+ +++F E VLR+ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
+ A++ ++ SL L+ + + + +DI A ++YLH +IH
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPEY---GSEGIVS 923
DLK +N+ L +D + DFG++ + Q L+ + +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 924 TCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVD 972
DVY+FGI++ E T ++P + + + L +++V
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-55
Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 8/283 (2%)
Query: 739 LQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLD-GAIKSFDAECEVLRR 796
++ D F + + +GAG+ G V+K + P G+ +A K+ +L++ E +VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+V + + G ++ +E+M GSL++ L + Q + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 119
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
L H ++H D+KPSN+L++ L DFG+S L DS+ + T YM+PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPER 174
Query: 917 GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELL 976
S D++S G+ ++E + P E L + A T
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 977 SSEEEEGADLGDSNKLKRLSISVNKITGTIPRTVGNLTELREL 1019
G D + L + + E ++
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-52
Identities = 68/313 (21%), Positives = 122/313 (38%), Gaps = 32/313 (10%)
Query: 1330 LRLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKS-FDAECEVMRR 1387
+ L + F + + LG G V+K + G A K+ L+ A+++ E +V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 1388 IRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEY 1447
+ + + G ++ +++M GSL++ L + + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-PEQILGKVSIAVIKGLTY 119
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY 1507
L + I+H D+KPSN+L++ L DFG++ L DSM + T YM+PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPER 174
Query: 1508 GSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567
S D++S G+ ++E R P E+ L + A T
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 1568 SGEEEADIAAKK-----------------KCMSSVMS-----LALKCSEEIPEERMNVKD 1605
+ ++ K S V S KC + P ER ++K
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 1606 ALAN--LKKIKTK 1616
+ + +K+ +
Sbjct: 295 LMVHAFIKRSDAE 307
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-53
Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 7/233 (3%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV 803
+ +GAG FG V+ VA+K + +F AE ++++++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHP 862
++ + + +I EYM GSL +L + L I + LD+ +A + ++ +
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIV 922
IH DL+ +N+L+ D ++DFG+++L++ + + + APE + G
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 923 STCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
+ DV+SFGIL+ E T T ++ +E R+ + EL
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEEL 239
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-52
Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G F V+ + T A+K Q + +F AE +M++++H+ L ++ +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYL-LNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+ +I +YM GSL +L + + + L I + LD+ +A + ++ + IH
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
DL+ +N+L+ D + + DFG+A+L++ + + I + APE + G + DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 1520 YSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579
+SFGIL+ E +T + T +++ E +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------------------ERGYRMVRPD 233
Query: 1580 KCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615
C + L C +E PE+R + L+ T
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-52
Identities = 60/247 (24%), Positives = 113/247 (45%), Gaps = 14/247 (5%)
Query: 737 QELQRLTDGFSESNL-IGAGSFGSVYKATLPY---GMNVAIKVFNLQLD-GAIKSFDAEC 791
++L D +++ +G G+FGSV + ++VAIKV + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
+++ ++ + +V++I C L++E G L K+L + + + +++ V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA--TF 909
++YL +H DL NVLL + A +SDFG+SK L +DS +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFTR-KMPTDEMFTGETSLKKWVEESLRLAVT 968
+ APE + S+ DV+S+G+ M E + + P +M E + ++E+ R+
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRMECP 234
Query: 969 EVVDAEL 975
EL
Sbjct: 235 PECPPEL 241
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-52
Identities = 56/302 (18%), Positives = 118/302 (39%), Gaps = 31/302 (10%)
Query: 1328 QELRLATNGFSESNL-LGTGIFSSVYKATFA---DGTNAAIKIFSLQEDRA-LKSFDAEC 1382
++L L + +++ LG G F SV + + + AIK+ ++A + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 1383 EVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVA 1442
++M ++ + + +++ C L+++ G L K+L + + +++ V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 1443 CALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA--TI 1500
++YL + + +H DL NVLL + A + DFG++K L DS + +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 1501 GYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560
+ APE + S+ DV+S+G+ M E L+ + G + + + +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKD 1620
C + +L C E+R + ++
Sbjct: 237 --------------------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
Query: 1621 VQ 1622
V+
Sbjct: 277 VE 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 4e-52
Identities = 60/307 (19%), Positives = 122/307 (39%), Gaps = 43/307 (14%)
Query: 1326 SYQELRLATNGFSES---------NLLGTGIFSSVYKATFA----DGTNAAIKIFSLQE- 1371
++++ A F++ ++G G F V AIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 1372 DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNI 1431
++ + F +E +M + H N+ + + +I ++M GSL+ +L ++ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 1432 EQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491
Q + ++ +A ++YL + +H DL N+L++ ++V + DFG+++ L+ S
Sbjct: 128 IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 1492 KQTMT----LATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRK-PTDDMFTGEVCL 1546
+ I + APE +++ DV+S+GI+M E ++ + P DM +V
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244
Query: 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDA 1606
+ LP C S++ L L C ++ R
Sbjct: 245 AIEQDYRLPP---------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 1607 LANLKKI 1613
+ L K+
Sbjct: 284 VNTLDKM 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (454), Expect = 2e-50
Identities = 56/259 (21%), Positives = 111/259 (42%), Gaps = 22/259 (8%)
Query: 735 SYQELQRLTDGFSES---------NLIGAGSFGSVYKATLPY----GMNVAIKVFNLQL- 780
++++ F++ +IGAG FG V L + VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 781 DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNI 840
+ + F +E ++ + H N++ + + +I E+M GSL+ +L + +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 841 QQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900
Q + ++ +A+ ++YL + +H DL N+L++ + V +SDFG+S+ L+ + S
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 901 TQTMT----LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
+ + APE ++ DV+S+GI+M E + T + +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVI 243
Query: 957 KWVEESLRLAVTEVVDAEL 975
+E+ RL + L
Sbjct: 244 NAIEQDYRLPPPMDCPSAL 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-52
Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 24/277 (8%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
+ +G+G F V+ + + AIK + + + F E EVM ++ H L ++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
C L+ ++M G L +L + L E L + +DV + YL + +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CV 122
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTS 1516
IH DL N L+ ++ V + DFG+ + + T T + + +PE S S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 1517 GDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576
DV+SFG+LM E + K + + ++ ++ +G
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----------------DISTGFRLYK-- 223
Query: 1577 AKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
+ + V + C +E PE+R L L +I
Sbjct: 224 -PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 9e-51
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 5/232 (2%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+ IG+G FG V+ VAIK + F E EV+ ++ H LV++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQL 65
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
C L+ E+M G L +L + + + L + +DV + YL V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC 925
IH DL N L+ ++ V +SDFG+++ + + + T T + +PE S S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 926 GDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
DV+SFG+LM E F+ E + + + + + RL + +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQ 233
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 72/277 (25%), Positives = 112/277 (40%), Gaps = 32/277 (11%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
+G G F V + G A+K ++ D ++F AE VM ++RH NL +++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 1401 -SNPGFKALILQYMPQGSLEKWLYSHNY-LLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
G ++ +YM +GSL +L S +L + L +DV A+EYL + +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
DL NVL+ +D VA + DFG+ K S Q + + APE E ST D
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578
V+SFGIL+ E + + + + + DA
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-------------------- 222
Query: 1579 KKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615
C +V + C R + L+ IKT
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 7e-49
Identities = 70/230 (30%), Positives = 107/230 (46%), Gaps = 13/230 (5%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
IG G FG V G VA+K ++ D ++F AE V+ ++RH NLV+++
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 810 -SNHGFKALILEYMPQGSLEKWLYSHKYT-LNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
G ++ EYM +GSL +L S + L L +DV A+EYL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 126
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
DL NVL+ +D VA +SDFG++K S TQ + APE E ST D
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 928 VYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
V+SFGIL+ E ++ + + + VE+ ++ + +
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYE 231
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 5/232 (2%)
Query: 746 FSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI 805
+ +G G FG V +VAIK+ F E +V+ + H LV++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
C+ +I EYM G L +L ++ QQ L++ DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC 925
+H DL N L++D V +SDFG+S+ + ++ + + + PE S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 926 GDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
D+++FG+LM E ++ E FT + + + + LRL + ++ +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYT 232
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-51
Identities = 61/277 (22%), Positives = 107/277 (38%), Gaps = 24/277 (8%)
Query: 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKI 1396
+ LGTG F V + + AIK+ + + F E +VM + H L ++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
C+ +I +YM G L +L + +Q L++ DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTS 1516
+H DL N L++D V + DFG+++ + + + + + PE S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 1517 GDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576
D+++FG+LM E + K + FT +H +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------------- 221
Query: 1577 AKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
V ++ C E +ER K L+N+ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 6e-51
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 26/292 (8%)
Query: 1325 ISYQELRLATNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEV 1384
++ + LG G F V+ T+ T AIK + ++F E +V
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQV 65
Query: 1385 MRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIE-QRLDIMIDVAC 1443
M+++RH L ++ + S ++ +YM +GSL +L Q +D+ +A
Sbjct: 66 MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 1444 ALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYM 1503
+ Y+ + + +H DL+ +N+L+ +++V + DFG+A+L++ + + I +
Sbjct: 125 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563
APE G + DV+SFGIL+ E T+ + L
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------- 234
Query: 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615
+C S+ L +C + PEER + A L+ T
Sbjct: 235 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-50
Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 7/233 (3%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLV 803
+ +G G FG V+ T VAIK ++F E +V++++RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLN-IQQRLDIMIDVASALEYLHHGHP 862
++ + S ++ EYM +GSL +L + Q +D+ +AS + Y+ +
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIV 922
+H DL+ +N+L+ ++ V ++DFG+++L++ + + + APE G
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 923 STCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
+ DV+SFGIL+ E T+ L + VE R+ L
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL 243
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-50
Identities = 61/249 (24%), Positives = 101/249 (40%), Gaps = 13/249 (5%)
Query: 736 YQELQR---LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAEC 791
Y+ + R D + +G G+FG VYKA + A KV + + + ++ + E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 792 EVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVA 851
++L H N+VK++ + +++E+ G+++ + + L Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 852 SALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGY 911
AL YLH +IH DLK N+L D L+DFG+S + T +
Sbjct: 121 DALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYW 176
Query: 912 MAPEY-----GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLA 966
MAPE + DV+S GI +IE + P E+ LK E LA
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 967 VTEVVDAEL 975
+
Sbjct: 237 QPSRWSSNF 245
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 6e-49
Identities = 61/288 (21%), Positives = 105/288 (36%), Gaps = 31/288 (10%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
LG G F VYKA AA K+ + + L+ + E +++ H N+ K++ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
+++++ G+++ + L Q + AL YLH IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY-----GSEGIVS 1514
DLK N+L D L DFG++ + + T +MAPE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 193
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574
DV+S GI ++E P ++ V LK E
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------------------- 234
Query: 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKIKTKFLKD 1620
+A + S+ KC E+ + R L + + K +++
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (444), Expect = 2e-49
Identities = 57/248 (22%), Positives = 112/248 (45%), Gaps = 7/248 (2%)
Query: 732 RRISYQELQRLTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAE 790
+Y + + + + +G G +G VY+ Y + VA+K ++ F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63
Query: 791 CEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLY-SHKYTLNIQQRLDIMID 849
V++ ++H NLV+++ C+ +I E+M G+L +L ++ ++ L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 850 VASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF 909
++SA+EYL IH DL N L+ ++ + ++DFG+S+L+ G+
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 910 GYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTE 969
+ APE + S DV++FG+L+ E T M + + +E+ R+ E
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPE 239
Query: 970 VVDAELLS 977
++
Sbjct: 240 GCPEKVYE 247
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 3e-49
Identities = 58/293 (19%), Positives = 117/293 (39%), Gaps = 26/293 (8%)
Query: 1323 RRISYQELRLATNGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAE 1381
+Y + + + + LG G + VY+ + A+K ++ ++ F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 63
Query: 1382 CEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL-LNIEQRLDIMID 1440
VM+ I+H NL +++ C+ +I ++M G+L +L N ++ L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATI 1500
++ A+EYL + IH DL N L+ ++ + + DFG+++L+ G I
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 1501 GYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTD 1560
+ APE + S DV++FG+L+ E T V +
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------PYPGIDLSQVYE 227
Query: 1561 VIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
+++ + + + C V L C + P +R + + + +
Sbjct: 228 LLEKDY-------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-48
Identities = 61/290 (21%), Positives = 123/290 (42%), Gaps = 31/290 (10%)
Query: 1332 LATNGFSESNLLGTGIFSSVYKATFADGTNA-----AIKIFSLQE-DRALKSFDAECEVM 1385
+ + + ++G G F VYK + AIK ++ F E +M
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 1386 RRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACAL 1445
+ H N+ ++ S +I +YM G+L+K+L + ++ Q + ++ +A +
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA--TIGYM 1503
+YL + + +H DL N+L++ ++V + DFG++++L+ T + I +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563
APE S +++ DV+SFGI+M E +T + + +K + D
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD--- 237
Query: 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
C S++ L ++C ++ R D ++ L K+
Sbjct: 238 -----------------CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-48
Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 12/239 (5%)
Query: 746 FSESNLIGAGSFGSVYKATLP-----YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRH 799
+ +IGAG FG VYK L + VAIK + F E ++ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
N++++ S + +I EYM G+L+K+L ++ Q + ++ +A+ + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM---KY 125
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA--TFGYMAPEYG 917
+H DL N+L++ + V +SDFG+S++L+ + T T + + APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 918 SEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELL 976
S ++ DV+SFGI+M E T + +K + + RL + +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDCPSAIY 243
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-48
Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 28/293 (9%)
Query: 1343 LGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN 1402
+G G F V++ + G A+KIFS +E+R+ +AE +RH N+ +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 1403 PGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY-----S 1453
L+ Y GSL +L + Y + +E + + + A L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD---SMKQTMTLATIGYMAPEYGSE 1510
+I H DLK N+L+ + + D G+A D + + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 1511 GI------VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564
I D+Y+ G++ E R ++ V D + +
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV---PSDPSVEEMRK 243
Query: 1565 NLLSGEEEADIAAK---KKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614
+ + +I + + + + + +C R+ L ++
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 22/226 (9%)
Query: 752 IGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN 811
IG G FG V++ G VA+K+F+ + + + +AE +RH N++ I++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 812 HGFKA----LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH-----GHP 862
L+ +Y GSL +L ++YT+ ++ + + + AS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT---LATFGYMAPEYGSE 919
+ H DLK N+L+ + ++D G++ D + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 920 GIVSTCG------DVYSFGILMIETFTRKMPTDEMFTGETSLKKWV 959
I D+Y+ G++ E R + V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-48
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 11/215 (5%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHR 800
+ + IG GS+G K G + K + + + +E +LR ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 801 NLVKIISSC--SNHGFKALILEYMPQGSLEKWLYSH---KYTLNIQQRLDIMIDVASALE 855
N+V+ + +++EY G L + + L+ + L +M + AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 856 YLHHGHPT--PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
H V+H DLKP+NV LD L DFG++++L+ + S + T YM+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMS 182
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
PE + + D++S G L+ E P
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-46
Identities = 55/281 (19%), Positives = 101/281 (35%), Gaps = 32/281 (11%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNL 1393
+ +GTG + K +DG K + + +E ++R ++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 1394 AKIVSSCSNPGFKAL--ILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYL 1448
+ + L +++Y G L + L+ E L +M + AL+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 1449 HQ--GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
H+ +++H DLKP+NV LD LGDFG+A++L+ S + T YM+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPE 184
Query: 1507 YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566
+ + D++S G L+ E P E+ E
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRR---------- 233
Query: 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDAL 1607
+ + + + R +V++ L
Sbjct: 234 ----------IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-48
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 14/232 (6%)
Query: 752 IGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISS 808
IG GSF +VYK + VA + + F E E+L+ ++H N+V+ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 809 C----SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
L+ E M G+L+ +L K + I+ + L++LH P P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP-P 134
Query: 865 VIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVS 923
+IH DLK N+ + T + D G++ L + + T +MAPE E
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEEK-YD 190
Query: 924 TCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
DVY+FG+ M+E T + P E ++ + +V E+
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-46
Identities = 58/273 (21%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 1343 LGTGIFSSVYKATFAD-GTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSS 1399
+G G F +VYK + A ++ + F E E+++ ++H N+ + S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 1400 C----SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
L+ + M G+L+ +L ++ I+ + L++LH +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPP 134
Query: 1456 IIHCDLKPSNVLLDD-DMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVS 1514
IIH DLK N+ + +GD G+A L + T +MAPE E
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEEK-YD 190
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574
S DVY+FG+ M+E T P + + P + V +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV-------- 242
Query: 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDAL 1607
+ C + +ER ++KD L
Sbjct: 243 -----------KEIIEGCIRQNKDERYSIKDLL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-48
Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 17/237 (7%)
Query: 748 ESNLIGAGSFGSVYKATLP---YGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNL 802
E +G+G+FG+V K VA+K+ + + AE V++++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHP 862
V++I C + L++E G L K+L +++ + + ++++ V+ ++YL +
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA--TFGYMAPEYGSEG 920
+H DL NVLL A +SDFG+SK L +++ + T + APE +
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 921 IVSTCGDVYSFGILMIETFTRKMPTDEMFTGETS--LKKWVEESLRLAVTEVVDAEL 975
S+ DV+SFG+LM E F+ + G + +E+ R+ E+
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK---PYRGMKGSEVTAMLEKGERMGCPAGCPREM 239
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-46
Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 34/283 (12%)
Query: 1339 ESNLLGTGIFSSVYKATFAD---GTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNL 1393
E LG+G F +V K + A+KI + + AE VM+++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+++ C + L+++ G L K+L + ++ + ++++ V+ ++YL +
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEE--- 125
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA--TIGYMAPEYGSEG 1511
++ +H DL NVLL A + DFG++K L ++ + T + + APE +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 1512 IVSTSGDVYSFGILMMETLTR-RKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570
S+ DV+SFG+LM E + +KP M EV E +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------------- 230
Query: 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
C + L C E R L+
Sbjct: 231 ------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 5e-48
Identities = 62/240 (25%), Positives = 93/240 (38%), Gaps = 17/240 (7%)
Query: 743 TDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL---QLDGAIKSFDAECEVLRRVR 798
FS+ IG GSFG+VY A + VAIK + Q + + E L+++R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
H N ++ L++EY + + HK L + + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY-- 916
+ +IH D+K N+LL + + L DFG + ++ +S T +MAPE
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP-----YWMAPEVIL 184
Query: 917 -GSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
EG DV+S GI IE RK P M L + +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYF 243
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 6e-48
Identities = 63/278 (22%), Positives = 103/278 (37%), Gaps = 36/278 (12%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSL---QEDRALKSFDAECEVMRRIRHRN 1392
FS+ +G G F +VY A + AIK S Q + + E ++++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ L+++Y + + H L + + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY---GS 1509
S ++IH D+K N+LL + + LGDFG A ++ + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMD 187
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569
EG DV+S GI +E R+ P +M L H + P +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFR-- 244
Query: 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDAL 1607
+ C ++IP++R + L
Sbjct: 245 -----------------NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 51/238 (21%), Positives = 96/238 (40%), Gaps = 8/238 (3%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL-QLDGAIKSFDAECEVLRRVRHRN 801
+ + +G G++G V A VA+K+ ++ + ++ E + + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
+VK + L LEY G L + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMAPEY-GSE 919
+ H D+KP N+LLD+ +SDFG++ + + + T Y+APE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 920 GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
+ DV+S GI++ ++P D+ W E+ L + +D+ L+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 60/282 (21%), Positives = 96/282 (34%), Gaps = 33/282 (11%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDR-ALKSFDAECEVMRRIRHRNLAKIVS 1398
LG G + V A A+KI ++ ++ E + + + H N+ K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
+ L L+Y G L + + + + YLH I H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLH---GIGITH 126
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEY-GSEGIVSTS 1516
D+KP N+LLD+ + DFG+A + + + + T+ Y+APE +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 1517 GDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576
DV+S GI++ L P D W E+ ID+ L
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--------- 237
Query: 1577 AKKKCMSSVMSLALKCSEEIPEERMNVKDALA------NLKK 1612
+L K E P R+ + D LKK
Sbjct: 238 ----------ALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-47
Identities = 61/291 (20%), Positives = 117/291 (40%), Gaps = 34/291 (11%)
Query: 1340 SNLLGTGIFSSVYKATFADGTN----AAIKIFSLQEDRA-LKSFDAECEVMRRIRHRNLA 1394
+ ++G G F VY T D A+K + D + F E +M+ H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 1395 KIVSSCS-NPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
++ C + G ++L YM G L ++ + + ++ + + VA +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK---QTMTLATIGYMAPEYGSE 1510
+H DL N +LD+ + DFG+A+ + + +T + +MA E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 1511 GIVSTSGDVYSFGILMMETLTRRK-PTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569
+T DV+SFG+L+ E +TR P D+ T ++ + L
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP------------ 256
Query: 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKD 1620
+ C + + LKC E R + + ++ + I + F+ +
Sbjct: 257 ---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-46
Identities = 55/236 (23%), Positives = 102/236 (43%), Gaps = 13/236 (5%)
Query: 749 SNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLV 803
+ +IG G FG VY TL ++ A+K N D G + F E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 804 KIISSCS-NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHP 862
++ C + G ++L YM G L ++ + + ++ + + VA +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 863 TPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT---QTMTLATFGYMAPEYGSE 919
+H DL N +LD+ ++DFG+++ + ++ + +T +MA E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 920 GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
+T DV+SFG+L+ E TR P + ++ + RL E L
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRLLQPEYCPDPL 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-46
Identities = 63/227 (27%), Positives = 93/227 (40%), Gaps = 7/227 (3%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISS 808
IG G+ G+VY A + G VAI+ NLQ + E V+R ++ N+V + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHC 868
+++EY+ GSL + Q + + ALE+LH VIH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 869 DLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDV 928
D+K N+LL D L+DFG + E S TM T +MAPE + D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 929 YSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
+S GI+ IE + P + L E + A
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-44
Identities = 58/268 (21%), Positives = 103/268 (38%), Gaps = 26/268 (9%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSS 1399
+G G +VY A A G AI+ +LQ+ + E VMR ++ N+ + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 1400 CSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHC 1459
++++Y+ GSL + + Q + + ALE+LH S +IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 1460 DLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDV 1519
D+K N+LL D L DFG + + K++ + T +MAPE + D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 1520 YSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKK 1579
+S GI+ +E + P + + + +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-------------------LQNPE 240
Query: 1580 KCMSSVMSLALKCSEEIPEERMNVKDAL 1607
K + +C + E+R + K+ L
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-46
Identities = 58/256 (22%), Positives = 107/256 (41%), Gaps = 34/256 (13%)
Query: 751 LIGAGSFGSVYKATLP------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNL 802
++G+G+FG V AT + VA+K+ + D ++ +E +++ ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 803 VKIISSCSNHGFKALILEYMPQGSLEKWLYSHK----------------------YTLNI 840
V ++ +C+ G LI EY G L +L S + L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 841 QQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900
+ L VA +E+L +H DL NVL+ V + DFG+++ + + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 901 TQTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWV 959
+MAPE EGI + DV+S+GIL+ E F+ + + + K +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 960 EESLRLAVTEVVDAEL 975
+ ++ E+
Sbjct: 281 QNGFKMDQPFYATEEI 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 6e-43
Identities = 59/301 (19%), Positives = 107/301 (35%), Gaps = 53/301 (17%)
Query: 1342 LLGTGIFSSVYKATFADGTNA------AIKIFSLQEDRA-LKSFDAECEVMRRI-RHRNL 1393
+LG+G F V AT + A+K+ + D + ++ +E ++M ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHN----------------------YLLNI 1431
++ +C+ G LI +Y G L +L S +L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 1432 EQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491
E L VA +E+L S +H DL NVL+ V + DFG+A+ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 1492 KQTMTLA-TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV 1550
+ +MAPE EGI + DV+S+GIL+ E + + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 1551 EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610
+ + + + C +R + + + L
Sbjct: 281 QNGFK-------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 1611 K 1611
Sbjct: 322 G 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 15/214 (7%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPY-GMNVAIKVFN---LQLDGAIKSFDAECEVLRRVRH 799
+ F +G G FG+VY A +A+KV L+ G E E+ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
N++++ + LILEY P G++ + L + Q+ + ++A+AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 124
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
VIH D+KP N+LL ++DFG S T TL Y+ PE
Sbjct: 125 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL---DYLPPEMIEG 178
Query: 920 GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ D++S G+L E K P F T
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPP----FEANT 208
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 35/276 (12%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRN 1392
F LG G F +VY A A+K+ L++ E E+ +RH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ ++ + LIL+Y P G++ + L + + ++ + ++A AL Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH--- 123
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI 1512
S +IH D+KP N+LL + DFG + S ++T T+ Y+ PE +
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 1513 VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH-WVEESLPDAVTDVIDANLLSGEE 1571
D++S G+L E L + P + E + VE + PD VT+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE----------- 229
Query: 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDAL 1607
L + + P +R +++ L
Sbjct: 230 ------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 4e-46
Identities = 63/319 (19%), Positives = 118/319 (36%), Gaps = 54/319 (16%)
Query: 1326 SYQELRLATNGFSESNLLGTGIFSSVYKAT------FADGTNAAIKIFSLQED-RALKSF 1378
L N +G G F V++A + T A+K+ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 1379 DAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL---------- 1428
E +M + N+ K++ C+ L+ +YM G L ++L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 1429 -------------LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475
L+ ++L I VA + YL +H DL N L+ ++MV
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 1476 LGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRK 1534
+ DFG+++ + D K A I +M PE +T DV+++G+++ E +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 1535 PTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSE 1594
+ + + + V D N+L+ E C + +L C
Sbjct: 241 Q------------PYYGMAHEEVIYYVRDGNILACPEN--------CPLELYNLMRLCWS 280
Query: 1595 EIPEERMNVKDALANLKKI 1613
++P +R + L+++
Sbjct: 281 KLPADRPSFCSIHRILQRM 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 3e-44
Identities = 61/274 (22%), Positives = 107/274 (39%), Gaps = 35/274 (12%)
Query: 735 SYQELQRLTDGFSESNLIGAGSFGSVYKATLPY------GMNVAIKVFNLQLD-GAIKSF 787
L+ + IG G+FG V++A P VA+K+ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 788 DAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY----------- 836
E ++ + N+VK++ C+ L+ EYM G L ++L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 837 ------------TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAH 884
L+ ++L I VA+ + YL +H DL N L+ ++ V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 885 LSDFGISKLLDGEDSVTQTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKM 943
++DFG+S+ + D A +M PE +T DV+++G+++ E F+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 944 PTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
E + +V + LA E EL +
Sbjct: 241 QPYYGMAHE-EVIYYVRDGNILACPENCPLELYN 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 4e-46
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 13/222 (5%)
Query: 737 QELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECE 792
Q ++ + F ++G GSF +V A L AIK+ + + + E +
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 793 VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS 852
V+ R+ H VK+ + + L Y G L K++ + + ++ S
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVS 119
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATF-GY 911
ALEYLH +IH DLKP N+LL++D ++DFG +K+L E + + Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 912 MAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
++PE +E D+++ G ++ + P F
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGN 214
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-44
Identities = 64/291 (21%), Positives = 106/291 (36%), Gaps = 31/291 (10%)
Query: 1337 FSESNLLGTGIFSSVYKAT-FADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRN 1392
F +LG G FS+V A A AIKI + ++ + E +VM R+ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
K+ + + L Y G L K++ + ++ ALEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLH--- 125
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYGSEG 1511
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571
S D+++ G ++ + + P + K
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI----------------------I 223
Query: 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKDVQ 1622
+ + +K L K +R+ ++ F + V
Sbjct: 224 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (424), Expect = 7e-46
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 12/206 (5%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G G+FG V++ T G N A K + ++ E + + +RH LV + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ +I E+M G L + + ++ + ++ M V L ++H + +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149
Query: 870 LKPSNVLL--DDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
LKP N++ L DFG++ LD + SV T A + APE V D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEGKPVGYYTD 207
Query: 928 VYSFGILMIETFTRKMPTDEMFTGET 953
++S G+L + P F GE
Sbjct: 208 MWSVGVLSYILLSGLSP----FGGEN 229
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (417), Expect = 5e-45
Identities = 62/270 (22%), Positives = 102/270 (37%), Gaps = 26/270 (9%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LGTG F V++ T A G N A K + ++ E + M +RH L + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
+ +I ++M G L + + + ++ ++ ++ M V L ++H+ + +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 149
Query: 1461 LKPSNVLL--DDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
LKP N++ L DFG+ LD S+K T T + APE V D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTD 207
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578
++S G+L L+ P E N+ S + D +A
Sbjct: 208 MWSVGVLSYILLSGLSPFGGENDDETL------------------RNVKSCDWNMDDSAF 249
Query: 1579 KKCMSSVMSLALKCSEEIPEERMNVKDALA 1608
K P RM + AL
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 8e-46
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 31/266 (11%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLD-GAIKSFDAE 790
E R + S +GAG+FG V +AT M VA+K+ ++ +E
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 791 CEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYT------------ 837
+VL + H N+V ++ +C+ G +I EY G L +L + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 838 -----LNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892
L+++ L VA + +L + IH DL N+LL + + DFG+++
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 893 LL-DGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTG 951
+ + + V + +MAPE + + DV+S+GI + E F+
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 952 ETSLKKWVEESLRLAVTEVVDAELLS 977
++ K ++E R+ E AE+
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYD 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-43
Identities = 55/303 (18%), Positives = 109/303 (35%), Gaps = 48/303 (15%)
Query: 1337 FSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQEDRA-LKSFDAECEVMRRI- 1388
S LG G F V +AT A+K+ ++ +E +V+ +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 1389 RHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL-----------------LNI 1431
H N+ ++ +C+ G +I +Y G L +L L++
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 1432 EQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL-DGVDS 1490
E L VA + +L S + IH DL N+LL + + DFG+A+ + + +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV 1550
+ + + +MAPE + + DV+S+GI + E + + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 1551 EESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANL 1610
+E + + + + + + C + P +R K + +
Sbjct: 262 KEGFR-------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 1611 KKI 1613
+K
Sbjct: 303 EKQ 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-45
Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 13/242 (5%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKATLP-----YGMNVAIKVFNLQLDG-AIKSFDAECEVL 794
+ T+ F + ++G+G+FG+VYK + VAIK A K E V+
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 795 RRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
V + ++ +++ C + LI + MP G L ++ HK + Q L+ + +A +
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLA-TFGYMA 913
YL ++H DL NVL+ ++DFG++KLL E+ +MA
Sbjct: 125 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDA 973
E I + DV+S+G+ + E T + + +E+ RL +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTI 240
Query: 974 EL 975
++
Sbjct: 241 DV 242
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-44
Identities = 59/285 (20%), Positives = 109/285 (38%), Gaps = 31/285 (10%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIK-----IFSLQEDRALKSFDAECEVMRRIRH 1390
F + +LG+G F +VYK + +G I + +A K E VM + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
++ +++ C + LI Q MP G L ++ H + + L+ + +A + YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA-TIGYMAPEYGS 1509
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569
I + DV+S+G+ + E +T D ++ +++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------------ASEISSILEKGER-- 231
Query: 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614
+ C V + +KC + R ++ + K+
Sbjct: 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (417), Expect = 5e-45
Identities = 48/233 (20%), Positives = 100/233 (42%), Gaps = 16/233 (6%)
Query: 731 WRRISYQELQ----RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIK 785
W++ Q ++ + D + +G+G+FG V++ G K N
Sbjct: 12 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 786 SFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLD 845
+ E ++ ++ H L+ + + + LILE++ G L + + Y ++ + ++
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131
Query: 846 IMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD--DDTVAHLSDFGISKLLDGEDSVTQT 903
M L+++H ++H D+KP N++ + + + DFG++ L+ ++ V T
Sbjct: 132 YMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188
Query: 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
T + APE V D+++ G+L + P F GE L+
Sbjct: 189 TA--TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLE 235
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 2e-43
Identities = 55/270 (20%), Positives = 100/270 (37%), Gaps = 26/270 (9%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG+G F V++ A G K + + E +M ++ H L + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
+ LIL+++ G L + + +Y ++ + ++ M L+++H SI+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 1461 LKPSNVLLD--DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
+KP N++ + + DFG+A L+ +T AT + APE V D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578
+++ G+L L+ P E + E D A
Sbjct: 211 MWAIGVLGYVLLSGLSPFAGEDDLETLQNV------------------KRCDWEFDEDAF 252
Query: 1579 KKCMSSVMSLALKCSEEIPEERMNVKDALA 1608
++ P +R+ V DAL
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 58/245 (23%), Positives = 100/245 (40%), Gaps = 12/245 (4%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATLP----YGMNVAIKVFNLQL-DGAIKSFDAECE 792
E+QR + IG G FG V++ + VAIK D + F E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 793 VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS 852
+R+ H ++VK+I + +I+E G L +L KY+L++ + +++
Sbjct: 61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
AL YL +H D+ NVL+ + L DFG+S+ ++ + +M
Sbjct: 120 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 913 APEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVD 972
APE + ++ DV+ FG+ M E + + + +E RL +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNCP 235
Query: 973 AELLS 977
L S
Sbjct: 236 PTLYS 240
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 59/277 (21%), Positives = 101/277 (36%), Gaps = 29/277 (10%)
Query: 1342 LLGTGIFSSVYKATFADGTNA----AIKIFS-LQEDRALKSFDAECEVMRRIRHRNLAKI 1396
+G G F V++ + N AIK D + F E MR+ H ++ K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+ + +I++ G L +L Y L++ + ++ AL YL S
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTS 1516
+H D+ NVL+ + LGDFG+++ ++ K + I +MAPE + +++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 1517 GDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIA 1576
DV+ FG+ M E L + +
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN---------------- 233
Query: 1577 AKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
C ++ SL KC P R + A L I
Sbjct: 234 ----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-44
Identities = 68/310 (21%), Positives = 128/310 (41%), Gaps = 52/310 (16%)
Query: 1324 RISYQELRLATNGFSESNLLGTGIFSSVYKATFADG---TNAAIKIFSLQEDR-ALKSFD 1379
+ + +++ +++G G F V KA +AAIK + + F
Sbjct: 6 VLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 1380 AECEVMRRI-RHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL---------- 1428
E EV+ ++ H N+ ++ +C + G+ L ++Y P G+L +L L
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 1429 -----LNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483
L+ +Q L DVA ++YL IH DL N+L+ ++ VA + DFG+++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGE 1543
+ +K+TM + +MA E + + +T+ DV+S+G+L+ E ++ T
Sbjct: 176 GQE--VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233
Query: 1544 VCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNV 1603
+ + + + C V L +C E P ER +
Sbjct: 234 ELYEKLPQGYRLEKPLN--------------------CDDEVYDLMRQCWREKPYERPSF 273
Query: 1604 KDALANLKKI 1613
L +L ++
Sbjct: 274 AQILVSLNRM 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 4e-43
Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 26/254 (10%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPYG---MNVAIKVFNLQLD-GAIKSFDAECEVLRRV-R 798
+ ++IG G+FG V KA + M+ AIK + F E EVL ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY---------------TLNIQQR 843
H N++ ++ +C + G+ L +EY P G+L +L + TL+ QQ
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 844 LDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903
L DVA ++YL IH DL N+L+ ++ VA ++DFG+S+ E V +T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184
Query: 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESL 963
M +MA E + + +T DV+S+G+L+ E + T +K + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY 243
Query: 964 RLAVTEVVDAELLS 977
RL D E+
Sbjct: 244 RLEKPLNCDDEVYD 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 59/235 (25%), Positives = 92/235 (39%), Gaps = 13/235 (5%)
Query: 752 IGAGSFGSVYKATLP----YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVK 804
+G GSFG V + ++VA+K + A+ F E + + HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 805 IISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTP 864
+ K ++ E P GSL L H+ + + VA + YL
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 131
Query: 865 VIHCDLKPSNVLLDDDTVAHLSDFGISKLL--DGEDSVTQTMTLATFGYMAPEYGSEGIV 922
IH DL N+LL + + DFG+ + L + + V Q F + APE
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 923 STCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAELLS 977
S D + FG+ + E FT G L K +E RL E ++ +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 60/281 (21%), Positives = 97/281 (34%), Gaps = 32/281 (11%)
Query: 1343 LGTGIFSSVYKATF----ADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAK 1395
LG G F V + + + A+K L + A+ F E M + HRNL +
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ P K ++ + P GSL L H + + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLA--TIGYMAPEYGSEGIV 1513
IH DL N+LL + +GDFG+ + L D + APE
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 1514 STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573
S + D + FG+ + E T + G L +E
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------------------ 233
Query: 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614
+ + C + ++ ++C PE+R L + +
Sbjct: 234 -LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-43
Identities = 61/302 (20%), Positives = 122/302 (40%), Gaps = 40/302 (13%)
Query: 1337 FSESNLLGTGIFSSVYKATF------ADGTNAAIKIFSLQED-RALKSFDAECEVMRRIR 1389
+ S LG G F VY+ T AIK + R F E VM+
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 1390 HRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL---------LNIEQRLDIMID 1440
++ +++ S +I++ M +G L+ +L S ++ + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 1441 VACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT-LAT 1499
+A + YL+ + +H DL N ++ +D +GDFG+ + + D ++ L
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 1500 IGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT 1559
+ +M+PE +G+ +T DV+SFG+++ E T + + E L+ +E L D
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 257
Query: 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLK 1619
C + L C + P+ R + + ++++K+ +
Sbjct: 258 -------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
Query: 1620 DV 1621
+V
Sbjct: 299 EV 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-41
Identities = 56/244 (22%), Positives = 106/244 (43%), Gaps = 22/244 (9%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLD-GAIKSFDAE 790
E+ R + + S +G GSFG VY+ VAIK N F E
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 791 CEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY---------TLNIQ 841
V++ ++V+++ S +I+E M +G L+ +L S + ++
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
+ + + ++A + YL+ +H DL N ++ +D + DFG+++ + D
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 902 QTMT-LATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVE 960
+ L +M+PE +G+ +T DV+SFG+++ E T + + E L+ +E
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 961 ESLR 964
L
Sbjct: 251 GGLL 254
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 1e-41
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 9/223 (4%)
Query: 736 YQELQRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQ-LDGAIKSFDAECEV 793
+++ + + D + +++G G+F V A VAIK + L+G S + E V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 794 LRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASA 853
L +++H N+V + + G LI++ + G L + + + ++ V A
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 119
Query: 854 LEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMA 913
++YLH LD+D+ +SDFG+SK+ D SV T T GY+A
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTAC-GTPGYVA 177
Query: 914 PEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
PE ++ S D +S G++ P F E K
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAK 216
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 1e-38
Identities = 60/270 (22%), Positives = 99/270 (36%), Gaps = 23/270 (8%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVS 1398
++LGTG FS V A AIK + + + S + E V+ +I+H N+ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
+ G LI+Q + G L + + ++ V A++YLH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
LD+D + DFG++K+ D + T GY+APE ++ S + D
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578
+S G++ L P D ++ + L E E D
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQI------------------LKAEYEFDSPYW 233
Query: 1579 KKCMSSVMSLALKCSEEIPEERMNVKDALA 1608
S E+ PE+R + AL
Sbjct: 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 57/291 (19%), Positives = 116/291 (39%), Gaps = 33/291 (11%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G F V++ + K ++ E ++ RHRN+ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
+ +I +++ + + + + + LN + + + V AL++LH S +I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 1461 LKPSNVLLDDDMVAH--LGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
++P N++ + + +FG A+ L D+ + T Y APE +VST+ D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVVSTATD 185
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAK 1578
++S G L+ L+ P ++ N+++ E D A
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQII------------------ENIMNAEYTFDEEAF 227
Query: 1579 KKCMSSVMSLALKCSEEIPEERMNVKDALA------NLKKIKTKFLKDVQQ 1623
K+ M + + + RM +AL ++++ TK ++ ++
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKH 278
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-40
Identities = 46/206 (22%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G G FG V++ K ++ E +L RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
+ +I E++ + + + + + LN ++ + + V AL++LH + + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127
Query: 870 LKPSNVLLDDDTVAH--LSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
++P N++ + + +FG ++ L D+ T Y APE +VST D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVVSTATD 185
Query: 928 VYSFGILMIETFTRKMPTDEMFTGET 953
++S G L+ + P F ET
Sbjct: 186 MWSLGTLVYVLLSGINP----FLAET 207
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-41
Identities = 70/299 (23%), Positives = 121/299 (40%), Gaps = 49/299 (16%)
Query: 1341 NLLGTGIFSSVYKATF--------ADGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RH 1390
LG G F V A T A+K+ ++ L +E E+M+ I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYL---------------LNIEQRL 1435
+N+ ++ +C+ G +I++Y +G+L ++L + L+ + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 1436 DIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTM 1495
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D K+T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 1496 TLA-TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL 1554
+ +MAPE + I + DV+SFG+L+ E T E K E
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
D ++ C + + + C +P +R K + +L +I
Sbjct: 256 MDKPSN--------------------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 32/266 (12%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKATLP--------YGMNVAIKVFNLQL-DGAIKSFD 788
EL R D +G G+FG V A VA+K+ + +
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 789 AECEVLRRV-RHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKY----------- 836
+E E+++ + +H+N++ ++ +C+ G +I+EY +G+L ++L + +
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 837 ----TLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892
L+ + + VA +EYL IH DL NVL+ +D V ++DFG+++
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 893 LLDGEDSVTQTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTG 951
+ D +T +MAPE + I + DV+SFG+L+ E FT
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 952 ETSLKKWVEESLRLAVTEVVDAELLS 977
E L K ++E R+ EL
Sbjct: 244 E-ELFKLLKEGHRMDKPSNCTNELYM 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 148 bits (374), Expect = 4e-40
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRR 796
L+D + ++G G V+ A L +VA+KV L F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 797 VRHRNLVKIISSC----SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS 852
+ H +V + + +++EY+ +L +++ + ++ ++++ D
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQ 122
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL-DGEDSVTQTMTLA-TFG 910
AL + H +IH D+KP+N+++ + DFGI++ + D +SVTQT + T
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
Y++PE V DVYS G ++ E T + P FTG++
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDS 218
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (358), Expect = 5e-38
Identities = 55/283 (19%), Positives = 111/283 (39%), Gaps = 33/283 (11%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
+LG G S V+ A + A+K+ ++ F E + + H + +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 1398 SSCSNPGFKA----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+ ++++Y+ +L +++ + ++ ++++ D AL + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNFSH---Q 129
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT--LATIGYMAPEYGSEG 1511
IIH D+KP+N+++ + DFGIA+ + + + T Y++PE
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571
V DVYS G ++ E LT P V +H E+ +P
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------------- 233
Query: 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERM-NVKDALANLKKI 1613
A + + + ++ LK + PE R + A+L ++
Sbjct: 234 --PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 146 bits (370), Expect = 1e-39
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNL---------QLDGAIKSFDAECEV 793
+ + ++G G V + P A+K+ ++ ++ ++ E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 794 LRRVR-HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS 852
LR+V H N++++ + + F L+ + M +G L +L TL+ ++ IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLE 121
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYM 912
+ LH + ++H DLKP N+LLDDD L+DFG S LD + + + T Y+
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG--TPSYL 176
Query: 913 APEYGSEGIVSTCG------DVYSFGILMIETFTRKMPTDEMFTGET 953
APE + D++S G++M P F
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRK 219
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (352), Expect = 3e-37
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 41/289 (14%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSL---------QEDRALKSFDAECEVMR 1386
+ +LG G+ S V + A+KI + + ++ E +++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 1387 RIR-HRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACAL 1445
++ H N+ ++ + F L+ M +G L +L L + ++ IM + +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-SEKETRKIMRALLEVI 123
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAP 1505
LH +I+H DLKP N+LLDDDM L DFG + LD K T Y+AP
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAP 178
Query: 1506 EY------GSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT 1559
E + D++S G++M L P +
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI----------- 227
Query: 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608
+SG + +V L + P++R ++ALA
Sbjct: 228 -------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-39
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 14/215 (6%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN---LQLDGAIKSFDAECEVLRRV-R 798
+ F ++G GSFG V+ A AIK + +D ++ E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 799 HRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
H L + + ++EY+ G L + S ++ + ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGS 918
+++ DLK N+LLD D ++DFG+ K D+ T Y+APE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILL 176
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ D +SFG+L+ E + P F G+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQD 207
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-35
Identities = 60/274 (21%), Positives = 102/274 (37%), Gaps = 32/274 (11%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDAECEVMRR-IRHRNLAK 1395
+LG G F V+ A F AIK + D ++ E V+ H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 1396 IVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ + +++Y+ G L + S + ++ + ++ L++LH S
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH---SKG 123
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVST 1515
I++ DLK N+LLD D + DFG+ K + K T Y+APE +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENM-LGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 1516 SGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADI 1575
S D +SFG+L+ E L + P F G+ + L +
Sbjct: 183 SVDWWSFGVLLYEMLIGQSP----FHGQ------------------DEEELFHSIRMDNP 220
Query: 1576 AAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609
+ L +K PE+R+ V+ +
Sbjct: 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 3e-38
Identities = 51/240 (21%), Positives = 96/240 (40%), Gaps = 15/240 (6%)
Query: 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNL------QLDGAIKSFDAECEVLRR 796
+ FS +IG G FG VY G A+K + Q + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 797 VRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEY 856
+V + + + IL+ M G L L H + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY 916
+H+ V++ DLKP+N+LLD+ +SD G++ + ++ T GYMAPE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176
Query: 917 GSEGI-VSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEVVDAEL 975
+G+ + D +S G ++ + P + T + + ++ + + + EL
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (347), Expect = 1e-35
Identities = 58/297 (19%), Positives = 103/297 (34%), Gaps = 37/297 (12%)
Query: 1335 NGFSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSL------QEDRALKSFDAECEVMRR 1387
N FS ++G G F VY AD G A+K Q + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 1388 IRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEY 1447
+ + + P + IL M G L L H + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY 1507
+H + +++ DLKP+N+LLD+ + D G+A K ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPEV 176
Query: 1508 GSEGI-VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566
+G+ +S D +S G ++ + L P T + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------------HEI 217
Query: 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT-KFLKDVQ 1622
+ + SL + R+ A +++K F + +
Sbjct: 218 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA--QEVKESPFFRSLD 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 4e-38
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKI 805
+G GSFG V+ G A+KV ++ ++ + E +L V H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 806 ISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ + +I++Y+ G L +V ALEYLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---I 125
Query: 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTC 925
I+ DLKP N+LLD + ++DFG +K + T Y+APE S +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 926 GDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
D +SFGIL+ E P F ++K
Sbjct: 182 IDWWSFGILIYEMLAGYTP----FYDSNTMK 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (355), Expect = 3e-37
Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 17/232 (7%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKI 1396
LGTG F V+ +G A+K+ + + ++ + E ++ + H + ++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 1397 VSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+ + +I+ Y+ G L + +V ALEYLH S I
Sbjct: 70 WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTS 1516
I+ DLKP N+LLD + + DFG AK + T Y+APE S + S
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 1517 GDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-----SLPDAVTDVID 1563
D +SFGIL+ E L P D T + K E + V D++
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-38
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL-----DGAIKSFDAECEVLRRVRHRNLV 803
+ +G G F +VYKA VAIK L DG ++ E ++L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 804 KIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPT 863
++ + + +L+ ++M LE + + L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 864 PVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE-YGSEGIV 922
++H DLKP+N+LLD++ V L+DFG++K G + T + T Y APE +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 923 STCGDVYSFGILMIETFTRKMPTDEMFTGET 953
D+++ G ++ E R G++
Sbjct: 179 GVGVDMWAVGCILAELLLRVPF----LPGDS 205
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 18/281 (6%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ-----EDRALKSFDAECEVMRRIRHRNLA 1394
+ LG G F++VYKA AIK L +D ++ E ++++ + H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
++ + + +L+ +M LE + ++ +L M+ LEYLHQ +
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 1455 SIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-YGSEGIV 1513
I+H DLKP+N+LLD++ V L DFG+AK + T + T Y APE +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 1514 STSGDVYSFGILMMETLTRRKPTDDMFTGEV------CLKHWVEESLPDAVTDVIDANLL 1567
D+++ G ++ E L R + L EE PD +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608
S ++ L P R+ AL
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 9e-38
Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 10/206 (4%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG G++G VYKA YG A+K L+ +G + E +L+ ++H N+VK+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 808 SCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIH 867
L+ E++ L+K L + L ++ + + + Y H V+H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLH 123
Query: 868 CDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGD 927
DLKP N+L++ + ++DFG+++ + + ST D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 928 VYSFGILMIETFTRKMPTDEMFTGET 953
++S G + E F G +
Sbjct: 184 IWSVGCIFAEMVNGTPL----FPGVS 205
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (350), Expect = 8e-37
Identities = 52/289 (17%), Positives = 105/289 (36%), Gaps = 19/289 (6%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSL--QEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G G + VYKA G A+K L +++ + E +++ ++H N+ K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIH 1458
L+ +++ L+K L L ++ + + Y H ++H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 1459 CDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGD 1518
DLKP N+L++ + + DFG+A+ + ST+ D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 1519 VYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT-------DVIDANLLSGEE 1571
++S G + E + + + ++ + P++ D N E
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKD 1620
+ K S + L K + P +R+ K AL + + K+
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH------AYFKE 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-37
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 10/210 (4%)
Query: 742 LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFN-LQLDGAIKSFDAECEVLRRVRH 799
+ ++ + IG G++G V A + VAIK + + + E ++L R RH
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYS--HKYTLNIQQRLDIMIDVASALEYL 857
N++ I + + Y+ + LY L+ + + L+Y+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 858 HHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMT--LATFGYMAPE 915
H + V+H DLKPSN+LL+ + DFG++++ D + T +T +AT Y APE
Sbjct: 126 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 916 YGSEGIVSTC-GDVYSFGILMIETFTRKMP 944
T D++S G ++ E + +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-37
Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 19/291 (6%)
Query: 1334 TNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRA-LKSFDAECEVMRRIRHR 1391
++ + +G G + V A + AIK S E + + E +++ R RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 1392 NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYS--HNYLLNIEQRLDIMIDVACALEYLH 1449
N+ I P + + Y+ + LY L+ + + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL--DGVDSMKQTMTLATIGYMAPEY 1507
S +++H DLKPSN+LL+ + DFG+A++ D + T +AT Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 1508 GSEGIVST-SGDVYSFGILMMETLTRRKP------TDDMFTGEVCLKHWVEESLPDAVTD 1560
T S D++S G ++ E L+ R D + L +E L +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 1561 VIDANLLSGEEEADIAAKK---KCMSSVMSLALKCSEEIPEERMNVKDALA 1608
LLS + + + S + L K P +R+ V+ ALA
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 10/213 (4%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHR 800
+ F + IG G++G VYKA G VA+K L +G + E +L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 801 NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG 860
N+VK++ L+ E++ Q + S + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 861 HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEG 920
V+H DLKP N+L++ + L+DFG+++ + +
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 921 IVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
ST D++S G + E TR+ F G++
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRAL----FPGDS 207
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-37
Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 21/296 (7%)
Query: 1337 FSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSL--QEDRALKSFDAECEVMRRIRHRNL 1393
F + +G G + VYKA G A+K L + + + E +++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 1394 AKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
K++ L+ +++ Q + S + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-YGSEGI 1512
++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 1513 VSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572
ST+ D++S G + E +TRR + + + PD V ++ +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 1573 ADIAAKK-------KCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKDV 1621
A++ SL + P +R++ K ALA+ F +DV
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH------PFFQDV 289
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 44/216 (20%), Positives = 91/216 (42%), Gaps = 17/216 (7%)
Query: 740 QRLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL------DGAIKSFDAECE 792
+ + D + +G+G F V K G+ A K + + + + E
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 793 VLRRVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVAS 852
+L+ ++H N++ + N LILE + G L +L + +L ++ + + + +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILN 124
Query: 853 ALEYLHHGHPTPVIHCDLKPSNVLLDDDTVA----HLSDFGISKLLDGEDSVTQTMTLAT 908
+++ H + H DLKP N++L D V + DFG++ +D + T
Sbjct: 125 G---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GT 179
Query: 909 FGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
++APE + + D++S G++ + P
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 8e-35
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 37/288 (12%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSL------QEDRALKSFDAECEVMRRIRHRNLA 1394
LG+G F+ V K + G A K + + + + E +++ I+H N+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 1395 KIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYST 1454
+ N LIL+ + G L +L L E+ + + + + YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ-- 133
Query: 1455 SIIHCDLKPSNVLLDDDMVA----HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE 1510
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 134 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIVNY 190
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570
+ D++S G++ L+ P E AN+ +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------------ANVSAVN 232
Query: 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKIKTK 1616
E + + + + P++RM ++D+L + +K T+
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 6e-37
Identities = 56/265 (21%), Positives = 107/265 (40%), Gaps = 30/265 (11%)
Query: 738 ELQRLTDGFSESNLIGAGSFGSVYKAT------LPYGMNVAIKVFNL-QLDGAIKSFDAE 790
E R D +G G+FG V +A VA+K+ ++ +E
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 791 CEVLRRVRHR-NLVKIISSCSNHGFKALIL-EYMPQGSLEKWLYSH-------------- 834
++L + H N+V ++ +C+ G +++ E+ G+L +L S
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 835 -KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893
K L ++ + VA +E+L IH DL N+LL + V + DFG+++
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 894 LDGEDSVTQTMTLA-TFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGE 952
+ + + +MAPE + + + DV+SFG+L+ E F+ +
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 953 TSLKKWVEESLRLAVTEVVDAELLS 977
+ ++E R+ + E+
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQ 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-35
Identities = 59/299 (19%), Positives = 110/299 (36%), Gaps = 49/299 (16%)
Query: 1341 NLLGTGIFSSVYKATF------ADGTNAAIKIFSLQEDRA-LKSFDAECEVMRRIRHR-N 1392
LG G F V +A A A+K+ + ++ +E +++ I H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 1393 LAKIVSSCSNPGFKALIL-QYMPQGSLEKWLYSHNY---------------LLNIEQRLD 1436
+ ++ +C+ PG +++ ++ G+L +L S L +E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 1437 IMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMT 1496
VA +E+L S IH DL N+LL + V + DFG+A+ + +
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 1497 LA-TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRK-PTDDMFTGEVCLKHWVEESL 1554
+ +MAPE + + + DV+SFG+L+ E + P + E + E +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 255
Query: 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
A + L C P +R + + +L +
Sbjct: 256 MRAP--------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-36
Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 20/228 (8%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGA------IKSFDAECEVLRRVR--HRN 801
L+G+G FGSVY + + VAIK E +L++V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 802 LVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
+++++ LILE + + L + V A+ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 862 PTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEY-GSE 919
V+H D+K N+L+D + L DFG LL T T Y PE+
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYH 184
Query: 920 GIVSTCGDVYSFGILMIETFTRKMP---TDEMFTGETSLKKWVEESLR 964
V+S GIL+ + +P +E+ G+ ++ V +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 56/294 (19%), Positives = 95/294 (32%), Gaps = 57/294 (19%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQ------EDRALKSFDAECEVMRRIR--HRN 1392
LLG+G F SVY +D AIK E E +++++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 1393 LAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ +++ P LIL+ + L E V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 1453 STSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEY-GSE 1510
+ ++H D+K N+L+D + L DFG LL T T Y PE+
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYH 184
Query: 1511 GIVSTSGDVYSFGILMMETLTRRKP---TDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567
S V+S GIL+ + + P +++ G+V + V
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----------- 233
Query: 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKDV 1621
L C P +R ++ + +++DV
Sbjct: 234 --------------------LIRWCLALRPSDRPTFEEIQNH------PWMQDV 261
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-36
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 28/300 (9%)
Query: 1341 NLLGTGIFSSVYKATFA--DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRI---RHRNL 1393
+G G + V+KA G A+K +Q E+ S E V+R + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 1394 AKIVSSCSNPGFKA-----LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYL 1448
++ C+ L+ +++ Q + E D+M + L++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 1449 HQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYG 1508
H S ++H DLKP N+L+ L DFG+A++ M T + T+ Y APE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVL 187
Query: 1509 SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568
+ +T D++S G + E R+ + K LP D L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 1569 GEEEADIAAKKKCMSSVMS-----LALKCSEEIPEERMNVKDALANLKKIKTKFLKDVQQ 1623
+ A + + + L LKC P +R++ AL++ + +D+++
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH------PYFQDLER 301
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-34
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 21/227 (9%)
Query: 739 LQRLTDGFSESNLIGAGSFGSVYKAT--LPYGMNVAIKVFNLQL--DGAIKSFDAECEVL 794
L R + IG G++G V+KA G VA+K +Q +G S E VL
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 795 RR---VRHRNLVKIISSCSNHGFKA-----LILEYMPQGSLEKWLYSHKYTLNIQQRLDI 846
R H N+V++ C+ L+ E++ Q + + + D+
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 847 MIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTL 906
M + L++LH V+H DLKP N+L+ L+DFG++++ + ++T +
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV- 177
Query: 907 ATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
T Y APE + +T D++S G + E F RK F G +
Sbjct: 178 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSS 219
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-36
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 746 FSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVK 804
++++ +IG GSFG VY+A L G VAIK + + E +++R++ H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 805 IISSCSNHG------FKALILEYMPQGSLEKWLY--SHKYTLNIQQRLDIMIDVASALEY 856
+ + G + L+L+Y+P+ + K TL + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 857 LHHGHPTPVIHCDLKPSNVLLDDDTVAH-LSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
+H + H D+KP N+LLD DT L DFG +K L + + +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRAPEL 193
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
++ DV+S G ++ E + F G++
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDS 227
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-34
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 25/289 (8%)
Query: 1337 FSESNLLGTGIFSSVYKATFAD-GTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAK 1395
++++ ++G G F VY+A D G AIK + + + E ++MR++ H N+ +
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 1396 IVSSCSNPG------FKALILQYMPQGSLEKWLY--SHNYLLNIEQRLDIMIDVACALEY 1447
+ + G + L+L Y+P+ + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 1448 LHQGYSTSIIHCDLKPSNVLLDDD-MVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
+H S I H D+KP N+LLD D V L DFG AK L + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPEL 193
Query: 1507 YGSEGIVSTSGDVYSFGILMMETLTRRKP------TDDMFTGEVCLKHWVEESLPDAVTD 1560
++S DV+S G ++ E L + D + L E + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 1561 VIDANLLSGEEEADIAAKKKCMS-SVMSLALKCSEEIPEERMNVKDALA 1608
+ + + ++L + E P R+ +A A
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 1e-35
Identities = 48/249 (19%), Positives = 93/249 (37%), Gaps = 15/249 (6%)
Query: 741 RLTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRH 799
R+ + + IG+GSFG +Y T + G VAIK+ ++ E ++ + ++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQG 61
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
+ I C G +++ + SLE +++ L + + S +EY+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 860 GHPTPVIHCDLKPSNVL---LDDDTVAHLSDFGISKLLDGEDSVTQTMT------LATFG 910
+ IH D+KP N L + ++ DFG++K + T
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 911 YMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKWVEESLRLAVTEV 970
Y + S D+ S G +++ +P + K +++
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 971 VDAELLSSE 979
V + SE
Sbjct: 239 VLCKGYPSE 247
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 1e-34
Identities = 50/297 (16%), Positives = 101/297 (34%), Gaps = 34/297 (11%)
Query: 1329 ELRLATNGFSESNLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRR 1387
ELR+ N + +G+G F +Y T A G AIK+ ++ E ++ +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 1388 IRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEY 1447
++ + C G +++ + SLE + +++ L + + +EY
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 1448 LHQGYSTSIIHCDLKPSNVL---LDDDMVAHLGDFGIAKLLDGVDSMKQTMT------LA 1498
+H S + IH D+KP N L + ++ DFG+AK + +
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 1499 TIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH--WVEESLPD 1556
T Y + S D+ S G ++M P + K+ E+ +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613
+ + K S + C +++ + + +
Sbjct: 236 PIEVLC----------------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-35
Identities = 56/276 (20%), Positives = 101/276 (36%), Gaps = 34/276 (12%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSS 1399
+LG GI V + A+K+ + E E+ R + ++ +IV
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 1400 CSNPGFKA----LILQYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYST 1454
N ++++ + G L + + + +IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 1455 SIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEG 1511
+I H D+KP N+L + + L DFG AK +S+ T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 1512 IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571
S D++S G++M L P A++ + + G+
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNH--------------GLAISPGMKTRIRMGQY 234
Query: 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDAL 1607
E + V L + P +RM + + +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-35
Identities = 43/204 (21%), Positives = 81/204 (39%), Gaps = 20/204 (9%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISS 808
++G G G V + A+K+ E E+ R + ++V+I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 809 C----SNHGFKALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPT 863
+ +++E + G L + ++ +IM + A++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 864 PVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEG 920
+ H D+KP N+L + + L+DFG +K +S+T T Y+APE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 921 IVSTCGDVYSFGILMIETFTRKMP 944
D++S G++M P
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (334), Expect = 1e-34
Identities = 36/210 (17%), Positives = 72/210 (34%), Gaps = 17/210 (8%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
IG GSFG +++ T L VAIK + D E + + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 810 SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCD 869
G +++ + SLE L +++ + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 870 LKPSNVLLDDDTVAH-----LSDFGISKLLDGEDSVTQTMT------LATFGYMAPEYGS 918
+KP N L+ + + DFG+ K + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 919 EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948
S D+ + G + + +P +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (315), Expect = 4e-32
Identities = 36/220 (16%), Positives = 72/220 (32%), Gaps = 17/220 (7%)
Query: 1342 LLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
+G G F +++ T + AIK + D E + + V
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCD 1460
G +++ + SLE L +++ + ++ +H S+++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 1461 LKPSNVLLDDDMVAH-----LGDFGIAKLLD------GVDSMKQTMTLATIGYMAPEYGS 1509
+KP N L+ + + DFG+ K + ++ T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 1510 EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW 1549
S D+ + G + M L P + K+
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 42/198 (21%), Positives = 83/198 (41%), Gaps = 7/198 (3%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKII 806
IG G++G+V+KA VA+K L D G S E +L+ ++H+N+V++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 807 SSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVI 866
+ L+ E+ Q + + + + + + + L + H + V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 867 HCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCG 926
H DLKP N+L++ + L++FG+++ + + + ST
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 927 DVYSFGILMIETFTRKMP 944
D++S G + E P
Sbjct: 184 DMWSAGCIFAELANAGRP 201
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 48/279 (17%), Positives = 101/279 (36%), Gaps = 15/279 (5%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQED--RALKSFDAECEVMRRIRHRNLAKIV 1397
+G G + +V+KA A+K L +D S E +++ ++H+N+ ++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 1398 SSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457
+ L+ ++ Q + + + L + E + + L + H +++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSG 1517
H DLKP N+L++ + L +FG+A+ + + STS
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 1518 DVYSFGILMMETLTRRKP-------TDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570
D++S G + E +P D + L EE P
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 1571 EEADIAAKKKCMSS-VMSLALKCSEEIPEERMNVKDALA 1608
+ +++ L + P +R++ ++AL
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-34
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 14/218 (6%)
Query: 741 RLT-DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLR 795
++T + F L+G G+FG V G A+K+ ++ + E VL+
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 796 RVRHRNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALE 855
RH L + + H ++EY G L L S + ++ ++ SAL
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSAL- 118
Query: 856 YLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPE 915
+ H V++ D+K N++LD D ++DFG+ K + + +T T Y+APE
Sbjct: 119 --EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE 175
Query: 916 YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ D + G++M E ++P F +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQD 209
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-31
Identities = 56/242 (23%), Positives = 93/242 (38%), Gaps = 14/242 (5%)
Query: 1331 RLATNGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFS---LQEDRALKSFDAECEVMR 1386
++ N F LLG G F V A G A+KI + + E V++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 1387 RIRHRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALE 1446
RH L + + +++Y G L L S + E+ ++ ALE
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALE 119
Query: 1447 YLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE 1506
YLH S +++ D+K N++LD D + DFG+ K D T Y+APE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPE 175
Query: 1507 YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-----SLPDAVTDV 1561
+ + D + G++M E + R P + + +EE +L +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 1562 ID 1563
+
Sbjct: 236 LA 237
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 3e-33
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 16/217 (7%)
Query: 744 DGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRH 799
D F +G GSFG V G + A+K+ + Q I+ E +L+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHH 859
LVK+ S ++ +++EY+ G + L + + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS 159
Query: 860 GHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE 919
+I+ DLKP N+L+D ++DFG +K + G +APE
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP----EALAPEIILS 212
Query: 920 GIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLK 956
+ D ++ G+L+ E P F + ++
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQ 245
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (322), Expect = 2e-32
Identities = 53/254 (20%), Positives = 95/254 (37%), Gaps = 24/254 (9%)
Query: 1300 LLRRRKRDKSRPTENNLLNTAALRRISYQELRLATNGFSESNLLGTGIFSSVYKATF-AD 1358
L + K D + E NTA L + + ++ LGTG F V
Sbjct: 18 FLAKAKEDFLKKWETPSQNTAQLDQ--FDRIKT----------LGTGSFGRVMLVKHKES 65
Query: 1359 GTNAAIKIFS---LQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415
G + A+KI + + + ++ E +++ + L K+ S + ++++Y+
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAH 1475
G + L + + EYLH S +I+ DLKP N+L+D
Sbjct: 126 GEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQ 181
Query: 1476 LGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKP 1535
+ DFG AK + T +APE + + D ++ G+L+ E P
Sbjct: 182 VTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 1536 TDDMFTGEVCLKHW 1549
++ K
Sbjct: 238 FFADQPIQIYEKIV 251
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-32
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 23/219 (10%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKII 806
IG G+FG V+KA G VA+K ++ +G + E ++L+ ++H N+V +I
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 807 SSCSNHGFKA--------LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
C L+ ++ + + +M + + L Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS---VTQTMTLATFGYMAPE 915
++H D+K +NVL+ D V L+DFG+++ + T + T Y PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 916 -YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
E D++ G +M E +TR G T
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNT 226
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 55/293 (18%), Positives = 102/293 (34%), Gaps = 29/293 (9%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIV 1397
+G G F V+KA G A+K ++ ++ + E ++++ ++H N+ ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 1398 SSCSNPGFKA--------LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLH 1449
C L+ + + + +M + L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQML---LNGLY 131
Query: 1450 QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS---MKQTMTLATIGYMAPE 1506
+ I+H D+K +NVL+ D V L DFG+A+ + + T + T+ Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 1507 -YGSEGIVSTSGDVYSFGILMMETLTRRKP-----TDDMFTGEVCLKHWVEESLPDAVTD 1560
E D++ G +M E TR L + + V +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 1561 VIDANLLSGEEEADIAAKKKCMSSVMS-----LALKCSEEIPEERMNVKDALA 1608
L + K + + V L K P +R++ DAL
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-31
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 19/221 (8%)
Query: 744 DGFSESNLIGAGSFGSVYKATLPY----GMNVAIKVFN----LQLDGAIKSFDAECEVLR 795
+ F ++G G++G V+ G A+KV +Q + E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 796 RVRHR-NLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
+R LV + + LIL+Y+ G L L ++ I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIV 139
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAP 914
L H H +I+ D+K N+LLD + L+DFG+SK +++ T YMAP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 915 E--YGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ G + D +S G+LM E T P FT +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDG 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-29
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 36/304 (11%)
Query: 1331 RLATNGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFS----LQEDRALKSFDAEC 1382
++ F +LGTG + V+ G A+K+ +Q+ + + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 1383 EVMRRIRHR-NLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDV 1441
+V+ IR L + + LIL Y+ G L L E + I V
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYV 135
Query: 1442 ACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIG 1501
+ L + II+ D+K N+LLD + L DFG++K ++ + TI
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 1502 YMAPE--YGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVT 1559
YMAP+ G + + D +S G+LM E LT P FT +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQ---------- 241
Query: 1560 DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT-KFL 1618
A + +++ ++ + L + + P++R+ A +IK F
Sbjct: 242 ----AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA--DEIKEHLFF 295
Query: 1619 KDVQ 1622
+ +
Sbjct: 296 QKIN 299
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-30
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 26/237 (10%)
Query: 735 SYQELQRLTDGFSES----NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSF 787
QE+ + +G+G++G+V A G VAIK + K
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 788 DAECEVLRRVRHRNLVKIISSCSNHGFKA------LILEYMPQGSLEKWLYSHKYTLNIQ 841
E +L+ +RH N++ ++ + L++ +M G+ L H+ L
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGED 121
Query: 842 QRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901
+ ++ + L Y+H IH DLKP N+ +++D + DFG+++ D E
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADSE---M 175
Query: 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKKW 958
+ + + + D++S G +M E T K F G L +
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQL 228
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-30
Identities = 56/283 (19%), Positives = 110/283 (38%), Gaps = 23/283 (8%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIF--SLQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G+G + +V A G AIK Q + K E +++ +RH N+ ++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 1399 SCSNPGFKALILQYMPQGSLEKWLYSH---NYLLNIEQRLDIMIDVACALEYLHQGYSTS 1455
+ + + L ++ ++ + L Y+H +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 1456 IIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPE-YGSEGIVS 1514
IIH DLKP N+ +++D + DFG+A+ D + T + T Y APE + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYT 197
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHW-VEESLPDAVTDVIDANLLSGEEEA 1573
+ D++S G +M E +T + + + V + P + ++ +
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 1574 DIAAKKKCMSSVMS--------LALKCSEEIPEERMNVKDALA 1608
+KK +S+++ L K E+R+ +ALA
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 1e-28
Identities = 40/201 (19%), Positives = 83/201 (41%), Gaps = 18/201 (8%)
Query: 750 NLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIIS 807
+G G + V++A + V +K+ K E ++L +R N++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97
Query: 808 SCSNHGFK--ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPV 865
+ + AL+ E++ ++ TL M ++ AL+Y H +
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---I 150
Query: 866 IHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSE-GIVS 923
+H D+KP NV++D + L D+G+++ + +A+ + PE + +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYD 208
Query: 924 TCGDVYSFGILMIETFTRKMP 944
D++S G ++ RK P
Sbjct: 209 YSLDMWSLGCMLASMIFRKEP 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (284), Expect = 1e-27
Identities = 52/290 (17%), Positives = 114/290 (39%), Gaps = 34/290 (11%)
Query: 1341 NLLGTGIFSSVYKAT-FADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVS 1398
LG G +S V++A + +KI + K E +++ +R N+ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 1399 SCSNPGFK--ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSI 1456
+P + AL+ +++ ++ + L M ++ AL+Y H S I
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGI 150
Query: 1457 IHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSE-GIVS 1514
+H D+KP NV++D + L D+G+A+ + + +A+ + PE + +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 1515 TSGDVYSFGILMMETLTRRKPTDDMFT------------GEVCLKHWVEE---SLPDAVT 1559
S D++S G ++ + R++P G L ++++ L
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 1560 DVIDANLLSGEEEADIAAKKKCMSS-VMSLALKCSEEIPEERMNVKDALA 1608
D++ + E + + +S + K + R+ ++A+
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-28
Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIIS 807
IG+G+ G V A NVAIK + K E +++ V H+N++ +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 808 SCSNHGFK------ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH 861
+ L++E M + L+ ++ ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGI 921
IH DLKPSN+++ D + DFG+++ S T + T Y APE
Sbjct: 140 I---IHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMG 194
Query: 922 VSTCGDVYSFGILMIETFTRKMP 944
D++S G +M E K+
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-27
Identities = 62/296 (20%), Positives = 104/296 (35%), Gaps = 38/296 (12%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFS--LQEDRALKSFDAECEVMRRIRHRNLAKIVS 1398
+G+G V A N AIK S Q K E +M+ + H+N+ +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 1399 SCSNPGFK------ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGY 1452
+ L+++ M + ++ E+ ++ + C +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH----ERMSYLLYQMLCGIKHLHSAG 139
Query: 1453 STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGI 1512
IIH DLKPSN+++ D + DFG+A+ S T + T Y APE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMG 194
Query: 1513 VSTSGDVYSFGILMMETLTRR--------------------KPTDDMFTGEVCLKHWVEE 1552
+ D++S G +M E + + P + E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 1553 SLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608
+ P AD K S L K P +R++V DAL
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-28
Identities = 49/229 (21%), Positives = 94/229 (41%), Gaps = 22/229 (9%)
Query: 736 YQELQR----LTDGFSESNLIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAI--KSFD 788
QEL + + + + + +G+G++GSV A G+ VA+K + I K
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 789 AECEVLRRVRHRNLVKIISSC----SNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRL 844
E +L+ ++H N++ ++ S F + L G+ + + L
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQ 124
Query: 845 DIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQTM 904
++ + L+Y+H +IH DLKPSN+ +++D + DFG+++ D E
Sbjct: 125 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGY 178
Query: 905 TLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGET 953
+ + + D++S G +M E T + F G
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTD 223
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-25
Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 27/286 (9%)
Query: 1341 NLLGTGIFSSVYKATF-ADGTNAAIKIFS--LQEDRALKSFDAECEVMRRIRHRNLAKIV 1397
+ +G+G + SV A G A+K S Q K E +++ ++H N+ ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 1398 SSCSNPG----FKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYS 1453
+ F + L G+ + L + + ++ + L+Y+H S
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH---S 139
Query: 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIV 1513
IIH DLKPSN+ +++D + DFG+A+ D +
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 1514 STSGDVYSFGILMMETLTRRKP---TDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570
+ + D++S G +M E LT R TD + ++ L+ + + + I +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR--LVGTPGAELLKKISSESARNY 254
Query: 1571 EEADIAAKKKCMSSV--------MSLALKCSEEIPEERMNVKDALA 1608
++ K ++V + L K ++R+ ALA
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 4e-27
Identities = 43/212 (20%), Positives = 79/212 (37%), Gaps = 21/212 (9%)
Query: 751 LIGAGSFGSVYKAT-LPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSC 809
+G G F +V+ A + +VA+K+ ++ + E ++L+RV + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 810 SNHGFK---------------ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASAL 854
+NH K ++ E + + L + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 855 EYLHHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDSVTQTMTLATF-GYM 912
+Y+H +IH D+KP NVL++ D+ +L I+ L + Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 913 APEYGSEGIVSTCGDVYSFGILMIETFTRKMP 944
+PE D++S L+ E T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 2e-24
Identities = 56/324 (17%), Positives = 111/324 (34%), Gaps = 53/324 (16%)
Query: 1342 LLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSC 1400
LG G FS+V+ A + T+ A+KI + ++ + E ++++R+ + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 1401 SNPGFK---------------ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACAL 1445
+N K ++ + + + L + + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 1446 EYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSMKQTMTLATI-GYM 1503
+Y+H+ IIH D+KP NVL++ D +L IA L + + Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 1504 APEYGSEGIVSTSGDVYSFGILMMETLTRRKP-------TDDMFTGEVCLKHWVEESLPD 1556
+PE D++S L+ E +T + + + LP
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 1557 AV--------TDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEI-----------P 1597
+ T LL + + ++ + ++EI P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 1598 EERMNVKDALANLKKIKTKFLKDV 1621
+R + + + +LKD
Sbjct: 317 RKRADAGGLVNH------PWLKDT 334
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 105 bits (261), Expect = 6e-25
Identities = 67/329 (20%), Positives = 117/329 (35%), Gaps = 27/329 (8%)
Query: 38 TDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCNWVGVTC--GSRHGRVTDLS 95
D+ ALLQ+K + +P +W ++ W+GV C ++ RV +L
Sbjct: 6 QDKQALLQIKKDLG-NPTTL--SSWL------PTTDCCNRTWLGVLCDTDTQTYRVNNLD 56
Query: 96 IPNLGLGG--TIPPHVANLSFLVSLNISGN-RFHGTLPNELWLMPRLRIIDLSSNRISGN 152
+ L L IP +ANL +L L I G G +P + + +L + ++ +SG
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 153 LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTEL 212
D + + L + D S N ++G LP S+ L ++ N ++G IP + G+ ++L
Sbjct: 117 -IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 213 MELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTT 272
N P F N +L +
Sbjct: 176 FTSMTISRNRLTGKIPPTFA----------NLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 273 GRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLP 332
+ K+ L ++ D N + G +P + + + + N+L G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 333 SSTGINLPNLLRLYLWGNNLSGVIPSSIC 361
NL N P C
Sbjct: 286 QGG--NLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.4 bits (181), Expect = 1e-14
Identities = 55/283 (19%), Positives = 99/283 (34%), Gaps = 22/283 (7%)
Query: 257 RLPSLQELNLRDCMTTGR--IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
+ + L+L IP + N LN+L + NL G IP I
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN-------NLVGPIPPAIAKL 100
Query: 315 SNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRN 374
+ + + + ++SG + L+ L N LSG +P SI + L + N
Sbjct: 101 TQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 375 LFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGI 434
SG + +++G+ +L + L + +
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRN---------RLTGKIPPTFANLNLAFVDLSRNMLE 210
Query: 435 LPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNL 494
SV S + + G N+ L L N++ T+P + +L+ L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 495 QGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQ--NQIPTC 535
L++S+NN+ G IP + L+ + N + +P C
Sbjct: 271 HSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.6 bits (179), Expect = 3e-14
Identities = 66/312 (21%), Positives = 108/312 (34%), Gaps = 36/312 (11%)
Query: 296 TDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI-NLPNLLRLYLWGN-NLS 353
TD G++ + + L G +L P + + NLP L LY+ G NL
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 354 GVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFS 413
G IP +I ++L L ++ SG + + + L L+ +Y+ +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA-------LSGTLPP 143
Query: 414 SLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIAL 473
S+++ L + N G +P+S G+ SK L G IP F NL+
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203
Query: 474 SLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIP 533
+ + N ++ ++LN L L+ N + +P
Sbjct: 204 LSRNML--EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261
Query: 534 TCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGL 593
L L L +LN+S N L IP GNL+
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQ-------------------------GGNLQRFDVS 296
Query: 594 YLSGNQLSCSIP 605
+ N+ C P
Sbjct: 297 AYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 1e-13
Identities = 63/295 (21%), Positives = 98/295 (33%), Gaps = 45/295 (15%)
Query: 987 GDSNKLKRLSISVNKITG--TIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLG 1044
+ ++ L +S + IP ++ NL L L++ G N G IP +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN--------NLVGPIPPAIA 98
Query: 1045 NCTLLNFLILRQNQ--------------LTGVRLASNKLIGRIPSMIFNNSNIEAIQLYG 1090
T L++L + L + + N L G +P I + N+ I G
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 1091 NHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTF 1150
N SG +P S G + + + N L+G IP + N + + L
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 1151 GNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLST 1210
+ + + + L L L+NN + G LP + L
Sbjct: 219 SDKNT---------QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL-K 268
Query: 1211 SLEYFFASSTELRGAIPVEFEGEIPSGGPFVNFTAESLMQNLVLGGSSRLQVPPC 1265
L S L GEIP GG F + N L GS +P C
Sbjct: 269 FLHSLNVSFNNL--------CGEIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.8 bits (143), Expect = 8e-10
Identities = 63/291 (21%), Positives = 98/291 (33%), Gaps = 21/291 (7%)
Query: 376 FSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGIL 435
+ G++ +T ++ L+L+ L + SSL N YL +L I
Sbjct: 38 WLGVLCDTDTQTYRVNNLDLSGLNL-----PKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 436 PNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQ 495
L Y Y + G IP + ++ L N L+ T+P ++ L NL
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 496 GLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNST 555
G+ N I G+IP L T + + A S +
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 556 IPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLT 615
S + + +G K L GL L N++ ++P + LK L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 616 YLALARNGFQGSIPEAIGSLISLEKGEIPSGGPFVNFTEGSFMQNYALCGS 666
L ++ N GEIP GG F ++ N LCGS
Sbjct: 272 SLNVSFNNLC---------------GEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.4 bits (116), Expect = 2e-06
Identities = 16/68 (23%), Positives = 31/68 (45%), Gaps = 4/68 (5%)
Query: 119 NISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQL 178
++ NR +GTLP L + L +++S N + G + +L + ++N+
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGS 307
Query: 179 PSSLGDCS 186
P L C+
Sbjct: 308 P--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.3 bits (90), Expect = 0.003
Identities = 12/41 (29%), Positives = 15/41 (36%), Gaps = 1/41 (2%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNL 1026
L L L++S N + G IP GNL N
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (253), Expect = 3e-23
Identities = 72/397 (18%), Positives = 134/397 (33%), Gaps = 38/397 (9%)
Query: 136 MPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSF 195
+ L ++ + + +T L I + + L +++ S
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTL---QADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 196 NELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLC 255
N+LT P + NLT+L+++ +N N + P + + + L
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 256 RRLP-----SLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSI 310
++ +++ +T+ + T L L ++N S+
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS-DISV 192
Query: 311 IFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLE 370
+ +N+E + N +S P L NL L L GN L ++ + + LT L+
Sbjct: 193 LAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 371 LSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNP 430
L+ N S L +L L L +Q+ S + LT L Q
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQI------SNISPLAGLTALTNLELNENQLED 299
Query: 431 WKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGK 490
I K+L Y + P +L+ + L N++ + +++
Sbjct: 300 ISPISNL------KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLAN 349
Query: 491 LQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNA 527
L N+ L +N I P L L + L L A
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.2 bits (243), Expect = 5e-22
Identities = 69/378 (18%), Positives = 138/378 (36%), Gaps = 46/378 (12%)
Query: 289 GLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI-NLPNLLRLYL 347
L + T G N+T + + + +Q + S G+ L NL ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK----SIDGVEYLNNLTQINF 73
Query: 348 WGNNLSGVIPSSICNASKLTVLELSRNLFSGLVA-----NTFGNCRQLQILNLAYSQLAT 402
N L+ + P + N +KL + ++ N + + N G +
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 403 GSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPA 462
+L++ + +++++ L L G + L+ +
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 463 EFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLL 522
L+N+ +L NQ++ P + NL L L+ N ++ L L +L L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 523 LQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIP--------------------STFWS 562
L N + N P L+ LT L L L +N++++ P S +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 563 LEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
L+ + + N +S P + +L L L+ + N++S SS+ L ++ +L+ N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVSSLANLTNINWLSAGHN 361
Query: 623 GFQGSIPEAIGSLISLEK 640
P + +L + +
Sbjct: 362 QISDLTP--LANLTRITQ 377
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.4 bits (223), Expect = 1e-19
Identities = 80/442 (18%), Positives = 142/442 (32%), Gaps = 81/442 (18%)
Query: 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNG 219
+L E + +T + + D ++ L + + L L ++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 220 NNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDI 279
N L P + N++ L I++ NN + P+ L L N +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 280 GNCTLLNYLGLRDNQLTDFGANNLTGLIP---SIIFNNSNIEVIQLYGNHLSGNLPSSTG 336
N L+ + D + + + +N+ ++ + S
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 337 INLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396
L NL L N +S + P I + L L L+ N + T + L L+LA
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 249
Query: 397 YSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCEL 456
+Q+ S + L+ L L + N I P
Sbjct: 250 NNQI---------SNLAPLSGLTKLTELKLGANQISNISP-------------------- 280
Query: 457 GGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLE 516
L+ + L L +NQ + + L+NL L L +NNI P + L
Sbjct: 281 -------LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 517 SLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLL 576
L L N + + + LANLT++ L+ N+++ P
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP------------------- 368
Query: 577 SGCLPQDIGNLKVLTGLYLSGN 598
+ NL +T L L+
Sbjct: 369 -------LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.7 bits (203), Expect = 6e-17
Identities = 80/415 (19%), Positives = 140/415 (33%), Gaps = 51/415 (12%)
Query: 208 NLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267
L E M+ L N+ + ++ + + + +D L +L ++N
Sbjct: 20 ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFS 74
Query: 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHL 327
+ T P + N T L + + +NQ+ D + + N+ I I N
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 328 SGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNC 387
+ N + + ++ L + + + + L NL + + N
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA------NLTTLERLDISSNK 186
Query: 388 RQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLE 447
S L L L N I P + +L+
Sbjct: 187 VS---------------------DISVLAKLTNLESLIATNNQISDITPL---GILTNLD 222
Query: 448 YFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGS 507
+L +L+N+ L L NQ+++ P + L L L L N I
Sbjct: 223 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 278
Query: 508 IPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYIL 567
P L L +L L L N Q + + ++NL +L L L N ++ P SL +
Sbjct: 279 SP--LAGLTALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332
Query: 568 VVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622
+ F+ N +S + NL + L NQ+S P + L +T L L
Sbjct: 333 RLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 2e-13
Identities = 48/208 (23%), Positives = 79/208 (37%), Gaps = 33/208 (15%)
Query: 995 LSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLIL 1054
L + N+I+ P LT L EL L+GN L + L + T L L L
Sbjct: 202 LIATNNQISDITPLG--ILTNLDELSLNGNQL-----------KDIGTLASLTNLTDLDL 248
Query: 1055 RQNQLTGV-------RLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPN 1107
NQ++ + +L KL S I + + A+ + + S L N
Sbjct: 249 ANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 1108 LQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLT 1167
L L L+ NN+S I P + + +++ L + N S ++ N + L N ++
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364
Query: 1168 TGSSTQGHSFYTSLTNCRYLRRLVLQNN 1195
T L N + +L L +
Sbjct: 365 D---------LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 4e-11
Identities = 33/164 (20%), Positives = 64/164 (39%), Gaps = 29/164 (17%)
Query: 77 CNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLP------ 130
+ + +TDL + N + P ++ L+ L L + N+ P
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA 286
Query: 131 --------------NELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176
+ + + L + L N IS +SLT+L+ ++N+++
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSD 343
Query: 177 QLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGN 220
SSL + + + LS N+++ P + NLT + +L LN
Sbjct: 344 --VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 6e-10
Identities = 43/201 (21%), Positives = 72/201 (35%), Gaps = 33/201 (16%)
Query: 1029 YLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQL 1088
NN+ + P T L+ L L NQL + + +N+ + L
Sbjct: 203 IATNNQISDITPLG--ILTNLDELSLNGNQLKD------------IGTLASLTNLTDLDL 248
Query: 1089 YGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPN 1148
N S P S L L L L N +S I P + A + N +
Sbjct: 249 ANNQISNLAPLS---GLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDIS 301
Query: 1149 TFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNL 1208
N + L L L N+++ S +++ L+RL NN + +S+ NL
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP---------VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 1209 STSLEYFFASSTELRGAIPVE 1229
T++ + A ++ P+
Sbjct: 351 -TNINWLSAGHNQISDLTPLA 370
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 5e-04
Identities = 17/72 (23%), Positives = 28/72 (38%), Gaps = 13/72 (18%)
Query: 986 LGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGN 1045
+ KL+RL + NK++ ++ NLT + L N + + P L N
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI---------SDLTP--LAN 371
Query: 1046 CTLLNFLILRQN 1057
T + L L
Sbjct: 372 LTRITQLGLNDQ 383
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 8e-22
Identities = 25/161 (15%), Positives = 50/161 (31%), Gaps = 20/161 (12%)
Query: 750 NLIGAGSFGSVYKATLPYGMNVAIKVFNLQL----------DGAIKSFDAECEVLRRVRH 799
L+G G +V+ +K + D F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 800 RNLVKIISSCSNHGFKALILEYMPQGSL-EKWLYSHKYTLNIQQRLDIMIDVASALEYLH 858
R L K+ + + L E Y + ++ +++ + + +
Sbjct: 66 RALQKL-----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 859 HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899
H ++H DL NVL+ ++ + + DF S + E
Sbjct: 121 HRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGW 157
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 2e-19
Identities = 24/156 (15%), Positives = 49/156 (31%), Gaps = 18/156 (11%)
Query: 1341 NLLGTGIFSSVYKATFADGTNAAIKIFSL----------QEDRALKSFDAECEVMRRIRH 1390
L+G G S+V+ +K + + D F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQ 1450
R L K+ + +E Y + +E +++ + + +
Sbjct: 66 RALQKL----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 1451 GYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486
I+H DL NVL+ ++ + + DF + +
Sbjct: 122 RG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 9e-21
Identities = 61/315 (19%), Positives = 108/315 (34%), Gaps = 36/315 (11%)
Query: 307 IPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKL 366
+P + + ++ L N ++ + NL NL L L N +S + P + KL
Sbjct: 25 VPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 367 TVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAI 426
L LS+N L ++L++ +++ + N + L
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNG--------LNQMIVVELGT 133
Query: 427 QTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPT 486
GI + + K L Y + IP G ++ L L N++
Sbjct: 134 NPLKSSGIENGAFQGM-KKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAA 189
Query: 487 TVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALN 546
++ L NL L LS+N+I L L L L N L P LA+ ++ +
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVY 248
Query: 547 LSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCS--I 604
L +N +++ + F C P +G+ L N +
Sbjct: 249 LHNNNISAIGSNDF------------------CPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 605 PSSIGGLKDLTYLAL 619
PS+ + + L
Sbjct: 291 PSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.3 bits (207), Expect = 6e-18
Identities = 55/327 (16%), Positives = 107/327 (32%), Gaps = 39/327 (11%)
Query: 77 CNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLM 136
C+ V C +P +PP L++ N+ + +
Sbjct: 10 CHLRVVQCSDLGLE----KVPK-----DLPPD------TALLDLQNNKITEIKDGDFKNL 54
Query: 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFN 196
L + L +N+IS L +LE +S NQ+ +L+
Sbjct: 55 KNLHTLILINNKISKISPGAFAP-LVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113
Query: 197 ELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCR 256
++ + + N ++EL N G + L I +A+ ++ ++P L
Sbjct: 114 KVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL-- 169
Query: 257 RLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSN 316
PSL EL+L T + L L N+++ + + N +
Sbjct: 170 -PPSLTELHLDGNKITKVDAASLKGLNNLAKL--------GLSFNSISAVDNGSLANTPH 220
Query: 317 IEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSIC------NASKLTVLE 370
+ + L N L + + +YL NN+S + + C + + +
Sbjct: 221 LRELHLNNNKLVKVPGGLA--DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 278
Query: 371 LSRN--LFSGLVANTFGNCRQLQILNL 395
L N + + +TF + L
Sbjct: 279 LFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.8 bits (203), Expect = 2e-17
Identities = 51/271 (18%), Positives = 98/271 (36%), Gaps = 16/271 (5%)
Query: 162 TELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNN 221
+ D+ +N+IT + L L + N+++ P L +L LYL+ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 222 LQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGN 281
L+ + LRV + S+ L + EL ++G
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLN--QMIVVELGTNPLKSSGIENGAFQG 148
Query: 282 CTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPN 341
L+Y+ + D +T ++ + L GN ++ +S L N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLP-----------PSLTELHLDGNKITKVDAASL-KGLNN 196
Query: 342 LLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLA 401
L +L L N++S V S+ N L L L+ N V + + +Q++ L + ++
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 255
Query: 402 TGSLSQGQSFFSSLTNCRYLRYLAIQTNPWK 432
+ T +++ +NP +
Sbjct: 256 AIGSNDFCP-PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.1 bits (183), Expect = 6e-15
Identities = 35/181 (19%), Positives = 64/181 (35%), Gaps = 6/181 (3%)
Query: 460 IPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLN 519
+P + + L L N++ L+NL L L N I P L L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579
L L N L+ L LR ++ ++ + + ++ + + SG
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN-GLNQMIVVELGTNPLKSSGI 141
Query: 580 LPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSLISLE 639
+K L+ + ++ ++ +IP + LT L L N ++ L +L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 640 K 640
K
Sbjct: 199 K 199
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.9 bits (167), Expect = 7e-13
Identities = 44/241 (18%), Positives = 82/241 (34%), Gaps = 32/241 (13%)
Query: 985 DLGDSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLG 1044
D + L L + NKI+ P L +L L+L N L+ T + +
Sbjct: 50 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE 109
Query: 1045 NC----TLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSS 1100
N F L Q + + K G + I++ + + +P
Sbjct: 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 168
Query: 1101 IGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLI-------------- 1146
+ P+L L L GN ++ + +S+ + + LGLS N S +
Sbjct: 169 L---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225
Query: 1147 ---------PNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
P + + +Q++ L N+++ S T + L +NP+
Sbjct: 226 LNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSND-FCPPGYNTKKASYSGVSLFSNPV 284
Query: 1198 K 1198
+
Sbjct: 285 Q 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.8 bits (159), Expect = 9e-12
Identities = 42/250 (16%), Positives = 73/250 (29%), Gaps = 42/250 (16%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
L + NKIT NL L L L N + + P L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI---------SKISPGAFAPLVKLER 83
Query: 1052 LILRQNQLTGVR----------LASNKLIGRIPSMIFNNSNIE---AIQLYGNHFSGHLP 1098
L L +NQL + I ++ +FN N + SG
Sbjct: 84 LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 1099 SSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQI 1158
+ + L + + N++ IP + + L L N + + + L
Sbjct: 144 GAFQ-GMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 1159 LDLSLNHL----------------TTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALP 1202
L LS N + ++ + L + +Y++ + L NN +
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 259
Query: 1203 NSIGNLSTSL 1212
N +
Sbjct: 260 NDFCPPGYNT 269
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 4e-08
Identities = 37/195 (18%), Positives = 63/195 (32%), Gaps = 31/195 (15%)
Query: 1014 TELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRI 1073
+ L L NNK T + N L+ LIL N+++ +
Sbjct: 31 PDTALLDLQ---------NNKITEIKDGDFKNLKNLHTLILINNKISKI----------S 71
Query: 1074 PSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVI 1133
P +E + L N LP + L L+ + + + N V+
Sbjct: 72 PGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVF-NGLNQMIVV 129
Query: 1134 LLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLRRLVLQ 1193
LG + SG+ F ++L + ++ ++TT S L L L
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS----------LTELHLD 179
Query: 1194 NNPLKGALPNSIGNL 1208
N + S+ L
Sbjct: 180 GNKITKVDAASLKGL 194
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 1e-06
Identities = 19/73 (26%), Positives = 28/73 (38%), Gaps = 3/73 (4%)
Query: 1096 HLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQ 1155
+P + P + L L N ++ I N + L L N S + P F +
Sbjct: 24 KVPKDLPP---DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 1156 LQILDLSLNHLTT 1168
L+ L LS N L
Sbjct: 81 LERLYLSKNQLKE 93
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 2e-17
Identities = 60/293 (20%), Positives = 94/293 (32%), Gaps = 35/293 (11%)
Query: 343 LRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLAT 402
+ L +P I + + L N S + A +F CR L IL
Sbjct: 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILW-------- 62
Query: 403 GSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPA 462
+ +N I + L+ + + + +L PA
Sbjct: 63 -----------------------LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA 99
Query: 463 EFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLL 522
F L + L L + L P L LQ L L N +Q L +L L
Sbjct: 100 TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159
Query: 523 LQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQ 582
L GN + + L SL L L NR+ P F L ++ + N LS +
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 583 DIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIGSL 635
+ L+ L L L+ N C + L + + S+P+ +
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 4e-12
Identities = 44/258 (17%), Positives = 72/258 (27%), Gaps = 38/258 (14%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNF 1051
+R+ + N+I+ + L L LH N L + + L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD---- 89
Query: 1052 LILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGL 1111
N + + F+ L + L LQ L
Sbjct: 90 ---------------NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134
Query: 1112 ILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTT--- 1168
L N L + + + + L L N S + F L L L N +
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 1169 --------------GSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLSTSLEY 1214
++ +L R L+ L L +NP L L+
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQK 252
Query: 1215 FFASSTELRGAIPVEFEG 1232
F SS+E+ ++P G
Sbjct: 253 FRGSSSEVPCSLPQRLAG 270
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 5e-12
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 24/261 (9%)
Query: 135 LMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVS 194
+ + I L NRIS + + L + SN + ++ + L++L +S
Sbjct: 30 IPAASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 195 FNELTGRI-PQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVD 253
N + P L L L+L+ LQ P +++L+ + L +N+L LP D
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDD 147
Query: 254 LCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT----------------D 297
R L +L L L + + L+ L L N++
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 298 FGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIP 357
ANNL+ L + ++ ++L N + + L + + + +P
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP--LWAWLQKFRGSSSEVPCSLP 265
Query: 358 SSICNASKLTVLELSRNLFSG 378
+ + L+ N G
Sbjct: 266 QRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (110), Expect = 9e-06
Identities = 51/201 (25%), Positives = 76/201 (37%), Gaps = 1/201 (0%)
Query: 441 NLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLS 500
+ + + + + A F N+ L L+ N LA L L+ LDLS
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 501 YNNIQGSI-PSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPST 559
N S+ P+ L L+TL L LQ P L +L+ L L N L + T
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 560 FWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLAL 619
F L + + N +S + L L L L N+++ P + L L L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 620 ARNGFQGSIPEAIGSLISLEK 640
N EA+ L +L+
Sbjct: 209 FANNLSALPTEALAPLRALQY 229
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (100), Expect = 2e-04
Identities = 29/169 (17%), Positives = 52/169 (30%), Gaps = 28/169 (16%)
Query: 990 NKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLL 1049
L+ L + N + T +L L L LHGN + + + L
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI---------SSVPERAFRGLHSL 179
Query: 1050 NFLILRQNQLTGVRLAS--------------NKLIGRIPSMIFNNSNIEAIQLYGNHFSG 1095
+ L+L QN++ V + N L + ++ ++L N +
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 1096 HLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSG 1144
P LQ + + +P + L L+ N G
Sbjct: 240 DCR--ARPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 3e-11
Identities = 46/293 (15%), Positives = 92/293 (31%), Gaps = 30/293 (10%)
Query: 117 SLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176
+L+++G H + L L + + + L + S ++ D+S++ I
Sbjct: 4 TLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEV 60
Query: 177 -QLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSS 235
L L CSKL+ LS+ L+ I + + L+ L L+G +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS-------------- 106
Query: 236 LRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQL 295
L L ELN K + + L
Sbjct: 107 ---------GFSEFALQTLLSSCSRLDELN--LSWCFDFTEKHVQVAVAHVSETITQLNL 155
Query: 296 TDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWG-NNLSG 354
+ + N + +++ N+ + L + + N L L L L ++
Sbjct: 156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215
Query: 355 VIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQ 407
+ L L++ + G + LQI ++ +A ++
Sbjct: 216 ETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 2e-09
Identities = 36/261 (13%), Positives = 89/261 (34%), Gaps = 38/261 (14%)
Query: 93 DLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGN 152
DL+ NL + + + +++ + L R++ +DLS++ I +
Sbjct: 6 DLTGKNLH--PDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVS 61
Query: 153 LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSV------------------- 193
+ + ++L++ + +++ + ++L S L RL++
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 194 -------------SFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIV 240
+ + + +T+L N + + + +L +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 241 LANNSLFGSLPVDLCRRLPSLQELNLRDC-MTTGRIPKDIGNCTLLNYLGLRDNQLTDFG 299
L+++ + + +L LQ L+L C ++G L L + + D
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGT 240
Query: 300 ANNLTGLIPSIIFNNSNIEVI 320
L +P + N S+ I
Sbjct: 241 LQLLKEALPHLQINCSHFTTI 261
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 2e-04
Identities = 14/100 (14%), Positives = 34/100 (34%), Gaps = 3/100 (3%)
Query: 495 QGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLN- 553
Q LDL+ N+ + L + + + + + ++ ++LS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 554 STIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGL 593
ST+ + + LS + + L L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 2e-04
Identities = 22/101 (21%), Positives = 39/101 (38%), Gaps = 8/101 (7%)
Query: 1109 QGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTT 1168
Q L L G NL + + + VI + + F R +Q +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 1169 GSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
+ + L+ C L+ L L+ L + N++ S
Sbjct: 61 S------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 3e-10
Identities = 33/190 (17%), Positives = 52/190 (27%), Gaps = 12/190 (6%)
Query: 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQ 399
+ L+L N L +++ ++LT L L R L +L
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-----TKLQVDGTLPVLGTLDLS 85
Query: 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGG 459
+ + + + P + Y EL
Sbjct: 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ------ELYLKGNELKTL 139
Query: 460 IPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLN 519
P + LSL N L + L+NL L L N++ +IP L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 520 TLLLQGNALQ 529
L GN
Sbjct: 199 FAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 5e-10
Identities = 42/219 (19%), Positives = 64/219 (29%), Gaps = 17/219 (7%)
Query: 158 CNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217
+ + + +T LP L L +S N L + T L +L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPK 277
+ L L + L L
Sbjct: 63 DRAELTKLQVDGTLP------------VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110
Query: 278 DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI 337
+ + L GL + Q N L L P ++ +E + L N+L+ LP+
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLN 169
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLF 376
L NL L L N+L IP + L L N +
Sbjct: 170 GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 3e-09
Identities = 39/211 (18%), Positives = 58/211 (27%), Gaps = 30/211 (14%)
Query: 1009 TVGNLTELRELHLHGNNLEA------------YLYNNKFTGRIPQNLGNCTLLNFLILRQ 1056
V + E++ NL A +L N L T L L L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 1057 NQLTGVR-------LASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYL---P 1106
+LT ++ L + L + + L S L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 1107 NLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHL 1166
LQ L L GN L + P + ++ L L+ N + L L L L N
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN-- 182
Query: 1167 TTGSSTQGHSFYTSLTNCRYLRRLVLQNNPL 1197
++ L L NP
Sbjct: 183 ------SLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 7e-09
Identities = 33/174 (18%), Positives = 50/174 (28%), Gaps = 2/174 (1%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTG-RIPQNLGNCTLLN 1050
L +S N + T+ T L +L+L L + N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92
Query: 1051 FLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQG 1110
L+ + V S + +P + LP + P L+
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 1111 LILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLN 1164
L L NNL+ + + + L L EN IP F L L N
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 1e-07
Identities = 43/266 (16%), Positives = 69/266 (25%), Gaps = 63/266 (23%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
+ + L + NL+ +P + T+L LS NL T +L LNL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
++ +L L Q + L
Sbjct: 65 AE------LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-----TVLDVSFNRLT 113
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
L + L L N+L + P + L+ L L+ NN+ L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN---- 169
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLS 577
L +L L L N L +
Sbjct: 170 --------------------GLENLDTLLLQENSLYT----------------------- 186
Query: 578 GCLPQDIGNLKVLTGLYLSGNQLSCS 603
+P+ +L +L GN C+
Sbjct: 187 --IPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 4e-07
Identities = 50/192 (26%), Positives = 70/192 (36%), Gaps = 8/192 (4%)
Query: 104 TIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTE 163
+PP + L++S N + L RL ++L ++ D L
Sbjct: 24 ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 164 LESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223
L+ + L L VSFN LT + L EL ELYL GN L+
Sbjct: 82 LDLSHNQLQSLPLLGQ----TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 224 GEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCT 283
P + L + LANN+ LP L L +L L L++ IPK
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNN-LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 284 LLNYLGLRDNQL 295
LL + L N
Sbjct: 196 LLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 8e-06
Identities = 37/208 (17%), Positives = 58/208 (27%), Gaps = 50/208 (24%)
Query: 487 TVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALN 546
V K+ + ++ N+ ++P +L + L L N L L T L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 547 LSSNR---------------------------------------------LNSTIPSTFW 561
L L S
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 562 SLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALAR 621
L + + N L P + L L L+ N L+ + GL++L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 622 NGFQGSIPEAIGSLISLEKGEIPSGGPF 649
N +IP+ L + G P+
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFL-HGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.002
Identities = 16/72 (22%), Positives = 26/72 (36%), Gaps = 1/72 (1%)
Query: 152 NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTE 211
L + +LE +++N +T L L L + N L IP+
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 212 LMELYLNGNNLQ 223
L +L+GN
Sbjct: 197 LPFAFLHGNPWL 208
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.5 bits (142), Expect = 2e-09
Identities = 50/359 (13%), Positives = 111/359 (30%), Gaps = 45/359 (12%)
Query: 185 CSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANN 244
+ L ++ L+ +P+ +L L + N+L E P + L+ +++ NN
Sbjct: 37 DRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQS---LKSLLVDNN 88
Query: 245 SLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLT 304
+L L P L+ L + + N +
Sbjct: 89 NLKA-----LSDLPPLLEYLGVSNNQLEKLPEL-----------------------QNSS 120
Query: 305 GLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNAS 364
L + NNS ++ L + ++ LP L L +
Sbjct: 121 FLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDL 180
Query: 365 KLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYL 424
L++ + N L + + L T ++ +
Sbjct: 181 PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLP 240
Query: 425 AIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTI 484
+ + + ++ + L I + ++ L++ N+L +
Sbjct: 241 ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IEL 299
Query: 485 PTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLR 543
P +L+ L S+N++ +P L+ L+ ++ N L+ + P ++ LR
Sbjct: 300 PALPPRLER---LIASFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 4e-09
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 146 SNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQN 205
S N +C+ LE +VS+N++ +LP+ +L+RL SFN L +P+
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL 322
Query: 206 IGNLTELMELYLNGNNLQGEFPPTIFNVSSLRV 238
NL +L++ N L+ EFP +V LR+
Sbjct: 323 PQNLK---QLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 4e-09
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 523 LQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQ 582
NA N+I + SL LN+S+N+L +P+ LE + S N L+ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERL---IASFNHLAE-VPE 321
Query: 583 DIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDL 614
NLK L++ N L P ++DL
Sbjct: 322 LPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 2e-08
Identities = 53/335 (15%), Positives = 102/335 (30%), Gaps = 25/335 (7%)
Query: 234 SSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDN 293
+ L N L SLP P L+ L T +P+ + L + +N
Sbjct: 38 RQAHELELNNLGL-SSLP----ELPPHLESLVASCNSLT-ELPELPQSLKSLL---VDNN 88
Query: 294 QLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLS 353
L L+ L P + + + ++ + + ++ +L +L +L
Sbjct: 89 NL-----KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 354 GVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFS 413
+ + + L N+ L + + +
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 414 SLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYA--GSCELGGGIPAEFGNLSNII 471
Y ++T P ++ L S F LS +
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 472 ALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQ 531
Y N ++ I + +L+ L++S N + +P+ +LE L N L +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-E 318
Query: 532 IPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYI 566
+P NL L ++ N L P S+E +
Sbjct: 319 VPELPQNLKQL---HVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 7e-07
Identities = 49/333 (14%), Positives = 89/333 (26%), Gaps = 28/333 (8%)
Query: 314 NSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSR 373
+ ++L LS +LP P+L L N+L+ +P + L L +
Sbjct: 37 DRQAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELPQS---LKSLLVDN 87
Query: 374 NLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKG 433
N L N + S + N + + +
Sbjct: 88 NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVD--NNSLKKLPDLPPSLEFI 145
Query: 434 ILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQN 493
N+ L+ + + + S+ + L
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF 205
Query: 494 LQGLDLSYNNIQGSIPSELCQLESLNTL--------LLQGNALQNQIPTCLANLTSLRAL 545
L + N ++ L Q + + L+ L
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265
Query: 546 NLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIP 605
N ++ I S + ++ S N L LP L+ L S N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320
Query: 606 SSIGGLKDLTYLALARNGFQGSIPEAIGSLISL 638
LK L + N + P+ S+ L
Sbjct: 321 ELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 9e-07
Identities = 19/90 (21%), Positives = 37/90 (41%), Gaps = 10/90 (11%)
Query: 123 NRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSL 182
N + + L P L +++S+N++ ++ LE S N + ++P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLA-EVPELP 323
Query: 183 GDCSKLKRLSVSFNELTGRIPQNIGNLTEL 212
LK+L V +N L P ++ +L
Sbjct: 324 Q---NLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 7e-05
Identities = 55/341 (16%), Positives = 99/341 (29%), Gaps = 30/341 (8%)
Query: 84 CGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIID 143
C R +L+ NLGL ++P +L SL S N LP L+ +
Sbjct: 35 CLDRQAHELELN--NLGLS-SLPELPPHLE---SLVASCNSLT-ELPELP---QSLKSLL 84
Query: 144 LSSNRISG-----NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNEL 198
+ +N + L + + S +LE N ++ + K E
Sbjct: 85 VDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144
Query: 199 TGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRL 258
+ L EL L + + + + + L
Sbjct: 145 IAAGNNQLEELPELQNLP-FLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 259 PSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIE 318
P L + + + L + + + +I S +
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 319 VIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378
Y N S N S P+L L + N L +P+ L L S N +
Sbjct: 264 PNLYYLNASS-NEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLAE 318
Query: 379 LVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCR 419
+ + L+ L++ Y+ L + S+ + R
Sbjct: 319 V----PELPQNLKQLHVEYNP-----LREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 3e-04
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
N + I S+ ++E + + N L LP+ P L RL N+L+ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL----PPRLERLIASFNHLAE-VPELP 323
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILN 394
N L L + N + + L++ +
Sbjct: 324 QN---LKQLHVEYNPLREF-PDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.003
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 11/99 (11%)
Query: 216 YLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI 275
N E SL + ++NN L ++L P L+ L +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKL-----IELPALPPRLERLIASFNHLA-EV 319
Query: 276 PKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
P+ N L L + N L +F ++ + + N+
Sbjct: 320 PELPQN---LKQLHVEYNPLREFP--DIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.003
Identities = 17/78 (21%), Positives = 30/78 (38%), Gaps = 8/78 (10%)
Query: 1091 NHFSGHLPSSIGPYLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTF 1150
+ S + S+ P+L+ L + N L +P+ + L S N + +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLAE-VPELP 323
Query: 1151 GNCRQLQILDLSLNHLTT 1168
N L+ L + N L
Sbjct: 324 QN---LKQLHVEYNPLRE 338
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 4e-08
Identities = 13/92 (14%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 139 LRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQ----LPSSLGDCSKLKRLSVS 194
++ +D+ +S + ++ L + + + +T + S+L L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 195 FNELTGRIPQNIG-----NLTELMELYLNGNN 221
NEL + ++ +L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 1e-07
Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 5/73 (6%)
Query: 493 NLQGLDLSYNNIQGSIPSELC-QLESLNTLLLQGNALQNQ----IPTCLANLTSLRALNL 547
++Q LD+ + + +EL L+ + L L I + L +L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 548 SSNRLNSTIPSTF 560
SN L
Sbjct: 63 RSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 3e-06
Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 7/96 (7%)
Query: 235 SLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIG----NCTLLNYLGL 290
++ + + L + +L L Q + L DC T KDI L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 291 RDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNH 326
R N+L D G + + + + + I+ + L
Sbjct: 63 RSNELGDVGVHCVLQGLQT---PSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 7e-06
Identities = 18/121 (14%), Positives = 39/121 (32%), Gaps = 8/121 (6%)
Query: 77 CNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGT----LPNE 132
+ + ++++ + + G+ S L L ++ + L
Sbjct: 333 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392
Query: 133 LWLMPRLRIIDLSSNRISGN----LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKL 188
L LR +DLS+N + L + + LE + + ++ L K
Sbjct: 393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452
Query: 189 K 189
K
Sbjct: 453 K 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 9e-06
Identities = 19/119 (15%), Positives = 36/119 (30%), Gaps = 9/119 (7%)
Query: 314 NSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGV----IPSSICNASKLTVL 369
+ +I+ + + LS + L + L L+ I S++ L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 370 ELSRNLFSGLVANTFG-----NCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRY 423
L N + + ++Q L+L L S +L + L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 1e-05
Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 9/118 (7%)
Query: 1080 NSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLSGI----IPSSICNASQVILL 1135
+ +I+++ + S + + P L Q + L L+ I S++ + L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 1136 GLSENLFSGLIPNTFG-----NCRQLQILDLSLNHLTTGSSTQGHSFYTSLTNCRYLR 1188
L N + + ++Q L L LT S +L + L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 2e-05
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 12/97 (12%)
Query: 281 NCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGN----LPSSTG 336
++L L L D ++D ++L + + N ++ + L N L L S
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSL----AATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 337 INLPNLLRLYLWGNNLSGVIPSSICNASK----LTVL 369
L +L L+ S + + K L V+
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 15/89 (16%), Positives = 36/89 (40%), Gaps = 9/89 (10%)
Query: 115 LVSLNISGNRFHGTLPNELW-LMPRLRIIDLSSNRISGNLFDDMCNSL---TELESFDVS 170
+ SL+I EL L+ + +++ L ++ D+ ++L L ++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 171 SNQITGQLPSSLGD-----CSKLKRLSVS 194
SN++ + K+++LS+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 3e-05
Identities = 12/75 (16%), Positives = 26/75 (34%), Gaps = 5/75 (6%)
Query: 163 ELESFDVSSNQIT-GQLPSSLGDCSKLKRLSVSFNELTGR----IPQNIGNLTELMELYL 217
+++S D+ +++ + L + + + + LT I + L EL L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 218 NGNNLQGEFPPTIFN 232
N L +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 5e-05
Identities = 17/88 (19%), Positives = 31/88 (35%), Gaps = 9/88 (10%)
Query: 461 PAEFGNLSNIIALSLYQNQL----ASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ-- 514
S + L L + S++ T+ +L+ LDLS N + + +L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 515 ---LESLNTLLLQGNALQNQIPTCLANL 539
L L+L ++ L L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 5e-05
Identities = 17/80 (21%), Positives = 27/80 (33%), Gaps = 7/80 (8%)
Query: 259 PSLQELNLRDCMTTGR----IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNN 314
L+ L L DC + + + L L L +N L D G L +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ---PG 425
Query: 315 SNIEVIQLYGNHLSGNLPSS 334
+E + LY + S +
Sbjct: 426 CLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 1e-04
Identities = 14/97 (14%), Positives = 32/97 (32%), Gaps = 9/97 (9%)
Query: 260 SLQELNLRDC-MTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIE 318
+Q L+++ ++ R + + + L D LT+ ++ S + N +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI----SSALRVNPALA 58
Query: 319 VIQLYGNHLSG----NLPSSTGINLPNLLRLYLWGNN 351
+ L N L + + +L L
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 2e-04
Identities = 17/98 (17%), Positives = 28/98 (28%), Gaps = 5/98 (5%)
Query: 443 SKSLEYFYAGSCELG-GGIPAEFGNLSNIIALSLYQNQL----ASTIPTTVGKLQNLQGL 497
S ++ EL L + L L I + + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 498 DLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTC 535
+L N + + Q + +Q +LQN T
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 3e-04
Identities = 16/98 (16%), Positives = 32/98 (32%), Gaps = 12/98 (12%)
Query: 308 PSIIFNNSNIEVIQLYGNHLSGNLPSSTG---INLPNLLRLYLWGNNLSGVIPSSICNA- 363
+ S + V+ L +S + SS + +L L L N L + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 364 ----SKLTVLELSRNLFSGLVANTFG----NCRQLQIL 393
L L L +S + + + L+++
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 6e-04
Identities = 18/105 (17%), Positives = 32/105 (30%), Gaps = 14/105 (13%)
Query: 1074 PSMIFNNSNIEAIQLYGNHFSGHLPSSIG---PYLPNLQGLILWGNNLSGIIPSSICNA- 1129
+ S + + L S SS+ +L+ L L N L + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 1130 ----SQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTTGS 1170
+ L L + +S + +LQ L+ L S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 7e-04
Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 12/97 (12%)
Query: 232 NVSSLRVIVLANNSLFGSLPVDLC---RRLPSLQELNLRDCMTTGRIPKDIG-----NCT 283
S LRV+ LA+ + S L SL+EL+L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 284 LLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVI 320
LL L L D ++ + L L + ++ VI
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL----EKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 9e-04
Identities = 14/74 (18%), Positives = 24/74 (32%), Gaps = 6/74 (8%)
Query: 989 SNKLKRLSISVNKITGT-IPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCT 1047
S ++ L I +++ + L + + + L L I L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL-----TEARCKDISSALRVNP 55
Query: 1048 LLNFLILRQNQLTG 1061
L L LR N+L
Sbjct: 56 ALAELNLRSNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 0.001
Identities = 17/107 (15%), Positives = 28/107 (26%), Gaps = 18/107 (16%)
Query: 1015 ELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIP 1074
+++ L + L R + L + L LT R I
Sbjct: 3 DIQSLDIQCEELS--------DARWAELLPLLQQCQVVRLDDCGLTEARCKD------IS 48
Query: 1075 SMIFNNSNIEAIQLYGNHFSGHLPSSIGPYL----PNLQGLILWGNN 1117
S + N + + L N + L +Q L L
Sbjct: 49 SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.002
Identities = 20/100 (20%), Positives = 31/100 (31%), Gaps = 23/100 (23%)
Query: 517 SLNTLLLQGNALQNQ----IPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFS 572
L L L + + + L SLR L+LS+N L D
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG----------------DAG 413
Query: 573 LNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLK 612
+ L + Q L+ L L S + + L+
Sbjct: 414 ILQLVESVRQPGCLLEQL---VLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.003
Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 12/92 (13%)
Query: 185 CSKLKRLSVSFNELTGR----IPQNIGNLTELMELYLNGNNLQGEFPPTIF-----NVSS 235
S L+ L ++ +++ + + L EL L+ N L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 236 LRVIVLANNSLFGSLP---VDLCRRLPSLQEL 264
L +VL + + L + PSL+ +
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 3e-07
Identities = 36/226 (15%), Positives = 71/226 (31%), Gaps = 16/226 (7%)
Query: 152 NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTE 211
+F D +L + +T + D + LS +T + + L
Sbjct: 11 VIFPD--PALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNN 64
Query: 212 LMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMT 271
L+ L L N + P + + ++ + L + D
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 272 TGRIPKDIGNCTLLNYLGLRDNQLTDFGANN-----LTGLIPSIIFNNSNIEVIQLYGNH 326
+ LN + + + N S + ++ N
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 327 LSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELS 372
+S P + +LPNL+ ++L N +S V P + N S L ++ L+
Sbjct: 185 ISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 3e-07
Identities = 35/231 (15%), Positives = 70/231 (30%), Gaps = 25/231 (10%)
Query: 311 IFNNSNIE---VIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLT 367
IF + + I ++++ + + +L + L +G ++ + + + L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI--EGVQYLNNLI 66
Query: 368 VLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQ 427
LEL N + L L+ + + LT+ + +
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 428 TNPWKGIL------PNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLA 481
+L ++ L+ Y NLS + L N+++
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIP-SELCQLESLNTLLLQGNALQNQ 531
P + L NL + L N I P + L + L NQ
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT--------LTNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 8e-07
Identities = 35/214 (16%), Positives = 71/214 (33%), Gaps = 12/214 (5%)
Query: 186 SKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNS 245
+ +++ + +T + Q +L + L G + + +++L + L +N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 246 L-FGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLT 304
+ + +L + N ++ + I L + L +
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 305 GLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLW---GNNLSGVIPSSIC 361
L + I N S + + GN S L NL +L N +S + P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 362 NASKLTVLELSRNLFSGLVANTFGNCRQLQILNL 395
+ L + L N S + N L I+ L
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 4e-05
Identities = 40/235 (17%), Positives = 74/235 (31%), Gaps = 26/235 (11%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
L N +++ +N++ + + + +T L + + L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+Q+ + +LT L I
Sbjct: 73 NQI------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQ--------SIKTLDLTSTQ 118
Query: 458 GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLES 517
LSN+ L L NQ+ + P S N Q S + L L
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYL----SIGNAQVSDLTPLANLSK 174
Query: 518 LNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFS 572
L TL N + + P LA+L +L ++L +N+++ P + + +V +
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 5e-04
Identities = 32/212 (15%), Positives = 61/212 (28%), Gaps = 46/212 (21%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLE--------------AYLYNNKFT 1036
+++ + +T T+ + +L + L G + N
Sbjct: 20 NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITD 77
Query: 1037 GRIPQNLGNCTLLNFLILRQNQLTGVRLASNK-----------------------LIGRI 1073
+NL T L ++ + + ++
Sbjct: 78 LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137
Query: 1074 PSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILW---GNNLSGIIPSSICNAS 1130
+ I N S + + G+ S L NL L N +S I P + +
Sbjct: 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLP 195
Query: 1131 QVILLGLSENLFSGLIPNTFGNCRQLQILDLS 1162
+I + L N S + P N L I+ L+
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 18/62 (29%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 182 LGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVL 241
L + SKL L N+++ P + +L L+E++L N + P + N S+L ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 242 AN 243
N
Sbjct: 225 TN 226
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 26/219 (11%), Positives = 58/219 (26%), Gaps = 7/219 (3%)
Query: 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQ 399
N + L L + + L +E+S+N ++ +
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGG 459
++ + I+ P + + L + + E
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE---- 144
Query: 460 IPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLN 519
+ G + L L +N + Q + NN++
Sbjct: 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 204
Query: 520 TLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPS 558
L + + + L NL LRA + + + +P+
Sbjct: 205 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 36/231 (15%), Positives = 73/231 (31%), Gaps = 11/231 (4%)
Query: 166 SFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGE 225
F +++T ++PS L L +L +L ++ ++ N++
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 226 FPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLL 285
+F+ + + NL + I + +
Sbjct: 69 IEADVFSNLP-------KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 121
Query: 286 NYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRL 345
+ + L D N I F + E + L+ N + N L L
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181
Query: 346 YLWGNNLSGVIPSSI-CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNL 395
L NN +P+ + AS +L++SR L + N ++L+ +
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 3e-04
Identities = 35/220 (15%), Positives = 61/220 (27%), Gaps = 18/220 (8%)
Query: 992 LKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGR------IPQNLGN 1045
L + K+ +L ++ + N++ + + F+ + N
Sbjct: 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90
Query: 1046 CTLLNFLILRQNQLTGVRLASNKLIGRIP--SMIFNNSNIEAIQLYGNHFSGHLPSSIGP 1103
+N + L SN I +P I + + + +S
Sbjct: 91 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 150
Query: 1104 YLPNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSL 1163
L L N + I + L N L + F ILD+S
Sbjct: 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 210
Query: 1164 NHLTTGSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPN 1203
+ + S L N + LR LK LP
Sbjct: 211 TRIHSLPS-------YGLENLKKLR--ARSTYNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 7e-04
Identities = 25/233 (10%), Positives = 74/233 (31%), Gaps = 10/233 (4%)
Query: 140 RIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELT 199
R+ ++++ + D+ + EL ++ + L+++ +S N++
Sbjct: 11 RVFLCQESKVT-EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66
Query: 200 GRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLP 259
I ++ + + + + + L + +
Sbjct: 67 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS------NTGIKHLPD 120
Query: 260 SLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEV 319
+ +L+ + + +I +++GL + + N I + FN + ++
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 320 IQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELS 372
+ L N+ LP+ + L + + + + N KL
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 39/222 (17%), Positives = 83/222 (37%), Gaps = 28/222 (12%)
Query: 151 GNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLT 210
+F D ++ E ++ +T + + + + ++ + +++ Q I L
Sbjct: 15 KQIFSD--DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--VQGIQYLP 68
Query: 211 ELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCM 270
+ +L+LNGN L I +++L+ + + + L L+ L+L
Sbjct: 69 NVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 271 TTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGN 330
+ + L L L +N++TD + + ++ ++ I I
Sbjct: 124 I--SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAG----- 176
Query: 331 LPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELS 372
L L LYL N++S + ++ L VLEL
Sbjct: 177 --------LTKLQNLYLSKNHISDL--RALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 3e-05
Identities = 31/207 (14%), Positives = 73/207 (35%), Gaps = 25/207 (12%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
+ + ++ +T + T L + ++ + +++++ Q + +
Sbjct: 25 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-----------QGIQYLPNVT 71
Query: 1051 FLILRQNQLTGVR-LASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQ 1109
L L N+LT ++ LA+ K +G + ++ +++ S L + + L
Sbjct: 72 KLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 1110 GLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPN--TFGNCRQLQILDLSLNHLT 1167
L + G + + + +L I + +LQ L LS NH++
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191
Query: 1168 TGSSTQGHSFYTSLTNCRYLRRLVLQN 1194
+L + L L L +
Sbjct: 192 D---------LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 4e-05
Identities = 25/194 (12%), Positives = 57/194 (29%), Gaps = 12/194 (6%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
++ L +++ + + + + + + + + + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 398 SQLAT----GSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGS 453
++L +L F + L L L ++ + L +
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 454 CELGGGIPAEFGNLSNIIALSLYQNQLASTIPT--TVGKLQNLQGLDLSYNNIQGSIPSE 511
G + + + + + I + L LQ L LS N+I
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195
Query: 512 LCQLESLNTLLLQG 525
L L++L+ L L
Sbjct: 196 LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 31/193 (16%), Positives = 58/193 (30%), Gaps = 46/193 (23%)
Query: 466 NLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQG 525
+ I +L + + + +L ++ + + ++I+ + L ++ L L G
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 526 NAL---------------------------------------QNQIPTCLANLTSLRALN 546
N L ++ + + L L L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 547 LSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPS 606
N T S L + + + L L LYLS N +S
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LR 194
Query: 607 SIGGLKDLTYLAL 619
++ GLK+L L L
Sbjct: 195 ALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 4e-04
Identities = 11/76 (14%), Positives = 33/76 (43%), Gaps = 10/76 (13%)
Query: 483 TIPTTVGK------LQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCL 536
T+PT + + +L ++ ++ +L S++ ++ + +++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 537 ANLTSLRALNLSSNRL 552
L ++ L L+ N+L
Sbjct: 65 QYLPNVTKLFLNGNKL 80
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 9e-04
Identities = 32/212 (15%), Positives = 67/212 (31%), Gaps = 25/212 (11%)
Query: 289 GLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLW 348
+ + ++T + ++I+ I + + LPN+ +L+L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFLN 76
Query: 349 GNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQG 408
GN L+ + P + L+ ++ + + G
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE-------------HNG 123
Query: 409 QSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLS 468
S + L + L L + N I S +L ++ L+
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLT 178
Query: 469 NIIALSLYQNQLASTIPTTVGKLQNLQGLDLS 500
+ L L +N + S + + L+NL L+L
Sbjct: 179 KLQNLYLSKNHI-SDLR-ALAGLKNLDVLELF 208
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 3e-06
Identities = 25/127 (19%), Positives = 45/127 (35%), Gaps = 5/127 (3%)
Query: 482 STIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTS 541
+ + K + L ++ +L L + + + + N+
Sbjct: 10 EQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPE 66
Query: 542 LRALNLSSNRL--NSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQ 599
L +LNLS+NRL + S + +++ S N L D L L+L GN
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 600 LSCSIPS 606
LS +
Sbjct: 127 LSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 3e-04
Identities = 25/118 (21%), Positives = 46/118 (38%), Gaps = 3/118 (2%)
Query: 463 EFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQG--SIPSELCQLESLNT 520
+ + + L+ ++ +A+T+ + L L+LS N + + S + + +L
Sbjct: 37 DLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95
Query: 521 LLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
L L GN L+++ L L L N L+ T + I L L G
Sbjct: 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 3e-04
Identities = 32/154 (20%), Positives = 62/154 (40%), Gaps = 26/154 (16%)
Query: 117 SLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176
+L++ G R +L +++ S+ + ++ EL S ++S+N++
Sbjct: 26 ALDLKGLRSD----PDLVAQNIDVVLNRRSSMA--ATLRIIEENIPELLSLNLSNNRLYR 79
Query: 177 Q--LPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVS 234
+ S + LK L++S NEL + +L EL+L+GN+L F +S
Sbjct: 80 LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139
Query: 235 SLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
++R R P L L+ +
Sbjct: 140 AIR------------------ERFPKLLRLDGHE 155
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 5e-04
Identities = 26/153 (16%), Positives = 50/153 (32%), Gaps = 20/153 (13%)
Query: 201 RIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPS 260
++ + + + L+ L+ P + + V+ ++ + +L + + +P
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRI-IEENIPE 66
Query: 261 LQELNLRDCMTTGR--IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIE 318
L LNL + + + L L L N+L +E
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS--------ERELDKIKGLKLE 118
Query: 319 VIQLYGNHLSGNLPSSTGI------NLPNLLRL 345
+ L GN LS + P LLRL
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 6e-04
Identities = 24/125 (19%), Positives = 39/125 (31%), Gaps = 8/125 (6%)
Query: 278 DIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGI 337
D+ L ++ + +++ + I N + + L N L S+ +
Sbjct: 28 DLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIV 87
Query: 338 -NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFG-------NCRQ 389
PNL L L GN L KL L L N S + +
Sbjct: 88 QKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPK 147
Query: 390 LQILN 394
L L+
Sbjct: 148 LLRLD 152
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (109), Expect = 3e-06
Identities = 19/149 (12%), Positives = 38/149 (25%), Gaps = 10/149 (6%)
Query: 214 ELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273
L + + + +L + + N L + R L L+ L +
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 274 RIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPS 333
P L+ L L N L + +++ + L GN L +
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALES---------LSWKTVQGLSLQELVLSGNPLHCSCAL 121
Query: 334 STGINLPNLLRLYLWGNNLSGVIPSSICN 362
+ L + +
Sbjct: 122 RWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 24/138 (17%), Positives = 41/138 (29%), Gaps = 1/138 (0%)
Query: 478 NQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQ-LESLNTLLLQGNALQNQIPTCL 536
A + +NL L + + + L L L + + L+ P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 537 ANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLS 596
L LNLS N L S T L +V L C + + + +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVP 136
Query: 597 GNQLSCSIPSSIGGLKDL 614
+L C + + +
Sbjct: 137 EQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 16/101 (15%), Positives = 33/101 (32%), Gaps = 1/101 (0%)
Query: 1058 QLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNN 1117
+G+R + + + N+ + + HL L L+ L + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 1118 LSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQI 1158
L + P + ++ L LS N L T ++
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQEL 108
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 26/157 (16%), Positives = 48/157 (30%), Gaps = 4/157 (2%)
Query: 107 PHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELES 166
P L + + + L L + + + + +L L EL +
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 167 FDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF 226
+ + + P + +L RL++SFN L + L EL L+GN L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 227 PPTIF-NVSSLRVIVLANNSLFGSLPVDLCRRLPSLQ 262
+ + L L +P+
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPL-AHMPNAS 155
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 6e-06
Identities = 39/317 (12%), Positives = 89/317 (28%), Gaps = 30/317 (9%)
Query: 260 SLQELNLRDCMTTGR----IPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNS 315
S++ +L+ T + + + + L N + A L I +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWL----SENIASKK 59
Query: 316 NIEVIQLYGNH---LSGNLP------SSTGINLPNLLRLYLWGNNLSGVIPSSICNASKL 366
++E+ + + +P + P L + L N + +
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119
Query: 367 TVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAI 426
L + + G + LA ++ A + N +
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL--RSIICGRNRLENGSMKE 177
Query: 427 QTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPT 486
++ + ++ L G+ + + + + +S +
Sbjct: 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237
Query: 487 TVGKLQNLQGLDLSYNNIQGSIPSEL------CQLESLNTLLLQGNALQNQIPTCLA--- 537
+ NL+ L L+ + + + + L TL LQ N ++ L
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297
Query: 538 --NLTSLRALNLSSNRL 552
+ L L L+ NR
Sbjct: 298 DEKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.4 bits (108), Expect = 2e-05
Identities = 34/295 (11%), Positives = 77/295 (26%), Gaps = 20/295 (6%)
Query: 105 IPPHVANLSFLVSLNISGNRFHG----TLPNELWLMPRLRIIDLSSNRIS--GNLFDDMC 158
+ + + + +SGN L + L I + S + +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 159 NSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLN 218
L + + + + + +S + + + L +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 219 GNNLQGEFPPTIFNVSSLRVIVLANNSL---FGSLPVDLCRRLPSLQELNLRDCMTTGRI 275
+ N LR I+ N L + L + +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 276 PKDIGNCTLLNYLGL-RDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334
+ + L L + + + + + + + N+ + L LS ++
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 335 -----TGINLPNLLRLYLWGNNLSGVIPSSICNA-----SKLTVLELSRNLFSGL 379
+ + L L L N + ++ L LEL+ N FS
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 3e-04
Identities = 16/106 (15%), Positives = 33/106 (31%), Gaps = 11/106 (10%)
Query: 125 FHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSL-----TELESFDVSSNQITGQLP 179
L L P LR + L+ +S + ++ L++ + N+I
Sbjct: 231 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290
Query: 180 SSLGD-----CSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGN 220
+L L L ++ N + + + E+ G
Sbjct: 291 RTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 4e-04
Identities = 34/321 (10%), Positives = 81/321 (25%), Gaps = 15/321 (4%)
Query: 187 KLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGE----FPPTIFNVSSLRVIVLA 242
LK +++ + + + + E+ L+GN + E I + L + +
Sbjct: 9 SLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 243 NNSL--FGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGA 300
+ + R L + L + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 301 NNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSI 360
+ GL P + P + I N L +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 361 CNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQS--FFSSLTNC 418
+ K+ + L+ C++L++L+L + S
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 419 RYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIP-----AEFGNLSNIIAL 473
L + ++ + L+ E+ + +++ L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 474 SLYQNQLASTIPTTVGKLQNL 494
L N+ S V +++ +
Sbjct: 308 ELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 6e-04
Identities = 38/292 (13%), Positives = 78/292 (26%), Gaps = 20/292 (6%)
Query: 129 LPNELWLMPRLRIIDLSSNRISGNLFDDM------CNSLTELESFDVSSNQITGQLPSSL 182
+ L ++ I LS N I + L E D+ + ++ ++P +L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 183 GDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLA 242
+ + + E + +L+ + + +A
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 243 NNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANN 302
++ P + R+ + G + + L
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 303 LTGLIPSIIFNNSNIEVIQLYGNHLSGNLPS---STGINLPNLLRLYLWGNNLSGVIPSS 359
+ L+ + ++V+ L N + S + PNL L L LS ++
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 360 I------CNASKLTVLELSRNLFSG-----LVANTFGNCRQLQILNLAYSQL 400
+ L L L N L L L L ++
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.002
Identities = 13/109 (11%), Positives = 36/109 (33%), Gaps = 6/109 (5%)
Query: 988 DSNKLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCT 1047
+ LK +I+ ++ + ++E+ L GN + + + +N+ +
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTI-----GTEAARWLSENIASKK 59
Query: 1048 LLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGH 1096
L V+ + + + + + ++L N F
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 1e-05
Identities = 36/142 (25%), Positives = 52/142 (36%), Gaps = 29/142 (20%)
Query: 473 LSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQI 532
L L L T+ + +L + LDLS+N ++ P+ L L L L NAL+N
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 533 PTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTG 592
NL L+ L L +NRL + Q + + L
Sbjct: 60 GVA--NLPRLQELLLCNNRLQQSAA-----------------------IQPLVSCPRLVL 94
Query: 593 LYLSGNQLSCSIPSSIGGLKDL 614
L L GN L C L ++
Sbjct: 95 LNLQGNSL-CQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 1e-05
Identities = 23/101 (22%), Positives = 38/101 (37%), Gaps = 5/101 (4%)
Query: 168 DVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFP 227
++ +T L + L +S N L P + L L L ++ E
Sbjct: 4 HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENV 58
Query: 228 PTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268
+ N+ L+ ++L NN L S + P L LNL+
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 99
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 5e-05
Identities = 22/110 (20%), Positives = 45/110 (40%), Gaps = 9/110 (8%)
Query: 118 LNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELES-FDVSSNQITG 176
L+++ T+ L + + +DLS NR+ + +L L + ++
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-----LPPALAALRCLEVLQASDNAL 55
Query: 177 QLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNGNNLQGE 225
+ + + +L+ L + N L Q + + L+ L L GN+L E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 1e-04
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 25/108 (23%)
Query: 90 RVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPN------------------ 131
RV L+ +L T+ H+ L + L++S NR P
Sbjct: 1 RVLHLAHKDL----TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE 56
Query: 132 ---ELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176
+ +PRL+ + L +NR+ + S L ++ N +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.002
Identities = 19/106 (17%), Positives = 36/106 (33%), Gaps = 9/106 (8%)
Query: 1064 LASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILW-GNNLSGII 1122
LA L + + + + L N P+ L L+ L + ++ +
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-----LAALRCLEVLQASDNALEN 57
Query: 1123 PSSICNASQVILLGLSENLFSGL-IPNTFGNCRQLQILDLSLNHLT 1167
+ N ++ L L N +C +L +L+L N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.004
Identities = 20/134 (14%), Positives = 41/134 (30%), Gaps = 25/134 (18%)
Query: 993 KRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAY------------LYNNKFTGRIP 1040
+ L ++ +T + + L + L L N L A L +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 1041 QNLGNCTLLNFLILRQNQLTGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSG--HLP 1098
+ N L L+L N+L + + + + L GN +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQS---------AAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109
Query: 1099 SSIGPYLPNLQGLI 1112
+ LP++ ++
Sbjct: 110 ERLAEMLPSVSSIL 123
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 29/180 (16%), Positives = 70/180 (38%), Gaps = 8/180 (4%)
Query: 117 SLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITG 176
+++ +G +P ++ + L+ N + D + L L ++ NQ+TG
Sbjct: 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 177 QLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSL 236
P++ S ++ L + N++ + L +L L L N + P + +++SL
Sbjct: 69 IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128
Query: 237 RVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT 296
+ LA+N + + ++ +L P + + + + L ++
Sbjct: 129 TSLNLASNPFNCNCHLAWFAEWL--RKKSLNGGAARCGAPSKVRDVQIKD---LPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 4e-05
Identities = 38/175 (21%), Positives = 69/175 (39%), Gaps = 7/175 (4%)
Query: 460 IPAEFGNLSNIIALSLYQNQLASTIPTTV-GKLQNLQGLDLSYNNIQGSIPSELCQLESL 518
IP + + L L N+L + G+L +L L+L N + G P+ +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 519 NTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSG 578
L L N ++ L L+ LNL N+++ +P +F L + ++ + +
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA-SNPFN 139
Query: 579 CLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQGSIPEAIG 633
C + L L+G C PS ++D+ L + F+ S + G
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 0.004
Identities = 35/166 (21%), Positives = 57/166 (34%), Gaps = 19/166 (11%)
Query: 1060 TGVRLASNKLIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYLPNLQGLILWGNNLS 1119
T V L IP I + + L N + LP+L L L N L+
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 1120 GIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNHLTT----------- 1168
GI P++ AS + L L EN + F QL+ L+L N ++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 1169 -----GSSTQGHSFYTSLTNCRYLRRLVLQNNPLKGALPNSIGNLS 1209
+S + +LR+ L + P+ + ++
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ 173
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 26/190 (13%), Positives = 57/190 (30%), Gaps = 12/190 (6%)
Query: 338 NLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY 397
L ++ L N++ + + + ++T L+ R + + L +N +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 398 SQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELG 457
+QL + + + + + ++ N + L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 458 ------GGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSE 511
I L + T + L L+ LD+S N + S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189
Query: 512 LCQLESLNTL 521
L +L +L +L
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 6e-04
Identities = 33/202 (16%), Positives = 65/202 (32%), Gaps = 26/202 (12%)
Query: 991 KLKRLSISVNKITGTIPRTVGNLTELRELHLHGNNLEAYLYNNKFTGRIPQNLGNCTLLN 1050
+ + + +T T+ +T +L ++ L +++ + L
Sbjct: 19 EKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI-----------DGVEYLNNLT 65
Query: 1051 FLILRQNQLTGVRLASNK-----LIGRIPSMIFNNSNIEAIQLYGNHFSGHLPSSIGPYL 1105
+ NQLT + N ++ + L G + + I P
Sbjct: 66 QINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 1106 PNLQGLILWGNNLSGIIPSSICNASQVILLGLSENLFSGLIPNTFGNCRQLQILDLSLNH 1165
L ++ + S++ + + L S N + L P N L+ LD+S N
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNK 183
Query: 1166 LTTGSSTQGHSFYTSLTNCRYL 1187
++ S LTN L
Sbjct: 184 VS------DISVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 2e-04
Identities = 22/101 (21%), Positives = 33/101 (32%), Gaps = 3/101 (2%)
Query: 462 AEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTL 521
A++ N L L ++ I L +D S N I+ L L TL
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68
Query: 522 LLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWS 562
L+ N + L L L L++N L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 109
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.002
Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 8/137 (5%)
Query: 107 PHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELES 166
N L++ G + + N + + ID S N I D L L++
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 67
Query: 167 FDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTG-RIPQNIGNLTELMELYLNGNN---L 222
V++N+I L L ++ N L + +L L L + N
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 223 QGEFPPTIFNVSSLRVI 239
+ I+ V +RV+
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1624 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.86 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.6 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.59 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.57 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.4 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.39 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.36 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.35 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.33 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.3 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.25 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.18 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.16 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.05 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.03 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.22 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.21 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.08 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.36 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.72 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.72 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.39 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.25 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=452.99 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=202.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4566778999999999999999888899999986432 334789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++......++|+.+++|+.|||+||+|||+ .+|+||||||+|||+|+++.+||+|||+|+...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 999999998877789999999999999999999997 78999999999999999999999999999987654444444
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEAD 1574 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1574 (1624)
...||+.|||||++.+..++.|+|||||||++|||+|+..|+........... .+.......
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~-------------~i~~~~~~~----- 222 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-------------DISTGFRLY----- 222 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH-------------HHHHTCCCC-----
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH-------------HHHhcCCCC-----
Confidence 56799999999999999999999999999999999996555433221111111 111111000
Q ss_pred HHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1575 IAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1575 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.+..++.++.+++.+||+.||++||||+|+++.|+++++
T Consensus 223 --~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 --KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 012345678899999999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=457.55 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=207.5
Q ss_pred hCCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.++|...+.||+|+||+||+|++. ..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 456788899999999999999874 36999998643 34556889999999999999999999998864 56799999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC-
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS- 1490 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~- 1490 (1624)
||++|+|.++++..+..+++.++++|+.|||+||+|||+ .+||||||||+|||+|+++++||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999998777789999999999999999999996 7999999999999999999999999999987654322
Q ss_pred ccccccccccccccccccCC---CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhcc
Q 047591 1491 MKQTMTLATIGYMAPEYGSE---GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLL 1567 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~---~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~ 1567 (1624)
.......||+.|||||++.. +.|+.++|||||||++|||+||+.||.+......... .+.....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~-------------~~~~~~~ 227 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF-------------MVGRGYL 227 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH-------------HHHHTSC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH-------------HHhcCCC
Confidence 23344679999999998753 4589999999999999999999999976432221111 1111111
Q ss_pred CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1568 SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1568 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.... ...+..++..+.+++.+||+.+|++||||+|+++.|+.+++..
T Consensus 228 ~p~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 228 SPDL---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCCG---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCcc---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 0000 0011245677899999999999999999999999999887643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-48 Score=455.86 Aligned_cols=267 Identities=22% Similarity=0.400 Sum_probs=205.4
Q ss_pred cCHHHHHHHhCCCC---------cCCeEeecCceEEEEEEEcC-C---ceEEEEEeccc-hhhHHHHHHHHHHHHHhcCC
Q 047591 1325 ISYQELRLATNGFS---------ESNLLGTGIFSSVYKATFAD-G---TNAAIKIFSLQ-EDRALKSFDAECEVMRRIRH 1390 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~---------~~~~lG~G~~G~Vyk~~~~~-~---~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~H 1390 (1624)
++|+|+..|+.+|+ ..++||+|+||+||+|++.. + ..||||.+... .....+.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 44555555555443 34689999999999998752 3 25888887543 34556789999999999999
Q ss_pred CceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC
Q 047591 1391 RNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD 1470 (1624)
Q Consensus 1391 pNIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 1470 (1624)
||||+++|+|.+++..++|||||++|+|.+++......++|.++++|+.|||+||+|||+ .+||||||||+|||+|+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECC
Confidence 999999999999999999999999999999998877779999999999999999999996 79999999999999999
Q ss_pred CCcEEEeeecceeecCCCCCcc----ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchh
Q 047591 1471 DMVAHLGDFGIAKLLDGVDSMK----QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVC 1545 (1624)
Q Consensus 1471 ~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~ 1545 (1624)
++++||+|||+|+.+....... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-- 241 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 241 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999775432211 122458999999999999999999999999999999998 899987543211
Q ss_pred hhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1546 LKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1546 l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
+.. .+....... .+..++..+.+++.+||+.+|++||||+||++.|+++.+
T Consensus 242 ~~~------------~i~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 242 VIN------------AIEQDYRLP-------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHH------------HHHTTCCCC-------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHH------------HHHcCCCCC-------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111 111111100 112456778899999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=449.64 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=210.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||+||+|++.+++.||||+++... ...+.|.+|++++++++|||||+++|+|.+ +..++|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4566778999999999999999888899999986432 345789999999999999999999998864 56799999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+|+|.+++... +..++|.++++|+.|||+||+|||+ .+|+||||||+|||+|+++.+||+|||+|+.+........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999988643 3458999999999999999999996 7999999999999999999999999999998865554445
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....||+.|||||++.++.++.++|||||||++|||+||+.|+.........+. . +.......
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~-~------------i~~~~~~~---- 230 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-N------------LERGYRMV---- 230 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-H------------HHTTCCCC----
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH-H------------HHhcCCCC----
Confidence 556799999999999888999999999999999999997766543322111111 1 11110000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+..++..+.+++.+||+.+|++||||+||++.|+++-+.
T Consensus 231 ---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 ---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0123556788999999999999999999999999987553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=437.54 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=215.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788889999999999999999888899999987433 234689999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++......+++..+.+|+.|||+||+|||+ .+|+||||||+|||+|+++.+||+|||+|+...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999999998877788999999999999999999996 79999999999999999999999999999887655544455
Q ss_pred ccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1495 MTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...||+.|||||.+.+..++.|+|||||||++|||+| |+.||......+. ... +.......
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-~~~-------------i~~~~~~~---- 221 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEH-------------IAQGLRLY---- 221 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-HHH-------------HHTTCCCC----
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-HHH-------------HHhCCCCC----
Confidence 5679999999999999999999999999999999998 7989876532221 111 11110000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.+..++..+.+++.+||+.+|++||||+|+++.|.+|
T Consensus 222 ---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 ---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 0123456788999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=442.42 Aligned_cols=263 Identities=22% Similarity=0.376 Sum_probs=213.8
Q ss_pred CCCCcCCe-EeecCceEEEEEEEc---CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNL-LGTGIFSSVYKATFA---DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~-lG~G~~G~Vyk~~~~---~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...++ ||+|+||+||+|++. ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999874 3457999998643 34456889999999999999999999999865 467999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
||||++|+|.+++...+..+++.++++|+.|||+||+|||+ .+||||||||+|||++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999999999998777789999999999999999999996 799999999999999999999999999999876433
Q ss_pred C--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1490 S--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1490 ~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
. .......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+. .. .+....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~------------~i~~~~ 229 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA------------FIEQGK 229 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH------------HHHTTC
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HH------------HHHcCC
Confidence 2 22234568999999999998999999999999999999998 8999976432211 11 111110
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhhh
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFLKDVQ 1622 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~~~~~ 1622 (1624)
.. ..+..++.++.+++.+||+.+|++||||.+|++.|+.+.......++
T Consensus 230 ~~-------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 230 RM-------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp CC-------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CC-------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 00 01124567789999999999999999999999999988766655543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-48 Score=448.99 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=214.2
Q ss_pred HHhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1332 LATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1332 ~at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
...++|...+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34456777789999999999999986 5888999998643 234578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1411 QYMPQGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|||++|+|.+++++. ...+++..+++|+.|||+||+|||+ .+||||||||+|||+|+++++||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999754 5678999999999999999999997 799999999999999999999999999999876544
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
........||+.|||||++.++.|+.|+|||||||++|||+||+.|+....... .+.+.+.......
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------------~~~~~i~~~~~~~ 236 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------QVYELLEKDYRME 236 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------HHHHHHHTTCCCC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------------HHHHHHhcCCCCC
Confidence 444455678999999999999999999999999999999999877764322111 1112222211110
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
.+..++..+.+++.+||+.||++||||+|+++.|+.+.
T Consensus 237 -------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 237 -------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01235667889999999999999999999999998863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=439.38 Aligned_cols=258 Identities=23% Similarity=0.404 Sum_probs=204.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCC-----ceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADG-----TNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~-----~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
+.|...++||+|+||+||+|++... ..||||+++.. .+...++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999988642 36999998643 33445689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
|||||.+|++.+++......++|.++++|+.|||.||+|||+ .+||||||||+|||+|+++.+||+|||+|+.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 999999999999998877789999999999999999999996 79999999999999999999999999999987543
Q ss_pred CC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
.. .......||+.|||||++.++.++.++|||||||++|||+||+.|+........ +.+.+....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-------------~~~~i~~~~ 230 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------------VMKAINDGF 230 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------------HHHHHHTTC
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-------------HHHHHhccC
Confidence 22 122345689999999999999999999999999999999997776543222111 111122111
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
... .+..++..+.+++.+||+.+|++||||+||++.|+++.+
T Consensus 231 ~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 RLP-------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCC-------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC-------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111 112356678899999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=432.97 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=202.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56788899999999999999885 68999999986543 23456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-Cc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD-SM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~-~~ 1491 (1624)
|++|+|.+++... ..+++.++..|+.||++||+|||+ .+||||||||+|||+++++.+||+|||+|+...... ..
T Consensus 85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999998654 468899999999999999999996 799999999999999999999999999999875332 22
Q ss_pred cccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||+...........+...... ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------------~~- 227 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------LN- 227 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------------ST-
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------CC-
Confidence 2345689999999999877765 678999999999999999999997543322222222111100 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
....++..+.+++.+||+.||++|||++|+++
T Consensus 228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01123456778999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=431.71 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=207.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46888899999999999999874 68999999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|+|.+++.+. .+++.++..|+.||+.||+|||+ .+||||||||+|||++.++++||+|||+|+.+.... ...
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999999988754 48899999999999999999996 799999999999999999999999999999875433 233
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
...+||+.|||||++.+..++.++|||||||++|||+||+.||.+...... +........+. +
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~---------~------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE---------L------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC---------C-------
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCCC---------C-------
Confidence 456799999999999999999999999999999999999999965322111 11111110000 0
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..+..++..+.+++.+||+.||++|||++|+++
T Consensus 237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001234566889999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=429.98 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=200.5
Q ss_pred CeEeecCceEEEEEEEcC---CceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecCC
Q 047591 1341 NLLGTGIFSSVYKATFAD---GTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMPQ 1415 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~---~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~~ 1415 (1624)
+.||+|+||+||+|.+.+ ++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 457999998643 23345789999999999999999999999965 456899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc--c
Q 047591 1416 GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK--Q 1493 (1624)
Q Consensus 1416 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~--~ 1493 (1624)
|+|.+++++. ..+++.++++|+.|||+||+|||+ .+||||||||+|||++.++.+||+|||+|+.+....... .
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999865 458999999999999999999996 789999999999999999999999999999875433222 2
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEE 1572 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~ 1572 (1624)
....||+.|||||.+.+..++.++|||||||++|||+| |+.||.+....+ +.+.+.......
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------------~~~~i~~~~~~~--- 230 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERMG--- 230 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------HHHHHHTTCCCC---
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------------HHHHHHcCCCCC---
Confidence 23579999999999999999999999999999999998 899997643211 111111111000
Q ss_pred HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1573 ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1573 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.+..++..+.+++.+||+.||++||||+||++.|+..-.
T Consensus 231 ----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 112456778899999999999999999999999887643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=434.05 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=206.5
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
.|...+.||+|+||+||+|+.. +++.||||+++.......+.|.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 4666788999999999999875 688999999976666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcccc
Q 047591 1415 QGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQT 1494 (1624)
Q Consensus 1415 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 1494 (1624)
+|+|.+++.+.+..+++.++..|+.||++||+|||+ .+||||||||+|||++.++++||+|||+|+...... ....
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 168 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHT
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccc
Confidence 999999988766678999999999999999999996 799999999999999999999999999998654221 1223
Q ss_pred cccccccccccccc-----CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1495 MTLATIGYMAPEYG-----SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1495 ~~~gt~~y~APE~~-----~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
...||+.|||||++ ....|+.++|||||||++|||+||+.||.+....+. +........+ ...
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~~----------~~~- 236 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP----------TLA- 236 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCCC----------CCS-
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCC----------CCC-
Confidence 46799999999986 355689999999999999999999999976432221 1111111100 000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..++..+.+++.+||+.||++|||++|+++
T Consensus 237 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 -------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01234567889999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=433.86 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=201.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEecC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYMP 1414 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~~ 1414 (1624)
++|...+.||+|+||+||+|++.+++.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4577778999999999999999888889999986433 345789999999999999999999999854 56799999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1415 QGSLEKWLYSH-NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1415 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
+|+|..+++.. ...++|.++++|+.|||.||+|||+ .+|+||||||+|||+|+++++||+|||+|+..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999988753 3568999999999999999999997 7899999999999999999999999999998765444444
Q ss_pred cccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHH
Q 047591 1494 TMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEA 1573 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1573 (1624)
....||+.|||||++..+.++.++|||||||++|||+||+.|+.........+. + +.......
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~-~------------i~~~~~~~---- 234 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-Q------------VERGYRMP---- 234 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-H------------HHTTCCCC----
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH-H------------HHhcCCCC----
Confidence 556799999999999999999999999999999999998777654322211111 1 11111000
Q ss_pred HHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1574 DIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1574 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
.+..++.++.+++.+||+.||++||||+||++.|++..
T Consensus 235 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11245667889999999999999999999999888754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=423.91 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=204.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 45777889999999999999885 6889999998643 2334678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|||++|+|.+++.+.+ .+++.++..|+.||++||+|||+ .+||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 9999999999998654 57899999999999999999996 79999999999999999999999999999876432
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|||||++.+..++.++|||||||++|||+||+.||.+....+ .+...... ... .
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~------------~~~-~- 223 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV------------EFT-F- 223 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT------------CCC-C-
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcC------------CCC-C-
Confidence 2344679999999999999999999999999999999999999997532111 11111110 000 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+..+++.+.+++.+|++.||++|||++|+++
T Consensus 224 -------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 -------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0123456788999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=438.48 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=204.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-C-----ceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-G-----TNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-~-----~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...++||+|+||+||+|++.. + ..||||++... .....+.|.+|+++|+++ +|||||+++++|.+++..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 456777899999999999998753 2 25899988543 334457899999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCC
Q 047591 1407 ALILQYMPQGSLEKWLYSHN----------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPS 1464 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~ 1464 (1624)
++|||||++|+|.++++... ..+++..++.|+.|||+||+|||+ .+||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 99999999999999997643 247899999999999999999996 79999999999
Q ss_pred cEEecCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCcc
Q 047591 1465 NVLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTG 1542 (1624)
Q Consensus 1465 NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~ 1542 (1624)
|||++.++++||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543322 2334578999999999999999999999999999999998 89999764322
Q ss_pred chhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 047591 1543 EVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLK 1611 (1624)
Q Consensus 1543 ~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~ 1611 (1624)
.. +.. ++....... .+..++..+.+++.+||+.+|++||||+|++++|.
T Consensus 274 ~~-~~~------------~~~~~~~~~-------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN-FYK------------LIQNGFKMD-------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH-HHH------------HHHTTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-HHH------------HHhcCCCCC-------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 111 121111100 11235667889999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-46 Score=426.59 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=192.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--CCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--PGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .+...+.|.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888899999999999999875 6899999998643 23456789999999999999999999999864 4567999
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1410 LQYMPQGSLEKWLYS---HNYLLNIEQRLDIMIDVACALEYLHQGY--STSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
||||++|+|.+++.+ .+..+++..+..|+.||+.||+|||+.. ..+||||||||+|||+++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3457899999999999999999999732 23599999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1485 LDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1485 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
+..... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+ .... +...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~------------i~~~ 229 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGK------------IREG 229 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH------------HHHT
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHH------------HHcC
Confidence 754322 2344689999999999999999999999999999999999999997532211 1111 1111
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
..... +..+++++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~--------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 KFRRI--------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC--------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11100 1134556889999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=425.43 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=199.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC----CceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD----GTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~----~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|++.. +..||||.++.. .+...+.|.+|++++++++|||||+++|+|. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 457777899999999999998753 345888887543 3445678999999999999999999999985 4678999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
||||++|++.+++......+++.+++.++.|||+||+|||+ .+||||||||+||++++++.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 99999999999988777789999999999999999999996 899999999999999999999999999999876544
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
....+...||+.|||||++....++.++|||||||++|||+| |+.||.+....+. ....... ....
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-~~~i~~~------------~~~~ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENG------------ERLP 229 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTT------------CCCC
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-HHHHHcC------------CCCC
Confidence 444555678999999999999999999999999999999998 8888876433221 1111110 0000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+..++..+.+++.+||+.||++|||++|+++.|+++..+
T Consensus 230 --------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1124566788999999999999999999999999988654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=419.88 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=193.9
Q ss_pred CCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc----CCeeEEEEEe
Q 047591 1340 SNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN----PGFKALILQY 1412 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~----~~~~~lV~ey 1412 (1624)
.+.||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++++|||||++++++.+ ....++||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 457999999999999875 5788999988643 23456789999999999999999999999864 3457999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec-CCCcEEEeeecceeecCCCCCc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD-DDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|++|+|.+++.+. ..++++++..|+.||++||+|||+. ..+||||||||+|||++ +++.+||+|||+|+.....
T Consensus 94 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--- 168 (270)
T d1t4ha_ 94 MTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168 (270)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred CCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---
Confidence 9999999999765 3578999999999999999999962 23499999999999996 5789999999999865432
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+................+..
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~-------------- 233 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-------------- 233 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--------------
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc--------------
Confidence 2335679999999998865 5999999999999999999999999754322211111111111100
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..+++++.+++.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01123456788999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=432.87 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=212.7
Q ss_pred HHHHHHhCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeee
Q 047591 1328 QELRLATNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSC 1400 (1624)
Q Consensus 1328 ~~l~~at~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~ 1400 (1624)
.+++...++|...+.||+|+||+||+|++. +++.||||+++... ....++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445556678888999999999999999874 35689999986543 34467899999999999999999999999
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSHN-----------------------YLLNIEQRLDIMIDVACALEYLHQGYSTSII 1457 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii 1457 (1624)
.+.+..++||||+++|+|.++++... ..+++.+++.|+.|+|.||+|||+ .+||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 99999999999999999999997532 247899999999999999999996 7999
Q ss_pred EcCCCCCcEEecCCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCC-C
Q 047591 1458 HCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRK-P 1535 (1624)
Q Consensus 1458 HrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~-P 1535 (1624)
||||||+|||+|+++++||+|||+|+.+...... ..+...||+.|||||++.+..|+.|+|||||||++|||+||.. |
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999999876543322 2334578999999999999999999999999999999999964 5
Q ss_pred CCCCCccchhhhhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1536 TDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1536 ~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
|.+....+ .. ..+ .+..... .+..++.++.+++.+||+.+|++||||.||++.|+++.
T Consensus 243 ~~~~~~~e-~~-~~v-----------~~~~~~~--------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEE-VI-YYV-----------RDGNILA--------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHH-HH-HHH-----------HTTCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHH-HH-HHH-----------HcCCCCC--------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 65432211 11 111 1111110 01245667889999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=439.26 Aligned_cols=275 Identities=22% Similarity=0.253 Sum_probs=207.2
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
..++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+++|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577888899999999999999875 6889999998654 3344578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|||++|+|.+++.+.+ .+++..+..++.|+++||+|||+. .+||||||||+|||+++++++||+|||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 9999999999998654 578999999999999999999961 37999999999999999999999999999876422
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh--hhcCChhH----------
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV--EESLPDAV---------- 1558 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~--~~~~~~~~---------- 1558 (1624)
.....+||+.|||||++.+..|+.++||||+||++|||+||+.||......+....... ........
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 23346899999999999999999999999999999999999999965332211110000 00000000
Q ss_pred -HHHHhhhccCCchHHHHHHH---------HHhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 047591 1559 -TDVIDANLLSGEEEADIAAK---------KKCMSSVMSLALKCSEEIPEERMNVKDALAN--LKKI 1613 (1624)
Q Consensus 1559 -~~~~d~~l~~~~~~~~~~~~---------~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~--L~~i 1613 (1624)
....+........+...... ...+.++.+++.+|++.||++|||++|+++. +++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000000000000000000 0124568899999999999999999999874 5543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=428.41 Aligned_cols=256 Identities=23% Similarity=0.410 Sum_probs=207.5
Q ss_pred CCeEeecCceEEEEEEEcCC----ceEEEEEecc-chhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-CCeeEEEEEec
Q 047591 1340 SNLLGTGIFSSVYKATFADG----TNAAIKIFSL-QEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-PGFKALILQYM 1413 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~~~----~~vAvK~~~~-~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-~~~~~lV~ey~ 1413 (1624)
.++||+|+||+||+|++.++ ..||||+++. ......++|.+|+++|++++|||||+++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999988542 3589999864 345566889999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc--
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM-- 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~-- 1491 (1624)
++|+|.++++......++..+++++.|+|+||.|||+ ++|+||||||+|||+|+++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999998877788899999999999999999996 79999999999999999999999999999987543222
Q ss_pred -cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1492 -KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1492 -~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......||+.|+|||+...+.++.++|||||||++|||+||+.|+....... .+..++ .......
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i-----------~~g~~~~-- 254 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYL-----------LQGRRLL-- 254 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH-----------HTTCCCC--
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHH-----------HcCCCCC--
Confidence 2233578999999999999999999999999999999999888875422111 111111 1100000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKFL 1618 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~~ 1618 (1624)
.+..++..+.+++.+||+.||++||+|+||+++|+++...+.
T Consensus 255 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 255 ------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 012355678899999999999999999999999999987654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=425.35 Aligned_cols=274 Identities=20% Similarity=0.287 Sum_probs=200.7
Q ss_pred CCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC----eeEEEEEe
Q 047591 1337 FSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG----FKALILQY 1412 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~----~~~lV~ey 1412 (1624)
|...+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+++++|||||+++|+|.+++ ..++||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 44557899999999999997 6889999998644321 122334555556789999999999997644 57899999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQG-----YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
|++|+|.+++++. .++|+++++++.|+|.||+|+|+. ..++||||||||+|||+|+++++||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 9999999999865 489999999999999999999962 247999999999999999999999999999998754
Q ss_pred CCCc---cccccccccccccccccCCC------CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC-Chh
Q 047591 1488 VDSM---KQTMTLATIGYMAPEYGSEG------IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL-PDA 1557 (1624)
Q Consensus 1488 ~~~~---~~~~~~gt~~y~APE~~~~~------~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~-~~~ 1557 (1624)
.... ......||++|||||++... .++.|+|||||||++|||+||+.|+.................. .+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 3321 22346799999999987653 3688999999999999999999887532221111111100000 011
Q ss_pred HHHHH-hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1558 VTDVI-DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1558 ~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..+.+ +..+...... ......++..+.+++.+||+.||++||||.||++.|+++...
T Consensus 241 ~~~~~~~~~~~p~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 241 MRKVVCEQKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTTSCCCCCCCG--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhccccCCCCCc--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 12221 1111111111 011123566788999999999999999999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=427.72 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=205.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCc----eEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGT----NAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~----~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~l 1408 (1624)
.+|...++||+|+||+||+|++. +|+ .||||.++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888899999999999999875 343 5888887543 334568899999999999999999999999764 5678
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
||||+.+|+|.+++......+++..+++|+.|||+||+|||+ .+||||||||+|||++.++++||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 999999999999999888889999999999999999999996 79999999999999999999999999999987543
Q ss_pred CCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1489 DSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1489 ~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
... ......||+.|||||++.++.++.++|||||||++|||+| |+.||+.....+ +...+....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------------~~~~i~~~~ 230 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------ISSILEKGE 230 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------------HHHHHHHTC
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHcCC
Confidence 322 2234568999999999999999999999999999999999 788886543221 111121111
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
... .+..++..+.+++.+||+.+|++||||+|+++.|+++..
T Consensus 231 ~~~-------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 RLP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCC-------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 100 112456678899999999999999999999999988754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=418.03 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=197.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-CCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-PGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||+||+|++ .|+.||||+++.. ...+.|.+|++++++++|||||+++|+|.+ ++..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3455678899999999999998 4788999998643 345789999999999999999999999865 46689999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1414 PQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
++|+|.+++++.+ ..++|+.+++|+.|||.||+|||+ .+||||||||+|||++.++++|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999997643 458999999999999999999996 79999999999999999999999999999875432
Q ss_pred ccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1493 QTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
.....+|+.|||||++.++.++.++|||||||++|||+| |+.|+......+ +..++... ....
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~~------------~~~~-- 220 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG------------YKMD-- 220 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTT------------CCCC--
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC------------CCCC--
Confidence 233468999999999998999999999999999999999 677765432221 11122111 0000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
.+..++..+.+++.+||+.||++||||.|++++|+++++.
T Consensus 221 -----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 221 -----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 0123456788999999999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=423.83 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=202.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 45778899999999999999885 68999999986432 334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC-
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD- 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~- 1489 (1624)
|||++|+|.+++...+ .+++..+..++.|++.||+|||+ .+||||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999987654 57889999999999999999996 799999999999999999999999999999875432
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ........ ... .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~------------~~~-~- 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIK------------LEY-D- 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHT------------TCC-C-
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HHHHHHHc------------CCC-C-
Confidence 22233467999999999999999999999999999999999999999753211 11111111 000 0
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. +..++..+.+++.+||+.||++|||++|+++.
T Consensus 229 ~-------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 F-------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C-------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C-------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0 01234567889999999999999999997653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-44 Score=429.90 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=208.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46888899999999999999875 68999999997666666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec--CCCcEEEeeecceeecCCCCCc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD--DDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld--~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++|+|.+++.+....+++..+..|+.||+.||+|||+ .+||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence 9999999997666679999999999999999999996 8999999999999996 46789999999999875432
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......||+.|||||++.+..++.++||||+||++|||+||+.||.+.... ..+... .........
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i------------~~~~~~~~~- 246 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNV------------KSCDWNMDD- 246 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH------------HHTCCCSCC-
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHH------------HhCCCCCCc-
Confidence 234467999999999999999999999999999999999999999753221 111111 111000000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....++..+.+++.+|++.||++|||++|+++.
T Consensus 247 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0012344567889999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-44 Score=420.85 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=199.1
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
.|+..+.||+|+||+||+|+.. +++.||||+++.. .....+.|.+|+++|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3777789999999999999875 6888999998643 33456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
||++|++..++... ..+++.++..|+.||+.||+|||+ .+||||||||+|||+++++++||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 99999997766543 468999999999999999999996 7999999999999999999999999999986543
Q ss_pred cccccccccccccccccC---CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccC
Q 047591 1492 KQTMTLATIGYMAPEYGS---EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLS 1568 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~---~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~ 1568 (1624)
.....||+.|||||++. .+.|+.++|||||||++|||+||+.||.+....+. +........+ ...
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~~---------~~~- 235 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESP---------ALQ- 235 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCC---------CCS-
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCC---------CCC-
Confidence 23457999999999875 35689999999999999999999999965322111 1111111100 000
Q ss_pred CchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1569 GEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1569 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
...++..+.+++.+||+.||++|||++|+++
T Consensus 236 ---------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0123456788999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=418.14 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=197.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC--C--ceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD--G--TNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~--~--~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...+.||+|+||+||+|++.. + ..||||+++.. .....++|.+|+++|++++|||||+++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 356667889999999999998742 2 36899988643 334567899999999999999999999999764 668
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+|||||++|++.+++..+...+++..+++++.|||+||+|||+ .+|+||||||+|||++.++++||+|||+|+....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999999988776779999999999999999999996 7999999999999999999999999999998754
Q ss_pred CCC--ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1488 VDS--MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1488 ~~~--~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+. ..++. ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~i~-----------~~ 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKID-----------KE 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHH-----------TS
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHHHH-----------hC
Confidence 332 12233468899999999999999999999999999999998 8999875422211 11111 11
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKI 1613 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i 1613 (1624)
.... ..+..++..+.+++.+||+.||++||||+|+++.|++.
T Consensus 231 ~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERL-------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0000 00123456788999999999999999999999988865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=424.77 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=188.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch-hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE-DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
+.|...+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999875 68899999986443 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec---CCCcEEEeeecceeecCCCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~kl~DFGla~~~~~~~ 1489 (1624)
|++|+|.+++.+. ..+++.+...|+.||+.||+|||+ .+||||||||+|||+. +++.+||+|||+|+......
T Consensus 89 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999764 458999999999999999999996 7999999999999994 57899999999998765332
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+. ....... .....
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~------------~~~~~ 229 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKA------------EYEFD 229 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHTT------------CCCCC
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHhcc------------CCCCC
Confidence 23345799999999999999999999999999999999999999975422111 1111110 00000
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......++..+.+++.+|++.||++|||++|+++.
T Consensus 230 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 -----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00112345668899999999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=413.89 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=205.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch------hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE------DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46788899999999999999885 68999999986432 123578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC----cEEEeeeccee
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM----VAHLGDFGIAK 1483 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~kl~DFGla~ 1483 (1624)
+|||||++|+|.+++.+.+ .+++.++..|+.|++.||+|||+ .+||||||||+|||++.++ .+|++|||+|+
T Consensus 90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence 9999999999999997654 58999999999999999999996 7999999999999999876 49999999999
Q ss_pred ecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||.+....+ .+........
T Consensus 166 ~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~--------- 233 (293)
T d1jksa_ 166 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNY--------- 233 (293)
T ss_dssp ECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCC---------
T ss_pred hcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCC---------
Confidence 875432 2334579999999999999999999999999999999999999997532211 1111111000
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.........++..+.+++.+||+.||++|||++|+++
T Consensus 234 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 --------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001122345667889999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=419.44 Aligned_cols=259 Identities=22% Similarity=0.369 Sum_probs=198.4
Q ss_pred HhCCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccC-
Q 047591 1333 ATNGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNP- 1403 (1624)
Q Consensus 1333 at~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~- 1403 (1624)
..++|...+.||+|+||+||+|++. +++.||||+++.. .....+.|.+|.+++.++ +|+|||++++++.++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3456777899999999999999864 2467999998643 334467788898888887 689999999988664
Q ss_pred CeeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEe
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLL 1468 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 1468 (1624)
+..++|||||++|+|.++++... ..+++.+++.|+.|||+||+|||+ .+||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeE
Confidence 46899999999999999997542 348899999999999999999996 799999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCC-CCCCCCCccchhh
Q 047591 1469 DDDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRR-KPTDDMFTGEVCL 1546 (1624)
Q Consensus 1469 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~-~P~~~~~~~~~~l 1546 (1624)
++++++||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+||. .||......+. +
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-H
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-H
Confidence 9999999999999987654332 2334567999999999999999999999999999999999975 46654322211 1
Q ss_pred hhhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 047591 1547 KHWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIK 1614 (1624)
Q Consensus 1547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~ 1614 (1624)
. ..+....... .+..+++++.+++.+||+.||++||||+|++++|+++.
T Consensus 247 ~------------~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 C------------RRLKEGTRMR-------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp H------------HHHHHTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H------------HHHhcCCCCC-------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 1111111000 01234567889999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=422.97 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=202.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC-Cc--eEEEEEeccc-hhhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD-GT--NAAIKIFSLQ-EDRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~-~~--~vAvK~~~~~-~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...++||+|+||+||+|++.+ |. .||||.++.. .....+.|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 345567899999999999998864 44 4778877533 334567899999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcE
Q 047591 1410 LQYMPQGSLEKWLYSH---------------NYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVA 1474 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 1474 (1624)
|||+++|+|.++++.. ...++|.++++++.|||+||+|||+ .+||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999753 3568999999999999999999996 799999999999999999999
Q ss_pred EEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCC-CCCCCCccchhhhhhhhhc
Q 047591 1475 HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRK-PTDDMFTGEVCLKHWVEES 1553 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~-P~~~~~~~~~~l~~~~~~~ 1553 (1624)
||+|||+|+..... .......||+.|+|||.+.++.++.++|||||||++|||+||.. ||.+....+ +...+.
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i~-- 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP-- 240 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGG--
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHHH--
Confidence 99999999865422 22234569999999999999999999999999999999999765 565432111 111111
Q ss_pred CChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1554 LPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1554 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..... ..+..++..+.+++.+||+.||++||||+||++.|+++...
T Consensus 241 ----------~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 ----------QGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ----------GTCCC-------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----------hcCCC-------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 00000 01123566788999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-44 Score=427.03 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=208.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 45778899999999999999874 68999999987665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec--CCCcEEEeeecceeecCCCCCc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD--DDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld--~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++|+|.+++...+..+++.+...|+.||+.||+|||+ .+||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 9999999887777779999999999999999999996 7999999999999998 67899999999999876432
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......||+.|||||++.+..++.++||||+||++|||+||+.||.+....+ .+........ ....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~------------~~~~- 249 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDW------------EFDE- 249 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCC------------CCCS-
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC------------CCCc-
Confidence 2344579999999999999999999999999999999999999997532211 1111111000 0000
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.....++..+.+++.+|++.||++|||++|+++
T Consensus 250 ----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 ----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001123456789999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=416.79 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=208.9
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCCee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPGFK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~~~ 1406 (1624)
++|...+.||+|+||+||+|++. +++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 45566789999999999999863 35679999997543 34556899999999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1407 ALILQYMPQGSLEKWLYSHN-----------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
++|||||++|+|.+++++.. ..+++..+.+|+.|||+||+|||+ .+||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999998542 258899999999999999999996 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKH 1548 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~ 1548 (1624)
.++.+|++|||+++....... .......||+.|||||++.++.++.++|||||||++|||+|++.|+.........+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~- 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY- 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH-
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence 999999999999998754332 233446799999999999999999999999999999999996555433222222222
Q ss_pred hhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1549 WVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1549 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
++++....... +..++..+.+|+.+||+.||++||||+|++++|+++..
T Consensus 259 -----------~~i~~~~~~~~-------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 -----------KMIKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp -----------HHHHHTCCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHhcCCCCCC-------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 22222211111 11245678899999999999999999999999987644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=418.69 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=208.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc------CCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA------DGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~------~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...+.||+|+||+||+|++. +++.||||+++.. .......|.+|++++++++|||||+++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 45666788999999999999873 3578999998643 3345568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEee
Q 047591 1408 LILQYMPQGSLEKWLYSHN---------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGD 1478 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~D 1478 (1624)
+|||||++|+|.++++... ..+++..+.+|+.|+|+||+|||+ .+|+||||||+|||+|+++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999987431 346899999999999999999996 7999999999999999999999999
Q ss_pred ecceeecCCCCC-ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCC-CCCCCCCccchhhhhhhhhcCCh
Q 047591 1479 FGIAKLLDGVDS-MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRR-KPTDDMFTGEVCLKHWVEESLPD 1556 (1624)
Q Consensus 1479 FGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~-~P~~~~~~~~~~l~~~~~~~~~~ 1556 (1624)
||+|+.+..... .......||+.|||||.+.++.++.++|||||||++|||+||+ .||.+.... ..+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-~~~---------- 245 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL---------- 245 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HHH----------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-HHH----------
Confidence 999987654332 2233446899999999999999999999999999999999985 556443211 111
Q ss_pred hHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 047591 1557 AVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTK 1616 (1624)
Q Consensus 1557 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~ 1616 (1624)
..+.+...... +..++..+.+++.+||+.+|++||||.||+++|++...+
T Consensus 246 --~~i~~~~~~~~--------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 246 --RFVMEGGLLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp --HHHHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred --HHHHhCCCCCC--------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11111111110 123556789999999999999999999999999876443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.7e-43 Score=406.08 Aligned_cols=258 Identities=21% Similarity=0.355 Sum_probs=201.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC----ee
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG----FK 1406 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~----~~ 1406 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||+++.. +....+.|.+|++++++++|||||++++++..++ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56888899999999999999874 6899999998643 2345678999999999999999999999987543 47
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecC
Q 047591 1407 ALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLD 1486 (1624)
Q Consensus 1407 ~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~ 1486 (1624)
|+|||||++|+|.+++...+ .+++.++..|+.||+.||+|||+ .+||||||||+|||++.++..+++|||.++...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 89999999999999887654 57899999999999999999996 799999999999999999999999999988664
Q ss_pred CCC--CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhh
Q 047591 1487 GVD--SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDA 1564 (1624)
Q Consensus 1487 ~~~--~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 1564 (1624)
... .......+||+.|||||++.+..++.++|||||||++|||+||+.||.+....+.. ...+....
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~~~~~~~---------- 231 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVREDP---------- 231 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHCCC----------
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH-HHHHhcCC----------
Confidence 322 12334467999999999999999999999999999999999999999753222111 11111100
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERM-NVKDALANLKKIK 1614 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-t~~evl~~L~~i~ 1614 (1624)
.. . ......++..+.+++.+|++.||++|| |++|+.+.|.+++
T Consensus 232 --~~-~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 --IP-P----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --CC-G----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --CC-C----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 0 000123456688999999999999999 8999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=412.38 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=203.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56888899999999999999874 68999999986432 334678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|||++|+|.+++.+.+ .++.+....++.||+.||+|||+ .+||||||||+|||+|+++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999998754 46778888899999999999996 899999999999999999999999999999764332
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+. ........ . .-
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~~~~------------~-~~- 224 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEE------------I-RF- 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC------------C-CC-
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHhcCC------------C-CC-
Confidence 233456899999999999999999999999999999999999999975422111 11111110 0 00
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
+..++.++.+++.+|++.||++||+ ++|+++
T Consensus 225 -------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1123456788999999999999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-42 Score=408.22 Aligned_cols=245 Identities=26% Similarity=0.317 Sum_probs=202.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 45777899999999999999874 6899999998643 2334678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
|||++|++..++.... .++++....++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999887644 56788888899999999999995 89999999999999999999999999999987532
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .... +......-
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~------------i~~~~~~~-- 220 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEK------------ILNAELRF-- 220 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH------------HHHCCCCC--
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHH------------HHcCCCCC--
Confidence 234679999999999999999999999999999999999999997532211 1111 11111000
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALAN 1609 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~~ 1609 (1624)
+..++..+.+++.+|++.||++|| |++|++++
T Consensus 221 -------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 -------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 012345678899999999999996 88888763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-42 Score=400.85 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=203.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---------hhHHHHHHHHHHHHHhcC-CCceeEEEeeeccC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---------DRALKSFDAECEVMRRIR-HRNLAKIVSSCSNP 1403 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---------~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~ 1403 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 56888899999999999999874 68899999985431 123457899999999997 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
+..++|||||++|+|.++++..+ .++++++..++.||++||+|||+ .+||||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999998654 57999999999999999999997 799999999999999999999999999999
Q ss_pred ecCCCCCccccccccccccccccccC------CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGS------EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA 1557 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~ 1557 (1624)
...... ..+...||+.|+|||++. ...++.++||||+||++|||+||+.||.+....+ .........
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~---- 231 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGN---- 231 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC----
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCC----
Confidence 875432 234467999999999764 3457889999999999999999999997642211 111111111
Q ss_pred HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
..... .....+++++.+++.+|++.+|++|||++||++.
T Consensus 232 --------~~~~~-----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 --------YQFGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --------CCCCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --------CCCCC-----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000 0112345678899999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=408.86 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=203.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEcC--------CceEEEEEeccch-hhHHHHHHHHHHHHHhc-CCCceeEEEeeeccCC
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFAD--------GTNAAIKIFSLQE-DRALKSFDAECEVMRRI-RHRNLAKIVSSCSNPG 1404 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~--------~~~vAvK~~~~~~-~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~~~ 1404 (1624)
++|...+.||+|+||+||+|+... +..||||+++... ....++|.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 356667889999999999998632 2469999986543 34567899999999988 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec
Q 047591 1405 FKALILQYMPQGSLEKWLYSHN---------------YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD 1469 (1624)
Q Consensus 1405 ~~~lV~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 1469 (1624)
..++|||||++|+|.++++... ..+++.++++++.|||.||+|||+ .+||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999997543 358999999999999999999996 7999999999999999
Q ss_pred CCCcEEEeeecceeecCCCCCc-cccccccccccccccccCCCCcCcccchHHHHHHHHHHHc-CCCCCCCCCccchhhh
Q 047591 1470 DDMVAHLGDFGIAKLLDGVDSM-KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLT-RRKPTDDMFTGEVCLK 1547 (1624)
Q Consensus 1470 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Ellt-g~~P~~~~~~~~~~l~ 1547 (1624)
.++.+||+|||+++........ ......||+.|||||++.++.|+.|+|||||||++|||+| |+.||.+..... +
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~- 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L- 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--H-
Confidence 9999999999999977543322 2334579999999999999999999999999999999998 677776532211 1
Q ss_pred hhhhhcCChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1548 HWVEESLPDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
.+.+....... .+..++..+.+++.+||+.||++|||+.||++.|+++..
T Consensus 247 -----------~~~i~~~~~~~-------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 -----------FKLLKEGHRMD-------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----------HHHHHTTCCCC-------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHcCCCCC-------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11111111100 012345678899999999999999999999999998854
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=399.04 Aligned_cols=198 Identities=28% Similarity=0.427 Sum_probs=166.3
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|...+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4577788999999999999999888999999987543 344789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|+|.+++......++|..+.+|+.|||+||+|||+. +|+||||||+|||+|+++.+||+|||+|+...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999999988777899999999999999999999984 5999999999999999999999999999987655444444
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPT 945 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~ 945 (1624)
...||+.|||||++..+.++.++|||||||++|||+|+..|+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~ 202 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC
Confidence 457999999999999999999999999999999999965554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=408.83 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=206.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
+.|...+.||+|+||+||+|+.. +++.||||+++.... ....+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 56777889999999999999885 688899999975433 3456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCC--CcEEEeeecceeecCCCCCc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDD--MVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~--~~~kl~DFGla~~~~~~~~~ 1491 (1624)
++|+|.+++.+.+..+++.+...|+.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+|+......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-- 158 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence 9999999998777678999999999999999999996 799999999999999854 589999999998775432
Q ss_pred cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCch
Q 047591 1492 KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGEE 1571 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~~ 1571 (1624)
......||+.|||||...+..|+.++||||+||++|||+||+.||......+ .+.. +.......
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~------------i~~~~~~~--- 222 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIEN------------IMNAEYTF--- 222 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH------------HHHTCCCC---
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHH------------HHhCCCCC---
Confidence 2334579999999999999999999999999999999999999997532211 1111 11111100
Q ss_pred HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1572 EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1572 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.......++..+.+++.+|++.||++|||++|+++
T Consensus 223 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112235567889999999999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=397.83 Aligned_cols=198 Identities=29% Similarity=0.401 Sum_probs=179.3
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
++|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999985 579999999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
++|+|.+++... .+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+....+... .
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-c
Confidence 999999988653 589999999999999999999984 5999999999999999999999999999987544332 3
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...+||+.|||||++.++.++.++||||+||++|||+||+.||..
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 345799999999999999999999999999999999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=407.94 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=196.8
Q ss_pred CCCCcC-CeEeecCceEEEEEEE-cCCceEEEEEeccchhhHHHHHHHHHHHHHhc-CCCceeEEEeeecc----CCeeE
Q 047591 1335 NGFSES-NLLGTGIFSSVYKATF-ADGTNAAIKIFSLQEDRALKSFDAECEVMRRI-RHRNLAKIVSSCSN----PGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~-~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l-~HpNIv~l~g~~~~----~~~~~ 1407 (1624)
++|... ++||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 456654 4699999999999987 46899999998632 4577899987665 89999999998864 45689
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC---CCcEEEeeeccee
Q 047591 1408 LILQYMPQGSLEKWLYSHN-YLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD---DMVAHLGDFGIAK 1483 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~kl~DFGla~ 1483 (1624)
+|||||++|+|.+++.+.+ ..+++.+...|+.||+.||+|||+ .+|+||||||+|||+++ ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 9999999999999998653 568999999999999999999996 89999999999999985 5679999999999
Q ss_pred ecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
...... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+...... ... +..
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~-~~~----------- 227 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPG-MKT----------- 227 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------
T ss_pred eccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHH-HHH-----------
Confidence 875433 23446799999999999999999999999999999999999999964321111 000 000
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.+..............++.++.+++.+|++.||++|||+.|+++
T Consensus 228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000000001122345677899999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-42 Score=411.45 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=196.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHH---HHHHHHHhcCCCceeEEEeeeccCCeeE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFD---AECEVMRRIRHRNLAKIVSSCSNPGFKA 1407 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~---~E~~~l~~l~HpNIv~l~g~~~~~~~~~ 1407 (1624)
++|...++||+|+||+||+|+.. +|+.||||++.... ......+. +|+++++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67888899999999999999875 68999999986332 12223344 4467777788999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCC
Q 047591 1408 LILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1408 lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~ 1487 (1624)
+|||||++|+|.+++.+.. .+++.++..|+.||+.||+|||+ .+||||||||+|||+++++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999997653 56888899999999999999996 8999999999999999999999999999997754
Q ss_pred CCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhc
Q 047591 1488 VDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANL 1566 (1624)
Q Consensus 1488 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l 1566 (1624)
. ......||+.|||||++.. ..|+.++|||||||++|||+||+.||......... ........ ...
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~--------~~~ 226 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT--------MAV 226 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSS--------CCC
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccc--------CCC
Confidence 3 2334579999999998864 56899999999999999999999999754322111 00000000 000
Q ss_pred cCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047591 1567 LSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMN-----VKDALA 1608 (1624)
Q Consensus 1567 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~evl~ 1608 (1624)
. .+..+++.+.+++.+|++.||++||| ++|+++
T Consensus 227 -~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 -E--------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -C--------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -C--------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 00123456788999999999999999 577764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-42 Score=408.45 Aligned_cols=244 Identities=21% Similarity=0.250 Sum_probs=203.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccch---hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQE---DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~---~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46788899999999999999875 68999999986432 234578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDS 1490 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~ 1490 (1624)
||+++|+|.+++.+.+ .+++.+...|+.||+.||+|||+ .+||||||||+|||++.++++||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999997654 57889999999999999999996 79999999999999999999999999999987532
Q ss_pred ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCCc
Q 047591 1491 MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSGE 1570 (1624)
Q Consensus 1491 ~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~~ 1570 (1624)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+.... ..... +...... .
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~------------i~~~~~~-~- 257 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEK------------IVSGKVR-F- 257 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH------------HHHCCCC-C-
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHH------------HhcCCCC-C-
Confidence 23467999999999999999999999999999999999999999753211 11111 1111100 0
Q ss_pred hHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1571 EEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1571 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
+..++..+.+++.+|++.||++|+ |++|+++
T Consensus 258 -------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 -------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 012445678899999999999994 8999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-42 Score=395.74 Aligned_cols=200 Identities=28% Similarity=0.462 Sum_probs=169.5
Q ss_pred cCCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367888899999999999999864 469999986542 3456789999999999999999999999865 45799999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC-
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS- 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~- 899 (1624)
||++|+|.++++..+..+++.++.+|+.|||+||+|||+. +||||||||+|||+|+++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999999987777899999999999999999999984 599999999999999999999999999987654322
Q ss_pred cccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 900 VTQTMTLATFGYMAPEYGSE---GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~---~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.......||+.|||||++.. +.++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 22334579999999998753 45899999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-42 Score=402.16 Aligned_cols=212 Identities=25% Similarity=0.449 Sum_probs=169.6
Q ss_pred cCHHHHHhhcCCC---------CCcceeecCCccceEEEEec-CC---CEEEEEEeeccc-chhHHHHHHHHHHHHhcCC
Q 047591 734 ISYQELQRLTDGF---------SESNLIGAGSFGSVYKATLP-YG---MNVAIKVFNLQL-DGAIKSFDAECEVLRRVRH 799 (1624)
Q Consensus 734 ~~~~el~~~t~~f---------~~~~~iG~G~~G~Vy~~~~~-~g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H 799 (1624)
++|++..+++.+| +..++||+|+||+||+|++. +| ..||||++.... ....+.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555555655444 44578999999999999874 23 368999886543 3455789999999999999
Q ss_pred CceeeeeeeeccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC
Q 047591 800 RNLVKIISSCSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD 879 (1624)
Q Consensus 800 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~ 879 (1624)
||||+++|+|.+++..++|||||++|+|.+++......++|.++..|+.|||+||+|||+. +||||||||+|||+|+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECC
Confidence 9999999999999999999999999999999988777899999999999999999999984 5999999999999999
Q ss_pred CCceEEEeeeeeeccCCCCCcc----cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 880 DTVAHLSDFGISKLLDGEDSVT----QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 880 ~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
++++||+|||+|+......... .....||+.|||||++..+.++.++|||||||++|||+| |+.||...
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 9999999999999875433221 122358999999999998999999999999999999998 89998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=403.96 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=200.7
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc---hhhHHHHHHHHHHHHH-hcCCCceeEEEeeeccCCeeEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ---EDRALKSFDAECEVMR-RIRHRNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~---~~~~~~~f~~E~~~l~-~l~HpNIv~l~g~~~~~~~~~lV 1409 (1624)
++|...+.||+|+||+||+|+.. +++.||||+++.. .+...+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888899999999999999885 6889999999643 2334566777777765 68999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCC
Q 047591 1410 LQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1410 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~ 1489 (1624)
||||++|+|.++++..+ .++..+...++.||+.||+|||+ .+||||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999997654 46888899999999999999996 799999999999999999999999999998764332
Q ss_pred CccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHhhhccCC
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVIDANLLSG 1569 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~l~~~ 1569 (1624)
...+...||+.|||||++.+..++.++|||||||++|||+||+.||.+...... ... +..... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~------------i~~~~~-~- 221 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHS------------IRMDNP-F- 221 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHHCCC-C-
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHH------------HHcCCC-C-
Confidence 334456799999999999999999999999999999999999999975422111 110 000000 0
Q ss_pred chHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 047591 1570 EEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVK-DALA 1608 (1624)
Q Consensus 1570 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~-evl~ 1608 (1624)
.+..++..+.+++.+|++.||++|||+. |+++
T Consensus 222 -------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0012445678999999999999999985 6653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=395.78 Aligned_cols=203 Identities=23% Similarity=0.356 Sum_probs=174.8
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35788899999999999999986 4799999999975432 334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC-
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS- 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~- 899 (1624)
||++|+|.+++... ..+++.++..|+.|+++||+|||+. +||||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999654 4789999999999999999999984 599999999999999999999999999997654322
Q ss_pred cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
...+..+||+.|||||++....+ +.++||||+||++|||+||+.||....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 22344579999999999877665 678999999999999999999997543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=399.75 Aligned_cols=263 Identities=24% Similarity=0.259 Sum_probs=193.3
Q ss_pred CCeEeecCceEEEEEEEc-CCceEEEEEeccchh-----hHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEec
Q 047591 1340 SNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED-----RALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQYM 1413 (1624)
Q Consensus 1340 ~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~-----~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey~ 1413 (1624)
.++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999875 689999999864322 22357899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCccc
Q 047591 1414 PQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMKQ 1493 (1624)
Q Consensus 1414 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 1493 (1624)
++|++..+. ..+..+++.++..++.||+.||+|||+ .+||||||||+|||+++++.+||+|||+|+...... ...
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAY 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCC
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc-ccc
Confidence 987766544 445567888899999999999999996 899999999999999999999999999998765432 223
Q ss_pred cccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-------cCChhHHHHHhhh
Q 047591 1494 TMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-------SLPDAVTDVIDAN 1565 (1624)
Q Consensus 1494 ~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-------~~~~~~~~~~d~~ 1565 (1624)
...+||+.|||||++.. ..|+.++|||||||++|||+||+.||......+. +....+. ..++.........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccchhhh
Confidence 34579999999998754 5689999999999999999999999865322111 1111100 0000000000000
Q ss_pred ccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1566 LLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1566 l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.................+.+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000000011123467889999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=398.40 Aligned_cols=271 Identities=21% Similarity=0.262 Sum_probs=201.0
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
++|...+.||+|+||+||+|+. .+|+.||||+++... +...+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788889999999999999987 468999999986443 2335789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+.++.+..........+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 998654444434455678999999999999999999996 789999999999999999999999999998775332 2
Q ss_pred cccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh--HHHHHh-hhcc
Q 047591 1492 KQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA--VTDVID-ANLL 1567 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~--~~~~~d-~~l~ 1567 (1624)
......||+.|+|||..... .++.++||||+||++|||+||+.||.+....+.....+.....++. ...... ....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 33445799999999976554 4589999999999999999999999754322111110000000000 000000 0000
Q ss_pred ----CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1568 ----SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1568 ----~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.................+.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000011112344678899999999999999999999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.4e-41 Score=400.73 Aligned_cols=297 Identities=28% Similarity=0.471 Sum_probs=228.8
Q ss_pred cCChhhHHHHHHHHHHhccCCccccccCCCCCCCCCCCCCCCCcc--ceeeEecCCC--CcEEEEecCCCCCCc--cCCc
Q 047591 34 ANITTDEAALLQVKAHIALDPQNFFERNWNLSATTNTSSSNSVCN--WVGVTCGSRH--GRVTDLSIPNLGLGG--TIPP 107 (1624)
Q Consensus 34 ~~~~~d~~aLl~~k~~~~~~p~~~~~~~W~~~~~~~~~~~~~~C~--W~Gv~C~~~~--~~v~~l~l~~~~l~g--~ip~ 107 (1624)
.|+++|++||++||++++ ||. .+ ++|+. ++|||. |+||+|++.+ +||+.|+|+++++.| +||+
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~~-~l-~sW~~--------~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~ 70 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NPT-TL-SSWLP--------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS 70 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GG-TTCCT--------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG
T ss_pred CCCHHHHHHHHHHHHHCC-CCC-cC-CCCCC--------CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh
Confidence 489999999999999996 554 33 57863 458994 9999998754 499999999999998 6899
Q ss_pred cccCCCcccEEEecC-CCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCC
Q 047591 108 HVANLSFLVSLNISG-NRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCS 186 (1624)
Q Consensus 108 ~i~~L~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 186 (1624)
+|++|++|++|+|++ |+++|.+|++|++|++|++|||++|+|++.. +..+..+..|+.+++++|++.+.+|.++++++
T Consensus 71 ~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~-~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~ 149 (313)
T d1ogqa_ 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI-PDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEEC-CGGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred HHhcCccccccccccccccccccccccccccccchhhhccccccccc-cccccchhhhcccccccccccccCchhhccCc
Confidence 999999999999997 8999999999999999999999999998744 44557788899999999998888888898888
Q ss_pred cccccccccccccccccCcccccccc-cceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEee
Q 047591 187 KLKRLSVSFNELTGRIPQNIGNLTEL-MELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELN 265 (1624)
Q Consensus 187 ~L~~L~Ls~N~l~g~ip~~~~~l~~L-~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~ 265 (1624)
+|+.+++++|.++|.+|..++.+.++ +.+++++|+++|..|..+.++..+ .+++++|.+.
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~------------------ 210 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE------------------ 210 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE------------------
T ss_pred ccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc------------------
Confidence 89999999998888888888888776 678888888887777766655433 3555555554
Q ss_pred cccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEE
Q 047591 266 LRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRL 345 (1624)
Q Consensus 266 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L 345 (1624)
|.+|..++.+++|+.|++++|. ++|.+| .+..+++|++|+|++|+|+|.+|+.++ ++++|++|
T Consensus 211 -------~~~~~~~~~~~~l~~l~~~~~~--------l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~-~L~~L~~L 273 (313)
T d1ogqa_ 211 -------GDASVLFGSDKNTQKIHLAKNS--------LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSL 273 (313)
T ss_dssp -------ECCGGGCCTTSCCSEEECCSSE--------ECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG-GCTTCCEE
T ss_pred -------cccccccccccccccccccccc--------cccccc-ccccccccccccCccCeecccCChHHh-CCCCCCEE
Confidence 4445555555555555554433 233333 345556666666777777777777665 67788888
Q ss_pred EecCCccCCcCcccccCCCCCcEEecCCcc-cccc
Q 047591 346 YLWGNNLSGVIPSSICNASKLTVLELSRNL-FSGL 379 (1624)
Q Consensus 346 ~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~-l~g~ 379 (1624)
+|++|+|+|.+|. ++++++|+.+++++|+ ++|.
T Consensus 274 ~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 274 NVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp ECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred ECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 8888888887774 5777888888888886 6665
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=386.21 Aligned_cols=197 Identities=28% Similarity=0.433 Sum_probs=176.7
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999874 68999999986432 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|||++|+|.+++.... .+++.++..|+.||++||+|||+. +||||||||+|||+++++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999997654 689999999999999999999984 59999999999999999999999999998765432
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 2345799999999999998999999999999999999999999964
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=392.35 Aligned_cols=199 Identities=26% Similarity=0.444 Sum_probs=174.5
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|+|.+ +..++|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5677788999999999999999888999999997543 345789999999999999999999998865 45699999999
Q ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 824 QGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 824 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
+|+|.+++.... ..++|.++++|+.|||+||+|||+. +|+||||||+|||+|+++.+||+|||+|+..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 999999875433 3589999999999999999999984 599999999999999999999999999998865544444
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....||+.|||||++..+.++.++|||||||++|||+||..|+..
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 556799999999999888999999999999999999997666543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=393.84 Aligned_cols=201 Identities=27% Similarity=0.385 Sum_probs=178.2
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
+.|+..+.||+|+||+||+|+. .+|+.||||+++.......+.|.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4678889999999999999986 468999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
++|+|.+++.+....+++.++..|+.||++||+|||+. +||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 99999999877666799999999999999999999984 599999999999999999999999999986543211 22
Q ss_pred ccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 903 TMTLATFGYMAPEYG-----SEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~-----~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
....||+.|||||++ ....++.++|||||||++|||+||+.||...
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 345799999999986 3556899999999999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-41 Score=394.86 Aligned_cols=200 Identities=27% Similarity=0.476 Sum_probs=178.3
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|...+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356777889999999999999875 58999999987543 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 822 MPQGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 822 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|++|+|.+++... ...+++..+..|+.|||+||+|||+. +||||||||+|||+|+++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999764 34789999999999999999999984 5999999999999999999999999999987665554
Q ss_pred ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 047591 901 TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTD 946 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~ 946 (1624)
......||+.|||||++.++.++.++|||||||++|||+||+.|+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 4455568999999999998999999999999999999999887764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=389.71 Aligned_cols=203 Identities=25% Similarity=0.386 Sum_probs=165.0
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc--CCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN--HGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 818 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||++.... +...+.|.+|+++|++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788899999999999999986 479999999987543 2345678999999999999999999999864 4568999
Q ss_pred EEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 819 LEYMPQGSLEKWLYSH---KYTLNIQQRLDIMIDVASALEYLHHGH--PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
||||++|+|.+++... ...+++.+++.|+.|++.||+|||+.+ ..+||||||||+|||+++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 346999999999999999999999853 23599999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....... .....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 7654332 2345799999999999999999999999999999999999999965
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=381.97 Aligned_cols=201 Identities=28% Similarity=0.451 Sum_probs=182.6
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|...+.||+|+||+||+|+++++++||||+++.... ..++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999998888999999975433 34689999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcccc
Q 047591 824 QGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQT 903 (1624)
Q Consensus 824 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 903 (1624)
+|+|.+++......+++..+.+|+.|+|+||+|||+ .+|+||||||+|||+|+++.+||+|||+|+...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999999988777789999999999999999999998 45999999999999999999999999999987655544444
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 904 MTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 904 ~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
...||+.|||||.+....++.|+|||||||++|||+| |+.||...
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 5679999999999998999999999999999999998 79998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-41 Score=388.66 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=175.3
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688899999999999999986 479999999997432 334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|||++|+|.+++...+ .+++.++..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999987654 689999999999999999999994 599999999999999999999999999998754332
Q ss_pred c-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 V-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 2 23345799999999999988999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=389.35 Aligned_cols=240 Identities=22% Similarity=0.267 Sum_probs=194.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchh------hHHHHHHHHHHHHHhcC--CCceeEEEeeeccCCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQED------RALKSFDAECEVMRRIR--HRNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~------~~~~~f~~E~~~l~~l~--HpNIv~l~g~~~~~~~ 1405 (1624)
+.|...++||+|+||+||+|+.. +|+.||||+++.... ...+++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46788899999999999999875 689999999864321 12345778999999997 9999999999999999
Q ss_pred eEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-CCcEEEeeeccee
Q 047591 1406 KALILQYMPQ-GSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-DMVAHLGDFGIAK 1483 (1624)
Q Consensus 1406 ~~lV~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~kl~DFGla~ 1483 (1624)
.++||||+.+ +++.+++... ..++++++..++.||++||+|||+ .+||||||||+|||++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 6788887654 457899999999999999999996 89999999999999985 4799999999998
Q ss_pred ecCCCCCccccccccccccccccccCCCCc-CcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHH
Q 047591 1484 LLDGVDSMKQTMTLATIGYMAPEYGSEGIV-STSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVI 1562 (1624)
Q Consensus 1484 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1562 (1624)
..... ..+...||+.|||||++.+..+ +.++||||+||++|||+||+.||.... . +.
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~---------------i~ 217 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E---------------II 217 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H---------------HH
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----H---------------Hh
Confidence 76432 2345679999999998876654 678999999999999999999986420 0 00
Q ss_pred hhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1563 DANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1563 d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
.....- +..++.++.+++.+|++.||++|||++|+++.
T Consensus 218 ~~~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 RGQVFF---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hcccCC---------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000000 01234567889999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=382.54 Aligned_cols=195 Identities=28% Similarity=0.426 Sum_probs=167.7
Q ss_pred CcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc----CCeEEEEEE
Q 047591 748 ESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN----HGFKALILE 820 (1624)
Q Consensus 748 ~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~E 820 (1624)
..+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|||||++++++.+ +...|+|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 3467999999999999864 68999999987543 3345679999999999999999999999864 356799999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC-CCCceEEEeeeeeeccCCCCC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD-DDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||++|+|.+++.... .+++.++..|+.||++||+|||+.. ++||||||||+|||++ +++.+||+|||+|+......
T Consensus 93 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~- 169 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF- 169 (270)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-
T ss_pred CCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc-
Confidence 999999999997654 6899999999999999999999854 4599999999999996 57899999999998754332
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+.
T Consensus 170 --~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 170 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred --cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 234579999999998865 5899999999999999999999999653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=400.82 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=177.4
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
..|+|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+++..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999986 4789999999976533 34567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|||++|+|.+++.+.+ .+++..+..++.|+++||+|||+.+ +||||||||+|||+++++.+||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 9999999999997654 6899999999999999999999732 49999999999999999999999999998764321
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2345799999999999999999999999999999999999999965
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=386.83 Aligned_cols=201 Identities=27% Similarity=0.474 Sum_probs=174.0
Q ss_pred CCCCCcce-eecCCccceEEEEec---CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNL-IGAGSFGSVYKATLP---YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~-iG~G~~G~Vy~~~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+. ||+|+||+||+|.+. ++..||||+++.... ...++|.+|+++|++++|||||+++|+|.++ ..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 44555564 999999999999763 356899999975443 3467899999999999999999999999754 57999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
||||++|+|.+++...+..+++.++.+|+.|||+||+|||+. +||||||||+|||+++++.+||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999987767899999999999999999999984 59999999999999999999999999999876543
Q ss_pred Ccc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SVT--QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
... .....||+.|||||++..+.++.++|||||||++|||+| |+.||...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 322 233468999999999988899999999999999999998 89999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=385.77 Aligned_cols=201 Identities=28% Similarity=0.452 Sum_probs=168.1
Q ss_pred CCCCCcceeecCCccceEEEEecCC-----CEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYG-----MNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g-----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
+.|+..++||+|+||+||+|.++.. ..||||++..... ...++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987532 4799999975433 345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
|||||.+|++.+++......++|.++.+|+.|||.||+|||+. +||||||||+|||+|.++.+||+|||+|+.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999999988777899999999999999999999984 5999999999999999999999999999987543
Q ss_pred CCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 898 DSV--TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 898 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
... ......||+.|||||++..+.++.++|||||||++|||+||+.|+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 222 22334689999999999999999999999999999999998776543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=391.50 Aligned_cols=269 Identities=23% Similarity=0.295 Sum_probs=198.6
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-C-CceEEEEEeccch--hhHHHHHHHHHHHHHhc---CCCceeEEEeeecc----
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-D-GTNAAIKIFSLQE--DRALKSFDAECEVMRRI---RHRNLAKIVSSCSN---- 1402 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~-~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l---~HpNIv~l~g~~~~---- 1402 (1624)
.++|...+.||+|+||+||+|+.. + ++.||||+++... +.....+.+|+++++.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 457888899999999999999874 4 5679999986432 22334567788887766 79999999998852
Q ss_pred -CCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecc
Q 047591 1403 -PGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGI 1481 (1624)
Q Consensus 1403 -~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGl 1481 (1624)
....++||||+++|++..........++++....|+.|++.||+|||+ .+||||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 346799999999988876666666778999999999999999999996 7999999999999999999999999999
Q ss_pred eeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh-------cC
Q 047591 1482 AKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE-------SL 1554 (1624)
Q Consensus 1482 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~-------~~ 1554 (1624)
++..... .......||+.|||||++.+..|+.++||||+||++|||+||+.||......+ .+...... ..
T Consensus 163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGS
T ss_pred hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchhcc
Confidence 9865432 23345689999999999999999999999999999999999999997542211 11111110 00
Q ss_pred ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
+.... ........................+.+++.+|++.||++|||++|+++.
T Consensus 240 ~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCS-SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccc-chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000000000000011234567889999999999999999999764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-40 Score=386.53 Aligned_cols=269 Identities=20% Similarity=0.247 Sum_probs=199.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEcCCceEEEEEeccch--hhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE--DRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~--~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|+..+|+.||||+++... +...++|.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5677888999999999999999999999999986542 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCcc
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSMK 1492 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~~ 1492 (1624)
+.++.+..+. .....++..++..|+.||+.||+|||+ .+||||||||+|||++.++.+|++|||.|....... ..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 9876665554 445678999999999999999999996 799999999999999999999999999998765332 23
Q ss_pred ccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcC--ChhHHHHHh-----h
Q 047591 1493 QTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESL--PDAVTDVID-----A 1564 (1624)
Q Consensus 1493 ~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~--~~~~~~~~d-----~ 1564 (1624)
.....||+.|+|||.+.. ..++.++||||+||++|||++|+.||.+....+.....+..... .....+... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 344579999999998754 56799999999999999999999999764322211111100000 000000000 0
Q ss_pred hccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
....................+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000001123456789999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-40 Score=389.45 Aligned_cols=200 Identities=27% Similarity=0.398 Sum_probs=161.4
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
..+.|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567889999999999999999864 68999999997543 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC---CCCceEEEeeeeeeccCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~~kl~DFGla~~~~~ 896 (1624)
|||++|+|.+++...+ .+++.++..|+.|++.||+|||+. +||||||||+|||++ +++.+||+|||+|+....
T Consensus 87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999997644 799999999999999999999984 599999999999994 578999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
... ....+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 163 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 163 GSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 322 2335799999999999999999999999999999999999999965
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=386.93 Aligned_cols=199 Identities=26% Similarity=0.377 Sum_probs=178.2
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688999999999999999986 579999999997542 334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|||++|+|.+++...+ .+++..+..++.|++.||+|||+. +||||||||+|||+|+++.+||+|||+|+.......
T Consensus 85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 9999999999998654 688899999999999999999994 599999999999999999999999999997654332
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence 23345799999999999999999999999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-39 Score=381.04 Aligned_cols=261 Identities=16% Similarity=0.201 Sum_probs=200.6
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEE-eeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIV-SSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~-g~~~~~~~~~lV~ey 1412 (1624)
+.|...+.||+|+||+||+|++. +|+.||||++..... .+++.+|++++++++|+|+|..+ ++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 45788899999999999999874 688999998864432 24578999999999888766555 455677888999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEec---CCCcEEEeeecceeecCCCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLD---DDMVAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~kl~DFGla~~~~~~~ 1489 (1624)
+ +|++.+.+......+++..+..++.|++.||+|||+ .+||||||||+|||++ .+..+||+|||+|+.+....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 567777777666779999999999999999999996 7999999999999976 45579999999999875433
Q ss_pred Cc------cccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1490 SM------KQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1490 ~~------~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
.. ......||+.|||||...+..++.++|||||||++|||+||+.||............ .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~----------~~~~~ 230 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----------ERISE 230 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H----------HHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH----------HHhhc
Confidence 21 223457999999999999999999999999999999999999999754322211100 00000
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKT 1615 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~ 1615 (1624)
..+... .......+++++.+++.+||+.+|++||+++++.+.|+.+..
T Consensus 231 ~~~~~~----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 KKMSTP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHSC----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCC----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000000 001112456778999999999999999999999998887644
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-40 Score=378.47 Aligned_cols=194 Identities=29% Similarity=0.459 Sum_probs=166.0
Q ss_pred ceeecCCccceEEEEec---CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecCC
Q 047591 750 NLIGAGSFGSVYKATLP---YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMPQ 824 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 824 (1624)
+.||+|+||+||+|.++ .++.||||+++... ....++|.+|+++|++++|||||+++|+|.++ ..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999864 35689999986433 23456899999999999999999999999754 56899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc--c
Q 047591 825 GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT--Q 902 (1624)
Q Consensus 825 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~--~ 902 (1624)
|+|.++++... .+++.++.+|+.|||+||+|||+. +||||||||+|||++.++.+||+|||+|+......... .
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999998654 689999999999999999999984 59999999999999999999999999999876543322 2
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
....||+.|||||.+..+.++.++|||||||++|||+| |+.||...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 23469999999999988899999999999999999998 89998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.6e-40 Score=390.05 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=179.8
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46788999999999999999986 47999999999766555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC--CCCceEEEeeeeeeccCCCCC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD--DDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|++|+|.+++......+++.++..|+.||+.||+|||+. +||||||||+|||++ .++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999999999976666799999999999999999999994 599999999999996 467899999999998754432
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 3345799999999999988999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-39 Score=382.80 Aligned_cols=196 Identities=28% Similarity=0.375 Sum_probs=176.1
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688889999999999999986 569999999997432 234578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|||++|+|.+++.... .+++..+..++.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999887654 678888889999999999999984 5999999999999999999999999999987543
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....+||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 2235799999999999998999999999999999999999999965
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-39 Score=388.33 Aligned_cols=200 Identities=21% Similarity=0.365 Sum_probs=180.3
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
.+.|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46788999999999999999986 57999999999866555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC--CCCceEEEeeeeeeccCCCCC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD--DDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~~~kl~DFGla~~~~~~~~ 899 (1624)
|++|+|.+++......+++.++..|+.||+.||+|||+. +||||||||+|||++ .++.+||+|||+|+.......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 999999998877666799999999999999999999984 599999999999998 578999999999998765432
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 3345799999999999999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=387.45 Aligned_cols=202 Identities=28% Similarity=0.479 Sum_probs=172.5
Q ss_pred CCCCCcceeecCCccceEEEEecC-C-----CEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPY-G-----MNVAIKVFNLQL-DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~-g-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 815 (1624)
++|...+.||+|+||+||+|++.. + ..||||++.... ......|.+|+.+|+++ +|||||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 567788999999999999998642 2 369999986443 33456799999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCC
Q 047591 816 ALILEYMPQGSLEKWLYSHK----------------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPS 873 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~ 873 (1624)
|+|||||++|+|.++|+... ..+++.+++.|+.|||+||+|||+. +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 99999999999999997643 2478999999999999999999984 5999999999
Q ss_pred CeeeCCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 874 NVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 874 NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999876544332 2334568999999999999999999999999999999998 89998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-39 Score=382.94 Aligned_cols=194 Identities=29% Similarity=0.347 Sum_probs=171.3
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 478889999999999999985 578999999987543 2345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
||++|+|..++... ..+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999998776554 4799999999999999999999994 5999999999999999999999999999875432
Q ss_pred ccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGS---EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~---~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....||+.|||||++. .+.++.++|||||||++|||+||+.||..
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 2347999999999874 35689999999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-39 Score=375.33 Aligned_cols=263 Identities=14% Similarity=0.139 Sum_probs=208.4
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCC-CceeEEEeeeccCCeeEEEEEe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRH-RNLAKIVSSCSNPGFKALILQY 1412 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~H-pNIv~l~g~~~~~~~~~lV~ey 1412 (1624)
++|...+.||+|+||+||+|++. +|+.||||++....+ .+.+.+|+++++.++| +|++++++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 46778899999999999999875 688999998854332 3457789999999976 8999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecC-----CCcEEEeeecceeecCC
Q 047591 1413 MPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDD-----DMVAHLGDFGIAKLLDG 1487 (1624)
Q Consensus 1413 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-----~~~~kl~DFGla~~~~~ 1487 (1624)
+ +|+|.+++...+..+++.++..++.|++.||+|||+ .+||||||||+|||++. ++.+||+|||+|+....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 689999998877789999999999999999999995 89999999999999974 57899999999998753
Q ss_pred CCC------ccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHH
Q 047591 1488 VDS------MKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDV 1561 (1624)
Q Consensus 1488 ~~~------~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~ 1561 (1624)
... ......+||+.|||||.+.+..++.++|||||||++|||+||+.||............ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~----------~~i 228 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------ERI 228 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH----------HHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH----------HHH
Confidence 321 1223457999999999999999999999999999999999999999754322111100 000
Q ss_pred HhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 047591 1562 IDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALANLKKIKTKF 1617 (1624)
Q Consensus 1562 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~L~~i~~~~ 1617 (1624)
.+....... ......+++++.+++..|++.+|++||+++.+.+.|+++..+.
T Consensus 229 ~~~~~~~~~----~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 229 GEKKQSTPL----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHSCH----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhccCCCCh----HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 000000000 0011235677899999999999999999999998888875543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-40 Score=379.13 Aligned_cols=199 Identities=27% Similarity=0.448 Sum_probs=167.4
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEecC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYMP 823 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 823 (1624)
++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4678889999999999999999888899999997543 345789999999999999999999999965 45799999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 824 QGSLEKWLYSH-KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 824 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
+|+|.+++... ...++|.++..|+.|||+||+|||+. +|+||||||+|||+|+++++||+|||+|+..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999988754 34689999999999999999999984 599999999999999999999999999998765444444
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....||+.|+|||++..+.++.++|||||||++|||+||+.|+..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 456799999999999999999999999999999999998777543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-39 Score=379.30 Aligned_cols=270 Identities=20% Similarity=0.263 Sum_probs=195.1
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc--------C
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN--------P 1403 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~--------~ 1403 (1624)
++|...+.||+|+||+||+|+.. +|+.||||++... .+...+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 46777889999999999999874 7899999998644 23446789999999999999999999998754 3
Q ss_pred CeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1404 GFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1404 ~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
+..++||||++++.+..+ ......++...+..|+.||+.||+|||+ .+||||||||+|||+++++.+||+|||+|+
T Consensus 90 ~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence 457899999988766543 3445567888889999999999999996 799999999999999999999999999998
Q ss_pred ecCCCCC---ccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhh--hhcCChh
Q 047591 1484 LLDGVDS---MKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWV--EESLPDA 1557 (1624)
Q Consensus 1484 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~--~~~~~~~ 1557 (1624)
....... ......+||+.|+|||.+.+ ..++.++||||+||++|||+||+.||.+....+. +.... ....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCCChh
Confidence 7653221 12223579999999998765 4689999999999999999999999975422111 11100 0000000
Q ss_pred ---------HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 ---------VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 ---------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+......................+.+++.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000100000000011111122334567889999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-39 Score=374.08 Aligned_cols=199 Identities=23% Similarity=0.368 Sum_probs=176.9
Q ss_pred cCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc------hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD------GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 815 (1624)
.+.|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|+++|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46788999999999999999986 5799999999864321 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC----ceEEEeeeee
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT----VAHLSDFGIS 891 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~~kl~DFGla 891 (1624)
|+|||||++|+|.+++...+ .+++.++..|+.|++.||+|||+. +|+||||||+|||++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999997654 699999999999999999999984 599999999999999876 4999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... .....||+.|||||++....++.++|||||||++|||+||+.||..
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 98754332 2345799999999999988999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=382.38 Aligned_cols=269 Identities=22% Similarity=0.231 Sum_probs=197.0
Q ss_pred CCCCcCCeEeecCceEEEEEEE-cCCceEEEEEeccc-hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC----eeEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATF-ADGTNAAIKIFSLQ-EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG----FKAL 1408 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~-~~~~~vAvK~~~~~-~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~----~~~l 1408 (1624)
+.|...+.||+|+||+||+|+. .+|+.||||+++.. .....+++.+|+++|++++|||||++++++..+. ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4577788999999999999986 47899999998643 3445678999999999999999999999986543 3456
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCC
Q 047591 1409 ILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGV 1488 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~ 1488 (1624)
+++|+.+|+|.+++... .+++.....++.|++.||+|||+ .+||||||||+|||+++++.+||+|||+|+.....
T Consensus 88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 66778899999999764 47899999999999999999996 79999999999999999999999999999876433
Q ss_pred CC--cccccccccccccccccc-CCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChh--------
Q 047591 1489 DS--MKQTMTLATIGYMAPEYG-SEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDA-------- 1557 (1624)
Q Consensus 1489 ~~--~~~~~~~gt~~y~APE~~-~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~-------- 1557 (1624)
.. ......+||+.|+|||.+ ....++.++||||+||++|||+||+.||......+...........+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 123346799999999987 4456799999999999999999999999754322111110000000100
Q ss_pred --HHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1558 --VTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1558 --~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
............... ..........++.+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCC-HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCC-HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 000111234568899999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=372.49 Aligned_cols=201 Identities=25% Similarity=0.406 Sum_probs=163.4
Q ss_pred CCCCCcceeecCCccceEEEEecC----CCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||+||+|++.. +..||||+++... ....+.|.+|++++++++|||||+++|+|.+ +..|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 567788999999999999998642 4568999886543 3345679999999999999999999999964 568999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
|||+++|+|.+++......+++.++..++.||++||+|||+. +||||||||+||++++++.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999887777899999999999999999999994 59999999999999999999999999999876554
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
....+...||+.|||||++..+.++.++|||||||++|||+| |+.||...
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 444455678999999999998999999999999999999998 88898754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-39 Score=379.33 Aligned_cols=209 Identities=26% Similarity=0.424 Sum_probs=178.6
Q ss_pred HHHHHhhcCCCCCcceeecCCccceEEEEec------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCceeeeeee
Q 047591 736 YQELQRLTDGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRVRHRNLVKIISS 808 (1624)
Q Consensus 736 ~~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~ 808 (1624)
+.+++...++|+..+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455666788999999999999999999864 457899999975443 345679999999999999999999999
Q ss_pred eccCCeEEEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 047591 809 CSNHGFKALILEYMPQGSLEKWLYSHK-----------------------YTLNIQQRLDIMIDVASALEYLHHGHPTPV 865 (1624)
Q Consensus 809 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~I 865 (1624)
|.+.+..++||||+++|+|.++++... ..+++.++..|+.|+|.||+|||+ .+|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence 999999999999999999999997532 247899999999999999999998 459
Q ss_pred EeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCC-
Q 047591 866 IHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKM- 943 (1624)
Q Consensus 866 iHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~- 943 (1624)
|||||||+|||+|.++.+||+|||+|+........ ..+...||+.|||||++....++.++|||||||++|||+||..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876543322 2334568999999999999999999999999999999999964
Q ss_pred CCCc
Q 047591 944 PTDE 947 (1624)
Q Consensus 944 P~~~ 947 (1624)
||..
T Consensus 242 p~~~ 245 (301)
T d1lufa_ 242 PYYG 245 (301)
T ss_dssp TTTT
T ss_pred CCCC
Confidence 5544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-38 Score=381.20 Aligned_cols=196 Identities=26% Similarity=0.317 Sum_probs=176.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 819 (1624)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5788899999999999999986 479999999987432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDS 899 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 899 (1624)
||+.+|+|.+++...+ .+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999997654 689999999999999999999984 5999999999999999999999999999987543
Q ss_pred cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 900 VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 900 ~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 2235799999999999999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=381.39 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=193.0
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCC------e
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPG------F 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~------~ 1405 (1624)
+.|...+.||+|+||+||+|+.. +|+.||||+++.. .+...+.+.+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 56777889999999999999875 6899999998643 3345678999999999999999999999987654 4
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+ +++|.++.+.. .+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||+|+..
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence 69999999 56788777543 58999999999999999999996 79999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh--hcCChhHH---
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE--ESLPDAVT--- 1559 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~--~~~~~~~~--- 1559 (1624)
... .+...||+.|||||.+.+ ..++.++||||+||++|||++|+.||....... .+..... ...+....
T Consensus 172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHTC
T ss_pred CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHHHhhh
Confidence 532 344679999999998765 567999999999999999999999997542211 1111111 11111100
Q ss_pred -----HHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1560 -----DVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1560 -----~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......+................+.+.+++.+|++.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000000001234567889999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=379.41 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=191.8
Q ss_pred CCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCceeEEEeeecc------CCeeEE
Q 047591 1336 GFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLAKIVSSCSN------PGFKAL 1408 (1624)
Q Consensus 1336 ~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~------~~~~~l 1408 (1624)
.|...++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|||||+++++|.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3666788999999999999985 689999999864432 23579999999999999999998853 234789
Q ss_pred EEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeeecceeec
Q 047591 1409 ILQYMPQGSLEKWLY--SHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLL 1485 (1624)
Q Consensus 1409 V~ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DFGla~~~ 1485 (1624)
|||||++|.+....+ .....+++.++..|+.||+.||+|||+ .+||||||||+|||++.++ .+||+|||+|+..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444332 345678999999999999999999995 8999999999999999775 8999999999887
Q ss_pred CCCCCccccccccccccccccccC-CCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh--cCCh-hHHHH
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGS-EGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE--SLPD-AVTDV 1561 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~--~~~~-~~~~~ 1561 (1624)
.... ......||+.|+|||.+. ...++.++||||+||++|||+||+.||......+ .+...+.. .... .+.+.
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhhh
Confidence 5433 233457999999999765 4578999999999999999999999996543221 11111110 0000 11110
Q ss_pred H----hhhccCCc-hHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1562 I----DANLLSGE-EEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1562 ~----d~~l~~~~-~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
. +....... ............+.+.+|+.+|++.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000 000000011234568899999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=381.08 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=199.5
Q ss_pred CCCCcCCeEeecCceEEEEEEEc----CCceEEEEEeccc----hhhHHHHHHHHHHHHHhcCC-CceeEEEeeeccCCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA----DGTNAAIKIFSLQ----EDRALKSFDAECEVMRRIRH-RNLAKIVSSCSNPGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~----~~~~vAvK~~~~~----~~~~~~~f~~E~~~l~~l~H-pNIv~l~g~~~~~~~ 1405 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++.. +....+.+.+|++++++++| |||+++++++.+++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 45888899999999999999762 4789999998643 22345678999999999977 899999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++|||||.+|+|.+++...+. +.......++.|++.||+|+|+ .+||||||||+|||+|.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999986653 4567778899999999999996 78999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccccccCCC--CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCChhHHHHHh
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEG--IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLPDAVTDVID 1563 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~d 1563 (1624)
............||+.|+|||..... .++.++|||||||+||||+||+.||............+ .....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~---------~~~~~ 250 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---------RRILK 250 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---------HHHHH
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------Hhccc
Confidence 65444444556899999999987543 57889999999999999999999997543222110000 00011
Q ss_pred hhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047591 1564 ANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERM-----NVKDALA 1608 (1624)
Q Consensus 1564 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~evl~ 1608 (1624)
.... .+..++..+.+++.+|++.||++|| |++|+++
T Consensus 251 ~~~~---------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SEPP---------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCC---------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCC---------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000 0123456788999999999999999 4788875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=376.05 Aligned_cols=201 Identities=28% Similarity=0.437 Sum_probs=170.1
Q ss_pred CCCCCcceeecCCccceEEEEec-CCC----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGM----NVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKAL 817 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 817 (1624)
++|+..++||+|+||+||+|.+. +|+ +||||+++... ....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999864 444 68999886433 34567899999999999999999999999875 4688
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCC
Q 047591 818 ILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGE 897 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 897 (1624)
||||+.+|+|.+++......+++..+++|+.|||+||+|||+. +||||||||+|||+|.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 9999999999999988877899999999999999999999994 5999999999999999999999999999987654
Q ss_pred CCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 898 DSVT-QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 898 ~~~~-~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.... .....||+.|||||++..+.++.++|||||||++|||+| |+.||+..
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 3332 233468999999999999999999999999999999999 78888754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=368.45 Aligned_cols=195 Identities=34% Similarity=0.513 Sum_probs=161.9
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeecc-CCeEEEEEEec
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN-HGFKALILEYM 822 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 822 (1624)
++|+..+.||+|+||+||+|+++ |++||||+++.. ...+.|.+|++++++++|||||+++|+|.+ .+..|+||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 34666789999999999999984 889999999643 345789999999999999999999999865 45689999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 823 PQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 823 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
++|+|.++++.+. ..++|..+++|+.|||.||+|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999997643 3589999999999999999999984 5999999999999999999999999999875432
Q ss_pred cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
.....+|+.|||||++.++.+++++|||||||++|||+| |+.|+...
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 223468999999999988999999999999999999999 67777653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=371.87 Aligned_cols=196 Identities=26% Similarity=0.460 Sum_probs=170.4
Q ss_pred cceeecCCccceEEEEecC----CCEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCceeeeeeeecc-CCeEEEEEEec
Q 047591 749 SNLIGAGSFGSVYKATLPY----GMNVAIKVFNLQ-LDGAIKSFDAECEVLRRVRHRNLVKIISSCSN-HGFKALILEYM 822 (1624)
Q Consensus 749 ~~~iG~G~~G~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 822 (1624)
.++||+|+||+||+|++.. ...||||+++.. .....++|.+|+++|++++|||||+++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 3689999999999998643 236899998743 34456789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc-
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT- 901 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~- 901 (1624)
++|+|.++++.....+++..+++|+.|+|+||.|+|+ ++|+||||||+|||+|+++.+||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999998877788999999999999999999998 459999999999999999999999999999775443222
Q ss_pred --cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 902 --QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 902 --~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....||+.|+|||++..+.++.++|||||||++|||+||+.|+..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 2234689999999999999999999999999999999998888754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-38 Score=381.02 Aligned_cols=198 Identities=23% Similarity=0.329 Sum_probs=170.6
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHH---HHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDA---ECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
++|+..++||+|+||+||+|+.. +|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67889999999999999999864 69999999986432 122233444 466777788999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+|||||++|+|.+++.... .+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999997654 688999999999999999999994 599999999999999999999999999997754
Q ss_pred CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 897 EDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 897 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.. .....||+.|||||++.. ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 32 233579999999999865 46899999999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=372.75 Aligned_cols=199 Identities=25% Similarity=0.368 Sum_probs=175.2
Q ss_pred CCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc---chhHHHHHHHHHHHH-hcCCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL---DGAIKSFDAECEVLR-RVRHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999864 68999999997532 334556777887765 68999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCC
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 898 (1624)
||||++|+|.++++... .+++.++..++.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999997654 688999999999999999999995 59999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. ..+...||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 2 23345799999999999999999999999999999999999999964
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-39 Score=377.23 Aligned_cols=197 Identities=25% Similarity=0.382 Sum_probs=162.2
Q ss_pred CCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHH--HHHHHHHhcCCCceeeeeeeeccCC----eEEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFD--AECEVLRRVRHRNLVKIISSCSNHG----FKALI 818 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~--~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV 818 (1624)
.|...+.||+|+||+||+|++ +|+.||||+++... .+.+. +|+..+++++|||||+++|+|.+.+ ..|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 344567899999999999987 58999999986442 23344 4555556789999999999997653 57999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 819 LEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHG-----HPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
||||++|+|.+++++. .++|.++.+++.|+|.||+|+|+. +.++||||||||+|||+|+++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999864 589999999999999999999974 346899999999999999999999999999998
Q ss_pred cCCCCCc---ccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSV---TQTMTLATFGYMAPEYGSEG------IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
....... ......||++|||||++... .++.|+|||||||++|||+||..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 7544322 22345799999999987653 267899999999999999999988643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=372.63 Aligned_cols=200 Identities=22% Similarity=0.354 Sum_probs=177.8
Q ss_pred hcCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
..++|...+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578889999999999999999864 689999999976533 33568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC--CceEEEeeeeeeccCCCC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD--TVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~--~~~kl~DFGla~~~~~~~ 898 (1624)
||++|+|.+++...+..+++.++..|+.||++||+|||+. +|+||||||+|||++.+ ..+||+|||+++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999999987766799999999999999999999984 59999999999999854 489999999999865432
Q ss_pred CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....||+.|+|||...+..++.++||||+||++|||+||+.||..
T Consensus 159 ~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 2 3345799999999999999999999999999999999999999865
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=369.03 Aligned_cols=269 Identities=18% Similarity=0.224 Sum_probs=201.8
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeeccCCeeEEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~~~~~~lV~e 1411 (1624)
+.|...+.||+|+||+||+|+.. +++.||||+++.. .+...+++.+|+.++++++|||||+++++|.+++..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46778899999999999999875 6888999998643 33456889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeecCCCCCc
Q 047591 1412 YMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLLDGVDSM 1491 (1624)
Q Consensus 1412 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~~~~~~~ 1491 (1624)
|+.++++..++... ..+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 99999988877644 467888899999999999999997 7999999999999999999999999999998754332
Q ss_pred cccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhc---CChhHH---HHHhh
Q 047591 1492 KQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEES---LPDAVT---DVIDA 1564 (1624)
Q Consensus 1492 ~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~---~~~~~~---~~~d~ 1564 (1624)
......+++.|+|||.+... .++.++||||+||++|||++|+.||.........+....... ...... ...+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 33345678899999987655 469999999999999999999999754322211111111000 000000 00000
Q ss_pred hcc--CCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1565 NLL--SGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1565 ~l~--~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
.-. .................+.+++.+|++.||++|||++||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000000011123456788999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=369.59 Aligned_cols=202 Identities=26% Similarity=0.441 Sum_probs=162.5
Q ss_pred cCCCCCcceeecCCccceEEEEec------CCCEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeccC-C
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNH-G 813 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 813 (1624)
.++|...+.||+|+||+||+|++. +++.||||+++... ....+.+.+|..++.++ +|+|||++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 356888899999999999999853 34689999987543 23456788888888877 689999999988654 4
Q ss_pred eEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC
Q 047591 814 FKALILEYMPQGSLEKWLYSHK---------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD 878 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 878 (1624)
..++|||||++|+|.++++... ..+++.++..|+.|||+||+|||+. +||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6899999999999999997542 2488999999999999999999984 599999999999999
Q ss_pred CCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC-CCCCc
Q 047591 879 DDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRK-MPTDE 947 (1624)
Q Consensus 879 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~-~P~~~ 947 (1624)
+++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+||. .||..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999976544332 233457999999999999999999999999999999999975 56654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=367.07 Aligned_cols=201 Identities=26% Similarity=0.414 Sum_probs=164.5
Q ss_pred CCCCCcceeecCCccceEEEEec--CC--CEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP--YG--MNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~--~g--~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
++|+..+.||+|+||+||+|++. ++ ..||||++.... ....++|.+|+.+|++++|||||+++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 45777889999999999999853 23 478999986432 34457899999999999999999999999764 568
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCC
Q 047591 817 LILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDG 896 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 896 (1624)
+|||||++|++.+++..+...+++..+++++.|+|+||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999999988776689999999999999999999998 4599999999999999999999999999998755
Q ss_pred CCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCcc
Q 047591 897 EDSVT--QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDEM 948 (1624)
Q Consensus 897 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~~ 948 (1624)
..... .....||+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 43322 233468889999999999999999999999999999998 89998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-37 Score=360.06 Aligned_cols=199 Identities=26% Similarity=0.390 Sum_probs=174.7
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc---------hhHHHHHHHHHHHHhcC-CCceeeeeeeeccC
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD---------GAIKSFDAECEVLRRVR-HRNLVKIISSCSNH 812 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 812 (1624)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788899999999999999986 5789999999875431 12346889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
+..|+|||||++|||.++++.++ .+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999998654 789999999999999999999984 59999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGS------EGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
....... .+...||+.|+|||++. ...++.++||||+||++|||+||+.||...
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 8755332 33457999999999764 345788999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-38 Score=365.16 Aligned_cols=202 Identities=22% Similarity=0.426 Sum_probs=168.8
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC----
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL---DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG---- 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 813 (1624)
..++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.|.+|++++++++|||||++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357799999999999999999985 579999999997543 234567999999999999999999999987543
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+|||||++|+|.+++...+ .+++.++..|+.||+.||+|||+. +||||||||+|||++.++..|++|||.++.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 4799999999999999987654 689999999999999999999984 599999999999999999999999999876
Q ss_pred cCCCCC--cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDS--VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...... ......+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 543322 223345799999999999988999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-37 Score=370.05 Aligned_cols=261 Identities=19% Similarity=0.282 Sum_probs=194.2
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC-CCceeEEEeeecc--CCeeEEEE
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSCSN--PGFKALIL 1410 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~--~~~~~lV~ 1410 (1624)
++|...+.||+|+||+||+|+.. +|+.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 46888899999999999999874 68899999986432 367889999999995 9999999999864 45689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC-cEEEeeecceeecCCCC
Q 047591 1411 QYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM-VAHLGDFGIAKLLDGVD 1489 (1624)
Q Consensus 1411 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~kl~DFGla~~~~~~~ 1489 (1624)
|||++|+|.++. ..++..++..|+.||+.||+|||+ .+||||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999987653 357889999999999999999996 8999999999999998655 69999999999875432
Q ss_pred CccccccccccccccccccCCC-CcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhhcCC-hhHHHHHhhh--
Q 047591 1490 SMKQTMTLATIGYMAPEYGSEG-IVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEESLP-DAVTDVIDAN-- 1565 (1624)
Q Consensus 1490 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~~~~-~~~~~~~d~~-- 1565 (1624)
......||+.|+|||...+. .++.++||||+||++|||++|+.||.............. .... ....+.....
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~-~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA-KVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH-HHHCHHHHHHHHHHTTC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHH-HHHCCchhhhhhhhccc
Confidence 23455799999999986654 579999999999999999999999865322111100000 0000 0000000000
Q ss_pred --------c-----cCCchH-HHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1566 --------L-----LSGEEE-ADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1566 --------l-----~~~~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
. ...... ........+..++.+++.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 000011224466889999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=368.88 Aligned_cols=195 Identities=23% Similarity=0.342 Sum_probs=168.8
Q ss_pred cCCCCCc-ceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhc-CCCceeeeeeeecc----CCeE
Q 047591 743 TDGFSES-NLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRV-RHRNLVKIISSCSN----HGFK 815 (1624)
Q Consensus 743 t~~f~~~-~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~ 815 (1624)
.++|.+. ++||+|+||+||+|+. .+|+.||||+++.. +.+.+|++++.++ +|||||++++++++ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4678765 4699999999999986 57999999998632 4577899987654 89999999998864 4678
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC---CCceEEEeeeee
Q 047591 816 ALILEYMPQGSLEKWLYSHK-YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD---DTVAHLSDFGIS 891 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~~kl~DFGla 891 (1624)
|+|||||++|+|.++|...+ ..+++.++..|+.|++.||+|||+. +|+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 99999999999999998653 4689999999999999999999984 5999999999999986 467999999999
Q ss_pred eccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 892 KLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 892 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+....... .....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 98765433 2345799999999999999999999999999999999999999954
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-37 Score=367.19 Aligned_cols=265 Identities=23% Similarity=0.248 Sum_probs=190.3
Q ss_pred CCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc------CCe
Q 047591 1335 NGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN------PGF 1405 (1624)
Q Consensus 1335 ~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~------~~~ 1405 (1624)
+.|...++||+|+||+||+|+.. +|+.||||++... .....+++.+|++++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56788899999999999999875 6899999998643 33455689999999999999999999999853 367
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++|||||.++.+ +.++ ..+++.+...++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 8999999976544 4443 347889999999999999999996 79999999999999999999999999998866
Q ss_pred CCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhh----------hcCC
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVE----------ESLP 1555 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~----------~~~~ 1555 (1624)
... .......||+.|+|||++.+..+++++||||+||+++||++|+.||.+...... ...... ....
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTTSC
T ss_pred ccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccCCCHHHHHHhh
Confidence 432 233455799999999999999999999999999999999999999864321111 000000 0011
Q ss_pred hhHHHHHhhhccCCch-----------HHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1556 DAVTDVIDANLLSGEE-----------EADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1556 ~~~~~~~d~~l~~~~~-----------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
....+..+........ ..........+..+.+++.+|++.||++|||++||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1112222211100000 00111223456778999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=364.61 Aligned_cols=215 Identities=26% Similarity=0.434 Sum_probs=179.0
Q ss_pred CCCCCcceeecCCccceEEEEe------cCCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL------PYGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 815 (1624)
++|...+.||+|+||+||+|++ .+++.||||+++.... .....|.+|+.+++++ +|||||+++|+|.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5667788999999999999975 2467899999975443 3456799999999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC
Q 047591 816 ALILEYMPQGSLEKWLYSHK-----------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD 878 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 878 (1624)
++|||||++|+|.++++... ..+++.++.+|+.|||+||+|||+. +||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999997643 2588999999999999999999994 599999999999999
Q ss_pred CCCceEEEeeeeeeccCCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccCcCcchHHH
Q 047591 879 DDTVAHLSDFGISKLLDGEDS-VTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMFTGETSLKK 957 (1624)
Q Consensus 879 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~~~~~~l~~ 957 (1624)
.++.+|++|||+++....... ...+...||+.|+|||++..+.++.++|||||||++|||+|+..|+.........+.+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999998765433 2334467999999999999999999999999999999999965554333333333444
Q ss_pred HHHH
Q 047591 958 WVEE 961 (1624)
Q Consensus 958 ~~~~ 961 (1624)
++..
T Consensus 260 ~i~~ 263 (311)
T d1t46a_ 260 MIKE 263 (311)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 4443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=366.13 Aligned_cols=199 Identities=32% Similarity=0.517 Sum_probs=166.9
Q ss_pred CCCCCcceeecCCccceEEEEec-CCC--EEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCceeeeeeeeccCCeEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP-YGM--NVAIKVFNLQL-DGAIKSFDAECEVLRRV-RHRNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 818 (1624)
++|+..++||+|+||+||+|++. +|. .||||+++... ....+.|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 45667789999999999999875 444 57888875432 33456899999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCce
Q 047591 819 LEYMPQGSLEKWLYSH---------------KYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVA 883 (1624)
Q Consensus 819 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~ 883 (1624)
|||+++|+|.++|+.. ...+++.++.+++.|||+||.|+|+. +||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 24689999999999999999999984 69999999999999999999
Q ss_pred EEEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCC-CCCc
Q 047591 884 HLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKM-PTDE 947 (1624)
Q Consensus 884 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~-P~~~ 947 (1624)
||+|||+|+...... ......||+.|+|||.+..+.++.++|||||||++|||+||.. ||..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 999999998654322 1223468999999999999999999999999999999999765 5543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=362.44 Aligned_cols=200 Identities=27% Similarity=0.389 Sum_probs=169.9
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD--GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
|+|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6889999999999999999986 5799999999965432 335789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+.++.+..........+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 9986544443344455799999999999999999999984 599999999999999999999999999988754433
Q ss_pred ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
......||+.|+|||..... .++.++||||+||++|||+||+.||..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 23345799999999976554 468999999999999999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=362.89 Aligned_cols=201 Identities=28% Similarity=0.483 Sum_probs=168.9
Q ss_pred CCCCCcceeecCCccceEEEEec--------CCCEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCceeeeeeeeccCC
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP--------YGMNVAIKVFNLQLD-GAIKSFDAECEVLRRV-RHRNLVKIISSCSNHG 813 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 813 (1624)
++|...+.||+|+||+||+|+.. ++..||||+++.... ....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46777889999999999999753 235799999976543 3457889999999888 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC
Q 047591 814 FKALILEYMPQGSLEKWLYSHK---------------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD 878 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 878 (1624)
..++|||||++|+|.++|+.+. ..+++.++++++.|+|.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999997553 3589999999999999999999995 599999999999999
Q ss_pred CCCceEEEeeeeeeccCCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 047591 879 DDTVAHLSDFGISKLLDGEDSV-TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFT-RKMPTDE 947 (1624)
Q Consensus 879 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~ellt-g~~P~~~ 947 (1624)
.++.+||+|||+++........ ......||+.|+|||++..+.++.|+|||||||++|||+| |+.||..
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999999999999977544332 2334578999999999999999999999999999999998 6778754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-37 Score=369.88 Aligned_cols=265 Identities=22% Similarity=0.250 Sum_probs=195.2
Q ss_pred hCCCCcCCeEeecCceEEEEEEEc-CCceEEEEEeccc--hhhHHHHHHHHHHHHHhcCCCceeEEEeeecc-----CCe
Q 047591 1334 TNGFSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQ--EDRALKSFDAECEVMRRIRHRNLAKIVSSCSN-----PGF 1405 (1624)
Q Consensus 1334 t~~f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~--~~~~~~~f~~E~~~l~~l~HpNIv~l~g~~~~-----~~~ 1405 (1624)
.+.|...+.||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+++|++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 456888899999999999999864 6899999998643 33455788999999999999999999998853 334
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeecceeec
Q 047591 1406 KALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKLL 1485 (1624)
Q Consensus 1406 ~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~~ 1485 (1624)
.++||||+.+|+|.++++.. .+++.++..|+.||+.||+|||+ .+||||||||+|||++.++.+|++|||+|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 57778889999999998653 58899999999999999999996 79999999999999999999999999999765
Q ss_pred CCCCCccccccccccccccccccCC-CCcCcccchHHHHHHHHHHHcCCCCCCCCCccchhhhhhhhh----------cC
Q 047591 1486 DGVDSMKQTMTLATIGYMAPEYGSE-GIVSTSGDVYSFGILMMETLTRRKPTDDMFTGEVCLKHWVEE----------SL 1554 (1624)
Q Consensus 1486 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~~~~l~~~~~~----------~~ 1554 (1624)
.. ......||+.|+|||...+ ..++.++||||+||++|||++|+.||.+...... ....... ..
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTC
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhc
Confidence 32 2334579999999997655 4568999999999999999999999975321111 1111000 00
Q ss_pred -ChhHHHHHhhhccCCchHHHHHHHHHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047591 1555 -PDAVTDVIDANLLSGEEEADIAAKKKCMSSVMSLALKCSEEIPEERMNVKDALAN 1609 (1624)
Q Consensus 1555 -~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~~ 1609 (1624)
......... .+..............+...+.+++.+|++.||++|||++|++++
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhh-hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000111111 110000000001112345668899999999999999999999863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-37 Score=362.12 Aligned_cols=194 Identities=26% Similarity=0.381 Sum_probs=164.1
Q ss_pred cceeecCCccceEEEEe-cCCCEEEEEEeecccc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEec
Q 047591 749 SNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD-----GAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEYM 822 (1624)
Q Consensus 749 ~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 822 (1624)
.++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 47899999999999986 4699999999864322 12357899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCccc
Q 047591 823 PQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVTQ 902 (1624)
Q Consensus 823 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 902 (1624)
+++++.... .....+++.++..|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+........ .
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 987766554 4455789999999999999999999984 5999999999999999999999999999876554332 2
Q ss_pred ccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 903 TMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 903 ~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
...+||+.|||||++.. ..++.++|||||||++|||+||+.||..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 33579999999998764 4679999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-37 Score=362.54 Aligned_cols=201 Identities=25% Similarity=0.424 Sum_probs=172.8
Q ss_pred CCCCCcceeecCCccceEEEEec------CCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATLP------YGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKA 816 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 816 (1624)
++|...+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++|||||+++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 45677889999999999999763 35789999997543 334467999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEe
Q 047591 817 LILEYMPQGSLEKWLYSHK---------YTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSD 887 (1624)
Q Consensus 817 lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~D 887 (1624)
+|||||++|+|.++++... ..+++..+.+|+.|+|+||.|||+. +|+||||||+|||+|+++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 9999999999999987532 2468999999999999999999984 599999999999999999999999
Q ss_pred eeeeeccCCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC-CCCCc
Q 047591 888 FGISKLLDGEDSVT-QTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRK-MPTDE 947 (1624)
Q Consensus 888 FGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~-~P~~~ 947 (1624)
||+|+......... .....||+.|||||.+.++.++.++|||||||++|||+||+ .||..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 99999765433322 23346899999999999999999999999999999999995 56643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-37 Score=354.25 Aligned_cols=197 Identities=24% Similarity=0.320 Sum_probs=168.3
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccc------hhHHHHHHHHHHHHhcC--CCceeeeeeeeccCCe
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLD------GAIKSFDAECEVLRRVR--HRNLVKIISSCSNHGF 814 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 814 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788899999999999999986 5799999999875321 12234678999999997 8999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCC-CceEEEeeeeee
Q 047591 815 KALILEYMPQ-GSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDD-TVAHLSDFGISK 892 (1624)
Q Consensus 815 ~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~~kl~DFGla~ 892 (1624)
.|+||||+.+ +++.+++.... .+++.++..++.|+++||+|||+. +||||||||+|||++.+ +.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 68888886543 689999999999999999999984 59999999999999854 799999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSEGIV-STCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ..+...||+.|||||++....+ +.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 76433 2234579999999999876655 6778999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-36 Score=352.76 Aligned_cols=200 Identities=24% Similarity=0.363 Sum_probs=170.8
Q ss_pred CCCCCcceeecCCccceEEEEecCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 821 (1624)
++|...+.||+|+||+||+|+.++|+.||||+++... +...+.|.+|+.+|++++|||||++++++..++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999899999999996543 23357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCcc
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSVT 901 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 901 (1624)
+.++.+..+.. ....+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+|++|||+|........ .
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 98776666554 445799999999999999999999984 599999999999999999999999999988754332 2
Q ss_pred cccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 902 QTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 902 ~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
.....||+.|+|||.+.. ..++.++||||+||++|||+||+.||...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 233468999999998754 56799999999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-36 Score=354.38 Aligned_cols=201 Identities=28% Similarity=0.393 Sum_probs=170.2
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cC-CCEEEEEEeecccc--hhHHHHHHHHHHHHhc---CCCceeeeeeeec----
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PY-GMNVAIKVFNLQLD--GAIKSFDAECEVLRRV---RHRNLVKIISSCS---- 810 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~-g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 810 (1624)
..++|+..+.||+|+||+||+|+. ++ ++.||||+++.... .....+.+|+.+|+.+ +|||||+++++|.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 346899999999999999999986 44 56799999875432 2234567888887766 7999999999985
Q ss_pred -cCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeee
Q 047591 811 -NHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFG 889 (1624)
Q Consensus 811 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFG 889 (1624)
.....++||||+++|++..........+++..+..|+.|++.||+|||+. +||||||||+|||+++++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 33568999999999888766666666789999999999999999999984 59999999999999999999999999
Q ss_pred eeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 890 ISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 890 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+++..... .......||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 99865432 233445799999999999999999999999999999999999999965
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-35 Score=341.41 Aligned_cols=200 Identities=18% Similarity=0.232 Sum_probs=173.4
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCC-CceeeeeeeeccCCeEEEEEE
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRH-RNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E 820 (1624)
.++|...+.||+|+||+||+|+.. +|+.||||++..... .+.+.+|++.+++++| +|++++++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357888999999999999999864 689999999865432 2457789999999975 899999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCC-----CCceEEEeeeeeeccC
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDD-----DTVAHLSDFGISKLLD 895 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-----~~~~kl~DFGla~~~~ 895 (1624)
|+ +|+|.+++...+..+++.++..|+.|++.||+|||+. +||||||||+|||++. ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 6899999987777899999999999999999999984 5999999999999975 5689999999999875
Q ss_pred CCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 047591 896 GEDSV------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEM 948 (1624)
Q Consensus 896 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~ 948 (1624)
..... .....+||+.|||||.+.+..++.++|||||||++|||+||+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 43221 122357999999999999989999999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=348.52 Aligned_cols=202 Identities=27% Similarity=0.344 Sum_probs=173.3
Q ss_pred CCCCCcceeecCCccceEEEEe----cCCCEEEEEEeeccc----chhHHHHHHHHHHHHhcCC-CceeeeeeeeccCCe
Q 047591 744 DGFSESNLIGAGSFGSVYKATL----PYGMNVAIKVFNLQL----DGAIKSFDAECEVLRRVRH-RNLVKIISSCSNHGF 814 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 814 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688999999999999999974 258999999986432 2334678899999999976 899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeecc
Q 047591 815 KALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLL 894 (1624)
Q Consensus 815 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~ 894 (1624)
.++||||+.+|+|.+++...+ .++......++.|++.||+|+|+. +|+||||||+|||+|.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999997665 567788889999999999999984 5999999999999999999999999999987
Q ss_pred CCCCCcccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 895 DGEDSVTQTMTLATFGYMAPEYGSEG--IVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 895 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
............||+.|+|||.+... .++.++||||+||++|||+||+.||....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 65444444456799999999987543 47889999999999999999999997643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-35 Score=349.96 Aligned_cols=201 Identities=24% Similarity=0.317 Sum_probs=167.6
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC----eE
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL-DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG----FK 815 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 815 (1624)
.+++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456798999999999999999985 579999999997543 344578999999999999999999999986543 23
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccC
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLD 895 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~ 895 (1624)
++++||+.+|+|.+++... .+++..+..++.|+++||+|||+. +||||||||+|||+++++.+||+|||+|+...
T Consensus 86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 5556677899999999754 589999999999999999999984 59999999999999999999999999998765
Q ss_pred CCCCc--ccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 896 GEDSV--TQTMTLATFGYMAPEYGS-EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 896 ~~~~~--~~~~~~gt~~Y~aPE~~~-~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... .....+||+.|+|||++. ...++.++||||+||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 43222 223457999999999874 45678999999999999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=343.15 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=165.0
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc--------C
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN--------H 812 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 812 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||++.... +...+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788899999999999999986 579999999986442 3345778999999999999999999998854 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 813 GFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 813 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
+..|+||||++++.+..+. .....++..++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 4579999999887665443 3445788899999999999999999984 59999999999999999999999999998
Q ss_pred ccCCCCCc---ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 893 LLDGEDSV---TQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 893 ~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.+...... .....+||+.|+|||.+... .++.++||||+||++|||+||+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 76543221 12234699999999987654 689999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=346.82 Aligned_cols=196 Identities=26% Similarity=0.366 Sum_probs=163.8
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCC-----
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHG----- 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 813 (1624)
..++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 457899999999999999999986 569999999997543 234567899999999999999999999997654
Q ss_pred -eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 814 -FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 814 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
..|+||||+ +++|.++++.. .+++..+..|+.|++.||+|||+. +||||||||+|||++.++.+|++|||+|+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 569999999 56788877543 689999999999999999999984 59999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 893 LLDGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 893 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 76543 234579999999998754 5678999999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=345.41 Aligned_cols=194 Identities=29% Similarity=0.381 Sum_probs=160.7
Q ss_pred CCCCcceeecCCccceEEEEec-CCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeeeeeeecc------CCeEEE
Q 047591 745 GFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKIISSCSN------HGFKAL 817 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~l 817 (1624)
.|...++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|||||+++++|.. ..+.|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4667789999999999999964 699999999975432 23479999999999999999999843 335789
Q ss_pred EEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC-ceEEEeeeeeecc
Q 047591 818 ILEYMPQGSLEKWLY--SHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLL 894 (1624)
Q Consensus 818 V~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~~kl~DFGla~~~ 894 (1624)
|||||++|.+....+ .....+++.++..|+.||+.||+|||+. +||||||||+|||++.++ .+||+|||+|+..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998764443322 2345799999999999999999999984 599999999999999775 8999999999877
Q ss_pred CCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 895 DGEDSVTQTMTLATFGYMAPEYGS-EGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 895 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ....+||+.|+|||.+. ...++.++||||+||++|||+||+.||..
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 54432 22347999999999765 45789999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-34 Score=333.49 Aligned_cols=199 Identities=23% Similarity=0.332 Sum_probs=173.5
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeeccCCeEEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 820 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.+|++++|||||+++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788899999999999999986 578999999997543 2346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeeccCCCCCc
Q 047591 821 YMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKLLDGEDSV 900 (1624)
Q Consensus 821 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 900 (1624)
|+.++++..++... ..+++..+..++.|+++||+|||+. +||||||||+|||++.++.+||+|||.|+........
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999998877654 4788999999999999999999984 5999999999999999999999999999987544332
Q ss_pred ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 901 TQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 901 ~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.....+++.|+|||.+... .++.++||||+||++|||+||+.||..
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 2334578899999987654 469999999999999999999999743
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-34 Score=335.00 Aligned_cols=200 Identities=21% Similarity=0.289 Sum_probs=167.6
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCceeee-eeeeccCCeEEEEEEe
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNLVKI-ISSCSNHGFKALILEY 821 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~~~~~~~~~~~lV~Ey 821 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||++..... .+++.+|++++++++|+|+|.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5688899999999999999986 5689999999875432 2457899999999987775555 4555777888999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeC---CCCceEEEeeeeeeccCCCC
Q 047591 822 MPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLD---DDTVAHLSDFGISKLLDGED 898 (1624)
Q Consensus 822 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~~kl~DFGla~~~~~~~ 898 (1624)
+ +|++.+.+......+++..+..++.|++.||+|||+. +||||||||+|||++ .+..+|++|||+|+.+....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 4677777776666899999999999999999999994 599999999999875 45579999999999876443
Q ss_pred Cc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCccC
Q 047591 899 SV------TQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDEMF 949 (1624)
Q Consensus 899 ~~------~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~~~ 949 (1624)
.. ......||+.|||||...+..++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 22 1234579999999999998899999999999999999999999997643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-33 Score=336.20 Aligned_cols=192 Identities=21% Similarity=0.356 Sum_probs=165.5
Q ss_pred CCCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcC-CCceeeeeeeecc--CCeEEEEE
Q 047591 744 DGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSCSN--HGFKALIL 819 (1624)
Q Consensus 744 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~ 819 (1624)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999986 57899999998643 3467889999999995 9999999999874 45689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC-ceEEEeeeeeeccCCCC
Q 047591 820 EYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT-VAHLSDFGISKLLDGED 898 (1624)
Q Consensus 820 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~~kl~DFGla~~~~~~~ 898 (1624)
|||++|+|.++. ..+++.++..|+.||+.||+|||+. +||||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999997753 3689999999999999999999984 599999999999998655 68999999999875443
Q ss_pred CcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 899 SVTQTMTLATFGYMAPEYGSEG-IVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 899 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
. .....||+.|+|||.+... .++.++||||+||++|||++|+.||..
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 2 2345799999999987654 579999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.7e-33 Score=334.33 Aligned_cols=196 Identities=24% Similarity=0.298 Sum_probs=158.5
Q ss_pred cCCCCCcceeecCCccceEEEEec-CCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc------CC
Q 047591 743 TDGFSESNLIGAGSFGSVYKATLP-YGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN------HG 813 (1624)
Q Consensus 743 t~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 813 (1624)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999864 69999999997543 2345678999999999999999999999853 36
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..|+|||||.++ +.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 789999999765 444443 3588999999999999999999994 599999999999999999999999999887
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
..... ..+...||+.|+|||++.+..+++++||||+||++|||++|+.||..
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 65432 23345799999999999988999999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5e-33 Score=333.80 Aligned_cols=197 Identities=24% Similarity=0.354 Sum_probs=164.8
Q ss_pred hcCCCCCcceeecCCccceEEEEe-cCCCEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCceeeeeeeecc-----CC
Q 047591 742 LTDGFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQL--DGAIKSFDAECEVLRRVRHRNLVKIISSCSN-----HG 813 (1624)
Q Consensus 742 ~t~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 813 (1624)
..++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|||||++++++.. ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999985 579999999997543 2345678999999999999999999999853 33
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 814 FKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 814 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
..++||||+.+|+|.++++.. .+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+|++|||+|..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 457778888999999999643 589999999999999999999984 599999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 894 LDGEDSVTQTMTLATFGYMAPEYGSE-GIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 894 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
.... .....||+.|+|||.... ..++.++||||+||++|||+||+.||..
T Consensus 171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 5322 233569999999997554 4568999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=3e-32 Score=328.95 Aligned_cols=266 Identities=19% Similarity=0.227 Sum_probs=189.4
Q ss_pred CCcCCeEeecCceEEEEEEEc-CCceEEEEEeccchhhHHHHHHHHHHHHHhcC-----------CCceeEEEeeecc--
Q 047591 1337 FSESNLLGTGIFSSVYKATFA-DGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-----------HRNLAKIVSSCSN-- 1402 (1624)
Q Consensus 1337 f~~~~~lG~G~~G~Vyk~~~~-~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-----------HpNIv~l~g~~~~-- 1402 (1624)
|...+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+|||++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 777899999999999999874 68999999997443 33567889999998876 4789999988754
Q ss_pred CCeeEEEEEecCCCCHHHH-H-HhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCC------cE
Q 047591 1403 PGFKALILQYMPQGSLEKW-L-YSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDM------VA 1474 (1624)
Q Consensus 1403 ~~~~~lV~ey~~~gsL~~~-l-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~------~~ 1474 (1624)
....++||+++..+..... . ......+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 4567788888766643332 2 2344667888999999999999999996 37899999999999998665 39
Q ss_pred EEeeecceeecCCCCCccccccccccccccccccCCCCcCcccchHHHHHHHHHHHcCCCCCCCCCcc-----chhhhhh
Q 047591 1475 HLGDFGIAKLLDGVDSMKQTMTLATIGYMAPEYGSEGIVSTSGDVYSFGILMMETLTRRKPTDDMFTG-----EVCLKHW 1549 (1624)
Q Consensus 1475 kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DV~SfGvil~Elltg~~P~~~~~~~-----~~~l~~~ 1549 (1624)
|++|||.|+..... ....+||+.|||||+.....++.++||||+||+++||++|+.||...... ...+...
T Consensus 172 kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999999865422 23457999999999998889999999999999999999999998642111 0111111
Q ss_pred h--hhcCChhHH-------HHHhh-----hccCCc--hHHHHH-----HHHHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047591 1550 V--EESLPDAVT-------DVIDA-----NLLSGE--EEADIA-----AKKKCMSSVMSLALKCSEEIPEERMNVKDALA 1608 (1624)
Q Consensus 1550 ~--~~~~~~~~~-------~~~d~-----~l~~~~--~~~~~~-----~~~~~~~~~~~l~~~C~~~~P~~RPt~~evl~ 1608 (1624)
+ -...+.... ...+. .+.... ...... ........+.+++.+|++.||++|||++||++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 111111110 00000 000000 000000 01245677899999999999999999999986
Q ss_pred H
Q 047591 1609 N 1609 (1624)
Q Consensus 1609 ~ 1609 (1624)
.
T Consensus 328 H 328 (362)
T d1q8ya_ 328 H 328 (362)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=8.5e-32 Score=318.15 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=184.1
Q ss_pred CccEEEeecccCCC--CCCCcccccCCCccEEEecC-CccCCcCcccccCCCCCcEEecCCccccccCcccccccccccE
Q 047591 316 NIEVIQLYGNHLSG--NLPSSTGINLPNLLRLYLWG-NNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQI 392 (1624)
Q Consensus 316 ~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~ 392 (1624)
.++.|+|++|+++| .||+.++ +|++|++|+|++ |+++|.+|.+|+++++|++|+|++|+|++.++..+.++.+|+.
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~-~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEECCCCCCCCCCCCChHHh-cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 46667777777776 3666665 677777777765 6777777777777777777777777777776666666666666
Q ss_pred EEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccE
Q 047591 393 LNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIA 472 (1624)
Q Consensus 393 L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~ 472 (1624)
+++++|++ .+.+|.++++++.|+.
T Consensus 130 l~l~~N~~--------------------------------------------------------~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 130 LDFSYNAL--------------------------------------------------------SGTLPPSISSLPNLVG 153 (313)
T ss_dssp EECCSSEE--------------------------------------------------------ESCCCGGGGGCTTCCE
T ss_pred cccccccc--------------------------------------------------------cccCchhhccCcccce
Confidence 65554443 2345566677777777
Q ss_pred EeccCCccCCCccchhcccccc-ceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCcc
Q 047591 473 LSLYQNQLASTIPTTVGKLQNL-QGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNR 551 (1624)
Q Consensus 473 L~L~~N~l~g~iP~~~~~l~~L-~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 551 (1624)
+++++|.++|.+|..++.+..+ +.+++++|+++|..|..+.++..+ .+++++|.+.|.+|..++.+++|+.+++++|+
T Consensus 154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 232 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred eeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence 7788887777777777777665 777888888887777777776544 57788888888888888888888888888888
Q ss_pred ccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCC-CCCC
Q 047591 552 LNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNG-FQGS 627 (1624)
Q Consensus 552 l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~-l~g~ 627 (1624)
+++.+| .++.+.+|+.|||++|+|+|.+|++|+++++|++|||++|+|+|.||. ++++++|+.+++++|+ ++|.
T Consensus 233 l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 233 LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp ECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred cccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 877644 577777788888888888888888888888888888888888887773 5777788888887776 5553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=5.6e-27 Score=284.26 Aligned_cols=123 Identities=29% Similarity=0.352 Sum_probs=59.6
Q ss_pred cccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhcccccccee
Q 047591 490 KLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVV 569 (1624)
Q Consensus 490 ~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~l 569 (1624)
.+++|++|++++|++++. + .+.++..++.+++++|++++ + ..+..+++++.|++++|++++.. .+..+++|+.|
T Consensus 261 ~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L 334 (384)
T d2omza2 261 GLTKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRL 334 (384)
T ss_dssp TCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEE
T ss_pred ccccCCEeeccCcccCCC-C-cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCCc--ccccCCCCCEE
Confidence 344444444444444421 1 13344444444444444443 1 22444444444444444444421 14444455555
Q ss_pred ecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccC
Q 047591 570 DFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARN 622 (1624)
Q Consensus 570 dLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N 622 (1624)
++++|++++ +| .++++++|+.|+|++|++++.+| ++++++|+.|+|++|
T Consensus 335 ~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 335 FFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 555555543 33 45666666666666666665333 566666666666665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=1.2e-28 Score=297.02 Aligned_cols=196 Identities=20% Similarity=0.263 Sum_probs=158.3
Q ss_pred CCCCcceeecCCccceEEEEe-cCCCEEEEEEeecccchhHHHHHHHHHHHHhcC-----------CCceeeeeeeecc-
Q 047591 745 GFSESNLIGAGSFGSVYKATL-PYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-----------HRNLVKIISSCSN- 811 (1624)
Q Consensus 745 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~- 811 (1624)
+|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 388889999999999999986 579999999997542 23467788999998875 5789999988764
Q ss_pred -CCeEEEEEEecCCCCHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCC------c
Q 047591 812 -HGFKALILEYMPQGSLEKWL--YSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDT------V 882 (1624)
Q Consensus 812 -~~~~~lV~Ey~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~------~ 882 (1624)
....++||+++..+...... ......+++..+..++.||+.||+|||+. .+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 35667777777665443332 22334688889999999999999999973 3699999999999998665 3
Q ss_pred eEEEeeeeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 047591 883 AHLSDFGISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGILMIETFTRKMPTDE 947 (1624)
Q Consensus 883 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gvil~elltg~~P~~~ 947 (1624)
+|++|||.|+..... ....+||+.|+|||+.....++.++||||+||+++||++|+.||..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 899999999865432 2334799999999998888899999999999999999999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=2.7e-26 Score=278.14 Aligned_cols=341 Identities=25% Similarity=0.344 Sum_probs=168.9
Q ss_pred CCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccce
Q 047591 136 MPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMEL 215 (1624)
Q Consensus 136 l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 215 (1624)
+.+|++|++++|.|+. + ++ +..|++|++|||++|+|++ +|+ |++|++|++|++++|++++. ++ ++++++|+.|
T Consensus 43 l~~l~~L~l~~~~I~~-l-~g-l~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i-~~-l~~l~~L~~L 115 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DG-VEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-TP-LANLTNLTGL 115 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCCEE
T ss_pred hCCCCEEECCCCCCCC-c-cc-cccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccccc-cc-cccccccccc
Confidence 3444555555554442 1 11 2345555555555555553 222 55555555555555555532 21 4555555555
Q ss_pred eccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcc
Q 047591 216 YLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQL 295 (1624)
Q Consensus 216 ~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 295 (1624)
++++|.+++..+ ......+..+....|.+...-+ ............... ......+...+.........|..
T Consensus 116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 187 (384)
T d2omza2 116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQ-----VTDLKPLANLTTLERLDISSNKV 187 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGG-GTTCTTCSEEEEEES-----CCCCGGGTTCTTCCEEECCSSCC
T ss_pred cccccccccccc--cccccccccccccccccccccc-ccccccccccccccc-----cchhhhhcccccccccccccccc
Confidence 555555553221 2223344444444444432111 111111111111111 11112233333333443333322
Q ss_pred cccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCcc
Q 047591 296 TDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNL 375 (1624)
Q Consensus 296 ~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 375 (1624)
. .+..+..+.+++.+++++|.+++..|.. ..++|++|++++|+++. + +.+..+++|+.|++++|.
T Consensus 188 ~----------~~~~~~~l~~~~~l~l~~n~i~~~~~~~---~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~ 252 (384)
T d2omza2 188 S----------DISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQ 252 (384)
T ss_dssp C----------CCGGGGGCTTCSEEECCSSCCCCCGGGG---GCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSC
T ss_pred c----------cccccccccccceeeccCCccCCCCccc---ccCCCCEEECCCCCCCC-c-chhhcccccchhccccCc
Confidence 1 1233344555666666666666433321 34566666666666664 2 245566666666666666
Q ss_pred ccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcc
Q 047591 376 FSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCE 455 (1624)
Q Consensus 376 l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~ 455 (1624)
+++..+ ++.+++|++|++++|+++. ..
T Consensus 253 l~~~~~--~~~~~~L~~L~l~~~~l~~-------------------------------~~-------------------- 279 (384)
T d2omza2 253 ISNLAP--LSGLTKLTELKLGANQISN-------------------------------IS-------------------- 279 (384)
T ss_dssp CCCCGG--GTTCTTCSEEECCSSCCCC-------------------------------CG--------------------
T ss_pred cCCCCc--ccccccCCEeeccCcccCC-------------------------------CC--------------------
Confidence 665543 5555556655555554431 10
Q ss_pred cCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccc
Q 047591 456 LGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTC 535 (1624)
Q Consensus 456 l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~ 535 (1624)
.+.++..++.+++++|++++ + ..+..+++++.|++++|++++. + .+..+++|+.|+|++|++++ +| .
T Consensus 280 -------~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~ 346 (384)
T d2omza2 280 -------PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-S 346 (384)
T ss_dssp -------GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred -------cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-h
Confidence 13334455556666666654 2 2355566666666666666643 2 25666666666666666663 33 4
Q ss_pred cccccCCccccccCccccccCchhhccccccceeecccc
Q 047591 536 LANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLN 574 (1624)
Q Consensus 536 ~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N 574 (1624)
++++++|++|+|++|++++.+| +.++++|+.|+|++|
T Consensus 347 l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred HcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 6666666666666666665433 666666777777666
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.5e-24 Score=254.49 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=181.4
Q ss_pred CCCCCccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCC
Q 047591 72 SSNSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISG 151 (1624)
Q Consensus 72 ~~~~~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 151 (1624)
+..+-|.|++|.|++. +|+ ++|+.|. +.+++|+|++|+|+...+.+|..+++|++|++++|.++.
T Consensus 5 p~~c~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 5 PFRCQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CTTCEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCEecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc
Confidence 4567899999999752 233 5676664 579999999999985445579999999999999999984
Q ss_pred ccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCC--CCCCCc
Q 047591 152 NLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ--GEFPPT 229 (1624)
Q Consensus 152 ~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~--g~~p~~ 229 (1624)
+++..+.++++|++|++++|+|+ .+|..+. ..|+.|++++|.+.+..+..+.....+..++...|... +..+..
T Consensus 70 -i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~ 145 (305)
T d1xkua_ 70 -ISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145 (305)
T ss_dssp -BCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTG
T ss_pred -cchhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccc
Confidence 66777789999999999999998 5776544 57889999999998766666777788888888888543 345667
Q ss_pred ccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCcccccccccc
Q 047591 230 IFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPS 309 (1624)
Q Consensus 230 ~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~ 309 (1624)
+..+++|+++++++|+++ .+|..+ +++|+.|++++|..++.++..+..++.++.|++++|++.++ .|.
T Consensus 146 ~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~--------~~~ 213 (305)
T d1xkua_ 146 FQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV--------DNG 213 (305)
T ss_dssp GGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE--------CTT
T ss_pred cccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhcccccccccccccccccc--------ccc
Confidence 788888899999998886 566554 46788888888888888888888888888888777765543 233
Q ss_pred ccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccC
Q 047591 310 IIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLS 353 (1624)
Q Consensus 310 ~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~ 353 (1624)
.+.++++|++|+|++|+|+ .||.++. .+++|++|+|++|+|+
T Consensus 214 ~~~~l~~L~~L~L~~N~L~-~lp~~l~-~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 214 SLANTPHLRELHLNNNKLV-KVPGGLA-DHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TGGGSTTCCEEECCSSCCS-SCCTTTT-TCSSCCEEECCSSCCC
T ss_pred cccccccceeeeccccccc-ccccccc-cccCCCEEECCCCccC
Confidence 4444455555555555554 3444332 3444445555444444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=9.3e-24 Score=247.63 Aligned_cols=221 Identities=23% Similarity=0.319 Sum_probs=125.3
Q ss_pred CCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceec
Q 047591 138 RLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYL 217 (1624)
Q Consensus 138 ~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~L 217 (1624)
.++.+|-++++|+ ++|+++. +++++|+|++|+|+...+.+|.++++|++|++++|.++...|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 3455666666665 4554432 34556666666665333334555556666666665555444555555555555555
Q ss_pred cCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccc
Q 047591 218 NGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTD 297 (1624)
Q Consensus 218 s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~ 297 (1624)
++|+++ .+|..+. ..|..|++++|.+.+..+..+.....+..++...|...
T Consensus 87 ~~n~l~-~l~~~~~---------------------------~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~- 137 (305)
T d1xkua_ 87 SKNQLK-ELPEKMP---------------------------KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK- 137 (305)
T ss_dssp CSSCCS-BCCSSCC---------------------------TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC-
T ss_pred cCCccC-cCccchh---------------------------hhhhhhhccccchhhhhhhhhhcccccccccccccccc-
Confidence 555555 3343322 24444555555554444444444555555555554322
Q ss_pred cCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCcccc
Q 047591 298 FGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFS 377 (1624)
Q Consensus 298 l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 377 (1624)
..+..+..+..+.+|+++++++|.++ .+|... .++|+.|++++|..++.+|..|.+++.+++|++++|.++
T Consensus 138 -----~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~ 208 (305)
T d1xkua_ 138 -----SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208 (305)
T ss_dssp -----GGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred -----ccCCCccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhcccccccccccccccc
Confidence 22223344455566666666666665 355443 456777777777777777777777777777777777777
Q ss_pred ccCcccccccccccEEEcccccc
Q 047591 378 GLVANTFGNCRQLQILNLAYSQL 400 (1624)
Q Consensus 378 g~~~~~f~~l~~L~~L~L~~N~l 400 (1624)
+..+..|.++++|++|+|++|+|
T Consensus 209 ~~~~~~~~~l~~L~~L~L~~N~L 231 (305)
T d1xkua_ 209 AVDNGSLANTPHLRELHLNNNKL 231 (305)
T ss_dssp EECTTTGGGSTTCCEEECCSSCC
T ss_pred ccccccccccccceeeecccccc
Confidence 77666666666666666666555
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=8.8e-24 Score=245.16 Aligned_cols=266 Identities=26% Similarity=0.290 Sum_probs=133.0
Q ss_pred EeecccCCCCCCCcccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccc-cc
Q 047591 321 QLYGNHLSGNLPSSTGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAY-SQ 399 (1624)
Q Consensus 321 ~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~-N~ 399 (1624)
+.++++++ .+|..+. +++++|+|++|+|++..|.+|.++++|++||+++|++.++.+..+.++..++.++... |.
T Consensus 17 ~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp ECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 34444444 4555442 3456666777766655555666666677777777776666666666666555554432 22
Q ss_pred cccCCCCCCcccccccccccccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCc
Q 047591 400 LATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQ 479 (1624)
Q Consensus 400 l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~ 479 (1624)
++ ...|..+.+++ +|++|++++|.+....+..+..+.+|+.+++++|+
T Consensus 93 ~~-------------------------------~l~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~ 140 (284)
T d1ozna_ 93 LR-------------------------------SVDPATFHGLG-RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140 (284)
T ss_dssp CC-------------------------------CCCTTTTTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cc-------------------------------cccchhhcccc-cCCEEecCCcccccccccccchhcccchhhhcccc
Confidence 21 11111122221 22222233333333333344445555555555555
Q ss_pred cCCCccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchh
Q 047591 480 LASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPST 559 (1624)
Q Consensus 480 l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~ 559 (1624)
+++..+..|..+++|+.|+|++|+|++..|..|.++++|+.+++++|++++..|..|.++++|++|++++|++++..|..
T Consensus 141 l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~ 220 (284)
T d1ozna_ 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHH
T ss_pred ccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccc
Confidence 55444444555555555555555555444455555555555555555555555555555555555555555555554455
Q ss_pred hccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccccccCCccccccccccCCCCC
Q 047591 560 FWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPSSIGGLKDLTYLALARNGFQG 626 (1624)
Q Consensus 560 ~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ls~N~l~g 626 (1624)
|..+.+|+.|++++|.+.+.-+. ..-...++.+....+++.|..|.++.+ +...+++.+.|+|
T Consensus 221 ~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 221 LAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 55555555555555555543221 111223445555555555555555432 2334444555544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=5.5e-24 Score=246.91 Aligned_cols=265 Identities=22% Similarity=0.237 Sum_probs=202.5
Q ss_pred cCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEcc-CCcc
Q 047591 96 IPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVS-SNQI 174 (1624)
Q Consensus 96 l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls-~N~l 174 (1624)
.++.+|. ++|..|. +.+++|+|++|+|+...|.+|..+++|++||+++|++.. ++...+..++.+..++.+ .|.+
T Consensus 18 c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~-i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 18 CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp CCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSCTTC
T ss_pred cCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccc-ccccccccccccccccccccccc
Confidence 3445555 5676654 568999999999986556679999999999999999974 566677788889888765 5567
Q ss_pred cccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccc
Q 047591 175 TGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDL 254 (1624)
Q Consensus 175 ~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 254 (1624)
+...|.+|.++++|++|++++|.+....+..+...++|+.+++++|+|++..+..|.++++|++|+|++|+++ .+|...
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~-~l~~~~ 172 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERA 172 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc-ccchhh
Confidence 7666788999999999999999998777778888999999999999998766777888899999999999987 577778
Q ss_pred cccCCCCcEeecccccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCc
Q 047591 255 CRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSS 334 (1624)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~ 334 (1624)
|.++++|++|++++|++++..|..|..+++|++||+++|++.. ..|..+.++.+|++|+|++|.+.+.-+..
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~--------~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA--------LPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC--------CCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred hccccccchhhhhhccccccChhHhhhhhhccccccccccccc--------ccccccccccccCEEEecCCCCCCCccch
Confidence 8888999999999999998888999999999999888776543 45566777788888888888877654321
Q ss_pred ccccCCCccEEEecCCccCCcCcccccCCCCCcEEecCCccccc
Q 047591 335 TGINLPNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSG 378 (1624)
Q Consensus 335 ~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 378 (1624)
. -...++.+....+++....|..+.+ +..++++.+.|+|
T Consensus 245 ~--l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 245 P--LWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp H--HHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred H--HHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 1 1223555566666666666666543 3444455555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.3e-21 Score=224.32 Aligned_cols=169 Identities=29% Similarity=0.341 Sum_probs=81.8
Q ss_pred EecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCc
Q 047591 94 LSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQ 173 (1624)
Q Consensus 94 l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~ 173 (1624)
++.++++|+ .||+.|. ++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .++. ++.+++|++|+|++|+
T Consensus 15 v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~Ls~N~ 88 (266)
T d1p9ag_ 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQ 88 (266)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSC
T ss_pred EEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--cccccccccccccccc
Confidence 355555555 3555543 34566666666666444445555666666666666554 2322 1344555555555555
Q ss_pred ccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCcc
Q 047591 174 ITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVD 253 (1624)
Q Consensus 174 l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~ 253 (1624)
+++ +|..+.++++|++|++++|.+.+..+..+..+.+|++|++++|.+++ +|..
T Consensus 89 l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~-------------------------l~~~ 142 (266)
T d1p9ag_ 89 LQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-------------------------LPPG 142 (266)
T ss_dssp CSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-------------------------CCTT
T ss_pred ccc-cccccccccccccccccccccceeeccccccccccccccccccccce-------------------------eccc
Confidence 542 34444444444444444444443333344444444444444444443 3334
Q ss_pred ccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCc
Q 047591 254 LCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQ 294 (1624)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~ 294 (1624)
.+..+++|+.|++++|++++..+..|+.+++|++|+|++|+
T Consensus 143 ~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 183 (266)
T d1p9ag_ 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183 (266)
T ss_dssp TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccccccchhcccccccccccCccccccccccceeecccCC
Confidence 44444444444444444444444444444444444444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=2e-21 Score=222.76 Aligned_cols=201 Identities=28% Similarity=0.333 Sum_probs=123.7
Q ss_pred CCccEEEecCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCccccccccccc
Q 047591 340 PNLLRLYLWGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCR 419 (1624)
Q Consensus 340 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 419 (1624)
..+.+.+.++++|+ .+|..+. ++|++|||++|+|+++++..|.++++|++|+|++|+|+..
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l---------------- 70 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL---------------- 70 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE----------------
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc----------------
Confidence 34445555566655 3454442 3566666666666666666666666666666666655320
Q ss_pred ccceeeeccCCCCccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecc
Q 047591 420 YLRYLAIQTNPWKGILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDL 499 (1624)
Q Consensus 420 ~L~~L~l~~N~~~g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~L 499 (1624)
| .++.+++|++|+|++|++++ +|..+..+++|++|++
T Consensus 71 -----------------------------------------~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 71 -----------------------------------------Q-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDV 107 (266)
T ss_dssp -----------------------------------------E-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEEC
T ss_pred -----------------------------------------c-cccccccccccccccccccc-cccccccccccccccc
Confidence 0 12234445555555555543 3445555566666666
Q ss_pred cccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCC
Q 047591 500 SYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGC 579 (1624)
Q Consensus 500 s~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~ 579 (1624)
++|.+.+..+..+..+.+++.|++++|.+++..|..+..+++|+.|++++|++++..|..|..+.+|+.|||++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 666666555555566666666666666666555555666666666666666666655566666666666677777666 5
Q ss_pred CCcccccccccceeeccCCcCCCC
Q 047591 580 LPQDIGNLKVLTGLYLSGNQLSCS 603 (1624)
Q Consensus 580 iP~~l~~l~~L~~L~Ls~N~l~g~ 603 (1624)
||+++..+++|+.|+|++|++.|.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cChhHCCCCCCCEEEecCCCCCCC
Confidence 787777888888888888888764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=3.1e-21 Score=209.40 Aligned_cols=162 Identities=16% Similarity=0.189 Sum_probs=120.9
Q ss_pred cCCeEeecCceEEEEEEEcCCceEEEEEeccch------------------hhHHHHHHHHHHHHHhcCCCceeEEEeee
Q 047591 1339 ESNLLGTGIFSSVYKATFADGTNAAIKIFSLQE------------------DRALKSFDAECEVMRRIRHRNLAKIVSSC 1400 (1624)
Q Consensus 1339 ~~~~lG~G~~G~Vyk~~~~~~~~vAvK~~~~~~------------------~~~~~~f~~E~~~l~~l~HpNIv~l~g~~ 1400 (1624)
..+.||+|+||+||+|+..+|+.||||+++... ......+.+|...+.++.|+++++.+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 457899999999999998899999999875211 11234556789999999999999988764
Q ss_pred ccCCeeEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcCCCCCcEEecCCCcEEEeeec
Q 047591 1401 SNPGFKALILQYMPQGSLEKWLYSHNYLLNIEQRLDIMIDVACALEYLHQGYSTSIIHCDLKPSNVLLDDDMVAHLGDFG 1480 (1624)
Q Consensus 1401 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~kl~DFG 1480 (1624)
. .++||||++++...+ ++.....+++.|+++|++|||+ .+|+||||||+|||+++++ ++|+|||
T Consensus 84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEECCCT
T ss_pred C----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EEEEECC
Confidence 2 379999999865432 2334456799999999999997 7999999999999999754 8999999
Q ss_pred ceeecCCCCCcccccccccccccc------ccccCCCCcCcccchHHHHHHH
Q 047591 1481 IAKLLDGVDSMKQTMTLATIGYMA------PEYGSEGIVSTSGDVYSFGILM 1526 (1624)
Q Consensus 1481 la~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~~~k~DV~SfGvil 1526 (1624)
+|+........ .|.. .|+. .+.|+.++||||..--+
T Consensus 148 ~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99876432210 1111 1111 35678999999986443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=3.9e-21 Score=208.62 Aligned_cols=167 Identities=17% Similarity=0.180 Sum_probs=119.9
Q ss_pred CCcceeecCCccceEEEEecCCCEEEEEEeecccc------------------hhHHHHHHHHHHHHhcCCCceeeeeee
Q 047591 747 SESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLD------------------GAIKSFDAECEVLRRVRHRNLVKIISS 808 (1624)
Q Consensus 747 ~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 808 (1624)
++.+.||+|+||+||+|+..+|++||||+++.... .....+.+|...+.++.|+++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34689999999999999988899999998753110 012345678999999999999998876
Q ss_pred eccCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCcCCCCCeeeCCCCceEEEee
Q 047591 809 CSNHGFKALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGHPTPVIHCDLKPSNVLLDDDTVAHLSDF 888 (1624)
Q Consensus 809 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~~kl~DF 888 (1624)
.. .++||||++++.+.+ ++.....+++.|+++|++|||+. +|+||||||+|||+++++ ++++||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECCC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEEC
Confidence 43 379999999865432 44555678999999999999984 599999999999999765 899999
Q ss_pred eeeeccCCCCCcccccccccccccCccccCCCCCCcchhHHHHHH
Q 047591 889 GISKLLDGEDSVTQTMTLATFGYMAPEYGSEGIVSTCGDVYSFGI 933 (1624)
Q Consensus 889 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~k~DvwS~Gv 933 (1624)
|+|+.......... .......+ .|++ .+.|+.++||||..-
T Consensus 147 G~a~~~~~~~~~~~--l~rd~~~~-~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 147 PQSVEVGEEGWREI--LERDVRNI-ITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp TTCEETTSTTHHHH--HHHHHHHH-HHHH-HHHHCCCCCHHHHHH
T ss_pred CCcccCCCCCcHHH--HHHHHHHH-HHHH-cCCCCCcccHHHHHH
Confidence 99987643321110 00000000 1122 245678889999753
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=1.8e-18 Score=205.65 Aligned_cols=138 Identities=28% Similarity=0.310 Sum_probs=98.9
Q ss_pred CCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCccccccccccee
Q 047591 137 PRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELY 216 (1624)
Q Consensus 137 ~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 216 (1624)
.+|++|||++|.++ .+|+ .+++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++... +.|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccc
Confidence 36889999999997 4664 3578999999999998 788765 46788888888887 555321 3588899
Q ss_pred ccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcCCccccccCcCCeeeccCCccc
Q 047591 217 LNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRIPKDIGNCTLLNYLGLRDNQLT 296 (1624)
Q Consensus 217 Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 296 (1624)
+++|.++ .+|. ++++++|++|++++|.+++ .|. ....+..|.+.++... .+..++.++.++.|++++|...
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccccc-cccc-hhhhccceeeccccccccc-ccc----ccccccchhhcccccc--ccccccccccceeccccccccc
Confidence 9999887 5664 5778888888888888763 332 2345666766655443 3455666777777777766544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=8.8e-18 Score=199.55 Aligned_cols=314 Identities=26% Similarity=0.337 Sum_probs=191.1
Q ss_pred CcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccc
Q 047591 113 SFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLS 192 (1624)
Q Consensus 113 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 192 (1624)
.+|++|||++|+++ .+|+. +++|++|+|++|+|+ .+|. .+.+|+.|++++|+++ .++.- .++|++||
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLK-ALSDL---PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCS-CCCSC---CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-cccc----chhhhhhhhhhhcccc-hhhhh---cccccccc
Confidence 36889999999998 68864 578999999999998 5664 3578999999999998 45532 24699999
Q ss_pred cccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeeccccccc
Q 047591 193 VSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTT 272 (1624)
Q Consensus 193 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~ 272 (1624)
+++|.++ .+|. ++.+++|++|++++|.++. .|... ..+..+.+.++.... ...+..++.++.|++++|...
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~---~~l~~l~~~~~~~~~---~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE---LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS---CCCCTTCTTCCEEECCSSCCS
T ss_pred ccccccc-cccc-hhhhccceeeccccccccc-ccccc---ccccchhhccccccc---cccccccccceeccccccccc
Confidence 9999998 6775 6889999999999999984 44443 445556666665432 122357889999999999876
Q ss_pred CcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCCcc
Q 047591 273 GRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGNNL 352 (1624)
Q Consensus 273 g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l 352 (1624)
.. +.. ....+.+..+++.+..+ | .+..+..|+.+++++|... .+|.. ..++..+.+..|++
T Consensus 176 ~~-~~~---~~~~~~l~~~~~~~~~~---------~-~~~~l~~L~~l~l~~n~~~-~~~~~----~~~l~~~~~~~~~~ 236 (353)
T d1jl5a_ 176 KL-PDL---PLSLESIVAGNNILEEL---------P-ELQNLPFLTTIYADNNLLK-TLPDL----PPSLEALNVRDNYL 236 (353)
T ss_dssp SC-CCC---CTTCCEEECCSSCCSSC---------C-CCTTCTTCCEEECCSSCCS-SCCSC----CTTCCEEECCSSCC
T ss_pred cc-ccc---ccccccccccccccccc---------c-ccccccccccccccccccc-ccccc----cccccccccccccc
Confidence 43 222 22334555554443321 1 1233445555555555443 22221 23344444444444
Q ss_pred CCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeeccCCCC
Q 047591 353 SGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQTNPWK 432 (1624)
Q Consensus 353 ~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~~N~~~ 432 (1624)
... +.. ...+...++..|.+.+... +
T Consensus 237 ~~~-~~~---~~~l~~~~~~~~~~~~l~~------------------------------------l-------------- 262 (353)
T d1jl5a_ 237 TDL-PEL---PQSLTFLDVSENIFSGLSE------------------------------------L-------------- 262 (353)
T ss_dssp SCC-CCC---CTTCCEEECCSSCCSEESC------------------------------------C--------------
T ss_pred ccc-ccc---ccccccccccccccccccc------------------------------------c--------------
Confidence 321 111 1223333333333222100 0
Q ss_pred ccCCCcccCccccchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccc
Q 047591 433 GILPNSVGNLSKSLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSEL 512 (1624)
Q Consensus 433 g~~p~~~~~l~~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l 512 (1624)
.......++..+.+. .....+++|++|+|++|+++ .+|.. +++|+.|+|++|+|+ .+|+.
T Consensus 263 ----------~~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~- 322 (353)
T d1jl5a_ 263 ----------PPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL- 322 (353)
T ss_dssp ----------CTTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC-
T ss_pred ----------cchhcccccccCccc----cccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc-
Confidence 001111112222221 11223467888888888887 56754 467888888888888 67753
Q ss_pred cCCCCCceeecccccccCCCccccccccCCccccc
Q 047591 513 CQLESLNTLLLQGNALQNQIPTCLANLTSLRALNL 547 (1624)
Q Consensus 513 ~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~L 547 (1624)
+++|+.|+|++|+++ .+|+... +|+.|.+
T Consensus 323 --~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~ 351 (353)
T d1jl5a_ 323 --PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRM 351 (353)
T ss_dssp --CTTCCEEECCSSCCS-SCCCCCT---TCCEEEC
T ss_pred --cCCCCEEECcCCcCC-CCCcccc---ccCeeEC
Confidence 457888888888887 6776433 4555444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=8.3e-21 Score=234.46 Aligned_cols=87 Identities=21% Similarity=0.248 Sum_probs=51.5
Q ss_pred CcccEEeccCCccCCCccc----hhccccccceecccccccccC----CCcccc-CCCCCceeecccccccC----CCcc
Q 047591 468 SNIIALSLYQNQLASTIPT----TVGKLQNLQGLDLSYNNIQGS----IPSELC-QLESLNTLLLQGNALQN----QIPT 534 (1624)
Q Consensus 468 ~~L~~L~L~~N~l~g~iP~----~~~~l~~L~~L~Ls~N~l~g~----iP~~l~-~l~~L~~L~L~~N~l~g----~iP~ 534 (1624)
..|+.+++++|.++..-.. .+....+|++|||++|+++.. +++.+. ..+.|++|+|++|+|+. .++.
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 3567777777776644222 233445677777777777532 333333 34557777777777753 2344
Q ss_pred ccccccCCccccccCccccc
Q 047591 535 CLANLTSLRALNLSSNRLNS 554 (1624)
Q Consensus 535 ~~~~l~~L~~L~Ls~N~l~g 554 (1624)
.+..+++|++|+|++|+++.
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCH
T ss_pred HHhcCCCCCEEECCCCcCCH
Confidence 55556677777777777654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=6.1e-18 Score=183.23 Aligned_cols=134 Identities=19% Similarity=0.317 Sum_probs=65.6
Q ss_pred CCCccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccC-CcccCCCCCCcEEEccCCCCCCc
Q 047591 74 NSVCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTL-PNELWLMPRLRIIDLSSNRISGN 152 (1624)
Q Consensus 74 ~~~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~i-P~~~~~l~~L~~L~Ls~N~l~g~ 152 (1624)
.+-|.|.-|.|++ ++|+ +||+.|. +++++|+|++|+|++.+ +..|..+++|++|+|++|++++
T Consensus 5 ~C~C~~~~v~Cs~------------~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~- 68 (192)
T d1w8aa_ 5 MCHCEGTTVDCTG------------RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG- 68 (192)
T ss_dssp TSEEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-
T ss_pred CCEEcCCEEEEeC------------CCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc-
Confidence 3556666666643 2333 3454442 34555555555555433 3334455555555555555543
Q ss_pred cchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCC
Q 047591 153 LFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQ 223 (1624)
Q Consensus 153 ~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 223 (1624)
++++.+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 69 IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp BCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 33333444555555555555555444444455555555555555555444444444445555555444444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=3.9e-17 Score=183.65 Aligned_cols=133 Identities=15% Similarity=0.192 Sum_probs=90.3
Q ss_pred CccceeeEecCCCCcEEEEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccch
Q 047591 76 VCNWVGVTCGSRHGRVTDLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFD 155 (1624)
Q Consensus 76 ~C~W~Gv~C~~~~~~v~~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~ 155 (1624)
-|.++.|.|.. .++. .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+++
T Consensus 7 ~C~~~~i~c~~------------~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~ 71 (242)
T d1xwdc1 7 HCSNRVFLCQE------------SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71 (242)
T ss_dssp EECSSEEEEES------------CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred CCcCCEEEEeC------------CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence 35666666643 3444 5666553 4688999999999854455688888999999999888877777
Q ss_pred hhhccCCCcCEEEcc-CCcccccCCccccCCCcccccccccccccccccC-cccccccccceeccCCcCC
Q 047591 156 DMCNSLTELESFDVS-SNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQ-NIGNLTELMELYLNGNNLQ 223 (1624)
Q Consensus 156 ~~~~~l~~L~~L~Ls-~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~ 223 (1624)
..+..++.+++|++. .|++....|..|.++++|++|++++|+++...+. .+..+..|..+..+++++.
T Consensus 72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccc
Confidence 777778888888765 4667766677777788888888888777632221 2334445555555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.5e-17 Score=178.37 Aligned_cols=173 Identities=17% Similarity=0.252 Sum_probs=149.8
Q ss_pred cEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCccccccccc
Q 047591 116 VSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSF 195 (1624)
Q Consensus 116 ~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~ 195 (1624)
+.++.++|+++ .||..+. +++++|+|++|+|++.+++..|.++++|++|+|++|++++..+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 46789999999 7998774 78999999999999888888899999999999999999999999999999999999999
Q ss_pred ccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccCcC
Q 047591 196 NELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTGRI 275 (1624)
Q Consensus 196 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g~i 275 (1624)
|+|++..|..|.++++|++|+|++|+|++..|.+|.++++|++|+|++|.+....+...+. ..++.+.+..|.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~--~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh--hhhhhhcccCCCeEeCC
Confidence 9999777888999999999999999999888888999999999999999998655443332 34677788888888877
Q ss_pred CccccccCcCCeeeccCCccc
Q 047591 276 PKDIGNCTLLNYLGLRDNQLT 296 (1624)
Q Consensus 276 p~~~~~l~~L~~L~Ls~N~l~ 296 (1624)
|..+ ..++.++|+.|++.
T Consensus 166 p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp STTT---TTSBGGGSCTTTCC
T ss_pred Chhh---cCCEeeecCHhhCc
Confidence 7654 45667788877654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=6.3e-17 Score=181.94 Aligned_cols=219 Identities=16% Similarity=0.208 Sum_probs=108.2
Q ss_pred cEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCC-ccccCCCcccccccc
Q 047591 116 VSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLP-SSLGDCSKLKRLSVS 194 (1624)
Q Consensus 116 ~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~Ls 194 (1624)
+.++.++++++ .+|+.+. +++++|||++|+|+ .+|+..|.++++|++|+|++|.+...+| ..|.+++++++|++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 45666666666 5665542 45666666666665 3555555555566666666655554333 234555555555544
Q ss_pred c-ccccccccCcccccccccceeccCCcCCCCCCC-cccccCccchheeccccccCCCCccccccCCCCcEeeccccccc
Q 047591 195 F-NELTGRIPQNIGNLTELMELYLNGNNLQGEFPP-TIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTT 272 (1624)
Q Consensus 195 ~-N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~ 272 (1624)
. |++....|..|.++++|++|++++|++....+. .+..+..++.+..+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~---------------------------- 138 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI---------------------------- 138 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCT----------------------------
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccccccccccc----------------------------
Confidence 2 445444444455555555555555555421111 1112222222222222
Q ss_pred CcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEE-EecCCc
Q 047591 273 GRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRL-YLWGNN 351 (1624)
Q Consensus 273 g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L-~Ls~N~ 351 (1624)
++.++..+.|.+. ...++.|++++|+++ .++...+ +.++++.+ ++++|+
T Consensus 139 ---------------------~l~~i~~~~~~~~-------~~~l~~L~l~~n~l~-~i~~~~~-~~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 139 ---------------------NIHTIERNSFVGL-------SFESVILWLNKNGIQ-EIHNCAF-NGTQLDELNLSDNNN 188 (242)
T ss_dssp ---------------------TCCEECTTSSTTS-------BSSCEEEECCSSCCC-EECTTTT-TTCCEEEEECTTCTT
T ss_pred ---------------------ccccccccccccc-------cccceeeeccccccc-ccccccc-cchhhhccccccccc
Confidence 2222222222211 013344444444444 2333333 23333333 445566
Q ss_pred cCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEcc
Q 047591 352 LSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396 (1624)
Q Consensus 352 l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~ 396 (1624)
++...+..|.++++|++|+|++|+|+.+++..|.++++|++|++.
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 664434456667777777777777776666667777777666553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=6.9e-20 Score=226.12 Aligned_cols=168 Identities=17% Similarity=0.093 Sum_probs=113.6
Q ss_pred CCCCcccEEeccCCccCCC----ccchhccccccceecccccccccCCCccc----c-CCCCCceeecccccccCCCccc
Q 047591 465 GNLSNIIALSLYQNQLAST----IPTTVGKLQNLQGLDLSYNNIQGSIPSEL----C-QLESLNTLLLQGNALQNQIPTC 535 (1624)
Q Consensus 465 ~~l~~L~~L~L~~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l----~-~l~~L~~L~L~~N~l~g~iP~~ 535 (1624)
.....++.+++++|.+... ....+...+.++.+++++|.++..-...+ . ....|+.+++++|.++..-...
T Consensus 252 ~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~ 331 (460)
T d1z7xw1 252 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH 331 (460)
T ss_dssp STTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhh
Confidence 3455677888888877533 33345567788888888888764322222 1 2357888888888887543333
Q ss_pred ----cccccCCccccccCcccccc----Cchhhc-cccccceeecccccccC----CCCcccccccccceeeccCCcCCC
Q 047591 536 ----LANLTSLRALNLSSNRLNST----IPSTFW-SLEYILVVDFSLNLLSG----CLPQDIGNLKVLTGLYLSGNQLSC 602 (1624)
Q Consensus 536 ----~~~l~~L~~L~Ls~N~l~g~----iP~~~~-~l~~L~~ldLs~N~l~g----~iP~~l~~l~~L~~L~Ls~N~l~g 602 (1624)
+....+|++|+|++|+++.. ++..+. ....|+.|+|++|.++. .+++.+..+++|++|+|++|+++.
T Consensus 332 l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 332 FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred cccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 34456789999999988653 333333 45678899999998874 255667777899999999999886
Q ss_pred Ccccccc-----CCccccccccccCCCCCCCchhh
Q 047591 603 SIPSSIG-----GLKDLTYLALARNGFQGSIPEAI 632 (1624)
Q Consensus 603 ~iP~~~~-----~l~~L~~L~ls~N~l~g~iP~~~ 632 (1624)
.....+. +.+.|+.|++++|++....+..+
T Consensus 412 ~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence 4333332 34578999999999876555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=9.2e-17 Score=178.82 Aligned_cols=98 Identities=20% Similarity=0.342 Sum_probs=47.1
Q ss_pred cEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccC
Q 047591 140 RIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNG 219 (1624)
Q Consensus 140 ~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~ 219 (1624)
..++++.+++++.+.. ..+.+|++|++++|.|+ .++ .+..+++|++|++++|++++..| +.++++|++|++++
T Consensus 22 ~~~~l~~~~~~d~~~~---~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 22 IKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHTTCSSTTSEECH---HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCCcCCH---HHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 3345555555543221 23445555555555555 232 35555555555555555553322 45555555555555
Q ss_pred CcCCCCCCCcccccCccchheeccccc
Q 047591 220 NNLQGEFPPTIFNVSSLRVIVLANNSL 246 (1624)
Q Consensus 220 N~l~g~~p~~~~~l~~L~~L~L~~N~l 246 (1624)
|.++ .++ .+.++++|+.+++++|..
T Consensus 95 n~~~-~i~-~l~~l~~L~~l~l~~~~~ 119 (227)
T d1h6ua2 95 NPLK-NVS-AIAGLQSIKTLDLTSTQI 119 (227)
T ss_dssp CCCS-CCG-GGTTCTTCCEEECTTSCC
T ss_pred cccc-ccc-cccccccccccccccccc
Confidence 5554 222 234444444444444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.5e-16 Score=177.17 Aligned_cols=204 Identities=22% Similarity=0.279 Sum_probs=97.2
Q ss_pred cccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeeccc
Q 047591 189 KRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRD 268 (1624)
Q Consensus 189 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~ 268 (1624)
..++++.+++++.+ .+..|++|++|++++|+++ .++ .+.++++|++|++++|++++..| +..+++|++|++++
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSG 94 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc---cccccccccccccc
Confidence 33444444444322 2334444444444444444 222 34444444444444444443211 23444555555555
Q ss_pred ccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEec
Q 047591 269 CMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLW 348 (1624)
Q Consensus 269 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls 348 (1624)
|.++. + +.+..+++|+.+++++++..++ ..+.....++.++++++.+....+ ....++|++|+++
T Consensus 95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~----------~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~L~~L~l~ 159 (227)
T d1h6ua2 95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDV----------TPLAGLSNLQVLYLDLNQITNISP---LAGLTNLQYLSIG 159 (227)
T ss_dssp CCCSC-C-GGGTTCTTCCEEECTTSCCCCC----------GGGTTCTTCCEEECCSSCCCCCGG---GGGCTTCCEEECC
T ss_pred ccccc-c-cccccccccccccccccccccc----------chhccccchhhhhchhhhhchhhh---hcccccccccccc
Confidence 54442 2 1344555555555555443321 112334455555555555543222 1245556666666
Q ss_pred CCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEccccccccCCCCCCcccccccccccccceeeec
Q 047591 349 GNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLAYSQLATGSLSQGQSFFSSLTNCRYLRYLAIQ 427 (1624)
Q Consensus 349 ~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~l~ 427 (1624)
+|++++.. .+.++++|+.|+|++|+++++.+ |+++++|++|+|++|++++. ..+.++++|++|+++
T Consensus 160 ~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i---------~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 160 NAQVSDLT--PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV---------SPLANTSNLFIVTLT 225 (227)
T ss_dssp SSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBC---------GGGTTCTTCCEEEEE
T ss_pred ccccccch--hhcccccceecccCCCccCCChh--hcCCCCCCEEECcCCcCCCC---------cccccCCCCCEEEee
Confidence 66655322 25556666666666666665432 55666666666666665431 124455556666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=4.6e-16 Score=170.79 Aligned_cols=183 Identities=20% Similarity=0.277 Sum_probs=106.9
Q ss_pred ccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecc
Q 047591 188 LKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLR 267 (1624)
Q Consensus 188 L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls 267 (1624)
+...+++.+.+++.++. ..+.+|++|++++|+++. ++ .+..+++|++|+|++|++++ ++. ++.+++|++|+++
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECC
T ss_pred HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-ccc--cccCccccccccc
Confidence 33445555555544432 245556666666666653 22 25556666666666666653 332 2456666666666
Q ss_pred cccccCcCCccccccCcCCeeeccCCcccccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEe
Q 047591 268 DCMTTGRIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYL 347 (1624)
Q Consensus 268 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 347 (1624)
+|++++ +| .+.++++|+.|++++|.+.++ ..+.++.+++.+++++|.+++ ++ . ...+++|+++++
T Consensus 99 ~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~----------~~l~~l~~l~~l~~~~n~l~~-~~-~-~~~l~~L~~l~l 163 (210)
T d1h6ta2 99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISDI----------NGLVHLPQLESLYLGNNKITD-IT-V-LSRLTKLDTLSL 163 (210)
T ss_dssp SSCCCC-GG-GGTTCTTCCEEECTTSCCCCC----------GGGGGCTTCCEEECCSSCCCC-CG-G-GGGCTTCSEEEC
T ss_pred cccccc-cc-ccccccccccccccccccccc----------ccccccccccccccccccccc-cc-c-cccccccccccc
Confidence 666654 33 466666777777766654432 124455666666666666653 22 1 225677777777
Q ss_pred cCCccCCcCcccccCCCCCcEEecCCccccccCcccccccccccEEEcc
Q 047591 348 WGNNLSGVIPSSICNASKLTVLELSRNLFSGLVANTFGNCRQLQILNLA 396 (1624)
Q Consensus 348 s~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~f~~l~~L~~L~L~ 396 (1624)
++|++++. + .++++++|+.|+|++|+++.+ | .|.++++|++|+|+
T Consensus 164 ~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 164 EDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF 208 (210)
T ss_dssp CSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred cccccccc-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence 77777753 3 267777777777777777754 2 46777777777765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.60 E-value=3.9e-16 Score=169.83 Aligned_cols=168 Identities=22% Similarity=0.279 Sum_probs=87.3
Q ss_pred cccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCccccccc
Q 047591 114 FLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSV 193 (1624)
Q Consensus 114 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L 193 (1624)
.+..+.++.+++++.++. ..+.+|++|++++|.++. +. .+..+++|++|++++|+|++. ++ ++++++|++|++
T Consensus 19 ~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~-l~--~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l 91 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEEC
T ss_pred HHHHHHhCCCCCCCccCH--HHhcCCCEEECCCCCCCC-cc--ccccCCCcCcCccccccccCc-cc-ccCCcccccccc
Confidence 334445555655544332 245566666666666552 21 134556666666666666542 22 566666666666
Q ss_pred ccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccccccCCCCccccccCCCCcEeecccccccC
Q 047591 194 SFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG 273 (1624)
Q Consensus 194 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g 273 (1624)
++|.+. .+| .++++++|+.|++++|.+... ..+.++++|+.|++++|++. .+| .+..+++|++|++++|++++
T Consensus 92 ~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~--~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 92 NNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS--ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG--GGTTCTTCSEEECCSSCCCC
T ss_pred cccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc--cccccccccccccccccccC
Confidence 666655 333 255666666666666665532 23445555555555555554 222 12345555555555555543
Q ss_pred cCCccccccCcCCeeeccCCcccc
Q 047591 274 RIPKDIGNCTLLNYLGLRDNQLTD 297 (1624)
Q Consensus 274 ~ip~~~~~l~~L~~L~Ls~N~l~~ 297 (1624)
.. .++++++|+.|+|++|++++
T Consensus 165 l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 165 LK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCC
T ss_pred Cc--cccCCCCCCEEECCCCCCCC
Confidence 21 24555555555555555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.59 E-value=2.3e-15 Score=165.05 Aligned_cols=163 Identities=28% Similarity=0.413 Sum_probs=123.0
Q ss_pred cchhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecc
Q 047591 445 SLEYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQ 524 (1624)
Q Consensus 445 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~ 524 (1624)
+++.|++++|.+... + .+..+++|++|+|++|++++ ++ .++.+++|++|++++|++++ +| .++++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccc
Confidence 344455555555432 2 36778888888888888876 44 35778888888888888884 55 57888888888888
Q ss_pred cccccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCc
Q 047591 525 GNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSI 604 (1624)
Q Consensus 525 ~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~i 604 (1624)
+|.+.. + ..+.+++.++.+++++|++++ +..+..+++|+.+++++|++++ ++ .++++++|+.|+|++|+++ .+
T Consensus 121 ~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l 193 (210)
T d1h6ta2 121 HNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DL 193 (210)
T ss_dssp TSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BC
T ss_pred cccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-CC
Confidence 888863 3 467888888888888888875 3457778888888888888886 44 3788888888888888888 46
Q ss_pred cccccCCcccccccccc
Q 047591 605 PSSIGGLKDLTYLALAR 621 (1624)
Q Consensus 605 P~~~~~l~~L~~L~ls~ 621 (1624)
| .+.++++|++|+|++
T Consensus 194 ~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 194 R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G-GGTTCTTCSEEEEEE
T ss_pred h-hhcCCCCCCEEEccC
Confidence 6 588888888888864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.57 E-value=3.1e-15 Score=162.60 Aligned_cols=177 Identities=25% Similarity=0.364 Sum_probs=136.8
Q ss_pred hhhccCCcccCCCCCCCcCCCCcccEEeccCCccCCCccchhccccccceecccccccccCCCccccCCCCCceeecccc
Q 047591 447 EYFYAGSCELGGGIPAEFGNLSNIIALSLYQNQLASTIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGN 526 (1624)
Q Consensus 447 ~~L~l~~n~l~g~ip~~~~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 526 (1624)
....++.+.+++.++ ...+.++++|++++|.++. + +.+..+++|++|+|++|++++ +++ ++++++|+.|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-ccc-ccCCccccccccccc
Confidence 345566666666543 3457788889999888874 4 357788899999999999885 443 888889999999999
Q ss_pred cccCCCccccccccCCccccccCccccccCchhhccccccceeecccccccCCCCcccccccccceeeccCCcCCCCccc
Q 047591 527 ALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWSLEYILVVDFSLNLLSGCLPQDIGNLKVLTGLYLSGNQLSCSIPS 606 (1624)
Q Consensus 527 ~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ldLs~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 606 (1624)
.+. .+| .+++++.|+.|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|++++ +|
T Consensus 95 ~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~-l~- 166 (199)
T d2omxa2 95 QIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTD-LK- 166 (199)
T ss_dssp CCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CG-
T ss_pred ccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccC-Cc-
Confidence 887 344 478888999999998888753 347788889999999998874 3 468888999999999999985 44
Q ss_pred cccCCccccccccccCCCCCCCchhhhcccccc
Q 047591 607 SIGGLKDLTYLALARNGFQGSIPEAIGSLISLE 639 (1624)
Q Consensus 607 ~~~~l~~L~~L~ls~N~l~g~iP~~~~~l~~L~ 639 (1624)
.++++++|++|++++|+++. +| .++++++|+
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~ 197 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSD-IS-VLAKLTNLE 197 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCS
T ss_pred cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCC
Confidence 48889999999999999885 55 466777665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=6.3e-15 Score=169.51 Aligned_cols=198 Identities=18% Similarity=0.231 Sum_probs=118.9
Q ss_pred EEecCCCCCCccCCccccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCC
Q 047591 93 DLSIPNLGLGGTIPPHVANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSN 172 (1624)
Q Consensus 93 ~l~l~~~~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N 172 (1624)
.+||++..+.+.....+.. ..+..+.++...+...+ .......+|++|||+++.++......++.++++|++|+|+++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 4677766654433333322 12455666655554322 233456688899998888876656667778888888888888
Q ss_pred cccccCCccccCCCccccccccc-cccccc-ccCcccccccccceeccCC-cCCCC-CCCcccc-cCccchheeccc--c
Q 047591 173 QITGQLPSSLGDCSKLKRLSVSF-NELTGR-IPQNIGNLTELMELYLNGN-NLQGE-FPPTIFN-VSSLRVIVLANN--S 245 (1624)
Q Consensus 173 ~l~g~iP~~l~~l~~L~~L~Ls~-N~l~g~-ip~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~-l~~L~~L~L~~N--~ 245 (1624)
.+++..+..++.+++|++|+|++ +.++.. +..-..++++|++|+++++ +++.. ++..+.. .++|+.|++++. .
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 161 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence 88887788888888888888888 456532 2233456788888888875 34321 1222222 345666666643 2
Q ss_pred ccCCCCccccccCCCCcEeecccc-cccCcCCccccccCcCCeeeccC
Q 047591 246 LFGSLPVDLCRRLPSLQELNLRDC-MTTGRIPKDIGNCTLLNYLGLRD 292 (1624)
Q Consensus 246 l~g~ip~~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~Ls~ 292 (1624)
++..--..++.++++|++|++++| .+++..+..++++++|++|+|++
T Consensus 162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~ 209 (284)
T d2astb2 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 209 (284)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCC
Confidence 321111123345566666666654 35555555566666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=3e-14 Score=163.73 Aligned_cols=225 Identities=18% Similarity=0.167 Sum_probs=119.4
Q ss_pred EEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCccccccccccccccc-ccCcccccccccceeccC
Q 047591 141 IIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGR-IPQNIGNLTELMELYLNG 219 (1624)
Q Consensus 141 ~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~-ip~~~~~l~~L~~L~Ls~ 219 (1624)
.|||+++.+.+........ ..+..+.++...+...+. ......+|++|||+++.++.. ++..+..+++|++|+|++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred EEECCCCCCCchHHHHHHh--ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 4555555554333333222 134455555555543222 233445677777777776543 344456677777777777
Q ss_pred CcCCCCCCCcccccCccchheeccc-cccCCCCccccccCCCCcEeeccccc-ccC-cCCccccc-cCcCCeeeccCCcc
Q 047591 220 NNLQGEFPPTIFNVSSLRVIVLANN-SLFGSLPVDLCRRLPSLQELNLRDCM-TTG-RIPKDIGN-CTLLNYLGLRDNQL 295 (1624)
Q Consensus 220 N~l~g~~p~~~~~l~~L~~L~L~~N-~l~g~ip~~~~~~l~~L~~L~Ls~N~-l~g-~ip~~~~~-l~~L~~L~Ls~N~l 295 (1624)
|.++...+..++.+++|++|+|+++ .++..--..+...+++|++|++++|. ++. .++..+.. +++|+.|++++..
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~- 159 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR- 159 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG-
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc-
Confidence 7776666666666666777777663 34311001123455666666666642 221 11122222 2445555554321
Q ss_pred cccCccccccccccccccCCCccEEEeecccCCCCCCCcccccCCCccEEEecCC-ccCCcCcccccCCCCCcEEecCC-
Q 047591 296 TDFGANNLTGLIPSIIFNNSNIEVIQLYGNHLSGNLPSSTGINLPNLLRLYLWGN-NLSGVIPSSICNASKLTVLELSR- 373 (1624)
Q Consensus 296 ~~l~~n~l~g~ip~~~~~~~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N-~l~g~iP~~~~~l~~L~~L~Ls~- 373 (1624)
+.++..--..+..++++|++|+|++| .+++.....+.++++|++|+|++
T Consensus 160 -----------------------------~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 160 -----------------------------KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp -----------------------------GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred -----------------------------cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 01111000011124566777777664 46666666777777777777777
Q ss_pred ccccccCcccccccccccEEEcccc
Q 047591 374 NLFSGLVANTFGNCRQLQILNLAYS 398 (1624)
Q Consensus 374 N~l~g~~~~~f~~l~~L~~L~L~~N 398 (1624)
+.++......++++++|++|+++++
T Consensus 211 ~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 211 YDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCChHHHHHHhcCCCCCEEeeeCC
Confidence 4566555556677777777777654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.39 E-value=2.7e-13 Score=134.69 Aligned_cols=86 Identities=30% Similarity=0.394 Sum_probs=42.6
Q ss_pred ccCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCC-CCcccccCccc
Q 047591 159 NSLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEF-PPTIFNVSSLR 237 (1624)
Q Consensus 159 ~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~ 237 (1624)
..+++|++||+++|+|+ .+|+.++.+++|+.|++++|+++ .+| .++++++|++|++++|+++... ...+..+++|+
T Consensus 17 ~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~ 93 (124)
T d1dcea3 17 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 93 (124)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred ccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCC
Confidence 34445555555555554 34545555555555555555555 233 2555555555555555555221 12344455555
Q ss_pred hheecccccc
Q 047591 238 VIVLANNSLF 247 (1624)
Q Consensus 238 ~L~L~~N~l~ 247 (1624)
+|++++|.++
T Consensus 94 ~L~l~~N~i~ 103 (124)
T d1dcea3 94 LLNLQGNSLC 103 (124)
T ss_dssp EEECTTSGGG
T ss_pred EEECCCCcCC
Confidence 5555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=2.1e-13 Score=142.23 Aligned_cols=128 Identities=21% Similarity=0.234 Sum_probs=63.5
Q ss_pred ccCCCcccEEEecCCCccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCcccccCCccccCCCcc
Q 047591 109 VANLSFLVSLNISGNRFHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQITGQLPSSLGDCSKL 188 (1624)
Q Consensus 109 i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 188 (1624)
+.+...|++|||++|+|+ .||..+..+++|++|||++|+|+ .++ .|..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~--------------------------~l~-~~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--------------------------KLD-GFPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC--------------------------EEC-CCCCCSSC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC--------------------------ccC-CcccCcch
Confidence 344455555555555555 34444444555555555555554 222 24445555
Q ss_pred cccccccccccccccCcccccccccceeccCCcCCCCCC--CcccccCccchheeccccccCCCCc---cccccCCCCcE
Q 047591 189 KRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFP--PTIFNVSSLRVIVLANNSLFGSLPV---DLCRRLPSLQE 263 (1624)
Q Consensus 189 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~L~~N~l~g~ip~---~~~~~l~~L~~ 263 (1624)
++|+|++|+++...+..+..+++|++|+|++|+++. ++ ..+..+++|++|++++|.++ .+|. .++..+++|++
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~ 143 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 143 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred hhhhcccccccCCCccccccccccccceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCe
Confidence 555555555552222223445555555555555542 22 23445555555555555554 2332 23456777777
Q ss_pred eec
Q 047591 264 LNL 266 (1624)
Q Consensus 264 L~L 266 (1624)
||-
T Consensus 144 LD~ 146 (162)
T d1a9na_ 144 LDF 146 (162)
T ss_dssp ETT
T ss_pred eCC
Confidence 764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.35 E-value=4.8e-13 Score=132.78 Aligned_cols=102 Identities=24% Similarity=0.285 Sum_probs=63.9
Q ss_pred CEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchheeccc
Q 047591 165 ESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVIVLANN 244 (1624)
Q Consensus 165 ~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N 244 (1624)
+.|||++|+|+ .+| .++++++|++||+++|+++ .+|+.++.+++|+.|++++|+|++ +| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 35667777776 444 3777778888888888887 567777777778888888777773 33 3666666666666666
Q ss_pred cccCCCCc-cccccCCCCcEeeccccccc
Q 047591 245 SLFGSLPV-DLCRRLPSLQELNLRDCMTT 272 (1624)
Q Consensus 245 ~l~g~ip~-~~~~~l~~L~~L~Ls~N~l~ 272 (1624)
+++ .+|. ..+..+++|++|++++|.++
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 665 2221 22334444444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=3.3e-13 Score=140.78 Aligned_cols=126 Identities=20% Similarity=0.153 Sum_probs=81.8
Q ss_pred cCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchh
Q 047591 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVI 239 (1624)
Q Consensus 160 ~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 239 (1624)
+..+|++|||++|+|+ .+|..+..+++|++||||+|+++ .++ .|..+++|++|++++|+++...+..+..+++|++|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 4556666777777766 45666667888888888888887 554 47788888888888888874434444567777777
Q ss_pred eeccccccCCCCc-cccccCCCCcEeecccccccCcC---CccccccCcCCeee
Q 047591 240 VLANNSLFGSLPV-DLCRRLPSLQELNLRDCMTTGRI---PKDIGNCTLLNYLG 289 (1624)
Q Consensus 240 ~L~~N~l~g~ip~-~~~~~l~~L~~L~Ls~N~l~g~i---p~~~~~l~~L~~L~ 289 (1624)
+|++|+++ .++. ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 93 ~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eecccccc-ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 77777775 3432 33455666666666666654321 12355555666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.30 E-value=3.3e-14 Score=168.34 Aligned_cols=250 Identities=18% Similarity=0.165 Sum_probs=140.2
Q ss_pred CCccccCCCcccEEEecCCCcccc----CCcccCCCCCCcEEEccCCCCCCc---cch------hhhccCCCcCEEEccC
Q 047591 105 IPPHVANLSFLVSLNISGNRFHGT----LPNELWLMPRLRIIDLSSNRISGN---LFD------DMCNSLTELESFDVSS 171 (1624)
Q Consensus 105 ip~~i~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~---~~~------~~~~~l~~L~~L~Ls~ 171 (1624)
+...+.+.+.|+.|+|++|.+... +-..+...++|+.|+++++.+... .++ +.+...++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 445567778888888888877532 344566778888888887754321 111 1123456777777777
Q ss_pred Cccccc----CCccccCCCcccccccccccccccccCcc-------------cccccccceeccCCcCCCCCCCcccccC
Q 047591 172 NQITGQ----LPSSLGDCSKLKRLSVSFNELTGRIPQNI-------------GNLTELMELYLNGNNLQGEFPPTIFNVS 234 (1624)
Q Consensus 172 N~l~g~----iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~-------------~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 234 (1624)
|.++.. +...+..+++|++|++++|.++..-...+ .....|+.|++++|+++-.--..
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~----- 177 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE----- 177 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH-----
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccc-----
Confidence 777643 23344456777777777776642211111 12234455555555443110000
Q ss_pred ccchheeccccccCCCCccccccCCCCcEeecccccccC-----cCCccccccCcCCeeeccCCcccccCcccccccccc
Q 047591 235 SLRVIVLANNSLFGSLPVDLCRRLPSLQELNLRDCMTTG-----RIPKDIGNCTLLNYLGLRDNQLTDFGANNLTGLIPS 309 (1624)
Q Consensus 235 ~L~~L~L~~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~g-----~ip~~~~~l~~L~~L~Ls~N~l~~l~~n~l~g~ip~ 309 (1624)
+. ..+...+.|++|+|++|++.. .+...+..+++|+.|+|++|++.+.+. ..+..
T Consensus 178 ---------------l~-~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~----~~L~~ 237 (344)
T d2ca6a1 178 ---------------WA-KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS----SALAI 237 (344)
T ss_dssp ---------------HH-HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH----HHHHH
T ss_pred ---------------cc-chhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccc----ccccc
Confidence 00 011234456666666665542 133445666777777777766543211 11334
Q ss_pred ccccCCCccEEEeecccCCCCCCCccc-----ccCCCccEEEecCCccCCc----Cccccc-CCCCCcEEecCCcccccc
Q 047591 310 IIFNNSNIEVIQLYGNHLSGNLPSSTG-----INLPNLLRLYLWGNNLSGV----IPSSIC-NASKLTVLELSRNLFSGL 379 (1624)
Q Consensus 310 ~~~~~~~L~~L~Ls~N~l~g~ip~~~~-----~~l~~L~~L~Ls~N~l~g~----iP~~~~-~l~~L~~L~Ls~N~l~g~ 379 (1624)
.+..+.+|++|+|++|.+++.-...+. ...+.|++|++++|+++.. +...+. ++++|+.|+|++|+|...
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 455667777777777776532111110 1235688899999888643 333442 567899999999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.25 E-value=1e-13 Score=164.13 Aligned_cols=95 Identities=25% Similarity=0.273 Sum_probs=50.7
Q ss_pred cCCcccCCCCCCcEEEccCCCCCCccch---hhhccCCCcCEEEccCCcccc---cCC-------ccccCCCcccccccc
Q 047591 128 TLPNELWLMPRLRIIDLSSNRISGNLFD---DMCNSLTELESFDVSSNQITG---QLP-------SSLGDCSKLKRLSVS 194 (1624)
Q Consensus 128 ~iP~~~~~l~~L~~L~Ls~N~l~g~~~~---~~~~~l~~L~~L~Ls~N~l~g---~iP-------~~l~~l~~L~~L~Ls 194 (1624)
.+...+.....|+.|+|++|.++..-.. +.+...++|+.|+++++.+.. ..| ..+..+++|+.|||+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3455666778888888888887542222 223455777777777765431 111 223344555555555
Q ss_pred ccccccc----ccCcccccccccceeccCCcC
Q 047591 195 FNELTGR----IPQNIGNLTELMELYLNGNNL 222 (1624)
Q Consensus 195 ~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l 222 (1624)
+|.++.. +...+...++|++|++++|.+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred ccccccccccchhhhhcccccchheecccccc
Confidence 5555432 222233344555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.18 E-value=6.2e-13 Score=143.64 Aligned_cols=115 Identities=30% Similarity=0.352 Sum_probs=83.2
Q ss_pred CccchhccccccceecccccccccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCccccccCchhhcc
Q 047591 483 TIPTTVGKLQNLQGLDLSYNNIQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNRLNSTIPSTFWS 562 (1624)
Q Consensus 483 ~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~ 562 (1624)
.+|..+..+++|++|+|++|+|+ .++ .+.++++|+.|+|++|+++ .+|..+..+++|+.|++++|+++. + +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 35667777888888888888887 454 4777778888888888876 566666666778888888888764 2 34677
Q ss_pred ccccceeecccccccCCCC--cccccccccceeeccCCcCCCC
Q 047591 563 LEYILVVDFSLNLLSGCLP--QDIGNLKVLTGLYLSGNQLSCS 603 (1624)
Q Consensus 563 l~~L~~ldLs~N~l~g~iP--~~l~~l~~L~~L~Ls~N~l~g~ 603 (1624)
+++|+.||+++|+++. ++ ..+..+++|+.|+|++|++...
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccC
Confidence 7777777887777764 33 3577778888888888877643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.16 E-value=7.8e-13 Score=142.85 Aligned_cols=108 Identities=24% Similarity=0.308 Sum_probs=47.5
Q ss_pred cCCCcCEEEccCCcccccCCccccCCCcccccccccccccccccCcccccccccceeccCCcCCCCCCCcccccCccchh
Q 047591 160 SLTELESFDVSSNQITGQLPSSLGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGEFPPTIFNVSSLRVI 239 (1624)
Q Consensus 160 ~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 239 (1624)
.|++|++|+|++|+|+ .++ .|..+++|++|+|++|+++ .+|..+..+.+|++|++++|+++. + +.+.++++|++|
T Consensus 46 ~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L 120 (198)
T d1m9la_ 46 TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVL 120 (198)
T ss_dssp HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEE
T ss_pred cccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccccccc
Confidence 3444444444444444 232 2444444555555555444 344333334445555555555442 2 123444444444
Q ss_pred eeccccccCCCCc-cccccCCCCcEeecccccccC
Q 047591 240 VLANNSLFGSLPV-DLCRRLPSLQELNLRDCMTTG 273 (1624)
Q Consensus 240 ~L~~N~l~g~ip~-~~~~~l~~L~~L~Ls~N~l~g 273 (1624)
+|++|+++ .++. ..+..+++|++|+|++|.+..
T Consensus 121 ~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 121 YMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccchhc-cccccccccCCCccceeecCCCcccc
Confidence 44444443 2221 223444555555555554443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=1.4e-10 Score=119.66 Aligned_cols=80 Identities=23% Similarity=0.198 Sum_probs=31.8
Q ss_pred EeccCCccCCCccchhccccccceecccccc-cccCCCccccCCCCCceeecccccccCCCccccccccCCccccccCcc
Q 047591 473 LSLYQNQLASTIPTTVGKLQNLQGLDLSYNN-IQGSIPSELCQLESLNTLLLQGNALQNQIPTCLANLTSLRALNLSSNR 551 (1624)
Q Consensus 473 L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~-l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 551 (1624)
++.+++++. .+|..+..+++|++|++++|+ |+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 344444433 233334344444444443332 332222334444444444444444443333334444444444444444
Q ss_pred cc
Q 047591 552 LN 553 (1624)
Q Consensus 552 l~ 553 (1624)
|+
T Consensus 92 l~ 93 (156)
T d2ifga3 92 LE 93 (156)
T ss_dssp CS
T ss_pred Cc
Confidence 43
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=2.9e-10 Score=117.19 Aligned_cols=70 Identities=16% Similarity=0.174 Sum_probs=33.7
Q ss_pred CCccccCCCcccEEEecCCC-ccccCCcccCCCCCCcEEEccCCCCCCccchhhhccCCCcCEEEccCCccc
Q 047591 105 IPPHVANLSFLVSLNISGNR-FHGTLPNELWLMPRLRIIDLSSNRISGNLFDDMCNSLTELESFDVSSNQIT 175 (1624)
Q Consensus 105 ip~~i~~L~~L~~L~Ls~N~-l~g~iP~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~l~~L~~L~Ls~N~l~ 175 (1624)
+|..+..+++|++|++++|+ ++..-+..|..+++|+.|+|++|+|+ .++++.|..+++|++|+|++|+|+
T Consensus 23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEEECCSSCCS
T ss_pred CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-CcccccccccccccceeccCCCCc
Confidence 34555555666666665443 54333334455555555555555554 233444444444444444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=1.1e-07 Score=98.08 Aligned_cols=106 Identities=19% Similarity=0.074 Sum_probs=59.6
Q ss_pred ccCCCcccccccccccccccccCcccccccccceeccCCcCCCC--CCCcccccCccchheeccccccCCCCccccccCC
Q 047591 182 LGDCSKLKRLSVSFNELTGRIPQNIGNLTELMELYLNGNNLQGE--FPPTIFNVSSLRVIVLANNSLFGSLPVDLCRRLP 259 (1624)
Q Consensus 182 l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~ 259 (1624)
+..+..+..|+..+|..+ .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|.++ .++.-.+....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhcc
Confidence 344444555555555443 4444445667777777777777642 2344556677777777777775 44443333344
Q ss_pred CCcEeecccccccCcCCcc-------ccccCcCCeee
Q 047591 260 SLQELNLRDCMTTGRIPKD-------IGNCTLLNYLG 289 (1624)
Q Consensus 260 ~L~~L~Ls~N~l~g~ip~~-------~~~l~~L~~L~ 289 (1624)
+|+.|++++|.+....... +..+++|+.||
T Consensus 116 ~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 5666666666665543321 34455565554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=1.5e-07 Score=97.22 Aligned_cols=81 Identities=28% Similarity=0.285 Sum_probs=36.5
Q ss_pred ccccCCccccccCcccccc--CchhhccccccceeecccccccCCCCc-ccccccccceeeccCCcCCCCcccc------
Q 047591 537 ANLTSLRALNLSSNRLNST--IPSTFWSLEYILVVDFSLNLLSGCLPQ-DIGNLKVLTGLYLSGNQLSCSIPSS------ 607 (1624)
Q Consensus 537 ~~l~~L~~L~Ls~N~l~g~--iP~~~~~l~~L~~ldLs~N~l~g~iP~-~l~~l~~L~~L~Ls~N~l~g~iP~~------ 607 (1624)
.++++|++|+|++|+++.. ++..+..+++|+.|||++|.++. +++ .......|+.|+|++|++++.....
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 3344444444444444432 12233344444444444444442 221 2222335666666666666543322
Q ss_pred -ccCCccccccc
Q 047591 608 -IGGLKDLTYLA 618 (1624)
Q Consensus 608 -~~~l~~L~~L~ 618 (1624)
+..+++|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 34556666554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.08 E-value=5.8e-06 Score=91.94 Aligned_cols=150 Identities=19% Similarity=0.198 Sum_probs=102.6
Q ss_pred HHHHhhcCCCCCcceeecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeE
Q 047591 737 QELQRLTDGFSESNLIGAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFK 815 (1624)
Q Consensus 737 ~el~~~t~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 815 (1624)
.|+.+.-..|+..+..+.++-+.||+... +++.+.||+...........+.+|...++.+. |--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666666676554444444568998865 45667788886554444456788999888774 43467778888888899
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 047591 816 ALILEYMPQGSLEKWLYSHKYTLNIQQRLDIMIDVASALEYLHHGH---------------------------------- 861 (1624)
Q Consensus 816 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------- 861 (1624)
++|||++++..+.+..... ....+++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999998876543211 112334555556666665311
Q ss_pred ----------------------CCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 862 ----------------------PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 862 ----------------------~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
+..++|+|+.|.||++++++.+-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999887778999987653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.92 E-value=1.5e-05 Score=88.54 Aligned_cols=130 Identities=17% Similarity=0.159 Sum_probs=88.9
Q ss_pred ceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcC-CCceeEEEeeeccCCeeEEEEEecCCCCHHHHHHhcC
Q 047591 1348 FSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIR-HRNLAKIVSSCSNPGFKALILQYMPQGSLEKWLYSHN 1426 (1624)
Q Consensus 1348 ~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~-HpNIv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~ 1426 (1624)
-+.||+... +++.+++|+...........+.+|.+.++.+. |--+.+++.++.+++..++||+++++.++.+.....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 468999864 55667788876544444456778888888774 333567888888888999999999998775543211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------------------
Q 047591 1427 YLLNIEQRLDIMIDVACALEYLHQG------------------------------------------------------- 1451 (1624)
Q Consensus 1427 ~~l~~~~~~~i~~~ia~gl~yLH~~------------------------------------------------------- 1451 (1624)
..+.+++.++++.++.||+.
T Consensus 105 -----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 179 (263)
T d1j7la_ 105 -----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP 179 (263)
T ss_dssp -----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCC
T ss_pred -----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCC
Confidence 11222444455555555531
Q ss_pred -CCCceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1452 -YSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1452 -~~~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
....++|+|+.|.|||++++..+-|.||+.+..
T Consensus 180 ~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 180 EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012378999999999999887778999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.38 E-value=0.00012 Score=80.33 Aligned_cols=140 Identities=14% Similarity=0.152 Sum_probs=85.1
Q ss_pred eeecCCc-cceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCC--CceeeeeeeeccCCeEEEEEEecCCCCH
Q 047591 751 LIGAGSF-GSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRH--RNLVKIISSCSNHGFKALILEYMPQGSL 827 (1624)
Q Consensus 751 ~iG~G~~-G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL 827 (1624)
.+..|.. +.||+...+.|..+.+|....... ..+.+|...++.+.. --+.++++++.+++..++||||++|-++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555654 578999887788888898654322 346678888877642 3366778888888889999999988655
Q ss_pred HH--------------HHHh-cC-----CCC--CHHHHHHHH--------------------HHHHHHHHHHhcC----C
Q 047591 828 EK--------------WLYS-HK-----YTL--NIQQRLDIM--------------------IDVASALEYLHHG----H 861 (1624)
Q Consensus 828 ~~--------------~l~~-~~-----~~l--~~~~~~~i~--------------------~~ia~gL~yLH~~----~ 861 (1624)
.+ .+.. +. ... .+.....-. ......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 32 1110 00 000 000000000 0011122222221 2
Q ss_pred CCCeEeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 862 PTPVIHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 862 ~~~IiHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
+..++|+|+.|.||+++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 23479999999999999887788999986653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.36 E-value=0.00016 Score=79.49 Aligned_cols=139 Identities=13% Similarity=0.128 Sum_probs=85.6
Q ss_pred EeecCc-eEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCc--eeEEEeeeccCCeeEEEEEecCCCCHH
Q 047591 1343 LGTGIF-SSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRN--LAKIVSSCSNPGFKALILQYMPQGSLE 1419 (1624)
Q Consensus 1343 lG~G~~-G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpN--Iv~l~g~~~~~~~~~lV~ey~~~gsL~ 1419 (1624)
+..|.. +.||+....++..+++|....... ..+.+|++.++.+.... +.++++++.+++..++||||+++-++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 445554 579999887788889998654322 34667888887765433 457788888888899999999876442
Q ss_pred H--------------HH---Hhc---C--CCCCHHHHHHHHH--------------------HHHHHHHHhhhc----CC
Q 047591 1420 K--------------WL---YSH---N--YLLNIEQRLDIMI--------------------DVACALEYLHQG----YS 1453 (1624)
Q Consensus 1420 ~--------------~l---~~~---~--~~l~~~~~~~i~~--------------------~ia~gl~yLH~~----~~ 1453 (1624)
+ .+ |.. . ....+.....-.. .....+..+.+. ..
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 1 11 110 0 0011111111000 012223333321 12
Q ss_pred CceEEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1454 TSIIHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1454 ~~iiHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
..++|+|+.|.|||++++..+-|.||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3479999999999999887788999997653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.84 E-value=0.00015 Score=74.25 Aligned_cols=65 Identities=20% Similarity=0.215 Sum_probs=30.4
Q ss_pred CCCcccEEEecCC-Ccccc----CCcccCCCCCCcEEEccCCCCCCcc---chhhhccCCCcCEEEccCCccc
Q 047591 111 NLSFLVSLNISGN-RFHGT----LPNELWLMPRLRIIDLSSNRISGNL---FDDMCNSLTELESFDVSSNQIT 175 (1624)
Q Consensus 111 ~L~~L~~L~Ls~N-~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~~---~~~~~~~l~~L~~L~Ls~N~l~ 175 (1624)
+.+.|++|+|+++ .++.. +-..+...+.|++|+|++|.+...- ..+.+..-+.|++|+|++|.|+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3456666666653 34321 2223445555666666666654211 1112223344555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.72 E-value=0.0023 Score=74.67 Aligned_cols=75 Identities=17% Similarity=0.143 Sum_probs=49.6
Q ss_pred ceeecCCccceEEEEecC-CCEEEEEEeeccc-------chhHHHHHHHHHHHHhcC-C--CceeeeeeeeccCCeEEEE
Q 047591 750 NLIGAGSFGSVYKATLPY-GMNVAIKVFNLQL-------DGAIKSFDAECEVLRRVR-H--RNLVKIISSCSNHGFKALI 818 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~~-g~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV 818 (1624)
+.||.|....||+.+..+ ++.|.||.-.... .....+...|.++|+.+. + ..+.+++.+..+ ..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEEE
Confidence 468999999999998654 6788999754211 112345567888887763 2 456677766544 44789
Q ss_pred EEecCCCC
Q 047591 819 LEYMPQGS 826 (1624)
Q Consensus 819 ~Ey~~~gs 826 (1624)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.61 E-value=0.0003 Score=72.00 Aligned_cols=86 Identities=12% Similarity=0.159 Sum_probs=44.2
Q ss_pred CCcccEEeccCC-ccCCC----ccchhccccccceecccccccccC----CCccccCCCCCceeecccccccCC----Cc
Q 047591 467 LSNIIALSLYQN-QLAST----IPTTVGKLQNLQGLDLSYNNIQGS----IPSELCQLESLNTLLLQGNALQNQ----IP 533 (1624)
Q Consensus 467 l~~L~~L~L~~N-~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~g~----iP 533 (1624)
.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...+.|+.|+|++|.++.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 456777777653 34321 222344556677777777666521 122333445666666666666532 11
Q ss_pred cccccccCCccccccCccc
Q 047591 534 TCLANLTSLRALNLSSNRL 552 (1624)
Q Consensus 534 ~~~~~l~~L~~L~Ls~N~l 552 (1624)
..+...++|++|+|++|++
T Consensus 94 ~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHTTTTCCCSEEECCCCSS
T ss_pred HHHHhCCcCCEEECCCCcC
Confidence 2333445566666665544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.55 E-value=0.0025 Score=74.44 Aligned_cols=75 Identities=12% Similarity=0.126 Sum_probs=48.2
Q ss_pred CeEeecCceEEEEEEEcC-CceEEEEEeccc----h---hhHHHHHHHHHHHHHhcC-C--CceeEEEeeeccCCeeEEE
Q 047591 1341 NLLGTGIFSSVYKATFAD-GTNAAIKIFSLQ----E---DRALKSFDAECEVMRRIR-H--RNLAKIVSSCSNPGFKALI 1409 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~-~~~vAvK~~~~~----~---~~~~~~f~~E~~~l~~l~-H--pNIv~l~g~~~~~~~~~lV 1409 (1624)
+.||.|....||+.+..+ ++.++||.-... . .....+...|.++|+.+. + ..+.+++.+. ++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 458999999999998754 567888864321 1 112344567888887663 2 3455666553 4566899
Q ss_pred EEecCCCC
Q 047591 1410 LQYMPQGS 1417 (1624)
Q Consensus 1410 ~ey~~~gs 1417 (1624)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.11 E-value=0.0057 Score=69.29 Aligned_cols=133 Identities=11% Similarity=0.210 Sum_probs=78.4
Q ss_pred eEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCcee--EEEe-----eeccCCeeEEEEEecCCCCH---
Q 047591 1349 SSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLA--KIVS-----SCSNPGFKALILQYMPQGSL--- 1418 (1624)
Q Consensus 1349 G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv--~l~g-----~~~~~~~~~lV~ey~~~gsL--- 1418 (1624)
-.||+++.++|+.+++|+.+... ...+++..|.+.+..+....+. ..+. .....+..+.|++|++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 48999999999999999986432 2346677888888887533321 1111 22345677899999986421
Q ss_pred --H------HH---HHh----c----CCCCCHHH-------------------HHHHHHHHHHHHHHhh----hcCCCce
Q 047591 1419 --E------KW---LYS----H----NYLLNIEQ-------------------RLDIMIDVACALEYLH----QGYSTSI 1456 (1624)
Q Consensus 1419 --~------~~---l~~----~----~~~l~~~~-------------------~~~i~~~ia~gl~yLH----~~~~~~i 1456 (1624)
. +. +|. . ....++.. +-.+...+.+.++.+. +....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 11 111 0 11122211 1112222233333332 2345689
Q ss_pred EEcCCCCCcEEecCCCcEEEeeecceee
Q 047591 1457 IHCDLKPSNVLLDDDMVAHLGDFGIAKL 1484 (1624)
Q Consensus 1457 iHrDlK~~NILld~~~~~kl~DFGla~~ 1484 (1624)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999854 45889998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.72 E-value=0.0012 Score=67.11 Aligned_cols=111 Identities=18% Similarity=0.165 Sum_probs=54.4
Q ss_pred cCCCcccEEEecC-CCcccc----CCcccCCCCCCcEEEccCCCCCCccch---hhhccCCCcCEEEccCCccccc----
Q 047591 110 ANLSFLVSLNISG-NRFHGT----LPNELWLMPRLRIIDLSSNRISGNLFD---DMCNSLTELESFDVSSNQITGQ---- 177 (1624)
Q Consensus 110 ~~L~~L~~L~Ls~-N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~~~~---~~~~~l~~L~~L~Ls~N~l~g~---- 177 (1624)
.+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++..... +.+...++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4456677777776 345321 223344566777777777766532211 2233445666666666665432
Q ss_pred CCccccCCCcccc--cccccccccc----cccCcccccccccceeccCC
Q 047591 178 LPSSLGDCSKLKR--LSVSFNELTG----RIPQNIGNLTELMELYLNGN 220 (1624)
Q Consensus 178 iP~~l~~l~~L~~--L~Ls~N~l~g----~ip~~~~~l~~L~~L~Ls~N 220 (1624)
+-..+...++|+. |+++.|.+.. .+...+...++|+.|+++.+
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 2233444455553 3334444432 22233334444555554433
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.50 E-value=0.00076 Score=68.68 Aligned_cols=90 Identities=21% Similarity=0.257 Sum_probs=51.5
Q ss_pred cCCCCCCcEEEccC-CCCCCccchhh---hccCCCcCEEEccCCccccc----CCccccCCCccccccccccccccc---
Q 047591 133 LWLMPRLRIIDLSS-NRISGNLFDDM---CNSLTELESFDVSSNQITGQ----LPSSLGDCSKLKRLSVSFNELTGR--- 201 (1624)
Q Consensus 133 ~~~l~~L~~L~Ls~-N~l~g~~~~~~---~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~Ls~N~l~g~--- 201 (1624)
....++|++|+|++ |.++......+ +...+.|++|+|++|.++.. +-..+...++|+.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34567888888887 55653322222 23566788888888877642 223345566777777777776532
Q ss_pred -ccCcccccccccceec--cCCcC
Q 047591 202 -IPQNIGNLTELMELYL--NGNNL 222 (1624)
Q Consensus 202 -ip~~~~~l~~L~~L~L--s~N~l 222 (1624)
+-..+...++|+.++| ++|.+
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCC
T ss_pred HHHHHHHhCccccEEeeccCCCcC
Confidence 2234445555655333 34444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.39 E-value=0.013 Score=66.19 Aligned_cols=133 Identities=11% Similarity=0.150 Sum_probs=77.8
Q ss_pred cceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCce-----eeee--eeeccCCeEEEEEEecCCCCHH--
Q 047591 758 GSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRNL-----VKII--SSCSNHGFKALILEYMPQGSLE-- 828 (1624)
Q Consensus 758 G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~l~--~~~~~~~~~~lV~Ey~~~gsL~-- 828 (1624)
-.||+++.++|+.|++|+.+... ...+++..|...+..+....+ +..- ......+..+.|++|++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999986432 234567788888877743222 1111 1223456788999999864321
Q ss_pred ---HH---------HHh----c----CCCCC-------------------HHHHHHHHHHHHHHHHHHh----cCCCCCe
Q 047591 829 ---KW---------LYS----H----KYTLN-------------------IQQRLDIMIDVASALEYLH----HGHPTPV 865 (1624)
Q Consensus 829 ---~~---------l~~----~----~~~l~-------------------~~~~~~i~~~ia~gL~yLH----~~~~~~I 865 (1624)
++ ++. . ....+ ...+..+...+.+.++.+. ...+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 111 0 00111 1111122222333333332 2334568
Q ss_pred EeCcCCCCCeeeCCCCceEEEeeeeeec
Q 047591 866 IHCDLKPSNVLLDDDTVAHLSDFGISKL 893 (1624)
Q Consensus 866 iHrDlKp~NILld~~~~~kl~DFGla~~ 893 (1624)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999854 45899986653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.07 E-value=0.08 Score=58.99 Aligned_cols=156 Identities=16% Similarity=0.136 Sum_probs=85.4
Q ss_pred cCHHHHHHHhCCCCcCCeEe-----ecCceEEEEEEEcCCceEEEEEeccchhhHHHHHHHHHHHHHhcCCCcee--EEE
Q 047591 1325 ISYQELRLATNGFSESNLLG-----TGIFSSVYKATFADGTNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLA--KIV 1397 (1624)
Q Consensus 1325 ~~~~~l~~at~~f~~~~~lG-----~G~~G~Vyk~~~~~~~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv--~l~ 1397 (1624)
++-+|++.....|...++.. .|---+.|+.+..+| ..++|++....+ .+....|+++|..+.+.++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 56677887778887765543 455577899987665 488998854322 23444566777776543321 111
Q ss_pred ee------eccCCeeEEEEEecCCCCHH--------------HHHHhc--C-------CCC-CHH---------------
Q 047591 1398 SS------CSNPGFKALILQYMPQGSLE--------------KWLYSH--N-------YLL-NIE--------------- 1432 (1624)
Q Consensus 1398 g~------~~~~~~~~lV~ey~~~gsL~--------------~~l~~~--~-------~~l-~~~--------------- 1432 (1624)
.. ..-.+....++.++.+.... ..++.. . ... .|.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 11234566777777764221 111100 0 000 000
Q ss_pred -HHHHHHHHHHHHHHHhh-hcCCCceEEcCCCCCcEEecCCCcEEEeeeccee
Q 047591 1433 -QRLDIMIDVACALEYLH-QGYSTSIIHCDLKPSNVLLDDDMVAHLGDFGIAK 1483 (1624)
Q Consensus 1433 -~~~~i~~~ia~gl~yLH-~~~~~~iiHrDlK~~NILld~~~~~kl~DFGla~ 1483 (1624)
.....+..+...+.-.+ ...+.++||+|+.+.||+++++...-|.||+.|.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01112222222222222 2456799999999999999999888899999864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.23 E-value=0.1 Score=58.11 Aligned_cols=157 Identities=15% Similarity=0.148 Sum_probs=84.9
Q ss_pred ccCHHHHHhhcCCCCCccee-----ecCCccceEEEEecCCCEEEEEEeecccchhHHHHHHHHHHHHhcCCCc-----e
Q 047591 733 RISYQELQRLTDGFSESNLI-----GAGSFGSVYKATLPYGMNVAIKVFNLQLDGAIKSFDAECEVLRRVRHRN-----L 802 (1624)
Q Consensus 733 ~~~~~el~~~t~~f~~~~~i-----G~G~~G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-----i 802 (1624)
.++.+|++....+|...++. ..|---+.|+.+..+|+ +++|++..... .++...|++++..+.+.. .
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccc
Confidence 45678888888888765443 34555678998876665 78898864322 234455666776664322 2
Q ss_pred eeee-e--eeccCCeEEEEEEecCCCCHHH--------------HHHhc--CC-------C-----------------CC
Q 047591 803 VKII-S--SCSNHGFKALILEYMPQGSLEK--------------WLYSH--KY-------T-----------------LN 839 (1624)
Q Consensus 803 v~l~-~--~~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~--~~-------~-----------------l~ 839 (1624)
+... | +....+....++.++.+..... .++.. .. . ..
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 1 1122345667777777643211 01100 00 0 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCCeEeCcCCCCCeeeCCCCceEEEeeeeee
Q 047591 840 IQQRLDIMIDVASALEYLH-HGHPTPVIHCDLKPSNVLLDDDTVAHLSDFGISK 892 (1624)
Q Consensus 840 ~~~~~~i~~~ia~gL~yLH-~~~~~~IiHrDlKp~NILld~~~~~kl~DFGla~ 892 (1624)
.......+..+...+.-.+ ..-+.+|||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111112222222222222 2345679999999999999998888899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.11 E-value=0.03 Score=65.00 Aligned_cols=71 Identities=13% Similarity=0.291 Sum_probs=47.5
Q ss_pred CeEeecCceEEEEEEEcCC--------ceEEEEEeccchhhHHHHHHHHHHHHHhcCCCcee-EEEeeeccCCeeEEEEE
Q 047591 1341 NLLGTGIFSSVYKATFADG--------TNAAIKIFSLQEDRALKSFDAECEVMRRIRHRNLA-KIVSSCSNPGFKALILQ 1411 (1624)
Q Consensus 1341 ~~lG~G~~G~Vyk~~~~~~--------~~vAvK~~~~~~~~~~~~f~~E~~~l~~l~HpNIv-~l~g~~~~~~~~~lV~e 1411 (1624)
..|+.|-.-.+|++...++ ..|.+++.-. ... .-...+|..+++.+.-.+++ ++++++.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577888889999987543 3466666542 222 22345788888887533444 88888753 68999
Q ss_pred ecCCCC
Q 047591 1412 YMPQGS 1417 (1624)
Q Consensus 1412 y~~~gs 1417 (1624)
|+++-.
T Consensus 122 fi~g~~ 127 (395)
T d1nw1a_ 122 YIPSRP 127 (395)
T ss_dssp CCCEEE
T ss_pred Eecccc
Confidence 998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.25 E-value=0.089 Score=60.77 Aligned_cols=72 Identities=18% Similarity=0.221 Sum_probs=47.9
Q ss_pred ceeecCCccceEEEEecCC--------CEEEEEEeecccchhHHHHHHHHHHHHhcC-CCceeeeeeeeccCCeEEEEEE
Q 047591 750 NLIGAGSFGSVYKATLPYG--------MNVAIKVFNLQLDGAIKSFDAECEVLRRVR-HRNLVKIISSCSNHGFKALILE 820 (1624)
Q Consensus 750 ~~iG~G~~G~Vy~~~~~~g--------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 820 (1624)
+.|+.|--=.+|++..+++ ..|.+++.. ..... ....+|..+++.+. |.-..++++++.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5677788889999986533 456665554 32222 23457888888874 4444578888764 68999
Q ss_pred ecCCCCH
Q 047591 821 YMPQGSL 827 (1624)
Q Consensus 821 y~~~gsL 827 (1624)
|+++-.+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|